PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Janickova, H; Kljakic, O; Rosborough, K; Raulic, S; Matovic, S; Gros, R; Saksida, LM; Bussey, TJ; Inoue, W; Prado, VF; Prado, MAM				Janickova, Helena; Kljakic, Ornela; Rosborough, Kaie; Raulic, Sanda; Matovic, Sara; Gros, Robert; Saksida, Lisa M.; Bussey, Timothy J.; Inoue, Wataru; Prado, Vania F.; Prado, Marco A. M.			Selective decrease of cholinergic signaling from pedunculopontine and laterodorsal tegmental nuclei has little impact on cognition but markedly increases susceptibility to stress	FASEB JOURNAL			English	Article						attention; touchscreen; cognitive flexibility; Parkinson's disease; VAChT	VESICULAR ACETYLCHOLINE TRANSPORTER; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; TOUCHSCREEN OPERANT PLATFORM; RECEPTOR MESSENGER-RNA; MESOPONTINE TEGMENTUM; BRAIN-STEM; EXECUTIVE FUNCTION; DOPAMINE EFFLUX; NERVOUS-SYSTEM; WORKING-MEMORY	The pedunculopontine tegmental nucleus (PPT) and laterodorsal tegmental nucleus (LDT) are heterogeneous brainstem structures that contain cholinergic, glutamatergic, and GABAergic neurons. PPT/LDT neurons are suggested to modulate both cognitive and noncognitive functions, yet the extent to which acetylcholine (ACh) signaling from the PPT/LDT is necessary for normal behavior remains uncertain. We addressed this issue by using a mouse model in which PPT/LDT cholinergic signaling is highly decreased by selective deletion of the vesicular ACh transporter (VAChT) gene. This approach interferes exclusively with ACh signaling, leaving signaling by other neurotransmitters from PPT/LDT cholinergic neurons intact and sparing other cells. VAChT mutants were examined on different PPT/LDT-associated cognitive domains. Interestingly, VAChT mutants showed no attentional deficits and only minor cognitive flexibility impairments while presenting large deficiencies in both spatial and cued Morris water maze (MWM) tasks. Conversely, working spatial memory determined with the Y-maze and spatial memory measured with the Barnes maze were not affected, suggesting that deficits in MWM were unrelated to spatial memory abnormalities. Supporting this interpretation, VAChT mutants exhibited alterations in anxiety-like behavior and increased corticosterone levels after exposure to the MWM, suggesting altered stress response. Thus, PPT/LDT VAChT-mutant mice present little cognitive impairment per se, yet they exhibit increased susceptibility to stress, which may lead to performance deficits in more stressful conditions.-Janickova, H., Kljakic, O., Rosborough, K., Raulic, S., Matovic, S., Gros, R., Saksida, L. M., Bussey, T. J., Inoue, W., Prado, V. F., Prado, M. A. M. Selective decrease of cholinergic signaling from pedunculopontine and laterodorsal tegmental nuclei has little impact on cognition but markedly increases susceptibility to stress.	[Janickova, Helena; Kljakic, Ornela; Rosborough, Kaie; Raulic, Sanda; Matovic, Sara; Gros, Robert; Saksida, Lisa M.; Bussey, Timothy J.; Inoue, Wataru; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; [Kljakic, Ornela; Rosborough, Kaie; Inoue, Wataru; Prado, Vania F.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Matovic, Sara; Gros, Robert; Saksida, Lisa M.; Bussey, Timothy J.; Inoue, Wataru; Prado, Vania F.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada; [Saksida, Lisa M.; Inoue, Wataru; Prado, Vania F.] Univ Western Ontario, Schulich Sch Med & Dent, Brain & Mind Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Prado, VF; Prado, MAM (corresponding author), Univ Western Ontario, Robarts Res Inst, 1151 Richmond St N, London, ON N6A 5B7, Canada.	vprado@robarts.ca; mprado@robarts.ca	Prado, Vania Ferreira/K-7630-2013; Inoue, Wataru/M-2163-2015; Bussey, Timothy J/M-2758-2016; Gros, Robert/A-3010-2009; Janickova, Helena/Q-7211-2017; Saksida, Lisa M/M-2753-2016; Gros, Robert/AAV-2237-2020; Prado, Marco Antonio Maximo/K-7638-2013	Prado, Vania Ferreira/0000-0003-4994-6393; Inoue, Wataru/0000-0002-2438-5123; Bussey, Timothy J/0000-0001-7518-4041; Gros, Robert/0000-0002-3667-8011; Janickova, Helena/0000-0003-0310-7893; Saksida, Lisa M/0000-0002-8416-8171; Gros, Robert/0000-0002-3667-8011; Kljakic, Ornela/0000-0003-3668-9391; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Matovic, Sara/0000-0001-6782-8150	Canadian Institutes of Health Research [MOP 126000, MOP 136930, MOP 89919]; Alzheimer's Society of Canada; Brain Canada; Weston Brain Institute; National Science and Engineering Research Council of Canada [402524-2013 RGPIN]; ALS Canada; Jonathan and Joshua Memorial Foundation; Ontario Government; Schulich Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada; Brain Canada; Weston Brain Institute; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); ALS Canada; Jonathan and Joshua Memorial Foundation; Ontario Government; Schulich Foundation	The authors thank Briannee Dover and Zijian Jacky Lou (The University of Western Ontario) for experimental assistance. M.A.M.P. and V.F.P. received support from the Canadian Institutes of Health Research (MOP 126000, MOP 136930, MOP 89919), Alzheimer's Society of Canada, ALS Canada, Brain Canada, Weston Brain Institute, and National Science and Engineering Research Council of Canada (402524-2013 RGPIN). O.K. received support from the Ontario Government, Schulich Foundation, and Jonathan and Joshua Memorial Foundation. M.A.M.P., V.F.P., T.J.B., L.M.S., and W.I. also received support from BrainsCAN for mouse cognitive testing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Aitta-aho T, 2018, CURR BIOL, V28, P2557, DOI 10.1016/j.cub.2018.06.064; Al-Onaizi MA, 2017, CEREB CORTEX, V27, P1615, DOI 10.1093/cercor/bhv349; Alessandro S, 2010, J NEUROL SCI, V289, P44, DOI 10.1016/j.jns.2009.08.017; Bahari Z, 2018, BEHAV PHARMACOL, V29, P584, DOI 10.1097/FBP.0000000000000429; Bhatnagar S, 1997, BRAIN RES, V766, P244, DOI 10.1016/S0006-8993(97)00684-7; Blaha CD, 1996, J NEUROSCI, V16, P714; BOLAM JP, 1991, NEUROSCIENCE, V41, P483, DOI 10.1016/0306-4522(91)90343-M; Borges Sonia, 2013, Front Endocrinol (Lausanne), V4, P190, DOI 10.3389/fendo.2013.00190; BRUDZYNSKI SM, 1993, CAN J PHYSIOL PHARM, V71, P394, DOI 10.1139/y93-060; Chudasama Y, 2004, LEARN MEMORY, V11, P78, DOI 10.1101/lm.70904; Costa A, 2010, PARKINSONISM RELAT D, V16, P64, DOI 10.1016/j.parkreldis.2009.05.009; Cyr M, 2015, BEHAV BRAIN RES, V278, P107, DOI 10.1016/j.bbr.2014.09.021; Darcet F, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00136; Dautan D, 2016, NAT NEUROSCI, V19, P1025, DOI 10.1038/nn.4335; Dautan D, 2016, FRONT NEUROANAT, V10, DOI [10.3389/fnana.2010.00001, 10.3389/fnana.2016.00001]; Dautan D, 2014, J NEUROSCI, V34, P4509, DOI 10.1523/JNEUROSCI.5071-13.2014; de Castro BM, 2009, GENES BRAIN BEHAV, V8, P23, DOI 10.1111/j.1601-183X.2008.00439.x; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; De Jaeger X, 2013, BEHAV BRAIN RES, V238, P62, DOI 10.1016/j.bbr.2012.10.016; DELLU F, 1991, BRAIN RES, V544, P126, DOI 10.1016/0006-8993(91)90893-Z; Deurveilher S, 2001, EUR J NEUROSCI, V13, P1963, DOI 10.1046/j.0953-816x.2001.01562.x; Diederich K, 2005, PSYCHOPHARMACOLOGY, V179, P402, DOI 10.1007/s00213-004-2052-y; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Gangarossa G, 2016, NEUROBIOL DIS, V87, P69, DOI 10.1016/j.nbd.2015.12.010; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Gut NK, 2016, MOVEMENT DISORD, V31, P615, DOI 10.1002/mds.26556; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; HALLANGER AE, 1988, J COMP NEUROL, V274, P483, DOI 10.1002/cne.902740403; Han JS, 2002, EUR J NEUROSCI, V16, P1399, DOI 10.1046/j.1460-9568.2002.02191.x; HAWKINS J, 1978, NATURE, V274, P512, DOI 10.1038/274512a0; Helm KA, 2002, NEUROSCIENCE, V115, P765, DOI 10.1016/S0306-4522(02)00487-6; Herman JP, 2012, BRAZ J MED BIOL RES, V45, P292, DOI 10.1590/S0100-879X2012007500041; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Ikemoto S, 2015, BEHAV BRAIN RES, V290, P17, DOI 10.1016/j.bbr.2015.04.018; Inglis WL, 2001, BEHAV BRAIN RES, V123, P117, DOI 10.1016/S0166-4328(01)00181-4; Janickova H, 2017, J NEUROCHEM, V142, P857, DOI 10.1111/jnc.14105; Janickova H, 2017, J NEUROCHEM, V140, P787, DOI 10.1111/jnc.13910; JONES BE, 1987, J COMP NEUROL, V261, P15, DOI 10.1002/cne.902610103; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Keating GL, 2002, NEUROSCIENCE, V112, P687, DOI 10.1016/S0306-4522(02)00108-2; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kimmel RA, 2000, GENE DEV, V14, P1377; KITADA Y, 1981, EUR J PHARMACOL, V72, P145, DOI 10.1016/0014-2999(81)90269-7; Kljakic O, 2017, J NEUROCHEM, V142, P90, DOI 10.1111/jnc.14003; Klug JR, 2018, ELIFE, V7, DOI 10.7554/eLife.35657; Kolisnyk B, 2017, CEREB CORTEX, V27, P3553, DOI 10.1093/cercor/bhw177; Kolisnyk B, 2016, J NEUROSCI, V36, P6287, DOI 10.1523/JNEUROSCI.4614-15.2016; Kolisnyk B, 2015, BRIT J PHARMACOL, V172, P4919, DOI 10.1111/bph.13260; Kolisnyk B, 2013, J NEUROSCI, V33, P14908, DOI 10.1523/JNEUROSCI.1933-13.2013; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; Kozak R, 2005, EXP BRAIN RES, V162, P257, DOI 10.1007/s00221-004-2143-3; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; LAVOIE B, 1994, J COMP NEUROL, V344, P190, DOI 10.1002/cne.903440203; Leblond M, 2014, EUR J NEUROSCI, V39, P1664, DOI 10.1111/ejn.12529; Leri F, 1998, BRAIN RES, V807, P187, DOI 10.1016/S0006-8993(98)00762-8; Lima RD, 2010, J NEUROCHEM, V113, P943, DOI 10.1111/j.1471-4159.2010.06657.x; Llorente I, 1996, J CLIN ENDOCR METAB, V81, P2902, DOI 10.1210/jc.81.8.2902; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Mar AC, 2013, NAT PROTOC, V8, P1985, DOI 10.1038/nprot.2013.123; Martins-Silva C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017611; Martyn AC, 2012, P NATL ACAD SCI USA, V109, P17651, DOI 10.1073/pnas.1215381109; MATTA SG, 1993, ENDOCRINOLOGY, V133, P2935, DOI 10.1210/en.133.6.2935; Mena-Segovia J, 2008, BRAIN RES REV, V58, P265, DOI 10.1016/j.brainresrev.2008.02.003; Mena-Segovia J, 2017, NEURON, V94, P7, DOI 10.1016/j.neuron.2017.02.027; Nagy PM, 2012, NEUROSCIENCE, V218, P1, DOI 10.1016/j.neuroscience.2012.05.047; Nithianantharajah J, 2013, NAT NEUROSCI, V16, P16, DOI 10.1038/nn.3276; Nuria SM, 2005, BEHAV BRAIN RES, V160, P115, DOI 10.1016/j.bbr.2004.11.022; OHMORI N, 1995, ENDOCRINOLOGY, V136, P4858, DOI 10.1210/en.136.11.4858; Patriarchi T, 2018, SCIENCE, V360, P1420, DOI 10.1126/science.aat4422; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pepeu G, 2017, BRAIN RES, V1670, P173, DOI 10.1016/j.brainres.2017.06.023; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Podhorna J, 1999, BEHAV NEUROSCI, V113, P550; Podhorna J, 2000, PHARMACOL BIOCHEM BE, V65, P267, DOI 10.1016/S0091-3057(99)00200-2; Prado MAM, 2002, NEUROCHEM INT, V41, P291, DOI 10.1016/S0197-0186(02)00044-X; Prado VF, 2017, NEUROSCIENCE, V345, P130, DOI 10.1016/j.neuroscience.2016.09.013; Prado VF, 2013, BIOCHEM J, V450, P265, DOI 10.1042/BJ20121662; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; Rocha-Resende C, 2012, J MOL CELL CARDIOL, V53, P206, DOI 10.1016/j.yjmcc.2012.05.003; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; Rossato JI, 2006, AN ACAD BRAS CIENC, V78, P515, DOI 10.1590/S0001-37652006000300011; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Rostron CL, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-16; Roy A, 2016, FASEB J, V30, P688, DOI 10.1096/fj.15-277046; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039997; Sakae DY, 2015, MOL PSYCHIATR, V20, P1448, DOI 10.1038/mp.2015.104; Salas R, 2003, J NEUROSCI, V23, P6255; Saunders A, 2015, NATURE, V521, P85, DOI 10.1038/nature14179; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Soreq H, 2015, TRENDS NEUROSCI, V38, P448, DOI 10.1016/j.tins.2015.05.007; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sugita S, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0105-7; Sun FM, 2018, CELL, V174, P481, DOI 10.1016/j.cell.2018.06.042; TAGO H, 1987, BRAIN RES, V415, P49, DOI 10.1016/0006-8993(87)90268-X; Takakusaki K, 2016, J NEURAL TRANSM, V123, P695, DOI 10.1007/s00702-015-1475-4; Taylor CL, 2004, BEHAV BRAIN RES, V153, P431, DOI 10.1016/j.bbr.2003.12.019; Van der Kloot W, 2003, PROG NEUROBIOL, V71, P269, DOI 10.1016/j.pneurobio.2003.10.003; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walker SC, 2007, NEUROSCIENCE, V150, P273, DOI 10.1016/j.neuroscience.2007.09.018; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Zhao RJ, 2007, J PHARMACOL EXP THER, V320, P837, DOI 10.1124/jpet.106.112474	107	12	12	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7018	7036		10.1096/fj.201802108R	http://dx.doi.org/10.1096/fj.201802108R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30857416	Bronze			2022-12-28	WOS:000476114200029
J	Palle, A; Zorzo, C; Luskey, VE; McGreevy, KR; Fernandez, S; Trejo, JL				Palle, Anna; Zorzo, Candela; Luskey, Valerie E.; McGreevy, Kerry R.; Fernandez, Silvia; Luis Trejo, Jose			Social dominance differentially alters gene expression in the medial prefrontal cortex without affecting adult hippocampal neurogenesis or stress and anxiety-like behavior	FASEB JOURNAL			English	Article						dominance hierarchy; tube test; corticosterone; elevated plus maze; vomeronasal; olfactory receptors	HOUSE MICE; MUS-MUSCULUS; RANK; WILD; TESTOSTERONE; PERSONALITY; ENVIRONMENT; MECHANISMS; EXPERIENCE; RECEPTORS	Social hierarchies are crucial for a group's survival and can influence the way an individual behaves and relates to a given social context. The study of social rank has been classically based on ethological and observational paradigms, but it recently has taken advantage of the use of other approaches, such as the tube test that measures territorial dominance without the display of in situ aggression and is executable in group-living animals. However, little is known about how previous basal individual differences affect the development of dominance hierarchy measured in the tube test. We have analyzed in male mice body weight, locomotion, anxiety, and serum corticosterone both before and after the tube test, as well as adult hippocampal neurogenesis and transcriptome in the prefrontal cortex after the hierarchy had been established. We found differential gene expression between dominants and subordinates but no association between the other parameters and social status, neither pre- nor posttest. Our findings reveal that social rank in mice is stable along time and is not related to basal differences in stress, mood, or physical features. Lastly, real-time quantitative PCR analysis confirmed differential expression of vomeronasal and olfactory receptors in the cerebral cortex between dominant and subordinate individuals, suggesting that differential brain gene expression in the medial prefrontal cortex could potentially be used as a biomarker of social dominance.-Palle, A., Zorzo, C., Luskey, V. E., McGreevy, K. R., Fernandez, S., Trejo, J. L. Social dominance differentially alters gene expression in the medial prefrontal cortex without affecting adult hippocampal neurogenesis or stress and anxiety-like behavior.	[Palle, Anna; Zorzo, Candela; Luskey, Valerie E.; McGreevy, Kerry R.; Luis Trejo, Jose] CSIC, Cajal Inst, Dept Translat Neurosci, Ave Doctor Arce 37, Madrid 28002, Spain; [Fernandez, Silvia] CSIC, Cajal Inst, Mol & Cellular Biol Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Trejo, JL (corresponding author), CSIC, Cajal Inst, Dept Translat Neurosci, Ave Doctor Arce 37, Madrid 28002, Spain.	jltrejo@cajal.csic.es	Zorzo, Candela/AAA-3102-2022; Fernandez, Silvia/Z-4848-2019	Zorzo, Candela/0000-0002-4424-5697; Palle Lopez, Anna/0000-0003-0389-1366	Spanish Ministry of Economy and Competitiveness [BFU2013-48907-R, BFU2016-77162-R]; Formacion Personal Investigador (FPI) grant	Spanish Ministry of Economy and Competitiveness(Spanish Government); Formacion Personal Investigador (FPI) grant	The authors are grateful to Maria de Ceballos [Cajal Institute, Consejo Superior de Investigaciones Cientificas (CSIC)] for useful advice, Laude Garmendia (Animal House at the Cajal Institute) for unpayable help and advice, the Image Analysis Unit of the Cajal Institute, and to all members of the Centro Nacional de Biotecnologia (CNB) Genome Analysis Unit. This work was supported by project grants from the Spanish Ministry of Economy and Competitiveness (BFU2013-48907-R and BFU2016-77162-R to J.L.T.). A.P. was funded by a Formacion Personal Investigador (FPI) grant, and K.R.M. was funded by a contract associated with the project grants to J.L.T. mentioned above. The authors declare no conflicts of interest.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Alcock J., 1989, ANIMAL BEHAV EVOLUTI; ANDERSON PK, 1961, T NEW YORK ACAD SCI, V23, P447, DOI 10.1111/j.2164-0947.1961.tb01373.x; Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336; Bartolomucci A, 2005, NEUROSCI BIOBEHAV R, V29, P67, DOI 10.1016/j.neubiorev.2004.06.009; BLANCHARD DC, 1993, BEHAV BRAIN RES, V58, P113, DOI 10.1016/0166-4328(93)90096-9; Chambers LK, 2000, J MAMMAL, V81, P59, DOI 10.1644/1545-1542(2000)081&lt;0059:MASOOW&gt;2.0.CO;2; Clutton-Brock TH, 2002, SCIENCE, V297, P253, DOI 10.1126/science.1071412; Colas-Zelin D, 2012, BEHAV BRAIN RES, V232, P294, DOI 10.1016/j.bbr.2012.04.017; Drickamer LC, 2001, BEHAV PROCESS, V53, P113, DOI 10.1016/S0376-6357(00)00152-2; ELY DL, 1981, PHYSIOL BEHAV, V26, P655, DOI 10.1016/0031-9384(81)90140-2; ELY DL, 1978, HORM BEHAV, V10, P156, DOI 10.1016/0018-506X(78)90005-3; Ferrer I, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00163; FREY DF, 1972, BEHAVIOUR, V42, P8, DOI 10.1163/156853972X00103; Fuxjager MJ, 2010, P NATL ACAD SCI USA, V107, P12393, DOI 10.1073/pnas.1001394107; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Gaudel F, 2019, MOL NEUROBIOL, V56, P2057, DOI 10.1007/s12035-018-1196-4; Ginsburg Benson, 1942, PHYSIOL ZOOL, V15, P485; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Haller J, 1999, BRAIN RES BULL, V50, P33, DOI 10.1016/S0361-9230(99)00087-8; Hardy MP, 2002, BIOL REPROD, V67, P1750, DOI 10.1095/biolreprod.102.006312; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Hollis F, 2015, P NATL ACAD SCI USA, V112, P15486, DOI 10.1073/pnas.1512653112; Holmes MM, 2016, FRONT NEUROENDOCRIN, V41, P59, DOI 10.1016/j.yfrne.2016.02.001; KAPLAN JR, 1982, ARTERIOSCLEROSIS, V2, P359, DOI 10.1161/01.ATV.2.5.359; Kempermann G., 2011, ADULT NEUROGENESIS, V2; Kim B, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0051-6; Kohn JN, 2016, PSYCHONEUROENDOCRINO, V74, P179, DOI 10.1016/j.psyneuen.2016.09.005; Kozorovitskiy Y, 2004, J NEUROSCI, V24, P6755, DOI 10.1523/JNEUROSCI.0345-04.2004; Larrieu T, 2017, CURR BIOL, V27, P2202, DOI 10.1016/j.cub.2017.06.027; Lenkov K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144750; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Llorens-Martin M, 2015, EXP NEUROL, V263, P285, DOI 10.1016/j.expneurol.2014.10.021; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; LOUCH CD, 1967, GEN COMP ENDOCR, V8, P441, DOI 10.1016/S0016-6480(67)80006-6; MACHIDA T, 1981, HORM BEHAV, V15, P238, DOI 10.1016/0018-506X(81)90013-1; MASUR J, 1974, NATURE, V249, P284, DOI 10.1038/249284a0; Matthews GA, 2016, CELL, V164, P617, DOI 10.1016/j.cell.2015.12.040; Matzel LD, 2017, BEHAV PROCESS, V134, P12, DOI 10.1016/j.beproc.2016.07.011; Mehrabian A, 1996, INT J AGING HUM DEV, V42, P251, DOI 10.2190/1QCY-VETT-JJAY-3EY1; Michopoulos V, 2012, HORM BEHAV, V62, P389, DOI 10.1016/j.yhbeh.2012.07.014; Opendak M, 2016, FRONT NEUROENDOCRIN, V41, P71, DOI 10.1016/j.yfrne.2016.02.002; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Peragine DE, 2014, NEUROSCIENCE, V268, P10, DOI 10.1016/j.neuroscience.2014.02.044; Romero LM, 2008, AM J PHYSIOL-REG I, V294, pR614, DOI 10.1152/ajpregu.00752.2007; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Saaltink DJ, 2014, CELL MOL LIFE SCI, V71, P2499, DOI 10.1007/s00018-014-1568-5; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; SELMANOFF MK, 1977, HORM BEHAV, V8, P107, DOI 10.1016/0018-506X(77)90026-5; SINGLETON GR, 1983, AUST J ZOOL, V31, P155, DOI 10.1071/ZO9830155; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Uhrich J, 1940, ECOLOGY, V21, P100, DOI 10.2307/1930628; van der Kooij MA, 2018, NEUROPHARMACOLOGY, V138, P275, DOI 10.1016/j.neuropharm.2018.06.023; Williamson CM, 2017, PHYSIOL BEHAV, V171, P110, DOI 10.1016/j.physbeh.2016.12.038; Wofford SJ, 2017, BEHAVIOUR, V154, P287, DOI 10.1163/1568539X-00003422; Wolff J.O., 2007, RODENT SOC ECOLOGICA; Wu MV, 2014, NEUROPSYCHOPHARMACOL, V39, P1861, DOI 10.1038/npp.2014.33; Zhou TT, 2018, CURR OPIN NEUROBIOL, V49, P99, DOI 10.1016/j.conb.2018.01.006; Zhou TT, 2017, SCIENCE, V357, P162, DOI 10.1126/science.aak9726	63	17	17	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6995	7008		10.1096/fj.201801600R	http://dx.doi.org/10.1096/fj.201801600R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30857420	Bronze			2022-12-28	WOS:000476114200027
J	Xu, X; Zhu, XP; Bai, JY; Xia, P; Li, Y; Lu, Y; Li, XY; Gao, X				Xu, Xi; Zhu, Xiao-Peng; Bai, Jin-Yun; Xia, Pu; Li, Yu; Lu, Yan; Li, Xiao-Ying; Gao, Xin			Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3	FASEB JOURNAL			English	Article						BBR; mitochondrial beta-OX; LCAD	ACID OXIDATION; HEPATIC STEATOSIS; DISEASE; ACYLCARNITINES; ACETYLATION; CARNITINE; MECHANISM; MITOCHONDRIA; DYSFUNCTION; KINASE	Berberine (BBR) shows promising effects in the treatment of nonalcoholic fatty liver disease (NAFLD) by influencing various metabolic aspects. Inhibition of mitochondrial beta-oxidation (beta-OX) participates in the pathogenesis of NAFLD. Silent mating-type information regulation 2 homolog 3 (SIRT3) has been reported to regulate mitochondrial beta-OX by deacetylating its substrate, long-chain acyl-coenzyme A dehydrogenase (LCAD). This study aimed to explore whether BBR can promote mitochondrial beta-OX and the role of SIRT3 as well as the mechanisms underlying the effects of BBR on hepatic lipid metabolism in mice fed a high-fat diet (HFD). BBR can significantly improve systematic and hepatic lipid metabolism in HFD-fed mice. Metabolomics analysis revealed that beta-OX was inhibited in HFD-induced mice, as indicated by the reduced production of short and medium carbon chain acyl-carnitines, the activated form of free fatty acids, via beta-OX, which was reversed by BBR intervention. Exploration of the mechanism found that BBR intervention reversed the down-regulation of SIRT3 and decreased the LCAD hyperacetylation level in HFD-fed mice. SIRT3 knockout (KO) mice were used to identify the role of SIRT3 in the BBR's influence of beta-OX. The beneficial effects of BBR on systemic and hepatic metabolism were profoundly attenuated in KO mice. Moreover, the promotive effect of BBR on beta-OX in HFD-induced mice was partially abolished in KO mice. These results suggested that BBR alleviates HFD-induced inhibition of fatty acid beta-OX partly through SIRT3-mediated LCAD deacetylation, which may provide a novel mechanism and support BBR as a promising therapeutic for NAFLD.-Xu, X., Zhu, X.-P., Bai, J.-Y., Xia, P., Li, Y., Lu, Y., Li, X.-Y., Gao, X. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.	[Xu, Xi; Zhu, Xiao-Peng; Bai, Jin-Yun; Xia, Pu; Lu, Yan; Li, Xiao-Ying; Gao, Xin] Fudan Univ, Affiliated Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Xia, Pu; Lu, Yan; Li, Xiao-Ying; Gao, Xin] Fudan Inst Metab Dis, Shanghai, Peoples R China; [Li, Yu] Univ Chinese Acad Sci, Key Lab Nutr & Metab, Shanghai Inst Biol Sci, Inst Nutr Sci,Chinese Acad Sci, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Gao, X (corresponding author), Fudan Univ, Affiliated Zhongshan Hosp, Fudan Inst Metab Dis, Dept Endocrinol & Metab, 180 Feng Lin Rd, Shanghai 200032, Peoples R China.	zhongshan_endo@126.com	Xia, Pu/G-3090-2010	Xia, Pu/0000-0003-4705-8878; Li, Xiaoying/0000-0002-9383-5757; Gao, Xin/0000-0003-1864-7796	National Natural Science Foundation of China [81570718, 81770865]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank the Central Laboratory of Zhongshan Hospital and the Institute of Chronic Metabolic Diseases of Fudan University. This work was supported by the National Natural Science Foundation of China (Grants 81570718 and 81770865 to X.G.). The authors declare no conflicts of interest.	Aarsland A, 1996, J CLIN INVEST, V98, P2008, DOI 10.1172/JCI119005; Bollinger JG, 2013, J LIPID RES, V54, P3523, DOI 10.1194/jlr.D040782; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; FOLCH J, 1957, J BIOL CHEM, V226, P497; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Gomes AP, 2012, BBA-MOL BASIS DIS, V1822, P185, DOI 10.1016/j.bbadis.2011.10.008; Grattagliano I, 2012, CLIN BIOCHEM, V45, P610, DOI 10.1016/j.clinbiochem.2012.03.024; Guo L, 2016, MOL CELL BIOL, V36, P2553, DOI 10.1128/MCB.00227-16; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Ji H, 2007, METABOLISM, V56, P1124, DOI 10.1016/j.metabol.2007.04.006; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kwon YM, 2012, AM J GASTROENTEROL, V107, P1852, DOI 10.1038/ajg.2012.314; Leng SH, 2004, ACTA PHARMACOL SIN, V25, P496; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li Z, 2014, BIOL PHARM BULL, V37, P1766, DOI 10.1248/bpb.b14-00412; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Magiera S, 2015, J PHARMACEUT BIOMED, V109, P171, DOI 10.1016/j.jpba.2015.02.044; Minkler PE, 2008, CLIN CHEM, V54, P1451, DOI 10.1373/clinchem.2007.099226; Minkler PE, 2015, MOL GENET METAB, V116, P231, DOI 10.1016/j.ymgme.2015.10.002; Ni Y X, 1988, Zhong Xi Yi Jie He Za Zhi, V8, P711; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Papazyan R, 2016, CELL METAB, V24, P863, DOI 10.1016/j.cmet.2016.10.012; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Sun YX, 2018, BRIT J PHARMACOL, V175, P374, DOI 10.1111/bph.14079; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Tseng AHH, 2014, BIOCHEM J, V464, P157, DOI 10.1042/BJ20140213; Wang CH, 2010, ANN NY ACAD SCI, V1201, P157, DOI 10.1111/j.1749-6632.2010.05625.x; Wang M, 2013, ANAL CHEM, V85, P9312, DOI 10.1021/ac402078p; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; Wu T, 2014, ANN CLIN LAB SCI, V44, P410; Yan HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134172; Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/C5FO00247H, 10.1039/c5fo00247h]; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhang YH, 2015, INT J CLIN EXP MED, V8, P7535; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493	50	28	29	2	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7289	7300		10.1096/fj.201802316R	http://dx.doi.org/10.1096/fj.201802316R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30848932	Bronze			2022-12-28	WOS:000476114200051
J	Kang, LJ; Yu, ZH; Cai, J; He, R; Lu, JT; Hou, C; Wang, QS; Li, XQ; Zhang, R; Feng, YM				Kang, Li-Juan; Yu, Zi-Han; Cai, Jun; He, Rui; Lu, Jun-Tao; Hou, Chen; Wang, Qing-Shan; Li, Xiao-Qing; Zhang, Rui; Feng, Yu-Mei			Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness	FASEB JOURNAL			English	Article						NCoR1; HDAC3; EMT; chemoresistance	EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; EXPRESSION; TRANSCRIPTION; PHENOTYPE; SIGNATURE	FOXF2 and FOXQ1, forkhead box transcription factor superfamily members, are encoded by neighboring genes located on human chromosome 6p25.3 and play opposite roles in epithelial-mesenchymal transition (EMT) and metastasis in basal-like breast cancer (BLBC). However, the relationship between FOXF2 and FOXQ1 in cancer remains unknown. Here, we found mutual transcriptional repression between FOXF2 and FOXQ1, and the reciprocal negative feedback loop controlled EMT, aggressiveness, and chemoresistance in BLBC cells. We further demonstrated that FOXF2 recruited nuclear receptor corepressor 1 and histone deacetylase 3 to the FOXQ1 promoter to inhibit its transcription in BLBC cells, but FOXQ1 did not exert such an effect on FOXF2. Our findings reveal novel mechanisms underlying the determination of BLBC aggressiveness and the transrepressive function of FOXF2 in a basal-like cell subtype-specific manner. Therefore, blocking the vicious cycle of the abnormal reciprocal feedback loop between FOXF2 and FOXQ1 to induce cell differentiation and restore tissue homeostasis is a promising strategy for the treatment of aggressive BLBC.Kang, L.-J., Yu, Z.-H., Cai, J., He, R., Lu, J.-T., Hou, C., Wang, Q.-S., Li, X.-Q., Zhang, R., Feng, Y.-M. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.	[Kang, Li-Juan; Yu, Zi-Han; Cai, Jun; He, Rui; Lu, Jun-Tao; Hou, Chen; Wang, Qing-Shan; Li, Xiao-Qing; Zhang, Rui; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Minist Educ,Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Wang, Qing-Shan; Li, Xiao-Qing; Zhang, Rui; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Breast Canc Prevent & Treatment,Minist Ed, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Feng, YM (corresponding author), Tianjin Med Univ, Dept Biochem & Mol Biol, Canc Inst & Hosp, Huan Hu Xi Rd, Tianjin 300060, Peoples R China.	ymfeng@tmu.edu.cn			National Natural Science Foundation of China [81272357, 81472680, 81672894, 81872403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81272357, 81472680, 81672894, and 81872403). The authors declare no conflicts of interest.	Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Cai J, 2015, CANCER LETT, V367, P129, DOI 10.1016/j.canlet.2015.07.001; Christensen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060051; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hupe M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2476; Junankar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7548; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Katoh M, 2004, INT J ONCOL, V25, P1495; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kong PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061591; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nik AM, 2013, GASTROENTEROLOGY, V144, P1001, DOI 10.1053/j.gastro.2013.01.045; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Peng XD, 2015, CANCER BIOL THER, V16, P1099, DOI 10.1080/15384047.2015.1047568; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Sun BC, 2017, ONCOTARGET, V8, P30502, DOI 10.18632/oncotarget.8461; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tian HP, 2015, J BIOL CHEM, V290, P19173, DOI 10.1074/jbc.M114.636126; Wang QS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0531-1; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Yu Y, 2014, BRIT J CANCER, V110, P724, DOI 10.1038/bjc.2013.768; Yu ZH, 2017, CANCER LETT, V402, P142, DOI 10.1016/j.canlet.2017.05.020; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825	34	13	13	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6564	6573		10.1096/fj.201801916R	http://dx.doi.org/10.1096/fj.201801916R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807702	Bronze			2022-12-28	WOS:000466932600059
J	Shih, JC; Lin, HH; Hsiao, AC; Su, YT; Tsai, S; Chien, CL; Kung, HN				Shih, Jin-Chung; Lin, Hua-Heng; Hsiao, An-Che; Su, Yi-Ting; Tsai, Shawn; Chien, Chung-Liang; Kung, Hsiu-Ni			Unveiling the role of microRNA-7 in linking TGF--Smad-mediated epithelial-mesenchymal transition with negative regulation of trophoblast invasion	FASEB JOURNAL			English	Article						Smad2; microarray; canonical pathway; preeclampsia; placenta accreta	GROWTH-FACTOR-BETA; CELL INVASION; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; PLACENTA-ACCRETA; UP-REGULATION; E-CADHERIN; ACTIVIN-A; CANCER; SNAIL	Several pregnancy complications result from abnormal trophoblast invasion. The dichotomous effect of TGF- on epithelial-mesenchymal transition (EMT) between trophoblast invasion and cancer progression remains unknown and a critical concern. We attenuated the expression of TGF- type 1 receptor (coding by TGFBR1) with RNA interference in trophoblastic cells and significantly enhanced the trophoblastic invasion. Analysis of microRNA profiles in trophoblasts indicated microRNA-7 as a key molecule linking TGF- with the negative regulation of trophoblast invasion. We then attenuated TGFBR1 and miR-7 transcription by transducing either short hairpin RNA targeting TGFBR1 or anti-miR-7-locked nucleonic acid, and we observed an up-regulation of EMT-related transcription factors (TFs) and their downstream effectors, causing a mesenchymal transition of trophoblasts. Conversely, overexpression of TGFBR1 or miR-7 led to the epithelial transition of trophoblasts. Our results showed that TGF--induced miR-7 expression negatively modulated the TGF--SMAD family member 2-mediated EMT pathway via targeting EMT-related TFs and down-regulating their mesenchymal markers. These findings possibly explain, at least in part, why TGF- exerts an opposite effect on EMT during trophoblast invasion and cancer progression.Shih, J.-C., Lin, H.-H., Hsiao, A.-C., Su, Y.-T., Tsai, S., Chien, C.-L., Kung, H.-N. Unveiling the role of microRNA-7 in linking TGF--Smad-mediated epithelial-mesenchymal transition with negative regulation of trophoblast invasion.	[Shih, Jin-Chung; Hsiao, An-Che; Su, Yi-Ting; Tsai, Shawn; Chien, Chung-Liang; Kung, Hsiu-Ni] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, 1,Sec 1,Jen Ai Rd, Taipei 10051, Taiwan; [Lin, Hua-Heng] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei, Taiwan; [Shih, Jin-Chung] Natl Taiwan Univ Hosp, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Kung, HN (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, 1,Sec 1,Jen Ai Rd, Taipei 10051, Taiwan.	kunghsiuni@gmail.com	SHIH, JIN-CHUNG/AAQ-8651-2021	SHIH, JIN-CHUNG/0000-0002-0296-4327; CHIEN, CHUNG-LIANG/0000-0001-9806-486X; KUNG, HSIU-NI/0000-0001-6979-8346	Ministry of Science and Technology [102-2314-B-002-152, 103-2314-B-002-160, 104-2320-B-002-062, 106-2314-B-002-201]; National Taiwan University Hospital [105-003054, 106-S3468]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University Hospital(National Taiwan University)	The authors deeply grieve the death of H.-H.L. (the second author of this research), who passed away from a heart attack while working on this project. This work was supported by funds from the Ministry of Science and Technology (102-2314-B-002-152, 103-2314-B-002-160, 104-2320-B-002-062, 106-2314-B-002-201) and research fund from the National Taiwan University Hospital (NTUH; 105-003054 and 106-S3468). The authors declare no conflicts of interest.	Abou-Kheir W, 2017, PLACENTA, V50, P1, DOI 10.1016/j.placenta.2016.12.007; Arimoto-Ishida E, 2009, ENDOCRINOLOGY, V150, P4306, DOI 10.1210/en.2008-1662; Bainbridge SA, 2005, FREE RADICAL BIO MED, V38, P979, DOI 10.1016/j.freeradbiomed.2004.11.002; Bi YL, 2017, INT J MOL MED, V39, P900, DOI 10.3892/ijmm.2017.2894; Blechschmidt K, 2007, VIRCHOWS ARCH, V450, P195, DOI 10.1007/s00428-006-0343-x; Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Cao MX, 2017, ONCOTARGET, V8, P12472, DOI 10.18632/oncotarget.13957; Chen C, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1278436; Chen CP, 2018, FREE RADICAL BIO MED, V124, P189, DOI 10.1016/j.freeradbiomed.2018.06.006; Chen Y, 2018, J CELL PHYSIOL, V233, P2257, DOI 10.1002/jcp.26098; Cheng JC, 2013, J BIOL CHEM, V288, P33181, DOI 10.1074/jbc.M113.488866; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042436; CHOU JY, 1978, P NATL ACAD SCI USA, V75, P1409, DOI 10.1073/pnas.75.3.1409; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Colucci F, 2011, PLACENTA, V32, P539, DOI 10.1016/j.placenta.2011.05.001; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Davies JE, 2016, CELL ADHES MIGR, V10, P310, DOI 10.1080/19336918.2016.1170258; Ding XM, 2013, J BIOL CHEM, V288, P10241, DOI 10.1074/jbc.M112.443655; Fu GD, 2013, INT J MOL SCI, V14, P5519, DOI 10.3390/ijms14035519; Fu GD, 2013, HYPERTENSION, V61, P864, DOI 10.1161/HYPERTENSIONAHA.111.203489; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Graham CH, 1997, PLACENTA, V18, P137, DOI 10.1016/S0143-4004(97)90085-0; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Hata A, 2009, CYTOKINE GROWTH F R, V20, P517, DOI 10.1016/j.cytogfr.2009.10.004; Huang JP, 2015, PLACENTA, V36, P1433, DOI 10.1016/j.placenta.2015.10.007; Huang ZY, 2017, ONCOTARGET, V8, P33560, DOI 10.18632/oncotarget.16826; IRVING JA, 1995, EXP CELL RES, V217, P419, DOI 10.1006/excr.1995.1105; Kataoka K, 2001, CANCER LETT, V163, P213, DOI 10.1016/S0304-3835(00)00685-6; Khong TY, 2008, J CLIN PATHOL, V61, P1243, DOI 10.1136/jcp.2008.055202; Khoo NKS, 1998, INT J CANCER, V77, P429, DOI 10.1002/(SICI)1097-0215(19980729)77:3<429::AID-IJC20>3.0.CO;2-1; Kim Sunghwan, 2013, J Lifestyle Med, V3, P80; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li Y, 2015, J CLIN ENDOCR METAB, V100, pE1415, DOI 10.1210/jc.2015-2134; Li Y, 2014, J CLIN ENDOCR METAB, V99, pE2216, DOI 10.1210/jc.2014-2118; Li YZ, 2016, ONCOL REP, V36, P1569, DOI 10.3892/or.2016.4912; Lindsey S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00358; Liu TM, 2015, MOL MED REP, V12, P7403, DOI 10.3892/mmr.2015.4374; Lv ZD, 2013, ONCOL REP, V29, P219, DOI 10.3892/or.2012.2111; Ma L, 2016, ADV CANCER RES, V132, P165, DOI 10.1016/bs.acr.2016.07.004; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng B, 2015, J CLIN ENDOCR METAB, V100, pE19, DOI 10.1210/jc.2014-1897; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Quan JJ, 2013, CLIN EXP METASTAS, V30, P659, DOI 10.1007/s10585-013-9570-0; Rama S, 2003, MOL CELL ENDOCRINOL, V206, P123, DOI 10.1016/S0303-7207(03)00202-8; Reiter JL, 2017, PLACENTA, V52, P17, DOI 10.1016/j.placenta.2017.02.010; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sivadas VP, 2014, TUMOR BIOL, V35, P2857, DOI 10.1007/s13277-013-1481-9; Suzuki HI, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071901; Tang JL, 2016, CANCER LETT, V371, P301, DOI 10.1016/j.canlet.2015.11.043; Tantbirojn P, 2008, PLACENTA, V29, P639, DOI 10.1016/j.placenta.2008.04.008; Wang H, 2012, ONCOL LETT, V3, P229, DOI 10.3892/ol.2011.448; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang Q, 2009, J HISTOCHEM CYTOCHEM, V57, P605, DOI 10.1369/jhc.2009.953166; Zeng CY, 2016, MOL MED REP, V13, P1297, DOI 10.3892/mmr.2015.4643; Zhang FF, 2016, CANCER LETT, V373, P203, DOI 10.1016/j.canlet.2016.01.037; Zhang HY, 2014, STEM CELLS, V32, P2858, DOI 10.1002/stem.1795; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao MR, 2006, REPRODUCTION, V132, P333, DOI 10.1530/rep.1.01112; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zhou XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19910	67	20	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6281	6295		10.1096/fj.201801898RR	http://dx.doi.org/10.1096/fj.201801898RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30789794	Bronze			2022-12-28	WOS:000466932600038
J	Ajith, A; Portik-Dobos, V; Nguyen-Lefebvre, AT; Callaway, C; Horuzsko, DD; Kapoor, R; Zayas, C; Maenaka, K; Mulloy, LL; Horuzsko, A				Ajith, Ashwin; Portik-Dobos, Vera; Anh Thu Nguyen-Lefebvre; Callaway, Christine; Horuzsko, Daniel D.; Kapoor, Rajan; Zayas, Carlos; Maenaka, Katsumi; Mulloy, Laura L.; Horuzsko, Anatolij			HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival	FASEB JOURNAL			English	Article						HLA-G; human kidney transplantation; humanized mouse	CLASS-I MOLECULES; CD8(+) T-CELLS; GENE-EXPRESSION; LILR FAMILY; PERFORIN; RECEPTOR; MECHANISMS; TRANSPLANTATION; INDUCE; IMPACT	Human leukocyte antigen G (HLA-G), a nonclassic HLA class Ib molecule involved in the maintenance of maternal tolerance to semiallogeneic fetal tissues during pregnancy, has emerged as a potential therapeutic target to control allograft rejection. We demonstrate here that the level of soluble HLA-G dimer was higher in a group of 90 patients with a functioning renal allograft compared with 40 patients who rejected (RJ) their transplants. The HLA-G dimer level was not affected by demographic status. One of the potential mechanisms in tissue-organ allograft rejection involves the induction of granzymes and perforin, which are the main effector molecules expressed by CD8(+) cytotoxic T lymphocytes and function to destroy allogeneic transplants. Using genomics and molecular and cellular analyses of cells from T-cell-mediated RJ and nonrejected kidney transplant patients, cells from leukocyte Ig-like receptor B1 (LILRB1) transgenic mice, humanized mice, and genetically engineered HLA-G dimer, we demonstrated a novel mechanism by which HLA-G dimer inhibits activation and cytotoxic capabilities of human CD8(+) T cells. This mechanism implicated the down-regulation of Granzyme B expression and the essential involvement of LILRB1. Thus, HLA-G dimer has the potential to be a specific and effective therapy for prevention of allograft rejection and prolongation of graft survival.	[Ajith, Ashwin; Portik-Dobos, Vera; Anh Thu Nguyen-Lefebvre; Horuzsko, Daniel D.; Horuzsko, Anatolij] Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN-3154, Augusta, GA 30912 USA; [Callaway, Christine; Kapoor, Rajan; Zayas, Carlos; Mulloy, Laura L.] Augusta Univ, Med Coll Georgia, Div Nephrol, Dept Med, Augusta, GA USA; [Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Hokkaido University	Horuzsko, A (corresponding author), Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN-3154, Augusta, GA 30912 USA.	ahoruzsko@augusta.edu			Department of Medicine; Georgia Cancer Center at the Augusta University community; Carlos and Marguerite Mason Trust; U.S. National Institutes of Health, National Cancer Institute [CA 172230]; NATIONAL CANCER INSTITUTE [R01CA172230] Funding Source: NIH RePORTER	Department of Medicine; Georgia Cancer Center at the Augusta University community; Carlos and Marguerite Mason Trust; U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. R. B. Markowitz (Georgia Cancer Center, Augusta University) for critically reading the manuscript. The authors thank Peggy Best, Walidah Walker, Joan Holloway, and physicians at the Medical College of Georgia for support of collection materials from kidney transplant recipients. The authors thank Eiko Kitamura (Georgia Cancer Center Integrated Genomics Shared Resource) for technical support. The authors are grateful to the Department of Medicine and the Georgia Cancer Center at the Augusta University community for fruitful discussion and support. These research results were supported by the Carlos and Marguerite Mason Trust, and by U.S. National Institutes of Health, National Cancer Institute Grant CA 172230 (to A.H.). The authors declare no conflicts of interest.	Altimari A, 2008, TRANSPLANTATION, V85, P1778, DOI 10.1097/TP.0b013e318177dfe4; Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Brugiere O, 2009, AM J TRANSPLANT, V9, P1427, DOI 10.1111/j.1600-6143.2009.02650.x; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; Carosella ED, 2007, SEMIN CANCER BIOL, V17, P411, DOI 10.1016/j.semcancer.2007.06.014; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Chapman JR, 2017, AM J KIDNEY DIS, V69, P287, DOI 10.1053/j.ajkd.2016.08.024; Choy JC, 2010, CELL DEATH DIFFER, V17, P567, DOI 10.1038/cdd.2009.161; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Desgrandchamps Francois, 2018, Oncotarget, V9, P33160, DOI 10.18632/oncotarget.26036; Esensten JH, 2017, ANNU REV PATHOL-MECH, V12, P305, DOI 10.1146/annurev-pathol-052016-100304; Ezeakile M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/153981; Favier B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021011; Gonen-Gross T, 2005, J IMMUNOL, V175, P4866, DOI 10.4049/jimmunol.175.8.4866; Gonen-Gross T, 2003, J IMMUNOL, V171, P1343, DOI 10.4049/jimmunol.171.3.1343; Halloran P. F, 2010, AM J TRANSPLANT, V10, P1496; Halloran Philip F, 2010, Am J Transplant, V10, P1111, DOI 10.1111/j.1600-6143.2010.03121.x; Hiebert PR, 2012, TRENDS MOL MED, V18, P732, DOI 10.1016/j.molmed.2012.09.009; Janas ML, 2005, J IMMUNOL, V175, P8003, DOI 10.4049/jimmunol.175.12.8003; Kelso A, 2002, INT IMMUNOL, V14, P605, DOI 10.1093/intimm/dxf028; KUMMER JA, 1995, CLIN EXP IMMUNOL, V100, P164; Kuroki K, 2013, HUM IMMUNOL, V74, P433, DOI 10.1016/j.humimm.2012.11.060; Leblanc J., 2018, CAN J KIDNEY HLTH DI, V5; LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101; LeMaoult J, 2013, FASEB J, V27, P3643, DOI 10.1096/fj.13-228247; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Liang SY, 2006, EUR J IMMUNOL, V36, P2457, DOI 10.1002/eji.200636031; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; LIU CC, 1989, J EXP MED, V170, P2105, DOI 10.1084/jem.170.6.2105; Lopez-Alvarez MR, 2014, IMMUNOGENETICS, V66, P73, DOI 10.1007/s00251-013-0742-5; Matas AJ, 2015, AM J TRANSPLANT, V15, DOI 10.1111/ajt.13195; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Qiu J, 2006, AM J TRANSPLANT, V6, P2152, DOI 10.1111/j.1600-6143.2006.01417.x; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Riella LV, 2017, TRANSPLANT REV-ORLAN, V31, P1, DOI 10.1016/j.trre.2016.10.005; Ristich V, 2007, HUM IMMUNOL, V68, P264, DOI 10.1016/j.humimm.2006.11.008; Rouas-Freiss N, 2007, TRANSPLANTATION, V84, pS21, DOI 10.1097/01.tp.0000269117.32179.1c; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Sanchez-Fueyo A, 2011, GASTROENTEROLOGY, V140, P51, DOI 10.1053/j.gastro.2010.10.059; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wagner C, 2004, BLOOD, V103, P1099, DOI 10.1182/blood-2003-04-1069; Wensink AC, 2015, J IMMUNOL, V194, P491, DOI 10.4049/jimmunol.1401214; Wensink AC, 2014, P NATL ACAD SCI USA, V111, P5974, DOI 10.1073/pnas.1317347111; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Yu CR, 1999, J IMMUNOL, V162, P2785; Zhang J, 1999, J EXP MED, V190, P1297, DOI 10.1084/jem.190.9.1297; Zhang WJ, 2008, IEEE INT SYM BROADB, P1	53	12	12	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5220	5236		10.1096/fj.201802017R	http://dx.doi.org/10.1096/fj.201802017R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30620626	Green Published, Bronze			2022-12-28	WOS:000462888500048
J	Jeffries, EP; Di Filippo, M; Galbiati, F				Jeffries, Elizabeth P.; Di Filippo, Michela; Galbiati, Ferruccio			Failure to reabsorb the primary cilium induces cellular senescence	FASEB JOURNAL			English	Article						caveolae; caveolin-1; aurora kinase A; alisertib; mitotic spindle	PREMATURE SENESCENCE; BREAST-CANCER; AURORA KINASE; CAVEOLIN-1; FIBROBLASTS; INHIBITION; GROWTH; CYCLE; TUMORIGENESIS; ACTIVATION	Aurora kinase A (AURKA) is necessary for proper primary cilium disassembly before mitosis. We found that depletion of caveolin-1 expression promotes primary cilia formation through the proteasomal-dependent degradation of aurora kinase A and induces premature senescence in human fibroblasts. Down-regulation of intraflagellar transport-88, a protein essential for ciliogenesis, inhibits premature senescence induced by the depletion of caveolin-1. In support of these findings, we showed that alisertib, a pharmacological inhibitor of AURKA, causes primary cilia formation and cellular senescence by irreversibly arresting cell growth. Suppression of primary cilia formation limits cellular senescence induced by alisertib. The primary cilium must be disassembled to free its centriole to form the centrosome, a necessary structure for mitotic spindle assembly and cell division. We showed that the use of the centriole to form primary cilia blocks centrosome formation and mitotic spindle assembly and prevents the completion of mitosis in cells in which cellular senescence is caused by the inhibition of AURKA. We also found that AURKA is down-regulated and primary cilia formation is enhanced when cellular senescence is promoted by other senescence-inducing stimuli, such as oxidative stress and UV light. Thus, we propose that impaired AURKA function induces premature senescence by preventing reabsorption of the primary cilium, which inhibits centrosome and mitotic spindle formation and consequently prevents the completion of mitosis. Our study causally links the inability of the cell to disassemble the primary cilium, a microtubule-based cellular organelle, to the development of premature senescence, a functionally and pathologically relevant cellular state.	[Jeffries, Elizabeth P.; Di Filippo, Michela; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), Univ Pittsburgh, 200 Lothrop St,Biomed Sci Tower,Room E1154, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Galbiati, Ferruccio/AAF-3527-2020		U.S. National Institutes of Health (NIH) National Cancer Institute [R01-CA205165]; NIH National Heart, Lung, and Blood Institute [R01-HL124747]; NATIONAL CANCER INSTITUTE [R01CA205165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124747] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant R01-CA205165 from the U.S. National Institutes of Health (NIH) National Cancer Institute (to F.G.), and Grant R01-HL124747 from the NIH National Heart, Lung, and Blood Institute (to F.G.). The authors declare no conflicts of interest.	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Breslin L, 2014, CELL CYCLE, V13, P2773, DOI 10.4161/15384101.2015.945868; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Capparelli C, 2012, CELL CYCLE, V11, P2285, DOI 10.4161/cc.20718; Carroll B, 2017, J CELL BIOL, V216, P1949, DOI 10.1083/jcb.201610113; Cirak Y, 2015, J BUON, V20, P1414; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Do TV, 2014, ONCOGENE, V33, P539, DOI 10.1038/onc.2012.632; Ferchichi I, 2013, DIS MARKERS, V34, P63, DOI [10.1155/2013/871929, 10.3233/DMA-120947]; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Goto H, 2013, CELL MOL LIFE SCI, V70, P3893, DOI 10.1007/s00018-013-1302-8; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027410; Korobeynikov V, 2017, BIOCHEM SOC T, V45, P37, DOI 10.1042/BST20160142; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Mercier I, 2008, CANCER BIOL THER, V7, P1212, DOI 10.4161/cbt.7.8.6220; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Park C, 2006, INT J MOL MED, V17, P715; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Seeger-Nukpezah Tamina, 2013, Drug Discov Today Dis Mech, V10, pe135; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Segal SS, 1999, AM J PHYSIOL-HEART C, V277, pH1167; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; SMART EJ, 1995, J CELL BIOL, V131, P929, DOI 10.1083/jcb.131.4.929; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Tang AQ, 2017, ONCOTARGET, V8, P23937, DOI 10.18632/oncotarget.14893; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856	49	11	11	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4866	4882		10.1096/fj.201801382R	http://dx.doi.org/10.1096/fj.201801382R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596512	Bronze, Green Published			2022-12-28	WOS:000462888500019
J	Jiang, L; Liu, XQ; Ma, QY; Yang, Q; Gao, L; Li, HD; Wang, JN; Wei, B; Wen, JG; Li, J; Wu, YG; Meng, XM				Jiang, Ling; Liu, Xue-Qi; Ma, Qiuying; Yang, Qin; Gao, Li; Li, Hai-Di; Wang, Jia-Nan; Wei, Biao; Wen, Jiagen; Li, Jun; Wu, Yong-Gui; Meng, Xiao-Ming			hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells	FASEB JOURNAL			English	Article						miRNA; inflammation; exosome; RIPK1; programmed cell death	MICRORNAS; PROTECTS; ACTIVATION; DEATH	MLKL is a central mediator for necroptosis. Its knockout significantly relieves acute kidney injury (AKI). However, its upstream regulatory mechanism in AKI has not been fully elucidated. We recently reviewed how microRNAs (miRNAs), a type of well-studied epigenetic regulator, play critical roles in AKI. Here, we evaluated miRNAs that potentially target MLKL and evaluated their function in human tubular epithelial cells in response to toxic and ischemic insults. TargetScan analysis showed that miR-194-5P, miR-338-3P, miR-500a-3P, and miR-577 had MLKL binding sites. Although all 4 miRNAs are reduced in AKI, our data show that only hsa-miR-500a-3P was significantly suppressed in cisplatin-treated human tubular epithelial (HK2) cells. We further found that hsa-miR-500a-3P alleviated cisplatin-induced HK2 cell death, which was confirmed by transmission electron microscopy and flow cytometry. In addition, overexpression of hsa-miR-500a-3P decreased kidney injury molecule-1 mRNA and protein levels. Real-time PCR, ELISA, and immunofluorescence data show that hsa-miR-500a-3P protected against inflammatory response, evidenced by decreased monocyte chemotactic protein-1 and proinflammatory cytokines TNF- and IL-8. Further, hsa-miR-500a-3P attenuated P65 NF-B phosphorylation and promoter activity. Mechanistically, luciferase reporter assay showed that hsa-miR-500a-3P bound the 3UTR of MLKL, thereby suppressing phosphorylation and membrane translocation of MLKL. In agreement with these findings, we identified that overexpression of hsa-miR-500a-3P attenuated cell injury and the inflammatory response in response to sodium azide treatment in an in vitro model. Results show that circulating exosomes from patients with AKI down-regulated miR-500a-3P, which suppressed cell injury and inflammation in HK2 cells. hsa-miR-500a-3P alleviated toxic and ischemic insults that were triggered by cell necroptosis and the inflammatory response in human HK2 cells by targeting MLKL. This may serve as a novel therapeutic target for treatment of AKI.Jiang, L., Liu, X.-Q., Ma, Q., Yang, Q., Gao, L., Li, H.-D., Wang, J.-N., Wei, B., Wen, J., Li, J., Wu, Y.-G., Meng, X.-M. hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells.	[Jiang, Ling; Liu, Xue-Qi; Wu, Yong-Gui] Anhui Med Univ, Dept Nephrol, Affiliated Hosp 1, Hefei 230000, Anhui, Peoples R China; [Jiang, Ling; Liu, Xue-Qi; Ma, Qiuying; Yang, Qin; Gao, Li; Li, Hai-Di; Wang, Jia-Nan; Wei, Biao; Wen, Jiagen; Li, Jun; Meng, Xiao-Ming] Anhui Med Univ, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Wen, Jiagen; Li, Jun; Meng, Xiao-Ming] Anhui Med Univ, Anhui Inst Innovat Drugs, Hefei, Anhui, Peoples R China; [Wen, Jiagen; Li, Jun; Meng, Xiao-Ming] Anhui Med Univ, Key Lab Major Autoimmune Dis, Hefei, Anhui, Peoples R China; [Wen, Jiagen; Li, Jun; Meng, Xiao-Ming] Minist Educ, Key Lab Antiinflammatory & Immune Med, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Wu, YG (corresponding author), Anhui Med Univ, Dept Nephrol, Affiliated Hosp 1, Hefei 230000, Anhui, Peoples R China.; Meng, XM (corresponding author), Anhui Med Univ, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	wuyonggui@medmail.com.cn; mengxiaoming@ahmu.edu.cn		Meng, Xiao-ming/0000-0002-1166-561X	National Natural Science Foundation of China (NSFC) [81570623]; Science and Technological Fund of Anhui Province for Outstanding Youth of China [1608085J07]; Training Program Foundation for the Talents by Anhui Education Commission Grant [gxyqZD2017021]; Training Program for Excellent Young Scientist Foundation of the NSFC of Anhui Medical University [GJYQ-1404]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technological Fund of Anhui Province for Outstanding Youth of China; Training Program Foundation for the Talents by Anhui Education Commission Grant; Training Program for Excellent Young Scientist Foundation of the NSFC of Anhui Medical University	The authors thank Austin Cape (ASJ Editors Academia Scholarly Journals (ASJ) Editors (Atlanta, GA, USA) for careful reading. This study was supported by National Natural Science Foundation of China (NSFC) Grant 81570623, Science and Technological Fund of Anhui Province for Outstanding Youth of China Grant 1608085J07, Training Program Foundation for the Talents by Anhui Education Commission Grant gxyqZD2017021, and by Training Program for Excellent Young Scientist Foundation of the NSFC of Anhui Medical University Grant GJYQ-1404. The authors declare no conflicts of interest.	Afonso MB, 2018, CELL DEATH DIFFER, V25, P857, DOI 10.1038/s41418-017-0019-x; Bhatt K, 2016, AM J PHYSIOL-RENAL, V310, pF109, DOI 10.1152/ajprenal.00387.2015; Bhattacharya S, 2016, ONCOGENE, V35, P5282, DOI 10.1038/onc.2016.68; Cai ZY, 2014, NAT CELL BIOL, V16, P200, DOI 10.1038/ncb2908; Cosar E, 2016, FERTIL STERIL, V106, P402, DOI 10.1016/j.fertnstert.2016.04.013; Galluzzi L, 2017, ANNU REV PATHOL-MECH, V12, P103, DOI 10.1146/annurev-pathol-052016-100247; Gao L, 2018, LAB INVEST, V98, P911, DOI 10.1038/s41374-018-0052-5; Gao L, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00479; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Jiang CL, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0568-3; Karpman D, 2017, NAT REV NEPHROL, V13, P545, DOI 10.1038/nrneph.2017.98; Kim YS, 2016, ONCOTARGET, V7, P42261, DOI 10.18632/oncotarget.9950; Linkermann A, 2016, KIDNEY INT, V89, P46, DOI 10.1016/j.kint.2015.10.008; Linkermann A, 2013, J AM SOC NEPHROL, V24, P1545, DOI 10.1681/ASN.2012121169; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Liu WJ, 2018, P NATL ACAD SCI USA, V115, pE1475, DOI 10.1073/pnas.1716959115; Lv LL, 2018, J AM SOC NEPHROL, V29, P919, DOI 10.1681/ASN.2017050523; Meng XM, 2018, LAB INVEST, V98, P63, DOI 10.1038/labinvest.2017.120; Meng XM, 2018, LAB INVEST, V98, P79, DOI 10.1038/labinvest.2017.115; Mulay SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10274; Pavkovic M, 2016, PHARMACOL THERAPEUT, V163, P48, DOI 10.1016/j.pharmthera.2016.03.016; Ren G. L., 2018, J CELL PHYSL; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Stahl A. L., 2017, PEDIAT NEPHROL; von Massenhausen A, 2018, NEPHRON, V140, P144, DOI 10.1159/000490807; Wang S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.37; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Xu YF, 2015, J AM SOC NEPHROL, V26, P2647, DOI 10.1681/ASN.2014080741; Yang TS, 2018, REDOX BIOL, V15, P159, DOI 10.1016/j.redox.2017.11.025; Zhang L, 2015, ONCOTARGET, V6, P2483, DOI 10.18632/oncotarget.2800	31	54	54	2	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3523	3535		10.1096/fj.201801711R	http://dx.doi.org/10.1096/fj.201801711R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30365367	Bronze			2022-12-28	WOS:000459794800035
J	Shi, Q; Zhuang, F; Liu, JT; Li, N; Chen, YX; Su, XB; Yao, AH; Yao, QP; Han, Y; Li, SS; Qi, YX; Jiang, ZL				Shi, Qian; Zhuang, Fei; Liu, Ji-Ting; Li, Na; Chen, Yuan-Xiu; Su, Xian-Bin; Yao, Ai-Hong; Yao, Qing-Ping; Han, Yue; Li, Shan-Shan; Qi, Ying-Xin; Jiang, Zong-Lai			Single-cell analyses reveal functional classification of dendritic cells and their potential roles in inflammatory disease	FASEB JOURNAL			English	Article						functional heterogeneity; single-cell qPCR; antigen-presenting cell; atherosclerotic mouse models	SCAVENGER-RECEPTORS; STEADY-STATE; RNA-SEQ; IDENTIFICATION; MACROPHAGES; POPULATION; SUBSETS; TISSUES; MYD88; MICE	Dendritic cells (DCs) have crucial roles in immune-related diseases. However, it is difficult to explore DCs because of their rareness and heterogeneity. Although previous studies had been performed to detect the phenotypic characteristics of DC populations, the functional diversity has been ignored. Using a combination of flow cytometry, single-cell quantitative PCR, and bioinformatic analysis, we depicted the DC panorama with not only phenotypic but also functional markers. Functional classification of DCs in mouse lymphoid tissue (spleen) and nonlymphoid tissue (liver) was performed. The results revealed that expression of macrophage scavenger receptor 1 (MSR1) and C-C motif chemokine receptors (CCR)1, CCR2, and CCR4 were elevated in liver DCs, suggesting increased lipid uptake and migration abilities. The enriched expression of costimulatory molecule CD80, TLR9, and TLR adaptor MYD88 in spleen DCs indicated a more-mature phenotype, enhanced pathogen recognition, and T-cell stimulation abilities. Furthermore, we compared DCs in the atherosclerotic mouse models with healthy controls. In addition to the quantitative increase in DCs in the liver and spleen of the apolipoprotein E-knockout (ApoE(-/-)) mice, the functional expression patterns of the DCs also changed at the single-cell level. These results promote our understanding of the participation of DCs in inflammatory diseases and have potential applications in DC clinical assessment.Shi, Q., Zhuang, F., Liu, J.-T., Li, N., Chen, Y.-X., Su, X.-B., Yao, A.-H., Yao, Q.-P., Han, Y., Li, S.-S., Qi, Y.-X., Jiang, Z.-L. Single-cell analyses reveal functional classification of dendritic cells and their potential roles in inflammatory disease.	[Shi, Qian; Zhuang, Fei; Liu, Ji-Ting; Li, Na; Chen, Yuan-Xiu; Yao, Qing-Ping; Han, Yue; Li, Shan-Shan; Qi, Ying-Xin; Jiang, Zong-Lai] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, 800 Dongchuan Rd,POB 888, Shanghai 200240, Peoples R China; [Su, Xian-Bin] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Shanghai, Peoples R China; [Yao, Ai-Hong] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harbin Engineering University	Qi, YX (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, 800 Dongchuan Rd,POB 888, Shanghai 200240, Peoples R China.	qiyx@sjtu.edu.cn		Su, Xianbin/0000-0001-5705-6062	National Natural Science Foundation of China [11625209, 11232010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Yu-Meng Tan and Qian Luo (Shanghai Jiao Tong University) for flow cytometry service. The authors thank Ling Di (Shanghai Jiao Tong University) for her assistance with confocal microscope. This research was supported by the National Natural Science Foundation of China (Grants 11625209 and 11232010). The authors declare no conflicts of interest.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Busch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088452; Chea S, 2016, CELL REP, V14, P1500, DOI 10.1016/j.celrep.2016.01.015; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Comrie WA, 2015, J CELL BIOL, V208, P457, DOI 10.1083/jcb.201406120; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Emara M, 2011, J BIOL CHEM, V286, P13033, DOI 10.1074/jbc.M111.220657; Fukata M, 2008, J IMMUNOL, V180, P1886, DOI 10.4049/jimmunol.180.3.1886; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gelman AE, 2006, IMMUNITY, V25, P783, DOI 10.1016/j.immuni.2006.08.023; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Muzaki ARBM, 2016, MUCOSAL IMMUNOL, V9, P336, DOI 10.1038/mi.2015.64; National Research Council, 2010, GUIDE CARE USE LAB A; Nickel T, 2009, ATHEROSCLEROSIS, V205, P442, DOI 10.1016/j.atherosclerosis.2009.01.002; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Poltorak MP, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00199; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Schraml BU, 2015, CURR OPIN IMMUNOL, V32, P13, DOI 10.1016/j.coi.2014.11.001; SCHULER G, 1985, J INVEST DERMATOL, V85, pS99, DOI 10.1111/1523-1747.ep12275566; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; STEINMAN RM, 1975, J EXP MED, V141, P804; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Wang D, 2015, HUM IMMUNOL, V76, P442, DOI 10.1016/j.humimm.2015.03.012; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zheng, 2015, F1000 RES, V4	44	6	6	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3784	3794		10.1096/fj.201801489R	http://dx.doi.org/10.1096/fj.201801489R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496701	Bronze			2022-12-28	WOS:000459794800056
J	Trujillo-Gonzalez, I; Wang, YY; Friday, WB; Vickers, KC; Toth, CL; Molina-Torres, L; Surzenko, N; Zeisel, SH				Trujillo-Gonzalez, Isis; Wang, Yanyan; Friday, Walter B.; Vickers, Kasey C.; Toth, Cynthia L.; Molina-Torres, Lorian; Surzenko, Natalia; Zeisel, Steven H.			MicroRNA-129-5p is regulated by choline availability and controls EGF receptor synthesis and neurogenesis in the cerebral cortex	FASEB JOURNAL			English	Article						cortical development; EGFR; maternal nutrition; brain development	DIETARY-INTAKE; MESSENGER-RNA; STEM-CELLS; S-ADENOSYLMETHIONINE; DNA METHYLATION; EXPRESSION; MICE; DIFFERENTIATION; MIR-129-5P; TARGETS	Choline availability modulates neurogenesis and cerebral cortex development through the regulation of neural progenitor cell (NPC) proliferative and differentiation capacity. In this study, we demonstrated that cortical NPC self-renewal is controlled by choline via the expression of a microRNA (miR-129-5p), whose role in the developing brain has not been examined, and which, in turn, inhibits synthesis of the epidermal growth factor receptor (EGFR) protein. Specifically, we found that low choline (LC) availability led to the upregulation of miR-129-5p expression in cortical NPCs in vitro and in vivo, causing the downregulation of EGFR and thereby disrupting NPC self-renewal and cortical neurogenesis. Furthermore, in response to LC availability, methylation potential (the S-adenosylmethionine:S-adenosylhomocysteine ratio) in the developing brain was reduced. Restoring methylation potential in LC cortical NPCs led to the re-establishment of normal miR-129-5p expression. We concluded that inhibiting miR-129-5p function and restoring EGFR protein levels in vivo is sufficient to reverse LC-induced defects in cortical NPC self-renewal. For the first time, to our knowledge, we have identified the molecular links that explain how a change in the availability of the diet metabolite choline impacts the essential cellular processes underlying brain development.Trujillo-Gonzalez, I., Wang, Y., Friday, W. B., Vickers, K. C., Toth, C. L., Molina-Torres, L., Surzenko, N., Zeisel, S. H. MicroRNA-129-5p is regulated by choline availability and controls EGF receptor synthesis and neurogenesis in the cerebral cortex.	[Trujillo-Gonzalez, Isis; Wang, Yanyan; Friday, Walter B.; Molina-Torres, Lorian; Surzenko, Natalia; Zeisel, Steven H.] Univ North Carolina Chapel Hill, Nutr Res Inst, 500 Laureate Way,Room 2218, Kannapolis, NC 28078 USA; [Wang, Yanyan] Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China; [Vickers, Kasey C.; Toth, Cynthia L.] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Surzenko, Natalia; Zeisel, Steven H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; Army Medical University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill	Surzenko, N; Zeisel, SH (corresponding author), Univ North Carolina Chapel Hill, Nutr Res Inst, 500 Laureate Way,Room 2218, Kannapolis, NC 28078 USA.	surzenko@email.unc.edu; steven_zeisel@unc.edu			U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK056350, DK115380]; Balchem (New Hampton NY, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128996, R01HL127173, P01HL116263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115380, P30DK056350] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Balchem (New Hampton NY, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Praveen Sethupathy (Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA) for providing support in the use of miR analysis tools; Dr. Eva Anton (UNC Neuroscience Center, Department of Cell Biology and Physiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA) and Dr. David Horita (Nutrition Research Institute) for critically evaluating the manuscript; Dr. Jiami Guo (UNC Neuroscience Center) for providing assistance with in utero electroporations; Dr. Ying Wang (Nutrition Research Institute) for help with metabolites assessment; Dr. Steve Orena (Nutrition Research Institute) for providing FACS services; Dr. Daniel Lupu (Nutrition Research Institute) for help with pyrosequencing; and Dr. Eneda Pjetri (Nutrition Research Institute) for help with statistical analyses. The study was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK056350 and DK115380 (to S.H.Z.). Dr. Zeisel has received research funding for other studies from Balchem (New Hampton NY, USA), a manufacturer of choline. The remaining authors declare no conflicts of interest.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Caric D, 2001, DEVELOPMENT, V128, P4203; Close JL, 2006, GLIA, V54, P94, DOI 10.1002/glia.20361; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Cremisi F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00141; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; FERRI RT, 1995, DEVELOPMENT, V121, P1151; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Gebhardt ML, 2014, NUCLEIC ACIDS RES, V42, P5436, DOI 10.1093/nar/gku231; Gossell-Williams M, 2005, W INDIAN MED J, V54, P355; Gstrein T, 2018, NAT NEUROSCI, V21, P207, DOI 10.1038/s41593-017-0053-5; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lillien L, 1998, MOL CELL NEUROSCI, V10, P296, DOI 10.1006/mcne.1997.0659; Lillien L, 2006, CEREB CORTEX, V16, pI74, DOI 10.1093/cercor/bhj169; Luan QX, 2016, EUR REV MED PHARMACO, V20, P4257; Lupu DS, 2017, FASEB J, V31, P2090, DOI 10.1096/fj.201601169R; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mehedint MG, 2010, FASEB J, V24, P184, DOI 10.1096/fj.09-140145; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; MOLLOY AM, 1990, BIOMED CHROMATOGR, V4, P257, DOI 10.1002/bmc.1130040611; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Reiter JL, 2001, GENOMICS, V71, P1, DOI 10.1006/geno.2000.6341; Resseguie ME, 2011, J BIOL CHEM, V286, P1649, DOI 10.1074/jbc.M110.106922; Scremin OU, 2015, NEUROSCIENCE, V301, P520, DOI 10.1016/j.neuroscience.2015.06.036; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Sinor-Anderson A, 2011, DEV NEUROBIOL, V71, P759, DOI 10.1002/dneu.20878; Sosanya NM, 2013, J CELL BIOL, V202, P53, DOI 10.1083/jcb.201212089; Tayebati SK, 2015, CURR MED CHEM, V22, P4328, DOI 10.2174/0929867322666151029104152; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Wallace TC, 2016, J AM COLL NUTR, V35, P108, DOI 10.1080/07315724.2015.1080127; Wallace TC, 2014, J AM COLL NUTR, V33, P94, DOI 10.1080/07315724.2013.846806; Wang J, 2013, P NATL ACAD SCI USA, V110, P19137, DOI 10.1073/pnas.1307224110; Wang YY, 2016, FASEB J, V30, P1566, DOI 10.1096/fj.15-282426; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Wu Q, 2014, ONCOTARGET, V5, P11552, DOI 10.18632/oncotarget.2594; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zeisel SH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050445; Zongaro S, 2013, HUM MOL GENET, V22, P1971, DOI 10.1093/hmg/ddt044	62	12	12	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3601	3612		10.1096/fj.201801094RR	http://dx.doi.org/10.1096/fj.201801094RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521373	Green Submitted, Green Published			2022-12-28	WOS:000459794800041
J	Zhao, LQ; Bartnikas, T; Chu, XP; Klein, J; Yun, C; Srinivasan, S; He, PJ				Zhao, Luqing; Bartnikas, Thomas; Chu, Xiangpeng; Klein, Janet; Yun, Chris; Srinivasan, Shanthi; He, Peijian			Hyperglycemia promotes microvillus membrane expression of DMT1 in intestinal epithelial cells in a PKC-dependent manner	FASEB JOURNAL			English	Article						diabetes; iron uptake; HIF2 ubiquitination	DIETARY IRON RESTRICTION; NA+/H+ EXCHANGER NHE3; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; OXIDATIVE STRESS; PROTEIN; TRANSPORTER; ACTIVATION; ABSORPTION; OVERLOAD	Excessive iron increases the incidence of diabetes and worsens diabetic complications. Reciprocally, diabetes induces iron loading, partially attributable to elevated intestinal iron export according to a recent report. Herein, we show that iron uptake and the mRNA expression of iron importer divalent metal transporter 1 (DMT1) were significantly increased in the duodenum of streptozotocin-induced diabetic mice. Immunofluorescence staining of human intestinal biopsies revealed increased brush border membrane (BBM) and decreased cytoplasmic DMT1 expression in patients with diabetes, suggesting translocation of DMT1. This pattern of DMT1 regulation was corroborated by immunoblotting results in diabetic mice showing that BBM DMT1 expression was increased by 210%, in contrast to a 60% increase in total DMT1. PKC mediates many diabetic complications, and PKC activity was increased in diabetic mouse intestine. Intriguingly, diabetic mice with PKC deficiency did not show increases in iron uptake and BBM DMT1 expression. High-glucose treatment increased plasma membrane DMT1 expression via the activation of PKC in cultured IECs. Inhibition of PKC potentiated the ubiquitination and degradation of DMT1 protein. We further showed that high glucose suppressed membrane DMT1 internalization. These findings demonstrate that PKC promotes microvillus membrane DMT1 expression and intestinal iron uptake, contributing to diabetic iron loading.Zhao, L., Bartnikas, T., Chu, X., Klein, J., Yun, C., Srinivasan, S., He, P. Hyperglycemia promotes microvillus membrane expression of DMT1 in intestinal epithelial cells in a PKC-dependent manner.	[Zhao, Luqing] Capital Med Univ, Dept Gastroenterol, Beijing Hosp Tradit Chinese Med, Beijing, Peoples R China; [Zhao, Luqing; Yun, Chris; Srinivasan, Shanthi; He, Peijian] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Whitehead Res Bldg,Room 201C,615 Michael St, Atlanta, GA 30322 USA; [Klein, Janet] Emory Univ, Sch Med, Dept Med, Div Renal Med, Atlanta, GA USA; [Bartnikas, Thomas] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Chu, Xiangpeng] Peoples Hosp Rizhao, Dept Thorac Surg, Rizhao, Shandong, Peoples R China; [Yun, Chris; Srinivasan, Shanthi] Atlanta Vet Adm Med Ctr, Decatur, GA USA	Capital Medical University; Emory University; Emory University; Brown University	He, PJ (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Whitehead Res Bldg,Room 201C,615 Michael St, Atlanta, GA 30322 USA.	phe3@emory.edu	Srinivasan, Shanthi/A-6133-2013		American Heart Association Scientist Development Grant [13SDG1623001]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK107719]; National Science Fund of China (NSFC) [81503514]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110049, R01DK107719] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Fund of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association Scientist Development Grant 13SDG1623001 (to P.H.) and in part by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK107719 (to C.Y.). L.Z. is a recipient of the National Science Fund of China (NSFC Grant 81503514). The authors declare no conflicts of interest.	Anderson ER, 2013, P NATL ACAD SCI USA, V110, pE4922, DOI 10.1073/pnas.1314197110; Angelopoulos NG, 2006, DIABETIC MED, V23, P1327, DOI 10.1111/j.1464-5491.2006.01988.x; BOFILL C, 1994, METABOLISM, V43, P614, DOI 10.1016/0026-0495(94)90204-6; Buckett PD, 2009, AM J PHYSIOL-GASTR L, V296, pG798, DOI 10.1152/ajpgi.90342.2008; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Chang Q, 2003, BRIT J PHARMACOL, V140, P41, DOI 10.1038/sj.bjp.0705398; Chaudhary K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21276-2; Chong WS, 2005, HUM REPROD, V20, P3532, DOI 10.1093/humrep/dei246; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; de Mello VDF, 2006, AM J CLIN NUTR, V83, P1032, DOI 10.1093/ajcn/83.5.1032; Diebold I, 2010, ANTIOXID REDOX SIGN, V13, P425, DOI 10.1089/ars.2009.3014; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Eshak ES, 2018, CLIN NUTR, V37, P667, DOI 10.1016/j.clnu.2017.02.010; Fernandez-Real JM, 2002, DIABETES CARE, V25, P2249, DOI 10.2337/diacare.25.12.2249; Fernandez-Real JM, 2002, DIABETES, V51, P1000, DOI 10.2337/diabetes.51.4.1000; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Foot NJ, 2011, BLOOD, V117, P638, DOI 10.1182/blood-2010-07-295287; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gwak J, 2009, J CELL MOL MED, V13, P2171, DOI 10.1111/j.1582-4934.2009.00683.x; He PJ, 2016, AM J PHYSIOL-RENAL, V311, pF343, DOI 10.1152/ajprenal.00247.2016; He PJ, 2015, J CLIN INVEST, V125, P3519, DOI 10.1172/JCI79552; He PJ, 2010, J BIOL CHEM, V285, P27869, DOI 10.1074/jbc.M110.133066; He PJ, 2008, J BIOL CHEM, V283, P33544, DOI 10.1074/jbc.M805534200; Hempel A, 1997, CIRC RES, V81, P363, DOI 10.1161/01.RES.81.3.363; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Ikeda Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11089-0; Ikeda Y, 2013, AM J PHYSIOL-RENAL, V304, pF1028, DOI 10.1152/ajprenal.00473.2012; JOHNSON WT, 1984, J NUTR, V114, P180, DOI 10.1093/jn/114.1.180; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Fernandez-Real JM, 2015, DIABETES CARE, V38, P2169, DOI 10.2337/dc14-3082; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McClain DA, 2006, DIABETOLOGIA, V49, P1661, DOI 10.1007/s00125-006-0200-0; Montalbetti N, 2015, BIOCHEM PHARMACOL, V96, P216, DOI 10.1016/j.bcp.2015.05.002; NANKIVELL BJ, 1994, J AM SOC NEPHROL, V4, P1598; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niwa M, 2014, ORG BIOMOL CHEM, V12, P6590, DOI 10.1039/c4ob00935e; No YR, 2014, J BIOL CHEM, V289, P18360, DOI 10.1074/jbc.M113.541706; Paramar PN, 2006, BIOCHEM J, V394, P173, DOI 10.1042/BJ20051296; Park SH, 2001, KIDNEY INT, V59, P1695, DOI 10.1046/j.1523-1755.2001.0590051695.x; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; Rowe PA, 2011, METABOLISM, V60, P1070, DOI 10.1016/j.metabol.2010.11.003; SCHAFER AI, 1981, NEW ENGL J MED, V304, P319, DOI 10.1056/NEJM198102053040603; Seo YA, 2016, BIOCHEM J, V473, P4243, DOI 10.1042/BCJ20160674; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015; Singh J, 2006, ANN NY ACAD SCI, V1084, P178, DOI 10.1196/annals.1372.028; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Touret N, 2004, BLOOD, V104, P1526, DOI 10.1182/blood-2004-02-0731; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; Trinder D, 2000, GUT, V46, P270, DOI 10.1136/gut.46.2.270; Wang CY, 2013, HEPATOLOGY, V58, P788, DOI 10.1002/hep.26401; Wang HY, 2014, DIABETES, V63, P1506, DOI 10.2337/db13-1195; Wolff NA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18584-4; Wright WS, 2010, EXP EYE RES, V90, P405, DOI 10.1016/j.exer.2009.12.002; Xue X, 2016, CELL METAB, V24, P447, DOI 10.1016/j.cmet.2016.07.015; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; Zhang WL, 2015, INT J MED SCI, V12, P441, DOI 10.7150/ijms.11986; Zhang ZH, 2012, BIOORG MED CHEM LETT, V22, P5108, DOI 10.1016/j.bmcl.2012.05.129; Zheng X, 2011, AM J CLIN NUTR, V94, P1012, DOI 10.3945/ajcn.111.015743	65	8	8	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3549	3561		10.1096/fj.201801855R	http://dx.doi.org/10.1096/fj.201801855R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30423260	Green Published, Bronze			2022-12-28	WOS:000459794800037
J	Carino, A; Marchiano, S; Biagioli, M; Bucci, M; Vellecco, V; Brancaleone, V; Fiorucci, C; Zampella, A; Monti, MC; Distrutti, E; Fiorucci, S				Carino, Adriana; Marchiano, Silvia; Biagioli, Michele; Bucci, Mariarosaria; Vellecco, Valentina; Brancaleone, Vincenzo; Fiorucci, Chiara; Zampella, Angela; Monti, Maria Chiara; Distrutti, Eleonora; Fiorucci, Stefano			Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis	FASEB JOURNAL			English	Article						NASH; TGR5; high fat diet; aortic rings	NONALCOHOLIC FATTY LIVER; BROWN ADIPOSE-TISSUE; FARNESOID-X-RECEPTOR; ACTIVATED RECEPTORS; CARDIOVASCULAR RISK; ENERGY-EXPENDITURE; GENE-EXPRESSION; DISEASE; TGR5; IDENTIFICATION	Nonalcoholic steatohepatitis (NASH) is associated with an increased risk of developing cardiovascular complications and mortality, suggesting that treatment of NASH might benefit from combined approaches that target the liver and the cardiovascular components of NASH. Using genetic and pharmacologic approaches, we show that G protein-coupled bile acid-activated receptor 1 (GPBAR1) agonism reverses liver and vascular damage in mouse models of NASH. NASH is associated with accelerated vascular inflammation representing an independent risk factor for development of cardiovascular diseases and cardiovascular-related mortality. GPBAR1, also known as TGR5, is a G protein-coupled receptor for secondary bile acids that reduces inflammation and promotes energy expenditure. Using genetic and pharmacologic approaches, we investigated whether GPBAR1 agonism by 6-ethyl-3,7-dihydroxy-5-cholan-24-ol (BAR501) reverses liver and vascular damage induced by exposure to a diet enriched in fat and fructose (HFD-F). Treating HFD-F mice with BAR501 reversed liver injury and promoted the browning of white adipose tissue in a Gpbar1-dependent manner. Feeding HFD-F resulted in vascular damage, as shown by the increased aorta intima-media thickness and increased expression of inflammatory genes (IL-6,TNF-, iNOS, and F4/80) and adhesion molecules (VCAM, intercellular adhesion molecule-1, and endothelial selectin) in the aorta, while reducing the expression of genes involved in NO and hydrogen sulfide generation, severely altering vasomotor activities of aortic rings in an ex vivo assay. BAR501 reversed this pattern in a Gpbar1-dependent manner, highlighting a potential role for GPBAR1 agonism in treating the liver and vascular component of NASH.Carino, A., Marchian, S., Biagioli, M., Bucci, M., Vellecco, V., Brancaleone, V., Fiorucci, C., Zampella, A., Monti, M. C., Distrutti, E., Fiorucci, S. Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis.	[Carino, Adriana; Marchiano, Silvia; Biagioli, Michele; Fiorucci, Chiara; Fiorucci, Stefano] Univ Perugia, Dept Surg & Biomed Sci, Piazza Lucio Severi 1, I-06122 Perugia, Italy; [Bucci, Mariarosaria; Vellecco, Valentina; Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Brancaleone, Vincenzo] Univ Basilicata, Dept Sci, Potenza, Italy; [Monti, Maria Chiara] Univ Salerno, Dept Pharm, Salerno, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, Perugia, Italy	University of Perugia; University of Naples Federico II; Italfarmaco; University of Basilicata; University of Salerno; University of Perugia; Azienda Ospedaliera di Perugia	Carino, A (corresponding author), Univ Perugia, Dept Surg & Biomed Sci, Piazza Lucio Severi 1, I-06122 Perugia, Italy.	adriana.carino@unipg.it	Fiorucci, Stefano/I-1251-2012; Biagioli, Michele/AAF-6419-2019	Biagioli, Michele/0000-0002-2995-6896; Vellecco, Valentina/0000-0002-5674-9112				Arulanandan A, 2015, CLIN GASTROENTEROL H, V13, P1513, DOI 10.1016/j.cgh.2015.01.027; Bertholet AM, 2017, BIOCHIMIE, V134, P28, DOI 10.1016/j.biochi.2016.10.013; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Biagioli M, 2017, J IMMUNOL, V199, P718, DOI 10.4049/jimmunol.1700183; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; Calligaris SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060931; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13102-y; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42801; Castro RE, 2018, J HEPATOL, V69, P272, DOI 10.1016/j.jhep.2018.05.002; Chaar LJ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12811; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Cipriani S, 2013, CIRCULATION, V127, P2114, DOI 10.1161/CIRCULATIONAHA.113.001278; Cipriani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025637; Cuspidi C, 2018, PHARMACOL RES, V129, P20, DOI 10.1016/j.phrs.2018.01.007; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Chantemele EJB, 2011, HYPERTENSION, V58, P271, DOI 10.1161/HYPERTENSIONAHA.110.168427; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Fiorucci S, 2017, AM J PHYSIOL-HEART C, V312, pH21, DOI 10.1152/ajpheart.00577.2016; Fiorucci S, 2016, PHARMACOL RES, V111, P749, DOI 10.1016/j.phrs.2016.07.040; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Francque SM, 2016, J HEPATOL, V65, P425, DOI 10.1016/j.jhep.2016.04.005; Freed JK, 2017, J CARDIOVASC PHARM, V69, P264, DOI 10.1097/FJC.0000000000000463; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2010, GLIA, V58, P1794, DOI 10.1002/glia.21049; Kida T, 2014, J PHARMACOL EXP THER, V348, P125, DOI 10.1124/jpet.113.209288; Kida T, 2013, ARTERIOSCL THROM VAS, V33, P1663, DOI 10.1161/ATVBAHA.113.301565; Kim D, 2012, HEPATOLOGY, V56, P605, DOI 10.1002/hep.25593; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Oni ET, 2013, ATHEROSCLEROSIS, V230, P258, DOI 10.1016/j.atherosclerosis.2013.07.052; Perino A, 2014, J CLIN INVEST, V124, P5424, DOI 10.1172/JCI76289; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Rathouska J, 2015, HEART VESSELS, V30, P241, DOI 10.1007/s00380-014-0493-8; Reddy DS, 2016, TRENDS PHARMACOL SCI, V37, P543, DOI 10.1016/j.tips.2016.04.003; Renga B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141082; Renga B, 2015, AM J PHYSIOL-HEART C, V309, pH114, DOI 10.1152/ajpheart.00087.2015; Rossiello MR, 2005, J THROMB HAEMOST, V3, P2554, DOI 10.1111/j.1538-7836.2005.01605.x; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Sepe V, 2014, J MED CHEM, V57, P7687, DOI 10.1021/jm500889f; Simas BB, 2018, STRESS, V21, P247, DOI 10.1080/10253890.2018.1437413; Sinn DH, 2016, GASTROENTEROLOGY, V151, P481, DOI 10.1053/j.gastro.2016.06.001; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Song C, 2007, INT J CANCER, V121, P1055, DOI 10.1002/ijc.22808; Tabas I, 2017, IMMUNITY, V47, P621, DOI 10.1016/j.immuni.2017.09.008; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Teufel A, 2016, GASTROENTEROLOGY, V151, P513, DOI 10.1053/j.gastro.2016.05.051; Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1; Vassileva G, 2010, J ENDOCRINOL, V205, P225, DOI 10.1677/JOE-10-0009; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zeb I, 2016, J AM COLL CARDIOL, V67, P1965, DOI 10.1016/j.jacc.2016.01.070	58	31	32	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2809	2822		10.1096/fj.201801373RR	http://dx.doi.org/10.1096/fj.201801373RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303744				2022-12-28	WOS:000457296600102
J	Wang, LY; Wang, WS; Wang, YW; Lu, JW; Lu, Y; Zhang, CY; Li, WJ; Sun, K; Ying, H				Wang, Lu-Yao; Wang, Wang-Sheng; Wang, Ya-Wei; Lu, Jiang-Wen; Lu, Yi; Zhang, Chu-Yue; Li, Wen-Jiao; Sun, Kang; Ying, Hao			Drastic induction of MMP-7 by cortisol in the human amnion: implications for membrane rupture at parturition	FASEB JOURNAL			English	Article						matrix metalloproteinase-7; fetal membranes; collagen; extracellular matrix; glucocorticoids	HUMAN FETAL MEMBRANES; DEHYDROGENASE TYPE-1 EXPRESSION; PREMATURE RUPTURE; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; PLACENTAL TROPHOBLAST; BASEMENT-MEMBRANE; CELL-DEATH; PRETERM	Preterm premature rupture of fetal membranes precedes 30-40% of preterm births. Activation of matrix metalloproteases (MMPs) is the one of the major causes of extracellular matrix (ECM) degradation in membrane rupture. Increased cortisol, regenerated by 11-hydroxysteroid dehydrogenase 1 in the amnion at parturition, is known to participate in a number of parturition-pertinent events. However, whether cortisol has a role in the regulation of MMPs in the membranes is not known. Here, we addressed this issue using human amnion tissue, the most tensile layer of the membranes. RNA-sequencing revealed that cortisol induced MMP7 expression dramatically in amnion fibroblasts, which was confirmed by real-time quantitative RT-PCR and Western blotting analysis in cortisol-treated amnion explants and fibroblasts. Measurement of collagen IV 5 chain (COL4A5), a substrate for MMP-7, showed that cortisol reduced its extracellular abundance, which was blocked by an antibody against MMP-7. Moreover, increased MMP-7 but decreased COL4A5 abundance was observed in the amnion tissue following labor-initiated spontaneous rupture of membranes. Mechanistic studies showed that cortisol increased the phosphorylation of c-Jun and the expression of c-Fos, the 2 major components of activated protein 1 (AP-1), respectively. The knocking down of c-Fos or c-Jun significantly attenuated the induction of MMP7 expression by cortisol. Chromatin immunoprecipitation assays showed that cortisol stimulated the enrichment of c-Fos and c-Jun at the AP-1 binding site in the MMP7 promoter. The data suggest that induction of MMP7 by cortisol via AP-1 may be a contributing factor to ECM degradation in membrane rupture at parturition.Wang, L.-Y., Wang, W.-S., Wang, Y.-W., Lu, J.-W., Lu, Y., Zhang, C.-Y., Li, W.-J., Sun, K., Ying, H. Drastic induction of MMP-7 by cortisol in the human amnion: implications for membrane rupture at parturition.	[Wang, Lu-Yao; Wang, Ya-Wei; Ying, Hao] Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 201204, Peoples R China; [Wang, Wang-Sheng; Lu, Jiang-Wen; Lu, Yi; Zhang, Chu-Yue; Sun, Kang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China; [Wang, Wang-Sheng; Lu, Jiang-Wen; Lu, Yi; Zhang, Chu-Yue; Sun, Kang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China; [Li, Wen-Jiao] Matern & Infant Hosp Changning Dist, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University	Ying, H (corresponding author), Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 201204, Peoples R China.; Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China.	sungangrenji@hotmail.com; stephenying_2011@163.com	Wang, Wang-sheng/E-9811-2017	Wang, Wang-sheng/0000-0003-1429-9237; Sun, Kang/0000-0003-2727-141X	National Natural Science Foundation of China [81330018, 81601320, 31671566, 81771600]; National Key R&D Program of China [2017YFC1001403]; National Key Basic Research Projects [2014CB943302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Key Basic Research Projects(National Basic Research Program of China)	The authors thank Dr. Dev Sooranna (Imperial College London, London, United Kingdom) for editing the manuscript. This work was supported by the National Natural Science Foundation of China (Grants 81330018, 81601320, 31671566, and 81771600), National Key R&D Program of China (2017YFC1001403), and National Key Basic Research Projects (2014CB943302). The authors declare no conflicts of interest.	Alfaidy N, 2003, J CLIN ENDOCR METAB, V88, P5033, DOI 10.1210/jc.2002-021915; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baraniuk JN, 1998, THORAX, V53, P577, DOI 10.1136/thx.53.7.577; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bryant-Greenwood GD, 1998, PLACENTA, V19, P1, DOI 10.1016/S0143-4004(98)90092-3; Challis JRG, 1997, ANN NY ACAD SCI, V828, P254, DOI 10.1111/j.1749-6632.1997.tb48546.x; Cosgrove D, 2017, MATRIX BIOL, V57-58, P45, DOI 10.1016/j.matbio.2016.08.005; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fortunato SJ, 2000, AM J OBSTET GYNECOL, V182, P1468, DOI 10.1067/mob.2000.107330; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Goldman S, 2003, EUR J OBSTET GYN R B, V111, P109, DOI 10.1016/S0301-2115(03)00341-5; Gomez-Lopez N, 2010, BIOL REPROD, V82, P809, DOI 10.1095/biolreprod.109.080432; GULLER S, 1995, J CLIN ENDOCR METAB, V80, P2244, DOI 10.1210/jc.80.7.2244; Kaden JJ, 2003, ATHEROSCLEROSIS, V170, P205, DOI 10.1016/S0021-9150(03)00284-3; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kossakowska AE, 1999, BLOOD, V94, P2080, DOI 10.1182/blood.V94.6.2080.418k30_2080_2089; Kwon MJ, 2014, BIOCHEM BIOPH RES CO, V446, P487, DOI 10.1016/j.bbrc.2014.02.142; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Lei HQ, 1996, J CLIN INVEST, V98, P1971, DOI 10.1172/JCI119001; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; Liu C, 2016, ENDOCRINOLOGY, V157, P4055, DOI 10.1210/en.2016-1406; Luo LG, 1998, BRAIN RES, V791, P56, DOI 10.1016/S0006-8993(97)01550-3; MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6; Maymon E, 2000, AM J OBSTET GYNECOL, V182, P1545, DOI 10.1067/mob.2000.107652; Menon R, 2004, J SOC GYNECOL INVEST, V11, P427, DOI 10.1016/j.jsgi.2004.04.001; Mi YB, 2018, J MOL ENDOCRINOL, V60, P45, DOI 10.1530/JME-17-0215; Mi YB, 2017, ENDOCRINOLOGY, V158, P1005, DOI 10.1210/en.2016-1829; MURPHY BEP, 1977, NATURE, V266, P179; MURPHY BEP, 1981, J STEROID BIOCHEM, V14, P811; Nishihara S, 2008, REPROD SCI, V15, P156, DOI 10.1177/1933719107310308; OCKLEFORD C, 1993, J ANAT, V183, P483; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Oyen ML, 2006, AM J OBSTET GYNECOL, V195, P510, DOI 10.1016/j.ajog.2006.02.010; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Patel FA, 1999, J CLIN ENDOCR METAB, V84, P395, DOI 10.1210/jc.84.2.395; POTESTIO FA, 1988, J CLIN ENDOCR METAB, V67, P1205, DOI 10.1210/jcem-67-6-1205; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Sado Y, 1998, J BIOCHEM-TOKYO, V123, P767; Schroen DJ, 1996, GENE EXPRESSION, V6, P197; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-269; Strauss JF, 2013, REPROD SCI, V20, P140, DOI 10.1177/1933719111424454; Sun K, 2003, ENDOCRINOLOGY, V144, P5568, DOI 10.1210/en.2003-0780; Sun K, 1997, J CLIN ENDOCR METAB, V82, P300, DOI 10.1210/jc.82.1.300; Sun K, 1997, ENDOCRINOLOGY, V138, P4912, DOI 10.1210/en.138.11.4912; TANSWELL AK, 1977, J CLIN ENDOCR METAB, V45, P721, DOI 10.1210/jcem-45-4-721; von Bredow DC, 1998, BIOCHEM J, V331, P965, DOI 10.1042/bj3310965; Wang WS, 2014, PLACENTA, V35, P30, DOI 10.1016/j.placenta.2013.10.018; Wang WS, 2018, ENDOCR REV, V39, P241, DOI 10.1210/er.2017-00188; Wang WS, 2016, ENDOCRINOLOGY, V157, P4487, DOI 10.1210/en.2016-1464; Wang WS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6151; Wang WS, 2012, ENDOCRINOLOGY, V153, P2012, DOI 10.1210/en.2011-1626; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303; Yin Z, 2017, NUCLEIC ACIDS RES, V45, P11425, DOI 10.1093/nar/gkx795; Yonemoto H, 2006, PLACENTA, V27, P669, DOI 10.1016/j.placenta.2005.05.014	57	8	9	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2770	2781		10.1096/fj.201801216R	http://dx.doi.org/10.1096/fj.201801216R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303742				2022-12-28	WOS:000457296600099
J	Zheng, HM; Zhang, YF; Chen, YC; Guo, PF; Wang, XX; Yuan, X; Ge, WZ; Yang, R; Yan, QF; Yang, XH; Xi, YM				Zheng, Huimei; Zhang, Yafei; Chen, Yuchen; Guo, Pengfei; Wang, Xuexiang; Yuan, Xin; Ge, Wanzhong; Yang, Ru; Yan, Qingfeng; Yang, Xiaohang; Xi, Yongmei			Prominin-like, a homolog of mammalian CD133, suppresses dilp6 and TOR signaling to maintain body size and weight in Drosophila	FASEB JOURNAL			English	Article						AC133; prominin-1; ecdysone; fat body	INSULIN-LIKE PEPTIDE; FAT-BODY; EPITHELIAL-CELLS; CELLULAR GROWTH; STEM-CELLS; RECEPTOR; METABOLISM; STARVATION; IDENTIFICATION; MOBILIZATION	CD133 (AC133/prominin-1) has been identified as a stem cell marker and a putative cancer stem cell marker in many solid tumors. Its biologic function and molecular mechanisms remain largely elusive. Here, we show that a fly mutant for prominin-like, a homolog of mammalian CD133, shows a larger body size and excess weight accompanied with higher fat deposits as compared with the wild type. The expression levels of prominin-like are mediated by ecdysone signaling where its protein levels increase dramatically in the fat body during metamorphosis. Prominin-like mutants exhibit higher Drosophila insulin-like peptide 6 (dilp6) levels during nonfeeding stages and increased Akt/Drosophila target of rapamycin (dTOR) signaling. On an amino acid-restricted diet, prominin-like mutants exhibit a significantly larger body size than the wild type does, similar to that which occurs upon the activation of the dTOR pathway in the fat body. Our data suggest that prominin-like functions by suppressing TOR and dilp6 signaling to control body size and weight. The identification of the physiologic function of prominin-like in Drosophila may provide valuable insight into the understanding of the metabolic function of CD133 in mammals.Zheng, H., Zhang, Y., Chen, Y., Guo, P., Wang, X., Yuan, X., Ge, W., Yang, R., Yan, Q., Yang, X., Xi, Y. Prominin-like, a homolog of mammalian CD133, suppresses dilp6 and TOR signaling to maintain body size and weight in Drosophila.	[Zheng, Huimei; Chen, Yuchen; Guo, Pengfei; Yuan, Xin; Ge, Wanzhong; Yang, Xiaohang; Xi, Yongmei] Zhejiang Univ, Womens Hosp, Sch Med, Div Human Reprod & Dev Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Chen, Yuchen; Guo, Pengfei; Yuan, Xin; Ge, Wanzhong; Yang, Xiaohang; Xi, Yongmei] Zhejiang Univ, Sch Med, Dept Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Chen, Yuchen; Guo, Pengfei; Yuan, Xin; Ge, Wanzhong; Yang, Xiaohang; Xi, Yongmei] Zhejiang Univ, Inst Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Zhang, Yafei; Guo, Pengfei; Wang, Xuexiang; Yan, Qingfeng] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Yang, Xiaohang] Zhejiang Univ, Zhejiang Univ Univ Toronto Joint Inst Genet & Gen, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yafei] Beijing Genom Inst, Shanghai, Peoples R China; [Yang, Ru] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Yang, Ru] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Beijing Genomics Institute (BGI); Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, XH; Xi, YM (corresponding author), Zhejiang Univ, Sch Med, Yuhangtang Rd 866, Hangzhou 310012, Zhejiang, Peoples R China.	xhyang@zju.edu.cn; xyyongm@zju.edu.cn	guo, peng/AAG-4052-2019; 席, 咏梅/AAE-1909-2022; yan, qing/GZN-2287-2022; Guo, Peng/GWC-0572-2022	ZHENG, HUIMEI/0000-0001-7129-8412; Ge, Wanzhong/0000-0003-1334-2723	National Key Basic Research Program of China (973 Program) [2012CB966804]; National Natural Science Foundation of China [31371319, 31801230]; China Postdoctoral Science Foundation [2018M632452]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors acknowledge the Bloomington Drosophila Stock Center, the Exelixis Collection at the Harvard Medical School, and the Tsinghua Fly Center for providing the fly stocks, and L. M. Wang (Zhejiang University) for providing the Drosophila Activity Monitoring System. This study was supported by grants from the National Key Basic Research Program of China (973 Program) (Grant 2012CB966804), the National Natural Science Foundation of China (Grants 31371319 and 31801230), and the China Postdoctoral Science Foundation (Grant 2018M632452). The authors declare no conflicts of interest.	Alves-Bezerra M, 2016, INSECT BIOCHEM MOLEC, V69, P51, DOI 10.1016/j.ibmb.2015.06.013; Asha H, 2003, GENETICS, V163, P203; Ballard JWO, 2008, J INSECT PHYSIOL, V54, P1371, DOI 10.1016/j.jinsphys.2008.07.009; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Bruno S, 2006, AM J PATHOL, V169, P2223, DOI 10.2353/ajpath.2006.060498; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Corbeil D, 2013, PROMININ 1 CD133 NEW; Demontis F, 2007, DEV DYNAM, V236, P3408, DOI 10.1002/dvdy.21324; Fossett N, 2013, BBA-GEN SUBJECTS, V1830, P2375, DOI 10.1016/j.bbagen.2012.06.005; Glatter T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.79; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Han Z, 2012, INVEST OPHTH VIS SCI, V53, P361, DOI 10.1167/iovs.11-8635; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennig KM, 2002, GENESIS, V34, P107, DOI 10.1002/gene.10139; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Klambt T. H. C., 2008, METHODS PROTOCOLS, P108; Lan X, 2013, INT J MOL MED, V31, P315, DOI 10.3892/ijmm.2012.1208; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Nassel DR, 2015, GEN COMP ENDOCR, V221, P255, DOI 10.1016/j.ygcen.2014.11.021; Nie J, 2012, DEV BIOL, V371, P312, DOI 10.1016/j.ydbio.2012.08.024; Okamoto N, 2015, DEV CELL, V35, P295, DOI 10.1016/j.devcel.2015.10.003; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2011, TRENDS ENDOCRIN MET, V22, P45, DOI 10.1016/j.tem.2010.11.002; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Parisi F, 2013, DEV BIOL, V379, P64, DOI 10.1016/j.ydbio.2013.04.008; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Shingleton AW, 2005, CURR BIOL, V15, pR825, DOI 10.1016/j.cub.2005.10.006; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slack C, 2007, DEVELOPMENT, V134, P3781, DOI 10.1242/dev.010900; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Slocumb ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131275; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Tiebe M, 2015, DEV CELL, V33, P272, DOI 10.1016/j.devcel.2015.03.013; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028405; Yang Z, 2015, P NATL ACAD SCI USA, V112, P5219, DOI 10.1073/pnas.1417838112; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zheng HM, 2017, FASEB J, V31, P1964, DOI 10.1096/fj.201601127R; Zheng HM, 2016, LIFE SCI, V167, P22, DOI 10.1016/j.lfs.2016.10.019; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	65	5	5	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2646	2658		10.1096/fj.201800123R	http://dx.doi.org/10.1096/fj.201800123R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307770				2022-12-28	WOS:000457296600089
J	Kohutova, A; Raska, J; Kruta, M; Seneklova, M; Barta, T; Fojtik, P; Jurakova, T; Walter, CA; Hampl, A; Dvorak, P; Rotrekl, V				Kohutova, Aneta; Raska, Jan; Kruta, Miriama; Seneklova, Monika; Barta, Tomas; Fojtik, Petr; Jurakova, Tereza; Walter, Christi A.; Hampl, Ales; Dvorak, Petr; Rotrekl, Vladimir			Ligase 3-mediated end-joining maintains genome stability of human embryonic stem cells	FASEB JOURNAL			English	Article						base excision repair; PARP1; 53BP1; pluripotent stem cells; alternative DNA end-joining	DOUBLE-STRAND BREAKS; BASE EXCISION-REPAIR; DNA-DAMAGE CLUSTERS; HOMOLOGOUS-RECOMBINATION; IONIZING-RADIATION; POLY(ADP-RIBOSE) POLYMERASE-1; MUTATION FREQUENCY; PATHWAY CHOICE; SOMATIC-CELLS; CHECKPOINT	Maintenance of human embryonic stem cells (hESCs) with stable genome is important for their future use in cell replacement therapy and disease modeling. Our understanding of the mechanisms maintaining genomic stability of hESC and our ability to modulate them is essential in preventing unwanted mutation accumulation during their in vitro cultivation. In this study, we show the DNA damage response mechanism in hESCs is composed of known, yet unlikely components. Clustered oxidative base damage is converted into DNA double-strand breaks (DSBs) by base excision repair (BER) and then quickly repaired by ligase (Lig)3-mediated end-joining (EJ). If there is further induction of clustered oxidative base damage by irradiation, then BER-mediated DSBs become essential in triggering the checkpoint response in hESCs. hESCs limit the mutagenic potential of Lig3-mediated EJ by DNA break end protection involving p53 binding protein 1 (53BP1), which results in fast and error-free microhomology-mediated repair and a low mutant frequency in hESCs. DSBs in hESCs are also repaired via homologous recombination (HR); however, DSB overload, together with massive end protection by 53BP1, triggers competition between error-free HR and mutagenic nonhomologous EJ.-Kohutova, A., Raska, J., Kruta, M., Seneklova, M., Barta, T., Fojtik, P., Jurakova, T., Walter, C. A., Hampl, A., Dvorak, P., Rotrekl, V. Ligase 3-mediated end-joining maintains genome stability of human embryonic stem cells.	[Kohutova, Aneta; Raska, Jan; Kruta, Miriama; Seneklova, Monika; Fojtik, Petr; Jurakova, Tereza; Dvorak, Petr; Rotrekl, Vladimir] Masaryk Univ, Dept Biol, Fac Med, Kamenice 5,Bldg A3, Brno 62500, Czech Republic; [Barta, Tomas; Hampl, Ales] Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic; [Kohutova, Aneta; Hampl, Ales; Dvorak, Petr; Rotrekl, Vladimir] St Annes Univ Hosp, ICRC, Brno, Czech Republic; [Walter, Christi A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, San Antonio, TX 78229 USA	Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); University of Texas System; University of Texas Health San Antonio	Rotrekl, V (corresponding author), Masaryk Univ, Dept Biol, Fac Med, Kamenice 5,Bldg A3, Brno 62500, Czech Republic.	vrotrekl@med.muni.cz	Rotrekl, Vladimir/C-8378-2018; Fojtík, Petr/GLR-7338-2022; Barta, Tomas/B-5076-2010	Rotrekl, Vladimir/0000-0002-1298-0849; Barta, Tomas/0000-0003-0703-066X; Fojtik, Petr/0000-0003-0188-0022	Grant Agency of the Czech Republic (GACR) [P302/12/G157]; National Program of Sustainability II (MEYS CR) [LQ1605]; European Research Center for Life Science, Advanced Materials and Nanotechnology (CEITEC 2020) [LQ1601]; Masaryk University [MUNI/C/0967/2013]	Grant Agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); National Program of Sustainability II (MEYS CR); European Research Center for Life Science, Advanced Materials and Nanotechnology (CEITEC 2020); Masaryk University	This work was supported by the Grant Agency of the Czech Republic (GACR; Grant P302/12/G157), the National Program of Sustainability II (MEYS CR; LQ1605), and the European Research Center for Life Science, Advanced Materials and Nanotechnology (CEITEC 2020; LQ1601). This work was also supported by the Rector's Program for Student Projects from Masaryk University (MUNI/C/0967/2013). The authors declare no conflicts of interest.	Abdou I, 2015, NUCLEIC ACIDS RES, V43, P875, DOI 10.1093/nar/gku1307; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ahrabi S, 2016, NUCLEIC ACIDS RES, V44, P5743, DOI 10.1093/nar/gkw326; Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bakr A, 2016, ONCOTARGET, V7, P57679, DOI 10.18632/oncotarget.11023; Barta T, 2010, STEM CELLS, V28, P1143, DOI 10.1002/stem.451; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Bennett PV, 2005, FREE RADICAL BIO MED, V39, P832, DOI 10.1016/j.freeradbiomed.2005.05.008; Bogomazova AN, 2011, AGING-US, V3, P584, DOI 10.18632/aging.100336; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chan CY, 2007, NUCLEIC ACIDS RES, V35, P5051, DOI 10.1093/nar/gkm442; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cooper DJ, 2017, STEM CELL RES, V19, P113, DOI 10.1016/j.scr.2016.12.029; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Deng SK, 2014, NAT STRUCT MOL BIOL, V21, P405, DOI 10.1038/nsmb.2786; Desmarais JA, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0279-2; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Ensminger M, 2014, J CELL BIOL, V206, P29, DOI 10.1083/jcb.201312078; Fan JS, 2011, MUTAT RES-FUND MOL M, V713, P8, DOI 10.1016/j.mrfmmm.2011.05.018; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Georgakilas AG, 2008, MOL BIOSYST, V4, P30, DOI 10.1039/b713178j; GERMAN J, 2001, CURR PROTOC HUM GENE, pCH8; Grabarz A, 2013, CELL REP, V5, P21, DOI 10.1016/j.celrep.2013.08.034; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gulston M, 2004, NUCLEIC ACIDS RES, V32, P1602, DOI 10.1093/nar/gkh306; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Kent T, 2016, ELIFE, V5, DOI 10.7554/eLife.13740; Kotter A, 2014, MOL ONCOL, V8, P1616, DOI 10.1016/j.molonc.2014.06.008; Kraft D, 2015, LEUKEMIA, V29, P1543, DOI 10.1038/leu.2015.28; Kruta M, 2014, STEM CELLS DEV, V23, P2443, DOI 10.1089/scd.2013.0611; Kruta M, 2013, STEM CELLS, V31, P693, DOI 10.1002/stem.1312; Kuhfittig-Kulle S, 2007, MUTAGENESIS, V22, P217, DOI 10.1093/mutage/gem007; Kunova M, 2013, STEM CELL TRANSL MED, V2, P246, DOI 10.5966/sctm.2012-0081; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039588; Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576; Lomax ME, 2013, CLIN ONCOL-UK, V25, P578, DOI 10.1016/j.clon.2013.06.007; Luo LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030541; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Ochs F, 2016, NAT STRUCT MOL BIOL, V23, P714, DOI 10.1038/nsmb.3251; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Serrano L, 2011, STEM CELLS DEV, V20, P363, DOI 10.1089/scd.2010.0159; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Shibata A, 2017, MUTAT RES-FUND MOL M, V803, P51, DOI 10.1016/j.mrfmmm.2017.07.011; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Tavecchio M, 2012, CANCER CHEMOTH PHARM, V69, P155, DOI 10.1007/s00280-011-1662-4; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Vamvakas S, 1997, CRIT REV TOXICOL, V27, P155, DOI 10.3109/10408449709021617; Vinarsky V, 2013, STEM CELLS DEV, V22, P2964, DOI 10.1089/scd.2013.0057; Wang HL, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0136-8; Weeks LD, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.477; Wyles SP, 2014, INT J MOL SCI, V15, P20948, DOI 10.3390/ijms151120948; Xiong XH, 2015, NUCLEIC ACIDS RES, V43, P1659, DOI 10.1093/nar/gku1406; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	76	2	3	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6778	6788		10.1096/fj.201801877RR	http://dx.doi.org/10.1096/fj.201801877RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30807703				2022-12-28	WOS:000476114200009
J	Li, S; Ghoshal, S; Sojoodi, M; Arora, G; Masia, R; Erstad, DJ; Ferriera, DS; Li, Y; Wang, G; Lanuti, M; Caravan, P; Or, YS; Jiang, LJ; Tanabe, KK; Fuchs, BC				Li, Shen; Ghoshal, Sarani; Sojoodi, Mozhdeh; Arora, Gunisha; Masia, Ricard; Erstad, Derek J.; Ferriera, Diego S.; Li, Yang; Wang, Guogiang; Lanuti, Michael; Caravan, Peter; Or, Yat Sun; Jiang, Li-Juan; Tanabe, Kenneth K.; Fuchs, Bryan C.			The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction	FASEB JOURNAL			English	Article						FXR; kidney; injury; UUO; YAP1	CHRONIC KIDNEY-DISEASE; FXR; YAP; PATHOGENESIS; PIRFENIDONE; PROGRESSION; ACTIVATION; MECHANISMS; TRANSITION; INDUCTION	Farnesoid X receptor (FXR) is a nuclear receptor that has emerged as a key regulator in the maintenance of hepatic steatosis, inflammation, and fibrosis. However, the role of FXR in renal fibrosis remains to be established. Here, we investigate the effects of the FXR agonist EDP-305 in a mouse model of tubulointerstitial fibrosis via unilateral ureteral obstruction (UUO). Male C57Bl/6 mice received a UUO on their left kidney. On postoperative d 4, mice received daily treatment by oral gavage with either vehicle control (0.5% methylcellulose) or 10 or 30 mg/kg EDP-305. All animals were euthanized on postoperative d 12. EDP-305 dose-dependently decreased macrophage infiltration as measured by the F4/80 staining area and proinflammatory cytokine gene expression. EDP-305 also dose-dependently reduced interstitial fibrosis as assessed by morphometric quantification of the collagen proportional area and kidney hydroxyproline levels. Finally, yes-associated protein (YAP) activation, a major driver of fibrosis, increased after UUO injury and was diminished by EDP-305 treatment. Consistently, EDP-305 decreased TGF-beta 1-induced YAP nuclear localization in human kidney 2 cells by increasing inhibitory YAP phosphorylation. YAP inhibition may be a novel antifibrotic mechanism of FXR agonism, and EDP-305 could be used to treat renal fibrosis.-Li, S., Ghoshal, S., Sojoodi, M., Arora, G., Masia, R., Erstad, D. J., Ferriera, D. S., Li, Y., Wang, G., Lanuti, M., Caravan, P., Or, Y. S., Jiang, L.-J., Tanabe, K. K., Fuchs, B. C. The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction.	[Li, Shen; Ghoshal, Sarani; Sojoodi, Mozhdeh; Arora, Gunisha; Erstad, Derek J.; Lanuti, Michael; Tanabe, Kenneth K.; Fuchs, Bryan C.] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Div Surg Oncol, Boston, MA 02115 USA; [Masia, Ricard] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Dept Pathol, Boston, MA 02115 USA; [Caravan, Peter] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Inst Innovat Imaging, Boston, MA 02115 USA; [Ferriera, Diego S.; Caravan, Peter] Harvard Med Sch, Massachusetts Gen Hosp, Martins Ctr Biomed Imaging, Charlestown, MA USA; [Li, Yang; Wang, Guogiang; Or, Yat Sun; Jiang, Li-Juan] Enanta Pharmaceut, Watertown, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Fuchs, BC (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Div Surg Oncol, 55 Fruit St,WRN 401, Boston, MA 02114 USA.	bfuchs@mgh.harvard.edu	dos Santos Ferreira, Diego/O-7637-2014	dos Santos Ferreira, Diego/0000-0003-1505-7950	NIDDK NIH HHS [U01 DK104302] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alikhan MA, 2013, NEPHROLOGY, V18, P81, DOI 10.1111/nep.12014; Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Burns WC, 2007, CELLS TISSUES ORGANS, V185, P222, DOI 10.1159/000101323; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Cho ME, 2007, CLIN J AM SOC NEPHRO, V2, P906, DOI 10.2215/CJN.01050207; Collins AJ, 2009, CLIN J AM SOC NEPHRO, V4, pS5, DOI 10.2215/CJN.05980809; Das A, 2016, J BIOL CHEM, V291, P6096, DOI 10.1074/jbc.M115.708313; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Ding L, 2015, ACTA PHARM SIN B, V5, P135, DOI 10.1016/j.apsb.2015.01.004; Eardley KS, 2008, KIDNEY INT, V74, P495, DOI 10.1038/ki.2008.183; Fiorucci S, 2007, TRENDS MOL MED, V13, P298, DOI 10.1016/j.molmed.2007.06.001; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Gai ZB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10168-6; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hodgkins KS, 2012, PEDIATR NEPHROL, V27, P901, DOI 10.1007/s00467-011-1992-9; Huen SC, 2013, AM J PHYSIOL-RENAL, V305, pF477, DOI 10.1152/ajprenal.00624.2012; Hutson PR, 2003, J CHROMATOGR B, V791, P427, DOI 10.1016/S1570-0232(03)00248-4; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Jung GS, 2009, J AM SOC NEPHROL, V20, P2162, DOI 10.1681/ASN.2008121232; Li XJ, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-15; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Ma LJ, 2003, AM J PATHOL, V163, P1261, DOI 10.1016/S0002-9440(10)63486-4; Mann JFE, 2010, J AM SOC NEPHROL, V21, P527, DOI 10.1681/ASN.2009060593; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; NAGLE RB, 1973, LAB INVEST, V28, P456; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Schnaper HW, 2017, ADV CHRONIC KIDNEY D, V24, P107, DOI 10.1053/j.ackd.2016.11.011; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Verbeke L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33453; Verma SK, 2015, SEMIN NEPHROL, V35, P96, DOI 10.1016/j.semnephrol.2015.01.010; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhao K, 2016, SCI REP-UK, V6, DOI 10.1038/srep37234; Zhong JY, 2017, AM J PHYSIOL-RENAL, V312, pF375, DOI 10.1152/ajprenal.00266.2016	39	14	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7103	7112		10.1096/fj.201801699R	http://dx.doi.org/10.1096/fj.201801699R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30884252	Green Published			2022-12-28	WOS:000476114200036
J	De Marchi, U; Galindo, AN; Thevenet, J; Hermant, A; Bermont, F; Lassueur, S; Domingo, JS; Kussmann, M; Dayon, L; Wiederkehr, A				De Marchi, Umberto; Galindo, Antonio Nunez; Thevenet, Jonathan; Hermant, Aurelie; Bermont, Flavien; Lassueur, Steve; Domingo, Jaime Santo; Kussmann, Martin; Dayon, Loic; Wiederkehr, Andreas			Mitochondrial lysine deacetylation promotes energy metabolism and calcium signaling in insulin-secreting cells	FASEB JOURNAL			English	Article						SIRT3; mitochondria; pancreatic; beta-cells; type 2 diabetes	SIRT3; PROTEIN; ACETYLATION; CA2+; PHOSPHORYLATION; DEFICIENCY; INDICATORS; PROTEOMICS; GLUCOSE	In pancreatic beta-cells, mitochondria generate signals that promote insulin granule exocytosis. Here we study how lysine acetylation of mitochondrial proteins mechanistically affects metabolism-secretion coupling in insulin-secreting cells. Using mass spectrometry-based proteomics, we identified lysine acetylation sites in rat insulinoma cell line clone 1E cells. In cells lacking the mitochondrial lysine deacetylase sirtuin-3 (SIRT3), several matrix proteins are hyperacetylated. Disruption of the SIRT3 gene has a deleterious effect on mitochondrial energy metabolism and Ca2+ signaling. Under resting conditions, SIRT3 deficient cells are overactivated, which elevates the respiratory rate and enhances calcium signaling and basal insulin secretion. In response to glucose, the SIRT3 knockout cells are unable to mount a sustained cytosolic ATP response. Calcium signaling is strongly reduced and the respiratory response as well as insulin secretion are blunted. We propose mitochondrial protein lysine acetylation as a control mechanism in beta-cell energy metabolism and Ca2+ signaling.	[De Marchi, Umberto; Thevenet, Jonathan; Hermant, Aurelie; Bermont, Flavien; Lassueur, Steve; Domingo, Jaime Santo; Wiederkehr, Andreas] Nestle Inst Hlth Sci, Mitochondrial Funct, Lausanne, Switzerland; [Galindo, Antonio Nunez; Dayon, Loic] Nestle Inst Hlth Sci, Prote, Lausanne, Switzerland; [Kussmann, Martin] Univ Auckland, Liggins Inst, Auckland, New Zealand	Nestle SA; Nestle SA; University of Auckland	Wiederkehr, A (corresponding author), Quartier Innovat, Nestle Inst Hlth Sci, Batiment G, CH-1015 Lausanne, Switzerland.	andreas.wiederkehr@rd.nestle.com	Domingo, Jaime Santo/AAA-4995-2020; Kussmann, Martin/AAB-7453-2022; Domingo, Jaime Santo/AAE-1100-2021; Dayon, Loïc/J-2499-2019	Domingo, Jaime Santo/0000-0001-5501-0482; Kussmann, Martin/0000-0002-0966-2313; Dayon, Loïc/0000-0002-8499-270X; De Marchi, Umberto/0000-0002-6011-5446	Nestle Institute of Health Sciences SA	Nestle Institute of Health Sciences SA(Nestle SA)	The authors thank Prof. A. Miyawaki (Riken Brain Science Institute, Wako, Japan) for the YC3.6cyto probe to measure cytosolic Ca<SUP>2+</SUP> signals. This research was fully funded by Nestle Institute of Health Sciences SA. The authors declare no conflicts of interest.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Akhmedov D, 2012, BBA-MOL CELL RES, V1823, P1815, DOI 10.1016/j.bbamcr.2012.07.005; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Ciregia F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13908-w; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Dayon Loic, 2012, Methods Mol Biol, V893, P115, DOI 10.1007/978-1-61779-885-6_9; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; De Marchi U, 2017, J CELL SCI, V130, P1929, DOI 10.1242/jcs.200741; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Guo L, 2016, MOL CELL BIOL, V36, P2553, DOI 10.1128/MCB.00227-16; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Kim M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124744; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Mielke C, 2014, BIOCHEMISTRY-US, V53, P3817, DOI 10.1021/bi401651e; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002; Xu YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep39517; Yang H, 2015, EMBO J, V34, P1110, DOI 10.15252/embj.201591041; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	39	16	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4660	4674		10.1096/fj.201801424R	http://dx.doi.org/10.1096/fj.201801424R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30589571				2022-12-28	WOS:000462888500003
J	Kaibori, Y; Saito, Y; Nakayama, Y				Kaibori, Yuichiro; Saito, Youhei; Nakayama, Yuji			EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity	FASEB JOURNAL			English	Article						RhoG; Ephexin4; mitosis; mitotic spindle formation; blebbing	MAP KINASE PATHWAY; CELL-MIGRATION; B-RAF; SPINDLE ORIENTATION; TYROSINE RESIDUES; MECHANISMS; CYCLIN; ACTIVATION; RESISTANCE; INHIBITION	Successful cell division is accomplished by the proper formation of the mitotic spindle. Here, we show that EphA2 knockdown causes mitotic errors, including a delay in M-phase progression, asymmetric spindle positioning, multipolar spindles, and cell blebs. It has been known that EphA2 is phosphorylated at Tyr588, which is triggered by the ligand binding, and at Ser897 downstream of growth factor signaling. Upon mitotic entry, EphA2 is phosphorylated at Ser897, accompanied by a reduction in Tyr588 phosphorylation. This EphA2 phosphorylation at Ser897 is inhibited by MEK/ERK and 90 kDa ribosomal S6 kinase (RSK) inhibitors and is induced by the introduction of active cyclin-dependent kinase 1 (Cdk1) and cyclin B1. EphA2 knockdown-induced M-phase delay and cell blebs are rescued by wild type EphA2 expression but not by Ser897Ala mutant. The Ras homolog gene family member G (RhoG) guanine nucleotide exchange factor Ephexin4 interacts with EphA2 in a Ser897 phosphorylation-dependent manner, and its knockdown delays M-phase progression and causes RhoG delocalization. RhoG knockdown delays M-phase progression, and EphA2 knockdown-induced M-phase delay is partially rescued by the constitutively active RhoG mutant. These results suggest that, in EphA2-expressing cells, EphA2 phosphorylation at Ser897 participates in proper M-phase progression downstream of the Cdk1/MEK/ERK/RSK pathway because of its role in maintaining cortical rigidity via Ephexin4 and RhoG and thereby regulating mitotic spindle formation.	[Kaibori, Yuichiro; Saito, Youhei; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto, Japan	Kyoto Pharmaceutical University	Nakayama, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Yamashina Ku, 5 Misasagi Nakauchi Cho, Kyoto 6078414, Japan.	nakayama@mb.kyoto-phu.ac.jp		Saito, Youhei/0000-0002-8545-6925; Nakayama, Yuji/0000-0001-7882-0066	Japan Society for the Promotion of Science [16K08253, 25460076, 26870701]; Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University, Chiba, Japan); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities [S1311035, S1511024L]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University, Chiba, Japan); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grants 16K08253, 25460076, and 26870701), grants from the Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University and Chiba University, Chiba, Japan), the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research (to Y.S.), and the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities [Grant S1311035 (to Y.S.) and S1511024L (to Y.N.)]. The authors declare no conflicts of interest.	Barquilla A, 2016, MOL BIOL CELL, V27, P2757, DOI 10.1091/mbc.E16-01-0048; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Borysov SI, 2008, MOL BIOL CELL, V19, P2907, DOI 10.1091/mbc.E07-07-0679; Borysov SI, 2006, J BIOL CHEM, V281, P22586, DOI 10.1074/jbc.M601432200; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Gucciardo E, 2014, CELL MOL LIFE SCI, V71, P3685, DOI 10.1007/s00018-014-1633-0; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Hamaoka Y, 2016, CELL SIGNAL, V28, P937, DOI 10.1016/j.cellsig.2016.04.009; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; IKEBE M, 1985, J BIOL CHEM, V260, P27; Iwamoto E, 2016, J CELL BIOCHEM, V117, P1340, DOI 10.1002/jcb.25424; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jones LA, 2014, J CELL BIOL, V207, P499, DOI 10.1083/jcb.201408025; Jungas T, 2016, J CELL BIOL, V214, P555, DOI 10.1083/jcb.201602057; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kawai H, 2013, FEBS OPEN BIO, V3, P78, DOI 10.1016/j.fob.2013.01.002; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Kwiatkowska A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-65; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Martiny-Baron G, 2010, ANGIOGENESIS, V13, P259, DOI 10.1007/s10456-010-9183-z; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Miozzo M, 2000, INT J CANCER, V87, P68, DOI 10.1002/1097-0215(20000701)87:1<68::AID-IJC10>3.0.CO;2-V; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Nam HJ, 2014, CELL SIGNAL, V26, P208, DOI 10.1016/j.cellsig.2013.11.014; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SOMLYO AP, 1994, NATURE, V372, P812; Song W, 2017, ONCOGENE, V36, P5620, DOI 10.1038/onc.2017.170; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; Tian D, 2015, CURR BIOL, V25, P1135, DOI 10.1016/j.cub.2015.02.072; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; ZernickaGoetz M, 1997, DEVELOPMENT, V124, P1133; Zhou Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8679; Zhuang GL, 2010, CANCER RES, V70, P299, DOI 10.1158/0008-5472.CAN-09-1845	75	10	11	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5334	5349		10.1096/fj.201801519RR	http://dx.doi.org/10.1096/fj.201801519RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668924	Bronze			2022-12-28	WOS:000462888500057
J	Kim, D; Kang, H				Kim, Donghyun; Kang, Hyunsik			Exercise training modifies gut microbiota with attenuated host responses to sepsis in wild-type mice	FASEB JOURNAL			English	Article						physical fitness; systemic inflammation; survival; organ injury	INFLAMMATION; ADAPTATIONS; MORTALITY; RISK	This study investigated the effects of exercise preconditioning-induced modification in gut microbiota composition and host responses to cecal ligation and puncture (CLP)-induced sepsis. Four-week-old C57BL/6N male mice were randomly assigned to either CLP (n = 30) or CLP-exercise (CLP+Exe; n = 30) groups. Prior to CLP-induced sepsis, the CLP+Exe mice were subjected to 8 wk of treadmill running. Fecal samples were collected and analyzed by 16S rRNA amplification sequencing to assess gut microbiota composition. Diversity analyses such as principal coordinates analysis and rarefaction curves showed that exercise preconditioning was associated with differences in gut microbiota community structure and species richness. Exercise preconditioning-induced differences in gut microbiota composition were also evident at the family level of taxonomic analysis, with the dominant phyla being Bacteriodetes, Firmicutes, Verrucomicrobia, and, to a lesser extent, Cyanobacteria. Compared with control mice, preconditioned mice had a higher survival rate and less organ damage during the acute phase of sepsis, secondary to attenuation of the host response to septic shock. The current findings suggest that exercise preconditioning-induced modification in gut microbiota composition may lead to an attenuated host response to CLP-induced sepsis in wild-type mice, as shown by increased survival and less organ damage, as well as the establishment of a balance between pro- and anti-inflammatory responses.	[Kim, Donghyun; Kang, Hyunsik] Sungkyunkwan Univ, Coll Sport Sci, Suwon, South Korea	Sungkyunkwan University (SKKU)	Kang, H (corresponding author), Sungkyunkwan Univ, Coll Sport Sci, Lab Exercise Physiol & Biochem, 2066 Seobu Ro, Suwon 16419, South Korea.	hkang@skku.edu			National Research Foundation - Korean Government [NRF-2018R1D1A1B07048153, NRF-2016R1A6A3A11932432]	National Research Foundation - Korean Government(Korean Government)	The National Research Foundation Grant funded by the Korean Government (NRF-2018R1D1A1B07048153 and NRF-2016R1A6A3A11932432) supported this work. The authors declare no conflicts of interest.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Al-Nassan S, 2018, GEN PHYSIOL BIOPHYS, V37, P433, DOI 10.4149/gpb_2018001; Allen JM, 2018, GUT MICROBES, V9, P115, DOI 10.1080/19490976.2017.1372077; Allen JM, 2018, MED SCI SPORT EXER, V50, P747, DOI [10.1249/MSS.0000000000001495, 10.1249/mss.0000000000001495]; Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Bermon S, 2015, EXERC IMMUNOL REV, V21, P70; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen MF, 2010, MED SCI SPORT EXER, V42, P2173, DOI 10.1249/MSS.0b013e3181e2158d; Choi JJ, 2013, ENVIRON HEALTH PERSP, V121, P725, DOI 10.1289/ehp.1306534; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; de Araujo CC, 2012, J APPL PHYSIOL, V112, P1206, DOI 10.1152/japplphysiol.01061.2011; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; French JP, 2008, FASEB J, V22, P2862, DOI 10.1096/fj.07-102541; Giamarellos-Bourboulis E, 2015, SCAND J GASTROENTERO, V50, P1076, DOI 10.3109/00365521.2015.1027261; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Lambert JE, 2015, APPL PHYSIOL NUTR ME, V40, P749, DOI 10.1139/apnm-2014-0452; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee SK, 2015, J EXP MED, V212, P1381, DOI 10.1084/jem.20141813; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01687; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marcinko K, 2015, MOL METAB, V4, P903, DOI 10.1016/j.molmet.2015.09.006; Martin CM, 2009, CRIT CARE MED, V37, P81, DOI 10.1097/CCM.0b013e31819285f0; McFadzean R., 2014, THESIS; Olivo CR, 2014, J APPL PHYSIOL, V117, P998, DOI 10.1152/japplphysiol.00290.2014; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Peters HPF, 2001, GUT, V48, P435, DOI 10.1136/gut.48.3.435; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Sossdorf M, 2013, CRIT CARE MED, V41, pE246, DOI 10.1097/CCM.0b013e31828a2ae3; Tyml K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1783-1; Yamada M, 2018, BIOCHEM BIOPHYS REP, V15, DOI 10.1016/j.bbrep.2018.06.001; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	39	15	17	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5772	5781		10.1096/fj.201802481R	http://dx.doi.org/10.1096/fj.201802481R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702933				2022-12-28	WOS:000462888500090
J	Sun, RF; Liu, ZG; Han, L; Yang, Y; Wu, F; Jiang, QY; Zhang, HH; Ma, RL; Miao, JY; He, K; Wang, XF; Zhou, D; Huang, C				Sun, Ruifang; Liu, Zhigang; Han, Lin; Yang, Yang; Wu, Fei; Jiang, Qiuyu; Zhang, Huahua; Ma, Ruili; Miao, Jiyu; He, Kang; Wang, Xiaofei; Zhou, Dangxia; Huang, Chen			miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer	FASEB JOURNAL			English	Article						BCL9-2; EMT; microRNA-22; microRNA-214; carcinoma of colon	SUPPRESSES GROWTH; PROSTATE-CANCER; CERVICAL-CANCER; TUMOR-GROWTH; E-CADHERIN; EXPRESSION; PROMOTES; MIGRATION; INVASION; GENE	The epithelial-mesenchymal transition (EMT) is crucial for cancer progression. Evidence has shown that miR-22 and miR-214 play a key role in colon cancer progression; however, the underlying mechanism remains to be known. The effects of miR-22 and miR-214 on EMT are contradictory in different cancers, and whether miR-22 and miR-214 are involved in the colon cancer EMT process needs to be elucidated. In this study, we evaluated the exact role and the regulation mechanism of miR-22 and miR-214 in colon cancer. After transfection with miR-22 expression vector, the cell proliferation and migration capacity of HCT116 and RKO cells were significantly suppressed. Also, E-cadherin was increased and vimentin was decreased by miR-22 overexpression. Similar effects were also observed after miR-214 expression vector transfection. Dual-luciferase reporter confirmed that BCL9L is the target gene of both miR-22 and miR-214. Silencing of BCL9L inhibits cell proliferation and migration, and the expression of E-cadherin and vimentin was also altered by BCL9L knockdown, which was consistent with miR-22 or miR-214 transfection. Furthermore, miR-22 and miR-214 inhibited tumor growth in nude mice. Moreover, although the association between BCL9L's lower expression and longer survival time was statistically nonsignificant, a trend existed; further studies in a larger cohort are needed. Collectively, these data suggest that miR-22 and miR-214 inhibit cell proliferation, migration, and EMT of colon cancer, most likely by targeting BCL9L.	[Sun, Ruifang; Zhou, Dangxia] Xi An Jiao Tong Univ, Stomatol Hosp, Dept Pathol, Xian, Shaanxi, Peoples R China; [Han, Lin; Wu, Fei; Jiang, Qiuyu; Miao, Jiyu; Wang, Xiaofei; Huang, Chen] Xi An Jiao Tong Univ, Stomatol Hosp, Sch Basic Med Sci, Dept Cell Biol & Genet, Xian, Shaanxi, Peoples R China; [Sun, Ruifang; Han, Lin; Yang, Yang; Wu, Fei; Jiang, Qiuyu; Miao, Jiyu; He, Kang; Wang, Xiaofei; Zhou, Dangxia; Huang, Chen] Xi An Jiao Tong Univ, Stomatol Hosp, Minist Educ China, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China; [Yang, Yang] Xi An Jiao Tong Univ, Stomatol Hosp, Sch Publ Hlth, Xian, Shaanxi, Peoples R China; [Huang, Chen] Xi An Jiao Tong Univ, Stomatol Hosp, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Shaanxi, Peoples R China; [He, Kang] Xi An Jiao Tong Univ, Stomatol Hosp, Dept Periodontol, Xian, Shaanxi, Peoples R China; [Liu, Zhigang] Shaanxi Prov Tumor Hosp, Dept Thorac Surg, Xian, Shaanxi, Peoples R China; [Zhang, Huahua] Yanan Univ, Med Coll, Yanan, Peoples R China; [Ma, Ruili] Xian Med Univ, Sch Basic Med Sci, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Ministry of Education, China; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Yanan University; Xi'an Medical University	Zhou, D (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pathol, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.; Huang, C (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Cell Biol & Genet, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	zhoudangxia@163.com; hchen@mail.xjtu.edu.cn			National Natural Science Foundation of China [81802788]; Shaanxi Provincial Natural Science Foundation of China [2018JM7028]; Postdoctoral Science Foundation of China [2017M620458]; Fundamental Research Funds for the Central Universities [xjj2017192]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Natural Science Foundation of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by National Natural Science Foundation of China (81802788), Shaanxi Provincial Natural Science Foundation of China (2018JM7028), Postdoctoral Science Foundation of China (2017M620458), and the Fundamental Research Funds for the Central Universities (xjj2017192). The authors declare no conflicts of interest.	Adachi S, 2004, CANCER RES, V64, P8496, DOI 10.1158/0008-5472.CAN-04-2254; Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Brembeck FH, 2011, GASTROENTEROLOGY, V141, P1359, DOI 10.1053/j.gastro.2011.06.039; Cai ZG, 2013, CELL BIOL INT, V37, P669, DOI 10.1002/cbin.10087; Chandrasekaran KS, 2017, CELL BIOCHEM FUNCT, V35, P464, DOI 10.1002/cbf.3304; Chandrasekaran KS, 2016, BRIT J CANCER, V115, P741, DOI 10.1038/bjc.2016.234; Chang SE, 2015, ONCOTARGET, V6, P7675, DOI 10.18632/oncotarget.3048; Chatterjee K, 2018, FASEB J, V32, P4560, DOI 10.1096/fj.201701382RR; Choi S, 2017, FASEB J, V31, P1516, DOI 10.1096/fj.201601098R; Deka J, 2010, CANCER RES, V70, P6619, DOI 10.1158/0008-5472.CAN-10-0148; Dhar S, 2017, FEBS LETT, V591, P924, DOI 10.1002/1873-3468.12603; El-Hage P, 2015, MOL CANCER RES, V13, P902, DOI 10.1158/1541-7786.MCR-14-0180; He GY, 2016, BRIT J CANCER, V115, P1367, DOI 10.1038/bjc.2016.362; Hu Y., 2018, FASEB J; Katoh M, 2003, INT J MOL MED, V12, P643; Li B, 2013, ONCOL REP, V29, P1932, DOI 10.3892/or.2013.2300; Li JJ, 2017, FASEB J, V31, P3774, DOI 10.1096/fj.201601140RR; Li Y, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0471-1; Liu ZG, 2017, INT J CLIN EXP PATHO, V10, P6799; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long HX, 2015, ONCOTARGET, V6, P38705, DOI 10.18632/oncotarget.5478; Long LM, 2015, ONCOL LETT, V9, P645, DOI 10.3892/ol.2014.2746; Lopez-Garcia C, 2017, CANCER CELL, V31, P79, DOI 10.1016/j.ccell.2016.11.001; Lu J, 2018, FASEB J, V32, P6123, DOI 10.1096/fj.201800113R; Lv JW, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.98; Matsuura K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1551; Miller TCR, 2010, J MOL BIOL, V401, P969, DOI 10.1016/j.jmb.2010.07.007; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peng RQ, 2017, BIOCHEM BIOPH RES CO, V484, P623, DOI 10.1016/j.bbrc.2017.01.152; Sannino G, 2016, ONCOTARGET, V7, P73725, DOI 10.18632/oncotarget.12455; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Sun RF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.134; Xia SS, 2017, ONCOTARGET, V8, P36266, DOI 10.18632/oncotarget.16742; Xin M, 2016, ONCOTARGET, V7, P44252, DOI 10.18632/oncotarget.10020; Yamakuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020291; Yang F, 2015, J BIOL CHEM, V290, P6507, DOI 10.1074/jbc.M114.620369; Yang LQ, 2018, CANCER LETT, V414, P44, DOI 10.1016/j.canlet.2017.11.007; Yang Y, 2015, ONCOTARGET, V6, P16227, DOI 10.18632/oncotarget.3970; Zatula N, 2014, ONCOTARGET, V5, P6770, DOI 10.18632/oncotarget.2252; Zhang GJ, 2012, MED ONCOL, V29, P3108, DOI 10.1007/s12032-012-0233-9; Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086149; Zhao LY, 2017, EBIOMEDICINE, V16, P87, DOI 10.1016/j.ebiom.2017.01.021; Zhao XJ, 2016, DNA CELL BIOL, V35, P715, DOI 10.1089/dna.2016.3398; Zheng LF, 2018, FASEB J, V32, P588, DOI 10.1096/fj.201700461RR; Zhu XB, 2017, MOL MED REP, V15, P1884, DOI 10.3892/mmr.2017.6203; Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.297	47	22	23	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5411	5424		10.1096/fj.201801798RR	http://dx.doi.org/10.1096/fj.201801798RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30698996	Bronze			2022-12-28	WOS:000462888500063
J	Verschuren, EHJ; Hoenderop, JGJ; Peters, DJM; Arjona, FJ; Bindels, RJM				Verschuren, Eric H. J.; Hoenderop, Joost G. J.; Peters, Dorien J. M.; Arjona, Francisco J.; Bindels, Rene J. M.			Tubular flow activates magnesium transport in the distal convoluted tubule	FASEB JOURNAL			English	Article						DCT; primary cilia; mechanosensation; ion channels; fluid shear stress	COLLECTING DUCT; SHEAR-STRESS; FUNCTIONAL-CHARACTERIZATION; MATHEMATICAL-MODEL; TRPM6; CHANNEL; NA; REABSORPTION; EXPRESSION; FUROSEMIDE	Magnesium (Mg2+) is an important cofactor of many enzymes crucial for life; therefore, maintaining a Mg2+ balance in the body is essential. In the kidney, the distal convoluted tubule (DCT) determines the final urinary Mg2+ excretion. The nephron is subjected to variable urinary flow, but little is known about the influence of flow on Mg2+ transport. Primary cilia, which are mechanosensory organelles that sense changes in flow, are expressed on tubular epithelial cells. This study aimed to elucidate whether urinary flow facilitates DCT Mg2+ transport. To this end, mouse DCT15 cells, with and without primary cilia, were exposed to physiologic fluid flow generating 0.3, 0.6, and 1.2 dyn/cm(2) fluid shear stress (FSS). FSS stimulated Mg2+ uptake significantly. Net Mg2+ uptake (i.e., the difference between static and FSS) followed a single component saturable first-order transport function and was independent of FSS magnitude and primary cilia. FSS did not affect the expression of magnesiotropic genes, including Cnnm2, Kcna1, Proegf, Trpm6, and Trpm7. Transient receptor potential cation channel subfamily melastatin (TRPM) member 7 (Trmp7) inhibition by 2-aminoethyl diphenyl borinate or knockout of TRPM6 did not alter net Mg2+ uptake, suggesting that TRPM6/TRPM7 homo/heterodimeric channels are not involved in FSS-activated Mg2+ transport. In summary, FSS generated by physiologic fluid flow is a new factor activating Mg2+ transport in DCT independent of primary cilia.	[Verschuren, Eric H. J.; Hoenderop, Joost G. J.; Arjona, Francisco J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Peters, Dorien J. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bindels, RJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol,NCMLS, POB 9101, NL-6500 HB Nijmegen, Netherlands.	rene.bindels@radboudumc.nl	Verschuren, Eric/AAG-9346-2020; Verschuren, Eric H.J./AAX-6774-2020; Peters, Dorien/AFH-8507-2022; Verschuren, Eric/G-4259-2016; Bindels, René JM/B-9824-2013; Arjona, Francisco/P-6059-2015	Verschuren, Eric/0000-0003-4046-4849; Peters, Dorien/0000-0001-6974-7143; Bindels, René JM/0000-0003-1167-1339; Arjona, Francisco/0000-0002-2479-0735	Dutch Kidney Foundation [15OP03]; Netherlands Organization for Scientific Research Grant NWO [VICI 016.130.668]	Dutch Kidney Foundation; Netherlands Organization for Scientific Research Grant NWO(Netherlands Organization for Scientific Research (NWO))	The authors thank Sami G. Mohammed (Radboud University Medical Center) for advice on the microfluidic cell culture experiments and Paul van der Ven (General Instruments, Radboud University) for help with the mass spectrometry analysis. This work was supported by Dutch Kidney Foundation Grant 15OP03 (to R.J.M.B. and D.J.M.P.), and by Netherlands Organization for Scientific Research Grant NWO VICI 016.130.668 (to J.G.J.H.). The authors declare no conflicts of interest.	Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Arjona F. J., 2018, PFLUGERS ARCH; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Arjona FJ, 2011, ENDOCRINOLOGY, V152, P5065, DOI 10.1210/en.2011-1166; BARTOLI E, 1973, J CLIN INVEST, V52, P843, DOI 10.1172/JCI107248; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2012, CLIN KIDNEY J, V5, P15, DOI 10.1093/ndtplus/sfr164; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Ernandez T, 2018, AM J PHYSIOL-RENAL, V314, pF763, DOI 10.1152/ajprenal.00200.2017; Essig M, 2003, J AM SOC NEPHROL, V14, pS33, DOI 10.1097/01.ASN.0000067650.43083.DF; Flores D, 2012, AM J PHYSIOL-RENAL, V303, pF632, DOI 10.1152/ajprenal.00169.2012; Galarreta CI, 2014, AM J PATHOL, V184, P1957, DOI 10.1016/j.ajpath.2014.03.007; Gilmer GG, 2018, AM J PHYSIOL-RENAL, V315, pF1398, DOI 10.1152/ajprenal.00219.2018; Glasdam SM, 2016, ADV CLIN CHEM, V73, P169, DOI 10.1016/bs.acc.2015.10.002; Glaudemans B, 2010, KIDNEY INT, V77, P17, DOI 10.1038/ki.2009.358; Glaudemans B, 2009, J CLIN INVEST, V119, P936, DOI 10.1172/JCI36948; GREEN R, 1981, KIDNEY INT, V20, P580, DOI 10.1038/ki.1981.180; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Houillier P, 2014, ANNU REV PHYSIOL, V76, P411, DOI 10.1146/annurev-physiol-021113-170336; Jang KJ, 2011, INTEGR BIOL-UK, V3, P134, DOI 10.1039/c0ib00018c; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Ko B, 2012, AM J PHYSIOL-RENAL, V303, pF700, DOI 10.1152/ajprenal.00139.2012; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Lu H, 2015, DEV BIOL, V397, P225, DOI 10.1016/j.ydbio.2014.11.009; Mohammed SG, 2018, FASEB J, V32, P3653, DOI 10.1096/fj.201701228R; Mohammed SG, 2017, FASEB J, V31, P1796, DOI 10.1096/fj.201600687RRR; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Mount DB, 2014, CLIN J AM SOC NEPHRO, V9, P1974, DOI 10.2215/CJN.04480413; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Palmer LG, 2015, CLIN J AM SOC NEPHRO, V10, P676, DOI 10.2215/CJN.12391213; Pandit MM, 2012, AM J PHYSIOL-RENAL, V302, pF1325, DOI 10.1152/ajprenal.00034.2012; Pham PCT, 2014, INT J NEPHROL RENOV, V7, P219, DOI 10.2147/IJNRD.S42054; Praetorius HA, 2003, CURR OPIN NEPHROL HY, V12, P517, DOI 10.1097/00041552-200309000-00006; Raghavan V, 2016, AM J PHYSIOL-RENAL, V310, pF1, DOI 10.1152/ajprenal.00373.2015; Raghavan V, 2015, CURR OPIN NEPHROL HY, V24, P359, DOI 10.1097/MNH.0000000000000135; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saez F, 2018, AM J PHYSIOL-RENAL, V314, pF934, DOI 10.1152/ajprenal.00631.2017; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; SCHRIER RW, 1973, KIDNEY INT, V3, P30, DOI 10.1038/ki.1973.5; Steinhausen M., 1976, MICROCIRCULATION TUB; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; van Angelen AA, 2012, CLIN KIDNEY J, V5, P535, DOI 10.1093/ckj/sfs140; Verschuren EHJ, 2018, AM J PHYSIOL-RENAL, V315, pF537, DOI 10.1152/ajprenal.00622.2017; Wang T, 2006, CURR OPIN NEPHROL HY, V15, P530, DOI 10.1097/01.mnh.0000242180.46362.c4; Weinbaum S, 2010, AM J PHYSIOL-RENAL, V299, pF1220, DOI 10.1152/ajprenal.00453.2010; Weinstein AM, 2007, AM J PHYSIOL-RENAL, V292, pF1164, DOI 10.1152/ajprenal.00392.2006; Weinstein AM, 2002, AM J PHYSIOL-RENAL, V283, pF1237, DOI 10.1152/ajprenal.00162.2002; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Xi Q, 2009, PFLUG ARCH EUR J PHY, V458, P89, DOI 10.1007/s00424-008-0601-7; Zierler S, 2011, J BIOL CHEM, V286, P39328, DOI 10.1074/jbc.M111.264341	54	4	4	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5034	5044		10.1096/fj.201802094R	http://dx.doi.org/10.1096/fj.201802094R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596515	Bronze			2022-12-28	WOS:000462888500032
J	Adachi, M; Shimizu, R; Shibazaki, C; Satoh, K; Fujiwara, S; Arai, S; Narumi, I; Kuroki, R				Adachi, Motoyasu; Shimizu, Rumi; Shibazaki, Chie; Satoh, Katsuya; Fujiwara, Satoru; Arai, Shigeki; Narumi, Issay; Kuroki, Ryota			Extended structure of pleiotropic DNA repair-promoting protein PprA from Deinococcus radiodurans	FASEB JOURNAL			English	Article						crystallography; binding protein; double-strand break; radiation; resistance	CELL-DIVISION; STRANDED-DNA; BREAK REPAIR; RADIATION; RECA; GENOME; RADIORESISTANCE; RECOMBINATION; MICROCOCCUS; RESISTANCE	Pleiotropic protein promoting DNA repair A (PprA) is a key protein facilitating the extreme radiation resistance of Deinococcus radiodurans. PprA is a unique protein to the genus Deinococcus and exists as an oligomer ranging from a tetramer to an approximate to 100-mer depending on protein concentrations. Here, the X-ray crystal structure of PprA was determined to clarify how PprA confers radiation resistance. The tertiary structure of dimeric PprA was elucidated by using mutants obtained with random and site-directed mutagenesis methods (W183R and A139R); these mutants have disabled DNA binding and polymerization functions. Because the mutant A139R and W183R proteins have dimeric assemblies with 2 different interfaces (Interfaces 1 and 2), the linear and oligomerized PprA model was constructed as a left-handed face-to-face periodic screw structure. In addition, the linear structure in solution was confirmed by small-angle scattering experiments. The site-directed mutational analysis identified essential basic amino acids for DNA binding. These analytical data support the hypothesis that a complex assembly of PprA molecules, which are extended and have a screw structure, surrounds and stretches the DNA strand, acting as a novel guide to colocalize the DNA strands for efficient DNA repairs.Adachi, M., Shimizu, R., Shibazaki, C., Satoh, K., Fujiwara, S., Arai, S., Narumi, I., Kuroki, R. Extended structure of pleiotropic DNA repair-promoting protein PprA from Deinococcus radiodurans.	[Adachi, Motoyasu; Shimizu, Rumi; Shibazaki, Chie; Fujiwara, Satoru; Arai, Shigeki] Tokai Quantum Beam Sci Ctr, Natl Inst Quantum & Radiol Sci & Technol, Tokai, Ibaraki, Japan; [Satoh, Katsuya] Natl Inst Quantum & Radiol Sci & Technol, Dept Radiat Appl Biol, Takasaki, Gunma, Japan; [Narumi, Issay; Kuroki, Ryota] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan; [Narumi, Issay] Toyo Univ, Gunma, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Japan Atomic Energy Agency; Toyo University	Adachi, M (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, 2-4 Shirakata, Tokai, Ibaraki 3191106, Japan.	adachi.motoyasu@qst.go.jp	Narumi, Issay/ABA-6740-2021	Narumi, Issay/0000-0001-9770-9574	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19370046, 19380054, JP16KT0063]; Photon Factory Program Advisory Committee [2008G524, 2011G088, 2012G672, 2014G645, 2016G510]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Photon Factory Program Advisory Committee(High Energy Accelerator Research Organization (KEK))	This research was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan through Grants-in-Aid for Scientific Research (B) (19370046 to R.K., 19380054 to I.N., and JP16KT0063 to M.A.). The synchrotron radiation experiments were performed at the BL38B1 and BL41XU beamlines of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (proposal numbers 2014B1313, and 2011A1124) and under the approval of the Photon Factory Program Advisory Committee (proposal numbers 2008G524, 2011G088, 2012G672, 2014G645, and 2016G510). The authors declare no conflicts of interest.	Adachi M, 2014, PROTEIN SCI, V23, P1349, DOI 10.1002/pro.2519; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; de la Tour CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177751; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Devigne A, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00036-15; Devigne A, 2015, MOL MICROBIOL, V96, P1069, DOI 10.1111/mmi.12991; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glatter O., 1982, ACTA PHY AUSTRIACA; Guinier  A., 1995, SMALL ANGLE SCATTERI; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Kikuchi M, 1999, FEMS MICROBIOL LETT, V174, P151, DOI 10.1016/S0378-1097(99)00135-4; Kota S, 2006, APPL MICROBIOL BIOT, V72, P790, DOI 10.1007/s00253-006-0340-7; Kota S, 2016, EXTREMOPHILES, V20, P195, DOI 10.1007/s00792-016-0814-1; Kota S, 2008, BIOCHEM CELL BIOL, V86, P448, DOI [10.1139/O08-122, 10.1139/o08-122]; KRASIN F, 1977, J MOL BIOL, V116, P81, DOI 10.1016/0022-2836(77)90120-6; Kratky O., 1948, ACTA PHYS AUSTRIACA, V2, P113; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lockhart JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071651; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludanyi M, 2014, MOL MICROBIOL, V94, P434, DOI 10.1111/mmi.12774; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Maurya GK, 2016, MICROBIOL-SGM, V162, P1321, DOI 10.1099/mic.0.000330; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSELEY BEB, 1971, J BACTERIOL, V105, P976, DOI 10.1128/JB.105.3.976-983.1971; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rajan R, 2004, J MOL BIOL, V344, P951, DOI 10.1016/j.jmb.2004.09.087; Repar J, 2010, DNA REPAIR, V9, P1151, DOI 10.1016/j.dnarep.2010.08.003; Sage E, 2017, FREE RADICAL BIO MED, V107, P125, DOI 10.1016/j.freeradbiomed.2016.12.008; Samadder P, 2016, PHARMACOL THERAPEUT, V161, P111, DOI 10.1016/j.pharmthera.2016.02.007; Sambrook J., 2001, MOL CLONING LAB MANU, pA2; Selvam K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069007; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Sugiman-Marangos SN, 2016, P NATL ACAD SCI USA, V113, P4308, DOI 10.1073/pnas.1520847113; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Toma M., 2018, CURR MED CHEM, V25, P1; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Wang YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122071; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Xu GZ, 2010, DNA REPAIR, V9, P805, DOI 10.1016/j.dnarep.2010.04.006; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	57	5	5	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3647	3658		10.1096/fj.201801506R	http://dx.doi.org/10.1096/fj.201801506R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481062	Bronze			2022-12-28	WOS:000459794800045
J	Kamsoi, O; Belles, X				Kamsoi, Orathai; Belles, Xavier			Myoglianin triggers the premetamorphosis stage in hemimetabolan insects	FASEB JOURNAL			English	Article						juvenile hormone; ecdysone; corpora allata; prothoracic gland; MEKRE93 pathway	DEPENDENT KINASE INHIBITOR; PROGRAMMED CELL-DEATH; JUVENILE-HORMONE; MICE LACKING; METAMORPHOSIS; TRANSCRIPTION; BIOSYNTHESIS; EXPRESSION; COCKROACH; PATHWAY	Insect metamorphosis is triggered by a decrease in juvenile hormone (JH) in the final juvenile instar. What induces this decrease is therefore a relevant question. Working with the cockroach Blattella germanica, we found that myoglianin (Myo), a ligand in the TGF- signaling pathway, is highly expressed in the corpora allata (CA, the JH-producing glands) and the prothoracic gland [(PG), which produce ecdysone] during the penultimate (fifth) nymphal instar (N5). In the CA, high Myo levels during N5 repress the expression of juvenile hormone acid methyl transferase, a JH biosynthesis gene. In the PG, decreasing JH levels trigger gland degeneration, regulated by the factors Kruppel homolog 1, FTZ-F1, E93, and inhibitor of apoptosis-1. Also in the PG, a peak of myo expression in N5 indirectly stimulates the expression of ecdysone biosynthesis genes, such as neverland, enhancing the production of the metamorphic ecdysone pulse in N6. The Myo expression peak in N5 also represses cell proliferation, which can enhance ecdysone production. The data indicate that Myo triggers the premetamorphic nymphal instar in B. germanica and possibly in other hemimetabolan insects.Kamsoi, O., Belles, X. Myoglianin triggers the premetamorphosis stage in hemimetabolan insects.	[Kamsoi, Orathai; Belles, Xavier] Univ Pompeu Fabra, CSIC, Spanish Natl Res Council, Inst Evolutionary Biol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Belles, X (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Passeig Maritim Barceloneta 37, Barcelona 08003, Spain.	xavier.belles@ibe.upf-csic.es	Belles, Xavier/G-2354-2015	Belles, Xavier/0000-0002-1566-303X	Spanish Ministry of Economy and Competitiveness [CGL2012-36251, CGL2015-64727-P]; Catalan Government [2017 SGR 1030]; European Fund for Economic and Regional Development (FEDER funds); Royal Thai Government	Spanish Ministry of Economy and Competitiveness(Spanish Government); Catalan Government; European Fund for Economic and Regional Development (FEDER funds); Royal Thai Government	The authors thank Guillem Ylla and Jose Carlos Montanes [both from the Institute of Evolutionary Biology (IBE), Spanish National Research Council-Universitat Pompeu Fabra] for helping with transcriptome comparisons and searching for genes in the B. germanica genome (available at https://www.hgsc.bcm.edu/arthropods/german-cockroach-genomeproject) as provided by the Baylor College of Medicine Human Genome Sequencing Center; Alba Ventos-Alfonso (IBE) for helping with different experiments and image treatment; and Maria-Dolors Piulachs and Jose-Luis Maestro (IBE) for helpful discussions. This work was supported by Spanish Ministry of Economy and Competitiveness Grants CGL2012-36251 and CGL2015-64727-P (to X.B.), by Catalan Government Grant 2017 SGR 1030 (to X.B.), and by the European Fund for Economic and Regional Development (FEDER funds). O.K. received a Royal Thai Government Scholarship to do a PhD thesis in X.B. laboratory, Barcelona. The authors declare no conflicts of interest.	Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; BAEHRECKE EH, 1995, DEV BIOL, V171, P85, DOI 10.1006/dbio.1995.1262; Barr AR, 2016, CELL SYST, V2, P27, DOI 10.1016/j.cels.2016.01.001; Belles X., 2011, ENCY LIFE SCI ELS; Belles X, 2017, ANNU REV ENTOMOL, V62, P111, DOI 10.1146/annurev-ento-031616-034925; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; CHIANG AS, 1995, MOL CELL ENDOCRINOL, V115, P51, DOI 10.1016/0303-7207(95)03669-X; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Cruz J, 2003, INSECT BIOCHEM MOLEC, V33, P1219, DOI 10.1016/j.ibmb.2003.06.004; Cruz J, 2008, DEV DYNAM, V237, P3179, DOI 10.1002/dvdy.21728; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Ishimaru Y, 2016, P NATL ACAD SCI USA, V113, P5634, DOI 10.1073/pnas.1600612113; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Lee CY, 2001, DEVELOPMENT, V128, P1443; Liu SN, 2018, P NATL ACAD SCI USA, V115, P139, DOI 10.1073/pnas.1716897115; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; Lozano J, 2015, P NATL ACAD SCI USA, V112, P3740, DOI 10.1073/pnas.1418522112; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Mane-Padros D, 2008, DEV BIOL, V315, P147, DOI 10.1016/j.ydbio.2007.12.015; Mane-Padros D, 2010, DEV BIOL, V346, P150, DOI 10.1016/j.ydbio.2010.07.012; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nijhout H.F., 1994, INSECT HORMONES; Niwa R, 2014, BIOSCI BIOTECH BIOCH, V78, P1283, DOI 10.1080/09168451.2014.942250; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Peterson AJ, 2014, METHODS, V68, P183, DOI 10.1016/j.ymeth.2014.03.016; Peterson AJ, 2013, DEVELOPMENT, V140, P649, DOI 10.1242/dev.085605; ROMANA I, 1995, EUR J ENTOMOL, V92, P93; Sakurai S., 2005, P409; Santos CG, 2016, DEV BIOL, V417, P104, DOI 10.1016/j.ydbio.2016.07.006; Swanson CI, 2015, DEVELOPMENT, V142, P4288, DOI 10.1242/dev.115006; Treiblmayr K, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.4301; Urena E, 2014, P NATL ACAD SCI USA, V111, P7024, DOI 10.1073/pnas.1401478111; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Ylla G, 2018, ISCIENCE, V4, P164, DOI 10.1016/j.isci.2018.05.017; Zhang TL, 2018, P NATL ACAD SCI USA, V115, P3960, DOI 10.1073/pnas.1800435115; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	47	17	17	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3659	3669		10.1096/fj.201801511R	http://dx.doi.org/10.1096/fj.201801511R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481489	Green Submitted, Bronze			2022-12-28	WOS:000459794800046
J	Roth, D; Chiang, AJ; Hu, WD; Gugiu, GB; Morra, CN; Versalovic, J; Kalkum, M				Roth, Daniel; Chiang, Abby J.; Hu, Weidong; Gugiu, Gabriel B.; Morra, Christina N.; Versalovic, James; Kalkum, Markus			Two-carbon folate cycle of commensal Lactobacillus reuteri 6475 gives rise to immunomodulatory ethionine, a source for histone ethylation	FASEB JOURNAL			English	Article						ethenyltetrahydrofolate; probiotic bacteria; microbiome; posttranslational modification; lysine ethylation	CHAIN FATTY-ACIDS; CROHNS-DISEASE; METABOLISM; METHIONINE; PROTEIN; PROBIOTICS; MICROBIOTA; BACTERIA; INFLAMMATION; REMISSION	Colonization of the gut by certain probiotic Lactobacillus reuteri strains has been associated with reduced risk of inflammatory diseases and colorectal cancer. Previous studies pointed to a functional link between immunomodulation, histamine production, and folate metabolism, the central 1-carbon pathway for the transfer of methyl groups. Using mass spectrometry and NMR spectroscopy, we analyzed folate metabolites of L. reuteri strain 6475 and discovered that the bacterium produces a 2-carbon-transporting folate in the form of 5,10-ethenyl-tetrahydrofolyl polyglutamate. Isotopic labeling permitted us to trace the source of the 2-carbon unit back to acetate of the culture medium. We show that the 2C folate cycle of L. reuteri is capable of transferring 2 carbon atoms to homocysteine to generate the unconventional amino acid ethionine, a known immunomodulator. When we treated monocytic THP-1 cells with ethionine, their transcription of TNF- was inhibited and cell proliferation reduced. Mass spectrometry of THP-1 histones revealed incorporation of ethionine instead of methionine into proteins, a reduction of histone-methylation, and ethylation of histone lysine residues. Our findings suggest that the microbiome can expose the host to ethionine through a novel 2-carbon transporting variant of the folate cycle and modify human chromatin via ethylation.Roth, D., Chiang, A. J., Hu, W., Gugiu, G. B., Morra, C. N., Versalovic, J., Kalkum, M. The two-carbon folate cycle of commensal Lactobacillus reuteri 6475 gives rise to immunomodulatory ethionine, a source for histone ethylation.	[Roth, Daniel; Chiang, Abby J.; Hu, Weidong; Gugiu, Gabriel B.; Kalkum, Markus] Beckman Res Inst City Hope, Dept Mol Imaging & Therapy, Duarte, CA USA; [Chiang, Abby J.; Kalkum, Markus] Beckman Res Inst City Hope, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA; [Hu, Weidong] Beckman Res Inst City Hope, Nucl Magnet Resonance Core, Duarte, CA USA; [Gugiu, Gabriel B.; Kalkum, Markus] Beckman Res Inst City Hope, Mass Spectrometry & Prote Core, Duarte, CA USA; [Morra, Christina N.] Baylor Coll Med, IMBS, Houston, TX 77030 USA; [Morra, Christina N.; Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Versalovic, James] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kalkum, M (corresponding author), Beckman Res Inst City Hope, 1500 East Duarte Rd, Duarte, CA 91010 USA.	mkalkum@coh.org	Roeth, Daniel/AAS-3185-2021	Roeth, Daniel/0000-0002-1190-3219; Kalkum, Markus/0000-0002-9506-671X	U.S. National Institutes of Health (NIH), National Cancer Institute [U01 CA170930]; NIH, National Cancer Institute [P30 CA33572]; NATIONAL CANCER INSTITUTE [U01CA170930, P30CA033572] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	D.R., A.J.C., C.N.M., J.V., and M.K. were supported by U.S. National Institutes of Health (NIH), National Cancer Institute Grant U01 CA170930 (to J.V.). The use of the City of Hope Mass Spectrometry and Proteomics core facility was partially supported by NIH, National Cancer Institute Grant P30 CA33572. The authors declare no conflicts of interest.	ALIX JH, 1982, MICROBIOL REV, V46, P281, DOI 10.1128/MMBR.46.3.281-295.1982; ASCHKENASY A, 1975, ANN NUTR ALIMENT, V29, P137; ASWAD DW, 1975, J MOL BIOL, V97, P207, DOI 10.1016/S0022-2836(75)80035-0; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Brosnan ME, 2015, BIOCHEM J, V472, P135, DOI 10.1042/BJ20150837; BROWN JL, 1973, BIOCHIM BIOPHYS ACTA, V294, P527, DOI 10.1016/0005-2787(73)90108-1; Bystrov V. F., 1976, Progress in Nuclear Magnetic Resonance Spectroscopy, V10, P41, DOI 10.1016/0079-6565(76)80001-5; COX R, 1984, CANCER RES, V44, P4938; Cummings JH, 1997, JPEN-PARENTER ENTER, V21, P357, DOI 10.1177/0148607197021006357; Dahl WJ, 2017, J AM COLL NUTR, V36, P127, DOI 10.1080/07315724.2016.1188737; De Man J. C., 2008, J APPL BACTERIOL, V23, P130; de Paiva E.P., 2015, SCI CHROMATOGR, V7, P199, DOI [10.4322/sc.2016.004, DOI 10.4322/SC.2016.004]; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; FISHER JF, 1961, J GEN PHYSIOL, V45, P1, DOI 10.1085/jgp.45.1.1; Food and Agriculture Organization of the United Nations World Health Organization, 2006, PROB FOOD HLTH NUTR; Fuller MF, 1998, ANNU REV NUTR, V18, P385, DOI 10.1146/annurev.nutr.18.1.385; Ganesh BP, 2018, MUCOSAL IMMUNOL, V11, P380, DOI 10.1038/mi.2017.58; Ganji-Arjenaki M, 2018, J CELL PHYSIOL, V233, P2091, DOI 10.1002/jcp.25911; Gao CX, 2015, MBIO, V6, DOI 10.1128/mBio.01358-15; Gupta P, 2000, J PEDIATR GASTR NUTR, V31, P453, DOI 10.1097/00005176-200010000-00024; GUYNN RW, 1982, ARCH BIOCHEM BIOPHYS, V217, P181, DOI 10.1016/0003-9861(82)90492-1; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; HOLLOWAY CT, 1970, J BACTERIOL, V104, P734, DOI 10.1128/JB.104.2.734-747.1970; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; LaBaume L B, 1985, Prog Clin Biol Res, V183, P189; Lichtenstein L, 2016, BEST PRACT RES CL GA, V30, P81, DOI 10.1016/j.bpg.2016.02.002; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; LOERCH JD, 1963, ARCH BIOCHEM BIOPHYS, V103, P272, DOI 10.1016/0003-9861(63)90405-3; MAW GA, 1966, ARCH BIOCHEM BIOPHYS, V115, P291, DOI 10.1016/0003-9861(66)90277-3; MOORE GE, 1967, J AMER MED ASSOC, V199, P519, DOI 10.1001/jama.199.8.519; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; RABINOVITZ M, 1957, J BIOL CHEM, V227, P217; RADIX PM, 1983, J NUTR, V113, P159, DOI 10.1093/jn/113.1.159; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rossi M, 2011, NUTRIENTS, V3, P118, DOI 10.3390/nu3010118; Saarela M, 2002, INT J FOOD MICROBIOL, V78, P99, DOI 10.1016/S0168-1605(02)00235-0; Santos F, 2008, APPL ENVIRON MICROB, V74, P3291, DOI 10.1128/AEM.02719-07; Scarpato E, 2018, J CLIN GASTROENTEROL, V52, pS7, DOI [10.1097/MCG.0000000000001095, 10.1097/mcg.0000000000001095]; Domingo JJS, 2017, GASTROENT HEPAT-BARC, V40, P417, DOI 10.1016/j.gastrohep.2016.12.003; Thomas CM, 2016, MICROBIOLOGYOPEN, V5, P802, DOI 10.1002/mbo3.371; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; van der Wielen N, 2017, J NUTR, V147, P1493, DOI 10.3945/jn.117.248187; Vigsnaes LK, 2012, BENEF MICROBES, V3, P287, DOI 10.3920/BM2012.0018; VILLANUEVA VR, 1966, BIOCHIM BIOPHYS ACTA, V130, P329, DOI 10.1016/0304-4165(66)90228-5; Walter J, 2005, APPL ENVIRON MICROB, V71, P979, DOI 10.1128/AEM.71.2.979-986.2005; Wlostowski M, 2010, TETRAHEDRON LETT, V51, P5977, DOI 10.1016/j.tetlet.2010.08.097; ZABOS P, 1978, BIOCHIM BIOPHYS ACTA, V520, P139, DOI 10.1016/0005-2787(78)90015-1; Zella GC, 2011, INFLAMM BOWEL DIS, V17, P1092, DOI 10.1002/ibd.21460	55	15	15	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3536	3548		10.1096/fj.201801848R	http://dx.doi.org/10.1096/fj.201801848R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30452879	Green Published, Bronze			2022-12-28	WOS:000459794800036
J	Davis, RAH; Deemer, SE; Bergeron, JM; Little, JT; Warren, JL; Fisher, G; Smith, DL; Fontaine, KR; Dickinson, SL; Allison, DB; Plaisance, EP				Davis, Rachel A. H.; Deemer, Sarah E.; Bergeron, Jonathan M.; Little, Jason T.; Warren, Jonathan L.; Fisher, Gordon; Smith, Daniel L., Jr.; Fontaine, Kevin R.; Dickinson, Stephanie L.; Allison, David B.; Plaisance, Eric P.			Dietary R,S-1,3-butanediol diacetoacetate reduces body weight and adiposity in obese mice fed a high-fat diet	FASEB JOURNAL			English	Article						ketones; ketogenic diet; energy expenditure; adipose tissue thermogenesis; weight loss	KETOGENIC DIET; FOOD-INTAKE; BETA-HYDROXYBUTYRATE; ACETOACETATE ESTERS; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; KETONE-BODIES; MALONYL-COA; MITOCHONDRIAL; METABOLISM	The dietary R-3-hydroxybutyrate-R-1,3-butanediol monoester increases resting energy expenditure (REE) and markers of brown and white adipose thermogenesis in lean mice. The purpose of this investigation was to determine whether the ketone ester, R,S-1,3-butanediol diacetoacetate (BD-AcAc2), increases energy expenditure and markers of adipose tissue thermogenesis in the context of high-fat diet (HFD)-induced obesity. Thirty-five-week-old male C57BL/6J mice were placed on an ad libitum HFD (45% kcal) for 10 wk. The mice were then randomized to 1 of 3 groups (n = 10 per group) for an additional 12 wk: 1) control (Con), continuous HFD, 2) pair-fed (PF) to ketone ester (KE); and 3) KE: HFD+30% energy from BD-AcAc2. Mean energy intake throughout the study was approximate to 26% lower in the KE compared to the Con group (8.2 +/- 0.5 vs. 11.2 +/- 0.7 kcal/d; P < 0.05). Final body weight (26.8 +/- 3.6 vs. 34.9 +/- 4.8 g; P < 0.001) and fat mass (5.2 +/- 1.2 vs. 11.3 +/- 4.5 g; P < 0.001) of the KE group was significantly lower than PF, despite being matched for energy provisions. Differences in body weight and adiposity were accompanied by higher REE and total energy expenditure in the KE group compared to PF after adjustment for lean body mass and fat-mass (P = 0.001 and 0.007, respectively). Coupled or uncoupled mitochondrial respiratory rates in skeletal muscle were not different among groups, but markers of mitochondrial uncoupling and thermogenesis (uncoupling protein-1, deiodinase-2, and peroxisome proliferator-activated receptor coactivator-1) were higher in interscapular brown adipose tissue (BAT) of mice receiving the KE diet. The absence of mitochondrial uncoupling in skeletal muscle and increased markers of mitochondrial uncoupling in BAT suggest that BD-AcAc2 initiates a transcriptional signature consistent with BAT thermogenesis in the context of HFD-induced obesity.Davis, R. A. H., Deemer, S. E., Bergeron, J. M., Little, J. T., Warren, J. L., Fisher, G., Smith, D. L., Jr., Fontaine, K. R., Dickinson, S. L., Allison, D. B., Plaisance, E. P. Dietary R,S-1,3-butanediol diacetoacetate reduces body weight and adiposity in obese mice fed a high-fat diet.	[Davis, Rachel A. H.; Warren, Jonathan L.; Fisher, Gordon; Smith, Daniel L., Jr.; Plaisance, Eric P.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Davis, Rachel A. H.; Deemer, Sarah E.; Fisher, Gordon; Smith, Daniel L., Jr.; Fontaine, Kevin R.; Plaisance, Eric P.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Bergeron, Jonathan M.; Little, Jason T.; Fisher, Gordon; Plaisance, Eric P.] Univ Alabama Birmingham, Dept Human Studies, 901 13th St South,Educ Bldg 201, Birmingham, AL 35294 USA; [Fontaine, Kevin R.; Plaisance, Eric P.] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL USA; [Dickinson, Stephanie L.; Allison, David B.] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University Bloomington	Plaisance, EP (corresponding author), Univ Alabama Birmingham, Dept Human Studies, 901 13th St South,Educ Bldg 201, Birmingham, AL 35294 USA.	plaisep@uab.edu	Deemer, Sarah/S-1647-2019	Deemer, Sarah/0000-0002-4758-6796; Smith Jr, Daniel/0000-0002-1602-2023; Dickinson, Stephanie/0000-0002-2998-4467	Pilot and Feasibility Grant NORC, U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) from the UAB Nutrition Obesity Research Center [P30DK056336]; NIH NIDDK [P30DK079626]; NIH National Institute on Aging [P30AG050886, U24AG056053]; T32 Predoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH, National Heart, Lung and Blood institute [T32HL105349]; T32 Postdoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH NIDDK [T32DK062710]; UAB NORC, NIH NIDDK [P30DK056336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD071866] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, T32DK062710, P30DK056336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG050886, U24AG056053] Funding Source: NIH RePORTER	Pilot and Feasibility Grant NORC, U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) from the UAB Nutrition Obesity Research Center; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); T32 Predoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH, National Heart, Lung and Blood institute; T32 Postdoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH NIDDK; UAB NORC, NIH NIDDK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Maria S. Johnson (University of Alabama at Birmingham, Department of Nutrition Sciences) for performing indirect calorimetry and condensing the results for analysis; Dr. Tim R. Nagy (University of Alabama at Birmingham, Department of Nutrition Sciences) for his expertise with interpretation of the indirect calorimetry results; and Michayla B. Brown (University of Alabama at Birmingham, Department of Human Studies) for development and assistance with measurement of BAT lipid content. This work was supported by Pilot and Feasibility Grant NORC, U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant P30DK056336 (to E.P.P.) from the UAB Nutrition Obesity Research Center; the NIH NIDDK Grant P30DK079626 (to the UAB Diabetes Research Center); the NIH National Institute on Aging Grants P30AG050886 and U24AG056053 (to the Nathan Shock Center Excellence in the Basic Biology of Aging); a T32 Predoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH, National Heart, Lung and Blood institute Grant T32HL105349 (to R.A.H.D.); a T32 Postdoctoral Award from the UAB Pre-Doctoral Training Program in Obesity-Related Research, NIH NIDDK Grant T32DK062710 (to S.E.D.); and a Named New Investigator Award from the UAB NORC, NIH NIDDK Grant P30DK056336 (to E.P.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or NIH. The authors declare no conflicts of interest.	ARASE K, 1988, AM J PHYSIOL, V255, pR974, DOI 10.1152/ajpregu.1988.255.6.R974; Ari C, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmal.2016.00137, 10.3389/fnmol.2016.00137]; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Carneiro L, 2016, AM J PHYSIOL-ENDOC M, V310, pE103, DOI 10.1152/ajpendo.00282.2015; Clarke K, 2012, REGUL TOXICOL PHARM, V63, P401, DOI 10.1016/j.yrtph.2012.04.008; D'Agostino DP, 2013, AM J PHYSIOL-REG I, V304, pR829, DOI 10.1152/ajpregu.00506.2012; DAVIS JD, 1981, SCIENCE, V212, P81, DOI 10.1126/science.7193909; DESROCHERS S, 1992, BIOCHEM J, V285, P647, DOI 10.1042/bj2850647; DESROCHERS S, 1995, AM J PHYSIOL-ENDOC M, V268, pE660, DOI 10.1152/ajpendo.1995.268.4.E660; DESROCHERS S, 1995, J NUTR BIOCHEM, V6, P111, DOI 10.1016/0955-2863(94)00011-A; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Hall KD, 2016, AM J CLIN NUTR, V104, P324, DOI 10.3945/ajcn.116.133561; HAWKINS RA, 1979, SCIENCE, V205, P325, DOI 10.1126/science.451608; HAYTER AJ, 1986, J AM STAT ASSOC, V81, P1000; Heymsfield SB, 2007, AM J CLIN NUTR, V85, P346, DOI 10.1093/ajcn/85.2.346; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kashiwaya Y, 2010, J BIOL CHEM, V285, P25950, DOI 10.1074/jbc.M110.138198; Keipert S, 2017, CELL METAB, V26, P437, DOI 10.1016/j.cmet.2017.07.016; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kesl SL, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0069-y; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Laeger T, 2010, APPETITE, V54, P450, DOI 10.1016/j.appet.2010.04.005; LANGHANS W, 1985, PHYSIOL BEHAV, V34, P579, DOI 10.1016/0031-9384(85)90052-6; LANGHANS W, 1985, J AUTONOM NERV SYST, V13, P255, DOI 10.1016/0165-1838(85)90014-1; LANGHANS W, 1983, PHYSIOL BEHAV, V31, P483, DOI 10.1016/0031-9384(83)90070-7; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P4521, DOI 10.1210/jc.2004-2537; LINCOLN BC, 1987, ARCH BIOCHEM BIOPHYS, V259, P149, DOI 10.1016/0003-9861(87)90480-2; Martin-Montalvo A, 2013, ANTIOXID REDOX SIGN, V19, P310, DOI 10.1089/ars.2012.4866; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; Moreno B, 2014, ENDOCRINE, V47, P793, DOI 10.1007/s12020-014-0192-3; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Park S, 2011, BRAIN RES, V1401, P95, DOI 10.1016/j.brainres.2011.05.040; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; Poff AM, 2014, INT J CANCER, V135, P1711, DOI 10.1002/ijc.28809; Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377; Rossi R, 2000, J VET MED A, V47, P9, DOI 10.1046/j.1439-0442.2000.00255.x; Sanchez-Gurmaches J, 2018, CELL METAB, V27, P195, DOI 10.1016/j.cmet.2017.10.008; Srivastava S, 2013, IUBMB LIFE, V65, P58, DOI 10.1002/iub.1102; Srivastava S, 2012, FASEB J, V26, P2351, DOI 10.1096/fj.11-200410; Stubbs BJ, 2018, OBESITY, V26, P269, DOI 10.1002/oby.22051; Stubbs BJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00848; Sun M, 1997, PHYSIOL BEHAV, V61, P433, DOI 10.1016/S0031-9384(9X)00455-8; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; WEBBER RJ, 1977, J BIOL CHEM, V252, P5222; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	51	24	25	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2409	2421		10.1096/fj.201800821RR	http://dx.doi.org/10.1096/fj.201800821RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303740	Green Published, Bronze			2022-12-28	WOS:000457296600070
J	Gentil, BJ; Lai, GT; Menade, M; Lariviere, R; Minotti, S; Gehring, K; Chapple, JP; Brais, B; Durham, HD				Gentil, Benoit J.; Gia-Thanh Lai; Menade, Marie; Lariviere, Roxanne; Minotti, Sandra; Gehring, Kalle; Chapple, J. -Paul; Brais, Bernard; Durham, Heather D.			Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics	FASEB JOURNAL			English	Article						chaperone proteins; rare neurological diseases; cytoskeleton	RECESSIVE SPASTIC ATAXIA; HEAT-SHOCK PROTEINS; MARIE-TOOTH-DISEASE; MOTOR-NEURONS; NEUROFILAMENT PROTEIN; FRIEDREICHS-ATAXIA; STRESS-RESPONSE; ACIDIC PROTEIN; RADIAL GROWTH; MUTANT	Loss of sacsin, a large 520 kDa multidomain protein, causes autosomal recessive spastic ataxia of the Charlevoix-Saguenay, one of the most common childhood-onset recessive ataxias. A prominent feature is abnormal bundling of neurofilaments in many neuronal populations. This study shows the direct involvement of sacsin domains in regulating intermediate filament assembly and dynamics and identifies important domains for alleviating neurofilament bundles in neurons lacking sacsin. Peptides encoding sacsin internal repeat (SIRPT) 1, J-domains, and ubiquitin-like domain modified neurofilament assembly in vivo. The domains with chaperone homology, the SIRPT and the J-domain, had opposite effects, promoting and preventing filament assembly, respectively. In cultured Sacs(-/-) motor neurons, both the SIRPT1 and J-domain resolved preexisting neurofilament bundles. Increasing expression of heat shock proteins also resolved neurofilament bundles, indicating that this endogenous chaperone system can compensate to some extent for sacsin deficiency.Gentil, B. J., Lai, G.-T., Menade, M., Lariviere, R., Minotti, S., Gehring, K., Chapple, J.-P., Brais, B., Durham, H. D. Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics.	[Gentil, Benoit J.; Gia-Thanh Lai; Minotti, Sandra; Durham, Heather D.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Gentil, Benoit J.; Gia-Thanh Lai] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Menade, Marie; Gehring, Kalle] McGill Univ, Grp Rech Axe Struct Prot, Dept Biochem, Montreal, PQ, Canada; [Lariviere, Roxanne; Brais, Bernard] McGill Univ, Montreal Neurol Inst, Lab Neurogenet Mot, Montreal, PQ, Canada; [Chapple, J. -Paul] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England	McGill University; McGill University; McGill University; McGill University; University of London; Queen Mary University London	Gentil, BJ (corresponding author), Currie Gym Off A210,475 Pine Ave West, Montreal, PQ H2W 1S4, Canada.	benoit.gentil@mcgill.ca	Gehring, Kalle/I-4403-2013; Brais, Bernard/Y-3910-2019	Gehring, Kalle/0000-0001-6500-1184; GENTIL, Benoit/0000-0003-2022-1890	Ataxia of Charlevoix-Saguenay Foundation; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/R003335/1]; BBSRC [BB/R003335/1] Funding Source: UKRI	Ataxia of Charlevoix-Saguenay Foundation; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Nicolas Sgarioto (Montreal Neurological Institute, McGill University) for the management of the Sacs<SUP>-/-</SUP> colonies. The authors thank Jeannie Mui and Dr. Vali (Facility for Electron Microscopy Research, McGill University) for help in microscope operation and data collection. This study was supported by grants from the Ataxia of Charlevoix-Saguenay Foundation (to H.D.D., B.B., K.G., and J.-P.C.) and Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/R003335/1 (to J.-P.C.). The authors declare no conflicts of interest.	Ackerley S, 2003, J CELL BIOL, V161, P489, DOI 10.1083/jcb.200303138; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Baets J, 2010, NEUROLOGY, V75, P1181, DOI 10.1212/WNL.0b013e3181f4d86c; Batulan Z, 2003, J NEUROSCI, V23, P5789; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Benndorf R., 2014, MUTAT RES-REV MUTAT; BOUCHARD JP, 1979, CAN J NEUROL SCI, V6, P185, DOI 10.1017/S0317167100119614; BOUCHARD RW, 1979, CAN J NEUROL SCI, V6, P191, DOI 10.1017/S0317167100119626; Boumil EF, 2018, BIOL OPEN, V7, DOI 10.1242/bio.028795; COHLBERG JA, 1995, J BIOL CHEM, V270, P9334, DOI 10.1074/jbc.270.16.9334; COHLBERG JA, 1987, J BIOL CHEM, V262, P17009; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Deane CAS, 2016, CELL STRESS CHAPERON, V21, P837, DOI 10.1007/s12192-016-0708-2; Dekker SL, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00035; Duncan EJ, 2017, HUM MOL GENET, V26, P3130, DOI 10.1093/hmg/ddx197; El Euch-Fayache G, 2003, ARCH NEUROL-CHICAGO, V60, P982, DOI 10.1001/archneur.60.7.982; Ellis RJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0398; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Gentil BJ, 2013, INT J BIOCHEM CELL B, V45, P1499, DOI 10.1016/j.biocel.2013.04.009; Gentil BJ, 2012, FASEB J, V26, P1194, DOI 10.1096/fj.11-196345; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Godsel LM, 2008, TRENDS CELL BIOL, V18, P28, DOI 10.1016/j.tcb.2007.11.004; He QX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142573; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Izawa I, 2000, J BIOL CHEM, V275, P34521, DOI 10.1074/jbc.M003492200; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884; Lariviere R, 2015, HUM MOL GENET, V24, P727, DOI 10.1093/hmg/ddu491; Laser-Azogui A, 2015, CURR OPIN CELL BIOL, V32, P92, DOI 10.1016/j.ceb.2015.01.003; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Lee S, 2014, J CELL SCI, V127, P4064, DOI 10.1242/jcs.153346; Leung C. L., 2006, CURR PROTOC CELL BIO; Li XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137298; Manzerra P, 1996, EXP CELL RES, V229, P35, DOI 10.1006/excr.1996.0341; MORRIS JR, 1982, J CELL BIOL, V92, P192, DOI 10.1083/jcb.92.1.192; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Ouyang Y, 2008, J NEUROL SCI, V264, P73, DOI 10.1016/j.jns.2007.07.022; Ouyang Y, 2006, NEUROLOGY, V66, P1103, DOI 10.1212/01.wnl.0000204300.94261.ea; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Perng MD, 1999, J CELL SCI, V112, P2099; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Robert A, 2016, BIOESSAYS, V38, P232, DOI 10.1002/bies.201500142; Romano A, 2013, HUM MUTAT, V34, P525, DOI 10.1002/humu.22269; Roy J, 1998, J NEUROSCI, V18, P9673; Sanchez I, 2000, J CELL BIOL, V151, P1013, DOI 10.1083/jcb.151.5.1013; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; Wiche Gerhard, 2011, Bioarchitecture, V1, P14; Wong NKY, 2000, J NEUROPATH EXP NEUR, V59, P972, DOI 10.1093/jnen/59.11.972; WONG PC, 1995, J CELL BIOL, V130, P1413, DOI 10.1083/jcb.130.6.1413; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309	61	16	16	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2982	2994		10.1096/fj.201801556R	http://dx.doi.org/10.1096/fj.201801556R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332300	Bronze			2022-12-28	WOS:000457296600115
J	Paumier, JM; Py, NA; Garcia-Gonzalez, L; Bernard, A; Stephan, D; Louis, L; Checler, F; Khrestchatisky, M; Baranger, K; Rivera, S				Paumier, Jean-Michel; Py, Nathalie A.; Garcia-Gonzalez, Laura; Bernard, Anne; Stephan, Delphine; Louis, Laurence; Checler, Frederic; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago			Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking	FASEB JOURNAL			English	Article						amyloid peptide; amyloid precursor protein; Alzheimer disease; secretase; endosome	AMYLOID PRECURSOR PROTEIN; A-BETA; CELL-SURFACE; IN-VITRO; ALZHEIMERS-DISEASE; TISSUE INHIBITOR; SECRETASE; ACTIVATION; PEPTIDE; MT1-MMP	We previously demonstrated that membrane type 1 (MT1) matrix metalloproteinase (MMP) was up-regulated in the hippocampus of the model of transgenic mice bearing 5 familial mutations on human amyloid precursor protein (APP) and presenilin 1 of Alzheimer disease (AD), and that the proteinase increased the levels of amyloid peptide (A) and its APP C-terminal fragment of 99 aa in a heterologous cell system. Here we provide further evidence that MT1-MMP interacts with APP and promotes amyloidogenesis in a proteolytic-dependent manner in Swedish APP-expressing human embryonic kidney 293 (HEKswe) cells. MT1-MMP-mediated processing of APP releases a soluble APP fragment, sAPP95. This process partly requires the activation of endogenous MMP-2 but is independent of -site APP cleaving enzyme 1 (BACE-1) or -secretase activities. In contrast, MT1-MMP-mediated increase of A levels involved BACE-1 activity and was inhibited by tissue inhibitor of MMP-2, a natural inhibitor of both MT1-MMP and MMP-2. Interestingly, near abolishment of basal A production upon BACE-1 inhibition was rescued by MT1-MMP, indicating that the latter could mimic -secretase-like activity. Moreover, MT1-MMP promoted APP/A localization in endosomes, where A production mainly occurs. These data unveil new mechanistic insights to support the proamyloidogenic role of MT1-MMP based on APP processing and trafficking, and reinforce the idea that this proteinase may become a new potential therapeutic target in AD.Paumier, J.-M., Py, N. A., Gonzalez, L. G., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., Rivera, S. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.	[Paumier, Jean-Michel; Py, Nathalie A.; Garcia-Gonzalez, Laura; Bernard, Anne; Stephan, Delphine; Louis, Laurence; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago] Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; [Checler, Frederic] UNS, Excellence Lab Labex Dev Innova Strategies Transd, IPMC, CNRS,UMR 7275, Valbonne, France; [Py, Nathalie A.] Neuron Experts, Fac Med Nord, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Aix-Marseille Universite	Baranger, K; Rivera, S (corresponding author), Aix Marseille Univ, CNRS, UMR 7051, Inst Neuropathophysiol INP,Fac Med Secteur Nord, CS80011,51 Bd Pierre Dramard, F-13344 Marseille 15, France.	kevin.baranger@univ-amu.fr; santiago.rivera@univ-amu.fr	Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750	Centre National de la Recherche Scientifique (CNRS); Aix-Marseille Universite; French National Research Agency (ANR), MAD5; Centre d'Excellence pour les Maladies Neurodegeneratives et le Vieillissement (DHUNE); Center of Excellence in Neurodegeneration (CoEN); Vaincre l'Alzheimer grants; Fonds Europeen de Developpement Regional (FEDER) in Provence-Alpes Cote d'Azur Region (PACA); Fondation pour la Recherche Medicale; Conseil General des Alpes Maritimes through the Excellence Laboratory (LabEx) Program Investment for the Future Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer Disease (DISTALZ); Excellence Initiative of Aix-Marseille Universite (A*MIDEX); French Investissements d'Avenir Programme; Fondation Plan Alzheimer; French Ministry of Research; Vaincre l'Alzheimer; ANR; France Alzheimer; French National Research Agency (ANR), PREVENTAD	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; French National Research Agency (ANR), MAD5(French National Research Agency (ANR)); Centre d'Excellence pour les Maladies Neurodegeneratives et le Vieillissement (DHUNE); Center of Excellence in Neurodegeneration (CoEN); Vaincre l'Alzheimer grants; Fonds Europeen de Developpement Regional (FEDER) in Provence-Alpes Cote d'Azur Region (PACA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes through the Excellence Laboratory (LabEx) Program Investment for the Future Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer Disease (DISTALZ); Excellence Initiative of Aix-Marseille Universite (A*MIDEX)(French National Research Agency (ANR)); French Investissements d'Avenir Programme(French National Research Agency (ANR)); Fondation Plan Alzheimer; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Vaincre l'Alzheimer; ANR(French National Research Agency (ANR)); France Alzheimer; French National Research Agency (ANR), PREVENTAD(French National Research Agency (ANR))	This work was supported by funding from the Centre National de la Recherche Scientifique (CNRS) and Aix-Marseille Universite, and by public grants overseen by the French National Research Agency (ANR), MAD5 to S.R. and F.C., and PREVENTAD to M.K., as part of the second Investissements d'Avernir Program. The work was also supported by Centre d'Excellence pour les Maladies Neurodegeneratives et le Vieillissement (DHUNE), and a Center of Excellence in Neurodegeneration (CoEN) grant to S.R., by the Fondation Plan Alzheimer and France Alzheimer to S.R., by Vaincre l'Alzheimer grants to S.R., F.C., and M.K., by a grant to S.R. and M.K. from Fonds Europeen de Developpement Regional (FEDER) in Provence-Alpes Cote d'Azur Region (PACA), by grants to F.C. from Fondation pour la Recherche Medicale, and by the Conseil General des Alpes Maritimes through the Excellence Laboratory (LabEx) Program Investment for the Future Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer Disease (DISTALZ). K.B. was granted a research associate fellowship (Management of Talents) by Excellence Initiative of Aix-Marseille Universite (A*MIDEX), a French Investissements d'Avenir Programme and the Fondation Plan Alzheimer. N.P. was recipient of a doctoral fellowship from the French Ministry of Research. J.-M.P. was recipient of a doctoral fellowship from Vaincre l'Alzheimer. L.G.G. was granted by the ANR. RXP03 was kindly provided by V. Dive, and the TfR plasmid and antibodies were kindly provided by M. David. The authors declare no conflicts of interest.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Ahmad M, 2006, J BIOCHEM, V139, P517, DOI 10.1093/jb/mvj054; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Baranger K, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00163; Baranger K, 2016, CELL MOL LIFE SCI, V73, P217, DOI 10.1007/s00018-015-1992-1; Baranger K, 2014, PROG BRAIN RES, V214, P313, DOI 10.1016/B978-0-444-63486-3.00014-1; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bylander JE, 2007, BIOL CHEM, V388, P1163, DOI 10.1515/BC.2007.156; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Dive V, 2005, INT J CANCER, V113, P775, DOI 10.1002/ijc.20459; Dunys J., J BIOL CHEM; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hara T, 2011, BIOCHEM BIOPH RES CO, V413, P277, DOI 10.1016/j.bbrc.2011.08.085; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jobin PG, 2017, BBA-MOL CELL RES, V1864, P2043, DOI 10.1016/j.bbamcr.2017.05.013; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Liao MC, 2010, BIOCHEMISTRY-US, V49, P1127, DOI 10.1021/bi901994d; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; Neve RL, 2000, BRAIN RES, V886, P54, DOI 10.1016/S0006-8993(00)02869-9; Ogier C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-68; Ould-Yahoui A, 2013, CELL TRANSPLANT, V22, P993, DOI 10.3727/096368912X657468; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Rose C, 2018, NEUROBIOL AGING, V61, P23, DOI 10.1016/j.neurobiolaging.2017.09.008; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Sato H, 1996, FEBS LETT, V385, P238, DOI 10.1016/0014-5793(96)00389-4; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Tu SC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-48; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Xie YQ, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.36; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Zhang ZT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9762	61	16	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2910	2927		10.1096/fj.201801076R	http://dx.doi.org/10.1096/fj.201801076R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332299				2022-12-28	WOS:000457296600110
J	Chen, M; Huang, RC; Yang, LQ; Ren, DL; Hu, B				Chen, Min; Huang, Rong-Chen; Yang, Lei-Qing; Ren, Da-Long; Hu, Bing			In vivo imaging of evoked calcium responses indicates the intrinsic axonal regenerative capacity of zebrafish	FASEB JOURNAL			English	Article						regeneration; activity	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; NEURAL ACTIVITY; MITOCHONDRIAL TRANSPORT; PTEN INHIBITION; LONG-DISTANCE; MAUTHNER CELL; ADULT CNS; NEURONS; RECOVERY	Calcium is an important messenger in the neuronal system, but its specific role in axonal regeneration has not been fully investigated. To clarify it, we constructed a noninvasive in vivo calcium-imaging model of zebrafish Mauthner cells and monitored subcellular calcium dynamics during axonal regeneration. Using the calcium indicator GCamp6f, we observed that the regenerative length correlated with the peak amplitude of the evoked calcium response before axotomy, which suggested that the evoked calcium response might serve as a useful indicator of evoked neuronal activity and axonal regenerative capacity. To investigate this possibility, we overexpressed an inward rectifying potassium channel protein, Kir2.1a, to decrease the Mauthner neuronal activity and found that the inhibition of the calcium response correlated with decreased axonal regeneration. In contrast, treatment of pentylenetetrazol and knockout of the sodium voltage-gated channel alpha subunit 1 gene increased the calcium response and thus enhanced axonal regeneration. Our results therefore increased the understanding of the correlation between the neural activity and the vertebrate axonal regeneration.-Chen, M., Huang, R.-C., Yang, L.-Q., Ren, D.-L., Hu, B. In vivo imaging of evoked calcium responses indicates the intrinsic axonal regenerative capacity of zebrafish.	[Chen, Min; Huang, Rong-Chen; Yang, Lei-Qing; Ren, Da-Long; Hu, Bing] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Ren, Da-Long; Hu, Bing] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Ren, DL; Hu, B (corresponding author), Univ Sci & Technol China, 96 Jinzhai Rd, Hefei 230026, Anhui, Peoples R China.	rendl@ustc.edu.cn; bhu@ustc.edu.cn	Ren, Da-long/G-3323-2018	Huang, Rongchen/0000-0001-9521-0163	National Natural Science Foundation of China [31771183, 31571068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (31771183, 31571068). The authors declare no conflicts of interest.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Auer TO, 2014, NAT PROTOC, V9, P2823, DOI 10.1038/nprot.2014.187; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Becker CG, 2000, J COMP NEUROL, V427, P469; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Becker T, 2014, CURR OPIN NEUROBIOL, V27, P186, DOI 10.1016/j.conb.2014.03.019; Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Cen LP, 2018, EXP EYE RES, V177, P153, DOI 10.1016/j.exer.2018.08.010; Chen MF, 2014, TRENDS NEUROSCI, V37, P583, DOI 10.1016/j.tins.2014.08.008; Chen M, 2017, MOL NEUROBIOL, V54, P6917, DOI 10.1007/s12035-016-0233-4; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dinday MT, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0068-15.2015; English AW, 2011, ANN ANAT, V193, P354, DOI 10.1016/j.aanat.2011.02.013; Fischer D, 2012, PROG RETIN EYE RES, V31, P688, DOI 10.1016/j.preteyeres.2012.06.005; Gahtan E, 2003, J COMP NEUROL, V459, P186, DOI 10.1002/cne.10621; Gordon T, 2016, EUR J NEUROSCI, V43, P336, DOI 10.1111/ejn.13005; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Hocking JC, 2012, MECH DEVELOP, V129, P125, DOI 10.1016/j.mod.2012.05.003; Hu BB, 2018, EXP NEUROL, V300, P67, DOI 10.1016/j.expneurol.2017.10.028; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Huang RC, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00375; Huang YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140752; Jaiswal P. B., 2017, J NEUROSCI RES; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lim JHA, 2016, NAT NEUROSCI, V19, P1073, DOI 10.1038/nn.4340; Luo XT, 2012, INT REV NEUROBIOL, V105, P141, DOI 10.1016/B978-0-12-398309-1.00008-1; Marsden KC, 2015, CELL REP, V13, P1733, DOI 10.1016/j.celrep.2015.10.060; Nagashima M, 2011, NEUROCHEM INT, V58, P888, DOI 10.1016/j.neuint.2011.02.017; Neki D, 2014, J NEUROSCI, V34, P3291, DOI 10.1523/JNEUROSCI.4610-13.2014; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; O'Brien Georgeann S, 2009, J Vis Exp, DOI 10.3791/1129; O'Donnell KC, 2013, J NEUROSCI, V33, P14778, DOI 10.1523/JNEUROSCI.1331-13.2013; Ohtake Y, 2015, NEURAL REGEN RES, V10, P1363, DOI 10.4103/1673-5374.165496; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Plunet W, 2002, J NEUROSCI RES, V68, P1, DOI 10.1002/jnr.10176; Sabatier MJ, 2015, EXERC SPORT SCI REV, V43, P163, DOI 10.1249/JES.0000000000000047; Satou C, 2009, J NEUROSCI, V29, P6780, DOI 10.1523/JNEUROSCI.0801-09.2009; Sillar KT, 2009, CURR BIOL, V19, pR353, DOI 10.1016/j.cub.2009.02.025; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Takahashi M, 2002, J NEUROSCI, V22, P3929, DOI 10.1523/JNEUROSCI.22-10-03929.2002; Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x; Vargas ME, 2015, J NEUROSCI, V35, P15026, DOI 10.1523/JNEUROSCI.2484-15.2015; Ward PJ, 2018, EUR J NEUROSCI, V47, P294, DOI 10.1111/ejn.13836; Xu Y, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00004; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00558; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101; Zou SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057280	62	3	3	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7721	7733		10.1096/fj.201802649R	http://dx.doi.org/10.1096/fj.201802649R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30893562	Bronze			2022-12-28	WOS:000476114200084
J	Shi, ZY; Xin, HH; Tian, DD; Lian, JR; Wang, JH; Liu, GH; Ran, RS; Shi, SY; Zhang, ZX; Shi, Y; Deng, Y; Hou, CH; Chen, YL				Shi, Zhaoying; Xin, Huhu; Tian, Dandan; Lian, Jingru; Wang, Jianhui; Liu, Guanghui; Ran, Rensen; Shi, Songyuan; Zhang, Zixuan; Shi, Yu; Deng, Yi; Hou, Chunhui; Chen, Yonglong			Modeling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 system	FASEB JOURNAL			English	Article						BE3; C-to-T conversion; Tbx5; Holt-Oram syndrome; oculocutaneous albinism type 1A	TARGETED GENE DISRUPTION; HOLT-ORAM-SYNDROME; GENOMIC DNA; BASE; TBX5; LIMB; HEART; RICE	Precise single-base editing in Xenopus tropicalis would greatly expand the utility of this true diploid frog for modeling human genetic diseases caused by point mutations. Here, we report the efficient conversion of C-to-T or G-to-A in X. tropicalis using the rat apolipoprotein B mRNA editing enzyme catalytic subunit 1-XTEN-clustered regularly interspaced short palindromic repeat-associated protein 9 (Cas9) nickase-uracil DNA glycosylase inhibitor-nuclear localization sequence base editor [base editor 3 (BE3)]. Coinjection of guide RNA and the Cas9 mutant complex mRNA into 1-cell stage X. tropicalis embryos caused precise C-to-T or G-to-A substitution in 14 out of 19 tested sites with efficiencies of 5-75%, which allowed for easy establishment of stable lines. Targeting the conserved T-box 5 R237 and Tyr C28 residues in X. tropicalis with the BE3 system mimicked human Holt-Oram syndrome and oculocutaneous albinism type 1A, respectively. Our data indicate that BE3 is an easy and efficient tool for precise base editing in X. tropicalis.-Shi, Z., Xin, H., Tian, D., Lian, J., Wang, J., Liu, G., Ran, R., Shi, S., Zhang, Z., Shi, Y., Deng, Y., Hou, C., Chen, Y. Modeling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 system.	[Shi, Zhaoying; Xin, Huhu; Tian, Dandan; Lian, Jingru; Wang, Jianhui; Liu, Guanghui; Ran, Rensen; Shi, Songyuan; Zhang, Zixuan; Deng, Yi; Hou, Chunhui; Chen, Yonglong] Southern Univ Sci & Technol, Dept Biol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen, Peoples R China; [Shi, Zhaoying; Xin, Huhu; Tian, Dandan; Lian, Jingru; Wang, Jianhui; Liu, Guanghui; Ran, Rensen; Shi, Songyuan; Zhang, Zixuan; Hou, Chunhui; Chen, Yonglong] Southern Univ Sci & Technol, Dept Biol, Shenzhen Key Lab Cell Microenvironm, Shenzhen, Peoples R China; [Shi, Yu] Chongqing Med Univ, Childrens Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Shi, Yu] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Shi, Yu] Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Pediat, Chongqing, Peoples R China; [Shi, Yu] Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Translat Med Res Cognit Dev & L, Chongqing, Peoples R China	Southern University of Science & Technology; Southern University of Science & Technology; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Chen, YL (corresponding author), Southern Univ Sci & Technol, Dept Biol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen Key Lab Cell Microenvironm, 1088 Xueyuan Rd, Shenzhen 518055, Guangdong, Peoples R China.	chenyl@sustech.edu.cn		Zhaoying, Shi/0000-0002-4208-6581	National Key Basic Research Program of China [2015CB942800]; National Natural Science Foundation of China [31471367, 31671519, 31701269, 31571347]; Shenzhen Science and Technology Innovation Commission [JCYJ20170412152835439]; Natural Science Foundation of Guangdong Province [2018A030310223]; Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research [2017B030301018]; Shenzhen Key Laboratory of Cell Microenvironment [ZDSYS20140509142721429]; Science and Technoogy (SUSTech) Research Foundation [FRG-SUSTC1501A-36]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Commission; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research; Shenzhen Key Laboratory of Cell Microenvironment; Science and Technoogy (SUSTech) Research Foundation	The authors thank Jiarong Wu for technical assistance and Pingyuan Zou (both from Southern University of Science and Technology) for frog husbandry. This work was supported by the National Key Basic Research Program of China (2015CB942800), the National Natural Science Foundation of China (31471367 and 31671519 to Y.C., 31701269 to Z.S., and 31571347 to C.H.), the Shenzhen Science and Technology Innovation Commission (JCYJ20170412152835439), the Natural Science Foundation of Guangdong Province (2018A030310223), the Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research (2017B030301018), the Shenzhen Key Laboratory of Cell Microenvironment (ZDSYS20140509142721429), and the Science and Technoogy (SUSTech) Research Foundation (FRG-SUSTC1501A-36). The authors declare no conflicts of interest.	Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; Aslan Y, 2017, DEVELOPMENT, V144, P2852, DOI 10.1242/dev.152967; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Blitz IL, 2016, DEVELOPMENT, V143, P2868, DOI 10.1242/dev.138057; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; HOLT M, 1960, BRIT HEART J, V22, P236; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Ishibashi Shoko, 2012, Methods Mol Biol, V917, P185, DOI 10.1007/978-1-61779-992-1_11; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Li QY, 1997, NAT GENET, V15, P21; Li XL, 2018, J METAMORPH GEOL, V36, P1, DOI 10.1111/jmg.12280; Li YF, 2018, G3-GENES GENOM GENET, V8, P1701, DOI 10.1534/g3.118.200134; Liang PP, 2017, PROTEIN CELL, V8, P601, DOI 10.1007/s13238-017-0418-2; Liu ZQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05232-2; Liu ZZ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0088-4; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Mao CZ, 2018, FASEB J, V32, P6495, DOI 10.1096/fj.201800093; Naert T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35264; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Ng JK, 2002, DEVELOPMENT, V129, P5161; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Park DS, 2017, MOL CELLS, V40, P823, DOI 10.14348/molcells.2017.0262; Rees HA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15790; Sasaguri H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05262-w; Sheeba CJ, 2017, CURR TOP DEV BIOL, V122, P355, DOI 10.1016/bs.ctdb.2016.08.009; Shi ZY, 2017, GENESIS, V55, DOI 10.1002/dvg.23006; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Shigeta M, 2016, GENES CELLS, V21, P755, DOI 10.1111/gtc.12379; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Sulaiman FA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006521; Van Nieuwenhuysen Tom, 2015, Oncoscience, V2, P555; Wang Y, 2009, J DERMATOL SCI, V53, P80, DOI 10.1016/j.jdermsci.2008.07.002; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108; Zong Y, 2018, NAT BIOTECHNOL, V36, P950, DOI 10.1038/nbt.4261; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	43	10	11	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6962	6968		10.1096/fj.201802661R	http://dx.doi.org/10.1096/fj.201802661R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30844313	Bronze			2022-12-28	WOS:000476114200024
J	Kumar, P; Becker, JC; Gao, KW; Carney, RP; Lankford, L; Keller, BA; Herout, K; Lam, KS; Farmer, DL; Wang, AJ				Kumar, Priyadarsini; Becker, James C.; Gao, Kewa; Carney, Randy P.; Lankford, Lee; Keller, Benjamin A.; Herout, Kyle; Lam, Kit S.; Farmer, Diana L.; Wang, Aijun			Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes	FASEB JOURNAL			English	Article						spina bifida; galectin 1; apoptosis; mesenchymal stromal cells; neuroprotection	EXTRACELLULAR VESICLES; CHORIONIC VILLI; IN-VITRO; FETAL; GALECTIN-1; PROTEIN; PROLIFERATION; ANGIOGENESIS; GROWTH; MODEL	We have established early-gestation chorionic villus-derived placenta mesenchymal stromal cells (PMSCs) as a potential treatment for spina bifida (SB), a neural tube defect. Our preclinical studies demonstrated that PMSCs have the potential to cure hind limb paralysis in the fetal lamb model of SB via a paracrine mechanism. PMSCs exhibit neuroprotective function by increasing cell number and neurites, as shown by indirect coculture and direct addition of PMSC-conditioned medium to the staurosporine-induced apoptotic human neuroblastoma cell line, SH-SY5Y. PMSC-conditioned medium suppressed caspase activity in apoptotic SH-SY5Y cells, suggesting that PMSC secretome contributes to neuronal survival after injury. As a part of PMSC secretome, PMSC exosomes were isolated and extensively characterized; their addition to apoptotic SH-SY5Y cells mediated an increase in neurites, suggesting that they exhibit neuroprotective function. Proteomic and RNA sequencing analysis revealed that PMSC exosomes contain several proteins and RNAs involved in neuronal survival and development. Galectin 1 was highly expressed on the surface of PMSCs and PMSC exosomes. Preincubation of exosomes with anti-galectin 1 antibody decreased their neuroprotective effect, suggesting that PMSC exosomes likely impart their effect via binding of galectin 1 to cells. Future studies will include in-depth analyses of the role of PMSC exosomes on neuroprotection and their clinical applications.Kumar, P., Becker, J. C., Gao, K., Carney, R. P., Lankford, L., Keller, B. A., Herout, K., Lam, K. S., Farmer, D. L., Wang, A. Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes.	[Kumar, Priyadarsini; Becker, James C.; Gao, Kewa; Lankford, Lee; Keller, Benjamin A.; Herout, Kyle; Farmer, Diana L.; Wang, Aijun] Univ Calif Davis, Sch Med, Dept Surg, Surg Bioengn Lab, Sacramento, CA 95817 USA; [Lam, Kit S.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Gao, Kewa] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Carney, Randy P.; Wang, Aijun] Cent South Univ, Dept Burns & Plast Surg, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Farmer, Diana L.; Wang, Aijun] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Central South University	Wang, AJ (corresponding author), Univ Calif Davis Hlth, Dept Surg, Surg Bioengn Lab, Res 2,Suite 3005,4625 2nd Ave, Sacramento, CA 95817 USA.	aawang@ucdavis.edu	Wang, Aijun/C-7559-2013; kumar, priyadarsini/AAG-7494-2019; Carney, Randy/ABB-8530-2020	Wang, Aijun/0000-0002-2985-3627; kumar, priyadarsini/0000-0001-6800-9632; Carney, Randy/0000-0001-8193-1664; Farmer, Diana/0000-0002-3530-5993	California Institute for Regenerative Medicine [PC1-08103]; Craig H. Neilsen Foundation Research Grant [546558]; Shriners Hospital for Children Research Grants [85120-NCA-16, 87410-NCA-17, 85119-NCA-18]; U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant [5R01NS100761-02]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [R03HD091601-01]; March of Dimes Foundation Grant [5FY1682]; University of California-Davis Center for Biophotonics Pilot grant; California Institute for Regenerative Medicine (CIRM) Training Grant [TG2-01163]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100761] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Craig H. Neilsen Foundation Research Grant; Shriners Hospital for Children Research Grants; U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; March of Dimes Foundation Grant; University of California-Davis Center for Biophotonics Pilot grant; California Institute for Regenerative Medicine (CIRM) Training Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by the California Institute for Regenerative Medicine (PC1-08103 to D.L.F. and A.W.), Craig H. Neilsen Foundation Research Grant 546558 (to D.L.F.), Shriners Hospital for Children Research Grants 85120-NCA-16 (to D.L.F.), 87410-NCA-17 and 85119-NCA-18 (to A.W.), U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant 5R01NS100761-02 (to A.W.), NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R03HD091601-01 (to A.W.), March of Dimes Foundation Grant 5FY1682 (to A.W.), a University of California-Davis Center for Biophotonics Pilot grant (to A.W.), and California Institute for Regenerative Medicine (CIRM) Training Grant TG2-01163 (to B.A.K.). The authors acknowledge Nicole Kreutzberg (University of California-Davis) for her help with manuscript editing and submission. The authors declare no conflicts of interest.	Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; Ahn Jee-Yin, 2014, Exp Neurobiol, V23, P200, DOI 10.5607/en.2014.23.3.200; Anderson JD, 2016, STEM CELLS, V34, P601, DOI 10.1002/stem.2298; Antoniadou E, 2016, BEST PRACT RES CL OB, V31, P13, DOI 10.1016/j.bpobgyn.2015.08.014; Beretti F, 2018, BIOFACTORS, V44, P158, DOI 10.1002/biof.1407; Bjorge IM, 2017, BIOMATER SCI-UK, V6, P60, DOI 10.1039/c7bm00479f; Brady K, 2014, STEM CELLS DEV, V23, P541, DOI 10.1089/scd.2013.0301; Calzarossa C, 2013, NEUROSCIENCE, V234, P158, DOI 10.1016/j.neuroscience.2012.12.038; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carney RP, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201600038; Carney RP, 2017, ANAL CHEM, V89, P5357, DOI 10.1021/acs.analchem.7b00017; Chen YJ, 2018, J PEDIATR SURG, V53, P183, DOI 10.1016/j.jpedsurg.2017.10.040; Colao IL, 2018, TRENDS MOL MED, V24, P242, DOI 10.1016/j.molmed.2018.01.006; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078; Fais S, 2016, ACS NANO, V10, P3886, DOI 10.1021/acsnano.5b08015; Fan YN, 2016, NUCLEIC ACIDS RES, V44, pW135, DOI 10.1093/nar/gkw288; Farmer DL, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.12.001; Ham O, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0134-x; He XT, 2018, J CELL MOL MED, V22, P1302, DOI 10.1111/jcmm.13431; Horie H, 1999, J NEUROSCI, V19, P9964; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kabagambe S, 2018, J PEDIATR SURG, V53, P178, DOI 10.1016/j.jpedsurg.2017.10.032; Keshtkar S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0791-7; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Kramer-Albers EM, 2016, CURR OPIN NEUROBIOL, V39, P101, DOI 10.1016/j.conb.2016.04.016; Lamichhane TN, 2015, TISSUE ENG PART B-RE, V21, P45, DOI [10.1089/ten.TEB.2014.0300, 10.1089/ten.teb.2014.0300]; Lankford KL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190358; Lankford L, 2017, CYTOTHERAPY, V19, P680, DOI 10.1016/j.jcyt.2017.03.003; Lankford L, 2015, WORLD J STEM CELLS, V7, P195, DOI 10.4252/wjsc.v7.i1.195; Li H, 2014, CYTOTHERAPY, V16, P319, DOI 10.1016/j.jcyt.2013.10.005; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Lopes FM, 2012, NEUROTOX RES, V22, P138, DOI 10.1007/s12640-012-9311-1; Mead B, 2017, STEM CELL TRANSL MED, V6, P1273, DOI 10.1002/sctm.16-0428; Meuli M, 2014, PEDIATR SURG INT, V30, P689, DOI 10.1007/s00383-014-3524-8; Peng X, 2011, CURR PROTEIN PEPT SC, V12, P52, DOI 10.2174/138920311795659452; Phan J, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1522236; Popa SJ, 2018, SEMIN CELL DEV BIOL, V83, P42, DOI 10.1016/j.semcdb.2018.02.022; Safford KA, 2005, CURR DRUG TARGETS, V6, P57, DOI 10.2174/1389450053345028; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Smith ZJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28533; Szekiova E, 2018, NEUROL RES, V40, P258, DOI 10.1080/01616412.2018.1432266; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang Ho Man, 2017, F1000Res, V6, P43, DOI 10.12688/f1000research.10568.2; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wagenaar N, 2018, PEDIATR RES, V83, P372, DOI 10.1038/pr.2017.243; Wang AJ, 2015, STEM CELL TRANSL MED, V4, P659, DOI 10.5966/sctm.2014-0296; Wang L, 2017, MINERAL MET MAT SER, P109, DOI 10.1007/978-3-319-51580-9_11; Willis GR, 2017, METHODS MOL BIOL, V1660, P409, DOI 10.1007/978-1-4939-7253-1_34	53	35	38	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5836	5849		10.1096/fj.201800972R	http://dx.doi.org/10.1096/fj.201800972R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753093	Green Published, Bronze			2022-12-28	WOS:000466932600004
J	Sackett, SD; Otto, T; Mohs, A; Sander, LE; Strauch, S; Streetz, KL; Kroy, DC; Trautwein, C				Sackett, Sara Dutton; Otto, Tobias; Mohs, Antje; Sander, Leif E.; Strauch, Sonja; Streetz, Konrad L.; Kroy, Daniela C.; Trautwein, Christian			Myeloid cells require gp130 signaling for protective anti-inflammatory functions during sepsis	FASEB JOURNAL			English	Article						IL-6; STAT3; M1 macrophages; M2 macrophages; macrophage polarization	ALTERNATIVE ACTIVATION; INTERLEUKIN-6 FAMILY; MACROPHAGES; EXPRESSION; CYTOKINE; SURVIVAL; TRANSDUCER; PROGRESS; GROWTH; MICE	Sepsis represents a major health problem worldwide because of high mortality rates and cost-intensive therapy. Immunomodulatory strategies as a means of controlling overshooting inflammatory responses during sepsis have thus far not been effective, and there is a general paucity of new therapies. Regulatory immune cells have been shown to play important roles in limiting systemic inflammation. However, the signals inducing a regulatory phenotype in myeloid cells during infection are unknown. Here, we report that myeloid cell-intrinsic glycoprotein 130 (gp130) signals constitute a critical element for immune homeostasis during polymicrobial sepsis. We identify an essential role for gp130 signaling in myeloid cells during M2 macrophage polarization in vitro and in vivo. Myeloid cell-specific deletion of gp130 signaling leads to a defective M2 macrophage polarization followed by exacerbated inflammatory responses and increased mortality during sepsis. These data provide new insights into the molecular basis of M1 and M2 phenotypic dichotomy and identify gp130 as a key regulator of immune homeostasis during sepsis. Our study highlights the Janus-faced role of IL-6 family cytokines during inflammation, which may explain the failure of IL-6-targeted anti-inflammatory approaches in the treatment of sepsis.Sackett, S. D., Otto, T., Mohs, A., Sander, L. E., Strauch, S., Streetz, K. L., Kroy, D. C., Trautwein, C. Myeloid cells require gp130 signaling for protective anti-inflammatory functions during sepsis.	[Sackett, Sara Dutton; Otto, Tobias; Mohs, Antje; Sander, Leif E.; Strauch, Sonja; Streetz, Konrad L.; Kroy, Daniela C.; Trautwein, Christian] Univ Hosp Rheinisch Westfalische TH RWTH Aachen, Dept Internal Med 3, Aachen, Germany; [Sackett, Sara Dutton] Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI USA; [Sander, Leif E.] Charite Univ Med Berlin, Dept Infect Dis & Pulm Med, Berlin, Germany; [Sander, Leif E.] Free Univ Berlin, Berlin, Germany; [Sander, Leif E.] Humboldt Univ, Berlin, Germany; [Sander, Leif E.] Berlin Inst Hlth, Berlin, Germany; [Sander, Leif E.] German Ctr Lung Res DZL, Berlin, Germany	University of Wisconsin System; University of Wisconsin Madison; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health	Trautwein, C (corresponding author), RWTH Aachen Univ Hosp, Dept Internal Med 3, Pauwelsstr 30, D-52074 Aachen, Germany.	ctrautwein@ukaachen.de	Sander, Leif Erik/AAI-8619-2020; Otto, Tobias/AAH-5141-2021	Otto, Tobias/0000-0001-5594-3055; Mohs, Antje/0000-0001-5937-0696	German Research Foundation [TR285/10-1, SFB/TRR57]; Interdisciplinary Center for Clinical Research within the Faculty of Medicine at the RWTH Aachen University [O3-6]	German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research within the Faculty of Medicine at the RWTH Aachen University	The authors thank Dr. Gernot Sellge and Dr. Roland Sonntag [both from the University Hospital Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen] for discussion of the results and critical review of the manuscript, as well as Dr. Francisco J. Cubero (University Hospital RWTH Aachen) for valuable discussions. The authors thank Malika Al Masaoudi (University Hospital RWTH Aachen) for technical support. The authors also thank the excellent assistance of Carmen G. Tag and Sibille Sauer-Lehnen from the Core Unit "Q3 - Cell Isolation" of the SFB/TRR57 (Aachen, Germany) for sorting of peritoneal exudate cells. This study was supported by grants from the German Research Foundation (TR285/10-1 and SFB/TRR57 to C.T.) and by a grant from the Interdisciplinary Center for Clinical Research within the Faculty of Medicine at the RWTH Aachen University (O3-6 to T.O. and C.T). The authors declare no conflicts of interest.	Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Dubey A, 2018, IMMUNOL CELL BIOL, V96, P257, DOI 10.1111/imcb.1035; Evans TJ, 1996, IMMUNOBIOLOGY, V195, P655, DOI 10.1016/S0171-2985(96)80029-5; Fernando ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099050; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Kroy DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039728; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Latifi SQ, 2002, INFECT IMMUN, V70, P4441, DOI 10.1128/IAI.70.8.4441-4446.2002; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Minnich DJ, 2004, P NUTR SOC, V63, P437, DOI 10.1079/PNS2004378; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munder M, 1999, J IMMUNOL, V163, P3771; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Oishi S, 2016, IMMUNOLOGY, V149, P320, DOI 10.1111/imm.12647; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITO M, 1992, J IMMUNOL, V148, P4066; Sander LE, 2008, J IMMUNOL, V181, P3586, DOI 10.4049/jimmunol.181.5.3586; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Wang Y., 2017, ONCOTARGET, V8; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	36	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6035	6044		10.1096/fj.201802118R	http://dx.doi.org/10.1096/fj.201802118R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30726111				2022-12-28	WOS:000466932600020
J	Werner, M; Jordan, PM; Romp, E; Czapka, A; Rao, ZG; Kretzer, C; Koeberle, A; Garscha, U; Pace, S; Claesson, HE; Serhan, CN; Werz, O; Gerstmeier, J				Werner, Markus; Jordan, Paul M.; Romp, Erik; Czapka, Anna; Rao, Zhigang; Kretzer, Christian; Koeberle, Andreas; Garscha, Ulrike; Pace, Simona; Claesson, Hans-Erik; Serhan, Charles N.; Werz, Oliver; Gerstmeier, Jana			Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome	FASEB JOURNAL			English	Article						resolution; macrophages; inflammation; leukotrienes; prostaglandins	CYTOSOLIC PHOSPHOLIPASE A(2); INFLAMMATION; MEDIATORS; INHIBITION; RESOLUTION; ACID; 15-LIPOXYGENASE-1; CYCLOOXYGENASE; IDENTIFICATION; POLARIZATION	Nonsteroidal anti-inflammatory drugs interfere with the metabolism of arachidonic acid to proinflammatory prostaglandins and leukotrienes by targeting cyclooxygenases (COXs), 5-lipoxygenase (LOX), or the 5-LOX-activating protein (FLAP). These and related enzymes act in conjunction with marked crosstalk within a complex lipid mediator (LM) network where also specialized proresolving LMs (SPMs) are formed. Here, we present how prominent LM pathways can be differentially modulated in human proinflammatory M1 and proresolving M2 macrophage phenotypes that, upon exposure to Escherichia coli, produce either abundant prostaglandins and leukotrienes (M1) or SPMs (M2). Targeted liquid chromatography-tandem mass spectrometry-based metabololipidomics was applied to analyze and quantify the specific LM profiles. Besides expected on-target actions, we found that: 1) COX or 15-LOX-1 inhibitors elevate inflammatory leukotriene levels, 2) FLAP and 5-LOX inhibitors reduce leukotrienes in M1 but less so in M2 macrophages, 3) zileuton blocks resolution-initiating SPM biosynthesis, whereas FLAP inhibition increases SPM levels, and 4) that the 15-LOX-1 inhibitor 3887 suppresses SPM formation in M2 macrophages. Conclusively, interference with discrete LM biosynthetic enzymes in different macrophage phenotypes considerably affects the LM metabolomes with potential consequences for inflammation-resolution pharmacotherapy. Our data may allow better appraisal of the therapeutic potential of these drugs to intervene with inflammatory disorders.Werner, M., Jordan, P. M., Romp, E., Czapka, A., Rao, Z., Kretzer, C., Koeberle, A., Garscha, U., Pace, S., Claesson, H.-E., Serhan, C. N., Werz, O., Gerstmeier, J. Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome.	[Werner, Markus; Jordan, Paul M.; Romp, Erik; Czapka, Anna; Rao, Zhigang; Kretzer, Christian; Koeberle, Andreas; Garscha, Ulrike; Pace, Simona; Werz, Oliver; Gerstmeier, Jana] Friedrich Schiller Univ Jena, Dept Pharmaceut Med Chem, Inst Pharm, Philosophenweg 14, D-07743 Jena, Germany; [Claesson, Hans-Erik] Karolinska Univ Hosp Solna, Div Hematol, Dept Med, Stockholm, Sweden; [Serhan, Charles N.] Harvard Med Sch, Dept Anesthesia Perioperat & Pain, Ctr Expt Therapeut & Reperfus Injury, Brigham & Womens Hosp, Boston, MA 02115 USA	Friedrich Schiller University of Jena; Karolinska Institutet; Karolinska University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Werz, O; Gerstmeier, J (corresponding author), Friedrich Schiller Univ Jena, Dept Pharmaceut Med Chem, Inst Pharm, Philosophenweg 14, D-07743 Jena, Germany.	oliver.werz@uni-jena.de; jana.gerstmeier@uni-jena.de	Koeberle, Andreas/ABB-2356-2020; Garscha, Ulrike/G-3559-2018	Koeberle, Andreas/0000-0001-6269-5088; Jordan, Paul Mike/0000-0002-8364-4236; Rao, Zhigang/0000-0002-9918-9100; Garscha, Ulrike/0000-0002-3645-7833	Deutsche Forschungsgemeinschaft [SFB1127, SFB1278]; Carl-Zeiss stipend; U.S. National Institutes of Health, National Institute of General Medical Sciences Grant [P01GM095467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Carl-Zeiss stipend; U.S. National Institutes of Health, National Institute of General Medical Sciences Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB1127, ChemBioSys, and SFB1278, Polytarget). J.G. received a Carl-Zeiss stipend, and C.N.S. was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grant P01GM095467. The authors declare no conflicts of interest.	Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238; Andersson CK, 2008, AM J RESP CELL MOL, V39, P648, DOI 10.1165/rcmb.2007-0443OC; Archambault AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202424; Aursnes M, 2015, J NAT PROD, V78, P2924, DOI 10.1021/acs.jnatprod.5b00574; Bhavsar PK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-71; Burnett BP, 2012, ADV THER, V29, P79, DOI 10.1007/s12325-011-0100-7; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Claesson HE, 2009, PROSTAG OTH LIPID M, V89, P120, DOI 10.1016/j.prostaglandins.2008.12.003; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Conte MS, 2018, J CLIN INVEST, V128, P3727, DOI 10.1172/JCI97947; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Fischer L, 2004, BRIT J PHARMACOL, V142, P861, DOI 10.1038/sj.bjp.0705860; Fischer L, 2003, FASEB J, V17, P949, DOI 10.1096/fj.02-0815fje; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Fukunaga K, 2005, J IMMUNOL, V174, P5033, DOI 10.4049/jimmunol.174.8.5033; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gerstmeier J, 2016, FASEB J, V30, P276, DOI 10.1096/fj.15-278010; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; GILLARD J, 1989, CAN J PHYSIOL PHARM, V67, P456, DOI 10.1139/y89-073; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Han HY, 2017, FASEB J, V31, P491, DOI 10.1096/fj.201600679RR; He C, 2012, MOL BIOSYST, V8, P1585, DOI 10.1039/c2mb05503a; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Kim SN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27221-7; Kutzner L, 2017, BBA-MOL CELL BIOL L, V1862, P666, DOI 10.1016/j.bbalip.2017.04.001; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lehmann C, 2015, FASEB J, V29, P5029, DOI 10.1096/fj.15-275487; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Mazaleuskaya LL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87031; Meng H, 2016, J MED CHEM, V59, P4202, DOI 10.1021/acs.jmedchem.5b01011; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Motwani MP, 2015, SEMIN IMMUNOL, V27, P257, DOI 10.1016/j.smim.2015.07.002; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Pace S, 2017, J CLIN INVEST, V127, P3167, DOI 10.1172/JCI92885; Primdahl KG, 2017, ORG BIOMOL CHEM, V15, P8606, DOI [10.1039/c7ob02113ersc.li/obc, 10.1039/c7ob02113e]; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Rainsford K. D., 2007, V42, P3; RAINSFORD KD, 1993, AGENTS ACTIONS, V39, pC24, DOI 10.1007/BF01972709; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SHIKANO M, 1994, BBA-LIPID LIPID MET, V1212, P211, DOI 10.1016/0005-2760(94)90255-0; Snodgrass RG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01906; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Titos E, 2005, J LEUKOCYTE BIOL, V78, P871, DOI 10.1189/jlb.1204747; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Werz O, 2017, EXPERT OPIN THER PAT, V27, P607, DOI 10.1080/13543776.2017.1276568; Yang K, 2007, PLOS COMPUT BIOL, V3, P523, DOI 10.1371/journal.pcbi.0030055	63	54	55	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6140	6153		10.1096/fj.201802509R	http://dx.doi.org/10.1096/fj.201802509R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30735438	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000466932600028
J	Zhang, ZG; Hunter, L; Wu, G; Maidstone, R; Mizoro, Y; Vonslow, R; Fife, M; Hopwood, T; Begley, N; Saer, B; Wang, P; Cunningham, P; Baxter, M; Durrington, H; Blaikley, JF; Hussell, T; Rattray, M; Hogenesch, JB; Gibbs, J; Ray, DW; Loudon, ASI				Zhang, Zhenguang; Hunter, Louise; Wu, Gang; Maidstone, Robert; Mizoro, Yasutaka; Vonslow, Ryan; Fife, Mark; Hopwood, Thomas; Begley, Nicola; Saer, Ben; Wang, Ping; Cunningham, Peter; Baxter, Matthew; Durrington, Hannah; Blaikley, John F.; Hussell, Tracy; Rattray, Magnus; Hogenesch, John B.; Gibbs, Julie; Ray, David W.; Loudon, Andrew S., I			Genome-wide effect of pulmonary airway epithelial cell-specific Bmal1 deletion	FASEB JOURNAL			English	Article						circadian clock; metabolic entrainment; circadian lung function; influenza infection; food entrainment	CIRCADIAN CLOCK; COMPONENT; INFLAMMATION; METABOLISM; RHYTHMS; INJURY; MICE	Pulmonary airway epithelial cells (AECs) form a critical interface between host and environment. We investigated the role of the circadian clock using mice bearing targeted deletion of the circadian gene brain and muscle ARNT-like 1 (Bmal1) in AECs. Pulmonary neutrophil infiltration, biomechanical function, and responses to influenza infection were all disrupted. A circadian time-series RNA sequencing study of laser-captured AECs revealed widespread disruption in genes of the core circadian clock and output pathways regulating cell metabolism (lipids and xenobiotics), extracellular matrix, and chemokine signaling, but strikingly also the gain of a novel rhythmic transcriptome in Bmal1-targeted cells. Many of the rhythmic components were replicated in primary AECs cultured in air-liquid interface, indicating significant cell autonomy for control of pulmonary circadian physiology. Finally, we found that metabolic cues dictate phasing of the pulmonary clock and circadian responses to immunologic challenges. Thus, the local circadian clock in AECs is vital in lung health by coordinating major cell processes such as metabolism and immunity.Zhang, Z. Hunter, L., Wu, G., Maidstone, R., Mizoro, Y., Vonslow, R., Fife, M., Hopwood, T., Begley, N., Saer, B., Wang, P., Cunningham, P., Baxter, M., Durrington, H., Blaikley, J. F., Hussell, T., Rattray, M., Hogenesch, J. B., Gibbs, J., Ray, D. W., Loudon, A. S. I. Genome-wide effect of pulmonary airway epithelial cell-specific Bmal1 deletion.	[Zhang, Zhenguang; Hunter, Louise; Mizoro, Yasutaka; Vonslow, Ryan; Hopwood, Thomas; Begley, Nicola; Saer, Ben; Cunningham, Peter; Baxter, Matthew; Durrington, Hannah; Blaikley, John F.; Gibbs, Julie; Ray, David W.; Loudon, Andrew S., I] Univ Manchester, Fac Biol Hlth & Med, Ctr Biol Timing, Oxford Rd, Manchester M13 9PT, Lancs, England; [Maidstone, Robert; Wang, Ping; Rattray, Magnus] Univ Manchester, Fac Biol Hlth & Med, Div Informat Imaging & Data Sci, Manchester, Lancs, England; [Fife, Mark; Hussell, Tracy] Univ Manchester, Fac Biol Hlth & Med, Manchester Ctr Collaborat Inflammat Res, Manchester, Lancs, England; [Wu, Gang; Hogenesch, John B.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Wu, Gang] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Ctr Chronobiol, Div Immunobiol, Cincinnati, OH 45229 USA; [Zhang, Zhenguang] Univ Cambridge, MRC Res Ctr, Dept Oncol, Cambridge, England; [Ray, David W.] Univ Oxford, Radcliffe Dept Med, Oxford, England	University of Manchester; University of Manchester; University of Manchester; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Cambridge; University of Oxford	Ray, DW; Loudon, ASI (corresponding author), Univ Manchester, Fac Biol Hlth & Med, Ctr Biol Timing, Oxford Rd, Manchester M13 9PT, Lancs, England.	david.w.ray@manchester.ac.uk; andrew.loudon@manchester.ac.uk	Maidstone, Robert/GOH-0414-2022; Rattray, Magnus/B-4393-2009; Rattray, Magnus/AAE-3297-2021; Wu, Gang/AAC-8206-2022; Durrington, Hannah/B-4564-2016; Hussell, Tracy/O-4630-2014	Maidstone, Robert/0000-0002-3482-3246; Rattray, Magnus/0000-0001-8196-5565; Rattray, Magnus/0000-0001-8196-5565; Wu, Gang/0000-0002-4526-2034; Durrington, Hannah/0000-0002-9990-9446; Baxter, Matthew/0000-0002-3612-2574; Blaikley, John/0000-0001-7651-5682; Loudon, Andrew/0000-0003-3648-445X; Hussell, Tracy/0000-0001-7186-6141; Hunter, Ann Louise/0000-0002-3874-4852; Mizoro, Yasutaka/0000-0002-5081-4884; Gibbs, Julie/0000-0002-4248-2947; Ray, David/0000-0002-4739-6773	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L000954/1, BB/K003097/1]; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [2R01NS054794]; Wellcome Trust [107849/Z/15/Z]; BBSRC [BB/L000954/1] Funding Source: UKRI; MRC [MR/L006499/1, MR/M008908/1] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Ian Donaldson and Andy Hayes (Bioinformatics and Genomic Technologies Core Facilities, University of Manchester) for providing support with regard to chromatin immunoprecipitation sequencint (ChIP) and RNA-seq analysis and sequencing, Dr. Halina Dobrzynski and Garry Ashton (University of Manchester) for access to LCM machines, Prof. Colin Bingle's group (University of Sheffield, Sheffield, England) in the training of primary AEC ALI culture, Dr. Emma Rawlins (University of Cambridge, Cambridge, United Kingdom) for communications of the Cre virus transfection method, Dr. Christoph Ballestrem, Rachel Lennon, and Patrick Caswell (all from the University of Manchester) for discussions of epithelial cell biology, the Genomics Center for RNA-seq Service, the Histology Laboratory, and Bioimaging Facility, University of Manchester for tissue section studies, and members of the laboratories of A.S.I.L. and D.W.R. for general discussions. The work is supported by Biotechnology and Biological Sciences Research Council (BBSRC) grants awarded to A.S.I.L. and D.W.R. (BB/L000954/1 and BB/K003097/1). D.W.R. and A.S.I.L. are Wellcome Investigators (Wellcome Trust; 107849/Z/15/Z). J.B.H. is supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (2R01NS054794 to J.B.H. and A.S.I.L.). The authors declare no conflicts of interest.	Akram KM, 2018, MUCOSAL IMMUNOL, V11, P71, DOI [10.1038/mi.2017.45, 10.1038/mi.2017.109]; Anafi RC, 2017, P NATL ACAD SCI USA, V114, P5312, DOI 10.1073/pnas.1619320114; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Balasooriya GI, 2016, DEV CELL, V37, P85, DOI 10.1016/j.devcel.2016.03.001; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Bayes HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35838; Betsuyaku T, 2004, MICRON, V35, P229, DOI 10.1016/j.micron.2003.11.015; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Edgar RS, 2016, P NATL ACAD SCI USA, V113, P10085, DOI 10.1073/pnas.1601895113; Ehlers A, 2018, MUCOSAL IMMUNOL, V11, P97, DOI 10.1038/mi.2017.24; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gregory DJ, 2015, AM J PHYSIOL-LUNG C, V309, pL1041, DOI 10.1152/ajplung.00283.2015; Haspel JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5753; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang JW, 2014, FASEB J, V28, P176, DOI 10.1096/fj.13-232629; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Ramkisoensing A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00128; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042; Sukumaran S, 2011, J APPL PHYSIOL, V110, P1732, DOI 10.1152/japplphysiol.00079.2011; Sundar IK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09927; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Yang ZT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3006; You Yingjian, 2013, Methods Mol Biol, V945, P123, DOI 10.1007/978-1-62703-125-7_9; Zhang R, 2016, J BIOL RHYTHM, V31, P244, DOI 10.1177/0748730416631895; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	36	29	29	0	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6226	6238		10.1096/fj.201801682R	http://dx.doi.org/10.1096/fj.201801682R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794439	Green Published, hybrid			2022-12-28	WOS:000466932600034
J	Gu, LL; Ye, P; Li, HL; Wang, Y; Xu, YQ; Tian, QH; Lei, GX; Zhao, C; Gao, Z; Zhao, WF; Tan, SH				Gu, Lili; Ye, Pei; Li, Hengli; Wang, Yue; Xu, Yaqiong; Tian, Qinghua; Lei, Gaoxin; Zhao, Cheng; Gao, Zhan; Zhao, Wenfeng; Tan, Shuhua			Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE(-/-) mice by up-regulating heme oxygenase-1 via PI3K/Akt/Nrf2/ARE pathway	FASEB JOURNAL			English	Article						atherosclerosis; endothelium; oxidative stress	OXIDATIVE STRESS; PEPTIDE LUNASIN; DYSFUNCTION; MECHANISMS; APOPTOSIS	Oxidative stress-induced vascular endothelial cell (VEC) injury is a major mechanism in the initiation and development of atherosclerosis. Lunasin, a soybean-derived 43-aa peptide, has been previously shown to possess potent antioxidant and anti-inflammatory activities other than its established anticancer activities. This study investigated the effects of lunasin on protecting VECs from oxidative damage and inhibiting atherosclerotic plaque progression in apolipoprotein E-deficient (ApoE(-/-)) mice and explored its underlying mechanism. Biochemical and histologic analyses were performed by using EA.hy926 human VECs and a high-fat diet (HFD) ApoE(-/-) mouse atherosclerosis model. Our data indicated that lunasin attenuated H2O2-induced, mitochondria-dependent endothelial apoptosis via down-regulating Bax and up-regulating Bcl-2, inhibiting the mitochondrial depolarization, and reducing the release of cytochrome c, as well as decreasing the activation of caspase-9 and caspase-3 invitro and invivo. Mechanic studies showed that lunasin significantly up-regulated heme oxygenase-1 via the PI3K/Akt/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway, and reduced H2O2-induced ROS production in VECs, thereby attenuating oxidant-induced endothelial injury and inhibiting atherosclerotic plaque progression in ApoE(-/-) mice. In conclusion, our in vitro and in vivo data suggest that lunasin protects VECs from oxidative damage by enhancing heme oxygenase-1 expression via activation of the PI3K/Akt/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway and inhibiting mitochondria-dependent apoptosis, thereby effectively attenuating atherosclerosis in HFD-fed ApoE(-/-) mice. Lunasin may act as a potential therapeutic agent for the prevention and treatment of atherosclerosis.	[Gu, Lili; Ye, Pei; Li, Hengli; Wang, Yue; Xu, Yaqiong; Tian, Qinghua; Lei, Gaoxin; Zhao, Cheng; Gao, Zhan; Zhao, Wenfeng; Tan, Shuhua] China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, 211 Mailbox,24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Tan, SH (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, 211 Mailbox,24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China.	tanshuhua163@163.com		Tan, shuhua/0000-0002-4992-8876	National Fund for Major Projects of China [2009ZX09103-653, 2013ZX09301303-006, 2018ZX09301035]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Fund for Fostering Talents of Basic Science (NFFTBS) [3050040016]; China Pharmaceutical University Double First-Class project [CPU2018GY15]	National Fund for Major Projects of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Fund for Fostering Talents of Basic Science (NFFTBS); China Pharmaceutical University Double First-Class project	This work was supported by the National Fund for Major Projects of China (2009ZX09103-653; 2013ZX09301303-006; 2018ZX09301035), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the National Fund for Fostering Talents of Basic Science (NFFTBS, 3050040016), and China Pharmaceutical University Double First-Class project (CPU2018GY15). The authors declare no conflicts of interest.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Ayer A, 2016, PHYSIOL REV, V96, P1449, DOI 10.1152/physrev.00003.2016; Azuma K, 2003, BIOCHEM BIOPH RES CO, V309, P384, DOI 10.1016/j.bbrc.2003.08.013; Bachschmid MM, 2013, ANN MED, V45, P17, DOI 10.3109/07853890.2011.645498; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Calay D, 2014, ANTIOXID REDOX SIGN, V20, P1789, DOI 10.1089/ars.2013.5659; Chen B, 2015, J ENDOCRINOL, V225, pR83, DOI 10.1530/JOE-14-0662; Daiber A, 2017, BRIT J PHARMACOL, V174, P1591, DOI 10.1111/bph.13517; Davis K., 2016, INT J CANC THER, V4, P1, DOI 10.14319/ijcto.42.18; de Mejia EG, 2009, PEPTIDES, V30, P2388, DOI 10.1016/j.peptides.2009.08.005; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Fernandez-Tome S, 2014, FOOD RES INT, V62, P793, DOI 10.1016/j.foodres.2014.04.054; Goettsch C, 2011, BASIC RES CARDIOL, V106, P551, DOI 10.1007/s00395-011-0170-3; Hashimoto Y, 2003, EUR J CANCER, V39, P2239, DOI 10.1016/S0959-8049(03)00599-9; Hernandez-Ledesma B, 2009, BIOCHEM BIOPH RES CO, V390, P803, DOI 10.1016/j.bbrc.2009.10.053; Hernandez-Ledesma B, 2009, PEPTIDES, V30, P426, DOI 10.1016/j.peptides.2008.11.002; Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005; Jensen HA, 2016, EXPERT REV CARDIOVAS, V14, P1021, DOI 10.1080/14779072.2016.1207527; Jeong JB, 2010, CANCER LETT, V293, P58, DOI 10.1016/j.canlet.2009.12.019; Garcia-Nebot MJ, 2014, FOOD CHEM TOXICOL, V65, P155, DOI 10.1016/j.fct.2013.12.021; Kattoor AJ, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0678-6; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; Petrovic A, 2011, BIOTECH HISTOCHEM, V86, P429, DOI 10.3109/10520295.2010.528026; Rafieian-Kopaei M, 2014, INT J PREVENTIVE MED, V5, P927; Schwendeman A, 2015, J LIPID RES, V56, P1727, DOI 10.1194/jlr.M060285; Shen HM, 2008, BRAIN RES BULL, V77, P274, DOI 10.1016/j.brainresbull.2008.08.002; Siasos G, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.06.21; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tian QH, 2017, PREP BIOCHEM BIOTECH, V47, P619, DOI 10.1080/10826068.2017.1286600; Victor VM, 2009, CURR PHARM DESIGN, V15, P2988, DOI 10.2174/138161209789058093; Wu ML, 2011, ANTIOXID REDOX SIGN, V15, P1835, DOI 10.1089/ars.2010.3726; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Zhou CC, 2011, J LIPID RES, V52, P1483, DOI 10.1194/jlr.M014092	43	25	27	2	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4836	4850		10.1096/fj.201802251R	http://dx.doi.org/10.1096/fj.201802251R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601695	Bronze			2022-12-28	WOS:000462888500017
J	Jing, H; Zhang, XY; Gao, MC; Luo, K; Fu, W; Yin, M; Wang, W; Zhu, ZQ; Zheng, JH; He, XM				Jing, Hui; Zhang, Xiaoyang; Gao, Manchen; Luo, Kai; Fu, Wei; Yin, Meng; Wang, Wei; Zhu, Zhongqun; Zheng, Jinghao; He, Xiaomin			Kartogenin preconditioning commits mesenchymal stem cells to a precartilaginous stage with enhanced chondrogenic potential by modulating JNK and beta-catenin-related pathways	FASEB JOURNAL			English	Article						chondrogenic; differentiation; endochondral ossification; TGF-beta 3; tracheal defect	ENGINEERED TRACHEAL REPLACEMENT; CROSS-TALK; GROWTH; DIFFERENTIATION; EXPRESSION; CHILD	Cartilage engineering strategies using mesenchymal stem cells (MSCs) could provide preferable solutions to resolve long-segment tracheal defects. However, the drawbacks of widely used chondrogenic protocols containing TGF-beta 3, such as inefficiency and unstable cellular phenotype, are problematic. In our research, to optimize the chondrogenic differentiation of human umbilical cord MSCs (hUCMSCs), kartogenin (KGN) preconditioning was performed prior to TGF-beta 3 induction. hUCMSCs were preconditioned with 1 mu M of KGN for 3 d, sequentially pelleted, and incubated with TGF-beta 3 for 28 d. Then, the expression of chondrogenesis- and ossification-related genes was evaluated by immunohistochemistry and RT-PCR. The underlying mechanism governing the beneficial effects of KGN preconditioning was explored by phosphorylated kinase screening and validated in vitro and in vivo using JNK inhibitor (SP600125) and beta-catenin activator (SKL2001). After KGN preconditioning, expression of fibroblast growth factor receptor 3, a marker of precartilaginous stem cells, was up-regulated in hUCMSCs. Furthermore, the KGN-preconditioned hUCMSCs efficiently differentiated into chondrocytes with elevated chondrogenic gene (SOX9, aggrecan, and collagen II) expression and reduced expression of ossific genes (collagen X and MMP13) compared with hUCMSCs treated with TGF-beta 3 only. Phosphokinase screening indicated that the beneficial effects of KGN preconditioning are directly related to an up-regulation of JNK phosphorylation and a suppression of beta-catenin levels. Blocking and activating tests revealed that the prochondrogenic effects of KGN preconditioning was achieved mainly by activating the JNK/Runt-related transcription factor (RUNX)1 pathway, and antiossific effects were imparted by suppressing the beta-catenin/RUNX2 pathway. Eventually, tracheal patches, based on KGN-preconditioned hUCMSCs and TGF-beta 3 encapsulated electrospun poly(l-lactic acid-co-epsilon-caprolactone)/collagen nanofilms, were successfully used for restoring tracheal defects in rabbit models. In summary, KGN preconditioning likely improves the chondrogenic differentiation of hUCMSCs by committing them to a precartilaginous stage with enhanced JNK phosphorylation and suppressed beta-catenin. This novel protocol consisting of KGN preconditioning and subsequent TGF-beta 3 induction might be preferable for cartilage engineering strategies using MSCs.	[Jing, Hui; Zhang, Xiaoyang; Gao, Manchen; Luo, Kai; Fu, Wei; Yin, Meng; Wang, Wei; Zhu, Zhongqun; Zheng, Jinghao; He, Xiaomin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Cardiothorac Surg, 1678 Dong Fang Rd, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University	Zheng, JH; He, XM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Cardiothorac Surg, 1678 Dong Fang Rd, Shanghai 200127, Peoples R China.	zhengjh210@163.com; mrxmhe@163.com	He, Xiaomin/AAH-5620-2020; Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-8389-8252	National Natural Science Foundation of China [81501604, 81771997, 31370982]; Science and Technology Development Fund of Shanghai Pudong New Area [PKJ2017-Y02]; Biomedical Engineering Fund of Shanghai Jiao Tong University [YG2015MS34]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Fund of Shanghai Pudong New Area; Biomedical Engineering Fund of Shanghai Jiao Tong University	This research was supported by the National Natural Science Foundation of China (Grants 81501604, 81771997, and 31370982), the Science and Technology Development Fund of Shanghai Pudong New Area (Grant PKJ2017-Y02), and the Biomedical Engineering Fund of Shanghai Jiao Tong University (Grant YG2015MS34). The authors declare no conflicts of interest.	[Anonymous], 2017, MED BALTIM; Branly T, 2017, STEM CELL REV REP, V13, P611, DOI 10.1007/s12015-017-9748-y; Cai GR, 2019, J DRUG TARGET, V27, P28, DOI 10.1080/1061186X.2018.1464011; Chen XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0279-5; Cheng L, 2014, INT J MOL SCI, V15, P12665, DOI 10.3390/ijms150712665; Coleman CM, 2013, STEM CELLS DEV, V22, P1968, DOI 10.1089/scd.2012.0282; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Decker RS, 2014, DEV BIOL, V395, P255, DOI 10.1016/j.ydbio.2014.09.011; Dexheimer V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36655; Donders R, 2018, STEM CELLS DEV, V27, P65, DOI 10.1089/scd.2017.0029; Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5; Etienne H, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02211-2017; Fan WS, 2018, DRUG DELIV, V25, P1004, DOI 10.1080/10717544.2018.1461279; Gao XR, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0216-4; Hamilton NJ, 2015, AM J TRANSPLANT, V15, P2750, DOI 10.1111/ajt.13318; He XM, 2013, J NANOSCI NANOTECHNO, V13, P3818, DOI 10.1166/jnn.2013.7436; Hu Q, 2017, NANOMED-NANOTECHNOL, V13, P2189, DOI 10.1016/j.nano.2017.05.011; Huang H, 2017, AM J SPORT MED, V45, P3289, DOI 10.1177/0363546517721192; Im GI, 2018, J BIOMED MATER RES A, V106, P1141, DOI 10.1002/jbm.a.36300; Jing H, 2018, ARTIF CELL NANOMED B, V46, pS985, DOI 10.1080/21691401.2018.1439844; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Kim D, 2012, J BIOL CHEM, V287, P12501, DOI 10.1074/jbc.M111.264382; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee PT, 2017, J CELL BIOCHEM, V118, P172, DOI 10.1002/jcb.25623; Liu C, 2015, CELL BIOL INT, V39, P1026, DOI 10.1002/cbin.10476; Marmotti A, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/1732094; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Wang J, 2017, MAT SCI ENG C-MATER, V70, P637, DOI 10.1016/j.msec.2016.09.044; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074255; Wang YM, 2017, AM J TRANSL RES, V9, P2656; Wu XW, 2018, BIOMATER SCI-UK, V6, P1147, DOI [10.1039/C8BM00127H, 10.1039/c8bm00127h]; Yang JH, 2007, J KOREAN MED SCI, V22, P491, DOI 10.3346/jkms.2007.22.3.491; Zhang TT, 2015, BIOMATERIALS, V38, P72, DOI 10.1016/j.biomaterials.2014.10.010	33	30	31	4	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5641	5653		10.1096/fj.201802137RRR	http://dx.doi.org/10.1096/fj.201802137RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30694703	Bronze			2022-12-28	WOS:000462888500080
J	Liu, JJ; Cui, ZZ; Wang, F; Yao, YP; Yu, GT; Liu, JJ; Cao, DC; Niu, SS; You, MH; Sun, Z; Lian, D; Zhao, TY; Kang, YM; Zhao, YF; Xue, HH; Yu, SY				Liu, Juanjuan; Cui, Zhengzhi; Wang, Fang; Yao, Yingpeng; Yu, Guotao; Liu, Jingjing; Cao, Dengchao; Niu, Shuaishuai; You, Menghao; Sun, Zhen; Lian, Di; Zhao, Tianyan; Kang, Youmin; Zhao, Yaofeng; Xue, Hai-Hui; Yu, Shuyang			Lrp5 and Lrp6 are required for maintaining self-renewal and differentiation of hematopoietic stem cells	FASEB JOURNAL			English	Article						Wnt signaling; reconstitution; development; lineage; cell cycle	BETA-CATENIN; BONE MASS; WNT; PROLIFERATION; TRANSCRIPTION; EXPRESSION; IMPAIRS; DEFICIENCY; ACTIVATION; MECHANISMS	Hematopoietic stem cells (HSCs) have the capacity for self-renewal to maintain the HSCs' pool and the ability for multilineage differentiation, which are responsible for sustained production of multiple blood lineages. The regulation of HSC development is controlled precisely by complex signal networks and hematopoietic microenvironment, which has been termed the HSCs' niche. The Wnt signaling pathway is one of a variety of signaling pathways that have been involved in HSC self-renewal and maintenance. Previous studies are indeterminant on the regulation of adult HSCs upon canonical Wnt signaling pathways because of the different experimental systems and models used. In this study, we generated the conditional knockout Wnt coreceptor low-density lipoprotein receptor-related protein 5 (Lrp5) and low-density lipoprotein receptor-related protein 6 (Lrp6) mice in adult hematopoiesis viaVav-Cre Loxp system. Inactivation of Lrp5 and -6 in a hematopoietic system diminished the pool of HSCs, but there were no obvious defects in mature immune cells. Lrp5 and -6 double deficiency HSCs showed intrinsic defects in self-renewal and differentiation due to reduced proliferation and increased quiescence of the cell cycle. Analysis of HSC gene expression suggested that the quiescence regulators were significantly up-regulated, such as Egr1, Cdkn1a, Nr4a1, Gata2, Junb and Btg2, and the positive cell cycle regulators were correspondingly down-regulated, such as Ccna2 and Ranbp1. Taken together, we investigated the roles of Lrp5 and -6 in HSCs by functional and bioinformatic assays, and we demonstrated that Lrp5 and -6 are required for the self-renewal and differentiation of adult HSCs. The canonical Wnt pathway may contribute to maintaining the HSC pool and regulate the differentiation of adult HSCs by controlling cell cycle gene regulatory module.	[Liu, Juanjuan; Cui, Zhengzhi; Wang, Fang; Yao, Yingpeng; Yu, Guotao; Liu, Jingjing; Cao, Dengchao; Niu, Shuaishuai; You, Menghao; Sun, Zhen; Lian, Di; Zhao, Tianyan; Kang, Youmin; Zhao, Yaofeng; Yu, Shuyang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Liu, Juanjuan; Cui, Zhengzhi; Wang, Fang; Yao, Yingpeng; Yu, Guotao; Liu, Jingjing; Cao, Dengchao; Niu, Shuaishuai; You, Menghao; Sun, Zhen; Lian, Di; Zhao, Tianyan; Yu, Shuyang] China Agr Univ, Coll Biol Sci, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Xue, Hai-Hui] Univ Iowa, Dept Microbiol & Immunol, Carver Coll Med, Iowa City, IA USA	China Agricultural University; China Agricultural University; University of Iowa	Yu, SY (corresponding author), China Agr Univ, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	ysy@cau.edu.cn	Wang, Fang/GLV-0025-2022; Cao, Dengchao/AIA-7934-2022	Wang, Fang/0000-0002-2604-4429; Cao, Dengchao/0000-0001-9808-991X; Liu, Jingjing/0000-0002-3266-7331; Yao, Yingpeng/0000-0002-5415-2443	National Key R&D Program of China [2017YFA0104401]; National Natural Science Foundation of China [31571522, 31630038, 31422037]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Bart Williams (Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids MI, USA) for providing Lrp5- and Lrp6-floxed mice. The authors also thank Dr. Jinping Song for her assistance with cell sorting at China Astronaut Research and Training Center, Beijing, China. This work is supported by National Key R&D Program of China (2017YFA0104401 to S.Y.) and the National Natural Science Foundation of China (31571522, 31630038, and 31422037 to S.Y.). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Battistoni A, 1997, J CELL SCI, V110, P2345; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; de Iongh RU, 2006, FRONT BIOSCI-LANDMRK, V11, P2442, DOI 10.2741/1982; de Pater E, 2013, J EXP MED, V210, P2843, DOI 10.1084/jem.20130751; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Freire PR, 2018, BLOOD, V131, P1081, DOI 10.1182/blood-2017-07-795757; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guarguaglini G, 1997, BIOCHEM J, V325, P277, DOI 10.1042/bj3250277; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kanakkanthara A, 2016, SCIENCE, V353, P1549, DOI 10.1126/science.aaf7463; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Liu CC, 2014, NEURON, V84, P63, DOI 10.1016/j.neuron.2014.08.048; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Ma F, 2016, J CLIN INVEST, V126, P1745, DOI 10.1172/JCI78815; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schumacher CA, 2016, BONE RES, V4, DOI 10.1038/boneres.2015.42; Song KD, 2016, HUM CELL, V29, P53, DOI 10.1007/s13577-016-0134-x; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsang JCH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0739-5; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yu SY, 2016, J BIOL CHEM, V291, P11148, DOI 10.1074/jbc.M116.717801; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Zhang LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154238; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	51	16	16	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5615	5625		10.1096/fj.201802072R	http://dx.doi.org/10.1096/fj.201802072R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668923	Green Published, Bronze			2022-12-28	WOS:000462888500078
J	Pan, WL; Chopp, M; Fan, BY; Zhang, RL; Wang, XL; Hu, JN; Zhang, XM; Zhang, ZG; Liu, XS				Pan, Wan Long; Chopp, Michael; Fan, Baoyan; Zhang, Ruilan; Wang, Xinli; Hu, Jiani; Zhang, Xiao Ming; Zhang, Zheng Gang; Liu, Xian Shuang			Ablation of the microRNA-17-92 cluster in neural stem cells diminishes adult hippocampal neurogenesis and cognitive function	FASEB JOURNAL			English	Article						cognition; hippocampus; small RNA; neuronal differentiation; adult NSC	SUBVENTRICULAR ZONE; PROGENITOR CELLS; DIFFERENTIATION; PROLIFERATION; MEMORY	Impairment of adult neurogenesis in the hippocampus causes cognitive deficits; however, the underlying molecular mechanisms have not been fully elucidated. microRNAs (miRNAs) regulate neural stem cell (NSC) function. With the use of a transgenic mouse line with conditional ablation of the miR-17-92 cluster in nestin lineage NSCs, we tested the hypothesis that the miR-17-92 cluster regulates adult neurogenesis and cognitive function in vivo. Compared with wild-type mice, ablation of the miR-17-92 cluster significantly reduced the number of proliferating NSCs and neuroblasts and neuronal differentiation in the dentate gyrus (DG) of the hippocampus and significantly impaired hippocampal-dependent learning and memory, as assayed by social recognition memory, novel object recognition, and Morris water-maze tests. Statistical analysis showed a highly significant correlation between newly generated neuroblasts in the DG and cognition deficits in miR-17-92 knockout (KO) mice. Western blot analysis showed that conditional KO of the miR-17-92 cluster significantly increased and reduced a cytoskeleton-associated protein, Enigma homolog 1 (ENH1), and its downstream transcription factor, inhibitor of differentiation 1 (ID1), respectively, as well as increased phosphatase and tensin homolog gene. These proteins are related to neuronal differentiation. Our study demonstrates that the miR-17-92 cluster in NSCs is critical for cognitive and behavioral function and regulates neurogenesis and that the miR-17-92 cluster may target ENH1/ID1 signaling.	[Pan, Wan Long] North Sichuan Med Coll, Affiliated Hosp, Dept Microbiol & Immunol, Nanchong, Peoples R China; [Zhang, Xiao Ming] North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Wenhua Rd 63, Nanchong 637000, Sichuan, Peoples R China; [Pan, Wan Long; Chopp, Michael; Fan, Baoyan; Zhang, Ruilan; Wang, Xinli; Zhang, Zheng Gang; Liu, Xian Shuang] Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA	North Sichuan Medical University; North Sichuan Medical University; Henry Ford Health System; Henry Ford Hospital; Oakland University; Wayne State University	Zhang, XM (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Wenhua Rd 63, Nanchong 637000, Sichuan, Peoples R China.; Liu, XS (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA.	zhangxm@nsmc.edu.cn; xliu2@hfhs.org	Wang, Xin/GYU-1129-2022; zhang, zheng/HCH-9684-2022; Pan, Wanlong/AAP-2420-2020	Pan, Wanlong/0000-0003-4590-0240	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [RO1 DK102861]; American Heart/Stroke Association [18IPA34170331]; NIH National Institute of Neurological Disorders and Stroke [RO1 NS075156, RO1 NS088656]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088656] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart/Stroke Association; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant RO1 DK102861 (to X.S.L.); American Heart/Stroke Association Grant 18IPA34170331 (to X.S.L.); and NIH National Institute of Neurological Disorders and Stroke Grants RO1 NS075156 (to Z.G.Z.) and RO1 NS088656 (to M.C.). The authors declare no conflicts of interest.	Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Amiri A, 2012, J NEUROSCI, V32, P5880, DOI 10.1523/JNEUROSCI.5462-11.2012; Bian S, 2013, CELL REP, V3, P1398, DOI 10.1016/j.celrep.2013.03.037; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; Coras R, 2010, BRAIN, V133, P3359, DOI 10.1093/brain/awq215; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Fineberg SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038562; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Guo L, 2012, GENE, V511, P187, DOI 10.1016/j.gene.2012.09.066; Guo WX, 2012, NAT PROTOC, V7, P2005, DOI 10.1038/nprot.2012.123; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, DOI 10.3791/2473; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; Lang MF, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00071; Lasorella A, 2006, P NATL ACAD SCI USA, V103, P4976, DOI 10.1073/pnas.0600168103; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Liu XS, 2017, MOL NEUROBIOL, V54, P227, DOI 10.1007/s12035-015-9655-7; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Liu XS, 2009, J BIOL CHEM, V284, P22680, DOI 10.1074/jbc.M109.006551; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Qiu H, 2016, CELL DEATH DIFFER, V23, P1658, DOI 10.1038/cdd.2016.56; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wang WY, 2012, LEARN MEMORY, V19, P359, DOI 10.1101/lm.026492.112; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Zhang RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050822; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	36	29	29	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5257	5267		10.1096/fj.201801019R	http://dx.doi.org/10.1096/fj.201801019R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668139	Green Published, Bronze			2022-12-28	WOS:000462888500051
J	Wang, CY; Zhu, GM; He, WY; Yin, HB; Lin, F; Gou, X; Li, XY				Wang, Chenyang; Zhu, Gongmin; He, Weiyang; Yin, Hubin; Lin, Fan; Gou, Xin; Li, Xinyuan			BMSCs protect against renal ischemia-reperfusion injury by secreting exosomes loaded with miR-199a-5p that target BIP to inhibit endoplasmic reticulum stress at the very early reperfusion stages	FASEB JOURNAL			English	Article						miRNA; I/R injury; time dependence	MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; EXTRACELLULAR VESICLES; LIVER ISCHEMIA; ER STRESS; KIDNEY; ACTIVATION; TRANSPLANTATION; COMBINATION; APOPTOSIS	Bone marrow-derived mesenchymal stem cells (BMSCs) have been recently reported to play a variety of vital roles in organ and tissue damage repair, mainly via potent paracrine activity, including secreting extracellular vesicles, such as exosomes, that serve as mediators facilitating intercellular communication and reprogramming recipient cells by delivering their contents to target cells. However, the underlying mechanisms are diverse and complex, and the influencing characteristics have rarely been studied. Accordingly, we designed this study to explore the time dependence of the effects of exosomes derived from BMSCs (BMexos) on renal ischemia-reperfusion (I/R) injury and the underlying mechanisms associated with the reperfusion time. Impressively, our study is the first to find that BMexos protected against renal I/R injury in vitro and in vivo at the very early reperfusion stages, especially 4-8 h after reperfusion in vitro and 8-16 h after reperfusion in vivo. Interestingly, we simultaneously found that endoplasmic reticulum (ER) stress was significantly suppressed following the administration of BMexos in vitro and in vivo with a similar time dependence. Additionally, we discovered that miR-199a-5p, which was abundant in the BMSCs, was transferred into renal tubular epithelial cells (NRK-52E) in a time-dependent manner and significantly inhibited I/R-induced ER stress by targeting binding immunoglobulin protein (BIP). Cocultivation with miR-199a-5p-overexpressing BMSCs amplified the suppression of ER stress and further protected against I/R injury. However, coculture with miR-199a-5p-knockdown BMSCs obviously increased ER stress and reversed the BMexos-induced protection, and silencing BIP by small interfering RNA-1098 in NRK-52E inhibited these effects. This study provides evidence that administering BMexos at the very early reperfusion stages significantly protects against renal I/R injury, and ER stress is closely linked to this protection. These results suggest a novel therapeutic strategy during the very early reperfusion stages of renal I/R injury.	[Wang, Chenyang; Zhu, Gongmin; He, Weiyang; Yin, Hubin; Lin, Fan; Gou, Xin; Li, Xinyuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Wang, Chenyang; Zhu, Gongmin; Yin, Hubin; Lin, Fan; Li, Xinyuan] Chongqing Key Lab Mol Oncol & Epigenet, Chongqing, Peoples R China; [Wang, Chenyang] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China	Chongqing Medical University; Sun Yat Sen University	Gou, X; Li, XY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, 1 Youyi Rd, Chongqing 400016, Peoples R China.	gouxincq@163.com; urologyxinyuan@163.com		Wang, Chenyang/0000-0003-3345-5725	Natural Science Foundation of Chongqing [cstc2015shmszx10014, cstc2016jcyjA0042]	Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	The authors thank Professors Xin Gou, Weiyang He, and Jie Li of The First Affiliated Hospital of Chongqing Medical University for providing technical support. This study was funded by the Natural Science Foundation of Chongqing (Grants cstc2015shmszx10014 and cstc2016jcyjA0042). The authors declare no conflicts of interest.	Amarnath S, 2015, STEM CELLS, V33, P1200, DOI 10.1002/stem.1934; Avril T, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.72; Bao CF, 2015, CELL PHYSIOL BIOCHEM, V37, P901, DOI 10.1159/000430217; Beiral HJV, 2014, CELL TRANSPLANT, V23, P207, DOI 10.3727/096368912X659862; Bi LY, 2015, EXP THER MED, V10, P851, DOI 10.3892/etm.2015.2592; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Chung YS, 2011, CHINESE J PHYSIOL, V54, P205, DOI 10.4077/CJP.2011.AMM078; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; Corazzari M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00078; Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129; Dai Y, 2017, BEHAV BRAIN RES, V332, P99, DOI 10.1016/j.bbr.2017.05.055; Deng MY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00205; Galluzzi L, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0020; Gu D, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2093940; Guzel E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040792; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hu JQ, 2017, AM J TRANSL RES, V9, P79; Leng SL, 2008, NEUROSCI LETT, V448, P282, DOI 10.1016/j.neulet.2008.10.016; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Lin KC, 2016, INT J CARDIOL, V216, P173, DOI 10.1016/j.ijcard.2016.04.061; Lindoso RS, 2014, STEM CELLS DEV, V23, P1809, DOI 10.1089/scd.2013.0618; Liu DX, 2017, MOL NEUROBIOL, V54, P5440, DOI 10.1007/s12035-016-0079-9; Liu L, 2012, CONTEMPORARY INNOVATION AND DEVELOPMENT IN STATISTICAL SCIENCE, P92; Mann MI, 2006, CANCER BIOL THER, V5, P736, DOI 10.4161/cbt.5.7.2969; MCDOUGAL WS, 1988, J UROLOGY, V140, P1325, DOI 10.1016/S0022-5347(17)42037-4; Mead B, 2017, STEM CELL TRANSL MED, V6, P1273, DOI 10.1002/sctm.16-0428; Minasyan L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1675230; Parra C, 2010, TRANSPL P, V42, P245, DOI 10.1016/j.transproceed.2009.11.018; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rao J, 2014, AM J TRANSPLANT, V14, P1552, DOI 10.1111/ajt.12711; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Shi DY, 2017, GUT, V66, P955, DOI 10.1136/gutjnl-2015-311146; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Takahashi Y, 2017, METHODS MOL BIOL, V1660, P245, DOI 10.1007/978-1-4939-7253-1_20; Tan SS, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22614; Taniguchi M, 2015, CURR OPIN NEPHROL HY, V24, P345, DOI 10.1097/MNH.0000000000000141; Umezu T, 2017, BLOOD ADV, V1, P812, DOI 10.1182/bloodadvances.2016003251; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Wang JH, 2015, ONCOTARGET, V6, P43992, DOI 10.18632/oncotarget.6083; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Wang Rulin, 2014, Zhonghua Yi Xue Za Zhi, V94, P3298; Wu H, 2016, INT J CARDIOL, V208, P65, DOI 10.1016/j.ijcard.2016.01.119; Zhang C, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00029; Zhu J, 2015, TRANSPL P, V47, P1646, DOI 10.1016/j.transproceed.2015.05.013	46	50	50	1	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5440	5456		10.1096/fj.201801821R	http://dx.doi.org/10.1096/fj.201801821R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30640521	Bronze			2022-12-28	WOS:000462888500065
J	Gwon, Y; Kim, SH; Kim, HT; Kam, TI; Park, J; Lim, B; Cha, H; Chang, HJ; Hong, YR; Jung, YK				Gwon, Youngdae; Kim, Seo-Hyun; Kim, Hyun Tae; Kam, Tae-In; Park, Jisu; Lim, Bitna; Cha, Hyunju; Chang, Ho-Jin; Hong, Yong Rae; Jung, Yong-Keun			Amelioration of amyloid -FcRIIb neurotoxicity and tau pathologies by targeting LYN	FASEB JOURNAL			English	Article						Alzheimer's disease; A; cocrystallization; memory impairment	SRC-FAMILY KINASES; PRION PROTEIN; A-BETA; FYN; TYROSINE; PHOSPHORYLATION; ENVIRONMENT; ACTIVATION; INHIBITION; IMPAIRMENT	SRC-family kinases (SFKs) have been implicated in Alzheimer's disease (AD), but their mode of action was scarcely understood. Here, we show that LYN plays an essential role in amyloid (A)-triggered neurotoxicity and tau hyperphosphorylation by phosphorylating Fc receptor IIb2 (FcRIIb2). We found that enzyme activity of LYN was increased in the brain of AD patients and was promoted in neuronal cells exposed to A 1-42 (A(1-42)). Knockdown of LYN expression inhibited A(1-42)-induced neuronal cell death. Of note, LYN interacted with FcRIIb2 upon exposure to A(1-42) and phosphorylated FcRIIb2 at Tyr273 within immunoreceptor tyrosine-based inhibitory motif in neuronal cells. With the use of the structure-based drug design, we isolated KICG2576, an ATP-competitive inhibitor of LYN. Determination of cocrystal structure illustrated that KICG2576 bound to the cleft in the LYN kinase domain and inhibited LYN with a half-maximal inhibitory concentration value of 0.15 M. KICG2576 inhibited A- or FcRIIb2-induced cell death, and this effect was better than pyrazolopyrimidine 1, a widely used inhibitor of SFK. Upon exposure to A, KICG2576 blocked the phosphorylation of FcRIIb2 and translocation of phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2, a binding protein to the phosphorylated FcRIIb2, to the plasma membrane, resulting in the inhibition of tau hyperphosphorylation, the downstream event of A(1-42)-FcRIIb2 binding. Furthermore, intracerebroventricular injection of KICG2576 into mice ameliorated A-induced memory impairment. These results suggest that LYN plays a crucial role in A(1-42)-mediated neurotoxicity and tau pathology, providing a therapeutic potential of LYN in AD.Gwon, Y., Kim, S.-H., Kim, H. T., Kam, T.-I., Park, J., Lim, B., Cha, H., Chang, H.-J., Hong, Y. R., Jung, Y.-K. Amelioration of amyloid -FcRIIb neurotoxicity and tau pathologies by targeting LYN.	[Gwon, Youngdae; Kim, Seo-Hyun; Kam, Tae-In; Park, Jisu; Lim, Bitna; Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 08826, South Korea; [Kim, Hyun Tae; Cha, Hyunju; Chang, Ho-Jin; Hong, Yong Rae] Crystalgenomics Inc, Gyeonggi Do, South Korea	Seoul National University (SNU)	Jung, YK (corresponding author), Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 08826, South Korea.	ykjung@snu.ac.kr	Gwon, Youngdae/AAK-1621-2021	Kam, Tae-In/0000-0002-7241-4902; Gwon, Youngdae/0000-0002-5618-9370	Creative Research Initiative (CRI) Grant [NRF-2016R1A2A1A05005304]; Bio and Medical Technology Development Program of the National Research Foundation - Ministry of Education, Science, and Technology (South Korea) [NRF-2017M3A9G7073521]	Creative Research Initiative (CRI) Grant; Bio and Medical Technology Development Program of the National Research Foundation - Ministry of Education, Science, and Technology (South Korea)	The authors thank Dr. D. Selkoe (Harvard Medical School, Boston, MA, USA) for CHO and 7PA2 cells, Harvard Brain Tissue Center of McLean Hospital for human brain tissues, and Jeong Eun Na (Crystalgenomics Inc.) for technical assistance. This work was also supported by a Creative Research Initiative (CRI) Grant (NRF-2016R1A2A1A05005304), and by the Bio and Medical Technology Development Program of the National Research Foundation Grant (NRF-2017M3A9G7073521), funded by the Ministry of Education, Science, and Technology (South Korea). The authors declare no conflicts of interest.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dallari S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14830; Dhawan G, 2012, NEUROBIOL AGING, V33, P2247, DOI 10.1016/j.neurobiolaging.2011.10.027; Dhawan G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-117; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freedman TS, 2015, ELIFE, V4, DOI 10.7554/eLife.09183; George C, 2017, BRAIN, V140, P2012, DOI 10.1093/brain/awx132; Gwon Y, 2018, J NEUROSCI, V38, P9001, DOI 10.1523/JNEUROSCI.1996-17.2018; Hernandez-Rapp J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04881; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Kam TI, 2016, ELIFE, V5, DOI 10.7554/eLife.18691; Kam TI, 2014, CELL MOL LIFE SCI, V71, P4803, DOI 10.1007/s00018-014-1706-0; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Ku M, 2015, LEUKEMIA LYMPHOMA, V56, P577, DOI 10.3109/10428194.2014.907897; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Li CJ, 2008, CELL SIGNAL, V20, P1960, DOI 10.1016/j.cellsig.2008.07.004; Loberto N, 2005, J NEUROCHEM, V95, P771, DOI 10.1111/j.1471-4159.2005.03397.x; Lonskaya I, 2013, EMBO MOL MED, V5, P1247, DOI 10.1002/emmm.201302771; Manocha GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132604; Martinez-Garay I, 2016, DEVELOPMENT, V143, P2121, DOI 10.1242/dev.132456; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084746; Nygaard HB, 2018, BIOL PSYCHIAT, V83, P369, DOI 10.1016/j.biopsych.2017.06.004; Ochs K, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00063; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Oh Y, 2012, CELL DEATH DIFFER, V19, P1196, DOI 10.1038/cdd.2011.209; Ohnishi H, 2011, TRENDS NEUROSCI, V34, P629, DOI 10.1016/j.tins.2011.09.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2012, HUM MOL GENET, V21, P2725, DOI 10.1093/hmg/dds100; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Socodato R, 2017, SCI REP-UK, V7, DOI 10.1038/srep40912; Song SM, 2008, J CELL BIOL, V182, P675, DOI 10.1083/jcb.200711066; Stepanek O, 2013, J IMMUNOL, V190, P1807, DOI 10.4049/jimmunol.1202401; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Summy JM, 2005, MOL CANCER THER, V4, P1900, DOI 10.1158/1535-7163.MCT-05-0171; Ul Amin F, 2017, SCI REP-UK, V7, DOI 10.1038/srep40753; Um JW, 2013, NEURON, V80, P531, DOI 10.1016/j.neuron.2013.10.001; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Umemori H, 2003, NEUROSCIENCE, V118, P709, DOI 10.1016/S0306-4522(03)00025-3; van der Vlist M, 2016, NAT REV RHEUMATOL, V12, P593, DOI 10.1038/nrrheum.2016.131; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002; Zhuang SG, 2012, J CELL PHYSIOL, V227, P2138, DOI 10.1002/jcp.22946	50	6	6	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4300	4313		10.1096/fj.201800926R	http://dx.doi.org/10.1096/fj.201800926R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30540497	Bronze			2022-12-28	WOS:000459794800096
J	Mosler, EL; Lukac, N; Flegar, D; Fadljevic, M; Radanovic, I; Cvija, H; Kelava, T; Ivcevic, S; Sucur, A; Markotic, A; Katavic, V; Marusic, A; Grcevic, D; Kovacic, N				Mosler, Elvira Lazic; Lukac, Nina; Flegar, Darja; Fadljevic, Martina; Radanovic, Igor; Cvija, Hrvoje; Kelava, Tomislav; Ivcevic, Sanja; Sucur, Alan; Markotic, Antonio; Katavic, Vedran; Marusic, Ana; Grcevic, Danka; Kovacic, Natasa			Fas receptor induces apoptosis of synovial bone and cartilage progenitor populations and promotes bone loss in antigen-induced arthritis	FASEB JOURNAL			English	Article						mesenchymal cells; osteoprogenitors; osteoblasts; rheumatoid arthritis	COLLAGEN-INDUCED ARTHRITIS; IN-VIVO; LIGAND; CELLS; DIFFERENTIATION; MACROPHAGES; INDUCTION; SYSTEM; OSTEOBLASTS; TOLERANCE	Rheumatoid arthritis (RA) is an inflammatory joint disease that eventually leads to permanent bone and cartilage destruction. Fas has already been established as the regulator of inflammation in RA, but its role in bone formation under arthritic conditions is not completely defined. The aim of this study was to assess the effect of Fas inactivation on the bone damage during murine antigen-induced arthritis. Subchondral bone of wild-type (WT) and Fas-knockout (Fas(-/-)) mice was evaluated by histomorphometry and microcomputerized tomography. Proportions of synovial bone and cartilage progenitors were assessed by flow cytometry. Synovial bone and cartilage progenitors were purified by fluorescence-activated cell sorting and expression of Fas and Fas-induced apoptosis were analyzed in vitro. Results showed that Fas(-/-) mice developed attenuated arthritis characterized by preserved epiphyseal bone and cartilage. A proportion of the earliest CD200(+) bone and cartilage progenitors was reduced in WT mice with arthritis and was unaltered in Fas(-/-) mice. During osteoblastic differentiation in vitro, CD200(+) cells express the highest levels of Fas and are removed by Fas ligation. These results suggest that Fas-induced apoptosis of early CD200(+) osteoprogenitor population represents potential mechanism underlying the impaired bone formation in arthritis, so their preservation may represent the bone-protective mechanism during arthritis.Lazi Mosler, E., Luka, N., Flegar, D., Fadljevi, M., Radanovi, I., Cvija, H., Kelava, T., Ivevi, S., Suur, A., Markoti, A., Katavi, V., Marui, A., Grevi, D., Kovai, N. Fas receptor induces apoptosis of synovial bone and cartilage progenitor populations and promotes bone loss in antigen-induced arthritis.	[Mosler, Elvira Lazic; Lukac, Nina; Flegar, Darja; Fadljevic, Martina; Radanovic, Igor; Cvija, Hrvoje; Kelava, Tomislav; Ivcevic, Sanja; Sucur, Alan; Markotic, Antonio; Katavic, Vedran; Grcevic, Danka; Kovacic, Natasa] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Lab Mol Immunol, Zagreb, Croatia; [Lukac, Nina; Katavic, Vedran; Kovacic, Natasa] Univ Zagreb, Sch Med, Dept Anat, Salata 11, HR-10000 Zagreb, Croatia; [Flegar, Darja; Kelava, Tomislav; Sucur, Alan; Grcevic, Danka] Univ Zagreb, Sch Med, Dept Physiol & Immunol, Zagreb, Croatia; [Mosler, Elvira Lazic] Gen Hosp Dr Ivo Pedisic, Dept Dermatol & Venerol, Sisak, Croatia; [Mosler, Elvira Lazic] Catholic Univ Croatia, Dept Nursing, Zagreb, Croatia; [Ivcevic, Sanja] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Markotic, Antonio] Univ Clin Hosp Mostar, Ctr Clin Pharmacol, Mostar, Bosnia & Herceg; [Marusic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia	University of Zagreb; University of Zagreb; University of Zagreb; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Mostar; University of Split	Kovacic, N (corresponding author), Univ Zagreb, Sch Med, Dept Anat, Salata 11, HR-10000 Zagreb, Croatia.	natasa.kovacic@mef.hr	Sucur, Alan/AAB-9952-2021; Grcevic, Danka/AAS-1666-2021; Kovacic, Natasa/AAA-4598-2021; Markotic, Antonio/AAB-1086-2020; Marusic, Ana/E-7683-2013; markotic, antonio/ABD-9539-2020	Grcevic, Danka/0000-0002-2365-8249; Markotic, Antonio/0000-0002-0410-542X; Marusic, Ana/0000-0001-6272-0917; Kovacic, Natasa/0000-0001-6042-2107; Lazic Mosler, Elvira/0000-0003-3186-6280; Radanovic, Igor/0000-0002-9486-4867	Croatian Science Foundation [7406, 5699]; Scientific Center of Excellence for Reproductive and Regenerative Medicine - European Union through the European Regional Development Fund [KK01.1.1.01.0008, KK01.1.1.01.0007]; Croatian Ministry of Science, Education and Sports [1080229-0140]	Croatian Science Foundation; Scientific Center of Excellence for Reproductive and Regenerative Medicine - European Union through the European Regional Development Fund; Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	The authors thank Katerina Zrinski-Petrovic (Laboratory for Molecular Immunology) for her technical assistance and Ivan Kresimir Lukic (Bjelovar University of Applied Sciences, Bjelovar, Croatia) for advice regarding statistical analysis. The authors thank the Laboratory for Mineralized Tissues, School of Medicine at the University of Zagreb, for access to the 1076 SkyScan mu CT instrument. This work was supported by Croatian Science Foundation Grants 7406 and 5699, the Scientific Center of Excellence for Reproductive and Regenerative Medicine (Project "Reproductive and Regenerative Medicine-Exploration of New Platforms and Potentials") Grant KK01.1.1.01.0008, Research Centre of Excellence of Fundamental Clinical and Translational Neuroscience, and CoRE-Neuro Grant KK01.1.1.01.0007, both funded by the European Union through the European Regional Development Fund, and Croatian Ministry of Science, Education and Sports Grant 1080229-0140. The authors declare no conflicts of interest.	Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Amouzegar A, 2017, STEM CELLS, V35, P1532, DOI 10.1002/stem.2611; Askenasy N, 2005, BLOOD, V105, P1396, DOI 10.1182/blood-2004-06-2364; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Calmon-Hamaty F, 2015, CYTOKINE, V75, P228, DOI 10.1016/j.cyto.2014.10.004; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Conover, 1999, PRACTICAL NONPARAMET; DANIEL PT, 1994, J IMMUNOL, V152, P5624; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Fujisawa K, 1996, J CLIN INVEST, V98, P271, DOI 10.1172/JCI118789; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Garcia S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2941; Grcevic D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00417; Hartgring SAY, 2006, ANN RHEUM DIS, V65, P69, DOI 10.1136/ard.2006.058479; Huang QQ, 2014, ARTHRITIS RHEUMATOL, V66, P68, DOI 10.1002/art.38198; Jagger AL, 2012, J AUTOIMMUN, V38, P29, DOI 10.1016/j.jaut.2011.11.015; Katavic V, 2003, J IMMUNOL, V170, P1540, DOI 10.4049/jimmunol.170.3.1540; Kim SH, 2002, MOL THER, V6, P584, DOI 10.1006/mthe.2002.0712; Kovacic N, 2007, J IMMUNOL, V178, P3379, DOI 10.4049/jimmunol.178.6.3379; Kovacic N, 2010, LAB INVEST, V90, P402, DOI 10.1038/labinvest.2009.144; Krause U., 2011, MESENCHYMAL STEM CEL; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Lazic E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3872; Li XL, 2006, P NATL ACAD SCI USA, V103, P17432, DOI 10.1073/pnas.0607939103; Lotito APN, 2007, AUTOIMMUN REV, V6, P253, DOI 10.1016/j.autrev.2006.08.010; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Malemud CJ, 2009, OPEN ACCESS RHEUMATO, V1, P133; Malemud Charles J, 2013, J Clin Cell Immunol, V4, P160; Malemud Charles J., 2011, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V10, P78; Matijasevic MI, 2016, CLIN EXP IMMUNOL, V186, P321, DOI 10.1111/cei.12862; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Odobasic D, 2008, IMMUNOLOGY, V124, P503, DOI 10.1111/j.1365-2567.2007.02802.x; Ostendorf B, 2003, ARTHRITIS RHEUM-US, V48, P157, DOI 10.1002/art.10753; Paquet J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3774; Park H, 2005, J IMMUNOL, V175, P7193, DOI 10.4049/jimmunol.175.11.7193; Peng SL, 2006, RHEUMATOLOGY, V45, P26, DOI 10.1093/rheumatology/kei113; Petrovic-Rackov L, 2006, CLIN RHEUMATOL, V25, P448, DOI 10.1007/s10067-005-0106-0; Rapp HT, 2004, ARTHRITIS RES THER, V6, pR404, DOI 10.1186/ar1205); Schedel J, 2002, ARTHRITIS RHEUM, V46, P1512, DOI 10.1002/art.10309; Schett G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2571; Sucur A, 2014, INT ORTHOP, V38, P1893, DOI 10.1007/s00264-014-2386-y; Van Parijs L, 1998, SCIENCE, V280, P243; Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x; Wu XJ, 2003, ENDOCRINOLOGY, V144, P5545, DOI 10.1210/en.2003-0296; Zhang HD, 1997, J CLIN INVEST, V100, P1951, DOI 10.1172/JCI119726	51	6	7	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3330	3342		10.1096/fj.201801426R	http://dx.doi.org/10.1096/fj.201801426R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383451	Bronze			2022-12-28	WOS:000459794800021
J	Nobuta, H; Katagi, M; Kume, S; Terashima, T; Araki, S; Maegawa, H; Kojima, H; Nakagawa, T				Nobuta, Hiroshi; Katagi, Miwako; Kume, Shinji; Terashima, Tomoya; Araki, Shin-ichi; Maegawa, Hiroshi; Kojima, Hideto; Nakagawa, Takahiko			A role for bone marrow-derived cells in diabetic nephropathy	FASEB JOURNAL			English	Article						diabetic kidney disease; hyperglycemia; glomerular endothelial cell; endothelial injury	ENDOTHELIAL GROWTH-FACTOR; AMELIORATES RENAL ALTERATIONS; PROGENITOR CELLS; KNOCKOUT MICE; MOUSE MODEL; EARLY-STAGE; ANGIOGENESIS; RETINOPATHY; REPAIR; INVOLVEMENT	Diabetes mellitus causes systemic disorders. We previously demonstrated that diabetic condition forced bone marrow-derived cells (BMDCs) to express TNF-, leading to the development of diabetic neuropathy in mice. Here, we hypothesized that these abnormal BMDCs are also involved in diabetic nephropathy. To test our hypothesis, mice were irradiated to receive total bone marrow (BM) from the transgenic mice expressing green fluorescent protein before diabetes was induced by streptozotocin. Confocal microscopy showed that the diabetic glomerulus had more BMDCs compared with the nondiabetic glomerulus. Most of these cells exhibited endothelial phenotypes, being negative for several markers, including podocin (a maker of podocyte), 8 integrin (mesangial cell), CD68, and F4/80 (macrophage). Next, the total BM of diabetic mice was transplanted into nondiabetic mice to examine if diabetic BM per se could cause glomerular injury. The recipient mice exhibiting normal glycemia developed albuminuria and mesangial expansion with an increase in capillary area. The number of BMDCs increased in the glomerulus of the recipient mice. These cells were found to exhibit the endothelial phenotype and to express TNF-. These data suggest that diabetic BMDCs per se could initiate glomerular disease. Finally, eNOS knockout mice were used to examine if residential endothelial injury could attract BMDCs into the glomerulus. However, endothelial dysfunction due to eNOS deficiency failed to attract BMDCs into the glomerulus. In summary, BMDCs may be involved in the development of diabetic nephropathy.Nobuta, H., Katagi, M., Kume, S., Terashima, T., Araki, S., Maegawa, H., Kojima, H., Nakagawa, T. A role for bone marrow-derived cells in diabetic nephropathy.	[Nobuta, Hiroshi; Kume, Shinji; Araki, Shin-ichi; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Nobuta, Hiroshi; Katagi, Miwako; Terashima, Tomoya; Kojima, Hideto] Shiga Univ Med Sci, Dept Stem Cell Biol & Regenerat Med, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Nakagawa, Takahiko] Nara Med Univ, Dept Future Basic Med, 840 Shijo Cho, Kashihara, Nara 6348521, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Nara Medical University	Kojima, H (corresponding author), Shiga Univ Med Sci, Dept Stem Cell Biol & Regenerat Med, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.; Nakagawa, T (corresponding author), Nara Med Univ, Dept Future Basic Med, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	kojima@belle.shiga-med.ac.jp; nakagawt@gmail.com		Maegawa, Hiroshi/0000-0002-4611-8149	SUMS President's Grant for the Encouragement of Young Researchers	SUMS President's Grant for the Encouragement of Young Researchers	The authors thank N. Yamanaka, K. Kosaka, Y. Nakae, and T. Yamamoto (Shiga University of Medical Science) and the Central Research Laboratory of Shiga University of Medical Science for technical assistance. This work was supported by the SUMS President's Grant for the Encouragement of Young Researchers (to H.N.). The funder had no role in any process of this work, including study design, data collection, data analysis, interpretation, and writing of the manuscript. The authors declare no conflicts of interest.	Abe-Yoshio Y, 2008, VIRCHOWS ARCH, V453, P97, DOI 10.1007/s00428-008-0618-5; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Cornacchia F, 2001, J CLIN INVEST, V108, P1649; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Duh E, 1999, DIABETES, V48, P1899, DOI 10.2337/diabetes.48.10.1899; Fadini GP, 2014, STEM CELL TRANSL MED, V3, P949, DOI 10.5966/sctm.2014-0052; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; Galderisi Umberto, 2010, World J Stem Cells, V2, P5, DOI 10.4252/wjsc.v2.i1.5; Guo M, 2005, J ANAT, V207, P813, DOI 10.1111/j.1469-7580.2005.00492.x; Hinamoto N, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096932, 10.1371/journal.pone.0107934]; Ichinose K, 2006, DIABETES, V55, P1232, DOI 10.2337/db05-1367; Ichinose K, 2005, DIABETES, V54, P2891, DOI 10.2337/diabetes.54.10.2891; Katagi M, 2014, FEBS LETT, V588, P1080, DOI 10.1016/j.febslet.2014.02.030; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Kosugi T, 2010, AM J PATHOL, V176, P619, DOI 10.2353/ajpath.2010.090578; Lee IG, 2006, EYE, V20, P546, DOI 10.1038/sj.eye.6701920; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Lim JJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00191; Masuda K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195779; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Nathan DM, 2013, DIABETES, V62, P3976, DOI 10.2337/db13-1093; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P189, DOI 10.1007/BF00399948; Perry TE, 2009, CARDIOVASC RES, V84, P317, DOI 10.1093/cvr/cvp215; Qian C, 2008, NETH HEART J, V16, P305, DOI 10.1007/BF03086169; Rookmaaker MB, 2003, AM J PATHOL, V163, P553, DOI 10.1016/S0002-9440(10)63683-8; Shinoda K, 1999, BRIT J OPHTHALMOL, V83, P834, DOI 10.1136/bjo.83.7.834; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; Urabe H, 2015, DIABETOLOGIA, V58, P402, DOI 10.1007/s00125-014-3440-4; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831; Yamashita T, 2012, FASEB J, V26, P1559, DOI 10.1096/fj.11-183194; Zheng F, 2004, DIABETES, V53, P2420, DOI 10.2337/diabetes.53.9.2420	36	3	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4067	4076		10.1096/fj.201801825R	http://dx.doi.org/10.1096/fj.201801825R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496699	Bronze			2022-12-28	WOS:000459794800077
J	Salama, Y; Lin, SY; Dhahri, D; Hattori, K; Heissig, B				Salama, Yousef; Lin, Shiou-Yuh; Dhahri, Douaa; Hattori, Koichi; Heissig, Beate			The fibrinolytic factor tPA drives LRP1-mediated melanoma growth and metastasis	FASEB JOURNAL			English	Article						cancer; protease; bortezomib; matrix metalloproteinase; plasmin	RECEPTOR-RELATED PROTEIN-1; PLASMINOGEN-ACTIVATOR; MATRIX METALLOPROTEINASES; CELL-LINES; INCREASED EXPRESSION; INHIBITORS; MMP-9; INVASION; VARIANTS; LRP-1	The multifunctional endocytic receptor low-density lipoprotein receptor-related protein (LRP)1 has recently been identified as a hub within a biomarker network for multicancer clinical outcome prediction. The mechanism how LRP1 modulates cancer progression is poorly understood. In this study we found that LRP1 and one of its ligands, tissue plasminogen activator (tPA), are expressed in melanoma cells and control melanoma growth and lung metastasis in vivo. Mechanistic studies were performed on 2 melanoma cancer cell lines, B16F10 and the B16F1 cells, both of which form primary melanoma tumors, but only B16F10 cells metastasize to the lungs. Tumor-, but not niche cell-derived tPA, enhanced melanoma cell proliferation in tPA(-/-) mice. Gain-of-function experiments revealed that melanoma LRP1 is critical for tumor growth, recruitment of mesenchymal stem cells into the tumor bed, and metastasis. Melanoma LRP1 was found to enhance ERK activation, resulting in increased matrix metalloproteinase (MMP)-9 RNA, protein, and secreted activity, a well-known modulator of melanoma metastasis. Restoration of LRP1 and tPA in the less aggressive, poorly metastatic B16F1 tumor cells enhanced tumor cell proliferation and led to massive lung metastasis in murine tumor models. Antimelanoma drug treatment induced tPA and LRP1 expression. tPA or LRP1 knockdown enhanced chemosensitivity in melanoma cells. Our results identify the tPA-LRP1 pathway as a key switch that drives melanoma progression, in part by modulating the cellular composition and proteolytic makeup of the tumor niche. Targeting this pathway may be a novel treatment strategy in combination treatments for melanoma.Salama, Y., Lin, S.-Y., Dhahri, D., Hattori, K., Heissig, B. The fibrinolytic factor tPA drives LRP1-mediated melanoma growth and metastasis.	[Salama, Yousef; Lin, Shiou-Yuh; Dhahri, Douaa; Heissig, Beate] Univ Tokyo, Inst Med Sci, Div Stem Cell Dynam, Ctr Stem Cell Biol & Regenerat Med, Tokyo, Japan; [Salama, Yousef] An Najah Natl Univ, Fac Med & Hlth Sci, Nablus, Palestine; [Hattori, Koichi] Juntendo Univ, Sch Med, Ctr Genome & Regenerat Med, Tokyo, Japan; [Heissig, Beate] Juntendo Univ, Sch Med, Atopy Allergy Ctr, Tokyo, Japan	University of Tokyo; An Najah National University; Juntendo University; Juntendo University	Heissig, B (corresponding author), Univ Tokyo, Inst Med Sci, Div Stem Cell Dynam, Ctr Stem Cell Biol & Regenerat Med,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	heissig@ims.u-tokyo.ac.jp	Al-Dhahri, Douaa/AAA-8324-2019; Heissig, Beate/AAF-6771-2021; salama, Yousef/AAP-8365-2021; Hattori, Koichi/AAF-6862-2021	Heissig, Beate/0000-0002-0348-5934; AL-Dhahri, Douaa/0000-0003-0141-1728; Salama, Yousef/0000-0001-6254-6381	Japan Society for the Promotion of Science [16K09821, 16K09866, 17K09941, 26461415]; Health and Labour Sciences Research Grant [24008]; Uehara Memorial Foundation; Collaborative research Fund Program for Women Researchers from Tokyo Medical and Dental University; Initiative for Realizing Diversity in the Research Environment from Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Collaborative research Fund Program for Women Researchers from Tokyo Medical and Dental University; Initiative for Realizing Diversity in the Research Environment from Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	This work was supported by Japan Society for the Promotion of Science Kiban (C) Grant 16K09821 (to B.H.) and Grants 16K09866, 17K09941, and 26461415 (to K.H.); Health and Labour Sciences Research Grant 24008 (to K.H); the Uehara Memorial Foundation grant (to B.H.); and the Collaborative research Fund Program for Women Researchers from the Tokyo Medical and Dental University, funded by the Initiative for Realizing Diversity in the Research Environment, from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). The authors declare no conflicts of interest.	ALIZADEH H, 1995, CURR EYE RES, V14, P449, DOI 10.3109/02713689509003755; Bizik J, 1997, BIOCHEM BIOPH RES CO, V239, P322, DOI 10.1006/bbrc.1997.7472; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; CILLO C, 1987, CANCER RES, V47, P2604; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; deVries TJ, 1996, MELANOMA RES, V6, P79, DOI 10.1097/00008390-199604000-00001; DEVRIES TJ, 1994, AM J PATHOL, V144, P70; deVries TJ, 1996, CANCER RES, V56, P1432; Dhahri D, 2016, BLOOD, V128, P1063, DOI 10.1182/blood-2015-10-673103; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Enomoto R, 2004, BBA-GEN SUBJECTS, V1674, P291, DOI 10.1016/j.bbagen.2004.07.004; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Heissig B, 2008, CELL STEM CELL, V3, P120, DOI 10.1016/j.stem.2008.06.010; Heissig B, 2016, ADV DRUG DELIVER REV, V99, P172, DOI 10.1016/j.addr.2015.11.010; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HOALVANHELDEN EG, 1986, BRIT J CANCER, V54, P287, DOI 10.1038/bjc.1986.175; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hofmann UB, 1999, BRIT J CANCER, V81, P774, DOI 10.1038/sj.bjc.6690763; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Hutchinson Lisa, 2015, Nat Rev Clin Oncol, V12, P1, DOI 10.1038/nrclinonc.2014.219; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; LARSEN GR, 1988, J BIOL CHEM, V263, P1023; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lin L, 2014, INT J MOL SCI, V15, P22887, DOI 10.3390/ijms151222887; Lin L, 2010, AM J PATHOL, V177, P1687, DOI 10.2353/ajpath.2010.100213; MacDougall JR, 1999, BRIT J CANCER, V80, P504, DOI 10.1038/sj.bjc.6690385; Maeda S, 2009, BRAIN RES, V1305, P1, DOI 10.1016/j.brainres.2009.09.025; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; Nwani NG, 2016, CANCER RES, V76, P2265, DOI 10.1158/0008-5472.CAN-15-2468; Ortiz-Zapater E, 2007, AM J PATHOL, V170, P1573, DOI 10.2353/ajpath.2007.060850; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Poklepovic A, 2013, INVEST NEW DRUG, V31, P937, DOI 10.1007/s10637-012-9913-8; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Sanchez MC, 2001, ARCH BIOCHEM BIOPHYS, V389, P218, DOI 10.1006/abbi.2001.2329; Shinagawa K, 2013, INT J CANCER, V132, P813, DOI 10.1002/ijc.27735; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Trevino-Villarreal JH, 2011, J HISTOCHEM CYTOCHEM, V59, P1060, DOI 10.1369/0022155411428078; Tsuda Y, 2001, CHEM PHARM BULL, V49, P1457, DOI 10.1248/cpb.49.1457; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Xing PP, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-015-0064-0; Xiong HZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14764-4; Yamamoto M, 1997, CANCER RES, V57, P2799; Zhao YH, 2016, REV NEUROSCIENCE, V27, P623, DOI 10.1515/revneuro-2015-0069	49	10	11	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3465	3480		10.1096/fj.201801339RRR	http://dx.doi.org/10.1096/fj.201801339RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30458112				2022-12-28	WOS:000459794800031
J	Schlotterer, A; Kolibabka, M; Lin, JH; Acunman, K; Dietrich, N; Sticht, C; Fleming, T; Nawroth, P; Hammes, HP				Schlotterer, Andrea; Kolibabka, Matthias; Lin, Jihong; Acunman, Kuebra; Dietrich, Nadine; Sticht, Carsten; Fleming, Thomas; Nawroth, Peter; Hammes, Hans-Peter			Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model	FASEB JOURNAL			English	Article						animal; glycation; AGE; retina	GLYCATION END-PRODUCTS; INCREASED SERUM-LEVELS; DIABETIC-RETINOPATHY; RETINAL PERICYTES; DICARBONYL STRESS; ALPHA-CRYSTALLIN; IN-VITRO; TNF-ALPHA; EXPRESSION; APOPTOSIS	The aim of this study was to evaluate whether damage to the neurovascular unit in diabetes depends on reactive metabolites such as methylglyoxal (MG), and to assess its impact on retinal gene expression. Male Wistar rats were supplied with MG (50 mM) by drinking water and compared with age-matched streptozotocin-diabetic animals and untreated controls. Retinal damage was evaluated for the accumulation of MG-derived advanced glycation end products, changes in hexosamine and PKC pathway activation, microglial activation, vascular alterations (pericyte loss and vasoregression), neuroretinal function assessed by electroretinogram, and neurodegeneration. Retinal gene regulation was studied by microarray analysis, and transcription factor involvement was identified by upstream regulator analysis. Systemic application of MG by drinking water increased retinal MG to levels comparable with diabetic animals. Elevated retinal MG resulted in MG-derived hydroimidazolone modifications in the ganglion cell layer, inner nuclear layer, and outer nuclear layer, a moderate activation of the hexosamine pathway, a pan-retinal activation of microglia, loss of pericytes, increased formation of acellular capillaries, decreased function of bipolar cells, and increased expression of the crystallin gene family. MG mimics important aspects of diabetic retinopathy and plays a pathogenic role in microglial activation, vascular damage, and neuroretinal dysfunction. In response to MG, the retina induces expression of neuroprotective crystallins.Schlotterer, A., Kolibabka, M., Lin, J., Acunman, K., Dietrich, N., Sticht, C., Fleming, T., Nawroth, P., Hammes, H.-P. Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model.	[Schlotterer, Andrea; Kolibabka, Matthias; Lin, Jihong; Acunman, Kuebra; Dietrich, Nadine; Hammes, Hans-Peter] Heidelberg Univ, Med Dept 5, Heidelberg, Germany; [Sticht, Carsten] Heidelberg Univ, Med Fac, Med Res Ctr, Heidelberg, Germany; [Fleming, Thomas; Nawroth, Peter] Heidelberg Univ, Dept Med & Clin Chem 1, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schlotterer, A (corresponding author), Heidelberg Univ, Med Dept 5, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	andrea.schlotterer@medma.uni-heidelberg.de	Kolibabka, Matthias/T-5812-2017; Hammes, Hans-Peter/S-3719-2019	Kolibabka, Matthias/0000-0001-6741-5436; 	German Research Foundation (Collaborative Research Center) [1118]	German Research Foundation (Collaborative Research Center)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (Collaborative Research Center 1118). The authors declare no conflicts of interest.	Alikhani M, 2010, MOL VIS, V16, P408; Andersson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077986; Barlovic DP, 2011, CLIN SCI, V121, P43, DOI 10.1042/CS20100501; Berlanga J, 2005, CLIN SCI, V109, P83, DOI 10.1042/CS20050026; Berner AK, 2012, DIABETOLOGIA, V55, P845, DOI 10.1007/s00125-011-2393-0; Cardoso S, 2014, J BIOENERG BIOMEMBR, V46, P347, DOI 10.1007/s10863-014-9551-2; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen M, 2013, CURR MED CHEM, V20, P3234, DOI 10.2174/09298673113209990025; CRAVEN PA, 1990, DIABETES, V39, P667, DOI 10.2337/diabetes.39.6.667; Crisostomo J, 2013, NUTR METAB CARDIOVAS, V23, P1223, DOI 10.1016/j.numecd.2013.01.005; Curtis TM, 2011, DIABETOLOGIA, V54, P690, DOI 10.1007/s00125-010-1971-x; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Dietrich N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167853; Dietrich Nadine, 2012, Methods Mol Biol, V933, P291, DOI 10.1007/978-1-62703-068-7_19; Dong N, 2014, MOL VIS, V20, P616; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Dutescu RM, 2013, INVEST OPHTH VIS SCI, V54, P2582, DOI 10.1167/iovs.12-11446; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Fort PE, 2009, MOL CELL PROTEOMICS, V8, P767, DOI 10.1074/mcp.M800326-MCP200; Fosmark DS, 2009, ACTA OPHTHALMOL, V87, P498, DOI 10.1111/j.1755-3768.2008.01300.x; Fosmark DS, 2006, METABOLISM, V55, P232, DOI 10.1016/j.metabol.2005.08.017; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Golej J, 1998, LIFE SCI, V63, P801, DOI 10.1016/S0024-3205(98)00336-1; Hadas K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074401; Hammes HP, 2011, DIABETOLOGIA, V54, P1977, DOI 10.1007/s00125-011-2198-1; Hammes HP, 2018, DIABETOLOGIA, V61, P29, DOI 10.1007/s00125-017-4435-8; Hammes HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132492; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Heise EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082520; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Karachalias N, 2003, BIOCHEM SOC T, V31, P1423; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; Kim J, 2012, FREE RADICAL BIO MED, V53, P357, DOI 10.1016/j.freeradbiomed.2012.04.030; Kim YS, 2015, BIOCHEM PHARMACOL, V93, P496, DOI 10.1016/j.bcp.2014.09.022; Kolibabka M, 2016, EXP CLIN ENDOCR DIAB, V124, P437, DOI 10.1055/s-0042-106081; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lecleire-Collet A, 2005, BRIT J OPHTHALMOL, V89, P1631, DOI 10.1136/bjo.2005.079491; Lecomte M, 2004, BBA-MOL BASIS DIS, V1689, P202, DOI 10.1016/j.bbadis.2004.03.010; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Liu GD, 2015, INT J MOL MED, V36, P1019, DOI 10.3892/ijmm.2015.2319; Losiewicz MK, 2011, INVEST OPHTH VIS SCI, V52, P5034, DOI 10.1167/iovs.10-6931; McVicar CM, 2015, DIABETOLOGIA, V58, P1129, DOI 10.1007/s00125-015-3523-x; Miller AG, 2010, DIABETES, V59, P3208, DOI 10.2337/db10-0552; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Morgenstern J, 2017, J BIOL CHEM, V292, P3224, DOI 10.1074/jbc.M116.760132; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Nigro C, 2014, DIABETOLOGIA, V57, P1485, DOI 10.1007/s00125-014-3243-7; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Pfister F, 2011, CELL PHYSIOL BIOCHEM, V28, P125, DOI 10.1159/000331721; Rabbani N, 2016, CLIN SCI, V130, P1677, DOI 10.1042/CS20160025; Rabbani N, 2016, GLYCOCONJUGATE J, V33, P553, DOI 10.1007/s10719-016-9709-8; Rabbani N, 2014, NAT PROTOC, V9, P1969, DOI 10.1038/nprot.2014.129; Rajamani D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21502; Rodrigues L, 2014, J PHYSIOL BIOCHEM, V70, P173, DOI 10.1007/s13105-013-0291-2; Safi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/801269; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shimatani Y, 2015, CLIN NEUROPHYSIOL, V126, P2226, DOI 10.1016/j.clinph.2015.02.058; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; Sohn EH, 2016, P NATL ACAD SCI USA, V113, pE2655, DOI 10.1073/pnas.1522014113; Stitt AW, 2004, DIABETOLOGIA, V47, P1735, DOI 10.1007/s00125-004-1523-3; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tikellis C, 2014, DIABETES, V63, P3915, DOI 10.2337/db13-0932; Wang AG, 2002, MOL BRAIN RES, V101, P82, DOI 10.1016/S0169-328X(02)00171-7; Wang AL, 2007, EXP EYE RES, V84, P905, DOI 10.1016/j.exer.2007.01.011; Wang J, 2014, ACTA DIABETOL, V51, P813, DOI 10.1007/s00592-014-0616-9; WANG KY, 1994, J BIOL CHEM, V269, P13601; Wang Q, 2010, DIABETOLOGIA, V53, P1227, DOI 10.1007/s00125-010-1727-7; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wongchai K, 2016, HORM METAB RES, V48, P70, DOI 10.1055/s-0035-1549876; Xi JH, 2003, MOL VIS, V9, P410; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Yatoh S, 2006, DIABETES-METAB RES, V22, P38, DOI 10.1002/dmrr.562; Ying X, 2014, LIFE SCI, V111, P42, DOI 10.1016/j.lfs.2014.07.008; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	80	17	18	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4141	4153		10.1096/fj.201801146RR	http://dx.doi.org/10.1096/fj.201801146RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30485119	Bronze			2022-12-28	WOS:000459794800083
J	Tamburini, E; Dallatomasina, A; Quartararo, J; Cortelazzi, B; Mangieri, D; Lazzaretti, M; Perris, R				Tamburini, Elisa; Dallatomasina, Alice; Quartararo, Jade; Cortelazzi, Barbara; Mangieri, Domenica; Lazzaretti, Mirca; Perris, Roberto			Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality	FASEB JOURNAL			English	Review						extracellular matrix; structure-function relationship; macromolecular interactions; signal transduction	CHONDROITIN SULFATE PROTEOGLYCAN; MELANOMA-ASSOCIATED ANTIGEN; CENTRAL-NERVOUS-SYSTEM; HIGH-MOLECULAR-WEIGHT; OLIGODENDROCYTE PRECURSOR CELLS; PDGF ALPHA-RECEPTOR; SPINAL-CORD-INJURY; PROTEIN-KINASE-C; NG2 PROTEOGLYCAN; MONOCLONAL-ANTIBODIES	The chondroitin sulfate proteoglycan 4 (CSPG4) gene encodes a transmembrane proteoglycan (PG) constituting the largest and most structurally complex macromolecule of the human surfaceome. Its transcript shows an extensive evolutionary conservation and, due to the elaborated intracellular processing of the translated protein, it generates an array of glycoforms with the potential to exert variant-specific functions. CSPG4-mediated molecular events are articulated through the interaction with more than 40 putative ligands and the concurrent involvement of the ectodomain and cytoplasmic tail. Alternating inside-out and outside-in signal transductions may thereby be elicited through a tight functional connection of the PG with the cytoskeleton and its regulators. The potential of CSPG4 to influence both types of signaling mechanisms is also asserted by its lateral mobility along the plasma membrane and its intersection with microdomain-restricted internalization and endocytic trafficking. Owing to the multitude of molecular interplays that CSPG4 may engage, and thanks to a differential phosphorylation of its intracellular domain accounted by crosstalking signaling pathways, the PG stands out for its unique capability to affect numerous cellular phenomena, including those purporting pathologic conditions. We discuss here the progresses made in advancing our understanding about the structural-functional bases for the ability of CSPG4 to widely impact on cell behavior, such as to highlight how its multivalency may be exploited to interfere with disease progression.Tamburini, E., Dallatomasina, A., Quartararo, J., Cortelazzi, B., Mangieri, D., Lazzaretti, M., Perris, R. Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.	[Tamburini, Elisa; Quartararo, Jade; Cortelazzi, Barbara; Lazzaretti, Mirca; Perris, Roberto] Univ Parma, Ctr Mol & Translat Oncol COMT, Parco Area Sci 11-A, I-43124 Parma, Italy; [Dallatomasina, Alice] IRCCS, San Raffaele Sci Inst, Div Expt Oncol, Milan, Italy; [Mangieri, Domenica] Univ Foggia, Dept Med Sci, Foggia, Italy	University of Parma; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Foggia	Perris, R (corresponding author), Univ Parma, Ctr Mol & Translat Oncol COMT, Parco Area Sci 11-A, I-43124 Parma, Italy.	roberto.perris@unipr.it			Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Health; European Union; Associazione "Casa via di Natale" (Pordenone, Italy)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission); Associazione "Casa via di Natale" (Pordenone, Italy)	The authors apologize to colleagues whose work has not been cited because of space limitations. The authors acknowledge the valuable financial support received in the past for the conduction of some of the published cited work from the Associazione Italiana per la Ricerca sul Cancro (AIRC; Grant Call 2009), the Italian Ministry of Health (RF2009 and RF2010), the European Union-funded Project POR-FESR 2007-2013 "Creazione di Tecnopoli," and by fellowships granted by Associazione "Casa via di Natale" (Pordenone, Italy) to several of the postdoctoral fellows who have contributed published and unpublished data described in this work. The authors declare no conflicts of interest.	Asher RA, 2005, MOL CELL NEUROSCI, V29, P82, DOI 10.1016/j.mcn.2005.02.001; Bai LH, 2013, NEUROSCI BULL, V29, P239, DOI 10.1007/s12264-013-1312-4; Barritt DS, 2000, J CELL BIOCHEM, V79, P213, DOI 10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G; Bausch-Fluck D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121314; BEAUMIER PL, 1986, J NUCL MED, V27, P824; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Bottai D, 2014, EXP NEUROL, V254, P121, DOI 10.1016/j.expneurol.2014.01.015; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; BUMOL TF, 1984, J BIOL CHEM, V259, P2733; BUMOL TF, 1982, P NATL ACAD SCI-BIOL, V79, P1245, DOI 10.1073/pnas.79.4.1245; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; Burg MA, 1997, EXP CELL RES, V235, P254, DOI 10.1006/excr.1997.3674; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Cattaruzza S, 2013, J MOL CELL BIOL, V5, P176, DOI 10.1093/jmcb/mjt010; Cattaruzza S, 2013, ANGIOGENESIS, V16, P309, DOI 10.1007/s10456-012-9316-7; Chatterjee N, 2008, J BIOL CHEM, V283, P8310, DOI 10.1074/jbc.M706074200; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Chekenya M, 2002, FASEB J, V16, P586, DOI 10.1096/fj.01-0632fje; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; DELVECCHIO S, 1988, CANCER RES, V48, P5475; DEVRIES JE, 1986, INT J CANCER, V38, P465, DOI 10.1002/ijc.2910380403; Di Bello IC, 1999, J NEUROCYTOL, V28, P365, DOI 10.1023/A:1007069815302; Doane KJ, 1998, INVEST OPHTH VIS SCI, V39, P263; Donnelly EM, 2012, CYTOTHERAPY, V14, P1235, DOI 10.3109/14653249.2012.714865; Donnelly EM, 2010, J GENE MED, V12, P863, DOI 10.1002/jgm.1509; DOU CL, 1994, J NEUROSCI, V14, P7616; Dou CL, 1997, J NEUROCHEM, V68, P1021; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Fang XX, 1999, MOL BIOL CELL, V10, P3373, DOI 10.1091/mbc.10.10.3373; Feutlinske F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9535; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Friand V, 2015, BIOL CELL, V107, P331, DOI 10.1111/boc.201500010; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; GARRIGUES HJ, 1986, J CELL BIOL, V103, P1699, DOI 10.1083/jcb.103.5.1699; Girolamo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084883; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; Goretzki L, 2000, J BIOL CHEM, V275, P28625, DOI 10.1074/jbc.M002290200; Grako KA, 1999, J CELL SCI, V112, P905; GRAKO KA, 1995, EXP CELL RES, V221, P231, DOI 10.1006/excr.1995.1371; HARPER JR, 1982, HYBRIDOMA, V1, P423, DOI 10.1089/hyb.1.1982.1.423; HARPER JR, 1984, J IMMUNOL, V132, P2096; HARPER JR, 1986, J BIOL CHEM, V261, P3600; HELLSTROM I, 1983, J IMMUNOL, V130, P1467; HERLYN M, 1983, CANCER INVEST, V1, P215, DOI 10.3109/07357908309041361; Hodor PG, 2000, DEV BIOL, V222, P181, DOI 10.1006/dbio.2000.9696; Hossain-Ibrahim MK, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-80; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Hunanyan AS, 2010, J NEUROSCI, V30, P7761, DOI 10.1523/JNEUROSCI.4659-09.2010; IIDA J, 1995, CANCER RES, V55, P2177; IIDA J, 1992, J CELL BIOL, V118, P431, DOI 10.1083/jcb.118.2.431; Iida J, 1998, J BIOL CHEM, V273, P5955, DOI 10.1074/jbc.273.10.5955; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Iida J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044418; IMAI K, 1981, J NATL CANCER I, V66, P489; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Jamil NSM, 2016, INT J EXP PATHOL, V97, P178, DOI 10.1111/iep.12189; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Joo NE, 2008, CELL DEATH DIFFER, V15, P899, DOI 10.1038/cdd.2008.22; Joo NE, 2014, DNA CELL BIOL, V33, P854, DOI 10.1089/dna.2014.2399; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Kinoshita M, 2014, J PROTEOME RES, V13, P1021, DOI 10.1021/pr401015b; Knutson JR, 1996, MOL BIOL CELL, V7, P383, DOI 10.1091/mbc.7.3.383; Kucharova K, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0385-6; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Lee SI, 2013, J NEUROSCI, V33, P2541, DOI 10.1523/JNEUROSCI.3154-12.2013; Lin XH, 1996, J CELL BIOCHEM, V63, P463, DOI 10.1002/(SICI)1097-4644(19961215)63:4<463::AID-JCB8>3.0.CO;2-R; Lin XH, 1996, MOL BIOL CELL, V7, P1977, DOI 10.1091/mbc.7.12.1977; Losada-Perez M, 2017, NEURAL REGEN RES, V12, P31, DOI 10.4103/1673-5374.198969; Losada-Perez M, 2016, J CELL BIOL, V214, P587, DOI 10.1083/jcb.201603054; Luo W, 2006, ONCOGENE, V25, P2873, DOI 10.1038/sj.onc.1209319; Majumdar M, 2003, CELL SIGNAL, V15, P79, DOI 10.1016/S0898-6568(02)00045-1; Makagiansar IT, 2007, J CELL BIOL, V178, P155, DOI 10.1083/jcb.200612084; Makagiansar IT, 2004, J BIOL CHEM, V279, P55262, DOI 10.1074/jbc.M411045200; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; Matsumoto S, 2015, J NEUROIMMUNOL, V282, P7, DOI 10.1016/j.jneuroim.2015.03.013; Maus F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137311; McTigue DM, 2006, J NEUROPATH EXP NEUR, V65, P406, DOI 10.1097/01.jnen.0000218447.32320.52; Midwood KS, 2001, J PATHOL, V195, P631, DOI 10.1002/path.985; Mitsui Y, 2012, J PHARMACEUT BIOMED, V70, P718, DOI 10.1016/j.jpba.2012.06.035; Morandi F, 2011, CANCER IMMUNOL IMMUN, V60, P1485, DOI 10.1007/s00262-011-1052-0; MORGAN AC, 1981, HYBRIDOMA, V1, P27, DOI 10.1089/hyb.1.1981.1.27; Morgenstern DA, 2003, MOL CELL NEUROSCI, V24, P787, DOI 10.1016/S1044-7431(03)00245-8; NATALI PG, 1981, JNCI-J NATL CANCER I, V67, P591; Nicolosi PA, 2015, THERANOSTICS, V5, P530, DOI 10.7150/thno.10824; Nishihara T, 2015, J BIOL CHEM, V290, P3693, DOI 10.1074/jbc.M114.603431; NISHIYAMA A, 1993, MOL BIOL CELL, V4, P1097, DOI 10.1091/mbc.4.11.1097; NISHIYAMA A, 1995, MOL BIOL CELL, V6, P1819, DOI 10.1091/mbc.6.12.1819; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; Nishiyama A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00133; Nolin WB, 2008, GLIA, V56, P177, DOI 10.1002/glia.20603; Pankova D, 2012, EUR J CELL BIOL, V91, P969, DOI 10.1016/j.ejcb.2012.05.001; Perez-Moreno JJ, 2017, J CELL SCI, V130, P950, DOI 10.1242/jcs.197459; Perez-Moreno JJ, 2014, J CELL SCI, V127, P3162, DOI 10.1242/jcs.150425; Petrini S, 2003, MOL CELL NEUROSCI, V23, P219, DOI 10.1016/S1044-7431(03)00033-2; Petrosyan HA, 2013, J NEUROSCI, V33, P4032, DOI 10.1523/JNEUROSCI.4702-12.2013; Pluschke G, 1996, P NATL ACAD SCI USA, V93, P9710, DOI 10.1073/pnas.93.18.9710; RETTIG WJ, 1986, SCIENCE, V231, P1281, DOI 10.1126/science.3633135; Rhodes KE, 2006, NEUROSCIENCE, V140, P87, DOI 10.1016/j.neuroscience.2006.01.055; ROSS AH, 1983, ARCH BIOCHEM BIOPHYS, V225, P370, DOI 10.1016/0003-9861(83)90042-5; Sakry D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001993; Sardone F, 2016, MATRIX BIOL, V55, P90, DOI 10.1016/j.matbio.2016.02.012; Schnorrer F, 2007, DEV CELL, V12, P751, DOI 10.1016/j.devcel.2007.02.017; Schultz N, 2014, J NEUROPATH EXP NEUR, V73, P684, DOI 10.1097/NEN.0000000000000084; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Smith PD, 2015, EXP NEUROL, V274, P100, DOI 10.1016/j.expneurol.2015.08.004; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; SPIRO RC, 1989, J BIOL CHEM, V264, P1779; SPIRO RC, 1986, J BIOL CHEM, V261, P5121; STALLCUP WB, 1990, J CELL BIOL, V111, P3177, DOI 10.1083/jcb.111.6.3177; Stallcup WB, 2001, J CELL SCI, V114, P2315; STALLCUP WB, 1981, DEV BIOL, V83, P154, DOI 10.1016/S0012-1606(81)80018-8; Stallcup WB, 2017, CANCERS, V9, DOI 10.3390/cancers9040031; Staub E, 2002, FEBS LETT, V527, P114, DOI 10.1016/S0014-5793(02)03195-2; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Tan AM, 2006, J NEUROSCI, V26, P4729, DOI 10.1523/JNEUROSCI.3900-05.2006; Tang FY, 2018, J BIOCHEM, V163, P399, DOI 10.1093/jb/mvy008; Tei N, 2013, J NEUROSCI RES, V91, P681, DOI 10.1002/jnr.23202; Terrile M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-550; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Tillet E, 1997, J BIOL CHEM, V272, P10769; Tillet E, 2002, J CELL BIOCHEM, V86, P726, DOI 10.1002/jcb.10268; Ughrin YM, 2003, J NEUROSCI, V23, P175; Vadivelu S, 2015, STEM CELL TRANSL MED, V4, P401, DOI 10.5966/sctm.2014-0107; Vergilis IJ, 2005, J INVEST DERMATOL, V125, P526, DOI 10.1111/j.0022-202X.2005.23798.x; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; Wen YF, 2006, J CELL BIOCHEM, V98, P115, DOI 10.1002/jcb.20768; WILSON BS, 1983, CANCER IMMUNOL IMMUN, V14, P196, DOI 10.1007/BF00205360; WILSON BS, 1981, INT J CANCER, V28, P293, DOI 10.1002/ijc.2910280307; WILSON BS, 1982, CANCER IMMUNOL IMMUN, V13, P69; Yadavilli S, 2016, TRANSL ONCOL, V9, P57, DOI 10.1016/j.tranon.2015.12.005; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; You WK, 2012, AM J PATHOL, V180, P1145, DOI 10.1016/j.ajpath.2011.11.006; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhen Y, 2018, BIOCHEMISTRY-US, V57, P3807, DOI 10.1021/acs.biochem.8b00120	142	12	12	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3112	3128		10.1096/fj.201801670R	http://dx.doi.org/10.1096/fj.201801670R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30550356	Bronze			2022-12-28	WOS:000459794800004
J	Jiang, XP; Xia, S; He, XM; Ma, H; Feng, YZ; Liu, ZG; Wang, WT; Tian, M; Chen, HS; Peng, FG; Wang, L; Zhao, P; Ge, JW; Liu, D				Jiang, Xinpeng; Xia, Shuang; He, Xinmiao; Ma, Hong; Feng, Yanzhong; Liu, Ziguang; Wang, Wentao; Tian, Ming; Chen, Heshu; Peng, Fugang; Wang, Liang; Zhao, Peng; Ge, Junwei; Liu, Di			Targeting peptide-enhanced antibody and CD11c(+) dendritic cells to inclusion bodies expressing protective antigen against ETEC in mice	FASEB JOURNAL			English	Article						enterotoxigenic Escherichia coli; mucosal immune response; dendritic cells	ENTEROTOXIGENIC ESCHERICHIA-COLI; FIMBRIAL ADHESIN FAEG; YERSINIA-ENTEROCOLITICA; IMMUNE-RESPONSE; ORAL IMMUNIZATION; HEAT-LABILE; SERUM RESISTANCE; IN-VITRO; FACTOR-H; VACCINE	Enterotoxigenic Escherichia coli (ETEC) remains a massive burden in developing countries with increasing morbidity and mortality rates; it is also an important pathogen in the farming industry and is a leading cause of bacterial diarrhea. Our previous study showed that nanometer-sized inclusion bodies (IBs) of the fimbrial adhesin subunit protein (FaeG), mutation heat-stable enterotoxin a (mSTa), heat-labile enterotoxin b (LTb), and STb (nontargeting) fusion protein as an oral vaccine induced both systemic and mucosal immune responses. In this study, to enhance the protective efficacy to ETEC, we used Yersinia enterocolitica adhesive and M-cell-targeting peptides to analyze high-efficiency antigen-specific immune presentation in the gut. Here, we showed that immunization with the IBs of ETECFaeG-mSTa-LTb-STbinduced a specific systemic and mucosal immune response in the gut, whereas the combination of both targeting peptides resulted in the highest titer, protective immune response against ETEC. A lymphocyte proliferation assay has shown that the IBs induced immunologic memory. The specific antibody of the targeting groups could effectively neutralize toxins, thereby protecting the cells of the small intestine and reducing the level of cAMP and cGMP, and the groups with double targeting showed the best effect. The most important finding was that the targeting peptides stimulate the T helper (T-h) cells through T(h)17 and T(h)1 and that T(h)1 cells dominated the cellular immune response. We found that the targeting peptide could also activate CD11c(+) on lymphoid dendritic cells, which processed and presented antigens to T cells through T(h)1-mediated IFN- and IL-12, thereby enhancing the antibody titers. The double-targeting peptide had a better effect on stimulating the immune cells to enhance the antibody titers.Jiang, X., Xia, S., He, X., Ma, H., Feng, Y., Liu, Z., Wang, W., Tian, M., Chen, H., Peng, F., Wang, L., Zhao, P., Ge, J., Liu, D. Targeting peptide-enhanced antibody and CD11c(+) dendritic cells to inclusion bodies expressing protective antigen against ETEC in mice.	[Jiang, Xinpeng; He, Xinmiao; Ma, Hong; Feng, Yanzhong; Liu, Ziguang; Wang, Wentao; Tian, Ming; Chen, Heshu; Peng, Fugang; Wang, Liang; Liu, Di] Heilongjiang Acad Agr Sci, Minist Agr, Anim Husb Res Inst, Key Lab Combining Farming & Anim Husb, 368 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China; [Jiang, Xinpeng; Tian, Ming] Heilongjiang Acad Agr Sci, Postdoctoral Workstn, Harbin, Heilongjiang, Peoples R China; [Jiang, Xinpeng; Xia, Shuang; Zhao, Peng; Ge, Junwei] Northeast Agr Univ, Coll Vet Med, Dept Prevent Vet Med, Mucai St 69, Harbin 150030, Heilongjiang, Peoples R China	Heilongjiang Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Heilongjiang Academy of Agricultural Sciences; Northeast Agricultural University - China	Liu, D (corresponding author), Heilongjiang Acad Agr Sci, Minist Agr, Anim Husb Res Inst, Key Lab Combining Farming & Anim Husb, 368 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.; Ge, JW (corresponding author), Northeast Agr Univ, Coll Vet Med, Dept Prevent Vet Med, Mucai St 69, Harbin 150030, Heilongjiang, Peoples R China.	gejunwei@neau.edu.cn; liudi1963@163.com	Jiang, Xinpeng/AAL-6237-2020; Ge, Junwei/GZM-8882-2022	Ge, Junwei/0000-0002-2460-1666	Scientific Research Institution Innovation Ability Raise Special in Heilongjiang Province [YC2016D001]; National Natural Science Foundation of China [31101845, 31671289]; Postdoctoral Foundation of Heilongjiang Province Grant [LBH-Z17202]	Scientific Research Institution Innovation Ability Raise Special in Heilongjiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Foundation of Heilongjiang Province Grant	This work was supported by Scientific Research Institution Innovation Ability Raise Special in Heilongjiang Province Grant YC2016D001, National Natural Science Foundation of China Grants 31101845 and 31671289, and Postdoctoral Foundation of Heilongjiang Province Grant LBH-Z17202. The authors declare no conflicts of interest.	Attia Z, 2018, EUR J IMMUNOL, V48, P1295, DOI 10.1002/eji.201747264; Becker Y, 2004, VIRUS GENES, V28, P5, DOI 10.1023/B:VIRU.0000012260.32578.72; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biedzka-Sarek M, 2005, INFECT IMMUN, V73, P2232, DOI 10.1128/IAI.73.4.2232-2244.2005; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P5016, DOI 10.1128/IAI.00314-08; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P4100, DOI 10.1128/IAI.00313-08; Bijvelds MJC, 2015, J INFECT DIS, V212, P1806, DOI 10.1093/infdis/jiv300; CHINA B, 1993, INFECT IMMUN, V61, P3129, DOI 10.1128/IAI.61.8.3129-3136.1993; Clark MA, 2003, INT J MED MICROBIOL, V293, P17, DOI 10.1078/1438-4221-00242; Coddens A, 2017, VET MICROBIOL, V202, P64, DOI 10.1016/j.vetmic.2017.01.019; Demiri M, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12458; Duan Qiangde, 2017, J Vaccines Vaccin, V8, DOI 10.4172/2157-7560.1000367; Dubreuil JD, 2017, MICROB PATHOGENESIS, V113, P129, DOI 10.1016/j.micpath.2017.10.037; Garcia-Fruitos E, 2012, TRENDS BIOTECHNOL, V30, P65, DOI 10.1016/j.tibtech.2011.09.003; Goh YS, 2015, INFECT IMMUN, V83, P3722, DOI 10.1128/IAI.00547-15; Gualdoni GA, 2016, FASEB J, V30, P3800, DOI 10.1096/fj.201600522R; Haughney SL, 2014, NANOSCALE, V6, P13770, DOI 10.1039/c4nr03724c; Hays MP, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00132; Hogg KG, 2003, INFECT IMMUN, V71, P3563, DOI 10.1128/IAI.71.6.3563-3571.2003; HOLMGREN J, 1990, SCAND J INFECT DIS, P47; Hu CX, 2009, BIOTECHNOL LETT, V31, P991, DOI 10.1007/s10529-009-9966-8; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; Jiang XP, 2014, APPL MICROBIOL BIOT, V98, P8301, DOI 10.1007/s00253-014-5893-2; Joensuu JJ, 2006, VACCINE, V24, P2387, DOI 10.1016/j.vaccine.2005.11.056; Kesik M, 2004, IMMUNOL LETT, V91, P197, DOI 10.1016/j.imlet.2003.12.001; Kim Sae-Hae, 2012, Immune Netw, V12, P165, DOI 10.4110/in.2012.12.5.165; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Lee MR, 2011, BIOCHEM BIOPH RES CO, V410, P602, DOI 10.1016/j.bbrc.2011.06.035; Liu HJ, 2017, FASEB J, V31, P1756, DOI 10.1096/fj.201601147R; LIU LM, 1993, J EXP MED, V177, P1299, DOI 10.1084/jem.177.5.1299; Liu WX, 2015, APPL MICROBIOL BIOT, V99, P3981, DOI 10.1007/s00253-014-6302-6; Liu WX, 2015, APPL MICROBIOL BIOT, V99, P855, DOI 10.1007/s00253-014-6099-3; Ma ST, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-0861-7; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Marquardt RR, 1999, FEMS IMMUNOL MED MIC, V23, P283, DOI 10.1016/S0928-8244(98)00147-3; Martinez V, 2005, J INFECT DIS, V191, P2053, DOI 10.1086/430320; Mayorga O, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00154; Neutra MR, 1999, J INFECT DIS, V179, pS441, DOI 10.1086/314800; NIELSEN E, 1980, ACTA PATH MICRO IM C, V88, P121; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Oth T, 2015, J INTERF CYTOK RES, V35, P748, DOI 10.1089/jir.2015.0022; Park SH, 2015, ONCOTARGET, V6, P21795, DOI 10.18632/oncotarget.5489; Peng HS, 2015, NANOSCALE, V7, P4354, DOI 10.1039/c4nr06377e; PILZ D, 1992, INFECT IMMUN, V60, P189, DOI 10.1128/IAI.60.1.189-195.1992; Rausch D, 2017, VET MICROBIOL, V202, P79, DOI 10.1016/j.vetmic.2016.02.002; Read LT, 2014, INFECT IMMUN, V82, P5308, DOI 10.1128/IAI.02496-14; Rivera F, 2016, EXP PARASITOL, V160, P31, DOI 10.1016/j.exppara.2015.11.002; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Siebers A, 1996, TRENDS MICROBIOL, V4, P22, DOI 10.1016/0966-842X(96)81501-0; Sioud M, 2013, FASEB J, V27, P3272, DOI 10.1096/fj.12-224758; Sperr WR, 2000, INT ARCH ALLERGY IMM, V122, P279, DOI 10.1159/000024410; Suzuki H, 2007, KIDNEY INT, V72, P319, DOI 10.1038/sj.ki.5002300; Trentini MM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00898; VANSNICK JL, 1979, J EXP MED, V149, P1519, DOI 10.1084/jem.149.6.1519; Verdonck F, 2005, VET IMMUNOL IMMUNOP, V103, P21, DOI 10.1016/j.vetimm.2004.08.012; Wang FJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-204; Wang XN, 2018, J APPL MICROBIOL, V124, P368, DOI 10.1111/jam.13652; Wedrychowicz H, 2007, VET PARASITOL, V147, P77, DOI 10.1016/j.vetpar.2007.03.023; Wijemanne P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113230; Xu WJ, 2013, NANOSCALE, V5, P9924, DOI 10.1039/c3nr03102k; Ye LP, 2017, MICROB PATHOGENESIS, V110, P325, DOI 10.1016/j.micpath.2017.07.015; Yu M, 2017, J APPL MICROBIOL, V122, P506, DOI 10.1111/jam.13352; Zhang W, 1999, FASEB J, V13, P913, DOI 10.1096/fasebj.13.8.913; Zhang WP, 2010, INFECT IMMUN, V78, P316, DOI 10.1128/IAI.00497-09; Zhang WP, 2009, INFECT IMMUN, V77, P699, DOI 10.1128/IAI.01165-08; Zhao Peng, 2015, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V37, P790	66	3	5	5	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2836	2847		10.1096/fj.201800289RRR	http://dx.doi.org/10.1096/fj.201800289RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30321067	Bronze			2022-12-28	WOS:000457296600104
J	Lim, SW; Shin, YJ; Luo, K; Quan, Y; Ko, EJ; Chung, BH; Yang, CW				Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo			Effect of Klotho on autophagy clearance in tacrolimus-induced renal injury	FASEB JOURNAL			English	Article						kidney; nephrotoxicity; lysosome; TFEB; bafilomycin A1	CANCER CELLS; INHIBITION; NEPHROTOXICITY; RESISTANCE	Recently, we showed that tacrolimus-induced renal injury was closely associated with impairment of autophagy clearance, and Klotho deficiency aggravated tacrolimus-induced renal injury. In this study, we evaluated the effect of Klotho treatment on autophagy clearance in tacrolimus-induced renal injury. We evaluated the effect of Klotho on tacrolimus-induced renal injury in an experimental mouse model and in vitro by treatment with tacrolimus and/or recombinant mouse Klotho. In vivo and in vitro studies showed that tacrolimus treatment impaired lysosomal acidification and decreased cathepsin B activity, expression of lysosome-associated membrane protein 2, and expression of transcription factor EB (TFEB), a master regulator for lysosomal biogenesis. These results were improved by Klotho treatment. Moreover, addition of bafilomycin A1, an inhibitor of lysosomal function, abolished the protective effect of Klotho, indicating that the protective effect of Klotho was closely associated with lysosome function. Klotho induced nuclear translocation of TFEB through inhibition of phosphorylation of glycogen synthase kinase 3 (GSK3) by confirming using CHIR99021, a GSK3 inhibitor. Collectively, our data suggest that Klotho improves autophagy clearance via activation of lysosomal function in tacrolimus-induced nephrotoxicity.Lim, S. W., Shin, Y. J., Luo, K., Quan, Y., Ko, E. J., Chung, B. H., Yang, C. W. Effect of Klotho on autophagy clearance in tacrolimus-induced renal injury.	[Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Transplant Res Ctr, Seoul, South Korea; [Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Sch Med, Seoul St Marys Hosp, Dept Internal Med,Div Nephrol, 222 Banpo Daero, Seoul 06591, South Korea.	yangch@catholic.ac.kr		Ko, Eun Jeong/0000-0002-5604-1296	Korean Health Technology Research and Development Project, Ministry for Health and Welfare [HI14C3417, HI16C1641]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, Information and Computer Technology (ICT) and Future Planning [NRF-2015R1A1A3A04000946, NRF-2018R1D1A1A02043014]	Korean Health Technology Research and Development Project, Ministry for Health and Welfare; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, Information and Computer Technology (ICT) and Future Planning	This work was supported by the Korean Health Technology Research and Development Project, Ministry for Health and Welfare (Grants HI14C3417 and HI16C1641), and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, Information and Computer Technology (ICT) and Future Planning (Grants NRF-2015R1A1A3A04000946 and NRF-2018R1D1A1A02043014). The authors declare no conflicts of interest.	Behera R, 2017, CLIN CANCER RES, V23, P3181, DOI 10.1158/1078-0432.CCR-17-0201; Chen J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00499; Chen TJ, 2016, DNA CELL BIOL, V35, P751, DOI 10.1089/dna.2016.3437; Cosner D, 2015, J TRANSPLANT, V2015, DOI 10.1155/2015/142521; Guan X, 2014, J PATHOL, V234, P560, DOI 10.1002/path.4420; Han DH, 2010, TRANSPLANTATION, V90, P135, DOI 10.1097/TP.0b013e3181e117b4; Huang CL, 2011, PFLUG ARCH EUR J PHY, V462, P185, DOI 10.1007/s00424-011-0950-5; Isaka Y, 2011, AUTOPHAGY, V7, P1085, DOI 10.4161/auto.7.9.16465; Issa N, 2013, AM J NEPHROL, V37, P602, DOI 10.1159/000351648; Jin J, 2016, AM J NEPHROL, V43, P357, DOI 10.1159/000446447; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuang X, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00353; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Leon J, 2017, CELL REP, V20, P1360, DOI 10.1016/j.celrep.2017.07.024; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li LL, 2017, LUNG, V195, P295, DOI 10.1007/s00408-017-9997-1; Lim SW, 2017, LAB INVEST, V97, P1271, DOI 10.1038/labinvest.2017.75; Lim SW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.365; Lim SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29921; Madathil SV, 2014, AM J PATHOL, V184, P827, DOI 10.1016/j.ajpath.2013.11.016; Marchand B, 2015, J BIOL CHEM, V290, P5592, DOI 10.1074/jbc.M114.616714; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Qian YY, 2018, CELL PHYSIOL BIOCHEM, V45, P2268, DOI 10.1159/000488172; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Song S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082968	33	22	24	4	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2694	2706		10.1096/fj.201800751R	http://dx.doi.org/10.1096/fj.201800751R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307767				2022-12-28	WOS:000457296600093
J	Pardo, R; Vila, M; Cervela, L; de Marco, M; Gama-Perez, P; Gonzalez-Franquesa, A; Statuto, L; Vilallonga, R; Simo, R; Garcia-Roves, PM; Villena, JA				Pardo, Rosario; Vila, Maria; Cervela, Luis; de Marco, Marina; Gama-Perez, Pau; Gonzalez-Franquesa, Alba; Statuto, Lucia; Vilallonga, Ramon; Simo, Rafael; Garcia-Roves, Pablo M.; Villena, Josep A.			Calorie restriction prevents diet-induced insulin resistance independently of PGC-1-driven mitochondrial biogenesis in white adipose tissue	FASEB JOURNAL			English	Article						oxidative metabolism; adipocytes; glucose homeostasis; mitochondria	TRANSCRIPTIONAL CONTROL; PGC-1 COACTIVATORS; SKELETAL-MUSCLE; WEIGHT-LOSS; FAT DIET; INFLAMMATION; MICE; METABOLISM; OBESITY; EXPRESSION	Calorie restriction (CR) exerts remarkable, beneficial effects on glucose homeostasis by mechanisms that are not fully understood. Given the relevance of white adipose tissue (WAT) in glucose homeostasis, we aimed at identifying the main cellular processes regulated in WAT in response to CR in a pathologic context of obesity. For this, a gene-expression profiling study was first conducted in mice fed ad libitum or subjected to 40% CR. We found that the gene network related to mitochondria was the most highly upregulated in WAT by CR. To study the role that increased mitochondrial biogenesis plays on glucose homeostasis following CR, we generated a mouse model devoid of the coactivators peroxisome proliferator-activated receptor coactivator 1 (PGC-1) and PGC-1 specifically in adipocytes. Our results show that mice lacking PGC-1s in adipocytes are unable to increase mitochondrial biogenesis in WAT upon CR. Despite a blunted induction of mitochondrial biogenesis in response to calorie deprivation, mice lacking adipose PGC-1s still respond to CR by improving their glucose homeostasis. Our study demonstrates that PGC-1 coactivators are major regulators of CR-induced mitochondrial biogenesis in WAT and that increased mitochondrial biogenesis and oxidative function in adipose tissue are not required for the improvement of glucose homeostasis mediated by CR.Pardo, R., Vila, M., Cervela, L., de Marco, M., Gama-Perez, P., Gonzalez-Franquesa, A., Statuto, L., Vilallonga, R., Simo, R., Garcia-Roves, P. M., Villena, J. A. Calorie restriction prevents diet-induced insulin resistance independently of PGC-1-driven mitochondrial biogenesis in white adipose tissue.	[Pardo, Rosario; Vila, Maria; Cervela, Luis; de Marco, Marina; Statuto, Lucia; Vilallonga, Ramon; Villena, Josep A.] Univ Autonoma Barcelona, Lab Metab & Obes, Barcelona, Spain; [Simo, Rafael] Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Unit Diabet & Metab, Barcelona, Spain; [Gama-Perez, Pau; Gonzalez-Franquesa, Alba; Garcia-Roves, Pablo M.] Univ Barcelona, Hosp Llobregat, Inst Invest Biomed Bellvitge, Dept Physiol Sci, Barcelona, Spain; [Vilallonga, Ramon] Vall dHebron Univ Hosp, European Accreditat Council Bariatr Surg, Ctr Excellence, Metab & Bariatr Surg Unit, Barcelona, Spain; [Simo, Rafael; Villena, Josep A.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Gonzalez-Franquesa, Alba] Univ Copenhagen, Novo Nordisk Ctr Basic Metab Res, Copenhagen, Denmark	Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; University of Copenhagen	Villena, JA (corresponding author), Vall dHebron Inst Recerca, Unit Diabet & Metab, Lab Metab & Obes, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.	josep.villena@vhir.org	Roves, Pablo Garcia/A-7113-2015; Gonzalez-Franquesa, Alba/G-1691-2015; Vilà-Rovira, Maria/GLT-6460-2022; , VILALLONGA/AAO-5437-2020; Cervela Cardona, Luis Manuel/AAP-3192-2021; Garcia-Roves, Pablo M./X-4585-2018	Gonzalez-Franquesa, Alba/0000-0001-9081-753X; Villena, Josep A/0000-0002-2200-2985; Simo Canonge, Rafael/0000-0003-0475-3096; Cervela Cardona, Luis Manuel/0000-0002-7293-4473; Garcia-Roves, Pablo M./0000-0002-8371-2067	Ministerio de Economia y competitividad (MINECO/FEDER; Spain) [SAF2011-23886, SAF2012-39484]; Instituto de Salud Carlos III (ISCIII) [PI15/00701]	Ministerio de Economia y competitividad (MINECO/FEDER; Spain); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission)	The authors thank Anastasia Kralli (Johns Hopkins University, Baltimore, MD, USA) for the Ppargc1a<SUP>flox/flox</SUP> and Ppargc1b<SUP>flox/flox</SUP> mice and helpful discussions. This work was supported by Grants SAF2011-23886 and SAF2012-39484 from Ministerio de Economia y competitividad (MINECO/FEDER; Spain) to J.A.V. and Grant PI15/00701 from Instituto de Salud Carlos III (ISCIII) to P.M.G.-R. The authors declare no conflicts of interest.	Barger JL, 2017, AGING CELL, V16, P750, DOI 10.1111/acel.12608; Barquissau V, 2018, CELL REP, V22, P1079, DOI 10.1016/j.celrep.2017.12.102; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791; Canto Carles, 2015, Curr Protoc Mouse Biol, V5, P135, DOI 10.1002/9780470942390.mo140061; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Enguix N, 2013, MOL METAB, V2, P215, DOI 10.1016/j.molmet.2013.05.004; Fabbiano S, 2016, CELL METAB, V24, P434, DOI 10.1016/j.cmet.2016.07.023; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hancock CR, 2011, FASEB J, V25, P785, DOI 10.1096/fj.10-170415; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; HIMMSHAGEN J, 1985, INT J OBESITY, V9, P17; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lasheras J, 2016, MOL CELL ENDOCRINOL, V430, P77, DOI 10.1016/j.mce.2016.04.004; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Meydani SN, 2016, AGING-US, V8, P1416, DOI 10.18632/aging.100994; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Pardo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026989; Park CY, 2017, BIOCHEM BIOPH RES CO, V490, P636, DOI 10.1016/j.bbrc.2017.06.090; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Pellegrinelli V, 2016, DIABETOLOGIA, V59, P1075, DOI 10.1007/s00125-016-3933-4; Pope BD, 2016, TRENDS CELL BIOL, V26, P745, DOI 10.1016/j.tcb.2016.05.005; REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; ROTHWELL NJ, 1982, BIOSCIENCE REP, V2, P543, DOI 10.1007/BF01314214; Sun K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4485; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; VILLARROYA F, 1986, BIOSCIENCE REP, V6, P669, DOI 10.1007/BF01114762; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wetter TJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE728; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Zamora M, 2014, CURR PHARM DESIGN, V20, P5527, DOI 10.2174/1381612820666140306102514	55	16	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2343	2358		10.1096/fj.201800310R	http://dx.doi.org/10.1096/fj.201800310R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277821	Green Submitted			2022-12-28	WOS:000457296600065
J	Ryu, I; Park, Y; Seo, JW; Park, OH; Ha, H; Nam, JW; Kim, YK				Ryu, Incheol; Park, Yeonkyoung; Seo, Jwa-Won; Park, Ok Hyun; Ha, Hongseok; Nam, Jin-Wu; Kim, Yoon Ki			HuR stabilizes a polyadenylated form of replication-dependent histone mRNAs under stress conditions	FASEB JOURNAL			English	Article						mRNA stability; 3UTR; polyadenylation signal; UVC	LOOP-BINDING-PROTEIN; ALTERNATIVE POLYADENYLATION; STEM-LOOP; RAPID DEGRADATION; EXPRESSION; GENE; CLEAVAGE; MECHANISM; COMPLEX; INTERACTS	All metazoan mRNAs have a poly(A) tail at the 3 end with the exception of replication-dependent histone (RDH) mRNAs, which end in a highly conserved stem-loop (SL) structure. However, a subset of RDH mRNAs are reported to be polyadenylated under physiologic conditions. The molecular details of the biogenesis of polyadenylated RDH [poly(A)(+) RDH] mRNAs remain unknown. In this study, our genome-wide analyses reveal that puromycin treatment or UVC irradiation stabilizes poly(A)(+) RDH mRNAs, relative to canonical RDH mRNAs, which end in an SL structure. We demonstrate that the stabilization of poly(A)(+) RDH mRNAs occurs in a translation-independent manner and is regulated via human antigen R (HuR) binding to the extended 3 UTR under stress conditions. Our data suggest that HuR regulates the expression of poly(A)(+) RDH mRNAs.Ryu, I., Park, Y., Seo, J.-W., Park, O. H., Ha, H., Nam, J.-W., Kim, Y. K. HuR stabilizes a polyadenylated form of replication-dependent histone mRNAs under stress conditions.	[Ryu, Incheol; Park, Yeonkyoung; Park, Ok Hyun; Ha, Hongseok; Kim, Yoon Ki] Korea Univ, Creat Res Initiat Ctr Mol Biol Translat, Seoul, South Korea; [Ryu, Incheol; Park, Yeonkyoung; Park, Ok Hyun; Ha, Hongseok; Kim, Yoon Ki] Korea Univ, Div Life Sci, Anam Ro 145, Seoul 02841, South Korea; [Seo, Jwa-Won; Nam, Jin-Wu] Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea; [Nam, Jin-Wu] Hanyang Univ, Res Inst Nat Sci, Seoul, South Korea	Korea University; Korea University; Hanyang University; Hanyang University	Kim, YK (corresponding author), Korea Univ, Div Life Sci, Anam Ro 145, Seoul 02841, South Korea.	yk-kim@korea.ac.kr	Nam, Jin-Wu/F-7370-2017	Kim, Yoon Ki/0000-0003-1303-072X; Ha, Hongseok/0000-0002-0923-9187	National Research Foundation (NRF) of Korea - Korean government (MSIP) [NRF-2015R1A3A2033665, NRF-2018R1A5A1024261, 2013R1A1A2063273, 2016R1D1A1B3933894]; Korea University	National Research Foundation (NRF) of Korea - Korean government (MSIP); Korea University	The authors thank Dr. Berndt Muller (University of Aberdeen, Aberdeen, United Kingdom) for providing the antibody against human SLBP, Dr. Lynne E. Maquat (University of Rochester, Rochester, NY, USA) for the antibody against human UPF1, and Dr. You-Sub Won (Korea University) for scientific comments. This work was supported by the National Research Foundation (NRF) of Korea funded by the Korean government (MSIP) (Grants NRF-2015R1A3A2033665 and NRF-2018R1A5A1024261 to Y.K.K.; and, in part, 2013R1A1A2063273 and 2016R1D1A1B3933894 to I.R.), and by a Korea University grant (to Y.K.K.). The authors declare no conflicts of interest.	BAUMBACH LL, 1984, BIOCHEMISTRY-US, V23, P1618, DOI 10.1021/bi00303a006; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Brocato J, 2015, BIOL TRACE ELEM RES, V166, P72, DOI 10.1007/s12011-015-0296-5; Brocato J, 2014, J BIOL CHEM, V289, P31751, DOI 10.1074/jbc.M114.591883; Celik A, 2017, CURR GENET, V63, P1007, DOI 10.1007/s00294-017-0709-4; Cho H, 2015, P NATL ACAD SCI USA, V112, pE1540, DOI 10.1073/pnas.1409612112; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Choe J, 2014, P NATL ACAD SCI USA, V111, pE4577, DOI 10.1073/pnas.1409695111; Choe J, 2014, NUCLEIC ACIDS RES, V42, P9334, DOI 10.1093/nar/gku610; Choe J, 2013, NUCLEIC ACIDS RES, V41, P1307, DOI 10.1093/nar/gks1196; COLLART D, 1991, BIOCHEMISTRY-US, V30, P1610, DOI 10.1021/bi00220a024; Danckwardt S, 2011, MOL CELL, V41, P298, DOI 10.1016/j.molcel.2010.12.032; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Gabler C, 2004, ANN RHEUM DIS, V63, P1135, DOI 10.1136/ard.2003.011452; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; Graber JH, 2013, GENOME RES, V23, P1690, DOI 10.1101/gr.144964.112; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gruber JJ, 2012, MOL CELL, V45, P87, DOI 10.1016/j.molcel.2011.12.020; Gupta P, 2018, MOL BIOL REP, V45, P39, DOI 10.1007/s11033-017-4139-7; Hoefig KP, 2014, WIRES RNA, V5, P577, DOI 10.1002/wrna.1232; Hollerer I, 2016, RNA, V22, P1441, DOI 10.1261/rna.055657.115; Hrossova D, 2015, NUCLEIC ACIDS RES, V43, P4236, DOI 10.1093/nar/gkv240; Jaeger S, 2005, BIOCHIMIE, V87, P827, DOI 10.1016/j.biochi.2005.03.012; Kari V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063745; Karousis ED, 2016, WIRES RNA, V7, P661, DOI 10.1002/wrna.1357; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kim M, 2015, METHODS, V83, P111, DOI 10.1016/j.ymeth.2015.04.011; KIRSH AL, 1989, GENE DEV, V3, P2172, DOI 10.1101/gad.3.12b.2172; Kraynik SM, 2015, BBA-GENE REGUL MECH, V1849, P688, DOI 10.1016/j.bbagrm.2015.02.004; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; Lubas M, 2015, CELL REP, V10, P178, DOI 10.1016/j.celrep.2014.12.026; Lyons SM, 2016, NUCLEIC ACIDS RES, V44, P9190, DOI 10.1093/nar/gkw620; Marzluff WF, 2017, TRENDS GENET, V33, P745, DOI 10.1016/j.tig.2017.07.014; Mayr C, 2017, ANNU REV GENET, V51, P171, DOI 10.1146/annurev-genet-120116-024704; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Neve J, 2017, RNA BIOL, V14, P865, DOI 10.1080/15476286.2017.1306171; Park J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15730; Park OH, 2016, GENE DEV, V30, P2093, DOI 10.1101/gad.286484.116; Pirngruber J, 2010, ONCOGENE, V29, P2853, DOI 10.1038/onc.2010.42; Romeo V, 2016, CURR OPIN CELL BIOL, V40, P23, DOI 10.1016/j.ceb.2016.01.015; Romeo V, 2014, MOL CELL BIOL, V34, P4272, DOI 10.1128/MCB.00791-14; Saldi T, 2018, GENE DEV, V32, P297, DOI 10.1101/gad.310896.117; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Tan DZ, 2013, SCIENCE, V339, P318, DOI 10.1126/science.1228705; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner RE, 2018, SEMIN CELL DEV BIOL, V75, P61, DOI 10.1016/j.semcdb.2017.08.056; von Roretz C, 2013, CELL DEATH DIFFER, V20, P154, DOI 10.1038/cdd.2012.111; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016; Yu LJ, 2013, NUCLEIC ACIDS RES, V41, P3104, DOI 10.1093/nar/gkt020; Zhao JY, 2004, CELL CYCLE, V3, P695	57	3	3	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2680	2693		10.1096/fj.201800431R	http://dx.doi.org/10.1096/fj.201800431R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303743				2022-12-28	WOS:000457296600092
J	Zhan, J; Jia, HS; Semchenko, EA; Bian, YQ; Zhou, AM; Li, ZX; Yang, YD; Wang, JH; Sarkar, S; Totsika, M; Blanchard, H; Jen, FEC; Ye, QZ; Haselhorst, T; Jennings, MP; Seib, KL; Zhou, YQ				Zhan, Jian; Jia, Husen; Semchenko, Evgeny A.; Bian, Yunqiang; Zhou, Amy M.; Li, Zhixiu; Yang, Yuedong; Wang, Jihua; Sarkar, Sohinee; Totsika, Makrina; Blanchard, Helen; Jen, Freda E. -C.; Ye, Qizhuang; Haselhorst, Thomas; Jennings, Michael P.; Seib, Kate L.; Zhou, Yaoqi			Self-derived structure-disrupting peptides targeting methionine aminopeptidase in pathogenic bacteria: a new strategy to generate antimicrobial peptides	FASEB JOURNAL			English	Article						antibiotic resistance; Neisseria gonorrhoeae; Escherichia coli; protein-specific denaturation	PROTEIN SECONDARY STRUCTURE; PARTICLE MESH EWALD; ESCHERICHIA-COLI; IDENTIFICATION; INHIBITION; POTENTIALS; PREDICTION; RESISTANCE; STABILITY; FORCE	Bacterial infection is one of the leading causes of death in young, elderly, and immune-compromised patients. The rapid spread of multi-drug-resistant (MDR) bacteria is a global health emergency and there is a lack of new drugs to control MDR pathogens. We describe a heretofore-unexplored discovery pathway for novel antibiotics that is based on self-targeting, structure-disrupting peptides. We show that a helical peptide, KFF-EcH3, derived from the Escherichia coli methionine aminopeptidase can disrupt secondary and tertiary structure of this essential enzyme, thereby killing the bacterium (including MDR strains). Significantly, no detectable resistance developed against this peptide. Based on a computational analysis, our study predicted that peptide KFF-EcH3 has the strongest interaction with the structural core of the methionine aminopeptidase. We further used our approach to identify peptide KFF-NgH1 to target the same enzyme from Neisseria gonorrhoeae. This peptide inhibited bacterial growth and was able to treat a gonococcal infection in a human cervical epithelial cell model. These findings present an exciting new paradigm in antibiotic discovery using self-derived peptides that can be developed to target the structures of any essential bacterial proteins.Zhan, J., Jia, H., Semchenko, E. A., Bian, Y., Zhou, A. M., Li, Z., Yang, Y., Wang, J., Sarkar, S., Totsika, M., Blanchard, H., Jen, F. E.-C., Ye, Q., Haselhorst, T., Jennings, M. P., Seib, K. L., Zhou, Y. Self-derived structure-disrupting peptides targeting methionine aminopeptidase in pathogenic bacteria: a new strategy to generate antimicrobial peptides.	[Zhan, Jian; Jia, Husen; Semchenko, Evgeny A.; Yang, Yuedong; Blanchard, Helen; Jen, Freda E. -C.; Haselhorst, Thomas; Jennings, Michael P.; Seib, Kate L.; Zhou, Yaoqi] Griffith Univ, Inst Glyc, Parklands Dr, Southport, Qld 4222, Australia; [Bian, Yunqiang; Wang, Jihua; Zhou, Yaoqi] Dezhou Univ, Shandong Key Lab Biophys, Inst Biophys, Dezhou, Peoples R China; [Zhou, Amy M.] Queensland Acad Hlth Sci, Southport, Qld, Australia; [Li, Zhixiu; Zhou, Yaoqi] Indiana Univ Purdue Univ, Indiana Univ, Sch Informat, Indianapolis, IN 46202 USA; [Sarkar, Sohinee; Totsika, Makrina] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, Brisbane, Qld, Australia; [Ye, Qizhuang] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Ye, Qizhuang] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China	Griffith University; Dezhou University; Indiana University System; Indiana University-Purdue University Indianapolis; Queensland University of Technology (QUT); Indiana University System; Indiana University Bloomington; Shenzhen University	Zhou, YQ (corresponding author), Griffith Univ, Inst Glyc, Parklands Dr, Southport, Qld 4222, Australia.	yaoqi.zhou@griffith.edu.au	Yang, Yuedong/C-9394-2009; Jennings, Michael P/G-4822-2013; Haselhorst, Thomas/A-5066-2015; Jian, Zhan/AAM-2759-2021; Li, Zhixiu/AAK-4021-2021; Zhou, Yaoqi/B-3284-2009; Seib, Kate L/B-4670-2015; Blanchard, Helen/A-4681-2009; Totsika, Makrina/A-8993-2011	Yang, Yuedong/0000-0002-6782-2813; Jennings, Michael P/0000-0002-1027-4684; Haselhorst, Thomas/0000-0002-3373-8680; Jian, Zhan/0000-0003-0856-2385; Zhou, Yaoqi/0000-0002-9958-5699; Seib, Kate L/0000-0002-7094-3528; Blanchard, Helen/0000-0003-3372-5027; Li, Zhixiu/0000-0002-2924-9120; Sarkar, Sohinee/0000-0001-9364-1920; Semchenko, Evgeny/0000-0002-5188-7946; Totsika, Makrina/0000-0003-2468-0293	National Institute of General Medical Sciences of the U.S. National Institutes of Health [R01GM085003]; National Health and Medical Research Council of Australia [1059775, 1121629, 1069370, 1071659, 1045235, 1138466]; National Natural Science Foundation of China [61271378, 61671107, 61540025]; Taishan Scholars Program of the Shandong Province of China	National Institute of General Medical Sciences of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of the Shandong Province of China	The authors acknowledge support from the National Institute of General Medical Sciences of the U.S. National Institutes of Health under award number R01GM085003 and National Health and Medical Research Council of Australia Grants 1059775 (to Y.Z.), 1121629 (to Y.Z., K.L.S., T.H., H.B., and Y.Y), 1069370 (to M.T.), and 1071659 (to M.P.J.), and Fellowships 1045235 (to K.L.S.) and 1138466 (to M.P.J.); National Natural Science Foundation of China Grants 61271378, 61671107, and 61540025 (to J.W.); and the Taishan Scholars Program of the Shandong Province of China. The authors also gratefully acknowledge the use of the High Performance Computing Cluster "Gowonda" to complete this research. This research/project was undertaken with the aid of the research cloud resources provided by the Queensland Cyber Infrastructure Foundation (QCIF). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	[Anonymous], 2012, Drug Discov Today Technol, V9, pe1, DOI 10.1016/j.ddtec.2011.07.006; Arya T, 2015, J MED CHEM, V58, P2350, DOI 10.1021/jm501790e; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Broglia RA, 2008, CURR OPIN STRUC BIOL, V18, P60, DOI 10.1016/j.sbi.2007.10.004; Caldarini M, 2009, PROTEINS, V74, P390, DOI 10.1002/prot.22161; CDC, 2013, ANTIBIOTIC RESISTANC; Cresci GA, 2015, NUTR CLIN PRACT, V30, P734, DOI 10.1177/0884533615609899; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Edwards JL, 2016, CRIT REV MICROBIOL, V42, P928, DOI 10.3109/1040841X.2015.1105782; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Herring CD, 2004, J BACTERIOL, V186, P2673, DOI 10.1128/JB.186.9.2673-2681.2004; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm T, 2006, NAT PROTOC, V1, P1001, DOI 10.1038/nprot.2006.174; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/nmat4157, 10.1038/NMAT4157]; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lu JP, 2010, J MED CHEM, V53, P1329, DOI 10.1021/jm901624n; Lushniak BD, 2014, PUBLIC HEALTH REP, V129, P314, DOI 10.1177/003335491412900402; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Otvos L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00062; Patel JB, 2015, 25 INFORMATIONAL SUP; RODERICK SL, 1993, BIOCHEMISTRY-US, V32, P3907, DOI 10.1021/bi00066a009; Simon MD, 2014, CHEMBIOCHEM, V15, P713, DOI 10.1002/cbic.201300796; Tan XX, 2005, ANTIMICROB AGENTS CH, V49, P3203, DOI 10.1128/AAC.49.8.3203-3207.2005; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Unemo M, 2009, J ANTIMICROB CHEMOTH, V63, P1142, DOI 10.1093/jac/dkp098; White TR, 2011, NAT CHEM BIOL, V7, P810, DOI 10.1038/nchembio.664; Yang YD, 2008, PROTEIN SCI, V17, P1212, DOI 10.1110/ps.033480.107; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	44	4	4	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2095	2104		10.1096/fj.201700613RR	http://dx.doi.org/10.1096/fj.201700613RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260702	Green Published			2022-12-28	WOS:000457296600046
J	Chen, H; Ji, X; Lee, WC; Shi, Y; Li, BE; Abel, ED; Jiang, DM; Huang, W; Long, FX				Chen, Hong; Ji, Xing; Lee, Wen-Chih; Shi, Yu; Li, Boer; Abel, E. Dale; Jiang, Dianming; Huang, Wei; Long, Fanxin			Increased glycolysis mediates Wnt7b-induced bone formation	FASEB JOURNAL			English	Article						Glut1; Slc2a1; glucose; osteoblast; mouse	AEROBIC GLYCOLYSIS; WNT1 MUTATIONS; BETA-CATENIN; SOST GENE; OSTEOBLAST; DIFFERENTIATION; ACTIVATION; METABOLISM; ANABOLISM; DELETION	Wingless/integrated (Wnt) signaling has emerged as a major mechanism for promoting bone formation and a target pathway for developing bone anabolic agents against osteoporosis. However, the downstream events mediating the potential therapeutic effect of Wnt proteins are not fully understood. Previous studies have indicated that increased glycolysis is associated with osteoblast differentiation in response to Wnt signaling, but direct genetic evidence for the importance of glucose metabolism in Wnt-induced bone formation is lacking. Here, we have generated compound transgenic mice to overexpress Wnt family member 7B (Wnt7b) transiently in the osteoblast lineage of postnatal mice, with or without concurrent deletion of the glucose transporter 1 (Glut1), also known as solute carrier family 2, facilitated glucose transporter member 1. Overexpression of Wnt7b in 1-mo-old mice for 1 wk markedly stimulated bone formation, but the effect was essentially abolished without Glut1, even though transient deletion of Glut1 itself did not affect normal bone accrual. Consistent with the in vivo results, Wnt7b increased Glut1 expression and glucose consumption in the primary culture of osteoblast lineage cells, and deletion of Glut1 diminished osteoblast differentiation in vitro. Thus, Wnt7b promotes bone formation in part through stimulating glucose metabolism in osteoblast lineage cells.-Chen, H., Ji, X., Lee, W.-C., Shi, Y., Li, B., Abel, E. D., Jiang, D., Huang, W., Long, F. Increased glycolysis mediates Wnt7b-induced bone formation.	[Chen, Hong; Huang, Wei] Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China; [Chen, Hong; Ji, Xing; Lee, Wen-Chih; Shi, Yu; Li, Boer; Long, Fanxin] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; [Abel, E. Dale] Univ Iowa, Div Endocrinol & Metab, Fraternal Order Eagles Diabet Res Ctr, Carver Coll Med, Iowa City, IA USA; [Jiang, Dianming] Chongqing Med Univ, Affiliated Hosp 3, Dept Orthoped, Chongqing, Peoples R China; [Ji, Xing; Lee, Wen-Chih; Shi, Yu; Long, Fanxin] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Chongqing Medical University; Washington University (WUSTL); University of Iowa; Chongqing Medical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Long, FX (corresponding author), Univ Penn, Dept Orthopaed Surg, Perelman Sch Med, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	longf1@email.chop.edu	CHEN, Hong/AAC-7879-2019	CHEN, Hong/0000-0002-4152-624X; Abel, E. Dale/0000-0001-5290-0738	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR060456]; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK111212]; Washington University Musculoskeletal Research Center [NIH P30 AR057235]; China Scholarship Council [201608500093]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR060456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK111212] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant; Washington University Musculoskeletal Research Center; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	T This work was supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR060456 (to F.L.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK111212 (to F.L.), and the Washington University Musculoskeletal Research Center (NIH P30 AR057235). H.C. is a visiting scholar supported by the China Scholarship Council (201608500093). The authors declare no conflicts of interest.	Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chen Jia-Shing, 2014, BMC Res Notes, V7, P15, DOI 10.1186/1756-0500-7-15; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Esen E, 2015, J BONE MINER RES, V30, P1959, DOI 10.1002/jbmr.2556; Esen E, 2014, CURR OSTEOPOROS REP, V12, P433, DOI 10.1007/s11914-014-0235-y; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567; Frey JL, 2015, MOL CELL BIOL, V35, P1979, DOI 10.1128/MCB.01343-14; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Joeng KS, 2017, J CLIN INVEST, V127, P2678, DOI 10.1172/JCI92617; Joeng KS, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.4; Karner CM, 2017, MOL CELL BIOL, V37; Karner CM, 2017, CELL MOL LIFE SCI, V74, P1649, DOI 10.1007/s00018-016-2425-5; Karner CM, 2015, J CLIN INVEST, V125, P551, DOI 10.1172/JCI78470; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458; Lee SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07316-5; Lee SY, 2018, J CLIN INVEST, V128, P5573, DOI 10.1172/JCI96221; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Medina-Gomez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002718; Moverare-Skrtic S, 2014, NAT MED, V20, P1279, DOI 10.1038/nm.3654; Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Song LG, 2012, J BONE MINER RES, V27, P2344, DOI 10.1002/jbmr.1694; Sun WW, 2016, BONE, V85, P1, DOI 10.1016/j.bone.2016.01.013; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745; Zhong ZD, 2014, WIRES DEV BIOL, V3, P489, DOI 10.1002/wdev.159	43	22	22	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7810	7821		10.1096/fj.201900201RR	http://dx.doi.org/10.1096/fj.201900201RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30913395	Bronze, Green Published			2022-12-28	WOS:000476234700003
J	Han, J; Meng, TT; Chen, XY; Han, Y; Fu, JJ; Zhou, F; Fei, YY; Li, CL				Han, Jing; Meng, Tingting; Chen, Xinyu; Han, Yue; Fu, Junjie; Zhou, Feng; Fei, Yingying; Li, Chenglin			The chronic administration of two novel long-acting Xenopus glucagon-like peptide-1 analogs xGLP159 and xGLP296 potently improved systemic metabolism and glycemic control in rodent models	FASEB JOURNAL			English	Article						metabolic disease; Xenopus GLP-1; antidiabetic	GLP-1 RECEPTOR AGONISTS; FOOD-INTAKE; BODY-WEIGHT; DERIVATIVES; STABILITY; EXENDIN-4; DESIGN; DISCOVERY; OBESITY; NAUSEA	We here reported 2 novel Xenopus glucagon-like peptide-1 (xGLP-1) analogs, xGLP159 and xGLP296, whose therapeutic effects on metabolic efficacy and glycemic control were evaluated in rodents. The in vitro potency of xGLP159 and xGLP296 were investigated on human embryonic kidney 293 cells. The acute glucose-lowering and insulinotropic effects of xGLP159 and xGLP296 were assessed in the Institute of Cancer Research, Kunming, and diabetic (db/db) mice. The pharmacokinetic profiles of xGLP159 and xGLP296 were confirmed on Sprague-Dawley (SD) rats and their long-acting hypoglycemic and anorectic effects were evaluated in db/db mice. Chronic treatment effects of xGLP159 and xGLP296 were evaluated in diet-induced obese (DIO) mice and db/db mice. The results showed that xGLP159 and xGLP296 exhibited comparable receptor activation potency, hypoglycemic effect, and insulinotropic activity to liraglutide. The enhanced half-lives of xGLP159 and xGLP296 in SD rats (5.1 and 5.8 h, respectively) resulted in prolonged anti-db/db durations in db/db mice. Three weeks' administration of xGLP159 and xGLP296 normalized glucose tolerance and adiposity in DIO mice. Furthermore, 11-wk treatment of xGLP159 and xGLP296 corrected hyperglycemia and improved pancreatic function in db/db mice. These preclinical studies supported xGLP159 and xGLP296 as promising candidates for the treatment of metabolic diseases.-Han, J., Meng, T., Chen, X., Han, Y., Fu, J., Zhou, F., Fei, Y., Li, C. The chronic administration of two novel long-acting Xenopus glucagon-like peptide-1 analogs xGLP159 and xGLP296 potently improved systemic metabolism and glycemic control in rodent models.	[Han, Jing; Li, Chenglin] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China; [Han, Jing; Chen, Xinyu; Han, Yue; Zhou, Feng; Fei, Yingying] Jiangsu Normal Univ, Sch Chem & Mat Sci, Jiangsu Key Lab Green Synthet Chem Funct Mat, Xuzhou, Jiangsu, Peoples R China; [Meng, Tingting; Fu, Junjie] Nanjing Med Univ, Sch Pharm, Dept Med Chem, Nanjing, Jiangsu, Peoples R China	Xuzhou Medical University; Jiangsu Normal University; Nanjing Medical University	Li, CL (corresponding author), Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China.; Fu, JJ (corresponding author), Nanjing Med Univ, Sch Pharm, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	jfu@njmu.edu.cn; licl@xzhmu.edu.cn	Fu, Junjie/J-3270-2019	Fu, Junjie/0000-0002-2741-7469	National Natural Science Foundation of China [81602964, 81602960, 81402969]; Natural Science Foundation of Jiangsu Province [BK20150243, BK20161028]; 333 High-Level Talents Project of Jiangsu Province; Program for Distinguished Talents of Six Domains in Jiangsu Province [2017-SWYY-075]; Open Research Fund of Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy [KF-XY201404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); 333 High-Level Talents Project of Jiangsu Province; Program for Distinguished Talents of Six Domains in Jiangsu Province; Open Research Fund of Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy	This work is supported by the National Natural Science Foundation of China (Grants 81602964, 81602960, and 81402969), the Natural Science Foundation of Jiangsu Province (Grants BK20150243 and BK20161028), the 333 High-Level Talents Project of Jiangsu Province, the Program for Distinguished Talents of Six Domains in Jiangsu Province (Grant 2017-SWYY-075), and the Open Research Fund of Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy (KF-XY201404). The authors declare no conflicts of interest.	Baggio LL, 2008, GASTROENTEROLOGY, V134, P1137, DOI 10.1053/j.gastro.2008.01.017; Bartholome R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136618; Bech EM, 2017, J MED CHEM, V60, P7434, DOI 10.1021/acs.jmedchem.7b00787; Chae SY, 2010, J CONTROL RELEASE, V144, P10, DOI 10.1016/j.jconrel.2010.01.024; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Deacon CF, 1998, DIABETOLOGIA, V41, P271, DOI 10.1007/s001250050903; Ding LM, 2017, PHARMACOL RES, V122, P130, DOI 10.1016/j.phrs.2017.05.007; Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0; Evers A, 2017, J MED CHEM, V60, P4293, DOI 10.1021/acs.jmedchem.7b00174; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Gao HS, 2017, FASEB J, V31, P3527, DOI 10.1096/fj.201700002R; Hager MV, 2016, J AM CHEM SOC, V138, P14970, DOI 10.1021/jacs.6b08323; Han J, 2018, BIOCONJUGATE CHEM, V29, P390, DOI 10.1021/acs.bioconjchem.7b00712; Han J, 2018, MEDCHEMCOMM, V9, P67, DOI 10.1039/c7md00471k; Han J, 2018, BRIT J PHARMACOL, V175, P544, DOI 10.1111/bph.14107; Han J, 2017, MOL PHARMACEUT, V14, P3954, DOI 10.1021/acs.molpharmaceut.7b00632; Han J, 2017, BIOCHEM PHARMACOL, V142, P155, DOI 10.1016/j.bcp.2017.06.132; Han J, 2017, EUR J MED CHEM, V132, P81, DOI 10.1016/j.ejmech.2017.03.032; Han J, 2014, BRIT J PHARMACOL, V171, P5252, DOI 10.1111/bph.12843; Han J, 2013, J MED CHEM, V56, P9955, DOI 10.1021/jm4017448; Han J, 2013, BIOCHEM PHARMACOL, V86, P297, DOI 10.1016/j.bcp.2013.05.012; Irwin DM, 1997, P NATL ACAD SCI USA, V94, P7915, DOI 10.1073/pnas.94.15.7915; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Lau J, 2015, J MED CHEM, V58, P7370, DOI 10.1021/acs.jmedchem.5b00726; Lee JG, 2018, BIOCHEM PHARMACOL, V151, P59, DOI 10.1016/j.bcp.2018.03.004; Li CN, 2018, BIOCHEM PHARMACOL, V150, P46, DOI 10.1016/j.bcp.2018.01.029; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Liu YL, 2005, PHYSIOL BEHAV, V85, P271, DOI 10.1016/j.physbeh.2005.04.009; Mack CM, 2010, INT J OBESITY, V34, P385, DOI 10.1038/ijo.2009.238; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; Maida A, 2008, ENDOCRINOLOGY, V149, P5670, DOI 10.1210/en.2008-0336; Manandhar B, 2015, J MED CHEM, V58, P1020, DOI 10.1021/jm500810s; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Perez-Tilve D, 2006, ENDOCRINE, V29, P61, DOI 10.1385/ENDO:29:1:61; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Sun LD, 2016, BIOCHEM PHARMACOL, V110, P80, DOI 10.1016/j.bcp.2016.04.016; van Witteloostuijn SB, 2017, MOL PHARMACEUT, V14, P193, DOI 10.1021/acs.molpharmaceut.6b00787; Willems M, 2001, DIGEST DIS SCI, V46, P2256, DOI 10.1023/A:1011935603893; Yang X, 2014, MOL PHARMACEUT, V11, P4092, DOI 10.1021/mp5002685; Zhong X, 2018, EUR J MED CHEM, V150, P841, DOI 10.1016/j.ejmech.2018.03.050	41	9	9	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7113	7125		10.1096/fj.201801479R	http://dx.doi.org/10.1096/fj.201801479R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30860869	Bronze			2022-12-28	WOS:000476114200037
J	Harlan, BA; Pehar, M; Killoy, KM; Vargas, MR				Harlan, Benjamin A.; Pehar, Mariana; Killoy, Kelby M.; Vargas, Marcelo R.			Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis; NAD(+); nicotinamide mononucleotide; nicotinamide riboside; Nrf2	AMYOTROPHIC-LATERAL-SCLEROSIS; NICOTINAMIDE RIBOSIDE; NAD(+) METABOLISM; NRF2 ACTIVATION; MOTOR-NEURONS; MOUSE MODEL; PATHWAY; BIOSYNTHESIS; TOXICITY; PROTECTS	Sirtuins (SIRTs) are NAD(+)-dependent deacylases that play a key role in transcription, DNA repair, metabolism, and oxidative stress resistance. Increasing NAD(+) availability regulates endogenous SIRT activity, leading to increased resistance to oxidative stress and decreased mitochondrial reactive oxygen production in multiple cell types and disease models. This protection, at least in part, depends on the activation of antioxidant mitochondrial proteins. We now show that increasing total NAD(+) content in astrocytes leads to the activation of the transcription factor nuclear factor, erythroid-derived 2, like 2 (Nfe2l2 or Nrf2) and up-regulation of the antioxidant proteins heme oxygenase 1 (HO-1) and sulfiredoxin 1 (SRXN1). Nrf2 activation also occurs as a result of SIRT6 overexpression. Mutations in Cu-Zn superoxide dismutase 1 (SOD1) cause familial forms of amyotrophic lateral sclerosis (ALS). Astrocytes isolated from mutant human SOD1-overexpressing mice induce motor neuron death in coculture. Treatment with nicotinamide mononucleotide or nicotinamide riboside increases total NAD(+) content in ALS astrocytes and abrogates their toxicity toward cocultured motor neurons. The observed neuroprotection depends on SIRT6 expression in astrocytes. Moreover, overexpression of SIRT6 in astrocytes by itself abrogates the neurotoxic phenotype of ALS astrocytes. Our results identify SIRT6 as a potential therapeutic target to prevent astrocyte-mediated motor neuron death in ALS.-Harlan, B. A., Pehar, M., Killoy, K. M., Vargas, M. R. Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1.	[Harlan, Benjamin A.; Pehar, Mariana; Killoy, Kelby M.; Vargas, Marcelo R.] Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Basic Sci Bldg,Room 358,MSC 509,173 Ashley Ave, Charleston, SC 29425 USA	Medical University of South Carolina	Vargas, MR (corresponding author), Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Basic Sci Bldg,Room 358,MSC 509,173 Ashley Ave, Charleston, SC 29425 USA.	vargasm@musc.edu		Harlan, Benjamin/0000-0001-9026-543X	U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke [R01NS089640]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089640] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke Grant R01NS089640. The authors declare no conflicts of interest.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Baxter PS, 2016, FREE RADICAL BIO MED, V100, P147, DOI 10.1016/j.freeradbiomed.2016.06.027; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; de Picciotto NE, 2016, AGING CELL, V15, P522, DOI 10.1111/acel.12461; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Harlan BA, 2016, J BIOL CHEM, V291, P10836, DOI 10.1074/jbc.M115.698779; Hou YJ, 2018, P NATL ACAD SCI USA, V115, pE1876, DOI 10.1073/pnas.1718819115; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kia A, 2018, GLIA, V66, P1016, DOI 10.1002/glia.23298; Kraft AD, 2007, EXP NEUROL, V207, P107, DOI 10.1016/j.expneurol.2007.05.026; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Matsui S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07033-z; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Pehar M, 2017, CURR PHARM DESIGN, V23, P5010, DOI 10.2174/1381612823666170622095802; Pehar M, 2018, ANTIOXID REDOX SIGN, V28, P1652, DOI 10.1089/ars.2017.7145; Pehar M, 2016, MOL CELL PROTEOMICS, V15, P493, DOI 10.1074/mcp.M115.049288; Pehar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103438; Ravits J, 2013, AMYOTROPH LAT SCL FR, V14, P5, DOI 10.3109/21678421.2013.778548; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ruddick Jon P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000068; Schondorf DC, 2018, CELL REP, V23, P2979, DOI 10.1016/j.celrep.2018.05.009; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Vargas MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056625; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Wei CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00851-z; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206	54	27	28	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7084	7091		10.1096/fj.201802752R	http://dx.doi.org/10.1096/fj.201802752R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30841754	Green Published, Bronze			2022-12-28	WOS:000476114200034
J	Kudriaeva, A; Kuzina, ES; Zubenko, O; Smirnov, IV; Belogurov, A				Kudriaeva, Anna; Kuzina, Ekaterina S.; Zubenko, Oleg; Smirnov, Ivan, V; Belogurov, Alexey, Jr.			Charge-mediated proteasome targeting	FASEB JOURNAL			English	Article						ubiquitin-independent degradation; myelin basic protein; direct proteasomal signal; proteasome recognition; PA28; 11S; REG regulatory subunit	MYELIN BASIC-PROTEIN; ORNITHINE-DECARBOXYLASE; MULTIPLE-SCLEROSIS; DISTINCT MECHANISMS; 20S PROTEASOMES; PA28 ALPHA; DEGRADATION; CELL; RECOGNITION; PHOSPHORYLATION	A majority of thousands of intracellular mammalian proteins are recognized by proteasome only being conjugated with ubiquitin (Ub), representing a universal degradation signal operated by the ubiquitination system. Ub-independent proteasome targeting is rationalized by the existence of 2 types of direct proteasome signals (DPSs), specific amino acid sequences or post-translational modifications, which are recognized by proteasome regulatory subunits. Historically, the first type was shown to exist in ornithine decarboxylase, whereas acetylation of core histones recently was reported as a second type of DPS. Here we declare a third type, representing charge-mediated DPS. This discovered DPS may be classified as a monopartite composition- but not sequence-dependent element of similar to 70 angstrom in length enriched in basic and flexible amino acids. This type of degradation signal, which may be provided by cationic chemicals, is most efficiently engaged by proteasomes capped with regulator (REG)alpha or REG gamma in an ATP-independent manner. Taken together, our findings suggest a novel modality of proteasome-substrate interrelation bypassing ubiquitination.-Kudriaeva, A., Kuzina, E. S., Zubenko, O., Smirnov, I. V., Belogurov, A. Charge-mediated proteasome targeting.	[Kudriaeva, Anna; Kuzina, Ekaterina S.; Zubenko, Oleg; Smirnov, Ivan, V; Belogurov, Alexey, Jr.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Smirnov, Ivan, V] Kazan Fed Univ, Kazan, Russia; [Belogurov, Alexey, Jr.] Lomonosov Moscow State Univ, Dept Fundamental Med, Moscow, Russia; [Kuzina, Ekaterina S.] Yale Univ, Sch Med, New Haven, CT USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Kazan Federal University; Lomonosov Moscow State University; Yale University	Belogurov, A (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.	belogurov@ibch.ru	Belogurov, Alexey/L-5859-2017; Smirnov, Ivan/N-5635-2017	Belogurov, Alexey/0000-0002-2033-9621; Smirnov, Ivan/0000-0002-0384-6568; Kuzina, Ekaterina/0000-0002-5468-0262	Russian Scientific Foundation Project [14-14-00585];  [CPi 2445.2013.4]	Russian Scientific Foundation Project(Russian Science Foundation (RSF)); 	The authors thank Prof. Aaron Ciechanover (Technion-Israel Institute of Technology, Haifa, Israel) for many fruitful discussions, critical reading of the manuscript, and providing reagents and plasmids. The authors also thank Dr. Nikolai Bovin (Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry) and Dr. Alexey Khomutov (Engelhardt Institute of Molecular Biology, Moscow, Russia) for providing reagents; and Dr. Dmitry Staroverov (Shemyakin Ovchinnikov Institute of Bioorganic Chemistry) for assistance in flow cytometry. This study was performed in the framework of the Russian Scientific Foundation Project 14-14-00585 (Molecular mechanism and physiological significance of the ubiquitin-independent proteasomal degradation of the proteins), and personally supported by Presidential Fellowship C Pi 2445.2013.4 (to A.B. Jr.). The authors declare no conflicts of interest.	Ahmed MAM, 2010, BIOPHYS J, V99, P1247, DOI 10.1016/j.bpj.2010.06.022; Beenukumar RR, 2015, MICROB CELL, V2, P197, DOI 10.15698/mic2015.06.206; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Belogurov A, 2015, FASEB J, V29, P1901, DOI 10.1096/fj.14-259333; Belogurov A, 2014, J BIOL CHEM, V289, P17758, DOI 10.1074/jbc.M113.544247; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Boggs Joan M, 2014, BMC Res Notes, V7, P387, DOI 10.1186/1756-0500-7-387; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Ciechanover A, 2015, NAT REV MOL CELL BIO, V16, P322, DOI 10.1038/nrm3982; D'Souza CA, 2006, NEUROCHEM RES, V31, P1045, DOI 10.1007/s11064-006-9116-9; Eom JW, 1996, PLANT SCI, V115, P17, DOI 10.1016/0168-9452(96)04332-4; Fabre B, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145497; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Johnston SC, 1997, PROTEIN SCI, V6, P2469; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Komorek J, 2010, J VIROL, V84, P2719, DOI 10.1128/JVI.02119-09; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Kuzina ES, 2013, DOKL BIOCHEM BIOPHYS, V453, P300, DOI 10.1134/S1607672913060070; Kuzina E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/926394; LAMENSA JWE, 1993, J NEUROCHEM, V61, P987, DOI 10.1111/j.1471-4159.1993.tb03612.x; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Medveczky P, 2006, FEBS LETT, V580, P545, DOI 10.1016/j.febslet.2005.12.067; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Myers N, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800076; Nathan JA, 2013, CELL, V152, P1184, DOI 10.1016/j.cell.2013.01.037; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Pedraza L, 1997, NEURON, V18, P579, DOI 10.1016/S0896-6273(00)80299-8; Petrauskas V, 2015, J PHYS CHEM B, V119, P12164, DOI 10.1021/acs.jpcb.5b05767; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5374, DOI 10.1021/bi9925569; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Raule M, 2014, BBA-MOL CELL RES, V1843, P1942, DOI 10.1016/j.bbamcr.2014.05.005; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; ROSENBERGHASSON Y, 1989, EUR J BIOCHEM, V185, P469, DOI 10.1111/j.1432-1033.1989.tb15138.x; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schrader J, 2016, SCIENCE, V353, P594, DOI 10.1126/science.aaf8993; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Smith GST, 2013, J NEUROSCI RES, V91, P349, DOI 10.1002/jnr.23166; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Stepanenko A A, 2012, Tsitol Genet, V46, P36; Tekaia F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-307; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Vassall KA, 2015, J MOL BIOL, V427, P1977, DOI 10.1016/j.jmb.2015.03.011; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yu HQ, 2016, J BIOL CHEM, V291, P14526, DOI 10.1074/jbc.M116.727578; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zienowicz A, 2015, BIOCHEM BIOPH RES CO, V461, P136, DOI 10.1016/j.bbrc.2015.03.181	67	10	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6852	6866		10.1096/fj.201802237R	http://dx.doi.org/10.1096/fj.201802237R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811957				2022-12-28	WOS:000476114200015
J	Yang, D; Xiao, CX; Long, F; Wu, WJ; Huang, MW; Qu, LF; Liu, XH; Zhu, YZ				Yang, Di; Xiao, ChenXi; Long, Fen; Wu, WeiJun; Huang, MengWei; Qu, LeFeng; Liu, XinHua; Zhu, YiZhun			Fra-1 plays a critical role in angiotensin II-induced vascular senescence	FASEB JOURNAL			English	Article						endothelial cells; p21; p16	MUSCLE-CELL SENESCENCE; OXIDATIVE STRESS; PREMATURE SENESCENCE; C-FOS; ATHEROSCLEROSIS; DISEASE; CANCER; P53; INFLAMMATION; MECHANISMS	Vascular aging has a strong relationship with cardiovascular disease. Fos-related antigen 1 (Fra-1), also referred to as Fos-like antigen 1, is a transcription factor and has been reported to be involved in many pathologic processes. Here, we demonstrate that Fra-1 plays a critical role in angiotensin II (Ang II)-induced vascular senescence. Fra-1 expression is increased significantly in Ang II-induced rat aortic endothelial cell (RAEC) senescence and the arteries from Ang II-infused mice. Interestingly, silencing Fra-1 blocks Ang II-induced senescence phenotypes in RAECs, including decreased senescence-associated beta-galactosidase staining, and mitigated proliferation suppression and senescence-associated secretory phenotype. Further, knocking down Fra-1 inhibits vascular aging phenotypes in an Ang II-infused mice model. The up-regulated Fra-1 also exists in human atherosclerotic plaques and Ang II-induced vascular smooth muscle cells as well as in replicated senescence RAECs. Mechanistic studies reveal that Fra-1 preferentially associates with c-Jun and binds to the cyclin-dependent kinase inhibitor 1a (p21) and cyclin-dependent kinase inhibitor 2a (p16) promoter region, leading to elevated gene expression, which causes senescence-related phenotypes. In conclusion, our results identify that Fra-1 plays a novel and key role in promoting vascular aging by directly binding and transcriptionally activating p21 and p16 signaling, suggesting intervention of Fra-1 is a potential strategy for preventing aging-associated cardiovascular disorders.-Yang, D., Xiao, C., Long, F., Wu, W., Huang, M., Qu, L., Liu, X., Zhu, Y. Fra-1 plays a critical role in angiotensin II-induced vascular senescence.	[Yang, Di; Xiao, ChenXi; Long, Fen; Wu, WeiJun; Huang, MengWei; Liu, XinHua; Zhu, YiZhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai Key Lab Bioact Small Mol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China; [Yang, Di; Zhu, YiZhun] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Yang, Di; Zhu, YiZhun] Macau Univ Sci & Technol, Sch Pharm, Macau, Peoples R China; [Qu, LeFeng] Second Mil Med Univ, Changzheng Hosp, Dept Vasc Surg, Shanghai, Peoples R China	Fudan University; Macau University of Science & Technology; Macau University of Science & Technology; Naval Medical University	Liu, XH (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai Key Lab Bioact Small Mol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.; Zhu, YZ (corresponding author), Macau Univ Sci & Technol, Sch Pharm, Room N101,Block E, Taipa 999078, Macau, Peoples R China.	liuxinhua@fudan.edu.cn; yzzhu@must.edu.mo	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	National Natural Science Foundation of China [81673428, 81872861]; Macau Science and Technology Development Fund (FDCT) [055/2016/A2, 033/2017/AMJ, 067/2018/A2]; key laboratory program of the Education Commission of Shanghai Municipality [ZDSYS14005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Macau Science and Technology Development Fund (FDCT); key laboratory program of the Education Commission of Shanghai Municipality	This work was supported by grants from National Natural Science Foundation of China (81673428, 81872861), the Macau Science and Technology Development Fund (FDCT) (055/2016/A2, 033/2017/AMJ, and 067/2018/A2), and a key laboratory program of the Education Commission of Shanghai Municipality (ZDSYS14005). The authors declare no conflicts of interest.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen J, 2002, CIRC RES, V90, P1290, DOI 10.1161/01.RES.0000022161.42655.98; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fenton M, 2001, ARTERIOSCL THROM VAS, V21, P220, DOI 10.1161/01.ATV.21.2.220; He JY, 2015, INT J ONCOL, V47, P1725, DOI 10.3892/ijo.2015.3146; Herbert KE, 2008, CIRC RES, V102, P201, DOI 10.1161/CIRCRESAHA.107.158626; Iskit S, 2015, ONCOTARGET, V6, P43146, DOI 10.18632/oncotarget.6454; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lu D, 2012, CANCER RES, V72, P3451, DOI 10.1158/0008-5472.CAN-11-2536; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; O'Rourke MF, 2010, VASC MED, V15, P461, DOI 10.1177/1358863X10382946; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Usui A, 2012, CANCER-AM CANCER SOC, V118, P3387, DOI 10.1002/cncr.26652; Voghel G, 2007, MECH AGEING DEV, V128, P662, DOI 10.1016/j.mad.2007.09.006; Wang CN, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0555-8; Wang JL, 2012, ARTERIOSCL THROM VAS, V32, P712, DOI 10.1161/ATVBAHA.111.227389; Wang JL, 2015, CIRCULATION, V132, P1909, DOI 10.1161/CIRCULATIONAHA.115.016457; Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45; Wenzel A, 2002, J NEUROCHEM, V80, P1089, DOI 10.1046/j.0022-3042.2002.00807.x	39	15	15	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7603	7614		10.1096/fj.201801671RRRR	http://dx.doi.org/10.1096/fj.201801671RRRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30892941	Bronze			2022-12-28	WOS:000476114200075
J	Zhang, J; Lin, YB; Dai, XM; Fang, WT; Wu, XL; Chen, XC				Zhang, Jing; Lin, Yingbin; Dai, Xiaoman; Fang, Wenting; Wu, Xilin; Chen, Xiaochun			Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner	FASEB JOURNAL			English	Article						tau phosphorylation; insulin signaling; AMPK	ACTIVATED PROTEIN-KINASE; INCREASED TAU PHOSPHORYLATION; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; COGNITIVE IMPAIRMENT; INSULIN-RECEPTOR; TRANSLATIONAL CONTROL; INTRANASAL INSULIN; SIGNALING PATHWAY	Aging and apolipoprotein E4 (ApoE4) can increase the risk of cognitive impairment and neurodegenerative disorders, including Alzheimer's disease (AD), and patients with type 2 diabetes mellitus are highly susceptible to cognitive dysfunction. Recent research has indicated that metformin, a prescribed drug for type 2 diabetes, may affect cognitive function; however, findings regarding its efficacy are largely controversial. The current study reported that a 5-mo metformin administration (300 mg/kg/d) starting at 13 mo old improved the spatial memory of ApoE3-target replacement (TR) mice, not ApoE4-TR mice. It found that in aged ApoE3-TR mice, metformin treatment, at a molecular level, inhibited AMPK activity, increased insulin signaling, and activated mammalian target of rapamycin signaling, resulting in an enhanced expression of postsynaptic proteins; but the response of the neuronal AMPK activity and insulin signaling to metformin was blunt in aged ApoE4-TR mice. Meanwhile, metformin treatment also increased the phosphorylation of tau in both ApoE3-TR and ApoE4-TR mice, implying that metformin may have side effects in human. These findings suggest that metformin can improve the cognitive performance of aged mice in an APOE genotype-dependent manner, which provides empirical insights into the clinical value of metformin for ApoE4- and age-related AD prevention and treatment.-Zhang, J., Lin, Y., Dai, X., Fang, W., Wu, X., Chen, X. Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner.	[Zhang, Jing; Lin, Yingbin; Dai, Xiaoman; Fang, Wenting; Wu, Xilin; Chen, Xiaochun] Fujian Med Univ, Union Hosp, Fujian Inst Geriatr, Dept Neurol & Geriatr, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China; [Zhang, Jing; Dai, Xiaoman; Chen, Xiaochun] Fujian Med Univ, Fujian Key Lab Mol Neurol, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Chen, XC (corresponding author), Fujian Med Univ, Union Hosp, Fujian Inst Geriatr, Dept Neurol & Geriatr, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China.	chenxc998@mail.fjmu.edu.cn		Lin, Yingbin/0000-0002-5051-3256; CHEN, XIAOCHUN/0000-0002-2665-4155; Zhang, Jing/0000-0003-4037-9855; Wu, Xilin/0000-0003-0893-2147	National Natural Science Foundation of China [81171216, 91232709, 81401149, 81341098]; Fujian Health Education Joint Project [2018-ZQN-39, WKJ2016-2-19]; Fujian Province New Century Excellent Talents Support Program [2015B022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Health Education Joint Project; Fujian Province New Century Excellent Talents Support Program	These studies were funded by the National Natural Science Foundation of China (Grants 81171216 and 91232709 to X.C., and 81401149 and 81341098 to J.Z.), the Fujian Health Education Joint Project (2018-ZQN-39 and WKJ2016-2-19), and the Fujian Province New Century Excellent Talents Support Program (2015B022). The authors declare no conflicts of interest.	Alzoubi KH, 2014, CURR NEUROPHARMACOL, V12, P186, DOI 10.2174/1570159X11666131120223201; Ashabi G, 2014, METAB BRAIN DIS, V29, P47, DOI 10.1007/s11011-013-9475-2; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Barini E, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0082-7; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Cheng C, 2014, J GERONTOL A-BIOL, V69, P1299, DOI 10.1093/gerona/glu073; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; DiTacchio KA, 2015, J ALZHEIMERS DIS, V44, P43, DOI 10.3233/JAD-141332; Garabadu Debapriya, 2017, Pharm Biol, V55, P722, DOI 10.1080/13880209.2016.1268635; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Gratuze M, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0298-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Imfeld P, 2012, J AM GERIATR SOC, V60, P916, DOI 10.1111/j.1532-5415.2012.03916.x; Inbar D, 2010, NEURODEGENER DIS, V7, P16, DOI 10.1159/000283477; Khang R, 2014, NEUROSCI LETT, V579, P145, DOI 10.1016/j.neulet.2014.07.029; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Lin LY, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0107-2; Liu DR, 2015, IEEE COMPUT INTELL M, V10, P7, DOI 10.1109/MCI.2015.2472117; Luchsinger JA, 2016, J ALZHEIMERS DIS, V51, P501, DOI 10.3233/JAD-150493; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-14; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Moore EM, 2013, DIABETES CARE, V36, P2981, DOI 10.2337/dc13-0229; Mostafa DK, 2016, PSYCHOPHARMACOLOGY, V233, P2513, DOI 10.1007/s00213-016-4301-2; Ng TP, 2014, J ALZHEIMERS DIS, V41, P61, DOI 10.3233/JAD-131901; Ong QR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03754; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Peng M, 2017, CANCER TREAT REV, V54, P24, DOI 10.1016/j.ctrv.2017.01.005; Pintana H, 2012, LIFE SCI, V91, P409, DOI 10.1016/j.lfs.2012.08.017; Potts MB, 2012, CELL STEM CELL, V11, P5, DOI 10.1016/j.stem.2012.06.003; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Rosenbloom MH, 2014, CNS DRUGS, V28, P1185, DOI 10.1007/s40263-014-0214-y; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Thal DR, 2000, EXP NEUROL, V163, P98, DOI 10.1006/exnr.2000.7380; Thangthaeng N, 2017, AGING DIS, V8, P17, DOI 10.14336/AD.2016.1010; Thome AD, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0293-1; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Vives M, 2012, REV ESP ANEST REANIM, V59, P276, DOI 10.1016/j.redar.2012.03.018; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wang JZ, 2014, NEUROSCI BULL, V30, P359, DOI 10.1007/s12264-013-1415-y; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wu XL, 2017, CHINESE MED J-PEKING, V130, P2978, DOI 10.4103/0366-6999.220313; Xu H, 2016, J ENDOCRINOL, V229, P133, DOI 10.1530/JOE-15-0409; Yarchoan M, 2014, ACTA NEUROPATHOL, V128, P679, DOI 10.1007/s00401-014-1328-5; Zhang B, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0291-3; Zhao N, 2017, NEURON, V96, P115, DOI 10.1016/j.neuron.2017.09.003; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou M, 2016, CURR ALZHEIMER RES, V13, P1048, DOI 10.2174/1567205013666160415154550	67	17	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7748	7757		10.1096/fj.201802718R	http://dx.doi.org/10.1096/fj.201802718R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30894020	Bronze			2022-12-28	WOS:000476114200086
J	Bousseau, S; Marchand, M; Soleti, R; Vergori, L; Hilairet, G; Recoquillon, S; Le Mao, M; Gueguen, N; Khiati, S; Clarion, L; Bakalara, N; Martinez, MC; Germain, S; Lenaers, G; Andriantsitohaina, R				Bousseau, Simon; Marchand, Marion; Soleti, Raffaella; Vergori, Luisa; Hilairet, Gregory; Recoquillon, Sylvain; Le Mao, Morgane; Gueguen, Naig; Khiati, Salim; Clarion, Ludovic; Bakalara, Norbert; Martinez, M. Carmen; Germain, Stephane; Lenaers, Guy; Andriantsitohaina, Ramaroson			Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization	FASEB JOURNAL			English	Article						angiogenesis; cancer growth; pharmacotherapy; endothelial metabolism; glycosylation	ANGIOGENESIS; RECEPTOR; PROLIFERATION; METABOLISM; PFKFB3; GLYCOSYLATION; GALECTIN-1; MIGRATION; OXIDASE; CANCER	Angiogenesis is a complex process leading to the growth of new blood vessels from existing vasculature, triggered by local proangiogenic factors such as VEGF. An excess of angiogenesis is a recurrent feature of various pathologic conditions such as tumor growth. Phostines are a family of synthetic glycomimetic compounds that exhibit anticancer properties, and the lead compound 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl2-oxo-25-[1,2]oxaphosphinane (PST 3.1a) shows antiglioblastoma properties both in vitro and in vivo. In the present study, we assessed the effect of PST 3.1a on angiogenesis and endothelial metabolism. In vitro, PST 3.1a (10 mu M) inhibited all steps that regulate angiogenesis, including migration, proliferation, adhesion, and tube formation. In vivo, PST 3.1a reduced intersegmental vessel formation and vascularization of the subintestinal plexus in zebrafish embryos and also altered pathologic angiogenesis and glioblastoma progression in vivo. Mechanistically, PST 3.1a altered interaction of VEGF receptor 2 and glycosylation-regulating protein galectin-1, a key component regulating angiogenesis associated with tumor resistance. Thus, these data show that use of PST 3.1a is an innovative approach to target angiogenesis.Bousseau, S., Marchand, M., Soleti, R., Vergori, L., Hilairet, G., Recoquillon, S., Le Mao, M., Gueguen, N., Khiati, S., Clarion, L., Bakalara, N., Martinez, M. C., Germain, S., Lenaers, G., Andriantsitohaina, R. Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization.	[Bousseau, Simon; Soleti, Raffaella; Vergori, Luisa; Hilairet, Gregory; Recoquillon, Sylvain; Martinez, M. Carmen; Andriantsitohaina, Ramaroson] Univ Angers, INSERM Unite Mixte Rech UMR 1063, Stress Oxydant & Pathol Metabol, Inst MitoVasc, Angers, France; [Bousseau, Simon; Le Mao, Morgane; Gueguen, Naig; Khiati, Salim; Lenaers, Guy] Univ Angers, Inst MitoVasc, INSERM Unite 1083, MitoLab,Ctr Natl Rech CNRS UMR 6015, Angers, France; [Marchand, Marion; Germain, Stephane] Paris Sci & Lettres PSL Res Univ, CIRB, Coll France, CNRS,INSERM, Paris, France; [Clarion, Ludovic] Phostin SAS Societe Act Simplifiee, Montpellier, France; [Bakalara, Norbert] Inst Neurosci Montpellier, INSERM Unite 1051, Montpellier, France	Universite d'Angers; Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite de Montpellier	Andriantsitohaina, R (corresponding author), Univ Angers, INSERM UMR 1063, Stress Oxydant & Pathol Metabol, Inst Biol Sante, 4 Rue Larrey, F-49933 Angers, France.	ramaroson.andriantsitohaina@univ-angers.fr	soleti, raffaella/AAC-1678-2021; Lenaers, guy/X-4727-2019; SOLETI, RAFFAELLA/ABB-5455-2020; Naig, Gueguen/K-2699-2015; Germain, Stephane/E-2301-2016	SOLETI, RAFFAELLA/0000-0002-0271-0490; Naig, Gueguen/0000-0002-3094-8121; Germain, Stephane/0000-0001-5992-1275; marchand, marion/0000-0001-7247-5003; andriantsitohaina, ramaroson/0000-0002-4770-3585; Bousseau, Simon/0000-0002-8678-3725; Martinez, M Carmen/0000-0003-3897-7397	French Ministry of Education and Research (Universite d'Angers); INSERM; Region Pays de la Loire; Angers Loire Metropole; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	French Ministry of Education and Research (Universite d'Angers); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Pays de la Loire(Region Pays de la Loire); Angers Loire Metropole(Region Pays de la Loire); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	The authors thank the Service Commun d'Animalerie Hospitalo-Universitaire (SCAHU) staff (Universite d'Angers) for taking care of mice, Dr. Christine Rampon and Matthieu Boukaissi [Center for Interdisciplinary Research in Biology (CIRB), Centre National de la Recherche (CNRS) Unite Mixte de Recherche (UMR) 7241, College de France] for the access to the zebrafish facilities, the staff of Plateforme d'Analyse Cellulaire et Moleculaire for the quantitative PCR experiments, and Dr. Zahra Hassani (Phost'in SAS) for experiment advice. S.B. is a recipient of a doctoral fellowship from French Ministry of Education and Research (Universite d'Angers). This work was supported by INSERM, Region Pays de la Loire, Angers Loire Metropole, Universite d'Angers, and the Centre Hospitalier Universitaire d'Angers. S.G., G.L., and R.A. are colast authors. The authors declare no conflicts of interest.	Valdes-Rives SA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7403747; Arbab AS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122732; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Chandler KB, 2017, J PROTEOME RES, V16, P677, DOI 10.1021/acs.jproteome.6b00738; Clarion L, 2014, J MED CHEM, V57, P8293, DOI 10.1021/jm500522y; Clarion L, 2012, J MED CHEM, V55, P2196, DOI 10.1021/jm201428a; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; Dimova I, 2014, J BUON, V19, P15; Duluc L, 2013, INT J BIOCHEM CELL B, V45, P783, DOI 10.1016/j.biocel.2013.01.007; Eelen G, 2018, PHYSIOL REV, V98, P3, DOI 10.1152/physrev.00001.2017; Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461; Griffioen AW, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.01; Harjes U, 2016, CRIT REV ONCOL HEMAT, V97, P15, DOI 10.1016/j.critrevonc.2015.10.011; Hassani Z, 2017, MOL CANCER RES, V15, P1376, DOI 10.1158/1541-7786.MCR-17-0120; Ito K, 2012, CANCER METAST REV, V31, P763, DOI 10.1007/s10555-012-9388-2; Ito K, 2011, ANGIOGENESIS, V14, P293, DOI 10.1007/s10456-011-9213-5; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Li B, 2016, MOL MED REP, V13, P469, DOI 10.3892/mmr.2015.4492; Liu Y, 2015, INT J ADV COMPUT SC, V6, P1; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; McIntyre A, 2015, EMBO MOL MED, V7, P368, DOI 10.15252/emmm.201404271; Mendez-Huergo SP, 2017, CURR OPIN IMMUNOL, V45, P8, DOI 10.1016/j.coi.2016.12.003; Merchan JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013699; Potente M, 2017, ANNU REV PHYSIOL, V79, P43, DOI 10.1146/annurev-physiol-021115-105134; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Stanley P, 2014, CELL, V156, P625, DOI 10.1016/j.cell.2014.01.059; Stapor P, 2014, J CELL SCI, V127, P4331, DOI 10.1242/jcs.153908; Treps L, 2016, PHARMACOL REV, V68, P872, DOI 10.1124/pr.116.012492; Yalcin A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.292; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816	35	3	3	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5864	5875		10.1096/fj.201801450RRR	http://dx.doi.org/10.1096/fj.201801450RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817178	Bronze, Green Submitted			2022-12-28	WOS:000466932600006
J	Kapellos, TS; Taylor, L; Feuerborn, A; Valaris, S; Hussain, MT; Rainger, GE; Greaves, DR; Iqbal, AJ				Kapellos, Theodore S.; Taylor, Lewis; Feuerborn, Alexander; Valaris, Sophia; Hussain, Mohammed T.; Rainger, G. E.; Greaves, David R.; Iqbal, Asif J.			Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment	FASEB JOURNAL			English	Article						innate immunity; leukocyte trafficking; adhesion	CB2 RECEPTOR; ACTIVATION; CELLS; 2-ARACHIDONOYLGLYCEROL; INHIBITION; EXPRESSION; MIGRATION; RESPONSES; ADHESION; ENDOCANNABINOIDS	Cannabinoid receptor (CB)(2) is an immune cell-localized GPCR that has been hypothesized to regulate the magnitude of inflammatory responses. However, there is currently no consensus as to the mechanism by which CB2 mediates its anti-inflammatory effects in vivo. To address this question, we employed a murine dorsal air pouch model with wild-type and CB2-/- 8-12-wk-old female and male C57BL/6 mice and found that acute neutrophil and lymphocyte antigen 6 complex, locus C-hi monocyte recruitment in response to Zymosan was significantly enhanced in CB2-/- mice. Additionally, levels of matrix metalloproteinase 9 and the chemokines C-C motif chemokine ligand (CCL)2, CCL4, and C-X-C motif chemokine ligand 10 in CB2-/- pouch exudates were elevated at earlier time points. Importantly, using mixed bone marrow chimeras, we revealed that the proinflammatory phenotype in CB2-/- mice is neutrophil-intrinsic rather than stromal cell-dependent. Indeed, neutrophils isolated from CB2-/- mice exhibited an enhanced migration-related transcriptional profile and increased adhesive phenotype, and treatment of human neutrophils with a CB2 agonist blocked their endothelial transmigration. Overall, we have demonstrated that CB2 plays a nonredundant role during acute neutrophil mobilization to sites of inflammation and, as such, it could represent a therapeutic target for the development of novel anti-inflammatory compounds to treat inflammatory human diseases.Kapellos, T. S., Taylor, L., Feuerborn, A., Valaris, S., Hussain, M. T., Rainger, G. E., Greaves, D. R., Iqbal, A. J. Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment.	[Kapellos, Theodore S.; Taylor, Lewis; Feuerborn, Alexander; Valaris, Sophia; Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Hussain, Mohammed T.; Rainger, G. E.; Iqbal, Asif J.] Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England	University of Oxford; University of Birmingham	Greaves, DR; Iqbal, AJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England.; Iqbal, AJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England.	david.greaves@path.ox.ac.uk; a.j.iqbal@bham.ac.uk		Iqbal, Asif/0000-0002-3224-3651	British Heart Foundation (BHF) Programme Grant [RG/15/10/31485]; BHF Studentship Award [FS/12/69/30008]; Edward P. Abraham Trust [RF 231]; BHF Centre of Research Excellence [RE/13/1/30181]; University of Birmingham Fellowship	British Heart Foundation (BHF) Programme Grant; BHF Studentship Award; Edward P. Abraham Trust; BHF Centre of Research Excellence; University of Birmingham Fellowship	The authors thank Angela Curran (Biomedical Sciences Unit, Oxford, United Kingdom) for excellent technical assistance. This work was supported by a British Heart Foundation (BHF) Programme Grant (RG/15/10/31485), and a BHF Studentship Award (FS/12/69/30008 to L.T.). T.S.K. received funding from the Edward P. Abraham Trust (RF 231). A.J.I. acknowledges support from the BHF Centre of Research Excellence (RE/13/1/30181). A.J.I. is supported by a University of Birmingham Fellowship. T.S.K. and L.T. share first authorship. D.R.G. and A.J.I. share senior authorship. The authors declare no conflicts of interest.	Adhikary S, 2012, BLOOD, V120, P3741, DOI 10.1182/blood-2012-06-435362; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Batkai S, 2012, BRIT J PHARMACOL, V165, P2450, DOI 10.1111/j.1476-5381.2011.01410.x; Chen DJ, 2017, ACTA PHARMACOL SIN, V38, P312, DOI 10.1038/aps.2016.149; Chiurchiu V, 2015, IMMUNOLOGY, V144, P352, DOI 10.1111/imm.12441; Comelli F, 2007, BRIT J PHARMACOL, V152, P787, DOI 10.1038/sj.bjp.0707425; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; Coopman K, 2007, INT IMMUNOPHARMACOL, V7, P360, DOI 10.1016/j.intimp.2006.11.008; Costola-De-Souza C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077706; Csoka B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006409; DAWSON J, 1991, INT J TISSUE REACT, V13, P171; Defer N, 2009, FASEB J, V23, P2120, DOI 10.1096/fj.09-129478; Di Filippo C, 2004, J LEUKOCYTE BIOL, V75, P453, DOI 10.1189/jlb.0703303; Duerr GD, 2015, LIFE SCI, V138, P8, DOI 10.1016/j.lfs.2014.11.005; Engel MA, 2010, J PHYSIOL PHARMACOL, V61, P89; Gasperi V, 2014, INT J BIOCHEM CELL B, V51, P79, DOI 10.1016/j.biocel.2014.03.028; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gokoh M, 2005, FEBS LETT, V579, P6473, DOI 10.1016/j.febslet.2005.10.030; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Gui H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/741303; Halade GV, 2013, PHARMACOL THERAPEUT, V139, P32, DOI 10.1016/j.pharmthera.2013.03.009; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Kapellos TS, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4315412; Kurihara R, 2006, J BIOL CHEM, V281, P12908, DOI 10.1074/jbc.M510871200; Laprairie RB, 2012, BRIT J PHARMACOL, V167, P1583, DOI 10.1111/j.1476-5381.2012.02175.x; Lu HC, 2016, BIOL PSYCHIAT, V79, P516, DOI 10.1016/j.biopsych.2015.07.028; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; MARTIN SW, 1994, J PHARMACOL TOX MET, V32, P139, DOI 10.1016/1056-8719(94)90067-1; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McHugh D, 2008, MOL PHARMACOL, V73, P441, DOI 10.1124/mol.107.041863; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Netherland CD, 2010, ATHEROSCLEROSIS, V213, P102, DOI 10.1016/j.atherosclerosis.2010.07.060; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Oka S, 2004, J LEUKOCYTE BIOL, V76, P1002, DOI 10.1189/jlb.0404252; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Persidsky Y, 2015, J NEUROIMMUNE PHARM, V10, P302, DOI 10.1007/s11481-015-9591-3; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406; Raborn ES, 2014, LIFE SCI, V104, P15, DOI 10.1016/j.lfs.2014.04.008; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Sardinha J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/978678; Sexton M, 2013, INFLAMMOPHARMACOLOGY, V21, P253, DOI 10.1007/s10787-012-0133-9; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Taylor L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10682; Tschop J, 2009, J IMMUNOL, V183, P499, DOI 10.4049/jimmunol.0900203; Turcotte C, 2016, CELL MOL LIFE SCI, V73, P4449, DOI 10.1007/s00018-016-2300-4; Turcotte C, 2015, J LEUKOCYTE BIOL, V97, P1049, DOI 10.1189/jlb.3RU0115-021R; Wang H, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw677; Wen J, 2015, NEUROPHARMACOLOGY, V99, P196, DOI 10.1016/j.neuropharm.2015.07.010; Witkamp R, 2016, EUR J PHARMACOL, V785, P96, DOI 10.1016/j.ejphar.2015.08.051; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang M, 2009, MICROVASC RES, V78, P86, DOI 10.1016/j.mvr.2009.03.005; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d	64	33	33	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6154	6167		10.1096/fj.201802524R	http://dx.doi.org/10.1096/fj.201802524R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30799631	Green Published, hybrid			2022-12-28	WOS:000466932600029
J	Mazzone, A; Gibbons, SJ; Eisenman, ST; Strege, PR; Zheng, TH; D'Amato, M; Ordog, T; Fernandez-Zapico, ME; Farrugia, G				Mazzone, Amelia; Gibbons, Simon J.; Eisenman, Seth T.; Strege, Peter R.; Zheng, Tenghao; D'Amato, Mauro; Ordog, Tamas; Fernandez-Zapico, Martin E.; Farrugia, Gianrico			Direct repression of anoctamin 1 (ANO1) gene transcription by Gli proteins	FASEB JOURNAL			English	Article						ion channels; gastrointestinal tract; calcium-activated chloride currents; TMEM16A; SNP	CA2+-ACTIVATED CL-CHANNEL; INTERSTITIAL-CELLS; CHLORIDE CHANNELS; TMEM16A; HEDGEHOG; CANCER; INHIBITION; IDENTIFICATION; PROLIFERATION; MARKER	The Ca2+-activated Cl- channel, anoctamin 1 (Ano1, also known as transmembrane protein 16A) contributes to intestinal pacemaking, fluid secretion, cellular excitability, and tissue development. The human ANO1 promoter contains binding sites for the glioma-associated oncogene (Gli) proteins. We investigated regulation of ANO1 transcription by Gli. ANO1 promoter activity was determined using a luciferase reporter system. Binding and functional effects of Glis on ANO1 transcription and expression were demonstrated by chromatin immunoprecipitation, small interfering RNA knockdown, PCR, immunolabeling, and recordings of Ca2+-activated Cl- currents in human embryonic kidney 293 (HEK293) cells. Results from previous genome-wide association studies were used to test ANO1 promoter polymorphisms for association with disease. Gli1 and Gli2 bound to the promoter and repressed ANO1 transcription. Repression depended on Gli binding to a site close to the ANO1 transcriptional start site. Mutation of this site prevented Gli binding and transcriptional repression. Knockdown of Gli expression and inhibition of Gli activity increased expression of ANO1 RNA and Ca2+-activated Cl- currents in HEK293 cells. A single-nucleotide polymorphism prevented Gli binding and showed association with irritable bowel syndrome. We conclude that Gli1 and Gli2 repress ANO1 by a novel mechanism that is independent of Gli cleavage and that has a role in gastrointestinal function.Mazzone, A., Gibbons, S. J., Eisenman, S. T., Strege, P. R., Zheng, T., D'Amato, M., Ordog, T., Fernandez-Zapico, M. E., Farrugia, G. Direct repression of anoctamin 1 (ANO1) gene transcription by Gli proteins.	[Mazzone, Amelia; Gibbons, Simon J.; Eisenman, Seth T.; Strege, Peter R.; Ordog, Tamas; Farrugia, Gianrico] Mayo Clin, Enter NeuroSci, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Zheng, Tenghao; D'Amato, Mauro] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Zheng, Tenghao; D'Amato, Mauro] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [D'Amato, Mauro] Biodonostia Hlth Res Inst, San Sebastian, Spain; [D'Amato, Mauro] Basque Sci Fdn, Ikerbasque, San Sebastian, Spain	Mayo Clinic; Mayo Clinic; Karolinska Institutet; Karolinska Institutet; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science	Gibbons, SJ; Farrugia, G (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Enter NeuroSci Program, 200 First St SW, Rochester, MN 55905 USA.	gibbons.simon@mayo.edu; farrugia.gianrico@mayo.edu	D'Amato, Mauro/F-2450-2010; D'Amato, Mauro/B-5050-2019	D'Amato, Mauro/0000-0003-2743-5197; D'Amato, Mauro/0000-0003-2743-5197; Strege, Peter/0000-0003-4571-2207; MAZZONE, Amelia/0000-0001-6236-6962; Zheng, Tenghao/0000-0003-1587-7481	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK57061, DK84567]; Swedish Research Council (VR) Project [2017-02403]; Health Department of the Basque Government [2015111133]; Spanish Ministry of Economy and Competitiveness [Instituto de Salud Carlos III (ISCIII) Grant Fondo de Investigacion en Salud (FIS)] [PI17/00308]; NATIONAL CANCER INSTITUTE [R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK057061] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Research Council (VR) Project(Swedish Research Council); Health Department of the Basque Government; Spanish Ministry of Economy and Competitiveness [Instituto de Salud Carlos III (ISCIII) Grant Fondo de Investigacion en Salud (FIS)]; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Kristy Zodrow (Enteric NeuroSciences, Mayo Clinic) for assistance in manuscript preparation. This work is supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK57061 (to G.F. and S.J.G.) and DK84567 (to G.F., S.J.G.), the Swedish Research Council (VR) Project 2017-02403 (to M.D.A.), the Health Department of the Basque Government (Grant 2015111133 to M.D.A.), and the Spanish Ministry of Economy and Competitiveness [Instituto de Salud Carlos III (ISCIII) Grant Fondo de Investigacion en Salud (FIS) PI17/00308 to M.D.A.]. The authors declare no conflicts of interest.	Agyeman A, 2014, ONCOTARGET, V5, P4492, DOI 10.18632/oncotarget.2046; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Amjad A, 2015, J GEN PHYSIOL, V145, P285, DOI 10.1085/jgp.201411348; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Beyder A, 2016, AM J PHYSIOL-GASTR L, V311, pG581, DOI 10.1152/ajpgi.00237.2016; Beyder A, 2014, GASTROENTEROLOGY, V146, P1659, DOI 10.1053/j.gastro.2014.02.054; Bijos DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106190; Bonfiglio F, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13358; Bonfiglio F, 2018, GASTROENTEROLOGY, V155, P168, DOI 10.1053/j.gastro.2018.03.064; Buchholz B, 2014, KIDNEY INT, V85, P1058, DOI 10.1038/ki.2013.418; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen GC, 2011, BIOCHEM BIOPH RES CO, V404, P809, DOI 10.1016/j.bbrc.2010.12.065; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Danielsson J, 2015, ANESTHESIOLOGY, V123, P569, DOI 10.1097/ALN.0000000000000769; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Dutta AK, 2011, J BIOL CHEM, V286, P766, DOI 10.1074/jbc.M110.164970; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Heinze C, 2014, J CLIN INVEST, V124, P675, DOI 10.1172/JCI70025; Henstrom M, 2017, GUT, V66, P1725, DOI 10.1136/gutjnl-2016-313346; Holtmann GJ, 2016, LANCET GASTROENTEROL, V1, P133, DOI 10.1016/S2468-1253(16)30023-1; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jankipersadsing SA, 2017, GUT, V66, P756, DOI 10.1136/gutjnl-2016-312398; Kasai K, 2008, CANCER RES, V68, P7723, DOI 10.1158/0008-5472.CAN-07-6661; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Malysz J, 2017, AM J PHYSIOL-GASTR L, V312, pG228, DOI 10.1152/ajpgi.00363.2016; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Mazzone A, 2015, FASEB J, V29, P152, DOI 10.1096/fj.14-258541; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Mazzone A, 2011, J BIOL CHEM, V286, P13393, DOI 10.1074/jbc.M110.196089; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Mercer AJ, 2011, J NEUROPHYSIOL, V105, P321, DOI 10.1152/jn.00332.2010; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; O'Driscoll KE, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-35; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Qu ZQ, 2014, CANCER MED-US, V3, P453, DOI 10.1002/cam4.232; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sancho M, 2012, AM J PHYSIOL-RENAL, V302, pF390, DOI 10.1152/ajprenal.00344.2011; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Singh RD, 2014, J PHYSIOL-LONDON, V592, P4051, DOI 10.1113/jphysiol.2014.277152; Sondo E, 2014, BBA-BIOMEMBRANES, V1838, P89, DOI 10.1016/j.bbamem.2013.08.010; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Strege PR, 2017, AM J PHYSIOL-GASTR L, V312, pG572, DOI 10.1152/ajpgi.00429.2016; Strege PR, 2015, AM J PHYSIOL-GASTR L, V309, pG743, DOI 10.1152/ajpgi.00074.2015; Sung TS, 2018, J PHYSIOL-LONDON, V596, P1549, DOI 10.1113/JP275478; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Ubby I, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-75; Veit G, 2012, MOL BIOL CELL, V23, P4188, DOI 10.1091/mbc.E12-06-0424; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wang BX, 2015, J MOL CELL CARDIOL, V82, P22, DOI 10.1016/j.yjmcc.2015.02.020; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8	64	11	11	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6632	6642		10.1096/fj.201802373R	http://dx.doi.org/10.1096/fj.201802373R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30802137	Green Published			2022-12-28	WOS:000466932600065
J	Amior, L; Srivastava, R; Nano, R; Bertuzzi, F; Melloul, D				Amior, Livnat; Srivastava, Rohit; Nano, Rita; Bertuzzi, Federico; Melloul, Danielle			The role of Cox-2 and prostaglandin E-2 receptor EP3 in pancreatic beta-cell death	FASEB JOURNAL			English	Article						islet; palmitate; apoptosis; cyclooxygenase-2; diabetes mellitus	FREE FATTY-ACIDS; STIMULATED INSULIN-SECRETION; HIGH GLUCOSE; PGE2 INHIBITION; HUMAN ISLETS; APOPTOSIS; EXPRESSION; CYCLOOXYGENASE-2; DYSFUNCTION; MECHANISMS	Elevated levels of lipids, in particular saturated fatty acids, are known to be associated with type 2 diabetes (T2D) and to have a negative effect on beta-cell function and survival. We bring new evidence indicating that palmitate up-regulates cyclooxygenase-2 (COX-2) expression levels in human islets and in MIN6 beta cells, and that it is elevated in islets isolated from T2D donors. Both small interfering specific cyclooxygenase-2 small interfering RNA (siRNA) or the COX-2 inhibitor celecoxib significantly inhibited apoptosis induced by palmitate. Prostaglandin E-2 (PGE(2)), the predominant product of COX-2 enzymatic activity, activates membrane receptors, which are members of the GPCR-family (EP1-EP4). In the present study, elevated expression of the PGE(2) receptor subtype 3 (EP3) receptor was observed in cells exposed to palmitate and in islets from individuals with T2D. Down-regulation of the pathway using EP3 siRNA or the specific L-798,106 antagonist markedly decreased the levels of palmitate-induced apoptosis. Altogether, our data put forward the COX-2-PGE(2)-EP3 pathway as one of the mediators of palmitate-induced apoptosis in beta-cells.	[Amior, Livnat; Srivastava, Rohit; Melloul, Danielle] Hadassah Univ Hosp, Dept Endocrinol, POB 12000, IL-91120 Jerusalem, Israel; [Nano, Rita; Bertuzzi, Federico] Ist Sci San Raffaele, IRCCS, Diabet Res Inst, Milan, Italy; [Bertuzzi, Federico] Osped Niguarda Ca Granda, Milan, Italy	Hebrew University of Jerusalem; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Melloul, D (corresponding author), Hadassah Univ Hosp, Dept Endocrinol, POB 12000, IL-91120 Jerusalem, Israel.	daniellem@ekmd.huji.ac.il	Nano, Rita/AAC-1934-2019	Nano, Rita/0000-0003-4520-8481; Srivastava, Rohit/0000-0002-6703-9642	Israel Science Foundation [ISF 1370/15]	Israel Science Foundation(Israel Science Foundation)	The authors are grateful to Gerard Elberg and Ronit Sionov (both from The Hebrew University of Jerusalem-Hadassah Medical School, Jerusalem, Israel), for technical help and helpful discussions. This work was supported by a grant from the Israel Science Foundation (ISF 1370/15). The authors declare no conflicts of interest.	Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carboneau BA, 2017, MOL METAB, V6, P548, DOI 10.1016/j.molmet.2017.04.002; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Fujita H, 2007, BIOCHEM BIOPH RES CO, V363, P37, DOI 10.1016/j.bbrc.2007.08.090; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; HUGHES JH, 1989, DIABETES, V38, P1251, DOI 10.2337/diabetes.38.10.1251; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Keanei DC, 2011, CLIN SCI, V120, P195, DOI 10.1042/CS20100282; Kimple ME, 2005, J BIOL CHEM, V280, P31708, DOI 10.1074/jbc.M506700200; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Luo C, 2002, CELL TISSUE RES, V310, P169, DOI 10.1007/s00441-002-0628-6; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ly LD, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.157; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Maedler K, 2008, FASEB J, V22, P1905, DOI 10.1096/fj.07-101824; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Meng ZX, 2006, DIABETOLOGIA, V49, P2959, DOI 10.1007/s00125-006-0447-5; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Neuman JC, 2017, DIABETES, V66, P1572, DOI 10.2337/db16-1362; Oshima H, 2006, J BIOL CHEM, V281, P29330, DOI 10.1074/jbc.M602424200; Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77; Papadimitriou A, 2007, CELL PHYSIOL BIOCHEM, V20, P607, DOI 10.1159/000107544; Persaud Shanta J., 2007, Archives of Physiology and Biochemistry, V113, P104, DOI 10.1080/13813450701531177; Persaud SJ, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.2007.S190; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; ROBERTSON RP, 1988, DIABETES, V37, P367, DOI 10.2337/diabetes.37.4.367; ROBERTSON RP, 1987, DIABETES, V36, P1047, DOI 10.2337/diabetes.36.9.1047; Salgin B, 2012, J CLIN ENDOCR METAB, V97, P3302, DOI 10.1210/jc.2012-1428; Sargsyan E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-115; SEAQUIST ER, 1989, DIABETES, V38, P1439, DOI 10.2337/diabetes.38.11.1439; Shanmugam N, 2006, DIABETOLOGIA, V49, P100, DOI 10.1007/s00125-005-0065-7; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shridas P, 2014, J BIOL CHEM, V289, P27410, DOI 10.1074/jbc.M114.591735; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Wormser U, 2004, TOXICOL APPL PHARM, V200, P40, DOI 10.1016/j.taap.2004.03.013; Zawalich WS, 2007, METABOLISM, V56, P12, DOI 10.1016/j.metabol.2006.08.016	52	15	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4975	4986		10.1096/fj.201801823R	http://dx.doi.org/10.1096/fj.201801823R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629897	Bronze			2022-12-28	WOS:000462888500027
J	Chen, XY; Zhu, SY; Zhenin, M; Xu, WY; Bose, SJ; Wong, MPF; Leung, GPH; Senderowitz, H; Chen, JH				Chen, Xinying; Zhu, Siyu; Zhenin, Michael; Xu, Weiyi; Bose, Samuel J.; Wong, Molly Pik-Fan; Leung, George P. H.; Senderowitz, Hanoch; Chen, Jeng-Haur			A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis-causing mutation	FASEB JOURNAL			English	Article						CFTR; Delta F508 mutation; chloride channel; low temperature; corrector C18	TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; SMALL-MOLECULE CORRECTORS; DELTA-F508 CFTR; THERMODYNAMIC STABILITY; CHANNEL FUNCTION; RESCUE; MUTANT; NBD1; PHOSPHORYLATION	People with the genetic disease cystic fibrosis (CF) often carry a deletion mutation Delta F508 on the gene encoding the CF transmembrane conductance regulator (CFTR) Cl- channel. This mutation greatly reduces the CFTR maturation process and slows the channel opening rate. Here, we investigate whether residues near F508 contribute to these defects in Delta F508-CFTR. Most deletion mutations, but not alanine substitutions, of individual residues from positions 503 to 513 impaired CFTR maturation. Interestingly, only protein processing of Delta Y512-CFTR, like that of Delta F508-CFTR, was greatly improved by low-temperature culture at 27 degrees C or small-molecule corrector C18. The 2 mutant Cl- channels were equally slow to open, suggesting that they may share common structural flaws. Studies on the H3-H4 loop that links residues F508 and Y512 demonstrate that G509A/V510G mutations, moving G509 1 position backward in the loop, markedly enhanced Delta F508-CFTR maturation and opening rate while promoting protein stability and persistence of the H3 helix in Delta F508 nucleotide-binding domain 1. Moreover, V510A/S511A mutations noticeably increased Delta Y512-CFTR maturation at 27 degrees C and its opening rate. Thus, loop abnormalities may contribute to Delta F508- and Delta Y512-CFTR defects. Importantly, correcting defects from G509 displacement in Delta F508-CFTR may offer a new avenue for drug discovery and CF treatments.	[Chen, Xinying; Zhu, Siyu; Xu, Weiyi; Wong, Molly Pik-Fan; Chen, Jeng-Haur] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Leung, George P. H.] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Peoples R China; [Chen, Xinying; Zhu, Siyu; Xu, Weiyi; Wong, Molly Pik-Fan; Chen, Jeng-Haur] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China; [Zhenin, Michael; Senderowitz, Hanoch] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel; [Bose, Samuel J.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; Bar Ilan University; University of Bristol	Chen, JH (corresponding author), Univ Hong Kong, Sch Biomed Sci, Pokfulam, Fac Med Bldg,21 Sassoon Rd, Hong Kong, Peoples R China.	jeng-haur-chen@hku.hk	Chen, Jeng-Haur/E-1483-2011; Leung, George Pak Heng/B-4529-2009	Chen, Jeng-Haur/0000-0001-6756-6939; Leung, George Pak Heng/0000-0003-3529-9367; Bose, Samuel/0000-0003-2922-3075	Hong Kong Research Grants Council [789713M, 17106315]; National Natural Science Foundation of China [31370765, 81570001]; Cystic Fibrosis Foundation Therapeutics [SENDER13XX0]; Binational Science Foundation [2013391]; University of Hong Kong; Lee Shau Kee Postgraduate Fellowship at the University of Hong Kong; Collaborative Awards in Science and Engineering (CASE) studentship from the Medical Research Council [MR/L015919/1]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Binational Science Foundation(US-Israel Binational Science Foundation); University of Hong Kong(University of Hong Kong); Lee Shau Kee Postgraduate Fellowship at the University of Hong Kong; Collaborative Awards in Science and Engineering (CASE) studentship from the Medical Research Council	The authors thank Prof. Michael J. Welsh (University of Iowa, Iowa City, IA, USA) for generous gifts of WT human CFTR plasmids, Prof. Robert J. Bridges (Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA) and Cystic Fibrosis Foundation Therapeutics for providing the CFTR correctors, and departmental colleagues for valuable discussions. The authors acknowledge S. M. Chan for great assistance with experiments. This work was supported by grants from the Hong Kong Research Grants Council (789713M and 17106315) and National Natural Science Foundation of China (31370765 and 81570001) to J.-H.C. This work was also supported by grants from the Cystic Fibrosis Foundation Therapeutics (SENDER13XX0) and Binational Science Foundation (2013391) to H.S. In addition, X.C., S.Z., and W.X. were recipients of postgraduate scholarships from the University of Hong Kong. W.X. was also a recipient of Lee Shau Kee Postgraduate Fellowship at the University of Hong Kong. S.J.B. was the recipient of a Collaborative Awards in Science and Engineering (CASE) studentship from the Medical Research Council (Grant MR/L015919/1). The authors declare no conflicts of interest.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; [Anonymous], 2016, DISC STUD MOD ENV RE; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Awatade NT, 2019, J CYST FIBROS, V18, P182, DOI 10.1016/j.jcf.2018.07.001; Bebok Z, 1998, AM J PHYSIOL-CELL PH, V275, pC599, DOI 10.1152/ajpcell.1998.275.2.C599; Bisignano P, 2010, BIOCHIMIE, V92, P51, DOI 10.1016/j.biochi.2009.09.007; Cai ZW, 2002, J BIOL CHEM, V277, P19546, DOI 10.1074/jbc.M108023200; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; Chen JH, 2017, J PHYSIOL-LONDON, V595, P1059, DOI 10.1113/JP273205; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dong Q, 2012, P NATL ACAD SCI USA, V109, P917, DOI 10.1073/pnas.1120065109; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Guimbellot J, 2017, PEDIATR PULM, V52, pS4, DOI 10.1002/ppul.23773; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Lella M, 2017, BIOCHEMISTRY-US, V56, P2971, DOI 10.1021/acs.biochem.7b00375; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liu J, 2018, BRIT J PHARMACOL, V175, P1017, DOI 10.1111/bph.14141; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Loo TW, 2017, BIOCHEM PHARMACOL, V136, P24, DOI 10.1016/j.bcp.2017.03.020; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; Lopes-Pacheco M, 2016, CHEMBIOCHEM, V17, P493, DOI 10.1002/cbic.201500620; Luz S, 2011, MOL CELL BIOL, V31, P4392, DOI 10.1128/MCB.05517-11; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Meng X, 2017, J BIOL CHEM, V292, P3706, DOI 10.1074/jbc.M116.751537; Odolczyk N, 2013, EMBO MOL MED, V5, P1484, DOI 10.1002/emmm.201302699; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; THOMAS PJ, 1992, J BIOL CHEM, V267, P5727; Vauthier V, 2017, BIOCHEM PHARMACOL, V136, P1, DOI 10.1016/j.bcp.2017.02.020; VENGLARIK CJ, 1994, J GEN PHYSIOL, V104, P123, DOI 10.1085/jgp.104.1.123; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; Wang YT, 2014, BRIT J PHARMACOL, V171, P4490, DOI 10.1111/bph.12791; Welsh MJ, 2010, NEW ENGL J MED, V363, P2056, DOI 10.1056/NEJMe1010123; Xu Z, 2014, J PHYSIOL-LONDON, V592, P1931, DOI 10.1113/jphysiol.2014.271817; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhenin M, 2015, J CHEM INF MODEL, V55, P2349, DOI 10.1021/acs.jcim.5b00312	75	1	1	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5126	5142		10.1096/fj.201801218RR	http://dx.doi.org/10.1096/fj.201801218RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668920	Green Submitted, Bronze			2022-12-28	WOS:000462888500041
J	Lionikaite, V; Henning, P; Drevinge, C; Shah, FA; Palmquist, A; Wikstrom, P; Windahl, SH; Lerner, UH				Lionikaite, Vikte; Henning, Petra; Drevinge, Christina; Shah, Furqan A.; Palmquist, Anders; Wikstrom, Pernilla; Windahl, Sara H.; Lerner, Ulf H.			Vitamin A decreases the anabolic bone response to mechanical loading by suppressing bone formation	FASEB JOURNAL			English	Article						osteoblasts retinoids; physical activity; Raman spectroscopy	SUBCLINICAL HYPERVITAMINOSIS-A; MINERAL DENSITY; RETINOIC ACID; HETEROTOPIC OSSIFICATION; DIETARY-INTAKE; MASS; METAANALYSIS; EXERCISE; MODEL; RISK	Increased vitamin A consumption is associated with decreased cortical bone mass and increased fracture risk in humans. Rodent studies have demonstrated that hypervitaminosis A increases cortical bone resorption, whereas the importance of the effects on bone formation is less well defined. We used an experimental model of increased bone formation by loading of the tibiae to investigate the effect of vitamin A on bone formation. Control [retinol activity equivalents (RAE) 4.5 mu g/g chow] or vitamin A (RAE 60 mu g/g chow) diets were given to female C57BL/6N mice for 4 wk, after which the tibiae were subjected to axial loading on alternate days for 2 wk, while the diets were continued. Vitamin A inhibited the loading-induced increase in trabecular and cortical bone volume. This was attributed to inhibition of loading-induced increase in osteoblast number and activity, and expression of osteoblastic genes Sp7, Alpl, and Col1a1 in cortical bone. Vitamin A, loading, and combination thereof also resulted in site-specific effects on bone composition measured by Raman spectroscopy. In summary, a clinically relevant dose of vitamin A suppresses the loading-induced gain of bone mass by decreasing bone formation. These observations may have implications for regulation of bone mass caused by physical activity and the risk of osteoporosis in humans.	[Lionikaite, Vikte; Henning, Petra; Drevinge, Christina; Windahl, Sara H.; Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res,Inst Med, Gothenburg, Sweden; [Shah, Furqan A.; Palmquist, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Inst Clin Sci, Gothenburg, Sweden; [Wikstrom, Pernilla] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden; [Windahl, Sara H.] Karolinska Inst, Huddinge, Sweden	University of Gothenburg; University of Gothenburg; Umea University; Karolinska Institutet	Lerner, UH (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res, Vita Straket 11, S-41345 Gothenburg, Sweden.	sara.windahl@ki.se; ulf.lerner@gu.se	Shah, Furqan/Y-9485-2019; Palmquist, Anders/D-2171-2014	Shah, Furqan/0000-0002-9876-0467; Palmquist, Anders/0000-0002-6974-2577; Lerner, Ulf/0000-0002-3579-1960; Henning, Petra/0000-0002-9330-6265; Windahl, Sara/0000-0002-6611-6001	Marie Curie Initial Training Network (FP7-People-2013-ITN) [607446]; Swedish Research Council; Swedish government [237551]; Swedish county councils [237551]; IngaBritt and Arne Lundberg Foundation; Royal 80 Year Fund of King Gustav V; Ake Wibergs Foundation	Marie Curie Initial Training Network (FP7-People-2013-ITN); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish government; Swedish county councils; IngaBritt and Arne Lundberg Foundation; Royal 80 Year Fund of King Gustav V; Ake Wibergs Foundation	The authors thank the late Anette Hansevi, Anna Westerlund (Centre for Bone and Arthritis Research at Sahlgrenska Academy, University of Gothenburg), and Maria Norgard (Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden) for excellent technical assistance. This work was funded by the Marie Curie Initial Training Network (FP7-People-2013-ITN, Grant 607446, Euroclast), the Swedish Research Council, the Swedish state under the agreement between the Swedish government and the county councils (the ALF agreement, Grant 237551), the IngaBritt and Arne Lundberg Foundation, the Royal 80 Year Fund of King Gustav V, and the Ake Wibergs Foundation. The authors declare no conflicts of interest.	Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Bergstrom I, 2018, BONE, V112, P10, DOI 10.1016/j.bone.2018.04.002; Bergstrom I, 2017, OSTEOPOROSIS INT, V28, P1121, DOI 10.1007/s00198-016-3846-6; Conaway HH, 2013, ENDOCR REV, V34, P766, DOI 10.1210/er.2012-1071; Conaway HH, 2011, J BIOL CHEM, V286, P31425, DOI 10.1074/jbc.M111.247734; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Fonseca H, 2014, SPORTS MED, V44, P37, DOI 10.1007/s40279-013-0100-7; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Green AC, 2018, J BONE MINER RES, V33, P2202, DOI 10.1002/jbmr.3558; Green AC, 2016, J STEROID BIOCHEM, V155, P135, DOI 10.1016/j.jsbmb.2015.09.036; Green AC, 2015, J STEROID BIOCHEM, V150, P46, DOI 10.1016/j.jsbmb.2015.03.005; Henning P, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00031; HOUGH S, 1988, ENDOCRINOLOGY, V122, P2933, DOI 10.1210/endo-122-6-2933; Howe TE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000333.pub2; Huk DJ, 2013, ARTERIOSCL THROM VAS, V33, P285, DOI 10.1161/ATVBAHA.112.300388; Johansson S, 2002, BONE, V31, P685, DOI 10.1016/S8756-3282(02)00910-9; Kelley GA, 2001, AM J PHYS MED REHAB, V80, P65, DOI 10.1097/00002060-200101000-00017; Kneissel M, 2005, BONE, V36, P202, DOI 10.1016/j.bone.2004.11.006; KRASINSKI SD, 1989, AM J CLIN NUTR, V49, P112, DOI 10.1093/ajcn/49.1.112; Lind PM, 2006, CHEM-BIOL INTERACT, V159, P73, DOI 10.1016/j.cbi.2005.10.104; Lind T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176217; Lind T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082388; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; Lionikaite V, 2018, J ENDOCRINOL, V239, P389, DOI 10.1530/JOE-18-0316; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; Meakin LB, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00154; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Milgrom C, 2000, AM J SPORT MED, V28, P245, DOI 10.1177/03635465000280021701; Milgrom C, 2001, AM J PHYS MED REHAB, V80, P433, DOI 10.1097/00002060-200106000-00009; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nilsson M, 2017, J BONE MINER RES, V32, P473, DOI 10.1002/jbmr.3006; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR, P437; Osborne DL, 2005, J HISTOTECHNOL, V28, P73; Pacifici M, 2018, BONE, V109, P267, DOI 10.1016/j.bone.2017.08.010; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; TRECHSEL U, 1987, J CLIN INVEST, V80, P1679, DOI 10.1172/JCI113257; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; Wallace BA, 2000, CALCIFIED TISSUE INT, V67, P10, DOI 10.1007/s00223001089; Windahl SH, 2013, P NATL ACAD SCI USA, V110, P2294, DOI 10.1073/pnas.1220811110; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109; Wray AE, 2011, J NUTR, V141, P660, DOI 10.3945/jn.110.132126; Wu AM, 2014, J BONE MINER RES, V29, P2032, DOI 10.1002/jbmr.2237; Yorgan TA, 2016, J BONE MINER METAB, V34, P161, DOI 10.1007/s00774-015-0666-2; 1999, NUTR REV, V57, P192	58	9	9	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5237	5247		10.1096/fj.201802040R	http://dx.doi.org/10.1096/fj.201802040R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668919	hybrid, Green Published			2022-12-28	WOS:000462888500049
J	Takase, R; Hino, S; Nagaoka, K; Anan, K; Kohrogi, K; Araki, H; Hino, Y; Sakamoto, A; Nicholson, TB; Chen, TP; Nakao, M				Takase, Ryuta; Hino, Shinjiro; Nagaoka, Katsuya; Anan, Kotaro; Kohrogi, Kensaku; Araki, Hirotaka; Hino, Yuko; Sakamoto, Akihisa; Nicholson, Thomas B.; Chen, Taiping; Nakao, Mitsuyoshi			Lysine-specific demethylase-2 is distinctively involved in brown and beige adipogenic differentiation	FASEB JOURNAL			English	Article						LSD2; adipogenesis; gene regulation; oxidative metabolism	ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; EPIGENETIC CONTROL; FAT; OBESITY; ADIPOCYTES; ACTIVATION; REVEALS	Transcriptional and epigenetic regulation is fundamentally involved in initiating and maintaining progression of cellular differentiation. The 2 types of thermogenic adipocytes, brown and beige, are thought to be of different origins but share functionally similar phenotypes. Here, we report that lysine-specific demethylase 2 (LSD2) regulates the expression of genes associated with lineage identity during the differentiation of brown and beige adipogenic progenitors in mice. In HB2 mouse brown preadipocytes, short hairpin RNA-mediated knockdown (KD) of LSD2 impaired formation of lipid droplet-containing adipocytes and down-regulated brown adipogenesis-associated genes. Transcriptomic analysis revealed that myogenesis-associated genes were up-regulated in LSD2-KD cells under adipogenic induction. In addition, loss of LSD2 during later phases of differentiation had no obvious influence on adipogenic traits, suggesting that LSD2 functions during earlier phases of brown adipocyte differentiation. Using adipogenic cells from the brown adipose tissues of LSD2-knockout (KO) mice, we found reduced expression of brown adipogenesis genes, whereas myogenesis genes were not affected. In contrast, when LSD2-KO cells from inguinal white adipose tissues were subjected to beige induction, these cells showed a dramatic rise in myogenic gene expression. Collectively, these results suggest that LSD2 regulates distinct sets of genes during brown and beige adipocyte formation.	[Takase, Ryuta; Hino, Shinjiro; Nagaoka, Katsuya; Anan, Kotaro; Kohrogi, Kensaku; Araki, Hirotaka; Hino, Yuko; Sakamoto, Akihisa; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan; [Nicholson, Thomas B.] Novartis Pharmaceut, Novartis Inst BioMed Res, Cambridge, MA USA; [Chen, Taiping] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX USA	Kumamoto University; Novartis; University of Texas System; UTMD Anderson Cancer Center	Hino, S; Nakao, M (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	s-hino@kumamoto-u.ac.jp; mnakao@gpo.kumamoto-u.ac.jp	Nagaoka, Katsuya/ABU-5640-2022; NAGAOKA, Katsuya/GQZ-0492-2022	Nagaoka, Katsuya/0000-0002-7152-6101; NAGAOKA, Katsuya/0000-0002-7152-6101; Anan, Kotaro/0000-0001-8370-6292	Japan Society for the Promotion of Science (JSPS) [JP15H04707, JP18H02618, JP16K07215, 25430178]; Takeda Science Foundation; The Shinnihon Foundation of Advanced Medical Treatment Research; Ono Medical Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant [1R01DK106418-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106418] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); The Shinnihon Foundation of Advanced Medical Treatment Research; Ono Medical Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Shingo Usuki and Sayoko Fujimura (both of Kumamoto University) for their technical support in RNA-seq and histological analyses, respectively. This work was supported by the following funding sources: Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15H04707 (to M.N.), JP18H02618 (to M.N.), JP16K07215 (to S.H.), and 25430178 (to S.H.)], Takeda Science Foundation (to M.N. and S.H.), The Shinnihon Foundation of Advanced Medical Treatment Research (to S.H.), Ono Medical Research Foundation (to S.H.), Mochida Memorial Foundation for Medical and Pharmaceutical Research (to S.H.), and U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant 1R01DK106418-01 (to T.C.). The authors declare no conflicts of interest.	Abe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8052; Allott EH, 2015, ENDOCR-RELAT CANCER, V22, pR365, DOI 10.1530/ERC-15-0400; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Avgustinova A, 2016, NAT REV MOL CELL BIO, V17, P643, DOI 10.1038/nrm.2016.76; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen Y, 2016, CELL CHEM BIOL, V23, P1228, DOI 10.1016/j.chembiol.2016.08.010; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Duteil D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5093; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Hasegawa Y, 2018, CELL METAB, V27, P180, DOI 10.1016/j.cmet.2017.12.005; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Inagaki T, 2016, NAT REV MOL CELL BIO, V17, P480, DOI 10.1038/nrm.2016.62; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Jiang YW, 2014, CELL REP, V9, P1007, DOI 10.1016/j.celrep.2014.09.049; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Molchadsky A, 2013, CELL DEATH DIFFER, V20, P774, DOI 10.1038/cdd.2013.9; Nagaoka K, 2015, MOL CELL BIOL, V35, P1068, DOI 10.1128/MCB.01404-14; Niwa H, 2017, EPIGENETICS-US, V12, P340, DOI 10.1080/15592294.2017.1290032; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Pan DN, 2015, DEV CELL, V35, DOI 10.1016/j.devcel.2015.11.002; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Perino M, 2016, DEV CELL, V38, P610, DOI 10.1016/j.devcel.2016.08.004; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sanchez-Gurmaches J, 2016, TRENDS CELL BIOL, V26, P313, DOI 10.1016/j.tcb.2016.01.004; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shapira SN, 2017, GENE DEV, V31, P660, DOI 10.1101/gad.294405.116; van Essen D, 2010, MOL CELL, V39, P750, DOI 10.1016/j.molcel.2010.08.010; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Yang Y, 2015, MOL CELL, V58, P47, DOI 10.1016/j.molcel.2015.01.038; Zeng X, 2016, GENE DEV, V30, P1822, DOI 10.1101/gad.285312.116; Zhang Q, 2013, CELL RES, V23, P225, DOI 10.1038/cr.2012.177	39	2	3	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5300	5311		10.1096/fj.201801422RR	http://dx.doi.org/10.1096/fj.201801422RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30681884	Green Published, Bronze			2022-12-28	WOS:000462888500054
J	van der Veen, JN; Lingrell, S; McCloskey, N; LeBlond, ND; Galleguillos, D; Zhao, YY; Curtis, JM; Sipione, S; Fullerton, MD; Vance, DE; Jacobs, RL				van der Veen, Jelske N.; Lingrell, Susanne; McCloskey, Nicholas; LeBlond, Nicholas D.; Galleguillos, Danny; Zhao, Yuan Y.; Curtis, Jonathan M.; Sipione, Simonetta; Fullerton, Morgan D.; Vance, Dennis E.; Jacobs, Rene L.			A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling	FASEB JOURNAL			English	Article						phospholipid; insulin resistance; PEMT; fatty liver disease; lipids	DIET-INDUCED OBESITY; N-METHYLTRANSFERASE; CGI-58 KNOCKDOWN; LIPID-METABOLISM; RESISTANCE; MICE; SENSITIVITY; INHIBITION; STEATOSIS; PREVENTS	Phosphatidylethanolamine N-methyltransferase (PEMT) is an important enzyme in hepatic phosphatidylcholine (PC) biosynthesis. Pemt(-/-) mice fed a high-fat diet are protected from obesity and whole-body insulin resistance. However, Pemt(-/-) mice develop severe nonalcoholic steatohepatitis (NASH). Because NASH is often associated with hepatic insulin resistance, we investigated whether the increased insulin sensitivity in Pemt(-/-) mice was restricted to nonhepatic tissues or whether the liver was also insulin sensitive. Strikingly, the livers of Pemt(-/-) mice compared with those of Pemt(+/+) mice were not insulin resistant, despite elevated levels of hepatic triacylglycerols and diacylglycerols, as well as increased hepatic inflammation and fibrosis. Endogenous glucose production was lower in Pemt(-/-) mice under both basal and hyperinsulinemic conditions. Experiments in primary hepatocytes and hepatoma cells revealed improved insulin signaling in the absence of PEMT, which was not due to changes in diacylglycerols, ceramides, or gangliosides. On the other hand, the phospholipid composition in hepatocytes seems critically important for insulin signaling such that lowering the PC:phosphatidylethanolamine (PE) ratio improves insulin signaling. Thus, treatments to reduce the PC:PE ratio in liver may protect against the development of hepatic insulin resistance.	[van der Veen, Jelske N.; Lingrell, Susanne; Galleguillos, Danny; Sipione, Simonetta; Vance, Dennis E.; Jacobs, Rene L.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada; [van der Veen, Jelske N.; Lingrell, Susanne; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Galleguillos, Danny; Sipione, Simonetta] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Zhao, Yuan Y.; Curtis, Jonathan M.; Jacobs, Rene L.] Univ Alberta, Dept Agr Food & Nutr Sci, 4-002E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada; [McCloskey, Nicholas; LeBlond, Nicholas D.; Fullerton, Morgan D.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Ottawa	Jacobs, RL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, 4-002E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada.	rjacobs@ualberta.ca			Canadian Institutes of Health Research [OCN143065, MSH141981, MOP 5182]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from the Canadian Institutes of Health Research [Bridge Funding OCN143065 and New Investigator MSH141981 (to M.D.F.), and MOP 5182 (to J.N.V.D.V., D.E.V., and R.L.J.)]. The authors declare no conflicts of interest.	Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Farese RV, 2010, AM J PHYSIOL-ENDOC M, V298, pE385, DOI 10.1152/ajpendo.00608.2009; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gao X, 2015, J LIPID RES, V56, P1701, DOI 10.1194/jlr.M059287; Gao X, 2015, BBA-MOL CELL BIOL L, V1851, P152, DOI 10.1016/j.bbalip.2014.11.006; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Ling J, 2012, HEPATOLOGY, V55, P1094, DOI 10.1002/hep.24782; Maglione V, 2010, J NEUROSCI, V30, P4072, DOI 10.1523/JNEUROSCI.6348-09.2010; Mi S, 2016, J CHROMATOGR B, V1031, P50, DOI 10.1016/j.jchromb.2016.07.028; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Salinas M, 2000, MOL CELL NEUROSCI, V15, P156, DOI 10.1006/mcne.1999.0813; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Sasaki N, 2015, J BIOL CHEM, V290, P25475, DOI 10.1074/jbc.M115.684274; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; van der Veen JN, 2016, AM J PHYSIOL-GASTR L, V310, pG526, DOI 10.1152/ajpgi.00243.2015; van der Veen JN, 2014, DIABETES, V63, P2620, DOI 10.2337/db13-0993; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Wang B, 2016, CELL METAB, V23, P492, DOI 10.1016/j.cmet.2016.01.001; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; ZHOU X, 1992, J LIPID RES, V33, P1233	51	21	21	2	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5045	5057		10.1096/fj.201802117R	http://dx.doi.org/10.1096/fj.201802117R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30615497	Bronze			2022-12-28	WOS:000462888500033
J	Ye, LY; Cao, Z; Lai, XR; Wang, WW; Guo, ZQ; Yan, LL; Wang, YY; Shi, Y; Zhou, NM				Ye, Lingyan; Cao, Zheng; Lai, Xiangru; Wang, Weiwei; Guo, Zhiqiang; Yan, Lili; Wang, Yuyan; Shi, Ying; Zhou, Naiming			Niacin fine-tunes energy homeostasis through canonical GPR109A signaling	FASEB JOURNAL			English	Article						obesity; de novo lipogenesis; thermogenesis; intestinal fat absorption	PROTEIN-COUPLED RECEPTOR; DE-NOVO LIPOGENESIS; NICOTINIC-ACID; OXIDATIVE STRESS; ADIPOSE-TISSUE; FATTY LIVER; MOLECULAR-IDENTIFICATION; INSULIN-SECRETION; PUMA-G; OBESITY	The incidence of overweight and obesity has become a global public health problem, constituting a major risk factor for numerous comorbidities. Despite tremendous efforts, effective pharmacological agents for the treatment of obesity are still limited. Here, we showed that in contrast to lactate receptor GPR81, niacin receptor GPR109A-deficient mice had progressive weight gain and hepatic fat accumulation. Using high-fat diet-induced mouse model of obesity, we demonstrated that niacin treatment apparently protected against obesity without affecting food intake in wild-type mice but not in GPR109A-deficient mice. Further investigation showed that niacin treatment led to a remarkable inhibition of hepatic de novo lipogenesis. Additionally, we demonstrated that niacin treatment triggered brown adipose tissue and/or white adipose tissue thermogenic activity via activation of GPR109A. Moreover, we observed that mice exposed to niacin exhibited a dramatic decrease in intestinal absorption of sterols and fatty acids. Taken together, our findings demonstrate that acting on GPR109A, niacin shows the potential to maintain energy homeostasis through multipathways, representing a potential approach to the treatment of obesity, diabetes and cardiovascular disease.	[Ye, Lingyan; Cao, Zheng; Lai, Xiangru; Wang, Weiwei; Guo, Zhiqiang; Yan, Lili; Wang, Yuyan; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Shi, Y; Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	shi_y@zju.edu.cn; zhounaiming@zju.edu.cn	Zhou, Naiming/AHC-1121-2022		Ministry of Science and Technology of China [2012CB910402]; National Natural Science Foundation of China [81173106, 31200621, 31771543]; Zhejiang Provincial Natural Science Foundation of China [LY15C050001]; Siyuan Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Siyuan Foundation	The authors thank Dr. Stefan Offermanns (Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany) for providing GPR109A KO (C57BL) breeders and critical comments. Junying Li (Center of Analysis and Measurement, Zhejiang University), Qiong Huang (Core Facilities, School of Medicine, Zhejiang University), and Shenghui Hong (Laboratory Animal Center, Zhejiang University) are acknowledged for their technical assistance. This work was supported by grants from the Ministry of Science and Technology of China (2012CB910402 to N.Z.), the National Natural Science Foundation of China (81173106, 31200621, and 31771543 to N.Z. and Y.S.), the Zhejiang Provincial Natural Science Foundation of China (LY15C050001 to N.Z.), and the Siyuan Foundation (to N.Z. and Y.S.). The authors declare no conflicts of interest.	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Besnard P, 2002, MOL CELL BIOCHEM, V239, P139, DOI 10.1023/A:1020505512364; Buhler S, 2018, J ANIM PHYSIOL AN N, V102, pE87, DOI 10.1111/jpn.12705; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Chang AM, 2006, J CLIN ENDOCR METAB, V91, P3303, DOI 10.1210/jc.2006-0913; Chen H, 2014, J CLIN INVEST, V124, P2188, DOI 10.1172/JCI72151; Chen LH, 2015, MOL CELL ENDOCRINOL, V404, P56, DOI 10.1016/j.mce.2015.01.029; Chen YL, 2018, J HEPATOL, V69, P687, DOI 10.1016/j.jhep.2018.04.004; Cho KH, 2009, AM J PHYSIOL-RENAL, V297, pF106, DOI 10.1152/ajprenal.00126.2009; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cunningham JW, 2014, CLIN CARDIOL, V37, P693, DOI 10.1002/clc.22304; DAVIS JD, 1981, SCIENCE, V212, P81, DOI 10.1126/science.7193909; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Digby JE, 2009, CURR OPIN LIPIDOL, V20, P321, DOI 10.1097/MOL.0b013e32832d3b9d; Dou XB, 2013, J NUTR BIOCHEM, V24, P1520, DOI 10.1016/j.jnutbio.2012.12.012; Elam MB, 2000, JAMA-J AM MED ASSOC, V284, P1263, DOI 10.1001/jama.284.10.1263; FOLCH J, 1957, J BIOL CHEM, V226, P497; FULCHER GR, 1992, DIABETES, V41, P1400, DOI 10.2337/diabetes.41.11.1400; Ganji SH, 2004, J LIPID RES, V45, P1835, DOI 10.1194/jlr.M300403-JLR200; Ganji SH, 2015, METABOLISM, V64, P982, DOI 10.1016/j.metabol.2015.05.002; Ganji SH, 2014, AM J PHYSIOL-GASTR L, V306, pG320, DOI 10.1152/ajpgi.00181.2013; Ganji SH, 2009, ATHEROSCLEROSIS, V202, P68, DOI 10.1016/j.atherosclerosis.2008.04.044; GARG A, 1990, JAMA-J AM MED ASSOC, V264, P723, DOI 10.1001/jama.264.6.723; Gautam J, 2018, BRIT J PHARMACOL, V175, P2581, DOI 10.1111/bph.14174; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Goldberg RB, 2008, MAYO CLIN PROC, V83, P470, DOI 10.4065/83.4.470; Graff EC, 2016, METABOLISM, V65, P102, DOI 10.1016/j.metabol.2015.10.001; Guyton JR, 1998, AM J CARDIOL, V82, P737, DOI 10.1016/S0002-9149(98)00448-2; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hu M, 2012, J LIPID RES, V53, P802, DOI 10.1194/jlr.P023614; Kamanna VS, 2013, CURR OPIN LIPIDOL, V24, P239, DOI 10.1097/MOL.0b013e3283613a68; KATSURADA A, 1990, EUR J BIOCHEM, V190, P435, DOI 10.1111/j.1432-1033.1990.tb15593.x; Kolovou GD, 2008, HELL J CARDIOL, V49, P79; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kwon WY, 2011, CRIT CARE MED, V39, P328, DOI 10.1097/CCM.0b013e3181feeae4; Li HM, 2011, PANCREAS, V40, P615, DOI 10.1097/MPA.0b013e31820b4b23; Li Q, 2014, ALCOHOL CLIN EXP RES, V38, P1982, DOI 10.1111/acer.12396; Li XY, 2010, BIOCHEM PHARMACOL, V80, P1450, DOI 10.1016/j.bcp.2010.07.023; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848; Mielenz M, 2013, J DAIRY SCI, V96, P278, DOI 10.3168/jds.2012-5816; Mitrofanov VA, 2005, B EXP BIOL MED+, V140, P702, DOI 10.1007/s10517-006-0059-6; Moreira FA, 2009, BEST PRACT RES CL EN, V23, P133, DOI 10.1016/j.beem.2008.09.003; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Offermanns S, 2011, PHARMACOL REV, V63, P269, DOI 10.1124/pr.110.003301; Olsen MK, 2017, SCAND J GASTROENTERO, V52, P442, DOI 10.1080/00365521.2016.1267791; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Shehadah A, 2010, NEUROBIOL DIS, V40, P277, DOI 10.1016/j.nbd.2010.05.034; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Shi YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40000; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Solinas G, 2015, MOL METAB, V4, P367, DOI 10.1016/j.molmet.2015.03.004; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Titchenell PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8078; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Wang N, 2016, GEN COMP ENDOCR, V237, P98, DOI 10.1016/j.ygcen.2016.08.011; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wong TP, 2015, NUTRIENTS, V7, P7543, DOI 10.3390/nu7095352; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129; Xu F, 2009, DIABETES, V58, pA3, DOI 10.2337/db08-1637	74	18	19	4	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4765	4779		10.1096/fj.201801951R	http://dx.doi.org/10.1096/fj.201801951R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596513	Green Submitted, Bronze			2022-12-28	WOS:000462888500011
J	Fontana, JM; Khodus, GR; Unnersjo-Jess, D; Blom, H; Aperia, A; Brismar, H				Fontana, Jacopo M.; Khodus, Georgiy R.; Unnersjo-Jess, David; Blom, Hans; Aperia, Anita; Brismar, Hjalmar			Spontaneous calcium activity in metanephric mesenchymal cells regulates branching morphogenesis in the embryonic kidney	FASEB JOURNAL			English	Article						organogenesis; nephron; calcium imaging	INTRACELLULAR CA2+; EGG; DIFFERENTIATION; BIOLOGY; GUDMAP	The central role of calcium signaling during development of early vertebrates is well documented, but little is known about its role in mammalian embryogenesis. We have used immunofluorescence and time-lapse calcium imaging of cultured explanted embryonic rat kidneys to study the role of calcium signaling for branching morphogenesis. In mesenchymal cells, we recorded spontaneous calcium activity that was characterized by irregular calcium transients. The calcium signals were dependent on release of calcium from intracellular stores in the endoplasmic reticulum. Down-regulation of the calcium activity, both by blocking the sarco-endoplasmic reticulum Ca2+-ATPase and by chelating cytosolic calcium, resulted in retardation of branching morphogenesis and a reduced formation of primitive nephrons but had no effect on cell proliferation. We propose that spontaneous calcium activity contributes with a stochastic factor to the self-organizing process that controls branching morphogenesis, a major determinant of the ultimate number of nephrons in the kidney.Fontana, J. M., Khodus, G. R., Unnersjo-Jess, D., Blom, H., Aperia, A., Brismar, H. Spontaneous calcium activity in metanephric mesenchymal cells regulates branching morphogenesis in the embryonic kidney.	[Fontana, Jacopo M.; Khodus, Georgiy R.; Unnersjo-Jess, David; Blom, Hans; Brismar, Hjalmar] Kungliga Tekniska Hogskolan KTH Royal Inst Techno, Sci Life Lab, Dept Appl Phys, Solna, Sweden; [Aperia, Anita; Brismar, Hjalmar] Karolinska Inst, Sci Life Lab, Dept Womens & Childrens Hlth, Solna, Sweden	Karolinska Institutet	Brismar, H (corresponding author), Sci Life Lab, Box 1031, S-17121 Solna, Sweden.	brismar@kth.se	Fontana, Jacopo Maria/AAC-4766-2022; Fontana, Jacopo Maria/GQP-4980-2022; Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Fontana, Jacopo Maria/0000-0003-4784-4713; Khodus, Georgiy/0000-0001-5372-9354	Swedish Research Council [K62102273, VR-2013-6041, VR-2015-04198]; Erling-Persson Family Foundation; Marta and Gunnar V. Philipsson Foundation; Soderberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Erling-Persson Family Foundation; Marta and Gunnar V. Philipsson Foundation; Soderberg Foundation	This work was supported by Swedish Research Council Grants K62102273 (to A.A.), VR-2013-6041 (to H. Blom), and VR-2015-04198 (to H. Brismar); the Erling-Persson Family Foundation (to A.A.); the Marta and Gunnar V. Philipsson Foundation (to H. Brismar); and the Soderberg Foundation (to A.A.). The authors declare no conflicts of interest.	Blake J, 2014, SEMIN CELL DEV BIOL, V36, P2, DOI 10.1016/j.semcdb.2014.07.011; Chang LW, 2009, J NEUROSCI, V29, P7877, DOI 10.1523/JNEUROSCI.4264-08.2009; Deng HS, 2015, NATURE, V528, P212, DOI 10.1038/nature16170; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Dziarmaga A, 2006, J AM SOC NEPHROL, V17, P1568, DOI 10.1681/ASN.2005101074; Futel M, 2015, J CELL SCI, V128, P888, DOI 10.1242/jcs.155499; Gerber SD, 2009, DEV BIOL, V335, P106, DOI 10.1016/j.ydbio.2009.08.019; Hannezo E, 2017, CELL, V171, P242, DOI 10.1016/j.cell.2017.08.026; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Kim TJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04876; Leclerc C, 2008, DEV BIOL, V321, P357, DOI 10.1016/j.ydbio.2008.06.029; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Little MH, 2016, KIDNEY INT, V90, P289, DOI 10.1016/j.kint.2016.03.030; Luyckx VA, 2015, NAT REV NEPHROL, V11, P135, DOI 10.1038/nrneph.2014.251; Maeshima A, 2007, J AM SOC NEPHROL, V18, P3147, DOI 10.1681/ASN.2007060642; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Menshykau D, 2014, DEVELOPMENT, V141, P4526, DOI 10.1242/dev.116202; Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; PERANTONI AO, 1995, P NATL ACAD SCI USA, V92, P4696, DOI 10.1073/pnas.92.10.4696; Pruitt BL, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001996; Resende RR, 2010, STEM CELLS DEV, V19, P379, DOI 10.1089/scd.2008.0289; Rosenberg SS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004259; Sampogna RV, 2015, J AM SOC NEPHROL, V26, P2414, DOI 10.1681/ASN.2014090886; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Sebinger DDR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010550; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Varner VD, 2017, SEMIN CELL DEV BIOL, V67, P170, DOI 10.1016/j.semcdb.2016.06.003; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Xu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174946	33	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4089	4096		10.1096/fj.201802054R	http://dx.doi.org/10.1096/fj.201802054R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496703	Green Published, hybrid			2022-12-28	WOS:000459794800079
J	Hong, S; Hwang, I; Gim, E; Yang, J; Park, S; Yoon, SH; Lee, WW; Yu, JW				Hong, Sujeong; Hwang, Inhwa; Gim, Eunji; Yang, Jungmin; Park, Sangjun; Yoon, Sung-Hyun; Lee, Won-Woo; Yu, Je-Wook			Brefeldin A-sensitive ER-Golgi vesicle trafficking contributes to NLRP3-dependent caspase-1 activation	FASEB JOURNAL			English	Article						BFA; BIG1; inflammasome; IL-1 secretion	NLRP3 INFLAMMASOME ACTIVATION; CELL-DEATH; INTERLEUKIN-1; EXCHANGE; PROTEIN; MECHANISM; LOCALIZATION; MITOCHONDRIA; PYROPTOSOME; MONOCYTES	Endoplasmic reticulum (ER)-Golgi vesicle trafficking plays a pivotal role in the conventional secretory pathway of many cytokines; however, the precise release mechanism of a major inflammasome mediator, IL-1, is not thought to follow the conventional ER-Golgi route and remains elusive. Here, we found that perturbation of ER-Golgi trafficking by brefeldin A (BFA) treatment attenuated nucleotide-binding oligomerization domain-like receptor family, pyrin-domain-containing 3 (NLRP3) inflammasome activation in mouse bone marrow-derived macrophages (BMDMs). BFA treatment inhibited NLRP3-mediated inflammasome assembly and caspase-1 activation but did not block IL-1 secretion from BMDMs following BFA administration after NLRP3 inflammasome activation. Consistently, short-hairpin RNA-dependent knockdown of BFA-inhibited guanine nucleotide-exchange protein 1 (BIG1), a molecular target of BFA and an initiator of Golgi-specific vesicle trafficking, abolished NLRP3-dependent apoptosis-associated speck-like protein containing a caspase-recruitment domain oligomerization and caspase-1 activation in BMDMs. Similarly, knockdown of Golgi-specific BFA-resistance guanine nucleotide exchange factor 1, another target of BFA, clearly attenuated NLRP3-mediated caspase-1 activation in BMDMs. Mechanistically, inhibition of BIG1-mediated vesicle trafficking did not impair NLRP3-activating signal 2-promoted events, such as potassium efflux and mitochondrial rearrangement, but caused significant impairment of signal 1-triggered priming steps, including NF-B-mediated pathways. These data suggest that BFA-targeted vesicle trafficking at the Golgi contributes to activation of the NLRP3 inflammasome signaling.Hong, S., Hwang, I., Gim, E., Yang, J., Park, S., Yoon, S.-H., Lee, W.-W., Yu, J.-W. Brefeldin A-sensitive ER-Golgi vesicle trafficking contributes to NLRP3-dependent caspase-1 activation.	[Hong, Sujeong; Hwang, Inhwa; Gim, Eunji; Yang, Jungmin; Park, Sangjun; Yoon, Sung-Hyun; Yu, Je-Wook] Yonsei Univ, Brain Korea Program Leading Univ & Students PLUS, Inst Immunol & Immunol Dis, Dept Microbiol & Immunol,Coll Med, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU)	Yu, JW (corresponding author), Yonsei Univ, Brain Korea 21 PLUS Project Med Sci, Inst Immunol & Immunol Dis, Dept Microbiol & Immunol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.	jewookyu@yuhs.ac		Yoon, SungHyun/0000-0002-8267-4740; Yu, Je-Wook/0000-0001-5943-4071; Lee, Won-Woo/0000-0002-5347-9591; Hwang, Inhwa/0000-0001-5235-3519	National Research Foundation of Korea - Korean Government [2014R1A4A1008625, 2015M3A9B6073856, 2017R1A2B2007467]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by National Research Foundation of Korea Grants 2014R1A4A1008625, 2015M3A9B6073856, and 2017R1A2B2007467 funded by the Korean Government. The authors declare no conflicts of interest.	AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Galindo A, 2016, CELL REP, V16, P839, DOI 10.1016/j.celrep.2016.06.022; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13129; Jin HS, 2017, IMMUNE NETW, V17, P77, DOI 10.4110/in.2017.17.2.77; Kay J, 2004, RHEUMATOLOGY, V43, P2, DOI 10.1093/rheumatology/keh201; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KUNO K, 1994, J LEUKOCYTE BIOL, V56, P542, DOI 10.1002/jlb.56.5.542; Kurokawa K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4653; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MATSUSHIMA K, 1986, J IMMUNOL, V136, P2883; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Yang J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00333; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2016, ARCH PHARM RES, V39, P1503, DOI 10.1007/s12272-016-0827-4; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	40	19	19	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4547	4558		10.1096/fj.201801585R	http://dx.doi.org/10.1096/fj.201801585R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30592629	Bronze			2022-12-28	WOS:000459794800115
J	Inglis, S; Kanczler, JM; Oreffo, ROC				Inglis, Stefanie; Kanczler, Janos M.; Oreffo, Richard O. C.			3D human bone marrow stromal and endothelial cell spheres promote bone healing in an osteogenic niche	FASEB JOURNAL			English	Article						coculture; bone drill defect; cell construct; organotypic culture; ex vivo	MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; IN-VITRO; PROGENITOR CELLS; MULTICELLULAR SPHEROIDS; CULTURE-SYSTEM; DIFFERENTIATION; ANGIOGENESIS; REGENERATION; COCULTURE	The current study used an ex vivo [embryonic day (E)18] chick femur defect model to examine the bone regenerative capacity of implanted 3-dimensional (3D) skeletal-endothelial cell constructs. Human bone marrow stromal cell (HBMSC) and HUVEC spheroids were implanted within a bone defect site to determine the osteogenic potential of the skeletal-endothelial cell unit. Cells were pelleted as co- or monocell spheroids and placed within 1-mm-drill defects in the mid-diaphysis of E18 chick femurs and cultured organotypically for 10 d. Micro-computed tomography analysis revealed significantly (P = 0.0001) increased levels of bone volume (BV) and BV/tissue volume ratio in all cell-pellet groups compared with the sham defect group. The highest increase was seen in BV in femurs containing the HUVEC and HBMSC monocell constructs. Type II collagen expression was particularly pronounced within the cell spheres containing HBMSCs and HUVECs, and CD31-positive cell clusters were prominent within HUVEC-implanted defects. These studies demonstrate the importance of the 3D osteogenic-endothelial niche interaction in bone regeneration. Elucidating the component cell interactions in the osteogenic-vascular niche and the role of exogenous factors in driving these osteogenic processes will aid the development of better bone reparative strategies.Inglis, S., Kanczler, J. M., Oreffo, R. O. C. 3D human bone marrow stromal and endothelial cell spheres promote bone healing in an osteogenic niche.	[Inglis, Stefanie; Kanczler, Janos M.; Oreffo, Richard O. C.] Univ Southampton, Bone & Joint Res Grp, Ctr Human Dev Stem Cells & Regenerat, Inst Dev Sci,Southampton Gen Hosp, Southampton, Hants, England	University of Southampton	Oreffo, ROC (corresponding author), Univ Southampton, Southampton Gen Hosp, Ctr Human Dev Stem Cells & Regenerat, Inst Dev Sci,Univ Orthopaed, MP887,CF86,Tremona Rd,IDS Bldg, Southampton SO16 6YD, Hants, England.	roco@soton.ac.uk	; Oreffo, Richard/A-4615-2011	Kanczler, Janos/0000-0001-7249-0414; Oreffo, Richard/0000-0001-5995-6726	Biotechnology and Biological Sciences Research Council (LOLA) [BB/G010579/1]; BBSRC [BB/G010579/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (LOLA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the doctors and nurses at the Princess Anne Maternity Hospital for providing human umbilical cords, Dr. Gry Hulsart Billstrom (Department of Surgical Sciences, Uppsala University, Uppsala, Sweden) for expert advice on mu CT imaging, Dr. David Johnston of the Biomedical Imaging Unit at Southampton General Hospital for confocal imaging, and members of the Bone and Joint research group for their help. This work was supported by the Biotechnology and Biological Sciences Research Council (LOLA Grant BB/G010579/1). The authors declare no conflicts of interest.	Akiyama M, 2006, CELL TRANSPLANT, V15, P521, DOI 10.3727/000000006783981765; BRUDER SP, 1989, CONNECT TISSUE RES, V20, P65, DOI 10.3109/03008208909023875; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Einhorn TA, 2005, J ORTHOP TRAUMA, V19, pS4, DOI 10.1097/00005131-200511101-00002; El-Serafi AT, 2011, EUR CELLS MATER, V21, P558, DOI 10.22203/eCM.v021a42; Ferrera D, 2002, BONE, V30, P718, DOI 10.1016/S8756-3282(02)00691-9; Finkenzeller G, 2009, CELL PROLIFERAT, V42, P498, DOI 10.1111/j.1365-2184.2009.00610.x; Freeman FE, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0210-2; Freeman FE, 2015, TISSUE ENG PT A, V21, P1320, DOI [10.1089/ten.TEA.2014.0249, 10.1089/ten.tea.2014.0249]; Futrega K, 2017, TISSUE ENG PART C-ME, V23, P200, DOI 10.1089/ten.tec.2016.0329; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Goerke SM, 2015, MICROVASC RES, V98, P40, DOI 10.1016/j.mvr.2014.12.001; Goerke SM, 2012, TISSUE ENG PT A, V18, P2395, DOI [10.1089/ten.TEA.2012.0147, 10.1089/ten.tea.2012.0147]; Gomez-Barrena E, 2011, J CELL MOL MED, V15, P1266, DOI 10.1111/j.1582-4934.2011.01265.x; Inglis S, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0270-3; Jahn K, 2010, EUR CELLS MATER, V20, P149; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jeon S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07049-3; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Langen UH, 2017, NAT CELL BIOL, V19, P189, DOI 10.1038/ncb3476; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Metzger W, 2017, MAT SCI ENG C-MATER, V73, P310, DOI 10.1016/j.msec.2016.12.087; Ong LJY, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa8858; Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rao RR, 2015, TISSUE ENG PT A, V21, P530, DOI [10.1089/ten.tea.2013.0740, 10.1089/ten.TEA.2013.0740]; Rossi MID, 2005, BRAZ J MED BIOL RES, V38, P1455, DOI 10.1590/S0100-879X2005001000002; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Saleh F A, 2011, Eur Cell Mater, V22, P242; Sandell L., 1999, FRONT BIOSCI-LANDMRK, V4, P731; Sasaki JI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129266; van der Stok J, 2014, EUR CELLS MATER, V27, P137, DOI 10.22203/eCM.v027a11; Walser R, 2013, EUR CELLS MATER, V26, P222, DOI 10.22203/eCM.v026a16; Whyte JL, 2011, STEM CELL RES, V6, P238, DOI 10.1016/j.scr.2011.02.001	37	14	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3279	3290		10.1096/fj.201801114R	http://dx.doi.org/10.1096/fj.201801114R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30403537	Green Published, hybrid			2022-12-28	WOS:000459794800017
J	Li, DY; Chen, AM; Lan, T; Zou, Y; Zhao, L; Yang, P; Qu, HY; Wei, L; Varghese, Z; Moorhead, JF; Chen, YX; Ruan, XZ				Li, Danyang; Chen, Amei; Lan, Tan; Zou, Yang; Zhao, Lei; Yang, Ping; Qu, Haiyang; Wei, Li; Varghese, Zac; Moorhead, John F.; Chen, Yaxi; Ruan, Xiong Z.			SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE(-/-) mice	FASEB JOURNAL			English	Article						AMPK pathway; ROS; VSMC; foam cell	LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; REACTIVE OXYGEN; FOAM CELL; MACROPHAGE; INFLAMMATION; CHOLESTEROL; ACTIVATION; MECHANISMS; LESIONS	Sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) is a cholesterol sensor that plays a critical role in regulating intracellular cholesterol levels, but the association between SCAP and foam cell formation in vascular smooth muscle cells (VSMCs) is poorly understood. Using tissue-specific SCAP knockdown in apolipoprotein E (ApoE)(-/-) mice, we sought to search the mechanism through which SCAP signaling affects VSMC foam cell development. VSMC-specific SCAP knockdown mice were generated by Cre/LoxP-mediated gene targeting in ApoE(-/-) mice. Breeding SCAP(flox/flox) mice with SM22-Cre mice resulted in no viable offspring with the homozygote SM22-Cre: SCAP(flox/flox) genotype due to embryonic lethality. We found that the heterozygote SM22-Cre:SCAP(flox/+):ApoE(-/-) mice fed a Western diet for 12 wk had significantly fewer atherosclerotic plaques in their aortas than the control mice due to reduced cholesterol uptake and synthesis. Furthermore, we found that autophagy in VSMCs was increased in SM22-Cre:SCAP(flox/+):ApoE(-/-) mice. Similarly, in vitro, SCAP knockdown in human coronary artery VSMCs by RNA interference reduced lipid accumulation and increased autophagy under LDL cholesterol loading. SCAP knockdown in VSMCs reduced oxidative stress and increased AMPK phosphorylation, which contributed to the up-regulation of autophagy in vivo and in vitro. VSMC-specific SCAP knockdown decreased the lipid accumulation and intracellular oxidative stress, increased excessive lipid clearance by enhancing lipid autophagy mediated by the reactive oxygen species/AMPK pathway in VSMCs, and consequently alleviated atherosclerosis plaque formation.Li, D., Chen, A., Lan, T., Zou, Y., Zhao, L., Yang, P., Qu, H., Wei, L., Varghese, Z., Moorhead, J. F., Chen, Y., Ruan, X. Z. SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE(-/-) mice.	[Li, Danyang; Chen, Amei; Lan, Tan; Zou, Yang; Zhao, Lei; Yang, Ping; Qu, Haiyang; Wei, Li; Chen, Yaxi; Ruan, Xiong Z.] Chongqing Med Univ, Affiliated Hosp 2, Ctr Lipid Res, Inst Viral Hepatitis,Dept Infect Dis, Chongqing, Peoples R China; [Li, Danyang; Chen, Amei; Lan, Tan; Zou, Yang; Zhao, Lei; Yang, Ping; Qu, Haiyang; Wei, Li; Chen, Yaxi; Ruan, Xiong Z.] Chongqing Med Univ, Affiliated Hosp 2, Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China; [Varghese, Zac; Moorhead, John F.; Ruan, Xiong Z.] UCL, Med Sch, Ctr Nephrol, John Moorhead Res Lab, Royal Free Campus, London, England; [Ruan, Xiong Z.] Zhejiang Univ, Collaborat Innovat Ctr Consortium Diag & Treatmen, Hangzhou, Zhejiang, Peoples R China	Chongqing Medical University; Chongqing Medical University; University of London; University College London; Zhejiang University	Chen, YX (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Ctr Lipid Res, Chongqing 400016, Peoples R China.; Chen, YX (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Minist Educ,Inst Viral Hepatitis, Chongqing 400016, Peoples R China.; Ruan, XZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Ctr Lipid Res, Chongqing 400016, Peoples R China.; Ruan, XZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Minist Educ,Inst Viral Hepatitis,Dept Infect Dis, Chongqing 400016, Peoples R China.	chenyaxi@cqmu.edu.cn; x.ruan@ucl.ac.uk	Ruan, Xiong Zhong/GZA-5963-2022; li, danyang/HHS-3319-2022	Ruan, Xiong Zhong/0000-0001-5199-4971; 	National Natural Science Foundation of China [81390354, 81570517, 81873569]; National Key R&D Program of China [2018YFC1312700]; Chongqing Research Program of Basic Research and Frontier Technology [cstc2015jcyjBX0044]; Program for Innovation Team of Higher Education in Chongqing [CXTDX201601015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Chongqing Research Program of Basic Research and Frontier Technology; Program for Innovation Team of Higher Education in Chongqing	This work was supported by the National Natural Science Foundation of China (Key Program, Grants 81390354, 81570517, and 81873569), the National Key R&D Program of China (Grant 2018YFC1312700), the Chongqing Research Program of Basic Research and Frontier Technology (Grant cstc2015jcyjBX0044), and the Program for Innovation Team of Higher Education in Chongqing (Grant CXTDX201601015). The authors declare no conflicts of interest.	AVIRAM M, 1989, METABOLISM, V38, P445, DOI 10.1016/0026-0495(89)90196-0; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Chen ML, 2013, AUTOPHAGY, V9, P2033, DOI 10.4161/auto.26336; Chen YX, 2014, ARTERIOSCL THROM VAS, V34, P365, DOI 10.1161/ATVBAHA.113.301301; Chistiakov DA, 2017, J MOL MED, V95, P1153, DOI 10.1007/s00109-017-1575-8; Das N, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12404; Ding ZF, 2013, INT J CARDIOL, V168, P1378, DOI 10.1016/j.ijcard.2012.12.045; Francis GA, 2015, CIRCULATION, V131, pE25, DOI 10.1161/CIRCULATIONAHA.114.012817; GALLO LL, 1978, J LIPID RES, V19, P913; GAMBLE W, 1978, J LIPID RES, V19, P1068; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Gorenne I, 2013, CIRCULATION, V127, P386, DOI 10.1161/CIRCULATIONAHA.112.124404; Grootaert MOJ, 2015, AUTOPHAGY, V11, P2014, DOI 10.1080/15548627.2015.1096485; Guo ZM, 2002, MECH AGEING DEV, V123, P1121, DOI 10.1016/S0047-6374(02)00008-8; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jiang XS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42764; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Lee WJ, 2005, ARTERIOSCL THROM VAS, V25, P2488, DOI 10.1161/01.ATV.0000190667.33224.4c; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu XP, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0274-z; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Murrant CL, 2001, MICROSC RES TECHNIQ, V55, P236, DOI 10.1002/jemt.1173; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nelson J, 2015, FASEB J, V29, P3085, DOI 10.1096/fj.14-267989; OGATA J, 1990, STROKE, V21, P1740, DOI 10.1161/01.STR.21.12.1740; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P680, DOI 10.1161/01.ATV.10.5.680; Ruan XZ, 2006, ARTERIOSCL THROM VAS, V26, P1150, DOI 10.1161/01.ATV.0000217957.93135.c2; Ruan XZ, 1999, KIDNEY INT, V56, P440, DOI 10.1046/j.1523-1755.1999.00587.x; Saberi B, 2008, AM J PHYSIOL-CELL PH, V295, pC50, DOI 10.1152/ajpcell.90654.2007; Scoville DK, 2017, FASEB J, V31, P4600, DOI 10.1096/fj.201700187R; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Tian YM, 2011, CANCER SCI, V102, P569, DOI 10.1111/j.1349-7006.2010.01833.x; WOLFBAUER G, 1986, P NATL ACAD SCI USA, V83, P7760, DOI 10.1073/pnas.83.20.7760; Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	45	18	20	3	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3437	3450		10.1096/fj.201800975RRR	http://dx.doi.org/10.1096/fj.201800975RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30462530	Bronze			2022-12-28	WOS:000459794800029
J	Obiedat, A; Seidel, E; Mahameed, M; Berhani, O; Tsukerman, P; Voutetakis, K; Chatziioannou, A; McMahon, M; Avril, T; Chevet, E; Mandelboim, O; Tirosh, B				Obiedat, Akram; Seidel, Einat; Mahameed, Mohamed; Berhani, Orit; Tsukerman, Pinchas; Voutetakis, Konstantinos; Chatziioannou, Aristotelis; McMahon, Mari; Avril, Tony; Chevet, Eric; Mandelboim, Ofer; Tirosh, Boaz			Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1	FASEB JOURNAL			English	Article						ER stress; UPR; NK cells; immunotherapy	NATURAL-KILLER-CELLS; ER STRESS; IRE1-DEPENDENT DECAY; IMMUNE-RESPONSES; DOWN-REGULATION; MESSENGER-RNAS; EXPRESSION; CANCER; XBP1; ACTIVATION	The unfolded protein response (UPR) is an adaptive signaling pathway activated in response to endoplasmic reticulum (ER) stress. The effectors of the UPR are potent transcription activators; however, some genes are suppressed by ER stress at the mRNA level. The mechanisms underlying UPR-mediated gene suppression are less known. Exploration of the effect of UPR on NK cells ligand expression found that the transcription of NK group 2 member D (NKG2D) ligand major histocompatibility complex class I polypeptide-related sequence A/B (MICA/B) is suppressed by the inositol-requiring enzyme 1 (IRE1)/X-box binding protein 1 (XBP1) pathway of the UPR. Deletion of IRE1 or XBP1 was sufficient to promote mRNA and surface levels of MICA. Accordingly, NKG2D played a greater role in the killing of IRE1/XBP1 knockout target cells. Analysis of effectors downstream to XBP1s identified E2F transcription factor 1 (E2F1) as linking UPR and MICA transcription. The inverse correlation between XBP1 and E2F1 or MICA expression was corroborated in RNA-Seq analysis of 470 primary melanoma tumors. While mechanisms that connect XBP1 to E2F1 are not fully understood, we implicate a few microRNA molecules that are modulated by ER stress and possess dual suppression of E2F1 and MICA. Because of the importance of E2F1 and MICA in cancer progression and recognition, these observations could be exploited for cancer therapy by manipulating the UPR in tumor cells.Obiedat, A., Seidel, E., Mahameed, M., Berhani, O., Tsukerman, P., Voutetakis, K., Chatziioannou, A., McMahon, M., Avril, T., Chevet, E., Mandelboim, O., Tirosh, B. Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1.	[Obiedat, Akram; Mahameed, Mohamed; Tirosh, Boaz] Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Fac Med, Jerusalem, Israel; [Seidel, Einat; Berhani, Orit; Tsukerman, Pinchas; Mandelboim, Ofer] Hebrew Univ Jerusalem, Lautenberg Ctr Immunol & Canc Res, Biomed Res Inst Israel Canada, Fac Med,Med Sch, Jerusalem, Israel; [Voutetakis, Konstantinos; Chatziioannou, Aristotelis] NHRF, Inst Biol Med Chem & Biotechnol, Athens, Greece; [Voutetakis, Konstantinos] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Chatziioannou, Aristotelis] E Noesis Inspired Operat Syst Applicat Private Co, Kallithea Athens, Greece; [McMahon, Mari; Avril, Tony; Chevet, Eric] Univ Rennes, INSERM, U1242, Rennes, France; [McMahon, Mari; Avril, Tony; Chevet, Eric] Ctr Lutte Canc Eugene Marquis, Rennes, France; [McMahon, Mari] NUIG, ARC, Galway, Ireland	Hebrew University of Jerusalem; Hebrew University of Jerusalem; National Hellenic Research Foundation; University of Thessaly; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UNICANCER; Centre Eugene Marquis; Ollscoil na Gaillimhe-University of Galway	Tirosh, B (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, POB 12065, IL-91120 Jerusalem, Israel.	boazt@ekmd.huji.ac.il	Avril, Tony/ABG-7611-2020; chevet, eric/E-4992-2016	Avril, Tony/0000-0002-1129-8514; chevet, eric/0000-0001-5855-4522; Obiedat, Akram/0000-0002-7827-3370; McMahon, Mari/0000-0002-6131-9416; Tsukerman, Pinchas/0000-0002-5813-7048; Voutetakis, Konstantinos/0000-0001-7163-7381; Mandelboim, Ofer/0000-0002-9354-1855	David R. Bloom Center for Pharmacy; Dr. Adolph and Klara Brettler Center for Research in Pharmacology; Israeli Cancer Association; Israel Science Foundation [696/14]; PHC-Maimonide 2017-2018 Grant; ARED (Allocations de recherche doctorale, Region Bretagne)	David R. Bloom Center for Pharmacy; Dr. Adolph and Klara Brettler Center for Research in Pharmacology; Israeli Cancer Association; Israel Science Foundation(Israel Science Foundation); PHC-Maimonide 2017-2018 Grant; ARED (Allocations de recherche doctorale, Region Bretagne)	Research was funded by grants from the David R. Bloom Center for Pharmacy, the Dr. Adolph and Klara Brettler Center for Research in Pharmacology, the Israeli Cancer Association, the Israel Science Foundation (Grant 696/14, to B.T.), and PHC-Maimonide 2017-2018 Grant (to B.T. and E.C.). M.M. was funded by an ARED (Allocations de recherche doctorale, Region Bretagne) international doctoral fellowship. The authors declare no conflicts of interest.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Andres-Leon E, 2018, SCI REP-UK, V8, DOI 10.1038/srep46928; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Ashiru O, 2013, BIOCHEM J, V454, P295, DOI 10.1042/BJ20130194; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Benhamron S, 2014, EUR J IMMUNOL, V44, P867, DOI 10.1002/eji.201343953; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casado JG, 2009, CANCER IMMUNOL IMMUN, V58, P1517, DOI 10.1007/s00262-009-0682-y; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cheent K, 2009, IMMUNOLOGY, V126, P449, DOI 10.1111/j.1365-2567.2009.03045.x; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Deng WW, 2015, SCIENCE, V348, P136, DOI 10.1126/science.1258867; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ebrahimnejad A, 2004, AM J PATHOL, V165, P1781, DOI 10.1016/S0002-9440(10)63433-5; Ertosun MG, 2016, CYTOKINE GROWTH F R, V31, P17, DOI 10.1016/j.cytogfr.2016.02.001; Fang L, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0076-7; Franklin C, 2017, EJSO-EUR J SURG ONC, V43, P604, DOI 10.1016/j.ejso.2016.07.145; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; He Y, 2010, GENE EXPRESSION, V15, P13, DOI 10.3727/105221610X12819686555051; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hosomi S, 2017, J EXP MED, V214, P2985, DOI 10.1084/jem.20162041; Hu FL, 2011, EUR J IMMUNOL, V41, P1086, DOI 10.1002/eji.201040831; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jung H, 2012, J EXP MED, V209, P2409, DOI 10.1084/jem.20120565; Kroemer G, 2018, NAT REV IMMUNOL, V18, P87, DOI 10.1038/nri.2018.4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lhomond S, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201707929; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lonez C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017075; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Niederreiter L, 2013, J EXP MED, V210, P2041, DOI 10.1084/jem.20122341; Pagliarini V, 2015, J CELL SCI, V128, P1166, DOI 10.1242/jcs.164103; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Paschen A, 2014, EUR J CELL BIOL, V93, P49, DOI 10.1016/j.ejcb.2014.01.009; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Rodero S, 2007, EUR J IMMUNOL, V37, P1938, DOI 10.1002/eji.200737031; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rouaud F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0566-1; Rubio-Patino C, 2018, CELL METAB, V27, P828, DOI 10.1016/j.cmet.2018.02.009; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Soriani A, 2014, J IMMUNOL, V193, P950, DOI 10.4049/jimmunol.1400271; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Tallerico R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00179; Tang CHA, 2014, J CLIN INVEST, V124, P2585, DOI 10.1172/JCI73448; Tay KH, 2014, CELL SIGNAL, V26, P287, DOI 10.1016/j.cellsig.2013.11.008; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wu MR, 2015, J IMMUNOL, V194, P5305, DOI 10.4049/jimmunol.1402517; Wu MR, 2015, CANCER IMMUNOL IMMUN, V64, P409, DOI 10.1007/s00262-014-1648-2; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeng LF, 2013, CIRCULATION, V127, P1712, DOI 10.1161/CIRCULATIONAHA.112.001337; Zhuang LQ, 2009, HISTOPATHOLOGY, V54, P462, DOI 10.1111/j.1365-2559.2009.03242.x; Zippel D, 2015, ONCOL REP, V33, P1314, DOI 10.3892/or.2014.3703	71	13	15	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3481	3495		10.1096/fj.201801350RR	http://dx.doi.org/10.1096/fj.201801350RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30452881	Bronze			2022-12-28	WOS:000459794800032
J	Park, JK; Kim, YS; Kang, SU; Lee, YS; Won, HR; Kim, CH				Park, Ju Kyeong; Kim, Yeon Soo; Kang, Sung Un; Lee, Yun Sang; Won, Ho-Ryun; Kim, Chul-Ho			Nonthermal atmospheric plasma enhances myoblast differentiation by eliciting STAT3 phosphorylation	FASEB JOURNAL			English	Article						muscle regeneration; myogenin; myosin heavy chain	MUSCLE SATELLITE CELLS; TISSUE; REGENERATION; CONTRIBUTES; PATHWAY	The use of nonthermal atmospheric plasma (NTP) in the biomedical field has recently expanded into cell death induction in cancer, infection prevention, inflammation treatment, and wound-healing enhancement. NTP has been demonstrated to enhance skin and muscle regeneration, but its effects on tissue regeneration, following deep tissue or muscle damage, remains underinvestigated. In this study, we determined the effects of NTP on muscle differentiation and the mechanisms of NTP's contribution to differentiation and regeneration. NTP treatment enhanced cell differentiation in primary normal human skeletal muscle myoblast cells and increased the relative expression of mRNA levels of MyoD which is one of the earliest markers of myogenic commitment, and myogenin, which are important transcription factors required for myogenic differentiation. Furthermore, NTP treatment induced increases in the levels of myosin heavy chain, a differentiated muscle-specific protein, and in myotube formation of myoblasts. We observed that signal transducer and activator of transcription 3 (STAT3) activation induced by NTP treatment affects the myogenic differentiation. In addition, STAT3 phosphorylation was also enhanced by NTP treatment in injured animal muscle. These findings indicate that NTP could enhance musculoskeletal differentiation by acting as an external stimulus for myoblast differentiation, suggesting its treatment potential in promoting regeneration of damaged muscle.Park, J. K., Kim, Y. S., Kang, S. U., Lee, Y. S., Won, H.-R., Kim, C.-H. Nonthermal atmospheric plasma enhances myoblast differentiation by eliciting STAT3 phosphorylation.	[Park, Ju Kyeong] Natl Inst Food & Drug Safety Evaluat, Toxicol Evaluat Res Dept, Lab Anim Resources Div, Cheongju, South Korea; [Kim, Yeon Soo] Konyang Univ, Konyang Univ Hosp, Coll Med, Dept Otorhinolaryngol,Myunggok Med Res Inst, Daejeon, South Korea; [Kang, Sung Un; Lee, Yun Sang; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, 164 World Cup Ro, Suwon 443380, South Korea; [Kim, Chul-Ho] Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea; [Won, Ho-Ryun] Chungnam Natl Univ Hosp, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea	Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation; Konyang University; Konyang University Hospital; Ajou University; Ajou University; Chungnam National University; Chungnam National University Hospital	Kim, CH (corresponding author), Ajou Univ, Sch Med, Dept Otolaryngol, 164 World Cup Ro, Suwon 443380, South Korea.	ostium@ajou.ac.kr	kang, sung un/AAK-8050-2021		Basic Science Research Program through the National Research Foundation (NRF) - Korean Ministry of Science, Information, and Communications Technology and Future Planning [2017M3A9F7079339]; Ministry of Education [2016R1D1A3B03933948]	Basic Science Research Program through the National Research Foundation (NRF) - Korean Ministry of Science, Information, and Communications Technology and Future Planning; Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) funded by the Korean Ministry of Science, Information, and Communications Technology and Future Planning (Grant 2017M3A9F7079339 to C.-H.K.), and the Ministry of Education (Grant 2016R1D1A3B03933948 to Y.S.K.). The authors declare no conflicts of interest.	Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Assis L, 2013, LASER MED SCI, V28, P947, DOI 10.1007/s10103-012-1183-3; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019; Bryan N, 2014, J BIOMED MATER RES B, V102, P709, DOI 10.1002/jbm.b.33050; Chang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105705; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Choi JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep28829; Corona BT, 2014, TISSUE ENG PT A, V20, P705, DOI 10.1089/ten.TEA.2012.0761; Jang YN, 2013, JAK STAT, V2; Kang SU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.33; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Kim SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20332; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee OJ, 2016, J TISSUE ENG REGEN M, V10, P348, DOI 10.1002/term.2074; Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001; Rizzi Roberto, 2012, Muscles Ligaments Tendons J, V2, P230; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Shin YS, 2014, INT J PEDIATR OTORHI, V78, P32, DOI 10.1016/j.ijporl.2013.10.014; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Steinbeck MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082143; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Xing HY, 2015, MUSCLE NERVE, V51, P400, DOI 10.1002/mus.24322	25	4	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4097	4106		10.1096/fj.201800695RR	http://dx.doi.org/10.1096/fj.201800695RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30548079	Bronze			2022-12-28	WOS:000459794800080
J	David, JP; Lisewski, U; Crump, SM; Jepps, TA; Bocksteins, E; Wilck, N; Lossie, J; Roepke, TK; Schmitt, N; Abbott, GW				David, Jens-Peter; Lisewski, Ulrike; Crump, Shawn M.; Jepps, Thomas A.; Bocksteins, Elke; Wilck, Nicola; Lossie, Janine; Roepke, Torsten K.; Schmitt, Nicole; Abbott, Geoffrey W.			Deletion in mice of X-linked, Brugada syndrome- and atrial fibrillation-associated Kcne5 augments ventricular K-V currents and predisposes to ventricular arrhythmia	FASEB JOURNAL			English	Article						MiRP4; I-Kslow; I-to; potassium channel	POTASSIUM CHANNEL; I-KS; MENTAL-RETARDATION; BETA-SUBUNITS; REPOLARIZATION; MOUSE; MINK; KV2.1; GENE; EXPRESSION	KCNE5 is an X-linked gene encoding KCNE5, an ancillary subunit to voltage-gated potassium (K-V) channels. Human KCNE5 mutations are associated with atrial fibrillation (AF)- and Brugada syndrome (BrS)-induced cardiac arrhythmias that can arise from increased potassium current in cardiomyocytes. Seeking to establish underlying molecular mechanisms, we created and studied Kcne5 knockout (Kcne5(-/0)) mice. Intracardiac ECG revealed that Kcne5 deletion caused ventricular premature beats, increased susceptibility to induction of polymorphic ventricular tachycardia (60 vs. 24% in Kcne5(+/0) mice), and 10% shorter ventricular refractory period. Kcne5 deletion increased mean ventricular myocyte K-V current density in the apex and also in the subpopulation of septal myocytes that lack fast transient outward current (I-to,I-f). The current increases arose from an apex-specific increase in slow transient outward current-1 (I-Kslow,I-1) (conducted by K(V)1.5) and I-to,I-f (conducted by K(V)4) and an increase in I-Kslow,I-2 (conducted by K(V)2.1) in both apex and septum. Kcne5 protein localized to the intercalated discs in ventricular myocytes, where K(V)2.1 was also detected in both Kcne5(-/0) and Kcne5(+/0) mice. In HL-1 cardiac cells and human embryonic kidney cells, KCNE5 and K(V)2.1 colocalized at the cell surface, but predominantly in intracellular vesicles, suggesting that Kcne5 deletion increases I-K,I-slow2 by reducing K(V)2.1 intracellular sequestration. The human AF-associated mutation KCNE5-L65F negative shifted the voltage dependence of K(V)2.1-KCNE5 channels, increasing their maximum current density >2-fold, whereas BrS-associated KCNE5 mutations produced more subtle negative shifts in K(V)2.1 voltage dependence. The findings represent the first reported native role for Kcne5 and the first demonstrated Kcne regulation of K(V)2.1 in mouse heart. Increased K-V current is a manifestation of KCNE5 disruption that is most likely common to both mouse and human hearts, providing a plausible mechanistic basis for human KCNE5-linked AF and BrS.David, J.-P., Lisewski, U., Crump, S. M., Jepps, T. A., Bocksteins, E., Wilck, N., Lossie, J., Roepke, T. K., Schmitt, N., Abbott, G. W. Deletion in mice of X-linked, Brugada syndrome- and atrial fibrillation-associated Kcne5 augments ventricular K-V currents and predisposes to ventricular arrhythmia.	[David, Jens-Peter; Jepps, Thomas A.; Schmitt, Nicole] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [David, Jens-Peter; Jepps, Thomas A.; Schmitt, Nicole] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Lisewski, Ulrike; Wilck, Nicola; Lossie, Janine; Roepke, Torsten K.] Charite Med Univ Berlin, Med Clin & Polyclin Cardiol & Angiol, Berlin, Germany; [Lisewski, Ulrike; Wilck, Nicola; Lossie, Janine; Roepke, Torsten K.] Charite Med Univ Berlin, ECRC, Berlin, Germany; [Crump, Shawn M.; Abbott, Geoffrey W.] Univ Calif Irvine, Dept Physiol & Biophys, Bioelect Lab, Irvine, CA 92717 USA; [Bocksteins, Elke] Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, Antwerp, Belgium; [Bocksteins, Elke] Qual Design NV, Antwerp, Belgium; [Wilck, Nicola] Charite Univ Med Berlin, Med Klin Schwerpunkt Nephrol & Internist Intens M, Berlin, Germany; [Wilck, Nicola] ECRC, Berlin, Germany; [Lossie, Janine] Omeicos Therapeut, Berlin, Germany	Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Irvine; University of Antwerp; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Abbott, GW (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Bioelect Lab, Med Sci D337, Irvine, CA 92697 USA.	abbottg@uci.edu	Jepps, Thomas/U-3630-2017	Jepps, Thomas/0000-0002-9903-714X; Wilck, Nicola/0000-0003-3189-5364	Danish National Research Foundation; Faculty of Health and Medical Sciences, UCPH; Arvid Nilsson Foundation; European Union [608765]; Lundbeck Foundation; Research Foundation-Flanders (FWO); U.S. National Institutes of Health/National Heart, Lung and Blood Institute [HL079275, HL079275-S1]	Danish National Research Foundation(Danmarks Grundforskningsfond); Faculty of Health and Medical Sciences, UCPH; Arvid Nilsson Foundation; European Union(European Commission); Lundbeck Foundation(Lundbeckfonden); Research Foundation-Flanders (FWO)(FWO); U.S. National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Morten Thomsen [University of Copenhagen (UCPH), Copenhagen, Denmark] for advice on mouse ECG analysis and the Core Facility for Integrated Microscopy at UCPH. This work was supported by a framework grant of the Danish National Research Foundation (to N.S.); a Ph.D. stipend from the Faculty of Health and Medical Sciences, UCPH (to J.-P.D.); funding from the Arvid Nilsson Foundation (to J.-P.D.); the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme Grant FP7/2007-2013 (Research Executive Agency Grant Agreement 608765) and a grant from the Lundbeck Foundation (to T.A.J.); a postdoctoral fellowship from the Research Foundation-Flanders (FWO) (to E.B.); and U.S. National Institutes of Health/National Heart, Lung and Blood Institute Grant HL079275 and Postdoctoral Diversity Supplement Grant HL079275-S1 (to G.W.A.). The authors declare no conflicts of interest.	Abbott GW, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00066; Abbott GW, 2016, J VASC RES, V53, P138, DOI 10.1159/000449060; Abbott GW, 2016, GENE, V593, P249, DOI 10.1016/j.gene.2016.07.069; Abbott GW, 2016, GENE, V576, P1, DOI 10.1016/j.gene.2015.09.059; Abbott GW, 2015, GENE, V569, P162, DOI 10.1016/j.gene.2015.06.061; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bou-Abboud E, 2000, J PHYSIOL-LONDON, V529, P345, DOI 10.1111/j.1469-7793.2000.00345.x; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crump SM, 2016, FASEB J, V30, P360, DOI 10.1096/fj.15-278754; Crump SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00003; David JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12813; David JP, 2013, TRAFFIC, V14, P399, DOI 10.1111/tra.12042; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Hu ZY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26599-8; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Jonsson JJ, 1998, J MED GENET, V35, P273, DOI 10.1136/jmg.35.4.273; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Lee SM, 2017, FASEB J, V31, P2674, DOI 10.1096/fj.201601347; Lee SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23118; Lisewski U, 2016, FASEB J, V30, P2476, DOI 10.1096/fj.201600317R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; O'Connell KMS, 2008, AM J PHYSIOL-HEART C, V294, pH229, DOI 10.1152/ajpheart.01038.2007; Ohno S, 2011, CIRC-ARRHYTHMIA ELEC, V4, P352, DOI 10.1161/CIRCEP.110.959619; Olesen MS, 2014, HEART RHYTHM, V11, P246, DOI 10.1016/j.hrthm.2013.10.034; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Ravn LS, 2008, HEART RHYTHM, V5, P427, DOI 10.1016/j.hrthm.2007.12.019; Ravn LS, 2005, AM J CARDIOL, V96, P405, DOI 10.1016/j.amjcard.2005.03.086; ROBSON WLM, 1994, CLIN GENET, V45, P314; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanWagoner DR, 1997, CIRC RES, V80, P772; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Warth R, 2002, AM J PHYSIOL-REG I, V282, pR639, DOI 10.1152/ajpregu.00649.2001; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Zhou J, 2003, AM J PHYSIOL-HEART C, V284, pH491, DOI 10.1152/ajpheart.00576.2002	47	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2537	2552		10.1096/fj.201800502R	http://dx.doi.org/10.1096/fj.201800502R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30289750	Green Published			2022-12-28	WOS:000457296600080
J	Delhon, L; Mahaut, C; Goudin, N; Gaudas, E; Piquand, K; Le Goff, W; Cormier-Daire, V; Le Goff, C				Delhon, Laure; Mahaut, Clementine; Goudin, Nicolas; Gaudas, Emilie; Piquand, Kevin; Le Goff, Wilfried; Cormier-Daire, Valerie; Le Goff, Carine			Impairment of chondrogenesis and microfibrillar network in Adamtsl2 deficiency	FASEB JOURNAL			English	Article						cartilage; mouse model; geleophysic dysplasia; extracellular matrix	TGF-BETA; GROWTH; FIBRILLIN-1; MUTATIONS; DYSPLASIA; PROTEINS; MATRIX; DIFFERENTIATION; BIOAVAILABILITY; PROLIFERATION	Mutations in the a disintegrin and metalloproteinase with thrombospondin motif-like 2 (ADAMTSL2) gene are responsible for the autosomal recessive form of geleophysic dysplasia, which is characterized by short stature, short extremities, and skeletal abnormalities. However, the exact function of ADAMTSL2 is unknown. To elucidate the role of this protein in skeletal development, we generated complementary knockout (KO) mouse models with either total or chondrocyte Adamtsl2 deficiency. We observed that the Adamtsl2 KO mice displayed skeletal abnormalities reminiscent of the human phenotype. Adamtsl2 deletion affected the growth plate formation with abnormal differentiation and proliferation of chondrocytes. In addition, a TGF- signaling impairment in limbs lacking Adamtsl2 was demonstrated. Further investigations revealed that Adamtsl2 KO chondrocytes failed to establish a microfibrillar network composed by fibrillin1 and latent TGF- binding protein 1 fibrils. Chondrocyte Adamtsl2 KO mice also exhibited dwarfism. These studies uncover the function of Adamtsl2 in the maintenance of the growth plate ECM by modulating the microfibrillar network.Delhon, L., Mahaut, C., Goudin, N., Gaudas, E., Piquand, K., Le Goff, W., Cormier-Daire, V., Le Goff, C. Impairment of chondrogenesis and microfibrillar network in Adamtsl2 deficiency.	[Delhon, Laure; Mahaut, Clementine; Gaudas, Emilie; Piquand, Kevin; Cormier-Daire, Valerie; Le Goff, Carine] Paris Descartes Univ, Sorbonne Paris Cite, INSERM,Imagine Inst, UMR 1163,Lab Mol & Physiopathol Bases Osteochondr, Paris, France; [Goudin, Nicolas] Imaging Platform Necker Enfants Malades Hosp, Struct Federat Rech SFR Necker, Paris, France; [Le Goff, Wilfried] Sorbonne Univ, INSERM, Hop Pitie, UMR S1166,Inst Cardiometab & Nutr ICAN, Paris, France; [Cormier-Daire, Valerie] Necker Enfants Malades Hosp, AP HP, Reference Ctr Skeletal Dysplasia, Dept Med Genet, Paris, France; [Le Goff, Carine] Hop Xavier Bichat, INSERM, UMR 1148, Lab Vasc Translat Sci, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Le Goff, C (corresponding author), Lab Vasc Translat Sci, UMR1148, 46 Rue Henri Huchard, F-75018 Paris, France.	carine.le-goff@inserm.fr	Le Goff, Wilfried/N-6326-2017; Le Goff, Wilfried/N-7593-2019; LE GOFF, Carine/AAG-2390-2020	Le Goff, Wilfried/0000-0002-7611-9644; Le Goff, Wilfried/0000-0002-7611-9644; LE GOFF, Carine/0000-0002-7788-708X	French National Research Agency Grant ANR [R09183KS]; FP7 Sybil Program; FRM Prix Pomaret de Lalande; National Research Agency under the Investments for the Future Program [ANR-A0-IAHU-01]	French National Research Agency Grant ANR; FP7 Sybil Program; FRM Prix Pomaret de Lalande; National Research Agency under the Investments for the Future Program(French National Research Agency (ANR))	The authors thank Dr. L. Legeai-Mallet for critical reading of the manuscript, the animal facilities and histology platform from Imagine Institute, and the mouse clinic at Strasbourg (IGBMC). This work was supported by French National Research Agency Grant ANR R09183KS (to C.L.G. and V.C.-D.), the FP7 Sybil Program (to V.C.-D.), and by FRM Prix Pomaret de Lalande (to L.D. and C.L.G.). This program has received a state subsidy managed by the National Research Agency under the Investments for the Future Program (ANR-A0-IAHU-01). The authors declare no conflicts of interest.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bader HL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012817; Ballut L, 2013, J MOL RECOGNIT, V26, P76, DOI 10.1002/jmr.2250; Cain SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048634; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Dubail J, 2015, MATRIX BIOL, V44-46, P24, DOI 10.1016/j.matbio.2015.03.001; Duplan MB, 2016, HUM MOL GENET, V25, P2997, DOI 10.1093/hmg/ddw153; Hubmacher D, 2015, DIS MODEL MECH, V8, P487, DOI 10.1242/dmm.017046; Hubmacher D, 2011, CELL MOL LIFE SCI, V68, P3137, DOI 10.1007/s00018-011-0780-9; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; Jonquoy A, 2012, HUM MOL GENET, V21, P841, DOI 10.1093/hmg/ddr514; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Liu CJ, 2007, FRONT BIOSCI, V12, P3899, DOI 10.2741/2359; McInerney-Leo AM, 2016, J MED GENET, V53, P457, DOI 10.1136/jmedgenet-2015-103647; Melrose J, 2016, MATRIX BIOL, V52-54, P363, DOI 10.1016/j.matbio.2016.01.008; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Pannier S, 2010, BONE, V47, P905, DOI 10.1016/j.bone.2010.07.020; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Sengle G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002425; Yadin DA, 2013, STRUCTURE, V21, P1743, DOI 10.1016/j.str.2013.08.004	30	17	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2707	2718		10.1096/fj.201800753RR	http://dx.doi.org/10.1096/fj.201800753RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303737				2022-12-28	WOS:000457296600094
J	Hewitt, SC; Li, R; Adams, N; Winuthayanon, W; Hamilton, KJ; Donoghue, LJ; Lierz, SL; Garcia, M; Lydon, JP; DeMayo, FJ; Adelman, K; Korach, KS				Hewitt, Sylvia C.; Li, Rong; Adams, Nyssa; Winuthayanon, Wipawee; Hamilton, Katherine J.; Donoghue, Lauren J.; Lierz, Sydney L.; Garcia, Marleny; Lydon, John P.; DeMayo, Francesco J.; Adelman, Karen; Korach, Kenneth S.			Negative elongation factor is essential for endometrial function	FASEB JOURNAL			English	Article						uterus; NELF; Pol II pausing; decidualization	TRANSCRIPTION; DECIDUALIZATION; EXPRESSION	Pausing of RNA polymerase II (Pol II) during early transcription, mediated by the negative elongation factor (NELF) complex, allows cells to coordinate and appropriately respond to signals by modulating the rate of transcriptional pause release. Promoter proximal enrichment of Pol II occurs at uterine genes relevant to reproductive biology; thus, we hypothesized that pausing might impact endometrial response by coordinating hormonal signals involved in establishing and maintaining pregnancy. We deleted the NELF-B subunit in the mouse uterus using PgrCre (NELF-B UtcKO). Resulting females were infertile. Uterine response to the initial decidual stimulus of NELF-B UtcKO was similar to that of control mice; however, subsequent full decidual response was not observed. Cultured NELF-B UtcKO stromal cells exhibited perturbances in extracellular matrix components and also expressed elevated levels of the decidual prolactin Prl8a2, as well as altered levels of transcripts encoding enzymes involved in prostaglandin synthesis and metabolism. Because endometrial stromal cell decidualization is also critical to human reproductive health and fertility, we used small interfering to suppress NELF-B or NELF-E subunits in cultured human endometrial stromal cells, which inhibited decidualization, as reflected by the impaired induction of decidual markers PRL and IGFBP1. Overall, our study indicates NELF-mediated pausing is essential to coordinate endometrial responses and that disruption impairs uterine decidual development during pregnancy.Hewitt, S. C., Li, R., Adams, N., Winuthayanon, W., Hamilton, K. J., Donoghue, L. J., Lierz, S. L., Garcia, M., Lydon, J. P., DeMayo, F. J., Adelman, K., Korach, K. S. Negative elongation factor is essential for endometrial function.	[Hewitt, Sylvia C.; Hamilton, Katherine J.; Donoghue, Lauren J.; Lierz, Sydney L.; Garcia, Marleny; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, POB 12233, Res Triangle Pk, NC 27709 USA; [Li, Rong; Adams, Nyssa; DeMayo, Francesco J.] NIEHS, Pregnancy & Female Reprod Grp, Reprod & Dev Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA; [Winuthayanon, Wipawee] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Adelman, Karen] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Washington State University; Baylor College of Medicine; Harvard University; Harvard Medical School	Hewitt, SC (corresponding author), NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, 111 Alexander Dr,MD E4-01, Res Triangle Pk, NC 27701 USA.	sylvia.hewitt@nih.gov	Hewitt, Sylvia/W-8752-2019; Winuthayanon, Wipawee/U-2153-2019	Hewitt, Sylvia/0000-0001-7713-0805; Winuthayanon, Wipawee/0000-0002-5196-8471; Adelman, Karen/0000-0001-5364-334X; Lierz, Sydney/0000-0002-9185-8576	NIH (NIEHS) [1Z1AE5070065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103311, ZICES102445, ZIAES070065] Funding Source: NIH RePORTER	NIH (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Drs. Karina Rodriguez and Ru-Pin Alicia Chi [both from the U.S. National Institutes of Health/National Institute of Environmental Health Sciences (NIH/NIEHS)] for critically reading the manuscript. The authors thank the NIH, NIEHS Histology Core for processing of tissue samples, and the NIEHS Microarray Core for analysis of samples. The expert surgical and animal care of the NIEHS Comparative Medicine Branch is greatly appreciated. This research was supported, in part, by the Intramural Research Program of the NIH, (NIEHS Grant 1Z1AE5070065 to K.S.K). The authors declare no conflicts of interest.	Adams NR, 2017, BIOL REPROD, V97, P400, DOI 10.1093/biolre/iox108; Adams NR, 2015, ADV ANAT EMBRYOL CEL, V216, P27, DOI 10.1007/978-3-319-15856-3_3; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Cha JM, 2015, ADV ANAT EMBRYOL CEL, V216, P69, DOI 10.1007/978-3-319-15856-3_5; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gupte R, 2013, P NATL ACAD SCI USA, V110, P14616, DOI 10.1073/pnas.1309898110; Hewitt SC, 2018, ENDOCR REV, V39, P664, DOI 10.1210/er.2018-00087; Hewitt SC, 2015, ENVIRON HEALTH PERSP, V123, P344, DOI 10.1289/ehp.1307935; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Kommagani R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005937; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liu XL, 2015, TRENDS BIOCHEM SCI, V40, P516, DOI 10.1016/j.tibs.2015.07.003; McEwan M, 2009, CYTOKINE GROWTH F R, V20, P241, DOI 10.1016/j.cytogfr.2009.05.004; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Patel B, 2015, HUM REPROD UPDATE, V21, P155, DOI 10.1093/humupd/dmu056; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Sun JL, 2010, J BIOL CHEM, V285, P6443, DOI 10.1074/jbc.M109.084285; Teng CT, 2002, BIOCHEM CELL BIOL, V80, P7, DOI 10.1139/o01-215; Watanabe H, 2006, J MOL ENDOCRINOL, V36, P81, DOI 10.1677/jme.1.01825; Williams LH, 2015, MOL CELL, V58, P311, DOI 10.1016/j.molcel.2015.02.003; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007	28	5	5	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3010	3023		10.1096/fj.201801752	http://dx.doi.org/10.1096/fj.201801752			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332301	Green Published, Bronze			2022-12-28	WOS:000457296600117
J	Liddelow, SA				Liddelow, Shane A.			Modern approaches to investigating non-neuronal aspects of Alzheimer's disease	FASEB JOURNAL			English	Review						astrocyte; glia; neurodegenerative disease; microglia	ASTROCYTE-SECRETED PROTEINS; GENOME-WIDE ASSOCIATION; CNS SYNAPTOGENESIS; BRAIN-BARRIER; SYNAPSE LOSS; MOUSE; CELLS; PROMOTE; TRANSCRIPTOME; PURIFICATION	The slow, continuous, devastating march of Alzheimer's disease continues to move across the globe. As a society, we are at a loss for options to treat or reverse the death of neuronsthe final, apparently inescapable, hallmark of the disease. A continued focus on these dying neurons has taught us much about the disease but with no knowledge-based effective treatment in sight. A surge of interest in non-neuronal cells, including glia, blood vasculature, and immune cells, has shed new light on how we may better diagnose and treat patients. This may be our best hope to treat the millions patients with cognitive decline and memory loss.Liddelow, S. A. Modern approaches to investigating non-neuronal aspects of Alzheimer's disease.	[Liddelow, Shane A.] NYU, Langone Med Ctr, Inst Neurosci, 435 E 30th St,11th Floor,New Sci Bldg,Room 1116, New York, NY 10016 USA; [Liddelow, Shane A.] NYU, Langone Med Ctr, Dept Neurosci & Physiol, 550 1St Ave, New York, NY 10016 USA; [Liddelow, Shane A.] Univ Melbourne, Melbourne, Vic, Australia	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Melbourne	Liddelow, SA (corresponding author), NYU, Langone Med Ctr, Inst Neurosci, 435 E 30th St,11th Floor,New Sci Bldg,Room 1116, New York, NY 10016 USA.	shane.liddelow@med.nyu.edu	Liddelow, Shane/ABE-6456-2020	Liddelow, Shane/0000-0002-0840-1437				Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; Bielschowsky M., 1903, NEUROL CENTRALBL, V22, P997; Blanco-Suarez E, 2018, NEURON, V100, P1116, DOI 10.1016/j.neuron.2018.09.043; Bohlen Christopher J, 2019, Curr Protoc Immunol, V125, pe70, DOI 10.1002/cpim.70; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Cajal S. R., 1920, Trabajos del Labororatorio de Investigaciones Biologicas de la Universidad de Madrid, V18, P129; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Eng F.L., 1970, T AM SOC NEUROCHEM, V1, P42; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Enzmann G, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418794184; Erickson MA, 2018, PHARMACOL REV, V70, P278, DOI 10.1124/pr.117.014647; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Ghersi-Egea JF, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-018-2375-8; Gorle N, 2018, BRAIN BEHAV IMMUN, V69, P35, DOI 10.1016/j.bbi.2017.12.010; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Guttenplan KA, 2019, J EXP MED, V216, P71, DOI 10.1084/jem.20180200; Hammond T. R., 2018, COMPLEX CELL STATE C; He LQ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.160; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jian WX, 2018, BRAIN RES BULL, V142, P360, DOI 10.1016/j.brainresbull.2018.08.012; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Li Q., 2018, DEV HETEROGENEITY MI; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Ramon y Cajal S., 1903, ARCH LATINOS MED BIO, V1, P1; Ramon y Cajal S., 1913, B SOC ESP BIO, V2, P104; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Saunders NR, 2008, TRENDS NEUROSCI, V31, P279, DOI 10.1016/j.tins.2008.03.003; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stogsdill JA, 2017, NATURE, V551, P192, DOI 10.1038/nature24638; UYEDA CT, 1972, BRAIN RES, V37, P81, DOI 10.1016/0006-8993(72)90347-2; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; WISNIEWSKI HM, 1991, NEUROBIOL AGING, V12, P593, DOI 10.1016/0197-4580(91)90091-W; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	67	11	12	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1528	1535		10.1096/fj.201802592	http://dx.doi.org/10.1096/fj.201802592			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30703873	Bronze			2022-12-28	WOS:000457296600002
J	Kiuchi, Z; Nishibori, Y; Kutsuna, S; Kotani, M; Hada, I; Kimura, T; Fukutomi, T; Fukuhara, D; Ito-Nitta, N; Kudo, A; Takata, T; Ishigaki, Y; Tomosugi, N; Tanaka, H; Matsushima, S; Ogasawara, S; Hirayama, Y; Takematsu, H; Yan, K				Kiuchi, Zentaro; Nishibori, Yukino; Kutsuna, Satoru; Kotani, Masashi; Hada, Ichiro; Kimura, Toru; Fukutomi, Toshiyuki; Fukuhara, Daisuke; Ito-Nitta, Noriko; Kudo, Akihiko; Takata, Takanobu; Ishigaki, Yasuhito; Tomosugi, Naohisa; Tanaka, Hirotoshi; Matsushima, Satsuki; Ogasawara, Shinya; Hirayama, Yoshiaki; Takematsu, Hiromu; Yan, Kunimasa			GLCCI1 is a novel protector against glucocorticoid-induced apoptosis in T cells	FASEB JOURNAL			English	Article						thymus; PAK1; LC8; phosphorylation	LIGHT-CHAIN; DYNEIN LIGHT-CHAIN-1; INDUCED GENE; THYMOCYTES; EXPRESSION; RECEPTOR; BIM; PHOSPHORYLATION; DEXAMETHASONE; TRANSCRIPTION	Glucocorticoids (GCs) potently induce T-cell apoptosis in a GC receptor (GR)-dependent manner and are used to control lymphocyte function in clinical practice. However, its downstream pathways remain controversial. Here, we showed that GC-induced transcript 1 (GLCCI1) is a novel downstream molecule of the GC-GR cascade that acts as an antiapoptotic mediator in thymic T cells. GLCCI1 was highly phosphorylated and colocalized with microtubules in GLCCI1-transfected human embryonic kidney QBI293A cells. GR-dependent up-regulation of GLCCI1 was associated with GC-induced proapoptotic events in a cultured thymocyte cell line. However, GLCCI1 knockdown in a thymocyte cell line led to apoptosis. Consistently, transgenic mice overexpressing human GLCCI1 displayed enlarged thymi that consisted of larger numbers of thymocytes. Further molecular characterization showed that GLCCI1 bound to both dynein light chain LC8-type 1 (LC8) and its functional kinase, p21-protein activated kinase 1 (PAK1), thereby inhibiting the kinase activity of PAK1 toward LC8 phosphorylation, a crucial event in apoptotic signaling. GLCCI1 induction facilitated LC8 dimer formation and reduced Bim expression. Thus, GLCCI1 is a candidate factor involved in apoptosis regulation of thymic T cells.-Kiuchi, Z., Nishibori, Y., Kutsuna, S., Kotani, M., Hada, I., Kimura, T., Fukutomi, T., Fukuhara, D., Ito-Nitta, N., Kudo, A., Takata, T., Ishigaki, Y., Tomosugi, N., Tanaka, H., Matsushima, S., Ogasawara, S., Hirayama, Y., Takematsu, H., Yan, K. GLCCI1 is a novel protector against glucocorticoid-induced apoptosis in T cells.	[Kiuchi, Zentaro; Nishibori, Yukino; Kutsuna, Satoru; Kotani, Masashi; Hada, Ichiro; Fukuhara, Daisuke; Ito-Nitta, Noriko; Yan, Kunimasa] Kyorin Univ, Sch Med, Dept Pediat, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan; [Kimura, Toru; Fukutomi, Toshiyuki] Kyorin Univ, Sch Med, Dept Toxicol & Pharmacol, Tokyo, Japan; [Kudo, Akihiko] Kyorin Univ, Sch Med, Dept Anat, Tokyo, Japan; [Matsushima, Satsuki] Kyorin Univ, Sch Med, Dept Lab Med, Tokyo, Japan; [Takata, Takanobu; Ishigaki, Yasuhito; Tomosugi, Naohisa] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa, Japan; [Tanaka, Hirotoshi] Univ Tokyo, Ctr Antibody & Vaccine Therapy, Inst Med Sci, Dept Rheumatol, Tokyo, Japan; [Ogasawara, Shinya; Hirayama, Yoshiaki] Denka Seiken Co Ltd, Res & Dev Dept, Gosen, Japan; [Takematsu, Hiromu] Kyoto Univ, Dept Biol Chem, Human Hlth Sci, Grad Sch Med, Kyoto, Japan; [Takematsu, Hiromu] Fujita Hlth Univ, Fac Med Technol, Grad Sch Hlth Sci, Dept Mol Cell Biol, Toyoake, Aichi, Japan	Kyorin University; Kyorin University; Kyorin University; Kyorin University; Kanazawa Medical University; University of Tokyo; Denka Company Limited; Kyoto University; Fujita Health University	Yan, K (corresponding author), Kyorin Univ, Sch Med, Dept Pediat, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	kuniyan@ks.kyorin-u.ac.jp	Kudo, Akihiko/ACZ-3340-2022	Kudo, Akihiko/0000-0002-2630-5991; Takematsu, Hiromu/0000-0003-1689-9500; Kiuchi, Zentaro/0000-0003-1302-7512	Ministry of Education, Culture, Sport, Science, and Technology of Japan [C 21591398]	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Yuko Kimura (Kyorin University School of Medicine) for the excellent technical assistance and Dr. Noritada Yoshikawa (University of Tokyo) for the valuable comments. This work was supported by The Ministry of Education, Culture, Sport, Science, and Technology of Japan, Grants-in-Aid for Scientific Research (Kakenhi; C 21591398). Z.K. and Y.N. are cofirst authors. The authors declare no conflicts of interest.	Al-Muhsen S, 2015, J ASTHMA, V52, P115, DOI 10.3109/02770903.2014.955189; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benison G, 2009, BIOCHEMISTRY-US, V48, P11381, DOI 10.1021/bi901589w; Berki T, 2002, INT IMMUNOL, V14, P463, DOI 10.1093/intimm/14.5.463; Boldizsar F, 2010, IMMUNOBIOLOGY, V215, P521, DOI 10.1016/j.imbio.2009.10.003; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; CHAPMAN MS, 1995, MOL CELL ENDOCRINOL, V108, pR1, DOI 10.1016/0303-7207(95)03481-L; Chapman MS, 1996, MOL ENDOCRINOL, V10, P967, DOI 10.1210/me.10.8.967; Chatzidionysiou K, 2017, ANN RHEUM DIS, V76, P1102, DOI 10.1136/annrheumdis-2016-210711; Chow SC, 1997, FEBS LETT, V408, P141, DOI 10.1016/S0014-5793(97)00308-6; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Daley SR, 2017, IMMUNOL REV, V277, P9, DOI 10.1111/imr.12532; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Espinasse MA, 2016, J INNATE IMMUN, V8, P81, DOI 10.1159/000439052; FORSTHOEFEL AM, 1987, MOL ENDOCRINOL, V1, P899, DOI 10.1210/mend-1-12-899; Gascoigne NRJ, 2016, ANNU REV CELL DEV BI, V32, P327, DOI 10.1146/annurev-cellbio-111315-125324; Gruver-Yates Amanda L, 2013, Cells, V2, P202, DOI 10.3390/cells2020202; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; KING SM, 1995, J CELL SCI, V108, P3757; King SM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.147pe51; Kohli V, 2018, DEV DYNAM, V247, P222, DOI 10.1002/dvdy.24556; Kong FK, 2002, J IMMUNOL, V168, P6500, DOI 10.4049/jimmunol.168.12.6500; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Malone MH, 2004, J BIOL CHEM, V279, P52850, DOI 10.1074/jbc.M408040200; Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067; Nishibori Y, 2011, J AM SOC NEPHROL, V22, P2037, DOI 10.1681/ASN.2010111147; Palinkas L, 2008, IMMUNOBIOLOGY, V213, P39, DOI 10.1016/j.imbio.2007.06.004; Pani A, 2013, AUTOIMMUN REV, V12, P848, DOI 10.1016/j.autrev.2012.11.012; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Savino W, 2016, NAT REV ENDOCRINOL, V12, P77, DOI 10.1038/nrendo.2015.168; SCREPANTI I, 1989, J IMMUNOL, V142, P3378; Sionov RV, 2015, ONCOTARGET, V6, P23058, DOI 10.18632/oncotarget.5492; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Takata T, 2012, ONCOL REP, V28, P1968, DOI 10.3892/or.2012.2020; Tantisira KG, 2011, NEW ENGL J MED, V365, P1173, DOI 10.1056/NEJMoa0911353; Trevor JL, 2014, ALLERGY, V69, P817, DOI 10.1111/all.12412; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Varughese AG, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0443-y; Vijverberg SJH, 2014, PHARMACOGENOMICS, V15, P799, DOI [10.2217/pgs.14.37, 10.2217/PGS.14.37]; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; Wiegers GJ, 2001, EUR J IMMUNOL, V31, P2293, DOI 10.1002/1521-4141(200108)31:8<2293::AID-IMMU2293>3.0.CO;2-I	50	13	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7387	7402		10.1096/fj.201800344RR	http://dx.doi.org/10.1096/fj.201800344RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30860871	Bronze			2022-12-28	WOS:000476114200058
J	Pin, F; Novinger, LJ; Huot, JR; Harris, RA; Couch, ME; O'Connell, TM; Bonetto, A				Pin, Fabrizio; Novinger, Leah J.; Huot, Joshua R.; Harris, Robert A.; Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea			PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia	FASEB JOURNAL			English	Article						skeletal muscle atrophy; energy metabolism; chemotherapy; mitochondria	PYRUVATE-DEHYDROGENASE KINASE; HUMAN SKELETAL-MUSCLE; UP-REGULATION; GENE FAMILY; MOUSE MODEL; EXPRESSION; MECHANISMS; TRANSCRIPTION; ACTIVATION; OXIDATION	Cachexia is frequently accompanied by severe metabolic derangements, although the mechanisms responsible for this debilitating condition remain unclear. Pyruvate dehydrogenase kinase (PDK)4, a critical regulator of cellular energetic metabolism, was found elevated in experimental models of cancer, starvation, diabetes, and sepsis. Here we aimed to investigate the link between PDK4 and the changes in muscle size in cancer cachexia. High PDK4 and abnormal energetic metabolism were found in the skeletal muscle of colon-26 tumor hosts, as well as in mice fed a diet enriched in Pirinixic acid, previously shown to increase PDK4 levels. Viral-mediated PDK4 overexpression in myotube cultures was sufficient to promote myofiber shrinkage, consistent with enhanced protein catabolism and mitochondrial abnormalities. On the contrary, blockade of PDK4 was sufficient to restore myotube size in C2C12 cultures exposed to tumor media. Our data support, for the first time, a direct role for PDK4 in promoting cancer-associated muscle metabolic alterations and skeletal muscle atrophy.-Pin, F., Novinger, L. J., Huot, J. R., Harris, R. A., Couch, M. E., O'Connell, T. M., Bonetto, A. PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia.	[Pin, Fabrizio; Bonetto, Andrea] Indiana Univ Purdue Univ, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Pin, Fabrizio; Huot, Joshua R.; Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea] Indiana Univ Purdue Univ, Ctr Cachexia Res Innovat & Therapy, Indianapolis, IN 46202 USA; [Novinger, Leah J.; Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [Huot, Joshua R.; Bonetto, Andrea] Indiana Univ Sch Med, Dept Surg, 980 W Walnut St,R3-C522, Indianapolis, IN 46202 USA; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea] Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bonetto, A (corresponding author), Indiana Univ Sch Med, Dept Surg, 980 W Walnut St,R3-C522, Indianapolis, IN 46202 USA.	abonetto@iu.edu		Bonetto, Andrea/0000-0002-3235-1871	IU Simon Cancer Center Support Grant [P30CA082709]; Department of Surgery; Department of Otolaryngology-Head and Neck Surgery at IU; V Foundation for Cancer Research [V2017-021]; American Cancer Society [132013-RSG-18-010-01-CCG]; IU Simon Cancer Center; Indiana Clinical and Translational Sciences Institute [UL1TR001108]; Showalter Research Trust; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER	IU Simon Cancer Center Support Grant; Department of Surgery; Department of Otolaryngology-Head and Neck Surgery at IU; V Foundation for Cancer Research; American Cancer Society(American Cancer Society); IU Simon Cancer Center; Indiana Clinical and Translational Sciences Institute; Showalter Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank the Cancer Center at Indiana University (IU) School of Medicine funded by the IU Simon Cancer Center Support Grant (P30CA082709) for the use of the In Vivo Therapeutics Core Facility, which generated the NSG mice used in this study. The 12G10 anti-tubulin mAb developed by J. Frankel and E.M. Nelson (University of Iowa, Iowa City, IA, USA) and the MF-20 anti-myosin heavy chain antibody developed by Donald A. Fischman (Cornell University, Ithaca, NY, USA) were obtained from the Developmental Studies Hybridoma Bank, created by the U.S. National Institutes of Health, National Institute of Child Health, and maintained at the Department of Biology at The University of Iowa. The authors thank John Spence, Ph.D. for contributions in editing the manuscript, and Teresa A. Zimmers, Ph.D. (both from the IU School of Medicine) for allowing access to the equipment for in vivo characterization of cachexia. This study was supported by the Department of Surgery and the Department of Otolaryngology-Head and Neck Surgery at IU, and by grants from the V Foundation for Cancer Research (V2017-021 to A.B.), the American Cancer Society (Research Scholar Grant 132013-RSG-18-010-01-CCG to A. B.), the IU Simon Cancer Center (Associate Member Pilot Funding Mechanism to A.B.), the Indiana Clinical and Translational Sciences Institute (Core Pilot Grant UL1TR001108 to T.M.O. and A.B.),and the Showalter Research Trust (to A.B.). The authors declare no conflicts of interest.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Araki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072148; Asp ML, 2011, CANCER BIOL THER, V12, P957, DOI 10.4161/cbt.12.11.18134; Barreto R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00472; Barreto R, 2016, ONCOTARGET, V7, P43442, DOI 10.18632/oncotarget.9779; Bonetto A, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.101; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bossola M, 2001, AM J PHYSIOL-REG I, V280, pR1518, DOI 10.1152/ajpregu.2001.280.5.R1518; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023; Constantin-Teodosiu D, 2012, DIABETES, V61, P1017, DOI 10.2337/db11-0799; Crossland H, 2017, CLIN SCI, V131, P1437, DOI 10.1042/CS20170958; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Degenhardt T, 2007, J MOL BIOL, V372, P341, DOI 10.1016/j.jmb.2007.06.091; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fukawa T, 2016, NAT MED, V22, P666, DOI 10.1038/nm.4093; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Fuster G, 2007, CANCER RES, V67, P6512, DOI 10.1158/0008-5472.CAN-07-0231; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Gudiksen A, 2017, AM J PHYSIOL-ENDOC M, V312, pE204, DOI 10.1152/ajpendo.00291.2016; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; He WA, 2014, P NATL ACAD SCI USA, V111, P4525, DOI 10.1073/pnas.1402714111; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Johns N, 2013, INT J BIOCHEM CELL B, V45, P2215, DOI 10.1016/j.biocel.2013.05.032; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim YI, 2006, DIABETES, V55, P2311, DOI 10.2337/db05-1606; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Leclerc D, 2017, BRIT J CANCER, V116, P930, DOI 10.1038/bjc.2017.38; Liu ZB, 2014, J BIOL CHEM, V289, P29739, DOI 10.1074/jbc.M114.584821; Mallinson JE, 2012, J PHYSIOL-LONDON, V590, P6389, DOI 10.1113/jphysiol.2012.238022; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Murphy KT, 2013, AM J PHYSIOL-REG I, V304, pR854, DOI 10.1152/ajpregu.00057.2013; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433; Peters SJ, 2003, BIOCHEM SOC T, V31, P1274, DOI 10.1042/BST0311274; Petruzzelli M, 2016, GENE DEV, V30, P489, DOI 10.1101/gad.276733.115; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Pin F., 2019, J CACHEXIA SARCOPENI; Pin F, 2018, J CACHEXIA SARCOPENI, V9, P685, DOI 10.1002/jcsm.12311; Pin F, 2015, ONCOTARGET, V6, P43202, DOI 10.18632/oncotarget.6439; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shrivastav S, 2013, MOL ENDOCRINOL, V27, P1564, DOI 10.1210/me.2012-1370; Skipworth RJE, 2007, CLIN NUTR, V26, P667, DOI 10.1016/j.clnu.2007.03.011; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; Srivastava N, 2014, CELL METAB, V20, P650, DOI 10.1016/j.cmet.2014.08.003; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; Tzika AA, 2013, INT J ONCOL, V43, P886, DOI 10.3892/ijo.2013.1998; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Wu PF, 1999, DIABETES, V48, P1593, DOI 10.2337/diabetes.48.8.1593; Zhang Y, 2016, J BIOL CHEM, V291, P17405, DOI 10.1074/jbc.M116.713735; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	64	30	31	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7778	7790		10.1096/fj.201802799R	http://dx.doi.org/10.1096/fj.201802799R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30894018	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000476114200089
J	Wu, M; Lin, PL; Li, L; Chen, DP; Yang, XJ; Xu, L; Zhou, B; Wang, C; Zhang, YY; Luo, C; Ye, CY				Wu, Ming; Lin, Pinglan; Li, Lin; Chen, Dongping; Yang, Xuejun; Xu, Lin; Zhou, Bing; Wang, Chen; Zhang, Yuanyuan; Luo, Cheng; Ye, Chaoyang			Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys	FASEB JOURNAL			English	Article						PRMT1; ADMA; NO; CKD	RAT MODEL; DISEASE; PROGRESSION; METABOLISM; PATHWAYS	The role of asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD) is unclear. Through inhibition of type I protein arginine methyltransferases (PRMTs), a novel strategy, we aimed to determine the effect of ADMA on renal fibrosis and explore its underlying working mechanisms. After sham or unilateral ureter ligation (UUO) operation, 20-25 g male c57 mice were treated with vehicle or PT1001B, an inhibitor of type I PRMTs, for 13 d. Moreover, human kidney 2 (HK2) and normal rat kidney 49F (NRK-49F) cells were treated with various concentrations of PT1001B or ADMA in the presence of 2.5 ng/ml TGF-beta. We found that treatment with PT1001B increased the deposition of extracellular matrix proteins, the expression of alpha smooth muscle actin, and connective tissue growth factor in UUO-induced fibrotic kidneys, which is correlated with reduced expression of PRMT1, reduced the production of ADMA, and increased expression of uromodulin. In TGF-beta-stimulated HK2 and NRK-49F cells, PT1001B dose-dependently inhibited ADMA production, increased NO concentrations, and enhanced the expression of profibrotic proteins. Exogenous addition of ADMA inhibited the expression of profibrotic proteins dose-dependently and attenuated the profibrotic effect of PT1001B. Moreover, ADMA reduced the NO concentration in PT1001B-treated HK2 cells. Finally, we conclude that ADMA has an antifibrotic effect in obstructed kidneys, and future application of type I PRMT inhibitor should be done cautiously for patients with CKD.-Wu, M., Lin, P., Li, L., Chen, D., Yang, X., Xu, L., Zhou, B., Wang, C., Zhang, Y., Luo, C., Ye, C. Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys.	[Wu, Ming; Lin, Pinglan; Chen, Dongping; Yang, Xuejun; Xu, Lin; Ye, Chaoyang] Shanghai Univ Tradit Chinese Med, Dept Nephrol, Shuguang Hosp,Shanghai Key Lab Tradit Chinese Cli, Key Lab Liver & Kidney Dis,Minist Educ,TCM,Inst K, Shanghai, Peoples R China; [Li, Lin] Second Mil Med Univ, Shanghai Changzheng Hosp, Kidney Inst, Dept Nephrol, Shanghai, Peoples R China; [Zhou, Bing; Wang, Chen; Zhang, Yuanyuan; Luo, Cheng] Chinese Acad Sci, Key Lab Receptor Res, Drug Discovery & Design Ctr, Shanghai Inst Mat Med,State Key Lab Drug Res, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Naval Medical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Wu, M; Ye, CY (corresponding author), Shanghai Univ Tradit Chinese Med, Dept Nephrol, Shuguang Hosp, 528 Zhangheng Rd, Shanghai 201203, Peoples R China.	mingwunl@126.com; yechaoyang63@126.com		Wu, Ming/0000-0002-8095-8766	Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai [PWZxq2017-07]; Three Year Action Plan Project of Shanghai Accelerating Development of Traditional Chinese Medicine [(2018-2020)-CCCX-2003-08]; National Natural Science Foundation of China [81873617, 81603591, 81470914, 81100482]; Scientific Research Foundation of Shanghai Municipal Commission of Health and Family Planning [201740193]; Science Foundation of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (TCM) [SGKJ-201712]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2018ZX09711002]	Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai; Three Year Action Plan Project of Shanghai Accelerating Development of Traditional Chinese Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Shanghai Municipal Commission of Health and Family Planning; Science Foundation of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (TCM); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"	This work was supported by the Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai (PWZxq2017-07), the Three Year Action Plan Project of Shanghai Accelerating Development of Traditional Chinese Medicine [ZY(2018-2020)-CCCX-2003-08], the National Natural Science Foundation of China (81873617 to C.Y. and 81603591 to L.X.), the Scientific Research Foundation of Shanghai Municipal Commission of Health and Family Planning (201740193 to M.W.), the National Natural Science Foundation of China General Projects (81470914 and 81100482 to L.L.), the Science Foundation of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (TCM; SGKJ-201712 to P.L.), and the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2018ZX09711002 to Y.Z.). The authors declare no conflicts of interest.	Bayen S, 2018, ENDOCRINE, V59, P151, DOI 10.1007/s12020-017-1463-6; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Eiselt J, 2014, KIDNEY BLOOD PRESS R, V39, P50, DOI 10.1159/000355776; Elliott MJ, 2017, NEPHROL DIAL TRANSPL, V32, P838, DOI 10.1093/ndt/gfw208; Gewin L, 2017, KIDNEY INT, V91, P552, DOI 10.1016/j.kint.2016.08.025; Jager KJ, 2017, NEPHROL DIAL TRANSPL, V32, P121, DOI 10.1093/ndt/gfw330; Jing Y, 2018, AM J PHYSIOL-RENAL, V315, pF479, DOI 10.1152/ajprenal.00329.2017; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu T, 2019, FASEB J, V33, P1565, DOI 10.1096/fj.201701355RR; Matsumoto Y, 2007, J AM SOC NEPHROL, V18, P1525, DOI 10.1681/ASN.2006070696; Mihout F, 2011, J PATHOL, V223, P37, DOI 10.1002/path.2769; Shi LL, 2017, ANTIOXID REDOX SIGN, V27, P1347, DOI 10.1089/ars.2017.7022; Tomlinson JAP, 2015, J AM SOC NEPHROL, V26, P3045, DOI 10.1681/ASN.2014030280; Ueda Seiji, 2007, Clin Exp Nephrol, V11, P115, DOI 10.1007/s10157-007-0471-x; Wang C, 2017, J MED CHEM, V60, P8888, DOI 10.1021/acs.jmedchem.7b01134; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457	18	13	14	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6948	6956		10.1096/fj.201802585RR	http://dx.doi.org/10.1096/fj.201802585RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30840839	Bronze			2022-12-28	WOS:000476114200022
J	Lin, Y; Wu, CC; Wang, XY; Liu, S; Kemper, T; Li, FH; Squire, A; Zhu, Y; Zhang, JM; Chen, XW; Lu, MJ				Lin, Yong; Wu, Chunchen; Wang, Xueyu; Liu, Shi; Kemper, Thekla; Li, Fahong; Squire, Anthony; Zhu, Ying; Zhang, Jiming; Chen, Xinwen; Lu, Mengji			Synaptosomal-associated protein 29 is required for the autophagic degradation of hepatitis B virus	FASEB JOURNAL			English	Article						HBV; SNAP29; VAMP8; autophagy	LYSOSOME FUSION; REPLICATION; COMPLEX; SUPPRESSION; ACTIVATION; INFECTION	Hepatitis B virus (HBV) replication and envelopment is dependent on cellular autophagy. Previously, we have provided evidence for the extensive lysosomal degradation of HBV virions and the hepatitis B surface antigen (HBsAg), which is likely controlled by autophagosome-lysosome fusion. Synaptosomal-associated protein 29 (SNAP29) has been identified as a protein specifically mediating autophagosome-lysosome fusion. Thus, in the present study, we addressed the hypothesis that SNAP29 is required for the autophagic degradation of HBV virions and HBsAg. We found that silencing SNAP29 significantly increased the number of autophagosomes and concomitantly promoted HBV replication and HBsAg production. Conversely, SNAP29 overexpression decreased HBV production. Consistent with this, SNAP29 modulated HBV production by interacting with vesicle-associated membrane protein 8 (VAMP8) and synergistically regulated HBV replication with Rab7 complexes. Moreover, the production and release of the small HBsAg is strongly regulated by SNAP29 expression, suggesting that its export occurs partly through the autophagic pathway. Our findings provide new evidence, strongly suggesting that autophagic degradation critically determines the production of HBV virions and HBsAg and that this is controlled by the SNAP29-VAMP8 interaction.Lin, Y., Wu, C., Wang, X., Liu, S., Kemper, T., Li, F., Squire, A., Zhu, Y., Zhang, J., Chen, X., Lu, M. Synaptosomal-associated protein 29 is required for the autophagic degradation of hepatitis B virus.	[Lin, Yong; Wang, Xueyu; Liu, Shi; Kemper, Thekla; Li, Fahong; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Squire, Anthony] Univ Duisburg Essen, Univ Hosp Essen, Inst Expt Immunol & Imaging, Essen, Germany; [Wu, Chunchen; Chen, Xinwen] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Liu, Shi; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Li, Fahong; Zhang, Jiming] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China	University of Duisburg Essen; University of Duisburg Essen; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan University; Fudan University	Lu, MJ (corresponding author), Univ Hosp Essen, Inst Virol, Hufelandstr 55, D-45122 Essen, Germany.	mengji.lu@uni-due.de	Lu, Mengji/ABF-9410-2020		Deutsche Forschungsgemeinschaft [RTG1949/2, Transregio TRR60]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RTG1949/2 and Transregio TRR60). The authors declare no conflicts of interest.	Arasaki K, 2018, EMBO REP, V19, DOI 10.15252/embr.201745584; Carman WF, 1997, HEPATOLOGY, V26, P1658, DOI 10.1002/hep.510260640; Chua CEL, 2012, J CELL PHYSIOL, V227, P3722, DOI 10.1002/jcp.24082; Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147; Ding BB, 2014, CELL HOST MICROBE, V15, P564, DOI 10.1016/j.chom.2014.04.004; Doring T, 2018, J VIROL, V92, DOI 10.1128/JVI.01513-17; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Inoue J, 2015, J CELL SCI, V128, P1696, DOI 10.1242/jcs.158097; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Kimura T, 2017, EMBO J, V36, P42, DOI 10.15252/embj.201695081; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Lin Y, 2019, PROTEIN CELL, V10, P60, DOI 10.1007/s13238-018-0555-2; Lin Y, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12709; Liu B, 2014, AUTOPHAGY, V10, P416, DOI 10.4161/auto.27286; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mohamud Y, 2018, CELL REP, V22, P3292, DOI 10.1016/j.celrep.2018.02.090; Pellegrini P, 2014, AUTOPHAGY, V10, P562, DOI 10.4161/auto.27901; SCHIRMBECK R, 1995, J VIROL, V69, P5929, DOI 10.1128/JVI.69.10.5929-5934.1995; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Selzer L, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021394; Sir D, 2010, AUTOPHAGY, V6, P548, DOI 10.4161/auto.6.4.11669; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Szatmari Z, 2014, AUTOPHAGY, V10, P1154, DOI 10.4161/auto.29395; Tang LSY, 2018, JAMA-J AM MED ASSOC, V319, P1802, DOI 10.1001/jama.2018.3795; Tian YJ, 2011, J VIROL, V85, P13453, DOI 10.1128/JVI.06064-11; Tong SP, 2016, J HEPATOL, V64, pS4, DOI 10.1016/j.jhep.2016.01.027; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Xie N, 2016, AUTOPHAGY, V12, P1507, DOI 10.1080/15548627.2016.1191857; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zhou TH, 2016, BIOSCI TRENDS, V10, P244, DOI 10.5582/bst.2016.01049	34	16	16	6	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6023	6034		10.1096/fj.201801995RR	http://dx.doi.org/10.1096/fj.201801995RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30742775	Bronze			2022-12-28	WOS:000466932600019
J	Wang, QJ; Hassan, BH; Lou, NJ; Merritt, J; Feng, YJ				Wang, Qingjing; Hassan, Bachar H.; Lou, Ningjie; Merritt, Justin; Feng, Youjun			Functional definition of NrtR, a remnant regulator of NAD(+) homeostasis in the zoonotic pathogen Streptococcus suis	FASEB JOURNAL			English	Article						NAD(+) salvage; Nudix-related transcriptional regulator; ADP-ribose; SS2; virulence	DEPENDENT TRANSCRIPTIONAL REGULATOR; ADP-RIBOSE; NADR REGULATOR; METABOLISM; VIRULENCE; BIOSYNTHESIS; REPRESSOR; BINDING; FAMILY; DOMAIN	NAD(+) is an enzyme cofactor required for the 3 domains of life. However, little is known about the NAD(+) biosynthesis and salvage pathways in the opportunistic pathogen Streptococcus suis. A genome-wide search allows us to identify the NAD(+) salvage pathway encoded by an operon of nadR-pnuC-nrtR (from SSU05_1973 to SSU05_1971 on the reverse strand) in the S. suis 05ZYH33 that causes streptococcal toxin shock-like syndrome. The regulator of this pathway is Nudix-related transcriptional regulator (NrtR), a transcription regulator of the Nudix family comprising an N-terminal Nudix-like effector domain, and a C-terminal DNA-binding winged helix-turn-helix-like domain. Intriguingly, the S. suis NrtR naturally contains a single amino acid substitution (K92E) in the catalytic site of its Nudix domain that renders it catalytically inactive but does not influence its ability to bind DNA. Despite its lack of enzymatic activity, DNA-binding activity of NrtR is antagonized by the effector ADP-ribose. Furthermore, nrtR knockout in S. suis serotype 2 reduces its capacity to form biofilms and attenuates its virulence in a mouse infection model. Genome mining indicates that nrtR appears in a strain-specific manner whose occupancy is correlated to bacterial infectivity. Unlike the paradigmatic member of NrtR family having 2 unrelated functions (Nudix hydrolase and DNA binding), S. suis 2 retains a single regulatory role in the modulation of NAD(+) salvage. This control of NAD(+) homeostasis contributes to S. suis virulence.Wang, Q., Hassan, B. H., Lou, N., Merritt, J., Feng, Y. Functional definition of NrtR, a remnant regulator of NAD(+) homeostasis in the zoonotic pathogen Streptococcus suis.	[Wang, Qingjing; Lou, Ningjie; Feng, Youjun] Zhejiang Univ, Dept Pathogen Biol & Microbiol, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Qingjing; Lou, Ningjie; Feng, Youjun] Zhejiang Univ, Dept Gen Intens Care Unit, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Hassan, Bachar H.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Merritt, Justin] Oregon Hlth & Sci Univ, Dept Restorat Dent, Portland, OR 97201 USA	Zhejiang University; Zhejiang University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Oregon Health & Science University	Feng, YJ (corresponding author), Zhejiang Univ, Dept Pathogen Biol & Microbiol, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Feng, YJ (corresponding author), Zhejiang Univ, Dept Gen Intens Care Unit, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	fengyj@zju.edu.cn			National Natural Science Foundation of China [81772142, 31830001]; National Key R&D Program of China [2017YFD0500202]; national Thousand Talents Program of China; National Institutes of Health; National Institute of Dental and Craniofacial Research Grants [DE018893, DE022083, DE028252]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; national Thousand Talents Program of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research Grants	This work was supported by the National Natural Science Foundation of China (81772142 and 31830001, to Y.F.) and the National Key R&D Program of China (2017YFD0500202, to Y.F.). Y.F. is a recipient of the national Thousand Talents Program of China. J.M. is supported by National Institutes of Health and National Institute of Dental and Craniofacial Research Grants (DE018893, DE022083, and DE028252). The authors declare no conflicts of interest.	Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Chen C, 2018, NUCLEIC ACIDS RES, V46, pD640, DOI 10.1093/nar/gkx1043; DOM P, 1992, J VET MED B, V39, P303, DOI 10.1111/j.1439-0450.1992.tb01173.x; Feng Y, 2009, ZOONOSES PUBLIC HLTH, V56, P506, DOI 10.1111/j.1863-2378.2008.01225.x; Feng YJ, 2014, VIRULENCE, V5, P477, DOI 10.4161/viru.28595; Feng YJ, 2014, MOL MICROBIOL, V91, P300, DOI 10.1111/mmi.12460; Feng YJ, 2011, MOL MICROBIOL, V80, P195, DOI 10.1111/j.1365-2958.2011.07564.x; Feng YJ, 2010, J BACTERIOL, V192, P4289, DOI 10.1128/JB.00516-10; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Calixto GMF, 2018, INT J NANOMED, V13, P31, DOI 10.2147/IJN.S147553; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gerasimova Anna V., 2005, Journal of Bioinformatics and Computational Biology, V3, P1007, DOI 10.1142/S0219720005001387; Grose JH, 2005, J BACTERIOL, V187, P2774, DOI 10.1128/JB.187.8.2774-2782.2005; Huang N, 2008, STRUCTURE, V16, P196, DOI 10.1016/j.str.2007.11.017; Huang N, 2009, STRUCTURE, V17, P939, DOI 10.1016/j.str.2009.05.012; Johnson MDL, 2015, MICROBIOL-SGM, V161, P2127, DOI 10.1099/mic.0.000164; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; Kurnasov OV, 2002, J BACTERIOL, V184, P6906, DOI 10.1128/JB.184.24.6906-6917.2002; Li Q, 2018, VET MICROBIOL, V216, P198, DOI 10.1016/j.vetmic.2018.02.013; Mushegian Arcady, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P127; Okon E, 2017, INT J MED MICROBIOL, V307, P83, DOI 10.1016/j.ijmm.2016.09.007; Okuda K, 2005, J BACTERIOL, V187, P4984, DOI 10.1128/JB.187.14.4984-4991.2005; Penfound T, 1999, J BACTERIOL, V181, P648, DOI 10.1128/JB.181.2.648-655.1999; Raffaelli N, 1999, J BACTERIOL, V181, P5509, DOI 10.1128/JB.181.17.5509-5511.1999; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2032, DOI 10.1093/nar/gkn046; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rossolillo P, 2005, J BACTERIOL, V187, P7155, DOI 10.1128/JB.187.20.7155-7160.2005; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tang JQ, 2006, PLOS MED, V3, P1439, DOI 10.1371/journal.pmed.0030377; Teramoto H, 2012, MICROBIOL-SGM, V158, P975, DOI 10.1099/mic.0.057513-0; Vu CQ, 1997, ADV EXP MED BIOL, V419, P381; Ye HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26479; Zhang HM, 2015, MICROBIOLOGYOPEN, V4, P983, DOI 10.1002/mbo3.307	36	8	8	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6055	6068		10.1096/fj.201802179RR	http://dx.doi.org/10.1096/fj.201802179RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30759348	Bronze, Green Published			2022-12-28	WOS:000466932600022
J	Zhang, XD; Xie, XT; Heckmann, BL; Saarinen, AM; Gu, HW; Zechner, R; Liu, J				Zhang, Xiaodong; Xie, Xitao; Heckmann, Bradlee L.; Saarinen, Alicia M.; Gu, Haiwei; Zechner, Rudolf; Liu, Jun			Identification of an intrinsic lysophosphatidic acid acyltransferase activity in the lipolytic inhibitor G(0)/G(1) switch gene 2 (G0S2)	FASEB JOURNAL			English	Article						LPA acyltransferase; fatty liver disease; hepatic steatosis; lipolysis; lipogenesis	ADIPOSE TRIGLYCERIDE LIPASE; FATTY LIVER-DISEASE; TRIACYLGLYCEROL LIPASE; MOLECULAR-MECHANISMS; MEDIATED LIPOLYSIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; LIPID-METABOLISM; X-RECEPTOR; MICE	G(0)/G(1) switch gene 2 (G0S2) is a specific inhibitor of adipose triglyceride lipase (ATGL), the rate-limiting enzyme for intracellular lipolysis. Recent studies show that G0S2 plays a critical role in promoting triacylglycerol (TG) accumulation in the liver, and its encoding gene is a direct target of a major lipogenic transcription factor liver X receptor (LXR). Here we sought to investigate a lipolysis-independent role of G0S2 in hepatic triglyceride synthesis. Knockdown of G0S2 decreased hepatic TG content in mice with ATGL ablation. Conversely, overexpression of G0S2 promoted fatty acid incorporation into TGs and diacylglycerols in both wild-type and ATGL-deficient hepatocytes. Biochemical characterization showed that G0S2 mediates phosphatidic acid synthesis from lysophosphatidic acid (LPA) and acyl-coenzyme A. In response to a high-sucrose lipogenic diet, G0S2 is up-regulated via LXR and required for the increased TG accumulation in liver. Furthermore, deletion of a distinct 4-aa motif necessary for the LPA-specific acyltransferase (LPAAT) activity impaired G0S2's ability to mediate TG synthesis both in vitro and in vivo. These studies identify G0S2 as a dual-function regulator of lipid metabolism as well as a novel mechanism whereby hepatic TG storage is promoted in response to lipogenic stimulation. In addition to its role as a lipolytic inhibitor, G0S2 is capable of directly promoting TG synthesis by acting as a lipid-synthesizing enzyme.Zhang, X., Xie, X., Heckmann, B. L., Saarinen, A. M., Gu, H., Zechner, R., Liu, J. Identification of an intrinsic lysophosphatidic acid acyltransferase activity in the lipolytic inhibitor G(0)/G(1) switch gene 2 (G0S2).	[Zhang, Xiaodong; Saarinen, Alicia M.; Liu, Jun] Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Liu, Jun] Mayo Clin, Coll Med & Sci, Div Endocrinol, Rochester, MN 55905 USA; [Xie, Xitao] Arizona State Univ, Dept Chem Engn, Tempe, AZ USA; [Heckmann, Bradlee L.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Gu, Haiwei] Arizona State Univ, Coll Hlth Solut, Ctr Metab & Vasc Biol, Scottsdale, AZ USA; [Zechner, Rudolf] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria	Mayo Clinic; Mayo Clinic; Arizona State University; Arizona State University-Tempe; St Jude Children's Research Hospital; Arizona State University; University of Graz	Liu, J (corresponding author), Mayo Clin, Coll Med & Sci, Guggenheim Bldg 14-05,222 3rd Ave SW, Rochester, MN 55905 USA.	liu.jun@mayo.edu		Heckmann, Bradlee/0000-0002-3271-7183	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK089178, DK109096]; Mayo Foundation for Medical Education and Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109096] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Foundation for Medical Education and Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the West Coast Metabolomics Center (University of California-Davis, Davis, CA, USA) for expertise and assistance in lipid profiling. This work was supported by research grants from the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (DK089178 and DK109096 to J.L.), as well as predoctoral funding to B.L.H. from the Mayo Foundation for Medical Education and Research. The authors declare no conflicts of interest.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2011, J BIOL CHEM, V286, P37676, DOI 10.1074/jbc.M111.250449; Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Barrows BR, 2005, DIABETES, V54, P2668, DOI 10.2337/diabetes.54.9.2668; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Cerk IK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602599; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; El-Assaad W, 2015, DIABETOLOGIA, V58, P149, DOI 10.1007/s00125-014-3429-z; Girousse A, 2012, INT J OBESITY, V36, P581, DOI 10.1038/ijo.2011.113; Green CJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE1, DOI 10.1152/ajpendo.00192.2014; Guo F, 2013, J LIPID RES, V54, P2109, DOI 10.1194/jlr.M035519; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Heckmann BL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88735; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kato M, 2008, SCAND J GASTROENTERO, V43, P1018, DOI 10.1080/00365520802008140; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lou-Bonafonte JM, 2011, CURR OPIN LIPIDOL, V22, P159, DOI 10.1097/MOL.0b013e3283462288; Ma T, 2014, CANCER BIOL THER, V15, P643, DOI 10.4161/cbt.28251; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839; McMahon D, 2014, J LIPID RES, V55, P1750, DOI 10.1194/jlr.M051151; Miyazaki M, 2001, J LIPID RES, V42, P1018; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Petta S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122082; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Schreiber R, 2015, P NATL ACAD SCI USA, V112, P13850, DOI 10.1073/pnas.1516004112; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweitzer GG, 2015, J LIPID RES, V56, P848, DOI 10.1194/jlr.M055962; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Yamashita Atsushi, 2014, Biology (Basel), V3, P801, DOI 10.3390/biology3040801; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	49	11	11	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6655	6666		10.1096/fj.201802502R	http://dx.doi.org/10.1096/fj.201802502R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30802154	Green Published, Bronze			2022-12-28	WOS:000466932600067
J	Cohen-Sharir, Y; Kuperman, Y; Apelblat, D; den Hertog, J; Spiegel, I; Knobler, H; Elson, A				Cohen-Sharir, Yael; Kuperman, Yael; Apelblat, Daniella; den Hertog, Jeroen; Spiegel, Ivo; Knobler, Hilla; Elson, Ari			Protein tyrosine phosphatase alpha inhibits hypothalamic leptin receptor signaling and regulates body weight in vivo	FASEB JOURNAL			English	Article						obesity; leptin resistance; JAK2; PTPRA	PTP-ALPHA; RPTP-ALPHA; MEDIATED PHOSPHORYLATION; INSULIN SENSITIVITY; KINASE ACTIVATION; MICE LACKING; SRC; EPSILON; CONTRIBUTES; RESISTANCE	Understanding how body weight is regulated at the molecular level is essential for treating obesity. We show that female mice genetically lacking protein tyrosine phosphatase (PTP) receptor type (PTPRA) exhibit reduced weight and adiposity and increased energy expenditure, and are more resistant to diet-induced obesity than matched wild-type control mice. These mice also exhibit reduced levels of circulating leptin and are leptin hypersensitive, suggesting that PTPRA inhibits leptin signaling in the hypothalamus. Male and female PTPRA-deficient mice fed a high-fat diet were leaner and displayed increased metabolic rates and lower circulating leptin levels, indicating that the effects of loss of PTPRA persist in the obese state. Molecularly, PTPRA down-regulates leptin receptor signaling by dephosphorylating the receptor-associated kinase JAK2, with which the phosphatase associates constitutively. In contrast to the closely related tyrosine phosphatase epsilon, leptin induces only weak phosphorylation of PTPRA at its C-terminal regulatory site Y789, and this does not affect the activity of PTPRA toward JAK2. PTPRA is therefore an inhibitor of hypothalamic leptin signaling in vivo and may prevent premature activation of leptin signaling, as well as return signaling to baseline after exposure to leptin.	[Cohen-Sharir, Yael; Elson, Ari] Weizmann Inst Sci, Dept Mol Genet, 234 Herzl St, IL-76100 Rehovot, Israel; [Kuperman, Yael] Weizmann Inst Sci, Dept Vet Resources, Rehovot, Israel; [Apelblat, Daniella; Spiegel, Ivo] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [den Hertog, Jeroen] Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [den Hertog, Jeroen] Inst Biol Leiden, Leiden, Netherlands; [Knobler, Hilla] Kaplan Med Ctr, Diabet Endocrinol & Metab Inst, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Leiden University; Hebrew University of Jerusalem; Kaplan Medical Center	Elson, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, 234 Herzl St, IL-76100 Rehovot, Israel.	ari.elson@weizmann.ac.il		Elson, Ari/0000-0001-9808-9135	Kekst Family Institute for Medical Genetics of The Weizmann Institute of Science; David and Fela Shapell Family Center for Genetic Disorders Research of The Weizmann Institute of Science	Kekst Family Institute for Medical Genetics of The Weizmann Institute of Science; David and Fela Shapell Family Center for Genetic Disorders Research of The Weizmann Institute of Science	The authors thank Prof. Michel Tremblay (McGill University) for reagents, and Prof. Alon Chen (Weizmann Institute) for discussions. The authors also thank Dr. Maayan Barnea, Dr. Ron Rotkopf, and Dr. Michael Tsoory for assistance with statistical analyses; and Ofira Higfa and Neriah Sharabi (all from the Weizmann Institute) for expert animal care. This study was supported by the Kekst Family Institute for Medical Genetics and the David and Fela Shapell Family Center for Genetic Disorders Research, both of The Weizmann Institute of Science (to A.E.). A.E. is the incumbent of the Marshall and Renette Ezralow Professorial Chair. Y.K. is the incumbent of the Sarah and Rolando Uziel Research Associate Chair. The authors declare no conflicts of interest.	Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Berman-Golan D, 2007, ONCOGENE, V26, P7028, DOI 10.1038/sj.onc.1210505; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cheng SYS, 2014, MOL CELL BIOL, V34, P348, DOI 10.1128/MCB.00825-13; Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Finkelshtein E, 2014, MOL BIOL CELL, V25, P1808, DOI 10.1091/mbc.E14-03-0788; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; Huang J, 2011, EMBO J, V30, P3200, DOI 10.1038/emboj.2011.212; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Krajewska M, 2008, AM J PATHOL, V172, P1312, DOI 10.2353/ajpath.2008.070594; Levy-Apter E, 2014, J BIOL CHEM, V289, P36048, DOI 10.1074/jbc.M114.603548; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Maksumova L, 2007, J BIOL CHEM, V282, P20925, DOI 10.1074/jbc.M703157200; Meyer DS, 2014, ONCOGENE, V33, P398, DOI 10.1038/onc.2012.585; Morrison CD, 2007, ENDOCRINOLOGY, V148, P433, DOI 10.1210/en.2006-0672; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002; Park Hyeong-Kyu, 2014, F1000Prime Rep, V6, P73, DOI 10.12703/P6-73; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Rousso-Noori L, 2011, CELL METAB, V13, P562, DOI 10.1016/j.cmet.2011.02.017; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Shintani T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12070-7; Sines T, 2007, MOL CELL BIOL, V27, P7102, DOI 10.1128/MCB.02096-06; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; Truffi M, 2014, J CELL SCI, V127, P2420, DOI 10.1242/jcs.134379; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Wauman J, 2011, FRONT BIOSCI-LANDMRK, V16, P2771, DOI 10.2741/3885; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2002, J BIOL CHEM, V277, P21922, DOI 10.1074/jbc.M201394200; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	51	2	3	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5101	5111		10.1096/fj.201800860RR	http://dx.doi.org/10.1096/fj.201800860RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30615487				2022-12-28	WOS:000462888500039
J	Goetzl, EJ; Elahi, FM; Mustapic, M; Kapogiannis, D; Pryhoda, M; Gilmore, A; Gorgens, KA; Davidson, B; Granholm, AC; Ledreux, A				Goetzl, Edward J.; Elahi, Fanny M.; Mustapic, Maja; Kapogiannis, Dimitrios; Pryhoda, Moira; Gilmore, Anah; Gorgens, Kimberly A.; Davidson, Bradley; Granholm, Anne-Charlotte; Ledreux, Aurelie			Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury	FASEB JOURNAL			English	Article						biomarkers; exosome immunoabsorption; proteinopathic neurodegeneration	BARRIER DISRUPTION; BIOMARKERS; EPIDEMIOLOGY; PATHOGENESIS; AQUAPORIN-4; ANNEXINS; HYPOXIA; BETA; TAU	Neuron-derived exosomes (NDEs) were enriched by anti-L1CAM antibody immunoabsorption from plasmas of subjects ages 18-26 yr within 1 wk after a sports-related mild traumatic brain injury (acute mTBI) (n = 18), 3 mo or longer after the last of 2-4 mTBIs (chronic mTBI) (n = 14) and with no recent history of TBI (controls) (n = 21). Plasma concentrations of NDEs, assessed by counts and levels of extracted exosome marker CD81, were significantly depressed by a mean of 45% in acute mTBI (P < 0.0001), but not chronic mTBI, compared with controls. Mean CD81-normalized NDE levels of a range of functional brain proteins were significantly abnormal relative to those of controls in acute but not chronic mTBI, including ras-related small GTPase 10, 73% decrease; annexin VII, 8.8-fold increase; ubiquitin C-terminal hydrolase L1, 2.5-fold increase; AII spectrin fragments, 1.9-fold increase; claudin-5, 2.7-fold increase; sodium-potassium-chloride cotransporter-1, 2.8-fold increase; aquaporin 4, 8.9-fold increase (3.6-fold increase in chronic mTBI); and synaptogyrin-3, 3.1-fold increase (1.3-fold increase in chronic mTBI) (all acute mTBI proteins P < 0.0001). In chronic mTBI, there were elevated CD81-normalized NDE levels of usually pathologic beta-amyloid peptide 1-42 (1.6-fold, P < 0.0001), P-T181-tau (2.2-fold, P < 0.0001), P-S396-tau (1.6-fold, P < 0.01), IL-6 (16-fold, P < 0.0001), and prion cellular protein (PRPc) (5.1-fold, P < 0.0001) with lesser or greater (IL-6, PRPc) increases in acute mTBI. Increases in NDE levels of most neurofunctional proteins in acute, but not chronic, mTBI, and elevations of most NDE neuropathological proteins in chronic and acute mTBI delineated phase-specificity. Longitudinal studies of more mTBI subjects may identify biomarkers predictive of and etiologically involved in mTBI-induced neurodegeneration.	[Goetzl, Edward J.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Med, San Francisco, CA 94143 USA; [Elahi, Fanny M.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Cellular & Mol Neurosci Sect, Lab Neurosci, Baltimore, MD 21224 USA; [Pryhoda, Moira; Davidson, Bradley] Univ Denver, Dept Mech Engn, Human Dynam Lab, Denver, CO USA; [Gilmore, Anah; Granholm, Anne-Charlotte; Ledreux, Aurelie] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO USA; [Gorgens, Kimberly A.] Univ Denver, Grad Sch Profess Psychol, Denver, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Denver; University of Denver; University of Denver	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Mustapic, Maja/AAV-3212-2020; Ledreux, Aurélie/M-3967-2018; Pryhoda, Moira/AAQ-1580-2021; Kapogiannis, Dimitrios/AAW-4934-2020	Ledreux, Aurélie/0000-0001-6232-7672; Kapogiannis, Dimitrios/0000-0003-2181-3118; Elahi, Fanny/0000-0003-4663-4992; Mustapic, Maja/0000-0003-0511-2047	Knoebel Institute for Healthy Aging; Intramural Program of the U.S. National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000975] Funding Source: NIH RePORTER	Knoebel Institute for Healthy Aging; Intramural Program of the U.S. National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to Judith H. Goetzl (Geriatric Research Center, San Francisco, CA, USA) for preparation of the graphic illustrations. This research described was supported by a pilot grant from the Knoebel Institute for Healthy Aging (to A.-C.G.), and by the Intramural Program of the U.S. National Institutes of Health, National Institute on Aging (to M.M. and D.K.). The authors declare no conflicts of interest.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Bucci C, 2014, MEMBRANES, V4, P642, DOI 10.3390/membranes4040642; Buki A, 2000, J NEUROSCI, V20, P2825; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; Dailey NS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00118; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Leong DF., 2015, CONCUSSION, V1, pCNC8; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McInnes J, 2018, NEURON, V97, P823, DOI 10.1016/j.neuron.2018.01.022; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Shah R, 2018, NEW ENGL J MED, V379, P958, DOI 10.1056/NEJMra1704286; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Stern RA, 2016, JAMA NEUROL, V73, P1280, DOI 10.1001/jamaneurol.2016.3169; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Unsain N, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00010; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087	49	46	47	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5082	5088		10.1096/fj.201802319R	http://dx.doi.org/10.1096/fj.201802319R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30605353	Green Published, Bronze			2022-12-28	WOS:000462888500037
J	Roisman, LC; Han, S; Chuei, MJ; Connor, AR; Cappai, R				Roisman, Laila C.; Han, Sen; Chuei, Mun Joo; Connor, Andrea R.; Cappai, Roberto			The crystal structure of amyloid precursor-like protein 2 E2 domain completes the amyloid precursor protein family	FASEB JOURNAL			English	Article						APLP2; dimerization; X-ray macromolecule structure; copper; zinc	COPPER-BINDING DOMAIN; ALZHEIMERS-DISEASE; APP; HEPARIN; APLP2; HOMOLOG; REVEAL; BETA; MICE; SITE	The amyloid precursor-like protein 2 (APLP2) molecule is a type I transmembrane protein that is crucial for survival, cell-cell adhesion, neuronal development, myelination, cancer metastasis, modulation of metal, and glucose and insulin homeostasis. Moreover, the importance of the amyloid precursor protein (APP) family in biology and disease is very well known because of its central role in Alzheimer disease. In this study, we determined the crystal structure of the independently folded E2 domain of APLP2 and compared that with its paralogues APP and APLP2, demonstrating high overall structural similarities. The crystal structure of APLP2 E2 was solved as an antiparallel dimer, and analysis of the protein interfaces revealed a distinct mode of dimerization that differs from the previously reported dimerization of either APP or APLP1. Analysis of the APLP2 E2 metal binding sites suggested it binds zinc and copper in a similar manner to APP and APLP1. The structure of this key protein might suggest a relationship between the distinct mode of dimerization and its biologic functions.	[Roisman, Laila C.; Han, Sen; Chuei, Mun Joo; Connor, Andrea R.; Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Roisman, Laila C.; Han, Sen; Chuei, Mun Joo; Connor, Andrea R.; Cappai, Roberto] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic, Australia; [Cappai, Roberto] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia; [Roisman, Laila C.] Soroka Univ, Med Ctr, Y Rager 151, IL-85101 Beer Sheva, Israel	University of Melbourne; University of Melbourne; University of Melbourne; Ben Gurion University; Soroka Medical Center	Roisman, LC (corresponding author), Soroka Univ, Med Ctr, Y Rager 151, IL-85101 Beer Sheva, Israel.	dr.roisman@gmail.com	Roisman, Laila C./P-9129-2019	Roisman, Laila C./0000-0001-8455-9327	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank the Australian Synchrotron, especially the staff at the MX2 Beamline, for friendly and helpful assistance with data collection; Dr. Zhiguang Xiao (Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne), for helpful review of the manuscript; and Nathan Gerstman for helpful visual crystal screening. This work was supported by funding from the National Health and Medical Research Council of Australia (to R.C). The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Bayer TA, 1999, MOL PSYCHIATR, V4, P524, DOI 10.1038/sj.mp.4000552; Cheng F, 2014, J BIOL CHEM, V289, P20871, DOI 10.1074/jbc.M114.552810; Coulson EJ, 2000, NEUROCHEM INT, V36, P175, DOI 10.1016/S0197-0186(99)00125-4; Dahms SO, 2015, ACTA CRYSTALLOGR D, V71, P494, DOI 10.1107/S1399004714027114; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; Dinet V, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0245-z; Dunsing V, 2017, MOL BIOL CELL, V28, P3609, DOI 10.1091/mbc.E17-07-0459; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenton H, 1998, BRAIN RES, V779, P262, DOI 10.1016/S0006-8993(97)00958-X; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Heber S, 2000, J NEUROSCI, V20, P7951; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hoopes JT, 2010, J BIOL CHEM, V285, P2165, DOI 10.1074/jbc.M109.018432; JIN LW, 1994, J NEUROSCI, V14, P5461; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaden D, 2012, EUR J CELL BIOL, V91, P234, DOI 10.1016/j.ejcb.2011.01.017; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Klevanski M, 2014, MOL CELL NEUROSCI, V61, P201, DOI 10.1016/j.mcn.2014.06.004; Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Leveugle B, 1997, NEUROCHEM INT, V30, P543, DOI 10.1016/S0197-0186(96)00103-9; Ludewig S, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00161; Mayer MC, 2014, J BIOL CHEM, V289, P19019, DOI 10.1074/jbc.M114.570382; Maynard CJ, 2005, INT J EXP PATHOL, V86, P147, DOI 10.1111/j.0959-9673.2005.00434.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; MULTHAUP G, 1994, FEBS LETT, V355, P151, DOI 10.1016/0014-5793(94)01176-1; Needham BE, 2008, J PATHOL, V215, P155, DOI 10.1002/path.2343; Needham BE, 2014, METALLOMICS, V6, P598, DOI 10.1039/c3mt00358b; NINOMIYA H, 1994, J NEUROCHEM, V63, P495; Pandey P, 2015, ONCOTARGET, V6, P2064, DOI 10.18632/oncotarget.2990; Shariati SAM, 2013, J CELL SCI, V126, P1268, DOI 10.1242/jcs.122440; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Truong PH, 2019, GLIA, V67, P525, DOI 10.1002/glia.23561; Truong PH, 2019, NEUROCHEM RES, V44, P1356, DOI 10.1007/s11064-018-2669-6; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xue Y, 2011, P NATL ACAD SCI USA, V108, P16229, DOI 10.1073/pnas.1103407108; Yang G, 2005, NEUROSCI LETT, V384, P66, DOI 10.1016/j.neulet.2005.04.040; Young TR, 2018, BIOCHEMISTRY-US, V57, P4165, DOI 10.1021/acs.biochem.8b00572	51	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5076	5081		10.1096/fj.201802315R	http://dx.doi.org/10.1096/fj.201802315R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30608876				2022-12-28	WOS:000462888500036
J	Yoneshiro, T; Shin, W; Machida, K; Fukano, K; Tsubota, A; Chen, Y; Yasui, H; Inanami, O; Okamatsu-Ogura, Y; Kimura, K				Yoneshiro, Takeshi; Shin, Woongchul; Machida, Ken; Fukano, Keigo; Tsubota, Ayumi; Chen, Yong; Yasui, Hironobu; Inanami, Osamu; Okamatsu-Ogura, Yuko; Kimura, Kazuhiro			Differentiation of bone marrow-derived cells toward thermogenic adipocytes in white adipose tissue induced by the beta 3 adrenergic stimulation	FASEB JOURNAL			English	Article						brown adipocytes; beige adipocytes; bone marrow cells; beta 3 adrenergic receptor	ALTERNATIVELY ACTIVATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; BROWN ADIPOCYTES; BEIGE FAT; CATECHOLAMINES; CONTRIBUTE	Bone marrow provides progenitors of several types of cells, including muscle and white adipocytes, ensuring peripheral tissue homeostasis. However, the role of bone marrow-derived cells (BMCs) in induction of thermogenic adipocytes is unresolved. The purpose of this study is to examine whether BMCs are involved in the emergence of thermogenic adipocytes through adrenergic activation. Irradiation of mice with 8 Gy of X-ray-depleted BMCs and peripheral blood mononucleated cells (PBMCs), which in turn impaired induction of uncoupling protein 1 (UCP1) through administration of beta 3 adrenergic receptor agonist, CL 316,243 (CL), in inguinal white adipose tissue (iWAT). In contrast, CL-induced UCP1 induction in brown adipose tissue was unaffected by BMC depletion. Transplantation of normal BMCs into mice depleted of BMCs recovered PBMC levels and rescued the ability of iWAT browning by CL. Furthermore, analyses of mice transplanted with green fluorescent protein (GFP)-labeled BMCs revealed that the number of GFP-positive BMCs and PBMCs were significantly decreased by CL and that GFP-positive stromal cells and GFP-positive UCP1-expressing multilocular adipocytes appeared in iWAT after CL administration, demonstrating differentiation of BMC-derived preadipocytes into UCP1-expressing thermogenic adipocytes. These results unveiled a crucial role of the BMC as a nonresident origin for a subset of thermogenic adipocytes, contributing to browning of white adipose tissue.	[Yoneshiro, Takeshi; Shin, Woongchul; Machida, Ken; Fukano, Keigo; Tsubota, Ayumi; Okamatsu-Ogura, Yuko; Kimura, Kazuhiro] Hokkaido Univ, Grad Sch Vet Med, Lab Biochem, Dept Biomed Sci, Sapporo, Hokkaido, Japan; [Yasui, Hironobu; Inanami, Osamu] Hokkaido Univ, Grad Sch Vet Med, Lab Radiat Biol, Dept Environm Vet Sci, Sapporo, Hokkaido, Japan; [Chen, Yong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Internal Med, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Hokkaido University; Hokkaido University; Huazhong University of Science & Technology	Yoneshiro, T (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Lab Biochem,Kita Ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.	yoneshiro@vetmed.hokudai.ac.jp	Inanami, Osamu/A-5197-2012; Yasui, Hironobu/E-3794-2010; Yoneshiro, Takeshi/V-3856-2019; Okamatsu-Ogura, Yuko/AAI-5602-2020	Inanami, Osamu/0000-0001-7895-3918; Yasui, Hironobu/0000-0002-6757-1110; Yoneshiro, Takeshi/0000-0001-5298-5831; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [2610103, 26860703]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Momoko Yoneshiro (University of California-San Francisco, San Francisco, CA, USA) for technical support. This work was supported by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (2610103, 26860703). The authors declare no conflicts of interest.	Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; Bagchi M, 2013, FASEB J, V27, P3257, DOI 10.1096/fj.12-221812; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; Bukowska J, 2018, CURR OSTEOPOROS REP, V16, P312, DOI 10.1007/s11914-018-0442-z; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Dannheim K, 2016, AM J HEMATOL, V91, P545, DOI 10.1002/ajh.24330; de Jong JMA, 2017, AM J PHYSIOL-ENDOC M, V312, pE508, DOI 10.1152/ajpendo.00437.2016; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Fukano K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166579; Gavin KM, 2016, FASEB J, V30, P1096, DOI 10.1096/fj.15-278994; Hepler C, 2017, GENE DEV, V31, P127, DOI 10.1101/gad.293704.116; Koh YJ, 2007, J CLIN INVEST, V117, P3684, DOI 10.1172/JCI32504; Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016; Lee MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21173; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Nagaya K., 2018, J PHYSL SCI; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Okamatsu-Ogura Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07206-8; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Ryden M, 2015, CELL METAB, V22, P408, DOI 10.1016/j.cmet.2015.06.011; Scheller EL, 2016, TRENDS ENDOCRIN MET, V27, P392, DOI 10.1016/j.tem.2016.03.016; Shin W, 2017, OBESITY, V25, P417, DOI 10.1002/oby.21727; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Takahashi M, 2008, J RADIAT RES, V49, P153, DOI 10.1269/jrr.07082; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	36	6	6	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5196	5207		10.1096/fj.201801757RR	http://dx.doi.org/10.1096/fj.201801757RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30624970				2022-12-28	WOS:000462888500046
J	Kazmierczak, K; Liang, JS; Yuan, CC; Yadav, S; Sitbon, YH; Walz, K; Ma, WK; Irving, TC; Cheah, JX; Gomes, AV; Szczesna-Cordary, D				Kazmierczak, Katarzyna; Liang, Jingsheng; Yuan, Chen-Ching; Yadav, Sunil; Sitbon, Yoel H.; Walz, Katherina; Ma, Weikang; Irving, Thomas C.; Cheah, Jenice X.; Gomes, Aldrin V.; Szczesna-Cordary, Danuta			Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain	FASEB JOURNAL			English	Article						cardioskeletal myopathy; muscle proteomics; R58Q-RLC mutation; X-ray diffraction	CROSS-BRIDGE KINETICS; HYPERTROPHIC CARDIOMYOPATHY; CA2+ BINDING; PHOSPHORYLATION; MODEL; IDENTIFICATION; DIAGNOSIS; MYOPATHY; DISEASE; FIBERS	Myosin light chain 2 (MYL2) gene encodes the myosin regulatory light chain (RLC) simultaneously in heart ventricles and in slow-twitch skeletal muscle. Using transgenic mice with cardiac-specific expression of the human R58Q-RLC mutant, we sought to determine whether the hypertrophic cardiomyopathy phenotype observed in papillary muscles (PMs) of R58Q mice is also manifested in slow-twitch soleus (SOL) muscles. Skinned SOL muscles and ventricular PMs of R58Q animals exhibited lower contractile force that was not observed in the fast-twitch extensor digitorum longus muscles of R58Q vs. wild-type-RLC mice, but mutant animals did not display gross muscle weakness in vivo. Consistent with SOL muscle abnormalities in R58Q vs. wild-type mice, myosin ATPase staining revealed a decreased proportion of fiber type I/type II only in SOL muscles but not in the extensor digitorum longus muscles. The similarities between SOL muscles and PMs of R58Q mice were further supported by quantitative proteomics. Differential regulation of proteins involved in energy metabolism, cell-cell interactions, and protein-protein signaling was concurrently observed in the hearts and SOL muscles of R58Q mice. In summary, even though R58Q expression was restricted to the heart of mice, functional similarities were clearly observed between the hearts and slow-twitch skeletal muscle, suggesting that MYL2 mutated models of hypertrophic cardiomyopathy may be useful research tools to study the molecular, structural, and energetic mechanisms of cardioskeletal myopathy associated with myosin RLC.Kazmierczak, K., Liang, J., Yuan, C.-C., Yadav, S., Sitbon, Y. H., Walz, K., Ma, W., Irving, T. C., Cheah, J. X., Gomes, A. V., Szczesna-Cordary, D. Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain.	[Kazmierczak, Katarzyna; Liang, Jingsheng; Yuan, Chen-Ching; Yadav, Sunil; Sitbon, Yoel H.; Szczesna-Cordary, Danuta] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave,RMSB 6113, Miami, FL 33136 USA; [Walz, Katherina] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Dr John T Macdonald Fdn,Dept Human Genet, Miami, FL 33136 USA; [Ma, Weikang; Irving, Thomas C.] IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Cheah, Jenice X.; Gomes, Aldrin V.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of Miami; University of Miami; Illinois Institute of Technology; University of California System; University of California Davis	Szczesna-Cordary, D (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave,RMSB 6113, Miami, FL 33136 USA.	dszczesna@miami.edu	Ma, Weikang/AAA-4847-2021	Ma, Weikang/0000-0001-9535-7114; Cheah, Jenice/0000-0002-0453-7433	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL123255, HL096819]; NIH National Institute of General Medical Sciences [9P41-GM103622]; American Heart Association [15PRE23020006, 17PRE33650085]; Department of Energy Office of Science [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Clemer Abad (Mouse Behavioral Core, University of Miami) for technical assistance. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL123255 (to D.S.-C.) and HL096819 (to A.V.G.), NIH National Institute of General Medical Sciences Grant 9P41-GM103622 (to T.C.I.), and American Heart Association Grants 15PRE23020006 (to C.C.-Y.) and 17PRE33650085 (to S.Y.). This research used resources from the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. Mass spectrometry was conducted with the use of the Q-Exactive Plus at the University of California, Davis Proteomic Core Facility. The authors declare no conflicts of interest.	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Al-Salam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086994; Alfares AA, 2015, GENET MED, V17, P880, DOI [10.1038/gim.2014.205, 10.1038/gim.2015.16]; Barth PG, 1998, NEUROMUSCULAR DISORD, V8, P296, DOI 10.1016/S0960-8966(98)00028-5; Bers DM, 2011, HEART RHYTHM, V8, P1101, DOI 10.1016/j.hrthm.2011.01.030; Bonetto A, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.101; CAFORIO ALP, 1989, J AM COLL CARDIOL, V14, P1464, DOI 10.1016/0735-1097(89)90383-5; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; de Boer Rudolf A, 2010, Curr Heart Fail Rep, V7, P1, DOI 10.1007/s11897-010-0004-x; Flavigny J, 1998, J MOL MED-JMM, V76, P208, DOI 10.1007/s001090050210; Geeves MA, 2002, NATURE, V415, P129, DOI 10.1038/415129a; Gomes AV, 2015, J MUSCLE RES CELL M, V36, P447, DOI 10.1007/s10974-015-9434-0; Greenberg MJ, 2010, P NATL ACAD SCI USA, V107, P17403, DOI 10.1073/pnas.1009619107; Greenberg MJ, 2009, J MOL CELL CARDIOL, V46, P108, DOI 10.1016/j.yjmcc.2008.09.126; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Gu RC, 2018, CELL PHYSIOL BIOCHEM, V46, P351, DOI 10.1159/000488435; Huang W, 2014, J MOL CELL CARDIOL, V74, P318, DOI 10.1016/j.yjmcc.2014.06.011; Kabaeva ZT, 2002, EUR J HUM GENET, V10, P741, DOI 10.1038/sj.ejhg.5200872; Kampourakis T, 2018, J MOL CELL CARDIOL, V117, P72, DOI 10.1016/j.yjmcc.2018.02.009; Karabina A, 2015, ARCH BIOCHEM BIOPHYS, V580, P14, DOI 10.1016/j.abb.2015.06.014; Karwi QG, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00068; Kerrick WGL, 2009, FASEB J, V23, P855, DOI 10.1096/fj.08-118182; Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059; Marston SB, 2001, J MUSCLE RES CELL M, V22, P1, DOI 10.1023/A:1010355716511; Mettikolla P, 2011, J THEOR BIOL, V284, P71, DOI 10.1016/j.jtbi.2011.06.014; Millman BM, 1998, PHYSIOL REV, V78, P359, DOI 10.1152/physrev.1998.78.2.359; Morner S, 2003, J MOL CELL CARDIOL, V35, P841, DOI 10.1016/S0022-2828(03)00146-9; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Obata K, 2005, BIOCHEM BIOPH RES CO, V338, P1299, DOI 10.1016/j.bbrc.2005.10.083; Oberg AL, 2008, J PROTEOME RES, V7, P225, DOI 10.1021/pr700734f; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Seidman CE, 1998, BASIC RES CARDIOL, V93, P13; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna Danuta, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P187, DOI 10.2174/1568006033481474; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; Szczesna-Cordary D, 2004, J BIOL CHEM, V279, P3535, DOI 10.1074/jbc.M307092200; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Vafiadaki E, 2014, FEBS J, V281, P3261, DOI 10.1111/febs.12859; Van Ry PM, 2015, MOL THER, V23, P1285, DOI 10.1038/mt.2015.105; Vianey-Saban C, 1998, CLIN CHIM ACTA, V269, P43, DOI 10.1016/S0009-8981(97)00185-X; Wang D., 2011, MOL CELL PROTEOMICS, V10; Wang L, 2013, J MOL CELL CARDIOL, V62, P153, DOI 10.1016/j.yjmcc.2013.05.012; Wang Y, 2006, J MOL BIOL, V361, P286, DOI 10.1016/j.jmb.2006.06.018; Weterman MAJ, 2013, BRAIN, V136, P282, DOI 10.1093/brain/aws293; Williams CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0697; Yuan CC, 2018, P NATL ACAD SCI USA, V115, pE2338, DOI 10.1073/pnas.1716925115; Yuan CC, 2017, CARDIOVASC RES, V113, P1124, DOI 10.1093/cvr/cvx060; Yuan CC, 2015, P NATL ACAD SCI USA, V112, pE4138, DOI 10.1073/pnas.1505819112; Zhang L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/831092; Zhou ZQ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00240; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	53	7	7	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3152	3166		10.1096/fj.201801402R	http://dx.doi.org/10.1096/fj.201801402R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30365366	Green Published, Bronze			2022-12-28	WOS:000459794800007
J	Canfield, J; Arlier, S; Mong, EF; Lockhart, J; VanWye, J; Guzeloglu-Kayisli, O; Schatz, F; Magness, RR; Lockwood, CJ; Tsibris, JCM; Kayisli, UA; Totary-Jain, H				Canfield, John; Arlier, Sefa; Mong, Ezinne F.; Lockhart, John; VanWye, Jeffrey; Guzeloglu-Kayisli, Ozlem; Schatz, Frederick; Magness, Ronald R.; Lockwood, Charles J.; Tsibris, John C. M.; Kayisli, Umit A.; Totary-Jain, Hana			Decreased LIN28B in preeclampsia impairs human trophoblast differentiation and migration	FASEB JOURNAL			English	Article						C19MC; inflammation; cell invasion; DOHaD	NECROSIS-FACTOR-ALPHA; MICRORNA BIOGENESIS; PLACENTAL SYNCYTIN; DOWN-REGULATION; EXPRESSION; LET-7; CELLS; RECEPTOR; CANCER; LIN-28	Preeclampsia (PE) is a common cause of maternal morbidity, characterized by impaired trophoblast invasion and spiral artery transformation resulting in progressive uteroplacental hypoxia. Given the primary role of LIN28A and LIN28B in modulating cell metabolism, differentiation, and invasion, we hypothesized that LIN28A and/or LIN28B regulates trophoblast differentiation and invasion, and that its dysregulation may contribute to PE. Here we show that LIN28B is expressed approximate to 1300-fold higher than LIN28A in human term placenta and is the predominant paralog expressed in primary human trophoblast cultures. The expression of LIN28B mRNA and protein levels are significantly reduced in gestational age-matched preeclamptic vs. normal placentas, whereas LIN28A expression is not different. First trimester human placental sections displayed stronger LIN28B immunoreactivity in extravillous (invasive) cytotrophoblasts and syncytial sprouts vs. villous trophoblasts. LIN28B overexpression increased HTR8 cell proliferation, migration, and invasion, whereas LIN28B knockdown in JEG3 cells reduced cell proliferation. Moreover, LIN28B knockdown in JEG3 cells suppressed syncytin 1 (SYN-1), apelin receptor early endogenous ligand (ELABELA), and the chromosome 19 microRNA cluster, and increased mRNA expression of ITG4 and TNF-. Incubation of BeWo and JEG3 cells under hypoxia significantly decreased expression of LIN28B and LIN28A, SYN-1, and ELABELA, whereas TNF- is increased. These results provide the first evidence that LIN28B is the predominant paralog in human placenta and that decreased LIN28B may play a role in PE by reducing trophoblast invasion and syncytialization, and by promoting inflammation.Canfield, J., Arlier, S., Mong, E. F., Lockhart, J., VanWye, J., Guzeloglu-Kayisli, O., Schatz, F., Magness, R. R., Lockwood, C. J., Tsibris, J. C. M., Kayisli, U. A., Totary-Jain, H. Decreased LIN28B in preeclampsia impairs human trophoblast differentiation and migration.	[Canfield, John; Mong, Ezinne F.; Lockhart, John; VanWye, Jeffrey; Totary-Jain, Hana] Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Arlier, Sefa; Guzeloglu-Kayisli, Ozlem; Schatz, Frederick; Magness, Ronald R.; Lockwood, Charles J.; Tsibris, John C. M.; Kayisli, Umit A.] Morsani Coll Med, Dept Obstet & Gynecol, Tampa, FL USA		Totary-Jain, H (corresponding author), Univ S Florida, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC08,2170, Tampa, FL 33612 USA.	totaryjainh@health.usf.edu	arlıer, sefa/GLS-1518-2022; arlıer, sefa/AAQ-3582-2021; arlıer, sefa/Y-7888-2019; Totary-Jain, Hana/A-6387-2014; arlier, sefa/P-3698-2016; Totary-Jain, Hana/ABC-3469-2021	arlıer, sefa/0000-0002-0019-8403; arlıer, sefa/0000-0002-0019-8403; arlıer, sefa/0000-0002-0019-8403; arlier, sefa/0000-0002-0019-8403; Totary-Jain, Hana/0000-0003-2203-0377; Lockhart, John/0000-0002-2727-6969; Tsibris, John/0000-0002-6725-2734	American Heart Association [15PRE25850019]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL128411]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128411, R01HL117341] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge Dr. Ananth Karumanchi (Beth Israel Deaconess Medical Center, Harvard Medical School) for providing total placental RNA from normal and preeclampsia affected pregnancies. J.C. was supported by the American Heart Association (Grant 15PRE25850019), and H.T.J. was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant R01HL128411). The authors declare no conflicts of interest.	Ali PSS, 2012, FEBS LETT, V586, P3986, DOI 10.1016/j.febslet.2012.09.034; Balzeau J, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00031; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Chen CP, 2006, BJOG-INT J OBSTET GY, V113, P152, DOI 10.1111/j.1471-0528.2005.00843.x; Choudhry H, 2016, BRIEF FUNCT GENOMICS, V15, P174, DOI 10.1093/bfgp/elv050; Degner K, 2017, REPROD SCI, V24, P753, DOI 10.1177/1933719116669056; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fu JJ, 2009, PLACENTA, V30, P305, DOI 10.1016/j.placenta.2009.01.005; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hafner M, 2013, RNA, V19, P613, DOI 10.1261/rna.036491.112; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hakim J, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/953150; Henderson JT, 2017, JAMA-J AM MED ASSOC, V317, P1668, DOI 10.1001/jama.2016.18315; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Ho LN, 2017, SCIENCE, V357, P707, DOI 10.1126/science.aam6607; Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1; Hromadnikova I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171756; Hromadnikova I, 2015, DNA CELL BIOL, V34, P437, DOI 10.1089/dna.2014.2687; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; Jun-Hao ET, 2016, TRENDS ENDOCRIN MET, V27, P132, DOI 10.1016/j.tem.2015.12.006; Karumanchi SA, 2004, ENDOCRINOLOGY, V145, P4835, DOI 10.1210/en.2004-1028; Knerr I, 2002, AM J OBSTET GYNECOL, V186, P210, DOI 10.1067/mob.2002.119636; Kucera J, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4386947; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; KUPFERMINC MJ, 1994, AM J OBSTET GYNECOL, V170, P1752, DOI 10.1016/S0002-9378(94)70351-5; Lee MJ, 2005, ENDOCRINOLOGY, V146, P4619, DOI 10.1210/en.2005-0235; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lockwood CJ, 2009, J CLIN ENDOCR METAB, V94, P2164, DOI 10.1210/jc.2009-0065; Lockwood CJ, 2006, AM J PATHOL, V169, P1294, DOI 10.2353/ajpath.2006.060185; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Mayr F, 2013, INT J MOL SCI, V14, P16532, DOI 10.3390/ijms140816532; Mong EF, 2018, ARTERIOSCL THROM VAS, V38, P1321, DOI 10.1161/ATVBAHA.118.310908; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ni XT, 2009, PLACENTA, V30, P1023, DOI 10.1016/j.placenta.2009.10.005; Nwabuobi C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102037; Paauw ND, 2016, CLIN SCI, V130, P239, DOI 10.1042/CS20150567; Park Sung Won, 2012, Korean J Pediatr, V55, P388, DOI 10.3345/kjp.2012.55.10.388; Nguyen PNN, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0326-z; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROBERTS JM, 1992, AM J REPROD IMMUNOL, V27, P101, DOI 10.1111/j.1600-0897.1992.tb00735.x; Saito Y, 2009, ONCOGENE, V28, P2738, DOI 10.1038/onc.2009.140; Santulli G, 2014, J CLIN INVEST, V124, P4102, DOI 10.1172/JCI76069; Serin IS, 2002, EUR J OBSTET GYN R B, V104, P86; Shih T, 2016, AM J PERINAT, V33, P329, DOI 10.1055/s-0035-1564881; Shinoda G, 2013, STEM CELLS, V31, P1563, DOI 10.1002/stem.1423; Smyth A, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0714-5; Tang ZH, 2011, AM J REPROD IMMUNOL, V66, P336, DOI 10.1111/j.1600-0897.2011.01006.x; Totary-Jain H, 2013, J BIOL CHEM, V288, P6034, DOI 10.1074/jbc.M112.416446; Totary-Jain H, 2012, CANCER RES, V72, P1836, DOI 10.1158/0008-5472.CAN-11-2195; Tsanov KM, 2017, NAT CELL BIOL, V19, P60, DOI 10.1038/ncb3453; Tsialikas J, 2015, DEVELOPMENT, V142, P2397, DOI 10.1242/dev.117580; Usha K, 2011, J OBSTET GYN INDIA, V61, P505, DOI 10.1007/s13224-011-0092-x; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Widen E, 2010, AM J HUM GENET, V86, P773, DOI 10.1016/j.ajhg.2010.03.010; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060; Wu L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0045-0; Yen CF, 2017, REPROD SCI, V24, P1176, DOI 10.1177/1933719116681515; Zeng YX, 2016, MOL CELL, V61, P153, DOI 10.1016/j.molcel.2015.11.020; Zhang J, 2013, MOL CELL ENDOCRINOL, V375, P53, DOI 10.1016/j.mce.2013.04.022; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	68	33	35	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2759	2769		10.1096/fj.201801163R	http://dx.doi.org/10.1096/fj.201801163R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307771	Green Published			2022-12-28	WOS:000457296600098
J	Horscroft, JA; O'Brien, KA; Clark, AD; Lindsay, RT; Steel, AS; Procter, NEK; Devaux, J; Frenneaux, M; Harridge, SDR; Murray, AJ				Horscroft, James A.; O'Brien, Katie A.; Clark, Anna D.; Lindsay, Ross T.; Steel, Alice Strang; Procter, Nathan E. K.; Devaux, Jules; Frenneaux, Michael; Harridge, Stephen D. R.; Murray, Andrew J.			Inorganic nitrate, hypoxia, and the regulation of cardiac mitochondrial respiration-probing the role of PPAR alpha	FASEB JOURNAL			English	Article						heart; metabolism; mitochondria; fatty acids	HIGH-ALTITUDE HYPOXIA; NITRIC-OXIDE; DIETARY NITRATE; SKELETAL-MUSCLE; BLOOD-FLOW; COMPLEX I; NO; OXYGEN; METABOLISM; ADAPTATION	Dietary inorganic nitrate prevents aspects of cardiac mitochondrial dysfunction induced by hypoxia, although the mechanism is not completely understood. In both heart and skeletal muscle, nitrate increases fatty acid oxidation capacity, and in the latter case, this involves up-regulation of peroxisome proliferator-activated receptor (PPAR)alpha expression. Here, we investigated whether dietary nitrate modifies mitochondrial function in the hypoxic heart in a PPAR alpha-dependent manner. Wild-type (WT) mice and mice without PPAR alpha (Ppara(-/-)) were given water containing 0.7 mM NaCl (control) or 0.7 mM NaNO3 for 35 d. After 7 d, mice were exposed to normoxia or hypoxia (10% O-2) for the remainder of the study. Mitochondrial respiratory function and metabolism were assessed in saponin-permeabilized cardiac muscle fibers. Environmental hypoxia suppressed mass-specific mitochondrial respiration and additionally lowered the proportion of respiration supported by fatty acid oxidation by 18% (P < 0.001). This switch away from fatty acid oxidation was reversed by nitrate treatment in hypoxic WT but not Ppara(-/-) mice, indicating a PPAR alpha-dependent effect. Hypoxia increased hexokinase activity by 33% in all mice, whereas lactate dehydrogenase activity increased by 71% in hypoxic WT but not Ppara(-/-) mice. Our findings indicate that PPAR alpha plays a key role in mediating cardiac metabolic remodeling in response to both hypoxia and dietary nitrate supplementation.-Horscroft, J. A., O'Brien, K. A., Clark, A. D., Lindsay, R. T., Steel, A. S., Procter, N. E. K., Devaux, J., Frenneaux, M., Harridge, S. D. R., Murray, A. J. Inorganic nitrate, hypoxia, and the regulation of cardiac mitochondrial respiration-probing the role of PPAR alpha.	[Horscroft, James A.; O'Brien, Katie A.; Clark, Anna D.; Lindsay, Ross T.; Steel, Alice Strang; Devaux, Jules; Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England; [O'Brien, Katie A.; Harridge, Stephen D. R.] Kings Coll London, Ctr Human & Appl Physiol Sci, London, England; [Procter, Nathan E. K.; Frenneaux, Michael] Univ East Anglia, Bob Champ Res & Educ Bldg, Norwich, Norfolk, England	University of Cambridge; University of London; King's College London; University of East Anglia	Murray, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	ajm267@cam.ac.uk	Jules, Devaux/GSN-5859-2022	Devaux, Jules/0000-0002-5280-3871; Lindsay, Ross/0000-0001-7760-613X; Murray, Andrew/0000-0002-0929-9315	Biotechnology and Biological Sciences Research Council, UK [BB/F016581/1]; Research Councils UK [EP/E500552/1]	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research Councils UK(UK Research & Innovation (UKRI))	The authors acknowledge the support of Prof. Kieran Clarke (University of Oxford, Oxford, United Kingdom) and Prof. Martin Feelisch (University of Southampton, Southampton, United Kingdom). This work was supported by the Biotechnology and Biological Sciences Research Council, UK (Grant BB/F016581/1) and the Research Councils UK (Grant EP/E500552/1). The authors declare no conflicts of interest.	Ashmore T, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0221-6; Ashmore T, 2015, FASEB J, V29, P1102, DOI 10.1096/fj.14-263004; Ashmore T, 2014, J PHYSIOL-LONDON, V592, P4715, DOI 10.1113/jphysiol.2014.275263; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Carlstrom M, 2010, P NATL ACAD SCI USA, V107, P17716, DOI 10.1073/pnas.1008872107; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cohen BH, 2013, J CHEM INF MODEL, V4th; Cole MA, 2016, FASEB J, V30, P2684, DOI 10.1096/fj.201500094R; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dass S, 2015, CIRC-HEART FAIL, V8, P1088, DOI 10.1161/CIRCHEARTFAILURE.114.002169; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Heather LC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0268-2; Hezel MP, 2015, REDOX BIOL, V5, P234, DOI 10.1016/j.redox.2015.05.004; Holloway CJ, 2011, FASEB J, V25, P792, DOI 10.1096/fj.10-172999; Horscroft JA, 2017, P NATL ACAD SCI USA, V114, P6382, DOI 10.1073/pnas.1700527114; Horscroft JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138564; Horscroft JA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-19; Houle-Leroy P, 2000, J APPL PHYSIOL, V89, P1608, DOI 10.1152/jappl.2000.89.4.1608; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Larsen FJ, 2010, FREE RADICAL BIO MED, V48, P342, DOI 10.1016/j.freeradbiomed.2009.11.006; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Martin DS, 2009, EUR J APPL PHYSIOL, V106, P473, DOI 10.1007/s00421-009-1023-8; McClelland GB, 2005, J EXP BIOL, V208, P515, DOI 10.1242/jeb.01423; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; MITTAL CK, 1977, J CYCLIC NUCL PROT, V3, P381; Mulkareddy V., 2018, BIOCH BIOPHYS ACTA M; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; O'Brien K. A., 2018, BIOCH BIOPHYS ACTA M; PALMER JW, 1985, ARCH BIOCHEM BIOPHYS, V236, P691, DOI 10.1016/0003-9861(85)90675-7; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pannala AS, 2003, FREE RADICAL BIO MED, V34, P576, DOI 10.1016/S0891-5849(02)01353-9; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Roberts LD, 2017, DIABETES, V66, P674, DOI 10.2337/db16-0843; Roberts LD, 2015, DIABETES, V64, P471, DOI 10.2337/db14-0496; SELMECI L., 1967, LIFE SCI, V6, P649, DOI 10.1016/0024-3205(67)90102-6; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Siervo M, 2011, FREE RADICAL BIO MED, V51, P795, DOI 10.1016/j.freeradbiomed.2011.05.032; TAYLOR DA, 1989, J BIOL CHEM, V264, P6207; Velmurugan S, 2013, FREE RADICAL BIO MED, V65, P1521, DOI 10.1016/j.freeradbiomed.2013.06.031; Wu RX, 2014, J CLIN INVEST, V124, P4795, DOI 10.1172/JCI76737	58	11	11	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7563	7577		10.1096/fj.201900067R	http://dx.doi.org/10.1096/fj.201900067R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30870003	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000476114200072
J	Kurstjens, S; Smeets, B; Overmars-Bos, C; Dijkman, HB; den Braanker, DJW; de Bel, T; Bindels, RJM; Tack, CJJ; Hoenderop, JGJ; de Baaij, JHF				Kurstjens, Steef; Smeets, Bart; Overmars-Bos, Caro; Dijkman, Henry B.; den Braanker, Dirk J. W.; de Bel, Thomas; Bindels, Rene J. M.; Tack, Cees J. J.; Hoenderop, Joost G. J.; de Baaij, Jeroen H. F.			Renal phospholipidosis and impaired magnesium handling in high-fat-diet-fed mice	FASEB JOURNAL			English	Article						hypomagnesemia; type 2 diabetes; proximal tubule; distal tubule; phospholipid	DIABETIC-NEPHROPATHY; SERUM MAGNESIUM; HYPOMAGNESEMIA; TRANSPORT; GLUCOSE; ACTIVATION; CHANNELS; KIDNEYS; DISEASE; PLASMA	Hypomagnesemia (blood Mg2+ concentration <0.7 mM) is a common electrolyte disorder in patients with type 2 diabetes (T2D), but the etiology remains largely unknown. In patients with T2D, reduced blood Mg2+ levels are associated with an increased decline in renal function, independent of glycemic control and hypertension. To study the underlying mechanism of this phenomenon, we investigated the renal effects of hypomagnesemia in high-fat-diet (HFD)-fed mice. In mice fed a low dietary Mg2+, the HFD resulted in severe hypomagnesemia within 4 wk. Renal or intestinal Mg2+ wasting was not observed after 16 wk on the diets. Despite the absence of urinary or fecal Mg2+ loss, the HFD induced a reduction in the mRNA expression transient receptor potential melastatin type 6 in both the kidney and colon. mRNA expression of distal convoluted tubule (DCT)-specific genes was down-regulated by the LowMg-HFD, indicating atrophy of the DCT. The low dietary Mg2+ resulted in severe HFD-induced proximal tubule phospholipidosis, which was absent in mice on a NormalMg-HFD. This was accompanied by albuminuria, moderate renal damage, and alterations in renal energy metabolism, including enhanced gluconeogenesis and cholesterol synthesis. In conclusion, this study shows that hypomagnesemia is a consequence of diet-induced obesity and insulin resistance. Moreover, hypomagnesemia induces major structural changes in the diabetic kidney, including proximal tubular phospholipidosis, providing a novel mechanism for the increased renal decline in patients with hypomagnesemic T2D.-Kurstjens, S., Smeets, B., Overmars-Bos, C., Dijkman, H. B., den Braanker, D. J. W., de Bel, T., Bindels, R. J. M., Tack, C. J. J., Hoenderop, J. G. J., de Baaij, J. H. F. Renal phospholipidosis and impaired magnesium handling in high-fat-diet-fed mice.	[Kurstjens, Steef; Overmars-Bos, Caro; Bindels, Rene J. M.; Hoenderop, Joost G. J.; de Baaij, Jeroen H. F.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Smeets, Bart; Dijkman, Henry B.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Tack, Cees J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [den Braanker, Dirk J. W.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Radboud Inst Hlth Sci, Nijmegen, Netherlands; [de Bel, Thomas] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Radboud Inst Hlth Sci, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	de Baaij, JHF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol 286, POB 9101, NL-6500 HB Nijmegen, Netherlands.	jeroen.debaaij@radboudumc.nl	Dijkman, Henry/L-4274-2015; de Baaij, Jeroen/P-5704-2015; Tack, Cees J/A-2368-2014; Smeets, Bart/D-5179-2014; Braanker, Dirk JW den/J-8987-2015	de Baaij, Jeroen/0000-0003-2372-8486; Smeets, Bart/0000-0002-8466-3367; 	Radboud Institute for Molecular Life Sciences; Netherlands Organisation for Scientific Research [NWO 016.130.668, 016.186.012]; Dutch Kidney Foundation [Kolff 14OKG17]; Dutch Diabetes Research Foundation [2017.81.014]	Radboud Institute for Molecular Life Sciences; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation; Dutch Diabetes Research Foundation	The authors thank Frank Krewinkel, Tim Peters, Karin de Haas-Cremers, Maikel School, Helma Janssen-Wagener, Saskia Mulder, Huib Croes, and Marieke Willemse (all from Radboud University Medical Center) for technical support, and the authors also thank Johan van der Vlag (Radboud University Medical Center) for facilitating the urinary albumin measurements. This work was supported by funding from the Radboud Institute for Molecular Life Sciences, and by grants from the Netherlands Organisation for Scientific Research (NWO 016.130.668, 016.186.012), the Dutch Kidney Foundation (Kolff 14OKG17), and the Dutch Diabetes Research Foundation (2017.81.014). The authors declare no conflicts of interest.	Altunkaynak ME, 2008, J ANAT, V212, P845, DOI 10.1111/j.1469-7580.2008.00902.x; BIRCH JR, 1971, J CELL SCI, V8, P693; BRUNETTE MG, 1974, AM J PHYSIOL, V227, P891, DOI 10.1152/ajplegacy.1974.227.4.891; Chubanov V, 2016, ELIFE, V5, DOI 10.7554/eLife.20914; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; DRESKIN SC, 1993, J IMMUNOL, V151, P3199; FUJII S, 1982, HORM METAB RES, V14, P161, DOI 10.1055/s-2007-1018954; Grafft CA, 2009, CLIN KIDNEY J, V2, P448, DOI 10.1093/ndtplus/sfp101; KACEW S, 1987, TOXICOL APPL PHARM, V91, P469, DOI 10.1016/0041-008X(87)90068-8; Kieboom BCT, 2017, DIABETOLOGIA, V60, P843, DOI 10.1007/s00125-017-4224-4; Kieboom BCT, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002707; Kurstjens S, 2018, DIABETOLOGIA, V61, P2030, DOI 10.1007/s00125-018-4680-5; Kurstjens S, 2017, EUR J ENDOCRINOL, V176, P11, DOI 10.1530/EJE-16-0517; Lal J, 2003, J Assoc Physicians India, V51, P37; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Liamis G, 2013, AM J MED, V126, P256, DOI 10.1016/j.amjmed.2012.06.037; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; Loffing J, 1996, KIDNEY INT, V50, P1180, DOI 10.1038/ki.1996.426; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; Morrison MC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02444-2; Nair AV, 2012, P NATL ACAD SCI USA, V109, P11324, DOI 10.1073/pnas.1113811109; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ribeiro MCP, 2013, MAGNESIUM RES, V26, P32, DOI 10.1684/mrh.2013.0334; Peters KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074355; Pham PCT, 2005, CLIN NEPHROL, V63, P429; Pizauro JM, 1995, MOL CELL BIOCHEM, V152, P121, DOI 10.1007/BF01076074; QUAMME GA, 1980, AM J PHYSIOL, V239, pF393, DOI 10.1152/ajprenal.1980.239.5.F393; Sakaguchi Y, 2012, DIABETES CARE, V35, P1591, DOI 10.2337/dc12-0226; Shayman JA, 2013, BBA-MOL CELL BIOL L, V1831, P602, DOI 10.1016/j.bbalip.2012.08.013; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Takayanagi K, 2015, AM J PHYSIOL-RENAL, V308, pF1386, DOI 10.1152/ajprenal.00593.2013; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Torra R, 2008, KIDNEY INT, V74, pS29, DOI 10.1038/ki.2008.522; Toth-Manikowski S, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/697010; Tuttle KR, 2014, DIABETES CARE, V37, P2864, DOI 10.2337/dc14-1296; van Angelen AA, 2012, CLIN KIDNEY J, V5, P535, DOI 10.1093/ckj/sfs140; Xu JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056750	42	6	6	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7192	7201		10.1096/fj.201801778RR	http://dx.doi.org/10.1096/fj.201801778RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30848940	Bronze			2022-12-28	WOS:000476114200043
J	Murthy, AMV; Sullivan, MJ; Nhu, NTK; Lo, AW; Phan, MD; Peters, KM; Boucher, D; Schroder, K; Beatson, SA; Ulett, GC; Schembri, MA; Sweet, MJ				Murthy, Ambika M., V; Sullivan, Matthew J.; Nguyen Thi Khanh Nhu; Lo, Alvin W.; Phan, Minh-Duy; Peters, Kate M.; Boucher, Dave; Schroder, Kate; Beatson, Scott A.; Ulett, Glen C.; Schembri, Mark A.; Sweet, Matthew J.			Variation in hemolysin A expression between uropathogenic Escherichia coli isolates determines NLRP3-dependent vs. -independent macrophage cell death and host colonization	FASEB JOURNAL			English	Article						alpha-hemolysin; inflammasome; ST131; UPEC; UTI	URINARY-TRACT; ALPHA-HEMOLYSIN; NLRP3 INFLAMMASOME; MURINE MODEL; IN-VITRO; ACTIVATION; BLADDER; STRAIN; PERSISTENT; PYROPTOSIS	Uropathogenic Escherichia coli (UPEC) is the major cause of urinary tract infections (UTIs). The multidrug-resistant E. coli sequence type 131 (ST131) clone is a serious threat to human health, yet its effects on immune responses are not well understood. Here we screened a panel of ST131 isolates, finding that only strains expressing the toxin hemolysin A (HlyA) killed primary human macrophages and triggered maturation of the inflammasome-dependent cytokine IL-1 beta. Using a representative strain, the requirement for the hlyA gene in these responses was confirmed. We also observed considerable heterogeneity in levels of cell death initiated by different HlyA(+ve) ST131 isolates, and this correlated with secreted HlyA levels. Investigation into the biological significance of this variation revealed that an ST131 strain producing low levels of HlyA initiated cell death that was partly dependent on the nod-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, with this response being associated with a host-protective role in a mouse UTI model. When the same ST131 strain was engineered to overexpress high HlyA levels, macrophage cell death occurred even when NLRP3 function was abrogated, and bladder colonization was significantly increased. Thus, variation in HlyA expression in UPEC affects mechanisms by which macrophages die, as well as host susceptibility vs. resistance to colonization.-Murthy, A. M. V., Sullivan, M. J., Nhu, N. T. K., Lo, A. W., Phan, M.-D., Peters, K. M., Boucher, D., Schroder, K., Beatson, S. A., Ulett, G. C., Schembri, M. A., Sweet, M. J. Variation in hemolysin A expression between uropathogenic Escherichia coli isolates determines NLRP3-dependent vs. -independent macrophage cell death and host colonization.	[Murthy, Ambika M., V; Boucher, Dave; Schroder, Kate; Sweet, Matthew J.] Univ Queensland, Ctr Inflammat & Dis Res, IMB, Brisbane, Qld 4072, Australia; [Murthy, Ambika M., V; Nguyen Thi Khanh Nhu; Lo, Alvin W.; Phan, Minh-Duy; Peters, Kate M.; Boucher, Dave; Schroder, Kate; Beatson, Scott A.; Schembri, Mark A.; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Nguyen Thi Khanh Nhu; Lo, Alvin W.; Phan, Minh-Duy; Peters, Kate M.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Sullivan, Matthew J.; Ulett, Glen C.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Sullivan, Matthew J.; Ulett, Glen C.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Griffith University; Griffith University; Menzies Health Institute Queensland	Sweet, MJ (corresponding author), Univ Queensland, Ctr Inflammat & Dis Res, IMB, Brisbane, Qld 4072, Australia.; Schembri, MA; Sweet, MJ (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.; Schembri, MA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	m.schembri@uq.edu.au; m.sweet@imb.uq.edu.au	Nguyen, Nhu/O-5696-2019; Schroder, Kate/C-6132-2008; Sullivan, Matthew J/C-3857-2009; Sweet, Matthew J/F-2229-2011; Beatson, Scott/B-6985-2013; Schembri, Mark A/C-7262-2009; Murthy, Ambika Mosale Venkatesh/C-8021-2017; Phan, Minh-Duy/I-9147-2012; Boucher, Dave/J-1830-2014	Nguyen, Nhu/0000-0002-0158-850X; Schroder, Kate/0000-0001-9261-3805; Sullivan, Matthew J/0000-0003-2276-3132; Sweet, Matthew J/0000-0002-0406-8139; Beatson, Scott/0000-0002-1806-3283; Schembri, Mark A/0000-0003-4863-9260; Murthy, Ambika Mosale Venkatesh/0000-0002-9767-1999; Phan, Minh-Duy/0000-0002-3426-1044; Ulett, Glen/0000-0002-9638-8091; Boucher, Dave/0000-0003-0075-8893	National Health and Medical Research Council of Australia (NHMRC) [GNT1068593, GNT1129273]; University of Queensland Postdoctoral Fellowship; NHMRC Career Development Fellowship [GNT1141131, GNT1090456]; NHMRC Senior Research Fellowships [GNT1107914, GNT1106930]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Postdoctoral Fellowship(University of Queensland); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Rodney Welch (University of Wisconsin, Madison, WI, USA) for providing the hemolysin A antibody, Avril Robertson (The University of Queensland) for providing MCC950, and the Australian Red Cross Blood Service for providing buffy coats that were used to isolate monocytes in these studies. This work was supported by Project Grants GNT1068593 and GNT1129273 from the National Health and Medical Research Council of Australia (NHMRC). D.B. was supported by a University of Queensland Postdoctoral Fellowship; K.S. was supported by an NHMRC Career Development Fellowship (GNT1141131); S.A.B. is supported by an NHMRC Career Development Fellowship (GNT1090456); and M.J.S. and M.A.S. were supported by NHMRC Senior Research Fellowships (GNT1107914, GNT1106930). The authors declare no conflicts of interest.	Ambite I, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005848; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Barbieri NL, 2014, INFECT IMMUN, V82, P5086, DOI 10.1128/IAI.02315-14; Ben Zakour NL, 2016, MBIO, V7, DOI 10.1128/mBio.00347-16; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; BHAKDI S, 1989, J EXP MED, V169, P737, DOI 10.1084/jem.169.3.737; Bhushan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028452; Bielaszewska M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003797; CAVALIERI SJ, 1982, INFECT IMMUN, V36, P455, DOI 10.1128/IAI.36.2.455-461.1982; Chen SW, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007240; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Demirel I, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00081; Dhakal BK, 2012, CELL HOST MICROBE, V11, P58, DOI 10.1016/j.chom.2011.12.003; Diabate M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004732; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; FELMLEE T, 1985, J BACTERIOL, V163, P88, DOI 10.1128/JB.163.1.88-93.1985; Ferrand J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00344; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gaidt MM, 2018, J MOL BIOL, V430, P133, DOI 10.1016/j.jmb.2017.11.013; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; Haugen BJ, 2007, INFECT IMMUN, V75, P278, DOI 10.1128/IAI.01319-06; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; Hilbert DW, 2012, MICROBES INFECT, V14, P628, DOI 10.1016/j.micinf.2012.01.010; Hohenhaus DM, 2013, IMMUNOBIOLOGY, V218, P1345, DOI 10.1016/j.imbio.2013.07.001; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; JONAS D, 1993, INFECT IMMUN, V61, P1715, DOI 10.1128/IAI.61.5.1715-1721.1993; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim JJ, 2013, J KOREAN MED SCI, V28, P1415, DOI 10.3346/jkms.2013.28.10.1415; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Leclercq SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29000; Lu YN, 2018, FASEB J, V32, P4107, DOI 10.1096/fj.201700768R; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Murthy AMV, 2018, VIRULENCE, V9, P967, DOI 10.1080/21505594.2018.1465786; Nagamatsu K, 2015, P NATL ACAD SCI USA, V112, pE871, DOI 10.1073/pnas.1500374112; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; PELLETT S, 1990, INFECT IMMUN, V58, P822, DOI 10.1128/IAI.58.3.822-827.1990; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Price LB, 2013, MBIO, V4, DOI 10.1128/mBio.00377-13; Ristow LC, 2016, BBA-BIOMEMBRANES, V1858, P538, DOI 10.1016/j.bbamem.2015.08.015; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Russo TA, 2005, AM J PHYSIOL-LUNG C, V289, pL207, DOI 10.1152/ajplung.00482.2004; Schaale K, 2016, MUCOSAL IMMUNOL, V9, P124, DOI 10.1038/mi.2015.44; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sivick KE, 2010, J IMMUNOL, V184, P2065, DOI 10.4049/jimmunol.0902386; Smith YC, 2008, INFECT IMMUN, V76, P2978, DOI 10.1128/IAI.00075-08; Smith YC, 2006, INFECT IMMUN, V74, P750, DOI 10.1128/IAI.74.1.750-757.2006; Stoesser N, 2016, MBIO, V7, DOI 10.1128/mBio.02162-15; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Valeva A, 2005, J BIOL CHEM, V280, P36657, DOI 10.1074/jbc.M507690200; Waldhuber A, 2016, J CLIN INVEST, V126, P2425, DOI 10.1172/JCI81916; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; WELCH RA, 1984, INFECT IMMUN, V43, P156, DOI 10.1128/IAI.43.1.156-160.1984; Welch RA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0011-2012	63	9	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7437	7450		10.1096/fj.201802100R	http://dx.doi.org/10.1096/fj.201802100R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30869997				2022-12-28	WOS:000476114200062
J	Peters, F; Scharfenberg, F; Colmorgen, C; Armbrust, F; Wichert, R; Arnold, P; Potempa, B; Potempa, J; Pietrzik, CU; Hasler, R; Rosenstiel, P; Becker-Pauly, C				Peters, Florian; Scharfenberg, Franka; Colmorgen, Cynthia; Armbrust, Fred; Wichert, Rielana; Arnold, Philipp; Potempa, Barbara; Potempa, Jan; Pietrzik, Claus U.; Hasler, Robert; Rosenstiel, Philip; Becker-Pauly, Christoph			Tethering soluble meprin alpha in an enzyme complex to the cell surface affects IBD-associated genes	FASEB JOURNAL			English	Article						protease; quaternary structure; chronic intestinal inflammation; meprin beta	PABA-PEPTIDE; BETA; METALLOPROTEASE; EXPRESSION; MEMBRANE; SUBUNIT; RAT; MECHANISM; RELEASE; DIMERS	Biologic activity of proteases is mainly characterized by the substrate specificity, tissue distribution, and cellular localization. The human metalloproteases meprin alpha and meprin beta share 41% sequence identity and exhibit a similar cleavage specificity with a preference for negatively charged amino acids. However, shedding of meprin alpha by furin on the secretory pathway makes it a secreted enzyme in comparison with the membrane-bound meprin beta. In this study, we identified human meprin alpha and meprin beta as forming covalently linked membrane-tethered heterodimers in the early endoplasmic reticulum, thereby preventing furin-mediated secretion of meprin alpha. Within this newly formed enzyme complex, meprin alpha was able to be activated on the cell surface and detected by cleavage of a novel specific fluorogenic peptide substrate. However, the known meprin beta substrates amyloid precursor protein and CD99 were not shed by membrane-tethered meprin alpha. On the other hand, being linked to meprin alpha, activation of or substrate cleavage by meprin beta on the cell surface was not altered. Interestingly, proteolytic activity of both proteases was increased in the heteromeric complex, indicating an increased proteolytic potential at the plasma membrane. Because meprins are susceptibility genes for inflammatory bowel disease (IBD), and to investigate the physiologic impact of the enzyme complex, we performed transcriptome analyses of intestinal mucosa from meprin-knockout mice. Comparison of the transcriptional gene analysis data with gene analyses of IBD patients revealed that different gene subsets were dysregulated if meprin alpha was expressed alone or in the enzyme complex, demonstrating the physiologic and pathophysiological relevance of the meprin heterodimer formation.-Peters, F., Scharfenberg, F., Colmorgen, C., Armbrust, F., Wichert, R., Arnold, P., Potempa, B., Potempa, J., Pietrzik, C. U., Hasler, R., Rosenstiel, P., Becker-Pauly, C. Tethering soluble meprin alpha in an enzyme complex to the cell surface affects IBD-associated genes.	[Peters, Florian; Scharfenberg, Franka; Colmorgen, Cynthia; Armbrust, Fred; Wichert, Rielana; Becker-Pauly, Christoph] Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24098 Kiel, Germany; [Arnold, Philipp] Univ Kiel, Anat Inst, Kiel, Germany; [Hasler, Robert; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Potempa, Barbara; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Pietrzik, Claus U.] Univ Med Ctr Mainz, Inst Pathobiochem, Mainz, Germany	University of Kiel; University of Kiel; University of Kiel; Jagiellonian University; Johannes Gutenberg University of Mainz	Becker-Pauly, C (corresponding author), Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24098 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Potempa, Jan/AAA-6850-2021; Scharfenberg, Franka/AAS-9798-2021; Rosenstiel, Philip/A-5137-2009; Häsler, Robert/A-4908-2009; Becker-Pauly, Christoph/B-7569-2011	Rosenstiel, Philip/0000-0002-9692-8828; Häsler, Robert/0000-0003-4174-8229; Peters, Florian/0000-0002-8529-2326	Deutsche Forschungsgemeinschaft (DFG) [SFB 877, EXC 22167-390884018, BE 4086/2-2, BE 4086/5-1]; U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) [DE 022597]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Judith Bond (Pennsylvania State University, State College, PA, USA) for intense discussions on biochemical properties of meprin oligomerization. The authors also thank Lennard Arp (University of Kiel) for excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB 877 (Proteolysis as a Regulatory Event in Pathophysiology, Projects A9, A13, and A15) under Germany's Excellence Strategy, EXC 22167-390884018, and BE 4086/2-2 and BE 4086/5-1 (both to C.B.P.). J.P. is supported by the U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) (Grant DE 022597). The authors declare no conflicts of interest.	Agg B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30163-9; Agg B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27740-3; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Banerjee S, 2011, AM J PHYSIOL-GASTR L, V300, pG273, DOI 10.1152/ajpgi.00504.2009; BARNES K, 1989, BIOCHEM J, V264, P335, DOI 10.1042/bj2640335; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bedau T, 2017, FASEB J, V31, P1226, DOI 10.1096/fj.201601113R; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; Biasin V, 2018, THROMB HAEMOSTASIS, V118, P1790, DOI 10.1055/s-0038-1670657; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Chevallier S, 1996, BIOCHEM J, V317, P731, DOI 10.1042/bj3170731; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; Hasler R, 2017, GUT, V66, P2087, DOI 10.1136/gutjnl-2016-311651; Hahn D, 2000, BIOCHEM J, V346, P83, DOI 10.1042/0264-6021:3460083; Hata S, 2016, J BIOL CHEM, V291, P27313, DOI 10.1074/jbc.M116.763912; Herzog C, 2014, J BIOL CHEM, V289, P13308, DOI 10.1074/jbc.M114.559088; Ishmael SS, 2006, J BIOL CHEM, V281, P37404, DOI 10.1074/jbc.M602769200; Jackle F, 2015, BIOCHEM J, V470, P91, DOI 10.1042/BJ20141417; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; JOHNSON GD, 1994, J BIOL CHEM, V269, P7682; Johnson GD, 1997, J BIOL CHEM, V272, P28126, DOI 10.1074/jbc.272.44.28126; JOHNSON GD, 1992, J BIOL CHEM, V267, P13505; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Lottaz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026450; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARCHAND P, 1995, J BIOL CHEM, V270, P5449, DOI 10.1074/jbc.270.10.5449; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; TRACHTMAN H, 1995, BIOCHEM BIOPH RES CO, V208, P498, DOI 10.1006/bbrc.1995.1366; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wichert R, 2017, CELL REP, V21, P2090, DOI 10.1016/j.celrep.2017.10.087	42	12	12	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7490	7504		10.1096/fj.201802391R	http://dx.doi.org/10.1096/fj.201802391R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30916990	Bronze, Green Published			2022-12-28	WOS:000476114200066
J	Phillipps, HR; Rand, CJ; Brown, RSE; Kokay, IC; Stanton, JA; Grattan, DR				Phillipps, Hollian R.; Rand, Christy J.; Brown, Rosemary S. E.; Kokay, Ilona C.; Stanton, Jo-Ann; Grattan, David R.			Prolactin regulation of insulin-like growth factor 2 gene expression in the adult mouse choroid plexus	FASEB JOURNAL			English	Article						nanoString; RNA-seq; transcriptome	RECEPTOR MESSENGER-RNA; FACTOR-II GENE; LONG-FORM; SUBVENTRICULAR ZONE; PLACENTAL-LACTOGEN; EPITHELIAL-CELLS; BRAIN; PREGNANCY; TRANSCRIPTION; ISOFORM	There is clear evidence for carrier-mediated transport of prolactin into the brain, and it has been widely assumed that prolactin receptors (PRLRs) in the choroid plexus (ChP) might mediate this transport. Using PRLR knockout mice, we recently showed that PRLRs in ChP are not required for prolactin transport into the brain. Hence, the function of PRLR in the ChP remains unknown. PRLR expression is increased in the ChP during lactation, suggesting a possible role in adaptive function of prolactin at this time. To gain insight into prolactin function in the ChP, we have utilized RNA sequencing and NanoString techniques to characterize transcriptional changes in response to differing levels of prolactin at diestrus, during pregnancy, and in lactation. We have observed opposing transcriptional effects of prolactin on the ChP in different physiologic states, being primarily inhibitory during diestrus but stimulatory in lactation. Insulin-like growth factor 2 (Igf2), a highly expressing transcript found in the ChP, showed a 6-fold increase at lactation that returned to baseline on suppression of prolactin levels. These results indicate that Igf2 may be an important downstream mediator of prolactin-induced signaling in the ChP.Phillipps, H. R., Rand, C. J., Brown, R. S. E., Kokay, I. C., Stanton, J.-A., Grattan, D. R. Prolactin regulation of insulin-like growth factor 2 gene expression in the adult mouse choroid plexus.	[Phillipps, Hollian R.; Brown, Rosemary S. E.; Kokay, Ilona C.; Grattan, David R.] Univ Otago, Ctr Neuroendocrinol, 270 Great King St,POB 913, Dunedin 9054, New Zealand; [Phillipps, Hollian R.; Rand, Christy J.; Brown, Rosemary S. E.; Kokay, Ilona C.; Stanton, Jo-Ann; Grattan, David R.] Univ Otago, Sch Med Sci, Dept Anat, 270 Great King St,POB 913, Dunedin 9054, New Zealand	University of Otago; University of Otago	Phillipps, HR (corresponding author), Univ Otago, Ctr Neuroendocrinol, 270 Great King St,POB 913, Dunedin 9054, New Zealand.; Phillipps, HR (corresponding author), Univ Otago, Sch Med Sci, Dept Anat, 270 Great King St,POB 913, Dunedin 9054, New Zealand.	holly.phillipps@otago.ac.nz	Stanton, Jo-Ann L/C-6621-2009; Grattan, David/M-4307-2019	Stanton, Jo-Ann L/0000-0001-8139-4694; Grattan, David/0000-0001-5606-2559; Brown, Rosemary/0000-0001-6775-3072	Marsden Fund; Health Research Council (HRC) of New Zealand; Ministry of Business, Innovation, and Employment (MBIE) Grant [000X1507]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council (HRC) of New Zealand(Health Research Council of New Zealand); Ministry of Business, Innovation, and Employment (MBIE) Grant	The authors thank staff at New Zealand Genomics Limited (NZGL) for their NanoString expertise. This work was funded by grants from the Marsden Fund, administered by the Royal Society of New Zealand and the Health Research Council (HRC) of New Zealand. C.J.R. and J.-A.S. were supported by Ministry of Business, Innovation, and Employment (MBIE) Grant 000X1507. The authors declare no conflicts of interest.	Augustine RA, 2003, J MOL ENDOCRINOL, V31, P221, DOI 10.1677/jme.0.0310221; Bakowska JC, 1997, J COMP NEUROL, V386, P161, DOI 10.1002/(SICI)1096-9861(19970922)386:2<161::AID-CNE1>3.0.CO;2-#; Benarroch EE, 2012, NEUROLOGY, V79, P2148, DOI 10.1212/WNL.0b013e3182752eef; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Blume A, 2009, ENDOCRINOLOGY, V150, P1841, DOI 10.1210/en.2008-1023; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BOUTIN JM, 1989, MOL ENDOCRINOL, V3, P1455, DOI 10.1210/mend-3-9-1455; Breves JP, 2014, GEN COMP ENDOCR, V203, P21, DOI 10.1016/j.ygcen.2013.12.014; Breves JP, 2013, MOL CELL ENDOCRINOL, V369, P98, DOI 10.1016/j.mce.2013.01.021; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Brooker GJF, 2000, J NEUROSCI RES, V59, P332, DOI 10.1002/(SICI)1097-4547(20000201)59:3<332::AID-JNR6>3.0.CO;2-2; Brown RSE, 2017, P NATL ACAD SCI USA, V114, P10779, DOI 10.1073/pnas.1708025114; Brown RSE, 2016, FASEB J, V30, P1002, DOI 10.1096/fj.15-276519; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; CHIU SF, 1994, J NEUROENDOCRINOL, V6, P191, DOI 10.1111/j.1365-2826.1994.tb00572.x; CLARKE DL, 1993, ENDOCRINOLOGY, V133, P224, DOI 10.1210/en.133.1.224; DAVIS JA, 1989, MOL ENDOCRINOL, V3, P674, DOI 10.1210/mend-3-4-674; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Devi YS, 2009, ENDOCRINOLOGY, V150, P3327, DOI 10.1210/en.2008-1719; Dziegielewska KM, 2001, MICROSC RES TECHNIQ, V52, P5, DOI 10.1002/1097-0029(20010101)52:1<5::AID-JEMT3>3.3.CO;2-A; Ferron SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9265; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Halperin J, 2008, MOL ENDOCRINOL, V22, P513, DOI 10.1210/me.2007-0399; Hong-Goka BC, 2004, NEUROSCI LETT, V360, P113, DOI 10.1016/j.neulet.2004.01.075; Hovey RC, 2003, MOL ENDOCRINOL, V17, P460, DOI 10.1210/me.2002-0214; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kline JB, 1999, J BIOL CHEM, V274, P35461, DOI 10.1074/jbc.274.50.35461; Kokay Ilona C, 2018, J Neuroendocrinol, V30, pe12634, DOI 10.1111/jne.12634; Larsen CM, 2010, ENDOCRINOLOGY, V151, P3805, DOI 10.1210/en.2009-1385; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; MARKOFF E, 1981, BIOL REPROD, V24, P846, DOI 10.1095/biolreprod24.4.846; Marques F, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-10; Mayr S, 1998, EUR J BIOCHEM, V258, P784, DOI 10.1046/j.1432-1327.1998.2580784.x; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; MOLLGARD K, 1976, NATURE, V264, P293, DOI 10.1038/264293a0; MOORE RC, 1993, GENE, V134, P263, DOI 10.1016/0378-1119(93)90104-B; NAGANO M, 1994, J BIOL CHEM, V269, P13337; OHLSSON R, 1994, DEVELOPMENT, V120, P361; OUHTIT A, 1993, ENDOCRINOLOGY, V133, P135, DOI 10.1210/en.133.1.135; Phillipps HR, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.162; Pi XJ, 1999, J NEUROENDOCRINOL, V11, P693; Pi XJ, 2003, NEUROENDOCRINOLOGY, V77, P187, DOI 10.1159/000069510; PICKFORD GE, 1959, SCIENCE, V130, P454, DOI 10.1126/science.130.3373.454; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; Quintela T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060199; Sakamoto T, 2006, GEN COMP ENDOCR, V147, P24, DOI 10.1016/j.ygcen.2005.10.008; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Shu YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18597; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; SPECTOR R, 1989, SCI AM, V261, P68, DOI 10.1038/scientificamerican1189-68; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; Tabata H, 2012, J MOL ENDOCRINOL, V48, P169, DOI 10.1530/JME-11-0122; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trott JF, 2003, J MOL ENDOCRINOL, V30, P31, DOI 10.1677/jme.0.0300031; WALSH RJ, 1987, ENDOCRINOLOGY, V120, P1846, DOI 10.1210/endo-120-5-1846; WALSH RJ, 1984, ENDOCRINOLOGY, V114, P1496, DOI 10.1210/endo-114-5-1496; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Ye XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141078; Ziegler AN, 2012, STEM CELLS, V30, P1265, DOI 10.1002/stem.1095	65	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6115	6128		10.1096/fj.201802262R	http://dx.doi.org/10.1096/fj.201802262R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30735445	Bronze			2022-12-28	WOS:000466932600026
J	Mak, SOK; Zhang, L; Chow, BKC				Mak, Sarah O. K.; Zhang, Li; Chow, Billy K. C.			In vivo actions of SCTR/AT1aR heteromer in controlling Vp expression and release via cFos/cAMP/CREB pathway in magnocellular neurons of PVN	FASEB JOURNAL			English	Article						secretin receptor; GPCR heteromerization; vasopressin; transmembrane peptides	SIGNALING PATHWAY; GENE-EXPRESSION; SECRETIN; VASOPRESSIN; ANGIOTENSIN; ACTIVATION; ELEMENT; HETERODIMERIZATION; IDENTIFICATION; DIMERIZATION	With an increasing body of evidence regarding GPCR oligomerization and its clinical implications over the last decade, the modulation and dynamics of GPCR homo- and hetero-oligomers has more recently become an area of intense research focus. Previously, our lab showed in vitro heteromer formation between angiotensin II receptor type 1 subtype a (AT1aR) and secretin receptor (SCTR), which is involved in in vivo control of hyperosmolality-induced water drinking behavior. Because the secretin (SCT)/SCTR axis is crucial to the central actions of angiotensin II (ANGII) and both SCT and ANGII are capable of triggering vasopressin (Vp) release from hypothalamus, we investigated here the in vivo role of SCTR-AT1aR heteromer in regulating Vp release in hypothalamus using transmembrane peptides as tools. We showed that SCTR-AT1aR heteromer mediates stimulatory actions of both SCT and ANGII in hypothalamic Vp expression and release as well as neuronal activities via the immediate early gene cFos. The results from this study not only are consistent with our hypothesis that SCT and ANGII interact at the receptor level to mediate their water homeostatic activities but also provide evidence for in vivo functions of cross-class GPCR heteromers.	[Mak, Sarah O. K.; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, 4N-12,Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong 12345, Peoples R China; [Zhang, Li] Jinan Univ, Cent Nervous Syst CNS Regenerat, Guangdong Hong Kong Macau GHM Inst, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; Jinan University	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, 4N-12,Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong 12345, Peoples R China.	bkcc@hku.hk	ZHANG, Li/L-7460-2019	ZHANG, Li/0000-0003-1489-0879; Chow, Billy, KC/0000-0003-3390-0307; Mak, Oi Kwan/0000-0002-1761-6931	Hong Kong Government Research Grant Council [GRF 17127718, 764812M]	Hong Kong Government Research Grant Council	The authors thank Dr. Harald Janovjak (Monash University, Clayton, VIC, Australia) for proofreading the article. This work is supported by Hong Kong Government Research Grant Council Grants GRF 17127718 and 764812M (to B.K.C.C.). The authors declare no conflicts of interest.	Althammer F, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12549; Bailey WJ, 2001, EXPERT OPIN THER PAT, V11, P1861; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Carlsson PO, 2001, WORLD J SURG, V25, P835, DOI 10.1007/s00268-001-0037-0; Chen J, 2015, CELL SIGNAL, V27, P1426, DOI 10.1016/j.cellsig.2015.03.027; Cheng CYY, 2011, NEUROPSYCHOPHARMACOL, V36, P459, DOI 10.1038/npp.2010.178; Cheng LC, 2015, J NUTR BIOCHEM, V26, P541, DOI 10.1016/j.jnutbio.2014.12.011; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Dong MQ, 2006, MOL PHARMACOL, V70, P206, DOI 10.1124/mol.105.021840; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gomes I, 2016, ANNU REV PHARMACOL, V56, P403, DOI 10.1146/annurev-pharmtox-011613-135952; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hallbeck M, 1999, J COMP NEUROL, V411, P201; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Ihnatko R, 2013, BRIT J CANCER, V109, P1867, DOI 10.1038/bjc.2013.525; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Kabli N, 2014, MOL PSYCHIATR, V19, P986, DOI 10.1038/mp.2013.115; Kamal M, 2011, PHARMACEUTICALS-BASE, V4, P273, DOI 10.3390/ph4020273; Kasai RS, 2018, CELL BIOCHEM BIOPHYS, V76, P29, DOI 10.1007/s12013-017-0829-y; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; McKinley MJ, 2001, JPN J PHYSIOL, V51, P281, DOI 10.2170/jjphysiol.51.281; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Nikitina LS, 2014, BIOTECH HISTOCHEM, V89, P199, DOI 10.3109/10520295.2013.832799; O'Dowd BF, 2012, BIOCHEM BIOPH RES CO, V422, P556, DOI 10.1016/j.bbrc.2012.05.023; Paxinos G, 2013, PAXINOS FRANKLINS MO; PHILLIPS PA, 1985, CLIN SCI, V68, P669, DOI 10.1042/cs0680669; Premer C, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/175428; Rana BK, 2001, ANNU REV PHARMACOL, V41, P593, DOI 10.1146/annurev.pharmtox.41.1.593; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Sekar R, 2014, FASEB J, V28, P3494, DOI 10.1096/fj.13-247536; Sladek CD, 1996, AM J PHYSIOL-REG I, V271, pR554, DOI 10.1152/ajpregu.1996.271.3.R554; Spiegel AM, 1996, ANNU REV PHYSIOL, V58, P143, DOI 10.1146/annurev.ph.58.030196.001043; SWAAB DF, 1975, J ENDOCRINOL, V67, P461, DOI 10.1677/joe.0.0670461; Tabor A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33233; Walton KLW, 2009, ADV PHYSIOL EDUC, V33, P165, DOI 10.1152/advan.00023.2009; Xue QJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00245; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; Zhang L, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00077	50	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5389	5398		10.1096/fj.201801732RR	http://dx.doi.org/10.1096/fj.201801732RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702925	Bronze			2022-12-28	WOS:000462888500061
J	Smith, RJ; Yi, T; Nasiri, B; Breuer, CK; Andreadis, ST				Smith, Randall J., Jr.; Yi, Tai; Nasiri, Bita; Breuer, Christopher K.; Andreadis, Stelios T.			Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response	FASEB JOURNAL			English	Article						monocytes; endothelialization; immunoengineering; inflammation	ENDOTHELIAL PROGENITOR CELLS; SMALL-INTESTINAL SUBMUCOSA; SMALL-DIAMETER; HUMAN MONOCYTES; ARTERIAL GRAFT; BLOOD-VESSELS; IN-VIVO; TISSUE; DIFFERENTIATION; MACROPHAGES	Recently, our group demonstrated that immobilized VEGF can capture flowing endothelial cells (ECs) from the blood in vitro and promote endothelialization and patency of acellular tissue-engineered vessels (A-TEVs) into the arterial system of an ovine animal model. Here, we demonstrate implantability of submillimeter diameter heparin and VEGF-decorated A-TEVs in a mouse model and discuss the cellular and immunologic response. At 1 mo postimplantation, the graft lumen was fully endothelialized, as shown by expression of EC markers such as CD144, eNOS, CD31, and VEGFR2. Interestingly, the same cells coexpressed leukocyte/macrophage (M phi) markers CD14, CD16, VEGFR1, CD38, and EGR2. Notably, there was a stark difference in the cellular makeup between grafts containing VEGF and those containing heparin alone. In VEGF-containing grafts, infiltrating monocytes (MCs) converted into anti-inflammatory M2-M phi s, and the grafts developed well-demarcated luminal and medial layers resembling those of native arteries. In contrast, in grafts containing only heparin, MCs converted primarily into M1-M phi s, and the endothelial and smooth muscle layers were not well defined. Our results indicate that VEGF may play an important role in regulating A-TEV patency and regeneration, possibly by regulating the inflammatory response to the implants.	[Smith, Randall J., Jr.; Andreadis, Stelios T.] SUNY Buffalo, Dept Biomed Engn, Amherst, NY USA; [Nasiri, Bita; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Amherst, NY USA; [Andreadis, Stelios T.] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Amherst, NY USA; [Yi, Tai; Breuer, Christopher K.] Nationwide Childrens Hosp, Columbus, OH USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Andreadis, ST (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall,North Campus, Amherst, NY 14260 USA.	sandread@buffalo.edu		Smith, Randall/0000-0001-8114-3086	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL086582, F31 HL134323]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086582, F31HL134323, R01HL139796, R01HL128847] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute to S.T.A. (R01 HL086582) and to R.J.S. (F31 HL134323 Fellowship). The authors declare no conflicts of interest.	Aubin H, 2016, TISSUE ENG PART C-ME, V22, P496, DOI [10.1089/ten.tec.2015.0556, 10.1089/ten.TEC.2015.0556]; Avraham-Davidi I, 2013, J EXP MED, V210, P2611, DOI 10.1084/jem.20120690; Baer C, 2013, EXP CELL RES, V319, P1626, DOI 10.1016/j.yexcr.2013.03.026; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Chambers SEJ, 2013, IMMUNOBIOLOGY, V218, P1370, DOI 10.1016/j.imbio.2013.06.010; Dahan N, 2017, TISSUE ENG PT A, V23, P69, DOI [10.1089/ten.tea.2016.0126, 10.1089/ten.TEA.2016.0126]; Dahan N, 2012, TISSUE ENG PT A, V18, P411, DOI [10.1089/ten.tea.2011.0173, 10.1089/ten.TEA.2011.0173]; De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016; Digiacomo G, 2017, CELL ADHES MIGR, V11, P327, DOI 10.1080/19336918.2016.1221566; Dimitrievska S, 2015, ACTA BIOMATER, V13, P177, DOI 10.1016/j.actbio.2014.11.015; Gabriel M, 2016, JOVE-J VIS EXP, DOI 10.3791/54272; Gao YH, 2016, ADV HEALTHC MATER, V5, P2427, DOI 10.1002/adhm.201600400; Harrington JK, 2011, FASEB J, V25, P4150, DOI 10.1096/fj.11-185140; Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549; Hibino N, 2015, FASEB J, V29, P2431, DOI 10.1096/fj.14-268334; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Hiebl B, 2008, CLIN HEMORHEOL MICRO, V39, P221, DOI 10.3233/CH-2008-1086; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Jang JH, 2007, ACTA PHARMACOL SIN, V28, P367, DOI 10.1111/j.1745-7254.2007.00519.x; Janis AD, 2012, J BIOMATER APPL, V26, P1013, DOI 10.1177/0885328210391688; Kang J, 2014, J MOL CELL CARDIOL, V75, P64, DOI 10.1016/j.yjmcc.2014.06.019; Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.0.CO;2-Z; Khosravi R, 2016, ANN BIOMED ENG, V44, P2402, DOI 10.1007/s10439-015-1545-7; Koobatian MT, 2016, BIOMATERIALS, V76, P344, DOI 10.1016/j.biomaterials.2015.10.020; Koobatian MT, 2015, JOVE-J VIS EXP, DOI 10.3791/52354; Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017; Kristofik NJ, 2017, BIOMATERIALS, V141, P63, DOI 10.1016/j.biomaterials.2017.06.025; Kruger A, 2014, CLIN HEMORHEOL MICRO, V58, P229, DOI 10.3233/CH-141875; Lanuti P, 2016, CYTOM PART A, V89A, P259, DOI 10.1002/cyto.a.22730; Lee KW, 2013, BIOMATERIALS, V34, P9877, DOI 10.1016/j.biomaterials.2013.08.082; Li B, 2011, MOL CANCER RES, V9, P702, DOI 10.1158/1541-7786.MCR-10-0484; Ma X, 2017, J CARDIOTHORAC SURG, V12, DOI 10.1186/s13019-017-0661-x; Mahara A, 2015, BIOMATERIALS, V58, P54, DOI 10.1016/j.biomaterials.2015.04.031; Malm CJ, 2012, SCAND CARDIOVASC J, V46, P57, DOI 10.3109/14017431.2011.623788; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Matsuda T, 2013, J BIOMED MATER RES B, V101B, P50, DOI 10.1002/jbm.b.32812; Mayer A, 2012, ACTA BIOMATER, V8, P4253, DOI 10.1016/j.actbio.2012.08.011; Mirensky TL, 2010, J PEDIATR SURG, V45, P1299, DOI 10.1016/j.jpedsurg.2010.02.102; Murakami M, 2008, ARTERIOSCL THROM VAS, V28, P658, DOI 10.1161/ATVBAHA.107.150433; Nakul-Aquaronne D, 2003, CARDIOVASC RES, V57, P816, DOI 10.1016/S0008-6363(02)00776-9; Onwuka E, 2017, REGEN MED, V12, P249, DOI 10.2217/rme-2016-0141; Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002; Pavcnik D, 2009, CARDIOVASC INTER RAD, V32, P106, DOI 10.1007/s00270-008-9449-7; Pelosi E, 2014, BLOOD CELL MOL DIS, V52, P186, DOI 10.1016/j.bcmd.2013.11.004; Peng HF, 2011, TISSUE ENG PT A, V17, P981, DOI [10.1089/ten.tea.2010.0109, 10.1089/ten.TEA.2010.0109]; Peng HF, 2012, CELLS TISSUES ORGANS, V195, P108, DOI 10.1159/000331415; Pennel T, 2014, BIOMATERIALS, V35, P6311, DOI 10.1016/j.biomaterials.2014.04.062; Pujol BF, 2001, EUR J CELL BIOL, V80, P99, DOI 10.1078/0171-9335-00136; Putzu M, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045009; Qiu XF, 2017, ACTA BIOMATER, V51, P138, DOI 10.1016/j.actbio.2017.01.012; Quint C, 2012, J VASC SURG, V55, P790, DOI 10.1016/j.jvs.2011.07.098; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Rambol MH, 2018, EBIOMEDICINE, V32, P215, DOI 10.1016/j.ebiom.2018.05.012; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0; Row S, 2015, BIOMATERIALS, V50, P115, DOI 10.1016/j.biomaterials.2015.01.045; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Shi CC, 2015, ACS APPL MATER INTER, V7, P20389, DOI 10.1021/acsami.5b06286; Smith RJ, 2015, BIOMATERIALS, V51, P303, DOI 10.1016/j.biomaterials.2015.02.025; Song L, 2016, CELL MOL BIOL, V62, P31, DOI 10.14715/cmb/2016.62.3.7; Sopova K, 2012, CURR VASC PHARMACOL, V10, P555, DOI 10.2174/157016112801784486; Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012; Swartz DD, 2013, CURR OPIN BIOTECH, V24, P916, DOI 10.1016/j.copbio.2013.05.005; Syedain ZH, 2014, TISSUE ENG PT A, V20, P1726, DOI [10.1089/ten.tea.2013.0550, 10.1089/ten.TEA.2013.0550]; Tara S, 2015, J VASC SURG, V62, P734, DOI 10.1016/j.jvs.2014.03.011; Tchaikovski V, 2008, ARTERIOSCL THROM VAS, V28, P322, DOI 10.1161/ATVBAHA.107.158022; Teixeira TM, 2017, J NUTR, V147, P506, DOI 10.3945/jn.116.239475; Thomas GD, 2017, ARTERIOSCL THROM VAS, V37, P1548, DOI 10.1161/ATVBAHA.117.309145; Usui T, 2004, INVEST OPHTH VIS SCI, V45, P368, DOI 10.1167/iovs.03-0106; Wragg A, 2008, J MOL MED, V86, P1221, DOI 10.1007/s00109-008-0390-7; Wu HK, 2005, J SURG RES, V126, P193, DOI 10.1016/j.jss.2005.01.016; Wu W, 2012, NAT MED, V18, P1148, DOI 10.1038/nm.2821; Wystrychowski W, 2011, J VASC ACCESS, V12, P67, DOI 10.5301/JVA.2011.6360; Xiang P, 2011, INT J BIOL MACROMOL, V49, P281, DOI 10.1016/j.ijbiomac.2011.05.004; Xu SY, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0344-9; Zhang RX, 2005, EXP HEMATOL, V33, P1554, DOI 10.1016/j.exphem.2005.08.011; Zhao YL, 2010, BIOMATERIALS, V31, P296, DOI 10.1016/j.biomaterials.2009.09.049; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	81	23	26	2	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5089	5100		10.1096/fj.201801856R	http://dx.doi.org/10.1096/fj.201801856R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629890	Green Published, Bronze			2022-12-28	WOS:000462888500038
J	Calatayud, M; Dezutter, O; Hernandez-Sanabria, E; Hidalgo-Martinez, S; Meysman, FJR; Van de Wiele, T				Calatayud, Marta; Dezutter, Olivier; Hernandez-Sanabria, Emma; Hidalgo-Martinez, Silvia; Meysman, Filip J. R.; Van de Wiele, Tom			Development of a host-microbiome model of the small intestine	FASEB JOURNAL			English	Article						in vitro microbiome; inflammation; Caco-2; HT29-MTX; THP-1	IN-VITRO; EPITHELIAL-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; PARACELLULAR PERMEABILITY; CHEMOKINE CXCL16; BARRIER FUNCTION; COCULTURE MODEL; GUT; CACO-2	The intestinal epithelium plays an essential role in the balance between tolerant and protective immune responses to infectious agents. In vitro models do not typically consider the innate immune response and gut microbiome in detail, so these models do not fully mimic the physiologic aspects of the small intestine. We developed and characterized a long-term in vitro model containing enterocyte, goblet, and immune-like cells exposed to a synthetic microbial community representative of commensal inhabitants of the small intestine. This model showed differential responses toward a synthetic microbial community of commensal bacterial inhabitants of the small intestine in the absence or presence of LPS from Escherichia coli O111:B4. Simultaneous exposure to LPS and microbiota induced impaired epithelial barrier function; increased production of IL-8, IL-6, TNF-, and C-X-C motif chemokine ligand 16; and augmented differentiation and adhesion of macrophage-like cells and the overexpression of dual oxidase 2 and TLR-2 and -4 mRNA. In addition, the model demonstrated the ability to assess the adhesion of specific bacterial strains from the synthetic microbial communitymore specifically, Veillonella parvulato the simulated epithelium. This novel in vitro model may assist in overcoming sampling and retrieval difficulties when studying host-microbiome interactions in the small intestine.Calatayud, M., Dezutter, O., Hernandez-Sanabria, E., Hidalgo-Martinez, S., Meysman, F. J. R., Van de Wiele, T. Development of a host-microbiome model of the small intestine.	[Calatayud, Marta; Dezutter, Olivier; Hernandez-Sanabria, Emma; Van de Wiele, Tom] Univ Ghent, CMET, Ghent, Belgium; [Hidalgo-Martinez, Silvia; Meysman, Filip J. R.] Univ Antwerp, Dept Biol, Ecosyst Management Res Grp ECOBE, Antwerp, Belgium; [Meysman, Filip J. R.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Ghent University; University of Antwerp; Delft University of Technology	Calatayud, M; Van de Wiele, T (corresponding author), Univ Ghent, CMET UGent, Coupure Links 653, B-9000 Ghent, Belgium.	marta.calatayudarroyo@ugent.be; tom.vandewiele@ugent.be	CALATAYUD, MARTA/AAB-7099-2019; Van de Wiele, Tom/C-8638-2011; Meysman, Filip JR/C-9585-2009; Calatayud, Marta/B-6850-2019	Van de Wiele, Tom/0000-0001-6854-5689; Meysman, Filip JR/0000-0001-5334-7655; Calatayud, Marta/0000-0003-3592-3377; Hernandez Sanabria, Emma/0000-0002-5845-9821	Research Foundation Flanders (FWO) [12R2717N]; Ghent University [BOF-GOA-2017]; Flemish Agency for Innovation and Entrepreneurship; FWO Grant [G031416N]; Vici grant from Netherlands Organisation for Scientific Research [016.VICI.170.072]	Research Foundation Flanders (FWO)(FWO); Ghent University(Ghent University); Flemish Agency for Innovation and Entrepreneurship; FWO Grant(FWO); Vici grant from Netherlands Organisation for Scientific Research	The authors thank Charlotte de Rudder, Annelore Beterams, Rachael Hage, Brecht Hoflack, and Evelien Heiremans [all from the Center for Microbial Ecology and Technology (CMET), Ghent University] for their assistance in the cell laboratory. Special thanks are given to Geert Meesens (Department of Biotechnology, Faculty of Bioscience Engineering, Ghent University) for his technical assistance during confocal imaging. This work was supported by a postdoctoral fellowship from Research Foundation Flanders (FWO) (12R2717N, to M.C.), and a Ghent University Concerted Research Action Grant (BOF-GOA-2017). O.D. was supported by Ghent University as a M.Sc. student. E.H.-S. is a postdoctoral fellow supported by the Flemish Agency for Innovation and Entrepreneurship (Agentschap Innoveren en Ondernemen). S.H.M. and F.J.R.M. were supported by FWO Grant G031416N, and a Vici grant from the Netherlands Organisation for Scientific Research (016.VICI.170.072). The authors declare no conflicts of interest.	Abreu M. T., 2001, GASTROENTEROLOGY, V120, P1609; Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Al-Ghadban S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29783; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Alvarez G, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-1; Andersen SJ, 2014, ENVIRON SCI TECHNOL, V48, P7135, DOI 10.1021/es500483w; [Anonymous], CURR PROTOC IMMUNOL; Antunes F, 2013, EUR J PHARM BIOPHARM, V83, P427, DOI 10.1016/j.ejpb.2012.10.003; Arroyo MC, 2018, JOVE-J VIS EXP, DOI 10.3791/57699; ARTURSSON P, 1993, PHARMACEUT RES, V10, P1123, DOI 10.1023/A:1018903931777; Barrila J, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0011-2; Bein A, 2017, J CELL PHYSIOL, V232, P381, DOI 10.1002/jcp.25435; Beloqui A, 2017, NAT PROTOC, V12, P1387, DOI 10.1038/nprot.2017.041; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bosshart H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.53; Bowdish D., 2011, MAINTENANCE CULTURE; Calatayud M, 2013, TOXICOL LETT, V218, P70, DOI 10.1016/j.toxlet.2013.01.013; Calatayud M, 2012, CHEM RES TOXICOL, V25, P2654, DOI 10.1021/tx300295n; Calatayud M, 2012, CHEM RES TOXICOL, V25, P446, DOI 10.1021/tx200491f; Calatayud M, 2010, CHEM RES TOXICOL, V23, P547, DOI 10.1021/tx900279e; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Costello CM, 2014, BIOTECHNOL BIOENG, V111, P1222, DOI 10.1002/bit.25180; Didierlaurent A, 2002, CELL MICROBIOL, V4, P61, DOI 10.1046/j.1462-5822.2002.00177.x; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; El Aidy S, 2015, CURR OPIN BIOTECH, V32, P14, DOI 10.1016/j.copbio.2014.09.005; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Fischer Elizabeth R, 2012, Curr Protoc Microbiol, VChapter 2, DOI 10.1002/9780471729259.mc02b02s25; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Grasberger H, 2015, GASTROENTEROLOGY, V149, P1849, DOI 10.1053/j.gastro.2015.07.062; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hernandez-Sanabria E, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00235; Hernandez-Sanabria E, 2010, APPL ENVIRON MICROB, V76, P6338, DOI 10.1128/AEM.01052-10; Hilgendorf C, 2000, J PHARM SCI-US, V89, P63, DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6; Kampfer AAM, 2017, TOXICOL IN VITRO, V45, P31, DOI 10.1016/j.tiv.2017.08.011; Kanzato H, 2001, BIOSCI BIOTECH BIOCH, V65, P449, DOI 10.1271/bbb.65.449; Kubow KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9026; Kvietys PR, 2010, ANN NY ACAD SCI, V1207, pE29, DOI 10.1111/j.1749-6632.2010.05709.x; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Ma T. Y., 2005, GASTROENTEROLOGY, V128, pG422; Mani V., 2012, THESIS; McClure R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00386; Moyes SM, 2010, J ANAT, V217, P740, DOI 10.1111/j.1469-7580.2010.01304.x; Nicoletti C, 2009, MUCOSAL IMMUNOL, V2, P462, DOI 10.1038/mi.2009.92; Noel G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45270; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Props R, 2016, METHODS ECOL EVOL, V7, P1376, DOI 10.1111/2041-210X.12607; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sjoberg A, 2013, EUR J PHARM SCI, V48, P166, DOI 10.1016/j.ejps.2012.10.007; Sommer F, 2015, MUCOSAL IMMUNOL, V8, P372, DOI 10.1038/mi.2014.74; Song JC, 2001, AM J PHYSIOL-CELL PH, V281, pC649, DOI 10.1152/ajpcell.2001.281.2.C649; STENSON WF, 1993, AM J PHYSIOL, V265, pG955, DOI 10.1152/ajpgi.1993.265.5.G955; Sundin OH, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1059-6; van den Bogert B, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01013-13; van den Bogert B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114277; von Martels JZH, 2017, ANAEROBE, V44, P3, DOI 10.1016/j.anaerobe.2017.01.001; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012	61	14	17	5	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3985	3996		10.1096/fj.201801414R	http://dx.doi.org/10.1096/fj.201801414R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521380				2022-12-28	WOS:000459794800070
J	Han, JH; Shin, H; Park, JY; Rho, JG; Son, DH; Kim, KW; Seong, JK; Yoon, SH; Kim, W				Han, Ji Hye; Shin, Hanho; Park, Ju-Young; Rho, Jun Gi; Son, Dong Hwee; Kim, Ki Woo; Seong, Je Kyung; Yoon, Sung-Hwa; Kim, Wook			A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice	FASEB JOURNAL			English	Article						cannabinoid receptor; CB1R antagonist; inflammation; insulin resistance; obesity	ENDOCANNABINOID SYSTEM; OVERWEIGHT PATIENTS; NLRP3 INFLAMMASOME; RISK-FACTORS; BODY-WEIGHT; FOOD-INTAKE; RIMONABANT; DERIVATIVES; ACTIVATION; REVERSES	The overactivity of cannabinoid 1 receptor (CB1R) is associated with obesity and type 2 diabetes. First-generation CB1R antagonists, such as rimonabant, offered therapeutic advantages for the control of obesity and related metabolic abnormalities, but their therapeutic potential was limited by undesirable neuropsychiatric side effects. Here, we evaluated AJ5012 as a novel potent peripheral CB1R antagonist and, using this antagonist, investigated the role of peripheral CB1R on adipose tissue inflammation in obese mouse models. AJ5012 had a high degree of CB1R and cannabinoid 2 receptor selectivity but a low brain:plasma concentration ratio without eliciting centrally mediated neurobehavioral effects. In diet-induced obese (DIO) mice, AJ5012 did not reduce food intake but did induce a significant weight loss, likely owing to an increased energy expenditure. It was as effective as rimonabant for the improvement of hormonal or metabolic abnormalities, glycemic control, and insulin sensitivity. The treatment of DIO and leptin receptor-deficient mice with AJ5012 also exhibited effects comparable to rimonabant for the prevention of macrophage infiltration, activation of the nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome, and production of proinflammatory cytokines, which resulted in the suppression of adipose tissue inflammation. In addition to macrophage, activation of CB1R in 3T3-L1 adipocytes induced the expression of proinflammatory genes, which was fully inhibited by AJ5012. Our findings identified AJ5012 as a novel peripheral CB1R antagonist and suggest that peripheral CB1R blockade might break the links between insulin resistance and adipose tissue inflammation.Han, J. H., Shin, H., Park, J.-Y., Rho, J. G., Son, D. H., Kim, K. W., Seong, J. K., Yoon, S.-H., Kim, W. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.	[Han, Ji Hye; Shin, Hanho; Park, Ju-Young; Rho, Jun Gi; Yoon, Sung-Hwa; Kim, Wook] Ajou Univ, Dept Mol Sci & Technol, 206 Worldcup Ro, Suwon 16499, South Korea; [Son, Dong Hwee; Kim, Ki Woo] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul, South Korea; [Seong, Je Kyung] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Lab Dev Biol & Genom, Seoul, South Korea; [Seong, Je Kyung] Seoul Natl Univ, KMPC, Seoul, South Korea	Ajou University; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU)	Yoon, SH; Kim, W (corresponding author), Ajou Univ, Dept Mol Sci & Technol, 206 Worldcup Ro, Suwon 16499, South Korea.	shyoon@ajou.ac.kr; wookkim21@ajou.ac.kr	Kim, Ki Woo Woo/AAW-9645-2021	Kim, Ki Woo Woo/0000-0002-7790-1515; Seong, Je Kyung/0000-0003-1177-6958	BK21 PLUS Program for Creative Veterinary Science Research; Interdisciplinary Program for Bioinformatics; Program for Cancer Biology and Bio-Max/N-Bio Institute of Seoul National University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT [2013M3A9D5072550, 2016R1E1A1A01941213]; Ministry of Education [2009-0093826]	BK21 PLUS Program for Creative Veterinary Science Research; Interdisciplinary Program for Bioinformatics; Program for Cancer Biology and Bio-Max/N-Bio Institute of Seoul National University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT; Ministry of Education	The authors thank the Korea Mouse Phenotyping Center for support with indirect calorimetry; Jung-Hyuck Park, Byungjeong Song, and Chang-Sik Choi (JW Pharmaceutical, Seoul, South Korea) for assistance with the measurement of antagonist levels; and JaeSung Yang and JaeSung Hwang (Dong-A ST Research Center, Youngin, South Korea) for assistance with the measurement of polar surface area and atom-based logarithm of the partition coefficient between n-octanol and water. J.K.S. was supported by the BK21 PLUS Program for Creative Veterinary Science Research, Interdisciplinary Program for Bioinformatics, and Program for Cancer Biology and Bio-Max/N-Bio Institute of Seoul National University. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science and ICT (Grants 2013M3A9D5072550 and 2016R1E1A1A01941213) and the Ministry of Education (Grant 2009-0093826). The authors declare no conflicts of interest.	Addy C, 2008, CELL METAB, V7, P68, DOI 10.1016/j.cmet.2007.11.012; Alam S, 2014, DRUG DES DEV THER, V8, P183, DOI 10.2147/DDDT.S51577; Boon MR, 2014, FASEB J, V28, P5361, DOI 10.1096/fj.13-247643; Chorvat RJ, 2013, BIOORG MED CHEM LETT, V23, P4751, DOI 10.1016/j.bmcl.2013.06.066; Cluny NL, 2010, BRIT J PHARMACOL, V161, P629, DOI 10.1111/j.1476-5381.2010.00908.x; de Azua IR, 2017, J CLIN INVEST, V127, P4148, DOI 10.1172/JCI83626; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2009, NAT REV ENDOCRINOL, V5, P633, DOI 10.1038/nrendo.2009.197; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Ghose AK, 2012, ACS CHEM NEUROSCI, V3, P50, DOI 10.1021/cn200100h; Gomez R, 2002, J NEUROSCI, V22, P9612; Han JH, 2018, DIABETES OBES METAB, V20, P2179, DOI 10.1111/dom.13350; Jang HL, 2014, BIOORG MED CHEM LETT, V24, P571, DOI 10.1016/j.bmcl.2013.12.018; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jones D, 2008, NAT REV DRUG DISCOV, V7, P961, DOI 10.1038/nrd2775; Jourdan T, 2017, MOL METAB, V6, P1517, DOI 10.1016/j.molmet.2017.08.011; Jourdan T, 2017, DIABETES, V66, P994, DOI 10.2337/db16-1199; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Jourdan T, 2012, HEPATOLOGY, V55, P790, DOI 10.1002/hep.24733; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Le Foll B, 2009, PSYCHOPHARMACOLOGY, V205, P171, DOI 10.1007/s00213-009-1506-7; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032; Meinguet C, 2015, EUR J MED CHEM, V94, P45, DOI 10.1016/j.ejmech.2015.02.044; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Rho JG, 2018, J CONTROL RELEASE, V279, P89, DOI 10.1016/j.jconrel.2018.04.006; Rosenstock J, 2008, DIABETES CARE, V31, P2169, DOI 10.2337/dc08-0386; Shin JJ, 2015, AGEING RES REV, V24, P66, DOI 10.1016/j.arr.2015.06.004; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228	43	20	20	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4314	4326		10.1096/fj.201801152RR	http://dx.doi.org/10.1096/fj.201801152RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566396	Bronze			2022-12-28	WOS:000459794800097
J	Lin, SB; Haque, A; Raeman, R; Guo, LL; He, PJ; Denning, TL; El-Rayes, B; Moolenaar, WH; Yun, CC				Lin, Songbai; Haque, Abedul; Raeman, Reben; Guo, Leilei; He, Peijian; Denning, Timothy L.; El-Rayes, Bassel; Moolenaar, Wouter H.; Yun, C. Chris			Autotaxin determines colitis severity in mice and is secreted by B cells in the colon	FASEB JOURNAL			English	Article						lysophosphatidic acid; inflammation; lymphocytes	NA+/H+ EXCHANGER 3; ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID; ENTEROENDOCRINE CELLS; T-CELLS; LYSOPHOSPHOLIPASE-D; CANCER CELLS; BINDING; IDENTIFICATION; MACROPHAGES	Autotaxin (ATX or ENPP2) is a secreted lysophospholipase D that produces lysophosphatidic acid (LPA), a pleiotropic lipid mediator acting on specific GPCRs. ATX and LPA have been implicated in key (patho)physiologic processes, including embryonic development, lymphocyte homing, inflammation, and cancer progression. Using LPA receptor knockout mice, we previously uncovered a role for LPA signaling in promoting colitis and colorectal cancer. Here, we examined the role of ATX in experimental colitis through inducible deletion of Enpp2 in adult mice. ATX expression was increased upon induction of colitis, whereas ATX deletion reduced the severity of inflammation in both acute and chronic colitis, accompanied by transient weight loss. ATX expression in lymphocytes was strongly reduced in Rag1(-/-) and MT mice, suggesting B cells as a major ATX-producing source, which was validated by immunofluorescence and biochemical analyses. ATX secretion by B cells from control, but not Enpp2 knockout, mice led to ERK activation in colorectal cancer cells and promoted T cell migration. We conclude that ATX deletion suppresses experimental colitis and that B cells are a major source of ATX in the colon. Our study suggests that pharmacological inhibition of ATX could be a therapeutic strategy in colitis.Lin, S., Haque, A., Raeman, R., Guo, L., He, P., Denning, T. L., El-Rayes, B., Moolenaar, W. H., Yun, C. C. Autotaxin determines colitis severity in mice and is secreted by B cells in the colon.	[Lin, Songbai; Haque, Abedul; He, Peijian; Yun, C. Chris] Atlanta Vet Adm Med Ctr, Decatur, GA USA; [Lin, Songbai; Haque, Abedul; Guo, Leilei; He, Peijian; Yun, C. Chris] Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA; [El-Rayes, Bassel] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [El-Rayes, Bassel; Yun, C. Chris] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Raeman, Reben] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Denning, Timothy L.] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA; [Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Emory University; Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Georgia State University; Netherlands Cancer Institute	Yun, CC (corresponding author), Emory Univ, Sch Med, Div Digest Dis, 615 Michael St,Whitehead Bldg,Suite 201, Atlanta, GA 30324 USA.	ccyun@emory.edu	Raeman, Reben/AAF-7282-2021; el-rayes, bassel/ABD-2901-2021	Raeman, Reben/0000-0002-3914-1797; el-rayes, bassel/0000-0002-2661-5746	Veterans Administration Merit Award [I01BX002540]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [K01DK110264]; NIH National Cancer Institute [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK110264] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002540] Funding Source: NIH RePORTER	Veterans Administration Merit Award; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The current study was supported by the Veterans Administration Merit Award I01BX002540 (to C.C.Y.). R.R. was supported by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases K01 Career Development Grant K01DK110264. Confocal microscopic analyses were supported in part by the Integrated Cellular Imaging Shared Resources of the Winship Cancer Institute of Emory University (Atlanta, GA, USA) and NIH National Cancer Institute under Award P30CA138292. The authors declare no conflicts of interest.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Aranda R, 1997, J IMMUNOL, V158, P3464; Ashley JW, 2016, J BIOL CHEM, V291, P23268, DOI 10.1074/jbc.M116.754945; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Bolier R, 2016, BBA-MOL BASIS DIS, V1862, P696, DOI 10.1016/j.bbadis.2016.01.012; Castagna D, 2016, J MED CHEM, V59, P5604, DOI 10.1021/acs.jmedchem.5b01599; Chennupati V, 2010, J IMMUNOL, V185, P5160, DOI 10.4049/jimmunol.1001652; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; COOPER HS, 1993, LAB INVEST, V69, P238; Cupi ML, 2014, J IMMUNOL, V192, P6083, DOI 10.4049/jimmunol.1302238; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Euer N, 2002, ANTICANCER RES, V22, P733; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Hausmann Jens, 2013, Advances in Biological Regulation, V53, P112, DOI 10.1016/j.jbior.2012.09.010; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; He PJ, 2015, J CLIN INVEST, V125, P3519, DOI 10.1172/JCI79552; Houben AJS, 2013, J BIOL CHEM, V288, P510, DOI 10.1074/jbc.M112.358416; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Hozumi H, 2013, LAB INVEST, V93, P508, DOI 10.1038/labinvest.2013.45; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Katsifa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143083; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Leblanc R, 2014, BLOOD, V124, P3141, DOI 10.1182/blood-2014-04-568683; Lee SJ, 2013, MOL CELL BIOL, V33, P2016, DOI 10.1128/MCB.00038-13; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Lin SB, 2018, AM J PATHOL, V188, P353, DOI 10.1016/j.ajpath.2017.10.006; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Lycke NY, 2017, MUCOSAL IMMUNOL, V10, P1361, DOI 10.1038/mi.2017.62; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Moran GW, 2012, J CROHNS COLITIS, V6, P871, DOI 10.1016/j.crohns.2012.01.013; Nakasaki T, 2008, AM J PATHOL, V173, P1566, DOI 10.2353/ajpath.2008.071153; Nikolaou A, 2017, EXPERT OPIN THER PAT, V27, P815, DOI 10.1080/13543776.2017.1323331; O'Hara JR, 2004, AM J PHYSIOL-GASTR L, V287, pG998, DOI 10.1152/ajpgi.00090.2004; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Olson TS, 2004, J CLIN INVEST, V114, P389, DOI 10.1172/jci200420855; Rahman K, 2016, GASTROENTEROLOGY, V151, P733, DOI 10.1053/j.gastro.2016.06.022; Ray R, 2017, BLOOD, V129, P1177, DOI 10.1182/blood-2016-10-743757; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Stassar MJJG, 2001, BRIT J CANCER, V85, P1372, DOI 10.1054/bjoc.2001.2074; Sturm A, 1999, GASTROENTEROLOGY, V117, P368, DOI 10.1053/gast.1999.0029900368; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wang L, 2015, MUCOSAL IMMUNOL, V8, P1297, DOI 10.1038/mi.2015.20; Yoo BK, 2011, AM J PHYSIOL-CELL PH, V301, pC1008, DOI 10.1152/ajpcell.00231.2011; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zhang R, 2011, CLIN EXP IMMUNOL, V164, P417, DOI 10.1111/j.1365-2249.2011.04374.x; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604	59	15	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3623	3635		10.1096/fj.201801415RR	http://dx.doi.org/10.1096/fj.201801415RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481488	Green Published, Bronze			2022-12-28	WOS:000459794800043
J	Yang, SJ; Allahverdian, S; Saunders, ADR; Liu, E; Dorscheid, DR				Yang, S. Jasemine; Allahverdian, Sima; Saunders, Angela D. R.; Liu, Emily; Dorscheid, Delbert R.			IL-13 signaling through IL-13 receptor 2 mediates airway epithelial wound repair	FASEB JOURNAL			English	Article						asthma; type 2 inflammation; barrier function; EGFR; HB-EGF	INTERLEUKIN (IL)-13 RESPONSES; UNCONTROLLED ASTHMA; ALPHA-1 EXPRESSION; DOUBLE-BLIND; T-CELLS; IL-13R-ALPHA-2; MECHANISM; EFFICACY; ISOFORMS; FIBROSIS	Asthma is an airway inflammatory disease characterized by epithelial barrier dysfunction and airway remodeling. Interleukin-13 (IL-13) is a pleiotropic cytokine shown to contribute to features of airway remodeling. We have previously demonstrated that IL-13 is an important mediator of normal airway epithelial repair and health. The role of IL-13 signaling via its receptor subunits (IL-13R1/IL-4R and IL-13R2) in airway epithelial repair and restoration of intact barrier function is not well understood and was investigated in this study using in vitro models. The blocking of IL-13 signaling via IL-13R2 significantly reduced airway epithelial repair by 24 h post-mechanical wounding in 1HAEo(-) cells. Expression and release of repair-mediating growth factor, heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF), and subsequent activation of EGF receptor (EGFR) were also significantly reduced in response to wounding when IL-13R2 was blocked. Our data support that IL-13 signals via IL-13R2 to mediate normal airway epithelial repair via HB-EGF-dependent activation of EGFR. In human donor lung tissues, we observed that airway epithelium of asthmatics expressed significantly decreased levels of IL-13R2 and increased levels of IL-13R1 compared with nonasthmatics. Dysregulated expression of IL-13 receptor subunits in the airways of asthmatics may thus contribute to the epithelial barrier dysfunction observed in asthma.Yang, S. J., Allahverdian, S., Saunders, A. D. R., Liu, E., Dorscheid, D. R. IL-13 signaling through IL-13 receptor 2 mediates airway epithelial wound repair.	[Yang, S. Jasemine; Allahverdian, Sima; Saunders, Angela D. R.; Liu, Emily; Dorscheid, Delbert R.] Univ British Columbia, Dept Med, Ctr Heart Lung Innovat, Providence Hlth Care, Vancouver, BC, Canada	University of British Columbia	Dorscheid, DR (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, Room 166,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	del.dorscheid@hli.ubc.ca			AllerGen-Networks of Centres of Excellence; Canadian Institutes of Health Research; British Columbia Lung Association	AllerGen-Networks of Centres of Excellence; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association	The authors thank the Centre for Heart Lung Innovation Lung Registry for lung tissue collection; Dr. W. Mark Elliott and Amrit Aitken for tissue processing and histology advice; and Beth Whalen for flow cytometry training and advice (W. M. Elliott, A. Aitken, and B. Whalen are members of the Centre for Heart Lung Innovation). This study was funded by AllerGen-Networks of Centres of Excellence, Canadian Institutes of Health Research, and the British Columbia Lung Association. The authors declare no conflicts of interest.	Akaiwa M, 2001, CYTOKINE, V13, P75, DOI 10.1006/cyto.2000.0814; Allahverdian S, 2008, AM J RESP CELL MOL, V38, P153, DOI 10.1165/rcmb.2007-0173OC; Andrews AL, 2006, J ALLERGY CLIN IMMUN, V118, P858, DOI 10.1016/j.jaci.2006.06.041; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Brightling CE, 2015, LANCET RESP MED, V3, P692, DOI 10.1016/S2213-2600(15)00197-6; Campbell-Harding G, 2013, J ALLERGY CLIN IMMUN, V131, P849, DOI 10.1016/j.jaci.2012.08.030; Chandriani S, 2014, J IMMUNOL, V193, P111, DOI 10.4049/jimmunol.1301761; Chen WG, 2009, J IMMUNOL, V183, P7870, DOI 10.4049/jimmunol.0901028; Cho WK, 2013, AM J PHYSIOL-LUNG C, V304, pL112, DOI 10.1152/ajplung.00101.2012; COZENS AL, 1992, IN VITRO CELL DEV-AN, V28A, P735; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Daines MO, 2007, J ALLERGY CLIN IMMUN, V119, P375, DOI 10.1016/j.jaci.2006.09.039; Daines MO, 2006, J IMMUNOL, V176, P7495, DOI 10.4049/jimmunol.176.12.7495; Daines MO, 2002, J BIOL CHEM, V277, P10387, DOI 10.1074/jbc.M108109200; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Graber P, 1998, EUR J IMMUNOL, V28, P4286, DOI 10.1002/(SICI)1521-4141(199812)28:12<4286::AID-IMMU4286>3.0.CO;2-H; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hajoui O, 2007, J ALLERGY CLIN IMMUN, V120, P1425, DOI 10.1016/j.jaci.2007.07.011; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hall SL, 2017, J ALLERGY CLIN IMMUN, V139, P462, DOI 10.1016/j.jaci.2016.04.037; Hanania NA, 2016, LANCET RESP MED, V4, P781, DOI 10.1016/S2213-2600(16)30265-X; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Hecker M, 2010, AM J RESP CRIT CARE, V182, P805, DOI 10.1164/rccm.200909-1367OC; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Humbert M, 1997, J ALLERGY CLIN IMMUN, V99, P657, DOI 10.1016/S0091-6749(97)70028-9; Ingram JL, 2011, AM J RESP CRIT CARE, V183, P1625, DOI 10.1164/rccm.201009-1452OC; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandal D, 2010, INFLAMM BOWEL DIS, V16, P753, DOI 10.1002/ibd.21133; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; O'Toole M, 2008, CLIN EXP ALLERGY, V38, P594, DOI 10.1111/j.1365-2222.2007.02921.x; Schmid-Grendelmeier P, 2002, J IMMUNOL, V169, P1021, DOI 10.4049/jimmunol.169.2.1021; Singhera GK, 2008, EXP LUNG RES, V34, P579, DOI 10.1080/01902140802369372; Tabata Y, 2007, CURR ALLERGY ASTHM R, V7, P338, DOI 10.1007/s11882-007-0051-x; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Toru H, 1998, J ALLERGY CLIN IMMUN, V102, P491, DOI 10.1016/S0091-6749(98)70140-X; White SR, 2010, AM J PHYSIOL-LUNG C, V299, pL681, DOI 10.1152/ajplung.00422.2009; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xu J, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0177-7; Yamada Y, 2004, PEDIAT ALLERG IMM-UK, V15, P159, DOI 10.1111/j.1399-3038.2004.00155.x; Ying S, 1997, J IMMUNOL, V158, P5050; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	52	13	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3746	3757		10.1096/fj.201801285R	http://dx.doi.org/10.1096/fj.201801285R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481486	Bronze			2022-12-28	WOS:000459794800053
J	Zhao, YG; Wu, JY; Jia, H; Wang, XY; Zheng, RZ; Jiang, F; Chen, DN; Chen, ZH; Li, JD				Zhao, Yaguang; Wu, Jiayu; Jia, Hong; Wang, Xinying; Zheng, Ruizhi; Jiang, Fang; Chen, Dan-Na; Chen, Zhiheng; Li, Jia-Da			PROKR2 mutations in idiopathic hypogonadotropic hypogonadism: selective disruption of the binding to a G-protein leads to biased signaling	FASEB JOURNAL			English	Article						prokineticin receptor 2; GPCR; GnRH	GONADOTROPIN-RELEASING-HORMONE; KALLMANN-SYNDROME; INTRACELLULAR LOOP; COUPLED RECEPTORS; OLFACTORY-BULB; PROKINETICIN 2; DEFICIENCY; IDENTIFICATION; HETEROGENEITY; CHD7	Idiopathic hypogonadotropic hypogonadism (IHH) is a rare disorder caused by the deficient production, secretion, or action of gonadotropin-releasing hormone. Prokineticin (PROK) receptor 2 (PROKR2), a causative gene for IHH, encodes a GPCR PROKR2. When PROKR2 binds to its ligands PROKs, it may activate several signaling pathways, including IP3/Ca2+, MAPK, and cAMP pathways. However, the mutational spectrum of PROKR2 in Chinese patients with IHH has not been established. In the present study, we found that up to 13.3% (18/135) of patients with IHH in China carried mutations in PROKR2. Most of the variants in this study were private; however, a PROKR2 (c.533G > C; p.W178S) mutation was identified in 10 independent patients, implying a possible founder mutation. Functional studies indicated that 6 novel PROKR2 mutations led to decreased signaling to various extents. Two IHH-associated mutations (L218P and R270H) disrupted Gq-dependent signaling but maintained normal Gs and ERK1/2 signaling. A glutathione S-transferase pull-down experiment demonstrated that R270H mutation disrupted the interaction of intracellular loop 3 of PROKR2 to Gq protein but not Gs protein. Our results indicated that selective disruption of the interaction with a specific G-protein might underlie the biased signaling for certain IHH-associated PROKR2 mutations.Zhao, Y., Wu, J., Jia, H., Wang, X., Zheng, R., Jiang, F., Chen, D.-N., Chen, Z., Li, J.-D. PROKR2 mutations in idiopathic hypogonadotropic hypogonadism: selective disruption of the binding to a G-protein leads to biased signaling.	[Zhao, Yaguang; Wu, Jiayu; Jia, Hong; Wang, Xinying; Jiang, Fang; Li, Jia-Da] Cent S Univ, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China; [Zhao, Yaguang; Wu, Jiayu; Jia, Hong; Wang, Xinying; Jiang, Fang; Li, Jia-Da] Cent S Univ, Hunan Key Lab Anim Models Human Dis, Changsha, Hunan, Peoples R China; [Zhao, Yaguang; Wu, Jiayu; Jia, Hong; Wang, Xinying; Jiang, Fang; Li, Jia-Da] Cent S Univ, Hunan Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Zheng, Ruizhi] Peoples Hosp Henan Prov, Dept Endocrinol, Zhengzhou, Henan, Peoples R China; [Chen, Dan-Na] Changsha Med Univ, Dept Basic Med Sci, Changsha, Hunan, Peoples R China; [Chen, Zhiheng] Cent S Univ, Xiangya Hosp 3, Dept Pediat, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Zhengzhou University; Changsha Medical University; Central South University	Li, JD (corresponding author), Cent S Univ, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.; Chen, ZH (corresponding author), Cent S Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China.	chenzh_36@163.com; lijiada@sklmg.edu.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Wu, Jiayu/0000-0001-9802-0250; Li, Jia-Da/0000-0002-4236-3518	National High-Tech Research and Development Program [2015AA020502]; National Basic Research Program of China [2012CB517904]; National Natural Science Foundation of China [31371187, 81770780, 81728013]; Key Research and Development Programs from Hunan Province [2018DK2010, 2018DK2013]; Fundamental Research Funds for the Central Universities of Central South University [1053320181293, 1053320181270]; Natural Science Foundation of Hunan Province [2018JJ3573]; Training Program Foundation for Excellent Innovation Youth of Changsha [kq1802019]	National High-Tech Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Programs from Hunan Province; Fundamental Research Funds for the Central Universities of Central South University; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Training Program Foundation for Excellent Innovation Youth of Changsha	The authors thank Q. Y. Zhou (University of California, Irvine, Irvine, CA, USA) and P. Rondard (Institut de Genomique Fonctionnelle, Montpellier, France) for the reagents. This project was supported by National High-Tech Research and Development Program Grant 2015AA020502 (to J.-D.L.); National Basic Research Program of China Grant 2012CB517904 (to J.-D.L.); National Natural Science Foundation of China Grants 31371187 (to D.-N.C.), 81770780 (to J.-D.L.), and 81728013 (to J.-D.L.); Key Research and Development Programs from Hunan Province Grants 2018DK2010, 2018DK2013 (both to J.-D.L.); the Fundamental Research Funds for the Central Universities of Central South University (1053320181293 to J.Y.W., and 1053320181270 to X.Y.W.), Natural Science Foundation of Hunan Province (2018JJ3573 to D.-N.C.), and the Training Program Foundation for Excellent Innovation Youth of Changsha (kq1802019 to D.-N.C.). The authors declare no conflicts of interest.	Au MG, 2011, MOL CELL ENDOCRINOL, V346, P102, DOI 10.1016/j.mce.2011.05.041; Beneduzzi D, 2014, FERTIL STERIL, V102, P838, DOI 10.1016/j.fertnstert.2014.05.044; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; Boehm U, 2015, NAT REV ENDOCRINOL, V11, P547, DOI 10.1038/nrendo.2015.112; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; BOYAR RM, 1976, J CLIN ENDOCR METAB, V43, P1268, DOI 10.1210/jcem-43-6-1268; Brioude F, 2010, EUR J ENDOCRINOL, V162, P835, DOI 10.1530/EJE-10-0083; Cariboni A, 2015, J CLIN INVEST, V125, P2413, DOI 10.1172/JCI78448; Chen DN, 2014, J BIOL CHEM, V289, P15518, DOI 10.1074/jbc.M114.556381; Di Pietro F, 2011, MOL CELL PROBE, V25, P44, DOI 10.1016/j.mcp.2010.10.003; Gutierrez-Amavizca Bianca Ethel, 2012, Rev Med Inst Mex Seguro Soc, V50, P157; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Jethwa PH, 2008, AM J PHYSIOL-REG I, V294, pR1968, DOI 10.1152/ajpregu.00778.2007; Jongmans MCJ, 2009, CLIN GENET, V75, P65, DOI 10.1111/j.1399-0004.2008.01107.x; Kim HG, 2008, AM J HUM GENET, V83, P511, DOI 10.1016/j.ajhg.2008.09.005; Kim SH, 2015, ENDOCRINOL METAB, V30, P456, DOI 10.3803/EnM.2015.30.4.456; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Miraoui H, 2013, AM J HUM GENET, V92, P725, DOI 10.1016/j.ajhg.2013.04.008; Mitchell AL, 2011, TRENDS ENDOCRIN MET, V22, P249, DOI 10.1016/j.tem.2011.03.002; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Moreira IS, 2014, BBA-GEN SUBJECTS, V1840, P16, DOI 10.1016/j.bbagen.2013.08.027; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Peng Z, 2011, J BIOL CHEM, V286, P16615, DOI 10.1074/jbc.M111.223784; Pitteloud N, 2006, P NATL ACAD SCI USA, V103, P6281, DOI 10.1073/pnas.0600962103; Pitteloud N, 2002, J CLIN ENDOCR METAB, V87, P4128, DOI 10.1210/jc.2002-020518; Quinton R, 2001, CLIN ENDOCRINOL, V55, P163, DOI 10.1046/j.1365-2265.2001.01277.x; REITANO JF, 1975, J CLIN ENDOCR METAB, V41, P1035, DOI 10.1210/jcem-41-6-1035; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Sarfati J, 2013, EUR J ENDOCRINOL, V169, P805, DOI 10.1530/EJE-13-0419; Sbai O, 2014, FASEB J, V28, P3734, DOI 10.1096/fj.13-243402; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Stefanija MA, 2012, HUM MOL GENET, V21, P4314, DOI 10.1093/hmg/dds264; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Waldstreicher J, 1996, J CLIN ENDOCR METAB, V81, P4388, DOI 10.1210/jc.81.12.4388; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600; Zhou WB, 2012, REGUL PEPTIDES, V179, P84, DOI 10.1016/j.regpep.2012.08.003; Zhou XT, 2013, BIOCHEM BIOPH RES CO, V439, P12, DOI 10.1016/j.bbrc.2013.08.039	43	13	12	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4538	4546		10.1096/fj.201801575R	http://dx.doi.org/10.1096/fj.201801575R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30576231				2022-12-28	WOS:000459794800114
J	Singh, AK; Fechtner, S; Chourasia, M; Sicalo, J; Ahmed, S				Singh, Anil K.; Fechtner, Sabrina; Chourasia, Mukesh; Sicalo, Jerry; Ahmed, Salahuddin			Critical role of IL-1 in IL-1-induced inflammatory responses: cooperation with NF-Bp65 in transcriptional regulation	FASEB JOURNAL			English	Article						rheumatoid arthritis; synovial fibroblasts; nuclear factor B; signal transduction	INTERLEUKIN-1-ALPHA; IL-1-BETA; ACTIVATION; IL-1-ALPHA; MECHANISM; SUPPRESSION; EXPRESSION; PRECURSOR; PATHWAYS; PROMOTER	The IL-1 cytokines are considered among the first family of cytokines that orchestrate acute and chronic inflammatory diseases. Both IL-1 and IL-1 are members of the IL-1 family; however, their distinct roles in the inflammatory processes remain poorly understood. We explored the role of IL-1 in IL-1-activated signaling pathways causing synovial inflammation in rheumatoid arthritis (RA). Using synovial fibroblasts isolated from RA joints, we found that IL-1 significantly stimulated IL-1 expression, which was selectively inhibited by blocking the NF-B pathway. Knockdown of IL-1 using small interfering RNA abolished IL-1-induced pro-IL-1 and pro-IL-1 expression and suppressed inflammation. Native and chromatin immunoprecipitation studies showed that IL-1 cooperates in NF-Bp65 binding to the distal region of IL-1 promoter and to the proximal region of IL-1 promoter upstream of the transcription start site to stabilize their gene transcription. Molecular dynamics simulation of IL-1 or IL-1 binding to IL-1 receptor showed distinct interaction sites that corroborate with the ability of IL-1 to differentially activate phosphorylation of signaling proteins compared with IL-1. Our study highlights the importance of IL-1 in mediating IL-1-induced inflammation in addition to maintaining its expression and providing a rationale for targeting IL-1 to minimize the role of IL-1 in inflammatory diseases like RA.Singh, A. K., Fechtner, S., Chourasia, M., Sicalo, J., Ahmed, S. Critical role of IL-1 in IL-1-induced inflammatory responses: cooperation with NF-Bp65 in transcriptional regulation.	[Singh, Anil K.; Fechtner, Sabrina; Sicalo, Jerry; Ahmed, Salahuddin] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, SPBS Room 411,412 E Spokane Falls Blvd, Spokane, WA 99210 USA; [Chourasia, Mukesh] Amity Univ, Amity Inst Biotechnol, Ctr Computat Biol & Bioinformat, Noida, India; [Ahmed, Salahuddin] Univ Washington, Sch Med, Div Rheumatol, Seattle, WA USA	Washington State University; Amity University Noida; University of Washington; University of Washington Seattle	Ahmed, S (corresponding author), Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, SPBS Room 411,412 E Spokane Falls Blvd, Spokane, WA 99210 USA.	salah.ahmed@wsu.edu	Chourasia, Mukesh/ABI-6012-2020; Singh, Anil K/H-6225-2019; Chourasia, Mukesh/S-3976-2016	Singh, Anil K/0000-0002-4102-2420; Fechtner, Sabrina/0000-0001-5931-4600; Chourasia, Mukesh/0000-0002-4565-5348	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR-063104]; Washington State University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063104] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Washington State University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the Cooperative Human Tissue Network (CHTN) and National Disease Research Interchange (NDRI) for providing RA and NL synovial tissues. This work was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant AR-063104 to S.A.), and Start-Up Funds from Washington State University (to S.A.). The authors declare no conflicts of interest.	Ahmed S, 2008, P NATL ACAD SCI USA, V105, P14692, DOI 10.1073/pnas.0802675105; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; CLINTON SK, 1991, AM J PATHOL, V138, P1005; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Genovese MC, 2009, ARTHRITIS RHEUM, V60, P317, DOI 10.1002/art.24264; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Huber MD, 2007, J CELL BIOL, V179, P583, DOI 10.1083/jcb.200710156; Jhang JJ, 2015, CELL MOL IMMUNOL, V12, P424, DOI 10.1038/cmi.2014.65; Jones DS, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aal1601; KAVITA U, 1995, J BIOL CHEM, V270, P27758, DOI 10.1074/jbc.270.46.27758; Kim EY, 2018, FASEB J, V32, P6174, DOI 10.1096/fj.201800425R; Lamacchia C, 2013, CYTOKINE, V63, P135, DOI 10.1016/j.cyto.2013.04.010; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Luheshi NM, 2009, TRAFFIC, V10, P16, DOI 10.1111/j.1600-0854.2008.00840.x; Moldovan F, 2000, OSTEOARTHR CARTILAGE, V8, P186, DOI 10.1053/joca.1999.0289; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Ogata S, 2007, J DENT RES, V86, P186, DOI 10.1177/154405910708600215; Ren XM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00864-2; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Rider P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00290; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Singh AK, 2016, ARTHRITIS RHEUMATOL, V68, P347, DOI 10.1002/art.39447; Singh AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009912; Umekawa T, 2003, NEPHROL DIAL TRANSPL, V18, P664, DOI 10.1093/ndt/gfg140; Vollmer S, 2017, BIOCHEM J, V474, P2027, DOI 10.1042/BCJ20170097; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Yaron M, 1999, OSTEOARTHR CARTILAGE, V7, P272, DOI 10.1053/joca.1998.0201; Zhu QZ, 2015, MUTAT RES-FUND MOL M, V776, P16, DOI 10.1016/j.mrfmmm.2015.01.005	39	17	19	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2526	2536		10.1096/fj.201801513R	http://dx.doi.org/10.1096/fj.201801513R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30272996	Green Published			2022-12-28	WOS:000457296600079
J	Koshy, A; Cuesta, M; Boudreau, P; Cermakian, N; Boivin, DB				Koshy, Anna; Cuesta, Marc; Boudreau, Philippe; Cermakian, Nicolas; Boivin, Diane B.			Disruption of central and peripheral circadian clocks in police officers working at night	FASEB JOURNAL			English	Article						night-shift work; oral mucosa cells; PBMCs; urinary 6-sulfatoxymelatonin; salivary cortisol	BLOOD MONONUCLEAR-CELLS; SHIFT WORK; GENE-EXPRESSION; MESSENGER-RNA; RHYTHMS; NURSES; LIGHT; MELATONIN; CORTISOL; CANCER	Working atypical schedules leads to temporal misalignments between a worker's rest-activity cycle and their endogenous circadian system. Several studies have reported disturbed centrally controlled rhythms, but little is known on shift workers' peripheral clocks. Here, we assessed central clock markers, urinary 6-sulfatoxymelatonin and salivary cortisol, and clock gene expression in 2 peripheral clocks, oral mucosa cells and peripheral blood mononuclear cells (PBMCs), in 11 police officers. Before working 7 consecutive nights, officers' centrally controlled rhythms were aligned to a day-oriented schedule. These rhythms were partially realigned to the shifted schedule and dampened after a week working nights. For peripheral clocks at baseline, Period (PER)1-3 and nuclear receptor subfamily 1, group D, member 1 (REV-ERB alpha) in oral mucosa cells had a significant mRNA peak in the afternoon, whereas in PBMCs, higher PER1-3 expression was observed at 10:00 compared with 19:30. After a week working nights, PER1-3 and REV-ERB alpha expression in oral mucosa cells lost rhythmicity, and in PBMCs, the morning/evening difference observed at baseline was lost. To our knowledge, this is the first study to demonstrate the disruption of several peripheral clocks in real shift workers. Molecular circadian disturbances are believed to have important clinical implications for the occurrence of shift work-associated medical disorders.-Koshy, A., Cuesta, M., Boudreau, P., Cermakian, N., Boivin, D. B. Disruption of central and peripheral circadian clocks in police officers working at night.	[Koshy, Anna; Cuesta, Marc; Boudreau, Philippe; Boivin, Diane B.] McGill Univ, Dept Psychiat, Ctr Study & Treatment Circadian Rhythms, Montreal, PQ, Canada; [Koshy, Anna; Cuesta, Marc; Cermakian, Nicolas] McGill Univ, Dept Psychiat, Lab Mol Chronobiol, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University	Cermakian, N (corresponding author), Douglas Mental Hlth Univ Inst, Lab Mol Chronobiol, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.; Boivin, DB (corresponding author), Douglas Mental Hlth Univ Inst, Ctr Study & Treatment Circadian Rhythms, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.	nicolas.cermakian@mcgill.ca; diane.boivin@douglas.mcgill.ca		Boudreau, Philippe/0000-0002-9367-2919	Canadian Institutes of Health Research [MOP-137052, MOP-102724]; Institut de Recherche Robert-Sauve en Sante et en Securite du Travail [2013-0046]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institut de Recherche Robert-Sauve en Sante et en Securite du Travail	The authors thank the clinical team from the Douglas Mental Health University Institute, which consisted of the physician on call, Dr. Sylvie Rheaume, and nurse, Xing Dai; Dr. Claire-Dominique Walker, who provided hormone assays; Manon Gagnon and Johanne Gauthier, who provided administrative help; the research technicians and trainees of the laboratory, who assisted with this study; and the participating police officers and their municipal department in the Province of Quebec. This study was supported by grants from the Canadian Institutes of Health Research (MOP-137052 and MOP-102724, to D.B.B and N.C.) and the Institut de Recherche Robert-Sauve en Sante et en Securite du Travail (Operating Grant 2013-0046 to D.B.B. and Graduate Fellowship Award to A.K.) D.B.B. provided consultation and medico-legal advices on shift work and sleep/wake related issues. The remaining authors declare no conflicts of interest.	Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; Alibhai FJ, 2015, CAN J CARDIOL, V31, P860, DOI 10.1016/j.cjca.2015.01.015; Archer SN, 2008, SLEEP, V31, P608, DOI 10.1093/sleep/31.5.608; Benloucif S, 2008, J CLIN SLEEP MED, V4, P66; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Boivin DB, 2002, J BIOL RHYTHM, V17, P556, DOI 10.1177/0748730402238238; Boivin DB, 2012, CHRONOBIOL INT, V29, P619, DOI 10.3109/07420528.2012.675257; Boudreau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070813; Bracci M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050623; Bracci M, 2014, SCAND J WORK ENV HEA, V40, P295, DOI 10.5271/sjweh.3414; Buijs RM, 2003, J ENDOCRINOL, V177, P17, DOI 10.1677/joe.0.1770017; Cermakian N, 2011, J BIOL RHYTHM, V26, P160, DOI 10.1177/0748730410395732; Cochran WG, 1957, EXPT DESIGNS; Cuesta M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16429-8; Cuesta M, 2016, J IMMUNOL, V196, P2466, DOI 10.4049/jimmunol.1502422; Cuesta M, 2015, FASEB J, V29, P1360, DOI 10.1096/fj.14-265686; Davis S, 2006, CANCER CAUSE CONTROL, V17, P539, DOI 10.1007/s10552-005-9010-9; Emerson KJ, 2009, J COMP PHYSIOL A, V195, P385, DOI 10.1007/s00359-009-0416-9; Fang MZ, 2015, SLEEP MED, V16, P1388, DOI 10.1016/j.sleep.2015.06.011; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Fukuoka Y, 2005, J BIOL RHYTHM, V20, P550, DOI 10.1177/0748730405279866; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; James FO, 2004, CHRONOBIOL INT, V21, P961, DOI 10.1081/CBI-200035944; James FO, 2007, CHRONOBIOL INT, V24, P1009, DOI 10.1080/07420520701800736; James FO, 2007, SLEEP, V30, P1427, DOI 10.1093/sleep/30.11.1427; Johnston JD, 2016, ADV NUTR, V7, P399, DOI 10.3945/an.115.010777; Kervezee L, 2018, P NATL ACAD SCI USA, V115, P5540, DOI 10.1073/pnas.1720719115; Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007; Kiessling S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0349-7; Kusanagi H, 2008, NEUROSCI RES, V61, P136, DOI 10.1016/j.neures.2008.01.012; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moore RY, 1998, CHRONOBIOL INT, V15, P475, DOI 10.3109/07420529808998703; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Oster H, 2006, GENES BRAIN BEHAV, V5, P73, DOI 10.1111/j.1601-183X.2006.00226.x; Peplonska B, 2012, OCCUP ENVIRON MED, V69, P339, DOI 10.1136/oemed-2011-100273; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Reszka E, 2013, SCAND J WORK ENV HEA, V39, P187, DOI 10.5271/sjweh.3303; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Rosenthal N., 1987, SEASONAL PATTERN ASS; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Skene DJ, 2006, ANN CLIN BIOCHEM, V43, P344, DOI 10.1258/000456306778520142; Statistics Canada, 2005, GEN SOCIAL SURVEY; Teboul M, 2005, J MOL MED, V83, P693, DOI 10.1007/s00109-005-0697-6; US Bureau of Labor Statistics/US Census Bureau, 2004, CURR POP SURV CPS S; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wehrens SMT, 2017, CURR BIOL, V27, P1768, DOI 10.1016/j.cub.2017.04.059; Weissova K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146200	49	20	20	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6789	6800		10.1096/fj.201801889R	http://dx.doi.org/10.1096/fj.201801889R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811213	Bronze			2022-12-28	WOS:000476114200010
J	Saalbach, A; Anderegg, U				Saalbach, Anja; Anderegg, Ulf			Thy-1: more than a marker for mesenchymal stromal cells	FASEB JOURNAL			English	Review						CD90; osteogenesis; adipogenesis; adipose tissue; differentiation	ACTIVATED ENDOTHELIAL-CELLS; SURFACE GLYCOPROTEIN THY-1; SRC FAMILY KINASE; BONE-MARROW; PPAR-GAMMA; STEM-CELLS; OSTEOBLAST DIFFERENTIATION; MOLECULE THY-1; EXPRESSION; INTEGRIN	Balanced differentiation of mesenchymal stromal cells (MSCs) into osteoblasts and adipocytes is essential for healthy bone and fat homeostasis. A disturbed balance of MSC differentiation results in bone loss and increased adipogenesis as observed in several human conditions, such as osteoporosis, obesity, and aging. This reflects the importance of MSC fate decision. Therefore, it is important to identify factors that regulate the balance between osteogenic and adipogenic differentiation of MSCs so as to identify new targets to improve bone formation in osteoporosis and control adipose tissue development. There is accumulating evidence that thymus cell antigen 1 (Thy-1), also known as CD90, expressed on MSCs, plays a critical role in the fate decision of MSCs. Recently, Thy-1 has been shown to promote osteogenic differentiation of MSCs and thus bone formation while inhibiting adipogenic differentiation and restricting adipose tissue accumulation. The clinical importance of these findings was validated by the detection of reduced serum soluble Thy-1 in patients with disturbed bone remodeling. In this review, we aim to summarize data on the impact of Thy-1 on the control of MSC differentiation and its consequences for bone and fat formation.-Saalbach, A., Anderegg, U. Thy-1: more than a marker for mesenchymal stromal cells.	[Saalbach, Anja; Anderegg, Ulf] Univ Leipzig, Fac Med, Dept Dermatol Venerol & Allergol, Johannisallee 30, D-04013 Leipzig, Germany	Leipzig University	Saalbach, A (corresponding author), Univ Leipzig, Fac Med, Dept Dermatol Venerol & Allergol, Johannisallee 30, D-04013 Leipzig, Germany.	anja.saalbach@medizin.uni-leipzig.de	Saalbach, Anja/ABD-4003-2021	Saalbach, Anja/0000-0002-1084-3875	Deutsche Forschungsgemeinschaft [SA863/2-3, (SFB)/Transregio 67 59307082]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research study was supported by the Deutsche Forschungsgemeinschaft (SA863/2-3 to A.S.; Collaborative Research Centers (SFB)/Transregio 67 59307082, Project B4 to U.A. and A.S.). The authors declare no conflicts of interest.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Amoui M, 1997, EUR J IMMUNOL, V27, P1881, DOI 10.1002/eji.1830270810; Angeli A, 2006, BONE, V39, P253, DOI 10.1016/j.bone.2006.02.005; Avalos AM, 2002, BIOL RES, V35, P231, DOI 10.4067/S0716-97602002000200015; Barker TH, 2009, BBA-MOL CELL RES, V1793, P921, DOI 10.1016/j.bbamcr.2008.10.004; Barlow JZ, 2000, J COMP NEUROL, V421, P215, DOI 10.1002/(SICI)1096-9861(20000529)421:2<215::AID-CNE7>3.0.CO;2-U; Barlow JZ, 2002, NEUROSCIENCE, V111, P837, DOI 10.1016/S0306-4522(02)00023-4; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Beissert S, 1998, J IMMUNOL, V161, P5296; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Bradley JS, 2009, BIOFACTORS, V35, P258, DOI 10.1002/biof.41; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Cheng BQ, 2014, GENET MOL RES, V13, P5115, DOI 10.4238/2014.July.7.4; Chung MT, 2013, TISSUE ENG PT A, V19, P989, DOI [10.1089/ten.tea.2012.0370, 10.1089/ten.TEA.2012.0370]; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; CRAWFORD JM, 1986, LAB INVEST, V54, P122; Dormuth CR, 2009, ARCH INTERN MED, V169, P1395, DOI 10.1001/archinternmed.2009.214; DRABEROVA L, 1993, P NATL ACAD SCI USA, V90, P3611, DOI 10.1073/pnas.90.8.3611; Fairfield H, 2018, J CELL PHYSIOL, V233, P1156, DOI 10.1002/jcp.25976; Fiore VF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5886; FREIMUTH WW, 1978, J IMMUNOL, V120, P1651; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Hachemi Y, 2018, J MOL ENDOCRINOL, V61, pR75, DOI 10.1530/JME-18-0024; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; HE HT, 1991, J EXP MED, V173, P515, DOI 10.1084/jem.173.2.515; Hermosilla T, 2008, BBA-MOL CELL RES, V1783, P1111, DOI 10.1016/j.bbamcr.2008.01.034; Herrera-Molina R, 2013, INT REV CEL MOL BIO, V305, P163, DOI 10.1016/B978-0-12-407695-2.00004-4; Hosoya A, 2012, HISTOCHEM CELL BIOL, V137, P733, DOI 10.1007/s00418-012-0928-1; HUEBER AO, 1994, BRAZ J MED BIOL RES, V27, P275; Hueber AO, 1997, CURR BIOL, V7, P705, DOI 10.1016/S0960-9822(06)00300-9; James AW, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/684736; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Killeen N, 1997, CURR BIOL, V7, pR774, DOI 10.1016/S0960-9822(06)00402-7; Kim J, 2014, CELL DEATH DIFFER, V21, P1642, DOI 10.1038/cdd.2014.80; Kim YK, 2016, STEM CELL TRANSL MED, V5, P227, DOI 10.5966/sctm.2015-0013; Kollert F, 2013, ARTHRIT CARE RES, V65, P281, DOI 10.1002/acr.21799; Kong M, 2013, BBA-MOL CELL RES, V1833, P1409, DOI 10.1016/j.bbamcr.2013.02.013; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; Koyama Y, 2017, J CLIN INVEST, V127, P1254, DOI 10.1172/JCI88845; Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P178, DOI 10.1007/s11914-010-0027-y; Lee MJ, 2013, J DERMATOL SCI, V69, P95, DOI 10.1016/j.jdermsci.2012.11.009; Leyton L, 2001, CURR BIOL, V11, P1028, DOI 10.1016/S0960-9822(01)00262-7; Liu CJL, 1996, INVEST OPHTH VIS SCI, V37, P1469; Liu XQ, 2017, LAB INVEST, V97, P256, DOI 10.1038/labinvest.2016.145; Luo J, 2016, ONCOTARGET, V7, P9526, DOI 10.18632/oncotarget.6672; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Maldonado H, 2017, BBA-MOL CELL RES, V1864, P243, DOI 10.1016/j.bbamcr.2016.11.006; Avalos AM, 2009, J CELL SCI, V122, P3462, DOI 10.1242/jcs.034827; Mayeux-Portas V, 2000, CURR BIOL, V10, P68, DOI 10.1016/S0960-9822(99)00278-X; MCINTOSH JC, 1994, EUR RESPIR J, V7, P2131, DOI 10.1183/09031936.94.07122131; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Moraes DA, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0359-3; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; MORRIS RJ, 1992, BIOCHEM SOC T, V20, P401, DOI 10.1042/bst0200401; MORRIS RJ, 1983, J HISTOCHEM CYTOCHEM, V31, P263, DOI 10.1177/31.2.6131917; Morris RJ, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00173; Nicola T, 2009, AM J PHYSIOL-LUNG C, V296, pL738, DOI 10.1152/ajplung.90603.2008; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Paine A, 2018, FASEB J, V32, P3174, DOI 10.1096/fj.201701379R; Picke AK, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00127; Picke AK, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6806; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raff M C, 1971, Transplant Rev, V6, P52; Rege TA, 2006, EXP CELL RES, V312, P3752, DOI 10.1016/j.yexcr.2006.07.029; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; REIF AE, 1964, J EXP MED, V120, P413, DOI 10.1084/jem.120.3.413; REIF AE, 1964, NATURE, V203, P886, DOI 10.1038/203886a0; Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142; Saalbach A, 1999, CELL TISSUE RES, V298, P307, DOI 10.1007/s004419900079; Saalbach A, 2005, ONCOGENE, V24, P4710, DOI 10.1038/sj.onc.1208559; Saalbach A, 1998, ARCH DERMATOL RES, V290, P360, DOI 10.1007/s004030050318; Sanders YY, 2008, AM J RESP CELL MOL, V39, P610, DOI 10.1165/rcmb.2007-0322OC; Sanders YY, 2007, AM J RESP CELL MOL, V36, P226, DOI 10.1165/rcmb.2006-0178OC; SCHMID S, 1995, NEUROSCI LETT, V199, P91, DOI 10.1016/0304-3940(95)12020-5; Schmidt M, 2016, J INVEST DERMATOL, V136, P526, DOI 10.1016/j.jid.2015.10.063; Schmidt M, 2015, J INVEST DERMATOL, V135, P1893, DOI 10.1038/jid.2015.86; Schubert K, 2013, AM J PATHOL, V182, P266, DOI 10.1016/j.ajpath.2012.10.003; Schubert K, 2011, EUR J IMMUNOL, V41, P645, DOI 10.1002/eji.201041117; Shan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011662; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Steinbuch M, 2004, OSTEOPOROSIS INT, V15, P323, DOI 10.1007/s00198-003-1548-3; Tolar P, 1997, EUR J IMMUNOL, V27, P3389, DOI 10.1002/eji.1830271238; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; Varisco BM, 2012, AM J RESP CELL MOL, V46, P765, DOI 10.1165/rcmb.2011-0316OC; VITETTA ES, 1973, EUR J IMMUNOL, V3, P446, DOI 10.1002/eji.1830030714; Wang C, 2016, MED SCI MONITOR, V22, P226, DOI 10.12659/MSM.897044; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Woeller CF, 2017, TOXICOL SCI, V157, P305, DOI 10.1093/toxsci/kfx046; Woeller CF, 2015, FASEB J, V29, P920, DOI 10.1096/fj.14-257121; XUE GP, 1991, DEVELOPMENT, V112, P161; XUE GP, 1992, J NEUROCHEM, V58, P430, DOI 10.1111/j.1471-4159.1992.tb09740.x; Yamamoto M, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/576358; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zhou Y, 2004, AM J PATHOL, V165, P659, DOI 10.1016/S0002-9440(10)63330-5; Zhou Y, 2010, J BIOL CHEM, V285, P22382, DOI 10.1074/jbc.M110.126227	97	22	24	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6689	6696		10.1096/fj.201802224R	http://dx.doi.org/10.1096/fj.201802224R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811954	Bronze			2022-12-28	WOS:000476114200002
J	Gonzalez-Mariscal, I; Montoro, RA; O'Connell, JF; Kim, Y; Gonzalez-Freire, M; Liu, QR; Alfaras, I; Carlson, OD; Lehrmann, E; Zhang, YQ; Becker, KG; Hardiville, S; Ghosh, P; Egan, JM				Gonzalez-Mariscal, Isabel; Montoro, Rodrigo A.; O'Connell, Jennifer F.; Kim, Yoo; Gonzalez-Freire, Marta; Liu, Qing-Rong; Alfaras, Irene; Carlson, Olga D.; Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.; Hardiville, Stephan; Ghosh, Paritosh; Egan, Josephine M.			Muscle cannabinoid 1 receptor regulates Il-6 and myostatin expression, governing physical performance and whole-body metabolism	FASEB JOURNAL			English	Article						CB1R; insulin sensitivity; myokines; skeletal muscle	SKELETAL-MUSCLE; MYOBLAST DIFFERENTIATION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GENE-EXPRESSION; MECHANISMS; OBESITY; INHIBITION; ANTAGONIST; ACTIVATION	Sarcopenic obesity, the combination of skeletal muscle mass and function loss with an increase in body fat, is associated with physical limitations, cardiovascular diseases, metabolic stress, and increased risk of mortality. Cannabinoid receptor type 1 (CB1R) plays a critical role in the regulation of whole-body energy metabolism because of its involvement in controlling appetite, fuel distribution, and utilization. Inhibition of CB1R improves insulin secretion and insulin sensitivity in pancreatic -cells and hepatocytes. We have now developed a skeletal muscle-specific CB1R-knockout (Skm-CB1R(-/-)) mouse to study the specific role of CB1R in muscle. Muscle-CB1R ablation prevented diet-induced and age-induced insulin resistance by increasing IR signaling. Moreover, muscle-CB1R ablation enhanced AKT signaling, reducing myostatin expression and increasing IL-6 secretion. Subsequently, muscle-CB1R ablation increased myogenesis through its action on MAPK-mediated myogenic gene expression. Consequently, Skm-CB1R(-/-) mice had increased muscle mass and whole-body lean/fat ratio in obesity and aging. Muscle-CB1R ablation improved mitochondrial performance, leading to increased whole-body muscle energy expenditure and improved physical endurance, with no change in body weight. These results collectively show that CB1R in muscle is sufficient to regulate whole-body metabolism and physical performance and is a novel target for the treatment of sarcopenic obesity. Gonzalez-Mariscal, I., Montoro, R. A., O'Connell, J. F., Kim, Y., Gonzalez-Freire, M., Liu, Q.-R., Alfaras, I., Carlson, O. D., Lehrmann, E., Zhang, Y., Becker, K. G., Hardiville, S., Ghosh, P., Egan, J. M. Muscle cannabinoid 1 receptor regulates Il-6 and myostatin expression, governing physical performance and whole-body metabolism.	[Gonzalez-Mariscal, Isabel; Montoro, Rodrigo A.; O'Connell, Jennifer F.; Kim, Yoo; Liu, Qing-Rong; Carlson, Olga D.; Ghosh, Paritosh; Egan, Josephine M.] NIA, Lab Clin Invest, NIH, 251 Bayview Blvd,Suite 100, Bethesda, MD 21224 USA; [Gonzalez-Freire, Marta; Alfaras, Irene] NIA, Translat Gerontol Branch, NIH, Bethesda, MD 21224 USA; [Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.] NIA, Lab Genet & Genom, NIH, Bethesda, MD 21224 USA; [Hardiville, Stephan] Univ Lille, Unite Rech 8576, UGSF, Ctr Natl Rech CNRS, Lille, France	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universite de Lille - ISITE; Universite de Lille	Gonzalez-Mariscal, I; Egan, JM (corresponding author), NIA, Lab Clin Invest, NIH, 251 Bayview Blvd,Suite 100, Bethesda, MD 21224 USA.	isabel.gonzalez@ibima.com; eganj@grc.nia.nih.gov	Gonzalez-Freire, Marta/ABG-1197-2020; Montoro, Rodrigo/AAM-2105-2020; Liu, Qing-Rong/A-3059-2012	Montoro, Rodrigo/0000-0002-3830-2827; Liu, Qing-Rong/0000-0001-8477-6452; Gonzalez Mariscal, Isabel/0000-0003-1186-1212; Alfaras Cardenal, Irene/0000-0002-2073-9641; Hardiville, Stephan/0000-0002-3554-277X; Lehrmann, Elin/0000-0002-9869-9475; Gonzalez-Freire, Marta/0000-0001-9741-2826	U.S. National Institutes of Health, National Institute on Aging Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging Intramural Research Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the U.S. National Institutes of Health, National Institute on Aging Intramural Research Program. S961 was donated by Novo Nordisk. The authors declare no conflicts of interest.	Ali S, 2014, GERONTOLOGY, V60, P294, DOI 10.1159/000356760; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; Bogdanis GC, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00142; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Chouhan AK, 2010, J NEUROSCI, V30, P1869, DOI 10.1523/JNEUROSCI.4701-09.2010; Cinar R, 2014, HEPATOLOGY, V59, P143, DOI 10.1002/hep.26606; de Azua IR, 2017, J CLIN INVEST, V127, P4148, DOI 10.1172/JCI83626; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; Fiori JL, 2013, DIABETES, V62, P3500, DOI 10.2337/db13-0266; Gonzalez-Freire M, 2018, AGING CELL, V17, DOI 10.1111/acel.12725; Gonzalez-Freire M, 2017, J CACHEXIA SARCOPENI, V8, P5, DOI 10.1002/jcsm.12121; Gonzalez-Mariscal I, 2018, DIABETOLOGIA, V61, P1470, DOI 10.1007/s00125-018-4576-4; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Holmes AG, 2004, METABOLISM, V53, P1492, DOI 10.1016/j.metabol.2004.05.015; Iannotti FA, 2014, P NATL ACAD SCI USA, V111, pE2472, DOI 10.1073/pnas.1406728111; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Liao YL, 2013, INT J CARDIOL, V167, P1936, DOI 10.1016/j.ijcard.2012.05.033; Lindborg KA, 2011, CARDIORENAL MED, V1, P31, DOI 10.1159/000322826; Lipina C, 2010, DIABETES, V59, P375, DOI 10.2337/db09-0979; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mazier W, 2015, TRENDS ENDOCRIN MET, V26, P524, DOI 10.1016/j.tem.2015.07.007; Mendizabal-Zubiaga J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00476; Nordfors L, 1998, DIABETOLOGIA, V41, P935, DOI 10.1007/s001250051010; Olah T, 2016, J PHYSIOL-LONDON, V594, P7381, DOI 10.1113/JP272449; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Stern-Straeter J, 2011, J TISSUE ENG REGEN M, V5, pE197, DOI 10.1002/term.417; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Trouwborst I, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050605; Trujillo X, 2014, J MEMBRANE BIOL, V247, P1199, DOI 10.1007/s00232-014-9721-5; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070; Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Waters DL, 2011, CLIN GERIATR MED, V27, P401, DOI 10.1016/j.cger.2011.03.007; Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673	44	21	20	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5850	5863		10.1096/fj.201801145R	http://dx.doi.org/10.1096/fj.201801145R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30726112	Green Published			2022-12-28	WOS:000466932600005
J	Royce, SG; Mao, WY; Lim, R; Kelly, K; Samuel, CS				Royce, Simon G.; Mao, WeiYi; Lim, Rebecca; Kelly, Kilian; Samuel, Chrishan S.			iPSC- and mesenchymoangioblast-derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid	FASEB JOURNAL			English	Article						asthma; airway remodeling; fibrosis; stem cell therapy; MSC	EXPERIMENTAL-MODEL; ASTHMA; FIBROSIS; PATHOGENESIS; SALMETEROL; THERAPY	The airway remodeling (AWR) associated with chronic allergic airways disease (AAD)/asthma contributes to irreversible airway obstruction. This study compared and combined the antiremodeling and other effects of induced pluripotent stem cell and mesenchymoangioblast-derived mesenchymal stem cells (MCA-MSCs) with the corticosteroid dexamethasone (Dex) in experimental chronic AAD/asthma. Female BALB/c mice subjected to 11 wk of ovalbumin (Ova)-induced chronic AAD were intranasally administered MCA-MSCs (1 x 10(6) cells/mouse; once weekly on wk 10 and 11), Dex (0.5 mg/ml; once daily for 2 wk), or both combined. MCA-MSC detection and changes in airway inflammation (AI), AWR, and airway hyperresponsiveness (AHR) were measured at the end of wk 11. Mice with chronic AAD had significant AI, goblet cell metaplasia, epithelial damage/thickening, aberrant TGF-1 levels, subepithelial myofibroblast accumulation, airway/lung fibrosis, and AHR (all P < 0.001 vs. healthy controls). MCA-MSCs were detected in the lungs up to 5-7 d postadministration and demonstrated modest anti-inflammatory but striking antifibrotic effects against Ova-induced AAD, effectively decreasing AHR by 70-75% (all P < 0.05 vs. Ova alone). In comparison, Dex predominantly demonstrated anti-inflammatory effects, decreasing AHR by approximate to 30%. Combining MCA-MSCs with Dex provided equivalent protection to that offered by either therapy alone. MCA-MSCs reduce chronic AAD-induced AWR and AHR to a greater extent than Dex and may act as a suitable adjunct therapy to corticosteroid treatment of asthma.Royce, S. G., Mao, W., Lim, R., Kelly, K., Samuel, C. S. iPSC- and mesenchymoangioblast-derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid.	[Royce, Simon G.; Mao, WeiYi; Samuel, Chrishan S.] Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic, Australia; [Royce, Simon G.; Mao, WeiYi; Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic, Australia; [Royce, Simon G.] Monash Univ, Cent Clin Sch, Clayton, Vic, Australia; [Lim, Rebecca] Monash Univ, Ritchie Ctr, Ctr Hudson Inst Med Res, Clayton, Vic, Australia; [Lim, Rebecca] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic, Australia; [Kelly, Kilian] Cynata Therapeut, Carlton, Vic, Australia; [Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia	Monash University; Monash University; Monash University; Monash University; Monash University; University of Melbourne	Samuel, CS (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dept Pharmacol, 9 Ancora Imparo Way, Clayton, Vic 3800, Australia.	chrishan.samuel@monash.edu			National Health and Medical Research Council (NHMRC) of Australia Senior Research Fellowship [GNT1041766]; Cynata Therapeutics Ltd. (Carlton, VIC, Australia)	National Health and Medical Research Council (NHMRC) of Australia Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cynata Therapeutics Ltd. (Carlton, VIC, Australia)	The authors acknowledge the facilities and technical assistance of the Monash Histology Platform (Monash University). This work was supported by a National Health and Medical Research Council (NHMRC) of Australia Senior Research Fellowship (GNT1041766 to C.S.S.) and Cynata Therapeutics Ltd. (Carlton, VIC, Australia) funding (to C.S.S. and S.G.R.). K.K. is an employee and shareholder of Cynata Therapeutics, but was not involved with performing the experiments or analysis of data.	Abreu SC, 2013, RESP PHYSIOL NEUROBI, V187, P190, DOI 10.1016/j.resp.2013.03.014; Alangari AA, 2014, ANN THORAC MED, V9, P187, DOI 10.4103/1817-1737.140120; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; BENNETT JA, 1994, THORAX, V49, P771, DOI 10.1136/thx.49.8.771; Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Cazzola M, 2011, BRIT J PHARMACOL, V163, P4, DOI 10.1111/j.1476-5381.2011.01216.x; Decramer M, 2005, INT J CLIN PRACT, V59, P385, DOI 10.1111/j.1368-5031.2005.00509.x; DUNLAP NE, 1984, CLIN CHEST MED, V5, P669; Durrani SR, 2011, J ALLERGY CLIN IMMUN, V128, P439, DOI 10.1016/j.jaci.2011.06.002; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; Henderson WR, 2006, AM J RESP CRIT CARE, V173, P718, DOI 10.1164/rccm.200501-088OC; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; Knight Darryl A, 2010, Expert Rev Respir Med, V4, P747, DOI 10.1586/ers.10.72; Kramer EL, 2011, J APPL PHYSIOL, V111, P1760, DOI 10.1152/japplphysiol.00737.2011; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Murphy Sean, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e06s13; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Patel KP, 2016, BRIT J PHARMACOL, V173, P2016, DOI 10.1111/bph.13494; Rolfe K J, 2012, ISRN Dermatol, V2012, P698034, DOI 10.5402/2012/698034; Royce SG, 2017, FASEB J, V31, P4168, DOI 10.1096/fj.201700178R; Royce SG, 2016, CLIN SCI, V130, P2151, DOI 10.1042/CS20160328; Royce SG, 2015, STEM CELL RES, V15, P495, DOI 10.1016/j.scr.2015.09.007; Royce SG, 2014, PHARMACOL THERAPEUT, V141, P250, DOI 10.1016/j.pharmthera.2013.10.008; Royce SG, 2014, AM J RESP CELL MOL, V50, P180, DOI 10.1165/rcmb.2013-0008OC; Royce SG, 2013, CLIN SCI, V124, P41, DOI 10.1042/CS20120024; Soncini M, 2006, XENOTRANSPLANTATION, V13, P80, DOI 10.1111/j.1399-3089.2005.00256.x; Sueblinvong V, 2010, TRANSL RES, V156, P188, DOI 10.1016/j.trsl.2010.06.007; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wener RRL, 2013, EUR RESPIR REV, V22, P227, DOI 10.1183/09059180.00001913; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510	34	14	14	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6402	6411		10.1096/fj.201802307R	http://dx.doi.org/10.1096/fj.201802307R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768365	Bronze			2022-12-28	WOS:000466932600047
J	Jarry, AC; Merah, N; Cisse, F; Cayetanot, F; Fiamma, MN; Willemetz, A; Gueddouri, D; Barka, B; Valet, P; Guilmeau, S; Bado, A; Le Beyec, J; Bodineau, L; Le Gall, M				Jarry, Anne-Charlotte; Merah, Nadir; Cisse, Fanta; Cayetanot, Florence; Fiamma, Marie-Noelle; Willemetz, Alexandra; Gueddouri, Dalale; Barka, Besma; Valet, Philippe; Guilmeau, Sandra; Bado, Andre; Le Beyec, Johanne; Bodineau, Laurence; Le Gall, Maude			Neuromedin U is a gut peptide that alters oral glucose tolerance by delaying gastric emptying via direct contraction of the pylorus and vagal-dependent mechanisms	FASEB JOURNAL			English	Article						enteropeptide; decretin; vagus nerve	CENTRAL-NERVOUS-SYSTEM; GASTROINTESTINAL MOTILITY; INSULIN-SECRETION; BRAIN; IDENTIFICATION; EXPRESSION; ENERGY; FOOD; NMU	The gut-brain peptide neuromedin U (NMU) decreases food intake and body weight and improves glucose tolerance. Here, we characterized NMU as an enteropeptide and determined how it impacts glucose excursion. NMU was expressed predominantly in the proximal small intestine, and its secretion was triggered by ingestion of a mixed meal. Although a single peripheral injection of NMU in C57BL/6NRj mice prevented the rise of glycemia upon an oral but not an intraperitoneal load of glucose, it unexpectedly prevented insulin secretion, only slightly improved peripheral insulin sensitivity, and barely reduced intestinal glucose absorption. Interestingly, peripheral administration of NMU abrogated gastric emptying. NMU receptors 1 and 2 were detected in pyloric muscles and NMU was able to directly induce pyloric contraction in a dose-dependent manner ex vivo in isometric chambers. Using a modified glucose tolerance test, we demonstrate that improvement of oral glucose tolerance by NMU was essentially, if not exclusively, because of its impact on gastric emptying. Part of this effect was abolished in vagotomized (VagoX) mice, suggesting implication of the vagus tone. Accordingly, peripheral injection of NMU was associated with increased number of c-FOS-positive neurons in the nucleus of the solitary tract, which was partly prevented in VagoX mice. Finally, NMU kept its ability to improve oral glucose tolerance in obese and diabetic murine models. Together, these data demonstrate that NMU is an enteropeptide that prevents gastric emptying directly by triggering pylorus contraction and indirectly through vagal afferent neurons. This blockade consequently reduces intestinal nutrient absorption and thereby results in an apparent improved tolerance to oral glucose challenge.	[Jarry, Anne-Charlotte; Merah, Nadir; Cisse, Fanta; Willemetz, Alexandra; Bado, Andre; Le Beyec, Johanne; Le Gall, Maude] Univ Paris Diderot, AP HP, INSERM, UMR 1149, Paris, France; [Cayetanot, Florence; Fiamma, Marie-Noelle; Barka, Besma; Bodineau, Laurence] Sorbonne Univ, INSERM, UMR Neurophysiol Resp Expt & Clin S1158, Paris, France; [Gueddouri, Dalale; Guilmeau, Sandra] Univ Paris 05, CNRS, INSERM, Unite 1016,UMR 8104,Inst Cochin, Paris, France; [Valet, Philippe] Univ Toulouse III Paul Sabatier, INSERM, Unite 1048, I2MC, Toulouse, France; [Le Beyec, Johanne] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Endocrine & Oncol Biochem, Paris, France	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Le Gall, M (corresponding author), Univ Paris Diderot Paris 7, Fac Med Site Bichat, Gastrointestinal & Metab Dysfunct Nutr Pathol, Ctr Rech Inflammat Paris Montmartre,INSERM,UMRS 1, 16 Rue Henri Huchard, F-75890 Paris 18, France.	maude.le-gall@inserm.fr	Le Gall, Maude/W-2593-2019; Le Gall, Maude/C-3917-2017; BADO, Andre/G-3408-2013; Valet, Philippe/N-7472-2017	Le Gall, Maude/0000-0002-5372-4585; Le Gall, Maude/0000-0002-5372-4585; Le Beyec - Le Bihan, johanne/0000-0002-5647-2002; BADO, Andre/0000-0002-8007-1460; CAYETANOT, Florence/0000-0003-0441-0720; Valet, Philippe/0000-0001-6520-7393; BODINEAU, Laurence/0000-0002-0085-9021	INSERM; Universite Paris Diderot; Universite Paris Descartes; Sorbonne Universite; Ministry for Research and Education; Societe Francophone du Diabete; Institut Benjamin Delessert; Fondation pour la Recherche Medicale; European Association for the Study of Diabetes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Diderot; Universite Paris Descartes; Sorbonne Universite; Ministry for Research and Education; Societe Francophone du Diabete; Institut Benjamin Delessert; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Association for the Study of Diabetes	The authors thank R. Ducroc (UMRS1149, Paris, France) for help in setting up the Ussing chamber experiments, and B. Eto (UMRS1149, Paris) for assistance in the measurement of pyloric contractions. The authors are grateful to Nicholas Nguyen (UMRS1149, Paris) and Sara Zaat (UMRS 1149, Paris) for English editing, Prof. F. Gribble (University of Cambridge, Cambridge, United Kingdom) for discussing and sharing unpublished data, and Prof. J. Hommel (University of Texas-Galveston, Galveston, TX, USA) for advice with NMU receptor antibodies and immunostaining. This work was supported by INSERM, Universite Paris Diderot, Universite Paris Descartes, and Sorbonne Universite. A.-C.J. and D.G. received funding from the Ministry for Research and Education. M.L.G. received research grants from Societe Francophone du Diabete and Institut Benjamin Delessert. D.G. and S.G. received funding from Fondation pour la Recherche Medicale, Societe Francophone du Diabete, and European Association for the Study of Diabetes. The authors declare no conflicts of interest.	Alfa RW, 2015, CELL METAB, V21, P323, DOI 10.1016/j.cmet.2015.01.006; AUGOOD SJ, 1988, REGUL PEPTIDES, V20, P281, DOI 10.1016/0167-0115(88)90063-8; AUSTIN C, 1995, J MOL ENDOCRINOL, V14, P157, DOI 10.1677/jme.0.0140157; BALLESTA J, 1988, NEUROSCIENCE, V25, P797, DOI 10.1016/0306-4522(88)90037-1; BENITOORFILA MA, 1991, EUR J PHARMACOL, V193, P329, DOI 10.1016/0014-2999(91)90147-I; Brighton PJ, 2008, J PHARMACOL EXP THER, V325, P154, DOI 10.1124/jpet.107.132803; Browning KN, 2014, COMPR PHYSIOL, V4, P1339, DOI 10.1002/cphy.c130055; Dalboge LS, 2015, PEPTIDES, V69, P56, DOI 10.1016/j.peptides.2015.04.010; Dass NB, 2007, BRIT J PHARMACOL, V150, P502, DOI 10.1038/sj.bjp.0707004; Gage G. J., 2012, JOVE-J VIS EXP, V65, P3562; Gevaert B, 2016, NEUROPHARMACOLOGY, V107, P460, DOI 10.1016/j.neuropharm.2016.03.051; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Ingallinella P, 2012, BIOORGAN MED CHEM, V20, P4751, DOI 10.1016/j.bmc.2012.06.003; Joubert F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00609; Kaczmarek P, 2006, INT J MOL MED, V18, P951; Kaczmarek P, 2009, PANCREAS, V38, P208, DOI 10.1097/MPA.0b013e31818d9095; Kaplan JM, 1997, AM J PHYSIOL-REG I, V273, pR1786, DOI 10.1152/ajpregu.1997.273.5.R1786; Kowalski TJ, 2005, J ENDOCRINOL, V185, P151, DOI 10.1677/joe.1.05948; Kuhre RE, 2019, CELL METAB, V29, P719, DOI 10.1016/j.cmet.2018.10.008; Martinez VG, 2015, CLIN CHEM, V61, P471, DOI 10.1373/clinchem.2014.231753; McCue DL, 2017, INT J OBESITY, V41, P120, DOI 10.1038/ijo.2016.178; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Mondal MS, 2003, AM J PHYSIOL-GASTR L, V284, pG963, DOI 10.1152/ajpgi.00218.2002; Nakashima Y, 2010, ANN NY ACAD SCI, V1200, P104, DOI 10.1111/j.1749-6632.2010.05504.x; Nakazato M, 2000, BIOCHEM BIOPH RES CO, V277, P191, DOI 10.1006/bbrc.2000.3669; Peier A, 2009, ENDOCRINOLOGY, V150, P3101, DOI 10.1210/en.2008-1772; Peier AM, 2011, ENDOCRINOLOGY, V152, P2644, DOI 10.1210/en.2010-1463; Szekeres PG, 2000, J BIOL CHEM, V275, P20247, DOI 10.1074/jbc.C000244200; Takayama K, 2016, BIOPOLYMERS, V106, P440, DOI 10.1002/bip.22770; Wren AM, 2002, ENDOCRINOLOGY, V143, P4227, DOI 10.1210/en.2002-220308; Zeng HK, 2006, MOL CELL BIOL, V26, P9352, DOI 10.1128/MCB.01148-06; Zhang WD, 2017, BIOCHEM BIOPH RES CO, V493, P677, DOI 10.1016/j.bbrc.2017.08.132	33	11	11	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5377	5388		10.1096/fj.201801718R	http://dx.doi.org/10.1096/fj.201801718R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30753087				2022-12-28	WOS:000462888500060
J	Liu, YG; Teng, YS; Cheng, P; Kong, H; Lv, YP; Mao, FY; Wu, XL; Hao, CJ; Chen, WS; Yang, SM; Zhang, JY; Peng, LS; Wang, TT; Han, B; Ma, Q; Zou, QM; Zhuang, Y				Liu, Yu Gang; Teng, Yong Sheng; Cheng, Ping; Kong, Hui; Lv, Yi Pin; Mao, Fang Yuan; Wu, Xiao Long; Hao, Chuan Jie; Chen, Weisan; Yang, Shi Ming; Zhang, Jin Yu; Peng, Liu Sheng; Wang, Ting Ting; Han, Bin; Ma, Qiang; Zou, Quan Ming; Zhuang, Yuan			Abrogation of cathepsin C by Helicobacter pylori impairs neutrophil activation to promote gastric infection	FASEB JOURNAL			English	Article						CtsC; gastric epithelial cells; cagA; TGF-beta 1	DIPEPTIDYL-PEPTIDASE-I; EPITHELIAL-CELLS; SERINE PROTEASES; B ACTIVATION; H. PYLORI; NK CELL; CAGA; EXPRESSION; PROTEIN; TGF-BETA-1	Cathepsin C (CtsC) functions as a central coordinator for activation of many serine proteases in immune cells. However, CtsC expression in gastric epithelial cells and its role in Helicobacter pylori infection remain unclear. Real-time PCR, Western blot, and immunohistochemistry analyses identified that CtsC was decreased in gastric mucosa of H. pylori-infected patients and mice. Isolated gastric epithelial cells and cell lines were stimulated with H. pylori and/or TGF-beta 1 showed that down-regulation of CtsC in gastric epithelial cells largely depended on H. pylori cagA via Src/ERK and Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathways, and the effect could be synergistically augmented by TGF-beta 1 in an autocrine manner. In human gastric mucosa, CtsC expression was negatively correlated with bacteria colonization; accordingly, provision of exogenous active CtsC overwhelmed H. pylori persistence in gastric mucosa of mice. In the presence of active CtsC, isolated human neutrophils activated via NF-kappa B pathway with augmented bactericidal capacity in vitro. We also found that neutrophils activated and cleared bacteria in active CtsC-injected mice and that there was no bactericidal capacity in mice that were simultaneously neutrophil-depleted by Ly6G antibody. Our findings identified a mechanism that H. pylori abrogate CtsC to impair neutrophil activation and to ensure persistence in gastric mucosa. Efforts to enable and boost this neutrophil activation pathway by active CtsC may therefore become valuable strategies in treating H. pylori infection.	[Liu, Yu Gang; Teng, Yong Sheng; Cheng, Ping; Kong, Hui; Lv, Yi Pin; Mao, Fang Yuan; Wu, Xiao Long; Hao, Chuan Jie; Zhang, Jin Yu; Peng, Liu Sheng; Wang, Ting Ting; Zou, Quan Ming; Zhuang, Yuan] Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, 30 Gaotanyan St, Chongqing 400038, Peoples R China; [Yang, Shi Ming] Third Mil Med Univ, Dept Gastroenterol, XinQiao Hosp, Chongqing, Peoples R China; [Chen, Weisan] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Han, Bin] North Sichuan Med Coll, Affiliated Hosp, Dept Pharm, Nanchong, Peoples R China; [Ma, Qiang] North Sichuan Med Coll, Affiliated Hosp, Dept Clin Lab, Nanchong, Peoples R China	Army Medical University; Army Medical University; La Trobe University; North Sichuan Medical University; North Sichuan Medical University	Zou, QM; Zhuang, Y (corresponding author), Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	qmzou@tmmu.edu.cn; yuanzhuang1983@yahoo.com	wang, tingting/AAK-2640-2020; Teng, Yong-sheng/CAG-8033-2022; Chen, Weisan/E-7828-2012; Mao, Fangyuan/CAF-1614-2022	Chen, Weisan/0000-0002-5221-9771; 	National Natural Science Foundation of China [81870394]; National Key Research and Development Program of China [2016YFC1302200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	The authors thank Yong-Liang Zhao (Xinan Hospital, Chongqing, China), Gang Guo (Third Military Medical University), and Lijuan Wu (General Hospital of Western Theater Command, Chengdu, China) for their helpful comments and constructive suggestions; Jia Han (Dianjiang County Hospital of Traditional Chinese Medicine, Chongqing, China) for his help in obtaining fresh nontumor gastric tissues; Xin Liu (Second Affiliated Hospital of Kunming Medical University, Kunming, China) and Rui Zhang (General Hospital of Western Theater Command) for their involvement in experiments and statistical analysis of the revised manuscript; and Dan Li (Guangdong University of Foreign Studies, Guangzhou, China) for her language revision. This work was funded by the National Natural Science Foundation of China (Grant 81870394) and National Key Research and Development Program of China (Grant 2016YFC1302200). The authors declare no conflicts of interest.	Abdoh Qusay, 2018, Lancet, V391 Suppl 2, pS32, DOI 10.1016/S0140-6736(18)30398-2; Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Akk AM, 2008, J IMMUNOL, V180, P3535, DOI 10.4049/jimmunol.180.5.3535; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Andoniou CE, 2011, IMMUNOL CELL BIOL, V89, P540, DOI 10.1038/icb.2010.115; Bauer B, 2012, CELL HOST MICROBE, V11, P576, DOI 10.1016/j.chom.2012.04.013; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cottrell GS, 2007, GASTROENTEROLOGY, V132, P2422, DOI 10.1053/j.gastro.2007.03.101; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; Fan K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-96; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Gerber A, 2001, J INTERF CYTOK RES, V21, P11, DOI 10.1089/107999001459114; Hamon Y, 2016, J BIOL CHEM, V291, P8486, DOI 10.1074/jbc.M115.707109; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Jo Y, 2010, GUT LIVER, V4, P43, DOI 10.5009/gnl.2010.4.1.43; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; Korkmaz B, 2009, J BIOL CHEM, V284, P19896, DOI 10.1074/jbc.M901471200; Krueger S, 2009, J PATHOL, V217, P581, DOI 10.1002/path.2485; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Liu ZH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15196; Liu ZF, 2012, J CELL BIOCHEM, V113, P1080, DOI 10.1002/jcb.23440; Lv YP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0493-1; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Meade JL, 2006, BLOOD, V107, P3665, DOI 10.1182/blood-2005-03-1140; Mikula M, 2003, J MICROBIOL METH, V55, P351, DOI 10.1016/S0167-7012(03)00166-0; Moghaddasian M, 2014, GENE, V538, P182, DOI 10.1016/j.gene.2013.11.079; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pagano MB, 2007, P NATL ACAD SCI USA, V104, P2855, DOI 10.1073/pnas.0606091104; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rahimian G, 2014, MICROB PATHOGENESIS, V67-68, P1, DOI 10.1016/j.micpath.2013.12.006; Raju D, 2012, GASTROENTEROLOGY, V142, P1160, DOI 10.1053/j.gastro.2012.01.043; Ramarao N, 2000, MOL MICROBIOL, V37, P1389, DOI 10.1046/j.1365-2958.2000.02089.x; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Roussel Y, 2005, J MICROBIOL METH, V62, P71, DOI 10.1016/j.mimet.2005.01.011; Ruffell B, 2013, GENE DEV, V27, P2086, DOI 10.1101/gad.224899.113; Shao LL, 2019, FASEB J, V33, P264, DOI 10.1096/fj.201701456RR; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Suban D, 2012, BIOCHIMIE, V94, P719, DOI 10.1016/j.biochi.2011.10.018; Sutherland RE, 2014, BIOCHEM BIOPH RES CO, V450, P818, DOI 10.1016/j.bbrc.2014.06.062; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Tang LY, 2017, J BIOL CHEM, V292, P4302, DOI 10.1074/jbc.M116.773085; Tsai CC, 2015, VIRULENCE, V6, P755, DOI 10.1080/21505594.2015.1043505; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Ueha S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00071; Wei LM, 2014, PATHOG DIS, V72, P45, DOI 10.1111/2049-632X.12182; Whitmore LC, 2017, J IMMUNOL, V198, P1793, DOI 10.4049/jimmunol.1601292; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Wu MS, 2007, J INFECT DIS, V196, P1386, DOI 10.1086/522520; Wu ZQ, 2015, NUCLEIC ACIDS RES, V43, P3167, DOI 10.1093/nar/gkv161; Yong X, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0111-0	61	7	8	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5018	5033		10.1096/fj.201802016RR	http://dx.doi.org/10.1096/fj.201802016RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596522	Bronze			2022-12-28	WOS:000462888500031
J	Haapasalo, K; Wollman, AJM; de Haas, CJC; van Kessel, KPM; van Strijp, JAG; Leake, MC				Haapasalo, Karita; Wollman, Adam J. M.; de Haas, Carla J. C.; van Kessel, Kok P. M.; van Strijp, Jos A. G.; Leake, Mark C.			Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration	FASEB JOURNAL			English	Article						bacterial toxin; pore formation; single molecule; super-resolution; immune response	PANTON-VALENTINE LEUKOCIDIN; PORE-FORMING TOXINS; SINGLE-MOLECULE; CRYSTAL-STRUCTURE; POLYMORPHONUCLEAR LEUKOCYTES; C5A RECEPTOR; S-COMPONENT; PROTEIN; RESISTANT; STOICHIOMETRY	Staphylococcus aureus Panton-Valentine leukocidin is a pore-forming toxin targeting the human C5a receptor (hC5aR), enabling this pathogen to battle the immune response by destroying phagocytes through targeted lysis. The mechanisms that contribute to rapid cell lysis are largely unexplored. Here, we show that cell lysis may be enabled by a process of toxins targeting receptor clusters and present indirect evidence for receptor recycling that allows multiple toxin pores to be formed close together. With the use of live cell single-molecule super-resolution imaging, Forster resonance energy transfer and nanoscale total internal reflection fluorescence colocalization microscopy, we visualized toxin pore formation in the presence of its natural docking ligand. We demonstrate disassociation of hC5aR from toxin complexes and simultaneous binding of new ligands. This effect may free mobile receptors to amplify hyperinflammatory reactions in early stages of microbial infections and have implications for several other similar bicomponent toxins and the design of new antibiotics.Haapasalo, K., Wollman, A. J. M., de Haas, C. J. C., van Kessel, K. P. M., van Strijp, J. A. G., Leake, M. C. Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.	[Haapasalo, Karita; de Haas, Carla J. C.; van Kessel, Kok P. M.; van Strijp, Jos A. G.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Haapasalo, Karita] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Wollman, Adam J. M.; Leake, Mark C.] Univ York, Biol Phys Sci Inst, Dept Biol, York, N Yorkshire, England; [Leake, Mark C.] Univ York, Biol Phys Sci Inst, Dept Phys, York, N Yorkshire, England	Utrecht University; Utrecht University Medical Center; University of Helsinki; University of York - UK; University of York - UK	Leake, MC (corresponding author), Univ York, Biol Phys Sci Inst, York YO10 5DD, N Yorkshire, England.	mark.leake@york.ac.uk	Haapasalo, Karita/AAG-1215-2020; Wollman, Adam/F-2971-2015; van Strijp, Jos A.G./J-9549-2014	Wollman, Adam/0000-0002-5501-8131; van Strijp, Jos A.G./0000-0001-6253-0830; Leake, Mark/0000-0002-1715-1249; Haapasalo, Karita/0000-0002-9619-625X	Finnish Cultural Foundation [00131060, 00142390]; Biological Physical Sciences Institute; Royal Society; Medical Research Council (MRC) [MR/K01580X/1]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N006453/1]; Engineering and Physical Sciences Research Council (EPSRC) Physics of Life UK Network; Wellcome Trust through Centre for Future Health (CFH) at the University of York, United Kingdom [204829]; BBSRC [BB/N006453/1, BB/R001235/1, BB/P000746/1] Funding Source: UKRI; MRC [MR/K01580X/1] Funding Source: UKRI	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Biological Physical Sciences Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC) Physics of Life UK Network(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust through Centre for Future Health (CFH) at the University of York, United Kingdom; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Piet Aerts and Angelino Tromp (both from University Medical Center Utrecht) for assistance in sample preparation and labeling, Esther van't Veld and Richard Wubbolts [both from Utrecht University (UU)] for assistance with light microscopy, and Dr. Karin Strijbis (UU) for providing the sortase A enzyme. This work was supported by The Finnish Cultural Foundation (Grants 00131060 and 00142390); Biological Physical Sciences Institute, Royal Society, Medical Research Council (MRC; Grant MR/K01580X/1); Biotechnology and Biological Sciences Research Council (BBSRC; Grant BB/N006453/1); Engineering and Physical Sciences Research Council (EPSRC) Physics of Life UK Network; and Wellcome Trust (204829) through the Centre for Future Health (CFH) at the University of York, United Kingdom. The authors declare no conflicts of interest.	Amdahl H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172675; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Berends ETM, 2015, MOL IMMUNOL, V65, P328, DOI 10.1016/j.molimm.2015.01.020; Chiu SW, 2011, INT J MOL SCI, V12, P2518, DOI 10.3390/ijms12042518; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; Croker DE, 2013, IMMUNOL CELL BIOL, V91, P625, DOI 10.1038/icb.2013.48; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Delalez NJ, 2010, P NATL ACAD SCI USA, V107, P11347, DOI 10.1073/pnas.1000284107; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; EASMON CSF, 1976, INFECT IMMUN, V13, P399, DOI 10.1128/IAI.13.2.399-406.1976; FEARON DT, 1977, J EXP MED, V146, P22, DOI 10.1084/jem.146.1.22; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hirota N, 2010, J BIOL CHEM, V285, P5931, DOI 10.1074/jbc.M109.066282; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Koch G, 2014, CELL, V158, P1060, DOI 10.1016/j.cell.2014.06.046; LaChapelle S, 2009, J BIOL CHEM, V284, P12719, DOI 10.1074/jbc.M900772200; Laventie BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092094; Leake MC, 2014, PHYS CHEM CHEM PHYS, V16, P12635, DOI 10.1039/c4cp00219a; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Lenn T, 2008, MOL MICROBIOL, V70, P1397, DOI 10.1111/j.1365-2958.2008.06486.x; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Llorente-Garcia I, 2014, BBA-BIOENERGETICS, V1837, P811, DOI 10.1016/j.bbabio.2014.01.020; Meyer F, 2009, INFECT IMMUN, V77, P266, DOI 10.1128/IAI.00402-08; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Miller H, 2015, METHODS, V88, P81, DOI 10.1016/j.ymeth.2015.01.010; Moreno-Fernandez ME, 2016, AIDS RES HUM RETROV, V32, P399, DOI [10.1089/aid.2015.0099, 10.1089/AID.2015.0099]; Mullaly SC, 2006, J IMMUNOL, V177, P8154, DOI 10.4049/jimmunol.177.11.8154; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nocadello S, 2016, ACTA CRYSTALLOGR D, V72, P113, DOI 10.1107/S2059798315023207; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Pandya PH, 2014, AM J RESP CELL MOL, V51, P467, DOI 10.1165/rcmb.2013-0485TR; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; Plank M, 2009, INTEGR BIOL-UK, V1, P602, DOI 10.1039/b907837a; Postma B, 2005, J BIOL CHEM, V280, P2020, DOI 10.1074/jbc.M412230200; Rabiet MJ, 2008, J BIOL CHEM, V283, P31038, DOI 10.1074/jbc.M805260200; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1; Robson A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0029; Spaan AN, 2017, NAT REV MICROBIOL, V15, P435, DOI 10.1038/nrmicro.2017.27; Spaan AN, 2015, J IMMUNOL, V195, P1034, DOI 10.4049/jimmunol.1500604; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Sugawara N, 1999, BIOSCI BIOTECH BIOCH, V63, P884, DOI 10.1271/bbb.63.884; Tromp AT, 2018, NAT MICROBIOL, V3, P708, DOI 10.1038/s41564-018-0159-x; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Unnewehr H, 2013, J IMMUNOL, V190, P4215, DOI 10.4049/jimmunol.1200534; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Veldkamp KE, 2000, INFECT IMMUN, V68, P5908, DOI 10.1128/IAI.68.10.5908-5913.2000; Veya L, 2015, J BIOL CHEM, V290, P27723, DOI 10.1074/jbc.M115.666677; von Kockritz-Blickwede M, 2010, J INNATE IMMUN, V2, P87, DOI 10.1159/000247157; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wollman AJM, 2015, FARADAY DISCUSS, V184, P401, DOI 10.1039/c5fd00077g; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yamashita D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5897; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	70	10	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3807	3824		10.1096/fj.201801910R	http://dx.doi.org/10.1096/fj.201801910R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509126	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000459794800058
J	Liang, XL; Gupta, K; Quintero, JR; Cernadas, M; Kobzik, L; Christou, H; Pier, GB; Owen, CA; Cataltepe, S				Liang, Xiaoliang; Gupta, Kushagra; Quintero, Joselyn Rojas; Cernadas, Manuela; Kobzik, Lester; Christou, Helen; Pier, Gerald B.; Owen, Caroline A.; Cataltepe, Sule			Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia	FASEB JOURNAL			English	Article						CXCL1; host defense; innate immunity	ACID-BINDING PROTEIN; ALVEOLAR MACROPHAGES; PNEUMOCOCCAL PNEUMONIA; KLEBSIELLA INFECTION; MOUSE MODEL; KAPPA-B; AP2; INFLAMMATION; EXPRESSION; LUNG	Fatty acid binding protein 4 (FABP4), an intracellular lipid chaperone and adipokine, is expressed by lung macrophages, but the function of macrophage-FABP4 remains elusive. We investigated the role of FABP4 in host defense in a murine model of Pseudomonas aeruginosa pneumonia. Compared with wild-type (WT) mice, FABP4-deficient (FABP4(-/-)) mice exhibited decreased bacterial clearance and increased mortality when challenged intranasally with P. aeruginosa. These findings in FABP4(-/-) mice were associated with a delayed neutrophil recruitment into the lungs and were followed by greater acute lung injury and inflammation. Among leukocytes, only macrophages expressed FABP4 in WT mice with P. aeruginosa pneumonia. Chimeric FABP4(-/-) mice with WT bone marrow were protected from increased mortality seen in chimeric WT mice with FABP4(-/-) bone marrow during P. aeruginosa pneumonia, thus confirming the role of macrophages as the main source of protective FABP4 against that infection. There was less production of C-X-C motif chemokine ligand 1 (CXCL1) in FABP4(-/-) alveolar macrophages and lower airway CXCL1 levels in FABP4(-/-) mice. Delivering recombinant CXCL1 to the airways protected FABP4(-/-) mice from increased susceptibility to P. aeruginosa pneumonia. Thus, macrophage-FABP4 has a novel role in pulmonary host defense against P. aeruginosa infection by facilitating crosstalk between macrophages and neutrophils via regulation of macrophage CXCL1 production.Liang, X., Gupta, K., Rojas Quintero, J., Cernadas, M., Kobzik, L., Christou, H., Pier, G. B., Owen, C. A., Cataltepe, S. Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia.	[Liang, Xiaoliang; Christou, Helen; Cataltepe, Sule] Harvard Med Sch, Dept Pediat Newborn Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Gupta, Kushagra; Quintero, Joselyn Rojas; Cernadas, Manuela; Owen, Caroline A.] Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Pier, Gerald B.] Harvard Med Sch, Div Infect Dis, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kobzik, Lester] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Owen, Caroline A.] Lovelace Resp Res Inst, Albuquerque, NM USA; [Gupta, Kushagra] Carilion Clin, Roanoke, VA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Lovelace Respiratory Research Institute	Cataltepe, S (corresponding author), Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA.	scataltepe@bwh.harvard.edu	Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331; Christou, Helen/0000-0002-3104-4570	American Heart Association [11GRNT4900002]; Brigham Research Institute; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [P50 HL107165-01, R21 HL111835]; NIH National Institute of Allergy and Infectious Diseases [RO1AI111475]; Brigham and Women's Hospital-Lovelace Respiratory Research Institute Consortium; Flight Attendants Medical Research Institute [CIA 046123]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111475] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Brigham Research Institute; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Brigham and Women's Hospital-Lovelace Respiratory Research Institute Consortium; Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Dr. Gokhan Hotamisligil (Sabri Ulker Center, Harvard T. H. Chan School of Public Health, Boston, MA, USA) for FABP4<SUP>-/-</SUP> mice, Dr. Gregory Priebe (Boston Children's Hospital, Boston, MA, USA) for helpful discussions, and Meher Iqbal (Brigham and Women's Hospital, Boston, MA, USA) for assistance with immunostaining. This work was supported by the American Heart Association (Grant 11GRNT4900002 to S.C.); the Brigham Research Institute (to S.C.); U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grants P50 HL107165-01, R21 HL111835, and NIH National Institute of Allergy and Infectious Diseases Grant RO1AI111475 (to C.A.O.); Brigham and Women's Hospital-Lovelace Respiratory Research Institute Consortium grants (to C.A.O.); and the Flight Attendants Medical Research Institute (Grant CIA 046123 to C.A.O.). The authors declare no conflicts of interest.	Amiri KI, 2003, PROG NUCLEIC ACID RE, V74, P1, DOI 10.1016/S0079-6603(03)01009-2; Anas AA, 2016, AM J PHYSIOL-LUNG C, V311, pL219, DOI 10.1152/ajplung.00078.2016; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Batra S, 2012, J IMMUNOL, V188, P3458, DOI 10.4049/jimmunol.1101985; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Burak MF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6336; Byrne AJ, 2015, THORAX, V70, P1189, DOI 10.1136/thoraxjnl-2015-207020; Cabre A, 2012, ATHEROSCLEROSIS, V222, P229, DOI 10.1016/j.atherosclerosis.2012.02.003; Cai SS, 2010, J IMMUNOL, V185, P6214, DOI 10.4049/jimmunol.0903843; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Cataltepe S, 2015, NEUROPATH APPL NEURO, V41, P646, DOI 10.1111/nan.12159; Chung YW, 2017, SCI REP-UK, V7, DOI 10.1038/srep40445; Coleman SL, 2011, EUR J NUTR, V50, P323, DOI 10.1007/s00394-010-0140-9; Elmasri H, 2012, ANGIOGENESIS, V15, P457, DOI 10.1007/s10456-012-9274-0; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gaspar MC, 2013, EUR J CLIN MICROBIOL, V32, P1231, DOI 10.1007/s10096-013-1876-y; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Ghelfi E, 2013, AM J PATHOL, V182, P1425, DOI 10.1016/j.ajpath.2012.12.009; Ghelfi E, 2011, AM J RESP CELL MOL, V45, P550, DOI 10.1165/rcmb.2010-0376OC; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Hashimoto S, 1996, AM J PHYSIOL-LUNG C, V270, pL819, DOI 10.1152/ajplung.1996.270.5.L819; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Knolle MD, 2013, J IMMUNOL, V190, P6434, DOI 10.4049/jimmunol.1202329; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Kooguchi K, 1998, INFECT IMMUN, V66, P3164, DOI 10.1128/IAI.66.7.3164-3169.1998; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Manicone AM, 2009, J IMMUNOL, V182, P3866, DOI 10.4049/jimmunol.0713949; Matute-Bello G, 2004, J IMMUNOL METHODS, V292, P25, DOI 10.1016/j.jim.2004.05.010; Miao XL, 2015, MOL CELL ENDOCRINOL, V403, P1, DOI 10.1016/j.mce.2014.12.017; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Morissette C, 1996, INFECT IMMUN, V64, P4984, DOI 10.1128/IAI.64.12.4984-4992.1996; Rello J, 2013, INTENS CARE MED, V39, P2204, DOI 10.1007/s00134-013-3046-1; Rittig N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162167; Saksi J, 2014, CIRC-CARDIOVASC GENE, V7, P588, DOI 10.1161/CIRCGENETICS.113.000499; Schneberger D, 2011, CELL TISSUE RES, V343, P97, DOI 10.1007/s00441-010-1032-2; Sugii S, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.199; Sun HY, 2011, CHEST, V139, P1172, DOI 10.1378/chest.10-0167; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Warszawska JM, 2013, J CLIN INVEST, V123, P3363, DOI 10.1172/JCI67911; Wilson R, 2013, J INFECTION, V67, P497, DOI 10.1016/j.jinf.2013.08.010; Zhang Y, 2011, NAT MED, V17, P341, DOI 10.1038/nm.2296	51	13	13	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3562	3574		10.1096/fj.201802002R	http://dx.doi.org/10.1096/fj.201802002R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30462529	Green Published, Bronze			2022-12-28	WOS:000459794800038
J	Romer-Seibert, JS; Hartman, NW; Moss, EG				Romer-Seibert, Jennifer S.; Hartman, Nathaniel W.; Moss, Eric G.			The RNA-binding protein LIN28 controls progenitor and neuronal cell fate during postnatal neurogenesis	FASEB JOURNAL			English	Article						let-7; circRNA; developmental timing	NEURAL STEM-CELLS; MESSENGER-RNA; LINEAGE PROGRESSION; SELF-RENEWAL; LIN-28; EXPRESSION; MICRORNA; MIGRATION; DIFFERENTIATION; PROMOTES	The RNA-binding protein LIN28 is known to regulate cell fate, tissue growth, and pluripotency; however, a unified understanding of its role at the cellular level has not been achieved. Here, we address its developmental activity in mammalian postnatal neurogenesis. Constitutive expression of LIN28 in progenitor cells of the mouse subventricular zone (SVZ) caused several distinct effects: 1) the number of differentiated neurons in the olfactory bulb was dramatically reduced, whereas the relative abundance of 2 neuronal subtypes was significantly altered, 2) the population of proliferating neural progenitors in the SVZ was reduced, whereas the proportion of neuroblasts was increased, and 3) the number of astrocytes was reduced, occasionally causing them to appear early. Thus, LIN28 acts at a poststem cell/predifferentiation step, and its continuous expression caused a precocious phenotype unlike in other experimental systems. Furthermore, for the first time in a vertebrate system, we separate the majority of the biologic role of LIN28 from its known activity of blocking the microRNA let-7 by using a circular RNA sponge. We find that although LIN28 has a multifaceted role in the number and types of cells produced during postnatal neurogenesis, it appears that its action through let-7 is responsible for only a fraction of these effects.Romer-Seibert, J. S., Hartman, N. W., Moss, E. G. The RNA-binding protein LIN28 controls progenitor and neuronal cell fate during postnatal neurogenesis.	[Romer-Seibert, Jennifer S.; Moss, Eric G.] Rowan Univ, Grad Sch Biomed Sci, Dept Mol Biol, 42 E Laurel Rd, Stratford, NJ 08084 USA; [Hartman, Nathaniel W.] Stockton Univ, Sch Nat Sci & Math, Galloway, NJ USA	Rowan University	Moss, EG (corresponding author), Rowan Univ, Grad Sch Biomed Sci, Dept Mol Biol, 42 E Laurel Rd, Stratford, NJ 08084 USA.	mosseg@rowan.edu	Hartman, Nathaniel/P-7654-2014	Hartman, Nathaniel/0000-0003-4976-5525	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [R15NS092026-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS092026] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank John Rokita and the animal laboratory staff at Stockton University for animal care, Dr. Hristo Houbaviy (Rowan University) for expert advice and plasmids, and Kevin Kemper and Madeleine Minutillo (Rowan University) for comments on the manuscript. This work was funded, in part, by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke, Grant R15NS092026-01A1 (to N.W.H). The authors declare no conflicts of interest.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Betizeau Marion, 2016, Stem Cell Investig, V3, P39, DOI 10.21037/sci.2016.08.02; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Costa MR, 2011, DEVELOPMENT, V138, P1057, DOI 10.1242/dev.061663; de Vasconcellos JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106924; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Faas L, 2013, DEVELOPMENT, V140, P976, DOI 10.1242/dev.089797; Feliciano DM, 2013, JOVE-J VIS EXP, DOI 10.3791/50197; Feliciano DM, 2012, HUM MOL GENET, V21, P799, DOI 10.1093/hmg/ddr511; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Hafner M, 2013, RNA, V19, P613, DOI 10.1261/rna.036491.112; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hartman NW, 2013, CELL REP, V5, P433, DOI 10.1016/j.celrep.2013.09.017; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Lacar B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00043; Lei XX, 2012, NUCLEIC ACIDS RES, V40, P3574, DOI 10.1093/nar/gkr1279; Li N, 2012, J BIOL CHEM, V287, P17386, DOI 10.1074/jbc.M111.321158; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mahoney C, 2016, NEUROSCI LETT, V614, P112, DOI 10.1016/j.neulet.2015.12.042; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MCCONNELL SK, 1985, SCIENCE, V229, P1268, DOI 10.1126/science.4035355; McDonald J.H., 2014, HDB BIOL STAT; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nagayama S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00098; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Pathania M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038174; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Petri R, 2017, EMBO J, V36, P1379, DOI 10.15252/embj.201695235; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rougvie AE, 2013, CURR TOP DEV BIOL, V105, P153, DOI 10.1016/B978-0-12-396968-2.00006-3; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Tsialikas J, 2015, DEVELOPMENT, V142, P2397, DOI 10.1242/dev.117580; Vadla B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002588; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wu SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090107; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yang M, 2015, DEVELOPMENT, V142, P1616, DOI 10.1242/dev.120543; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	57	14	14	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3291	3303		10.1096/fj.201801118R	http://dx.doi.org/10.1096/fj.201801118R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30423261	Green Published, hybrid			2022-12-28	WOS:000459794800018
J	Haraguchi, H; Hirota, Y; Saito-Fujita, T; Tanaka, T; Shimizu-Hirota, R; Harada, M; Akaeda, S; Hiraoka, T; Matsuo, M; Matsumoto, L; Hirata, T; Koga, K; Wada-Hiraike, O; Fujii, T; Osuga, Y				Haraguchi, Hirofumi; Hirota, Yasushi; Saito-Fujita, Tomoko; Tanaka, Tomoki; Shimizu-Hirota, Ryoko; Harada, Miyuki; Akaeda, Shun; Hiraoka, Takehiro; Matsuo, Mitsunori; Matsumoto, Leona; Hirata, Tetsuya; Koga, Kaori; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka			Mdm2-p53-SF1 pathway in ovarian granulosa cells directs ovulation and fertilization by conditioning oocyte quality	FASEB JOURNAL			English	Article						infertility; oocyte maturation; cumulus granulosa; cell-oocyte complex	HYALURONIC-ACID SYNTHESIS; STEROIDOGENIC FACTOR-1; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; CUMULUS EXPANSION; ONCOPROTEIN MDM2; FEMALE FERTILITY; OXIDATIVE STRESS; PRETERM BIRTH; MOUSE	Functions of tumor suppressor p53 and its negative regulator mouse double minute 2 homolog (Mdm2) in ovarian granulosa cells remain to be elucidated, and the current study aims at clarifying this issue. Mice with Mdm2 deficiency in ovarian granulosa cells [Mdm2-loxP/progesterone receptor (Pgr)-Cre mice] were infertile as a result of impairment of oocyte maturation, ovulation, and fertilization, and those with Mdm2/p53 double deletion in granulosa cells (Mdm2-loxP/p53-loxP/Pgr-Cre mice) showed normal fertility, suggesting that p53 induction in the ovarian granulosa cells is detrimental to ovarian function by disturbing oocyte quality. Another model of Mdm2 deletion in ovarian granulosa cells (Mdm2-loxP/anti-Mullerian hormone type 2 receptor-Cre mice) also showed subfertility as a result of the failure of ovulation and fertilization, indicating critical roles of ovarian Mdm2 in ovulation and fertilization. Mdm2-p53 pathway in cumulus granulosa cells transcriptionally controlled an orphan nuclear receptor steroidogenic factor 1 (SF1), a key regulator of ovarian function. Importantly, MDM2 and SF1 levels in human cumulus granulosa cells were positively associated with the outcome of oocyte maturation and fertilization in patients undergoing infertility treatment. These findings suggest that the Mdm2-p53-SF1 axis in ovarian cumulus granulosa cells directs ovarian function by affecting their neighboring oocyte quality.Haraguchi, H., Hirota, Y., Saito-Fujita, T., Tanaka, T., Shimizu-Hirota, R., Harada, M., Akaeda, S., Hiraoka, T., Matsuo, M., Matsumoto, L., Hirata, T., Koga, K., Wada-Hiraike, O., Fujii, T., Osuga, Y. Mdm2-p53-SF1 pathway in ovarian granulosa cells directs ovulation and fertilization by conditioning oocyte quality.	[Haraguchi, Hirofumi; Hirota, Yasushi; Saito-Fujita, Tomoko; Tanaka, Tomoki; Harada, Miyuki; Akaeda, Shun; Hiraoka, Takehiro; Matsuo, Mitsunori; Matsumoto, Leona; Hirata, Tetsuya; Koga, Kaori; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Hirota, Yasushi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Hirota, Yasushi] Japan Agcy Med Res & Dev, Precursory Res Innovat Med Care, Tokyo, Japan; [Shimizu-Hirota, Ryoko] Keio Univ, Sch Med, Ctr Prevent Med, Dept Internal Med, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Keio University	Hirota, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yhirota-tky@umin.ac.jp	Hirota, Yasushi/AAD-8713-2020; Koga, Kaori/ABA-5601-2020	Hirota, Yasushi/0000-0003-0241-9780; Koga, Kaori/0000-0002-5057-4120; Hirata, Tetsuya/0000-0002-9975-6208	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Society for the Promotion of Science [16H04679, 16H05469, 16K15700, 16K15701, 15H04979, 15K10660, 17K16833, 16K10668, 17H06640, 15K15597, 18K19601, 18K19600, 18H02943, 18K09284]; Takeda Science Foundation; Japan Agency for Medical Research and Development-Precursory Research for Innovative Medical Care (AMED-PRIME) [JP17gm5910010]	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Society for the Promotion of Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Agency for Medical Research and Development-Precursory Research for Innovative Medical Care (AMED-PRIME)(Japan Agency for Medical Research and Development (AMED))	The authors thank Dr. Francesco J. DeMayo (National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA) and Dr. John P. Lydon (Baylor College of Medicine, Houston, TX, USA) for providing Pgr-Cre mice, the National Cancer Institute for providing p53-loxP and Mdm2-loxP mice, Dr. Richard Behringer (The University of Texas MD Anderson Cancer Center, Houston, TX, USA) for providing Amhr2-Cre mice, and Dr. Toshihiro Nakajima (Tokyo Medical University, Tokyo, Japan) for providing a p53-expression plasmid. This work was supported by Precursory Research for Embryonic Science and Technology (PRESTO), Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (JSPS KAKENHI; Grants16H04679, 16H05469, 16K15700, 16K15701, 15H04979, 15K10660, 17K16833, 16K10668, 17H06640, 15K15597, 18K19601, 18K19600, 18H02943, and 18K09284), Japan Agency for Medical Research and Development-Precursory Research for Innovative Medical Care (AMED-PRIME; JP17gm5910010), and Takeda Science Foundation. The authors declare no conflicts of interest.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F; Burnum KE, 2012, ENDOCRINOLOGY, V153, P4568, DOI 10.1210/en.2012-1335; Cha J, 2013, J CLIN INVEST, V123, P4063, DOI 10.1172/JCI70098; Chan Y, 2016, GYNECOL ENDOCRINOL, V32, P136, DOI 10.3109/09513590.2015.1092515; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; Deng WB, 2016, J CLIN INVEST, V126, P2941, DOI 10.1172/JCI87715; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Egashira M, 2017, ENDOCRINOLOGY, V158, P2344, DOI 10.1210/en.2016-1886; EPPIG JJ, 1981, BIOL REPROD, V25, P191, DOI 10.1095/biolreprod25.1.191; EPPIG JJ, 1979, NATURE, V281, P483, DOI 10.1038/281483a0; EPPIG JJ, 1983, DEV BIOL, V100, P39, DOI 10.1016/0012-1606(83)90198-7; FIELD JK, 1991, BRIT J CANCER, V64, P573, DOI 10.1038/bjc.1991.352; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fouchecourt S, 2016, CELL DEATH DIFFER, V23, P521, DOI 10.1038/cdd.2015.120; Harada M, 2015, GYNECOL ENDOCRINOL, V31, P783, DOI 10.3109/09513590.2015.1062862; Haraguchi H, 2014, MOL ENDOCRINOL, V28, P1108, DOI 10.1210/me.2014-1097; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hosokawa K, 1998, ENDOCRINOLOGY, V139, P4688, DOI 10.1210/en.139.11.4688; Huang ZW, 2012, CURR PHARM DESIGN, V18, P310, DOI 10.2174/138161212799040439; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kugu K, 1998, CELL DEATH DIFFER, V5, P67, DOI 10.1038/sj.cdd.4400316; Livera G, 2016, FEBS LETT, V590, P2566, DOI 10.1002/1873-3468.12275; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; LUNA RMD, 1995, NATURE, V378, P203; Makrigiannakis A, 2000, J CLIN ENDOCR METAB, V85, P449, DOI 10.1210/jc.85.1.449; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS248; Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS172; Richards Joanne S, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-02062-9_1; Richards JS, 2005, MOL CELL ENDOCRINOL, V234, P75, DOI 10.1016/j.mce.2005.01.004; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Ruder EH, 2009, CURR OPIN OBSTET GYN, V21, P219, DOI 10.1097/GCO.0b013e32832924ba; Rui X, 2008, ENDOCRINOLOGY, V149, P3668, DOI 10.1210/en.2008-0203; SALUSTRI A, 1985, BIOL REPROD, V33, P229, DOI 10.1095/biolreprod33.1.229; Sbisa E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S20; Shukla KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076959; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Takahashi N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11252-7; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490	58	16	17	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2610	2620		10.1096/fj.201801401R	http://dx.doi.org/10.1096/fj.201801401R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260703				2022-12-28	WOS:000457296600086
J	Li, WT; Luo, QQ; Wang, B; Chen, X; Yan, XJ; Qiu, HY; Chen, SL				Li, Wen-Ting; Luo, Qing-Qing; Wang, Bo; Chen, Xin; Yan, Xiu-Juan; Qiu, Hong-Yi; Chen, Sheng-Liang			Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis	FASEB JOURNAL			English	Article						pain processing; IBS; p38 MAPK; NF-B	IRRITABLE-BOWEL-SYNDROME; COLONIC TRANSIT; EXPRESSION; NGF; INFLAMMATION; ACTIVATION; NEURONS; PREVALENCE; DISORDERS; EXCRETION	Increased colonic bile acid (BA) exposure, frequent in diarrhea-predominant irritable bowel syndrome (IBS-D), can affect gut function. Nerve growth factor (NGF) is implicated in the development of visceral hypersensitivity (VH). In this study, we tested the hypothesis that BAs cause VH via mucosal mast cell (MMC)-to-nociceptor signaling, which involves the farnesoid X receptor (FXR)/NGF/transient receptor potential vanilloid (TRPV)1 axis. BAs were intracolonically administered to rats for 15 d. Visceral sensitivity to colorectal distention and colonic NGF expression were examined. BAs caused VH, an effect that involved MMC-derived NGF and was accompanied by enhanced TRPV1 expression in the dorsal root ganglia. Anti-NGF treatment and TRPV1 antagonism inhibited BA-induced VH. BAs induced NGF mRNA and protein expression and release in cultured mast cells. Colonic supernatants from patients with IBS-D with elevated colonic BA content transcriptionally induced NGF expression. In FXR-/- mice, visceral sensitivity and colonic NGF expression were unaltered after BA treatment. Pharmacological antagonism and FXR silencing suppressed BA-induced NGF expression and release in mast cells. Mitogen-activated protein kinase kinase (MKK) 3/6/p38 MAPK/NF-B signaling was mechanistically responsible for FXR-mediated NGF expression and secretion. The findings show an MMC-dependent and FXR-mediated pronociceptive effect of BAs and identify the BA/FXR/NGF/TRPV1 axis as a key player in MMC-to-neuron communication during pain processing in IBS.Li, W.-T., Luo, Q.-Q., Wang, B., Chen, X., Yan, X.-J., Qiu, H.-Y., Chen, S.-L. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.	[Li, Wen-Ting; Luo, Qing-Qing; Wang, Bo; Chen, Xin; Yan, Xiu-Juan; Qiu, Hong-Yi; Chen, Sheng-Liang] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Div Gastroenterol & Hepatol,Renji Hosp, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China	Shanghai Jiao Tong University	Chen, SL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Div Gastroenterol & Hepatol,Renji Hosp, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China.	slchenmd@hotmail.com	Shen, Nan/AGK-6807-2022		National Natural Science Foundation of China [81670484, 81470812, 81270463, 81500412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 81670484, 81470812, 81270463, and 81500412 from the National Natural Science Foundation of China (to S.-L.C. and X.-J.Y.). The authors declare no conflicts of interest.	Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Bajor A, 2015, GUT, V64, P84, DOI 10.1136/gutjnl-2013-305965; Bajor A, 2010, SCAND J GASTROENTERO, V45, P645, DOI 10.3109/00365521003702734; Bampton PA, 2002, AM J PHYSIOL-GASTR L, V282, pG443, DOI 10.1152/ajpgi.00194.2001; Bannwarth B, 2014, DRUGS, V74, P619, DOI 10.1007/s40265-014-0208-6; Barreau F, 2004, GASTROENTEROLOGY, V127, P524, DOI 10.1053/j.gastro.2004.05.019; Camilleri M, 2014, AM J GASTROENTEROL, V109, P1621, DOI 10.1038/ajg.2014.215; Camilleri M, 2012, NEW ENGL J MED, V367, P1626, DOI 10.1056/NEJMra1207068; Carey LM, 2016, MOL PAIN, V12, DOI 10.1177/1744806916649192; Cenac N, 2010, GUT, V59, P481, DOI 10.1136/gut.2009.192567; Coelho A, 2015, BRIT J PHARMACOL, V172, P1691, DOI 10.1111/bph.12958; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Dothel G, 2015, GASTROENTEROLOGY, V148, P1002, DOI 10.1053/j.gastro.2015.01.042; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1257, DOI 10.1053/j.gastro.2016.03.035; Guerrero-Alba R, 2017, GUT, V66, P2121, DOI 10.1136/gutjnl-2016-311456; He JL, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0427-9; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; Lee KN, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/2031480; LEON A, 1994, P NATL ACAD SCI USA, V91, P3739, DOI 10.1073/pnas.91.9.3739; Lieu T, 2014, BRIT J PHARMACOL, V171, P1156, DOI 10.1111/bph.12426; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MEKHJIAN HS, 1971, J CLIN INVEST, V50, P1569, DOI 10.1172/JCI106644; MEKHJIAN HS, 1979, DIGEST DIS SCI, V24, P545, DOI 10.1007/BF01489324; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Peleman C, 2017, CLIN GASTROENTEROL H, V15, P720, DOI 10.1016/j.cgh.2016.11.012; QUIST RG, 1991, GASTROENTEROLOGY, V101, P446, DOI 10.1016/0016-5085(91)90024-F; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Serna H, 2006, J PHARMACOL EXP THER, V319, P1104, DOI 10.1124/jpet.106.104620; Shin A, 2013, CLIN GASTROENTEROL H, V11, P1270, DOI 10.1016/j.cgh.2013.04.020; Shutov LP, 2016, J NEUROSCI, V36, P5055, DOI 10.1523/JNEUROSCI.3249-15.2016; Slattery SA, 2015, ALIMENT PHARM THER, V42, P3, DOI 10.1111/apt.13227; Sun Y, 2004, GUT, V53, P362, DOI 10.1136/gut.2003.015867; Tam SY, 1997, BLOOD, V90, P1807, DOI 10.1182/blood.V90.5.1807; Traub RJ, 2008, GASTROENTEROLOGY, V135, P2075, DOI 10.1053/j.gastro.2008.08.051; Veenstra TD, 1998, BIOCHEMISTRY-US, V37, P5988, DOI 10.1021/bi972965+; Wang Lina, 2014, Cells, V3, P662, DOI 10.3390/cells3030662; Xu XJ, 2017, ALIMENT PHARM THER, V45, P100, DOI 10.1111/apt.13848; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005	41	28	31	2	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2435	2450		10.1096/fj.201800935RR	http://dx.doi.org/10.1096/fj.201800935RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260705				2022-12-28	WOS:000457296600072
J	Qiu, LL; Wang, C; Yao, S; Li, N; Hu, YH; Yu, YQ; Xia, R; Zhu, JS; Ji, MH; Zhang, Z; Wang, SL				Qiu, Liang-Lin; Wang, Chao; Yao, Shen; Li, Na; Hu, Yuhuan; Yu, Yongquan; Xia, Rong; Zhu, Jiansheng; Ji, Minghui; Zhang, Zhan; Wang, Shou-Lin			Fenvalerate induces oxidative hepatic lesions through an overload of intracellular calcium triggered by the ERK/IKK/NF-B pathway	FASEB JOURNAL			English	Article						pyrethroid pesticides; liver injury; reactive oxygen species; calcium signal pathway	HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; INDUCED APOPTOSIS; MAPK ACTIVATION; LIVER-INJURY; STRESS; EXPOSURE; MITOCHONDRIA; DAMAGE; INDUCTION	Fenvalerate (FEN), a mainstream pyrethroid pesticide, was initially recommended as a low-toxicity agent for controlling agricultural and domestic pests. Despite the widespread use of FEN worldwide, little data are available on FEN-induced hepatic lesions and molecular mechanisms. In the present study, we first performed an occupational cross-sectional study on FEN factory workers and found that the levels of serum alanine aminotransferase (ALT) and total antioxidant capacity increased, whereas malondialdehyde decreased in laborers in the working areas where the levels of airborne FEN were much higher compared with the office area. The results were then confirmed by animal experiments that abnormal hepatic histology, increased ALT level, and compromised hepatic oxidative capability were observed in rats exposed to a high concentration of FEN. Furthermore, the bioinformatics analysis of gene microarray in rat liver tissue showed that FEN significantly changed the expressions of genes related to the regulation of intracellular calcium ion homeostasis and the calcium signal pathway. Finally, the functional experiments in Buffalo rat liver (BRL) cells demonstrated that FEN first activated ERK MAPK, followed by IKK and NF-B, which triggered the transcription of genes responsible for accelerating an overload of intracellular calcium ions, prompted reactive oxygen species generation in the mitochondria, and finally, induced hepatic cellular apoptosis. The calcium signaling pathway and in particular, an overload of intracellular calcium play a critical role in this pathophysiological process via the ERK/IKK/NF-B pathway. Our study furthers the understanding of the mechanism of FEN-induced hepatic injuries and may have implications in the prevention and control of liver diseases induced by environmental pesticides.Qiu, L.-L., Wang, C., Yao, S., Li, N., Hu, Y., Yu, Y., Xia, R., Zhu, J., Ji, M., Zhang, Z., Wang S.-L. Fenvalerate induces oxidative hepatic lesions through an overload of intracellular calcium triggered by the ERK/IKK/NF-B pathway.	[Qiu, Liang-Lin; Wang, Chao; Yao, Shen; Li, Na; Hu, Yuhuan; Yu, Yongquan; Xia, Rong; Zhu, Jiansheng; Ji, Minghui; Zhang, Zhan; Wang, Shou-Lin] Nanjing Med Univ, Minist Educ, Sch Publ Hlth, Key Lab Modern Toxicol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China; [Wang, Chao; Hu, Yuhuan; Yu, Yongquan; Zhu, Jiansheng; Zhang, Zhan; Wang, Shou-Lin] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Qiu, Liang-Lin] Nantong Univ, Sch Publ Hlth, Nantong, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nantong University	Wang, SL (corresponding author), Nanjing Med Univ, Minist Educ, Sch Publ Hlth, Key Lab Modern Toxicol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	wangshl@njmu.edu.cn	Zhang, Zhan/AAR-6278-2020	Zhang, Zhan/0000-0002-9685-5753	National Natural Science Foundation of China [81573194, 91743205, 81372956]; National 973 Program of China [2009CB941701]; Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP) [PPZY2015A067]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Natural Science Foundation of China (81573194, 91743205, and 81372956), National 973 Program of China (2009CB941701), Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP; PPZY2015A067), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors declare no conflicts of interest.	Anadon A, 2013, TOXICOL LETT, V220, P135, DOI 10.1016/j.toxlet.2013.04.015; Aouey B, 2017, ENVIRON SCI POLLUT R, V24, P5841, DOI 10.1007/s11356-016-8323-4; Atkinson L, 2002, NATURE, V420, P42, DOI 10.1038/420042a; Bhattacharyya S, 2012, FREE RADICAL RES, V46, P1296, DOI 10.3109/10715762.2012.712690; BLOCKI FA, 1992, NATURE, V360, P269, DOI 10.1038/360269a0; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Cave M, 2010, ENVIRON HEALTH PERSP, V118, P1735, DOI 10.1289/ehp.1002720; Chaabane M, 2017, HUM EXP TOXICOL, V36, P854, DOI 10.1177/0960327116672911; Chien JM, 2013, ENVIRON TOXICOL PHAR, V35, P178, DOI 10.1016/j.etap.2012.12.007; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Du XF, 2013, CELL, V154, P118, DOI 10.1016/j.cell.2013.05.059; Du XL, 2017, J CELL PHYSIOL, V232, P3296, DOI 10.1002/jcp.25773; Espino J, 2011, J PINEAL RES, V51, P195, DOI 10.1111/j.1600-079X.2011.00876.x; Ghasemi-Niri SF, 2016, WORLD J GASTROENTERO, V22, P4999, DOI 10.3748/wjg.v22.i21.4999; Ghosh J, 2010, FREE RADICAL BIO MED, V49, P1779, DOI 10.1016/j.freeradbiomed.2010.09.011; Giray B, 2011, HUM EXP TOXICOL, V30, P1575, DOI 10.1177/0960327110393762; Han D, 2013, TRENDS PHARMACOL SCI, V34, P243, DOI 10.1016/j.tips.2013.01.009; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Lieven CJ, 2003, ANTIOXID REDOX SIGN, V5, P641, DOI 10.1089/152308603770310310; Medina J, 2005, DRUGS, V65, P2445, DOI 10.2165/00003495-200565170-00003; Miao YL, 2018, FASEB J, V32, P1328, DOI 10.1096/fj.201700908R; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Pizzutti IR, 2009, J CHROMATOGR A, V1216, P3305, DOI 10.1016/j.chroma.2009.01.088; Prasanthi K, 2005, FOOD CHEM TOXICOL, V43, P299, DOI 10.1016/j.fct.2004.10.005; Ramesh A, 2004, J ANAL TOXICOL, V28, P660, DOI 10.1093/jat/28.8.660; Richardson JR, 2015, FASEB J, V29, P1960, DOI 10.1096/fj.14-260901; Rodrigues ACM, 2015, ENVIRON POLLUT, V207, P273, DOI 10.1016/j.envpol.2015.09.035; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Tan LF, 2006, CONTRACEPTION, V73, P92, DOI 10.1016/j.contraception.2005.06.067; Tao GZ, 2013, J BIOL CHEM, V288, P17214, DOI 10.1074/jbc.M112.445965; Toledo FD, 2014, ARCH TOXICOL, V88, P1695, DOI 10.1007/s00204-014-1219-5; Tomlin C. D. S., 2006, PEST MAN 14 ED, P691; Tos-Luty S, 2001, ANN AGR ENV MED, V8, P245; Wang B, 2017, TOXICOL SCI, V157, P377, DOI 10.1093/toxsci/kfx052; Wang JC, 2014, BIOL TRACE ELEM RES, V161, P180, DOI 10.1007/s12011-014-0105-6; Wang J, 2009, TOXICOLOGY, V259, P122, DOI 10.1016/j.tox.2009.02.011; Wang WL, 2015, CANCER LETT, V358, P47, DOI 10.1016/j.canlet.2014.12.025; Wang X, 2013, CARCINOGENESIS, V34, P1323, DOI 10.1093/carcin/bgt058; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Xing L, 2016, ELIFE, V5, DOI 10.7554/elite.11123; Zavodnik IB, 2013, LIFE SCI, V92, P1110, DOI 10.1016/j.lfs.2013.04.009; Zepeda-Arce R, 2017, ENVIRON TOXICOL, V32, P1754, DOI 10.1002/tox.22398; Zhang LS, 2017, ENVIRON POLLUT, V220, P843, DOI 10.1016/j.envpol.2016.10.067; Zhang Z, 2013, ARCH TOXICOL, V87, P1557, DOI 10.1007/s00204-013-1059-8; Zhao XF, 2011, ARCH TOXICOL, V85, P1101, DOI 10.1007/s00204-011-0654-9; Zhong L, 2018, FASEB J, V32, P4070, DOI 10.1096/fj.201701536R	50	8	8	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2782	2795		10.1096/fj.201801289R	http://dx.doi.org/10.1096/fj.201801289R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307764				2022-12-28	WOS:000457296600100
J	Joo, MS; Shin, SB; Kim, EJ; Koo, JH; Yim, H; Kim, SG				Joo, Min Sung; Shin, Sol-Bi; Kim, Eun Jung; Koo, Ja Hyun; Yim, Hyungshin; Kim, Sang Geon			Nrf2-lncRNA controls cell fate by modulating p53-dependent Nrf2 activation as an miRNA sponge for Plk2 and p21(cip1)	FASEB JOURNAL			English	Article						ceRNA; DNA damage response; oxidative stress; hepatocelluar carcinoma; and miR-122	ANTIOXIDANT RESPONSE ELEMENT; INDUCED DNA-DAMAGE; NONCODING RNAS; MOLECULAR-BASIS; ENHANCER RNAS; PROTEIN; PATHWAY; PHOSPHORYLATION; TRANSCRIPTION; SURVIVAL	Long noncoding RNA (lncRNA) capable of controlling antioxidative capacity remains to be investigated. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a central molecule for cellular defense that increases antioxidative capacity. We identified a novel lncRNA named Nrf2-activating lncRNA (Nrf2-lncRNA) transcribed from an upstream region of the microRNA 122 gene (MIR122). Nrf2-lncRNA existed in the cytoplasm, suggestive of its function as a competing endogenous RNA [ceRNA, microRNA (miRNA) sponge]. Nrf2-lncRNA served as a ceRNA for polo-like kinase (Plk) 2 and cyclin-dependent kinase inhibitor 1 (p21(cip1)) through binding of miRNA 128 and miRNA 224, inducing Plk2/Nrf2/p21(cip1) complexation for Nrf2 activation in the cells under p53-activating conditions (i.e., DNA damage and serum deprivation). Nrf2-lncRNA expression was suppressed with the initiation of apoptosis, being a rheostat for cell fate determination. Nrf2-lncRNA levels correlated with the recurrence-free postsurgery survival rate of patients with hepatocellular carcinoma. Collectively, Nrf2-lncRNA promotes Plk2 and p21(cip1) translation by competing for specific miRNAs and activating Nrf2 under surviving conditions from oxidative stress, implying that Nrf2-lncRNA serves as a fine-tuning rheostat for cell fate decision.-Joo, M. S., Shin, S.-B., Kim, E. J., Koo, J. H., Yim, H., Kim, S. G. Nrf2-lncRNA controls cell fate by modulating p53-dependent Nrf2 activation as an miRNA sponge for Plk2 and p21(cip1).	[Joo, Min Sung; Kim, Eun Jung; Koo, Ja Hyun; Kim, Sang Geon] Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro,San 56-1, Seoul 08826, South Korea; [Joo, Min Sung; Kim, Sang Geon] Seoul Natl Univ, Res Inst Pharmaceut Sci, 1 Gwanak Ro,San 56-1, Seoul 08826, South Korea; [Shin, Sol-Bi; Yim, Hyungshin] Hanyang Univ, Coll Pharm, 55 Hanyangdaehak Ro, Ansan 15588, South Korea; [Shin, Sol-Bi; Yim, Hyungshin] Hanyang Univ, Inst Pharmaceut Sci & Technol, 55 Hanyangdaehak Ro, Ansan 15588, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Hanyang University	Kim, SG (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro,San 56-1, Seoul 08826, South Korea.; Kim, SG (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, 1 Gwanak Ro,San 56-1, Seoul 08826, South Korea.; Yim, H (corresponding author), Hanyang Univ, Coll Pharm, 55 Hanyangdaehak Ro, Ansan 15588, South Korea.; Yim, H (corresponding author), Hanyang Univ, Inst Pharmaceut Sci & Technol, 55 Hanyangdaehak Ro, Ansan 15588, South Korea.	hsyim@hanyang.ac.kr; sgk@snu.ac.kr	Koo, Ja Hyun/GQP-5440-2022	Koo, Ja Hyun/0000-0001-5738-1105; Joo, Min Sung/0000-0001-7857-8302	National Research Foundation (NRF) - Ministry of Science and Information and Communication Technology of the Korean government [2014M1A3A3A02034698, 2017K1A1A2004511, 2017R1A2B2012301]	National Research Foundation (NRF) - Ministry of Science and Information and Communication Technology of the Korean government	The authors thank Dr. Hye Eun Byeon (Hanyang University) for the technical support. This work was supported by National Research Foundation (NRF) grants funded by the Ministry of Science and Information and Communication Technology of the Korean government (2014M1A3A3A02034698 and 2017K1A1A2004511 to S.G.K., and 2017R1A2B2012301 to H.Y.). S.G.K. is lead contact. The authors declare no conflicts of interest.	Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Ge WJ, 2017, CANCER CELL, V32, P561, DOI 10.1016/j.ccell.2017.09.008; Grafi G, 2009, TRENDS BIOTECHNOL, V27, P329, DOI 10.1016/j.tibtech.2009.02.007; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jayakumar S, 2015, MUTAT RES-FUND MOL M, V779, P33, DOI 10.1016/j.mrfmmm.2015.06.007; Jeayeng S, 2017, FREE RADICAL BIO MED, V108, P918, DOI 10.1016/j.freeradbiomed.2017.05.009; Joo MS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.427; Joo MS, 2017, JOVE-J VIS EXP, DOI 10.3791/55708; Joo MS, 2016, MOL CELL BIOL, V36, P1931, DOI 10.1128/MCB.00118-16; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim SB, 2012, P NATL ACAD SCI USA, V109, pE2949, DOI 10.1073/pnas.1207718109; Kim TH, 2018, J CLIN INVEST, V128, P5587, DOI [10.1172/JCI97831, 10.1172/jci97831]; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li JE, 2014, FREE RADICAL BIO MED, V73, P270, DOI 10.1016/j.freeradbiomed.2014.05.022; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Matsumoto T, 2009, P NATL ACAD SCI USA, V106, P14542, DOI 10.1073/pnas.0904229106; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salvi M, 2012, BBA-PROTEINS PROTEOM, V1824, P1366, DOI 10.1016/j.bbapap.2012.07.003; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Villeneuve NF, 2009, CELL CYCLE, V8, P3255, DOI 10.4161/cc.8.20.9565; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wang Y, 2017, BIOMED PHARMACOTHER, V87, P548, DOI 10.1016/j.biopha.2016.12.040; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	61	23	25	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7953	7969		10.1096/fj.201802744R	http://dx.doi.org/10.1096/fj.201802744R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30897343	Bronze			2022-12-28	WOS:000476234700013
J	Huang, K; Ru, BB; Zhang, Y; Chan, WL; Chow, SC; Zhang, JW; Lo, C; Lui, WY				Huang, Kun; Ru, Beibei; Zhang, Yang; Chan, Wai-Lung; Chow, Sheung-Ching; Zhang, Jiangwen; Lo, Clive; Lui, Wing-Yee			Sertoli cell-specific coxsackievirus and adenovirus receptor knockout regulates cell adhesion and gene transcription via beta-catenin inactivation and Cdc42 activation	FASEB JOURNAL			English	Article						blood-testis barrier; ectoplasmic specialization; reproductive impairment; spermatogenesis	BLOOD-TESTIS BARRIER; GERM-CELLS; MICE; CAR; COMPLEX; BINDING; INFERTILITY; JUNCTIONS; COMPONENT; GTPASES	Blood-testis barrier (BTB) and apical ectoplasmic specialization (ES) serve as structural supports for germ cell (GC) development. We demonstrated that the Sertoli cell (SC)-specific coxsackievirus and adenovirus receptor (CXADR) knockout (SC-CXADR(-/-)), but not the GC-specific knockout, impaired spermatogenesis. An increase in GC apoptosis and premature loss of elongated spermatids were observed in SC-CXADR(-/-) testes. The BTB function was compromised in SC-CXADR(-/-) testes with dysregulation of oocludin and zonula occludens-1 expression at the basal compartment of the seminiferous epithelium. An integrated omics analyses confirmed that altered gene ontology terms identified in SC-CXADR(-/-) testes are highly associated with spermatid development and differentiation, spermatogenesis, and sperm motility and are considered as unique testicular function terms. Leptin, Nasp, Tektin3, Larp 7, and acrosin, which are highly associated with male fertility, were found to be down-regulated in SC-CXADR(-/-) testes. Based on the data from the omics analyses, we employed the CXADR-deficient SC model to further investigate the molecular mechanisms involved. We unraveled that SC-CXADRs are required for beta-catenin inactivation and cell division cycle protein 42 (Cdc42) activation, resulting in maintaining the integrity and function of the BTB and apical ES as well as inhibiting gene transcription, such as the Myc gene, in the testes. We demonstrated for the first time that CXADR is an important mediator governing beta-catenin and Cdc42 signaling that is essential for spermatogenesis. The molecular mechanisms identified herein may provide new insights to unravel the novel functions and signaling cascades of CXADR in other key CXADR-expressing tissues.-Huang, K., Ru, B., Zhang, Y., Chan, W.-L., Chow, S.-C., Zhang, J., Lo, C., Lui, W.-Y. Sertoli cell-specific coxsackievirus and adenovirus receptor knockout regulates cell adhesion and gene transcription via beta-catenin inactivation and Cdc42 activation.	[Huang, Kun; Ru, Beibei; Zhang, Yang; Chan, Wai-Lung; Chow, Sheung-Ching; Zhang, Jiangwen; Lo, Clive; Lui, Wing-Yee] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China	University of Hong Kong	Lui, WY (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China.	wylui@hku.hk	Lui, Yee/A-2743-2010; Young, Roger/C-8718-2016; Ru, Beibei/F-3830-2011	Young, Roger/0000-0001-8474-5947; 	Hong Kong Research Grants Council [GRF-HKU774213, GRF-HKU17100816]; University of Hong Kong (HKU)/Committee on Research and Conference Grants (CRCG) Seed Funding for Basic Research	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong (HKU)/Committee on Research and Conference Grants (CRCG) Seed Funding for Basic Research	The authors thank Dr. C. Yan Cheng (The Center for Biomedical Research, Population Council, New York, NY, USA) for valuable advice. This work was supported by grants from the Hong Kong Research Grants Council (GRF-HKU774213 and GRF-HKU17100816) and The University of Hong Kong (HKU)/Committee on Research and Conference Grants (CRCG) Seed Funding for Basic Research. The authors declare no conflicts of interest.	Barker P, 2008, TLS-TIMES LIT SUPPL, P5; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; Caruso L, 2010, J MOL CELL CARDIOL, V48, P1194, DOI 10.1016/j.yjmcc.2010.01.022; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Fujihara Y, 2012, DEVELOPMENT, V139, P3583, DOI 10.1242/dev.081778; Gao Y, 2016, ONCOTARGET, V7, P64203, DOI 10.18632/oncotarget.11887; Gao YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082782, 10.1371/journal.pone.0075065]; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Huang K, 2016, SEMIN CELL DEV BIOL, V59, P54, DOI 10.1016/j.semcdb.2016.01.034; Huang KC, 2007, FEBS LETT, V581, P2702, DOI 10.1016/j.febslet.2007.05.019; Inagaki M, 2006, GENES CELLS, V11, P1125, DOI 10.1111/j.1365-2443.2006.01006.x; Isotani A, 2017, BIOL REPROD, V97, P61, DOI 10.1093/biolre/iox066; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim JM, 2000, ENDOCRINOLOGY, V141, P1846, DOI 10.1210/en.141.5.1846; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lui WY, 2003, BBA-MOL CELL RES, V1593, P121, DOI 10.1016/S0167-4889(02)00348-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mirza M, 2005, EXP CELL RES, V309, P110, DOI 10.1016/j.yexcr.2005.05.023; Mirza M, 2007, ENDOCRINOLOGY, V148, P5459, DOI 10.1210/en.2007-0359; Mounzih K, 1997, ENDOCRINOLOGY, V138, P1190, DOI 10.1210/en.138.3.1190; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rotgers E, 2015, ANDROLOGY-US, V3, P947, DOI 10.1111/andr.12066; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schnabel D, 2005, DEV DYNAM, V233, P29, DOI 10.1002/dvdy.20292; Su LL, 2012, AM J PHYSIOL-CELL PH, V303, pC843, DOI 10.1152/ajpcell.00218.2012; Tanwar PS, 2011, MOL ENDOCRINOL, V25, P1725, DOI 10.1210/me.2011-0057; Vernet N, 2006, EMBO J, V25, P5816, DOI 10.1038/sj.emboj.7601447; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang CQF, 2007, EXP CELL RES, V313, P1373, DOI 10.1016/j.yexcr.2007.01.017; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Zhu FY, 2016, J PROTEOME RES, V15, P3528, DOI 10.1021/acs.jproteome.6b00258	42	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7588	7602		10.1096/fj.201801584R	http://dx.doi.org/10.1096/fj.201801584R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30892947				2022-12-28	WOS:000476114200074
J	Ko, TY; Li, SS				Ko, Tengyu; Li, Shisheng			Genome-wide screening identifies novel genes and biological processes implicated in cisplatin resistance	FASEB JOURNAL			English	Article						CRISPR-Cas9; ZNRF3; NF2; ARIH1	CANCER; APOPTOSIS; MELANOMA; COMPLEX; YAP; PROLIFERATION; STRESS; LIGASE; CELLS	Cisplatin-based chemotherapeutic regimens are frequently used for treatments of solid tumors. However, tumor cells may have inherent or acquired cisplatin resistance, and the underlying mechanisms are largely unknown. We performed genome-wide screening of genes implicated in cisplatin resistance in A375 human melanoma cells. A substantial fraction of genes whose disruptions cause cisplatin sensitivity or resistance overlap with those whose disruptions lead to increased or decreased cell growth, respectively. Protein translation, mitochondrial respiratory chain complex assembly, signal recognition particle-dependent cotranslational protein targeting to membrane, and mRNA catabolic processes are the top biologic processes responsible for cisplatin sensitivity. In contrast, proteasome-mediated ubiquitin-dependent protein catabolic process, negative regulations of cellular catabolic process, and regulation of cellular protein localization are the top biologic processes responsible for cisplatin resistance. ZNRF3, a ubiquitin ligase known to be a target and negative feedback regulator of Wnt-beta-catenin signaling, enhances cisplatin resistance in normal and melanoma cells independently of beta-catenin. Ariadne-1 homolog (ARIH1), another ubiquitin ligase, also enhances cisplatin resistance in normal and melanoma cells. By regulating ARIH1, neurofibromin 2, a tumor suppressor, enhances cisplatin resistance in melanoma but not normal cells. Our results shed new lights on cisplatin resistance mechanisms and may be useful for development of cisplatin-related treatment strategies.-Ko, T., Li, S. Genome-wide screening identifies novel genes and biological processes implicated in cisplatin resistance.	[Ko, Tengyu; Li, Shisheng] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, 1909 Skip Bertman Dr, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, 1909 Skip Bertman Dr, Baton Rouge, LA 70803 USA.	shli@lsu.edu			U.S. National Science Foundation [MCB-1615550]	U.S. National Science Foundation(National Science Foundation (NSF))	The authors thank Rutao Cui (Boston University, Boston, MA, USA) for critical comments on the manuscript. This study was supported by the U.S. National Science Foundation (MCB-1615550). The authors declare no conflicts of interest.	Berggren WT, 2008, GEN SPINFECTION PROT; Dalal S, 2017, FASEB J, V31; Ehmer U, 2016, MOL CANCER RES, V14, P127, DOI 10.1158/1541-7786.MCR-15-0305; Ferreira JA, 2016, DRUG RESIST UPDATE, V24, P34, DOI 10.1016/j.drup.2015.11.003; Fulda S, 2014, CLIN CANCER RES, V20, P289, DOI 10.1158/1078-0432.CCR-13-0227; Galluzzi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.428; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Gupta I, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00011; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang JM, 2013, ONCOGENE, V32, P2220, DOI 10.1038/onc.2012.231; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lasfargues C, 2013, INT J MOL SCI, V14, DOI 10.3390/ijms14010177; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu BT, 2014, WIRES RNA, V5, P301, DOI 10.1002/wrna.1212; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Ma LJ, 2015, ONCOL REP, V34, P3238, DOI 10.3892/or.2015.4315; Mattia G, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0059-7; Mezencev R, 2014, CURR CANCER DRUG TAR, V14, P794, DOI 10.2174/1568009614666141128105146; Morita M, 2012, MOL CELL BIOL, V32, P3585, DOI 10.1128/MCB.00455-12; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Petrilli AM, 2016, ONCOGENE, V35, P537, DOI 10.1038/onc.2015.125; Rocha CRR, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e478s; Ren AX, 2008, CANCER RES, V68, P2266, DOI 10.1158/0008-5472.CAN-07-6248; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scott MC, 2002, J CELL SCI, V115, P2349; Song SM, 2018, MOL CANCER THER, V17, P443, DOI 10.1158/1535-7163.MCT-17-0560; Stintzing S, 2014, CLIN CANCER RES, V20, P3064, DOI 10.1158/1078-0432.CCR-13-3175; Tang CH, 2004, J BIOL CHEM, V279, P288, DOI 10.1074/jbc.M310821200; Thomas MP, 2015, CELL REP, V11, P1079, DOI 10.1016/j.celrep.2015.04.026; Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087; von Stechow L, 2015, MOL CELL BIOL, V35, P1254, DOI 10.1128/MCB.01152-14; Wang SF, 2016, ONCOTARGET, V7, P74132, DOI 10.18632/oncotarget.12356; Winter C, 2011, NAT REV ENDOCRINOL, V7, P43, DOI 10.1038/nrendo.2010.196; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091770; Yuan T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.21; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8	45	10	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7143	7154		10.1096/fj.201801534RR	http://dx.doi.org/10.1096/fj.201801534RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30844312	Bronze			2022-12-28	WOS:000476114200039
J	Lind, S; Holdfeldt, A; Martensson, J; Sundqvist, M; Bjorkman, L; Forsman, H; Dahlgren, C				Lind, Simon; Holdfeldt, Andre; Martensson, Jonas; Sundqvist, Martina; Bjorkman, Lena; Forsman, Huamei; Dahlgren, Claes			Functional selective ATP receptor signaling controlled by the free fatty acid receptor 2 through a novel allosteric modulation mechanism	FASEB JOURNAL			English	Article						GPCRs; biased signaling; neutrophil; NADPH oxidase; GPR43	FORMYL PEPTIDE RECEPTORS; RESPIRATORY BURST; HUMAN NEUTROPHILS; FFA2 ANTAGONIST; CYTOSKELETON; ACTIVATION; AGONIST; POTENT; P2Y(2)	A nonactivating allosteric modulator of free fatty acid receptor 2 (FFA2R, also called GPCR 43) turns both propionate (an orthosteric FFA2R agonist) and ATP (an agonist for the purinergic P2Y(2) receptor), into potent activating ligands that trigger an assembly of the superoxide-generating neutrophil NADPH oxidase. The ATP-induced activation requires the participation of FFA2R, and the signaling is biased toward oxidase activation, leaving the ATP-induced rise in intracellular Ca2+ unaffected. No NADPH oxidase activity was induced by ATP when propionate replaced the allosteric modulator. Signaling downstream of propionate-activated FFA2Rs was insensitive to G alpha q inhibition, but the crosstalk activation involving both FFA2R and P2Y(2)R relied on G alpha q signaling. The receptor crosstalk, by which allosterically modulated FFA2Rs communicate with P2Y(2)Rs and generate NADPH oxidase activating signals downstream of G alpha q, represent a novel mechanism by which GPCR activities can be regulated from inside the plasma membrane. Further, the finding that an allosteric FFA2R modulator sensitizes not only the response induced by orthosteric FFA2R agonists, but also the response induced by ATP (P2Y(2)R-specific agonist) and formyl peptide receptor-specific agonists, violates the receptor restriction characteristics normally defining the selectivity of allosteric GPCR modulators.-Lind, S., Holdfeldt, A., Martensson, J., Sundqvist, M., Bjorkman, L., Forsman, H., Dahlgren, C. Functional selective ATP receptor signaling controlled by the free fatty acid receptor 2 through a novel allosteric modulation mechanism.	[Lind, Simon; Holdfeldt, Andre; Martensson, Jonas; Sundqvist, Martina; Bjorkman, Lena; Forsman, Huamei; Dahlgren, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Martensson, Jonas; Bjorkman, Lena] Sahlgrens Univ Hosp, Rheumatol Unit, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Dahlgren, C (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Guldhedsgatan 10A, S-41346 Gothenburg, Sweden.	claes.dahlgren@microbio.gu.se	Sundqvist, Martina/HCI-9371-2022; Sundqvist, Martina/AAA-8412-2019	Sundqvist, Martina/0000-0002-0859-0792; Lind, Simon/0000-0001-6469-4345	Swedish Medical Research Council [005601, 02448]; King Gustaf V 80-Year Foundation [FAI 2014-0011]; Clas Groschinsky Foundation [MI562]; Wilhelm and Martina Lundgrens Scientific Foundation [2018-2324]; Serena Ehrenstroms Foundation; Torsten and Sara Janssons Scientific Foundation; Radman and Ernst Collianders Foundation; Ake Wibergs Foundation [M15-005]; Swedish government; county councils, Avtalet om Lakarutbildning och Forskning (ALF) agreement [ALFGBG 72510]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); King Gustaf V 80-Year Foundation; Clas Groschinsky Foundation; Wilhelm and Martina Lundgrens Scientific Foundation; Serena Ehrenstroms Foundation; Torsten and Sara Janssons Scientific Foundation; Radman and Ernst Collianders Foundation; Ake Wibergs Foundation; Swedish government; county councils, Avtalet om Lakarutbildning och Forskning (ALF) agreement	The authors thank the members of the Phagocyte Research Group at the Sahlgrenska Academy, University of Gothenburg for critically discussing the results and the manuscript. The experimental work performed by Linda Bergqvist (University of Gothenburg) is also gratefully acknowledged. This work was supported by the Swedish Medical Research Council (005601 to C.D.; 02448 to H.F.) the King Gustaf V 80-Year Foundation (FAI 2014-0011 to C.D.), the Clas Groschinsky Foundation (MI562 to H.F.), the Wilhelm and Martina Lundgrens Scientific Foundation (2018-2324 to M.S.), the Serena Ehrenstroms and Torsten and Sara Janssons Scientific Foundation (2018 to M.S.), the Radman and Ernst Collianders Foundation (2018 to M.S.), the Ake Wibergs Foundation (M15-005 to H.F.), and the Swedish state under the agreement between the Swedish government and the county councils, Avtalet om Lakarutbildning och Forskning (ALF) agreement (ALFGBG 72510 to C.D.). The authors declare no conflicts of interest.	Alvarez-Curto E, 2016, BIOCHEM PHARMACOL, V114, P3, DOI 10.1016/j.bcp.2016.03.017; ANDERSSON T, 1986, MOL PHARMACOL, V30, P437; Bjorkman L., 2018, J LEUKOC BIOL; Bjorkman L, 2016, MOL CELL BIOL, V36, P2583, DOI 10.1128/MCB.00161-16; Bjornsdottir H, 2016, DATA BRIEF, V6, P386, DOI 10.1016/j.dib.2015.12.003; Bjornsdottir H, 2015, FREE RADICAL BIO MED, V89, P1024, DOI 10.1016/j.freeradbiomed.2015.10.398; Bjornsdottir H, 2013, EXP CELL RES, V319, P761, DOI 10.1016/j.yexcr.2012.12.020; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Bylund J, 2010, FREE RADICAL BIO MED, V49, P1834, DOI 10.1016/j.freeradbiomed.2010.09.016; Changeux JP, 2016, CELL, V166, P1084, DOI 10.1016/j.cell.2016.08.015; Choi M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar7084; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Dagur Pradeep K, 2015, Curr Protoc Cytom, V73, DOI 10.1002/0471142956.cy0501s73; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; Due-Hansen ME, 2016, ORG BIOMOL CHEM, V14, P430, DOI 10.1039/c5ob02129d; Erlandson SC, 2018, ANNU REV BIOPHYS, V47, P1, DOI 10.1146/annurev-biophys-070317-032931; Forsman H, 2011, SCAND J IMMUNOL, V74, P227, DOI 10.1111/j.1365-3083.2011.02570.x; Forsman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060169; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gabl M, 2015, EXP CELL RES, V336, P242, DOI 10.1016/j.yexcr.2015.07.014; Gabl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109516; Gao Zhan-Guo, 2013, Drug Discov Today Technol, V10, pe237, DOI 10.1016/j.ddtec.2012.08.004; Gentry PR, 2015, J BIOL CHEM, V290, P19478, DOI 10.1074/jbc.R115.662759; Holdfeldt A, 2017, J LEUKOCYTE BIOL, V102, P871, DOI 10.1189/jlb.2A0317-086RR; Hudson BD, 2013, J BIOL CHEM, V288, P17296, DOI 10.1074/jbc.M113.455337; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Kawakami Toshiaki, 2013, Advances in Biological Regulation, V53, P249, DOI 10.1016/j.jbior.2013.08.001; Kenakin T, 2017, MOL PHARMACOL, V92, P414, DOI 10.1124/mol.117.108787; Laschet C, 2018, BIOCHEM PHARMACOL, V153, P62, DOI 10.1016/j.bcp.2018.02.016; Martensson J, 2018, J LEUKOCYTE BIOL, V104, P1117, DOI 10.1002/JLB.2A0318-130RR; Milligan G, 2017, HANDB EXP PHARMACOL, V236, P17, DOI 10.1007/164_2016_49; Milligan G, 2017, CHEM REV, V117, P67, DOI 10.1021/acs.chemrev.6b00056; Namour F, 2016, BRIT J CLIN PHARMACO, V82, P139, DOI 10.1111/bcp.12900; Onnheim K, 2014, EXP CELL RES, V323, P209, DOI 10.1016/j.yexcr.2014.01.023; Ortiz ZNV, 2018, TRENDS PHARMACOL SCI, V39, P547; Pizzonero M, 2014, J MED CHEM, V57, P10044, DOI 10.1021/jm5012885; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sergeev E, 2016, J BIOL CHEM, V291, P303, DOI 10.1074/jbc.M115.687939; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Sun MM, 2017, J GASTROENTEROL, V52, P1, DOI 10.1007/s00535-016-1242-9; Sundqvist M, 2018, BBA-MOL CELL RES, V1865, P695, DOI 10.1016/j.bbamcr.2018.02.008; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; van de Geer A, 2018, J CLIN INVEST, V128, P3957, DOI 10.1172/JCI97116; Wang WJ, 2018, TRENDS PHARMACOL SCI, V39, P367, DOI 10.1016/j.tips.2018.01.001; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Welin A, 2015, INFECT IMMUN, V83, P205, DOI 10.1128/IAI.02493-14	50	12	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6887	6903		10.1096/fj.201802309R	http://dx.doi.org/10.1096/fj.201802309R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30808243	Bronze			2022-12-28	WOS:000476114200018
J	Smiles, WJ; Churchward-Venne, TA; van Loon, LJC; Hawley, JA; Camera, DM				Smiles, William J.; Churchward-Venne, Tyler A.; van Loon, Luc J. C.; Hawley, John A.; Camera, Donny M.			A single bout of strenuous exercise overcomes lipid-induced anabolic resistance to protein ingestion in overweight, middle-aged men	FASEB JOURNAL			English	Article						skeletal muscle; protein synthesis; high-fat; nutrition; sarcopenic obesity	HUMAN SKELETAL-MUSCLE; INSULIN; MYOFIBRILLAR; COINGESTION; BREAKDOWN; BASAL	High-circulating lipid availability attenuates protein feeding-induced muscle protein synthesis (MPS). Whether the combined effects of exercise and protein ingestion can rescue this inhibition is unknown. In a parallel-groups design, middle-aged sedentary males (n = 28) matched for fat-free mass and body mass index received a 5-h intravenous infusion of either saline/control (n = 9), 20% intralipid infusion (n = 9), or intralipid with concomitant exercise (n = 10). Two hours into each of these infusions, participants received a primed constant infusion of L-(ring-[C-13](6))-phenylalanine. Muscle biopsies were taken immediately after control and lipid infusions, at which time, a 30-g protein beverage was ingested. Further biopsies were taken 2 and 4 h after protein ingestion. Intralipid increased plasma free fatty acid concentrations from similar to 0.4-2 mM, resulting in an attenuated MPS response to protein ingestion, which was prevented by exercise. Intralipid resulted in a lower peak aminoacidemia following protein ingestion that was exacerbated by prior exercise, suggesting efficiency of the working skeletal muscle to utilize amino acid substrate to drive the postprandial anabolic response. We conclude that in the face of high-fat availability, exercise preserves the sensitivity of skeletal muscle to the anabolic properties of amino acids.-Smiles, W. J., Churchward-Venne, T. A., van Loon, L. J. C., Hawley, J. A., Camera, D. M. A single bout of strenuous exercise overcomes lipid-induced anabolic resistance to protein ingestion in overweight, middle-aged men.	[Smiles, William J.; van Loon, Luc J. C.; Hawley, John A.; Camera, Donny M.] Australian Catholic Univ, MMIHR, Melbourne, Vic, Australia; [Churchward-Venne, Tyler A.; van Loon, Luc J. C.] Maastricht Univ, Sch Nutr & Translat Res Metab, Med Ctr, Maastricht, Netherlands	Australian Catholic University; Maastricht University	Hawley, JA (corresponding author), Australian Catholic Univ, Exercise & Nutr Res Program, MMIHR, Level 5,215 Spring St, Melbourne, Vic 3000, Australia.	john.hawley@acu.edu.au	van Loon, Luc J C/G-5920-2010; van Loon, Luc J.C./ABG-9158-2020; Hawley, John A/U-3814-2018	van Loon, Luc J C/0000-0002-6768-9231; van Loon, Luc J.C./0000-0002-6768-9231; Hawley, John A/0000-0002-0886-9881; Smiles, William/0000-0002-6846-689X; Churchward-Venne, Tyler/0000-0001-6006-5461	Australian Catholic University [2013000443]; Novo Nordisk Foundation [NNF14OC0011493]	Australian Catholic University; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The authors thank Dr. Andrew Garnham (Australian Catholic University) for technical assistance during experimental trials and Joy Goessens and Janneau van Kranenburg (Maastricht University) for technical expertise with analysis of skeletal muscle and plasma samples. The authors also thank Dr. Evelyn Parr and Dr. Brooke Devlin [Mary MacKillop Institute for Health Research (MMIHR)] for assistance in dual-energy X-ray absorptiometry analysis and diet preparation throughout the study. This study was funded by Australian Catholic University Collaborative Research Network Grant 2013000443 (to J.A.H.). This research was also supported by funding from Novo Nordisk Foundation Challenge (Grant NNF14OC0011493 to J.A.H.). The funding source had no involvement in research conduct, article preparation, study design, data collection, analysis, or interpretation or in the decision to submit for publication. Parts of this study were presented as a poster (P1.109) at the Cell Metabolism: Exercise Metabolism Conference, May 21-23, 2017, (Gothenburg, Sweden). The authors declare no conflicts of interest.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Beals JW, 2016, AM J CLIN NUTR, V104, P1014, DOI 10.3945/ajcn.116.130385; Bogorad AM, 2017, NUCLEIC ACIDS RES, V45, P11962, DOI 10.1093/nar/gkx845; Burd NA, 2012, METABOLISM, V61, P931, DOI 10.1016/j.metabol.2011.11.004; Burd NA, 2011, J NUTR, V141, P568, DOI 10.3945/jn.110.135038; Camera DM, 2017, FASEB J, V31, P5478, DOI 10.1096/fj.201700531R; Camera DM, 2015, MED SCI SPORT EXER, V47, P82, DOI 10.1249/MSS.0000000000000390; Distefano G, 2018, COLD SPRING HARB PER, V8, P1; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Gorissen SHM, 2014, J CLIN ENDOCR METAB, V99, P2250, DOI 10.1210/jc.2013-3970; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; Guillet C, 2009, J CLIN ENDOCR METAB, V94, P3044, DOI 10.1210/jc.2008-2216; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Katsanos CS, 2009, J CLIN ENDOCR METAB, V94, P2984, DOI 10.1210/jc.2008-2686; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Murton AJ, 2015, DIABETES, V64, P3160, DOI 10.2337/db15-0021; Parr EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088384; Parr EB, 2013, MATURITAS, V74, P109, DOI 10.1016/j.maturitas.2012.10.014; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Smiles WJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE836, DOI 10.1152/ajpendo.00303.2016; Stephens FB, 2015, DIABETES, V64, P1615, DOI 10.2337/db14-0961; Tardif N, 2014, AGING CELL, V13, P1001, DOI 10.1111/acel.12263; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wilkinson DJ, 2013, J PHYSIOL-LONDON, V591, P2911, DOI 10.1113/jphysiol.2013.253203; Wolfe RR, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0184-9	30	7	7	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7009	7017		10.1096/fj.201801917R	http://dx.doi.org/10.1096/fj.201801917R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30840513				2022-12-28	WOS:000476114200028
J	Zhou, L; Liu, Q; Hong, GJ; Song, FM; Zhao, JM; Yuan, JB; Xu, J; Tan, RX; Tickner, J; Gu, Q; Xu, JK				Zhou, Lin; Liu, Qian; Hong, Guoju; Song, Fangming; Zhao, Jinmin; Yuan, Jinbo; Xu, Jun; Tan, Ren Xiang; Tickner, Jennifer; Gu, Qiong; Xu, Jiake			Cumambrin A prevents OVX-induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways	FASEB JOURNAL			English	Article						NF-kappa B; NFATc1; ERK; osteolysis	NF-KAPPA-B; SESQUITERPENE LACTONES; DIFFERENTIATION; EXPRESSION; NFATC1; SUPPRESSION; ACTIVATION; REGULATOR; MEDICINE; SURVIVAL	Being the principal cells responsible for bone resorption and pathologic bone loss, osteoclasts have become the main target for antiresorptive treatment. Cumambrin A is a natural compound isolated from Chrysanthemum indicum L. and belongs to a member of the sesquiterpene lactone family. To date, the therapeutic effect of cumambrin A on osteoporosis and its mechanisms of action are not known. In this study, we found that cumambrin A can significantly inhibit osteoclast formation and bone resorption through the suppression of receptor activator of NF-kappa B ligand (RANKL)-induced NF-kappa B and nuclear factor of activated T-cell activity and ERK phosphorylation. Furthermore, cumambrin A inhibits the expression of osteoclast marker genes including cathepsin K, calcitonin receptor, and V-ATPase d2. Using an in vivo ovariectomized mouse model, we showed that cumambrin A protects against estrogen withdrawal-induced bone loss. Collectively, our results reveal that cumambrin A can suppress osteoclast formation, bone resorption, and RANKL-induced signaling pathways, suggesting that cumambrin A is a potential therapeutic agent for the treatment of osteoporosis.-Zhou, L., Liu, Q., Hong, G., Song, F., Zhao, J., Yuan, J., Xu, J., Tan, R. X., Tickner, J., Gu, Q., Xu, J. Cumambrin A prevents OVX-induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways.	[Zhou, Lin; Liu, Qian; Hong, Guoju; Song, Fangming; Yuan, Jinbo; Tickner, Jennifer; Xu, Jiake] Univ Western Australia, Sch Biomed Sci, M504, Perth, WA 6009, Australia; [Zhou, Lin] Guangzhou Med Univ, Affiliated Hosp 5, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Liu, Qian; Song, Fangming; Zhao, Jinmin] Guangxi Med Univ, Res Ctr Regenerat Med, Nanning, Peoples R China; [Liu, Qian; Song, Fangming; Zhao, Jinmin] Guangxi Med Univ, Guangxi Key Lab Regenerat Med, Nanning, Peoples R China; [Hong, Guoju] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Orthoped Dept, Guangzhou, Guangdong, Peoples R China; [Xu, Jun] Sun Yat Sen Univ, Res Ctr Drug Discovery, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Tan, Ren Xiang; Gu, Qiong] Nanjing Univ, Inst Funct Biomol, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	University of Western Australia; Guangzhou Medical University; Guangxi Medical University; Guangxi Medical University; Guangzhou University of Chinese Medicine; Sun Yat Sen University; Nanjing University	Xu, JK (corresponding author), Univ Western Australia, Sch Biomed Sci, M504, Perth, WA 6009, Australia.; Gu, Q (corresponding author), Sun Yat Sen Univ, Res Ctr Drug Discovery, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.	guqiong@sysu.edu.cn; jiake.xu@uwa.edu.au	Hong, Guoju/AFP-4180-2022; Hong, Guoju/AAV-9433-2020; Tickner, Jennifer/H-5965-2014	Zhao, Jinmin/0000-0001-8423-0425; Tickner, Jennifer/0000-0002-5020-0671; Yuan, Jinbo/0000-0002-6240-9333; Gu, Qiong/0000-0001-6011-3697; Zhao, Jinmin/0000-0002-1047-8820; Xu, Jiake/0000-0003-2021-8309	Australian Health and Medical Research Council (NHMRC) [APP1107828, APP1127396, APP1127156]; Arthritis Foundation of Australia; Western Australia Medical and Health Research Infrastructure Fund; Young Innovative Talents Project of Guangdong Province [2017KQNCX167]; Nature Science Foundation of Guangxi [2015GXNSFDA139019]; National Natural Science Foundation of China [81573310]; China Scholarship Council; University of Western Australia Research Collaboration Awards	Australian Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Foundation of Australia; Western Australia Medical and Health Research Infrastructure Fund; Young Innovative Talents Project of Guangdong Province; Nature Science Foundation of Guangxi; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); University of Western Australia Research Collaboration Awards	The authors acknowledge the support from Australian Health and Medical Research Council (NHMRC; APP1107828, APP1127396, APP1127156), Arthritis Foundation of Australia (The H.J. and G.J. Mckenzie Grant), Western Australia Medical and Health Research Infrastructure Fund, University of Western Australia Research Collaboration Awards, and Young Innovative Talents Project of Guangdong Province (2017KQNCX167). This study was also funded, in part, by the Nature Science Foundation of Guangxi (2015GXNSFDA139019) and the National Natural Science Foundation of China (81573310). L.Z. is a recipient of a scholarship from the China Scholarship Council. G.H., Q.L., and F.S. are visiting scholars to the University of Western Australia. The authors declare no conflicts of interest.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Deng SQ, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.7636; Dixit V, 2002, CELL, V111, P615, DOI 10.1016/S0092-8674(02)01166-2; Feng HT, 2009, J BIOL CHEM, V284, P14667, DOI 10.1074/jbc.M901670200; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193; Jiang M, 2011, PLANTA MED, V77, P873, DOI 10.1055/s-0030-1270983; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Leibbrandt A., 2011, ENCY CANC, P3165; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; LEWELLEN TK, 1977, J NUCL MED, V18, P929; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Mazor RL, 2000, CYTOKINE, V12, P239, DOI 10.1006/cyto.1999.0526; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Nakamura H, 2003, J BONE MINER RES, V18, P1198, DOI 10.1359/jbmr.2003.18.7.1198; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Schmidt TJ, 1999, CURR ORG CHEM, V3, P577; Soysa Niroshani Surangika, 2012, J Med Dent Sci, V59, P65; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Takayanagi Hiroshi, 2009, Rinsho Ketsueki, V50, P447; Tarasov V. A., 1974, CHEM NAT COMPD, V10, P826; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tomoyasu A, 1998, BIOCHEM BIOPH RES CO, V245, P382, DOI 10.1006/bbrc.1998.8443; van der Kraan AGJ, 2013, BIOCHEM J, V451, P235, DOI 10.1042/BJ20121626; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Wang T, 2017, CURR DRUG TARGETS, V18, P1051, DOI 10.2174/1389450118666170321105425; Wang T, 2015, INT J MOL SCI, V16, P27470, DOI 10.3390/ijms161126039; Xu JK, 2009, CYTOKINE GROWTH F R, V20, P7, DOI 10.1016/j.cytogfr.2008.11.007; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yip KHM, 2004, J BONE MINER RES, V19, P1905, DOI 10.1359/JBMR.040919; Zhu LL, 2005, BIOCHEM BIOPH RES CO, V326, P131, DOI 10.1016/j.bbrc.2004.10.212; Zhu SP, 2018, BIOL REV, V93, P469, DOI 10.1111/brv.12353; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	46	10	10	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6726	6735		10.1096/fj.201800883RRR	http://dx.doi.org/10.1096/fj.201800883RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30807230	Bronze			2022-12-28	WOS:000476114200005
J	Barbosa, TD; Alm, PS; Krook, A; Barres, R; Zierath, JR				Barbosa, Thais de Castro; Alm, Petter S.; Krook, Anna; Barres, Romain; Zierath, Juleen R.			Paternal high-fat diet transgenerationally impacts hepatic immunometabolism	FASEB JOURNAL			English	Article						metabolism; epigenetics; cytokines; liver	NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; GENE-EXPRESSION; PARENTAL BMI; TNF-ALPHA; OBESITY; LIVER; MICE	Paternal preconceptional high-fat diet (HFD) alters whole-body glucose and energy homeostasis over several generations, which may be mediated by altered transcriptomic profiles of metabolic organs. We investigated the effect of paternal HFD on the hepatic transcriptomic and metabolic signatures of female grand-offspring. Paternal HFD strongly impacted the liver transcriptome of the second-generation offspring. Gene set enrichment analysis (GSEA) revealed grandpaternal-HFD altered the TNF- signaling via NFB pathway, independent of the grand-offspring's diet. Reduction in the hepatic cytokine levels, including the TNF-, as well as NFB content and activity, suggest that the basal inflammatory response in F2 rats is disturbed. GSEA also show altered expression of various genes annotated to the fatty acid metabolism. Grandpaternal-HFD reduced G(0)/G(1) switch gene 2 (G0S2) expression, concomitant with reduced hepatic triglyceride content in F2 rats. In conclusion, the hepatic transcriptome is altered in grand-offspring from HFD-fed grandfathers. Altered TNF-/NFB signaling and levels of inflammatory cytokines indicate grandpaternal HFD impacts hepatic immunometabolism. Overall, our findings indicate that paternal exposure to environmental factors transgenerationally reprograms metabolism in a tissue-specific manner, affecting the development and health of future generations.De Castro Barbosa, T., Alm, P. S., Krook, A., Barres, R., Zierath, J. R. Paternal high-fat diet transgenerationally impacts hepatic immunometabolism.	[Barbosa, Thais de Castro; Alm, Petter S.; Krook, Anna; Zierath, Juleen R.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Krook, Anna; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Barres, Romain; Zierath, Juleen R.] Univ Copenhagen, Novo Nord Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res, Copenhagen, Denmark	Karolinska Institutet; Karolinska Institutet; University of Copenhagen	Zierath, JR (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Sect Integrat Physiol, Solnavagen 9, S-17765 Stockholm, Sweden.	juleen.zierath@ki.se	BARRES, Romain/N-2501-2016	BARRES, Romain/0000-0002-0158-519X; Zierath, Juleen/0000-0001-6891-7497	Novo Nordisk Foundation [NNF14OC0011493, NNF14OC0009941, NNF18CC0034900]; Swedish Research Council [2011-3550, 2015-00165]; Diabetes Wellness Sweden [783_2015PG]; Swedish Diabetes Foundation [DIA2012-082, DIA2015-052]; Swedish Foundation for Strategic Research [SRL10-0027]; Torsten Soderbergs Stiftelse [M69/17]; Fredrik and Ingrid Thurings Foundation; Strategic Research Program in Diabetes at Karolinska Institutet [2009-1068]; Erik and Edith Fernstroms; Karolinska Institutet Fonder	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Research Council(Swedish Research CouncilEuropean Commission); Diabetes Wellness Sweden; Swedish Diabetes Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten Soderbergs Stiftelse; Fredrik and Ingrid Thurings Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; Erik and Edith Fernstroms; Karolinska Institutet Fonder(Karolinska Institutet)	This work was funded by the Novo Nordisk Foundation (NNF14OC0011493; NNF14OC0009941), Swedish Research Council (2011-3550; 2015-00165), Diabetes Wellness Sweden (783_2015PG), Swedish Diabetes Foundation (DIA2012-082; DIA2015-052), Swedish Foundation for Strategic Research (SRL10-0027), Torsten Soderbergs Stiftelse (M69/17), Fredrik and Ingrid Thurings Foundation, Erik and Edith Fernstroms, Karolinska Institutet Fonder, and the Strategic Research Program in Diabetes at Karolinska Institutet (2009-1068). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (NNF18CC0034900). The transcriptome data set is publically available at Gene Ontology Omnibus GSE107066. The remaining data are available upon request from the corresponding author. The authors declare no conflicts of interest.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Alm PS, 2017, MOL METAB, V6, P621, DOI 10.1016/j.molmet.2017.05.009; Anderson ER, 2013, COMPR PHYSIOL, V3, P315, DOI 10.1002/cphy.c120016; Sanchez-Garrido MA, 2018, ENDOCRINOLOGY, V159, P1005, DOI 10.1210/en.2017-00705; Barbosa TD, 2016, MOL METAB, V5, P184, DOI 10.1016/j.molmet.2015.12.002; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Borghi A, 2016, BIOCHEM PHARMACOL, V116, P1, DOI 10.1016/j.bcp.2016.03.009; Bundred P, 2001, BMJ-BRIT MED J, V322, P326, DOI 10.1136/bmj.322.7282.326; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cho H, 2008, AM J PHYSIOL-ENDOC M, V295, pE1142, DOI 10.1152/ajpendo.90298.2008; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; Dias C, 2014, NATURE, V516, P51, DOI 10.1038/nature13976; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Golden-Mason L, 2004, CLIN EXP IMMUNOL, V138, P94, DOI 10.1111/j.1365-2249.2004.02586.x; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Heckmann BL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88735; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jager J, 2016, J INTERN MED, V280, P209, DOI 10.1111/joim.12483; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kelly AM, 2006, CYTOKINE, V35, P171, DOI 10.1016/j.cyto.2006.07.019; Kirchner H, 2016, MOL METAB, V5, P171, DOI 10.1016/j.molmet.2015.12.004; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murashov AK, 2016, FASEB J, V30, P775, DOI 10.1096/fj.15-274274; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensson V, 2011, INT J OBESITY, V35, P46, DOI 10.1038/ijo.2010.189; Terashima M, 2015, EPIGENETICS-US, V10, P861, DOI 10.1080/15592294.2015.1075691; Tyrrell JS, 2013, INT J EPIDEMIOL, V42, P1714, DOI 10.1093/ije/dyt220; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang YP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057085, 10.1371/journal.pone.0065634]; Wu Q, 2006, OBES REV, V7, P201, DOI 10.1111/j.1467-789X.2006.00232.x; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003	52	10	10	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6269	6280		10.1096/fj.201801879RR	http://dx.doi.org/10.1096/fj.201801879RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768368	Bronze			2022-12-28	WOS:000466932600037
J	Mun, D; Kim, H; Kang, JY; Park, H; Park, H; Lee, SH; Yun, N; Joung, B				Mun, Dasom; Kim, Hyoeun; Kang, Ji-Young; Park, Hyelim; Park, Hyewon; Lee, Seung-Hyun; Yun, Nuri; Joung, Boyoung			Expression of miRNAs in circulating exosomes derived from patients with persistent atrial fibrillation	FASEB JOURNAL			English	Article						microRNA; biomarkers; pathway	MICRORNAS; HEART; BIOMARKERS; PROTEINS; VESICLES; CONTRIBUTES; SIGNATURES; ROLES	Atrial fibrillation (AF), the most common type of cardiac arrhythmia, is thought to be regulated by changes in microRNA (miRNA) expression. However, the evidence for this is inconsistent. The high stability and expression of circulating exosomal miRNAs may allow their use as candidate biomarkers. For the discovery phase, exosomes were isolated from the serum of patients with supraventricular tachycardia (SVT) as the controls (n = 5) and with paroxysmal AF (n = 4) and persistent AF (n = 5) for microarray analysis of miRNAs. Forty-five miRNAs were expressed significantly higher (>1.5-fold) in patients with persistent AF, but not in patients with paroxysmal AF, relative to the levels in patients with SVT control. Notably, expression of 5 miRNAs (miRNA-103a, -107, -320d, -486, and let-7b) was elevated by more than 4.5-fold in patients with persistent AF. For the validation phase, miRNAs were analyzed using quantitative RT-PCR analysis in exosomes from the serum of patients with SVT control (n = 20) and patients with persistent AF (n = 40). These miRNAs and their target genes were involved in atrial function and structure, oxidative stress, and fibrosis pathways. These findings suggest that serum exosomal miRNAs might be used as novel biomarkers to reflect the progression of AF.Mun, D., Kim, H., Kang, J.-Y., Park, H., Park, H., Lee, S.-H., Yun, N., Joung, B. Expression of miRNAs in circulating exosomes derived from patients with persistent atrial fibrillation.	[Mun, Dasom; Kim, Hyoeun; Kang, Ji-Young; Park, Hyelim; Park, Hyewon; Joung, Boyoung] Yonsei Univ, Coll Med, Div Cardiol, Seoul, South Korea; [Lee, Seung-Hyun] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Yun, Nuri] Yonsei Univ, Inst Life Sci & Biotechnol, 50 Yonsei Ro, Seoul SEOUL, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Yun, N (corresponding author), Yonsei Univ, Inst Life Sci & Biotechnol, 50 Yonsei Ro, Seoul SEOUL, South Korea.; Joung, B (corresponding author), Univ Coll Med, 250 Seungsanno, Seoul 120752, South Korea.	yunnuri@hanmail.net; cby6908@yuhs.ac		Yun, Nuri/0000-0003-1853-1304; Joung, Boyoung/0000-0001-9036-7225; Lee, Seung-Hyun/0000-0001-7549-9430	Brain Korea21 PLUS Project for Medical Science by the Yonsei University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2017R1A2B3003303]; Korean Healthcare Technology Research and Development Project - Ministry of Health and Welfare [HI16C0058]	Brain Korea21 PLUS Project for Medical Science by the Yonsei University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Korean Healthcare Technology Research and Development Project - Ministry of Health and Welfare	This study was supported by research grants from the Brain Korea21 PLUS Project for Medical Science by the Yonsei University, the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2017R1A2B3003303), and the Korean Healthcare Technology Research and Development Project funded by the Ministry of Health and Welfare (HI16C0058). The authors declare no conflicts of interest.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Cvjetkovic A, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23111; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Ebrahimkhani S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14301-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goren Y, 2014, AM J CARDIOL, V113, P976, DOI 10.1016/j.amjcard.2013.11.060; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Ham O, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0134-x; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hucker WJ, 2017, J AM COLL CARDIOL, V69, P2088, DOI 10.1016/j.jacc.2017.02.043; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Karagkouni D, 2018, NUCLEIC ACIDS RES, V46, pD239, DOI 10.1093/nar/gkx1141; Kim H, 2018, BIOCHEM BIOPH RES CO, V499, P803, DOI 10.1016/j.bbrc.2018.03.227; Koga Y, 2011, J GASTROINTEST ONCOL, V2, P215, DOI 10.3978/j.issn.2078-6891.2011.015; Kojima R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03733-8; Kuosmanen SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119646; Ling TY, 2013, HEART RHYTHM, V10, P1001, DOI 10.1016/j.hrthm.2013.03.005; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044906; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo XB, 2015, NAT REV CARDIOL, V12, P80, DOI 10.1038/nrcardio.2014.178; McManus DD, 2014, HEART RHYTHM, V11, P663, DOI 10.1016/j.hrthm.2014.01.018; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Natsume Y, 2018, CIRC J, V82, P965, DOI 10.1253/circj.CJ-17-1194; Sanz-Rubio D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28748-5; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Shin M, 2018, NAT BIOMED ENG, V2, P304, DOI 10.1038/s41551-018-0227-9; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Statello L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195969; Sun YH, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0549-7; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van den Berg NWE, 2017, CARDIOVASC DRUG THER, V31, P345, DOI 10.1007/s10557-017-6736-z; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350; Xu GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166235; Yim N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12277	52	29	31	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5979	5989		10.1096/fj.201801758R	http://dx.doi.org/10.1096/fj.201801758R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753098	Bronze			2022-12-28	WOS:000466932600015
J	Tan, YQ; Kwan, HY; Yao, XQ; Leung, LK				Tan, Yan Qin; Kwan, Hiu Yee; Yao, Xiaoqiang; Leung, Lai K.			The activity of transient receptor potential channel C-6 modulates the differentiation of fat cells	FASEB JOURNAL			English	Article						TRPC; adipogenesis; calcium signaling; quercetin	TRPC6 CHANNELS; ADIPOCYTE DIFFERENTIATION; CALCIUM; ADIPOGENESIS; INHIBITION; QUERCETIN; ANTAGONIST; ACTIVATION; OVERWEIGHT; EXERCISE	Previously, the V1-3 isoforms of the transient receptor potential channel (TRP) have been shown to promote or prevent adipocyte differentiation. In the current study, the C isoforms were screened for blocking adipogenesis. The hypothesis that the TRP classic or canonical (TRPC) deters adipocyte differentiation was investigated in 3T3-L1 cells employing the channel-specific activator and antagonist, silencing, and overexpression techniques. Fat accumulation in cells was visualized by Oil Red O staining. Intracellular calcium inflow was estimated by confocal microscopy. A high-fat (HF) feeding study was also performed on C57BL/6J mice to verify the findings in the cell model. Among the 6 C isoforms tested, only TRPC-6 inhibited the differentiation of fat cells. The phytochemical quercetin induced the channel protein expression. Calcium-imaging results also revealed that the flavonoid could trigger calcium inflow. Coadministration of quercetin (1 or 20 mg/kg body weight) in an HF diet prevented TRPC-6 from declining and attenuated phosphorylated (p)-PKB and PI3k, as well as the proliferation of visceral fat cells. The present study illustrated that TRPC-6 activation could perturb adipocyte differentiation. The food flavonoid quercetin was a TRPC-6 inducer and activator and it could prevent adipogenesis in mice.Tan, Y. Q., Kwan, H. Y., Yao, X., Leung, L. K. The activity of transient receptor potential channel C-6 modulates the differentiation of fat cells.	[Tan, Yan Qin; Leung, Lai K.] Chinese Univ Hong Kong, Sch Life Sci, Fac Sci, Hong Kong, Peoples R China; [Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Peoples R China; [Kwan, Hiu Yee] Baptist Univ, Sch Chinese Med, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Hong Kong Baptist University	Leung, LK (corresponding author), Chinese Univ Hong Kong, Food & Nutr Sci Programme, Room 507C MMW Bldg, Hong Kong, Peoples R China.	laikleung@cuhk.edu.hk	Tan, Yan Qin/AAF-4352-2021; Yao, Xiaoqiang/I-5413-2016; Leung, Lai K/E-6314-2011	Yao, Xiaoqiang/0000-0002-0687-8186; Leung, Lai K/0000-0002-7781-3099; KWAN, Hiu Yee/0000-0002-6088-7323; Tan, Yan Qin/0000-0001-7769-2023	Chinese University of Hong Kong [4053256]	Chinese University of Hong Kong(Chinese University of Hong Kong)	The authors are grateful to Prof. Howard Glauert (University of Kentucky, Lexington, KY, USA) for his help in proofreading this manuscript. This study was supported by Chinese University of Hong Kong Direct Grant 4053256. L.K.L. and Y.Q.T. are affiliated with the Food and Nutritional Sciences Programme of The Chinese University of Hong Kong. The authors declare no conflicts of interest.	Allison DB, 2003, EUR J CLIN NUTR, V57, P514, DOI 10.1038/sj.ejcn.1601587; Amiot MJ, 2016, OBES REV, V17, P573, DOI 10.1111/obr.12409; Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Benemei S, 2015, CURR OPIN PHARMACOL, V22, P18, DOI 10.1016/j.coph.2015.02.006; Bishnoi M, 2018, OBES REV, V19, P1269, DOI 10.1111/obr.12703; Bishnoi M, 2013, EXPERT REV ENDOCRINO, V8, P173, DOI [10.1586/eem.13.3, 10.1586/eem.13.4]; Bishnoi M, 2013, PHARMACOL REP, V65, P751, DOI 10.1016/S1734-1140(13)71055-7; Che H, 2014, PFLUG ARCH EUR J PHY, V466, P947, DOI 10.1007/s00424-013-1355-4; Cheung SY, 2015, ENDOCRINOLOGY, V156, P2074, DOI 10.1210/en.2014-1831; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Davison K, 2008, INT J OBESITY, V32, P1289, DOI 10.1038/ijo.2008.66; Dietrich A. G. T., 2014, HDB EXPT PHARM, V222; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Doleschal B, 2015, CARDIOVASC RES, V106, P163, DOI 10.1093/cvr/cvv022; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Funakoshi T., 2017, BIOCH BIOPHYS REP, V13, P39; Goudarzi F, 2018, MOL BIOTECHNOL, V60, P279, DOI 10.1007/s12033-018-0071-x; He YH, 2012, MOL CELL BIOCHEM, V361, P321, DOI 10.1007/s11010-011-1118-5; Ilatovskaya DV, 2015, AM J PHYSIOL-RENAL, V309, pF393, DOI 10.1152/ajprenal.00186.2015; Jensen B, 2004, EXP CELL RES, V301, P280, DOI 10.1016/j.yexcr.2004.08.030; Khalilpourfarshbafi M, 2019, EUR J NUTR, V58, P5, DOI 10.1007/s00394-018-1663-8; Kim MA, 2014, LIFE SCI, V101, P64, DOI 10.1016/j.lfs.2014.02.012; Lee SG, 2017, J NUTR BIOCHEM, V42, P62, DOI 10.1016/j.jnutbio.2016.12.018; Maier T, 2015, BRIT J PHARMACOL, V172, P3650, DOI 10.1111/bph.13151; Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293; Malczyk M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00707; Miller M. R., 2010, PROBE REPORTS NIH MO; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124; Nabavi SF, 2015, FOOD CHEM, V179, P305, DOI 10.1016/j.foodchem.2015.02.006; Nagao T, 2005, AM J CLIN NUTR, V81, P122; Neal JW, 2002, J BIOL CHEM, V277, P49776, DOI 10.1074/jbc.M207913200; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Ntambi JM, 1996, DIFFERENTIATION, V60, P151, DOI 10.1007/s002580050145; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Qiu J, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12501; Ramirez GA, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7070070; Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005; Seo M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030518; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Shi H, 2000, PHYSIOL GENOMICS, V3, P75, DOI 10.1152/physiolgenomics.2000.3.2.75; Shi J, 2007, BRIT J PHARMACOL, V152, P122, DOI 10.1038/sj.bjp.0707368; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Thiel G, 2018, INT REV CEL MOL BIO, V335, P167, DOI 10.1016/bs.ircmb.2017.07.010; Urban N, 2017, BRIT J PHARMACOL, V174, P4099, DOI 10.1111/bph.13977; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Weber EW, 2015, J EXP MED, V212, P1883, DOI 10.1084/jem.20150353; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zhou Y, 2017, SCIENCE, V358, P1332, DOI 10.1126/science.aal4178; Ziegenfuss TN, 2006, J INT SOC SPORT NUTR, V3, DOI 10.1186/1550-2783-3-2-45	53	5	5	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6526	6538		10.1096/fj.201801518RR	http://dx.doi.org/10.1096/fj.201801518RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30785766	Bronze			2022-12-28	WOS:000466932600056
J	Capri, M; Morsiani, C; Santoro, A; Moriggi, M; Conte, M; Martucci, M; Bellavista, E; Fabbri, C; Giampieri, E; Albracht, K; Fluck, M; Ruoss, S; Brocca, L; Canepari, M; Longa, E; Di Giulio, I; Bottinelli, R; Cerretelli, P; Salvioli, S; Gelfi, C; Franceschi, C; Narici, M; Rittweger, J				Capri, Miriam; Morsiani, Cristina; Santoro, Aurelia; Moriggi, Manuela; Conte, Maria; Martucci, Morena; Bellavista, Elena; Fabbri, Cristina; Giampieri, Enrico; Albracht, Kirsten; Fluck, Martin; Ruoss, Severin; Brocca, Lorenza; Canepari, Monica; Longa, Emanuela; Di Giulio, Irene; Bottinelli, Roberto; Cerretelli, Paolo; Salvioli, Stefano; Gelfi, Cecilia; Franceschi, Claudio; Narici, Marco; Rittweger, Joern			Recovery from 6-month spaceflight at the International Space Station: muscle-related stress into a proinflammatory setting	FASEB JOURNAL			English	Article						microRNA-206; inflamma-miRs; proteasome; SERPINA1	CIRCULATING MICRORNAS; SKELETAL-MUSCLE; INFLAMMATION; SENESCENCE; EXPRESSION; LONGEVITY; RELEVANCE; EXERCISE; TISSUES; MIR-21	The Sarcolab pilot study of 2 crewmembers, investigated before and after a 6-mo International Space Station mission, has demonstrated the substantial muscle wasting and weakness, along with disruption of muscle's oxidative metabolism. The present work aimed at evaluating the pro/anti-inflammatory status in the same 2 crewmembers (A, B). Blood circulating (c-)microRNAs (miRs), c-proteasome, c-mitochondrial DNA, and cytokines were assessed by real-time quantitative PCR or ELISA tests. Time series analysis was performed (i.e., before flight and after landing) at 1 and 15 d of recovery (R+1 and R+15, respectively). C-biomarkers were compared with an age-matched control population and with 2-dimensional proteomic analysis of the 2 crewmembers' muscle biopsies. Striking differences were observed between the 2 crewmembers at R+1, in terms of inflamma-miRs (c-miRs-21-5p, -126-3p, and -146a-5p), muscle specific (myo)-miR-206, c-proteasome, and IL-6/leptin, thus making the 2 astronauts dissimilar to each other. Final recovery levels of c-proteasome, c-inflamma-miRs, and c-myo-miR-206 were not reverted to the baseline values in crewmember A. In both crewmembers, myo-miR-206 changed significantly after recovery. Muscle biopsy of astronaut A showed an impressive 80% increase of alpha-1-antitrypsin, a target of miR-126-3p. These results point to a strong stress response induced by spaceflight involving muscle tissue and the proinflammatory setting, where inflamma-miRs and myo-miR-206 mediate the systemic recovery phase after landing.	[Capri, Miriam; Morsiani, Cristina; Santoro, Aurelia; Conte, Maria; Martucci, Morena; Bellavista, Elena; Fabbri, Cristina; Salvioli, Stefano] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Capri, Miriam; Morsiani, Cristina; Santoro, Aurelia; Conte, Maria; Martucci, Morena; Fabbri, Cristina; Giampieri, Enrico; Salvioli, Stefano] Univ Bologna, Galvani Interdept Ctr, Bologna, Italy; [Giampieri, Enrico] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Moriggi, Manuela; Cerretelli, Paolo] CNR, Natl Res Council, Inst Mol Bioimaging & Physiol, IBFM, Milan, Italy; [Moriggi, Manuela; Cerretelli, Paolo] Italian Natl Olymp Comm CONI, Rome, Italy; [Albracht, Kirsten] FH Aachen Univ Appl Sci, Fac Med Engn & Technomath, Aachen, Germany; [Albracht, Kirsten] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany; [Fluck, Martin; Ruoss, Severin] Univ Zurich, Dept Orthopaed, Zurich, Switzerland; [Brocca, Lorenza; Canepari, Monica; Bottinelli, Roberto] Univ Pavia, Dept Mol Med, Pavia, Italy; [Longa, Emanuela] Univ Pavia, Sport Med Ctr, Pavia, Italy; [Di Giulio, Irene] Kings Coll London, Ctr Human & Appl Physiol Sci, London, England; [Bottinelli, Roberto] Sci Inst Pavia, Inst Hospitalizat & Sci Care IRCCS, Fdn Salvatore Maugeri, Pavia, Italy; [Gelfi, Cecilia] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Gelfi, Cecilia] IRCCS, Ist Ortoped Galeazzi, Milan, Italy; [Franceschi, Claudio] Lobachevsky State Univ Nizhny Novgorod, Natl Res Univ UNN, Dept Appl Math, Inst Informat Technol Math & Mech ITMM, Nizhny Novogoro, Russia; [Narici, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Rittweger, Joern] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Rittweger, Joern] Univ Cologne, Dept Pediat & Adolescent Med, Cologne, Germany	University of Bologna; University of Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); German Sport University Cologne; University of Zurich; University of Pavia; University of Pavia; University of London; King's College London; Istituti Clinici Scientifici Maugeri IRCCS; University of Milan; IRCCS Istituto Ortopedico Galeazzi; Lobachevsky State University of Nizhni Novgorod; University of Padua; Helmholtz Association; German Aerospace Centre (DLR); University of Cologne	Morsiani, C (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Alma Mater Studiorum, Via San Giacomo 12, I-40126 Bologna, Italy.	cristina.morsiani2@unibo.it	Rittweger, Jörn/A-4308-2009; Bottinelli, Roberto/AAC-1904-2020; MORIGGI, MANUELA/AAB-5477-2021; Ruoss, Severin/AAH-6121-2021; Giampieri, Enrico/AAC-7354-2022	Rittweger, Jörn/0000-0002-2223-8963; Bottinelli, Roberto/0000-0002-4960-7490; MORIGGI, MANUELA/0000-0002-4718-0307; Ruoss, Severin/0000-0001-8896-635X; Giampieri, Enrico/0000-0003-2269-2338; Santoro, Aurelia/0000-0002-7187-1116; Albracht, Kirsten/0000-0002-4271-2511; Di Giulio, Irene/0000-0002-4987-6914; Conte, Maria/0000-0002-4621-9898	European Space Agency (ESA); DLR [2475 030]; Ricerca Fondamentale Orientata (RFO); Project Digital Personalised Medicine-Healthy Ageing: Network Analysis of Big Multiomics Data to Search from New Diagnostic, Prognostic, and Therapeutic Targets (DPM-AGEING) [14.Y26.31.0026]; Italian Ministry of Education, University, and Research (MIUR) [PRIN 2015FBNB5Y]	European Space Agency (ESA)(European Space Agency); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Ricerca Fondamentale Orientata (RFO); Project Digital Personalised Medicine-Healthy Ageing: Network Analysis of Big Multiomics Data to Search from New Diagnostic, Prognostic, and Therapeutic Targets (DPM-AGEING); Italian Ministry of Education, University, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	The authors thank the European Space Agency (ESA) for its support, with great help from Patrik Sundblad, Simone Thomas, and Marine le-Gouic (all from the ESA). Peter Gauger and Wolfram Sies [German Aerospace Center (DLR), Cologne, Germany] were instrumental in the preparation of human testing devices. Asa Beijer (DLR) helped with preprocessing of the muscle samples. This study was supported by internal funding from the DLR (2475 030, Muscle Mechanics and Metabolism); the Ricerca Fondamentale Orientata (RFO) (to M. Capri); and by the Project Digital Personalised Medicine-Healthy Ageing: Network Analysis of Big Multiomics Data to Search from New Diagnostic, Prognostic, and Therapeutic Targets (DPM-AGEING) (14.Y26.31.0026 to C. Franceschi); and by the Italian Ministry of Education, University, and Research (MIUR; Grant PRIN 2015FBNB5Y to C.G.). C.G., C.F., M.N., and J.R. share senior authorship. The authors declare no conflicts of interest.	Bektas A, 2017, J LEUKOCYTE BIOL, V102, P977, DOI 10.1189/jlb.3RI0716-335R; Biolo G, 2003, CURR OPIN CLIN NUTR, V6, P31, DOI 10.1097/00075197-200301000-00006; Bucci L, 2013, BIOGERONTOLOGY, V14, P261, DOI 10.1007/s10522-013-9428-5; Calabrese V, 2018, FREE RADICAL BIO MED, V115, P80, DOI 10.1016/j.freeradbiomed.2017.10.379; Calder PC, 2017, AGEING RES REV, V40, P95, DOI 10.1016/j.arr.2017.09.001; Capitanio D, 2009, PROTEOMICS, V9, P2004, DOI 10.1002/pmic.200701162; Carpentier WR, 2018, NPJ MICROGRAVITY, V4, DOI 10.1038/s41526-018-0040-5; Carrieri G, 2004, AGING CELL, V3, P443, DOI 10.1111/j.1474-9728.2004.00129.x; Cevenini E, 2010, CURR PHARM DESIGN, V16, P609, DOI 10.2174/138161210790883840; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; De Gasperi R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13105-9; Dianzani C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43718; Dittrich A, 2018, CELL PHYSIOL BIOCHEM, V45, P429, DOI 10.1159/000486920; Egerer K, 2002, J RHEUMATOL, V29, P2045; Fleshner M, 2017, TRENDS IMMUNOL, V38, P768, DOI 10.1016/j.it.2017.08.002; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Gabler NB, 2011, MED CARE, V49, P761, DOI 10.1097/MLR.0b013e318215d90d; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gomes CPC, 2014, BIOMARKERS, V19, P585, DOI 10.3109/1354750X.2014.952663; Hassan T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1466; Hochberg AM, 2000, J AOAC INT, V83, P1349; Hughes-Fulford M, 2015, FASEB J, V29, P4893, DOI 10.1096/fj.15-277392; Ikemoto M, 2001, FASEB J, V15, P1279, DOI 10.1096/fj.00-0629fje; Irwin MR, 2017, NEUROPSYCHOPHARMACOL, V42, P129, DOI 10.1038/npp.2016.148; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Lombardi G, 2016, ENDOCRINE, V54, P284, DOI 10.1007/s12020-015-0834-0; Margolis LM, 2017, J GERONTOL A-BIOL, V72, P1319, DOI 10.1093/gerona/glw243; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Narici MV, 2011, EUR J APPL PHYSIOL, V111, P403, DOI 10.1007/s00421-010-1556-x; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Ng SB, 2011, BLOOD, V118, P4919, DOI 10.1182/blood-2011-07-364224; Olivieri F, 2017, MECH AGEING DEV, V165, P162, DOI 10.1016/j.mad.2016.12.004; Olivieri F, 2014, AGING-US, V6, P771, DOI 10.18632/aging.100693; Olivieri F, 2013, AGEING RES REV, V12, P1056, DOI 10.1016/j.arr.2013.05.001; Olivieri F, 2013, AGE, V35, P1157, DOI 10.1007/s11357-012-9440-8; Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Picca A, 2018, REJUV RES, V21, P350, DOI 10.1089/rej.2017.1989; Rittweger J, 2018, NPJ MICROGRAVITY, V4, DOI 10.1038/s41526-018-0052-1; Roberts DR, 2017, NEW ENGL J MED, V377, P1746, DOI 10.1056/NEJMoa1705129; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Salvioli S, 2009, CANCER IMMUNOL IMMUN, V58, P1909, DOI 10.1007/s00262-008-0639-6; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Schwendner P, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0345-8; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Simionescu-Bankston A, 2016, J MOL MED, V94, P853, DOI 10.1007/s00109-016-1443-y; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Stahn AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15560-w; Vernikos J, 2010, GERONTOLOGY, V56, P157, DOI 10.1159/000252852; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Vigano A, 2011, PROTEOMICS, V11, P4202, DOI 10.1002/pmic.201000804; Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29; Wardle SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122107; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	63	13	13	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5168	5180		10.1096/fj.201801625R	http://dx.doi.org/10.1096/fj.201801625R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30620616	hybrid, Green Published			2022-12-28	WOS:000462888500044
J	Elsemuller, AK; Tomalla, V; Gartner, U; Troidl, K; Jeratsch, S; Graumann, J; Baal, N; Hackstein, H; Lasch, M; Deindl, E; Preissner, KT; Fischer, S				Elsemueller, Ann-Kathrin; Tomalla, Vanessa; Gaertner, Ulrich; Troidl, Kerstin; Jeratsch, Sylvia; Graumann, Johannes; Baal, Nelli; Hackstein, Holger; Lasch, Manuel; Deindl, Elisabeth; Preissner, Klaus T.; Fischer, Silvia			Characterization of mast cell-derived rRNA-containing microvesicles and their inflammatory impact on endothelial cells	FASEB JOURNAL			English	Article						MC degranulation; ECs; cytokines; inflammation; extracellular RNA	EXTRACELLULAR RNA; VASCULAR SYSTEM; IDENTIFICATION; GROWTH; PERMEABILITY; ARTERIOGENESIS; ANGIOGENESIS; STABILITY; PLATELETS; PROTEINS	Tissue-resident mast cells (MCs) are well known for their role in inflammatory responses and allergic and anaphylactic reactions, but they also contribute to processes of arterial remodeling. Although ribosomes and cytosolic RNAs are located around secretory granules in mature MCs, their functional role in MC responses remains unexplored. Previous studies by our group characterized extracellular RNA (eRNA) as an inflammatory and pathogenetic factor in vitro and in vivo. In the present study, RNA-containing MCs and eRNA were located in close proximity to growing collateral arteries in vivo. In vitro, various agonists were found to induce the degranulation of MCs and the concomitant release of eRNA in association with microvesicles (MVs). The liberation of eRNA from MCs was abolished by MC stabilizers or by preventing the increase of intracellular Ca2+ in MCs. eRNA was found to be mainly contained inside MVs, as demonstrated by electron microscopy and immunocytochemistry. The exposure to and the uptake of MC-released MVs by cultured endothelial cells increased their expression of cytokines, such as monocyte chemoattractant protein or IL-6, in a dose- and time-dependent manner. These results indicate that RNA-containing MC-derived MVs are likely to be involved in inflammatory responses, relevant, for example, to processes of vascular remodeling.	[Elsemueller, Ann-Kathrin; Tomalla, Vanessa; Preissner, Klaus T.; Fischer, Silvia] Justus Liebig Univ, Med Fac, Dept Biochem, Giessen, Germany; [Gaertner, Ulrich] Justus Liebig Univ, Dept Anat & Cell Biol, Giessen, Germany; [Baal, Nelli] Justus Liebig Univ, Med Fac, Dept Clin Immunol & Transfus Med, Giessen, Germany; [Troidl, Kerstin; Jeratsch, Sylvia; Graumann, Johannes] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Troidl, Kerstin] Univ Hosp Frankfurt, Dept Vasc & Endovasc Surg, Frankfurt, Germany; [Hackstein, Holger] Friedrich Alexander Univ, Univ Hosp Erlangen, Dept Transfus Med & Haemostaseol, Erlangen, Germany; [Lasch, Manuel; Deindl, Elisabeth] Ludwig Maximilians Univ Munchen, Univ Hosp, Walter Brendel Ctr Expt Med, Munich, Germany; [Lasch, Manuel] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Erlangen Nuremberg; University of Munich; University of Munich	Fischer, S (corresponding author), Univ Giessen, Dept Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	silvia.fischer@biochemie.med.uni-giessen.de	Deindl, Elisabeth/A-2511-2013; Fischer, Silvia/ABG-3104-2021; Graumann, Johannes/C-5241-2008	Graumann, Johannes/0000-0002-3015-5850	German Research Foundation (DFG) (Bonn, Germany) [SFB-TR84, FI543/4-1, TR1137/2-1]; von Behring-Rontgen Foundation (Marburg, Germany) [62780212]; Excellence Cluster Cardio-Pulmonary System (ECCPS) (Giessen, Germany)	German Research Foundation (DFG) (Bonn, Germany)(German Research Foundation (DFG)); von Behring-Rontgen Foundation (Marburg, Germany); Excellence Cluster Cardio-Pulmonary System (ECCPS) (Giessen, Germany)	The authors thank Silke Leiting, Sabrina Glasenhardt, and Dimitri Grun (all from Department of Biochemistry, Medical Faculty, Justus-Liebig-University) for skillful and dedicated technical assistance. Studies were generously supported in part by grants to K.T.P., S.F., and K.T. from the German Research Foundation (DFG) (Bonn, Germany; http://www.dfg.de), including SFB-TR84 (to S.F. and K.T.P.), FI543/4-1 (to S.F.), and TR1137/2-1 (to K.T.); the von Behring-Rontgen Foundation (Marburg, Germany; 62780212, to S.F.); and the Excellence Cluster Cardio-Pulmonary System (ECCPS) (Giessen, Germany; http://eccps.de, to K.T.P.). The authors declare no conflicts of interest.	Aharon A, 2016, ISR MED ASSOC J, V18, P530; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Benito-Martin A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00066; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Cabrera-Fuentes HA, 2014, THROMB HAEMOSTASIS, V112, P1110, DOI 10.1160/TH14-08-0703; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Chillo O, 2016, CELL REP, V16, P2197, DOI 10.1016/j.celrep.2016.07.040; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Dvorak AM, 2003, HISTOL HISTOPATHOL, V18, P943, DOI 10.14670/HH-18.943; Dvorak AM, 2000, J HISTOCHEM CYTOCHEM, V48, P1; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Ekstrom K, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18389; Fischer S, 2013, HAMOSTASEOLOGIE, V33, P37, DOI 10.5482/HAMO-13-01-0001; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fischer S, 2012, THROMB HAEMOSTASIS, V108, P730, DOI 10.1160/TH12-03-0186; Fischer S, 2009, FASEB J, V23, P2100, DOI 10.1096/fj.08-121608; Frenzel L, 2013, JOINT BONE SPINE, V80, P141, DOI 10.1016/j.jbspin.2012.08.013; Galli SJ, 1997, J EXP MED, V186, P343, DOI 10.1084/jem.186.3.343; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Grutzkau A, 1998, MOL BIOL CELL, V9, P875, DOI 10.1091/mbc.9.4.875; Ito WD, 1997, CIRC RES, V80, P829; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kitamura Y, 2005, P NATL ACAD SCI USA, V102, P11129, DOI 10.1073/pnas.0505073102; Kleinert E, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003429; Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347; Lasser C, 2017, RNA BIOL, V14, P58, DOI 10.1080/15476286.2016.1249092; Li Y, 2011, ACTA BIOCH BIOPH SIN, V43, P69, DOI 10.1093/abbs/gmq114; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Mulloy B, 2017, GLYCOCONJUGATE J, V34, P351, DOI 10.1007/s10719-016-9749-0; Nakazawa S, 2014, EUR J IMMUNOL, V44, P204, DOI 10.1002/eji.201343838; Noll F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190002; Osteikoetxea X, 2015, ORG BIOMOL CHEM, V13, P9775, DOI 10.1039/c5ob01451d; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Shefler I, 2011, CURR PHARM DESIGN, V17, P3797, DOI 10.2174/138161211798357836; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Vajen T, 2015, THROMB HAEMOSTASIS, V114, P228, DOI 10.1160/TH14-11-0962; Vukman KV, 2017, SEMIN CELL DEV BIOL, V67, P65, DOI 10.1016/j.semcdb.2017.02.002; Wei ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01196-x; Woska JR, 2012, J CELL MOL MED, V16, P649, DOI 10.1111/j.1582-4934.2011.01443.x; Zernecke A, 2016, CIRC RES, V118, P469, DOI 10.1161/CIRCRESAHA.115.307961; ZIMMERMAN SB, 1965, ANAL BIOCHEM, V10, P444, DOI 10.1016/0003-2697(65)90313-1	54	10	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5457	5467		10.1096/fj.201801853RR	http://dx.doi.org/10.1096/fj.201801853RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702929				2022-12-28	WOS:000462888500066
J	Kiser, PD; Kolesnikov, AV; Kiser, JZ; Dong, ZQ; Chaurasia, B; Wang, LP; Summers, SA; Hoang, T; Blackshaw, S; Peachey, NS; Kefalov, VJ; Palczewski, K				Kiser, Philip D.; Kolesnikov, Alexander V.; Kiser, Jianying Z.; Dong, Zhiqian; Chaurasia, Bhagirath; Wang, Liping; Summers, Scott A.; Thanh Hoang; Blackshaw, Seth; Peachey, Neal S.; Kefalov, Vladimir J.; Palczewski, Krzysztof			Conditional deletion of Des1 in the mouse retina does not impair the visual cycle in cones	FASEB JOURNAL			English	Article						retinoid cycle; sphingolipid delta(4) desaturase; Degs1; photoreceptor; Muller glia	CERAMIDE BIOSYNTHESIS; PIGMENT REGENERATION; BINDING PROTEINS; VITAMIN-A; IDENTIFICATION; CELLS; MICE; INHIBITION; DIHYDROCERAMIDE; ISOMERASE	Cone photoreceptors are essential for vision under moderate to high illuminance and allow color discrimination. Their fast dark adaptation rate and resistance to saturation are believed to depend in part on an intraretinal visual cycle that supplies 11-cis-retinaldehyde to cone opsins. Candidate enzymes of this pathway have been reported, but their physiologic contribution to cone photoresponses remains unknown. Here, we evaluate the role of a candidate retinol isomerase of this pathway, sphingolipid delta 4 desaturase 1 (Des1). Single-cell RNA sequencing analysis revealed Des1 expression not only in Muller glia but also throughout the retina and in the retinal pigment epithelium. We assessed cone functional dependence on Muller cell-expressed Des1 through a conditional knockout approach. Floxed Des1 mice, on a guanine nucleotide-binding protein subunit alpha transducin 1 knockout (Gnat1(-/-)) background to allow isolated recording of cone-driven photoresponses, were bred with platelet-derived growth factor receptor alpha (Pdgfr alpha)-Cre mice to delete Des1 in Muller cells. Conditional knockout of Des1 expression, as shown by tissue-selective Des1 gene recombination and reduced Des1 catalytic activity, caused no gross changes in the retinal structure and had no effect on cone sensitivity or dark adaptation but did slightly accelerate the rate of cone phototransduction termination. These results indicate that Des1 expression in Muller cells is not required for cone visual pigment regeneration in the mouse.	[Kiser, Philip D.; Peachey, Neal S.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Kiser, Philip D.; Kiser, Jianying Z.; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Kolesnikov, Alexander V.; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Dong, Zhiqian] Polgenix Inc, Cleveland, OH USA; [Chaurasia, Bhagirath; Wang, Liping; Summers, Scott A.] Univ Utah, Dept Nutr & Integrat Physiol NUIP, Salt Lake City, UT USA; [Chaurasia, Bhagirath; Wang, Liping; Summers, Scott A.] Univ Utah, Diabet & Metab Res Ctr, Salt Lake City, UT USA; [Thanh Hoang; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Palczewski, Krzysztof] Univ Calif Irvine, Sch Med, Dept Ophthalmol, Gavin Herbert Eye Inst, Irvine, CA 92717 USA; [Kiser, Philip D.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Kiser, Philip D.] VA Long Beach Healthcare Syst, Res Serv, Long Beach, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Washington University (WUSTL); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Johns Hopkins University; Cleveland Clinic Foundation; University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Kiser, PD (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 837 Hlth Sci Rd, Irvine, CA 92617 USA.	pkiser@uci.edu	/AAE-5384-2020; Kolesnikov, Alexander V/O-1840-2016; Peachey, Neal/G-5533-2010	Peachey, Neal/0000-0002-4419-7226; Summers, Scott/0000-0002-4919-0592; DONG, ZHIQIAN/0000-0002-8748-4532	U.S. Department of Veterans Affairs [IK2BX002683]; Research Career Scientist Award; U.S. National Institutes of Health (NIH) National Eye Institute [R01EY009339, R01EY024864, R01EY019312, R01EY021126, R24EY027283, R01DK115824, P30EY011373, P30EY025585, P30EY002687]; American Diabetes Association; American Heart Association; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY020560, R24EY024864, R24EY027283, P30EY011373, P30EY002687, R01EY025696, R01EY009339, P30EY025585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115824] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Research Career Scientist Award(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank David Peck and Elizabeth Bulman (both of Case Western Reserve University) for assistance with animal breeding, genotyping, and husbandry. This research was supported by funding from the U.S. Department of Veterans Affairs (IK2BX002683 to P.D.K.); a Research Career Scientist Award (to N.S.P.); the U.S. National Institutes of Health (NIH) National Eye Institute (R01EY009339 to K.P. and P.D.K., R01EY024864 to K.P., R01EY019312 to V.J.K., R01EY021126 to K.P. and V.J.K., R24EY027283 to K.P., P.D.K., V.J.K., S.B., and N.S.P., R01DK115824 to S.A.S., P30EY011373 to the Department of Ophthalmology and Visual Sciences at Case Western Reserve University, P30EY025585 to the Cleveland Clinic Cole Eye Institute, and P30EY002687 to the Department of Ophthalmology and Visual Sciences at Washington University); the American Diabetes Association (to S.A.S); the American Heart Association (to S.A.S.). The authors acknowledge departmental support from a Research to Prevent Blindness unrestricted grant. S.A.S. is a consultant and shareholder of Centaurus Therapeutics. The remaining authors declare no competing financial interests.	Arne JM, 2017, J LIPID RES, V58, P719, DOI 10.1194/jlr.M073692; Barak A, 2001, INVEST OPHTH VIS SCI, V42, P247; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Brush RS, 2010, INVEST OPHTH VIS SCI, V51, P4422, DOI 10.1167/iovs.09-5134; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen H, 2013, J LIPID RES, V54, P1616, DOI 10.1194/jlr.M035048; Chen H, 2012, ADV EXP MED BIOL, V723, P553, DOI 10.1007/978-1-4614-0631-0_70; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu J, 2014, J EXP MED, V211, P281, DOI 10.1084/jem.20131494; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Ingram NT, 2016, J PHYSIOL-LONDON, V594, P5415, DOI 10.1113/JP272556; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Kaylor JJ, 2014, P NATL ACAD SCI USA, V111, P7302, DOI 10.1073/pnas.1319142111; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kiser PD, 2018, J GEN PHYSIOL, V150, P571, DOI 10.1085/jgp.201711815; Kiser PD, 2015, NAT CHEM BIOL, V11, P409, DOI [10.1038/NCHEMBIO.1799, 10.1038/nchembio.1799]; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Krueger KC, 2014, STEM CELL REP, V3, P1147, DOI 10.1016/j.stemcr.2014.10.009; Leneuve P, 2001, BIOTECHNIQUES, V31, P1156, DOI 10.2144/01315rr05; Liu L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190253; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Muniz A, 2009, BIOCHEMISTRY-US, V48, P6854, DOI 10.1021/bi9002937; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; SAARI JC, 1982, J BIOL CHEM, V257, P13329; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; Schulze H, 2000, METHOD ENZYMOL, V311, P22; Scrucca L, 2016, R J, V8, P289; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Strettoi E, 2010, P NATL ACAD SCI USA, V107, P18706, DOI 10.1073/pnas.1007644107; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Xue YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02549-8; Xue YL, 2015, J CLIN INVEST, V125, P727, DOI 10.1172/JCI79651; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	54	18	18	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5782	5792		10.1096/fj.201802493R	http://dx.doi.org/10.1096/fj.201802493R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30645148	hybrid, Green Published			2022-12-28	WOS:000462888500091
J	Liu, XH; Chen, Z; Han, ZL; Liu, Y; Wu, X; Peng, YZ; Di, WC; Lan, RF; Sun, BG; Xu, B; Xu, W				Liu, Xuehua; Chen, Zheng; Han, Zhonglin; Liu, Yu; Wu, Xiang; Peng, Yuzhu; Di, Wencheng; Lan, Rongfang; Sun, Bugao; Xu, Biao; Xu, Wei			AMPK-mediated degradation of Nav1.5 through autophagy	FASEB JOURNAL			English	Article						sodium channel; protein degradation; SCN5A; ischemia and reperfusion injury; phosphorylation	CARDIAC SODIUM-CHANNEL; UBIQUITIN-PROTEASOME SYSTEM; HEART; MUTATIONS; PROTEIN; ISCHEMIA; NA(V)1.5; MYOCYTES; INJURY; REPERFUSION	The voltage-gated cardiac sodium channel, Nav1.5, is the key component that controls cardiac excitative electrical impulse and propagation. However, the dynamic alterations of Nav1.5 during cardiac ischemia and reperfusion (I/R) are seldom reported. We found that the protein levels of rat cardiac Nav1.5 were significantly decreased in response to cardiac I/R injury. By simulating I/R injury in cells through activating AMPK by glucose deprivation, AMPK activator treatment, or hypoxia and reoxygenation (H/R), we found that Nav1.5 was down-regulated by AMPK-mediated autophagic degradation. Furthermore, AMPK was found to phosphorylate Nav1.5 at threonine (T) 101, which then regulates the interaction between Nav1.5 and the autophagic adaptor protein, microtubule-associated protein 1 light chain 3 (LC3), by exposing the LC3-interacting region adjacent to T101 in Nav1.5. This study highlights an instrumental role of AMPK in mediating the autophagic degradation of Nav1.5 during cardiac I/R injury.	[Liu, Xuehua; Sun, Bugao] Nanjing Univ, Drum Tower Hosp, Med Sch, Dept Ultrasound Diag, Nanjing, Jiangsu, Peoples R China; [Liu, Xuehua; Chen, Zheng; Han, Zhonglin; Liu, Yu; Wu, Xiang; Peng, Yuzhu; Di, Wencheng; Lan, Rongfang; Xu, Biao; Xu, Wei] Nanjing Univ, Drum Tower Hosp, Med Sch, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Xu, W (corresponding author), Nanjing Univ, Med Sch, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	13390900868@163.com			National Natural Science Foundation of China [81600267]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 81600267). The authors declare no conflicts of interest.	Beltran-Alvarez P, 2014, J MOL CELL CARDIOL, V76, P126, DOI 10.1016/j.yjmcc.2014.08.014; Beltran-Alvarez P, 2011, J PROTEOME RES, V10, P3712, DOI 10.1021/pr200339n; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; Boccalini G, 2015, FASEB J, V29, P239, DOI 10.1096/fj.14-254854; Bonuccelli G, 2003, AM J PATHOL, V163, P1663, DOI 10.1016/S0002-9440(10)63523-7; Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; Calise J, 2013, AM J PHYSIOL-HEART C, V304, pH337, DOI 10.1152/ajpheart.00604.2012; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; COHEN SA, 1993, CIRC RES, V73, P735, DOI 10.1161/01.RES.73.4.735; Genereux P, 2014, J AM COLL CARDIOL, V64, P2605, DOI 10.1016/j.jacc.2014.08.052; Golden HB, 2012, METHODS MOL BIOL, V843, P205, DOI 10.1007/978-1-61779-523-7_20; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Huang WQ, 2018, J CELL PHYSIOL, V233, P6669, DOI 10.1002/jcp.26320; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kraft LJ, 2014, AUTOPHAGY, V10, P861, DOI 10.4161/auto.28175; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Luo L, 2017, ACTA PHYSIOL, V221, P44, DOI 10.1111/apha.12872; Ma S, 2015, BBA-MOL BASIS DIS, V1852, P271, DOI 10.1016/j.bbadis.2014.05.010; Makiyama T, 2008, J AM COLL CARDIOL, V52, P1326, DOI 10.1016/j.jacc.2008.07.013; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Murphy BJ, 1996, J BIOL CHEM, V271, P28837, DOI 10.1074/jbc.271.46.28837; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Qian X, 2017, MOL CELL, V65, P917, DOI 10.1016/j.molcel.2017.01.027; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Shy D, 2013, BBA-MOL CELL RES, V1833, P886, DOI 10.1016/j.bbamcr.2012.10.026; Tang HX, 2017, MOL MED REP, V15, P3747, DOI 10.3892/mmr.2017.6424; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wang C, 2016, PHARMACOL RES, V105, P164, DOI 10.1016/j.phrs.2016.01.028; Wei X, 2016, J CARDIOVASC PHARM, V68, P269; WEISS J, 1985, J CLIN INVEST, V75, P436, DOI 10.1172/JCI111718; Xiao J, 2016, MOL MED, V22, P643, DOI 10.2119/molmed.2016.00034; Xie M, 2011, CURR OPIN CARDIOL, V26, P216, DOI 10.1097/HCO.0b013e328345980a	45	8	9	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5366	5376		10.1096/fj.201801583RR	http://dx.doi.org/10.1096/fj.201801583RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30759345	Bronze			2022-12-28	WOS:000462888500059
J	Hirakata, T; Lee, HC; Ohba, M; Saeki, K; Okuno, T; Murakami, A; Matsuda, A; Yokomizo, T				Hirakata, Toshiaki; Lee, Hyeon-Cheol; Ohba, Mai; Saeki, Kazuko; Okuno, Toshiaki; Murakami, Akira; Matsuda, Akira; Yokomizo, Takehiko			Dietary-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T(h)2 immune responses	FASEB JOURNAL			English	Article						eicosanoid; inflammation; hay fever; lipidomics; fish oil	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FISH-OIL SUPPLEMENTATION; PROSTAGLANDIN D-2; MURINE MODEL; RESOLVIN D1; MAST-CELLS; HIGH-RISK; EOSINOPHILS; INFLAMMATION; RECEPTOR	Allergic conjunctivitis (AC) is one of the most common ocular surface diseases in the world. In AC, T helper type 2 (T(h)2) immune responses play central roles in orchestrating inflammatory responses. However, the roles of lipid mediators in the onset and progression of AC remain to be fully explored. Although previous reports have shown the beneficial effects of supplementation of -3 fatty acids in asthma or atopic dermatitis, the underlying molecular mechanisms are poorly understood. In this study, a diet rich in -3 fatty acids alleviated AC symptoms in both early and late phases without affecting T(h)2 immune responses, but rather by altering the lipid mediator profiles. The -3 fatty acids completely suppressed scratching behavior toward the eyes, an allergic reaction provoked by itch. Although total serum IgE levels and the expression levels of T(h)2 cytokines and chemokines in the conjunctiva were not altered by -3 fatty acids, eosinophil infiltration into the conjunctiva was dramatically suppressed. The levels of -6-derived proinflammatory lipid mediators, including those with chemoattractant properties for eosinophils, were markedly reduced in the conjunctivae of -3 diet-fed mice. Dietary -3 fatty acids can alleviate a variety of symptoms of AC by altering the lipid mediator profile.Hirakata, T., Lee, H.-C., Ohba, M., Saeki, K., Okuno, T., Murakami, A., Matsuda, A., Yokomizo, T. Dietary -3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T(h)2 immune responses.	[Hirakata, Toshiaki; Murakami, Akira; Matsuda, Akira] Juntendo Univ, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo, Japan; [Hirakata, Toshiaki; Lee, Hyeon-Cheol; Ohba, Mai; Saeki, Kazuko; Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Grad Sch Med, Dept Biochem, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan	Juntendo University; Juntendo University	Yokomizo, T (corresponding author), Juntendo Univ, Grad Sch Med, Dept Biochem, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	yokomizo-tky@umin.ac.jp	Yokomizo, Takehiko/P-5673-2016; Matsuda, Akira/A-9981-2010; Lee-Okada, Hyeon-Cheol/AAQ-4520-2021	Yokomizo, Takehiko/0000-0002-5219-1553; Matsuda, Akira/0000-0002-0792-3663; Lee-Okada, Hyeon-Cheol/0000-0002-5493-8112	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/Japan Society for the Promotion of Sport (KAKENHI) [18K16246, 15K08316, 18K06923, 15KK0320, 16K08596, 16K11303, 15H05904, 15H04708, 18H02627]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Takeda Science Foundation [S1311011]; Foundation of Strategic Research Projects in Private Universities from MEXT [S1311011]; Atopy Research Center at the Juntendo University Graduate School of Medicine	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/Japan Society for the Promotion of Sport (KAKENHI); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation of Strategic Research Projects in Private Universities from MEXT; Atopy Research Center at the Juntendo University Graduate School of Medicine	The authors thank members of the Laboratory of Morphology and Image Analysis Research Support Center at the Juntendo University Graduate School of Medicine for technical assistance with microscopy. This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/Japan Society for the Promotion of Sport Grants-in-Aid for Scientific Research (KAKENHI) (18K16246 to H.-C.L.; 15K08316 and 18K06923 to K.S.; 15KK0320 and 16K08596 to T.O.; 16K11303 to A. Matsuda; and 15H05904, 15H04708, and 18H02627 to T.Y.), and grants from the Naito Foundation, the Ono Medical Research Foundation, the Uehara Memorial Foundation, the Mitsubishi Foundation, the Takeda Science Foundation, and, in part, by Grant-in-Aid S1311011 from the Foundation of Strategic Research Projects in Private Universities from MEXT, and institutional grants for Environmental and Gender-Specific Medicine and the Atopy Research Center at the Juntendo University Graduate School of Medicine. The authors declare no conflicts of interest.	ABELSON MB, 1983, ARCH OPHTHALMOL-CHIC, V101, P555; Andoh T, 2007, J INVEST DERMATOL, V127, P2042, DOI 10.1038/sj.jid.5700810; Andoh T, 2012, EXP EYE RES, V98, P97, DOI 10.1016/j.exer.2012.03.021; Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Asada Y, 2015, INVEST OPHTH VIS SCI, V56, P5194, DOI 10.1167/iovs.15-16563; BALLAS Z, 1993, SURV OPHTHALMOL, V38, P141, DOI 10.1016/0039-6257(93)90038-9; Beermann C, 2016, NUTRITION, V32, P1165, DOI 10.1016/j.nut.2016.04.004; Best KP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4443; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Biteman B, 2007, FASEB J, V21, P2257, DOI 10.1096/fj.06-7918com; Bohm E, 2004, J BIOL CHEM, V279, P7663, DOI 10.1074/jbc.M310270200; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Ciaccio CE, 2014, ANN ALLERG ASTHMA IM, V112, P191, DOI 10.1016/j.anai.2014.01.009; CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504; Costa JJ, 1997, JAMA-J AM MED ASSOC, V278, P1815, DOI 10.1001/jama.278.22.1815; D'Vaz N, 2012, PEDIATRICS, V130, P674, DOI 10.1542/peds.2011-3104; Devenny A, 2004, BMJ-BRIT MED J, V329, P489, DOI 10.1136/bmj.38139.666447.F7; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Farjadian S, 2016, CYTOKINE, V85, P61, DOI 10.1016/j.cyto.2016.06.002; Fogarty A, 2000, CLIN EXP ALLERGY, V30, P615, DOI 10.1046/j.1365-2222.2000.00766.x; Foiles AM, 2016, PEDIAT ALLERG IMM-UK, V27, P156, DOI 10.1111/pai.12515; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Giudetti AM, 2012, PROSTAG OTH LIPID M, V99, P57, DOI 10.1016/j.prostaglandins.2012.09.006; Grant GE, 2009, PROSTAG OTH LIPID M, V89, P98, DOI 10.1016/j.prostaglandins.2009.05.002; Guidera AC, 2001, OPHTHALMOLOGY, V108, P936, DOI 10.1016/S0161-6420(00)00538-8; Hansen S, 2017, J ALLERGY CLIN IMMUN, V139, P104, DOI 10.1016/j.jaci.2016.02.042; Hashimoto T, 2003, J OCUL PHARMACOL TH, V19, P569, DOI 10.1089/108076803322660486; Hodges RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36124; Ishida W, 2012, GRAEF ARCH CLIN EXP, V250, P289, DOI 10.1007/s00417-011-1695-8; Kari O, 2010, J ASTHMA ALLERGY, V3, P149, DOI 10.2147/JAA.S13705; Keane-Myers A, 2001, Curr Allergy Asthma Rep, V1, P550, DOI 10.1007/s11882-001-0064-9; Kim N, 2016, EUR J IMMUNOL, V46, P81, DOI 10.1002/eji.201545673; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Kunisawa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032094; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Leonardi Andrea, 2002, Curr Allergy Asthma Rep, V2, P325, DOI 10.1007/s11882-002-0061-7; Lippestad M, 2017, INVEST OPHTH VIS SCI, V58, P4530, DOI 10.1167/iovs.17-21914; Livne-Bar I, 2017, J CLIN INVEST, V127, P4403, DOI 10.1172/JCI77398; Luna-Gomes T, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00027; Luna-Gomes T, 2011, J IMMUNOL, V187, P6518, DOI 10.4049/jimmunol.1101806; Magone MT, 1998, CLIN IMMUNOL IMMUNOP, V87, P75, DOI 10.1006/clin.1997.4507; Manley BJ, 2011, PEDIATRICS, V128, pE71, DOI 10.1542/peds.2010-2405; Matsuba-Kitamura S, 2010, INT IMMUNOL, V22, P479, DOI 10.1093/intimm/dxq035; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; NAKAJIMA M, 1991, GRAEF ARCH CLIN EXP, V229, P411, DOI 10.1007/BF00166301; Nakazawa Yosuke, 2017, Open Med (Wars), V12, P231, DOI 10.1515/med-2017-0034; Ohba M, 2018, BIOCHEM BIOPH RES CO, V504, P562, DOI 10.1016/j.bbrc.2018.06.026; Ono SJ, 2005, J ALLERGY CLIN IMMUN, V115, P118, DOI 10.1016/j.jaci.2004.10.042; Peinhaupt M, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00104; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Rupp H, 2004, HERZ, V29, P673, DOI 10.1007/s00059-004-2602-4; Sampson AP, 2000, CLIN EXP ALLERGY, V30, P22; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Singh K, 2010, J ALLERGY CLIN IMMUN, V126, P778, DOI 10.1016/j.jaci.2010.06.050; SPADA CS, 1986, PROSTAGLANDINS, V31, P795, DOI 10.1016/0090-6980(86)90181-4; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Swamy BN, 2007, OPHTHAL EPIDEMIOL, V14, P311, DOI 10.1080/09286580701299411; Teixeira MM, 1997, J CLIN INVEST, V100, P1657, DOI 10.1172/JCI119690; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Tull SP, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000177; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Whelan J, 1996, J NUTR, V126, pS1086, DOI 10.1093/jn/126.suppl_4.1086S; WOODWARD DF, 1990, INVEST OPHTH VIS SCI, V31, P138; Woodward DF, 1996, J PHARMACOL EXP THER, V279, P137; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737	72	20	20	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3392	3403		10.1096/fj.201801805R	http://dx.doi.org/10.1096/fj.201801805R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383446	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000459794800026
J	Stavenschi, E; Hoey, DA				Stavenschi, Elena; Hoey, David A.			Pressure-induced mesenchymal stem cell osteogenesis is dependent on intermediate filament remodeling	FASEB JOURNAL			English	Article						bone; mechanobiology; cytoskeleton; mechanotherapeutic; DMSO	CYCLIC HYDRAULIC PRESSURE; FLUID-FLOW; HYDROSTATIC-PRESSURE; MECHANICAL-STRESS; PRIMARY CILIA; BONE-MARROW; INTRAMEDULLARY PRESSURE; DIFFERENTIATION; CYTOSKELETON; STIMULATION	Macroscale loading of bone generates a complex local mechanical microenvironment that drives osteogenesis and bone mechanoadaptation. One such mechanical stimulus generated is hydrostatic pressure (HP); however, the effect of HP on mesenchymal stem cells (MSCs) and the mechanotransduction mechanisms utilized by these cells to sense this stimulus are yet to be fully elucidated. In this study, we demonstrate that cyclic HP is a potent mediator of cytoskeletal reorganization and increases in osteogenic responses in MSCs. In particular, we demonstrate that the intermediate filament (IF) network undergoes breakdown and reorganization with centripetal translocation of IF bundles toward the perinuclear region. Furthermore, we show for the first time that this IF remodeling is required for loading-induced MSC osteogenesis, revealing a novel mechanism of MSC mechanotransduction. In addition, we demonstrate that chemical disruption of IFs with withaferin A induces a similar mechanism of IF breakdown and remodeling as well as a subsequent increase in osteogenic gene expression in MSCs, exhibiting a potential mechanotherapeutic effect to enhance MSC osteogenesis. This study therefore highlights a novel mechanotransduction mechanism of pressure-induced MSC osteogenesis involving the understudied cytoskeletal structure, the IF, and demonstrates a potential new therapy to enhance bone formation in bone-loss diseases such as osteoporosis.Stavenschi, E., Hoey, D. A. Pressure-induced mesenchymal stem cell osteogenesis is dependent on intermediate filament remodeling.	[Stavenschi, Elena; Hoey, David A.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin, Ireland; [Stavenschi, Elena; Hoey, David A.] Trinity Coll Dublin, Sch Engn, Dept Mech & Mfg Engn, D02 DK07, Dublin 2, Ireland; [Hoey, David A.] Univ Limerick, Dept Mech Aeronaut & Biomed Engn, Limerick, Ireland; [Hoey, David A.] Trinity Coll Dublin, Adv Mat & Bioengn Res Ctr, Dublin, Ireland; [Hoey, David A.] RCSI, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; University of Limerick; Trinity College Dublin; Royal College of Surgeons - Ireland	Hoey, DA (corresponding author), Trinity Coll Dublin, Sch Engn, Dept Mech & Mfg Engn, D02 DK07, Dublin 2, Ireland.	dahoey@tcd.ie	Hoey, David/X-9231-2019; Hoey, David/G-3301-2013	Hoey, David/0000-0001-5898-0409	European Research Council (ERC) Starting Grant [336882]; Science Foundation Ireland (SFI) [SFI 13/ERC/L2864]	European Research Council (ERC) Starting Grant(European Research Council (ERC)); Science Foundation Ireland (SFI)(Science Foundation Ireland)	The authors acknowledge funding from European Research Council (ERC) Starting Grant (336882) and the Science Foundation Ireland (SFI) Support Grant SFI 13/ERC/L2864. The authors declare no conflicts of interest.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Becquart P, 2016, EUR CELLS MATER, V31, P160, DOI 10.22203/eCM.v031a11; BURGER EH, 1992, J BONE MINER RES, V7, pS397, DOI 10.1002/jbmr.5650071406; BURGER EH, 1991, J BIOMECH, V24, P101, DOI 10.1016/0021-9290(91)90381-V; Chen JC, 2016, FASEB J, V30, P1504, DOI 10.1096/fj.15-276402; Corrigan MA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22174-3; Danion F, 2003, GAIT POSTURE, V18, P69, DOI 10.1016/S0966-6362(03)00030-4; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Espinha LC, 2014, CYTOSKELETON, V71, P435, DOI 10.1002/cm.21183; Feria-Diaz J. J., 2018, INDIAN J SCI TECHNOL, V11, P1, DOI DOI 10.17485/ijst/2018/v11i16/121405; Gardinier JD, 2014, CELL MOL BIOENG, V7, P266, DOI 10.1007/s12195-014-0329-8; Gardinier JD, 2009, CELL MOL BIOENG, V2, P133, DOI 10.1007/s12195-008-0038-2; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Gurkan UA, 2008, ANN BIOMED ENG, V36, P1978, DOI 10.1007/s10439-008-9577-x; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Hu MY, 2012, BONE, V51, P819, DOI 10.1016/j.bone.2012.06.030; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Jiu YM, 2015, CELL REP, V11, P1511, DOI 10.1016/j.celrep.2015.05.008; Johnson GP, 2018, J CELL SCI, V131, DOI 10.1242/jcs.222737; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Klein-Nulend J, 2012, EUR CELLS MATER, V24, P278, DOI 10.22203/eCM.v024a20; KleinNulend J, 1997, J CELL PHYSIOL, V170, P174, DOI 10.1002/(SICI)1097-4652(199702)170:2<174::AID-JCP9>3.0.CO;2-L; Kwon RY, 2010, J BONE MINER RES, V25, P1798, DOI 10.1002/jbmr.74; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; Liu C, 2010, BONE, V46, P1449, DOI 10.1016/j.bone.2010.02.006; Liu J, 2009, J CELL BIOCHEM, V107, P224, DOI 10.1002/jcb.22118; Lopez MP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5778; Malone AMD, 2007, AM J PHYSIOL-CELL PH, V292, pC1830, DOI 10.1152/ajpcell.00352.2005; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MELGUIZO C, 1994, HISTOCHEM J, V26, P519, DOI 10.1007/BF00157897; Murray ME, 2014, MOL BIOL CELL, V25, P87, DOI 10.1091/mbc.E13-06-0326; Myers KA, 2007, BIOCHEM BIOPH RES CO, V364, P214, DOI 10.1016/j.bbrc.2007.09.109; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Ng JL, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00303; Nishio K, 2001, HISTOCHEM CELL BIOL, V116, P321, DOI 10.1007/s004180100325; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-9290(03)00127-1; Ren L, 2015, J MECH BEHAV BIOMED, V50, P104, DOI 10.1016/j.jmbbm.2015.04.021; Ridge KM, 2016, METHOD ENZYMOL, V568, P389, DOI 10.1016/bs.mie.2015.09.036; Riehl BD, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1351; Robert A, 2016, BIOESSAYS, V38, P232, DOI 10.1002/bies.201500142; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Roelofsen J, 1995, J BIOMECH, V28, P1493, DOI 10.1016/0021-9290(95)00097-6; Rubin Janet, 2017, Trans Am Clin Climatol Assoc, V128, P180; Sen B, 2015, STEM CELLS, V33, P3065, DOI 10.1002/stem.2090; Stavenschi E, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1025-8; Stavenschi E, 2017, J BIOMECH, V55, P99, DOI 10.1016/j.jbiomech.2017.02.002; Steward AJ, 2013, EUR CELLS MATER, V25, P167, DOI 10.22203/eCM.v025a12; Sugimoto A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18089-0; Tewari D, 2015, STEM CELL REV REP, V11, P309, DOI 10.1007/s12015-014-9573-5; Yourek G, 2010, REGEN MED, V5, P713, DOI 10.2217/RME.10.60; Zhang W, 2014, EUR SPINE J, V23, P2410, DOI 10.1007/s00586-014-3394-8; Zhao L, 2009, CALCIFIED TISSUE INT, V84, P56, DOI 10.1007/s00223-008-9189-3; Zhao YH, 2015, STEM CELL RES, V14, P283, DOI 10.1016/j.scr.2015.02.006; Zhao Y, 2016, ANN BIOMED ENG, V44, P2971, DOI 10.1007/s10439-016-1631-5	59	14	14	3	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4178	4187		10.1096/fj.201801474RR	http://dx.doi.org/10.1096/fj.201801474RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30550359	Green Submitted			2022-12-28	WOS:000459794800086
J	Pham, TL; Kakazu, A; He, JC; Bazan, HEP				Thang Luong Pham; Kakazu, Azucena; He, Jiucheng; Bazan, Haydee E. P.			Mouse strains and sexual divergence in corneal innervation and nerve regeneration	FASEB JOURNAL			English	Article						-estradiol; trigeminal ganglia; docosanoids; neurotrophic factors; dry eye	DOCOSAHEXAENOIC ACID; SCIATIC-NERVE; EXPRESSION; RECOVERY; NEUROCHEMISTRY; INFLAMMATION; SENSITIVITY; RESPONSES; RESOURCE; HORMONE	A variety of mouse strains and sexes are used in studies of corneal wound healing and nerve regeneration. However, there is a gap of knowledge about corneal nerve density and its function in different mouse strains and sexes. In this study, we report a strain divergence of total and substance P (SP) sensory corneal nerves in uninjured mice. The BALB/c mouse showed the highest nerve density, corneal sensitivity, and tear volume followed by CFW and then C57BL/6. No differences were found in total nerves and SP-positive nerves between sexes. After injury damaged the corneal nerves, an important role for mouse strains, biologic sex, and their association to corneal nerve regeneration was identified. All female mice have a faster nerve regeneration rate than males. The molecular mechanism of this sexual divergence involves higher secretion neurotrophic factors in tears, which in turn modulate gene expression in trigeminal ganglion neurons. An important upstream signaling regulator was -estradiol, and topical treatment with -estradiol confirmed its function in corneal nerve regeneration. In conclusion, our study shows that the strain and sex of laboratory mice significantly affect the different indicators of corneal innervation and nerve regeneration. Researchers investigating corneal diseases should carefully consider these factors.Pham, T. L., Kakazu, A., He, J., Bazan, H. E. P. Mouse strains and sexual divergence in corneal innervation and nerve regeneration.	[Thang Luong Pham; Kakazu, Azucena; He, Jiucheng; Bazan, Haydee E. P.] Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA; [He, Jiucheng; Bazan, Haydee E. P.] Louisiana State Univ Hlth New Orleans, Sch Med, Dept Ophthalmol, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bazan, HEP (corresponding author), Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA.; Bazan, HEP (corresponding author), Louisiana State Univ Hlth New Orleans, Sch Med, Dept Ophthalmol, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA.	hbazan1@lsuhsc.edu	PHAM, Thang/ABB-8181-2020	PHAM, Thang/0000-0001-7600-7450	Vietnam Education Foundation; U.S. National Institutes of Health, National Eye Institute [R01 EY19465]; NATIONAL EYE INSTITUTE [R01EY019465] Funding Source: NIH RePORTER	Vietnam Education Foundation; U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful to Dr. Nicolas Bazan [Louisiana State University (LSU) Health] for support with the Fluidigm technology, to Dr. Marie-Audrey Kautzmann (LSU Health) for assistance with running the Fluidigm system, and to Kenneth Terry II and Scott Sullivan (Neuroscience Center, Louisiana State University Health) for valuable help in calculating nerve density. This work was supported by the Vietnam Education Foundation (to T.L.P.) and U.S. National Institutes of Health, National Eye Institute Grant R01 EY19465 (to H.E.P.B.). The authors declare no conflicts of interest.	Barabino S, 2007, EXP EYE RES, V84, P973, DOI 10.1016/j.exer.2007.02.003; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Cortina MS, 2012, ARCH OPHTHALMOL-CHIC, V130, P76, DOI 10.1001/archophthalmol.2011.287; Cortina MS, 2010, INVEST OPHTH VIS SCI, V51, P804, DOI 10.1167/iovs.09-3641; Cortina MS, 2013, INVEST OPHTH VIS SCI, V54, P4109, DOI 10.1167/iovs.13-12075; Cruzat A, 2011, INVEST OPHTH VIS SCI, V52, P5136, DOI 10.1167/iovs.10-7048; Dvorscak L, 2008, INVEST OPHTH VIS SCI, V49, P910, DOI 10.1167/iovs.07-1324; Esquenazi S, 2005, INVEST OPHTH VIS SCI, V46, P3121, DOI 10.1167/iovs.05-0241; Gao Y, 2018, MUCOSAL IMMUNOL, V11, P1674, DOI 10.1038/s41385-018-0070-z; Gao Y, 2015, J IMMUNOL, V195, P3086, DOI 10.4049/jimmunol.1500610; He B, 2014, NEURAL REGEN RES, V9, P661, DOI 10.4103/1673-5374.130094; He J., 2018, VET OPHTHALMOL; He JC, 2017, DIABETES, V66, P2511, DOI 10.2337/db17-0249; He JC, 2017, CURR EYE RES, V42, P181, DOI 10.3109/02713683.2016.1167919; He JC, 2016, INVEST OPHTH VIS SCI, V57, P664, DOI 10.1167/iovs.15-18019; He JC, 2013, OPHTHALMIC RES, V49, P185, DOI 10.1159/000345766; He JC, 2010, EXP EYE RES, V91, P513, DOI 10.1016/j.exer.2010.07.007; Hopkinson CL, 2017, AM J TRANSPLANT, V17, P210, DOI 10.1111/ajt.13926; Islamov RR, 2002, BRAIN RES, V943, P283, DOI 10.1016/S0006-8993(02)02827-5; Kakazu A, 2012, EXP EYE RES, V103, P9, DOI 10.1016/j.exer.2012.07.008; Kanda N, 2003, J INVEST DERMATOL, V121, P771, DOI 10.1046/j.1523-1747.2003.12487.x; Knott EJ, 2018, CELL MOL NEUROBIOL, V38, P901, DOI 10.1007/s10571-017-0565-2; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Mack AF, 2006, BRAIN RES, V1103, P25, DOI 10.1016/j.brainres.2006.04.135; Marfurt CF, 2001, INVEST OPHTH VIS SCI, V42, P2242; McCarty CA, 1996, AUST NZ J OPHTHALMOL, V24, P215, DOI 10.1111/j.1442-9071.1996.tb01583.x; Mietto BS, 2015, J NEUROSCI, V35, P16431, DOI 10.1523/JNEUROSCI.2119-15.2015; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Nobakhti-Afshar Ahmadreza, 2016, Bull Emerg Trauma, V4, P141; Pal-Ghosh S, 2008, EXP EYE RES, V87, P478, DOI 10.1016/j.exer.2008.08.013; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Sakalidou M, 2011, J PERIPHER NERV SYST, V16, P334, DOI 10.1111/j.1529-8027.2011.00368.x; Sator MO, 1998, BRIT J OBSTET GYNAEC, V105, P100, DOI 10.1111/j.1471-0528.1998.tb09358.x; Schellino R, 2016, SCI REP-UK, V6, DOI 10.1038/srep36063; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2011, CHEM BIOL, V18, P976, DOI 10.1016/j.chembiol.2011.06.008; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stenberg L, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-107; Suzuki T, 2001, CURR EYE RES, V22, P28, DOI 10.1076/ceyr.22.1.28.6980; Tachibana M, 2000, INVEST OPHTH VIS SCI, V41, P668; Pham TL, 2017, J BIOL CHEM, V292, P18486, DOI 10.1074/jbc.M117.801472; Vacca V, 2016, SCI REP-UK, V6, DOI 10.1038/srep18980; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Wood K, 2012, DEV NEUROBIOL, V72, P688, DOI 10.1002/dneu.20960; Yoshida Y, 2009, INVEST OPHTH VIS SCI, V50, P2103, DOI 10.1167/iovs.08-3046	48	19	19	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4598	4609		10.1096/fj.201801957R	http://dx.doi.org/10.1096/fj.201801957R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30561223	Green Published, hybrid			2022-12-28	WOS:000459794800119
J	Yoshida, K; Kita, Y; Tokuoka, SM; Hamano, F; Yamazaki, M; Sakimura, K; Kano, M; Shimizu, T				Yoshida, Kenji; Kita, Yoshihiro; Tokuoka, Suzumi M.; Hamano, Fumie; Yamazaki, Maya; Sakimura, Kenji; Kano, Masanobu; Shimizu, Takao			Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB1 cannabinoid receptor-deficient mice	FASEB JOURNAL			English	Article						metabolic syndrome; satiety; adipose tissue; liver; intestine	GLUCAGON-LIKE PEPTIDE-1; FOOD-INTAKE; MOLECULAR REGULATION; PROTECTS MICE; ENERGY; RESISTANCE; LIPOLYSIS; INSULIN; CHOLESTEROL; SENSITIVITY	Excess energy intake causes obesity, which leads to insulin resistance and various other complications of metabolic syndrome, including diabetes, atherosclerosis, dyslipidemia, and nonalcoholic fatty liver disease. Although recent studies have depicted altered lipid metabolism as an underlying feature, the detailed mechanisms are still unclear. Here we describe a possible role in high-fat diet (HFD)-induced obesity for monoacylglycerol lipase (MGL), an enzyme that is also known to hydrolyze the endocannabinoid 2-arachidonoylglycerol in brain. MGL-deficient [MGL-knockout (KO)] mice fed a HFD gained less body weight than wild-type mice and were protected from insulin resistance and hepatic steatosis. Food intake and energy expenditure were not altered in MGL-KO mice, but blood triglyceride levels after oral olive oil gavage were suppressed, indicating a role for MGL in intestinal fat absorption. Experiments with cannabinoid receptor type 1 (CB1)/MGL double-KO mice revealed that these phenotypes may include mechanisms that are independent of CB1-receptor-mediated endocannabinoid functions. We also noted that MGL-KO mice had less preference for HFD over normal chow diet. Oral but not intraperitoneal lipid administration strongly suppressed the appetites of MGL-KO and CB1/MGL double-KO mice, but not of wild-type and CB1-KO mice. Appetite suppression was reversed by vagotomy, suggesting involvement of MGL in the gut-brain axis regulation of appetite. Our results provide mechanistic insights of MGL's role in diet-induced obesity, lipid metabolic disorder, and regulation of appetite.Yoshida, K., Kita, Y., Tokuoka, S. M., Hamano, F., Yamazaki, M., Sakimura, K., Kano, M., Shimizu, T. Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB1 cannabinoid receptor-deficient mice.	[Yoshida, Kenji; Kita, Yoshihiro; Tokuoka, Suzumi M.; Hamano, Fumie; Shimizu, Takao] Univ Tokyo, Dept Lipid, Tokyo, Japan; [Kita, Yoshihiro; Hamano, Fumie] Univ Tokyo, Life Sci Core Facil, Tokyo, Japan; [Kano, Masanobu] Univ Tokyo, Dept Neurophysiol, Grad Sch Med, Tokyo, Japan; [Kano, Masanobu] Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, UTIAS, Tokyo, Japan; [Hamano, Fumie; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Yamazaki, Maya; Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata, Japan; [Yamazaki, Maya] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan; Niigata University; University of California System; University of California San Francisco	Kita, Y (corresponding author), Univ Tokyo, Dept Lipid, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	kita@m.u-tokyo.ac.jp	Yamazaki, Maya/C-6952-2012; Shimizu, Takao/AAV-7052-2021	Kano, Masanobu/0000-0002-0725-3292	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) [15K08296, 16H06276, 25000015, 24229003]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors thank J. Aoki and K. Kano (Tohoku University, Sendai, Japan) for technical assistance with mouse vagotomy. The authors also thank W. Valentine (National Center for Global Health and Medicine, Tokyo, Japan) and A. Kobayashi (The University of Tokyo) for critical reading and technical assistance, respectively, as well as other laboratory members for valuable discussions. This work was supported, in part, by Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grants 15K08296 (to Y.K.), 16H06276 (to K.S.), 25000015 (to M.K.), and 24229003 (to T.S.), and Takeda Science Foundation (to T.S.). CB<INF>1</INF>-KO mice were kindly provided by A. Zimmer (University of Bonn, Bonn, Germany). The authors declare no conflicts of interest.	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Agudo J, 2010, DIABETOLOGIA, V53, P2629, DOI 10.1007/s00125-010-1894-6; Bederman IR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1048, DOI 10.1152/ajpendo.00340.2005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Botham KM, 2013, PROG LIPID RES, V52, P446, DOI 10.1016/j.plipres.2013.06.001; Castro-Perez J, 2011, J LIPID RES, V52, P159, DOI 10.1194/jlr.D009787; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Chon SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043962; Derbenev AV, 2016, SEMIN IMMUNOPATHOL, V38, P397, DOI 10.1007/s00281-015-0529-x; Douglass JD, 2015, J LIPID RES, V56, P1153, DOI 10.1194/jlr.M058586; EDWARDS GL, 1986, AM J PHYSIOL, V251, pR971, DOI 10.1152/ajpregu.1986.251.5.R971; Ertunc ME, 2016, J LIPID RES, V57, P2099, DOI 10.1194/jlr.R066514; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hankir MK, 2017, CELL METAB, V25, P335, DOI 10.1016/j.cmet.2016.12.006; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Jung KM, 2012, CELL METAB, V15, P299, DOI 10.1016/j.cmet.2012.01.021; Kentish SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135892; Kita Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133663; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; LEE JS, 1960, AM J PHYSIOL, V199, P238, DOI 10.1152/ajplegacy.1960.199.2.238; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Neeland IJ, 2018, CIRCULATION, V137, P1391, DOI 10.1161/CIRCULATIONAHA.117.029617; Nelson DW, 2014, J BIOL CHEM, V289, P17338, DOI 10.1074/jbc.M114.555961; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Palmer RK, 2013, CURR TOP MED CHEM, V13, P247; Petrosino S, 2016, BRIT J PHARMACOL, V173, P1154, DOI 10.1111/bph.13084; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Rachdaoui N, 2009, MOL CELL PROTEOMICS, V8, P2653, DOI 10.1074/mcp.M900026-MCP200; Richey JM, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0924-x; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schmitz K, 2016, INT J OBESITY, V40, P366, DOI 10.1038/ijo.2015.169; SCHOTZ MC, 1957, AM J PHYSIOL, V188, P399, DOI 10.1152/ajplegacy.1957.188.2.399; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Skibicka KP, 2013, CURR OPIN PHARMACOL, V13, P977, DOI 10.1016/j.coph.2013.09.004; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Taschler U, 2015, BRIT J PHARMACOL, V172, P4419, DOI 10.1111/bph.13224; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; Verty ANA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140592; Vujic N, 2017, ONCOTARGET, V8, P33122, DOI 10.18632/oncotarget.16529; Yen CLE, 2015, J LIPID RES, V56, P489, DOI 10.1194/jlr.R052902; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Zhang XY, 2016, CELL PHYSIOL BIOCHEM, V40, P1175, DOI 10.1159/000453171; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zygmunt PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081618	53	17	17	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2484	2497		10.1096/fj.201801203R	http://dx.doi.org/10.1096/fj.201801203R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30265576				2022-12-28	WOS:000457296600076
J	Tanaka, M; Sugimoto, K; Fujimoto, T; Xie, KY; Takahashi, T; Akasaka, H; Kurinami, H; Yasunobe, Y; Matsumoto, T; Fujino, H; Rakugi, H				Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Kurinami, Hitomi; Yasunobe, Yukiko; Matsumoto, Tomohiro; Fujino, Hidemi; Rakugi, Hiromi			Preventive effects of low-intensity exercise on cancer cachexia-induced muscle atrophy	FASEB JOURNAL			English	Article						protein degradation; protein synthesis; hypoxia; AMPK; mTOR	ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; ELECTRICAL-STIMULATION; SYSTEMIC INFLAMMATION; VEGF EXPRESSION; TNF-ALPHA; AMPK; BEARING; CELLS; MICE	We hypothesized that low-intensity endurance exercise might be more effective in preventing cancer cachexia-induced muscle atrophy through both an increase in protein synthesis and a decrease in protein degradation. The purpose of present study was to evaluate the effects and to clarify the mechanism of low-intensity endurance exercise on cancer cachexia-induced muscle atrophy. Twenty-four male Wistar rats were randomly divided into 4 groups: control (Cont), Cont plus exercise (Ex), AH130-induced cancer cachexia (AH130), and AH130 plus Ex. Cancer cachexia was induced by intraperitoneal injections with AH130 Yoshida ascites hepatoma cells; we analyzed the changes in muscle mass and the gene and protein expression levels of major regulators or indicators of skeletal muscle protein degradation and synthesis pathway in the soleus muscles. Low-intensity exercise inhibited the muscle mass loss through a suppression of the ubiquitin-proteasome pathway, increased hypoxia-inducible factor- 1 alpha and phosphorylated AMPK, and inhibited the deactivation of mammalian target of rapamycin pathway in the soleus muscle, which contributed to the prevention of cancer cachexia-induced muscle atrophy. These results suggest that low-intensity exercise has the potential to become an effective therapeutic intervention for the prevention of cancer cachexia-induced muscle atrophy.-Tanaka, M., Sugimoto, K., Fujimoto, T., Xie, K., Takahashi, T., Akasaka, H., Kurinami, H., Yasunobe, Y., Matsumoto, T., Fujino, H., Rakugi, H. Preventive effects of low-intensity exercise on cancer cachexia-induced muscle atrophy.	[Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Kurinami, Hitomi; Yasunobe, Yukiko; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, B6 2-2, Suita, Osaka 5650871, Japan; [Tanaka, Minoru; Matsumoto, Tomohiro; Fujino, Hidemi] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Kobe, Hyogo, Japan; [Tanaka, Minoru; Sugimoto, Ken] Osaka Hlth Sci Univ, Dept Rehabil Sci, Osaka, Japan	Osaka University; Kobe University	Sugimoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, B6 2-2, Suita, Osaka 5650871, Japan.	sugimoto@geriat.med.osaka-u.ac.jp		Takahashi, Toshimasa/0000-0002-5203-155X	Japanese Ministry of Education, Culture, Sports, Science, and Technology	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors are grateful to Koichi Yamamoto and Yoichi Takami (both from Osaka University) for their advice. The authors also thank Tomoko Sato (Osaka University) for her excellent technical assistance. This study was supported by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The authors declare no conflicts of interest.	ARAKI CT, 1994, J VASC SURG, V20, P872, DOI 10.1016/0741-5214(94)90223-2; Argiles JM, 2012, J CACHEXIA SARCOPENI, V3, P73, DOI 10.1007/s13539-012-0067-5; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Cannavino J, 2015, J PHYSIOL-LONDON, V593, P1981, DOI 10.1113/jphysiol.2014.286740; Carbo N, 2002, BRIT J CANCER, V86, P1012, DOI 10.1038/sj.bjc.6600167; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; Devine RD, 2017, AM J PHYSIOL-HEART C, V312, pH1154, DOI 10.1152/ajpheart.00090.2016; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fernandez-Celemin L, 2002, AM J PHYSIOL-ENDOC M, V283, pE1279, DOI 10.1152/ajpendo.00054.2002; Fillmore N, 2010, J APPL PHYSIOL, V109, P511, DOI 10.1152/japplphysiol.00126.2010; Frier BC, 2012, AM J PHYSIOL-CELL PH, V302, pC1772, DOI 10.1152/ajpcell.00410.2011; Fujita J, 1996, INT J CANCER, V68, P637, DOI 10.1002/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z; HANSENSMITH FM, 1992, J APPL PHYSIOL, V73, P776, DOI 10.1152/jappl.1992.73.2.776; Harber MP, 2009, AM J PHYSIOL-REG I, V296, pR708, DOI [10.1152/ajpregu.00354.2009, 10.1152/ajpregu.90906.2008]; Huttemann M, 2012, FASEB J, V26, P1413, DOI 10.1096/fj.11-196154; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jiang CM, 2016, INT J BIOCHEM CELL B, V72, P118, DOI 10.1016/j.biocel.2016.01.011; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim Hye Jin, 2017, J Exerc Nutrition Biochem, V21, P19, DOI 10.20463/jenb.2017.0022; KJAER M, 1993, AM J PHYSIOL, V265, pE275, DOI 10.1152/ajpendo.1993.265.2.E275; Kondo H, 2015, MUSCLE NERVE, V51, P391, DOI 10.1002/mus.24316; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Lira FS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00856; Llovera M, 1998, MOL CELL ENDOCRINOL, V142, P183, DOI 10.1016/S0303-7207(98)00105-1; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Mijwel S, 2018, FASEB J, V32, P5495, DOI 10.1096/fj.201700968R; Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Perry BD, 2016, EXERC IMMUNOL REV, V22, P94; Phillips SM, 2009, APPL PHYSIOL NUTR ME, V34, P403, DOI 10.1139/H09-042; Qi Y, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0156-4; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sanchez AMJ, 2012, AM J PHYSIOL-CELL PH, V303, pC475, DOI 10.1152/ajpcell.00125.2012; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Takeshita H, 2017, SCI REP-UK, V7, DOI 10.1038/srep42323; Tanaka M, 2016, J MUSCULOSKEL NEURON, V16, P152; Tanaka M, 2014, ACTA HISTOCHEM, V116, P1192, DOI 10.1016/j.acthis.2014.06.009; Tanaka M, 2013, J MOL HISTOL, V44, P203, DOI 10.1007/s10735-012-9473-4; TESSITORE L, 1987, BIOCHEM J, V241, P153, DOI 10.1042/bj2410153; Tisdale MJ, 2010, CURR OPIN GASTROEN, V26, P146, DOI 10.1097/MOG.0b013e3283347e77; Uchida K, 2016, GEN PHYSIOL BIOPHYS, V35, P425, DOI 10.4149/gpb_2016016; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339	50	19	19	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7852	7862		10.1096/fj.201802430R	http://dx.doi.org/10.1096/fj.201802430R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30916585	Bronze			2022-12-28	WOS:000476234700006
J	Cappelletti, C; Galbardi, B; Bruttini, M; Salerno, F; Canioni, E; Pasanisi, MB; Rodolico, C; Brizzi, T; Mora, M; Renieri, A; Maggi, L; Bernasconi, P; Mantegazza, R				Cappelletti, Cristina; Galbardi, Barbara; Bruttini, Mirella; Salerno, Franco; Canioni, Eleonora; Pasanisi, Maria Barbara; Rodolico, Carmelo; Brizzi, Teresa; Mora, Marina; Renieri, Alessandra; Maggi, Lorenzo; Bernasconi, Pia; Mantegazza, Renato			Aging-associated genes and let-7 microRNAs: a contribution to myogenic program dysregulation in oculopharyngeal muscular dystrophy	FASEB JOURNAL			English	Article						differentiation; regeneration; skeletal muscle	GROUP BOX PROTEIN-1; SKELETAL-MUSCLE; SATELLITE CELLS; INTERLEUKIN-6; EXPRESSION; HMGB1; DIFFERENTIATION; PROGRESSION; MECHANISMS; DECLINE	Oculopharyngeal muscular dystrophy (OPMD) is a late-onset muscle disease caused by an abnormal (GCN) triplet expansion within the polyadenylate-binding protein nuclear 1 gene and consequent mRNA processing impairment and myogenic defects. Because a reduced cell proliferation potential and the consequent regeneration failure of aging muscle have been shown to be governed by lethal-7 (let-7) microRNA-mediated mechanisms, in the present study, we evaluated the role of let-7 in the pathogenesis of OPMD. By a multidisciplinary approach, including confocal microscopy, Western blot, and quantitative PCR analyses on muscle biopsies from patients and unaffected individuals, we found a significant increase in let-7 expression in OPMD muscles associated with an unusual high percentage of paired box 7-positive satellite cells. Furthermore, IL-6, a cytokine involved in the regulation of satellite cell proliferation and differentiation and a potential target of let-7, was found strongly down-regulated in OPMD compared with control muscles. The decrease in IL-6 transcript levels and protein content was also confirmed in vitro during differentiation of patients' and controls' muscle cells. Overall, our data suggest a key role of let-7 in the regeneration and degeneration process in OPMD muscle and pointed to IL-6 as a potential target molecule for new therapeutic approaches for this disorder.-Cappelletti, C., Galbardi, B., Bruttini, M., Salerno, F., Canioni, E., Pasanisi, M. B., Rodolico, C., Brizzi, T., Mora, M., Renieri, A., Maggi, L., Bernasconi, P., Mantegazza, R. Aging-associated genes and let-7 microRNAs: a contribution to myogenic program dysregulation in oculopharyngeal muscular dystrophy.	[Cappelletti, Cristina; Galbardi, Barbara; Salerno, Franco; Canioni, Eleonora; Pasanisi, Maria Barbara; Mora, Marina; Maggi, Lorenzo; Bernasconi, Pia; Mantegazza, Renato] Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Neurol Neuroimmunol & Neuromuscular Dis Unit 4, Ist Neurol Carlo Besta, Milan, Italy; [Bruttini, Mirella; Renieri, Alessandra] Univ Siena, Med Genet, Siena, Italy; [Bruttini, Mirella; Renieri, Alessandra] Azienda Osped Univ Senese, Genet Med, Siena, Italy; [Rodolico, Carmelo; Brizzi, Teresa] Univ Messina, Dept Neurosci, Messina, Italy; [Brizzi, Teresa] Univ Palermo, Dipartimento Biomed Med Interna & Specialist DiBi, Palermo, Italy	IRCCS Istituto Neurologico Besta; University of Siena; University of Siena; University Hospital of Siena; University of Messina; University of Palermo	Bernasconi, P (corresponding author), Fdn IRCCS Ist Neurol Carlo Sesta, Neurol Neuroimmunol & Neuromuscular Dis Unit 4, Via Celoria 11, I-20133 Milan, Italy.	pia.bernasconi@istituto-besta.it	Bernasconi, Pia/AAB-7590-2019; Galbardi, Barbara/ABH-4699-2020; Salerno, Franco/J-9198-2016; Mantegazza, Renato/AAB-7569-2019; Cappelletti, Cristina/AAH-5493-2021; Canioni, Eleonora/AAM-8989-2021; Mora, Marina/J-2883-2018; Renieri, Alessandra/K-5950-2016	Salerno, Franco/0000-0003-0811-4443; Mantegazza, Renato/0000-0002-9810-5737; Cappelletti, Cristina/0000-0002-4855-3136; Canioni, Eleonora/0000-0003-0483-9754; Mora, Marina/0000-0002-5765-2320; Bernasconi, Pia/0000-0003-0869-2104; RODOLICO, Carmelo/0000-0003-2543-6356; Renieri, Alessandra/0000-0002-0846-9220	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The authors gratefully acknowledge Dr. L. Morandi [Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Neurologico Carlo Besta] for the precious suggestions in the experimental design and the interpretation of the results as well as EuroBioBank and Telethon Network of Genetic Biobanks (GTB07001F) for providing biological samples (muscle biopsies). This work was supported by grants to R.M. from the Annual Research Funding of the Italian Ministry of Health. The authors declare no conflicts of interest.	Abu-Baker A, 2007, BBA-MOL BASIS DIS, V1772, P173, DOI 10.1016/j.bbadis.2006.10.003; Anvar SY, 2013, AGING-US, V5, P412, DOI 10.18632/aging.100567; Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Belizario JE, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2197-2; Brais B, 2009, CURR NEUROL NEUROSCI, V9, P76, DOI 10.1007/s11910-009-0012-y; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; D'Souza RF, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00383; De Mori R, 2007, ARTERIOSCL THROM VAS, V27, P2377, DOI 10.1161/ATVBAHA.107.153429; Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559; Dormoy-Raclet V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3388; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Gidaro T, 2013, J NEUROPATH EXP NEUR, V72, P234, DOI 10.1097/NEN.0b013e3182854c07; Hurschler BA, 2011, NUCLEIC ACIDS RES, V39, P5647, DOI 10.1093/nar/gkr145; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jung HJ, 2019, J GERONTOL A-BIOL, V74, P1008, DOI 10.1093/gerona/gly207; Kami K, 1998, MUSCLE NERVE, V21, P819, DOI 10.1002/(SICI)1097-4598(199806)21:6<819::AID-MUS20>3.0.CO;2-M; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Lawson-Smith MJ, 1998, J ANAT, V192, P161, DOI 10.1046/j.1469-7580.1998.19220161.x; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Muth IE, 2015, EXP NEUROL, V271, P189, DOI 10.1016/j.expneurol.2015.05.023; Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Raz Y, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00317; Riuzzi F, 2012, J CELL SCI, V125, P1440, DOI 10.1242/jcs.092163; Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Tirone M, 2018, J EXP MED, V215, P303, DOI 10.1084/jem.20160217; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Yang H, 2015, MOL MED, V21, pS6, DOI 10.2119/molmed.2015.00087; Zacharewicz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114009; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	43	7	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7155	7167		10.1096/fj.201801577RR	http://dx.doi.org/10.1096/fj.201801577RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30860873	Bronze			2022-12-28	WOS:000476114200040
J	Ma, H; Li, YZ; Liang, HJ; Chen, SJY; Pan, SY; Chang, LL; Li, SL; Zhang, Y; Liu, XY; Xu, YW; Shao, YC; Yang, YB; Guo, JH				Ma, Huan; Li, Yunzhen; Liang, Haojian; Chen, Shijunyin; Pan, Siyu; Chang, Lulin; Li, Silin; Zhang, Ying; Liu, Xinyan; Xu, Yanwen; Shao, Yongcong; Yang, Yebing; Guo, Jinhu			Sleep deprivation and a non-24-h working schedule lead to extensive alterations in physiology and behavior	FASEB JOURNAL			English	Article						cognition; hormone; salivary microbiota; circadian rhythms	CIRCADIAN-RHYTHMS; PSYCHOLOGICAL FUNCTIONS; MERCHANT VESSELS; NEUROBEHAVIORAL PERFORMANCE; SHIFT WORK; JET-LAG; SEA; WATCHKEEPERS; MICROBIOTA; SUBMARINERS	Most organisms on Earth possess circadian rhythms in their physiology and behaviors that allow them to resonate with the cycling environment over a 24-h period. However, in human society, a substantial quantity of jobs requires non-24-h working and rest or shift schedules, which causes more or less misalignment in circadian rhythms and disorders as a consequence. In this work, we conducted a sleep deprivation (SD) and non-24-h working and rest schedule (8 h on and 4 h off) experiment over 10 d in total and measured the changes in a series of physiologic and cognitive parameters. The results show that although the subjects could sleep during the schedule, their sleepiness increased significantly. Actigraphy data suggest that a 12-h schedule might result in chronic SD. Along with the increased sleepiness revealed by the Karolinska Sleepiness Scale questionnaire, the neurobehavioral psychomotor vigilance test data reveal that, compared with the control period, the reaction time of the subjects was significantly delayed. The saliva insulin levels were significantly changed in the morning in SD and non-24-h cycles. Salivary biochemical parameters were also altered, including aspartate aminotransferase and K+. 16S rRNA-based analysis of the salivary microbiota showed differentially changed patterns in bacteria composition and concentration. Together, these data demonstrate that an abnormal working and rest schedule might produce comprehensive interference with circadian rhythms, metabolism, and cognition.-Ma, H., Li, Y., Liang, H., Chen, S., Pan, S., Chang, L., Li, S., Zhang, Y., Liu, X., Xu, Y., Shao, Y., Yang, Y., Guo, J. Sleep deprivation and a non-24-h working schedule lead to extensive alterations in physiology and behavior.	[Ma, Huan; Li, Yunzhen; Liang, Haojian; Chen, Shijunyin; Pan, Siyu; Chang, Lulin; Li, Silin; Guo, Jinhu] Sun Yat Sen Univ, Minist Educ MOE Key Lab Gene Funct & Regulat, Sch Life Sci, State Key Lab Biocontrol, Xingang Rd, Guangzhou 510006, Guangdong, Peoples R China; [Liu, Xinyan; Xu, Yanwen] Sun Yat Sen Univ, Affiliated Hosp 1, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China; [Chang, Lulin] Guangdong Jiangmen Chinese Tradit Med Coll, Jiangmen, Peoples R China; [Zhang, Ying; Shao, Yongcong] Gen Hosp Chinese Peoples Liberat Army, Med Ctr 8, Beijing, Peoples R China; [Yang, Yebing] Gen Hosp Chinese Peoples Liberat Army, Med Ctr 6, Beijing 100048, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sixth Medical Center of Chinese PLA General Hospital	Guo, JH (corresponding author), Sun Yat Sen Univ, Minist Educ MOE Key Lab Gene Funct & Regulat, Sch Life Sci, State Key Lab Biocontrol, Xingang Rd, Guangzhou 510006, Guangdong, Peoples R China.; Yang, YB (corresponding author), Gen Hosp Chinese Peoples Liberat Army, Med Ctr 6, Beijing 100048, Peoples R China.	552045196@qq.com; guojinhu@mail.sysu.edu.cn			National 973 Program of China [2011CB711000, 2012CB947600]; Open Fund of the National Key Laboratory of Human Factors Engineering in the Astronaut Center of China [SYFD180051809K]; National Natural Science Foundation of China [31571205, 31171119, 81501622]; Science Foundation of 309 Hospital [2015MS018]; NDSTISZP [1716312ZT00210001]	National 973 Program of China(National Basic Research Program of China); Open Fund of the National Key Laboratory of Human Factors Engineering in the Astronaut Center of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of 309 Hospital; NDSTISZP	The authors thank Prof. Qianxiang Zhou (Beihang University, Beijing, China) for help in organizing the experiment, and all of the volunteers and staff who participated in this experiment. This work was supported by the NDSTISZP (1716312ZT00210001), the National 973 Program of China (Grants 2011CB711000 and 2012CB947600), the Open Fund of the National Key Laboratory of Human Factors Engineering in the Astronaut Center of China (SYFD180051809K), the National Natural Science Foundation of China (Grants 31571205, 31171119, 81501622, and 81501622), and the Science Foundation of 309 Hospital (Grant 2015MS018). The authors declare no conflicts of interest.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Collado MC, 2018, FASEB J, V32, P2060, DOI 10.1096/fj.201700697RR; Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008; COLQUHOUN WP, 1985, ERGONOMICS, V28, P637, DOI 10.1080/00140138508963178; COLQUHOUN WP, 1988, INT ARCH OCC ENV HEA, V60, P321, DOI 10.1007/BF00405665; CONDON R, 1988, INT ARCH OCC ENV HEA, V60, P405, DOI 10.1007/BF00381387; CONDON R, 1988, INT ARCH OCC ENV HEA, V61, P39, DOI 10.1007/BF00381606; Duplessis CA, 2007, UNDERSEA HYPERBAR M, V34, P21; Eriksen CA, 2006, CHRONOBIOL INT, V23, P1193, DOI 10.1080/07420520601057981; Flynn-Evans EE, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2015.19; Guo JH, 2014, MILITARY MED RES, V1, DOI 10.1186/2054-9369-1-23; Harma M, 2008, CHRONOBIOL INT, V25, P413, DOI 10.1080/07420520802106769; Hilditch CJ, 2016, CHRONOBIOL INT, V33, P685, DOI 10.3109/07420528.2016.1167724; Honma S, 2018, J PHYSIOL SCI, V68, P207, DOI 10.1007/s12576-018-0597-5; Kang J, 2018, ENDOCRINE, V59, P614, DOI 10.1007/s12020-017-1518-8; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kelly TL, 1999, J BIOL RHYTHM, V14, P190, DOI 10.1177/074873099129000597; Kosmadopoulos A, 2014, CHRONOBIOL INT, V31, P1209, DOI 10.3109/07420528.2014.957763; Liang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033861; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Nagaya T, 2002, INT ARCH OCC ENV HEA, V75, P562, DOI 10.1007/s00420-002-0370-0; Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967; Perelis M, 2015, SCIENCE, V350, DOI 10.1126/science.aac4250; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reid KJ, 2015, SLEEP MED CLIN, V10, P523, DOI 10.1016/j.jsmc.2015.08.006; Sack RL, 2007, SLEEP, V30, P1460, DOI 10.1093/sleep/30.11.1460; Sharpley CF, 2012, REV NEUROSCIENCE, V23, P111, DOI 10.1515/RNS.2011.058; Short MA, 2016, APPL ERGON, V54, P72, DOI 10.1016/j.apergo.2015.12.004; Shub Y, 2001, CHRONOBIOL INT, V18, P987, DOI 10.1081/CBI-100107973; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Thomann J, 2014, J CLIN SLEEP MED, V10, P1019, DOI 10.5664/jcsm.4042; Tonetti L, 2016, BIOL RHYTHM RES, V47, P573, DOI 10.1080/09291016.2016.1167312; Vaze KM, 2013, CHRONOBIOL INT, V30, P413, DOI 10.3109/07420528.2012.754457; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Wefers J, 2018, P NATL ACAD SCI USA, V115, P7789, DOI 10.1073/pnas.1722295115; WINGET CM, 1984, AVIAT SPACE ENVIR MD, V55, P1085; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Xu T., 2016, J PREV MED CHIN PLA, V34, P556	42	8	10	3	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6969	6979		10.1096/fj.201802727R	http://dx.doi.org/10.1096/fj.201802727R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30841753	Bronze			2022-12-28	WOS:000476114200025
J	Kuehn, C; Tauchi, M; Furtmair, R; Urschel, K; Raaz-Schrauder, D; Neumann, AL; Frohberger, SJ; Hoerauf, A; Regus, S; Lang, W; Sagban, TA; Stumpfe, FM; Achenbach, S; Hubner, MP; Dietel, B				Kuehn, Constanze; Tauchi, Miyuki; Furtmair, Roman; Urschel, Katharina; Raaz-Schrauder, Dorette; Neumann, Anna-Lena; Frohberger, Stefan J.; Hoerauf, Achim; Regus, Susanne; Lang, Werner; Sagban, Tolga Atilla; Stumpfe, Florian Matthias; Achenbach, Stephan; Huebner, Marc P.; Dietel, Barbara			Filarial extract of Litomosoides sigmodontis induces a type 2 immune response and attenuates plaque development in hyperlipidemic ApoE-knockout mice	FASEB JOURNAL			English	Article						atherosclerosis; inflammation; helminth; endothelial activation; JNK	NONOBESE DIABETIC MICE; SHEAR-STRESS; ATHEROSCLEROTIC PLAQUES; T-LYMPHOCYTES; TH1; MECHANISMS; HELMINTHS; CYTOKINE; ANTIGEN; PROTEIN	A type 1 immune response is involved in atherosclerosis progression, whereas the role of a type 2 polarization, especially with regard to an enhanced T helper (T-h)2 cell differentiation, is still unclear. Helminths trigger type 2 immune responses, protecting the host from inflammatory disorders. We investigated whether an increased type 2 polarization by administration of Litomosoides sigmodontis adult worm extract (LsAg) affects atherosclerosis in apolipoprotein E-deficient (ApoE(-/-)) mice. Injections of 50 mu g LsAg, i.p. into ApoE(-/-) mice induced a type 2 immune response shown by increased frequencies of peritoneal eosinophils and alternatively activated macrophages. To analyze the effect of LsAg on atherosclerosis initiation, ApoE(-/-) mice received a high-fat diet for 12 wk and weekly injections of 50 mu g LsAg from wk 5 to 12. Therapeutic effects on advanced atherosclerosis were analyzed in mice that were fed a high-fat diet for 12 wk followed by 12 wk of normal chow and weekly LsAg injections. Both preventive and therapeutic LsAg application significantly decreased plaque size. Therapeutic treatment even caused regression of plaque size and macrophage density in the aortic root and reduced T(h)1-specific gene expression and intraplaque inflammation. In addition, plaque size after therapeutic treatment was inversely correlated with plaque-infiltrated alternatively activated macrophages. In vitro, LsAg treatment of HUVECs reduced intracellular levels of phosphorylated NF-B-p65, IB-, and JNK1/2. In bifurcation flow-through slides, THP-1 cell adhesion to a HUVEC monolayer was decreased by LsAg in regions of nonuniform shear stress. Applying inhibitors of the respective kinases suggests JNK1/2 inhibition is involved in the suppressed cell adhesion. A switch to an enhanced type 2 immune response by LsAg exerts antiatherogenic effects on murine plaque development, indicating a protective role of a hampered type 1 polarization. In vitro, LsAg affects endothelial signaling pathways, among which JNK1/2 inhibition seems to be involved in the suppression of monocytic cell adhesion under proatherogenic shear stress.Constanze, K., Tauchi, M., Furtmair, R., Urschel, K., Raaz-Schrauder, D., Neumann, A.-L., Frohberger, S. J., Hoerauf, A., Regus, S., Lang, W., Sagban, T. A., Stumpfe, F. M., Achenbach, S., Hubner, M. P., Dietel, B. Filarial extract of Litomosoides sigmodontis induces a type 2 immune response and attenuates plaque development in hyperlipidemic ApoE-knockout mice.	[Kuehn, Constanze; Tauchi, Miyuki; Furtmair, Roman; Urschel, Katharina; Raaz-Schrauder, Dorette; Achenbach, Stephan; Dietel, Barbara] Friedrich Alexander Univ FAU Erlangen Nuernberg, Dept Med Cardiol & Angiol 2, Erlangen, Germany; [Regus, Susanne; Lang, Werner; Sagban, Tolga Atilla] Univ Hosp Erlangen, Dept Vasc Surg, Erlangen, Germany; [Stumpfe, Florian Matthias] Univ Hosp Erlangen, Dept Obstet & Gynecol, Erlangen, Germany; [Neumann, Anna-Lena; Frohberger, Stefan J.; Hoerauf, Achim; Huebner, Marc P.] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Hoerauf, Achim] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany; [Sagban, Tolga Atilla] Sana Klinikum Hameln Pyrmt, Hameln, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Bonn; German Center for Infection Research	Dietel, B (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Med Cardiol & Angiol 2, Schwabachanlage 12, D-91054 Erlangen, Germany.	barbara.dietel@uk-erlangen.de	Hübner, Marc P/O-1684-2019; Hübner, Marc P/W-9529-2018; Stumpfe, Florian/AAM-8821-2020	Hübner, Marc P/0000-0001-8885-418X; Hübner, Marc P/0000-0001-8885-418X; 	Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN)-Fonds fur Forschung und Lehre des Klinikums der Friedrich-Alexander-Universitat Erlangen-Nurnberg [15-06-02-1-Dietel]; Else Kroner-Fresenius-Stiftung [2016_A104]; Excellence Cluster Immunosensation [Deutsche Forschungsgemeinschaft (DFG), Excellence Cluster (EXC)] [1023]	Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN)-Fonds fur Forschung und Lehre des Klinikums der Friedrich-Alexander-Universitat Erlangen-Nurnberg; Else Kroner-Fresenius-Stiftung; Excellence Cluster Immunosensation [Deutsche Forschungsgemeinschaft (DFG), Excellence Cluster (EXC)]	The authors thank Nina Jaziri, Regina Altendorf, Doris Flick, and Heike Kloos (all from Friedrich-Alexander-University Erlangen-Nuernberg) for excellent technical assistance. This work was supported by the Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN)-Fonds fur Forschung und Lehre des Klinikums der Friedrich-Alexander-Universitat Erlangen-Nurnberg (15-06-02-1-Dietel) and the Else Kroner-Fresenius-Stiftung (2016_A104). A.H. is a member of the Excellence Cluster Immunosensation [Deutsche Forschungsgemeinschaft (DFG), Excellence Cluster (EXC) 1023], which supported the study. The authors declare no conflicts of interest.	Ajendra J, 2016, CLIN IMMUNOL, V164, P119, DOI 10.1016/j.clim.2016.02.005; Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Aprahamian TR, 2015, INT J PARASITOL, V45, P203, DOI 10.1016/j.ijpara.2014.12.006; Berbudi A, 2016, J INNATE IMMUN, V8, P601, DOI 10.1159/000448401; Berbudi A, 2016, DIABETES-METAB RES, V32, P238, DOI 10.1002/dmrr.2673; Bhat OM, 2015, J CARDIOL, V66, P28, DOI 10.1016/j.jjcc.2014.10.012; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Daugherty A, 2004, J CLIN INVEST, V114, P317, DOI 10.1172/jci200422561; Daugherty A, 2002, CIRC RES, V90, P1039, DOI 10.1161/01.RES.0000021397.28936.F9; Dietel B, 2013, ATHEROSCLEROSIS, V230, P92, DOI 10.1016/j.atherosclerosis.2013.06.014; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Elliott DE, 2007, INT J PARASITOL, V37, P457, DOI 10.1016/j.ijpara.2006.12.009; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Elliott DE, 2003, AM J PHYSIOL-GASTR L, V284, pG385, DOI 10.1152/ajpgi.00049.2002; Fernandes JL, 2004, CYTOKINE, V26, P131, DOI 10.1016/j.cyto.2004.01.007; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gimbrone MA, 1997, J CLIN INVEST, V99, P1809, DOI 10.1172/JCI119346; Gondorf F, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004616; Gurven MD, 2018, EUR HEART J, V39, P1653, DOI 10.1093/eurheartj/ehy129; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Harnett MM, 2008, ANN RHEUM DIS, V67, P518, DOI 10.1136/ard.2007.073502; Hoffmann WH, 2000, PARASITOL TODAY, V16, P387, DOI 10.1016/S0169-4758(00)01738-5; Huber SA, 2001, CIRCULATION, V103, P2610; Hubner MP, 2009, IMMUNOLOGY, V127, P512, DOI 10.1111/j.1365-2567.2008.02958.x; Hubner MP, 2013, PATHOG DIS, V69, P127, DOI 10.1111/2049-632X.12080; Hubner MP, 2012, J IMMUNOL, V188, P559, DOI 10.4049/jimmunol.1100335; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347; Lee WH, 2001, ARTERIOSCL THROM VAS, V21, P2004, DOI 10.1161/hq1201.098945; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Pineda MA, 2014, MOL BIOCHEM PARASIT, V194, P1, DOI 10.1016/j.molbiopara.2014.03.003; Pothineni NVK, 2017, EUR HEART J, V38, P3195, DOI 10.1093/eurheartj/ehx362; Ria F, 1998, EUR J IMMUNOL, V28, P2003, DOI 10.1002/(SICI)1521-4141(199806)28:06<2003::AID-IMMU2003>3.0.CO;2-S; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Santos-Gallego CG, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0401-9; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Surendar J, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12401; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Walunas TL, 1998, J IMMUNOL, V160, P3855; Wang J, 2011, MOL MED, V17, P990, DOI 10.2119/molmed.2011.00073; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Xiong QY, 2009, AUTOIMMUNITY, V42, P475, DOI 10.1080/08916930902887086; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Ziewer S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001558	56	2	2	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6497	6513		10.1096/fj.201800947RR	http://dx.doi.org/10.1096/fj.201800947RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807258	Bronze			2022-12-28	WOS:000466932600054
J	Gaspar, D; Ryan, CNM; Zeugolis, DI				Gaspar, Diana; Ryan, Christina N. M.; Zeugolis, Dimitrios I.			Multifactorial bottom-up bioengineering approaches for the development of living tissue substitutes	FASEB JOURNAL			English	Article						cell phenotype maintenance; cell differentiation; cell transdifferentiation; macromolecular crowding; mechanical stimulation	MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX DEPOSITION; ENGINEERED BLOOD-VESSEL; FOCAL ADHESION KINASE; I COLLAGEN-SYNTHESIS; CHONDROITIN-SULFATE; MECHANICAL STIMULATION; SUBSTRATE STIFFNESS; TENOGENIC DIFFERENTIATION; GENE-EXPRESSION	Bottom-up bioengineering utilizes the inherent capacity of cells to build highly sophisticated structures with high levels of biomimicry. Despite the significant advancements in the field, monodomain approaches require prolonged culture time to develop an implantable device, usually associated with cell phenotypic drift in culture. Herein, we assessed the simultaneous effect of macromolecular crowding (MMC) and mechanical loading in enhancing extracellular matrix (ECM) deposition while maintaining tenocyte (TC) phenotype and differentiating bone marrow stem cells (BMSCs) or transdifferentiating neonatal and adult dermal fibroblasts toward tenogenic lineage. At d 7, all cell types presented cytoskeleton alignment perpendicular to the applied load independently of the use of MMC. MMC enhanced ECM deposition in all cell types. Gene expression analysis indicated that MMC and mechanical loading maintained TC phenotype, whereas tenogenic differentiation of BMSCs or transdifferentiation of dermal fibroblasts was not achieved. Our data suggest that multifactorial bottom-up bioengineering approaches significantly accelerate the development of biomimetic tissue equivalents.	[Gaspar, Diana; Ryan, Christina N. M.; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway, Regenerat Modular & Dev Engn Lab REMODEL, Galway, Ireland; [Gaspar, Diana; Ryan, Christina N. M.; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Sci Fdn Ireland, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Zeugolis, DI (corresponding author), NUI Galway, Regenerat Modular & Dev Engn Lab, Biomed Sci Bldg, Galway H91 TK33, Ireland.	dimitrios.zeugolis@nuigalway.ie		zeugolis, dimitrios/0000-0002-7599-5191	NUI-Galway; Irish Government; Irish Research Council, Embark Initiative, Postgraduate Scholarship [RS/2012/82]; Health Research Board, Health Research Awards Programme [HRA_POR/2011/84]; Science Foundation Ireland, Career Development Award [15/CDA/3629]; Science Foundation Ireland; European Regional Development Fund [13/RC/2073]	NUI-Galway; Irish Government; Irish Research Council, Embark Initiative, Postgraduate Scholarship(Irish Research Council for Science, Engineering and Technology); Health Research Board, Health Research Awards Programme; Science Foundation Ireland, Career Development Award(Science Foundation Ireland); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Regional Development Fund(European Commission)	The authors thank Dr. Peadar Rooney [Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CuRAM), National University of Ireland-Galway (NUI-Galway)] for his assistance with the gene expression analysis. The authors acknowledge the Centre for Microscopy and Imaging of the National Centre for Biomedical Engineering Science (NCBES) at NUI-Galway, which is funded by NUI-Galway and the Irish Government's Programme for Research in Third Level Institutions, Cycles 4 and 5, National Development Plan 2007-2013. This work was supported by the Irish Research Council, Embark Initiative, Postgraduate Scholarship (Grant RS/2012/82); Health Research Board, Health Research Awards Programme (Grant HRA_POR/2011/84); and Science Foundation Ireland, Career Development Award (Grant 15/CDA/3629). This work was also supported by Science Foundation Ireland and the European Regional Development Fund (Grant 13/RC/2073). The authors declare no conflicts of interest.	Abbah SA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt426; Ang XM, 2014, TISSUE ENG PT A, V20, P966, DOI [10.1089/ten.TEA.2013.0337, 10.1089/ten.tea.2013.0337]; Barreira APB, 2008, INT J APPL RES VET M, V6, P46; BATEMAN JF, 1986, J BIOL CHEM, V261, P4198; BATEMAN JF, 1990, BIOCHEM J, V267, P573, DOI 10.1042/bj2670573; Becerra P, 2013, J ORTHOP RES, V31, P1096, DOI 10.1002/jor.22338; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Boccafoschi F, 2007, CELL ADHES MIGR, V1, P124, DOI 10.4161/cam.1.3.5144; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1; Chen B, 2016, PLAST RECONSTR SURG, V137, p536E, DOI 10.1097/01.prs.0000479980.83169.31; Chen C, 2011, ADV DRUG DELIVER REV, V63, P277, DOI 10.1016/j.addr.2011.03.003; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Chen J, 2014, ADV FUNCT MATER, V24, P2216, DOI 10.1002/adfm.201302949; Chen WC, 2013, J TISSUE ENG REGEN M, V7, P665, DOI 10.1002/term.1463; Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027; Chen YJ, 2008, CONNECT TISSUE RES, V49, P7, DOI 10.1080/03008200701818561; Cigognini D, 2016, SCI REP-UK, V6, DOI 10.1038/srep30746; Clarke AW, 2011, AM J SPORT MED, V39, P614, DOI 10.1177/0363546510387095; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; DARTSCH PC, 1986, ACTA ANAT, V125, P108; Deng D, 2009, BIOMATERIALS, V30, P6724, DOI 10.1016/j.biomaterials.2009.08.054; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eastwood M, 1998, P I MECH ENG H, V212, P85, DOI 10.1243/0954411981533854; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Engebretson B, 2018, CONNECT TISSUE RES, V59, P167, DOI 10.1080/03008207.2017.1324431; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; English A, 2012, J MATER SCI-MATER M, V23, P137, DOI 10.1007/s10856-011-4471-8; English A, 2015, ACTA BIOMATER, V27, P3, DOI 10.1016/j.actbio.2015.08.035; EVANKO SP, 1990, MATRIX, V10, P420, DOI 10.1016/S0934-8832(11)80150-2; Evans ND, 2009, EUR CELLS MATER, V18, P1; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]; Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078; Galloway MT, 2013, J BONE JOINT SURG AM, V95A, P1620, DOI 10.2106/JBJS.L.01004; Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619; Gaspar D, 2015, ADV DRUG DELIVER REV, V84, P240, DOI 10.1016/j.addr.2014.11.023; GAY S, 1976, P NATL ACAD SCI USA, V73, P4037, DOI 10.1073/pnas.73.11.4037; Goodman SA, 2004, BIORHEOLOGY, V41, P613; Gosiewska A, 2001, WOUND REPAIR REGEN, V9, P213, DOI 10.1046/j.1524-475x.2001.00213.x; Goude MC, 2014, CELLS TISSUES ORGANS, V199, P117, DOI 10.1159/000365966; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Guillaumin S, 2017, J AM ACAD ORTHOP SUR, V25, pE144, DOI 10.5435/JAAOS-D-17-00324; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Holladay C, 2016, J TISSUE ENG REGEN M, V10, P783, DOI 10.1002/term.1852; Horimizu M, 2013, MICRON, V48, P1, DOI 10.1016/j.micron.2013.02.001; Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Huisman E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-386; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Jaasma MJ, 2006, ANN BIOMED ENG, V34, P759, DOI 10.1007/s10439-005-9052-x; Jarvinen TAH, 1999, J CELL SCI, V112, P3157; Jiang YK, 2011, BIOMATERIALS, V32, P4085, DOI 10.1016/j.biomaterials.2011.02.033; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P2291, DOI 10.1089/ten.2006.12.2291; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083; Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kumar P, 2015, TISSUE ENG PART C-ME, V21, P660, DOI [10.1089/ten.tec.2014.0387, 10.1089/ten.TEC.2014.0387]; Kumar P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08729; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Lareu RR, 2007, FEBS LETT, V581, P2709, DOI 10.1016/j.febslet.2007.05.020; Lareu RR, 2007, TISSUE ENG, V13, P385, DOI 10.1089/ten.2006.0224; Lee IC, 2007, BIOCHEM BIOPH RES CO, V352, P147, DOI 10.1016/j.bbrc.2006.10.170; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021; Liu W, 2006, TISSUE ENG, V12, P775, DOI 10.1089/ten.2006.12.775; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lohberger B, 2016, KNEE SURG SPORT TR A, V24, P3884, DOI 10.1007/s00167-015-3790-6; Mao AS, 2016, BIOMATERIALS, V98, P184, DOI 10.1016/j.biomaterials.2016.05.004; Mateu R, 2016, INT J MOL MED, V38, P1063, DOI 10.3892/ijmm.2016.2706; Merceron C, 2012, STEM CELLS, V30, P471, DOI 10.1002/stem.1686; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Morita Y, 2013, ACTA BIOENG BIOMECH, V15, P71, DOI 10.5277/abb130309; Mwale F, 2006, J ORTHOP RES, V24, P1791, DOI 10.1002/jor.20200; Na J, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201604260; Neidlinger-Wilke C, 2002, J ORTHOPAED RES, V20, P953, DOI 10.1016/S0736-0266(02)00024-4; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Obaid H, 2012, J BONE JOINT SURG AM, V94A, P193, DOI [10.2106/JBJS.J.00781, 10.2106/JBJS.J.100781]; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Peck M, 2011, MATER TODAY, V14, P218, DOI 10.1016/S1369-7021(11)70117-1; Peroglio M, 2018, J ORTHOP RES, V36, P10, DOI 10.1002/jor.23655; Petersen W, 2004, J ORTHOP RES, V22, P847, DOI 10.1016/j.orthres.2003.11.009; Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001; Powell HM, 2010, TISSUE ENG PT A, V16, P1083, DOI [10.1089/ten.tea.2009.0542, 10.1089/ten.TEA.2009.0542]; Prewitz MC, 2015, BIOMATERIALS, V73, P60, DOI 10.1016/j.biomaterials.2015.09.014; Rashid R, 2014, TISSUE ENG PART C-ME, V20, P994, DOI [10.1089/ten.tec.2013.0733, 10.1089/ten.TEC.2013.0733]; Riboh J, 2008, J HAND SURG-AM, V33A, P1388, DOI 10.1016/j.jhsa.2008.04.019; Saber S, 2010, TISSUE ENG PT A, V16, P2085, DOI [10.1089/ten.tea.2010.0032, 10.1089/ten.TEA.2010.0032]; SANANTONIO JD, 1987, DEV BIOL, V123, P17; Satyam A, 2016, ACTA BIOMATER, V44, P221, DOI 10.1016/j.actbio.2016.08.008; Satyam A, 2014, ADV MATER, V26, P3024, DOI 10.1002/adma.201304428; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott A, 2011, J MUSCULOSKEL NEURON, V11, P124; Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359; Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040; SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331; Smith RKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075697; Sorushanova A, 2019, ADV MATER, V31, DOI 10.1002/adma.201801651; Spanoudes K, 2014, TRENDS BIOTECHNOL, V32, P474, DOI 10.1016/j.tibtech.2014.06.009; Sriram G, 2015, EUR J CELL BIOL, V94, P483, DOI 10.1016/j.ejcb.2015.08.001; Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012; Tang QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05515; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Waldman SD, 2006, OSTEOARTHR CARTILAGE, V14, P323, DOI 10.1016/j.joca.2005.10.007; Wall ME, 2007, J BIOMECH, V40, P173, DOI 10.1016/j.jbiomech.2005.10.032; Wang A, 2013, AM J SPORT MED, V41, P2925, DOI 10.1177/0363546513504285; Wang HC, 1995, J BIOMECH, V28, P1543, DOI 10.1016/0021-9290(95)00101-8; Wang JHC, 2004, J BIOMECH, V37, P573, DOI 10.1016/j.jbiomech.2003.09.011; Wang JHC, 2005, ANN BIOMED ENG, V33, P337, DOI 10.1007/s10439-005-1736-8; Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6; Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6; Wang PY, 2010, BIOTECHNOL BIOENG, V106, P285, DOI 10.1002/bit.22697; Wang W, 2007, INT J SPORTS MED, V28, P691, DOI 10.1055/s-2007-964864; Wenstrup RJ, 2011, J BIOL CHEM, V286, P20455, DOI 10.1074/jbc.M111.223693; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Wu JH, 2017, BONE JOINT RES, V6, P179, DOI 10.1302/2046-3758.63.BJR-2016-0207.R1; Xing Q, 2014, ADV FUNCT MATER, V24, P3027, DOI 10.1002/adfm.201303460; Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016; Xu BY, 2011, CONNECT TISSUE RES, V52, P373, DOI 10.3109/03008207.2010.541961; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083; Zeiger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037904; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071740; Zhang L, 2008, CELL BIOL INT, V32, P344, DOI 10.1016/j.cellbi.2007.12.018; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	139	20	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5741	5754		10.1096/fj.201802451R	http://dx.doi.org/10.1096/fj.201802451R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30681885				2022-12-28	WOS:000462888500088
J	Guo, W; Li, D; You, Y; Li, WZ; Hu, B; Zhang, SL; Miao, L; Xian, M; Zhu, YZ; Shen, XY				Guo, Wei; Li, Dong; You, Yan; Li, Wanzhen; Hu, Bin; Zhang, Sulin; Miao, Lei; Xian, Ming; Zhu, Yizhun; Shen, Xiaoyan			Cystathionine -lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis	FASEB JOURNAL			English	Article						hydrogen sulfide; hyperglycemia; hepatic insulin resistance; glucose homeostasis	TRANSCRIPTION FACTOR FOXO1; ACTIVATED PROTEIN-KINASE; HYDROGEN-SULFIDE; GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; IN-VIVO; GLUCOSE; LIVER; METABOLISM; FKHR	Hepatic gluconeogenesis makes a significant contribution to the pathogenesis of obesity and its related insulin resistance. Cystathionine -lyase (CSE; also cystathionase), a principal hydrogen sulfide (H2S)-synthesizing enzyme in the liver, is involved in glucose and lipid metabolism disorders. However, the roles and precise mechanisms of CSE/H2S in obesity and its related insulin resistance remain obscure. Here we show that CSE knockout exacerbated high-fat diet-induced mouse obesity as well as its related insulin resistance. Further study elucidated that the inhibition of insulin and AMPK signaling pathways by CSE deficiency resulted in nuclear accumulation of Forkhead box protein O1 and subsequently promoted hepatic gluconeogenesis. These phenomena can be reversed by NaHS supplementation. However, in wild-type mice, NaHS treatment ameliorates high fat diet-induced obesity and metabolism disorders, indicating that maintaining an appropriate level of H2S is critical for its mutual change of positive and negative effects of obesity-associated insulin resistance. Our study reveals a double-edged sword effect and a novel mechanism for CSE/H2S in obesity associated with insulin resistance and provides evidence for CSE/H2S as a promising therapeutic potential target for obesity-related insulin resistance.Guo, W., Li, D., You, Y., Li, W., Hu, B., Zhang, S., Miao, L., Xian, M., Zhu, Y., Shen, X. Cystathionine -lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis.	[Guo, Wei; Li, Dong; You, Yan; Li, Wanzhen; Hu, Bin; Zhang, Sulin; Miao, Lei; Zhu, Yizhun; Shen, Xiaoyan] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Xian, Ming] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Zhu, Yizhun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Macau, Peoples R China	Fudan University; Washington State University; Macau University of Science & Technology	Zhu, YZ (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.; Zhu, YZ (corresponding author), Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Ave Wai Long, Taipa, Macau, Peoples R China.; Shen, XY (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Pudong New Area, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.	yzzhu@must.edu.mo; shxiaoy@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041; , Xiaoyan/0000-0003-4828-3268	National Natural Science Foundation of China [81573441, 81371923, 81173056, 81872864]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81573441, 81371923, 81173056, and 81872864. The authors declare no conflicts of interest.	Balbis A, 2000, ENDOCRINOLOGY, V141, P4041, DOI 10.1210/en.141.11.4041; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Cheng ZY, 2012, NAT MED, V18, P351, DOI 10.1038/nm.2694; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Du XL, 2017, J CELL PHYSIOL, V232, P3296, DOI 10.1002/jcp.25773; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Ghoshal K, 2015, WORLD J DIABETES, V6, P151, DOI 10.4239/wjd.v6.i1.151; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gogiashvili M, 2017, ANAL BIOANAL CHEM, V409, P1591, DOI 10.1007/s00216-016-0100-1; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kaushik VK, 2001, AM J PHYSIOL-ENDOC M, V281, pE335, DOI 10.1152/ajpendo.2001.281.2.E335; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.119; Kitamura Y, 2004, REV ENDOCR METAB DIS, V5, P143, DOI 10.1023/B:REMD.0000021436.91347.93; Kundu S, 2014, BBA-MOL CELL RES, V1843, P2816, DOI 10.1016/j.bbamcr.2014.08.005; Li D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050635; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Majumder A, 2018, AM J PHYSIOL-CELL PH, V315, pC609, DOI 10.1152/ajpcell.00147.2018; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Miao L, 2016, ANTIOXID REDOX SIGN, V25, P268, DOI 10.1089/ars.2015.6577; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Song YX, 2016, J DAIRY SCI, V99, P9184, DOI 10.3168/jds.2016-11219; Sun XD, 2017, CELL PHYSIOL BIOCHEM, V42, P1109, DOI 10.1159/000478765; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; ter Horst KW, 2016, METABOLISM, V65, P757, DOI 10.1016/j.metabol.2016.02.010; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Untereiner AA, 2016, ANTIOXID REDOX SIGN, V24, P129, DOI 10.1089/ars.2015.6369; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Velmurugan GV, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac7135; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Xue R, 2013, ANTIOXID REDOX SIGN, V19, P5, DOI 10.1089/ars.2012.5024; Yadav H, 2017, J BIOL CHEM, V292, P3420, DOI 10.1074/jbc.M116.764910; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Yazdi FT, 2015, PEERJ, V3, DOI 10.7717/peerj.856; Zhang L, 2013, ENDOCRINOLOGY, V154, P114, DOI 10.1210/en.2012-1658	56	19	22	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4212	4224		10.1096/fj.201801894R	http://dx.doi.org/10.1096/fj.201801894R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526049				2022-12-28	WOS:000459794800089
J	Raz, V; Raz, Y; van de Vijver, D; Bindellini, D; van Putten, M; Ben van den Akker, E				Raz, Vered; Raz, Yotam; van de Vijver, Davy; Bindellini, Davide; van Putten, Maaike; Ben van den Akker, Erik			High-throughput data-driven analysis of myofiber composition reveals muscle-specific disease and age-associated patterns	FASEB JOURNAL			English	Article						myosin heavy chain; limb girdle muscular dystrophy; ageing; SGCA-null; SGCD-null	HEAVY-CHAIN ISOFORMS; MUSCULAR-DYSTROPHY; MOUSE MODEL; INVOLVEMENT; ATROPHY; SLOW	Contractile properties of myofibers are dictated by the abundance of myosin heavy chain (MyHC) isoforms. MyHC composition designates muscle function, and its alterations could unravel differential muscle involvement in muscular dystrophies and aging. Current analyses are limited to visual assessments in which myofibers expressing multiple MyHC isoforms are prone to misclassification. As a result, complex patterns and subtle alterations are unidentified. We developed a high-throughput, data-driven myofiber analysis to quantitatively describe the variations in myofibers across the muscle. We investigated alterations in myofiber composition between genotypes, 2 muscles, and 2 age groups. We show that this analysis facilitates the discovery of complex myofiber compositions and its dependency on age, muscle type, and genetic conditions.Raz, V., Raz, Y., van de Vijver, D., Bindellini, D., van Putten, M., van den Akker, E. B. High-throughput data-driven analysis of myofiber composition reveals muscle-specific disease and age-associated patterns.	[Raz, Vered; van de Vijver, Davy; Bindellini, Davide; van Putten, Maaike] Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20,Bldg 2,Room R3-17, NL-2333 ZC Leiden, Netherlands; [Raz, Yotam; Ben van den Akker, Erik] Leiden Univ, Med Ctr, Mol Epidemiol, Leiden, Netherlands; [Ben van den Akker, Erik] Leiden Univ, Med Ctr, Leiden Computat Biol Ctr, Leiden, Netherlands; [Ben van den Akker, Erik] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology	Raz, V (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20,Bldg 2,Room R3-17, NL-2333 ZC Leiden, Netherlands.	V.raz@lumc.nl		van de Vijver, David/0000-0001-5877-8526; van Putten, Maaike/0000-0002-0683-8897; van den Akker, Erik/0000-0002-7693-0728	AFM [20251, 21160]	AFM(Association Francaise contre les Myopathies)	The authors thank M. Reinders (Department of Biomedical Data Sciences, Leiden University Medical Centre, and Delft Bioinformatics Lab, Delft University, The Netherlands) and A. Aartsma-Rus (Department of Human Genetics, Leiden University Medical Center, TheNetherlands) for helpful suggestions and comments on the analyses and the manuscript. This work was funded by AFM Grant 20251 (to M.V.P.) and AFM Grant 21160 (to V.R.). The authors declare no conflicts of interest.	Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Banks GB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004431; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Coley WD, 2016, HUM MOL GENET, V25, P130, DOI 10.1093/hmg/ddv460; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Hack AA, 2000, J CELL SCI, V113, P2535; HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I; Hooijmans MT, 2015, NMR BIOMED, V28, P1589, DOI 10.1002/nbm.3427; Huovinen S, 2015, AM J PATHOL, V185, P2833, DOI 10.1016/j.ajpath.2015.06.018; McDonald AA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12391; Mizunoya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080152; Mul K, 2017, NEUROLOGY, V89, P2057, DOI 10.1212/WNL.0000000000004647; Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054; Pasteuning-Vuhman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182704; Purves-Smith FM, 2014, EXERC SPORT SCI REV, V42, P45, DOI 10.1249/JES.0000000000000012; Raz V, 2018, FASEB J, V32, P1579, DOI 10.1096/fj.201700861R; Raz Y, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00236; Riaz M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006031; Riaz M, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0064-4; Ruggiero L, 2015, MUSCLE NERVE, V51, P604, DOI 10.1002/mus.24467; Sawano S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166080; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; van der Sluijs BM, 2017, NEUROMUSCULAR DISORD, V27, P1099, DOI 10.1016/j.nmd.2017.09.010; Wang JF, 1999, NEUROMUSCULAR DISORD, V9, P150, DOI 10.1016/S0960-8966(98)00114-X; Wang JH, 2015, DEV BIOL, V402, P72, DOI 10.1016/j.ydbio.2015.02.025; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Willmann R, 2012, NEUROMUSCULAR DISORD, V22, P43, DOI 10.1016/j.nmd.2011.04.012; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Zhang D, 2014, J CELL BIOL, V207, P753, DOI 10.1083/jcb.201406068	35	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4046	4053		10.1096/fj.201801714R	http://dx.doi.org/10.1096/fj.201801714R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30485132	Green Submitted, Bronze			2022-12-28	WOS:000459794800075
J	Reade, S; Williams, JM; Aggio, R; Duckworth, CA; Mahalhal, A; Hough, R; Pritchard, DM; Probert, CS				Reade, Sophie; Williams, Jonathan M.; Aggio, Raphael; Duckworth, Carrie A.; Mahalhal, Awad; Hough, Rachael; Pritchard, D. Mark; Probert, Chris S.			Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice	FASEB JOURNAL			English	Article						colitis; VOCs; inflammatory bowel disease	DIAGNOSTIC BIOMARKERS; METABOLOMICS; COLITIS	Metabolomics studies have the potential to discover biomarkers. Fecal volatile organic compounds (VOCs) have been found to differ in patients with inflammatory bowel disease and irritable bowel syndrome. Murine models of colitis offer an alternative to human studies in which diet can be controlled. We aimed to investigate fecal VOCs from mice in which acute and chronic colitis was induced. Groups of adult C57BL/6 mice underwent treatment with oral dextran sulfate sodium to induce colitis. Control mice received no treatment or had acute osmotic diarrhea induced with magnesium sulfate. Colitis was assessed clinically and by histology. Samples of feces and/or colon contents were collected and volatile compounds determined by solid phase microextraction-GC-MS. Statistics were performed using metabolomics tools. Acute colitis was associated with an increase in aldehydes and chronic colitis with one specific ketone. Osmotic diarrhea was associated with a significant reduction in VOCs, especially alcohols. We provide evidence that the identification of disease-associated VOC concentration ranges, combined with specific marker compounds, would potentially increase the likelihood of finding an inflammatory bowel disease-specific fecal VOC marker profile.Reade, S., Williams, J. M., Aggio, R., Duckworth, C. A., Mahalhal, A., Hough, R., Pritchard, D. M., Probert, C. S., Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice.	[Reade, Sophie; Aggio, Raphael; Duckworth, Carrie A.; Mahalhal, Awad; Hough, Rachael; Pritchard, D. Mark; Probert, Chris S.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Ashton St, Liverpool L693GE, Merseyside, England; [Williams, Jonathan M.] Royal Vet Coll, Pathobiol & Populat Sci, Hatfield, Herts, England	University of Liverpool; University of London; University of London Royal Veterinary College	Probert, CS (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Ashton St, Liverpool L693GE, Merseyside, England.	chris.probert@liverpool.ac.uk		Pritchard, David Mark/0000-0001-7971-3561; Probert, Christopher/0000-0003-4550-0239; Williams, Jonathan/0000-0002-6617-0323	Institute of Translational Medicine at the University of Liverpool	Institute of Translational Medicine at the University of Liverpool	The authors acknowledge T. Khalid and A. Mayor (University of Liverpool) for support in preparation, running, and analysis of samples, and the Institute of Translational Medicine at the University of Liverpool for funding this work. The authors declare no conflicts of interest.	Aggio R, 2011, BIOINFORMATICS, V27, P2316, DOI 10.1093/bioinformatics/btr379; Ahmed I, 2016, ALIMENT PHARM THER, V43, P596, DOI 10.1111/apt.13522; Ahmed I, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058204, 10.1371/journal.pone.0077869]; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; COOPER HS, 1993, LAB INVEST, V69, P238; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Reade S., 2014, J ANAL BIOANAL TECH, V5, P184, DOI [10.4172/2155-9872.1000184, DOI 10.4172/2155-9872.1000184]; Reade S., 2016, VOLATILE ORGANIC COM; Robert FSM, 1996, J DIARRHOEAL DIS RES, V14, P218; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	16	7	7	2	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3129	3136		10.1096/fj.201800076RR	http://dx.doi.org/10.1096/fj.201800076RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30359099	Bronze, Green Submitted			2022-12-28	WOS:000459794800005
J	Svenson, KL; Paigen, B				Svenson, Karen L.; Paigen, Beverly			Recommended housing densities for research mice: filling the gap in data-driven alternatives	FASEB JOURNAL			English	Review						well-being; husbandry; physiology	CHRONIC SOCIAL STRESS; CAGE FLOOR SPACE; LABORATORY MICE; ENVIRONMENTAL ENRICHMENT; CORTICOSTERONE LEVELS; FEMALE BALB/C; BEHAVIOR; PHYSIOLOGY; PERFORMANCE; AGGRESSION	Space recommendations for mice made in the Guide for Care and Use of Laboratory Animals have not changed since 1972, despite important improvements in husbandry and caging practices. The 1996 version of the Guide put forth a challenge to investigators to produce new data evaluating the effects of space allocation on the well-being of mice. In this review, we summarize many studies published in response to this challenge. We distinguish between studies using ventilated or nonventilated caging systems and those evaluating reproductive performance or general well-being of adult mice. We discuss how these studies might affect current housing density considerations in both production and research settings and consider gaps in mouse housing density research. Additionally, we discuss reliable methods used to monitor and quantify general well-being of research mice. Collectively, this large body of new data suggests that husbandry practices dictating optimal breeding schemes and space allocation per mouse can be reconsidered. Specifically, these data demonstrate that prewean culling of litters has no benefit, trio breeding is an effective production strategy without adversely affecting pup survival and well-being, and housing of adult mice at densities of up to twice current Guide recommendations does not compromise well-being for most strains.Svenson, K. L., Paigen, B. Recommended housing densities for research mice: filling the gap in data-driven alternatives.	[Svenson, Karen L.; Paigen, Beverly] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Jackson Laboratory	Svenson, KL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	karen.svenson@jax.org			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL077796]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL077796] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Mark Adams, Janan Eppig, Ken Paigen, Marge Strobel, and Linda Waterman (all from The Jackson Laboratory) for review and helpful comments on this manuscript. This work was funded by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant HL077796 (to B.P). The authors declare no conflicts of interest.	Andre V, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005019; Bailoo JD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18493-6; Bains RS, 2018, J NEUROSCI METH, V300, P37, DOI 10.1016/j.jneumeth.2017.04.014; Baumans V, 2013, VET J, V195, P24, DOI [10.1016/j.tvjl.2012.09.023, 10.10]; Braden GC, 2017, J AM ASSOC LAB ANIM, V56, P369; Brown RE, 2007, LEARN MEMORY, V14, P134, DOI 10.1101/lm.473907; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Clipperton-Allen AE, 2015, J AM ASSOC LAB ANIM, V54, P718; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Del Rio D, 2016, BEHAV BRAIN RES, V311, P167, DOI 10.1016/j.bbr.2016.04.052; DiVincenti L, 2012, LAB ANIMAL, V41, P68, DOI 10.1038/laban0312-68; Finger BC, 2011, NEUROSCIENCE, V192, P351, DOI 10.1016/j.neuroscience.2011.06.072; Foltz C, 2007, LAB ANIMAL, V36, P40, DOI 10.1038/laban1107-40; Fuchs H, 2018, BEHAV BRAIN RES, V352, P187, DOI 10.1016/j.bbr.2017.09.048; Gaskill BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127875; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Horn MJ, 2012, J AM ASSOC LAB ANIM, V51, P781; Hutchinson EK, 2012, J AM ASSOC LAB ANIM, V51, P18; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/nmeth.2281, 10.1038/NMETH.2281]; Kedl RM, 2014, J IMMUNOL, V193, P4757, DOI 10.4049/jimmunol.1402306; Laber K, 2008, J AM ASSOC LAB ANIM, V47, P16; Laughlin MR, 2012, MAMM GENOME, V23, P623, DOI 10.1007/s00335-012-9425-z; LEVIN S, 1993, TOXICOL PATHOL, V21, P1; Lloyd KCK, 2015, SCIENCE, V349, P390, DOI 10.1126/science.349.6246.390-a; Pautassi RM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08795-0; Morgan JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090012; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (US) and National Academies Press (US), 2011, GUIDE CARE USE LAB A; National Research Council (US) Institute for Laboratory Animal Research, 1996, GUIDE CARE USE LAB A; Nicholson A, 2009, J AM ASSOC LAB ANIM, V48, P740; O'Malley J, 2008, J AM ASSOC LAB ANIM, V47, P9; Okva K, 2013, LAB ANIM-UK, V47, P220, DOI 10.1177/0023677213489280; Overall KL, 2005, ILAR J, V46, P202, DOI 10.1093/ilar.46.2.202; Paigen B, 2012, J ANIM SCI, V90, P5182, DOI 10.2527/jas.2012-5417; Paigen B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149647; Paigen B, 2014, LAB ANIM-UK, V48, P207, DOI 10.1177/0023677214521606; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Perez C, 1997, LAB ANIM, V31, P357, DOI 10.1258/002367797780596158; PETERS A, 1990, LAB ANIM, V24, P273, DOI 10.1258/002367790780866227; Reeb-Whitaker CK, 2001, LAB ANIM-UK, V35, P58, DOI 10.1258/0023677011911381; Russell WMS., 1959, MED J AUSTRALIA; Sa-Rocha VM, 2006, PHYSIOL BEHAV, V88, P108, DOI 10.1016/j.physbeh.2006.03.015; Salem GH, 2015, BEHAV RES METHODS, V47, P235, DOI 10.3758/s13428-014-0451-5; Schmidt MV, 2010, HORM BEHAV, V57, P415, DOI 10.1016/j.yhbeh.2010.01.010; Schweitzer IB, 2003, COMPARATIVE MED, V53, P487; Smith AL, 2005, COMPARATIVE MED, V55, P368; Smith AL, 2005, ILAR J, V46, P140, DOI 10.1093/ilar.46.2.140; Smith AL, 2004, COMPARATIVE MED, V54, P656; Smith E, 2004, CONTEMP TOP LAB ANIM, V43, P12; Sommershof A, 2011, BRAIN BEHAV IMMUN, V25, P340, DOI 10.1016/j.bbi.2010.10.016; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Toth LA, 2015, J AM ASSOC LAB ANIM, V54, P708; Van de Weerd HA, 2004, ATLA-ALTERN LAB ANIM, V32, P69, DOI 10.1177/026119290403202s14; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; Van Loo PLR, 2005, LAB ANIM-UK, V39, P58, DOI 10.1258/0023677052886501; Webers EM, 2017, LAB ANIMAL, V46, P157, DOI 10.1038/laban.1219; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; Whittaker AL, 2012, LAB ANIM-UK, V46, P3, DOI 10.1258/la.2011.011049; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Yadav Shikha, 2017, Lab Anim Res, V33, P68, DOI 10.5625/lar.2017.33.2.68; Young EE, 2013, J NEUROIMMUNOL, V254, P19, DOI 10.1016/j.jneuroim.2012.08.014; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	64	5	5	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3097	3111		10.1096/fj.201801972R	http://dx.doi.org/10.1096/fj.201801972R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521372	hybrid, Green Published			2022-12-28	WOS:000459794800003
J	Zhou, C; Wang, YZ; Zhang, JC; Su, JM; An, QL; Liu, X; Zhang, M; Wang, YS; Liu, J; Zhang, Y				Zhou, Chuan; Wang, Yizhi; Zhang, Jingcheng; Su, Jianmin; An, Quanli; Liu, Xin; Zhang, Min; Wang, Yongsheng; Liu, Jun; Zhang, Yong			H3K27me3 is an epigenetic barrier while KDM6A overexpression improves nuclear reprogramming efficiency	FASEB JOURNAL			English	Article						nuclear reprogramming barrier; cell adhesion; blastocyst formation; bovine	CLONING EFFICIENCY; X-CHROMOSOME; GERM-CELL; TRICHOSTATIN-A; METHYLATION; EXPRESSION; EMBRYOS; EZH2; PIG; PLACENTAS	Aberrant epigenetic reprogramming is a major factor of developmental failure of cloned embryos. Histone H3 lysine 27 trimethylation (H3K27me3), a histone mark for transcriptional repression, plays important roles in mammalian embryonic development and induced pluripotent stem cell (iPSC) generation. The global loss of H3K27me3 marks may facilitate iPSC generation in mice and humans. However, the H3K27me3 level and its role in bovine somatic cell nuclear transfer (SCNT) reprogramming remain poorly understood. Here, we show that SCNT embryos exhibit global H3K27me3 hypermethylation from the 2- to 8-cell stage and that its removal by ectopically expressed H3K27me3 lysine demethylase (KDM)6A greatly improves nuclear reprogramming efficiency. In contrast, H3K27me3 reduction by H3K27me3 methylase enhancer of zeste 2 polycomb repressive complex knockdown or donor cell treatment with the enhancer of zeste 2 polycomb repressive complex-selective inhibitor GSK343 suppressed blastocyst formation by SCNT embryos. KDM6A overexpression enhanced the transcription of genes involved in cell adhesion and cellular metabolism and X-linked genes. Furthermore, we identified methyl-CpG-binding domain protein 3-like 2, which was reactivated by KDM6A, as a factor that is required for effective reprogramming in bovines. These results show that H3K27me3 functions as an epigenetic barrier and that KDM6A overexpression improves SCNT efficiency by facilitating transcriptional reprogramming.Zhou, C., Wang, Y., Zhang, J., Su, J., An, Q., Liu, X., Zhang, M., Wang, Y., Liu, J., Zhang, Y. H3K27me3 is an epigenetic barrier while KDM6A overexpression improves nuclear reprogramming efficiency.	[Zhou, Chuan; Wang, Yizhi; Zhang, Jingcheng; Su, Jianmin; An, Quanli; Liu, Xin; Zhang, Min; Wang, Yongsheng; Liu, Jun; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, 3 Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	zhy1956@263.net			National High Technology Research and Development Program of China (863 Program) [2011AA100303]; National Major Project for Production of Transgenic Breeding [2016ZX08007-003]; National Natural Science Foundation of China [31772603]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Major Project for Production of Transgenic Breeding; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (863 Program) (2011AA100303); the National Major Project for Production of Transgenic Breeding (2016ZX08007-003); and the National Natural Science Foundation of China (31772603). The authors declare no conflicts of interest.	Auman HJ, 2002, DEVELOPMENT, V129, P2733; Bai GY, 2018, ZYGOTE, V26, P24, DOI 10.1017/S0967199417000673; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Bessonnard S, 2015, J CELL BIOL, V210, P1185, DOI 10.1083/jcb.201503042; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bogliotti YS, 2012, EPIGENETICS-US, V7, P976, DOI 10.4161/epi.21615; Breton A, 2010, J REPROD DEVELOP, V56, P379, DOI 10.1262/jrd.09-182A; Calder MD, 2017, MOL HUM REPROD, V23, P771, DOI 10.1093/molehr/gax050; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Dai XP, 2010, J BIOL CHEM, V285, P31002, DOI 10.1074/jbc.M110.136085; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Fu L, 2012, THERIOGENOLOGY, V78, P1929, DOI 10.1016/j.theriogenology.2012.07.017; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Guo SJ, 2015, AUTOPHAGY, V11, P560, DOI 10.1080/15548627.2015.1017181; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JJ, 2016, REPRODUCTION, V151, P39, DOI 10.1530/REP-15-0460; Huang XJ, 2014, REPROD FERT DEVELOP, V26, P1166, DOI 10.1071/RD13169; Huang YY, 2011, CELL REPROGRAM, V13, P513, DOI 10.1089/cell.2011.0032; Iager AE, 2008, CLONING STEM CELLS, V10, P371, DOI 10.1089/clo.2007.0002; Inoue A, 2017, GENE DEV, V31, P1927, DOI 10.1101/gad.304113.117; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jin SG, 2008, DEV DYNAM, V237, P3435, DOI 10.1002/dvdy.21767; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Jullien J, 2017, MOL CELL, V65, P873, DOI 10.1016/j.molcel.2017.01.030; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Liu TP, 2015, ANTI-CANCER DRUG, V26, P139, DOI 10.1097/CAD.0000000000000166; Liu X, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158261; Liu YF, 2017, P NATL ACAD SCI USA, V114, pE3796, DOI 10.1073/pnas.1700909114; Loi P, 2016, TRENDS BIOTECHNOL, V34, P791, DOI 10.1016/j.tibtech.2016.03.008; Luo HN, 2016, BIOCHEM BIOPH RES CO, V479, P253, DOI 10.1016/j.bbrc.2016.09.055; Malouf GG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r144; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Matoba S, 2018, CELL STEM CELL, V23, P343, DOI 10.1016/j.stem.2018.06.008; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; Nakaki F, 2014, TRENDS BIOCHEM SCI, V39, P289, DOI 10.1016/j.tibs.2014.04.003; Nwadike C, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00023-18; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Peng L, 2016, J CELL SCI, V129, P1059, DOI 10.1242/jcs.179044; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Ruan DG, 2018, STEM CELL REP, V10, P494, DOI 10.1016/j.stemcr.2017.12.015; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Su JM, 2011, THERIOGENOLOGY, V75, P1346, DOI 10.1016/j.theriogenology.2010.11.045; Su JM, 2015, J PINEAL RES, V59, P455, DOI 10.1111/jpi.12275; Taube JH, 2017, ONCOTARGET, V8, P65548, DOI 10.18632/oncotarget.19214; Terashima M, 2017, BIOCHEM BIOPH RES CO, V490, P1407, DOI 10.1016/j.bbrc.2017.07.048; Wang H, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140244; Wang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.198; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0366; Xie BT, 2016, REPRODUCTION, V151, P9, DOI 10.1530/REP-15-0338; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zenker J, 2018, CELL, V173, P776, DOI 10.1016/j.cell.2018.02.035; Zhang JC, 2017, J BIOL CHEM, V292, P15916, DOI 10.1074/jbc.M117.796771; Zhang M, 2009, J BIOL CHEM, V284, P24981, DOI 10.1074/jbc.M109.011973; Zhang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30345; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	66	31	34	3	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4638	4652		10.1096/fj.201801887R	http://dx.doi.org/10.1096/fj.201801887R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30673507	Bronze			2022-12-28	WOS:000459794800122
J	Britt, RD; Thompson, MA; Wicher, SA; Manlove, LJ; Roesler, A; Fang, YH; Roos, C; Smith, L; Miller, JD; Pabelick, CM; Prakash, YS				Britt, Rodney D., Jr.; Thompson, Michael A.; Wicher, Sarah A.; Manlove, Logan J.; Roesler, Anne; Fang, Yun-Hua; Roos, Carolyn; Smith, Leslie; Miller, Jordan D.; Pabelick, Christina M.; Prakash, Y. S.			Smooth muscle brain-derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma	FASEB JOURNAL			English	Article						TrkB; neurotrophin; fibrosis; extracellular matrix	MATRIX METALLOPROTEINASES; MECHANISMS; EXPRESSION; HYPEROXIA; RELEASE; HEALTH; PATHOGENESIS; REACTIVITY; SECRETION; SEVERITY	Recent studies have demonstrated an effect of neurotrophins, particularly brain-derived neurotrophic factor (BDNF), on airway contractility [via increased airway smooth muscle (ASM) intracellular calcium [Ca2+](i)] and remodeling (ASM proliferation and extracellular matrix formation) in the context of airway disease. In the present study, we examined the role of BDNF in allergen-induced airway inflammation using 2 transgenic models: 1) tropomyosin-related kinase B (TrkB) conditional knockin (TrkBKI) mice allowing for inducible, reversible disruption of BDNF receptor kinase activity by administration of 1NMPP1, a PP1 derivative, and 2) smooth muscle-specific BDNF knockout (BDNFfl/fl/SMMHC11(Cre/0)) mice. Adult mice were intranasally challenged with PBS or mixed allergen (Alternaria alternata, Aspergillus fumigatus, house dust mite, and ovalbumin) for 4 wk. Our data show that administration of 1NMPP1 in TrkBKI mice during the 4-wk allergen challenge blunted airway hyperresponsiveness (AHR) and reduced fibronectin mRNA expression in ASM layers but did not reduce inflammation per se. Smooth muscle-specific deletion of BDNF reduced AHR and blunted airway fibrosis but did not significantly alter airway inflammation. Together, our novel data indicate that TrkB signaling is a key modulator of AHR and that smooth muscle-derived BDNF mediates these effects during allergic airway inflammation.Britt, R. D., Jr., Thompson, M. A., Wicher, S. A., Manlove, L. J., Roesler, A., Fang, Y.-H., Roos, C., Smith, L., Miller, J. D., Pabelick, C. M., Prakash, Y. S. Smooth muscle brain-derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma.	[Britt, Rodney D., Jr.; Fang, Yun-Hua; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Thompson, Michael A.; Wicher, Sarah A.; Manlove, Logan J.; Roesler, Anne; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA; [Roos, Carolyn; Smith, Leslie; Miller, Jordan D.] Mayo Clin, Dept Surg, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Prakash, YS (corresponding author), Mayo Clin, Dept Anesthesiol & Physiol, 4-184 W Jos SMH,200 First St SW, Rochester, MN 55905 USA.	prakash.ys@mayo.edu	Britt, Rodney/AAA-8253-2022	Britt, Rodney/0000-0002-0027-9545; Miller, Jordan/0000-0002-9868-4097; Wicher, Sarah/0000-0002-0079-7924; Prakash, Y S/0000-0002-2968-224X	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL088029, HL56470, K99 HL131682, T32 HL105355]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105355, K99HL131682, R01HL088029, R01HL056470, R00HL131682] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Jacob Teske (Mayo Clinic) for technical assistance in the smooth muscle and airway thickness analyses. This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL088029 and HL56470 (to Y.S.P.), K99 HL131682 (to R.D.B., Jr.), and T32 HL105355 (to S.A.W.). The authors declare no conflicts of interest.	Abcejo AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044343; Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Aravamudan B, 2016, AM J PHYSIOL-LUNG C, V311, pL270, DOI 10.1152/ajplung.00414.2015; Aravamudan B, 2012, AM J PHYSIOL-LUNG C, V303, pL669, DOI 10.1152/ajplung.00018.2012; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Aven L, 2014, FASEB J, V28, P897, DOI 10.1096/fj.13-238212; Braun A, 2004, BRIT J PHARMACOL, V141, P431, DOI 10.1038/sj.bjp.0705638; Braun A, 2000, CLIN EXP ALLERGY, V30, P178; Braun A, 1999, AM J RESP CELL MOL, V21, P537, DOI 10.1165/ajrcmb.21.4.3670; Burgess JK, 2009, PULM PHARMACOL THER, V22, P379, DOI 10.1016/j.pupt.2008.12.007; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chapman DG, 2014, J CELL BIOCHEM, V115, P2055, DOI 10.1002/jcb.24881; Chaudhuri R, 2005, CLIN EXP ALLERGY, V35, P949, DOI 10.1111/j.1365-2222.2005.02286.x; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Elshaw SR, 2004, BRIT J PHARMACOL, V142, P1318, DOI 10.1038/sj.bjp.0705883; Faksh A, 2016, PEDIATR RES, V79, P391, DOI 10.1038/pr.2015.232; Freeman MR, 2017, AM J PHYSIOL-LUNG C, V313, pL360, DOI 10.1152/ajplung.00580.2016; Garcia-Suarez O, 2009, RESP PHYSIOL NEUROBI, V167, P281, DOI 10.1016/j.resp.2009.06.001; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hempstead Barbara L, 2015, Trans Am Clin Climatol Assoc, V126, P9; Hirota N, 2013, CHEST, V144, P1026, DOI 10.1378/chest.12-3073; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Hoyle GW, 2003, CYTOKINE GROWTH F R, V14, P551, DOI 10.1016/S1359-6101(03)00061-3; Iijima K, 2014, J IMMUNOL, V193, P1549, DOI 10.4049/jimmunol.1302984; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Lagente V, 2010, J MOL CELL CARDIOL, V48, P440, DOI 10.1016/j.yjmcc.2009.09.017; Namura K, 2007, CLIN IMMUNOL, V122, P181, DOI 10.1016/j.clim.2006.10.011; Nassenstein C, 2004, PROG BRAIN RES, V146, P347; Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010; Prakash YS, 2006, AM J PHYSIOL-LUNG C, V291, pL447, DOI 10.1152/ajplung.00501.2005; Prakash YS, 2016, AM J PHYSIOL-LUNG C, V311, pL1113, DOI 10.1152/ajplung.00370.2016; Prakash YS, 2014, PHARMACOL THERAPEUT, V143, P74, DOI 10.1016/j.pharmthera.2014.02.006; Prakash YS, 2013, AM J PHYSIOL-LUNG C, V305, pL912, DOI 10.1152/ajplung.00259.2013; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Raap U, 2005, J ALLERGY CLIN IMMUN, V115, P1268, DOI 10.1016/j.jaci.2005.02.007; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rochlitzer S, 2006, BIOCHEM SOC T, V34, P594, DOI 10.1042/BST0340594; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; Rydell-Tormanen K, 2013, PULM PHARMACOL THER, V26, P13, DOI 10.1016/j.pupt.2012.04.003; Sathish V, 2013, AM J RESP CELL MOL, V48, P431, DOI 10.1165/rcmb.2012-0129OC; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Song XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001707; Sopi RB, 2008, AM J PHYSIOL-LUNG C, V295, pL348, DOI 10.1152/ajplung.00067.2008; Thompson MA, 2015, BBA-MOL CELL RES, V1853, P2506, DOI 10.1016/j.bbamcr.2015.06.008; Virchow JC, 1998, AM J RESP CRIT CARE, V158, P2002, DOI 10.1164/ajrccm.158.6.9803023; Vohra PK, 2013, BBA-MOL CELL RES, V1833, P2953, DOI 10.1016/j.bbamcr.2013.07.019; Wang SY, 2016, J CELL PHYSIOL, V231, P1586, DOI 10.1002/jcp.25254; Watanabe T, 2015, AM J RESP CELL MOL, V53, P844, DOI 10.1165/rcmb.2015-0015OC; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yao Q, 2005, AM J PHYSIOL-LUNG C, V289, pL307, DOI 10.1152/ajplung.00030.2005; Yarova PL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0282; Zuccato C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022966	60	22	22	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3024	3034		10.1096/fj.201801002R	http://dx.doi.org/10.1096/fj.201801002R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30351991	Green Published, Bronze			2022-12-28	WOS:000457296600118
J	El Masry, MS; Chaffee, S; Das Ghatak, P; Mathew-Steiner, SS; Das, A; Higuita-Castro, N; Roy, S; Anani, RA; Sen, CK				El Masry, Mohamed S.; Chaffee, Scott; Das Ghatak, Piya; Mathew-Steiner, Shomita S.; Das, Amitava; Higuita-Castro, Natalia; Roy, Sashwati; Anani, Raafat A.; Sen, Chandan K.			Stabilized collagen matrix dressing improves wound macrophage function and epithelialization	FASEB JOURNAL			English	Article						antimicrobial peptides; ECM; scaffold; biofilm; cytokines	ANTIMICROBIAL PEPTIDES; EQUINE PERICARDIUM; SKIN; INNATE; INFLAMMATION; CYTOKINE; IMMUNITY; EXPRESSION; REPAIR; BETA-DEFENSIN-2	Decellularized matrices of biologic tissue have performed well as wound care dressings. Extracellular matrix-based dressings are subject to rapid degradation by excessive protease activity at the wound environment. Stabilized, acellular, equine pericardial collagen matrix (sPCM) wound care dressing is flexible cross-linked proteolytic enzyme degradation resistant. sPCM was structurally characterized utilizing scanning electron and atomic force microscopy. In murine excisional wounds, sPCM was effective in mounting an acute inflammatory response. Postwound inflammation resolved rapidly, as indicated by elevated levels of IL-10, arginase-1, and VEGF, and lowering of IL-1 and TNF-. sPCM induced antimicrobial proteins S100A9 and -defensin-1 in keratinocytes. Adherence of Pseudomonas aeruginosa and Staphylococcus aureus on sPCM pre-exposed to host immune cells in vivo was inhibited. Excisional wounds dressed with sPCM showed complete closure at d 14, while control wounds remained open. sPCM accelerated wound re-epithelialization. sPCM not only accelerated wound closure but also improved the quality of healing by increased collagen deposition and maturation. Thus, sPCM is capable of presenting scaffold functionality during the course of wound healing. In addition to inducing endogenous antimicrobial defense systems, the dressing itself has properties that minimize biofilm formation. It mounts robust inflammation, a process that rapidly resolves, making way for wound healing to advance.El Masry, M. S., Chaffee, S., Das Ghatak, P., Mathew-Steiner, S. S., Das, A., Higuita-Castro, N., Roy, S., Anani, R. A., Sen, C. K. Stabilized collagen matrix dressing improves wound macrophage function and epithelialization.	[El Masry, Mohamed S.; Das Ghatak, Piya; Mathew-Steiner, Shomita S.; Das, Amitava; Roy, Sashwati; Sen, Chandan K.] Indiana Univ Sch Med, Indiana Ctr Regenerat Med & Engn, Comprehens Wound Ctr, Dept Surg,IUH, Indianapolis, IN 46202 USA; [El Masry, Mohamed S.; Chaffee, Scott; Das Ghatak, Piya; Mathew-Steiner, Shomita S.; Das, Amitava; Higuita-Castro, Natalia; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [El Masry, Mohamed S.; Anani, Raafat A.] Zagazig Univ, Dept Plast & Reconstruct Surg, Zagazig, Egypt	Indiana University System; Indiana University Bloomington; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Zagazig University	Sen, CK (corresponding author), Indiana Univ Sch Med, 975 W Walnut St,Med Res Lib Bldg,Suite 454, Indianapolis, IN 46202 USA.	cksen@iu.edu	MATHEW-STEINER, SHOMITA S/AAE-8041-2022; El Masry, Mohamed S/J-4691-2017; Das, Amitava/AAJ-5682-2020	El Masry, Mohamed S/0000-0002-2686-1509; DAS, AMITAVA/0000-0003-4307-562X; Mathew-Steiner, Shomita/0000-0002-7730-9140	U.S. National Institutes of Health [GM077185, GM069589, NR013898, NR015676, DK076566]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114718, U01DK119099, R56DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR015676, R01NR013898] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	The authors thank Dr. B. Deng (Center for Electron Microscopy and Analysis College of Engineering, The Ohio State University) for her assistance with light microscopy studies on sPCM. This work was supported by U.S. National Institutes of Health Grants GM077185 and GM069589 (National Institute of General Medical Sciences), NR013898 and NR015676 (National Institute of Nursing Research), and DK076566 (National Institute of Diabetes and Digestive and Kidney Diseases). This work was supported, in part, by an unrestricted gift from Harbor MedTech (Irvine, CA, USA). The authors declare no conflicts of interest.	Achterberg VF, 2014, J INVEST DERMATOL, V134, P1862, DOI 10.1038/jid.2014.90; Alexander JH, 2012, J AM PODIAT MED ASSN, V102, P352, DOI 10.7547/1020352; Anderson Kristin, 2012, J Am Coll Clin Wound Spec, V4, P84, DOI 10.1016/j.jccw.2014.03.001; Autengruber A, 2012, EUR J MICROBIOL IMMU, V2, P112, DOI 10.1556/EuJMI.2.2012.2.3; Awad H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047569; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Barki KG, 2019, ANN SURG, V269, P756, DOI 10.1097/SLA.0000000000002504; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; Bosanquet DC, 2014, WOUND REPAIR REGEN, V22, P143, DOI 10.1111/wrr.12149; Braff MH, 2005, J INVEST DERMATOL, V124, P394, DOI 10.1111/j.0022-202X.2004.23443.x; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; Chen HW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28842-8; Chung PY, 2017, J MICROBIOL IMMUNOL, V50, P405, DOI 10.1016/j.jmii.2016.12.005; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Das A, 2016, J IMMUNOL, V196, P5089, DOI 10.4049/jimmunol.1502270; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Dhivya S, 2015, BIOMEDICINE-TAIWAN, V5, P24, DOI 10.7603/s40681-015-0022-9; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Edwards H, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-86; Efron PA, 2004, J BURN CARE REHABIL, V25, P149, DOI 10.1097/01.BCR.0000111766.97335.34; Elgharably H, 2014, WOUND REPAIR REGEN, V22, P720, DOI 10.1111/wrr.12229; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fleck Cynthia A, 2007, Adv Skin Wound Care, V20, P256, DOI 10.1097/01.ASW.0000269310.00145.e2; Fleischli JG, 2009, J AM PODIAT MED ASSN, V99, P301, DOI 10.7547/0980301; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghatak S, 2015, MOL THER, V23, P1201, DOI 10.1038/mt.2015.65; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gniadecki R, 2001, EXP DERMATOL, V10, P71, DOI 10.1034/j.1600-0625.2001.010002071.x; Grant CA, 2012, ACTA BIOMATER, V8, P4123, DOI 10.1016/j.actbio.2012.06.042; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Guo JJ, 2010, J SURG RES, V159, P503, DOI 10.1016/j.jss.2008.09.018; Held M, 2015, WOUNDS, V27, P123; Higuita-Castro N, 2014, J APPL PHYSIOL, V117, P1231, DOI 10.1152/japplphysiol.00752.2013; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Huang LC, 2007, ANTIMICROB AGENTS CH, V51, P3853, DOI 10.1128/AAC.01317-06; HURME T, 1991, LAB INVEST, V64, P76; IRETON JE, 2013, PRS GLOB OPEN, V1, DOI DOI 10.1097/GOX.0B013E31828FF9F4; Isomaki P, 1996, ARTHRITIS RHEUM-US, V39, P386, DOI 10.1002/art.1780390306; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; Jarbrink K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0329-y; Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kadler KE, 1996, BIOCHEM J, V316, P1; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kimball A, 2018, ARTERIOSCL THROM VAS, V38, P1102, DOI 10.1161/ATVBAHA.118.310703; Kirschner N, 2012, EXP DERMATOL, V21, P171, DOI 10.1111/j.1600-0625.2011.01431.x; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McDonald PP, 1999, J IMMUNOL, V163, P6164; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mirza RE, 2015, CYTOKINE, V71, P409, DOI 10.1016/j.cyto.2014.09.005; Moore Z, 1997, World Ir Nurs, V5, P15; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mulder G, 2009, WOUNDS, V21, P254; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Nataraj C, 2007, WOUNDS, V19, P148; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oren A, 2003, EXP MOL PATHOL, V74, P180, DOI 10.1016/S0014-4800(02)00023-0; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Ramos-e-Silva M, 2002, CLIN DERMATOL, V20, P715, DOI 10.1016/S0738-081X(02)00298-5; Roy S, 2014, J PATHOL, V233, P331, DOI 10.1002/path.4360; Rubin RH, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-171; Sebastian A, 2011, WOUND REPAIR REGEN, V19, P693, DOI 10.1111/j.1524-475X.2011.00736.x; Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI [10.1089/ten.tea.2009.0768, 10.1089/ten.TEA.2009.0768]; Shah Jayesh B, 2011, J Am Col Certif Wound Spec, V3, P65, DOI 10.1016/j.jcws.2012.04.002; Sheridan RL, 2001, BURNS, V27, P92, DOI 10.1016/S0305-4179(00)00076-0; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Strasser S, 2007, BIOCHEM BIOPH RES CO, V354, P27, DOI 10.1016/j.bbrc.2006.12.114; Strecker-McGraw MK, 2007, EMERG MED CLIN N AM, V25, P1, DOI 10.1016/j.emc.2006.12.002; Taylor PR, 2003, IMMUNITY, V19, P2, DOI 10.1016/S1074-7613(03)00178-X; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914; Yates CC, 2012, BIRTH DEFECTS RES C, V96, P325, DOI 10.1002/bdrc.21024; Yazdanpanah L, 2015, WORLD J DIABETES, V6, P37, DOI 10.4239/wjd.v6.i1.37; Zdrenghea MT, 2015, REV MED VIROL, V25, P33, DOI 10.1002/rmv.1817; Zelen CM, 2015, INT WOUND J, V12, P724, DOI 10.1111/iwj.12395; Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170	94	30	30	4	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2144	2155		10.1096/fj.201800352R	http://dx.doi.org/10.1096/fj.201800352R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260708	Green Published			2022-12-28	WOS:000457296600050
J	Helmke, A; Casper, J; Nordlohne, J; David, S; Haller, H; Zeisberg, EM; von Vietinghoff, S				Helmke, Alexandra; Casper, Janis; Nordlohne, Johannes; David, Sascha; Haller, Hermann; Zeisberg, Elisabeth M.; von Vietinghoff, Sibylle			Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage function	FASEB JOURNAL			English	Article						endothelium; disturbed flow; hypoxia; macrophage lipid uptake	APOPTOTIC CELL ACCUMULATION; HIGH-DENSITY-LIPOPROTEINS; PRIMARY CILIA; INFLAMMATION; MONOCYTES; RECEPTOR; DIFFERENTIATION; CONTRIBUTES; RECRUITMENT; DYSFUNCTION	Endothelial cells can acquire a mesenchymal phenotype upon irritation [endothelial-to-mesenchymal transition (EndMT)]. Macrophages accumulate in the atherosclerotic plaque. This study addressed whether macrophages modulate EndMT and delineated a reciprocal effect of EndMT on macrophage functions in atherosclerosis. In atherosclerotic murine and human aortas, endothelial cells with mesenchymal markers were elevated by confocal microscopy and flow cytometric analysis. Increased EndMT master transcription factor Snai1 expression and extracellular matrix are consistent with enhanced EndMT in this condition. Hypoxia was detected in individual aortic EndMT cells in vivo and rapidly induced a similar EndMT phenotype in vitro. As a novel inducer of EndMT, macrophages, which are abundant in the atherosclerotic lesions, enhance mesothelial marker expression during coculture in vitro. In the reverse relationship, EndMT altered endothelial colony-stimulating factor expression. Functionally, EndMT cell-conditioned media attenuated macrophage proliferation, antigen-presenting cell marker expression, and TNF- production in response to oxidized LDL but increased oxidized LDL uptake and scavenger receptor expression. These experiments demonstrate that macrophages promote partial EndMT. In turn, EndMT cells modulate macrophage phenotype and lipid uptake. Our data suggest that EndMT shapes macrophage and endothelial cell phenotypes, thus affecting internal atherosclerotic plaque in addition to surface structure.Helmke, A., Casper, J., Nordlohne, J., David, S., Haller, H., Zeisberg, E. M., von Vietinghoff, S. Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage function.	[Helmke, Alexandra; Casper, Janis; Nordlohne, Johannes; David, Sascha; Haller, Hermann; von Vietinghoff, Sibylle] Hannover Med Sch, Dept Internal Med, Div Nephrol & Hypertens, Hannover, Germany; [Zeisberg, Elisabeth M.] Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany; [Zeisberg, Elisabeth M.] German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany	Hannover Medical School; University of Gottingen; German Centre for Cardiovascular Research	von Vietinghoff, S (corresponding author), Hannover Med Sch, Dept Nephrol & Hypertens, OE 6840,Carl Neuberg Str 1, D-30625 Hannover, Germany.	vonvietinghoff.sibylle@mh-hannover.de	Zeisberg, Elisabeth/ABG-4970-2021; David, Sascha/AAL-6909-2021	Nordlohne, Alexandra/0000-0002-6177-0637	Bundesministerium fur Bildung und Forschung [Deutsches Zentrum fur Herz- und Kreislauferkrankungen (DZHK)]; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung [Deutsches Zentrum fur Herz- und Kreislauferkrankungen (DZHK)]; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge support of the Imaging and Flow Cytometry Sorting Core Facilities at Hannover Medical School, and also thank Martina Flechsig and Yvonne Nicolai for expert technical work. The authors acknowledge the Department of Pathology at Hannover Medical School for cooperation for acquisition of patient samples. This work was supported by Bundesministerium fur Bildung und Forschung [Deutsches Zentrum fur Herz- und Kreislauferkrankungen (DZHK)] to E.Z. and S.v.V., and Deutsche Forschungsgemeinschaft to S.D., H.H., and S.v.V. The authors declare no conflicts of interest.	Ait-Oufella H, 2008, ARTERIOSCL THROM VAS, V28, P1429, DOI 10.1161/ATVBAHA.108.169078; Akhtar S, 2015, HYPERTENSION, V66, P1220, DOI 10.1161/HYPERTENSIONAHA.115.05886; Boulanger CM, 2016, ARTERIOSCL THROM VAS, V36, pE26, DOI 10.1161/ATVBAHA.116.306940; Bryan MT, 2014, ARTERIOSCL THROM VAS, V34, P2199, DOI 10.1161/ATVBAHA.114.303424; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Chen PY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005504; Cheng SL, 2013, ARTERIOSCL THROM VAS, V33, P1679, DOI 10.1161/ATVBAHA.113.300647; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Dinsmore C, 2016, EMBO REP, V17, P156, DOI 10.15252/embr.201541019; Dong L, 2016, J AM SOC NEPHROL, V27, P1753, DOI 10.1681/ASN.2015050540; Doran AC, 2017, J CLIN INVEST, V127, P4075, DOI 10.1172/JCI94735; Draude G, 2000, AM J PHYSIOL-HEART C, V278, pH1042, DOI 10.1152/ajpheart.2000.278.4.H1042; Drechsler M, 2015, ARTERIOSCL THROM VAS, V35, P1050, DOI 10.1161/ATVBAHA.114.304649; Egorova AD, 2011, CIRC RES, V108, P1093, DOI 10.1161/CIRCRESAHA.110.231860; Evrard SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11853; Feng S, 2017, ARTERIOSCL THROM VAS, V37, P2087, DOI 10.1161/ATVBAHA.117.309249; Franck G, 2017, CIRC RES, V121, P31, DOI 10.1161/CIRCRESAHA.117.310694; Ge SW, 2013, CIRC RES, V113, P965, DOI 10.1161/CIRCRESAHA.113.301934; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Kim M, 2013, INT J RADIAT BIOL, V89, P356, DOI 10.3109/09553002.2013.763193; Koltsova EK, 2013, CURR OPIN LIPIDOL, V24, P371, DOI 10.1097/MOL.0b013e328363d298; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Mahmoud MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03532-z; Mahmoud MM, 2016, CIRC RES, V119, P450, DOI 10.1161/CIRCRESAHA.116.308870; Medici D, 2012, SEMIN CANCER BIOL, V22, P379, DOI 10.1016/j.semcancer.2012.04.004; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Moonen JRAJ, 2015, CARDIOVASC RES, V108, P377, DOI 10.1093/cvr/cvv175; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Retzlaff J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44113; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanchez-Duffhues G, 2015, ARTERIOSCL THROM VAS, V35, P616, DOI 10.1161/ATVBAHA.115.305268; Spillmann F, 2015, ARTERIOSCL THROM VAS, V35, P1774, DOI 10.1161/ATVBAHA.115.305887; Tarling EJ, 2013, CURR OPIN LIPIDOL, V24, P138, DOI 10.1097/MOL.0b013e32835da122; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Westhorpe CLV, 2012, EXP MOL PATHOL, V93, P220, DOI 10.1016/j.yexmp.2012.03.014; Witztum JL, 2005, J CLIN INVEST, V115, P2072, DOI 10.1172/JCI26130; Witztum JL, 2014, ANNU REV PATHOL-MECH, V9, P73, DOI 10.1146/annurev-pathol-020712-163936; Wu D, 2017, ELIFE, V6; Wu KQ, 2017, AM J PATHOL, V187, P2102, DOI 10.1016/j.ajpath.2017.05.014; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zuckerman SH, 2001, ATHEROSCLEROSIS, V155, P79, DOI 10.1016/S0021-9150(00)00540-2	51	25	25	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2278	2289		10.1096/fj.201801238R	http://dx.doi.org/10.1096/fj.201801238R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260706				2022-12-28	WOS:000457296600060
J	Kim, HS; Kim, Y; Lim, MJ; Park, YG; Park, SI; Sohn, J				Kim, Hee Suk; Kim, Yongjin; Lim, Min Jae; Park, Yun-Gyu; Park, Serk In; Sohn, Jeongwon			The p38-activated ER stress-ATF6 axis mediates cellular senescence	FASEB JOURNAL			English	Article						NBR1; NADPH oxidase; oxidative stress; p53; Ras	ENDOPLASMIC-RETICULUM STRESS; P38 MAPK; PREMATURE SENESCENCE; UP-REGULATION; ACTIVATION; KINASE; CELLS; APOPTOSIS; AUTOPHAGY; INHIBITION	The importance of proteostasis in preventing cellular senescence has been well recognized. However, the exact mechanism by which the loss of proteostasis or endoplasmic reticulum (ER) stress induces cellular senescence remains unclear. We report that ER stress mediates cellular senescence through the activating transcription factor (ATF)6 branch of the unfolded protein response (UPR). Cellular senescence was induced by the abrogation of neighbor of breast cancer (BRCA)1 gene (NBR1). NBR1 abrogation-induced senescence was p53 dependent and observed in both transformed and nontransformed human cell lines: MCF-7, Caki-1, and MRC-5. NBR1 bound to p38 MAPK, preferentially to an active form, and upon NBR1 abrogation, the activity of p38 increased. NADPH oxidase was activated in turn by p38, and the resulting oxidative stress triggered ER stress. It was found that ER stress mediated cellular senescence through the UPR sensor ATF6. Knockdown of ATF6 prevented senescence, whereas ATF6 overexpression triggered it. The transcriptional activity of ATF6 was important. The ER stress-ATF6 axis also mediated cellular senescence induced by H-RasV12 overexpression and UV irradiation, suggesting a common role of this axis in senescence induction. In summary, we presented an evidence for the novel role of the ER stress-ATF6 axis in cellular senescence.Kim, H. S., Kim, Y., Lim, M. J., Park, Y.-G., Park, S. I., Sohn, J. The p38-activated ER stress-ATF6 axis mediates cellular senescence.	[Kim, Hee Suk; Kim, Yongjin; Lim, Min Jae; Park, Yun-Gyu; Park, Serk In; Sohn, Jeongwon] Korea Univ, Dept Biochem & Mol Biol, Coll Med, Moonsook Med Hall,73 Inchon Ro, Seoul 02841, South Korea; [Kim, Hee Suk; Kim, Yongjin; Lim, Min Jae; Park, Yun-Gyu; Park, Serk In; Sohn, Jeongwon] Korea Inst Mol Med & Nutr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Sohn, J (corresponding author), Korea Univ, Dept Biochem & Mol Biol, Coll Med, Moonsook Med Hall,73 Inchon Ro, Seoul 02841, South Korea.	biojs@korea.ac.kr	Park, Serk In/D-2840-2011; cioffi, federica/AAB-8161-2019	Park, Serk In/0000-0001-8643-5096; cioffi, federica/0000-0002-1530-8556; Sohn, Jeongwon/0000-0003-2395-458X	National Research Foundation of Korea (NRF) - Korean Government [NRF-2014R1A1A2058003]; Korea University Executive Vice President for Medical Affairs [K1723221]	National Research Foundation of Korea (NRF) - Korean Government; Korea University Executive Vice President for Medical Affairs	This work was supported by the National Research Foundation of Korea (NRF) funded by the Korean Government (Grant NRF-2014R1A1A2058003 to J.S.), and the Korea University Executive Vice President for Medical Affairs (Grant K1723221 to J.S.). The authors declare no conflicts of interest.	Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chen HS, 2015, MOL CELL, V59, P719, DOI 10.1016/j.molcel.2015.07.011; Corazzari M, 2015, CELL DEATH DIFFER, V22, P946, DOI 10.1038/cdd.2014.183; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Druelle C, 2016, ONCOTARGET, V7, P67699, DOI 10.18632/oncotarget.11505; Dufey E, 2015, SEMIN CANCER BIOL, V33, P40, DOI 10.1016/j.semcancer.2015.04.003; Feaver RE, 2008, ARTERIOSCL THROM VAS, V28, P1534, DOI 10.1161/ATVBAHA.108.167999; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Haq R, 2002, CANCER RES, V62, P5076; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Karali E, 2014, MOL CELL, V54, P559, DOI 10.1016/j.molcel.2014.03.022; Kim HD, 2013, J BIOL CHEM, V288, P28743, DOI 10.1074/jbc.M113.499053; Kim HS, 2016, INT J CANCER, V138, P1432, DOI 10.1002/ijc.29879; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Li B, 2015, BBA-MOL BASIS DIS, V1852, P805, DOI 10.1016/j.bbadis.2015.01.010; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Liu J, 2014, CELL SIGNAL, V26, P110, DOI 10.1016/j.cellsig.2013.10.002; Luo Y, 2011, EXP GERONTOL, V46, P860, DOI 10.1016/j.exger.2011.07.005; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mardakheh FK, 2009, J CELL BIOL, V187, P265, DOI 10.1083/jcb.200905118; Matos L, 2015, J GERONTOL A-BIOL, V70, P924, DOI 10.1093/gerona/glu129; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Su DM, 2011, BIOCHEM J, V433, P333, DOI 10.1042/BJ20100404; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Teodoro T, 2012, AM J PHYSIOL-CELL PH, V302, pC992, DOI 10.1152/ajpcell.00160.2011; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Whitehouse CA, 2010, P NATL ACAD SCI USA, V107, P12913, DOI 10.1073/pnas.0913058107; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190; Zhang SS, 2003, CIRC RES, V93, P1026, DOI 10.1161/01.RES.0000104084.88317.91; Zhu BK, 2014, J BIOL CHEM, V289, P20102, DOI 10.1074/jbc.M114.551069	48	26	27	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2422	2434		10.1096/fj.201800836R	http://dx.doi.org/10.1096/fj.201800836R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260700				2022-12-28	WOS:000457296600071
J	Maridas, DE; Rendina-Ruedy, E; Helderman, RC; DeMambro, VE; Brooks, D; Guntur, AR; Lanske, B; Bouxsein, ML; Rosen, CJ				Maridas, David E.; Rendina-Ruedy, Elizabeth; Helderman, Ron C.; DeMambro, Victoria E.; Brooks, Daniel; Guntur, Anyonya R.; Lanske, Beate; Bouxsein, Mary L.; Rosen, Clifford J.			Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton	FASEB JOURNAL			English	Article						PTH; bone; marrow; fat; adipocytes	BONE-MARROW FAT; ANOREXIA-NERVOSA; INTERMITTENT TREATMENT; CALORIC RESTRICTION; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; VERTEBRAL BONE; PTH; ARCHITECTURE; TURNOVER	Intermittent administration of parathyroid hormone (PTH) stimulates bone formation in vivo and also suppresses the volume of bone marrow adipose tissue (BMAT). In contrast, a calorie-restricted (CR) diet causes bone loss and induces BMAT in both mice and humans. We used the CR model to test whether PTH would reduce BMAT in mice by both altering cell fate and inducing lipolysis of marrow adipocytes. Eight-week-old mice were placed on a control (Ctrl) diet or CR diet. At 12 wk, CR and Ctrl mice were injected daily with PTH (CR/PTH or Ctrl/PTH) or vehicle for 4 wk. Two other cohorts were CR and simultaneously injected (CR + PTH or CR + Veh) for 4 wk. CR mice had low bone mass and increased BMAT in the proximal tibias. PTH significantly increased bone mass in all cohorts despite calorie restrictions. Adipocyte density and size were markedly increased with restriction of calories. PTH reduced adipocyte numbers in CR + PTH mice, whereas adipocyte size was reduced in CR/PTH-treated mice. In contrast, osteoblast number was increased 3-8-fold with PTH treatment. In vitro, bone marrow stromal cells differentiated into adipocytes and, treated with PTH, exhibited increased production of glycerol and fatty acids. Moreover, in cocultures of bone marrow adipocyte and osteoblast progenitors, PTH stimulated the transfer of fatty acids to osteoblasts. In summary, PTH administration to CR mice increased bone mass by shifting lineage allocation toward osteogenesis and inducing lipolysis of mature marrow adipocytes. The effects of PTH on bone marrow adiposity could enhance its anabolic actions by providing both more cells and more fuel for osteoblasts during bone formation.Maridas, D. E., Rendina-Ruedy, E., Helderman, R. C., DeMambro, V. E., Brooks, D., Guntur, A. R., Lanske, B., Bouxsein, M. L., Rosen, C. J. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.	[Maridas, David E.; Rendina-Ruedy, Elizabeth; Helderman, Ron C.; DeMambro, Victoria E.; Guntur, Anyonya R.; Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME USA; [Maridas, David E.; Lanske, Beate] Harvard Sch Dent Med, 188 Longwood Ave,5th Floor, Boston, MA 02115 USA; [Brooks, Daniel; Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA	Maine Medical Center; Harvard University; Harvard School of Dental Medicine; Harvard University; Beth Israel Deaconess Medical Center	Maridas, DE (corresponding author), Harvard Sch Dent Med, 188 Longwood Ave,5th Floor, Boston, MA 02115 USA.	david_maridas@hsdm.harvard.edu	Maridas, David/ABA-8941-2021	Maridas, David/0000-0001-6680-6005; Lanske, Beate/0000-0003-4638-804X	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK092759, DK112374]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [AR072123]; NIH NIGMS [P30GM106391, P20GM121301, U54GM115516]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR072123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK112374, R24DK092759, R01DK112374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121301, U54GM115516, P30GM106391] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank D.B. for performing the mCT analyses. All grants are supported by the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS). The authors thank Dr. Vicki Rosen (Harvard School of Dental Medicine) for the use of her equipment. This project was primarily supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants DK092759 (to C.J.R.) and DK112374 (to C.J.R.). Additional support was provided by the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR072123 (to E.R.-R.). The experiments were performed using the Physiology, Molecular Phenotyping, and Histopathology Cores. These cores are supported by the following NIH NIGMS grants: Physiology and Histopathology Core are supported by Grants P30GM106391 [Centers of Biomedical Research Excellence (COBRE) in Stem Cell Biology and Regenerative Medicine; R. Friesel, Principal Investigator], P20GM121301 (COBRE in Metabolic Networks; L. Liaw, Principal Investigator) and U54GM115516 (Northern New England Clinical and Translational Research Network; C.J.R., Principal Investigator). The Molecular Phenotyping Core is supported by Grants P30GM106391 and U54GM115516. The authors declare no conflicts of interest.	Ahn H, 2014, NUTR RES, V34, P707, DOI 10.1016/j.nutres.2014.07.006; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Balani DH, 2017, J CLIN INVEST, V127, P3333, DOI 10.1172/JCI91699; Behrendt AK, 2016, J BONE MINER RES, V31, P852, DOI 10.1002/jbmr.2745; Ben-Awadh AN, 2014, ENDOCRINOLOGY, V155, P2797, DOI 10.1210/en.2014-1046; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bredella MA, 2014, BONE, V66, P199, DOI 10.1016/j.bone.2014.06.014; Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P2129, DOI 10.1210/jc.2008-2532; Cawthorn WP, 2014, CELL METAB, V20, P368, DOI 10.1016/j.cmet.2014.06.003; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; DeMambro VE, 2015, ENDOCRINOLOGY, V156, P4129, DOI 10.1210/en.2014-1452; Dempster DW, 2001, J BONE MINER RES, V16, P1846, DOI 10.1359/jbmr.2001.16.10.1846; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Esen E, 2015, J BONE MINER RES, V30, P1959, DOI 10.1002/jbmr.2556; Fan Y, 2017, CELL METAB, V25, P661, DOI 10.1016/j.cmet.2017.01.001; Fazeli PK, 2014, BONE, V66, P39, DOI 10.1016/j.bone.2014.05.014; Fazeli PK, 2014, J CLIN ENDOCR METAB, V99, P1322, DOI 10.1210/jc.2013-4105; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Fazeli PK, 2012, J BONE MINER RES, V27, P1864, DOI 10.1002/jbmr.1640; Gasparrini M, 2009, EXP GERONTOL, V44, P613, DOI 10.1016/j.exger.2009.05.009; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Iwaniec UT, 2013, BONE, V53, P145, DOI 10.1016/j.bone.2012.11.034; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Knopp E, 2005, ENDOCRINOLOGY, V146, P1983, DOI 10.1210/en.2004-0770; Kulkarni NH, 2007, J CELL BIOCHEM, V102, P1504, DOI 10.1002/jcb.21374; Larsson S, 2016, CELL SIGNAL, V28, P204, DOI 10.1016/j.cellsig.2015.12.012; Maridas DE, 2018, JOVE-J VIS EXP, DOI 10.3791/56750; Misra M, 2014, J ENDOCRINOL, V221, pR163, DOI 10.1530/JOE-14-0039; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Qiu T, 2015, J BONE MINER RES, V30, P309, DOI 10.1002/jbmr.2327; Rahman S, 2013, ENDOCRINOLOGY, V154, P2687, DOI 10.1210/en.2012-2162; Rickard DJ, 2006, BONE, V39, P1361, DOI 10.1016/j.bone.2006.06.010; Schwartz AV, 2013, J CLIN ENDOCR METAB, V98, P2294, DOI 10.1210/jc.2012-3949; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; SINHA TK, 1976, METABOLISM, V25, P251, DOI 10.1016/0026-0495(76)90083-4; Towell DB, 2001, BRIT J CLIN PSYCHOL, V40, P189, DOI 10.1348/014466501163634; TRZECIAK WH, 1974, EUR J BIOCHEM, V46, P201, DOI 10.1111/j.1432-1033.1974.tb03612.x; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074255; Wein MN, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14745	44	39	40	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2885	2898		10.1096/fj.201800948RR	http://dx.doi.org/10.1096/fj.201800948RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30354669	Bronze, Green Published			2022-12-28	WOS:000457296600108
J	Soluri, MF; Boccafoschi, F; Cotella, D; Moro, L; Forestieri, G; Autiero, I; Cavallo, L; Oliva, R; Griffin, M; Wang, Z; Santoro, C; Sblattero, D				Soluri, Maria Felicia; Boccafoschi, Francesca; Cotella, Diego; Moro, Laura; Forestieri, Gabriela; Autiero, Ida; Cavallo, Luigi; Oliva, Romina; Griffin, Martin; Wang, Zhuo; Santoro, Claudio; Sblattero, Daniele			Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells	FASEB JOURNAL			English	Article						extracellular matrix; gelatin binding domain (GBD); ovarian cancer; cell adhesion	TISSUE TRANSGLUTAMINASE; WEB SERVER; EXTRACELLULAR-MATRIX; 3T3 FIBROBLASTS; OVARIAN-CANCER; PROTEIN; EXPRESSION; INTEGRIN; COMPLEXES; BETA	The interaction between the enzyme transglutaminase 2 (TG2) and fibronectin (FN) is involved in the cell-matrix interactions that regulate cell signaling, adhesion, and migration and play central roles in pathologic conditions, particularly fibrosis and cancer. A precise definition of the exact interaction domains on both proteins could provide a tool to design novel molecules with potential therapeutic applications. Although specific residues involved in the interaction within TG2 have been analyzed, little is known regarding the TG2 binding site on FN. This site has been mapped to a large internal 45-kDa protein fragment coincident with the gelatin binding domain (GBD). With the goal of defining the minimal FN interacting domain for TG2, we produced several expression constructs encoding different portions or modules of the GBD and tested their binding and functional properties. The results demonstrate that the I-8 module is necessary and sufficient for TG2-binding in vitro, but does not have functional effects on TG2-expressing cells. Modules I-7 and I-9 increase the strength of the binding and are required for cell adhesion. A 15-kDa fragment encompassing modules I7-9 behaves as the whole 45-kDa GBD and mediates signaling, adhesion, spreading, and migration of TG2(+) cells. This study provides new insights into the mechanism for TG2 binding to FN.Soluri, M. F., Boccafoschi, F., Cotella, D., Moro, L., Forestieri, G., Autiero, I., Cavallo, L., Oliva, R., Griffin, M., Wang, Z., Santoro, C., Sblattero, D. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.	[Soluri, Maria Felicia; Boccafoschi, Francesca; Cotella, Diego; Forestieri, Gabriela; Santoro, Claudio] UPO, Dept Hlth Sci, Novara, Italy; [Soluri, Maria Felicia; Boccafoschi, Francesca; Cotella, Diego; Forestieri, Gabriela; Santoro, Claudio] UPO, IRCAD, Novara, Italy; [Moro, Laura] UPO, Dept Pharmaceut Sci, Novara, Italy; [Autiero, Ida; Cavallo, Luigi] KAUST, Catalysis Ctr KCC, Phys Sci & Engn Div, Thuwal, Saudi Arabia; [Oliva, Romina] KAUST, CBRC, Comp Elect & Math Sci & Engn CEMSE Div, Thuwal, Saudi Arabia; [Oliva, Romina] Univ Parthenope Naples, Dept Sci & Technol, Naples, Italy; [Griffin, Martin; Wang, Zhuo] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Sblattero, Daniele] Univ Trieste, Dept Life Sci, Via L Giorgieri 5, I-34127 Trieste, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Parthenope University Naples; Aston University; University of Trieste	Sblattero, D (corresponding author), Univ Trieste, Dept Life Sci, Via L Giorgieri 5, I-34127 Trieste, Italy.	dsblattero@units.it	Oliva, Romina/ABA-6313-2021; cotella, diego/J-8422-2019; Autiero, Ida/P-7002-2018; Boccafoschi, Francesca/ABG-1310-2020; Moro, Laura/ABF-2175-2020	Oliva, Romina/0000-0002-6156-6249; cotella, diego/0000-0003-2714-4744; Autiero, Ida/0000-0001-8886-8063; Boccafoschi, Francesca/0000-0002-6734-5447; Sblattero, Daniele/0000-0003-4309-242X; WANG, ZHUO/0000-0002-2212-8318; Griffin, Martin/0000-0003-3824-306X	Cariplo Foundation (Milan, Italy)	Cariplo Foundation (Milan, Italy)(Fondazione Cariplo)	This work was supported by the Cariplo Foundation (Milan, Italy). The authors declare no conflicts of interest.	Agnihotri N, 2017, AMINO ACIDS, V49, P425, DOI 10.1007/s00726-016-2320-2; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Assi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074437; Belkin AM, 2004, BIOCHEMISTRY-US, V43, P11760, DOI 10.1021/bi049266z; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Cardoso I, 2017, AMINO ACIDS, V49, P489, DOI 10.1007/s00726-016-2296-y; Chen SH, 2010, ANTICANCER RES, V30, P4177; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Chermak E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166460; D'Eletto M, 2009, AUTOPHAGY, V5, P1145, DOI 10.4161/auto.5.8.10040; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Di Niro R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq052; Eckert RL, 2015, MOL CARCINOGEN, V54, P947, DOI 10.1002/mc.22375; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Huang L, 2015, AM J CANCER RES, V5, P2756; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; INGHAM KC, 1995, ARCH BIOCHEM BIOPHYS, V316, P235, DOI 10.1006/abbi.1995.1033; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; JEONG JM, 1995, J BIOL CHEM, V270, P5654, DOI 10.1074/jbc.270.10.5654; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; Khanna M, 2011, MOL CANCER THER, V10, P626, DOI 10.1158/1535-7163.MCT-10-0912; Kotsakis P, 2011, AMINO ACIDS, V41, P909, DOI 10.1007/s00726-010-0790-1; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; LEMOSY EK, 1992, J BIOL CHEM, V267, P7880; Lensink MF, 2016, PROTEINS, V84, P323, DOI 10.1002/prot.25007; Lesort M, 1998, J BIOL CHEM, V273, P11991, DOI 10.1074/jbc.273.20.11991; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lortat-Jacob H, 2012, J BIOL CHEM, V287, P18005, DOI 10.1074/jbc.M111.337089; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; MARTINEZ J, 1994, BIOCHEMISTRY-US, V33, P2538, DOI 10.1021/bi00175a024; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Qiao SW, 2005, J IMMUNOL, V174, P1657, DOI 10.4049/jimmunol.174.3.1657; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Rossin F, 2012, AMINO ACIDS, V42, P1793, DOI 10.1007/s00726-011-0899-x; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Sblattero D, 2002, EUR J BIOCHEM, V269, P5175, DOI 10.1046/j.1432-1033.2002.03215.x; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Sottile J, 2000, J CELL SCI, V113, P4287; Stamnaes J, 2016, FEBS J, V283, P3994, DOI 10.1111/febs.13907; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; van Strien ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025037; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Yakubov B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089285; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zonca S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.30	71	8	8	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2327	2342		10.1096/fj.201800054RRR	http://dx.doi.org/10.1096/fj.201800054RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30285580				2022-12-28	WOS:000457296600064
J	Wiernicki, I; Parafiniuk, M; Kolasa-Wolosiuk, A; Gutowska, I; Kazimierczak, A; Clark, J; Baranowska-Bosiacka, I; Szumilowicz, P; Gutowski, P				Wiernicki, Ireneusz; Parafiniuk, Miroslaw; Kolasa-Wolosiuk, Agnieszka; Gutowska, Izabela; Kazimierczak, Arkadiusz; Clark, Jeremy; Baranowska-Bosiacka, Irena; Szumilowicz, Pawel; Gutowski, Piotr			Relationship between aortic wall oxidative stress/proteolytic enzyme expression and intraluminal thrombus thickness indicates a novel pathomechanism in the progression of human abdominal aortic aneurysm	FASEB JOURNAL			English	Article						vascular biology; arterial wall; parietal thrombus; antioxidant activity; matrix metalloproteinase-9	SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; ELASTIN DEGRADATION; COVERED WALL; STRESS; CATALASE; DEGENERATION; INFILTRATION; GELATINASE; ACTIVATION	The possibility that oxidative stress promotes degradation of the extracellular matrix and a relationship between intraluminal thrombus (ILT) thickness and proteolytic activity within the abdominal aortic aneurysm (AAA) wall has been suggested. In the present study, the hypothesis that thin ILT is correlated with an increase in oxidative stress-related enzymes and matrix metalloproteinase-9 (MMP-9) expression within the human AAA wall was investigated. We also studied the antioxidant activity of superoxide dismutases, catalase, glutathione peroxidase, glutathione reductase, and thioredoxin within the full-thickness AAA wall and through fluoroimmunohistochemical staining of catalase and MMP-9 expression within the inner and outer media, in relation to ILT thickness. Reactive oxygen species control the degradation and remodeling of the extracellular matrix by up-regulating proteolytic enzymes, such as MMPs. Results showed that oxidative stress and proteolytic enzyme expression were simultaneously, significantly higher within thin thrombus (10 mm)-covered aneurysm wall when compared with the wall covered by thick thrombus (25 mm). These findings provide the first demonstration, to our knowledge, of a causative link between oxidative stress instigating proteolytic enzyme expression at the tissue level and human AAA development. Presence of a thin circumferential thrombus should always be considered as a risk factor for the greatest increase in aneurysm growth rate and rupture, giving an indication for surgery timing.Wiernicki, I., Parafiniuk, M., Kolasa-Woosiuk, A., Gutowska, I., Kazimierczak, A., Clark, J., Baranowska-Bosiacka, I., Szumilowicz, P., Gutowski, P. Relationship between aortic wall oxidative stress/proteolytic enzyme expression and intraluminal thrombus thickness indicates a novel pathomechanism in the progression of human abdominal aortic aneurysm.	[Wiernicki, Ireneusz; Kazimierczak, Arkadiusz; Szumilowicz, Pawel; Gutowski, Piotr] Pomeranian Med Univ, Dept Vasc Surg & Angiol, Fac Lab Diagnost & Mol Med, Al Powstancow Wielkopolskich 72, PL-70111 Szczecin, Poland; [Parafiniuk, Miroslaw] Pomeranian Med Univ, Dept Forens Med, Fac Lab Diagnost & Mol Med, Szczecin, Poland; [Kolasa-Wolosiuk, Agnieszka] Pomeranian Med Univ, Dept Histol & Embryol, Fac Lab Diagnost & Mol Med, Szczecin, Poland; [Gutowska, Izabela] Pomeranian Med Univ, Dept Biochem & Human Nutr, Fac Lab Diagnost & Mol Med, Szczecin, Poland; [Clark, Jeremy] Pomeranian Med Univ, Dept Clin & Mol Biochem, Fac Lab Diagnost & Mol Med, Szczecin, Poland; [Baranowska-Bosiacka, Irena] Pomeranian Med Univ, Fac Lab Diagnost & Mol Med, Dept Biochem & Med Chem, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University	Wiernicki, I (corresponding author), Pomeranian Med Univ, Dept Vasc Surg & Angiol, Fac Lab Diagnost & Mol Med, Al Powstancow Wielkopolskich 72, PL-70111 Szczecin, Poland.	irekwie@wp.pl	Clark, Jeremy S.C./E-1665-2016; Wiernicki, Ireneusz/O-1803-2019; Kolasa-Wołosiuk, Agnieszka/M-5963-2014	Clark, Jeremy S.C./0000-0003-3179-5638; Kolasa-Wołosiuk, Agnieszka/0000-0002-6933-7643; Parafiniuk, Miroslaw/0000-0002-3005-2202				Adolph R, 1997, J VASC SURG, V25, P916, DOI 10.1016/S0741-5214(97)70223-4; Behr-Andersen C, 2019, J CARDIOVASC SURG, V60, P221, DOI 10.23736/S0021-9509.17.09921-9; BUSUTTIL RW, 1982, J SURG RES, V32, P214, DOI 10.1016/0022-4804(82)90093-2; CAMPA JS, 1987, ATHEROSCLEROSIS, V65, P13, DOI 10.1016/0021-9150(87)90003-7; Delbosc S, 2013, CARDIOVASC RES, V100, P307, DOI 10.1093/cvr/cvt194; DOBRIN PB, 1984, ARCH SURG-CHICAGO, V119, P405; Eliason JL, 2005, CIRCULATION, V112, P232, DOI 10.1161/CIRCULATIONAHA.104.517391; Elmore JR, 1998, ANN VASC SURG, V12, P221, DOI 10.1007/s100169900144; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Fontaine V, 2004, AM J PATHOL, V164, P2077, DOI 10.1016/S0002-9440(10)63766-2; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Golledge J, 2008, CIRCULATION, V118, P2382, DOI 10.1161/CIRCULATIONAHA.108.802074; Grigoryants V, 2005, J VASC SURG, V41, P108, DOI 10.1016/j.jvs.2004.09.033; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; HOLMES DR, 1995, J VASC SURG, V21, P761, DOI 10.1016/S0741-5214(05)80007-2; Houard X, 2009, FASEB J, V23, P1376, DOI 10.1096/fj.08-116202; Houard X, 2009, CARDIOVASC RES, V82, P532, DOI 10.1093/cvr/cvp048; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; Kazi M, 2005, ARTERIOSCL THROM VAS, V25, P1341, DOI 10.1161/01.ATV.0000166601.49954.21; KOCH AE, 1990, AM J PATHOL, V137, P1199; KUSHIHASHI T, 1991, Nippon Acta Radiologica, V51, P219; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; LopezCandales A, 1997, AM J PATHOL, V150, P993; Martin-Ventura JL, 2012, THROMB HAEMOSTASIS, V108, P435, DOI 10.1160/TH12-04-0248; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Mayranpaa MI, 2009, J VASC SURG, V50, P388, DOI 10.1016/j.jvs.2009.03.055; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Nchimi A, 2016, EUR RADIOL, V26, P2378, DOI 10.1007/s00330-015-4010-y; NEWMAN KM, 1994, ARTERIOSCLER THROMB, V14, P1315, DOI 10.1161/01.ATV.14.8.1315; Parastatidis I, 2013, ARTERIOSCL THROM VAS, V33, P2389, DOI 10.1161/ATVBAHA.113.302175; Pincemail J, 2012, REDOX REP, V17, P139, DOI 10.1179/1351000212Y.0000000012; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Ramella M, 2017, AM J TRANSL RES, V9, P5485; Ramos-Mozo P, 2011, ARTERIOSCL THROM VAS, V31, P3011, DOI 10.1161/ATVBAHA.111.237537; Reeps C, 2009, PATHOBIOLOGY, V76, P243, DOI 10.1159/000228900; Sakalihasan N, 1996, J VASC SURG, V24, P127, DOI 10.1016/S0741-5214(96)70153-2; Sho E, 2004, EXP MOL PATHOL, V76, P108, DOI 10.1016/j.yexmp.2003.11.003; Sillesen H, 2015, BRIT J SURG, V102, P894, DOI 10.1002/bjs.9824; Sinha I, 2007, J SURG RES, V138, P156, DOI 10.1016/j.jss.2006.07.011; Tamarina NA, 1997, SURGERY, V122, P264, DOI 10.1016/S0039-6060(97)90017-9; Tanaka H, 2017, JOVE-J VIS EXP, DOI 10.3791/55763; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Tsai SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28612; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; Umeda H, 2001, ARCH BIOCHEM BIOPHYS, V385, P209, DOI 10.1006/abbi.2000.2145; Urbonavicius S, 2008, EUR J VASC ENDOVASC, V36, P273, DOI 10.1016/j.ejvs.2008.05.009; Virag L, 2015, ANN BIOMED ENG, V43, P2852, DOI 10.1007/s10439-015-1354-z; Wiernicki I, 2008, EUR J CLIN INVEST, V38, P883, DOI 10.1111/j.1365-2362.2008.02040.x; Wiernicki I, 2011, DIS MARKERS, V31, P67, DOI [10.1155/2011/783721, 10.3233/DMA-2011-0799]; Wiernicki I, 2010, ATHEROSCLEROSIS, V212, P161, DOI 10.1016/j.atherosclerosis.2010.04.033; Wilson WRW, 2006, CIRCULATION, V113, P438, DOI 10.1161/CIRCULATIONAHA.105.551572; Xu CP, 2001, J VASC SURG, V33, P91, DOI 10.1067/mva.2001.109744; Yu ZH, 2016, J VASC SURG, V64, P737, DOI 10.1016/j.jvs.2015.03.045	54	15	16	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					885	895		10.1096/fj.201800633R	http://dx.doi.org/10.1096/fj.201800633R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30351992	Bronze			2022-12-28	WOS:000457401500069
J	Lu, YY; Li, XD; Zhou, HD; Shao, S; He, S; Hong, MN; Liu, JC; Xu, YL; Wu, YJ; Zhu, DL; Wang, JG; Gao, PJ				Lu, Yuan-Yuan; Li, Xiao-Dong; Zhou, Han-Dan; Shao, Shuai; He, Shun; Hong, Mo-Na; Liu, Jia-Chen; Xu, Ying-Le; Wu, Yong-Jie; Zhu, Ding-Liang; Wang, Ji-Guang; Gao, Ping-Jin			Transactivation domain of Kruppel-like factor 15 negatively regulates angiotensin II-induced adventitial inflammation and fibrosis	FASEB JOURNAL			English	Article						KLF15; Ang II; vascular remodeling; adenovirus; macrophage	PHOSPHOLIPASE C-GAMMA-1; PROTEIN; FIBROBLASTS; EXPRESSION; KLF15; DIFFERENTIATION; CONTRIBUTE; MIGRATION; DISEASE; INJURY	Kruppel-like factor (KLF) 15 has emerged as a critical regulator of fibrosis in cardiovascular diseases. However, the precise role that KLF15 and its functional domain played in adventitial inflammation and fibrosis remains unclear. This study aims to investigate the role of the transactivation domain (TAD) of KLF15 in angiotensin II (Ang II)-induced adventitial pathologic changes. KLF15 expression was decreased in the vascular adventitia of Ang II-infused mice (1000 ng/kg/min, 14 d) and in adventitial fibroblasts (AFs) stimulated by Ang II (10(-7) M). Adenovirus-mediated KLF15 overexpression normalized Ang II-induced vascular hypertrophy, increased collagen deposition, macrophage infiltration, and CCL2 and VCAM-1 expression. Interestingly, KLF15-TAD (KLF15 with deletion of TAD at amino acids 132-152) overexpression showed no effect on the above pathologic changes. Similarly, perivascularly overexpression of KLF15 but not KLF15-TAD in carotid arteries also attenuated Ang II-induced vascular inflammation and fibrosis. Furthermore, KLF15 overexpression after Ang II infusion rescued Ang II-induced vascular remodeling. CCL2 or VCAM-1-mediated monocyte and macrophage migration or adhesion to AFs in response to Ang II was negatively regulated by KLF15 through TAD. Ang II-enhanced Smad2/3 activation and adventitial migration, proliferation, and differentiation of AFs were suppressed by KLF15 but not KLF15-TAD overexpression. Conversely, small interfering RNA knockdown of KLF15 aggravated Ang II-induced Smad2/3 activation and dysfunction of AFs. Luciferase, coimmunoprecipitation, and chromatin immunoprecipitation assay were used to demonstrate that interaction of KLF15 with Smad2/3 suppressed CCL2 expression through TAD. Mechanistically, activation of Ang II type 1 receptor/phospholipase C 1/ERK1/2 signaling resulted in a decrease of KLF15 expression. In conclusion, these results demonstrate that KLF15 negatively regulates activation of AFs through TAD, which plays an important role in Ang II-induced adventitial inflammation and fibrosis.Lu, Y.-Y., Li, X.-D., Zhou, H.-D., Shao, S., He, S., Hong, M.-N., Liu, J.-C., Xu, Y.-L., Wu, Y.-J., Zhu, D.-L., Wang, J.-G., Gao, P.-J. Transactivation domain of Kruppel-like factor 15 negatively regulates angiotensin II-induced adventitial inflammation and fibrosis.	[Lu, Yuan-Yuan; Li, Xiao-Dong; Zhou, Han-Dan; Shao, Shuai; He, Shun; Hong, Mo-Na; Liu, Jia-Chen; Xu, Ying-Le; Wu, Yong-Jie; Zhu, Ding-Liang; Wang, Ji-Guang; Gao, Ping-Jin] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Shanghai Key Lab Hypertens, Ruijin Hosp,Dept Hypertens,Sch Med, Shanghai, Peoples R China; [Li, Xiao-Dong; Xu, Ying-Le; Wu, Yong-Jie; Zhu, Ding-Liang; Wang, Ji-Guang; Gao, Ping-Jin] Shanghai Res Inst Hypertens, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University	Li, XD (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Hypertens, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.; Li, XD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Sch Med, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	flylxd@163.com	Wang, Ji Guang/AAP-4045-2021	Wang, Ji Guang/0000-0001-8511-1524; Li, Xiaodong/0000-0002-3771-6286	Shanghai Sailing Program of Talented Youth in Science and Technology [15YF1409800]; Key Project of National Natural Science Foundation of China [91539202, 91639203, 91739303]; National Natural Science Foundation of China [81770415]; Natural Science Foundation of Shanghai [18ZR1431800]	Shanghai Sailing Program of Talented Youth in Science and Technology; Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study was supported by the Shanghai Sailing Program of Talented Youth in Science and Technology (15YF1409800), the Key Project of National Natural Science Foundation of China (91539202, 91639203, and 91739303), the National Natural Science Foundation of China (81770415), and the Natural Science Foundation of Shanghai (18ZR1431800). The authors declare no conflicts of interest.	Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bersi MR, 2016, HYPERTENSION, V67, P890, DOI 10.1161/HYPERTENSIONAHA.115.06262; Chen WD, 2009, BIOCHEM BIOPH RES CO, V389, P217, DOI 10.1016/j.bbrc.2009.08.104; Coen M, 2011, ARTERIOSCL THROM VAS, V31, P2391, DOI 10.1161/ATVBAHA.111.231548; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gao PJ, 2003, J MOL CELL CARDIOL, V35, P1105, DOI 10.1016/S0022-2828(03)00207-4; Gao XA, 2011, KIDNEY INT, V79, P987, DOI 10.1038/ki.2010.539; Gu XC, 2017, KIDNEY INT, V92, P1178, DOI 10.1016/j.kint.2017.03.037; Hong MN, 2016, ONCOTARGET, V7, P67828, DOI 10.18632/oncotarget.12182; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Jin X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023558; Karnik SS, 2015, PHARMACOL REV, V67, P754, DOI 10.1124/pr.114.010454; Kuang SQ, 2013, ARTERIOSCL THROM VAS, V33, P2172, DOI 10.1161/ATVBAHA.113.301624; Kuwabara JT, 2017, ARTERIOSCL THROM VAS, V37, P1598, DOI 10.1161/ATVBAHA.117.308199; Lehoux S, 2016, HYPERTENSION, V67, P836, DOI 10.1161/HYPERTENSIONAHA.116.06375; Li GH, 2000, CIRCULATION, V101, P1362, DOI 10.1161/01.CIR.101.12.1362; Li XD, 2012, ARTERIOSCL THROM VAS, V32, P2250, DOI 10.1161/ATVBAHA.112.255216; Lin JR, 2015, ARTERIOSCL THROM VAS, V35, P1413, DOI 10.1161/ATVBAHA.115.305706; Liu HW, 2006, LIFE SCI, V79, P475, DOI 10.1016/j.lfs.2006.01.031; Liu ZY, 2012, CIRC RES, V111, P1261, DOI [10.1161/CIRCRESAHA.112.270520, 10.1161/circresaha.112.270520]; Lu Y, 2013, J CLIN INVEST, V123, P4232, DOI 10.1172/JCI68552; Lu YA, 2010, ARTERIOSCL THROM VAS, V30, P1550, DOI 10.1161/ATVBAHA.110.207050; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Majesky MW, 2015, ARTERIOSCL THROM VAS, V35, pE31, DOI 10.1161/ATVBAHA.115.306088; Mas C, 2011, P NATL ACAD SCI USA, V108, P10484, DOI 10.1073/pnas.1017029108; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Meijles DN, 2016, HYPERTENSION, V67, P14, DOI 10.1161/HYPERTENSIONAHA.115.03622; Noack C, 2012, EMBO MOL MED, V4, P992, DOI 10.1002/emmm.201101043; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Pandey D, 2018, ARTERIOSCL THROM VAS, V38, P913, DOI 10.1161/ATVBAHA.117.310660; Patel SK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051303; Poduri A, 2015, ARTERIOSCL THROM VAS, V35, P1995, DOI 10.1161/ATVBAHA.115.305995; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Ruan CC, 2010, ARTERIOSCL THROM VAS, V30, P2568, DOI 10.1161/ATVBAHA.110.215525; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schmitz U, 1997, CIRC RES, V81, P550, DOI 10.1161/01.RES.81.4.550; Shannon LA, 2010, J BIOL CHEM, V285, P38781, DOI 10.1074/jbc.M110.152173; Shen WL, 2006, BIOCHEM BIOPH RES CO, V339, P337, DOI 10.1016/j.bbrc.2005.10.207; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Venema RC, 1998, J BIOL CHEM, V273, P7703, DOI 10.1074/jbc.273.13.7703; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wang YL, 2011, KIDNEY INT, V79, P933, DOI 10.1038/ki.2011.8; Xu SQ, 2011, HYPERTENSION, V58, P310, DOI 10.1161/HYPERTENSIONAHA.111.172031; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yu Y, 2015, CARDIOLOGY, V130, P143, DOI 10.1159/000369382; Zhang GN, 2016, NITRIC OXIDE-BIOL CH, V61, P20, DOI 10.1016/j.niox.2016.09.006	48	10	10	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6254	6268		10.1096/fj.201801809R	http://dx.doi.org/10.1096/fj.201801809R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30776250	Bronze			2022-12-28	WOS:000466932600036
J	Wang, WL; Geng, XQ; Lei, L; Jia, YL; Li, YJ; Zhou, H; Verkman, AS; Yang, BX				Wang, Weiling; Geng, Xiaoqiang; Lei, Lei; Jia, Yingli; Li, Yingjie; Zhou, Hong; Verkman, Alan S.; Yang, Baoxue			Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease	FASEB JOURNAL			English	Article						water channel; ADPKD; glucose metabolism; AMPK; mTOR signaling; HIF1-	HYDROGEN-PEROXIDE TRANSPORT; CELL PROLIFERATION; GLUCOSE-METABOLISM; MITOCHONDRIAL ROS; INHIBITION; GROWTH; ACTIVATION; EXPRESSION; PATHWAY; KINASE	Human autosomal dominant polycystic kidney disease (ADPKD) is characterized by bilateral renal cysts that lead to a decline in kidney function. Previous studies reported aquaporin (AQP)-3 expression in cysts derived from collecting ducts in ADPKD. To study the role of AQP3 in cyst development, we generated 2 polycystic kidney disease (PKD) mouse models: kidney-specific Pkd1 knockout mice and inducible Pkd1 knockout mice, each without and with AQP3 deletion. In both models, kidney sizes and cyst indexes were significantly reduced in AQP3-null PKD mice compared with AQP3-expressing PKD mice, with the difference seen mainly in collecting duct cysts. AQP3-deficient kidneys showed significantly reduced ATP content, increased phosphorylated (p)-AMPK, and decreased p-ERK and p-mammalian target of rapamycin (mTOR). In a matrix-grown Madin-Darby canine kidney cyst model, AQP3 expression promoted cyst enlargement and was associated with increased expression of hypoxia-inducible factor 1- and glucose transporter 1 and increased glucose uptake. Our data suggest that the slowed renal cyst enlargement in AQP3 deficiency involves impaired energy metabolism in the kidney through AMPK and mTOR signaling and impaired cellular glucose uptake. These findings implicate AQP3 as a novel determinant of renal cyst enlargement and hence a potential drug target in ADPKD.Wang, W., Geng, X., Lei, L., Jia, Y., Li, Y., Zhou, H., Verkman, A. S., Yang, B. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.	[Wang, Weiling; Geng, Xiaoqiang; Lei, Lei; Jia, Yingli; Li, Yingjie; Zhou, Hong; Yang, Baoxue] Peking Univ, Dept Pharmacol, Sch Basic Med Sci, 38 Xueyuan Lu,211 Bldg Physiol, Beijing 100191, Peoples R China; [Wang, Weiling; Geng, Xiaoqiang; Lei, Lei; Jia, Yingli; Li, Yingjie; Zhou, Hong; Yang, Baoxue] State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Yang, Baoxue] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Wang, Weiling] Beijing Univ Chinese Med, Beijing Res Inst Chinese Med, Beijing, Peoples R China; [Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Peking University; Beijing University of Chinese Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yang, BX (corresponding author), Peking Univ, Dept Pharmacol, Sch Basic Med Sci, 38 Xueyuan Lu,211 Bldg Physiol, Beijing 100191, Peoples R China.	baoxue@bjmu.edu.cn			National Natural Science Foundation of China [81620108029, 81261160507, 81330074, 81170632, 81370783]; Beijing Natural Science Foundation [7172113]; 111 Project; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK101373]; Fundamental Research Funds for the Central Universities [2018-JYBZZ-XJSJJ012]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101373] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); 111 Project(Ministry of Education, China - 111 Project); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Peter Igarashi (Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA) and Stefan Somlo (Section of Nephrology, Yale School of Medicine, New Haven, CT, USA) for the Ksp-Cre and Pkd1<SUP>flox/flox</SUP> mice. This work was supported by National Natural Science Foundation of China Grants 81620108029, 81261160507, 81330074, 81170632, and 81370783; Beijing Natural Science Foundation Grant 7172113; the 111 Project; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK101373; and the Fundamental Research Funds for the Central Universities (2018-JYBZZ-XJSJJ012). The authors declare no conflicts of interest.	Bland ML, 2011, SCIENCE, V332, P1387, DOI 10.1126/science.1208444; Brookes ZLS, 2013, AM J PHYSIOL-HEART C, V304, pH33, DOI 10.1152/ajpheart.01102.2011; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Byun YJ, 2009, NEUROSCI LETT, V461, P131, DOI 10.1016/j.neulet.2009.06.011; Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231; Cinq-Frais C, 2013, BBA-MOL CELL BIOL L, V1831, P1344, DOI 10.1016/j.bbalip.2013.04.014; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Dalla Sega FV, 2014, BBA-MOL CELL RES, V1843, P806, DOI 10.1016/j.bbamcr.2014.01.011; Damm E, 2012, MOL ENDOCRINOL, V26, P643, DOI 10.1210/me.2011-1218; Deubzer B, 2010, CELL PHYSIOL BIOCHEM, V25, P767, DOI 10.1159/000315098; Gattone VH, 1999, DEV GENET, V24, P309, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<309::AID-DVG14>3.0.CO;2-5; Grandjean G, 2016, CANCER RES, V76, P4259, DOI 10.1158/0008-5472.CAN-16-0401; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Hara-Chikuma M, 2016, BIOCHEM BIOPH RES CO, V471, P603, DOI 10.1016/j.bbrc.2016.02.010; Hara-Chikuma M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8454; Hardie DG, 2011, NATURE, V472, P176, DOI 10.1038/472176a; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayashi M, 1997, NEPHRON, V75, P321, DOI 10.1159/000189556; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Laforenza U, 2016, BBA-BIOMEMBRANES, V1858, P1, DOI 10.1016/j.bbamem.2015.10.004; Lei L, 2017, BBA-MOL BASIS DIS, V1863, P1231, DOI 10.1016/j.bbadis.2017.03.012; Li Z, 2016, TUMOR BIOL, V37, P9169, DOI 10.1007/s13277-015-4753-8; Liu CX, 2016, ONCOTARGET, V7, P7534, DOI 10.18632/oncotarget.7183; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Maser RL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134991; Menezes LF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003053; Metheni M, 2014, CELL MICROBIOL, V16, P269, DOI 10.1111/cmi.12218; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Nagaraju GP, 2016, CANCER LETT, V373, P12, DOI 10.1016/j.canlet.2016.01.003; Pema M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10786; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Radisavljevic ZM, 2004, J CELL BIOCHEM, V91, P1293, DOI 10.1002/jcb.20037; Riwanto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146654; Rossi A, 2013, APOPTOSIS, V18, P1469, DOI 10.1007/s10495-013-0893-8; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Shi WW, 2018, MOL CELL BIOCHEM, V449, P219, DOI 10.1007/s11010-018-3358-0; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shukla SK, 2017, CANCER CELL, V32, P71, DOI 10.1016/j.ccell.2017.06.004; Takakura A, 2008, J AM SOC NEPHROL, V19, P2351, DOI 10.1681/ASN.2007101139; Takiar V, 2011, BBA-MOL BASIS DIS, V1812, P1337, DOI 10.1016/j.bbadis.2010.11.014; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2010, CLIN J AM SOC NEPHRO, V5, P1312, DOI 10.2215/CJN.01360210; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wang W, 2017, ONCOTARGET, V8, P3344, DOI 10.18632/oncotarget.13763; Wang WL, 2015, FASEB J, V29, P1551, DOI 10.1096/fj.14-260828; Wang XQ, 2013, KIDNEY INT, V84, P962, DOI 10.1038/ki.2013.199; Warner G, 2016, J AM SOC NEPHROL, V27, P1437, DOI 10.1681/ASN.2015020132; Yuajit C, 2014, BIOCHEM PHARMACOL, V88, P412, DOI 10.1016/j.bcp.2014.01.038; Zhang JQ, 2016, INT J BIOCHEM CELL B, V70, P76, DOI 10.1016/j.biocel.2015.11.009; Zhao SM, 2016, ONCOTARGET, V7, P84839, DOI 10.18632/oncotarget.13321; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	59	11	11	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6185	6196		10.1096/fj.201801338RRR	http://dx.doi.org/10.1096/fj.201801338RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768374	Green Published, Bronze			2022-12-28	WOS:000466932600031
J	Zhang, L; Shen, ZY; Wang, K; Li, W; Shi, JM; Osoro, EK; Ullah, N; Zhou, Y; Ji, SR				Zhang, Lin; Shen, Zhi-Yuan; Wang, Ke; Li, Wei; Shi, Jing-Ming; Osoro, Ezra Kombo; Ullah, Naeem; Zhou, Yan; Ji, Shang-Rong			C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/-catenin and ERK signaling in streptozocin-induced diabetic nephropathy	FASEB JOURNAL			English	Article						diabetic kidney disease; apoptotic cells; mesenchymal fibrosis; cell remodeling	ACUTE KIDNEY INJURY; TGF-BETA; CELLS; EMT; SMAD; PROGRESSION; MECHANISMS; APOPTOSIS; PATHWAY; ACTIVATION	Previous studies have reported the pathogenic role of C-reactive protein (CRP) during diabetic kidney disease (DKD) in human CRP transgenic and Crp(-/-) mice. However, because humans and mice have inverse acute phase expression patterns of CRP and serum amyloid P component, this could lead to the inaccurate evaluation of CRP function with the above-mentioned CRP transgenic mouse. But different from mice, rats have the same acute phase protein expression pattern as human, which might avoid this problem and be a better choice for CRP function studies. To dispel this doubt and accurately define the role of CRP during diabetic nephropathy, we created the first Crp(-/-) rat model, which we treated with streptozocin to induce DKD for in vivo studies. Moreover, an established cell line (human kidney 2) was used to further investigate the pathologic mechanisms of CRP. We found that CRP promotes epithelial-mesenchymal transition (EMT) through Wnt/-catenin and ERK1/2 signaling, which are dependent on CRP binding to FcRII on apoptotic cells. By promoting EMT, CRP was demonstrated to accelerate the development of DKD. We thus present convincing evidence demonstrating CRP as a therapeutic target for DKD treatment.Zhang, L., Shen, Z.-Y., Wang, K., Li, W., Shi, J.-M., Osoro, E. K., Ullah, N., Zhou, Y., Ji, S.-R. C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/-catenin and ERK signaling in streptozocin-induced diabetic nephropathy.	[Zhang, Lin; Li, Wei; Osoro, Ezra Kombo; Ullah, Naeem] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Xian, Shaanxi, Peoples R China; [Shen, Zhi-Yuan; Wang, Ke; Ji, Shang-Rong] Lanzhou Univ, Sch Life Sci, MOE, Key Lab Cell Activ & Stress Adaptat, Life Sci Bldg,Room 227, Lanzhou 730000, Gansu, Peoples R China; [Shi, Jing-Ming] Xizang Minzu Univ, Sch Basic Med Sci, Dept Anat, Xianyang, Peoples R China; [Zhou, Yan] Xi An Jiao Tong Univ, Dept Dermatol, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Lanzhou University; Xizang Minzu University; Xi'an Jiaotong University	Ji, SR (corresponding author), Lanzhou Univ, Sch Life Sci, MOE, Key Lab Cell Activ & Stress Adaptat, Life Sci Bldg,Room 227, Lanzhou 730000, Gansu, Peoples R China.	jsr@lzu.edu.cn	Osoro, Ezra Kombo/AAZ-3414-2021; Shi, Jing-Ming/ACS-3321-2022	Osoro, Ezra Kombo/0000-0001-6565-5911; Shi, Jing-Ming/0000-0002-8185-3130; Ji, Shang-Rong/0000-0001-8595-3756; Zhang, Lin/0000-0002-2157-1588	National Natural Science Foundation of China [31700685, 31671339, 81703130]; China Postdoctoral Science Foundation [2016M602800]; Scientific Research Fund of Xi'an Jiaotong University [Z201806118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific Research Fund of Xi'an Jiaotong University	This work was supported by the National Natural Science Foundation of China (Grants 31700685, 31671339, and 81703130), the China Postdoctoral Science Foundation (Grant 2016M602800), and the Scientific Research Fund of Xi'an Jiaotong University (Grant Z201806118). The authors declare no conflicts of interest.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Devaraj S, 2005, ARTERIOSCL THROM VAS, V25, P1359, DOI 10.1161/01.ATV.0000168573.10844.ae; El Mouedden M, 2000, ANTIMICROB AGENTS CH, V44, P665, DOI 10.1128/AAC.44.3.665-675.2000; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gupta S, 2016, CELL, V164, P840, DOI 10.1016/j.cell.2016.02.024; Hayashino Y, 2014, DIABETES CARE, V37, P2947, DOI 10.2337/dc14-1357; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Jones NR, 2011, ARTHRITIS RHEUM-US, V63, P2641, DOI 10.1002/art.30444; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim SH, 2012, LAB INVEST, V92, P488, DOI 10.1038/labinvest.2011.194; Kizu A, 2009, AM J PATHOL, V175, P1371, DOI 10.2353/ajpath.2009.090698; Lai WY, 2016, KIDNEY INT, V90, P610, DOI 10.1016/j.kint.2016.06.010; Li DD, 2015, MOL MED REP, V12, P8148, DOI 10.3892/mmr.2015.4445; Li L, 2015, METABOLISM, V64, P597, DOI 10.1016/j.metabol.2015.01.014; Li Z, 2011, LAB INVEST, V91, P837, DOI 10.1038/labinvest.2011.42; Liu F, 2011, DIABETOLOGIA, V54, P2713, DOI 10.1007/s00125-011-2237-y; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Lopez-Parra V, 2012, J AM SOC NEPHROL, V23, P1518, DOI 10.1681/ASN.2011080822; Lu JH, 2011, P NATL ACAD SCI USA, V108, P4974, DOI 10.1073/pnas.1018369108; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Ma LB, 2018, INT UROL NEPHROL, V50, P373, DOI 10.1007/s11255-017-1757-x; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; McMorrow T, 2005, NEPHROL DIAL TRANSPL, V20, P2215, DOI 10.1093/ndt/gfh967; Menon V, 2005, KIDNEY INT, V68, P766, DOI 10.1111/j.1523-1755.2005.00455.x; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Ogden CA, 2005, ARTHRITIS RHEUM-US, V52, P378, DOI 10.1002/art.20847; Pegues MA, 2016, AM J PHYSIOL-RENAL, V311, pF176, DOI 10.1152/ajprenal.00107.2016; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; RASCH R, 1984, DIABETOLOGIA, V27, P32; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Shih HH, 2009, AM J PHYSIOL-HEART C, V296, pH1643, DOI 10.1152/ajpheart.00938.2008; Stein MP, 2000, J IMMUNOL, V164, P1514, DOI 10.4049/jimmunol.164.3.1514; Strutz F, 2000, NEPHROL DIAL TRANSPL, V15, P1729, DOI 10.1093/ndt/15.11.1729; Szalai Alexander J, 2004, Clin Dev Immunol, V11, P221, DOI 10.1080/17402520400001751; Tang Y, 2014, CLIN SCI, V126, P645, DOI 10.1042/CS20130471; Verma S, 2004, CIRCULATION, V109, P1914, DOI 10.1161/01.CIR.0000127085.32999.64; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; You YK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26740; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang L, 2015, J IMMUNOL, V194, P5243, DOI 10.4049/jimmunol.1402909; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhou C, 2017, J FORENSIC SCI, V62, P229, DOI 10.1111/1556-4029.13235	59	26	27	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6551	6563		10.1096/fj.201801865RR	http://dx.doi.org/10.1096/fj.201801865RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794428	Bronze			2022-12-28	WOS:000466932600058
J	Nishio, M; Miyachi, Y; Otani, J; Tane, S; Omori, H; Ueda, F; Togashi, H; Sasaki, T; Mak, TW; Nakao, K; Fujita, Y; Nishina, H; Maehama, T; Suzuki, A				Nishio, Miki; Miyachi, Yousuke; Otani, Junji; Tane, Shoji; Omori, Hirofumi; Ueda, Fumihito; Togashi, Hideru; Sasaki, Takehiko; Mak, Tak Wah; Nakao, Kazuwa; Fujita, Yasuyuki; Nishina, Hiroshi; Maehama, Tomohiko; Suzuki, Akira			Hippo pathway controls cell adhesion and context-dependent cell competition to influence skin engraftment efficiency	FASEB JOURNAL			English	Article						YAP1; MOB1; fibronectin	REGULATES YAP; CANCER; GROWTH; PROMOTES; METASTASIS; PROTEIN; MYC; DIFFERENTIATION; GLYCOPROTEIN; PROGRESSION	Cell competition is involved in mammalian embryogenesis and tumor elimination and progression. It was previously shown that, whereas NIH3T3 mouse fibroblasts expressing high levels of the yes-associated protein 1(YAP1) target TEA domain family (TEAD) transcription factors become "winners" in cell competitions, Madin-Darby canine kidney cells expressing activated YAP1 become "losers" and are eliminated from culture monolayers. Thus, YAP1's role in cell competitions is clearly context dependent. Here, we show that keratinocytes overexpressing a constitutively activated YAP1 mutant lose in in vitro competitions with control cells conducted in standard tissue culture dishes and undergo apical extrusion. Similarly, cells in which endogenous YAP1 is activated by NF2 knockdown become losers. The YAP1-overexpressing cells exhibit a decrease in cell-matrix adhesion because of defective expression of adhesion molecules such as fibronectin-1. Cell adhesion-mediated proliferation is also impaired. However, because of intrinsic factors, YAP1-expressing cells proliferate faster than control cells when cocultured in dishes impeding cell adhesion. In vivo, Mob1a/b-deficient (YAP1-activated) epidermis, which shows decreased expression of type XVII collagen, cannot be engrafted successfully onto donor mice. YAP1-activated skin grafts shrink away from surrounding control skin, and the epidermis peels off the basement membrane. Our data show that YAP1 activation controls cell competition in part by decreasing cell adhesion.	[Nishio, Miki; Miyachi, Yousuke; Otani, Junji; Omori, Hirofumi; Ueda, Fumihito; Togashi, Hideru; Maehama, Tomohiko; Suzuki, Akira] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo, Japan; [Nishio, Miki; Miyachi, Yousuke; Tane, Shoji; Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Div Canc Genet, Fukuoka, Fukuoka, Japan; [Sasaki, Takehiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Lipid Biol, Tokyo, Japan; [Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo, Japan; [Mak, Tak Wah] Univ Hlth Network, Univ Toronto, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Mak, Tak Wah] Univ Hlth Network, Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Fujita, Yasuyuki] Hokkaido Univ, Grad Sch Chem Sci & Engn, Inst Genet Med, Div Mol Oncol, Sapporo, Hokkaido, Japan	Kobe University; Kyushu University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Kyoto University; Hokkaido University	Maehama, T; Suzuki, A (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol,Chuo Ku, Kusunoki Cho 7-5-1, Kobe, Hyogo 6500017, Japan.	tmaehama@med.kobe-u.ac.jp; suzuki@med.kobe-u.ac.jp	Suzuki, Akira/GYD-6697-2022; Maehama, Tomohiko/AAX-8926-2020; Maehama, Tomohiko/HGB-4896-2022	Suzuki, Akira/0000-0002-5950-8808; Maehama, Tomohiko/0000-0002-9685-2317; Togashi, Hideru/0000-0002-3967-5940; Sasaki, Takehiko/0000-0003-1837-3748; Omori, Hirofumi/0000-0002-7932-2090; Ueda, Fumihito/0000-0003-1241-1643	Japanese Society for the Promotion of Science (JSPS) [15K21757, 17H01400, 26114005]; Japanese Agency for Medical Research and Development (AMED) [16770279]; Uehara Memorial Foundation; Shinnihon Advanced Medical Research Foundation; Daiichi-Sankyo Scholarship Donation Program; Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; Nanken-Kyoten, Tokyo Medical and Dental University (TMDU)	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Uehara Memorial Foundation(Uehara Memorial Foundation); Shinnihon Advanced Medical Research Foundation; Daiichi-Sankyo Scholarship Donation Program; Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; Nanken-Kyoten, Tokyo Medical and Dental University (TMDU)	The authors thank A. Fujimoto, M. Kamihashi, and M. Suzuki (all from Kyushu University), and Y. Shimono, K. Okada, and M. Fukumoto (all from Kobe University) for expert technical assistance and critical discussions. The authors are grateful for the funding provided by the Japanese Society for the Promotion of Science (JSPS; Grants 15K21757, 17H01400, and 26114005 to A.S.); the Japanese Agency for Medical Research and Development (AMED; Grant 16770279 to A.S.); the Uehara Memorial Foundation (to A.S.); the Shinnihon Advanced Medical Research Foundation (to A.S.); the Daiichi-Sankyo Scholarship Donation Program (to A.S.); the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; and Nanken-Kyoten, Tokyo Medical and Dental University (TMDU). The authors declare no conflicts of interest.	Abbi S, 2002, HISTOL HISTOPATHOL, V17, P1163, DOI 10.14670/HH-17.1163; Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Baker NE, 2011, CURR BIOL, V21, pR11, DOI 10.1016/j.cub.2010.11.030; Chiba T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28383; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; de Beco S, 2012, DEV DYNAM, V241, P831, DOI 10.1002/dvdy.23783; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Goto H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.159244; Grieve AG, 2014, J CELL SCI, V127, P3331, DOI 10.1242/jcs.147926; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Hu XB, 2014, PATHOL ONCOL RES, V20, P805, DOI 10.1007/s12253-014-9757-y; Ishihara E, 2018, CANCERS, V10, DOI 10.3390/cancers10040122; Kajita M, 2015, J BIOCHEM, V158, P15, DOI 10.1093/jb/mvv050; Kajita M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5428; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Kim HM, 2015, TUMOR BIOL, V36, P1207, DOI 10.1007/s13277-014-2735-x; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Lau AN, 2014, EMBO J, V33, P468, DOI 10.1002/embj.201386082; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Liu R, 2015, ONCOTARGET, V6, P935, DOI 10.18632/oncotarget.2822; Mamada H, 2015, J CELL SCI, V128, P790, DOI 10.1242/jcs.163675; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Morata G, 2007, DEV CELL, V13, P1, DOI 10.1016/j.devcel.2007.06.002; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nakatani K, 2017, J BIOCHEM, V161, P237, DOI 10.1093/jb/mvw074; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Nishio M, 2017, GENES CELLS, V22, P6, DOI 10.1111/gtc.12461; Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113; Nishio M, 2012, J CLIN INVEST, V122, P4505, DOI 10.1172/JCI63735; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Otsubo K, 2017, ONCOGENE, V36, P4201, DOI 10.1038/onc.2017.58; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Porazinski S, 2015, NATURE, V521, P217, DOI 10.1038/nature14215; Powell AM, 2005, CLIN EXP DERMATOL, V30, P682, DOI 10.1111/j.1365-2230.2005.01937.x; Sabra H, 2017, J BIOL CHEM, V292, P19179, DOI 10.1074/jbc.M117.808063; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166; Shigeeda W, 2017, ONCOTARGET, V8, P93729, DOI 10.18632/oncotarget.20750; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Thongon N, 2016, ONCOTARGET, V7, P26551, DOI 10.18632/oncotarget.8437; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; del Campo CV, 2014, CELL REP, V8, P1741, DOI 10.1016/j.celrep.2014.08.005; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639; Wang T, 2018, BBA-MOL BASIS DIS, V1864, P1744, DOI 10.1016/j.bbadis.2018.02.020; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yin K, 2018, BIOCHEM BIOPH RES CO, V496, P76, DOI 10.1016/j.bbrc.2017.12.170; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu SY, 2015, ONCOTARGET, V6, P2951, DOI 10.18632/oncotarget.3095; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Ziosi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001140	59	9	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5548	5560		10.1096/fj.201802005R	http://dx.doi.org/10.1096/fj.201802005R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30640535	Bronze			2022-12-28	WOS:000462888500073
J	Paul, HA; Collins, KH; Nicolucci, AC; Urbanski, SJ; Hart, DA; Vogel, HJ; Reimer, RA				Paul, Heather A.; Collins, Kelsey H.; Nicolucci, Alissa C.; Urbanski, Stefan J.; Hart, David A.; Vogel, Hans J.; Reimer, Raylene A.			Maternal prebiotic supplementation reduces fatty liver development in offspring through altered microbial and metabolomic profiles in rats	FASEB JOURNAL			English	Article						oligofructose; pregnancy; steatosis; gut microbiota; insulin sensitivity	COLONY-STIMULATING FACTOR; DIET-INDUCED OBESITY; GUT MICROBIOTA; SKELETAL-MUSCLE; INDUCED INFLAMMATION; LIPID-METABOLISM; DISEASE; PREGNANCY; FORMATE; GLUCOSE	A maternal high-fat/sucrose diet, in the presence of maternal obesity, can program increased susceptibility to obesity and metabolic disease in offspring. In particular, nonalcoholic fatty liver disease risk is associated with poor maternal nutrition and obesity status, which may manifest via alterations in gut microbiota. Here, we report that in a preclinical model of diet-induced maternal obesity, maternal supplementation of a high-fat/sucrose diet with the prebiotic oligofructose improves glucose tolerance, insulin sensitivity, and hepatic steatosis in offspring following a long-term high-fat/sucrose dietary challenge compared with offspring of untreated dams. These improvements are associated with alterations in gut microbial composition and serum inflammatory profiles in early life and improvements in inflammatory and fatty-acid gene expression profiles in tissues. Serum metabolomics analysis highlights potential metabolic links between the gut microbiota and the degree of steatosis, including alterations in 1-carbon metabolism. Overall, our data suggest that maternal prebiotic intake protects offspring against hepatic steatosis and insulin resistance following 21 wk of high fat/sucrose diet, which is in part due to alterations in gut microbiota.	[Paul, Heather A.; Vogel, Hans J.; Reimer, Raylene A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Urbanski, Stefan J.] Univ Calgary, Dept Pathol & Lab Med, Cumming Sch Med, Calgary, AB, Canada; [Collins, Kelsey H.; Nicolucci, Alissa C.; Hart, David A.; Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Hart, David A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Bionucl Magnet Resonance NMR Ctr, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Reimer, RA (corresponding author), Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	reimer@ucalgary.ca		Reimer, Raylene/0000-0001-5088-7947	Canadian Institutes of Health Research [MOP 115076]; Natural Sciences and Engineering Research Council (NSERC) Postgraduate Scholarship; Alberta Innovates Health Solutions Doctoral Scholarship; Canadian Institutes of Health Research Doctoral Scholarship; Honorary Walter Killam Doctoral Scholarship; Alberta Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Health Solutions Doctoral Scholarship; Canadian Institutes of Health Research Doctoral Scholarship(Canadian Institutes of Health Research (CIHR)); Honorary Walter Killam Doctoral Scholarship; Alberta Cancer Foundation	The authors thank Kristine Lee and Carolyn Hewitt (both from the University of Calgary) for technical assistance. This work was supported by a research grant from the Canadian Institutes of Health Research (MOP 115076). H.A.P. was supported by an Natural Sciences and Engineering Research Council (NSERC) Postgraduate Scholarship, an Alberta Innovates Health Solutions Doctoral Scholarship, and a Canadian Institutes of Health Research Doctoral Scholarship. K.H.C. was supported by a Canadian Institutes of Health Research Doctoral Scholarship, an Honorary Walter Killam Doctoral Scholarship, and an Alberta Innovates Health Solutions Doctoral Scholarship. H.J.V. acknowledges funding from the Alberta Cancer Foundation. R.A.R. previously held a research grant from Beneo-Orafti, the manufacturer of Raftilose P95, for a project unrelated to the current work. The authors declare no other conflicts of interest.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Barr J, 2012, J PROTEOME RES, V11, P2521, DOI 10.1021/pr201223p; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; Bomhof MR, 2016, FASEB J, V30, P2720, DOI 10.1096/fj.201600151R; Bomhof MR, 2014, OBESITY, V22, P763, DOI 10.1002/oby.20632; Boutagy NE, 2016, BIOCHIMIE, V124, P11, DOI 10.1016/j.biochi.2015.06.020; Brosnan ME, 2016, ANNU REV NUTR, V36, P369, DOI 10.1146/annurev-nutr-071715-050738; Caluwaerts S, 2007, METABOLISM, V56, P1431, DOI 10.1016/j.metabol.2007.06.007; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2017, NAT REV GASTRO HEPAT, V14, P321, DOI 10.1038/nrgastro.2017.54; Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902; Collins KH, 2015, OSTEOARTHR CARTILAGE, V23, P1989, DOI 10.1016/j.joca.2015.03.014; Collins KH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00112; Collins KH, 2016, J ORTHOP RES, V34, P2069, DOI 10.1002/jor.23230; Collins KH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37278; Collins KH, 2016, J ORTHOP RES, V34, P1010, DOI 10.1002/jor.23103; Cordero P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091041; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Simino LAD, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0168-4; FERRANNINI E, 1988, METABOLISM, V37, P79, DOI 10.1016/0026-0495(88)90033-9; Furmento VA, 2014, PLACENTA, V35, P937, DOI 10.1016/j.placenta.2014.09.003; Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Giesbertz P, 2015, DIABETOLOGIA, V58, P2133, DOI 10.1007/s00125-015-3656-y; Gralka E, 2015, AM J CLIN NUTR, V102, P1313, DOI 10.3945/ajcn.115.110536; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Heimann E, 2016, ADIPOCYTE, V5, P359, DOI 10.1080/21623945.2016.1252011; Hu CY, 2015, P NATL ACAD SCI USA, V112, P11318, DOI 10.1073/pnas.1513509112; Huang JL, 2012, TRANSGENIC RES, V21, P1311, DOI 10.1007/s11248-012-9615-1; Hughes ER, 2017, CELL HOST MICROBE, V21, P208, DOI 10.1016/j.chom.2017.01.005; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Liang QD, 2015, EUR J MASS SPECTROM, V21, P801, DOI 10.1255/ejms.1395; Liang WF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109757, 10.1371/journal.pone.0090827]; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mack I, 2016, SCI REP-UK, V6, DOI 10.1038/srep26752; Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Miegueu P, 2013, INT J OBESITY, V37, P366, DOI 10.1038/ijo.2012.73; Mitrou P, 2011, EXP CLIN ENDOCR DIAB, V119, P484, DOI 10.1055/s-0030-1269846; Morrow GP, 2015, J BIOL CHEM, V290, P2244, DOI 10.1074/jbc.M114.600718; Mouralidarane A, 2013, HEPATOLOGY, V58, P128, DOI 10.1002/hep.26248; Mulligan CM, 2017, J ENDOCRINOL, V235, pR1, DOI [10.1530/JOE-17-0303, 10.1530/joe-17-0303]; Nam HH, 2017, ONCOTARGET, V8, P97965, DOI 10.18632/oncotarget.18967; Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018; Newsome PN, 2018, LANCET GASTROENTEROL, V3, P25, DOI 10.1016/S2468-1253(17)30326-6; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Ortiz-Lopez C, 2012, DIABETES CARE, V35, P873, DOI 10.2337/dc11-1849; Pachikian BD, 2013, MOL NUTR FOOD RES, V57, P347, DOI 10.1002/mnfr.201200364; Parnell JA, 2012, LIVER INT, V32, P701, DOI 10.1111/j.1478-3231.2011.02730.x; Parnell JA, 2010, BRIT J NUTR, V103, P1577, DOI 10.1017/S0007114509993539; Paschos P, 2009, HIPPOKRATIA, V13, P9; Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653; Paul HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20683; Reinhardt C, 2009, J PEDIATR GASTR NUTR, V48, P249, DOI 10.1097/MPG.0b013e318183187c; Sohn K, 2017, SEMIN FETAL NEONAT M, V22, P284, DOI 10.1016/j.siny.2017.07.002; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Stoppeler S, 2013, LAB ANIM-UK, V47, P43, DOI 10.1177/0023677212473717; Sweeney G, 2001, ENDOCRINOLOGY, V142, P4806, DOI 10.1210/en.142.11.4806; Tsao CH, 2014, J LIPID RES, V55, P385, DOI 10.1194/jlr.M041392; Underwood MA, 2015, PEDIATR RES, V77, P229, DOI 10.1038/pr.2014.156; Van Herck MA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101072; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Walkers AK, 2017, TRENDS ENDOCRIN MET, V28, P63, DOI 10.1016/j.tem.2016.10.004; Walter TJ, 2014, AM J PHYSIOL-GASTR L, V306, pG849, DOI 10.1152/ajpgi.00426.2013; Wan XY, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/6489012; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang YL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010011; Wei W, 2017, GENE, V636, P23, DOI 10.1016/j.gene.2017.08.036; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160; Wree A., 2017, HEPATOLOGY, V67, P461; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592	84	30	30	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5153	5167		10.1096/fj.201801551R	http://dx.doi.org/10.1096/fj.201801551R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629464	Bronze			2022-12-28	WOS:000462888500043
J	Wang, TY; Chen, J; Hou, Y; Yu, Y; Wang, B				Wang, Tianyi; Chen, Jing; Hou, Yue; Yu, Yang; Wang, Bing			BAP31 deficiency contributes to the formation of amyloid-beta plaques in Alzheimer's disease by reducing the stability of RTN3	FASEB JOURNAL			English	Article						BACE1; APP; RIDNs	ENDOPLASMIC-RETICULUM; PRECURSOR PROTEIN; BACE1; EXPRESSION; PHOSPHORYLATION; ASSOCIATION; INHIBITION; BIOGENESIS; ACTIVATION; SECRETASE	Reticulon (RTN) 3 reduces amyloid-beta (A beta) plaques (APs) by negative modulation of beta-secretase 1 (BACE1) activity. However, RTN3 aggregates easily, which offsets RTN3's inhibitory effect on BACE1 activity and exacerbates AP deposition. We found that BAP31 was a binding partner of RTN3 and positively correlated with the expression level of RTN3. To further explore how BAP31 is involved in Alzheimer's disease (AD), conditional knockout mice with targeted BAP31 deletion (B-KO) in the hippocampus and cerebral cortex were generated and hybridized with amyloid precursor protein (APP) PS1 transgenic (AD model) mice to obtain B-KO-AD mice. BAP31 knock out in primary hippocampal neurons decreased RTN3 monomer availability and enhanced the level of RTN3 aggregates, indicating that BAP31 deficiency increases the instability of RTN3. More importantly, these effects contributed to BACE1-mediated APP processing and were responsible for the increased APs in the hippocampus and cerebral cortex of B-KO-AD mice. Thus, elevated expression of BAP31 in the human brain is likely to reduce the formation of both RTN3 aggregates and A by enhancing the stability of RTN3.	[Wang, Tianyi; Chen, Jing; Hou, Yue; Yu, Yang; Wang, Bing] Northeastern Univ, Coll Life Sci & Hlth, 195 Chuangxin Rd, Shenyang 110819, Liaoning, Peoples R China	Northeastern University - China	Wang, B (corresponding author), Northeastern Univ, Coll Life Sci & Hlth, 195 Chuangxin Rd, Shenyang 110819, Liaoning, Peoples R China.	wangbing@mail.neu.edu.cn		Chen, Jing/0000-0002-0351-2525; wang, bing/0000-0002-6549-8837	National Natural Science Foundation of China [31370784, 31500754, 31670770, 2016YFC1302402]; Fundamental Research Funds for the Central Universities of China [N172008008, N130120001, N141008001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	The authors thank Dr. Mwichie Namusamba (College of Life Science and Health, Northeastern University) who gave us so much useful advice on writing and improving the manuscript. This work was supported by the National Natural Science Foundation of China (Grants 31370784, 31500754, 31670770, and 2016YFC1302402) and the Fundamental Research Funds for the Central Universities of China (Grants N172008008, N130120001, and N141008001). The authors declare no conflicts of interest.	Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dickson TC, 2005, NEUROBIOL DIS, V18, P286, DOI 10.1016/j.nbd.2004.10.001; He WX, 2006, J MOL BIOL, V363, P625, DOI 10.1016/j.jmb.2006.07.094; Hu XY, 2007, EMBO J, V26, P2755, DOI 10.1038/sj.emboj.7601707; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Jiang ST, 2012, NEUROSCI LETT, V515, P125, DOI 10.1016/j.neulet.2012.03.026; Marwarha G, 2017, J ALZHEIMERS DIS, V57, P907, DOI 10.3233/JAD-161130; Marwarha G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070773; MASLIAH E, 1993, AM J PATHOL, V142, P871; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Niu KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44809; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Ogen-Shtern N, 2016, BRAIN RES, V1648, P658, DOI 10.1016/j.brainres.2016.03.044; Prior M, 2010, NEUROSCI BIOBEHAV R, V34, P1201, DOI 10.1016/j.neubiorev.2010.01.017; Sarajarvi T, 2009, J BIOL CHEM, V284, P34433, DOI 10.1074/jbc.M109.036202; Sharoar MG, 2016, MOL PSYCHIATR, V21, P1263, DOI 10.1038/mp.2015.181; Sharoar MG, 2017, REV NEUROSCIENCE, V28, P145, DOI 10.1515/revneuro-2016-0054; Shi Q, 2014, J NEUROSCI, V34, P13954, DOI 10.1523/JNEUROSCI.1588-14.2014; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; Shim S, 2011, CELL MOL LIFE SCI, V68, P2115, DOI 10.1007/s00018-010-0561-x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Su JH, 1996, BRAIN RES, V739, P79, DOI 10.1016/S0006-8993(96)00811-6; Su JH, 1998, ACTA NEUROPATHOL, V96, P463, DOI 10.1007/s004010050920; Suen KC, 2003, J BIOL CHEM, V278, P49819, DOI 10.1074/jbc.M306503200; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Wang B, 2003, J BIOL CHEM, V278, P14461, DOI 10.1074/jbc.M209684200; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Wojcik S, 2007, ACTA NEUROPATHOL, V114, P517, DOI 10.1007/s00401-007-0281-y; Xu JL, 2018, J LIPID RES, V59, P35, DOI [10.1194/jlr.M077016, 10.1194/jlr.m077016]; Yan R, 2006, CELL MOL LIFE SCI, V63, P877, DOI 10.1007/s00018-005-5338-2; Yang Z, 2014, MOL MICROBIOL, V93, P1043, DOI 10.1111/mmi.12716; Zhou WH, 2004, ANN NY ACAD SCI, V1035, P49, DOI 10.1196/annals.1332.004	39	10	10	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4936	4946		10.1096/fj.201801702R	http://dx.doi.org/10.1096/fj.201801702R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596517	Bronze			2022-12-28	WOS:000462888500024
J	Zhou, YF; Chen, AQ; Wu, JH; Mao, L; Xia, YP; Jin, HJ; He, QW; Miao, QR; Yue, ZY; Liu, XL; Huang, M; Li, YN; Hu, B				Zhou, Yi-Fan; Chen, An-Qi; Wu, Jie-Hong; Mao, Ling; Xia, Yuan-Peng; Jin, Hui-Juan; He, Quan-Wei; Miao, Qing Robert; Yue, Zhen-Yu; Liu, Xiu-Li; Huang, Ming; Li, Ya-Nan; Hu, Bo			Sema3E/PlexinD1 signaling inhibits postischemic angiogenesis by regulating endothelial DLL4 and filopodia formation in a rat model of ischemic stroke	FASEB JOURNAL			English	Article						vascular network; endothelial cell; brain; F-actin; focal adhesion	MOLECULAR-MECHANISMS; GROWTH-FACTOR; RHO GTPASES; TIP CELLS; SEMAPHORIN; BRAIN; RAC1; JNK; STRATEGY; GUIDANCE	Angiogenesis is a crucial defense response to hypoxia that regulates the process of raising the promise of long-term neurologic recovery during the management of stroke. A high expression of antiangiogenic factors leads to the loss of neovascularization capacity in pathologic conditions. We have previously documented an impairment of the cerebral vessel perfusion and neovascularization in the cortex neighboring the stroke-induced lesion, which was accompanied by an activation of semaphorin 3E (Sema3E)/PlexinD1 after ischemic stroke. In this study, we employed micro-optical sectioning tomography to fully investigate the details of the vascular pattern, including the capillaries. We found that after transient middle cerebral artery occlusion, inhibiting PlexinD1 signaling led to an organized recovery of the vascular network in the ischemic area. We then further explored the possible mechanisms. In vivo, Sema3E substantially decreased dynamic delta-like 4 (DLL4) expression. In cultured brain microvascular endothelial cells, Sema3E down-regulated DLL4 expression via inhibiting Ras-related C3 botulinum toxin substrate 1-induced JNK phosphorylation. At the microcosmic level, Sema3E/PlexinD1 signaling promoted F-actin disassembly and focal adhesion reduction by activating the small guanosine triphosphatase Ras homolog family member J by releasing RhoGEF Tuba from direct binding to PlexinD1, thus mediating endothelial cell motility and filopodia retraction. Our study reveals that Sema3E/PlexinD1 signaling, which suppressed endothelial DLL4 expression, cell motility, and filopodia formation, is expected to be a novel druggable target for angiogenesis during poststroke progression.	[Zhou, Yi-Fan; Chen, An-Qi; Wu, Jie-Hong; Mao, Ling; Xia, Yuan-Peng; Jin, Hui-Juan; He, Quan-Wei; Li, Ya-Nan; Hu, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China; [Liu, Xiu-Li] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan, Hubei, Peoples R China; [Liu, Xiu-Li] Huazhong Univ Sci & Technol, Key Lab Biomed Photon, Minist Educ, Dept Biomed Engn, Wuhan, Hubei, Peoples R China; [Miao, Qing Robert] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Miao, Qing Robert] Med Coll Wisconsin, Dept Pathol, Div Pediat Pathol, Childrens Res Inst, Milwaukee, WI 53226 USA; [Miao, Qing Robert] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Yue, Zhen-Yu] Icahn Sch Med Mt Sinai, Dept Neurol, Friedman Brain Inst, New York, NY 10029 USA; [Yue, Zhen-Yu] Icahn Sch Med Mt Sinai, Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA; [Huang, Ming] Three Gorges Univ, China Three Gorges Univ, Inst Translat Neurosci, Dept Neurol,Peoples Hosp,Coll Med, Yichang, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; China Three Gorges University	Li, YN; Hu, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China.	lyn.hust@qq.com; hubo@mail.hust.edu.cn	Miao, Qing/K-3186-2019	Miao, Qing/0000-0002-3125-1238	National Key Research and Development Program of China [2016YFC1300600]; National Natural Science Foundation of China [81571119, 81601027, 81571139, 81771249, 81400969, 81671147, 81400970]; Natural Science Foundation of Hubei Province of China [2016CFB518]; National Research Foundation for the Doctoral Program of Higher Education of China [20120142110068]; New Century Excellent Talents in University [NCET-10-0406]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Key Research and Development Program of China (2018YFC1312200), National Natural Science Foundation of China (81571119 to B.H., 81601027 to Y.N.L., 81571139 to L.M., 81771249 to Y.P.X., 81400969 to Q.W.H., 81671147 to H.J.J., and 81400970 to M.L.), National Key Research and Development Program of China (no. 2016YFC1300600), Natural Science Foundation of Hubei Province of China (2016CFB518 to M.H.), National Research Foundation for the Doctoral Program of Higher Education of China (20120142110068 to B.H.), and New Century Excellent Talents in University (NCET-10-0406 to B.H.). The authors declare no conflicts of interest.	Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Archibald A, 2015, ONCOGENE, V34, P3199, DOI 10.1038/onc.2014.242; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casazza A, 2010, J CLIN INVEST, V120, P2684, DOI 10.1172/JCI42118; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Cristofaro B, 2013, DEVELOPMENT, V140, P1720, DOI 10.1242/dev.092304; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Du HJ, 2013, P NATL ACAD SCI USA, V110, P2377, DOI 10.1073/pnas.1221729110; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gay CM, 2011, DEV BIOL, V349, P1, DOI 10.1016/j.ydbio.2010.09.008; Gelfand MV, 2009, TRENDS CELL BIOL, V19, P99, DOI 10.1016/j.tcb.2009.01.001; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hasan SS, 2017, NAT CELL BIOL, V19, P928, DOI 10.1038/ncb3574; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hernandez-Garcia R, 2015, VASC PHARMACOL, V74, P60, DOI 10.1016/j.vph.2015.10.003; Iglesias-Rey R, 2018, TRANSL STROKE RES, V9, P347, DOI 10.1007/s12975-017-0584-9; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Lange C, 2016, NAT REV NEUROL, V12, P439, DOI 10.1038/nrneurol.2016.88; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; RAMO K, 2016, R J, V5, DOI DOI 10.7554/ELIFE.18414; Salvucci O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7576; Sawada M, 2018, EMBO J, V37, DOI 10.15252/embj.201797404; Sharma M, 2012, J HEPATOL, V56, P192, DOI 10.1016/j.jhep.2011.03.019; Smith KR, 2017, J BIOL CHEM, V292, P20173, DOI 10.1074/jbc.M117.796292; Tata A, 2014, J CELL BIOL, V205, P573, DOI 10.1083/jcb.201309004; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; UBEZIO B, 2016, SYNCHRONIZATION, V5, DOI DOI 10.7554/ELIFE.12167; Walchli T, 2015, NEURON, V87, P271, DOI 10.1016/j.neuron.2015.06.038; Wu JP, 2014, NEUROIMAGE, V87, P199, DOI 10.1016/j.neuroimage.2013.10.036; Xu B, 2004, J CEREBR BLOOD F MET, V24, P237, DOI 10.1097/01.WCB.0000107730.66603.51; Zhou YF, 2018, NEUROBIOL AGING, V70, P102, DOI 10.1016/j.neurobiolaging.2018.06.003; Zhou YF, 2018, FASEB J, V32, P2181, DOI 10.1096/fj.201700786RR	53	13	16	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4947	4961		10.1096/fj.201801706RR	http://dx.doi.org/10.1096/fj.201801706RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30653356	Bronze			2022-12-28	WOS:000462888500025
J	Kudo, K; Yoneda, A; Sakiyama, D; Kojima, K; Miyaji, T; Yamazaki, M; Yaita, S; Hyodo, T; Satow, R; Fukami, K				Kudo, Kohya; Yoneda, Atsuko; Sakiyama, Daiki; Kojima, Kai; Miyaji, Takeki; Yamazaki, Miku; Yaita, Saori; Hyodo, Takuya; Satow, Reiko; Fukami, Kiyoko			Cell surface CD63 increased by up-regulated polylactosamine modification sensitizes human melanoma cells to the BRAF inhibitor PLX4032	FASEB JOURNAL			English	Article						vemurafenib; 1; 3-N-acetylglucosaminyltransferase; drug resistance	CANCER CELLS; N-GLYCAN; RESISTANCE; IDENTIFICATION; BIOSYNTHESIS; BETA-3GNT2; PROTEIN; CLONING	The BRAF inhibitor PLX4032 is effective in treating BRAF-mutated melanoma; however, because drug resistance develops in most cases, it is critical to develop a new strategy for inhibiting drug-resistant melanoma growth. The melanoma-associated membrane glycoprotein CD63 is involved in cell proliferation and metastasis. Here, we found that cell surface CD63 suppresses the proliferation of human melanoma cells and PLX4032-resistant cells. Endogenous CD63 protein levels were negatively correlated with PLX4032 resistance of human melanoma cell lines. CD63 overexpression in these cells, in which endogenous CD63 levels are low, suppressed cell proliferation under PLX4032 treatment. The cell surface levels and average molecular mass of CD63 were increased with PLX4032 treatment because of the up-regulated polylactosamine modification caused by induced 1,3-N-acetylglucosaminyltransferase 2 expression, which is involved in polylactosamine synthesis. Forced cell surface localization of CD63 led to reduced melanoma cell proliferation without PLX4032 treatment. CD63 overexpression in PLX4032-resistant cells, in which CD63 levels were lower and cell surface polylactosamine levels were higher than those in parental cells, effectively suppressed proliferation. Our study shows the potential of CD63 to sensitize melanoma cells to PLX4032 and to reduce the proliferation of PLX4032-resistant cells.Kudo, K., Yoneda, A., Sakiyama, D., Kojima, K., Miyaji, T., Yamazaki, M., Yaita, S., Hyodo, T., Satow, R., Fukami, K. Cell surface CD63 increased by up-regulated polylactosamine modification sensitizes human melanoma cells to the BRAF inhibitor PLX4032.	[Kudo, Kohya; Yoneda, Atsuko; Sakiyama, Daiki; Kojima, Kai; Miyaji, Takeki; Yamazaki, Miku; Yaita, Saori; Hyodo, Takuya; Satow, Reiko; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan; [Yoneda, Atsuko; Satow, Reiko; Fukami, Kiyoko] Japan Agcy Med Res & Dev, Adv Res & Dev Programs Med Innovat AMED CREST, Tokyo, Japan; [Kudo, Kohya] Novartis Pharma KK, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Novartis	Yoneda, A (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	ayoneda@toyaku.ac.jp			Advanced Research and Development Programs for Medical Innovation (AMED-CREST), Japan Agency for Medical Research and Development	Advanced Research and Development Programs for Medical Innovation (AMED-CREST), Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The authors thank Dr. Y. Nakamura (Tokyo University of Pharmacy and Life Sciences) for helpful discussion, Dr. T. Kitamura (University of Tokyo, Tokyo, Japan) for Platinum A cell lines and pMXs-IP, and Dr. J. R. Couchman (University of Copenhagen, Copenhagen, Denmark) for the syndecan construct. This study was supported by a Grant-in-Aid for Scientific Research (B) and the Advanced Research and Development Programs for Medical Innovation (AMED-CREST), Japan Agency for Medical Research and Development to K.F., Grant-in-Aid for Young Scientists (A) to R.S., and a Grant-in-Aid for Scientific Research (C) to A.Y. The authors declare no conflicts of interest.	Ageberg M, 2003, CLIN LAB HAEMATOL, V25, P297, DOI 10.1046/j.1365-2257.2003.00541.x; ATKINSON B, 1984, CANCER RES, V44, P2577; Braeuer RR, 2012, PIGM CELL MELANOMA R, V25, P592, DOI 10.1111/j.1755-148X.2012.01026.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Henion TR, 2014, J CELL PHYSIOL, V229, P471, DOI 10.1002/jcp.24467; Hirata E, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026781; Ji ZY, 2015, J INVEST DERMATOL, V135, P1863, DOI 10.1038/jid.2015.105; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kinoshita M, 2014, J PROTEOME RES, V13, P1021, DOI 10.1021/pr401015b; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KOJIMA T, 1993, BIOCHEM BIOPH RES CO, V190, P814, DOI 10.1006/bbrc.1993.1122; Kudo Kohya, 2016, Advances in Biological Regulation, V61, P68, DOI 10.1016/j.jbior.2015.11.004; Li CW, 2018, CANCER CELL, V33, P187, DOI 10.1016/j.ccell.2018.01.009; Lupia A, 2014, J INVEST DERMATOL, V134, P2947, DOI 10.1038/jid.2014.258; Ma HY, 2013, IUBMB LIFE, V65, P409, DOI 10.1002/iub.1133; Manzano JL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.07; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Michaloglou C, 2008, ONCOGENE, V27, P877, DOI 10.1038/sj.onc.1210704; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Richard G, 2016, EMBO MOL MED, V8, P1143, DOI 10.15252/emmm.201505971; Satow R, 2017, CANCER RES, V77, P366, DOI 10.1158/0008-5472.CAN-16-0991; Shen L, 2014, INT J ONCOL, V45, P2560, DOI 10.3892/ijo.2014.2672; Termini CM, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00034; Togayachi A, 2010, METHOD ENZYMOL, V479, P185, DOI 10.1016/S0076-6879(10)79011-X; Tominaga N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-134; Very N, 2018, ONCOTARGET, V9, P1380, DOI 10.18632/oncotarget.22377; Villanueva J, 2008, CURR ONCOL REP, V10, P439, DOI 10.1007/s11912-008-0067-y; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Xiao H, 2016, P NATL ACAD SCI USA, V113, P10304, DOI 10.1073/pnas.1608069113; Xiao JJ, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4583-3; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	35	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3851	3869		10.1096/fj.201800664RR	http://dx.doi.org/10.1096/fj.201800664RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30508500	Bronze			2022-12-28	WOS:000459794800061
J	Lin, TH; Pajarinen, J; Kohno, Y; Huang, JF; Maruyama, M; Romero-Lopez, M; Nathan, K; Yao, ZY; Goodman, SB				Lin, Tzuhua; Pajarinen, Jukka; Kohno, Yusuke; Huang, Jhih-Fong; Maruyama, Masahiro; Romero-Lopez, Monica; Nathan, Karthik; Yao, Zhenyu; Goodman, Stuart B.			Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation	FASEB JOURNAL			English	Article						trained immunity; immunomodulation; T lymphocyte	STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; REINFECTION; PROTECTION; TISSUE	Mesenchymal stem cell (MSC)-mediated immunomodulation affects both innate and adaptive immune systems. These responses to environmental cues, such as pathogen-associated molecular patterns, damage-associated molecular patterns, or proinflammatory cytokines, are crucial for resolution of inflammation, as well as successful tissue healing and regeneration. We observed that intermittent, repeated exposure of MSCs to LPS induced stronger NF-B activation than singular stimulation. A similar phenomenon, named innate immune memory or trained immunity, has been reported with macrophages. However, the potential regulation of immune memory in nonclassic immune cells, such as MSCs, has not been reported. In the current study, we chose IFN- plus TNF- restimulation-induced iNOS expression as a model of MSC activation, because IFN- and TNF- play crucial roles in MSC-mediated immunomodulation. The iNOS expression was enhanced in LPS-trained MSCs, 3 d after a washout period following primary stimulation. LPS-trained MSCs enhanced the anti-inflammatory (arginase 1 and CD206) marker expression, but decreased the proinflammatory marker (TNF-, IL-1, iNOS, and IL-6) expression using an MSC-macrophage coculture model. In contrast, LPS-trained MSCs demonstrated a defective regulation on CD4 T-cell proliferation. Mechanistic studies suggested that histone methylation and the JNK pathway are involved in LPS-trained immunomodulation in MSCs. Our results demonstrate differential immunomodulatory effects of trained MSCs on macrophages and T cells. These immunomodulatory consequences are critical, because they will have a major impact on current MSC-based cell therapies.Lin, T., Pajarinen, J., Kohno, Y., Huang, J.-F., Maruyama, M., Romero-Lopez, M., Nathan, K., Yao, Z., Goodman, S. B. Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation.	[Lin, Tzuhua; Pajarinen, Jukka; Kohno, Yusuke; Huang, Jhih-Fong; Maruyama, Masahiro; Romero-Lopez, Monica; Nathan, Karthik; Yao, Zhenyu; Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Goodman, Stuart B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Goodman, SB (corresponding author), Stanford Univ, Sch Med, Dept Orthopaed Surg, 450 Broadway St, Redwood City, CA 94063 USA.	goodbone@stanford.edu	Maruyama, Masahiro/AED-5275-2022; Kohno, Yusuke/AAO-9850-2021; Goodman, Stuart/AAZ-7499-2020	Maruyama, Masahiro/0000-0002-1339-0023; Kohno, Yusuke/0000-0003-1821-4560; Goodman, Stuart/0000-0002-1919-3717; Romero-Lopez, Monica/0000-0003-0148-6033	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [1R01AR063717]; Ellenburg Chair in Surgery at Stanford University; Jane and Aatos Erkko Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063717, R01AR073145] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; Ellenburg Chair in Surgery at Stanford University; Jane and Aatos Erkko Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Katie Hsu, Sai-Wen Tang, and Magdiel Perez Cruz (all from Stanford University) for consulting on the T-cell proliferation assay. The authors also thank Piera Smeriglio (Stanford University) for consulting on the mechanistic study of epigenetic regulation. This work was supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant 1R01AR063717 (to S.B.G.) and the Ellenburg Chair in Surgery at Stanford University. J.P. was supported by a grant from the Jane and Aatos Erkko Foundation. The authors declare no conflicts of interest.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Davies LC, 2017, STEM CELLS, V35, P766, DOI 10.1002/stem.2509; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Engela AU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00126; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Lin TH, 2015, TISSUE ENG PT A, V21, P875, DOI [10.1089/ten.tea.2014.0144, 10.1089/ten.TEA.2014.0144]; Lin TH, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0730-z; Lin T, 2017, CYTOTHERAPY, V19, P1025, DOI 10.1016/j.jcyt.2017.06.008; Ling WF, 2014, CANCER RES, V74, P1576, DOI 10.1158/0008-5472.CAN-13-1656; Lundin JI, 2009, ENVIRON HEALTH PERSP, V117, P1344, DOI 10.1289/ehp.0800439; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Redondo-Castro E, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0531-4; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Saparov A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3924858; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	27	16	17	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4203	4211		10.1096/fj.201801845R	http://dx.doi.org/10.1096/fj.201801845R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521384	Green Published, Bronze			2022-12-28	WOS:000459794800088
J	Quarta, S; Mitric, M; Kalpachidou, T; Mair, N; Schiefermeier-Mach, N; Andratsch, M; Qi, YM; Langeslag, M; Malsch, P; Rose-John, S; Kress, M				Quarta, Serena; Mitric, Miodrag; Kalpachidou, Theodora; Mair, Norbert; Schiefermeier-Mach, Natalia; Andratsch, Manfred; Qi, Yanmei; Langeslag, Michiel; Malsch, Philipp; Rose-John, Stefan; Kress, Michaela			Impaired mechanical, heat, and cold nociception in a murine model of genetic TACE/ADAM17 knockdown	FASEB JOURNAL			English	Article						pain; sensory neuron; neuroimmune interactions	NECROSIS-FACTOR-ALPHA; IN-VIVO; PAIN; INTERLEUKIN-6; RECEPTOR; ADAM17; NEURONS; SKIN; DISINTEGRIN; TACE	TNF--converting enzyme, a member of the ADAM (A disintegrin and metalloproteinase) protease family and also known as ADAM17, regulates inflammation and regeneration in health and disease. ADAM17 targets are involved in pain development and hypersensitivity in animal models of inflammatory and neuropathic pain. However, the role of ADAM17 in the pain pathway is largely unknown. Therefore, we used the hypomorphic ADAM17 (ADAM17(ex/ex)) mouse model to investigate the importance of ADAM17 in nociceptive behavior, morphology, and function of primary afferent nociceptors. ADAM17(ex/ex) mice were hyposensitive to noxious stimulation, showing elevated mechanical thresholds as well as impaired heat and cold sensitivity. Despite these differences, skin thickness and innervation were comparable to controls. Although dorsal root ganglia of ADAM17(ex/ex) mice exhibited normal morphology of peptidergic and nonpeptidergic neurons, a small but significant reduction in the number of isolectin -4-positive neurons was observed. Functional electrical properties of unmyelinated nociceptors showed differences in resting membrane potential, afterhyperpolarization, and firing patterns in specific subpopulations of sensory neurons in ADAM17(ex/ex) mice. However, spinal cord morphology and microglia activity in ADAM17(ex/ex) mice were not altered. Our data suggest that ADAM17 contributes to the processing of painful stimuli, with a complex mode of action orchestrating the function of neurons along the pain pathway.Quarta, S., Mitri, M., Kalpachidou, T., Mair, N., Schiefermeier-Mach, N., Andratsch, M., Qi, Y., Langeslag, M., Malsch, P., Rose-John, S., Kress, M. Impaired mechanical, heat, and cold nociception in a murine model of genetic TACE/ADAM17 knockdown.	[Quarta, Serena; Mitric, Miodrag; Kalpachidou, Theodora; Mair, Norbert; Schiefermeier-Mach, Natalia; Andratsch, Manfred; Qi, Yanmei; Langeslag, Michiel; Malsch, Philipp; Kress, Michaela] Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, Schopfstr 41, A-6020 Innsbruck, Austria; [Rose-John, Stefan] Christian Albrechts Univ Kiel, Dept Biochem, Kiel, Germany; [Schiefermeier-Mach, Natalia] Hlth Univ Appl Sci Tyrol, Innsbruck, Austria	Medical University of Innsbruck; University of Kiel	Kress, M (corresponding author), Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, Schopfstr 41, A-6020 Innsbruck, Austria.	michaela.kress@i-med.ac.at	Kalpachidou, Theodora/AAW-6538-2020; Schiefermeier-Mach, Natalia/AAW-6428-2021	Schiefermeier-Mach, Natalia/0000-0001-6638-5298; Kalpachidou, Theodora/0000-0002-7924-7772; Kress, Michaela/0000-0002-8921-7470; Langeslag, Michiel/0000-0003-4883-7339	Austrian Research Funding Agency FWF [P18444, P28611]; Innsbruck Medical University (Grant MUI-start) [ST201506016]; German Science Foundation [CRC877]; German Science Foundation (Cluster of Excellence "Inflammation at Interfaces")	Austrian Research Funding Agency FWF(Austrian Science Fund (FWF)); Innsbruck Medical University (Grant MUI-start); German Science Foundation(German Research Foundation (DFG)); German Science Foundation (Cluster of Excellence "Inflammation at Interfaces")	The authors thank T. Martha, K. Braun, and M. Doblander (all from Innsbruck Medical University) for expert technical assistance. This work was supported by the Austrian Research Funding Agency FWF (Grants P18444 and P28611, to M. K.) and Innsbruck Medical University (Grant MUI-start ST201506016, to S.Q.). The work of S.R.-J. was supported by the German Science Foundation (CRC877, Project A1, and the Cluster of Excellence "Inflammation at Interfaces"). The authors declare no conflicts of interest.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Ahmed Z, 2006, BRAIN, V129, P1517, DOI 10.1093/brain/awl080; Andratsch M, 2009, J NEUROSCI, V29, P13473, DOI 10.1523/JNEUROSCI.1822-09.2009; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Barabas ME, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-9; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Benatti C, 2018, PSYCHONEUROENDOCRINO, V87, P74, DOI 10.1016/j.psyneuen.2017.10.011; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Braun O, 2013, J INTERF CYTOK RES, V33, P254, DOI 10.1089/jir.2012.0096; Brierley SM, 2011, J PHYSIOL-LONDON, V589, P3575, DOI 10.1113/jphysiol.2011.206789; Brooke MA, 2014, J INVEST DERMATOL, V134, P2486, DOI 10.1038/jid.2014.228; Cabron AS, 2018, J IMMUNOL, V201, P3106, DOI 10.4049/jimmunol.1701556; Camprubi-Robles M, 2013, J NEUROSCI, V33, P2582, DOI 10.1523/JNEUROSCI.4479-12.2013; Capone C, 2016, ELIFE, V5, DOI 10.7554/eLife.17536; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Constantin CE, 2008, J NEUROSCI, V28, P5072, DOI 10.1523/JNEUROSCI.4476-07.2008; Cuevas-Olguin R, 2017, SYNAPSE, V71, DOI 10.1002/syn.21984; FORSTER C, 1990, J NEUROSCI METH, V31, P109, DOI 10.1016/0165-0270(90)90155-9; Garcia-Oscos F, 2012, BIOL PSYCHIAT, V71, P574, DOI 10.1016/j.biopsych.2011.11.018; Gelling RW, 2008, ENDOCRINOLOGY, V149, P6053, DOI 10.1210/en.2008-0775; Goddard DR, 2001, GLIA, V34, P267, DOI 10.1002/glia.1060; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hodes GE, 2015, NAT NEUROSCI, V18, P1386, DOI 10.1038/nn.4113; Karkkainen I, 2000, MOL CELL NEUROSCI, V15, P547, DOI 10.1006/mcne.2000.0848; Kefaloyianni E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87023; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; Kuner R, 2017, NAT REV NEUROSCI, V18, P20, DOI 10.1038/nrn.2016.162; Langeslag M, 2014, PFLUG ARCH EUR J PHY, V466, P2153, DOI 10.1007/s00424-014-1443-0; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Lindfors PH, 2006, J NEUROSCI, V26, P1953, DOI 10.1523/JNEUROSCI.4065-05.2006; Malsch P, 2014, J NEUROSCI, V34, P9845, DOI 10.1523/JNEUROSCI.5161-13.2014; Morley SJ, 2016, ELIFE, V5, DOI 10.7554/eLife.20813; Namer B, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00335; Nicolaou A, 2017, ARTERIOSCL THROM VAS, V37, P247, DOI 10.1161/ATVBAHA.116.308682; Obreja O, 2005, BRAIN, V128, P1634, DOI 10.1093/brain/awh490; Obreja O, 2002, PAIN, V96, P57, DOI 10.1016/S0304-3959(01)00420-1; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9512; Quarta S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00317; Quarta S, 2014, J NEUROSCI, V34, P13222, DOI 10.1523/JNEUROSCI.1209-13.2014; Quarta S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-73; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schmidt S, 2018, J EXP MED, V215, P1205, DOI 10.1084/jem.20171696; Skovronsky DM, 2001, J NEUROBIOL, V49, P40, DOI 10.1002/neu.1064; Smith AK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-61; Sommer A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11523; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sun YY, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-23; Tanabe Y, 2008, NEUROSCI LETT, V444, P16, DOI 10.1016/j.neulet.2008.08.023; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Weisshaar CL, 2017, NEUROSCI LETT, V655, P82, DOI 10.1016/j.neulet.2017.07.006; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	61	9	9	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4418	4431		10.1096/fj.201801901R	http://dx.doi.org/10.1096/fj.201801901R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30586315	hybrid, Green Published			2022-12-28	WOS:000459794800105
J	Kordon, MM; Szczurek, A; Berniak, K; Szelest, O; Solarczyk, K; Tworzydlo, M; Wachsmann-Hogiu, S; Vaahtokari, A; Cremer, C; Pederson, T; Dobrucki, JW				Kordon, Magdalena M.; Szczurek, Aleksander; Berniak, Krzysztof; Szelest, Oskar; Solarczyk, Kamil; Tworzydlo, Magdalena; Wachsmann-Hogiu, Sebastian; Vaahtokari, Anne; Cremer, Christoph; Pederson, Thoru; Dobrucki, Jurek W.			PML-like subnuclear bodies, containing XRCC1, juxtaposed to DNA replication-based single-strand breaks	FASEB JOURNAL			English	Article						DNA damage; PML nuclear bodies; superresolution microscopy	ORIGIN RECOGNITION COMPLEX; LIGASE III-ALPHA; DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; EXCISION-REPAIR; VISIBLE-LIGHT; BRCT DOMAIN; PROTEIN; PARP-1; INTERACTS	DNA lesions induce recruitment and accumulation of various repair factors, resulting in formation of discrete nuclear foci. Using superresolution fluorescence microscopy as well as live cell and quantitative imaging, we demonstrate that X-ray repair cross-complementing protein 1 (XRCC1), a key factor in single-strand break and base excision repair, is recruited into nuclear bodies formed in response to replication-related single-strand breaks. Intriguingly, these bodies are assembled immediately in the vicinity of these breaks and never fully colocalize with replication foci. They are structurally organized, containing canonical promyelocytic leukemia (PML) nuclear body protein SP100 concentrated in a peripheral layer, and XRCC1 in the center. They also contain other factors, including PML, poly(ADP-ribose) polymerase 1 (PARP1), ligase III, and origin recognition complex subunit 5. The breast cancer 1 and -2 C terminus domains of XRCC1 are essential for formation of these repair foci. These results reveal that XRCC1-contaning foci constitute newly recognized PML-like nuclear bodies that accrete and locally deliver essential factors for repair of single-strand DNA breaks in replication regions.Kordon, M. M., Szczurek, A., Berniak, K., Szelest, O., Solarczyk, K., Tworzydo, M., Wachsmann-Hogiu, S., Vaahtokari, A., Cremer, C., Pederson, T., Dobrucki, J. W. PML-like subnuclear bodies, containing XRCC1, juxtaposed to DNA replication-based single-strand breaks.	[Kordon, Magdalena M.; Szczurek, Aleksander; Berniak, Krzysztof; Szelest, Oskar; Solarczyk, Kamil; Dobrucki, Jurek W.] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biophys, Gronostajowa 7, PL-30387 Krakow, Poland; [Tworzydlo, Magdalena] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland; [Szczurek, Aleksander; Cremer, Christoph] Inst Mol Biol, Superresolut Microscopy Grp, Mainz, Germany; [Wachsmann-Hogiu, Sebastian] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Vaahtokari, Anne] Canc Res UK, Francis Crick Inst, London, England; [Pederson, Thoru] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Wachsmann-Hogiu, Sebastian] McGill Univ, Dept Bioengn, Montreal, PQ, Canada; [Vaahtokari, Anne] Univ Calgary, Arnie Charbonneau Canc Inst, Hlth Sci Ctr, Calgary, AB, Canada	Jagiellonian University; Jagiellonian University; Institute of Molecular Biology (IMB); University of California System; University of California Davis; Cancer Research UK; Francis Crick Institute; University of Massachusetts System; University of Massachusetts Worcester; McGill University; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Dobrucki, JW (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biophys, Gronostajowa 7, PL-30387 Krakow, Poland.	jerzy.dobrucki@uj.edu.pl		Dobrucki, Jerzy/0000-0002-4432-1522	Polish Ministry of Science and Higher Education; Polish National Science Centre (NCN) [2013/09/N/NZ3/00203, 2013/11/B/NZ3/00189, 2017/27/B/NZ3/01065]; Jagiellonian University; U.S. National Institutes of Health, National Institute on Drug Abuse [U01 DA-040588]; National Science Centre [DEC-2015/16/T/NZ3/00157]; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA040588] Funding Source: NIH RePORTER	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Centre (NCN); Jagiellonian University; U.S. National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Science Centre(National Science Centre, Poland); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank J. Drukaa for providing primary cultures of human fibroblasts, M. Dziedzicka-Wasylewska for making the molecular biology facilities in her laboratory available, and M. Rak and Z. Madeja (all from Jagiellonian University) for their support in transfection procedures of human fibroblasts (all from Jagiellonian University). The authors also thank B. Stillman (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) for providing the vectors encoding EYFP-ORC1 and EYFP-ORC5, V. Schreiber (Institut de Recherche de l'Ecole de Biotechnologie de Strasbourg, Illkirch, France) for providing the vector encoding GFP-PARP1, and M. Szklarczyk (freelance graphic designer) for help with computer graphics. The Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University is a partner within the Leading National Research Centre (KNOW) supported by the Polish Ministry of Science and Higher Education. This work was supported by Polish National Science Centre (NCN) (2013/09/N/NZ3/00203 to M.M.K., 2013/11/B/NZ3/00189 to J.W.D., and 2017/27/B/NZ3/01065 to J.W.D.). M.M.K. was a recipient of a Society-Environment-Technologies (SET) doctoral studentship from Jagiellonian University and a doctoral studentship awarded by the National Science Centre (DEC-2015/16/T/NZ3/00157). T.P. was partially supported by U.S. National Institutes of Health, National Institute on Drug Abuse Grant U01 DA-040588 with P. Kaufman (University of Massachusetts Medical School). M.M.K., K.S., and J.W.D. declare a potential conflict of interest associated with an invention (patent application pending) relating to a method of ultrasensitive detection of single- and double-stranded DNA breaks. The remaining authors declare no conflicts of interest.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Beernink PT, 2005, J BIOL CHEM, V280, P30206, DOI 10.1074/jbc.M502155200; Berniak K, 2013, CYTOM PART A, V83, P913, DOI 10.1002/cyto.a.22327; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Breslin C, 2015, NUCLEIC ACIDS RES, V43, P6934, DOI 10.1093/nar/gkv623; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; Conlan LA, 2004, ONCOGENE, V23, P307, DOI 10.1038/sj.onc.1207119; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Dillin A, 1997, GENETICS, V147, P1053; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; Godon C, 2008, NUCLEIC ACIDS RES, V36, P4454, DOI 10.1093/nar/gkn403; Hanssen-Bauer A, 2012, DNA REPAIR, V11, P357, DOI 10.1016/j.dnarep.2012.01.001; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; Hoischen C, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00125; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Jusuk I, 2015, SCI REP-UK, V5, DOI 10.1038/srep14075; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Kubota Y, 2003, DNA REPAIR, V2, P407, DOI 10.1016/S1568-7864(02)00242-2; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lang M, 2010, J CELL SCI, V123, P392, DOI 10.1242/jcs.053496; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Madeja Z, 2007, ACTA BIOCHIM POL, V54, P873, DOI 10.18388/abp.2007_3191; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mortusewicz O, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-81; Muratani M, 2002, NAT CELL BIOL, V4, P106, DOI 10.1038/ncb740; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Ozaydin B, 2010, MOL CELL BIOL, V30, P626, DOI 10.1128/MCB.00614-09; Parsons JL, 2010, DNA REPAIR, V9, P835, DOI 10.1016/j.dnarep.2010.04.008; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Seker H, 2003, ONCOGENE, V22, P1620, DOI 10.1038/sj.onc.1206140; Shore D, 2001, CURR BIOL, V11, pR816, DOI 10.1016/S0960-9822(01)00493-6; Solarczyk KJ, 2016, DNA REPAIR, V37, P12, DOI 10.1016/j.dnarep.2015.10.006; Solarczyk KJ, 2012, DNA REPAIR, V11, P996, DOI 10.1016/j.dnarep.2012.09.008; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; Strom CE, 2011, DNA REPAIR, V10, P961, DOI 10.1016/j.dnarep.2011.07.004; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Szczurek AT, 2014, NUCLEUS-PHILA, V5, P331, DOI 10.4161/nucl.29564; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Taylor RM, 2002, MOL CELL BIOL, V22, P2556, DOI 10.1128/MCB.22.8.2556-2563.2002; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Verdaasdonk JS, 2014, METHOD CELL BIOL, V123, P347, DOI 10.1016/B978-0-12-420138-5.00019-7; Wei LZ, 2013, J CELL SCI, V126, P4414, DOI 10.1242/jcs.128272; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Xu ZX, 2003, MOL CELL BIOL, V23, P4247, DOI 10.1128/MCB.23.12.4247-4256.2003; Ying SM, 2016, CANCER RES, V76, P1078, DOI 10.1158/0008-5472.CAN-15-0608; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128555; Zou YF, 2008, NUCLEIC ACIDS RES, V36, P5189, DOI 10.1093/nar/gkn465	57	5	5	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2301	2313		10.1096/fj.201801379R	http://dx.doi.org/10.1096/fj.201801379R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260704	Green Published			2022-12-28	WOS:000457296600062
J	Sahu, S; Li, R; Loers, G; Schachner, M				Sahu, Sudhanshu; Li, Rong; Loers, Gabriele; Schachner, Melitta			Knockdown of chondroitin-4-sulfotransferase-1, but not of dermatan-4-sulfotransferase-1, accelerates regeneration of zebrafish after spinal cord injury	FASEB JOURNAL			English	Article						axonal regrowth; glycosaminoglycans; chondroitin sulfate; dermatan sulfate	CHONDROITIN SULFATE PROTEOGLYCANS; PROMOTES FUNCTIONAL RECOVERY; CELL-ADHESION MOLECULE; DERMATAN SULFATE; HYBRID CHAINS; AXONAL REGENERATION; EXPRESSION CLONING; BINDING ACTIVITIES; GROWTH-FACTORS; SULFOTRANSFERASE	Glycosaminoglycans such as chondroitin sulfate (CS) and dermatan sulfate (DS) are long chains of repeating disaccharide units, covalently linked to core proteins to form proteoglycans. Proteoglycans can be cell membrane-bound or are part of the extracellular matrix. They are important in a wide range of biologic processes, including development, synaptic plasticity, and regeneration after injury, as well as modulation of growth factor signaling, cell migration, survival, and proliferation. Synthesis of CS and DS in the Golgi apparatus is mediated by sulfotransferases that modify sugar chains through transfer of sulfate groups to specific positions on the sugar moieties. To clarify the functions of CS and DS during nervous system regeneration, we studied the effect of chondroitin 4-O-sulfotransferase-1/carbohydrate sulfotransferase-11 (C4ST-1/Chst-11) and dermatan 4-O-sulfotransferase-1/Chst-14 (D4ST-1/Chst-14) down-regulation on spinal cord regeneration in larval and adult zebrafish. In our study, knockdown of C4ST1/Chst-11 accelerated regeneration after spinal cord injury in larval and adult zebrafish and knockdown of D4ST1/Chst-14 did not alter regenerative capacity. From these and previous observations, we drew the conclusion that different CS and DS expression patterns can be growth permitting, growth inhibiting, or neutral for regrowing or sprouting axons, depending on the tissue environment of a particular animal species.Sahu, S., Li, R., Loers, G., Schachner, M. Knockdown of chondroitin-4-sulfotransferase-1, but not of dermatan-4-sulfotransferase-1, accelerates regeneration of zebrafish after spinal cord injury.	[Sahu, Sudhanshu; Li, Rong; Schachner, Melitta] Shantou Univ, Med Coll, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China; [Loers, Gabriele] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Shantou University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick	Schachner, M (corresponding author), Shantou Univ, Med Coll, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China.	schachner@stu.edu.cn	Sahu, Sudhanshu Sekhar/M-2678-2019	RONG, LI/0000-0003-1828-5713	Li Kashing Foundation	Li Kashing Foundation	The authors thank and Prof. Junhui Bian and Dr. Frieda Law for encouragement during the work and Dr. Stanley Li Lin for editing the text (all from Shantou University Medical College). This work was funded by the Li Kashing Foundation. The authors declare no conflicts of interest.	Akyuaz N, 2013, EXP NEUROL, V247, P517, DOI 10.1016/j.expneurol.2013.01.025; Aquino RS, 2016, FRONT BIOSCI-LANDMRK, V21, P1260, DOI 10.2741/4455; Avram S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/642798; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bian S, 2011, J CELL SCI, V124, P4051, DOI 10.1242/jcs.088120; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Habicher J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121957; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Hiraoka N, 2001, GLYCOBIOLOGY, V11, P495, DOI 10.1093/glycob/11.6.495; James MO, 2013, DRUG METAB REV, V45, P401, DOI 10.3109/03602532.2013.835613; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kosho T, 2016, PEDIATR INT, V58, P88, DOI 10.1111/ped.12878; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Lee HJ, 2012, J NEUROTRAUM, V29, P1850, DOI 10.1089/neu.2011.2290; Li HP, 2013, J NEUROTRAUM, V30, P413, DOI 10.1089/neu.2012.2513; Li R, 2018, PHARMACOL BIOCHEM BE, V171, P30, DOI 10.1016/j.pbb.2018.05.013; Lieberoth Bettina C., 2003, Methods in Cell Science, V25, P65, DOI 10.1023/B:MICS.0000006848.57869.4c; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Ma LP, 2017, MOL NEUROBIOL, V54, P3253, DOI 10.1007/s12035-016-9876-4; Ma LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095098; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; MARK M P, 1990, International Journal of Developmental Biology, V34, P191; Miller GM, 2015, EXP NEUROL, V274, P115, DOI 10.1016/j.expneurol.2015.08.015; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Mizumoto S, 2009, BIOCHEM J, V419, P387, DOI 10.1042/BJ20081639; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Okuda T, 2000, J BIOL CHEM, V275, P40605, DOI 10.1074/jbc.M007983200; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Pomin VH, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010027; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Rost S, 2016, NEUROSCIENCE, V312, P74, DOI 10.1016/j.neuroscience.2015.11.013; Sahu S, 2018, MOL NEUROBIOL, V55, P859, DOI 10.1007/s12035-016-0254-z; Schwartz NB, 2018, FEBS LETT, V592, P3791, DOI 10.1002/1873-3468.13026; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yick LW, 2000, NEUROREPORT, V11, P1063, DOI 10.1097/00001756-200004070-00032; Yu Y, 2013, EUR J NEUROSCI, V38, P2280, DOI 10.1111/ejn.12222	51	11	11	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2252	2262		10.1096/fj.201800852RR	http://dx.doi.org/10.1096/fj.201800852RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30339470	Bronze			2022-12-28	WOS:000457296600058
J	Chen, SX; Sandford, S; Kirman, JR; Rehm, BHA				Chen, Shuxiong; Sandford, Sarah; Kirman, Joanna R.; Rehm, Bernd H. A.			Innovative antigen carrier system for the development of tuberculosis vaccines	FASEB JOURNAL			English	Article						polyester particle; particulate vaccine; bioengineering; Mycobacterium tuberculosis	PARTICLE-SIZE; POLYHYDROXYALKANOATE GRANULES; EFFICIENT PROTECTION; POLYESTER INCLUSIONS; BOVINE TUBERCULOSIS; IMMUNE-RESPONSE; DENDRITIC CELLS; T-CELLS; SURFACE; VACCINATION	A major obstacle to tuberculosis (TB)-subunit-vaccine development has been the induction of inadequate levels of protective immunity due to the limited breadth of antigen in vaccine preparations. In this study, immunogenic mycobacterial fusion peptides Ag85B-TB10.4 and Ag85B-TB10.4-Rv2660c were covalently displayed on the surface of self-assembled polyester particles. This study investigated whether polyester particles displaying mycobacterial antigens could provide augmented immunogenicity (i.e., offer an innovative vaccine formulation) when compared with free soluble antigens. Herein, polyester particle-based particulate vaccines were produced in an endotoxin-free Escherichia coli strain and emulsified with the adjuvant dimethyl dioctadecyl ammonium bromide. C57BL/6 mice were used to study the immunogenicity of formulated particulate vaccines. The result of humoral immunity showed the antibodies only interacted with target antigens and not with PhaC and the background proteins of the production host. The analysis of T helper 1 cellular immunity indicated that a relatively strong production of cellular immunity biomarkers, IFN-gamma and IL-17A cytokines, was induced by particulate vaccines when compared with the respective soluble controls. This study demonstrated that polyester particles have the potential to perform as a mycobacterial antigen-delivery agent to induce augmented antigen-specific immune responses in contrast to free soluble vaccines.-Chen, S., Sandford, S., Kirman, J. R., Rehm, B. H. A. Innovative antigen carrier system for the development of tuberculosis vaccines.	[Chen, Shuxiong] Massey Univ Manawatu, Inst Fundamental Sci, Palmerston North, New Zealand; [Sandford, Sarah; Kirman, Joanna R.] Univ Otago, Microbiol & Immunol Dept, Dunedin, New Zealand; [Rehm, Bernd H. A.] Griffith Univ, Ctr Cell Factories & Biopolymers, Griffith Inst Drug Discovery, Nathan Campus,Don Young Rd, Brisbane, Qld 4111, Australia	Massey University; University of Otago; Griffith University	Rehm, BHA (corresponding author), Griffith Univ, Ctr Cell Factories & Biopolymers, Griffith Inst Drug Discovery, Nathan Campus,Don Young Rd, Brisbane, Qld 4111, Australia.	b.rehm@griffith.edu.au	Chen, Shuxiong/ABE-3430-2020	Chen, Shuxiong/0000-0002-5275-0757; Kirman, Joanna/0000-0002-4802-7048; Sandford, Sarah/0000-0002-2901-4516	Massey University (Palmerston North, New Zealand); Griffith University (Brisbane, QLD, Australia)	Massey University (Palmerston North, New Zealand); Griffith University (Brisbane, QLD, Australia)	The authors thank research technician Michelle Wilson for the great support and advice with flow cytometry. The authors acknowledge the Manawatu Microscopy and Imaging Centre for preparation and development of transmission electron microscopic imaging. The authors are grateful to technicians at the University of Otago Department of Pathology for animal husbandry. Funding was provided by Massey University (Palmerston North, New Zealand) and Griffith University (Brisbane, QLD, Australia). The authors declare no conflicts of interest.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Amara AA, 2003, BIOCHEM J, V374, P413, DOI 10.1042/BJ20030431; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Anderson L., 2018, GLOBAL TUBERCULOSIS; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bhatt K, 2015, CLIN VACCINE IMMUNOL, V22, P258, DOI 10.1128/CVI.00721-14; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Billeskov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072185; Billeskov R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039909; Blatchford PA, 2012, BIOTECHNOL BIOENG, V109, P1101, DOI 10.1002/bit.24402; Burel JG, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.87499; Campisano A, 2008, J BIOTECHNOL, V133, P442, DOI 10.1016/j.jbiotec.2007.11.007; Chan J, 2014, SEMIN IMMUNOL, V26, P588, DOI 10.1016/j.smim.2014.10.005; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen SX, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201800118; Chen SX, 2014, APPL ENVIRON MICROB, V80, P2526, DOI 10.1128/AEM.04168-13; Chung CW, 2003, INT J BIOL MACROMOL, V32, P17, DOI 10.1016/S0141-8130(03)00020-5; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Deng YH, 2015, INFECT DIS-NOR, V47, P168, DOI 10.3109/00365548.2014.982167; Dey AK, 2014, EXPERT REV VACCINES, V13, P671, DOI 10.1586/14760584.2014.907528; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Fox Christopher B, 2013, Ther Adv Vaccines, V1, P7, DOI 10.1177/2051013613480144; Geldenhuys H, 2015, VACCINE, V33, P3592, DOI 10.1016/j.vaccine.2015.05.036; Gonzalez-Miro M, 2018, ACS BIOMATER SCI ENG, V4, P3413, DOI 10.1021/acsbiomaterials.8b00579; Gonzalez-Miro M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20205-7; Grage K, 2009, BIOMACROMOLECULES, V10, P660, DOI 10.1021/bm801394s; Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8; He H, 2015, EUR J CLIN MICROBIOL, V34, P1103, DOI 10.1007/s10096-015-2335-8; Hezayen FF, 2002, ARCH BIOCHEM BIOPHYS, V403, P284, DOI 10.1016/S0003-9861(02)00234-5; Honary S, 2013, TROP J PHARM RES, V12, P255, DOI 10.4314/tjpr.v12i2.19; Jacobs AJ, 2016, TUBERCULOSIS, V101, P102, DOI 10.1016/j.tube.2016.08.001; Jahns AC, 2012, MICROB BIOTECHNOL, V5, P188, DOI 10.1111/j.1751-7915.2011.00293.x; Katare YK, 2005, INT J PHARMACEUT, V301, P149, DOI 10.1016/j.ijpharm.2005.05.028; Kaufmann SHE, 2010, J INTERN MED, V267, P337, DOI 10.1111/j.1365-2796.2010.02216.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lee JW, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02289-16; Legat A, 2010, APPL MICROBIOL BIOT, V87, P1119, DOI 10.1007/s00253-010-2611-6; Lewinsohn DA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01262; Limbach LK, 2005, ENVIRON SCI TECHNOL, V39, P9370, DOI 10.1021/es051043o; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Lopez-Sagaseta J, 2016, COMPUT STRUCT BIOTEC, V14, P58, DOI 10.1016/j.csbj.2015.11.001; Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388; Mottram PL, 2007, MOL PHARMACEUT, V4, P73, DOI 10.1021/mp060096p; Parlane NA, 2016, CLIN VACCINE IMMUNOL, V23, P19, DOI 10.1128/CVI.00462-15; Parlane NA, 2012, CLIN VACCINE IMMUNOL, V19, P37, DOI 10.1128/CVI.05505-11; Parlane NA, 2011, APPL ENVIRON MICROB, V77, P8516, DOI 10.1128/AEM.06420-11; Parlane NA, 2009, APPL ENVIRON MICROB, V75, P7739, DOI 10.1128/AEM.01965-09; Peters V, 2005, FEMS MICROBIOL LETT, V248, P93, DOI 10.1016/j.femsle.2005.05.027; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rehm BHA, 2007, CURR ISSUES MOL BIOL, V9, P41; Rehm BHA, 2017, CURR OPIN BIOTECH, V48, P42, DOI 10.1016/j.copbio.2017.03.018; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Rehm BHA, 2002, BBA-PROTEIN STRUCT M, V1594, P178, DOI 10.1016/S0167-4838(01)00299-0; Reyes PR, 2016, INT J MED MICROBIOL, V306, P624, DOI 10.1016/j.ijmm.2016.10.002; Rubio-Reyes P, 2017, MICROB BIOTECHNOL, V10, P1434, DOI 10.1111/1751-7915.12754; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Snapper CM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00598; Steinmann B, 2010, APPL ENVIRON MICROB, V76, P5563, DOI 10.1128/AEM.00612-10; Thiele L, 2003, PHARM RES-DORDR, V20, P221, DOI 10.1023/A:1022271020390; Umemura M, 2016, IMMUN INFLAMM DIS, V4, P401, DOI 10.1002/iid3.121; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Woodard R. W., 2012, VIABLE NONTOXIC GRAM; Zhang JY, 2018, MAT SCI ENG C-MATER, V86, P144, DOI 10.1016/j.msec.2017.12.035	66	13	13	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7505	7518		10.1096/fj.201802501RR	http://dx.doi.org/10.1096/fj.201802501RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30870010	Bronze			2022-12-28	WOS:000476114200067
J	Meng, LK; Liu, XY; Teng, X; Gu, HY; Yuan, W; Meng, J; Li, J; Zheng, Z; Wei, YJ; Hu, SS				Meng, Liukun; Liu, Xiaoyan; Teng, Xiao; Gu, Haiyong; Yuan, Wen; Meng, Jian; Li, Jun; Zheng, Zhe; Wei, Yingjie; Hu, Shengshou			Osteopontin plays important roles in pulmonary arterial hypertension induced by systemic-to-pulmonary shunt	FASEB JOURNAL			English	Article						congenital heart disease; pulmonary vascular remodeling; OPN	MUSCLE CELL-MIGRATION; VASCULAR-DISEASE; MICE LACKING; INTEGRIN; ALPHA(V)BETA(3); PROLIFERATION; HYPERTROPHY; FIBROBLASTS; DEPOSITION; BLOCKADE	Recent studies indicated that osteopontin (OPN) was involved in the genesis and progression of pulmonary arterial hypertension (PAH); however, its role in congenital heart disease-associated PAH (CHD/PAH) remains unknown. Our results showed that OPN was increased in lungs and plasma of patients with Eisenmenger syndrome; moreover, OPN and alpha(V)beta(3)-integrin expression levels were augmented in rat lungs exposed to systemic-to-pulmonary shunt. Cell culture assay demonstrated that distal pulmonary arterial smooth muscle cells (PASMCs) from rat lungs suffering from volume and pressure overload exhibited enhanced proliferation compared with those from healthy rats. Mechanical stretch (20% at 1 Hz) increased OPN expression and activated ERK1/2 and protein kinase B (Akt) signal pathway in distal PASMCs from healthy rats. Interestingly, OPN enhanced the proliferation and migration of PASMCs while blocking alpha(V)beta(3)-integrin with neutralizing antibody LM609 or Arg-Gly-Asp peptidomimetic antagonist cyclo(Ala-Arg-Gly-Asp-3-aminomethylbenzoyl) (XJ735), rectified the proliferative and migratory effects of OPN, which were partially mediated via ERK1/2 and Akt signaling pathways. Furthermore, surgical correction of systemic-to-pulmonary shunt, particularly XJ735 supplementation after surgical correction of systemic-to-pulmonary shunt, significantly alleviated the pulmonary hypertensive status in terms of pulmonary hemodynamic indices, pulmonary vasculopathy, and right ventricular hypertrophy. In summary, OPN alteration in lungs exposed to systemic-to-pulmonary shunt exerts a deteriorative role in pulmonary vascular remodeling through modulating the proliferation and migration of PASMCs, at least in part, via alpha nu beta 3-ERK1/2 and alpha nu beta 3-Akt signaling pathways. Antagonizing OPN receptor alpha nu beta 3-integrin accelerated the regression of pulmonary vasculopathy after surgical correction of systemic-to-pulmonary shunt, indicating a potential therapeutic strategy for patients with CHD/PAH.-Meng, L., Liu, X., Teng, X., Gu, H., Yuan, W., Meng, J., Li, J., Zheng, Z., Wei, Y., Hu, S. Osteopontin plays important roles in pulmonary arterial hypertension induced by systemic-to-pulmonary shunt.	[Meng, Liukun; Teng, Xiao; Meng, Jian; Li, Jun; Zheng, Zhe; Wei, Yingjie; Hu, Shengshou] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Peking Union Med Coll, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing, Peoples R China; [Liu, Xiaoyan; Yuan, Wen] Capital Med Univ, Beijing Chaoyang Hosp, Med Res Ctr, Beijing, Peoples R China; [Liu, Xiaoyan] Capital Med Univ, Beijing Chaoyang Hosp, Beijing Key Lab Hypertens Res, Beijing, Peoples R China; [Gu, Haiyong] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Capital Medical University; Capital Medical University; Shanghai Jiao Tong University	Hu, SS (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beilishi Rd 167, Beijing 100037, Peoples R China.; Hu, SS (corresponding author), Peking Union Med Coll, Fuwai Hosp, Beilishi Rd 167, Beijing 100037, Peoples R China.	huss@fuwaihospital.org			National Natural Science Foundation [81500038, 81470424]; Beijing Natural Science Foundation [7172182, 7172078]; Fuwai Hospital Youth Fund [2014-F03]; Beijing Chaoyang Hospital Affiliated to Capital Medical University 1351 Talent Training Program [CYXX-2017-36]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fuwai Hospital Youth Fund; Beijing Chaoyang Hospital Affiliated to Capital Medical University 1351 Talent Training Program	This work was supported by research grants from the National Natural Science Foundation (81500038, and 81470424), the Beijing Natural Science Foundation (7172182 and 7172078), the Fuwai Hospital Youth Fund (2014-F03), and Beijing Chaoyang Hospital Affiliated to Capital Medical University Talent Training Program (CYXX-2017-36). The authors declare no conflicts of interest.	Anwar A, 2012, AM J PHYSIOL-LUNG C, V303, pL1, DOI 10.1152/ajplung.00050.2012; Bai YY, 2011, CARDIOLOGY, V120, P157, DOI 10.1159/000334431; Cascella T, 2010, ENDOCRINOLOGY, V151, P5851, DOI 10.1210/en.2010-0350; Chaulet H, 2001, CIRC RES, V89, P772, DOI 10.1161/hh2101.098617; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Fadel E, 2004, J THORAC CARDIOV SUR, V127, P1009, DOI 10.1016/j.jtcvs.2003.07.048; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; Han M, 2007, CARDIOVASC PATHOL, V16, P283, DOI 10.1016/j.carpath.2007.04.002; HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533; Isoda K, 2002, CIRC RES, V91, P77, DOI 10.1161/01.RES.0000025268.10302.0C; Kokubo T, 2007, J VASC SURG, V45, p33A, DOI 10.1016/j.jvs.2007.02.069; Liaw L, 1997, ARTERIOSCL THROM VAS, V17, P188, DOI 10.1161/01.ATV.17.1.188; LIAW L, 1995, CIRC RES, V77, P665, DOI 10.1161/01.RES.77.4.665; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Liaw L, 1998, J CLIN INVEST, V101, P1468; Liu QF, 2013, BIOCHEM BIOPH RES CO, V439, P235, DOI 10.1016/j.bbrc.2013.08.051; Liu XY, 2013, MATRIX BIOL, V32, P23, DOI 10.1016/j.matbio.2012.11.014; Lorenzen JM, 2011, CHEST, V139, P1010, DOI 10.1378/chest.10-1146; Meng LK, 2013, J THORAC CARDIOV SUR, V146, P1220, DOI 10.1016/j.jtcvs.2013.01.018; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Myers DL, 2003, ARTERIOSCL THROM VAS, V23, P1021, DOI 10.1161/01.ATV.0000073312.34450.16; Ochoa CD, 2008, AM J RESP CELL MOL, V39, P105, DOI 10.1165/rcmb.2007-0283OC; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; Peng GY, 2017, CYTOTECHNOLOGY, V69, P831, DOI 10.1007/s10616-017-0081-8; Rosenberg M, 2012, EUR J CLIN INVEST, V42, P933, DOI 10.1111/j.1365-2362.2012.02671.x; Saker M, 2016, ARTERIOSCL THROM VAS, V36, P1879, DOI 10.1161/ATVBAHA.116.307839; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Singh M, 2014, LIFE SCI, V118, P1, DOI 10.1016/j.lfs.2014.09.014; Singh M, 2010, J MOL CELL CARDIOL, V48, P538, DOI 10.1016/j.yjmcc.2009.06.015; Srivatsa SS, 1997, CARDIOVASC RES, V36, P408, DOI 10.1016/S0008-6363(97)00184-3; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; Umesh A, 2011, J VASC RES, V48, P525, DOI 10.1159/000329593; WAGENVOORT CA, 1985, HISTOPATHOLOGY, V9, P417, DOI 10.1111/j.1365-2559.1985.tb02825.x; Weissberg P L, 1995, Blood Press Suppl, V2, P68; Xie ZL, 2004, HYPERTENSION, V44, P826, DOI 10.1161/01.HYP.0000148458.03202.48; YUE TL, 1994, EXP CELL RES, V214, P459, DOI 10.1006/excr.1994.1282	40	10	10	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7236	7251		10.1096/fj.201802121RR	http://dx.doi.org/10.1096/fj.201802121RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30893567	Bronze			2022-12-28	WOS:000476114200047
J	Miao, LL; Yang, YS; Liu, Y; Lai, LL; Wang, L; Zhan, YQ; Yin, RH; Yu, M; Li, CY; Yang, XM; Ge, CH				Miao, Lili; Yang, Yongsheng; Liu, Yue; Lai, Lili; Wang, Lei; Zhan, Yiqun; Yin, Ronghua; Yu, Miao; Li, Changyan; Yang, Xiaoming; Ge, Changhui			Glycerol kinase interacts with nuclear receptor NR4A1 and regulates glucose metabolism in the liver	FASEB JOURNAL			English	Article						glucose homeostasis; diabetes; gluconeogenesis; protein-protein interaction	NGFI-B; MEDIATES TRANSACTIVATION; STIMULATED FACTOR; LIPID-METABOLISM; BINDING; GENE; DEFICIENCY; EXPRESSION; NURR1; DOMAIN	Glycerol kinase (Gyk), consisting of 4 isoforms, plays a critical role in metabolism by converting glycerol to glycerol 3-phosphate in an ATP-dependent reaction. Only Gyk isoform b is present in whole cells, but its function in the nucleus remains elusive. Previous studies have shown that nuclear orphan receptor subfamily 4 group A member (NR4A)-1 is an important regulator of hepatic glucose homeostasis and lipid metabolism in adipose tissue. We aimed to elucidate the functional interaction between nuclear Gyk and NR4A1 during hepatic gluconeogenesis in the unfed state and diabetes. We identified nuclear Gyk as a novel corepressor of NR4A1 in the liver; moreover, this recruitment was dependent on the C-terminal ligand-binding domain instead of the N-terminal activation function 1 domain, which interacts with other NR4A1 coregulators. NR4A1 transcriptional activity was inhibited by Gyk via protein-protein interaction but not enzymatic activity. Moreover, Gyk overexpression suppressed NR4A1 ability to regulate the expression of target genes involved in hepatic gluconeogenesis in vitro and in vivo as well as blood glucose regulation, which was observed in both unfed and diabetic mice. These results highlight the moonlighting function of nuclear Gyk, which was found to act as a coregulator of NR4A1, participating in the regulation of hepatic glucose homeostasis in the unfed state and diabetes.-Miao, L., Yang, Y., Liu, Y., Lai, L., Wang, L., Zhan, Y., Yin, R., Yu, M., Li, C., Yang, X., Ge, C. Glycerol kinase interacts with nuclear receptor NR4A1 and regulates glucose metabolism in the liver.	[Miao, Lili; Liu, Yue; Lai, Lili; Ge, Changhui] Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China; [Miao, Lili; Lai, Lili; Ge, Changhui] Anhui Med Univ, Grad Sch, Hefei, Anhui, Peoples R China; [Yang, Yongsheng] China Acad Chinese Med Sci, Inst AcuMoxibust, Beijing, Peoples R China; [Yang, Yongsheng; Wang, Lei; Zhan, Yiqun; Yin, Ronghua; Yu, Miao; Li, Changyan; Yang, Xiaoming] Beijing Inst Life, Natl Ctr Prot Sci, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Wang, Lei] Tianjin Univ, Dept Pharmaceut Engn, Tianjin, Peoples R China	Academy of Military Medical Sciences - China; Anhui Medical University; China Academy of Chinese Medical Sciences; Tianjin University	Ge, CH (corresponding author), Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.; Yang, YS (corresponding author), Beijing Inst Life, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Prote, 33 Sci Pk Rd, Beijing 102206, Peoples R China.	xiaomingyang@sina.com; chge502@163.com		YANG, Yongsheng/0000-0002-7546-1210	Chinese National Natural Science Foundation Project [30971402]; Special Funds for Major State Basic Research of China [2013CB910800]	Chinese National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); Special Funds for Major State Basic Research of China	The authors thank Dr. Huang Ailong (Chongqing University of Medical Sciences, Chongqing, China) for kindly providing materials, and Editage (www.editage.cn) for English language editing. This study was supported by the Chinese National Natural Science Foundation Project (30971402) and the Special Funds for Major State Basic Research of China (2013CB910800). The authors declare no conflicts of interest.	Arai K, 2002, J BIOCHEM, V132, P529, DOI 10.1093/oxfordjournals.jbchem.a003253; Castro DS, 2001, J BIOL CHEM, V276, P43277, DOI 10.1074/jbc.M107013200; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chiefari E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26968-3; Codina A, 2004, J BIOL CHEM, V279, P53338, DOI 10.1074/jbc.M409096200; CRAWFORD PA, 1995, MOL CELL BIOL, V15, P4331; Dipple KM, 2001, HUM GENET, V109, P55, DOI 10.1007/s004390100545; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Glass CK, 2000, GENE DEV, V14, P121; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; GUO WW, 1993, NAT GENET, V4, P367, DOI 10.1038/ng0893-367; Huq AHMM, 1997, HUM MOL GENET, V6, P1803, DOI 10.1093/hmg/6.11.1803; Kanzleiter T, 2010, DIABETOLOGIA, V53, P1174, DOI 10.1007/s00125-010-1703-2; Kurakula K, 2011, J BIOL CHEM, V286, P44336, DOI 10.1074/jbc.M111.308999; Lee DH, 2005, METABOLISM, V54, P1282, DOI 10.1016/j.metabol.2005.04.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLennan NK, 2006, HUM MOL GENET, V15, P405, DOI 10.1093/hmg/ddi457; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Agosto JAM, 2006, MOL GENET METAB, V88, P334, DOI 10.1016/j.ymgme.2006.01.002; McCabe E.R.B., 2001, METABOLIC MOL BASES, P2217; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Ohira RH, 2005, BIOCHEM BIOPH RES CO, V331, P239, DOI 10.1016/j.bbrc.2005.03.143; OKAMOTO K, 1984, BIOCHEM BIOPH RES CO, V121, P940, DOI 10.1016/0006-291X(84)90767-8; OKAMOTO K, 1989, ENDOCRINOLOGY, V124, P675, DOI 10.1210/endo-124-2-675; OSTLUND AK, 1983, BIOCHEM MED METAB B, V30, P231, DOI 10.1016/0006-2944(83)90089-3; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Pols TWH, 2008, BIOCHEM BIOPH RES CO, V366, P910, DOI 10.1016/j.bbrc.2007.12.039; Rahib L, 2007, EUR J HUM GENET, V15, P646, DOI 10.1038/sj.ejhg.5201801; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Sargent CA, 2000, J MED GENET, V37, P434, DOI 10.1136/jmg.37.6.434; Song KH, 2010, BIOCHEM BIOPH RES CO, V392, P63, DOI 10.1016/j.bbrc.2009.12.168; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Sriram G, 2008, MOL GENET METAB, V93, P145, DOI 10.1016/j.ymgme.2007.09.008; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhuo S, 2016, DIABETES, V65, P3276, DOI 10.2337/db16-0166	47	9	12	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6736	6747		10.1096/fj.201800945RR	http://dx.doi.org/10.1096/fj.201800945RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30821173	Bronze			2022-12-28	WOS:000476114200006
J	Tsubosaka, Y; Maehara, T; Imai, D; Nakamura, T; Kobayashi, K; Nagata, N; Fujii, W; Murata, T				Tsubosaka, Yoshiki; Maehara, Toko; Imai, Daiki; Nakamura, Tatsuro; Kobayashi, Koji; Nagata, Nanae; Fujii, Wataru; Murata, Takahisa			Hematopoietic prostaglandin D synthase-derived prostaglandin D-2 ameliorates adjuvant-induced joint inflammation in mice	FASEB JOURNAL			English	Article						vascular permeability; angiogenesis; macrophage; DP receptor	RHEUMATOID-ARTHRITIS; CELLS; HYPERPERMEABILITY; OSTEOARTHRITIS	Although prostaglandins (PGs) are known to be involved in the progression of arthritis, the role of PGD(2) remains unclear. In this study, we evaluated the role of PGD(2) in joint inflammation using genetically modified mice. Injection of complete Freund's adjuvant (CFA) increased the production of PGD(2) and induced paw swelling and cartilage erosion in wild-type (WT) mice. These phenomena were accompanied with an increase in the mRNA levels of TNF-alpha, IL-6, IL-1 beta, and matrix-degrading metalloproteinase-9. Knockdown of hematopoietic PGD synthase (H-PGDS) abolished the PGD(2) production and exacerbated all of the arthritic manifestations in the inflamed paw. Immunostaining revealed that infiltrating macrophages strongly expressed H-PGDS in the CFA-injected paw. Morphologic studies revealed vascular hyperpermeability and angiogenesis in the inflamed WT paw. H-PGDS deficiency was accelerated, whereas daily administration of a PGD(2) receptor D prostanoid (DP) agonist attenuated the CFA-induced hyperpermeability and angiogenesis. We further confirmed that DP deficiency exacerbated, whereas the administration of the DP agonist improved, the CFA-induced arthritic manifestations. The findings demonstrate that H-PGDS-derived PGD(2) ameliorates joint inflammation by attenuating vascular permeability and subsequent angiogenesis and indicates the therapeutic potential of a DP agonist for arthritis.-Tsubosaka, Y., Maehara, T., Imai, D., Nakamura, T., Kobayashi, K., Nagata, N., Fujii, W., Murata, T. Hematopoietic prostaglandin D synthase-derived prostaglandin D-2 ameliorates adjuvant-induced joint inflammation in mice.	[Tsubosaka, Yoshiki; Maehara, Toko; Imai, Daiki; Nakamura, Tatsuro; Kobayashi, Koji; Nagata, Nanae; Murata, Takahisa] Univ Tokyo, Dept Anim Radiol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Fujii, Wataru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Genet, Tokyo, Japan	University of Tokyo; University of Tokyo	Murata, T (corresponding author), Univ Tokyo, Dept Anim Radiol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1 Yayoi, Tokyo 1138657, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Fujii, Wataru/0000-0002-6438-7350; Murata, Takahisa/0000-0002-3328-0796	Research Fellowship for Young Scientists; Japan Society for the Promotion of Science; Novartis Foundation; Hoyu Science Foundation; Nakatomi Foundation	Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Novartis Foundation(Novartis); Hoyu Science Foundation; Nakatomi Foundation	This work was supported by the Research Fellowship for Young Scientists (to Y.T. and T.M.), and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, The Novartis Foundation, Hoyu Science Foundation, and The Nakatomi Foundation (to T.M.). The authors declare no conflicts of interest.	Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Chillingworth NL, 2003, J NEUROSCI METH, V128, P45, DOI 10.1016/S0165-0270(03)00147-X; Fujii W, 2014, BIOCHEM BIOPH RES CO, V445, P791, DOI 10.1016/j.bbrc.2014.01.141; Hennigan Stephanie, 2008, Ther Clin Risk Manag, V4, P767; Honda T, 2006, J EXP MED, V203, P325, DOI 10.1084/jem.20051310; Kobayashi K, 2013, ARTERIOSCL THROM VAS, V33, P565, DOI 10.1161/ATVBAHA.112.300993; Lainer-Carr D, 2007, NAT CLIN PRACT RHEUM, V3, P434, DOI 10.1038/ncprheum0559; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; MIHARA M, 1995, BRIT J RHEUMATOL, V34, P321; Moghaddami M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/329494; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Murata T, 2013, P NATL ACAD SCI USA, V110, P5205, DOI 10.1073/pnas.1218091110; Murata T, 2008, P NATL ACAD SCI USA, V105, P20009, DOI 10.1073/pnas.0805171105; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Prasad R, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-14; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Quinteiro MS, 2014, EUR J PHARMACOL, V740, P58, DOI 10.1016/j.ejphar.2014.07.002; ROONEY M, 1988, ARTHRITIS RHEUM, V31, P956, DOI 10.1002/art.1780310803; Ruiz-Miyazawa KW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32334-0; Sarashina H, 2014, J IMMUNOL, V192, P459, DOI 10.4049/jimmunol.1302080; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Sone H, 2001, BIOCHEM BIOPH RES CO, V281, P562, DOI 10.1006/bbrc.2001.4395; Tanaka K, 2000, J IMMUNOL, V164, P2277, DOI 10.4049/jimmunol.164.5.2277; Toussirot E, 2007, EXPERT OPIN PHARMACO, V8, P2089, DOI 10.1517/14656566.8.13.2089; TRANG LE, 1977, SCAND J RHEUMATOL, V6, P151, DOI 10.3109/03009747709095440; Tsubosaka Y, 2014, J IMMUNOL, V193, P5835, DOI 10.4049/jimmunol.1303478; URADE Y, 1989, J IMMUNOL, V143, P2982; URADE Y, 1990, J BIOL CHEM, V265, P371; Wang MJ, 2015, DISCOV MED, V19, P23	32	8	9	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6829	6837		10.1096/fj.201802153R	http://dx.doi.org/10.1096/fj.201802153R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811953	Bronze			2022-12-28	WOS:000476114200013
J	Wang, W; Hind, T; Lam, BWS; Herr, DR				Wang, Wei; Hind, Tatsuma; Lam, Brenda Wan Shing; Herr, Deron R.			Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells	FASEB JOURNAL			English	Article						EMT; epithelial-mesenchymal transition; MRTF-A; SPHK1; YAP	EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-COUPLED RECEPTOR; MRTF-A; TRANSCRIPTION FACTORS; KINASE 1; SLUG; RHOA; SPHINGOSINE-1-PHOSPHATE; PROLIFERATION; INDUCTION	Epithelial-mesenchymal transition (EMT) is a critical process implicated in the initial stage of cancer metastasis, which is the major cause of tumor recurrence and mortality. Although key transcription factors that regulate EMT, such as snail family transcriptional repressor 2 (SNAI2), are well characterized, the upstream signaling pathways controlling these transcriptional mediators are largely unknown, which limits therapeutic strategies. Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator, generated by sphingosine kinases (SPHK1 and SPHK2), that mainly exerts its effects by binding to the following 5 GPCRs: S1P(1) to S1P(5). S1P signaling has been reported to regulate different aspects of cancer progression including cell proliferation, apoptosis, and migration; nevertheless, its role in cancer metastasis, specifically via EMT, is not established. Here we show that SPHK1 expression correlates significantly with EMT score in breast cancer cell lines, and with SNAI2 in patient-derived breast tumors. Cell-based assays demonstrate that S1P can rapidly up-regulate the expression of SNAI2 in breast cancer cells via the activation of cognate receptors S1P(2) and S1P(3). Knockdown studies suggest that S1P(2) and S1P(3) mediate this effect by activating myocardin-related transcription factor A (MRTF-A) and yes-associated protein (YAP), respectively. Michigan Cancer Foundation 7 cells stably overexpressing S1P(2) or S1P(3) exhibit a more invasive phenotype, when compared to control cells. Taken together, our findings suggest that S1P produced by SPHK1 induces SNAI2 expression via S1P(2)-YAP and S1P(3)-MRTF-A pathways, leading to enhanced cell invasion. Cumulatively, this study reveals a novel mechanism by which S1P activates parallel pathways that regulate the expression of SNAI2, a master regulator of EMT, and provides new insights into druggable therapeutic targets that may limit cancer metastasis. Wang, W., Hind, T., Lam, B. W. S., Herr, D. R. Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.	[Wang, Wei; Hind, Tatsuma; Lam, Brenda Wan Shing; Herr, Deron R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, 16 Med Dr,MD3-04-01W, Singapore 117600, Singapore; [Hind, Tatsuma] Univ British Columbia, Dept Pharmacol, Vancouver, BC, Canada; [Herr, Deron R.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	National University of Singapore; University of British Columbia; California State University System; San Diego State University	Herr, DR (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, 16 Med Dr,MD3-04-01W, Singapore 117600, Singapore.	phcdrh@nus.edu.sg	Herr, Deron/AAB-7380-2020	Herr, Deron/0000-0001-5755-0896	Singapore Ministry of Education [T1-2013 Sep-09]; National University Health System [NUHSRO/2014/085/AF-Partner/01]	Singapore Ministry of Education(Ministry of Education, Singapore); National University Health System	The authors thank Prof. Joan Heller Brown (University of California-San Diego, La Jolla, CA, USA) for the SRE.L-luciferase reporter construct and Dr. Xiang Ping (National University of Singapore) for expert technical assistance. This work was supported by the Singapore Ministry of Education (T1-2013 Sep-09, to D.R.H.) and the National University Health System (NUHSRO/2014/085/AF-Partner/01 to D.R.H.). The authors declare no conflicts of interest.	Bao YH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102109; Baygi ME, 2010, TUMOR BIOL, V31, P297, DOI 10.1007/s13277-010-0037-5; Britten CD, 2017, CLIN CANCER RES, V23, P4642, DOI 10.1158/1078-0432.CCR-16-2363; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Castaldi A, 2016, CELL SIGNAL, V28, P871, DOI 10.1016/j.cellsig.2016.04.006; Chew WS, 2016, PHARMACOL RES, V113, P521, DOI 10.1016/j.phrs.2016.09.025; Dang CV, 2017, NAT REV CANCER, V17, P502, DOI 10.1038/nrc.2017.36; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; El Buri Ashref, 2018, Oncotarget, V9, P29453, DOI 10.18632/oncotarget.25658; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferrari-Amorotti G, 2014, NEOPLASIA, V16, P1047, DOI 10.1016/j.neo.2014.10.006; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Ha JH, 2016, ONCOTARGET, V7, P37664, DOI 10.18632/oncotarget.9224; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Harris GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035129; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Herr DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24541; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Ishizawa S, 2014, CLIN EXP NEPHROL, V18, P844, DOI 10.1007/s10157-014-0933-x; Jo EJ, 2012, ACS CHEM BIOL, V7, P1975, DOI 10.1021/cb300392z; Lai MKP, 2016, NEUROMOL MED, V18, P396, DOI 10.1007/s12017-016-8424-8; LaMontagne K, 2006, CANCER RES, V66, P221, DOI 10.1158/0008-5472.CAN-05-2001; Liu H, 2017, AUTOPHAGY, V13, P900, DOI 10.1080/15548627.2017.1291479; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Newton J, 2015, EXP CELL RES, V333, P195, DOI 10.1016/j.yexcr.2015.02.025; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Patmanathan SN, 2017, CELL SIGNAL, V34, P66, DOI 10.1016/j.cellsig.2017.03.002; Patmanathan SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep25650; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pendurthi UR, 2005, CANCER RES, V65, P9705, DOI 10.1158/0008-5472.CAN-05-0982; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ponnusamy S, 2012, EMBO MOL MED, V4, P761, DOI 10.1002/emmm.201200244; Pyne Nigel J., 2018, Advances in Biological Regulation, V68, P97, DOI 10.1016/j.jbior.2017.09.006; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rao A, 2017, BBA-MOL CELL RES, V1864, P1318, DOI 10.1016/j.bbamcr.2017.05.001; Satsu H, 2013, BIOORGAN MED CHEM, V21, P5373, DOI 10.1016/j.bmc.2013.06.012; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thirunavukkarasan M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186334; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266; Wang WL, 2015, ONCOGENE, V34, P1116, DOI 10.1038/onc.2014.58; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xu CY, 2017, INT J MOL MED, V39, P1277, DOI 10.3892/ijmm.2017.2921; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Young N, 2007, EXP CELL RES, V313, P1615, DOI 10.1016/j.yexcr.2007.02.009; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu OM, 2016, MOL CELL BIOL, V36, P39, DOI 10.1128/MCB.00772-15; Zeng Y, 2016, ONCOTARGET, V7, P63324, DOI 10.18632/oncotarget.11450; Zhang H, 2014, J BIOL CHEM, V289, P18681, DOI 10.1074/jbc.M114.554584; Zhao X, 2014, J MOL CELL CARDIOL, V75, P152, DOI 10.1016/j.yjmcc.2014.07.017	65	21	22	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7180	7191		10.1096/fj.201801635R	http://dx.doi.org/10.1096/fj.201801635R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30844311	Bronze			2022-12-28	WOS:000476114200042
J	Calvino-Sampedro, C; Gomez-Tourino, I; Cordero, OJ; Reche, PA; Gomez-Perosanz, M; Sanchez-Trincado, JL; Rodriguez, MA; Sueiro, AM; Vinuela, JE; Calvino, RV				Calvino-Sampedro, Cristina; Gomez-Tourino, Iria; Cordero, Oscar J.; Reche, Pedro A.; Gomez-Perosanz, Marta; Luis Sanchez-Trincado, Jose; Angel Rodriguez, Miguel; Sueiro, Aurelio M.; Vinuela, Juan E.; Varela Calvino, Ruben			Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-are targets of the autoimmune response in type 1 diabetes	FASEB JOURNAL			English	Article						cytotoxic lymphocytes; autoantigen; S100 peptide epitopes; immunotherapy; peri-insular Schwann cells	T-CELL TOLERANCE; SCHWANN-CELLS; RECENT-ONSET; PEPTIDE; IDENTIFICATION; ANTIGEN; VACCINATION; MOLECULES; AFFINITY; BINDING	Type 1 diabetes (T1D) results from the destruction of pancreatic -cells by the immune system, and CD8(+) T lymphocytes are critical actors in this autoimmune response. Pancreatic islets are surrounded by a mesh of nervous cells, the peri-insular Schwann cells, which are also targeted by autoreactive T lymphocytes and express specific antigens, such as the neurotrophic factor S100-. Previous work has shown increased proliferative responses to whole S100- in both human T1D patients and the nonobese diabetic (NOD) mouse model. We describe for the first time naturally processed and presented epitopes (NPPEs) presented by class I human leukocyte antigen-A*02:01 (A2.1) molecules derived from S100-. These NPPEs triggered IFN- responses more frequently in both newly diagnosed and long-term T1D patients compared with healthy donors. Furthermore, the same NPPEs are recognized during the autoimmune response leading to diabetes in A2.1-transgenic NOD mice as early as 4 wk of age. Interestingly, when these NPPEs are used to prevent diabetes in this animal model, an acceleration of the disease is observed together with an exacerbation in insulitis and an increase in S100--specific cytotoxicity in vaccinated animals. Whether these can be used in diabetes prevention needs to be carefully evaluated in animal models before use in future clinical assays.Calvino-Sampedro, C., Gomez-Tourino, I., Cordero, O. J., Reche, P. A., Gomez-Perosanz, M., Sanchez-Trincado, J. L., Rodriguez, M. a., Sueiro, A. M., Vinuela, J. E., Calvino, R. V. Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100- are targets of the autoimmune response in type 1 diabetes.	[Calvino-Sampedro, Cristina; Gomez-Tourino, Iria; Cordero, Oscar J.; Varela Calvino, Ruben] Univ Santiago Compostela, Dept Bioquim & Biol Mol, Fac Farm, Campus Vida S-N, Santiago De Compostela 15782, La Coruna, Spain; [Angel Rodriguez, Miguel] Univ Santiago Compostela, Dept Biol Func, Ctr Invest Bioloxia CIBUS, Santiago De Compostela, Spain; [Reche, Pedro A.; Gomez-Perosanz, Marta; Luis Sanchez-Trincado, Jose] Univ Complutense Madrid, Dept Inmunol, Fac Med, Madrid, Spain; [Sueiro, Aurelio M.] Complejo Hosp Univ Santiago Compostela CHUS, Hosp Clin Univ, Serv Endocrinol & Nutric, Santiago De Compostela, Spain; [Vinuela, Juan E.] Complejo Hosp Univ Santiago Compostela CHUS, Hosp Clin Univ, Serv Inmunol, Santiago De Compostela, Spain; [Gomez-Tourino, Iria] Univ Santiago Compostela, CIMUS Res Ctr, Dept Pharmacol Pharm & Pharmaceut Technol, BioFarma Res Grp, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complutense University of Madrid; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Calvino, RV (corresponding author), Univ Santiago Compostela, Dept Bioquim & Biol Mol, Fac Farm, Campus Vida S-N, Santiago De Compostela 15782, La Coruna, Spain.	ruben.varela@usc.es	Gomez-Tourino, Iria/AAA-9948-2019; Sampedro Torres Quevedo, Cristina/GVW-1493-2022; Varela-Calvino, Ruben/ABF-9910-2020; Reche, Pedro A/B-1881-2013; Calviño Sampedro, Cristina/AAC-3301-2021; Sanchez-Trincado, Jose Luis/AAH-5891-2020	Gomez-Tourino, Iria/0000-0001-6594-6110; Varela-Calvino, Ruben/0000-0002-4978-661X; Reche, Pedro A/0000-0003-3966-5838; Calviño Sampedro, Cristina/0000-0002-5121-0265; Sanchez-Trincado, Jose Luis/0000-0002-9150-1315; Gomez-Perosanz, Marta/0000-0002-2411-4358; Vinuela, Juan Evaristo/0000-0001-7778-901X	Ministerio de Economia y Competitividad [BIO2014-53091-C3-3-R]; Maria Barbeito predoctoral fellowship (Xunta de Galicia, La Coruna, Spain); Deputacion da Coruna grant	Ministerio de Economia y Competitividad(Spanish Government); Maria Barbeito predoctoral fellowship (Xunta de Galicia, La Coruna, Spain); Deputacion da Coruna grant	The authors thank Dr. Sefina Arif (King's College London, London, United Kingdom) for critically reviewing the manuscript. This work was funded by the Ministerio de Economia y Competitividad (Grant BIO2014-53091-C3-3-R to R.V.C.). During this work, I.G.-T. was supported by a Maria Barbeito predoctoral fellowship (Xunta de Galicia, La Coruna, Spain). During this work, C.C.-S. was supported by a Deputacion da Coruna grant (2012-2013 and 2016-2017). The authors declare no conflicts of interest.	AICHELE P, 1994, P NATL ACAD SCI USA, V91, P444, DOI 10.1073/pnas.91.2.444; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Banwell B, 2008, ANN NEUROL, V63, P98, DOI 10.1002/ana.21244; Bergman ML, 2017, J EXP MED, V214, P2153, DOI 10.1084/jem.20160471; Bunce Mike, 2003, Methods Mol Biol, V210, P143; Burbelo PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045216; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; Diez-Rivero CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-479; Gomez-Tourino I, 2015, CLIN EXP IMMUNOL, V180, P207, DOI 10.1111/cei.12572; Gomez-Tourino I, 2010, DIABETIC MED, V27, P247, DOI 10.1111/j.1464-5491.2009.02911.x; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Leete P, 2016, DIABETES, V65, P1362, DOI 10.2337/db15-1615; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Liu E, 2002, ANN NY ACAD SCI, V958, P224; LIU GY, 1995, INT IMMUNOL, V7, P1255, DOI 10.1093/intimm/7.8.1255; Marron MP, 2002, P NATL ACAD SCI USA, V99, P13753, DOI 10.1073/pnas.212221199; Morran MP, 2015, MOL ASPECTS MED, V42, P42, DOI 10.1016/j.mam.2014.12.004; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Noble JA, 2010, DIABETES, V59, P2972, DOI 10.2337/db10-0699; Nussbaum AK, 2001, IMMUNOGENETICS, V53, P87, DOI 10.1007/s002510100300; PARKER KC, 1994, J IMMUNOL, V152, P163; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Roep BO, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007781; Roep BO, 2011, CURR OPIN IMMUNOL, V23, P746, DOI 10.1016/j.coi.2011.10.001; Serre L, 2015, EUR J IMMUNOL, V45, P1946, DOI 10.1002/eji.201445290; SETTE A, 1994, J IMMUNOL, V153, P5586; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Standifer NE, 2006, DIABETES, V55, P3061, DOI 10.2337/db06-0066; Tang SC, 2013, DIABETOLOGIA, V56, P2424, DOI 10.1007/s00125-013-2977-y; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Tsui H, 2008, DIABETES, V57, P918, DOI 10.2337/db07-0226; Varela-Calvino R, 2004, J VIROL, V78, P13399, DOI 10.1128/JVI.78.24.13399-13408.2004; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WEKERLE H, 1986, EUR J IMMUNOL, V16, P1551, DOI 10.1002/eji.1830161214; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	51	3	3	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6390	6401		10.1096/fj.201802270R	http://dx.doi.org/10.1096/fj.201802270R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817223	Green Published, hybrid			2022-12-28	WOS:000466932600046
J	Partearroyo, T; Murillo-Cuesta, S; Vallecillo, N; Bermudez-Munoz, JM; Rodriguez-de la Rosa, L; Mandruzzato, G; Celaya, AM; Zeisel, SH; Pajares, MA; Varela-Moreiras, G; Varela-Nieto, I				Partearroyo, Teresa; Murillo-Cuesta, Silvia; Vallecillo, Nestor; Bermudez-Munoz, Jose M.; Rodriguez-de la Rosa, Lourdes; Mandruzzato, Giacomo; Celaya, Adelaida M.; Zeisel, Steven H.; Pajares, Maria A.; Varela-Moreiras, Gregorio; Varela-Nieto, Isabel			Betaine-homocysteine S-methyltransferase deficiency causes increased susceptibility to noise-induced hearing loss associated with plasma hyperhomocysteinemia	FASEB JOURNAL			English	Article						ARHL; cochlear injury; methionine cycle; NIHL	FOLIC-ACID; OXIDATIVE STRESS; RAT-LIVER; EXPRESSION; FOLATE; GLUTATHIONE; RISK; MICE; VITAMIN-B-12; INHIBITION	Betaine-homocysteine S-methyltransferases (BHMTs) are methionine cycle enzymes that remethylate homocysteine; hence, their malfunction leads to hyperhomocysteinemia. Epidemiologic and experimental studies have revealed a correlation between hyperhomocysteinemia and hearing loss. Here, we have studied the expression of methionine cycle genes in the mouse cochlea and the impact of knocking out the Bhmt gene in the auditory receptor. We evaluated age-related changes in mouse hearing by recording auditory brainstem responses before and following exposure to noise. Also, we measured cochlear cytoarchitecture, gene expression by RNA-arrays and quantitative RT-PCR, and metabolite levels in liver and plasma by HPLC. Our results indicate that there is an age-dependent strain-specific expression of methionine cycle genes in the mouse cochlea and a further regulation during the response to noise damage. Loss of Bhmt did not cause an evident impact in the hearing acuity of young mice, but it produced higher threshold shifts and poorer recovery following noise challenge. Hearing loss was associated with increased cochlear injury, outer hair cell loss, altered expression of cochlear methionine cycle genes, and hyperhomocysteinemia. Our results suggest that BHMT plays a central role in the homeostasis of cochlear methionine metabolism and that Bhmt2 up-regulation could carry out a compensatory role in cochlear protection against noise injury in the absence of BHMT.Partearroyo, T., Murillo-Cuesta, S., Vallecillo, N., Bermudez-Munoz, J. M., Rodriguez-de la Rosa, L., Mandruzzato, G., Celaya, A. M., Zeisel, S. H., Pajares, M. A., Varela-Moreiras, G., Varela-Nieto, I. Betaine-homocysteine S-methyltransferase deficiency causes increased susceptibility to noise-induced hearing loss associated with plasma hyperhomocysteinemia.	[Partearroyo, Teresa; Varela-Moreiras, Gregorio] Univ Ctr Estudios Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Salud, Madrid, Spain; [Partearroyo, Teresa; Murillo-Cuesta, Silvia; Vallecillo, Nestor; Bermudez-Munoz, Jose M.; Rodriguez-de la Rosa, Lourdes; Celaya, Adelaida M.; Pajares, Maria A.; Varela-Moreiras, Gregorio; Varela-Nieto, Isabel] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Murillo-Cuesta, Silvia; Bermudez-Munoz, Jose M.; Rodriguez-de la Rosa, Lourdes; Celaya, Adelaida M.; Pajares, Maria A.; Varela-Nieto, Isabel] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Murillo-Cuesta, Silvia; Rodriguez-de la Rosa, Lourdes; Varela-Nieto, Isabel] Inst Invest Sanitaria La Paz IdiPAZ, Madrid, Spain; [Mandruzzato, Giacomo] MED EL, Res & Dev, Innsbruck, Austria; [Zeisel, Steven H.] Univ North Carolina Chapel Hill, Nutr Res Inst, Kannapolis, NC USA; [Pajares, Maria A.] CSIC, Ctr Invest Biol, Madrid, Spain	San Pablo CEU University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of North Carolina; University of North Carolina Chapel Hill; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Murillo-Cuesta, S (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.	smurillo@iib.uam.es	de la Rosa, Lourdes Rodríguez/K-3037-2017; Partearroyo, Teresa/J-7322-2017; Murillo-Cuesta, Silvia/C-3557-2016; Varela-Moreiras, Gregorio/AAA-7153-2019; Celaya, Adelaida M./L-1577-2018; Varela-Nieto, Isabel/G-5289-2015; Pajares, Maria Angeles/I-5952-2012; Bermudez-Munoz, Jose M/K-5565-2018	de la Rosa, Lourdes Rodríguez/0000-0002-7518-6036; Partearroyo, Teresa/0000-0002-4401-1233; Murillo-Cuesta, Silvia/0000-0002-8706-4327; Varela-Moreiras, Gregorio/0000-0001-5158-4999; Celaya, Adelaida M./0000-0002-0757-6163; Varela-Nieto, Isabel/0000-0003-3077-0500; Pajares, Maria Angeles/0000-0002-4714-9051; Bermudez-Munoz, Jose M/0000-0002-6034-9285	Spanish Ministerio de Economia y Competitividad (MINECO)/FEDER [SAF2017-86107-R]; U.S. National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases [DK056350]; CEU-Banco Santander precompetitive project [MUSPB047]; CEU-Banco Santander consolidation project [MBS18C12]; Puleva BioFoods; TARGEAR (FP7 PEOPLE 2013) [IAPP-612261]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	Spanish Ministerio de Economia y Competitividad (MINECO)/FEDER; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CEU-Banco Santander precompetitive project; CEU-Banco Santander consolidation project; Puleva BioFoods; TARGEAR (FP7 PEOPLE 2013); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Tania Jareno (Centro de Investigacion Biomedica en Red de Enfermedades Raras, CIBERER) for technical support and colleagues at the Neurobiology of Hearing group for sharing data and helpful discussions. The authors thank the Non-invasive Neurofunctional Evaluation and the Genomics facilities [Instituto de Investigaciones Biomedicas Alberto Sols (IIBM), CSIC-UAM] and Histology [Centro Nacional de Biotecnologia (CNB), CSIC] for the technical support provided. This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO)/FEDER SAF2017-86107-R to I.V.-N., U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (Grant DK056350 to S.H.Z.), CEU-Banco Santander precompetitive project (MUSPB047) and CEU-Banco Santander consolidation project (MBS18C12) to T.P., and Puleva BioFoods (to I.V.-N., G.V.-M., and M.A.P.). G.M. was supported by TARGEAR (FP7 PEOPLE 2013 IAPP-612261). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Attias J, 2012, AUDIOL NEURO-OTOL, V17, P309, DOI 10.1159/000339356; Bowl MR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00595-4; Cadoni G, 2004, ACTA OTO-LARYNGOL, V124, P608, DOI 10.1080/00016480410016216; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Rodriguez RD, 2015, CELL MOL LIFE SCI, V72, P3983, DOI 10.1007/s00018-015-1919-x; Durga J, 2007, ANN INTERN MED, V146, P1, DOI 10.7326/0003-4819-146-1-200701020-00003; Emmett SD, 2014, MED HYPOTHESES, V82, P6, DOI 10.1016/j.mehy.2013.09.028; FELL D, 1985, J CHROMATOGR, V345, P150, DOI 10.1016/0378-4347(85)80146-8; Feng QP, 2011, MOL GENET METAB, V102, P126, DOI 10.1016/j.ymgme.2010.10.010; Garcia-Alcantara F, 2018, HEARING RES, V358, P10, DOI 10.1016/j.heares.2017.12.004; Givvimani S, 2012, AM J PHYSIOL-GASTR L, V303, pG281, DOI 10.1152/ajpgi.00423.2011; Gok U, 2004, AURIS NASUS LARYNX, V31, P19, DOI 10.1016/j.anl.2003.09.001; Gonzalez B, 2003, BIOCHEM J, V370, P945, DOI 10.1042/BJ20021510; Gopinath B, 2010, AM J CLIN NUTR, V92, P416, DOI 10.3945/ajcn.2010.29370; Gross J, 2005, HEARING RES, V204, P183, DOI 10.1016/j.heares.2005.02.001; Houston DK, 1999, AM J CLIN NUTR, V69, P564; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Iacobazzi V, 2013, MOL GENET METAB, V110, P25, DOI 10.1016/j.ymgme.2013.07.012; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; JENCKS DA, 1987, J BIOL CHEM, V262, P2485; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; JOHNSSON LG, 1972, ANN OTO RHINOL LARYN, V81, P364, DOI 10.1177/000348947208100307; Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118; Kamath AF, 2006, BLOOD, V107, P591, DOI 10.1182/blood-2005-06-2506; Kane KL, 2012, HEARING RES, V283, P80, DOI 10.1016/j.heares.2011.11.007; Karli R, 2013, ACTA OTORHINOLARYNGO, V33, P243; Koller A, 2018, CURR PHARM DESIGN, V24, P2911, DOI 10.2174/1381612824666180625125450; Kundu S, 2012, HEARING RES, V284, P42, DOI 10.1016/j.heares.2011.12.006; Lai D, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0164164; Lasisi AO, 2010, OTOLARYNG HEAD NECK, V143, P826, DOI 10.1016/j.otohns.2010.08.031; Lehotsky J, 2015, CELL MOL NEUROBIOL, V35, P7, DOI 10.1007/s10571-014-0112-3; Li F, 2008, MOL GENET METAB, V94, P326, DOI 10.1016/j.ymgme.2008.03.013; Liberman MC, 2014, J NEUROSCI, V34, P4599, DOI 10.1523/JNEUROSCI.4923-13.2014; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Liu HH, 2010, GENOME RES, V20, P28, DOI 10.1101/gr.097212.109; Liu ZG, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0140839, 10.1371/journal.pone.0128274]; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; MAKISHIMA K, 1978, OTOLARYNG HEAD NECK, V86, P322, DOI 10.1177/019459987808600225; Martinez-Vega R, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00209; Martinez-Vega R, 2015, FASEB J, V29, P418, DOI 10.1096/fj.14-259283; Murillo-Cuesta S, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/fnagi.2015.00032, 10.5589/fnagi.2015.00032]; Ou XP, 2007, BIOCHEM J, V401, P87, DOI 10.1042/BJ20061119; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Pan HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06600-6; Partearroyo T, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00107; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Perna AF, 2016, NEPHROL DIAL TRANSPL, V31, P860, DOI 10.1093/ndt/gfv409; ROSEN S, 1965, B NEW YORK ACAD MED, V41, P1052; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Sanchez JT, 2015, NEUROSCIENCE, V285, P248, DOI 10.1016/j.neuroscience.2014.11.027; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Savoy-Burke G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108160; Schalinske KL, 2012, ADV NUTR, V3, P755, DOI 10.3945/an.112.002758; Steevens AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04315-2; Sudduth TL, 2017, NEUROSCIENCE, V341, P42, DOI 10.1016/j.neuroscience.2016.11.024; Teng YW, 2012, J NUTR, V142, P1964, DOI 10.3945/jn.112.166835; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Wang J, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00043; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wu XY, 2017, NOISE HEALTH, V19, P245, DOI 10.4103/nah.NAH_56_16; Yamasoba T, 1998, BRAIN RES, V804, P72, DOI 10.1016/S0006-8993(98)00660-X; Yamasoba T, 1998, BRAIN RES, V784, P82, DOI 10.1016/S0006-8993(97)01156-6; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	64	5	7	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5942	5956		10.1096/fj.201801533R	http://dx.doi.org/10.1096/fj.201801533R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753104	Green Published, Green Submitted			2022-12-28	WOS:000466932600012
J	Timpano, S; Guild, BD; Specker, EJ; Melanson, G; Medeiros, PJ; Sproul, SLJ; Uniacke, J				Timpano, Sara; Guild, Brianna D.; Specker, Erin J.; Melanson, Gaelan; Medeiros, Philip J.; Sproul, Shannon L. J.; Uniacke, James			Physioxic human cell culture improves viability, metabolism, and mitochondrial morphology while reducing DNA damage	FASEB JOURNAL			English	Article						physioxia; oxygen; oxidative stress	OXIDATIVE STRESS; OXYGEN CONCENTRATION; LIFE-SPAN; HYPOXIA; TRANSLATION; LYMPHOCYTES; EXPRESSION; PROMOTER; PROTEIN	Multicellular organisms balance oxygen delivery and toxicity by having oxygen pass through several barriers before cellular delivery. In human cell culture, these physiologic barriers are removed, exposing cells to higher oxygen levels. Human cells cultured in ambient air may appear normal, but this is difficult to assess without a comparison at physiologic oxygen. Here, we examined the effects of culturing human cells throughout the spectrum of oxygen availability on oxidative damage to macromolecules, viability, proliferation, the antioxidant and DNA damage responses, metabolism, and mitochondrial fusion and morphology. We surveyed 4 human cell lines cultured for 3 d at 7 oxygen conditions between 1 and 21% O-2. We show that oxygen levels and cellular benefit are not inversely proportional, but the benefit peaks within the physioxic range. Normoxic cells are in a perpetual state of responding to damaged macromolecules and mitochondrial networks relative to physioxic cells, which could compromise an investigation. These data contribute to the concept of an optimal oxygen availability for cell culture in the physioxic range where the oxygen is not too high to reduce oxidative damage, and not too low for efficient oxidative metabolism, but just right: the Goldiloxygen zone.	[Timpano, Sara; Guild, Brianna D.; Specker, Erin J.; Melanson, Gaelan; Medeiros, Philip J.; Sproul, Shannon L. J.; Uniacke, James] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON, Canada; [Uniacke, James] Univ British Columbia, Vancouver, BC, Canada	University of Guelph; University of British Columbia	Uniacke, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON, Canada.	juniacke@uoguelph.ca			Natural Sciences and Engineering Council of Canada [04807]; Natural Sciences and Engineering Council of Canada Graduate Scholarship	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Council of Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank Katrina Sajewycz, Maria Berliant, David Dunbar, and Ahmed Al Khalil (all of the University of Guelph) for quantification of micrographs. The authors thank James Kirkland, Scott Ryan, and Michaela Strueder-Kypke (all of the University of Guelph) for technical advice. This work was funded by Natural Sciences and Engineering Council of Canada Grant 04807 to J.U. S.T. was supported by a Natural Sciences and Engineering Council of Canada Graduate Scholarship. The authors declare no conflicts of interest.	Abu-Amero KK, 2005, ARCH PATHOL LAB MED, V129, P1295; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Antoniali G, 2014, ANTIOXID REDOX SIGN, V20, P621, DOI 10.1089/ars.2013.5491; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; COOPER PD, 1958, NATURE, V182, P1508, DOI 10.1038/1821508b0; Gonzalez-Pinzon R, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001965; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Ho JJD, 2016, CELL REP, V14, P1293, DOI 10.1016/j.celrep.2016.01.036; Hsia CCW, 2013, COMPR PHYSIOL, V3, P849, DOI 10.1002/cphy.c120003; Iordanov MS, 2000, CANCER RES, V60, P1983; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Keeley TP, 2019, PHYSIOL REV, V99, P161, DOI 10.1152/physrev.00041.2017; Keeley TP, 2017, FASEB J, V31, P5172, DOI 10.1096/fj.201700211R; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Leone A, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2597581; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Liu ZW, 2013, CANCER BIOL THER, V14, P428, DOI 10.4161/cbt.23786; Mahalingaiah PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087371; Marzony ET, 2016, EXP LUNG RES, V42, P275, DOI 10.1080/01902148.2016.1205336; Marzony ET, 2016, EXP LUNG RES, V42, P217, DOI 10.1080/01902148.2016.1194501; McCarron JG, 2013, J VASC RES, V50, P357, DOI 10.1159/000353883; Miyazono Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18582-6; Morelra PI, 2008, FREE RADICAL BIO MED, V44, P1493, DOI 10.1016/j.freeradbiomed.2008.01.002; Mukherjee A, 2015, NEOPLASIA, V17, P723, DOI 10.1016/j.neo.2015.09.003; Newby D, 2005, PLACENTA, V26, P353, DOI 10.1016/j.placenta.2004.07.002; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pastukh V, 2015, AM J PHYSIOL-LUNG C, V309, pL1367, DOI 10.1152/ajplung.00236.2015; Rafelski SM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-71; Ricciardi A, 2014, ANN MICROBIOL, V64, P1861, DOI 10.1007/s13213-014-0819-x; RICHTER A, 1972, J NATL CANCER I, V49, P1705, DOI 10.1093/jnci/49.6.1705; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Timpano S, 2016, J BIOL CHEM, V291, P10772, DOI 10.1074/jbc.M116.717363; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Zhou XL, 2016, CELL SIGNAL, V28, P1163, DOI 10.1016/j.cellsig.2016.05.021	44	9	9	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5716	5728		10.1096/fj.201802279R	http://dx.doi.org/10.1096/fj.201802279R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30649960				2022-12-28	WOS:000462888500086
J	Yam, KY; Schipper, L; Reemst, K; Ruigrok, SR; Abbink, MR; Hoeijmakers, L; Naninck, EFG; Zarekiani, P; Oosting, A; Van der Beek, EM; Lucassen, PJ; Korosi, A				Yam, Kit-Yi; Schipper, Lidewij; Reemst, Kitty; Ruigrok, Silvie R.; Abbink, Maralinde R.; Hoeijmakers, Lianne; Naninck, Eva F. G.; Zarekiani, Parand; Oosting, Annemarie; Van der Beek, Eline M.; Lucassen, Paul J.; Korosi, Aniko			Increasing availability of omega-3 fatty acid in the early-life diet prevents the early-life stress-induced cognitive impairments without affecting metabolic alterations	FASEB JOURNAL			English	Article						neurogenesis; cognition; metabolism; long-chain polyunsaturated fatty acids; microglia	POLYUNSATURATED FATTY-ACIDS; ALPHA-LINOLENIC ACID; N-3 PUFAS DEFICIENCY; INSULIN-RESISTANCE; HIPPOCAMPAL NEUROGENESIS; BRAIN-DEVELOPMENT; LASTINGLY ALTERS; ADIPOSE-TISSUE; MOUSE MODEL; LACTATION	Exposure to early-life stress (ES) is associated with cognitive and metabolic deficits in adulthood. The role of early nutrition in programming these long-term effects is largely unknown. We focused on essential omega-3 and omega-6 long-chain polyunsaturated fatty acids (LCPUFA) and investigated whether ES affects central and peripheral FA profiles, as well as if and how an early diet with increased availability of omega-3 LCPUFA (via lowering omega-6/omega-3 ratio) protects against ES-induced impairments. ES exposure [limited nesting and bedding paradigm from postnatal day (P)2 to P9] altered central and peripheral FA profiles in mice. An early diet with low omega-6/omega-3 ratio from P2 to P42 notably prevented the ES-induced cognitive impairments, and the alterations in hippocampal newborn cell survival and in CD68(+) microglia, without affecting the ES-induced metabolic alterations. Other markers for hippocampal plasticity, apoptosis, and maternal care were unaffected by ES or diet. Our findings highlight the importance of early dietary lipid quality for later cognition in ES-exposed populations.	[Yam, Kit-Yi; Reemst, Kitty; Ruigrok, Silvie R.; Abbink, Maralinde R.; Hoeijmakers, Lianne; Naninck, Eva F. G.; Zarekiani, Parand; Lucassen, Paul J.; Korosi, Aniko] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Schipper, Lidewij; Oosting, Annemarie; Van der Beek, Eline M.] Danone Nutr Res, Utrecht, Netherlands; [Van der Beek, Eline M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands	University of Amsterdam; Danone Nutricia; University of Groningen	Korosi, A (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	a.korosi@uva.nl	Lucassen, Paul/ABA-3113-2020	Lucassen, Paul/0000-0001-9708-9133; Yam, Kit-Yi/0000-0002-9181-5605; Zarekiani, Parand/0000-0001-7760-7247; Korosi, Aniko/0000-0001-9701-3331	JPI CogniPlast; Nederlands Organisatie voor Wetenschappelijk Onderzoek (NWO)-Meervoud; Alzheimer Nederland; Danone Nutricia Research; NWO Food, Cognition, and Brain Grant	JPI CogniPlast; Nederlands Organisatie voor Wetenschappelijk Onderzoek (NWO)-Meervoud(Netherlands Organization for Scientific Research (NWO)); Alzheimer Nederland; Danone Nutricia Research(Danone Nutricia); NWO Food, Cognition, and Brain Grant	A.K. is supported by JPI CogniPlast, Nederlands Organisatie voor Wetenschappelijk Onderzoek (NWO)-Meervoud, and the NWO Food, Cognition, and Brain Grant. P.J.L. is supported by Alzheimer Nederland. This work received cofunding from Danone Nutricia Research, employer of L.S., A.O., and E.M.V.D.B. The authors declare no conflicts of interest.	Abbink MR, 2017, HIPPOCAMPUS, V27, P839, DOI 10.1002/hipo.22745; Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Aizawa F, 2016, BIOL PHARM BULL, V39, P1100, DOI 10.1248/bpb.b15-01037; Bernardi JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062031; Bertrand PC, 2006, J NUTR, V136, P1570, DOI 10.1093/jn/136.6.1570; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brenna JT, 2011, MATERN CHILD NUTR, V7, P59, DOI 10.1111/j.1740-8709.2011.00301.x; Carlson SE, 1999, LIPIDS, V34, P171, DOI 10.1007/s11745-999-0351-2; Chistiakov DA, 2017, LAB INVEST, V97, P4, DOI 10.1038/labinvest.2016.116; Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Clarke G, 2009, BEHAV BRAIN RES, V205, P319, DOI 10.1016/j.bbr.2009.07.008; Dalli J, 2018, CURR OPIN IMMUNOL, V50, P48, DOI 10.1016/j.coi.2017.10.007; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Delarue J, 2004, REPROD NUTR DEV, V44, P289, DOI 10.1051/rnd:2004033; Delpech JC, 2015, NEUROPSYCHOPHARMACOL, V40, P2774, DOI 10.1038/npp.2015.127; Diniz BS, 2012, J PSYCHIATR RES, V46, P1081, DOI 10.1016/j.jpsychires.2012.04.028; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; El-Badry AM, 2007, J HEPATOL, V47, P718, DOI 10.1016/j.jhep.2007.08.005; Fan CN, 2016, NUTR RES, V36, P1013, DOI 10.1016/j.nutres.2016.06.005; Farr OM, 2015, METABOLISM, V64, P114, DOI 10.1016/j.metabol.2014.07.004; Ferreira CF, 2013, PHARMACOL BIOCHEM BE, V107, P11, DOI 10.1016/j.pbb.2013.03.006; Gibson RA, 2011, MATERN CHILD NUTR, V7, P17, DOI 10.1111/j.1740-8709.2011.00299.x; Green P, 1998, J NEUROSCI RES, V52, P129, DOI 10.1002/(SICI)1097-4547(19980415)52:2<129::AID-JNR1>3.0.CO;2-C; Guilloux JP, 2011, J NEUROSCI METH, V197, P21, DOI 10.1016/j.jneumeth.2011.01.019; Guo M, 2013, INT J NEUROPSYCHOPH, V16, P857, DOI 10.1017/S1461145712000703; Harauma A, 2011, LIPIDS, V46, P409, DOI 10.1007/s11745-010-3523-z; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Hoeijmakers L, 2017, BRAIN BEHAV IMMUN, V63, P160, DOI 10.1016/j.bbi.2016.12.023; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Janssen CIF, 2015, J NUTR BIOCHEM, V26, P24, DOI 10.1016/j.jnutbio.2014.08.002; Jen KLC, 2009, PHYSIOL BEHAV, V98, P17, DOI 10.1016/j.physbeh.2009.03.031; Joffre C, 2014, PROSTAG LEUKOTR ESS, V91, P1, DOI 10.1016/j.plefa.2014.05.001; Jumpsen J, 1997, J NUTR, V127, P724, DOI 10.1093/jn/127.5.724; Korosi A, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.027.2009; Korotkova M, 2001, J LIPID RES, V42, P359; Lajud N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00003; Larrieu T, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.77; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; Loi M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00013; Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002; Lucassen PJ, 2013, TRENDS NEUROSCI, V36, P621, DOI 10.1016/j.tins.2013.08.002; Madore C, 2014, BRAIN BEHAV IMMUN, V41, P22, DOI 10.1016/j.bbi.2014.03.021; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Mathieu G, 2008, PROSTAG LEUKOTR ESS, V78, P391, DOI 10.1016/j.plefa.2008.05.003; Mathieu G, 2011, PROSTAG LEUKOTR ESS, V85, P129, DOI 10.1016/j.plefa.2011.07.001; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; Mennitti LV, 2015, J NUTR BIOCHEM, V26, P99, DOI 10.1016/j.jnutbio.2014.10.001; Milaneschi Y, 2017, BIOL PSYCHIAT, V81, P807, DOI 10.1016/j.biopsych.2015.10.023; Muhlhausler Beverly Sara, 2011, Frontiers in Genetics, V2, P48, DOI 10.3389/fgene.2011.00048; Murphy MO, 2017, AM J PHYSIOL-REG I, V313, pR1, DOI 10.1152/ajpregu.00185.2016; Naninck EFG, 2017, FASEB J, V31, P505, DOI 10.1096/fj.201600834R; Naninck EFG, 2015, HIPPOCAMPUS, V25, P309, DOI 10.1002/hipo.22374; Niculescu MD, 2011, INT J DEV NEUROSCI, V29, P795, DOI 10.1016/j.ijdevneu.2011.09.006; Oosting A, 2015, NUTR RES, V35, P800, DOI 10.1016/j.nutres.2015.06.010; Oosting A, 2010, PEDIATR RES, V68, P494, DOI 10.1203/PDR.0b013e3181f74940; Orr SK, 2013, PROSTAG LEUKOTR ESS, V88, P97, DOI 10.1016/j.plefa.2012.05.008; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pusceddu MM, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw078; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rey C, 2018, PROSTAG LEUKOTR ESS, V133, P1, DOI 10.1016/j.plefa.2018.04.003; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Rincel M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.235; Robertson RC, 2017, BRAIN BEHAV IMMUN, V59, P21, DOI 10.1016/j.bbi.2016.07.145; Roceri M, 2002, MOL PSYCHIATR, V7, P609, DOI 10.1038/sj.mp.4001036; Sakayori N, 2016, TOHOKU J EXP MED, V240, P31, DOI 10.1620/tjem.240.31; Salem N, 2001, J MOL NEUROSCI, V16, P299, DOI 10.1385/JMN:16:2-3:299; Sardinha FLC, 2013, AM J PHYSIOL-REG I, V304, pR313, DOI 10.1152/ajpregu.00392.2012; Schipper L, 2016, PROSTAG LEUKOTR ESS, V110, P8, DOI 10.1016/j.plefa.2016.05.001; Scorletti E, 2013, ANNU REV NUTR, V33, P231, DOI 10.1146/annurev-nutr-071812-161230; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos Artemis P., 1999, Annals of Nutrition and Metabolism, V43, P127, DOI 10.1159/000012777; Simopoulos AP, 2009, WORLD REV NUTR DIET, V100, P1, DOI 10.1159/000235706; Spencer SJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00144; Tian CY, 2011, CLIN NUTR, V30, P659, DOI 10.1016/j.clnu.2011.03.002; Venna VR, 2009, PSYCHONEUROENDOCRINO, V34, P199, DOI 10.1016/j.psyneuen.2008.08.025; Walker CD, 2005, PROG NEURO-PSYCHOPH, V29, P1249, DOI 10.1016/j.pnpbp.2005.08.010; Walker CD, 2010, DEV PSYCHOBIOL, V52, P638, DOI 10.1002/dev.20492; Wohleb ES, 2017, PROG NEURO-PSYCHOPH, V79, P40, DOI 10.1016/j.pnpbp.2016.04.013; Yam KY, 2017, PSYCHONEUROENDOCRINO, V77, P186, DOI 10.1016/j.psyneuen.2016.12.012; Yehuda S, 2003, WORLD REV NUTR DIET, V92, P37	83	18	18	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5729	5740		10.1096/fj.201802297R	http://dx.doi.org/10.1096/fj.201802297R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30673509	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000462888500087
J	Chen, WW; Zhang, J; Zhang, PJ; Hu, FY; Jiang, TT; Gu, JX; Chang, Q				Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing			Role of TLR4-MAP4K4 signaling pathway in models of oxygen-induced retinopathy	FASEB JOURNAL			English	Article						VEGF; angiogenesis; retina	RECEPTOR 4; ENDOTHELIAL-CELLS; PROTEIN-KINASE; C-JUN; ANGIOGENESIS; EXPRESSION; MAP4K4; INFLAMMATION; CANCER; VEGF	Retinopathy of prematurity is a vision-threatening condition, and therapies based on antagonizing VEGF may elicit serious side effects in premature infants. Mechanisms of retinal angiogenesis, particularly the signaling pathways independent of VEGF, remain elusive. The goals of our study were to explore TLR4-mediated signaling pathways in human retinal microvascular endothelial cells (HRMECs) and to examine the effects of TLR4 antagonists in models of oxygen-induced retinopathy (OIR). Our results show that intravitreal injection of the TLR4 antagonist TAK-242 reduced areas of nonperfusion, inhibited aberrant angiogenesis, and improved vascular density in the retina of OIR mice. The effects were further potentiated by the anti-VEGF antibody ranibizumab. In cultured HRMECs, the TLR4 agonist LPS up-regulated TLR4/MAPKK kinase kinase 4 (MAP4K4) signaling, and promoted cell proliferation and migration, and reduced barrier functions of the cells. Down-regulation of MAP4K4 in HRMECs abolished the proangiogenic effects by LPS. Our data suggest that the TLR4-MAP4K4 pathway can regulate retinal neovascularization via mechanisms independent of VEGF.Chen, W., Zhang, J., Zhang, P., Hu, F., Jiang, T., Gu, J., Chang, Q. Role of TLR4-MAP4K4 signaling pathway in models of oxygen-induced retinopathy.	[Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing] Fudan Univ, Eye & Ear Nose & Throat Hosp, Dept Ophthalmol & Vis Sci, Shanghai, Peoples R China; [Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing] Fudan Univ, Key Lab Myopia Natl Hlth Commiss, Shanghai, Peoples R China; [Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing] Chinese Acad Med Sci, Key Lab Myopia, Shanghai, Peoples R China; [Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing] Key Lab Visual Impairment & Restorat Shanghai, Shanghai, Peoples R China	Fudan University; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College	Chang, Q (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol & Vis Sci, 83 Fen Yang Rd, Shanghai 200031, Peoples R China.	qngchang@aliyun.com			National Natural Science Foundation of China [81870670, 81371041, 81500734]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81870670, 81371041, and 81500734). The funding organization had no role in the design or supervision of this study. The authors declare no conflicts of interest.	Axer-Siegel R, 2004, OPHTHALMOLOGY, V111, P1734, DOI 10.1016/j.ophtha.2004.03.024; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P391; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chan JJT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27082; Chan-Ling T, 2018, PROG RETIN EYE RES, V62, P77, DOI 10.1016/j.preteyeres.2017.09.002; Chuang HC, 2016, ADV IMMUNOL, V129, P277, DOI 10.1016/bs.ai.2015.09.006; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Feng YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139280; Flach RJR, 2016, MOL CELL BIOL, V36, P1740, DOI 10.1128/MCB.01121-15; Flach RJR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9995; Hartnett ME, 2016, EYE BRAIN, V8, P27, DOI 10.2147/EB.S105319; He C, 2013, ARTERIOSCL THROM VAS, V33, P330, DOI 10.1161/ATVBAHA.112.300679; Hu L, 2016, MOL ONCOL, V10, P1473, DOI 10.1016/j.molonc.2016.08.002; Jiang TT, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3528274; Lei CY, 2016, BRAIN RES, V1632, P1, DOI 10.1016/j.brainres.2015.11.045; Li N, 2012, CYTOKINE, V60, P806, DOI 10.1016/j.cyto.2012.08.003; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Liu AW, 2011, CLIN CANCER RES, V17, P710, DOI 10.1158/1078-0432.CCR-10-0331; Ma B, 2017, J TISSUE ENG REGEN M, V11, P1779, DOI 10.1002/term.2075; Ma M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004003; Martinez-Castellanos MA, 2013, RETINA-J RET VIT DIS, V33, P329, DOI 10.1097/IAE.0b013e318275394a; Monaghan-Benson E, 2011, METHODS MOL BIOL, V763, P281, DOI 10.1007/978-1-61779-191-8_19; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; Murad S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00313; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P4323, DOI 10.1167/iovs.11-9119; Ndubaku CO, 2015, ACS MED CHEM LETT, V6, P913, DOI 10.1021/acsmedchemlett.5b00174; Park SY, 2015, EUR J IMMUNOL, V45, P1216, DOI 10.1002/eji.201444908; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Sachdev U, 2013, J VASC SURG, V58, P460, DOI 10.1016/j.jvs.2012.11.071; Satta N, 2008, MOL IMMUNOL, V46, P145, DOI 10.1016/j.molimm.2008.07.017; Sinon SH, 2016, J ORAL PATHOL MED, V45, P28, DOI 10.1111/jop.12319; Sun YL, 2016, EXP CELL RES, V347, P274, DOI 10.1016/j.yexcr.2016.07.009; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Tremblay S, 2013, INVEST OPHTH VIS SCI, V54, P8125, DOI 10.1167/iovs.13-12496; Trigler L, 2005, J AAPOS, V9, P17, DOI 10.1016/j.jaapos.2004.10.007; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; VanderVeen DK, 2017, OPHTHALMOLOGY, V124, P619, DOI 10.1016/j.ophtha.2016.12.025; Vitorino P, 2015, NATURE, V519, P425, DOI 10.1038/nature14323; Wang HB, 2016, EYE BRAIN, V8, P81, DOI 10.2147/EB.S94449; Wang HB, 2014, INVEST OPHTH VIS SCI, V55, P737, DOI 10.1167/iovs.13-13429; Wang L, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0086-4; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003; Wu JH, 2014, AM J PATHOL, V184, P1900, DOI 10.1016/j.ajpath.2014.03.001; Xia S, 2018, J PHYSIOL-LONDON, V596, P1397, DOI 10.1113/JP275453; Xu WQ, 2016, INT J OPHTHALMOL-CHI, V9, P1343, DOI 10.18240/ijo.2016.09.19; Yang N, 2015, J HISTOCHEM CYTOCHEM, V63, P721, DOI 10.1369/0022155415590829; Yang S, 2014, J LEUKOCYTE BIOL, V95, P563, DOI 10.1189/jlb.0713412; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zabini D, 2015, J CELL MOL MED, V19, P1151, DOI 10.1111/jcmm.12519; Zhang X, 2015, PROTEOMICS, V15, P340, DOI 10.1002/pmic.201400315	50	5	5	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3451	3464		10.1096/fj.201801086RR	http://dx.doi.org/10.1096/fj.201801086RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30475644	Bronze			2022-12-28	WOS:000459794800030
J	Riedlinger, T; Liefke, R; Meier-Soelch, J; Jurida, L; Nist, A; Stiewe, T; Kracht, M; Schmitz, ML				Riedlinger, Tabea; Liefke, Robert; Meier-Soelch, Johanna; Jurida, Liane; Nist, Andrea; Stiewe, Thorsten; Kracht, Michael; Schmitz, M. Lienhard			NF-B p65 dimerization and DNA-binding is important for inflammatory gene expression	FASEB JOURNAL			English	Article						inflammation; chromatin; transcription	FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; CHROMATIN ACCESSIBILITY; SUBUNIT STOICHIOMETRY; RECEPTOR; ALPHA; DEGRADATION; SITES; TNF; NF-KAPPA-B1	Increasing evidence shows that many transcription factors execute important biologic functions independent from their DNA-binding capacity. The NF-B p65 (RELA) subunit is a central regulator of innate immunity. Here, we investigated the relative functional contribution of p65 DNA-binding and dimerization in p65-deficient human and murine cells reconstituted with single amino acid mutants preventing either DNA-binding (p65 E/I) or dimerization (p65 FL/DD). DNA-binding of p65 was required for RelB-dependent stabilization of the NF-B p100 protein. The antiapoptotic function of p65 and expression of the majority of TNF--induced genes were dependent on p65's ability to bind DNA and to dimerize. Chromatin immunoprecipitation with massively parallel DNA sequencing experiments revealed that impaired DNA-binding and dimerization strongly diminish the chromatin association of p65. However, there were also p65-independent TNF--inducible genes and a subgroup of p65 binding sites still allowed some residual chromatin association of the mutants. These sites were enriched in activator protein 1 (AP-1) binding motifs and showed increased chromatin accessibility and basal transcription. This suggests a mechanism of assisted p65 chromatin association that can be in part facilitated by chromatin priming and cooperativity with other transcription factors such as AP-1.Riedlinger, T., Liefke, R., Meier-Soelch, J., Jurida, L., Nist, A., Stiewe, T., Kracht, M., Schmitz, M. L. NF-B p65 dimerization and DNA-binding is important for inflammatory gene expression.	[Riedlinger, Tabea; Liefke, Robert; Schmitz, M. Lienhard] Justus Liebig Univ, Inst Biochem, German Ctr Lung Res, Friedrichstr 24, D-35392 Giessen, Germany; [Meier-Soelch, Johanna; Jurida, Liane; Kracht, Michael] Justus Liebig Univ, Rudolf Buchheim Inst Pharmacol, German Ctr Lung Res, Giessen, Germany; [Liefke, Robert] Philipps Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [Nist, Andrea; Stiewe, Thorsten] Philipps Univ Marburg, Inst Mol Oncol, Genom Core Facil, Marburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Philipps University Marburg; Philipps University Marburg	Schmitz, ML (corresponding author), Justus Liebig Univ, Inst Biochem, German Ctr Lung Res, Friedrichstr 24, D-35392 Giessen, Germany.	lienhard.schmitz@biochemie.med.uni-giessen.de	Schmitz, M. Lienhard/D-9328-2017; Liefke, Robert/AAF-6842-2021	Schmitz, M. Lienhard/0000-0002-6984-7192; Liefke, Robert/0000-0002-8549-637X; Stiewe, Thorsten/0000-0003-0134-7826	Deutsche Forschungsgemeinschaft [SCHM 1417/8-3, LI 2057/2-1, Kr1143/7-3, KR1143/9-1, KLIFO309, TRR81/2, SFB1213, SFB1021]; Deutsche Krebshilfe [111447]; International Max Planck Research Schools Program of the Max-Planck Society; Excellence Cluster Cardio-Pulmonary System;  [SFB/TRR81]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); International Max Planck Research Schools Program of the Max-Planck Society; Excellence Cluster Cardio-Pulmonary System(German Research Foundation (DFG)); 	The authors thank Dr. Feng Zhang (Massachusetts Institute of Technology, Boston, MA USA) for pX459. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SCHM 1417/8-3), SFB/TRR81, SFB1021, SFB1213, the Deutsche Krebshilfe (111447), and the International Max Planck Research Schools Program of the Max-Planck Society (to M.L.S.). The work of R.L. was supported by the Deutsche Forschungsgemeinschaft (LI 2057/2-1). The work of M.K. is supported by Deutsche Forschungsgemeinschaft Kr1143/7-3, KR1143/9-1 (KLIFO309), TRR81/2 (B02), SFB1213 (B03), and SFB1021 (C02). Work from the M.L.S. and M.K. laboratories was further supported by the Excellence Cluster Cardio-Pulmonary System. The authors declare no conflicts of interest.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bell LA, 2006, ONCOGENE, V25, P5656, DOI 10.1038/sj.onc.1209580; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Dennis G, 2003, GENOME BIOL, V4; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fusco AJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad9413; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Huang DB, 1997, STRUCTURE, V5, P1427, DOI 10.1016/S0969-2126(97)00293-1; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jurida L., 2015, CELL REP; Kao YS, 2008, CELL SIGNAL, V20, P771, DOI 10.1016/j.cellsig.2007.12.012; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kolovos P, 2016, GENOME RES, V26, P1478, DOI 10.1101/gr.210005.116; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanucara F, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160055; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Liu N, 2009, DEVELOPMENT, V136, P933, DOI 10.1242/dev.034025; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu YF, 2012, J INFRARED MILLIM W, V31, P1; MATTHEWS JR, 1995, INT J BIOCHEM CELL B, V27, P865, DOI 10.1016/1357-2725(95)00071-V; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Milanovic M, 2014, BIOCHEM J, V457, P401, DOI 10.1042/BJ20130780; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Mueller S, 2015, MOL BIOL CELL, V26, P2596, DOI 10.1091/mbc.E15-03-0168; Na SY, 1999, J BIOL CHEM, V274, P7674, DOI 10.1074/jbc.274.12.7674; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; O'Neil J, 2001, ONCOGENE, V20, P3897, DOI 10.1038/sj.onc.1204519; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Park SW, 2005, MOL CELL PROTEOMICS, V4, P300, DOI 10.1074/mcp.M400195-MCP200; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Porcher C, 1999, DEVELOPMENT, V126, P4603; Reintjes A, 2016, P NATL ACAD SCI USA, V113, P4326, DOI 10.1073/pnas.1522372113; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Riedlinger T, 2017, BBA-MOL CELL RES, V1864, P1785, DOI 10.1016/j.bbamcr.2017.07.005; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Stellzig J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.42; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wissink S, 1997, J BIOL CHEM, V272, P22278, DOI 10.1074/jbc.272.35.22278; Wolter S, 2008, MOL CELL BIOL, V28, P4407, DOI 10.1128/MCB.00535-07; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Yilmaz ZB, 2014, CELL REP, V9, P1756, DOI 10.1016/j.celrep.2014.11.014; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang LQ, 2010, J MOL BIOL, V396, P528, DOI 10.1016/j.jmb.2010.01.008; Zhao B, 2014, CELL REP, V8, P1595, DOI 10.1016/j.celrep.2014.07.037; Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916	64	20	21	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4188	4202		10.1096/fj.201801638R	http://dx.doi.org/10.1096/fj.201801638R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526044	hybrid, Green Published			2022-12-28	WOS:000459794800087
J	Patrick, RP				Patrick, Rhonda P.			Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease	FASEB JOURNAL			English	Review						omega-3 fatty acid; dementia; amyloid-beta plaques; tau tangles; phospholipid DHA	BLOOD-BRAIN-BARRIER; APOLIPOPROTEIN-E EPSILON-4; DIETARY DOCOSAHEXAENOIC ACID; POLYUNSATURATED FATTY-ACID; O-GLCNACYLATION; COGNITIVE DECLINE; GLUCOSE TRANSPORTERS; CEREBROSPINAL-FLUID; TAU PATHOLOGY; FISH-OIL	Dietary and supplemental intake of the -3 fatty acid docosahexaenoic acid (DHA) reduces risk of Alzheimer's disease (AD) and ameliorates symptoms. The apolipoprotein E (APOE)4 allele is the strongest risk factor for sporadic AD, exclusive of age. APOE4 carriers respond well to the DHA present in fish but do not respond as well to dietary supplements. The mechanisms behind this varied response remain unknown. I posit that the difference is that fish contain DHA in phospholipid form, whereas fish oil supplements do not. This influences whether DHA is metabolized to nonesterified DHA (free DHA) or a phospholipid form called lysophosphatidylcholine DHA (DHA-lysoPC). Free DHA is transported across the outer membrane leaflet of the blood-brain barrier (BBB) via passive diffusion, and DHA-lysoPC is transported across the inner membrane leaflet of the BBB via the major facilitator superfamily domain-containing protein 2A. I propose that APOE4 carriers have impaired brain transport of free DHA but not of DHA-lysoPC, as a consequence of a breakdown in the outer membrane leaflet of the BBB, putting them at increased risk for AD. Dietary sources of DHA in phospholipid form may provide a means to increase plasma levels of DHA-lysoPC, thereby decreasing the risk of AD.Patrick, R. P. Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease.	[Patrick, Rhonda P.] Univ Calif San Francisco, Benioff Childrens Hosp, Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Patrick, RP (corresponding author), Univ Calif San Francisco, Benioff Childrens Hosp, Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	rhonda@foundmyfitness.com			Children's Hospital Oakland Research Institute (CHORI)-Ames Supporting Foundation	Children's Hospital Oakland Research Institute (CHORI)-Ames Supporting Foundation	The author thanks Bruce Ames (University of California San Francisco Benioff Children's Hospital Oakland Research Institute), Giovanna Ferro-Luzzi Ames, Teresa L. Johnson, Daniel Patrick, and Robert Ryan (University of Nevada, Reno, NV, USA) for comments, editing, and suggestions on the manuscript, and Alison Gates for assistance during drafting of the figures. R.P.P. is grateful for the support of financial contributors to her website FoundMy-Fitness. com, and to the Children's Hospital Oakland Research Institute (CHORI)-Ames Supporting Foundation for financially sustaining her during different periods of the drafting of this manuscript. R.P.P. produces a web-based podcast series and provides single nucleotide polymorphism-related resources that help listeners identify their individual genotypes from raw data provided by consumer genetic testing services. The author declares no conflicts of interest.	Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Alata W, 2015, J CEREBR BLOOD F MET, V35, P86, DOI 10.1038/jcbfm.2014.172; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981; Bredesen DE, 2015, AGING-US, V7, P595, DOI 10.18632/aging.100801; Bredesen DE, 2014, AGING-US, V6, P707, DOI 10.18632/aging.100690; Brenna JT, 2007, PROSTAG LEUKOTR ESS, V77, P247, DOI 10.1016/j.plefa.2007.10.016; Brossard N, 1997, J LIPID RES, V38, P1571; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Burri L, 2012, INT J MOL SCI, V13, P15401, DOI 10.3390/ijms131115401; Chen S, 2008, CHEM PHYS LIPIDS, V152, P46, DOI 10.1016/j.chemphyslip.2008.01.001; Chen S, 2007, BBA-MOL CELL BIOL L, V1771, P1319, DOI 10.1016/j.bbalip.2007.08.001; Chen S, 2013, LIPIDS, V48, P675, DOI 10.1007/s11745-013-3791-5; Chen S, 2012, ANAL CHIM ACTA, V735, P76, DOI 10.1016/j.aca.2012.05.035; Cole GM, 2010, J NUTR, V140, P869, DOI 10.3945/jn.109.113910; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; da Silva AX, 2002, J NEUROCHEM, V81, P1328; Deng YQ, 2008, FASEB J, V22, P138, DOI 10.1096/fj.07-8309com; Dyerberg J, 2010, PROSTAG LEUKOTR ESS, V83, P137, DOI 10.1016/j.plefa.2010.06.007; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Frayn KN, 1997, P NUTR SOC, V56, P713, DOI 10.1079/PNS19970071; Gong CX, 2006, J ALZHEIMERS DIS, V9, P1; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Halliday MR, 2013, JAMA NEUROL, V70, P1198, DOI 10.1001/jamaneurol.2013.3841; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Huang TL, 2005, NEUROLOGY, V65, P1409, DOI 10.1212/01.wnl.0000183148.34197.2e; Huang YD, 2011, BIOCHEM SOC T, V39, P924, DOI 10.1042/BST0390924; Jochemsen HM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.016; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kitson AP, 2016, J NUTR BIOCHEM, V33, P91, DOI 10.1016/j.jnutbio.2016.02.009; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Lagarde M, 2015, PROSTAG LEUKOTR ESS, V92, P63, DOI 10.1016/j.plefa.2014.01.005; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; Lemaitre-Delaunay D, 1999, J LIPID RES, V40, P1867; Levi YF, 2014, J INTERN MED, V275, P428, DOI 10.1111/joim.12166; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; Lim ASP, 2013, JAMA NEUROL, V70, P1544, DOI 10.1001/jamaneurol.2013.4215; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu L, 2014, J LIPID RES, V55, P531, DOI 10.1194/jlr.M045930; Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Mooradian AD, 1997, NEUROBIOL AGING, V18, P469, DOI 10.1016/S0197-4580(97)00111-5; Morris MC, 2016, JAMA-J AM MED ASSOC, V315, P489, DOI 10.1001/jama.2015.19451; Mulder M, 1998, ALZ DIS ASSOC DIS, V12, P198, DOI 10.1097/00002093-199809000-00012; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Ouellet M, 2009, NEUROCHEM INT, V55, P476, DOI 10.1016/j.neuint.2009.04.018; Pifferi F, 2007, PROSTAG LEUKOTR ESS, V77, P279, DOI 10.1016/j.plefa.2007.10.011; Pifferi F, 2005, J NUTR, V135, P2241, DOI 10.1093/jn/135.9.2241; Quek DQY, 2016, J BIOL CHEM, V291, P9383, DOI 10.1074/jbc.M116.721035; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Richmond GS, 2011, INT J MOL SCI, V12, P588, DOI 10.3390/ijms12010588; Rodriguez-Vieitez E, 2016, BRAIN, V139, P922, DOI 10.1093/brain/awv404; Ruiz-Lopez N, 2015, MAR DRUGS, V13, P4255, DOI 10.3390/md13074255; Salloway S, 2002, J NEUROL SCI, V203, P183, DOI 10.1016/S0022-510X(02)00288-5; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507; Smith JC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00061; Smith JC, 2011, NEUROIMAGE, V54, P635, DOI 10.1016/j.neuroimage.2010.07.070; Solito E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00014; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; Stonehouse W, 2013, AM J CLIN NUTR, V97, P1134, DOI 10.3945/ajcn.112.053371; Subbaiah PV, 2016, BBA-MOL CELL BIOL L, V1861, P723, DOI 10.1016/j.bbalip.2016.05.002; Sugasini D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11766-0; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; THIES F, 1994, AM J PHYSIOL-REG I, V267, pR1273, DOI 10.1152/ajpregu.1994.267.5.R1273; TSO P, 1989, ADV PROSTAG THROMB L, V19, P623; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; Vandal M, 2014, J NEUROCHEM, V129, P516, DOI 10.1111/jnc.12640; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Winther B, 2011, LIPIDS, V46, P25, DOI 10.1007/s11745-010-3472-6; Yassine HN, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0194-x; Yu VWY, 2000, NEUROSCI LETT, V294, P179, DOI 10.1016/S0304-3940(00)01569-X	86	38	42	6	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1554	1564		10.1096/fj.201801412R	http://dx.doi.org/10.1096/fj.201801412R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30289748	Green Published, hybrid			2022-12-28	WOS:000457296600005
J	Poupeau, A; Garde, C; Sulek, K; Citirikkaya, K; Treebak, JT; Arumugam, M; Simar, D; Olofsson, LE; Backhed, F; Barres, R				Poupeau, Audrey; Garde, Christian; Sulek, Karolina; Citirikkaya, Kiymet; Treebak, Jonas T.; Arumugam, Manimozhiyan; Simar, David; Olofsson, Louise E.; Backhed, Fredrik; Barres, Romain			Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice	FASEB JOURNAL			English	Article						DNA methylation; epigenetic; gut microbiota; inflammation	HIGH-FAT DIET; DNA METHYLATION; GUT MICROBIOTA; FOLATE UPTAKE; INSULIN-RESISTANCE; ADAPTER PROTEIN; SKELETAL-MUSCLE; HOST GENE; EXPRESSION; MECHANISM	Remodeling of the gut microbiota is implicated in various metabolic and inflammatory diseases of the gastrointestinal tract. We hypothesized that the gut microbiota affects the DNA methylation profile of intestinal epithelial cells (IECs) which could, in turn, alter intestinal function. In this study, we used mass spectrometry and methylated DNA capture to respectively investigate global and genome-wide DNA methylation of intestinal epithelial cells from germ-free (GF) and conventionally raised mice. In colonic IECs from GF mice, DNA was markedly hypermethylated. This was associated with a dramatic loss of ten-eleven-translocation activity, a lower DNA methyltransferase activity and lower circulating levels of the 1-carbon metabolite, folate. At the gene level, we found an enrichment for differentially methylated regions proximal to genes regulating the cytotoxicity of NK cells (false-discovery rate < 8.9E(-6)), notably genes regulating the cross-talk between NK cells and target cells, such as members of the NK group 2 member D ligand superfamily Raet. This distinct epigenetic signature was associated with a marked decrease in Raet1 expression and a loss of CD56(+)/CD45(+) cells in the intestine of GF mice. Thus, our results indicate that altered activity of methylation-modifying enzymes in GF mice influences the IEC epigenome and modulates the crosstalk between IECs and NK cells. Epigenetic reprogramming of IECs may modulate intestinal function in diseases associated with altered gut microbiota.Poupeau, A., Garde, C., Sulek, K., Citirikkaya, K., Treebak, J. T., Arumugam, M., Simar, D., Olofsson, L. E., Backhed, F., Barres, R. Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice.	[Poupeau, Audrey; Garde, Christian; Sulek, Karolina; Citirikkaya, Kiymet; Treebak, Jonas T.; Arumugam, Manimozhiyan; Simar, David; Backhed, Fredrik; Barres, Romain] Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res, Copenhagen, Denmark; [Simar, David] Univ New South Wales, Sch Med Sci, Mech Dis & Translat Res, Sydney, NSW, Australia; [Olofsson, Louise E.; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Olofsson, Louise E.; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Inst Med, Gothenburg, Sweden	Novo Nordisk Foundation; University of Copenhagen; University of New South Wales Sydney; University of Gothenburg; University of Gothenburg	Barres, R (corresponding author), Univ Copenhagen, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	barres@sund.ku.dk	Treebak, Jonas Thue/B-4521-2017; Arumugam, Manimozhiyan/AAJ-2394-2020; Backhed, Fredrik/ABE-6613-2020; Sulek, Karolina/GLN-8212-2022; BARRES, Romain/N-2501-2016; Arumugam, Manimozhiyan/E-1211-2011	Treebak, Jonas Thue/0000-0003-1488-7012; Arumugam, Manimozhiyan/0000-0002-0886-9101; Backhed, Fredrik/0000-0002-4871-8818; Sulek, Karolina/0000-0002-7117-3756; BARRES, Romain/0000-0002-0158-519X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Olofsson, Louise/0000-0002-2302-2005; Simar, David/0000-0002-3862-1932	European Foundation for the Study of Diabetes (EFSD)/EFSD/Novo Nordisk Programme for Diabetes Research in Europe grant	European Foundation for the Study of Diabetes (EFSD)/EFSD/Novo Nordisk Programme for Diabetes Research in Europe grant	The authors acknowledge Pattarawan Pattamaprapanont (Mahidol University, Bangkok, Thailand), Louise Manneras Holm (Wallenberg Laboratory and Sahlgrenska Center for Cardiovascular and Metabolic Research), and Thomas Svava Nielsen (Novo Nordisk Foundation Center for Basic Metabolic Research) for their gracious help with mice experiments. The authors also thank The Danish National High-Throughput DNA Sequencing Centre (University of Copenhagen), for sequencing service, and Lene Ravn and Camilla Gitte Thomsen (Klinisk Biokemisk Afdeling, Rigshospitalet, Denmark) for analysis of methyl donors in plasma. R.B., F.B., and M.A. are recipients of a European Foundation for the Study of Diabetes (EFSD)/EFSD/Novo Nordisk Programme for Diabetes Research in Europe grant. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation. The authors declare no conflicts of interest.	Agardh E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0421-5; Aufreiter S, 2009, AM J CLIN NUTR, V90, P116, DOI 10.3945/ajcn.2008.27345; Barres R, 2005, EXP CELL RES, V308, P334, DOI 10.1016/j.yexcr.2005.05.008; Barres R, 2006, MOL ENDOCRINOL, V20, P2864, DOI 10.1210/me.2005-0455; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Burcelin R, 2016, MOL METAB, V5, P771, DOI 10.1016/j.molmet.2016.05.016; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Dudeja PK, 2001, AM J PHYSIOL-GASTR L, V281, pG54, DOI 10.1152/ajpgi.2001.281.1.G54; Dudeja PK, 1997, AM J PHYSIOL-GASTR L, V272, pG1408, DOI 10.1152/ajpgi.1997.272.6.G1408; Farias N, 2015, J NUTR BIOCHEM, V26, P818, DOI 10.1016/j.jnutbio.2015.02.002; Galuska D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028294; Galuska D, 2009, AM J PHYSIOL-ENDOC M, V297, pE38, DOI 10.1152/ajpendo.90990.2008; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Huang CZ, 2015, STEM CELLS DEV, V24, P2733, DOI 10.1089/scd.2015.0235; Jacobsen MJ, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8539057; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kelsey G, 1997, BIOESSAYS, V19, P361, DOI 10.1002/bies.950190502; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kirchner H, 2014, SURG OBES RELAT DIS, V10, P671, DOI 10.1016/j.soard.2013.12.019; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Loddo I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00551; Mischke M, 2013, AM J PHYSIOL-REG I, V304, pR1065, DOI 10.1152/ajpregu.00551.2012; Nik AM, 2013, BIOTECHNIQUES, V55, P42, DOI 10.2144/000114055; Nylander V, 2016, DIABETES, V65, P3573, DOI 10.2337/db16-0364; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Pompei A, 2007, APPL ENVIRON MICROB, V73, P179, DOI 10.1128/AEM.01763-06; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RONG N, 1991, J NUTR, V121, P1955, DOI 10.1093/jn/121.12.1955; Roostaee A, 2016, J CELL PHYSIOL, V231, P2361, DOI 10.1002/jcp.25401; Rossi M, 2011, NUTRIENTS, V3, P118, DOI 10.3390/nu3010118; Said HM, 2000, AM J PHYSIOL-CELL PH, V279, pC1889, DOI 10.1152/ajpcell.2000.279.6.C1889; SEMCHUK GM, 1994, J NUTR, V124, P1118, DOI 10.1093/jn/124.7.1118; Sepehr E, 2003, J NUTR, V133, P1347; Simar D, 2014, METABOLISM, V63, P1188, DOI 10.1016/j.metabol.2014.05.014; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Song J, 2000, CANCER RES, V60, P3191; Stempak JM, 2005, CARCINOGENESIS, V26, P981, DOI 10.1093/carcin/bgi037; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; Thomes PG, 2015, BIOCHEM PHARMACOL, V96, P30, DOI 10.1016/j.bcp.2015.04.018; Trembath AP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00231; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Winer DA, 2016, CELL METAB, V23, P413, DOI 10.1016/j.cmet.2016.01.003; Yang Y, 2016, INT J BIOCHEM CELL B, V79, P222, DOI 10.1016/j.biocel.2016.08.040; Yu DH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0763-5; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	61	6	6	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2719	2731		10.1096/fj.201800787R	http://dx.doi.org/10.1096/fj.201800787R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303739	Green Published, hybrid			2022-12-28	WOS:000457296600095
J	Ye, Q; Trivedi, M; Zhang, YT; Bohlke, M; Alsulimani, H; Chang, J; Maher, T; Deth, R; Kim, J				Ye, Qi; Trivedi, Malav; Zhang, Yiting; Bohlke, Mark; Alsulimani, Helal; Chang, JuOae; Maher, Timothy; Deth, Richard; Kim, Jonghan			Brain iron loading impairs DNA methylation and alters GABAergic function in mice	FASEB JOURNAL			English	Article						epigenetics; hemochromatosis; HFE; anxiety; oxidative stress	INCREASED OXIDATIVE STRESS; HEREDITARY HEMOCHROMATOSIS; HFE GENE; EXPRESSION; ACCUMULATION; MANGANESE; GABA; DEFICIENCY; METABOLISM; MECHANISMS	Iron deficiency is closely associated with altered GABA metabolism and affective behavior. While mutation in the hemochromatosis (HFE) gene disrupts iron homeostasis and promotes oxidative stress that increases the risk of neurodegeneration, it is largely unknown whether HFE mutation modifies GABAergic homeostasis and emotional behavior. The goal of our study was to investigate the impact of HFE on GABAergic neurochemistry and redox-epigenetic regulation in the brain using H67D HFE-mutant mice that recapitulates the H63D-HFE mutation in humans. H67D mice displayed elevated redox-active iron levels in the brain by 32% compared to age-matched wild-type mice. Moreover, the H67D brain had increased isoprostane and decreased glutathione, indicating elevated oxidative stress. Additionally, the H67D brain had decreased global methylation and attenuated DNA methyltransferase (DNMT) activity. Direct addition of iron to purified DNMT in vitro decreased enzyme activity in a concentration-dependent manner. Last, H67D mice exhibited decreased anxiety-like behavior, which was associated with increased expression of the GABA(A) receptor 2 subunits by 93%, and these changes were also observed in H67D mice fed a low-iron diet. Taken together, our results suggest a putative role of HFE in regulating labile iron status in the brain, and mutation in H67D perturbs redox-methylation status, contributing to GABAergic dysfunction.Ye, Q., Trivedi, M., Zhang, Y., Bohlke, M., Alsulimani, H., Chang, J., Maher, T., Deth, R., Kim, J. Brain iron loading impairs DNA methylation and alters GABAergic function in mice.	[Ye, Qi; Zhang, Yiting; Alsulimani, Helal; Chang, JuOae; Kim, Jonghan] Northeastern Univ, Dept Pharmaceut Sci, 360 Huntington Ave,148TF, Boston, MA 02115 USA; [Trivedi, Malav; Deth, Richard] Nova Southeastern Univ, Dept Pharmaceut Sci, Ft Lauderdale, FL 33314 USA; [Bohlke, Mark; Maher, Timothy] Massachusetts Coll Pharm & Hlth Sci MCPHS Univ, Dept Pharmaceut Sci, Boston, MA USA	Northeastern University; Nova Southeastern University	Kim, J (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, 360 Huntington Ave,148TF, Boston, MA 02115 USA.	j.kim@neu.edu	Alsulimani, Helal/AAS-6328-2021; Deth, Richard/AFV-2608-2022	Alsulimani, Helal/0000-0002-2717-4452	U.S. National Institutes of Health, National Institute of Environmental Health Sciences [K99/R00 ES017781]; Northeastern University	U.S. National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Northeastern University	The authors are grateful to M. Han (Northeastern University) for help during animal experiments, and P. Paydary and P. Larese-Casanova (Northeastern University) for help with ICP-MS analysis. This work was supported, in part, by U.S. National Institutes of Health, National Institute of Environmental Health Sciences Grant K99/R00 ES017781 (to J.K.) and a Northeastern University TIER1 Interdisciplinary grant (to J.K.). The authors declare no conflicts of interest.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Acosta-Cabronero J, 2016, J NEUROSCI, V36, P364, DOI 10.1523/JNEUROSCI.1907-15.2016; Ali-Rahmani F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00165; Archer T, 2007, NEUROCHEM RES, V32, P1625, DOI 10.1007/s11064-007-9358-1; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Bartzokis G, 2010, J ALZHEIMERS DIS, V20, P333, DOI 10.3233/JAD-2010-1368; Batra Jyoti, 2002, Indian J Clin Biochem, V17, P108, DOI 10.1007/BF02867982; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; Beard JL, 2007, J NUTR, V137, P1176, DOI 10.1093/jn/137.5.1176; Bianco LE, 2008, J NEUROCHEM, V106, P205, DOI 10.1111/j.1471-4159.2008.05358.x; Bishop GM, 2011, NEUROTOX RES, V19, P443, DOI 10.1007/s12640-010-9195-x; Bradley LA, 1998, J MED SCREEN, V5, P34, DOI 10.1136/jms.5.1.34; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Caceres JA, 2012, EMERG MED CLIN N AM, V30, P771, DOI 10.1016/j.emc.2012.06.003; Cai YQ, 2006, J NEUROSCI RES, V84, P255, DOI 10.1002/jnr.20884; Chang J, 2014, TOX RESEARCH, V30, P267, DOI 10.5487/TR.2014.30.4.267; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Dahl C, 2011, CLIN CHIM ACTA, V412, P831, DOI 10.1016/j.cca.2011.02.013; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Edden RAE, 2012, ARCH GEN PSYCHIAT, V69, P750, DOI 10.1001/archgenpsychiatry.2011.2280; Erikson KM, 2000, J NUTR, V130, P2831, DOI 10.1093/jn/130.11.2831; Erikson KM, 2001, PHARMACOL BIOCHEM BE, V69, P409, DOI 10.1016/S0091-3057(01)00563-9; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Fitsanakis VA, 2009, NEUROTOX RES, V15, P167, DOI 10.1007/s12640-009-9017-1; Garton T, 2016, STROKE VASC NEUROL, V1, P172, DOI 10.1136/svn-2016-000042; Grayson DR, 2013, NEUROPSYCHOPHARMACOL, V38, P138, DOI 10.1038/npp.2012.125; Han MR, 2016, J NEUROCHEM, V138, P918, DOI 10.1111/jnc.13717; Han M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120609; Hanson EH, 2001, AM J EPIDEMIOL, V154, P193, DOI 10.1093/aje/154.3.193; Heidari M, 2016, MOL PSYCHIATR, V21, P1599, DOI 10.1038/mp.2015.192; Hodgson N, 2013, J ALZHEIMERS DIS, V36, P197, DOI 10.3233/JAD-130101; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Klengel T, 2014, NEUROPHARMACOLOGY, V80, P115, DOI 10.1016/j.neuropharm.2014.01.013; Koziol MJ, 2016, NAT STRUCT MOL BIOL, V23, P24, DOI 10.1038/nsmb.3145; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367; Lertratanangkoon K, 1997, CANCER LETT, V120, P149, DOI 10.1016/S0304-3835(97)00300-5; Li Dan, 1998, Hokkaido Journal of Medical Science, V73, P215; Liu WH, 2008, NEUROSCI LETT, V432, P13, DOI 10.1016/j.neulet.2007.11.054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Garcia-Gimenez JL, 2017, FREE RADICAL BIO MED, V112, P36, DOI 10.1016/j.freeradbiomed.2017.07.008; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; MILMAN N, 1991, DAN MED BULL, V38, P385; Mittal Rama Devi, 2003, Indian J Clin Biochem, V18, P111, DOI 10.1007/BF02867677; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Nakai T, 2014, NEUROCHEM INT, V74, P74, DOI 10.1016/j.neuint.2014.06.009; Nandar W, 2013, BBA-MOL BASIS DIS, V1832, P729, DOI 10.1016/j.bbadis.2013.02.009; Nandar W, 2011, J NUTR, V141, p729S, DOI 10.3945/jn.110.130351; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oshiro S, 2000, BBA-MOL BASIS DIS, V1502, P405, DOI 10.1016/S0925-4439(00)00065-X; Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x; Pleau JM, 2001, BIOCHEM BIOPH RES CO, V283, P843, DOI 10.1006/bbrc.2001.4884; Pogribny IP, 2013, INT J ONCOL, V42, P1822, DOI 10.3892/ijo.2013.1855; Pulliam JF, 2003, AM J MED GENET B, V119B, P48, DOI 10.1002/ajmg.b.10069; Qian Y, 2015, CELL SIGNAL, V27, P934, DOI 10.1016/j.cellsig.2015.01.017; Ramsey AJ, 1996, J BIOL CHEM, V271, P24395, DOI 10.1074/jbc.271.40.24395; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Raud S, 2009, NEUROSCI LETT, V460, P138, DOI 10.1016/j.neulet.2009.05.054; Ravindran CRM, 2005, NEUROCHEM INT, V46, P313, DOI 10.1016/j.neuint.2004.10.004; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Roy CN, 2002, J CELL PHYSIOL, V190, P218, DOI 10.1002/JCP.10056; Salvador Gabriela A, 2010, Int J Alzheimers Dis, V2011, P720658, DOI 10.4061/2011/720658; Santos D, 2012, TOXICOLOGY, V292, P90, DOI 10.1016/j.tox.2011.11.017; Schipper HM, 2004, AGEING RES REV, V3, P265, DOI 10.1016/j.arr.2004.02.001; Serata D., 2012, GEN HOSP PSYCHIAT, V34; Shen XM, 1998, CHEM RES TOXICOL, V11, P824, DOI 10.1021/tx980036t; Tarale P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2548792; Thomas C, 2009, REDOX REP, V14, P102, DOI 10.1179/135100009X392566; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Trivedi M, 2014, MOL PHARMACOL, V85, P747, DOI 10.1124/mol.114.091728; Unger EL, 2008, J NUTR, V138, P2487, DOI 10.3945/jn.108.095224; Urrutia P, 2013, J NEUROCHEM, V126, P541, DOI 10.1111/jnc.12244; Veeraiah P, 2014, BIOL PSYCHIAT, V76, P231, DOI 10.1016/j.biopsych.2013.09.024; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Yao B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01195-y; Ye Q, 2016, METALLOMICS, V8, P618, DOI 10.1039/c6mt00080k; Ye Q, 2015, ENVIRON TOXICOL PHAR, V40, P333, DOI 10.1016/j.etap.2015.06.016; Zhang CG, 2014, PROTEIN CELL, V5, P750, DOI 10.1007/s13238-014-0083-7; Zhang YT, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3849087	87	17	18	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2460	2471		10.1096/fj.201801116RR	http://dx.doi.org/10.1096/fj.201801116RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277817	Green Published			2022-12-28	WOS:000457296600074
J	Kalka, M; Markiewicz, N; Ptak, M; Sone, ED; Ozyhar, A; Dobryszycki, P; Wojtas, M				Kalka, Marta; Markiewicz, Natalia; Ptak, Maciej; Sone, Eli D.; Ozyhar, Andrzej; Dobryszycki, Piotr; Wojtas, Magdalena			In vivo and in vitro analysis of starmaker activity in zebrafish otolith biomineralization	FASEB JOURNAL			English	Article						proteomics; phosphorylation; calcium carbonate; Danio rerio	INNER-EAR; MATRIX PROTEINS; HYDROXYAPATITE-BINDING; DENTIN PHOSPHOPHORYN; ENDOLYMPH CHEMISTRY; STATISTICAL-MODEL; SOLUBLE MATRIX; CICHLID FISH; PHOSPHORYLATION; BONE	Otoliths are one of the biominerals whose formation is highly controlled by proteins. The first protein discovered to be involved in otolith biomineralization in zebrafish was starmaker (Stm). Previously, Stm was shown to be responsible for the preferential formation of aragonite, a polymorph of calcium carbonate, in otoliths. In this work, proteomic analysis of adult zebrafish otoliths was performed. Stm is the only highly phosphorylated protein found in our studies. Besides previously studied otolith proteins, we discovered several dozens of unknown proteins that reveal the likely mechanism of biomineralization. A comparison of aragonite and vaterite otoliths showed similarities in protein composition. We observed the presence of Stm in both types of otoliths. In vitro studies of 2 characteristic Stm fragments indicated that the DS-rich region has a special biomineralization activity, especially after phosphorylation.-Kalka, M., Markiewicz, N., Ptak, M., Sone, E. D., O(z) over dotyhar, A., Dobryszycki, P., Wojtas, M. In vivo and in vitro analysis of starmaker activity in zebrafish otolith biomineralization.	[Kalka, Marta; Markiewicz, Natalia; Ozyhar, Andrzej; Dobryszycki, Piotr; Wojtas, Magdalena] Wroclaw Univ Sci & Technol, Fac Chem, Dept Biochem, Wybrzeze Wyspiatiskiego 27, PL-50370 Wroclaw, Poland; [Ptak, Maciej] Polish Acad Sci, Inst Low Temp & Struct Res, Div Opt Spect, Wroclaw, Poland; [Sone, Eli D.; Wojtas, Magdalena] Univ Toronto, Dept Mat Sci & Engn, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Sone, Eli D.; Wojtas, Magdalena] Univ Toronto, Fac Dent, Toronto, ON, Canada	Wroclaw University of Science & Technology; Polish Academy of Sciences; Institute of Low Temperature & Structure Research; University of Toronto; University of Toronto	Dobryszycki, P (corresponding author), Wroclaw Univ Sci & Technol, Fac Chem, Dept Biochem, Wybrzeze Wyspiatiskiego 27, PL-50370 Wroclaw, Poland.	piotr.dobryszycki@pwr.edu.pl		OZYHAR, Andrzej/0000-0002-5874-784X; Dobryszycki, Piotr/0000-0001-5522-2557; Ptak, Maciej/0000-0002-4639-2367	Polish National Science Center [UMO-2015/19/B/ST10/02148]; National Sciences and Engineering Research Council of Canada; Polish Ministry of Science and High Education	Polish National Science Center; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland)	The authors thank Jarosaw Stolarski (Institute of Paleobiology, Polish Academy of Science, Warsaw, Poland) and Alexander J. Lausch (Institute of Biomaterials and Biomedical Engineering, University of Toronto) for valuable comments and corrections. This work was supported by the Polish National Science Center (UMO-2015/19/B/ST10/02148) and, in part, by a statutory activity subsidy from the Polish Ministry of Science and High Education for the Faculty of Chemistry of Wrocaw University of Science and Technology, as well as a National Sciences and Engineering Research Council of Canada Discovery Grant to E.D.S. The authors declare no conflicts of interest.	Alvares K, 2014, CONNECT TISSUE RES, V55, P34, DOI 10.3109/03008207.2013.867336; Baht GS, 2010, BIOCHEM J, V428, P385, DOI 10.1042/BJ20091864; Borelli G, 2001, CALCIFIED TISSUE INT, V69, P356, DOI 10.1007/s00223-001-2016-8; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Deshpande AS, 2011, BIOMACROMOLECULES, V12, P2933, DOI 10.1021/bm2005214; Du JZ, 2018, CRYSTENGCOMM, V20, P3905, DOI 10.1039/c8ce00755a; Dwivedi PP, 2013, BONE, V55, P367, DOI 10.1016/j.bone.2013.04.013; Falini G, 2005, EUR J INORG CHEM, P162, DOI 10.1002/ejic.200400419; GAULDIE RW, 1993, J MORPHOL, V218, P1, DOI 10.1002/jmor.1052180102; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gungormus M, 2008, BIOMACROMOLECULES, V9, P966, DOI 10.1021/bm701037x; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; Hecker A, 2004, J STRUCT BIOL, V146, P310, DOI 10.1016/j.jsb.2004.01.009; Hecker A, 2003, FEBS LETT, V535, P49, DOI 10.1016/S0014-5793(02)03856-5; Hood MA, 2016, J STRUCT BIOL, V196, P147, DOI 10.1016/j.jsb.2016.09.010; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; Huq NL, 2000, J DENT RES, V79, P1914, DOI 10.1177/00220345000790111701; Kang YJ, 2008, JARO-J ASSOC RES OTO, V9, P436, DOI 10.1007/s10162-008-0137-8; Kaplon TM, 2008, BIOMACROMOLECULES, V9, P2118, DOI 10.1021/bm800135m; Kaplon TM, 2009, BBA-PROTEINS PROTEOM, V1794, P1616, DOI 10.1016/j.bbapap.2009.07.010; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kussmann M, 1999, BIOCHEMISTRY-US, V38, P7780, DOI 10.1021/bi982888y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeClair EE, 2009, DEV DYNAM, V238, P2550, DOI 10.1002/dvdy.22086; Li HY, 2011, ADV FUNCT MATER, V21, P2028, DOI 10.1002/adfm.201002709; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.3.CO;2-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundberg YW, 2015, DEV DYNAM, V244, P239, DOI 10.1002/dvdy.24195; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Metzler RA, 2010, J AM CHEM SOC, V132, P11585, DOI 10.1021/ja103089r; Motta CM, 2009, J ANAT, V214, P153, DOI 10.1111/j.1469-7580.2008.01003.x; Murayama E, 2005, MECH DEVELOP, V122, P791, DOI 10.1016/j.mod.2005.03.002; Murphy MB, 2007, BIOMACROMOLECULES, V8, P2237, DOI 10.1021/bm070121s; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Niemeier A, 2012, BONE, V50, P518, DOI 10.1016/j.bone.2011.07.015; Nuti D, 1996, J VESTIBUL RES-EQUIL, V6, P173, DOI 10.1016/0957-4271(95)02040-3; Oberg AL, 2008, J PROTEOME RES, V7, P225, DOI 10.1021/pr700734f; Oliveira AM, 1996, NATURWISSENSCHAFTEN, V83, P133; Payan P, 2004, CR PALEVOL, V3, P535, DOI 10.1016/j.crpv.2004.07.013; Petko JA, 2008, DEV NEUROBIOL, V68, P209, DOI 10.1002/dneu.20587; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Rozycka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114308; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Stooke-Vaughan GA, 2015, DEVELOPMENT, V142, P1137, DOI 10.1242/dev.116632; Suzuki Y, 1998, J DENT RES, V77, P1799, DOI 10.1177/00220345980770100701; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Takagi Y, 2002, MAR ECOL PROG SER, V231, P237, DOI 10.3354/meps231237; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Testeniere O, 2002, BIOCHEM J, V361, P327, DOI 10.1042/0264-6021:3610327; Tintut Y, 2014, TRENDS ENDOCRIN MET, V25, P53, DOI 10.1016/j.tem.2013.10.001; Tohse H, 2009, CRYST GROWTH DES, V9, P4897, DOI 10.1021/cg9006857; Tomas J, 2004, COMP BIOCHEM PHYS A, V139, P301, DOI 10.1016/j.cbpb.2004.09.013; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Varshney GK, 2016, MONOGR HUM GENET, V20, P110, DOI 10.1159/000444569; VEIS A, 1988, CIBA F SYMP, V136, P161; Veis A, 1997, CRIT REV ORAL BIOL M, V8, P360, DOI 10.1177/10454411970080040101; Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x; Walther LE, 2007, J VESTIBUL RES-EQUIL, V17, P89; Weber E, 2015, CRYSTENGCOMM, V17, P5873, DOI 10.1039/c5ce00389j; Weigele J, 2017, CONNECT TISSUE RES, V58, P172, DOI 10.1080/03008207.2016.1198337; Weigele J, 2016, ANAT REC, V299, P234, DOI 10.1002/ar.23289; Whitfield TT, 2002, J NEUROBIOL, V53, P157, DOI 10.1002/neu.10123; Wojtas M, 2015, BIOCHEMISTRY-US, V54, P6525, DOI 10.1021/acs.biochem.5b00933; Wojtas M, 2012, CRYST GROWTH DES, V12, P158, DOI 10.1021/cg200905f; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Yariz KO, 2012, AM J HUM GENET, V91, P872, DOI 10.1016/j.ajhg.2012.09.011; Younis S, 2012, CRYST GROWTH DES, V12, P4574, DOI 10.1021/cg3007734	70	12	12	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6877	6886		10.1096/fj.201802268R	http://dx.doi.org/10.1096/fj.201802268R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30840836	Bronze			2022-12-28	WOS:000476114200017
J	Yang, J; Tang, RH; Yi, J; Chen, YQ; Li, XH; Yu, T; Fei, J				Yang, Jing; Tang, Ruohui; Yi, Jin; Chen, Yueqi; Li, Xianghe; Yu, Tao; Fei, Jun			Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-kappa B-NFATc1 signal pathway	FASEB JOURNAL			English	Article						natural products; osteoclast; bone resorption	NF-KAPPA-B; RANKL-INDUCED OSTEOCLASTOGENESIS; CELL-CELL FUSION; BONE-RESORPTION; RECEPTOR ACTIVATOR; IN-VITRO; DIFFERENTIATION; LIGAND; MODULATION; MECHANISMS	Skeletal homeostasis is closely effectuated by the regulation of bone formation and bone resorption. Osteoclasts are multinuclear giant cells responsible for bone resorption. Overactivated osteoclasts and excessive bone resorption result in various lytic bone diseases, such as osteoporosis, osteoarthritis, periprosthetic infection, and inflammatory aseptic loosening of orthopedic implants. In consideration of the severe side effects caused by the currently available drugs, exploitation of novel drugs has gradually attracted attention. Because of its anti-inflammatory, antioxidant, and antitumor capacities, diallyl disulfide (DADS), a major oil-soluble organosulfur ingredient compound derived from garlic, has been widely researched. However, the effects of DADS on osteoclasts and lytic bone diseases are still unknown. In this study, we investigated the effects of DADS on receptor activator of NF-kappa B ligand (RANKL)- and LPS-mediated osteoclastogenesis, LPS-stimulated proinflammatory cytokines related to osteoclasts, and LPS-induced inflammatory osteolysis. The results showed that DADS significantly inhibited RANKL-mediated osteoclast formation, fusion, and bone resorption in a dose-dependent manner via inhibiting the NF-kappa B and signal transducer and activator of transcription 3 signaling and restraining the interaction of NF-kappa B p65 with nuclear factor of activated T cells cytoplasmic 1. Furthermore, DADS also markedly suppressed LPS-induced osteoclastogenesis and reduced the production of proinflammatory cytokines with LPS stimulation to indirectly mediate osteoclast formation. Consistent with the in vitro results, DADS prevented the LPS-induced severe bone loss by blocking the osteoclastogenesis. All of the results indicate that DADS may be a potential and exploitable drug used for preventing and impeding osteolytic lesions.-Yang, J., Tang, R., Yi, J., Chen, Y., Li, X., Yu, T., Fei, J. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-kappa B-NFATc1 signal pathway.	[Yang, Jing; Tang, Ruohui; Yi, Jin; Fei, Jun] Third Mil Med Univ, Daping Hosp, Ctr Trauma, Changjiang Zhilu 10, Chongqing 400042, Peoples R China; [Chen, Yueqi; Yu, Tao] Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Chongqing, Peoples R China; [Li, Xianghe] Guizhou Med Univ, Guizhou Prov Peoples Hosp, Dept Orthoped, Guiyang, Guizhou, Peoples R China	Army Medical University; Army Medical University; Guizhou Medical University	Fei, J (corresponding author), Third Mil Med Univ, Daping Hosp, Ctr Trauma, Changjiang Zhilu 10, Chongqing 400042, Peoples R China.	feijundoctor@sohu.com		Chen, Yueqi/0000-0001-6975-2874	Medical Research Funding of People's Liberation Army (PLA) of China [AWS14C003]; Special Funds for Social Undertaking and Livelihood Security Projects of Chongqing [CSTC2016SHMSZX130068]; Youth Dvelopment Program of Medical Technology of PLA [16QNP103]	Medical Research Funding of People's Liberation Army (PLA) of China; Special Funds for Social Undertaking and Livelihood Security Projects of Chongqing; Youth Dvelopment Program of Medical Technology of PLA	This work was funded by grants from Medical Research Funding of People's Liberation Army (PLA) of China (AWS14C003), Special Funds for Social Undertaking and Livelihood Security Projects of Chongqing (CSTC2016SHMSZX130068), and Youth Dvelopment Program of Medical Technology of PLA (16QNP103). The authors declare no conflicts of interest.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Bharti AC, 2004, J IMMUNOL, V172, P5940, DOI 10.4049/jimmunol.172.10.5940; Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CHI MS, 1982, J NUTR, V112, P241, DOI 10.1093/jn/112.2.241; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; Dou C, 2016, J CELL PHYSIOL, V231, P558, DOI 10.1002/jcp.24916; Druesne N, 2004, CARCINOGENESIS, V25, P1227, DOI 10.1093/carcin/bgh123; Feng C, 2017, INFLAMMATION, V40, P818, DOI 10.1007/s10753-017-0526-4; Feng W, 2017, SCI REP-UK, V7, DOI 10.1038/srep41411; Geurts J, 2016, J ORTHOP RES, V34, P262, DOI 10.1002/jor.23009; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guan XX, 2018, INT J CLIN EXP MED, V11, P6721; Heymann D, 2005, DRUG DISCOV TODAY, V10, P242, DOI 10.1016/S1359-6446(04)03265-9; Hosseinzadeh A, 2017, J CELL BIOCHEM, V118, P1879, DOI 10.1002/jcb.25907; Islam S, 2007, BIOCHEM BIOPH RES CO, V360, P346, DOI 10.1016/j.bbrc.2007.06.023; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Juybari KB, 2018, CELL TISSUE RES, V373, P407, DOI 10.1007/s00441-018-2825-y; Kanazawa K, 2005, J BONE MINER RES, V20, P840, DOI 10.1359/JBMR.041225; Kanazawa K, 2003, J BONE MINER RES, V18, P443, DOI 10.1359/jbmr.2003.18.3.443; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; KASSEM M, 1994, J BONE MINER RES, V9, P1365; Kimbaris AC, 2006, ULTRASON SONOCHEM, V13, P54, DOI 10.1016/j.ultsonch.2004.12.003; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kitaura H, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/181849; Komine M, 2001, BONE, V28, P474, DOI 10.1016/S8756-3282(01)00420-3; Lee IC, 2014, FOOD CHEM TOXICOL, V63, P174, DOI 10.1016/j.fct.2013.11.006; Lerner UH, 2000, MATRIX BIOL, V19, P107, DOI 10.1016/S0945-053X(00)00052-4; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Neale SD, 1999, J ORTHOP RES, V17, P686, DOI 10.1002/jor.1100170510; Nilforoushan D, 2009, NITRIC OXIDE-BIOL CH, V21, P27, DOI 10.1016/j.niox.2009.04.002; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027739; Park HY, 2012, TOXICOL APPL PHARM, V262, P177, DOI 10.1016/j.taap.2012.04.034; Park H, 2015, ANTIOXID REDOX SIGN, V22, P63, DOI 10.1089/ars.2013.5748; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Quan GH, 2015, INT J MOL SCI, V16, P29496, DOI 10.3390/ijms161226179; Quinn JMW, 2005, BIOCHEM BIOPH RES CO, V328, P739, DOI 10.1016/j.bbrc.2004.11.076; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rose-John S, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028415; Ruscitti P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/782382; Sabokbar A, 2003, J ORTHOP RES, V21, P73, DOI 10.1016/S0736-0266(02)00106-7; Saud SM, 2016, CANCER PREV RES, V9, P607, DOI 10.1158/1940-6207.CAPR-16-0044; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Shin IS, 2013, FOOD CHEM TOXICOL, V62, P506, DOI 10.1016/j.fct.2013.09.012; Smith BJ, 2006, BONE, V38, P378, DOI 10.1016/j.bone.2005.09.008; Song DZ, 2018, ARCH BIOCHEM BIOPHYS, V647, P76, DOI 10.1016/j.abb.2018.04.011; Song FM, 2018, J CELL PHYSIOL, V233, P1723, DOI 10.1002/jcp.26084; Sul OJ, 2017, MOL CELLS, V40, P880, DOI 10.14348/molcells.2017.0230; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Tang RH, 2019, J CELL PHYSIOL, V234, P7645, DOI 10.1002/jcp.27526; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teramachi J, 2017, ORAL DIS, V23, P181, DOI 10.1111/odi.12592; Tomomura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130174; Walton KJ, 2002, BLOOD, V100, P2530, DOI 10.1182/blood.V100.7.2530; Wei CM, 2018, J CELL PHYSIOL, V233, P476, DOI 10.1002/jcp.25907; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	66	17	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7261	7273		10.1096/fj.201802172R	http://dx.doi.org/10.1096/fj.201802172R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30857415	Green Published, hybrid			2022-12-28	WOS:000476114200049
J	Kwon, KW; Choi, HH; Han, SJ; Kim, JS; Kim, WS; Kim, H; Kim, LH; Kang, SM; Park, J; Shin, SJ				Kwon, Kee Woong; Choi, Hong-Hee; Han, Seung Jung; Kim, Jong-Seok; Kim, Woo Sik; Kim, Hongmin; Kim, Lee-Han; Kang, Soon Myung; Park, Jaehun; Shin, Sung Jae			Vaccine efficacy of a Mycobacterium tuberculosis Beijing-specific proline-glutamic acid (PE) antigen against highly virulent outbreak isolates	FASEB JOURNAL			English	Article						Beijing genotype; MTBK_20640; dendritic cells; subunit vaccine	T-CELL IMMUNITY; SECRETION SYSTEM; GENOME-SEQUENCE; DENDRITIC CELLS; LPRG RV1411C; ACTIVATION; PPE; RESPONSES; PROTEINS; MARINUM	Bacillus Calmette-Guerin vaccine confers insufficient pulmonary protection against tuberculosis (TB), particularly the Mycobacterium tuberculosis (Mtb) Beijing strain infection. Identification of vaccine antigens (Ags) by considering Mtb genetic diversity is crucial for the development of improved TB vaccine. MTBK_20640, a new Beijing genotype-specific proline-glutamic acid-family Ag, was identified by comparative genomic analysis. Its immunologic features were characterized by evaluating interactions with dendritic cells (DCs), and immunogenicity and vaccine efficacy were determined against highly virulent Mtb Beijing outbreak Korean Beijing (K) strain and HN878 strain in murine infection model. MTBK_20640 induced DCs via TLR2 and downstream MAPK and NF-B signaling pathways, effectively promoting naive CD4-positive (CD4(+)) T-cell proliferation and IFN- production. Different IFN- response was observed in mice infected with Mtb K or reference H37Rv strain. Significant induction of T helper type 1 cell-polarized Ag-specific multifunctional CD4(+) T cells and a marked Ag-specific IgG2c response were observed in mice immunized with MTBK_20640/glucopyranosyl lipid adjuvant-stable emulsion. The immunization conferred long-term protection against 2 Mtb Beijing outbreak strains, as evidenced by a significant reduction in colony-forming units in the lung and spleen and reduced lung inflammation. MTBK_20640 vaccination conferred long-term protection against highly virulent Mtb Beijing strains. MTBK_20640 may be developed into a novel Ag component in multisubunit TB vaccines in the future.Kwon, K. W., Choi, H.-H., Han, S. J., Kim, J.-S., Kim, W. S., Kim, H., Kim, L.-H., Kang, S. M., Park, J., Shin, S. J. Vaccine efficacy of a Mycobacterium tuberculosis Beijing-specific proline-glutamic acid (PE) antigen against highly virulent outbreak isolates.	[Kwon, Kee Woong; Choi, Hong-Hee; Han, Seung Jung; Kim, Jong-Seok; Kim, Woo Sik; Kim, Hongmin; Kim, Lee-Han; Kang, Soon Myung; Park, Jaehun; Shin, Sung Jae] Yonsei Univ, Coll Med, Dept Microbiol, Inst Immunol & Immunol Dis,Brain Korea 21 Program, Seoul, South Korea; [Kim, Jong-Seok] Konyang Univ, Coll Med, Myunggok Med Res Inst, Daejeon, South Korea; [Kim, Woo Sik] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup, South Korea	Yonsei University; Yonsei University Health System; Konyang University; Konyang University Hospital; Korea Atomic Energy Research Institute (KAERI)	Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, 50-1 Yonsei Ro,ABMRC 304, Seoul 03722, South Korea.; Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Brain Korea 21 Program Leading Univ & Students PL, 50-1 Yonsei Ro,ABMRC 304, Seoul 03722, South Korea.	sjshin@yuhs.ac		Shin, Sung Jae/0000-0003-0854-4582	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of science, ICT & Future Planning [NRF-2016R1A2A1A05005263]; Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea [HI17C0175]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of science, ICT & Future Planning; Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea	The authors thank Professor Sang-Jun Ha from the College of Life Science and Biotechnology, Department of Biochemistry, Yonsei University, for his helpful advice on the experimental design and technical support. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of science, ICT & Future Planning (NRF-2016R1A2A1A05005263) and by a grant from the Korean Health Technology R&D Project of the Ministry of Health & Welfare (HI17C0175), Republic of Korea. The authors declare no conflicts of interest.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abebe F, 2006, CLIN EXP IMMUNOL, V145, P389, DOI 10.1111/j.1365-2249.2006.03162.x; Aguilo N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16085; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Byun EH, 2012, FASEB J, V26, P2695, DOI 10.1096/fj.11-199588; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Chaitra MG, 2005, VACCINE, V23, P1265, DOI 10.1016/j.vaccine.2004.08.046; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Choi HG, 2017, ONCOTARGET, V8, P19947, DOI 10.18632/oncotarget.15256; Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Drage MG, 2010, NAT STRUCT MOL BIOL, V17, P1088, DOI 10.1038/nsmb.1869; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gehring AJ, 2004, J IMMUNOL, V173, P2660, DOI 10.4049/jimmunol.173.4.2660; Goulding JN, 2000, J CLIN MICROBIOL, V38, P1121, DOI 10.1128/JCM.38.3.1121-1126.2000; Groschel MI, 2017, CELL REP, V18, P2752, DOI 10.1016/j.celrep.2017.02.057; Han SJ, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0071-4; Hanif SNM, 2011, SCAND J IMMUNOL, V74, P554, DOI 10.1111/j.1365-3083.2011.02604.x; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Jeon BY, 2012, J MED MICROBIOL, V61, P1373, DOI 10.1099/jmm.0.047027-0; Jeon BY, 2011, MICROBES INFECT, V13, P284, DOI 10.1016/j.micinf.2010.11.002; Kaufmann SHE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4730; Kim JS, 2013, J LEUKOCYTE BIOL, V94, P733, DOI 10.1189/jlb.0912435; Kim WS, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00095; Kim WS, 2016, ONCOTARGET, V7, P24962, DOI 10.18632/oncotarget.8771; Kim WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145234; Kwon KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44151; Le Moigne V, 2005, TUBERCULOSIS, V85, P213, DOI 10.1016/j.tube.2005.02.002; Li H, 2016, APOPTOSIS, V21, P795, DOI 10.1007/s10495-016-1249-y; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Liu SQ, 2014, MOL IMMUNOL, V62, P227, DOI 10.1016/j.molimm.2014.06.026; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Okkels LM, 2003, INFECT IMMUN, V71, P6116, DOI 10.1128/IAI.71.11.6116-6123.2003; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Penn-Nicholson A, 2018, LANCET RESP MED, V6, P287, DOI [10.1016/S2213-2600(18)30077-8, 10.1016/s2213-2600(18)30077-8]; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Qiu ZG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00216; Rachman H, 2006, J BIOTECHNOL, V126, P61, DOI 10.1016/j.jbiotec.2006.02.020; Reece ST, 2008, INT J MED MICROBIOL, V298, P143, DOI 10.1016/j.ijmm.2007.07.004; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Sayes F, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005770; Su HB, 2018, J BIOL CHEM, V293, P10287, DOI 10.1074/jbc.RA118.001696; Su HB, 2015, ONCOTARGET, V6, P38517, DOI 10.18632/oncotarget.5956; Tiwari BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051686; Vani J, 2013, J INFECT DIS, V208, P1034, DOI 10.1093/infdis/jit281; Verwaerde C, 2014, VACCINE, V32, P6240, DOI 10.1016/j.vaccine.2014.09.024; Vipond J, 2006, TUBERCULOSIS, V86, P218, DOI 10.1016/j.tube.2006.01.014; Wang BL, 2007, CLIN VACCINE IMMUNOL, V14, P902, DOI 10.1128/CDLI.00077-07; Xu YW, 2015, IEEE 12TH INT CONF UBIQUITOUS INTELLIGENCE & COMP/IEEE 12TH INT CONF ADV & TRUSTED COMP/IEEE 15TH INT CONF SCALABLE COMP & COMMUN/IEEE INT CONF CLOUD & BIG DATA COMP/IEEE INT CONF INTERNET PEOPLE AND ASSOCIATED SYMPOSIA/WORKSHOPS, P93, DOI 10.1109/UIC-ATC-ScalCom-CBDCom-IoP.2015.37	55	7	7	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6483	6496		10.1096/fj.201802604R	http://dx.doi.org/10.1096/fj.201802604R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753099	Bronze			2022-12-28	WOS:000466932600053
J	Wang, JL; Dean, DC; Hornicek, FJ; Shi, HR; Duan, ZF				Wang, Jinglu; Dean, Dylan C.; Hornicek, Francis J.; Shi, Huirong; Duan, Zhenfeng			Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer	FASEB JOURNAL			English	Article						LDC000067; transcription; apoptosis	PRECLINICAL MODELS; CELL-CYCLE; TRANSCRIPTION; INHIBITION; EXPRESSION; PHOSPHORYLATION; FLAVOPIRIDOL; STATISTICS; ELONGATION; SYNERGIZES	Despite surgical and chemotherapeutic advances over the past few decades, the prognosis for ovarian cancer remains very poor. Although cyclin-dependent kinase (CDK) 9 has an established pathogenic role in various cancers, its function in ovarian cancer remains poorly defined. The purpose of this study was to evaluate the expression of CDK9 and its therapeutic potential in ovarian cancer. CDK9 expression was determined by immunohistochemistry in a unique ovarian cancer tissue microarray constructed with paired primary, metastatic, and recurrent tumor tissues from 26 ovarian cancer patients. CDK9 was highly expressed in human ovarian cancer cell lines and was also elevated in metastatic and recurrent ovarian tumor tissue compared with patient-matched primary ovarian tumor tissue. In addition, increased CDK9 significantly correlated with poor patient prognosis. Inhibition of CDK9 by small interfering RNA or CDK9 inhibitor functionally suppressed RNA transcription elongation, induced apoptosis, and reduced proliferation of ovarian cancer cells. Inhibition of CDK9 also suppressed ovarian cancer cell spheroid growth, clonogenicity formation, and migration activity. Our results reveal CDK9 as a novel prognostic biomarker and a promising therapeutic target for preventing metastasis and recurrence while also improving the overall clinical outcome for ovarian cancer patients.Wang, J., Dean, D. C., Hornicek, F. J., Shi, H., Duan, Z. Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer.	[Wang, Jinglu; Shi, Huirong; Duan, Zhenfeng] Zhengzhou Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China; [Wang, Jinglu; Dean, Dylan C.; Hornicek, Francis J.; Duan, Zhenfeng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, 615 Charles E Young Dr South, Los Angeles, CA 90095 USA	Zhengzhou University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shi, HR; Duan, ZF (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China.; Duan, ZF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, 615 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fccshihr@zzu.edu.cn; zduan@mednet.ucla.edu	Duan, Zhenfeng/AAK-5587-2020		National Natural Science Foundation of China [81402266, 81372875]; U.S. National Institutes of Health, National Cancer Institute [CA151452-01]; China Scholarship Council [201607040013]; Gattegno fund; Wechsler fund;  [228282]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); China Scholarship Council(China Scholarship Council); Gattegno fund; Wechsler fund; 	This work was supported, in part, by a Joint Research Fund (228282) devoted to clinical pharmacy and precision medicine (to Z.D.). Support has also been provided by the National Natural Science Foundation of China (Grants 81402266 and 81372875), and Gattegno and Wechsler funds. Z.D. was supported, in part, by the U.S. National Institutes of Health, National Cancer Institute (Grant UO1, CA151452-01). J.W. was supported by a scholarship from the China Scholarship Council (201607040013). The authors declare no conflicts of interest.	Ajiro M, 2018, CLIN CANCER RES, V24, P4518, DOI 10.1158/1078-0432.CCR-17-3119; Albert TK, 2014, BRIT J PHARMACOL, V171, P55, DOI 10.1111/bph.12408; Baker A, 2016, CANCER RES, V76, P1158, DOI 10.1158/0008-5472.CAN-15-1070; Bragelmann J, 2017, CELL REP, V20, P2833, DOI 10.1016/j.celrep.2017.08.082; Caracciolo V, 2012, CELL CYCLE, V11, P1202, DOI 10.4161/cc.11.6.19663; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Chen XX, 2015, ONCOTARGET, V6, P14926, DOI 10.18632/oncotarget.3717; De Falco G, 2005, CANCER BIOL THER, V4, P277; Du Bois A, 2005, INT J GYNECOL CANCER, V15, P42, DOI 10.1111/j.1525-1438.2005.15356.x; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gao Y, 2017, CELL ONCOL, V40, P209, DOI 10.1007/s13402-017-0316-x; Greifenberg AK, 2016, CELL REP, V14, P320, DOI 10.1016/j.celrep.2015.12.025; Herrmann D, 2014, CARCINOGENESIS, V35, P1671, DOI 10.1093/carcin/bgu108; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huang CH, 2014, GENE DEV, V28, P1800, DOI 10.1101/gad.244368.114; Kohoutek J, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-19; Kretz AL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694304; Lam F, 2014, ONCOTARGET, V5, P7691, DOI 10.18632/oncotarget.2296; Liu HB, 2005, J CELL PHYSIOL, V203, P251, DOI 10.1002/jcp.20224; Liu XZ, 2016, MOL CANCER THER, V15, P1691, DOI 10.1158/1535-7163.MCT-16-0032; Loschmann N, 2016, ONCOTARGET, V7, P58051, DOI 10.18632/oncotarget.11160; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mitra P, 2016, ONCOTARGET, V7, P9069, DOI 10.18632/oncotarget.6997; Morales F, 2016, CELL CYCLE, V15, P519, DOI 10.1080/15384101.2016.1138186; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Prudencio M, 2017, HUM MOL GENET, V26, P3421, DOI 10.1093/hmg/ddx233; Rahaman MH, 2016, ENDOCR-RELAT CANCER, V23, pT211, DOI 10.1530/ERC-16-0299; Rajput S, 2016, ONCOTARGET, V7, P56864, DOI 10.18632/oncotarget.10870; Romano G, 2008, CELL CYCLE, V7, P3664, DOI 10.4161/cc.7.23.7122; Sato S, 2014, THER ADV MED ONCOL, V6, P293, DOI 10.1177/1758834014544891; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Shore SM, 2005, GENE, V350, P51, DOI 10.1016/j.gene.2005.01.015; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Su YT, 2018, CLIN CANCER RES, V24, P1124, DOI 10.1158/1078-0432.CCR-17-2032; Walsby E, 2014, ONCOTARGET, V5, P375, DOI 10.18632/oncotarget.1568; Wang JL, 2018, GYNECOL ONCOL, V150, P143, DOI 10.1016/j.ygyno.2018.04.557; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Whittaker SR, 2018, MOL ONCOL, V12, P287, DOI 10.1002/1878-0261.12148; Zhang HH, 2018, CELL, V175, P1244, DOI 10.1016/j.cell.2018.09.051	46	32	34	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5990	6000		10.1096/fj.201801789RR	http://dx.doi.org/10.1096/fj.201801789RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30726104	Bronze, Green Published			2022-12-28	WOS:000466932600016
J	Ano, Y; Hoshi, A; Ayabe, T; Ohya, R; Uchida, S; Yamada, K; Kondo, K; Kitaoka, S; Furuyashiki, T				Ano, Yasuhisa; Hoshi, Ayaka; Ayabe, Tatsuhiro; Ohya, Rena; Uchida, Shinichi; Yamada, Koji; Kondo, Keiji; Kitaoka, Shiho; Furuyashiki, Tomoyuki			Iso-alpha-acids, the bitter components of beer, improve hippocampus-dependent memory through vagus nerve activation	FASEB JOURNAL			English	Article						dopamine; amnesia; beer; hop	SYNAPTIC PLASTICITY; ALCOHOL-CONSUMPTION; DORSAL HIPPOCAMPUS; LOCUS-COERULEUS; FOOD-INTAKE; RECEPTOR; TASTE; KINASE; GUT; CONSOLIDATION	Iso-alpha-acids (IAAs) are hop-derived bitter acids of beer. Epidemiologic studies suggest that moderate alcohol consumption is beneficial for cognitive function, but they do not show the ingredients in alcoholic beverages. Previously, we reported that long-term consumption of IAAs prevents inflammation and Alzheimer pathologies in mice, but their effects on cognitive function have not been evaluated. In the present study, we demonstrated that the consumption of IAAs improves spatial and object recognition memory functions not only in normal Crl:CD1(ICR) male mice but also in mice with pharmacologically induced amnesia. IAA consumption increased the total and extracellular levels of dopamine in the hippocampus of mice and Sprague-Dawley male rats, respectively. Dopamine D-1 receptor antagonist treatment and knockdown of dopamine D-1 receptor expression in the hippocampus attenuated IAA-induced spatial memory improvement. Furthermore, vagotomy attenuated the effects of IAAs in improving spatial and object recognition memory functions and increasing the total level of dopamine in the hippocampus. These results suggest that the consumption of IAAs activates dopamine D-1 receptor-signaling in the hippocampus in a vagus nerve-dependent manner and, consequently, improves spatial and object recognition memory functions. Vagal activation with food components including IAAs may be an easy and safe approach to improve cognitive functions.	[Ano, Yasuhisa; Hoshi, Ayaka; Ayabe, Tatsuhiro; Ohya, Rena; Kondo, Keiji] Kirin Co Ltd, Res Labs Hlth Sci & Food Technol, Yokohama, Kanagawa, Japan; [Uchida, Shinichi; Yamada, Koji] Kyowa Hakko Kirin Co Ltd, Cent Nervous Syst Res Labs, Div Res & Dev, Cent Nervous Syst CNS Res & Dev Unit, Shizuoka, Japan; [Kitaoka, Shiho; Furuyashiki, Tomoyuki] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo, Japan; [Kitaoka, Shiho; Furuyashiki, Tomoyuki] Japan Agcy Med Res & Dev Ctr Res Excellence Sci &, Tokyo, Japan	Kyowa Kirin Ltd; Kobe University	Ano, Y (corresponding author), Kirin Co, Res Labs Hlth Sci & Food Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	yasuhisa_ano@kirin.co.jp	Furuyashiki, Tomoyuki/AAG-5283-2019; Furuyashiki, Tomoyuki/B-8760-2014	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Ayabe, Tatsuhiro/0000-0002-5023-4986	Kirin Co.; Centers of Research Excellence in Science and Technology (CREST) Grant from Japan Agency for Medical Research and Development (AMED) [JP18gm0910012]; Japan Society for the Promotion of Science [16H05132, 17K19457, 17K08593]; Ministry of Education, Culture, Sports, Science, and Technology in Japan [18H05429]	Kirin Co.; Centers of Research Excellence in Science and Technology (CREST) Grant from Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Kirin Co. and, in part by a Centers of Research Excellence in Science and Technology (CREST) Grant from Japan Agency for Medical Research and Development (AMED; JP18gm0910012 to T.F.); Grants-in-Aid for Scientific Research (16H05132 and 17K19457 to T.F., 17K08593 to S.K.) from the Japan Society for the Promotion of Science; and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (18H05429 to T.F.). The authors declare no conflicts of interest.	Ano Y, 2018, NEUROBIOL AGING, V72, P23, DOI 10.1016/j.neurobiolaging.2018.07.016; Ano Y, 2017, J BIOL CHEM, V292, P3720, DOI 10.1074/jbc.M116.763813; Arntzen KA, 2010, ACTA NEUROL SCAND, V122, P23, DOI 10.1111/j.1600-0404.2010.01371.x; Ayabe T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23213-9; Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Berman DE, 1998, J NEUROSCI, V18, P10037; Blum S, 1999, J NEUROSCI, V19, P3535; Breit S, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00044; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Chan JP, 2017, BEHAV BRAIN RES, V321, P61, DOI 10.1016/j.bbr.2016.12.026; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; da Silva WCN, 2012, NEUROBIOL LEARN MEM, V97, P271, DOI 10.1016/j.nlm.2012.01.005; Dorr AE, 2006, J PHARMACOL EXP THER, V318, P890, DOI 10.1124/jpet.106.104166; Egan JM, 2008, MOL INTERV, V8, P78, DOI 10.1124/mi.8.2.5; Farrand AQ, 2017, BRAIN STIMUL, V10, P1045, DOI 10.1016/j.brs.2017.08.008; Follesa P, 2007, BRAIN RES, V1179, P28, DOI 10.1016/j.brainres.2007.08.045; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Furini CRG, 2014, BEHAV BRAIN RES, V271, P212, DOI 10.1016/j.bbr.2014.06.027; Hagena Hardy, 2016, Front Synaptic Neurosci, V8, P31; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Hebert AE, 2002, LEARN MEMORY, V9, P156, DOI 10.1101/lm.48502; Horvat P, 2015, NEUROLOGY, V84, P287, DOI 10.1212/WNL.0000000000001164; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; Kempadoo KA, 2016, P NATL ACAD SCI USA, V113, P14835, DOI 10.1073/pnas.1616515114; Lee KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135578; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Liu AF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0858-0; MacIntosh CG, 2001, J CLIN ENDOCR METAB, V86, P5830, DOI 10.1210/jc.86.12.5830; Matsui Toshifumi, 2011, Nihon Rinsho, V69 Suppl 10 Pt 2, P217; Moran TH, 1997, AM J PHYSIOL-REG I, V272, pR1245; Nagai T, 2007, LEARN MEMORY, V14, P117, DOI 10.1101/lm.461407; Neafsey EJ, 2011, NEUROPSYCH DIS TREAT, V7, P465, DOI 10.2147/NDT.S23159; Papaleonidopoulos V, 2018, SYNAPSE, V72, DOI 10.1002/syn.22033; Perez-Pardo P, 2017, EUR J PHARMACOL, V817, P86, DOI 10.1016/j.ejphar.2017.05.042; Pioli EY, 2014, BEHAV BRAIN RES, V261, P249, DOI 10.1016/j.bbr.2013.12.009; Schafe GE, 2000, J NEUROSCI, V20, P8177; Shinohara R, 2018, MOL PSYCHIATR, V23, P1717, DOI 10.1038/mp.2017.177; Smucny J, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00043; Suarez AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04639-1; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Takeuchi T, 2016, NATURE, V537, P357, DOI 10.1038/nature19325; Taniguchi Y, 2013, J AGR FOOD CHEM, V61, P3121, DOI 10.1021/jf3047187; Watson C, 2006, RAT BRAIN STEREOTAXI; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yamasaki M, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/8602690; Yang KC, 2017, EUR J NEUROSCI, V45, P138, DOI 10.1111/ejn.13406	48	14	15	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4987	4995		10.1096/fj.201801868RR	http://dx.doi.org/10.1096/fj.201801868RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601670	Green Published, hybrid			2022-12-28	WOS:000462888500028
J	Wang, QL; Liszt, KI; Deloose, E; Canovai, E; Thijs, T; Farre, R; Ceulemans, LJ; Lannoo, M; Tack, J; Depoortere, I				Wang, Qiaoling; Liszt, Kathrin I.; Deloose, Eveline; Canovai, Emilio; Thijs, Theo; Farre, Ricard; Ceulemans, Laurens J.; Lannoo, Matthias; Tack, Jan; Depoortere, Inge			Obesity alters adrenergic and chemosensory signaling pathways that regulate ghrelin secretion in the human gut	FASEB JOURNAL			English	Article						sympathetic nervous system; bitter taste receptor; glucose sensors; nutrient sensing	COUPLED RECEPTOR REPERTOIRE; BITTER TASTE RECEPTORS; GASTRIC GHRELIN; ACYLATED PEPTIDE; CELLS; SENSITIVITY; SWEET; WEIGHT; SOMATOSTATIN; SUPPRESSION	Chemosensory signaling in organs such as the mouth and gut contributes to the mechanisms that control metabolism. We investigated the chemosensory pathways that regulate secretion of the hunger hormone ghrelin in response to neurotransmitters, bitter and sweet tastants at the cellular level in the human gut mucosa, and the disturbances in this regulatory pathway induced by obesity. Obesity impaired ghrelin protein production and adrenalin-induced ghrelin secretion in fundic cells, which was counterbalanced by somatostatin. Bitter agonists selective for taste receptor type 2 (TAS2Rs), TAS2R5 and TAS2R10 stimulated ghrelin secretion in fundic cells. The stimulatory effect of the broadly tuned bitter agonist, denatonium benzoate, was selectively blunted by obesity in the small intestine but not in the fundus. Luminal glucose concentrations inhibited ghrelin secretion via sodium-dependent glucose cotransporter and taste receptor type 1 member 3. Obesity altered the sensitivity of the ghrelin cell to glucose in the small intestine but not in the fundus. Sweet taste receptor activation inhibited bitter taste signaling of the ghrelin cell. In conclusion, obesity impairs the sympathetic drive that controls ghrelin release in the fundus and affects the sensitivity of the ghrelin cell to bitter and sweet stimuli in the small intestine but not in the fundus. Region-selective targeting of gut taste receptors in obesity is indicated.	[Wang, Qiaoling; Liszt, Kathrin I.; Deloose, Eveline; Thijs, Theo; Farre, Ricard; Tack, Jan; Depoortere, Inge] Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Leuven, Belgium; [Canovai, Emilio; Ceulemans, Laurens J.] Univ Hosp Leuven, Dept Abdominal Surg & Transplant Coordinat, Leuven, Belgium; [Lannoo, Matthias] Univ Hosp Leuven, Dept Abdominal Surg, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Depoortere, I (corresponding author), Univ Leuven, Gut Peptide Res Lab, Translat Res Ctr Gastrointestinal Disorders TARGI, Gasthuisberg O&N1,Box 701, B-3000 Leuven, Belgium.	inge.depoortere@kuleuven.be	Canovai, Emilio/F-5985-2018; Farre, Ricard/M-9275-2013; Farre, Ricard/O-4549-2016; lannoo, matthias/AAB-1706-2020; Depoortere, Inge/I-5019-2013	Canovai, Emilio/0000-0003-4921-466X; Farre, Ricard/0000-0001-7158-171X; Farre, Ricard/0000-0001-7158-171X; Ceulemans, Laurens/0000-0002-4261-7100; Lannoo, matthias/0000-0001-7815-1157; Liszt, Kathrin/0000-0003-2507-0630; Thijs, Theo/0000-0001-5226-2633; Depoortere, Inge/0000-0002-0289-2175; Tack, Jan/0000-0002-3206-6704	research Foundation Flanders [FWO G073615N, 12R2618N]; Methusalem grant from KU Leuven; Chinese Scholarship Council (CSC) [201508370091]	research Foundation Flanders(FWO); Methusalem grant from KU Leuven; Chinese Scholarship Council (CSC)(China Scholarship Council)	The authors thank L. Nys (Translational Research Center for Gastrointestinal Disorders, University of Leuven) for her skillful technical assistance and doctors from the bariatric surgery team (University Hospitals Leuven) for recruiting the obese patients. This work was supported by grants from the research Foundation Flanders (FWO G073615N and 12R2618N), a Methusalem grant from KU Leuven, and the Chinese Scholarship Council (CSC; 201508370091). The authors declare no conflicts of interest.	Avau B, 2016, ACTA PHYSIOL, V216, P407, DOI 10.1111/apha.12621; Avau B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145538; Bertoli S, 2014, WORLD J DIABETES, V5, P717, DOI 10.4239/wjd.v5.i5.717; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chao DHM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29094; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; Dadan J, 2009, FOLIA HISTOCHEM CYTO, V47, P307, DOI 10.2478/v10042-009-0033-z; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; De Waele K, 2008, EUR J ENDOCRINOL, V159, P381, DOI 10.1530/EJE-08-0462; Deloose E, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13171; Deloose E, 2017, AM J CLIN NUTR, V105, P580, DOI 10.3945/ajcn.116.138297; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; Egerod KL, 2015, ENDOCRINOLOGY, V156, P3909, DOI 10.1210/EN.2015-1388; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; English PJ, 2002, J CLIN ENDOCR METAB, V87, P2984, DOI 10.1210/jc.87.6.2984; Foster-Schubert KE, 2008, J CLIN ENDOCR METAB, V93, P1971, DOI 10.1210/jc.2007-2289; Gagnon J, 2012, ENDOCRINOLOGY, V153, P3646, DOI 10.1210/en.2012-1040; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hardikar S, 2017, APPETITE, V111, P158, DOI 10.1016/j.appet.2016.12.017; Iven J, 2019, NUTR NEUROSCI, V22, P850, DOI 10.1080/1028415X.2018.1457841; Iwakura H, 2011, ENDOCRINOLOGY, V152, P2619, DOI 10.1210/en.2010-1455; Jaggupilli A, 2019, FASEB J, V33, P501, DOI 10.1096/fj.201800521RR; Jaggupilli A, 2016, INT J BIOCHEM CELL B, V77, P184, DOI 10.1016/j.biocel.2016.03.005; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kok BP, 2018, MOL METAB, V16, P76, DOI 10.1016/j.molmet.2018.07.013; Laermans J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16748; Laffitte A, 2014, CURR OPIN CLIN NUTR, V17, P379, DOI 10.1097/MCO.0000000000000058; Lee RJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7703; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Liszt KI, 2017, P NATL ACAD SCI USA, V114, pE6260, DOI 10.1073/pnas.1703728114; Mani BK, 2016, J CLIN INVEST, V126, P3467, DOI 10.1172/JCI86270; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Meyer-Gerspach AC, 2018, AM J CLIN NUTR, V107, P707, DOI 10.1093/ajcn/nqy004; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mundinger TO, 2006, ENDOCRINOLOGY, V147, P2893, DOI 10.1210/en.2005-1182; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nguyen NQ, 2015, J CLIN ENDOCR METAB, V100, P968, DOI 10.1210/jc.2014-3144; Olabi A, 2018, NUTR RES, V49, P48, DOI 10.1016/j.nutres.2017.10.001; Overberg J, 2012, ARCH DIS CHILD, V97, P1048, DOI 10.1136/archdischild-2011-301189; Park DC, 2015, ACTA OTO-LARYNGOL, V135, P478, DOI 10.3109/00016489.2014.975370; Park J, 2015, BIOCHEM BIOPH RES CO, V468, P306, DOI 10.1016/j.bbrc.2015.10.107; Parker BA, 2005, CLIN ENDOCRINOL, V62, P539, DOI 10.1111/j.1365-2265.2005.02254.x; Proserpio C, 2016, CHEM SENSES, V41, P169, DOI 10.1093/chemse/bjv072; Pydi SP, 2015, BIOCHEMISTRY-US, V54, P2622, DOI 10.1021/acs.biochem.5b00265; Rindi G, 2002, HISTOCHEM CELL BIOL, V117, P511, DOI 10.1007/s00418-002-0415-1; Ritze Y, 2016, NEUROGASTROENT MOTIL, V28, P806, DOI 10.1111/nmo.12773; Roper SD, 2017, NAT REV NEUROSCI, V18, P485, DOI 10.1038/nrn.2017.68; Roudnitzky N, 2016, CHEM SENSES, V41, P3, DOI 10.1093/chemse/bjw067; SAITO H, 1982, CANCER, V50, P560, DOI 10.1002/1097-0142(19820801)50:3<560::AID-CNCR2820500329>3.0.CO;2-I; Simchen U, 2006, EUR J CLIN NUTR, V60, P698, DOI 10.1038/sj.ejcn.1602371; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Steensels S, 2018, ANNU REV PHYSIOL, V80, P117, DOI 10.1146/annurev-physiol-021317-121332; Steensels S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120795; Steinert RE, 2012, AM J PHYSIOL-ENDOC M, V302, pE666, DOI 10.1152/ajpendo.00457.2011; Tamboli RA, 2016, AM J PHYSIOL-ENDOC M, V311, pE252, DOI 10.1152/ajpendo.00082.2016; Tentolouris N, 2004, HORM METAB RES, V36, P559, DOI 10.1055/s-2004-825761; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Uchida A, 2014, MOL METAB, V3, P717, DOI 10.1016/j.molmet.2014.07.009; Vancleef L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15725; Vancleef L, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700804; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walters DE, 1996, TRENDS FOOD SCI TECH, V7, P399, DOI 10.1016/S0924-2244(96)10040-6; Widmayer P, 2012, INT J OBESITY, V36, P1353, DOI 10.1038/ijo.2011.216; Wolnerhanssen BK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08487-9; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P15868, DOI 10.1073/pnas.1011116107; Zigman JM, 2016, TRENDS ENDOCRIN MET, V27, P54, DOI 10.1016/j.tem.2015.09.010	69	30	30	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4907	4920		10.1096/fj.201801661RR	http://dx.doi.org/10.1096/fj.201801661RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629462	Bronze, Green Accepted			2022-12-28	WOS:000462888500022
J	Zhang, XW; Wang, L; Ding, H				Zhang, Xiu Wei; Wang, Lei; Ding, Hong			Long noncoding RNA AK089579 inhibits epithelial-to-mesenchymal transition of peritoneal mesothelial cells by competitively binding to microRNA-296-3p via DOK2 in peritoneal fibrosis	FASEB JOURNAL			English	Article						JAK2/STAT3 signaling pathway; peritoneal fibrosis; ceRNA	INTEGRATIVE ANNOTATION; RAT MODEL; EXPRESSION; APOPTOSIS; MIR-296; PROLIFERATION; PROTEINS; THERAPY; COMPLEX; FLUID	Peritoneal fibrosis (PF) represents a well-recognized complication associated with continuous ambulatory peritoneal dialysis therapy, characterized by a reversible epithelial-to-mesenchymal transition (EMT) at the early stage. The aim of the current study was to investigate the effects linked with the long noncoding RNA (lncRNA) AK089579 on the EMT of peritoneal mesothelial cells (PMCs) as well as the associated regulatory mechanisms of AK089579 downstream of tyrosine kinase 2 (DOK2) and microRNA-296-3p (miR-296-3p). Enrichment analysis, gene intersection association analysis, and a gene-gene intersection network were initially constructed to ascertain whether AK089579 regulated the expression of DOK2 through the mediation of miR-296-3p via the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway in PF. After the PF mouse model had been constructed, the expression of the proteins associated with the JAK2/STAT3 signaling pathway and EMT and PMC migration and invasion were all determined accordingly. Based on the obtained results, AK089579 was determined to function as a competing endogenous RNA for miR-296-3p while acting to up-regulate the expression of DOK2, which is a target gene of miR-296-3p. AK089579 was detected to confer an inhibitory effect on the activation of the JAK2/STAT3 signaling pathway, whereby the migration and invasion of PMCs among the mice models were suppressed. Meanwhile, up-regulated miR-296-3p and down-regulated DOK2 produced contrasting effects when compared with the aforementioned findings. Treatment with wp10066, a JAK2/STAS3 signaling pathway inhibitor, was shown to reverse the effects exerted by up-regulated miR-296-3p. Taken together, the central findings of the current study present evidence highlighting the capability of the lncRNA AK089579 to bind competitively to miR-296-3p and indirectly enhance the expression of DOK2, which in turn suppresses the activation of the JAK2/STAT3 signaling pathway, whereby the EMT, migration, and invasion of PMCs was inhibited in PF.	[Zhang, Xiu Wei] China Med Univ, Affiliated Hosp 4, Dept Pathol, Shenyang, Liaoning, Peoples R China; [Wang, Lei; Ding, Hong] China Med Univ, Affiliated Hosp 4, Dept Nephrol, 4 Chongshan East Rd, Shenyang 110032, Liaoning, Peoples R China	China Medical University; China Medical University	Ding, H (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Nephrol, 4 Chongshan East Rd, Shenyang 110032, Liaoning, Peoples R China.	dinghong9209@126.com			Key Project of the Natural Science Foundation of Liaoning Province [20170541034]	Key Project of the Natural Science Foundation of Liaoning Province	The authors acknowledge the helpful comments on this paper received from reviewers. This study was supported by the Key Project of the Natural Science Foundation of Liaoning Province (20170541034). The authors declare no conflicts of interest.	Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chaudhary K, 2014, AM J PHYSIOL-RENAL, V307, pF777, DOI 10.1152/ajprenal.00653.2013; Che MW, 2017, J AM SOC NEPHROL, V28, P2459, DOI 10.1681/ASN.2016060663; Dinami R, 2017, ONCOTARGET, V8, P95674, DOI 10.18632/oncotarget.21180; Fu QF, 2017, CLIN CANCER RES, V23, P6336, DOI 10.1158/1078-0432.CCR-16-2813; Gunthner R, 2013, INT J MOL SCI, V14, P18124, DOI 10.3390/ijms140918124; Hong L, 2010, ANN SURG, V251, P1056, DOI 10.1097/SLA.0b013e3181dd4ea9; Huberdeau MQ, 2017, EMBO J, V36, P2088, DOI 10.15252/embj.201696386; Ishimatsu N, 2016, HISTOL HISTOPATHOL, V31, P1251, DOI 10.14670/HH-11-756; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Kim H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-528; Kuzuoglu-Ozturk D, 2016, EMBO J, V35, P1186, DOI 10.15252/embj.201592901; Li LK, 2018, KIDNEY INT, V93, P1384, DOI 10.1016/j.kint.2017.12.023; Li Q, 2018, MOL IMMUNOL, V94, P131, DOI 10.1016/j.molimm.2017.12.023; Lin F, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0039-z; Liu YL, 2015, GENE, V564, P210, DOI 10.1016/j.gene.2015.03.050; Lv LL, 2018, ONCOL RES, V26, P775, DOI 10.3727/096504017X15132494420120; Miguel V, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0044-2; Mizutani M, 2010, AM J PHYSIOL-RENAL, V298, pF721, DOI 10.1152/ajprenal.00368.2009; Morishita Y, 2016, TRANSL RES, V169, P47, DOI 10.1016/j.trsl.2015.10.009; Qu HY, 2017, J ETHNOPHARMACOL, V202, P28, DOI 10.1016/j.jep.2017.01.033; Rachagani S, 2015, ADV DRUG DELIVER REV, V81, P16, DOI 10.1016/j.addr.2014.10.020; Sakai N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05624-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Strippoli R, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3543678; Suzu S, 2000, EMBO J, V19, P5114, DOI 10.1093/emboj/19.19.5114; van Baal JOAM, 2017, TISSUE CELL, V49, P95, DOI 10.1016/j.tice.2016.11.004; Vorobiov M, 2008, PERITON DIALYSIS INT, V28, P648; Wang HW, 2017, NUCLEIC ACIDS RES, V45, P2786, DOI 10.1093/nar/gkw909; Wang Hui-Chao, 2016, Shengli Xuebao, V68, P747, DOI 10.13294/j.aps.2016.0084; Wang LY, 2016, FEBS LETT, V590, P4252, DOI 10.1002/1873-3468.12442; Yu JW, 2014, LAB INVEST, V94, P978, DOI 10.1038/labinvest.2014.91; Yung S, 2003, PERITON DIALYSIS INT, V23, pS37; Zhang L, 2013, EXP THER MED, V6, P1189, DOI 10.3892/etm_2013.1281; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786; Zhou Q, 2013, AM J PATHOL, V183, P808, DOI 10.1016/j.ajpath.2013.05.019	37	9	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5112	5125		10.1096/fj.201801111RR	http://dx.doi.org/10.1096/fj.201801111RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30652956	Bronze			2022-12-28	WOS:000462888500040
J	Liu, HB; Hou, CL; Li, N; Zhang, XY; Zhang, GL; Yang, FY; Zeng, XF; Liu, ZH; Qiao, SY				Liu, Hongbin; Hou, Chengli; Li, Ning; Zhang, Xiaoya; Zhang, Guolong; Yang, Feiyun; Zeng, Xiangfang; Liu, Zuohua; Qiao, Shiyan			Microbial and metabolic alterations in gut microbiota of sows during pregnancy and lactation	FASEB JOURNAL			English	Article						reproductive stages; maternal metabolism; host genetics; confounding factors	CHAIN FATTY-ACIDS; DIET; MOTHERS; ASSOCIATIONS; CHOLESTEROL; OVERWEIGHT; GROWTH; FIBER; SHAPE; SITES	The gut microbiota plays a critical role in various physiologic processes; however, maternal microbial and metabolic changes during pregnancy and lactation remain elusive. Using pigs as an animal model, we conducted comparative analyses of gut microbiota and short-chain fatty acid (SCFA) profiles across different stages of gestation, lactation, and the empty (nonpregnancy) phase in 2 distinct breeds of sow, Rongchang (RS) and Landrace (LS). Coriobacteriaceae were found to gradually increase over gestational time irrespective of breed, which was further validated in an independent cohort of sows, indicating that Coriobacteriaceae are likely associated with the progression of pregnancy. Escherichia increased as well. Relative to empty and gestation, lactation was associated with an increase in SCFA producers and a concomitant augmentation in SCFA production in both breeds. A comparison between the 2 breeds revealed that Ruminococcaceae were more abundant in RSs than in LSs, consistent with the strong ability of Rongchang pigs to digest highly fibrous feedstuffs. Taken together, we revealed characteristic structural and metabolic changes in maternal gut microbiota throughout pregnancy, lactation, and the empty phase, which could potentially help improve the pregnancy and lactation outcomes for both animals and humans.Liu, H., Hou, C., Li, N., Zhang, X., Zhang, G., Yang, F., Zeng, X., Liu, Z., Qiao, S. Microbial and metabolic alterations in gut microbiota of sows during pregnancy and lactation.	[Liu, Hongbin; Li, Ning; Zhang, Xiaoya; Zeng, Xiangfang; Qiao, Shiyan] China Agr Univ, Beijing Key Lab Biofeed Addit, State Key Lab Anim Nutr, Beijing, Peoples R China; [Hou, Chengli] CAAS, Inst Food Sci & Technol, Beijing, Peoples R China; [Zhang, Guolong] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA; [Yang, Feiyun; Liu, Zuohua] Chongqing Acad Anim Sci, Chongqing, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Food Science & Technology, CAAS; Oklahoma State University System; Oklahoma State University - Stillwater	Zeng, XF (corresponding author), China Agr Univ, Coll Anim Sci & Technol, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	ziyangzxf@163.com	Zhang, Guolong/HCI-5587-2022; chengli, Hou/AGZ-4530-2022; Hou, Chengli/AGY-1396-2022; Zhang, Guolong/AAU-8197-2020; hongbin, Liu/GPC-5156-2022	chengli, Hou/0000-0002-5617-8655; Zhang, Guolong/0000-0003-4781-5816; hongbin, Liu/0000-0002-5840-2374	National Natural Science Foundation of China [31420103908]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank the Chongqing Academy of Animal Science for the supply of materials and equipment. This study was supported by the National Natural Science Foundation of China (Grant 31420103908). The authors declare no conflicts of interest.	Avershina E, 2014, FEMS MICROBIOL ECOL, V87, P280, DOI 10.1111/1574-6941.12223; Bartels A, 2011, OBSTET MED, V4, P147, DOI 10.1258/om.2011.110003; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; Zavalza-Gomez AB, 2008, DIABETES RES CLIN PR, V80, P8, DOI 10.1016/j.diabres.2007.12.012; Bisanz JE, 2015, APPL ENVIRON MICROB, V81, P4965, DOI 10.1128/AEM.00780-15; Carrothers JM, 2015, J NUTR, V145, P2379, DOI 10.3945/jn.115.211110; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Frese SA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0091-8; Gacias M, 2016, ELIFE, V5, DOI 10.7554/eLife.13442; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Gohir W, 2015, GUT MICROBES, V6, P310, DOI 10.1080/19490976.2015.1086056; Gomez-Arango LF, 2016, DIABETES, V65, P2214, DOI 10.2337/db16-0278; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hermann-Bank ML, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-788; Ibanez-Escriche N, 2011, J ANIM SCI, V89, P3881, DOI 10.2527/jas.2011-3959; Jost T, 2014, CURR MICROBIOL, V68, P419, DOI 10.1007/s00284-013-0491-6; King JC, 2000, AM J CLIN NUTR, V71, p1218S, DOI 10.1093/ajcn/71.5.1218s; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kong XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37224; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Liu TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136150; Luan HM, 2014, J PROTEOME RES, V13, P1527, DOI 10.1021/pr401068k; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58; Martinez I, 2013, APPL ENVIRON MICROB, V79, P516, DOI 10.1128/AEM.03046-12; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Mitoulas LR, 2002, BRIT J NUTR, V88, P29, DOI [10.1079/BJN2002579, 10.1079/BJNBJN2002579]; Nakajima A, 2017, J IMMUNOL, V199, P3516, DOI 10.4049/jimmunol.1700248; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Pere MC, 2007, J ANIM SCI, V85, P101, DOI 10.2527/jas.2006-130; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Priyadarshini M, 2014, TRANSL RES, V164, P153, DOI 10.1016/j.trsl.2014.01.012; Qiu JS, 2002, J CHROMATOGR A, V950, P81, DOI 10.1016/S0021-9673(02)00034-1; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Small CLN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2957; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Thompson CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010335; Thum C, 2012, J NUTR, V142, P1921, DOI 10.3945/jn.112.166231; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Val-Laillet D, 2017, FASEB J, V31, P2037, DOI 10.1096/fj.201601015R; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Xiao L, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.161, 10.1038/nmicrobiol.2016.161]; Yan HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31786; Zeng Z, 2012, MEAT SCI, V90, P66, DOI 10.1016/j.meatsci.2011.06.004; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580	57	44	49	2	44	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4490	4501		10.1096/fj.201801221RR	http://dx.doi.org/10.1096/fj.201801221RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30653349				2022-12-28	WOS:000459794800110
J	Violante, S; Achetib, N; van Roermund, CWT; Hagen, J; Dodatko, T; Vaz, FM; Waterham, HR; Chen, HJ; Baes, M; Yu, CL; Argmann, CA; Houten, SM				Violante, Sara; Achetib, Nihad; van Roermund, Carlo W. T.; Hagen, Jacob; Dodatko, Tetyana; Vaz, Frederic M.; Waterham, Hans R.; Chen, Hongjie; Baes, Myriam; Yu, Chunli; Argmann, Carmen A.; Houten, Sander M.			Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4	FASEB JOURNAL			English	Article						fatty acid oxidation; mitochondria; organellar crosstalk; acylcarnitine; CPT2 deficiency	PALMITOYLTRANSFERASE-II DEFICIENCY; CARNITINE PALMITOYLTRANSFERASE; BETA-OXIDATION; MOUSE-LIVER; MOLECULAR-CLONING; PRISTANIC ACID; ACETYL MOIETY; PHYTANIC ACID; MALONYL-COA; MITOCHONDRIAL	Peroxisomes are essential organelles for the specialized oxidation of a wide variety of fatty acids, but they are also able to degrade fatty acids that are typically handled by mitochondria. Using a combination of pharmacological inhibition and clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 genome editing technology to simultaneously manipulate peroxisomal and mitochondrial fatty acid -oxidation (FAO) in HEK-293 cells, we identified essential players in the metabolic crosstalk between these organelles. Depletion of carnitine palmitoyltransferase (CPT)2 activity through pharmacological inhibition or knockout (KO) uncovered a significant residual peroxisomal oxidation of lauric and palmitic acid, leading to the production of peroxisomal acylcarnitine intermediates. Generation and analysis of additional single- and double-KO cell lines revealed that the D-bifunctional protein (HSD17B4) and the peroxisomal ABC transporter ABCD3 are essential in peroxisomal oxidation of lauric and palmitic acid. Our results indicate that peroxisomes not only accept acyl-CoAs but can also oxidize acylcarnitines in a similar biochemical pathway. By using an Hsd17b4 KO mouse model, we demonstrated that peroxisomes contribute to the plasma acylcarnitine profile after acute inhibition of CPT2, proving in vivo relevance of this pathway. We summarize that peroxisomal FAO is important when mitochondrial FAO is defective or overloaded.Violante, S., Achetib, N., van Roermund, C. W. T., Hagen, J., Dodatko, T., Vaz, F. M., Waterham, H. R., Chen, H., Baes, M., Yu, C., Argmann, C. A., Houten, S. M. Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4.	[Violante, Sara; Achetib, Nihad; Hagen, Jacob; Dodatko, Tetyana; Chen, Hongjie; Yu, Chunli; Argmann, Carmen A.; Houten, Sander M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave,Box 1498, New York, NY 10029 USA; [Violante, Sara; Achetib, Nihad; Hagen, Jacob; Dodatko, Tetyana; Argmann, Carmen A.; Houten, Sander M.] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA; [Violante, Sara; Chen, Hongjie; Yu, Chunli] Mt Sinai Genom Inc, New York, NY USA; [van Roermund, Carlo W. T.; Vaz, Frederic M.; Waterham, Hans R.] Dept Clin Chem, Amsterdam, Netherlands; [van Roermund, Carlo W. T.; Vaz, Frederic M.; Waterham, Hans R.] Dept Pediat, Amsterdam, Netherlands; [van Roermund, Carlo W. T.; Vaz, Frederic M.; Waterham, Hans R.] Lab Genet Metab Dis, Amsterdam, Netherlands; [Baes, Myriam] Univ Leuven, KU Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Cell Metab, Leuven, Belgium	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; KU Leuven	Houten, SM (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave,Box 1498, New York, NY 10029 USA.	sander.houten@mssm.edu	Houten, Sander/Y-3599-2019	Houten, Sander/0000-0002-6167-9147; Vaz, Frederic/0000-0002-9048-1041; Baes, Myriam/0000-0002-2525-2269	U.S. Natiional Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Award [R01DK113172]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113172] Funding Source: NIH RePORTER	U.S. Natiional Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Janet Koster (Academic Medical Center) for providing the ABCD3 plasmid, Ethellyn Panta and Tara Singh (Clinical Biochemical Genetics, Icahn School of Medicine at Mount Sinai) for assistance with the acylcarnitine measurements, Charles L. Hoppel (Case Western Reserve University, Cleveland, OH, USA) for quantification of the C14:1-carnitines, and Benny Das (University of Leuven) for technical assistance. Research reported in this publication was supported by U.S. Natiional Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Award R01DK113172. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Albers S, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e103; Anichini A, 2011, NEUROL RES, V33, P24, DOI 10.1179/016164110X12767786356390; Antonenkov VD, 2012, BBA-MOL BASIS DIS, V1822, P1374, DOI 10.1016/j.bbadis.2011.12.011; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Baes M, 2000, J BIOL CHEM, V275, P16329, DOI 10.1074/jbc.M001994200; Baker A, 2015, BIOCHEM SOC T, V43, P959, DOI 10.1042/BST20150127; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Bian F, 2005, J BIOL CHEM, V280, P9265, DOI 10.1074/jbc.M412850200; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Carnitine Palmitoyltransferase II Deficiency, 1993, GENEREVIEWS; Chegary M, 2008, MOL GENET METAB, V93, P403, DOI 10.1016/j.ymgme.2007.11.001; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; CHOI SJ, 1995, BBA-GENE STRUCT EXPR, V1264, P215, DOI 10.1016/0167-4781(95)00146-8; Ding J, 2013, CELL REP, V5, P248, DOI 10.1016/j.celrep.2013.08.032; Ebberink MS, 2011, HUM MUTAT, V32, P59, DOI 10.1002/humu.21388; FARRELL SO, 1983, ARCH BIOCHEM BIOPHYS, V222, P123, DOI 10.1016/0003-9861(83)90509-X; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Ferdinandusse S, 2015, HUM MOL GENET, V24, P361, DOI 10.1093/hmg/ddu448; Fontaine M, 1998, CLIN CHIM ACTA, V273, P161, DOI 10.1016/S0009-8981(98)00041-2; Furihata T, 2003, ARCH BIOCHEM BIOPHYS, V416, P101, DOI 10.1016/S0003-9861(03)00286-8; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Houten SM, 2012, J LIPID RES, V53, P1296, DOI 10.1194/jlr.M024463; Hurvitz H, 2000, PEDIATR NEUROL, V22, P148, DOI 10.1016/S0887-8994(99)00125-3; JAKOBS BS, 1995, BIOCHEM BIOPH RES CO, V213, P1035, DOI 10.1006/bbrc.1995.2232; Kasumov T, 2005, BIOCHEM J, V389, P397, DOI 10.1042/BJ20050144; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; LAZAROW PB, 1977, SCIENCE, V197, P580, DOI 10.1126/science.195342; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; Minkler PE, 2015, MOL GENET METAB, V116, P231, DOI 10.1016/j.ymgme.2015.10.002; Minkler PE, 2015, ANAL CHEM, V87, P8994, DOI 10.1021/acs.analchem.5b02198; MIYAZAWA S, 1983, J BIOCHEM, V94, P529, DOI 10.1093/oxfordjournals.jbchem.a134384; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; Satoh T, 2006, CHEM-BIOL INTERACT, V162, P195, DOI 10.1016/j.cbi.2006.07.001; Schrader M, 2015, J INHERIT METAB DIS, V38, P681, DOI 10.1007/s10545-015-9819-7; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; van Roermund CWT, 2014, BBA-MOL CELL BIOL L, V1841, P563, DOI 10.1016/j.bbalip.2013.12.001; Ventura FV, 1999, CLIN CHIM ACTA, V281, P1, DOI 10.1016/S0009-8981(98)00188-0; Verhoeven NM, 1998, J LIPID RES, V39, P66; Verhoeven NM, 1998, J INHERIT METAB DIS, V21, P753, DOI 10.1023/A:1005449200468; Violante S, 2013, BBA-MOL CELL BIOL L, V1831, P1467, DOI 10.1016/j.bbalip.2013.06.007; Violante S, 2013, FASEB J, V27, P2039, DOI 10.1096/fj.12-216689; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1430, DOI 10.1016/j.bbadis.2012.04.006; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445; Yamada K, 2017, MOL GENET METAB REP, V11, P59, DOI 10.1016/j.ymgmr.2017.04.008	51	40	41	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4355	4364		10.1096/fj.201801498R	http://dx.doi.org/10.1096/fj.201801498R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30540494	Green Published, Bronze			2022-12-28	WOS:000459794800100
J	Walczak, J; Debska-Vielhaber, G; Vielhaber, S; Szymanski, J; Charzynska, A; Duszynski, J; Szczepanowska, J				Walczak, Jaroslaw; Debska-Vielhaber, Grazyna; Vielhaber, Stefan; Szymanski, Jedrzej; Charzynska, Agata; Duszynski, Jerzy; Szczepanowska, Joanna			Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis; neurodegeneration; primary fibroblasts; PCA	SUPEROXIDE-DISMUTASE; OXIDATIVE-PHOSPHORYLATION; MUTANT SOD1; INHIBITOR TITRATIONS; INCREASED EXPRESSION; OSTEOSARCOMA CELLS; SEQUESTOSOME 1/P62; VCP MUTATIONS; MUSCLE-FIBERS; SPINAL-CORD	Bioenergetic failure, oxidative stress, and changes in mitochondrial morphology are common pathologic hallmarks of amyotrophic lateral sclerosis (ALS) in several cellular and animal models. Disturbed mitochondrial physiology has serious consequences for proper functioning of the cell, leading to the chronic mitochondrial stress. Mitochondria, being in the center of cellular metabolism, play a pivotal role in adaptation to stress conditions. We found that mitochondrial dysfunction and adaptation processes differ in primary fibroblasts derived from patients diagnosed with either sporadic or familial forms of ALS. The evaluation of mitochondrial parameters such as the mitochondrial membrane potential, the oxygen consumption rate, the activity and levels of respiratory chain complexes, and the levels of ATP, reactive oxygen species, and Ca2+ show that the bioenergetic properties of mitochondria are different in sporadic ALS, familial ALS, and control groups. Comparative statistical analysis of the data set (with use of principal component analysis and support vector machine) identifies and distinguishes 3 separate groups despite the small number of investigated cell lines and high variability in measured parameters. These findings could be a first step in development of a new tool for predicting sporadic and familial forms of ALS and could contribute to knowledge of its pathophysiology.Walczak, J., Dbska-Vielhaber, G., Vielhaber, S., Szymaski, J., Charzyska, A., Duszyski, J., Szczepanowska, J. Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics.	[Walczak, Jaroslaw; Szymanski, Jedrzej; Duszynski, Jerzy; Szczepanowska, Joanna] Polish Acad Sci, Lab Bioenerget & Biomembranes, Nencki Inst Expt Biol, Warsaw, Poland; [Charzynska, Agata] Polish Acad Sci, Nencki Inst Expt Biol, Lab Bioinformat, Warsaw, Poland; [Debska-Vielhaber, Grazyna; Vielhaber, Stefan] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Otto von Guericke University	Szczepanowska, J (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, 3 Pasteur St, PL-02093 Warsaw, Poland.	j.szczepanowska@nencki.gov.pl	Charzynska, Agata/AAC-2134-2020	Charzynska, Agata/0000-0003-4761-9831; Walczak, Jaroslaw/0000-0003-4123-763X; Szymanski, Jedrzej/0000-0002-4060-0196; Duszynski, Jerzy/0000-0003-2937-6725; Szczepanowska, Joanna/0000-0002-0434-1262	Polish National Science Center [2013/08/M/NZ3/00707]	Polish National Science Center	This work was supported by the grant from the Polish National Science Center (2013/08/M/NZ3/00707). The authors declare no conflicts of interest.	Aguirre T, 1998, ANN NEUROL, V43, P452, DOI 10.1002/ana.410430407; Allen SP, 2015, NEUROBIOL AGING, V36, P2893, DOI 10.1016/j.neurobiolaging.2015.07.013; Allen SP, 2014, NEUROBIOL AGING, V35, P1499, DOI 10.1016/j.neurobiolaging.2013.11.025; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Arthur KC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12408; Aschner M., 2016, CURR PROTOC TOXICOL, V69, P12; Bartolome F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22152-9; Bartolome F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01678-4; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cagin U, 2015, INT J BIOCHEM CELL B, V63, P10, DOI 10.1016/j.biocel.2015.01.026; Carri MT, 2011, J BIOENERG BIOMEMBR, V43, P593, DOI 10.1007/s10863-011-9394-z; Carri MT, 1997, FEBS LETT, V414, P365, DOI 10.1016/S0014-5793(97)01051-X; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Codron P, 2018, AMYOTROPH LAT SCL FR, V19, P446, DOI 10.1080/21678421.2018.1431787; Connolly GP, 1998, TRENDS PHARMACOL SCI, V19, P171, DOI 10.1016/S0165-6147(98)01202-4; Coussee E, 2011, CELL CALCIUM, V49, P217, DOI 10.1016/j.ceca.2011.02.004; Curti D, 1996, NEUROLOGY, V47, P1060, DOI 10.1212/WNL.47.4.1060; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Fang LB, 2009, J NEUROL SCI, V285, P62, DOI 10.1016/j.jns.2009.05.025; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; GELLERICH FN, 1990, FEBS LETT, V274, P167, DOI 10.1016/0014-5793(90)81355-R; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; Golpich M, 2017, CNS NEUROSCI THER, V23, P5, DOI 10.1111/cns.12655; Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002; Hand CK, 2002, MUSCLE NERVE, V25, P135; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Hardiman O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.71; Ishikawa H, 2012, J CLIN NEUROSCI, V19, P522, DOI 10.1016/j.jocn.2011.05.044; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Jaiswal Manoj Kumar, 2014, Mol Cell Ther, V2, P26, DOI 10.1186/2052-8426-2-26; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Konrad C, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0217-5; Kruman II, 1999, EXP NEUROL, V160, P28, DOI 10.1006/exnr.1999.7190; KUNZ D, 1995, BIOCHEM MOL MED, V54, P105, DOI 10.1006/bmme.1995.1015; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Kuznetsov AV, 1997, BBA-MOL BASIS DIS, V1360, P142, DOI 10.1016/S0925-4439(96)00072-5; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Ladd AC, 2014, NEUROMOL MED, V16, P714, DOI 10.1007/s12017-014-8321-y; Lund M, 2015, BRIT J CANCER, V112, P1134, DOI 10.1038/bjc.2015.66; Magrane J, 2012, J NEUROSCI, V32, P229, DOI 10.1523/JNEUROSCI.1233-11.2012; Martin LJ, 2012, PROG MOL BIOL TRANSL, V107, P355, DOI 10.1016/B978-0-12-385883-2.00005-9; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Nakamura A, 1996, J BIOCHEM, V119, P768; Panov A, 2011, NEUROBIOL DIS, V44, P53, DOI 10.1016/j.nbd.2011.06.003; Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rizzardini M, 2005, J NEUROL SCI, V232, P95, DOI 10.1016/j.jns.2005.02.004; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sala G, 2009, NEURODEGENER DIS, V6, P9, DOI 10.1159/000121390; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Seibenhener ML, 2013, BBA-MOL CELL RES, V1833, P452, DOI 10.1016/j.bbamcr.2012.11.004; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210; Silva JM, 2009, NEUROBIOL DIS, V34, P357, DOI 10.1016/j.nbd.2009.02.005; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smith EF, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.052; Suzuki M, 2010, ACTA NEUROL SCAND, V122, P367, DOI 10.1111/j.1600-0404.2010.01321.x; Swerdlow RH, 1998, EXP NEUROL, V153, P135, DOI 10.1006/exnr.1998.6866; Szelechowski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22318-5; Tan WZ, 2014, BBA-MOL BASIS DIS, V1842, P1295, DOI 10.1016/j.bbadis.2014.02.009; Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339; Wang CH, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0375-3; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wenz T, 2013, MITOCHONDRION, V13, P134, DOI 10.1016/j.mito.2013.01.006; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Wojewoda M, 2015, BIOCHEM PHARMACOL, V95, P170, DOI 10.1016/j.bcp.2015.03.016; Wojewoda M, 2010, BBA-BIOENERGETICS, V1797, P890, DOI 10.1016/j.bbabio.2010.01.035; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010; Zarei Sara, 2015, Surg Neurol Int, V6, P171, DOI 10.4103/2152-7806.169561	85	18	18	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4388	4403		10.1096/fj.201801843R	http://dx.doi.org/10.1096/fj.201801843R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30550341	Bronze			2022-12-28	WOS:000459794800103
J	Houdou, M; Lebredonchel, E; Garat, A; Duvet, S; Legrand, D; Decool, V; Klein, A; Ouzzine, M; Gasnier, B; Potelle, S; Foulquier, F				Houdou, Marine; Lebredonchel, Elodie; Garat, Anne; Duvet, Sandrine; Legrand, Dominique; Decool, Valerie; Klein, Andre; Ouzzine, Mohamed; Gasnier, Bruno; Potelle, Sven; Foulquier, Francois			Involvement of thapsigargin- and cyclopiazonic acid-sensitive pumps in the rescue of TMEM165-associated glycosylation defects by Mn2+	FASEB JOURNAL			English	Article						manganese homeostasis; congenital disorders of glycosylation; Golgi apparatus	MANGANESE TRANSPORT; CONGENITAL DISORDER; GOLGI; HOMEOSTASIS; ATPASE; DEFICIENCY; MEMBRANE; MUTATION; CELLS	Congenital disorders of glycosylation are severe inherited diseases in which aberrant protein glycosylation is a hallmark. Transmembrane protein 165 (TMEM165) is a novel Golgi transmembrane protein involved in type II congenital disorders of glycosylation. Although its biologic function is still a controversial issue, we have demonstrated that the Golgi glycosylation defect due to TMEM165 deficiency resulted from a Golgi Mn2+ homeostasis defect. The goal of this study was to delineate the cellular pathway by which extracellular Mn2+ rescues N-glycosylation in TMEM165 knockout (KO) cells. We first demonstrated that after extracellular exposure, Mn2+ uptake by HEK293 cells at the plasma membrane did not rely on endocytosis but was likely done by plasma membrane transporters. Second, we showed that the secretory pathway Ca2+-ATPase 1, also known to mediate the influx of cytosolic Mn2+ into the lumen of the Golgi apparatus, is not crucial for the Mn2+-induced rescue glycosylation of lysosomal-associated membrane protein 2 (LAMP2). In contrast, our results demonstrate the involvement of cyclopiazonic acid- and thapsigargin (Tg)-sensitive pumps in the rescue of TMEM165-associated glycosylation defects by Mn2+. Interestingly, overexpression of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 2b isoform in TMEM165 KO cells partially rescues the observed LAMP2 glycosylation defect. Overall, this study indicates that the rescue of Golgi N-glycosylation defects in TMEM165 KO cells by extracellular Mn2+ involves the activity of Tg and cyclopiazonic acid-sensitive pumps, probably the SERCA pumps.Houdou, M., Lebredonchel, E., Garat, A., Duvet, S., Legrand, D., Decool, V., Klein, A., Ouzzine, M., Gasnier, B., Potelle, S., Foulquier, F. Involvement of thapsigargin- and cyclopiazonic acid-sensitive pumps in the rescue of TMEM165-associated glycosylation defects by Mn2+.	[Houdou, Marine; Lebredonchel, Elodie; Duvet, Sandrine; Legrand, Dominique; Klein, Andre; Potelle, Sven; Foulquier, Francois] Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France; [Garat, Anne; Decool, Valerie] Univ Lille, CHU Lille, Inst Pasteur Lille, EA 4483,Impact Environm Chim Sante Humaine IMPECS, Lille, France; [Ouzzine, Mohamed] Univ Lorraine, CNRS, UMR 7365, Biopole Fac Med, Vandoeuvre Les Nancy, France; [Gasnier, Bruno] Paris Descartes Univ, Sorbonne Paris Cite, CNRS, Neurophoton Lab,UMR 8250, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Foulquier, F (corresponding author), Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France.	francois.foulquier@univ-lille1.fr	foulquier, francois/ABE-5886-2020; Lebredonchel, Elodie/W-4628-2019; Gasnier, Bruno/AAD-9124-2022; Legrand, Dominique/AAT-5715-2021; Klein, Andre/H-2830-2015; Garat, Anne/AAC-6868-2022; FOULQUIER, FRANCOIS/AAI-1182-2021; Ouzzine, Mohamed/G-4368-2013	foulquier, francois/0000-0002-6551-3240; Gasnier, Bruno/0000-0003-4458-6296; Klein, Andre/0000-0001-9234-2080; OUZZINE, Mohamed/0000-0003-0058-4950; Potelle, Sven/0000-0002-7044-688X; HOUDOU, Marine/0000-0002-9766-3163; LEGRAND, Dominique/0000-0002-0814-221X; Lebredonchel, Elodie/0000-0001-5119-6005	French National Research Agency (SOLV-CDG); Mizutani Foundation for Glycoscience	French National Research Agency (SOLV-CDG)(French National Research Agency (ANR)); Mizutani Foundation for Glycoscience	The authors are indebted to D. Legrand [Federation of Research Structural and Functional Biochemistry of Biomolecular Assemblies (FRABio), University of Lille] for providing the scientific and technical environment conducive to achieving this work. The authors thank the staff of the BioImagingCenter of Lille, especially C. Slomianny and E. Richard, for the use of the Leica LSM700 and LSM780 devices. The authors are indebted to D. Mouajjah (Centre National de la Recherche Scientifique Unites Mixte de Recherche 8576, University of Lille) for her helpful assistance in mass spectrometry experiments, and D. Allorge (Centre Hospitalier Universitaire Lille, EA 4483) for her kind assistance in ICP-MS experiments. This work was supported by the French National Research Agency (SOLV-CDG to F.F.) and the Mizutani Foundation for Glycoscience (to F.F.). The authors declare no conflicts of interest.	Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Chen JL, 2017, J BIOL CHEM, V292, P6938, DOI 10.1074/jbc.M117.778431; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; CHIESI M, 1981, ARCH BIOCHEM BIOPHYS, V208, P586, DOI 10.1016/0003-9861(81)90547-6; CHIESI M, 1980, BIOCHEMISTRY-US, V19, P2912, DOI 10.1021/bi00554a015; Delannoy CP, 2017, J PROTEOME RES, V16, P156, DOI 10.1021/acs.jproteome.6b00161; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Dutta Dipannita, 2012, Cell Logist, V2, P203; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; He WF, 2012, NEUROCHEM RES, V37, P455, DOI 10.1007/s11064-011-0644-6; Micaroni M, 2010, TRAFFIC, V11, P1315, DOI 10.1111/j.1600-0854.2010.01096.x; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Potelle S, 2016, HUM MOL GENET, V25, P1489, DOI 10.1093/hmg/ddw026; POWELL JT, 1976, J BIOL CHEM, V251, P3645; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Schneider A, 2016, PLANT CELL, V28, P892, DOI 10.1105/tpc.15.00812; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Yonekura SI, 2016, FEBS LETT, V590, P2086, DOI 10.1002/1873-3468.12244; Zeevaert R, 2013, JIMD REP, V8, P145, DOI 10.1007/8904_2012_172	28	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2669	2679		10.1096/fj.201800387R	http://dx.doi.org/10.1096/fj.201800387R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307768	Green Submitted			2022-12-28	WOS:000457296600091
J	Kosztelnik, M; Kurucz, A; Papp, D; Jones, E; Sigmond, T; Barna, J; Traka, MH; Lorincz, T; Szarka, A; Banhegyi, G; Vellai, T; Korcsmaros, T; Kapuy, O				Kosztelnik, Monika; Kurucz, Anita; Papp, Diana; Jones, Emily; Sigmond, Timea; Barna, Janos; Traka, Maria H.; Lorincz, Tamas; Szarka, Andras; Banhegyi, Gabor; Vellai, Tibor; Korcsmaros, Tamas; Kapuy, Orsolya			Suppression of AMPK/aak-2 by NRF2/SKN-1 down-regulates autophagy during prolonged oxidative stress	FASEB JOURNAL			English	Article						AMPK; prolonged stress; aging; C; elegans; network	TRANSCRIPTION FACTOR NRF2; SIGNALING PATHWAY; CELL-DEATH; P62 LINKS; PROTEIN; AMPK; GENE; LONGEVITY; SKN-1; DEGRADATION	NF-E2-related factor 2 (NRF2) transcription factor has a fundamental role in cell homeostasis maintenance as one of the master regulators of oxidative and electrophilic stress responses. Previous studies have shown that a regulatory connection exists between NRF2 and autophagy during reactive oxygen species-generated oxidative stress. The aim of the present study was to investigate how autophagy is turned off during prolonged oxidative stress, to avoid overeating and destruction of essential cellular components. AMPK is a key cellular energy sensor highly conserved in eukaryotic organisms, and it has an essential role in autophagy activation at various stress events. Here the role of human AMPK and its Caenorhabditis elegans counterpart AAK-2 was explored upon oxidative stress. We investigated the regulatory connection between NRF2 and AMPK during oxidative stress induced by tert-butyl hydroperoxide (TBHP) in HEK293T cells and C. elegans. Putative conserved NRF2/protein skinhead-1 binding sites were found in AMPK/aak-2 genes by in silico analysis and were later confirmed experimentally by using EMSA. After addition of TBHP, NRF2 and AMPK showed a quick activation; AMPK was later down-regulated, however, while NRF2 level remained high. Autophagosome formation and Unc-51-like autophagy activating kinase 1 phosphorylation were initially stimulated, but they returned to basal values after 4 h of TBHP treatment. The silencing of NRF2 resulted in a constant activation of AMPK leading to hyperactivation of autophagy during oxidative stress. We observed the same effects in C. elegans demonstrating the conservation of this self-defense mechanism to save cells from hyperactivated autophagy upon prolonged oxidative stress. We conclude that NRF2 negatively regulates autophagy through delayed down-regulation of the expression of AMPK upon prolonged oxidative stress. This regulatory connection between NRF2 and AMPK may have an important role in understanding how autophagy is regulated in chronic human morbidities characterized by oxidative stress, such as neurodegenerative diseases, certain cancer types, and in metabolic diseases.Kosztelnik, M., Kurucz, A., Papp, D., Jones, E., Sigmond, T., Barna, J., Traka, M. H., Lorincz, T., Szarka, A., Banhegyi, G., Vellai, T., Korcsmaros, T., Kapuy, O. Suppression of AMPK/aak-2 by NRF2/SKN-1 down-regulates autophagy during prolonged oxidative stress.	[Kosztelnik, Monika; Papp, Diana; Sigmond, Timea; Barna, Janos; Vellai, Tibor; Korcsmaros, Tamas] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Kurucz, Anita; Banhegyi, Gabor; Kapuy, Orsolya] Semmelweis Univ, Hungarian Acad Sci, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Banhegyi, Gabor] Semmelweis Univ, Hungarian Acad Sci, Pathobiochem Res Grp, Budapest, Hungary; [Jones, Emily; Korcsmaros, Tamas] Quadram Inst, Gut Hlth & Microbes, Norwich, Norfolk, England; [Traka, Maria H.] Quadram Inst, Food Innovat & Hlth, Norwich, Norfolk, England; [Jones, Emily; Korcsmaros, Tamas] Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England; [Lorincz, Tamas; Szarka, Andras] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Lab Biochem & Mol Biol, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; Budapest University of Technology & Economics	Korcsmaros, T (corresponding author), Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England.; Kapuy, O (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Tuzolto Utca 37-47, H-1094 Budapest, Hungary.	tamas.korcsmaros@earlham.ac.uk; kapuy.orsolya@med.semmelweis-univ.huu	Barna, Janos/AAM-9432-2020; Lőrincz, Tamás/AAA-3847-2022; Sigmond, Tímea/J-9819-2018; Kosztelnik, Monika/AAZ-6485-2021; Vellai, Tibor/AAG-2154-2020; Korcsmaros, Tamas/C-3526-2015	Lőrincz, Tamás/0000-0003-1762-4007; Sigmond, Tímea/0000-0002-1985-428X; Kosztelnik, Monika/0000-0001-6735-3597; Barna, Janos/0000-0002-9242-0939; Korcsmaros, Tamas/0000-0003-1717-996X	Earlham Institute; Quadram Institute; Biotechnological and Biosciences Research Council [BB/J004529/1, BB/P016774/1, BB/J004545/1]; Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-4-III-SE-75]; National Research, Development and Innovation Office [K112696, K124813, K123752]; European Cooperation in Science and Technology (COST) Action [PROTEOSTASIS BM1307]; Hungarian Scientific Research Fund (OTKA) [NK78012]; MEDinPROT Protein Science Research Synergy Program [Hungarian Academy of Sciences (MTA)]; Competitive Central-Hungarian Operational Program [VEKOP-2.3.2-16-2017-00014]; MTA-Eotvos Lorand Tudomanyegyetem (MTA-ELTE) Genetics Research Group [01062]; BBSRC [BBS/E/F/000PR10347, BBS/E/F/00044500, BBS/E/F/000PR10355, BBS/E/T/000PR9819] Funding Source: UKRI	Earlham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Quadram Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnological and Biosciences Research Council; Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University; New National Excellence Program of the Ministry of Human Capacities; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); European Cooperation in Science and Technology (COST) Action(European Cooperation in Science and Technology (COST)); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MEDinPROT Protein Science Research Synergy Program [Hungarian Academy of Sciences (MTA)]; Competitive Central-Hungarian Operational Program; MTA-Eotvos Lorand Tudomanyegyetem (MTA-ELTE) Genetics Research Group; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Computational Biology Fellowship (to T.K.) from the Earlham Institute in partnership with the Quadram Institute, and strategically supported by the Biotechnological and Biosciences Research Council (BB/J004529/1, BB/P016774/1, BB/J004545/1). O.K. was supported by the Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University, and by the UNKP-17-4-III-SE-75 New National Excellence Program of the Ministry of Human Capacities. O.K., A.S., and G.B. were supported by the National Research, Development and Innovation Office (K112696, K124813 and K123752). This article is based upon work from European Cooperation in Science and Technology (COST) Action (PROTEOSTASIS BM1307). This work was supported by the the Hungarian Scientific Research Fund (OTKA; Grant NK78012), the MEDinPROT Protein Science Research Synergy Program [provided by the Hungarian Academy of Sciences (MTA)], and the Competitive Central-Hungarian Operational Program (VEKOP-2.3.2-16-2017-00014). T.V. is supported by the MTA-Eotvos Lorand Tudomanyegyetem (MTA-ELTE) Genetics Research Group (01062). The authors declare no conflicts of interest.	Aschner M., 2016, CURR PROTOC TOXICOL, V69, P12; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Blackwell TK, 2015, FREE RADICAL BIO MED, V88, P290, DOI 10.1016/j.freeradbiomed.2015.06.008; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Brdlik CM, 2014, METHOD ENZYMOL, V539, P89, DOI 10.1016/B978-0-12-420120-0.00007-4; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Denton D, 2015, IMMUNOL CELL BIOL, V93, P35, DOI 10.1038/icb.2014.85; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Essick EE, 2010, OXID MED CELL LONGEV, V3, P168, DOI 10.4161/oxim.3.3.12106; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Geillinger KE, 2014, BBA-GEN SUBJECTS, V1840, P1747, DOI 10.1016/j.bbagen.2013.12.026; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; He H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.533; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jiang T, 2015, FREE RADICAL BIO MED, V88, P199, DOI 10.1016/j.freeradbiomed.2015.06.014; Jing D, 2003, PROTEOMICS, V3, P1172, DOI 10.1002/pmic.200300438; Joo MS, 2016, MOL CELL BIOL, V36, P1931, DOI 10.1128/MCB.00118-16; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kapuy O, 2014, FEBS OPEN BIO, V4, P704, DOI 10.1016/j.fob.2014.07.006; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kubisch J, 2013, SEMIN CANCER BIOL, V23, P252, DOI 10.1016/j.semcancer.2013.06.009; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Liu WJ, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0031-z; Liu XM, 2011, AM J PHYSIOL-HEART C, V300, pH84, DOI 10.1152/ajpheart.00749.2010; Loos B, 2014, AUTOPHAGY, V10, P2087, DOI 10.4161/15548627.2014.973338; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pajares M, 2016, AUTOPHAGY, V12, P1902, DOI 10.1080/15548627.2016.1208889; Palmisano N. J., 2016, COLD SPRING HARB PRO, V2016; Palmisano N. J., 2016, COLD SPRING HARB PRO, V2016; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Papp D, 2012, FEBS LETT, V586, P1795, DOI 10.1016/j.febslet.2012.05.016; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017; RUSH GF, 1985, TOXICOL APPL PHARM, V78, P473, DOI 10.1016/0041-008X(85)90255-8; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Salmon' TB, 2004, NUCLEIC ACIDS RES, V32, P3712, DOI 10.1093/nar/gkh696; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Staab TA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003354; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Turei D, 2015, AUTOPHAGY, V11, P155, DOI 10.4161/15548627.2014.994346; Turei D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/737591; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063799; Zhang B, 2013, J AGR FOOD CHEM, V61, P8765, DOI 10.1021/jf4012399; Zhang H, 2015, AUTOPHAGY, V11, P9, DOI 10.1080/15548627.2014.1003478; ZHANG L, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/3897250; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	75	26	27	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2372	2387		10.1096/fj.201800565RR	http://dx.doi.org/10.1096/fj.201800565RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277819	hybrid, Green Published			2022-12-28	WOS:000457296600067
J	Polianskyte-Prause, Z; Tolvanen, TA; Lindfors, S; Dumont, V; Van, M; Wang, H; Dash, SN; Berg, M; Naams, JB; Hautala, LC; Nisen, H; Mirtti, T; Groop, PH; Wahala, K; Tienari, J; Lehtonen, S				Polianskyte-Prause, Zydrune; Tolvanen, Tuomas A.; Lindfors, Sonja; Dumont, Vincent; Van, Mervi; Wang, Hong; Dash, Surjya N.; Berg, Mika; Naams, Jette-Britt; Hautala, Laura C.; Nisen, Harry; Mirtti, Tuomas; Groop, Per-Henrik; Wahala, Kristiina; Tienari, Jukka; Lehtonen, Sanna			Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity	FASEB JOURNAL			English	Article						diabetic kidney disease; insulin resistance; lipid phosphatase; podocyte; type 2 diabetes	ACTIVATED PROTEIN-KINASE; LIPID PHOSPHATASE SHIP2; INSULIN-RESISTANCE; PLASMA-MEMBRANE; METABOLISM; MECHANISM; PATHWAY; GLUT4; RAT; GLUCONEOGENESIS	Metformin, the first-line drug to treat type 2 diabetes (T2D), inhibits mitochondrial glycerolphosphate dehydrogenase in the liver to suppress gluconeogenesis. However, the direct target and the underlying mechanisms by which metformin increases glucose uptake in peripheral tissues remain uncharacterized. Lipid phosphatase Src homology 2 domain-containing inositol-5-phosphatase 2 (SHIP2) is upregulated in diabetic rodent models and suppresses insulin signaling by reducing Akt activation, leading to insulin resistance and diminished glucose uptake. Here, we demonstrate that metformin directly binds to and reduces the catalytic activity of the recombinant SHIP2 phosphatase domain in vitro. Metformin inhibits SHIP2 in cultured cells and in skeletal muscle and kidney of db/db mice. In SHIP2-overexpressing myotubes, metformin ameliorates reduced glucose uptake by slowing down glucose transporter 4 endocytosis. SHIP2 overexpression reduces Akt activity and enhances podocyte apoptosis, and both are restored to normal levels by metformin. SHIP2 activity is elevated in glomeruli of patients with T2D receiving nonmetformin medication, but not in patients receiving metformin, compared with people without diabetes. Furthermore, podocyte loss in kidneys of metformin-treated T2D patients is reduced compared with patients receiving nonmetformin medication. Our data unravel a novel molecular mechanism by which metformin enhances glucose uptake and acts renoprotectively by reducing SHIP2 activity.Polianskyte-Prause, Z., Tolvanen, T. A., Lindfors, S., Dumont, V., Van, M., Wang, H., Dash, S. N., Berg, M., Naams, J.-B., Hautala, L. C., Nisen, H., Mirtti, T., Groop, P.-H., Wahala, K., Tienari, J., Lehtonen, S. Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.	[Polianskyte-Prause, Zydrune; Tolvanen, Tuomas A.; Lindfors, Sonja; Dumont, Vincent; Van, Mervi; Wang, Hong; Dash, Surjya N.; Naams, Jette-Britt; Hautala, Laura C.; Mirtti, Tuomas; Tienari, Jukka; Lehtonen, Sanna] Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241,POB 21, Helsinki 00014, Finland; [Berg, Mika; Wahala, Kristiina] Univ Helsinki, Dept Chem, Helsinki, Finland; [Groop, Per-Henrik] Univ Helsinki, Folkhalsan Inst Genet, Folkhalsan Res Ctr, Helsinki, Finland; [Groop, Per-Henrik] Univ Helsinki, Res Program Unit, Diabet & Obes, Helsinki, Finland; [Nisen, Harry] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Groop, Per-Henrik] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland; [Groop, Per-Henrik] Helsinki Univ Hosp, Helsinki, Finland; [Groop, Per-Henrik] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Tienari, Jukka] Helsinki Univ Hosp, Hyvinkaa, Finland	University of Helsinki; University of Helsinki; Folkhalsan Research Center; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Monash University; University of Helsinki; Helsinki University Central Hospital	Lehtonen, S (corresponding author), Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241,POB 21, Helsinki 00014, Finland.	sanna.h.lehtonen@helsinki.fi	Lindfors, Sonja/AAP-2050-2021; Wang, Hong/AAW-6913-2020; Lehtonen, Sanna/GRJ-3642-2022; Lehtonen, Sanna/AAE-4545-2020	Lindfors, Sonja/0000-0002-2024-0760; Wang, Hong/0000-0001-5700-6786; Lehtonen, Sanna/0000-0003-4189-2415; Wahala, Kristiina/0000-0003-4082-8622; Mirtti, Tuomas/0000-0003-0455-9891; Polianskyte-Prause, Zydrune/0000-0002-0145-7032; Dumont, Vincent/0000-0002-2893-5479; Tolvanen, Tuomas Aleksi/0000-0002-3581-208X; Hautala, Laura/0000-0002-5501-2792	European Research Council [242820]; Academy of Finland [131255, 218021, 255551, 134379]; Jane and Aatos Erkko Foundation; European Foundation for the Study of Diabetes/Boehringer Ingelheim Research Programme; Sigrid Juselius Foundation; Paivikki and Sakari Sohlberg Foundation; Diabetes Research Foundation; Business Finland [1964/31/2017]; Helsinki University Hospital; Folkhalsan Research Foundation; Novo Nordisk Foundation; Eli Lilly; Roche; Faculty of Medicine, University of Helsinki; Doctoral Programme in Biomedicine	European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; European Foundation for the Study of Diabetes/Boehringer Ingelheim Research Programme; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paivikki and Sakari Sohlberg Foundation; Diabetes Research Foundation; Business Finland; Helsinki University Hospital; Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Eli Lilly(Eli Lilly); Roche(Roche Holding); Faculty of Medicine, University of Helsinki; Doctoral Programme in Biomedicine	The authors thank M. Saleem (Southmead Hospital, University of Bristol, Bristol United Kingdom) for kindly providing immortalized human podocytes, S. Cushman (National Institutes of Health, Bethesda, MD, USA) for the HA-GLUT4-GFP construct, and C. A. Mitchell (Monash University, Clayton, VIC, Australia) and G. Krystal (Terry Fox Laboratory, Vancouver, BC, Canada) for human SHIP2 (NP_001558) and SHIP1 (NP_005532) cDNA constructs, respectively. Leena Saikko, High Throughput Biomedicine Unit, Biomedicum Flow Cytometry Unit, Biochemical Analysis Core for Experimental Research, and Genome Biology Unit (University of Helsinki) are acknowledged for excellent technical assistance. This work was supported by the European Research Council (Grant 242820; to S.L.), Academy of Finland (Grants 131255, 218021, and 255551 to S.L.; Grant 134379 to P.-H.G.), Jane and Aatos Erkko Foundation (to S.L.), European Foundation for the Study of Diabetes/Boehringer Ingelheim Research Programme (to S.L.), Sigrid Juselius Foundation (to S.L.), Paivikki and Sakari Sohlberg Foundation (to S.L.), Diabetes Research Foundation (to S. L.), Business Finland (1964/31/2017 to S.L.), Faculty of Medicine, University of Helsinki (to S. L.), Helsinki University Hospital (to J.T.), Doctoral Programme in Biomedicine (to T.A.T. and V.D.), Folkhalsan Research Foundation (to P.-H. G.), and Novo Nordisk Foundation (to P.-H. G.). P.-H. G. has received research grants from Eli Lilly and Roche, and is an advisory board member for AbbVie, AstraZeneca, Boehringer-Ingelheim, Cebix, Eli Lilly, Janssen, Medscape, Musculoskeletal Diseases (MSD), and Novartis. P.-H. G. has received lecture honoraria from AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Genzyme, MSD, Novartis, Novo Nordisk, and Sanofi. However, none of the above are relevant to the article. The remaining authors declare no conflicts of interest.	Aatsinki SM, 2014, BRIT J PHARMACOL, V171, P2351, DOI 10.1111/bph.12585; Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Alsahli M, 2017, DIABETES RES CLIN PR, V133, P1, DOI 10.1016/j.diabres.2017.07.033; Amador-Licona N, 2000, ARCH MED RES, V31, P571, DOI 10.1016/S0188-4409(00)00241-1; Amin J, 2015, INFLAMM BOWEL DIS, V21, P445, DOI 10.1097/MIB.0000000000000197; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Dash SN, 2014, J CELL SCI, V127, P1476, DOI 10.1242/jcs.138495; Dutt V, 2015, PHARMACOL RES, V99, P86, DOI 10.1016/j.phrs.2015.05.010; Edimo WE, 2016, J CELL SCI, V129, P1101, DOI 10.1242/jcs.179663; Eisenreich A, 2017, CURR MED CHEM, V24, P3397, DOI 10.2174/0929867324666170404143102; Erneux C, 2011, J CELL BIOCHEM, V112, P2203, DOI 10.1002/jcb.23146; Eskens BJM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-175; Fery F, 1997, METABOLISM, V46, P227, DOI 10.1016/S0026-0495(97)90307-3; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gallo LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28124; Gallo LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26428; Guo JK, 2012, J AM SOC NEPHROL, V23, P429, DOI 10.1681/ASN.2011040396; Hale LJ, 2013, CLIN SCI, V124, P351, DOI 10.1042/CS20120378; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Hoekstra E, 2016, ONCOTARGET, V7, P73525, DOI 10.18632/oncotarget.12321; Hori H, 2002, DIABETES, V51, P2387, DOI 10.2337/diabetes.51.8.2387; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hyvonen ME, 2010, MOL CELL ENDOCRINOL, V328, P70, DOI 10.1016/j.mce.2010.07.016; Ichihara Y, 2013, EUR J MED CHEM, V62, P649, DOI 10.1016/j.ejmech.2013.01.014; Ishihara H, 1999, BIOCHEM BIOPH RES CO, V260, P265, DOI 10.1006/bbrc.1999.0888; Kagawa S, 2008, ENDOCRINOLOGY, V149, P642, DOI 10.1210/en.2007-0820; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Kim J, 2012, EXP DIABETES RES, DOI 10.1155/2012/210821; KLIP A, 1992, ENDOCRINOLOGY, V130, P2535, DOI 10.1210/en.130.5.2535; Langer S, 2016, J NEPHROL, V29, P765, DOI 10.1007/s40620-015-0258-1; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Marion E, 2002, DIABETES, V51, P2012, DOI 10.2337/diabetes.51.7.2012; Mills SJ, 2012, ACS CHEM BIOL, V7, P822, DOI 10.1021/cb200494d; Munshi PN, 2014, ONCOLOGIST, V19, P760, DOI 10.1634/theoncologist.2014-0178; Orchard TJ, 2002, KIDNEY INT, V62, P963, DOI 10.1046/j.1523-1755.2002.00507.x; Pan QR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003247; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Rogacka D, 2014, INT J BIOCHEM CELL B, V51, P120, DOI 10.1016/j.biocel.2014.04.008; Saurus P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.125; Saurus P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10512-w; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Suwa A, 2009, BRIT J PHARMACOL, V158, P879, DOI 10.1111/j.1476-5381.2009.00358.x; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Tolvanen TA, 2015, J CELL SCI, V128, P4588, DOI 10.1242/jcs.175075; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Viernes DR, 2014, MED RES REV, V34, P795, DOI 10.1002/med.21305; Wiernsperger NF, 1999, DIABETES METAB, V25, P110; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	53	41	44	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2858	2869		10.1096/fj.201800529RR	http://dx.doi.org/10.1096/fj.201800529RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30321069	Green Published, hybrid			2022-12-28	WOS:000457296600106
J	Ye, YZ; Tang, Y; Xiong, Y; Feng, LP; Li, XT				Ye, Yunzhen; Tang, Yao; Xiong, Yu; Feng, Liping; Li, Xiaotian			Bisphenol A exposure alters placentation and causes preeclampsia-like features in pregnant mice involved in reprogramming of DNA methylation of WNT2	FASEB JOURNAL			English	Article						trophoblast invasion; DNMT; maternal; endocrine disruptor; birth outcomes	INTRAUTERINE GROWTH RESTRICTION; ENDOCRINE DISRUPTORS; IN-VITRO; EXPRESSION; PROMOTER; INVASION; BPA; DIFFERENTIATION; NONYLPHENOL; METABOLISM	Preeclampsia leads to adverse outcomes for pregnant women. Bisphenol A (BPA) is an environmental endocrine disruptor and has been shown to be positively associated with increased risk of preeclampsia in human studies. We investigated whether BPA exposure causes preeclampsia-like features in pregnant mice and the associated underlying mechanisms. Experiments were performed in animal models and cell cultures. In pregnant mice, BPA-exposed mice exhibited preeclampsia-like features including hypertension, disruption of the circulation, and the placental angiogenesis biomarkers fms-related tyrosine kinase 1 and placenta growth factor, and glomerular atrophy; urinary protein was not affected. These preeclampsia-like features correlated with increased retention of smooth muscle cells and reduced vessel areas at the junctional zone of the placenta. In addition, there were disrupted expression of invasion-related genes including increased tissue inhibitors of metalloproteinases, decreased metalloproteinases, and Wnt family member WNT2/-catenin, which correlated with increased DNA methylation in its promoter region and upregulation of DNA methyltransferase (Dnmt)1. BPA exposure impeded the interaction between the human cytotrophoblast cell line, HTR-8/SVneo, and endothelium cells. BPA exposure down-regulated WNT2 expression, and elevated the DNA methylation of WNT2; these results were consistent with in vivo observations. Inhibition of DNMT in HTR-8/SVneo cells resulted in reduced DNA methylation and increased expression of WNT2. Taken together, these data demonstrate that BPA exposure alters trophoblast cell invasion and causes abnormal placental vessel remodeling, both of which lead to the development of preeclampsia-like features in pregnant mice. Our results suggest that this phenomenon involves the epigenetic reprogramming and down-regulation of WNT2 mediated by DNMT1.Ye, Y., Tang, Y., Xiong, Y., Feng, L., Li, X. Bisphenol A exposure alters placentation and causes preeclampsia-like features in pregnant mice involved in reprogramming of DNA methylation of WNT2.	[Ye, Yunzhen; Tang, Yao; Xiong, Yu; Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Fangxie Rd 419, Shanghai, Peoples R China; [Li, Xiaotian] Fudan Univ, Inst Biochem Sci, Shanghai, Peoples R China; [Ye, Yunzhen; Tang, Yao; Xiong, Yu; Li, Xiaotian] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China; [Feng, Liping] Duke Univ, Sch Med, Dept Obstet & Gynecol, 246 Sands Bldg,303 Res Dr, Durham, NC 27710 USA; [Feng, Liping] Minist Educ, Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China; [Li, Xiaotian] Shanghai Key Lab Birth Defects, Shanghai, Peoples R China	Fudan University; Fudan University; Duke University	Li, XT (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Fangxie Rd 419, Shanghai, Peoples R China.; Feng, LP (corresponding author), Duke Univ, Sch Med, Dept Obstet & Gynecol, 246 Sands Bldg,303 Res Dr, Durham, NC 27710 USA.	liping.feng@duke.edu; xiaotianli555@163.com	Li, Xiaotian/ABI-3309-2020	Li, Xiaotian/0000-0002-2051-4581	National Science Fund of China Emergency Management Project [81741047]; National Science Fund of China [81270712]; Shanghai Key Program of Clinical Science and Technology Innovation [17411950500, 17411950501]; Shanghai Medical Center of Key Programs for Female Reproductive Diseases Grant [2017ZZ01016]; National Key Basic Research Plan of China (973 Plan) [2015CB943300]; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Shanghai Key Laboratory of Birth Defects; Key Specialty Project of the Ministry of Health, People's Republic of China; FOGARTY INTERNATIONAL CENTER [K01TW010828] Funding Source: NIH RePORTER	National Science Fund of China Emergency Management Project; National Science Fund of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Program of Clinical Science and Technology Innovation; Shanghai Medical Center of Key Programs for Female Reproductive Diseases Grant; National Key Basic Research Plan of China (973 Plan)(National Basic Research Program of China); Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Shanghai Key Laboratory of Birth Defects; Key Specialty Project of the Ministry of Health, People's Republic of China; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Science Fund of China Emergency Management Project Grant 81741047 (to X.L); National Science Fund of China Grant 81270712 (to X.L); Shanghai Key Program of Clinical Science and Technology Innovation Grants 17411950500 and 17411950501 (to X.L); Shanghai Medical Center of Key Programs for Female Reproductive Diseases Grant 2017ZZ01016 (to X.L); National Key Basic Research Plan of China (973 Plan) Grant 2015CB943300 (to X.L); the Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Shanghai Key Laboratory of Birth Defects (to X.L); and the Key Specialty Project of the Ministry of Health, People's Republic of China (to X.L). The authors declare no conflicts of interest.	[Anonymous], 2013, HYPERTENSION PREGNAN; Benachour N, 2009, TOXICOL APPL PHARM, V241, P322, DOI 10.1016/j.taap.2009.09.005; Cantonwine DE, 2016, ENVIRON HEALTH PERSP, V124, P1651, DOI 10.1289/EHP188; Cantonwine DE, 2015, ENVIRON HEALTH PERSP, V123, P895, DOI 10.1289/ehp.1408126; Chou WC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-94; Degen GH, 2000, INT ARCH OCC ENV HEA, V73, P433, DOI 10.1007/s004200000163; Dodson RE, 2012, ENVIRON HEALTH PERSP, V120, P935, DOI 10.1289/ehp.1104052; Ferreira JC, 2011, EPIGENETICS-US, V6, P441, DOI 10.4161/epi.6.4.14554; Gao T, 2018, J OBSTET GYNAECOL RE, V44, P756, DOI 10.1111/jog.13560; Giannakou K, 2018, ULTRASOUND OBST GYN, V51, P720, DOI 10.1002/uog.18959; Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436; Hu JY, 2003, WATER RES, V37, P1213, DOI 10.1016/S0043-1354(02)00378-0; Jobe SO, 2013, HYPERTENSION, V61, P480, DOI 10.1161/HYPERTENSIONAHA.111.201624; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Kohan-Ghadr HR, 2016, CELL ADHES MIGR, V10, P126, DOI 10.1080/19336918.2015.1098800; Kovanecz I, 2013, J SEX MED, V10, P2952, DOI 10.1111/jsm.12336; Kurosawa T, 2002, ENDOCR J, V49, P465, DOI 10.1507/endocrj.49.465; Lan X, 2017, ONCOTARGET, V8, P51507, DOI 10.18632/oncotarget.17882; Leclerc F, 2014, HYPERTENS PREGNANCY, V33, P341, DOI 10.3109/10641955.2014.892607; Matthews JB, 2001, CHEM RES TOXICOL, V14, P149, DOI 10.1021/tx0001833; McElrath TF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.010; Morck TJ, 2010, REPROD TOXICOL, V30, P131, DOI 10.1016/j.reprotox.2010.02.007; Nahar MS, 2015, CHEMOSPHERE, V124, P54, DOI 10.1016/j.chemosphere.2014.10.071; Ogawa M, 2007, PLACENTA, V28, P224, DOI 10.1016/j.placenta.2006.01.023; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Poidatz D, 2015, FERTIL STERIL, V104, P483, DOI 10.1016/j.fertnstert.2015.05.005; Rahat B, 2016, REPRODUCTION, V152, P11, DOI 10.1530/REP-16-0060; Rebuli ME, 2014, TOXICOL SCI, V140, P190, DOI 10.1093/toxsci/kfu074; Saura M, 2014, FASEB J, V28, P4719, DOI 10.1096/fj.14-252460; Shen YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127886; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Spagnoletti A, 2015, MOL CELL ENDOCRINOL, V412, P56, DOI 10.1016/j.mce.2015.05.023; Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Tachibana T, 2007, J REPROD DEVELOP, V53, P509, DOI 10.1262/jrd.18171; Tait S, 2015, GENOM DATA, V4, P109, DOI 10.1016/j.gdata.2015.04.004; Tait S, 2015, J APPL TOXICOL, V35, P1278, DOI 10.1002/jat.3176; Tang Y, 2015, MOL HUM REPROD, V21, P736, DOI 10.1093/molehr/gav037; Tiwari SK, 2015, MOL NEUROBIOL, V52, P1735, DOI 10.1007/s12035-014-8940-1; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Wang ZY, 2015, INT J CLIN EXP PATHO, V8, P14355; Xiao J, 2011, BIOMED ENVIRON SCI, V24, P40, DOI 10.3967/0895-3988.2011.01.005; Ye YZ, 2017, EUR J PUBLIC HEALTH, V27, P1102, DOI 10.1093/eurpub/ckx148; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zhang Z, 2013, REPROD SCI, V20, P981, DOI 10.1177/1933719112472740	45	39	42	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2732	2742		10.1096/fj.201800934RRR	http://dx.doi.org/10.1096/fj.201800934RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303745	Green Accepted, Green Published			2022-12-28	WOS:000457296600096
J	Zhu, ED; Zhang, JJ; Li, YC; Yuan, HR; Zhou, J; Wang, BL				Zhu, Endong; Zhang, Juanjuan; Li, Yachong; Yuan, Hairui; Zhou, Jie; Wang, Baoli			Long noncoding RNA Plnc1 controls adipocyte differentiation by regulating peroxisome proliferator-activated receptor	FASEB JOURNAL			English	Article						adipogenesis; DNA methylation; obesity	ADIPOSE-TISSUE; GENE; ADIPOGENESIS; EXPRESSION; LNCRNA; OBESITY; PROMOTES; BINDING; ALPHA; GAMMA	Detailed understanding of molecular mechanisms controlling adipogenesis is of great importance to identify new targets for treating obesity. Emerging evidence suggests that long noncoding RNAs (lncRNAs) may play a pivotal role in adipogenesis. Here, we have identified a novel lncRNA, Plnc1, which is transcribed from a position approximate to 25,000 bp upstream of the peroxisome proliferator-activated receptor 2 (PPAR-2) gene. Plnc1 is abundantly expressed in adipose tissue, and obese mice have higher Plnc1 expression in adipose tissue than nonobese mice. Plnc1 was induced in established adipogenic lines ST2, 3T3-L1, and C3H10T1/2 as well as in bone marrow stromal cells (BMSCs) after adipogenic treatment. Plnc1 knockdown blocked differentiation of ST2 cells and BMSCs into mature adipocytes, along with the reduction of PPAR-, CCAAT/enhancer binding protein-, and adipocyte protein 2. Conversely, overexpression of Plnc1 promoted ST2 cells and BMSCs to fully differentiate. Mechanism studies revealed that Plnc1 could reduce the methylation level of CpG region in the PPAR-2 promoter and enhance the transcriptional activity of the promoter and thereby increase PPAR-2 transcription. Our study suggests that Plnc1 promotes adipogenic differentiation through controlling the key adipogenic transcription factor PPAR- and highlights the potential of Plnc1 as a target for new therapies to control metabolic disorders like obesity.Zhu, E., Zhang, J., Li, Y., Yuan, H., Zhou, J., Wang, B. Long noncoding RNA Plnc1 controls adipocyte differentiation by regulating peroxisome proliferator-activated receptor .	[Zhu, Endong; Zhang, Juanjuan; Yuan, Hairui; Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Zhu, Endong; Zhang, Juanjuan; Yuan, Hairui; Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Tianjin Metab Dis Hosp, Tianjin Key Lab Metab Dis, Tianjin, Peoples R China; [Zhu, Endong; Zhang, Juanjuan; Yuan, Hairui; Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China; [Li, Yachong] Tianjin Med Univ, Stomatol Hosp, Dept Endodont, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wang, BL (corresponding author), Tianjin Med Univ, Inst Endocrinol, Tianjin Key Lab Metab Dis, 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	blwang@tmu.edu.cn	Zhang, Juan/GRX-2638-2022		National Natural Science Foundation of China [81501846, 81601864, 81672116, 81472040]; Tianjin Municipal Natural Science Foundation [18JCZDJC32200, 18JCQNJC12900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin)	This work was supported by Grants 81501846 (to E.Z.), 81601864 (to H.Y.), and 81672116 and 81472040 (to B.W.) from the National Natural Science Foundation of China. This work was also partially supported by Tianjin Municipal Natural Science Foundation Grants 18JCZDJC32200 and 18JCQNJC12900. The authors declare no conflicts of interest.	Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001; Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Bianchessi V, 2017, ANAL BIOCHEM, V519, P84, DOI 10.1016/j.ab.2016.12.016; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Chen J, 2017, INT J OBESITY, V41, P299, DOI 10.1038/ijo.2016.189; Cooper DR, 2014, GENES-BASEL, V5, P1050, DOI 10.3390/genes5041050; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Divoux A, 2014, OBESITY, V22, P1781, DOI 10.1002/oby.20793; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Knoll M, 2015, NAT REV ENDOCRINOL, V11, P151, DOI 10.1038/nrendo.2014.229; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Liu S, 2014, J BIOL CHEM, V289, P13000, DOI 10.1074/jbc.M114.564658; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Luo LP, 2016, J ENDOCRINOL, V231, pR77, DOI 10.1530/JOE-16-0211; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Pang WJ, 2013, J CELL BIOCHEM, V114, P2500, DOI 10.1002/jcb.24595; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Sun Q., 2017, TRENDS GENET; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wei SJ, 2016, CELL MOL LIFE SCI, V73, P2079, DOI 10.1007/s00018-016-2169-2; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xiao TF, 2015, STEM CELL REP, V5, P856, DOI 10.1016/j.stemcr.2015.09.007; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002; Zhou J, 2017, FASEB J, V31, P1939, DOI 10.1096/fj.201600975RR; Zhu ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106049; Zhu ED, 2018, J MOL ENDOCRINOL, V60, P225, DOI 10.1530/JME-17-0183; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	46	32	38	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2396	2408		10.1096/fj.201800739RRR	http://dx.doi.org/10.1096/fj.201800739RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277818				2022-12-28	WOS:000457296600069
J	Yamada, M; Iwata, M; Warabi, E; Oish, H; Lira, VA; Okutsu, M				Yamada, Mami; Iwata, Masahiro; Warabi, Eiji; Oish, Hisashi; Lira, Vitor A.; Okutsu, Mitsuharu			p62/SQSTM1 and Nrf2 are essential for exercise-mediated enhancement of antioxidant protein expression in oxidative muscle	FASEB JOURNAL			English	Article						glycolytic skeletal muscle; voluntary running; CuZnSOD; EcSOD; NQO1	CUL3-BASED E3 LIGASE; NRF2-KEAP1 PATHWAY; AUTOPHAGY; P62; ADAPTER; ADAPTATION; DEFICIENCY; MECHANISMS; MICE	Increased muscle contractile activity, as observed with regular exercise, prevents oxidative stress-induced muscle wasting, at least partially, by improving the antioxidant defense system. Phosphorylated p62/sequestosome1 competitively binds to the Kelch-like ECH-associated protein 1, activating nuclear factor erythroid 2-related factor 2 (Nrf2), which stimulates transcription of antioxidant/electrophile responsive elements. However, it remains to be determined if this process is activated by regular exercise in skeletal muscle. Here, we demonstrate that muscle contractile activity increases antioxidants, Nrf2 translocation into nuclei, and Nrf2 DNA-binding activity in association with increased p62 phosphorylation (Ser351) in mouse oxidative skeletal muscle. Skeletal muscle-specific loss of Nrf2 [i.e., Nrf2 muscle-specific knockout (mKO) mice] abolished the expression of the Nrf2 target antioxidant gene NAD(P)H-quinone oxidoreductase 1 (NQO1) in both glycolytic and oxidative muscles but reduced exercise-mediated increases of antioxidants (i.e., copper/zinc superoxide dismutase (SOD) and extracellular SOD only in oxidative muscle. Interestingly, skeletal muscle-specific loss of p62 (i.e., p62 mKO mice) also abolished the expression of NQO1 and reduced exercise-mediated increases of the same antioxidants in soleus muscle. Collectively, these findings indicate that p62 and Nrf2 cooperatively regulate the exercise-mediated increase of antioxidants in oxidative muscle.-Yamada, M., Iwata, M., Warabi, E., Oishi, H., Lira, V. A., Okutsu, M. p62/SQSTM1 and Nrf2 are essential for exercise-mediated enhancement of antioxidant protein expression in oxidative muscle.	[Yamada, Mami; Okutsu, Mitsuharu] Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi, Japan; [Oish, Hisashi] Nagoya City Univ, Dept Comparat & Expt Med, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Iwata, Masahiro] Nihon Fukushi Univ, Dept Rehabil, Fac Hlth Sci, Handa, Japan; [Warabi, Eiji] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Lira, Vitor A.] Univ Iowa, Dept Hlth & Human Physiol, Pappajohn Biomed Inst,Obes Res & Educ Initiat, Diabet Res Ctr,Abboud Cardiovasc Res Ctr,FOE, Iowa City, IA USA	Nagoya City University; Nagoya City University; University of Tsukuba; University of Iowa	Okutsu, M (corresponding author), Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Yamanohata 1,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	okutsu@nsc.nagoya-cu.ac.jp	Lira, Vitor/AAN-3403-2021	Lira, Vitor/0000-0002-3162-3804	Suzuken Memorial Foundation; Toyoaki Scholarship Foundation; The Nakatomi Foundation; The Uehara Memorial Foundation;  [25882036];  [15H03080];  [18H03153]	Suzuken Memorial Foundation; Toyoaki Scholarship Foundation(Toyoaki Scholarship Foundation); The Nakatomi Foundation; The Uehara Memorial Foundation(Uehara Memorial Foundation); ; ; 	The authors thank Dr. Steven J. Burden (New York University, New York, New York, USA), Dr. Toru Yanagawa (University of Tsukuba), and Dr. Jingbo Pi (China Medical University, Shenyang, China) for their generosity in providing mlc1-cre mice, p62 flox mice, and Nrf2 flox, respectively. The authors also thank Dr. Ichiro Miyoshi, Dr. Masayuki Yamamoto, Dr. Takahumi Suzuki (all from Tohuku University, Sendai, Japan) and Yasuo Kitajima (Kumamoto University, Kumamoto, Japan) for the transfer arrangements for the mice. The authors thank Yasuhiko Hayakawa (Nepa Gene, Ichikawa, Japan) for his excellent technical support in plasmid transfection. This study was supported by Grant-in-Aid for Research Activity Start-Up (25882036), Grant-in-Aid for Scientific Research (B) (15H03080), Grant-in-Aid for Scientific Research (B) (18H03153), the Suzuken Memorial Foundation, Toyoaki Scholarship Foundation, The Nakatomi Foundation, and The Uehara Memorial Foundation (to M.O.). The authors declare no conflicts of interest.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Done AJ, 2016, FREE RADICAL BIO MED, V96, P130, DOI 10.1016/j.freeradbiomed.2016.04.024; Harada H, 2013, J NEUROSCI, V33, P14767, DOI 10.1523/JNEUROSCI.2954-12.2013; Horie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144835; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Iwata M, 2007, PATHOBIOLOGY, V74, P159, DOI 10.1159/000103375; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394; Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x; Okutsu M, 2014, CIRC-HEART FAIL, V7, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000841; Powers SK, 2016, MED SCI SPORT EXER, V48, P2307, DOI 10.1249/MSS.0000000000000975; Powers SK, 2016, FREE RADICAL BIO MED, V98, P208, DOI 10.1016/j.freeradbiomed.2016.02.021; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Wang P, 2016, EXP PHYSIOL, V101, P410, DOI 10.1113/EP085493; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Yamada M, 2018, BIOCHEM BIOPHYS REP, V15, DOI 10.1016/j.bbrep.2018.06.001	30	26	26	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8022	8032		10.1096/fj.201900133R	http://dx.doi.org/10.1096/fj.201900133R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30913396	Bronze			2022-12-28	WOS:000476234700018
J	Barr, T; Lewis, SA; Sureshchandra, S; Doratt, B; Grant, KA; Messaoudi, I				Barr, Tasha; Lewis, Sloan A.; Sureshchandra, Suhas; Doratt, Brianna; Grant, Kathleen A.; Messaoudi, Ilhem			Chronic ethanol consumption alters lamina propria leukocyte response to stimulation in a region-dependent manner	FASEB JOURNAL			English	Article						gastrointestinal tract; mucosal immunology; nonhuman primate; alcohol and immunity	DIFFERENTIAL EXPRESSION ANALYSIS; ALCOHOL-CONSUMPTION; GENE-EXPRESSION; LYMPHOCYTES; TURNOVER; DRINKING; IMMUNITY; MONKEYS; MUCOSA; CELLS	Chronic heavy alcohol consumption, also referred to as chronic heavy drinking (CHD), results in intestinal injury characterized by increased permeability, dysbiosis, nutrient malabsorption, potentially higher susceptibility to infection, and increased risk of colorectal cancer. However, our understanding of the mechanisms by which CHD results in intestinal damage remains incomplete. Here, we investigated the impact of chronic drinking on transcriptional and functional responses of lamina propria leukocytes (LPLs) isolated from the 4 major gut sections. Although no significant differences were detected between LPLs isolated from the ethanol and control groups at resting state within each major gut section, our analysis uncovered key regional differences in composition and function of LPLs independent of alcohol consumption. However, in response to phorbol myristate acetate and ionomycin, duodenal LPLs from ethanol-drinking animals generated a dampened response, whereas jejunal and ileal LPLs from ethanol-drinking animals produced a heightened response. Transcriptional responses following stimulation were pronounced in ileal and duodenal LPLs from the ethanol-drinking group but less evident in jejunal and colonic LPLs compared with controls, suggesting a more significant impact of alcohol on these gut regions. The altered intestinal LPL function detected in our study reveals remarkable region specificity and novel insight into potential mechanisms of intestinal injury associated with CHD.-Barr, T., Lewis, S. A., Sureshchandra, S., Doratt, B., Grant, K. A., Messaoudi, I. Chronic ethanol consumption alters lamina propria leukocyte response to stimulation in a region-dependent manner.	[Barr, Tasha; Lewis, Sloan A.; Sureshchandra, Suhas; Doratt, Brianna; Messaoudi, Ilhem] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Grant, Kathleen A.; Messaoudi, Ilhem] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	University of California System; University of California Irvine; Oregon Health & Science University; Oregon National Primate Research Center	Messaoudi, I (corresponding author), Univ Calif Irvine, 2400 Biol Sci 3, Irvine, CA 92697 USA.	imessaou@uci.edu	Sureshchandra, Suhas/AAW-4606-2021		U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) [F31 AA025278, R21 AA021947, R21 AA024981, U01 AA013510, R24 AA109431]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013510, R24AA019431, F31AA025278, R21AA024981] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Grants F31 AA025278 (to T.B.), R21 AA021947 (to I.M.), R21 AA024981 (to I.M.), U01 AA013510 (to K.A.G.), and R24 AA109431 (to K.A.G.). The authors declare no conflicts of interest.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Asquith M, 2014, ALCOHOL CLIN EXP RES, V38, P980, DOI 10.1111/acer.12325; Backman TWH, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1241-0; Baker EJ, 2014, ALCOHOL CLIN EXP RES, V38, P2835, DOI 10.1111/acer.12547; Barr T, 2018, GUT MICROBES, V9, P338, DOI 10.1080/19490976.2018.1441663; Bishehsari F, 2017, ALCOHOL RES-CURR REV, V38, P163; Bode C, 2003, BEST PRACT RES CL GA, V17, P575, DOI 10.1016/S1521-6918(03)00034-9; BROZINSKY S, 1978, DIS COLON RECTUM, V21, P329, DOI 10.1007/BF02586661; Cervera-Juanes R, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.266; Cervera-Juanes R, 2017, ALCOHOL, V60, P103, DOI 10.1016/j.alcohol.2016.11.003; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Frishberg A, 2016, BIOINFORMATICS, V32, P3842, DOI 10.1093/bioinformatics/btw535; Gaddini GW, 2015, BONE, V71, P227, DOI 10.1016/j.bone.2014.10.025; Grant KA, 2008, ALCOHOL CLIN EXP RES, V32, P1824, DOI 10.1111/j.1530-0277.2008.00765.x; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Iancu OD, 2018, ADDICT BIOL, V23, P196, DOI 10.1111/adb.12501; Jerrells TR, 1998, ALCOHOL CLIN EXP RES, V22, p212S, DOI 10.1111/j.1530-0277.1998.tb04004.x; Jimenez VA, 2017, NEUROPHARMACOLOGY, V122, P127, DOI 10.1016/j.neuropharm.2017.03.027; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Maier A, 1999, DIGEST DIS SCI, V44, P691, DOI 10.1023/A:1026697305769; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Poonia B, 2006, JAIDS-J ACQ IMM DEF, V41, P537, DOI 10.1097/01.qai.0000209907.43244.ee; Rajendram R, 2005, DIGEST DIS, V23, P214, DOI 10.1159/000090168; Riva A, 2018, GUT, V67, P918, DOI 10.1136/gutjnl-2017-314458; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RUBIN E, 1972, GASTROENTEROLOGY, V63, P801; Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi N, 2017, MILITARY MED RES, V4, DOI 10.1186/s40779-017-0122-9; SIBLEY DA, 1995, ALCOHOL CLIN EXP RES, V19, P324, DOI 10.1111/j.1530-0277.1995.tb01510.x; Souza HSP, 2003, ALCOHOL, V30, P183, DOI 10.1016/S0741-8329(03)00134-4; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Veazey RS, 2015, ALCOHOL CLIN EXP RES, V39, P1373, DOI 10.1111/acer.12784; ZEITZ M, 1991, IMMUNOL RES, V10, P199, DOI 10.1007/BF02919693; Zhu X, 2000, ALCOHOL ALCOHOLISM, V35, P25, DOI 10.1093/alcalc/35.1.25	41	3	3	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7767	7777		10.1096/fj.201802780R	http://dx.doi.org/10.1096/fj.201802780R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30897342	Green Published			2022-12-28	WOS:000476114200088
J	Cao, DC; Song, JP; Ling, SK; Niu, SS; Lu, L; Cui, ZZ; Li, YH; Hao, SS; Zhong, GH; Qi, ZH; Sun, WJ; Yuan, XX; Li, HX; Zhao, DS; Jin, XY; Liu, CZ; Wu, XR; Kan, GH; Cao, HQ; Kang, YM; Yu, SY; Li, YX				Cao, Dengchao; Song, Jinping; Ling, Shukuan; Niu, Shuaishuai; Lu, Liang; Cui, Zhengzhi; Li, Yuheng; Hao, Shanshan; Zhong, Guohui; Qi, Zhihong; Sun, Weijia; Yuan, Xinxin; Li, Hongxing; Zhao, Dingsheng; Jin, Xiaoyan; Liu, Caizhi; Wu, Xiaorui; Kan, Guanghan; Cao, Hongqing; Kang, Youmin; Yu, Shuyang; Li, Yingxian			Hematopoietic stem cells and lineage cells undergo dynamic alterations under microgravity and recovery conditions	FASEB JOURNAL			English	Article						spaceflight; immune dysfunction; hindlimb unloading; differentiation	BONE-MARROW; SIMULATED MICROGRAVITY; INDUCED APOPTOSIS; DIFFERENTIATION; SPACE; PROLIFERATION; HOMEOSTASIS; PRECURSORS; EXPRESSION; MIGRATION	Spaceflight leads to health risks including bone demineralization, skeletal muscle atrophy, cardiovascular dysfunction, and disorders of almost all physiologic systems. However, the impacts of microgravity on blood lineage cells and hematopoietic stem cells (HSCs) in vivo are largely unknown. In this study, we analyzed peripheral blood samples from 6 astronauts who had participated in spaceflight missions and found significant changes in several cell populations at different time points. These dynamic alterations of lineage cells and the role of HSCs were further studied in a mouse model, using hindlimb unloading (HU) to simulate microgravity. Large reductions in the frequency of NK cells, B cells, and erythrocyte precursors in the bone marrow of the HU mice were observed, together with an increased frequency of T cells, neutrophils, and HSCs. T cell levels recovered faster than those of B cells and erythrocyte precursors, whereas the recovery rates of NK cells and granulocytes were slow. In addition, competitive reconstitution experiments demonstrated the impaired function of HSCs, although these changes were reversible. Deep sequencing showed changes in the expression of regulatory molecules important for the differentiation of HSCs. This study provides the first determination of altered HSC function under simulated microgravity in vivo. The impairment of HSC function and differentiation provides an explanation for the immune disorders that occur under simulated microgravity. Thus, our findings demonstrated that spaceflight and simulated microgravity disrupt the homeostasis of immune system and cause dynamic alterations on both HSCs and lineage cells.-Cao, D., Song, J., Ling, S., Niu, S., Lu, L., Cui, Z., Li, Y., Hao, S., Zhong, G., Qi, Z., Sun, W., Yuan, X., Li, H., Zhao, D., Jin, X., Liu, C., Wu, X., Kan, G., Cao, H., Kang, Y., Yu, S., Li, Y. Hematopoietic stem cells and lineage cells undergo dynamic alterations under microgravity and recovery conditions.	[Cao, Dengchao; Niu, Shuaishuai; Cui, Zhengzhi; Hao, Shanshan; Qi, Zhihong; Yuan, Xinxin; Yu, Shuyang] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Cao, Dengchao; Niu, Shuaishuai; Cui, Zhengzhi; Hao, Shanshan; Yuan, Xinxin; Kang, Youmin; Yu, Shuyang] China Agr Univ, Coll Life Sci, State Key Lab Agrobiotechnol, 2 Yuan Mingyuan West Rd, Beijing 100193, Peoples R China; [Cao, Dengchao; Song, Jinping; Ling, Shukuan; Lu, Liang; Li, Yuheng; Zhong, Guohui; Qi, Zhihong; Sun, Weijia; Yuan, Xinxin; Li, Hongxing; Zhao, Dingsheng; Jin, Xiaoyan; Liu, Caizhi; Wu, Xiaorui; Kan, Guanghan; Cao, Hongqing; Li, Yingxian] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, 26 Beiqing Rd, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Yu, SY (corresponding author), China Agr Univ, Coll Life Sci, State Key Lab Agrobiotechnol, 2 Yuan Mingyuan West Rd, Beijing 100193, Peoples R China.; Li, YX (corresponding author), China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, 26 Beiqing Rd, Beijing 100094, Peoples R China.	ysy@cau.edu.cn; yingxianli@aliyun.com	Song, Jin/HHS-8731-2022; Cao, Dengchao/AIA-7934-2022	Cao, Dengchao/0000-0001-9808-991X; Ling, Shukuan/0000-0002-4622-4160	National Natural Science Foundation of China [31571522, 31422037, 31630038]; National Key Research and Development Program of China [2017YFA0104401]; Project for Extramural Scientists (State Key Laboratory of Agrobiotechnology, China Agricultural University) [2018SKLAB6-30]; 1226 Project [AWS16J018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Project for Extramural Scientists (State Key Laboratory of Agrobiotechnology, China Agricultural University); 1226 Project	This work was supported by the National Natural Science Foundation of China (31630038) and 1226 Project (AWS16J018), the National Key Research and Development Program of China (2017YFA0104401), the National Natural Science Foundation of China (31571522 and 31422037), and the Project for Extramural Scientists (State Key Laboratory of Agrobiotechnology, China Agricultural University) (2018SKLAB6-30). The authors declare no conflicts of interest.	Cheng LZ, 2000, J CELL PHYSIOL, V184, P58, DOI 10.1002/(SICI)1097-4652(200007)184:1<58::AID-JCP6>3.0.CO;2-B; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.13; Ferrero E, 2003, BLOOD, V101, P186, DOI 10.1182/blood-2002-03-0768; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Hua C, 2017, NEURAL REGEN RES, V12, P153, DOI 10.4103/1673-5374.199008; Kunz Hawley, 2017, BMC Hematol, V17, P12, DOI 10.1186/s12878-017-0083-y; Kuo YH, 2009, BLOOD, V113, P3323, DOI 10.1182/blood-2008-06-162248; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Li PP, 2015, FASEB J, V29, P3263, DOI 10.1096/fj.15-271700; Link DC, 2005, IMMUNOL RES, V32, P169, DOI 10.1385/IR:32:1-3:169; Mehta SK, 2001, J APPL PHYSIOL, V91, P1814, DOI 10.1152/jappl.2001.91.4.1814; Mills PJ, 2001, PSYCHOSOM MED, V63, P886, DOI 10.1097/00006842-200111000-00006; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paredes F, 2016, FREE RADICAL BIO MED, V90, P206, DOI 10.1016/j.freeradbiomed.2015.11.024; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Plett RA, 2001, IN VITRO CELL DEV-AN, V37, P73, DOI 10.1290/1071-2690(2001)037<0073:POHHBM>2.0.CO;2; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Sonnenfeld G, 2005, CURR PHARM BIOTECHNO, V6, P343, DOI 10.2174/1389201054553699; Sotnezova EV, 2017, B EXP BIOL MED+, V162, P496, DOI 10.1007/s10517-017-3647-8; Sun ZY, 2015, BONE, V76, P121, DOI 10.1016/j.bone.2015.04.006; Tober J, 2013, DEVELOPMENT, V140, P3765, DOI 10.1242/dev.094961; Williams DR, 2003, ANNU REV MED, V54, P245, DOI 10.1146/annurev.med.54.101601.152215; Zheng L, 2011, AVIAT SPACE ENVIR MD, V82, P513, DOI 10.3357/ASEM.2838.2011; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	29	15	17	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6904	6918		10.1096/fj.201802421RR	http://dx.doi.org/10.1096/fj.201802421RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811956				2022-12-28	WOS:000476114200019
J	Sawada, A; Wang, SS; Jian, MY; Leem, J; Wackerbarth, J; Egawa, J; Schilling, JM; Platoshyn, O; Zemljic-Harpf, A; Roth, DM; Patel, HH; Patel, PM; Marsala, M; Head, BP				Sawada, Atsushi; Wang, Shanshan; Jian, Minyu; Leem, Joseph; Wackerbarth, Jesse; Egawa, Junji; Schilling, Jan M.; Platoshyn, Oleksandr; Zemljic-Harpf, Alice; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Marsala, Martin; Head, Brian P.			Neuron-targeted caveolin-1 improves neuromuscular function and extends survival in SOD1(G93A) mice	FASEB JOURNAL			English	Article						neuroplasticity; motor neurons; MLR; TrkB; mitochondria	AXONAL-TRANSPORT; LIPID RAFTS; TRANSGENE EXPRESSION; MOTOR-NEURONS; GENE-THERAPY; RECEPTOR; SOD1; ALS; MITOCHONDRIA; METABOLISM	Interventions that preserve motor neurons or restore functional motor neuroplasticity may extend longevity in amyotrophic lateral sclerosis (ALS). Delivery of neurotrophins may potentially revive degenerating motor neurons, yet this approach is dependent on the proper subcellular localization of neurotrophin receptor (NTR) to plasmalemmal signaling microdomains, termed membrane/lipid rafts (MLRs). We previously showed that overexpression of synapsin-driven caveolin-1 (Cav-1) (SynCav1) increases MLR localization of NTR [e.g., receptor tyrosine kinase B (TrkB)], promotes hippocampal synaptic and neuroplasticity, and significantly improves learning and memory in aged mice. The present study crossed a SynCav1 transgene-positive (SynCav1(+)) mouse with the mutant human superoxide dismutase glycine to alanine point mutation at amino acid 93 (hSOD1(G93A)) mouse model of ALS. When compared with hSOD1(G93A), hSOD1(G93A)/SynCav1(+) mice exhibited greater body weight and longer survival as well as better motor function. Microscopic analyses of hSOD1(G93A)/SynCav1(+) spinal cords revealed preserved spinal cord alpha-motor neurons and preserved mitochondrial morphology. Moreover, hSOD1(G93A)/SynCav1(+) spinal cords contained more MLRs (cholera toxin subunit B positive) and MLR-associated TrkB and Cav-1 protein expression. These findings demonstrate that SynCav1 delays disease progression in a mouse model of ALS, potentially by preserving or restoring NTR expression and localization to MLRs.-Sawada, A., Wang, S., Jian, M., Leem, J., Wackerbarth, J., Egawa, J., Schilling, J. M., Platoshyn, O., Zemljic-Harpf, A., Roth, D. M., Patel, H. H., Patel, P. M., Marsala, M., Head, B. P. Neuron-targeted caveolin-1 improves neuromuscular function and extends survival in SOD1(G93A) mice.	[Sawada, Atsushi; Wang, Shanshan; Jian, Minyu; Leem, Joseph; Wackerbarth, Jesse; Egawa, Junji; Schilling, Jan M.; Zemljic-Harpf, Alice; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Head, Brian P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Sawada, Atsushi; Wang, Shanshan; Jian, Minyu; Leem, Joseph; Wackerbarth, Jesse; Egawa, Junji; Schilling, Jan M.; Platoshyn, Oleksandr; Zemljic-Harpf, Alice; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Marsala, Martin; Head, Brian P.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Sawada, Atsushi] Sapporo Med Univ, Dept Anesthesiol, Sapporo, Hokkaido, Japan; [Jian, Minyu] Capital Med Univ, Beijing Tiantan Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Egawa, Junji] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara, Japan; [Platoshyn, Oleksandr; Marsala, Martin] Sanford Consortium Regenerat Med, La Jolla, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Sapporo Medical University; Capital Medical University; Nara Medical University	Head, BP (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.; Head, BP (corresponding author), Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA.	bhead@ucsd.edu			U.S. National Institutes of Health (NIH) Office of the Director Award [S10OD023527]; Veteran Affairs Merit Award from the Department of Veterans Affairs [BX003671, BX000783, BX001963]; NIH National Institute of Neurological Disorders and Stroke [NS073653]; NIH National Heart, Lung, and Blood Institute [HL091071, HL107200]; NIH National Institute of General Medical Sciences [GM085179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085179] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023527] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001963, I01BX003671, I01BX000783] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Office of the Director Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs Merit Award from the Department of Veterans Affairs; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Ying Jones, Vanessa Taupin, and Timo Meerlo [University of California-San Diego (UCSD) Electron Microscopy Core] for preparation of the spinal cord samples and training on electron microscopy. The authors also thank Dr. Marilyn Farquhar (UCSD) for consultation on the project. The electron micrographs were taken in the Cellular and Molecular Medicine Electron Microscopy Core Facility, which is supported, in part, by the U.S. National Institutes of Health (NIH) Office of the Director Award S10OD023527. Work in the researchers' laboratories was supported by a Veteran Affairs Merit Award from the Department of Veterans Affairs BX003671 (to B.P.H.), BX000783 (to D.M.R.), and BX001963 (to H.H.P.), and NIH National Institute of Neurological Disorders and Stroke Grant NS073653 (to B.P.H.), NIH National Heart, Lung, and Blood Institute Grants HL091071 and HL107200 (to H.H.P.), and NIH National Institute of General Medical Sciences Grant GM085179 (to P.M.P.). D.M.R., P.M.P., H.H.P., and B.P.H. are scientific founders of CavoGene LifeSciences LLC, and hold equity interest in the company. A.S. and S.W. share equal first authorship. The authors declare no other conflicts of interest.	Ajroud-Driss S, 2015, BBA-MOL BASIS DIS, V1852, P679, DOI 10.1016/j.bbadis.2014.08.010; Bartlett SE, 1998, IMMUNOL CELL BIOL, V76, P419, DOI 10.1046/j.1440-1711.1998.00767.x; Boillee S, 2008, J CLIN INVEST, V118, P474, DOI [10.1172/JC134613, 10.1172/JCI34613]; Brahimi F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162307; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1016/S0140-6736(10)61156-7, 10.1056/NEJMc1710379, 10.1038/nrdp.2017.85, 10.1016/S0140-6736(17)31287-4]; Buk DM, 2004, J CELL SCI, V117, P2063, DOI 10.1242/jcs.01049; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Egawa J, 2018, CEREB CORTEX, V28, P3255, DOI 10.1093/cercor/bhx196; Egawa J, 2017, FASEB J, V31, P3403, DOI 10.1096/fj.201601288RRR; English AW, 2013, P NATL ACAD SCI USA, V110, P16217, DOI 10.1073/pnas.1303646110; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; GEISLER FH, 1993, ANN EMERG MED, V22, P1041, DOI 10.1016/S0196-0644(05)82748-9; Geisler Fred H., 1993, Journal of Emergency Medicine, V11, P49; Glover CPJ, 2002, MOL THER, V5, P509, DOI 10.1006/mthe.2002.0588; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Haller J, 2016, J AM ACAD ORTHOP SUR, V24, P160, DOI 10.5435/JAAOS-D-14-00314; Hardiman O, 2017, LANCET NEUROL, V16, P490, DOI 10.1016/S1474-4422(17)30163-1; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Head BP, 2011, J BIOL CHEM, V286, P33310, DOI 10.1074/jbc.M111.255976; Hefferan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042614; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Keifer OP, 2014, PHARMACOL THERAPEUT, V141, P261, DOI 10.1016/j.pharmthera.2013.10.009; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Korkmaz OT, 2014, NEUROSCI LETT, V566, P286, DOI 10.1016/j.neulet.2014.02.058; Laurenzana A, 2015, CELL MOL LIFE SCI, V72, P1537, DOI 10.1007/s00018-014-1814-x; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Mandyam CD, 2017, BIOL PSYCHIAT, V81, P101, DOI 10.1016/j.biopsych.2015.09.020; McLean JR, 2014, NEUROSCI LETT, V576, P73, DOI 10.1016/j.neulet.2014.05.044; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Nathanson NM, 2012, NEUROCHEM INT, V61, P874, DOI 10.1016/j.neuint.2012.01.018; O'Connor DM, 2015, TRENDS MOL MED, V21, P504, DOI 10.1016/j.molmed.2015.06.001; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Pasqua T, 2016, CELL TISSUE RES, V363, P693, DOI 10.1007/s00441-015-2316-3; Pearn ML, 2018, BRIT J ANAESTH, V120, P745, DOI 10.1016/j.bja.2017.12.033; Romanelli RJ, 2009, J NEUROSCI RES, V87, P3369, DOI 10.1002/jnr.22099; Rosenberg JB, 2018, HUM GENE THER CL DEV, V29, P24, DOI 10.1089/humc.2017.231; Saragovi HU, 2009, CURR ALZHEIMER RES, V6, P419, DOI 10.2174/156720509789207912; Silva-Hucha S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178616; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; Tovar-y-Romo LB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00061; Wang JW, 2014, ANESTHESIOLOGY, V121, P538, DOI 10.1097/ALN.0000000000000295; Yamashita N, 2016, CURR OPIN NEUROBIOL, V39, P139, DOI 10.1016/j.conb.2016.06.004; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zonta Barbara, 2013, Front Synaptic Neurosci, V5, P9, DOI 10.3389/fnsyn.2013.00009	51	13	13	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7545	7554		10.1096/fj.201802652RR	http://dx.doi.org/10.1096/fj.201802652RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30894019	Green Published			2022-12-28	WOS:000476114200070
J	Wang, XJ; Zheng, W				Wang, Xingjian; Zheng, Wei			Ca2+ homeostasis dysregulation in Alzheimer's disease: a focus on plasma membrane and cell organelles	FASEB JOURNAL			English	Review						AD; Ca2+ channel; endoplasmic reticulum; MAM; mPTP	MITOCHONDRIAL PERMEABILITY TRANSITION; OPERATED CALCIUM-ENTRY; AMYLOID-BETA-PEPTIDES; IN MOUSE MODEL; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTOR; A-BETA; ER MEMBRANES; PRESENILIN-1 MUTATIONS; CORTICAL-NEURONS	Emerging evidence indicates that Ca2+ is a vital factor in modulating the pathogenesis of Alzheimer's disease (AD). In healthy neurons, Ca2+ concentration is balanced to maintain a lower level in the cytosol than in the extracellular space or certain intracellular compartments such as endoplasmic reticulum (ER) and the lysosome, whereas this homeostasis is broken in AD. On the plasma membrane, the AD hallmarks amyloid-beta (A beta) and tau interact with ligand-gated or voltage-gated Ca2+-influx channels and inhibit the Ca2+-efflux ATPase or exchangers, leading to an elevated intracellular Ca2+ level and disrupted Ca2+ signal. In the ER, the disabled presenilin "Ca2+ leak" function and the direct implications of A beta and presenilin mutants contribute to Ca2+-signal disorder. The enhanced ryanodine receptor (RyR)-mediated and inositol 1,4,5-trisphosphate receptor (IP3R)-mediated Ca2+ release from the ER aggravates cytosolic Ca2+ disorder and triggers apoptosis; the down-regulated ER Ca2+ sensor, stromal interaction molecule (STIM), alleviates store-operated Ca2+ entry in plasma membrane, leading to spine loss. The increased transfer of Ca2+ from ER to mitochondria through mitochondria-associated ER membrane (MAM) causes Ca2+ overload in the mitochondrial matrix and consequently opens the cellular damage-related channel, mitochondrial permeability transition pore (mPTP). In this review, we discuss the effects of A beta, tau and presenilin on neuronal Ca2+ signal, focusing on the receptors and regulators in plasma membrane and ER; we briefly introduce the involvement of MAM-mediated Ca2+ transfer and mPTP opening in AD pathogenesis.-Wang, X., Zheng, W. Ca2+ homeostasis dysregulation in Alzheimer's disease: a focus on plasma membrane and cell organelles.	[Wang, Xingjian; Zheng, Wei] China Med Univ, Coll Basic Med Sci, Dept Histol & Embryol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China	China Medical University	Zheng, W (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Histol & Embryol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	wzheng@cmu.edu.cn	Wang, Xingjian/AAS-1694-2020	Wang, Xingjian/0000-0002-7762-2241	Natural Science Foundation of China [81471112, 81000468, 81771174, 81601113]; College Students' Innovation and Entrepreneurship Plan [201810159000175]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); College Students' Innovation and Entrepreneurship Plan	The authors thank Dr. Chen Ding (Northeastern University, Shenyang, China) for meticulous revision of the manuscript and for very constructive comments. The authors also thank Sarah Grace Lebovitz (University of Tennessee Health Science Center, Memphis, TN, USA) for careful proofreading. This work is supported by grants from the Natural Science Foundation of China (81471112, 81000468, 81771174, and 81601113) and College Students' Innovation and Entrepreneurship Plan (201810159000175). The authors declare no conflicts of interest.	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Amar F, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2021; Amirrad F, 2017, J PHARM PHARM SCI, V20, P184, DOI 10.18433/J3VS8P; Arancio O, 2017, ALZHEIMERS DEMENT, V13, P178, DOI 10.1016/j.jalz.2016.12.006; Area-Gomez E, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0215-0; Area-Gomez E, 2016, CURR OPIN GENET DEV, V38, P90, DOI 10.1016/j.gde.2016.04.006; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Atherton J, 2014, AGING CELL, V13, P49, DOI 10.1111/acel.12148; Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264; BAN TA, 1990, PROG NEURO-PSYCHOPH, V14, P525, DOI 10.1016/0278-5846(90)90005-2; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Beck SJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11483; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bobich JA, 2004, J ALZHEIMERS DIS, V6, P243; Boehm J, 2013, EUR J NEUROSCI, V37, P1925, DOI 10.1111/ejn.12251; Bojarski L, 2009, BBA-MOL CELL RES, V1793, P1050, DOI 10.1016/j.bbamcr.2008.11.008; Boyle JP, 2012, BRAIN RES, V1443, P75, DOI 10.1016/j.brainres.2011.12.061; Boyman L, 2013, J MOL CELL CARDIOL, V59, P205, DOI 10.1016/j.yjmcc.2013.03.012; Bussiere R, 2017, J BIOL CHEM, V292, P10153, DOI 10.1074/jbc.M116.743070; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Canitano A, 2002, ANN NY ACAD SCI, V976, P394; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Cataldi M, 2013, CURR NEUROPHARMACOL, V11, P276, DOI 10.2174/1570159X11311030004; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Chakroborty S, 2014, EUR J PHARMACOL, V739, P83, DOI 10.1016/j.ejphar.2013.11.012; Chakroborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052056; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Ciarcia R, 2013, CELL CYCLE, V12, P2839, DOI 10.4161/cc.25920; COLVIN RA, 1994, BRAIN RES, V665, P192, DOI 10.1016/0006-8993(94)91338-2; COWBURN RF, 1995, NEUROSCI LETT, V191, P31, DOI 10.1016/0304-3940(94)11549-3; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; da Rosa MM, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00066; Daschil N, 2014, PHARMACOLOGY, V93, P24, DOI 10.1159/000357383; Daschil N, 2013, J ALZHEIMERS DIS, V37, P439, DOI 10.3233/JAD-130560; De Stefani D, 2015, BBA-MOL CELL RES, V1853, P2006, DOI 10.1016/j.bbamcr.2015.04.008; De Strooper B, 2012, EMBO J, V31, P4095, DOI 10.1038/emboj.2012.279; Del Prete D, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-21; Demuro A, 2013, J NEUROSCI, V33, P3824, DOI 10.1523/JNEUROSCI.4367-12.2013; Di Scala C, 2014, BIOCHEMISTRY-US, V53, P4489, DOI 10.1021/bi500373k; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Ekinci FJ, 1999, J BIOL CHEM, V274, P30322, DOI 10.1074/jbc.274.42.30322; Espana J, 2010, J NEUROSCI, V30, P9402, DOI 10.1523/JNEUROSCI.2154-10.2010; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; Fedrizzi L, 2011, BIOFACTORS, V37, P189, DOI 10.1002/biof.157; de Sevilla DF, 2010, J NEUROSCI, V30, P11032, DOI 10.1523/JNEUROSCI.1848-10.2010; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Ferreiro E, 2008, NEUROBIOL DIS, V30, P331, DOI 10.1016/j.nbd.2008.02.003; Filadi R, 2016, CELL REP, V15, P2226, DOI 10.1016/j.celrep.2016.05.013; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Furukawa K, 2003, J NEUROCHEM, V87, P427, DOI 10.1046/j.1471-4159.2003.02020.x; Garcia-Alvarez G, 2015, MOL BIOL CELL, V26, P1141, DOI 10.1091/mbc.E14-07-1222; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Gerle C, 2016, BBA-BIOENERGETICS, V1857, P1191, DOI 10.1016/j.bbabio.2016.03.008; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Giladi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111949; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gomez-Villafuertes R, 2007, MOL NEUROBIOL, V35, P195, DOI 10.1007/s12035-007-0007-0; Goodison WV, 2012, J ALZHEIMERS DIS, V30, pS269, DOI 10.3233/JAD-2012-111664; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Green KN, 2011, ANN NEUROL, V69, P831, DOI 10.1002/ana.22325; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Guo L, 2017, J ALZHEIMERS DIS, V57, P1071, DOI 10.3233/JAD-160702; Gutierrez-Aguilar M, 2015, BBA-GEN SUBJECTS, V1850, P2041, DOI 10.1016/j.bbagen.2014.11.009; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; Hanley JG, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00362; Hansen KB, 2014, NEURON, V81, P1084, DOI 10.1016/j.neuron.2014.01.035; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hedskog L, 2013, P NATL ACAD SCI USA, V110, P7916, DOI 10.1073/pnas.1300677110; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hogan PG, 2015, BIOCHEM BIOPH RES CO, V460, P40, DOI 10.1016/j.bbrc.2015.02.110; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hu R, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.140; Huang Y, 2017, J ALZHEIMERS DIS, V57, P885, DOI 10.3233/JAD-161186; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Hwang D, 2016, CIRC J, V80, P2336, DOI 10.1253/circj.CJ-16-0692; Iannetti EF, 2015, INT J BIOCHEM CELL B, V63, P66, DOI 10.1016/j.biocel.2015.01.020; Inan S, 2010, ANESTH ANALG, V111, P1400, DOI 10.1213/ANE.0b013e3181f7181c; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Izquierdo JH, 2014, REUMATOL CLIN, V10, P43, DOI [10.1016/j.reumae.2013.11.004, 10.1016/j.reuma.2013.05.008]; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Karlstad J, 2012, ADV EXP MED BIOL, V740, P143, DOI 10.1007/978-94-007-2888-2_6; Kennelly S, 2012, INT J GERIATR PSYCH, V27, P415, DOI 10.1002/gps.2735; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Khan SS, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00031; Khanam H, 2016, EUR J MED CHEM, V124, P1121, DOI 10.1016/j.ejmech.2016.08.006; Kim HS, 1999, NEUROREPORT, V10, P113, DOI 10.1097/00001756-199901180-00022; Kim S, 2011, MOL CELLS, V32, P289, DOI 10.1007/s10059-011-0075-x; Kip SN, 2007, ANN NY ACAD SCI, V1099, P436, DOI 10.1196/annals.1387.005; Kobayashi S, 2017, EBIOMEDICINE, V20, P120, DOI 10.1016/j.ebiom.2017.05.012; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; Kraft R, 2015, CHANNELS, V9, P244, DOI 10.1080/19336950.2015.1071747; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Lacampagne A, 2017, ACTA NEUROPATHOL, V134, P749, DOI 10.1007/s00401-017-1733-7; Lawlor B, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002660; Lee S, 2013, CURR NEUROPHARMACOL, V11, P606, DOI 10.2174/1570159X11311060005; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Li Q, 2017, P NATL ACAD SCI USA, V114, P5527, DOI 10.1073/pnas.1613700114; Liang JY, 2015, BIOSYSTEMS, V134, P1, DOI 10.1016/j.biosystems.2015.05.003; Liao YH, 2014, HANDB EXP PHARMACOL, V223, P1055, DOI 10.1007/978-3-319-05161-1_14; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Liu J, 2014, CHANNELS, V8, DOI 10.4161/chan.27471; Liu JP, 2010, J ALZHEIMERS DIS, V22, P541, DOI 10.3233/JAD-2010-100948; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Lopez de Abiada JM, 2001, CUADERNOS HISPANOAM, P147; MacManus A, 2000, J BIOL CHEM, V275, P4713, DOI 10.1074/jbc.275.7.4713; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Mata AM, 2018, NEUROSCI LETT, V663, P55, DOI 10.1016/j.neulet.2017.08.004; McCombs JE, 2010, MOL BIOSYST, V6, P1640, DOI 10.1039/c001975e; McCombs JE, 2008, METHODS, V46, P152, DOI 10.1016/j.ymeth.2008.09.015; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Min DY, 2013, NEUROSCI LETT, V538, P60, DOI 10.1016/j.neulet.2013.02.001; Moccia F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00153; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Morciano G, 2015, J MOL CELL CARDIOL, V78, P142, DOI 10.1016/j.yjmcc.2014.08.015; Moriguchi S, 2018, NEUROPHARMACOLOGY, V131, P291, DOI 10.1016/j.neuropharm.2017.12.037; Moriguchi S, 2012, J NEUROCHEM, V121, P44, DOI 10.1111/j.1471-4159.2012.07667.x; Nelson O, 2011, J BIOL CHEM, V286, P22339, DOI 10.1074/jbc.M111.243063; Nelson O, 2010, J ALZHEIMERS DIS, V21, P781, DOI 10.3233/JAD-2010-100159; Nolt MJ, 2011, J NEUROSCI, V31, P5353, DOI 10.1523/JNEUROSCI.0282-11.2011; Ogawa Y, 1995, Nihon Yakurigaku Zasshi, V105, P423; Oseki KT, 2014, EUR J NEUROSCI, V40, P2471, DOI 10.1111/ejn.12599; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Palty R, 2012, CELL CALCIUM, V52, P9, DOI 10.1016/j.ceca.2012.02.010; Pankratov Y, 2014, EUR J PHARMACOL, V739, P60, DOI 10.1016/j.ejphar.2013.11.017; Pannaccione A, 2012, J NEUROSCI, V32, P10609, DOI 10.1523/JNEUROSCI.6429-11.2012; Park I, 2017, J COMPUT AID MOL DES, V31, P929, DOI 10.1007/s10822-017-0067-9; Parks RJ, 2018, METHODS MOL BIOL, V1782, P187, DOI [10.1007/978-1-61779-382-0_15, 10.1007/978-1-4939-7831-1_11]; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Payne AJ, 2013, EXP NEUROL, V250, P143, DOI 10.1016/j.expneurol.2013.09.001; Peng J, 2012, NEUROSCI LETT, V516, P274, DOI 10.1016/j.neulet.2012.04.008; Penke B, 2017, MOLECULES, V22, DOI 10.3390/molecules22101692; Pera M, 2017, EMBO J, V36, P3356, DOI 10.15252/embj.201796797; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Popugaeva E, 2015, NEURODEGENER DIS MAN, V5, P395, DOI 10.2217/nmt.15.36; Popugaeva E, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00029; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Price SA, 1998, NEUROREPORT, V9, P539; Racay P, 1996, GEN PHYSIOL BIOPHYS, V15, P193; Ramsden M, 2002, BRAIN RES, V956, P254, DOI 10.1016/S0006-8993(02)03547-3; Rao VK, 2014, BBA-MOL BASIS DIS, V1842, P1267, DOI 10.1016/j.bbadis.2013.09.003; Rice RA, 2014, NEUROBIOL AGING, V35, P1002, DOI 10.1016/j.neurobiolaging.2013.10.090; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Robinson M, 2017, J ALZHEIMERS DIS, V57, P317, DOI 10.3233/JAD-161149; Ronicke R, 2011, NEUROBIOL AGING, V32, P2219, DOI 10.1016/j.neurobiolaging.2010.01.011; Salazar C, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0072-9; Saleem H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054877; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; SanMartin CD, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00115; Satoh K, 2011, J BIOL CHEM, V286, P20591, DOI 10.1074/jbc.M110.204685; Saura CA, 2012, NEURODEGENER DIS, V10, P250, DOI 10.1159/000333341; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011; Schreiner B, 2015, J ALZHEIMERS DIS, V43, P369, DOI 10.3233/JAD-132543; Secondo A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00087; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shilling D, 2012, J BIOL CHEM, V287, P10933, DOI 10.1074/jbc.M111.300491; Shoshan-Barmatz V, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00060; Shtifman A, 2010, NEUROBIOL AGING, V31, P2080, DOI 10.1016/j.neurobiolaging.2008.11.003; Sibarov DA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P1173, DOI 10.1134/S0006297918100036; Skibinska-Kijek A, 2009, ACTA NEUROBIOL EXP, V69, P413; Small DH, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-7; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Sokolow S, 2011, CELL CALCIUM, V49, P208, DOI 10.1016/j.ceca.2010.12.008; Solovyova N, 2002, EMBO J, V21, P622, DOI 10.1093/emboj/21.4.622; Sorice Maurizio, 2012, Commun Integr Biol, V5, P217, DOI 10.4161/cib.19145; Stammers AN, 2015, CAN J PHYSIOL PHARM, V93, P843, DOI 10.1139/cjpp-2014-0463; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Supnet C, 2006, J BIOL CHEM, V281, P38440, DOI 10.1074/jbc.M606736200; Supnet C, 2011, SCI CHINA LIFE SCI, V54, P744, DOI 10.1007/s11427-011-4201-y; Supnet C, 2010, J NEUROCHEM, V112, P356, DOI 10.1111/j.1471-4159.2009.06487.x; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Thibault O, 2012, BBA-MOL BASIS DIS, V1822, P546, DOI 10.1016/j.bbadis.2012.01.004; Thompson PM, 2007, ANN NY ACAD SCI, V1097, P183, DOI 10.1196/annals.1379.017; Toglia P, 2016, CELL CALCIUM, V59, P240, DOI 10.1016/j.ceca.2016.02.013; TOLLEFSON GD, 1990, BIOL PSYCHIAT, V27, P1133, DOI 10.1016/0006-3223(90)90050-C; Tong BCK, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1371; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Tu SC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-48; Ueda K, 1997, J NEUROCHEM, V68, P265; Veeranna, 2004, AM J PATHOL, V165, P795, DOI 10.1016/S0002-9440(10)63342-1; Verkhratsky A, 2003, J CELL MOL MED, V7, P351, DOI 10.1111/j.1582-4934.2003.tb00238.x; Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005; Volgyi K, 2015, CURR ALZHEIMER RES, V12, P655, DOI 10.2174/1567205012666150710095035; Wang HB, 2018, FASEB J, V32, P6456, DOI 10.1096/fj.201701386; Wang LL, 2015, CELL MOL LIFE SCI, V72, P1489, DOI 10.1007/s00018-014-1810-1; Wang P, 2017, AGEING RES REV, V35, P265, DOI 10.1016/j.arr.2016.10.003; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wang Y, 2014, NEUROBIOL AGING, V35, P88, DOI 10.1016/j.neurobiolaging.2013.07.007; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; White JA, 2008, LEARN MEMORY, V15, P1, DOI 10.1101/lm.773208; Willis M, 2010, J ALZHEIMERS DIS, V20, P1167, DOI 10.3233/JAD-2010-091117; Wu A, 1997, NEUROSCIENCE, V80, P675, DOI 10.1016/S0306-4522(97)00053-5; Wu CL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004593; Wu Z, 2015, ALZ DIS ASSOC DIS, V29, P184, DOI 10.1097/WAD.0000000000000075; Zaidi A, 2010, WORLD J BIOL CHEM, V1, P271, DOI DOI 10.4331/WJBC.V1.I9.271; Zampese E, 2011, P NATL ACAD SCI USA, V108, P2777, DOI 10.1073/pnas.1100735108; Zhang H, 2016, J NEUROSCI, V36, P11837, DOI 10.1523/JNEUROSCI.1188-16.2016; Zhang H, 2015, J NEUROSCI, V35, P13275, DOI 10.1523/JNEUROSCI.1034-15.2015; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Zhang Y, 2016, NEUROL SCI, V37, P1039, DOI 10.1007/s10072-016-2546-5; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	223	38	45	2	45	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6697	6712		10.1096/fj.201801751R	http://dx.doi.org/10.1096/fj.201801751R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30848934				2022-12-28	WOS:000476114200003
J	Zhang, Y; Fu, B; Liu, CX; Yu, SY; Luo, TY; Zhang, L; Zhou, WJ; Yu, T				Zhang, Yu; Fu, Bao; Liu, Chengxi; Yu, Shouyang; Luo, Tianyuan; Zhang, Lin; Zhou, Wenjing; Yu, Tian			Activation of noradrenergic terminals in the reticular thalamus delays arousal from propofol anesthesia in mice	FASEB JOURNAL			English	Article						general anesthesia; thalamic reticular nucleus; adrenoceptor; locus coeruleus; DREADDs	LOCUS-COERULEUS; GLUTAMATERGIC TRANSMISSION; BASOLATERAL AMYGDALA; GABAERGIC INHIBITION; GENERAL-ANESTHESIA; SUBSTANTIA-NIGRA; MODULATION; NUCLEUS; NORADRENALINE; NEURONS	Electroencephalogram monitoring during propofol (PRO) anesthesia typically features low-frequency oscillations, which may be involved with thalamic reticular nucleus (TRN) modulation. TRN receives noradrenergic inputs from the locus coeruleus (LC). We hypothesized that specific noradrenergic connections in the TRN may contribute to the emergence from PRO anesthesia. Intranuclei norepinephrine (NE) injections (n = 10) and designer receptors exclusively activated by designer drugs (DREADDs) (n = 10) were used to investigate the role of noradrenergic inputs from the LC to the TRN during PRO anesthesia. Whole-cell recording in acute brain slice preparations was used to identify the type of adrenoceptor that regulates noradrenergic innervation in the TRN. An intracerebral injection of NE into the TRN delays arousal in mice recovering from PRO anesthesia (means +/- sd; 486.6 +/- 57.32 s for the NE injection group vs. 422.4 +/- 48.19 s for the control group; P = 0.0143) and increases the cortical-delta (0.1-4 Hz, 25.4 +/- 2.9 for the NE injection group vs. 21.0 +/- 1.7 for the control group; P = 0.0094) oscillation. An intra-TRN injection of NE also decreased the EC50 of PRO-induced unconsciousness (57.05 +/- 1.78 mg/kg for the NE injection group vs. 72.44 +/- 3.23 mg/kg for the control group; P = 0.0096). Moreover, the activation of LC-noradrenergic nerve terminals in the TRN using DREADDs increased the recovery time [466.1 +/- 44.57 s for the clozapine N-oxide (CNO) injection group vs. 426.1 +/- 38.75 s for the control group; P = 0.0033], decreased the EC50 of PRO-induced unconsciousness (64.77 +/- 3.40 mg/kg for the CNO injection group vs. 74.00 +/- 2.08 mg/kg for the control group; P = 0.0081), and increased the cortical-delta oscillation during PRO anesthesia (23.29 +/- 2.58 for the CNO injection group vs. 19.56 +/- 1.9 for the control group; P = 0.0213). In addition, whole-cell recording revealed that NE augmented the inhibitory postsynaptic currents in the TRN neurons via the alpha 1-adrenoceptor. Our data indicated that enhanced NE signaling at the noradrenergic terminals of the LC-TRN projection delays arousal from general anesthesia, which is likely mediated by the alpha 1-adrenoceptor activation. Our findings open a door for further understanding of the functions of various LC targets in both anesthesia and arousal.-Zhang, Y., Fu, B., Liu, C., Yu, S., Luo, T., Zhang, L., Zhou, W., Yu, T. Activation of noradrenergic terminals in the reticular thalamus delays arousal from propofol anesthesia in mice.	[Zhang, Yu] Zunyi Med Univ, Affiliated Hosp, Dept Anesthesiol, Zunyi, Guizhou, Peoples R China; [Fu, Bao] Zunyi Med Univ, Affiliated Hosp, Dept Crit Care Med, Zunyi, Guizhou, Peoples R China; [Zhang, Yu; Luo, Tianyuan; Zhang, Lin; Zhou, Wenjing; Yu, Tian] Zunyi Med Univ, Guizhou Key Lab Anesthesia & Organ Protect, Zunyi, Guizhou, Peoples R China; [Liu, Chengxi; Yu, Shouyang] Zunyi Med Univ, Guizhou Key Lab Brain Sci, Zunyi, Guizhou, Peoples R China	Zunyi Medical University; Zunyi Medical University; Zunyi Medical University; Zunyi Medical University	Yu, T (corresponding author), Zunyi Med Coll, Guizhou Key Lab Anesthesia & Organ Protect, Affiliated Hosp, 149 Dalian Rd, Zunyi 563000, Guizhou, Peoples R China.	dllyutian@163.com			National Natural Science Foundation of China (Beijing, China) [81760259, 81760206, 81571026]	National Natural Science Foundation of China (Beijing, China)(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Daqing Ma (Imperial College London, London, United Kingdom) for critical comments during manuscript preparation and revision. The study is supported in part by the National Natural Science Foundation of China (Beijing, China) Grants 81760259 (to Y.Z.), 81760206 (to B.F.), and 81571026 (to T.Y.). The authors declare no conflicts of interest.	AKASU T, 1985, J PHYSIOL-LONDON, V361, P165, DOI 10.1113/jphysiol.1985.sp015639; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; ANDREASEN M, 1991, J PHYSIOL-LONDON, V439, P649, DOI 10.1113/jphysiol.1991.sp018686; Bahraminasab A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103051; BICKFORD ME, 1994, J COMP NEUROL, V348, P481, DOI 10.1002/cne.903480402; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Chang AYW, 2001, HIPPOCAMPUS, V11, P783, DOI 10.1002/hipo.1094; CHEUN JE, 1992, NEUROSCIENCE, V51, P951, DOI 10.1016/0306-4522(92)90532-7; Chong W, 2004, J NEUROENDOCRINOL, V16, P450, DOI 10.1111/j.1365-2826.2004.01180.x; Crunelli V, 2014, REV NEUROSCIENCE, V25, P195, DOI 10.1515/revneuro-2013-0059; Dumont EC, 2004, J NEUROSCI, V24, P8198, DOI 10.1523/JNEUROSCI.0425-04.2004; DUNNE MJ, 1991, BRIT J PHARMACOL, V103, P1847, DOI 10.1111/j.1476-5381.1991.tb12340.x; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Fu B, 2017, J NEUROCHEM, V140, P862, DOI 10.1111/jnc.13939; Fu B, 2016, NEUROCHEM RES, V41, P3181, DOI 10.1007/s11064-016-2042-6; GANDIA JA, 1993, BRAIN RES BULL, V32, P351, DOI 10.1016/0361-9230(93)90199-L; Gire DH, 2008, J NEUROPHYSIOL, V99, P2021, DOI 10.1152/jn.01324.2007; Gottschalk A, 2009, ANESTHESIOLOGY, V110, P996, DOI 10.1097/ALN.0b013e31819db923; Hirono M, 2006, J NEUROPHYSIOL, V95, P700, DOI 10.1152/jn.00711.2005; Jin YH, 2009, BRAIN RES, V1286, P75, DOI 10.1016/j.brainres.2009.06.058; KACHIDIAN P, 1990, NEUROSCI LETT, V109, P23, DOI 10.1016/0304-3940(90)90532-E; Kaneko K, 2008, NEUROSCIENCE, V157, P781, DOI 10.1016/j.neuroscience.2008.09.029; Kolmac CI, 1998, J COMP NEUROL, V396, P531; Kulik A, 1999, J NEUROSCI, V19, P8401; LaLumiere RT, 2003, J NEUROSCI, V23, P6754; Leenders AGM, 2005, PHARMACOL THERAPEUT, V105, P69, DOI 10.1016/j.pharmthera.2004.10.012; Leung LS, 2014, PROG NEUROBIOL, V122, P24, DOI 10.1016/j.pneurobio.2014.08.001; Lewis LD, 2015, ELIFE, V4, DOI 10.7554/eLife.08760; McCarren HS, 2013, JOVE-J VIS EXP, DOI 10.3791/51079; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1988, J NEUROPHYSIOL, V59, P978, DOI 10.1152/jn.1988.59.3.978; MCCORMICK DA, 1989, TRENDS NEUROSCI, V12, P215, DOI 10.1016/0166-2236(89)90125-2; Moncada D, 2011, P NATL ACAD SCI USA, V108, P12931, DOI 10.1073/pnas.1104495108; Murata Y, 1996, J BRAIN RES, V37, P15; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Ni KM, 2016, ELIFE, V5, DOI 10.7554/eLife.10382; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; PARE D, 1990, BRAIN RES, V535, P139, DOI 10.1016/0006-8993(90)91832-2; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Purdon PL, 2015, ANESTHESIOLOGY, V123, P937, DOI 10.1097/ALN.0000000000000841; Salgado H, 2011, CEREB CORTEX, V21, P212, DOI 10.1093/cercor/bhq081; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Vazey EM, 2014, P NATL ACAD SCI USA, V111, P3859, DOI 10.1073/pnas.1310025111; Wakita M, 2013, EUR J PHARMACOL, V718, P63, DOI 10.1016/j.ejphar.2013.09.018; Ying SW, 2005, J NEUROPHYSIOL, V93, P1935, DOI 10.1152/jn.01058.2004; Zhao ZD, 2017, P NATL ACAD SCI USA, V114, P2042, DOI 10.1073/pnas.1616255114; Zhong HX, 2017, J CLIN INVEST, V127, P2295, DOI 10.1172/JCI91038	50	15	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7252	7260		10.1096/fj.201802164RR	http://dx.doi.org/10.1096/fj.201802164RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30860868	Bronze			2022-12-28	WOS:000476114200048
J	Choi, RH; McConahay, A; Silvestre, JG; Moriscot, AS; Carson, JA; Koh, HJ				Choi, Ran Hee; McConahay, Abigail; Silvestre, Joao G.; Moriscot, Anselmo S.; Carson, James A.; Koh, Ho-Jin			TRB3 regulates skeletal muscle mass in food deprivation-induced atrophy	FASEB JOURNAL			English	Article						protein synthesis; protein degradation; Akt; mTOR; FOXO	UNFOLDED PROTEIN RESPONSE; UBIQUITIN LIGASES; TRIBBLES HOMOLOG; FIBER-TYPE; ER STRESS; INSULIN; PATHWAY; HYPERTROPHY; ACTIVATION; DEGRADATION	Tribbles 3 (TRB3) is a pseudokinase that has been found in multiple tissues in response to various stress stimuli, such as nutrient deprivation and endoplasmic reticulum (ER) stress. We recently found that TRB3 has the potential to regulate skeletal muscle mass at the basal state. However, it has not yet been explored whether TRB3 regulates skeletal muscle mass under atrophic conditions. Here, we report that food deprivation for 48 h in mice significantly reduces muscle mass by similar to 15% and increases TRB3 expression, which is associated with increased ER stress. Interestingly, inhibition of ER stress in C2C12 myotubes reduces food deprivation-induced expression of TRB3 and muscle-specific E3-ubiquitin ligases. In further in vivo experiments, muscle-specific TRB3 transgenic mice increase food deprivation-induced muscle atrophy compared with wild-type (WT) littermates presumably by the increased proteolysis. On the other hand, TRB3 knockout mice ameliorate food deprivation-induced atrophy compared with WT littermates by preserving a higher protein synthesis rate. These results indicate that TRB3 plays a pivotal role in skeletal muscle mass regulation under food deprivation-induced muscle atrophy and TRB3 could be a pharmaceutical target to prevent skeletal muscle atrophy.	[Choi, Ran Hee; McConahay, Abigail; Silvestre, Joao G.; Carson, James A.; Koh, Ho-Jin] Univ South Carolina, Dept Exercise Sci, Div Appl Physiol, Columbia, SC 29208 USA; [Silvestre, Joao G.; Moriscot, Anselmo S.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil	University of South Carolina System; University of South Carolina Columbia; Universidade de Sao Paulo	Koh, HJ (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, 921 Assembly St, Columbia, SC 29208 USA.	kohh@mailbox.sc.edu	Moriscot, Anselmo S./C-4506-2012; Silvestre, João Guilherme/G-3273-2015	Moriscot, Anselmo S./0000-0003-3098-4613; Silvestre, João Guilherme/0000-0001-9948-6351; Carson, James/0000-0003-3733-8796	U.S. National Institues of Health [R03AR066825, P20GM10909]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR066825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109091] Funding Source: NIH RePORTER	U.S. National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Montminy (Salk Institute, La Jolla, CA, USA) for providing the muscle-specific TRB3 TG mice and Regeneron (Tarrytown, NY, USA) for KO mice. This work was supported by U.S. National Institues of Health grants to H.-J.K. [R03AR066825 (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and P20GM10909 (National Institute of General Medical Sciences)], and a departmental start-up grant to H.-J.K. The authors declare no conflicts of interest.	An D, 2014, AM J PHYSIOL-REG I, V306, pR925, DOI 10.1152/ajpregu.00027.2014; Avery J, 2010, CIRC RES, V106, P1516, DOI 10.1161/CIRCRESAHA.109.211920; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bohnert KR, 2018, J CELL PHYSIOL, V233, P67, DOI 10.1002/jcp.25852; Choi RH, 2017, BIOCHEM BIOPH RES CO, V493, P1236, DOI 10.1016/j.bbrc.2017.09.134; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hua F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8951; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Koh HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2851; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; Liu JR, 2010, AM J PHYSIOL-ENDOC M, V298, pE565, DOI 10.1152/ajpendo.00467.2009; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Ogata T, 2010, BIOCHEM BIOPH RES CO, V394, P136, DOI 10.1016/j.bbrc.2010.02.130; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xu JM, 2007, BBA-GEN SUBJECTS, V1770, P273, DOI 10.1016/j.bbagen.2006.09.025; Yu ZG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002321; Zhang W, 2016, DIABETES, V65, P2380, DOI 10.2337/db16-0154; Zhang W, 2013, DIABETES, V62, P4192, DOI 10.2337/db13-0312; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	44	9	10	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5654	5666		10.1096/fj.201802145RR	http://dx.doi.org/10.1096/fj.201802145RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30681896	Green Published, Bronze			2022-12-28	WOS:000462888500081
J	Kurano, M; Tsuneyama, K; Morimoto, Y; Nishikawa, M; Yatomi, Y				Kurano, Makoto; Tsuneyama, Koichi; Morimoto, Yuki; Nishikawa, Masako; Yatomi, Yutaka			Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice	FASEB JOURNAL			English	Article						sphingosine 1-phosphate; HDL; mesangial proliferation; renal fibrosis	GLUCOSE-INDUCED FIBROSIS; SPHINGOSINE 1-PHOSPHATE; LYMPHOCYTE EGRESS; SIGNALING PATHWAY; LDL RECEPTOR; SPHINGOSINE-1-PHOSPHATE; PROGRESSION; PROTECTS; APOM; OVEREXPRESSION	Because the association between sphingosine 1-phosphate (S1P)/apolipoprotein M (ApoM) and chronic kidney diseases has not been established, we investigated the involvement of S1P/ApoM in the phenotypes of IgA nephropathy in hyper-IgA (HIGA) mice. The overexpression of ApoM in adenoviral gene transfer ameliorated the phenotypes of IgA nephropathy in HIGA mice, whereas the knockdown of ApoM with siRNA caused deterioration. When ApoM-overexpressing HIGA mice were treated with VPC23019, an antagonist against S1P receptor 1 (S1P1) and 3 (S1P3), we observed that the protective effects of ApoM were reversed, whereas JTE013, an antagonist against S1P2, did not inhibit the effects. We also found that S1P bound to albumin accelerated the proliferation of MES13 cells and the fibrotic changes of HK2 cells, which were inhibited by JTE013, whereas S1P bound to ApoM suppressed these changes, which were inhibited by VPC23019. These results suggest that S1P bound to ApoM possesses properties protective against the phenotypes of IgA nephropathy through S1P1 and S1P3, whereas S1P bound to albumin exerts deteriorating effects through S1P2. ApoM may be useful as a therapeutic target to treat or retard the progression of IgA nephropathy.	[Kurano, Makoto; Nishikawa, Masako; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Tsuneyama, Koichi; Morimoto, Yuki] Univ Tokushima, Inst Biomed Sci, Dept Pathol & Lab Med, Grad Sch, Tokushima, Japan	University of Tokyo; Tokushima University	Kurano, M; Yatomi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurano-tky@umin.ac.jp; yatoyuta-tky@umin.ac.jp		Tsuneyama, Koichi/0000-0002-0670-9868; Yatomi, Yutaka/0000-0003-1719-4297	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)/Agency for Medical Research and Development (AMED); Leading Advanced Projects for Medical Innovation (LEAP) from AMED; Japan Society for the Promotion of Science (JSPS) KAKENHI [16H06236]; Research Fund of Mitsukoshi Health and Welfare Foundation 2017; Japan Heart Foundation; Astellas Grant for Research on Atherosclerosis Update; MSD Life Science Foundation, a Public Interest Incorporated Foundation;  [15H05906]	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)/Agency for Medical Research and Development (AMED); Leading Advanced Projects for Medical Innovation (LEAP) from AMED; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Fund of Mitsukoshi Health and Welfare Foundation 2017; Japan Heart Foundation; Astellas Grant for Research on Atherosclerosis Update; MSD Life Science Foundation, a Public Interest Incorporated Foundation; 	This work was supported by Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)/Agency for Medical Research and Development (AMED), Leading Advanced Projects for Medical Innovation (LEAP) from AMED, Grant-in-Aid for Scientific Research (KAKENHI) on Innovative Areas 15H05906 (to Y.Y.), Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 16H06236 (to M.K.), Research Fund of Mitsukoshi Health and Welfare Foundation 2017 (to M.K.), Japan Heart Foundation and Astellas Grant for Research on Atherosclerosis Update (to M.K.), and MSD Life Science Foundation, a Public Interest Incorporated Foundation (to M.K.). The authors declare no conflicts of interest.	Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; Bajwa A, 2015, J AM SOC NEPHROL, V26, P908, DOI 10.1681/ASN.2013121351; Blaho VA, 2015, NATURE, V523, P342, DOI 10.1038/nature14462; Borup A, 2015, CURR OPIN LIPIDOL, V26, P48, DOI 10.1097/MOL.0000000000000142; Burg N, 2018, ARTHRITIS RHEUMATOL, V70, P1879, DOI 10.1002/art.40558; Christensen PM, 2016, FASEB J, V30, P2351, DOI 10.1096/fj.201500064; Christoffersen C, 2012, J LIPID RES, V53, P2198, DOI 10.1194/jlr.P023697; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Coppo R, 2017, J NEPHROL, V30, P339, DOI 10.1007/s40620-016-0360-z; Coppo R, 2017, PEDIATR NEPHROL, V32, P725, DOI 10.1007/s00467-016-3390-9; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Ding BS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87058; Faber K, 2006, MOL ENDOCRINOL, V20, P212, DOI 10.1210/me.2005-0209; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Hanafusa N, 2002, NEPHROL DIAL TRANSPL, V17, P580, DOI 10.1093/ndt/17.4.580; Hanai K, 2012, NEPHROL DIAL TRANSPL, V27, P1070, DOI 10.1093/ndt/gfr417; Huang KS, 2012, J HUMAN RESOURCE ADU, V8, P7; Imasawa T, 2010, EXP TOXICOL PATHOL, V62, P53, DOI 10.1016/j.etp.2009.02.068; Ishizawa S, 2014, CLIN EXP NEPHROL, V18, P844, DOI 10.1007/s10157-014-0933-x; Katsuma S, 2002, GENES CELLS, V7, P1217, DOI 10.1046/j.1365-2443.2002.00594.x; Katsuma S., 2001, Pharmacogenomics Journal, V1, P211; Kleinwort A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020391; Kunisawa J, 2007, BLOOD, V109, P3749, DOI 10.1182/blood-2006-08-041582; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Kurano M, 2018, THROMB HAEMOSTASIS, V118, P1021, DOI 10.1055/s-0038-1641750; Kurano M, 2018, J ATHEROSCLER THROMB, V25, P16, DOI 10.5551/jat.RV17010; Kurano M, 2017, ARTERIOSCL THROM VAS, V37, P506, DOI 10.1161/ATVBAHA.116.308692; Kurano M, 2016, BRIT J PHARMACOL, V173, P222, DOI 10.1111/bph.13360; Kurano M, 2015, J BIOL CHEM, V290, P2477, DOI 10.1074/jbc.M114.596445; Kurano M, 2014, BBA-MOL CELL BIOL L, V1841, P1217, DOI 10.1016/j.bbalip.2014.05.002; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Lai KN, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.1; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu MX, 2014, J BIOL CHEM, V289, P2801, DOI 10.1074/jbc.M113.499913; Liu WH, 2012, EXP CELL RES, V318, P936, DOI 10.1016/j.yexcr.2012.02.020; Maixnerova D, 2016, J NEPHROL, V29, P535, DOI 10.1007/s40620-016-0299-0; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Mishima Y, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181288; Muso E, 1996, KIDNEY INT, V50, P1946, DOI 10.1038/ki.1996.517; Okajima F, 2002, BBA-MOL CELL BIOL L, V1582, P132, DOI 10.1016/S1388-1981(02)00147-6; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Park SW, 2011, KIDNEY INT, V80, P1315, DOI 10.1038/ki.2011.281; Poti F, 2014, CARDIOVASC RES, V103, P395, DOI 10.1093/cvr/cvu136; Pyne Nigel J., 2015, Advances in Biological Regulation, V60, P151, DOI 10.1016/j.jbior.2015.09.001; Rodrigues JC, 2017, CLIN J AM SOC NEPHRO, V12, P677, DOI 10.2215/CJN.07420716; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Shiohira S, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.172; Swendeman SL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2722; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Takahashi C, 2017, J ATHEROSCLER THROMB, V24, P954, DOI 10.5551/jat.37663; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Tian T, 2017, CLIN EXP IMMUNOL, V190, P68, DOI 10.1111/cei.13003; Tu ST, 2010, ARCH INTERN MED, V170, P155, DOI 10.1001/archinternmed.2009.471; Uranbileg B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149462; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yaghobian D, 2016, CLIN EXP PHARMACOL P, V43, P56, DOI 10.1111/1440-1681.12494; Yang ZY, 2016, PHARMACOL RES, V111, P226, DOI 10.1016/j.phrs.2016.05.035; Yang ZY, 2016, EXP CELL RES, V346, P241, DOI 10.1016/j.yexcr.2016.06.005; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006	65	16	17	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5181	5195		10.1096/fj.201801748R	http://dx.doi.org/10.1096/fj.201801748R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629456	Bronze			2022-12-28	WOS:000462888500045
J	Yu, DQ; Lv, PP; Yan, YS; Xu, GX; Sadhukhan, A; Dong, S; Shen, Y; Ren, J; Zhang, XY; Feng, C; Huang, YT; Tian, S; Zhou, Y; Cai, YT; Ming, ZH; Ding, GL; Zhu, H; Sheng, JZ; Jin, M; Huang, HF				Yu, Dan-Qing; Lv, Ping-Ping; Yan, Yi-Shang; Xu, Guan-Xin; Sadhukhan, Annapurna; Dong, Shan; Shen, Yan; Ren, Jun; Zhang, Xue-Ying; Feng, Chun; Huang, Yi-Ting; Tian, Shen; Zhou, Yin; Cai, Yi-Ting; Ming, Zhen-Hua; Ding, Guo-Lian; Zhu, Hong; Sheng, Jian-Zhong; Jin, Min; Huang, He-Feng			Intrauterine exposure to hyperglycemia retards the development of brown adipose tissue	FASEB JOURNAL			English	Article						gestational diabetes mellitus; mitochondrion; epigenetic modification	GESTATIONAL DIABETES-MELLITUS; DNA METHYLATION PROFILES; BETA-CELL PROLIFERATION; INSULIN SENSITIVITY; GLUCOSE-HOMEOSTASIS; CORD BLOOD; TRIGLYCERIDE; OBESITY; LEPTIN; RESISTANCE	Brown adipose tissue (BAT) is an exclusive tissue of nonshivering thermogenesis. It is fueled by lipids and glucose and involved in energy and metabolic homeostasis. Intrauterine exposure to hyperglycemia during gestational diabetes mellitus may result in abnormal fetal development and metabolic phenotypes in adulthood. However, whether intrauterine hyperglycemia influences the development of BAT is unknown. In this study, mouse embryos were exposed to the intrauterine hyperglycemia environment by injecting streptozocin into pregnant mice at 1 d post coitum (dpc). The structure of BAT was examined by hematoxylin and eosin staining and immunohistochemical analysis. The glucose uptake in BAT was measured in vivo by [F-18]-fluoro-2-deoxyglucose-micro-positron emission tomography. The gene expression in BAT was determined by real-time PCR, and the 5'-C-phosphate-G-3' site-specific methylation was quantitatively analyzed. Intrauterine hyperglycemia exposure resulted in the impaired structure of BAT and decreased glucose uptake function in BAT in adulthood. The expressions of the genes involved in thermogenesis and mitochondrial respiratory chain in BAT, such as Ucp1, Cox5b, and Elovl3, were down-regulated by intrauterine hyperglycemia exposure at 18.5 dpc and at 16 wk of age. Furthermore, higher methylation levels of Ucp1, Cox5b, and Elovl3 were found in offspring of mothers with streptozotocin-induced diabetes. Our results provide the evidence for enduring inhibitory effects of intrauterine hyperglycemia on BAT development in offspring. Intrauterine hyperglycemia is associated with increased DNA methylation of the BAT specific genes in offspring, which support an epigenetic involvement.	[Yu, Dan-Qing; Xu, Guan-Xin; Sadhukhan, Annapurna; Feng, Chun; Huang, Yi-Ting; Tian, Shen; Zhou, Yin; Cai, Yi-Ting; Jin, Min] Zhejiang Univ, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Yu, Dan-Qing; Lv, Ping-Ping; Yan, Yi-Shang; Dong, Shan; Shen, Yan; Ren, Jun; Feng, Chun; Huang, Yi-Ting; Tian, Shen; Zhou, Yin; Ming, Zhen-Hua; Zhu, Hong; Sheng, Jian-Zhong; Jin, Min; Huang, He-Feng] Zhejiang Univ, Minist Educ, Key Lab Reprod Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Lv, Ping-Ping; Ren, Jun; Huang, He-Feng] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Zhejiang, Peoples R China; [Sheng, Jian-Zhong] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou, Zhejiang, Peoples R China; [Dong, Shan] Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Shen, Yan] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xue-Ying; Ding, Guo-Lian; Huang, He-Feng] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Zhang, Xue-Ying; Ding, Guo-Lian] Shanghai Jiao Tong Univ, Sch Med, Inst Embryofetal Original Adult Dis, Shanghai, Peoples R China; [Huang, He-Feng] Shanghai Jiao Tong Univ, Biox Inst, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Shandong University; Zhejiang Provincial People's Hospital; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Jin, M (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.; Huang, HF (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Reprod Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	min_jin@zju.edu.cn; hhf57@zju.edu.cn	Huang, Hefeng/ABF-1117-2020; Huang, He-Feng/AAN-7985-2020; Ding, Guolian/GXG-7578-2022; huang, yiting/HDM-3648-2022; Huang, Hefeng/AAR-7184-2021	Huang, He-Feng/0000-0003-4344-8019; Ding, Guolian/0000-0002-0099-9980; 	National Natural Science Foundation of China [81671487, 81701461]; Zhejiang Provincial Natural Science Foundation of China [LY16H040007, LY17H040005]; Science and Technology Projects of the Competent Department [2017FZA7013]; National Key Basic Research Program [2013CB967404]; Medical and Health Science and Technology Plan of Zhejiang Province [2017KY078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science and Technology Projects of the Competent Department; National Key Basic Research Program(National Basic Research Program of China); Medical and Health Science and Technology Plan of Zhejiang Province	This study was supported by the National Natural Science Foundation of China (Grants 81671487 and 81701461), Zhejiang Provincial Natural Science Foundation of China (Grants LY16H040007 and LY17H040005), Science and Technology Projects of the Competent Department (Grant 2017FZA7013), National Key Basic Research Program (Grant 2013CB967404), and Medical and Health Science and Technology Plan of Zhejiang Province (Grant 2017KY078). D.-Q.Y., P.-P.L, and Y.-S.Y. contributed equally to this work and should be considered joint first authors. The authors declare no conflicts of interest.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Blue EK, 2015, DIABETES, V64, P2664, DOI 10.2337/db14-1709; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen DQ, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0108-3; Chen P, 2017, DIABETOLOGIA, V60, P645, DOI 10.1007/s00125-016-4203-1; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Cote S, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0239-9; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; del Rosario MC, 2014, METABOLISM, V63, P654, DOI 10.1016/j.metabol.2014.01.007; Ding GL, 2012, DIABETES, V61, P1133, DOI 10.2337/db11-1314; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Dong HP, 2017, EUR REV MED PHARMACO, V21, P3658; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Finer S, 2015, HUM MOL GENET, V24, P3021, DOI 10.1093/hmg/ddv013; Fontes G, 2010, DIABETOLOGIA, V53, P2369, DOI 10.1007/s00125-010-1850-5; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Han JY, 2007, AM J PHYSIOL-ENDOC M, V293, pE228, DOI 10.1152/ajpendo.00479.2006; Hanssen MJW, 2016, DIABETES, V65, P1179, DOI 10.2337/db15-1372; Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; Horjales-Araujo E, 2014, NEUROSCIENCE, V277, P87, DOI 10.1016/j.neuroscience.2014.06.043; Houde AA, 2014, J DEV ORIG HLTH DIS, V5, P132, DOI 10.1017/S2040174414000038; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kim E, 2017, EPIGENETICS-US, V12, P825, DOI 10.1080/15592294.2017.1370172; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Labbe SM, 2015, FASEB J, V29, P2046, DOI 10.1096/fj.14-266247; Li YG, 2018, CELL, V175, P1561, DOI 10.1016/j.cell.2018.10.016; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu L, 2014, CELL PHYSIOL BIOCHEM, V34, P1877, DOI 10.1159/000366386; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Nehring I, 2013, DIABETIC MED, V30, P1449, DOI 10.1111/dme.12286; Nilsson C, 2014, PEDIATR DIABETES, V15, P57, DOI 10.1111/pedi.12059; Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petitt D J, 1985, Diabetes, V34 Suppl 2, P119; Petropoulos S, 2015, ENDOCRINOLOGY, V156, P2222, DOI 10.1210/en.2014-1643; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Potter VJV, 2012, ENDOCRINOLOGY, V153, P4266, DOI 10.1210/en.2011-2006; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Quevedo S, 1998, PFLUG ARCH EUR J PHY, V436, P689, DOI 10.1007/s004240050690; Quilter CR, 2014, FASEB J, V28, P4868, DOI 10.1096/fj.14-255240; Rahman TU, 2017, ONCOTARGET, V8, P53450, DOI 10.18632/oncotarget.18519; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Simpkin AJ, 2016, HUM MOL GENET, V25, P191, DOI 10.1093/hmg/ddv456; Soberanes S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00275; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Steculorum SM, 2011, ENDOCRINOLOGY, V152, P4171, DOI 10.1210/en.2011-1279; Su R, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4952801; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Tawfik SH, 2017, J ANIM SCI TECHNOL, V59, DOI 10.1186/s40781-016-0125-1; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Vila-Bedmar R, 2012, FASEB J, V26, P3503, DOI 10.1096/fj.11-202267; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang HH, 2018, ENDOCRINOLOGY, V159, P465, DOI 10.1210/en.2017-03017; Wang X., 2012, JOVE-J VIS EXP, V69, P4060, DOI [10.3791/4060, DOI 10.3791/4060]; West Nancy A, 2013, Immunometabolism, V1, P1; Wu D, 2018, NATURE, V559, P637, DOI 10.1038/s41586-018-0350-5; Xu LY, 2018, AGING CELL, V17, DOI 10.1111/acel.12721; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yang IV, 2018, DIABETIC MED, V35, P612, DOI 10.1111/dme.13604; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zarrouki B, 2014, DIABETES, V63, P982, DOI 10.2337/db13-0425; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	70	10	10	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5425	5439		10.1096/fj.201801818R	http://dx.doi.org/10.1096/fj.201801818R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30759346	Bronze			2022-12-28	WOS:000462888500064
J	Zaman, F; Zhao, YH; Celvin, B; Mehta, HH; Wan, JX; Chrysis, D; Ohlsson, C; Fadeel, B; Cohen, P; Savendahl, L				Zaman, Farasat; Zhao, Yunhan; Celvin, Bettina; Mehta, Hemal H.; Wan, Junxiang; Chrysis, Dionisios; Ohlsson, Claes; Fadeel, Bengt; Cohen, Pinchas; Savendahl, Lars			Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid-induced bone growth impairment	FASEB JOURNAL			English	Article						glucocorticoids; inflammation; chondrocytes; apoptosis	INDIAN HEDGEHOG; PROLIFERATIVE CHONDROCYTES; NEUROPROTECTIVE FACTOR; APOPTOSIS; CELL; DEXAMETHASONE; ACTIVATION; PLATE; DIFFERENTIATION; DISEASE	Glucocorticoids (GCs) are frequently used to treat chronic disorders in children, including inflammation and cancer. Prolonged treatment with GCs is well known to impair bone growth, an effect linked to increased apoptosis and suppressed proliferation in growth plate chondrocytes. We hypothesized that the endogenous antiapoptotic protein humanin (HN) may prevent these effects. Interestingly, GC-induced bone growth impairment and chondrocyte apoptosis was prevented in HN overexpressing mice, HN-treated wild-type mice, and in HN-treated cultured rat metatarsal bones. GC-induced suppression of chondrocyte proliferation was also prevented by HN. Furthermore, GC treatment reduced Indian Hedgehog expression in growth plates of wild-type mice but not in HN overexpressing mice or HN-treated wild-type animals. A Hedgehog (Hh) antagonist, vismodegib, was found to suppress the growth of cultured rat metatarsal bones, and this effect was also prevented by HN. Importantly, HN did not interfere with the desired anti-inflammatory effects of GCs. We conclude that HN is a novel regulator of Hh signaling preventing GC-induced bone growth impairment without interfering with desired effects of GCs. Our data may open for clinical studies exploring a new possible strategy to prevent GC-induced bone growth impairment by cotreating with HN.	[Zaman, Farasat; Zhao, Yunhan; Celvin, Bettina; Savendahl, Lars] Karolinska Inst, Dept Womens & Childrens Hlth, J9 30,Vis Gatan 4, SE-17174 Solna, Sweden; [Zaman, Farasat; Zhao, Yunhan; Celvin, Bettina; Savendahl, Lars] Karolinska Univ Hosp, Pediat Endocrinol Unit, J9 30,Vis Gatan 4, SE-17174 Solna, Sweden; [Mehta, Hemal H.; Wan, Junxiang; Cohen, Pinchas] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA; [Chrysis, Dionisios] Univ Patras, Sch Med, Dept Pediat, Div Endocrinol, Patras, Greece; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Southern California; University of Patras; University of Gothenburg; Karolinska Institutet	Zaman, F (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, J9 30,Vis Gatan 4, SE-17174 Solna, Sweden.; Zaman, F (corresponding author), Karolinska Univ Hosp, Pediat Endocrinol Unit, J9 30,Vis Gatan 4, SE-17174 Solna, Sweden.	farasat.zaman@ki.se	Ohlsson, Claes/HIR-6959-2022; Zaman, Farasat/AAE-1144-2020; Ohlsson, Claes/AGP-3544-2022; CHRYSIS, DIONISIOS/HGB-4107-2022	Ohlsson, Claes/0000-0002-9633-2805; Ohlsson, Claes/0000-0002-9633-2805; 	Swedish Research Council [2015-02406]; Swedish Childhood Cancer Foundation [PR2014-0167, TJ2017-0089, PR2017-0167]; Stiftelsen Frimurare Barnhuset Stockholm; HKH Kronprinsessan Lovisas Forening for Barnasjukvard/Stiftelsen Axel Tielmans Minnesfond; Karolinska Institutet; AFAR BIG Award; U.S. National Institutes of Health, National Institute on Aging [1P01AG034906]; NATIONAL INSTITUTE ON AGING [P01AG034906] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Stiftelsen Frimurare Barnhuset Stockholm; HKH Kronprinsessan Lovisas Forening for Barnasjukvard/Stiftelsen Axel Tielmans Minnesfond; Karolinska Institutet(Karolinska Institutet); AFAR BIG Award; U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Swedish Research Council (Grant 2015-02406, to L.S.), the Swedish Childhood Cancer Foundation (Grants PR2014-0167, TJ2017-0089, and PR2017-0167, to L.S. and F.Z.), Stiftelsen Frimurare Barnhuset Stockholm (to F.Z., L.S., and B.C.), HKH Kronprinsessan Lovisas Forening for Barnasjukvard/Stiftelsen Axel Tielmans Minnesfond (to F.Z. and L.S.), and Karolinska Institutet (to L.S.); and by an AFAR BIG Award and by Grant 1P01AG034906 from the U.S. National Institutes of Health, National Institute on Aging (to P.C.). The authors declare no conflicts of interest.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; BARON J, 1992, AM J PHYSIOL, V263, pE489; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Boon LM, 1999, PLAST RECONSTR SURG, V104, P1616, DOI 10.1097/00006534-199911000-00002; Chagin AS, 2007, BONE, V40, P1415, DOI 10.1016/j.bone.2006.12.066; Charununtakorn ST, 2016, CARDIOVASC THER, V34, P107, DOI 10.1111/1755-5922.12168; Chin YP, 2013, ENDOCRINOLOGY, V154, P3739, DOI 10.1210/en.2012-2004; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; Chrysis D, 2003, J ENDOCRINOL, V176, P331, DOI 10.1677/joe.0.1760331; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Duan L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0512-2; Eriksson E, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt459; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Fernandez-Vojvodich P, 2013, ANN RHEUM DIS, V72, pE24, DOI 10.1136/annrheumdis-2013-204112; Forcioli-Conti N, 2015, BIOCHEM BIOPH RES CO, V458, P117, DOI 10.1016/j.bbrc.2015.01.078; Gidlund EK, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13063; Gulino A, 2009, J CLIN INVEST, V119, P243, DOI 10.1172/JCI38387; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Janzen C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193583; Jia Y, 2013, ANDROLOGY-US, V1, P651, DOI 10.1111/j.2047-2927.2013.00091.x; Jin H, 2010, NEUROCHEM INT, V56, P417, DOI 10.1016/j.neuint.2009.11.015; Juskewitch JE, 2012, AM J PATHOL, V180, P32, DOI 10.1016/j.ajpath.2011.10.001; Kim SJ, 2016, ONCOTARGET, V7, P46899, DOI 10.18632/oncotarget.10380; Konduru NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004398; Lai HC, 2000, NEW ENGL J MED, V342, P851, DOI 10.1056/NEJM200003233421204; LOEB JN, 1976, NEW ENGL J MED, V295, P547, DOI 10.1056/NEJM197609022951007; Long FX, 2001, DEVELOPMENT, V128, P541; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Maeda Y, 2010, BONE, V46, P472, DOI 10.1016/j.bone.2009.09.009; Martensson K, 2004, J BONE MINER RES, V19, P1805, DOI 10.1359/JBMR.040805; Mushtaq T, 2004, ENDOCRINOLOGY, V145, P2478, DOI 10.1210/en.2003-1435; Mushtaq T, 2002, J ENDOCRINOL, V175, P705, DOI 10.1677/joe.0.1750705; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Noguchi KK, 2015, NEUROBIOL DIS, V83, P35, DOI 10.1016/j.nbd.2015.08.020; Oh YK, 2011, ATHEROSCLEROSIS, V219, P65, DOI 10.1016/j.atherosclerosis.2011.06.038; Robinson GW, 2017, ONCOTARGET, V8, P69295, DOI 10.18632/oncotarget.20619; Rooman RPA, 2003, ENDOCRINOLOGY, V144, P2553, DOI 10.1210/en.2003-0062; Savendahl L, 2005, HORM RES, V64, P94, DOI 10.1159/000087764; Savendahl L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003484; Sekulic A, 2016, CELL, V164, P831, DOI 10.1016/j.cell.2016.02.021; Silva IN, 1997, ARCH DIS CHILD, V77, P214, DOI 10.1136/adc.77.3.214; Simon D, 2013, J CLIN ENDOCR METAB, V98, P2746, DOI 10.1210/jc.2012-4201; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Steinbicker AU, 2011, BLOOD, V117, P4915, DOI 10.1182/blood-2010-10-313064; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Thompson CL, 2016, FASEB J, V30, P716, DOI 10.1096/fj.15-274944; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang T, 2013, BEHAV BRAIN RES, V247, P132, DOI 10.1016/j.bbr.2013.03.023; Wei F, 2012, OSTEOARTHR CARTILAGE, V20, P755, DOI 10.1016/j.joca.2012.03.010; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamagishi Y, 2003, PEPTIDES, V24, P585, DOI 10.1016/S0196-9781(03)00106-2; Yang H, 2015, CANCER MED-US, V4, P245, DOI 10.1002/cam4.350; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Zaman F, 2007, CANCER RES, V67, P10078, DOI 10.1158/0008-5472.CAN-06-3982; Zaman F, 2014, TOXICOL LETT, V224, P196, DOI 10.1016/j.toxlet.2013.10.020; Zaman F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033168; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhang WJ, 2012, PHARMACOL BIOCHEM BE, V100, P361, DOI 10.1016/j.pbb.2011.09.012; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	64	23	27	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4962	4974		10.1096/fj.201801741R	http://dx.doi.org/10.1096/fj.201801741R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30657335	Bronze, Green Published			2022-12-28	WOS:000462888500026
J	Zhu, WW; Xu, RY; Du, JY; Fu, Y; Li, S; Zhang, P; Liu, LK; Jiang, HB				Zhu, Weiwen; Xu, Rongyao; Du, Jinying; Fu, Yu; Li, Sheng; Zhang, Ping; Liu, Laikui; Jiang, Hongbing			Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw	FASEB JOURNAL			English	Article						wound healing; inflammation; Toll-like receptors; NF-kappa B	MEDICATION-RELATED OSTEONECROSIS; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; MOUSE MODEL; KAPPA-B; ACTIVATION; REGENERATION; PATHOGENESIS; PHENOTYPE; RESPONSES	Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a detrimental side effect of the long-term administration of bisphosphonates. Although macrophages were reported to be an important mediator of BRONJ, the detailed potential mechanism of BRONJ remains unclear. Here, we reported an elevated TLR-4 expression in macrophages under action of zoledronic acid (ZA), resulting in enhanced M1 macrophage polarization and decreased M2 macrophage polarization both in vitro and in vivo. After inhibiting the TLR-4 signaling pathway, the activation of the TLR-4/NF-kappa B signaling pathway and the induction of NF-kappa B nuclear translocation and production of proinflammatory cytokines by ZA were suppressed in macrophages, thereby inhibiting M1 macrophage polarization. By utilizing the TLR-4(-/-) mice, development of BRONJ was markedly ameliorated, and M1 macrophages were significantly attenuated in the extraction socket tissues in the TLR-4(-/-) mice. Importantly, the systemic administration of the TLR-4 inhibitor TAK-242 improved the wound healing of the extraction socket and decreased the incidence rate of BRONJ. Taken together, our findings suggest that TLR-4-mediated macrophage polarization participates in the pathogenesis of BRONJ in mice, and TLR-4 may be a potential target for the prevention and therapeutic treatment of BRONJ.	[Zhu, Weiwen; Xu, Rongyao; Du, Jinying; Fu, Yu; Li, Sheng; Zhang, Ping; Jiang, Hongbing] Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing, Jiangsu, Peoples R China; [Liu, Laikui] Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Oral Pathol, Nanjing, Jiangsu, Peoples R China; [Zhu, Weiwen; Xu, Rongyao; Du, Jinying; Jiang, Hongbing] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, 136 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Jiang, HB (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, 136 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	jhb@njmu.edu.cn	Xu, Rongyao/AHB-8403-2022; Jiang, Hongbing/AAQ-6331-2021	Xu, Rongyao/0000-0002-1508-437X; Zhu, Weiwen/0000-0002-9736-5692; Jiang, Hongbing/0000-0002-3748-0381	National Natural Science Foundation of China [81771092]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions [2014-37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program for the Development of Jiangsu Higher Education Institutions	The authors are grateful to Wen Sun (Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University) for support with the cell culture. The authors also thank Jialin Lin and Zhenxing Zhang (both from Jiangsu Key Laboratory of Oral Diseases) for assistance with some of the mice procedures. This work was supported by National Natural Science Foundation of China Grant 81771092, and a project funded by the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (2014-37). The authors declare no conflicts of interest.	Adapala NS, 2016, AM J PATHOL, V186, P2987, DOI 10.1016/j.ajpath.2016.06.024; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Bi YM, 2010, AM J PATHOL, V177, P280, DOI 10.2353/ajpath.2010.090592; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Chen T, 2016, BRAIN BEHAV IMMUN, V56, P42, DOI 10.1016/j.bbi.2016.04.004; Chiu YG, 2017, EXPERT OPIN BIOL TH, V17, P119, DOI 10.1080/14712598.2017.1263614; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Davies LC, 2015, IMMUNOLOGY, V144, P541, DOI 10.1111/imm.12451; Dou C, 2018, J BONE MINER RES, V33, P899, DOI 10.1002/jbmr.3364; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Fowler DW, 2017, CANCER IMMUNOL IMMUN, V66, P1205, DOI 10.1007/s00262-017-2011-1; Gross C, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1230-8; Hao SS, 2017, BIOMATERIALS, V140, P16, DOI 10.1016/j.biomaterials.2017.06.013; Hayashi C, 2012, J IMMUNOL, V189, P3681, DOI 10.4049/jimmunol.1201541; Hokugo A, 2010, J BONE MINER RES, V25, P1337, DOI 10.1002/jbmr.23; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Juhas U, 2015, POSTEP HIG MED DOSW, V69, P496, DOI 10.5604/17322693.1150133; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keskinruzgar A, 2016, J ORAL MAXIL SURG, V74, P68, DOI 10.1016/j.joms.2015.07.005; Kim S, 2017, J BONE MINER RES, V32, P309, DOI 10.1002/jbmr.2985; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee KC, 2015, J HEPATOL, V63, P1405, DOI 10.1016/j.jhep.2015.07.035; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nagaoka Y, 2015, J DENT RES, V94, P594, DOI 10.1177/0022034514564187; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Pazianas M, 2011, JNCI-J NATL CANCER I, V103, P232, DOI 10.1093/jnci/djq516; Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014; Portou MJ, 2015, VASC PHARMACOL, V71, P31, DOI 10.1016/j.vph.2015.02.007; Ristow O, 2014, J CANCER RES CLIN, V140, P487, DOI 10.1007/s00432-014-1588-4; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Sinder BP, 2015, J BONE MINER RES, V30, P2140, DOI 10.1002/jbmr.2735; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Sun ST, 2016, BIOCONJUGATE CHEM, V27, P329, DOI 10.1021/acs.bioconjchem.5b00369; Sun W, 2017, J BONE MINER RES, V32, P1469, DOI 10.1002/jbmr.3117; Wang D, 2018, CLIN SCI, V132, P943, DOI 10.1042/CS20180083; Wang YK, 2018, J BONE MINER RES, V33, P732, DOI 10.1002/jbmr.3352; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Xu RY, 2018, AGING CELL, V17, DOI 10.1111/acel.12794; Xu RY, 2016, EXP GERONTOL, V84, P71, DOI 10.1016/j.exger.2016.09.001; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Yamaguchi T, 2016, INFECT IMMUN, V84, P2802, DOI 10.1128/IAI.00461-16; Yuan HM, 2017, ACTA BIOCH BIOPH SIN, V49, P935, DOI 10.1093/abbs/gmx092; Zhang QZ, 2015, J BONE MINER RES, V30, P2300, DOI 10.1002/jbmr.2577; Zhang QZ, 2013, CLIN CANCER RES, V19, P3176, DOI 10.1158/1078-0432.CCR-13-0042; Zhang Y, 2018, BIOCHEM PHARMACOL, V147, P104, DOI 10.1016/j.bcp.2017.11.012; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	49	50	57	2	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5208	5219		10.1096/fj.201801791RR	http://dx.doi.org/10.1096/fj.201801791RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30624969	Bronze			2022-12-28	WOS:000462888500047
J	Christensen, A; Pike, CJ				Christensen, Amy; Pike, Christian J.			APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice	FASEB JOURNAL			English	Article						-amyloid; inflammation; metabolism; microglia; obesity	APOLIPOPROTEIN-E GENOTYPE; TRANSGENIC MOUSE MODEL; COGNITIVE FUNCTION; RISK-FACTORS; DISEASE; SEX; DEMENTIA; ALLELE; INFLAMMATION; ASSOCIATION	Development of Alzheimer's disease (AD) is regulated by interactive effects of genetic and environmental risk factors. The most significant genetic risk factor for AD is the epsilon 4 allele of apolipoprotein E (APOE4), which has been shown to exert greater AD risk in women. An important modifiable AD risk factor is obesity and its associated metabolic dysfunctions. Whether APOE genotype might interact with obesity in females to regulate AD pathogenesis is unclear. To investigate this issue, we studied the effects of Western diet (WD) on female EFAD mice, a transgenic mouse model of AD that includes human APOE alleles epsilon 3 (E3FAD) and epsilon 4 (E4FAD). EFAD mice were fed either control (10% fat, 7% sugar) or WD (45% fat, 17% sugar), and both metabolic and neuropathologic outcomes were determined. Although E4FAD mice generally exhibited poorer metabolic status at baseline, E3FAD mice showed greater diet-induced metabolic impairments. Similarly, E4FAD mice exhibited higher levels of AD-related pathology overall, but only E3FAD showed significant increases on select measures of -amyloid pathology after exposure to WD. These data demonstrate a gene-environment interaction between APOE and obesogenic diets in females. Understanding how AD-promoting effects of obesity are modulated by genetic factors will foster the identification of at-risk populations and development of preventive interventions.Christensen, A., Pike, C. J. APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice.	[Christensen, Amy; Pike, Christian J.] Univ Southern Calif, Leonard Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA	University of Southern California	Pike, CJ (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	cjpike@usc.edu		Christensen, Amy/0000-0002-3357-0523; Pike, Christian/0000-0003-4577-7668	U.S. National Institutes of Health (NIH) National Institute on Aging Grant [AG026572]; NIH National Institute on Aging [T32 AG052374]; NATIONAL INSTITUTE ON AGING [P01AG026572] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging Grant; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the U.S. National Institutes of Health (NIH) National Institute on Aging Grant AG026572 (to C.J.P.). A.C. was supported, in part, by the NIH National Institute on Aging Grant T32 AG052374. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Arbones-Mainar JM, 2016, INT J OBESITY, V40, P1574, DOI 10.1038/ijo.2016.93; Barron AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078554; Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Biessels G.J., 2010, DIABETES BRAIN; Buckley RF, 2018, ALZHEIMERS DEMENT, V14, P1193, DOI 10.1016/j.jalz.2018.04.010; Cacciottolo M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.280; Cacciottolo M, 2016, NEUROBIOL AGING, V37, P47, DOI 10.1016/j.neurobiolaging.2015.10.010; Christensen A, 2018, NEUROSCI LETT, V683, P7, DOI 10.1016/j.neulet.2018.06.029; Christensen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178490; Christensen A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00130; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Craft S, 1999, NEUROENDOCRINOLOGY, V70, P146, DOI 10.1159/000054469; de la Monte SM, 2014, ENDOCRIN METAB CLIN, V43, P245, DOI 10.1016/j.ecl.2013.09.006; Oliveira BCD, 2018, NEUROSCIENCE, V376, P127, DOI 10.1016/j.neuroscience.2018.02.012; Dufouil C, 2014, J ALZHEIMERS DIS, V42, pS353, DOI 10.3233/JAD-141629; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Ghebranious N, 2011, CLIN MED RES, V9, P17, DOI 10.3121/cmr.2010.894; Hanson AJ, 2016, DEMENT GER COGN D EX, V6, P78, DOI 10.1159/000444079; Hayden KM, 2006, ALZ DIS ASSOC DIS, V20, P93, DOI 10.1097/01.wad.0000213814.43047.86; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Holmes C, 2013, NEUROPATH APPL NEURO, V39, P51, DOI 10.1111/j.1365-2990.2012.01307.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huebbe P, 2015, MOL NUTR FOOD RES, V59, P334, DOI 10.1002/mnfr.201400636; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Jayaraman A, 2014, ENDOCRINOLOGY, V155, P1398, DOI 10.1210/en.2013-1725; Johnson LA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43701; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Karim R., 2018, MENOPAUSE; Kohjima M, 2010, ENDOCRINOLOGY, V151, P1532, DOI 10.1210/en.2009-1196; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kuusisto J, 1997, BRIT MED J, V315, P1045, DOI 10.1136/bmj.315.7115.1045; Kypreos KE, 2018, J BIOMED RES, V32, P183, DOI 10.7555/JBR.32.20180007; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Liu YW, 2010, J ALZHEIMERS DIS, V21, P947, DOI 10.3233/JAD-2010-100201; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Morris JK, 2017, J ALZHEIMERS DIS, V58, P1129, DOI 10.3233/JAD-170148; Morris JK, 2016, NEUROBIOL AGING, V44, P138, DOI 10.1016/j.neurobiolaging.2016.04.017; Moser VA, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0077-17.2017; Moser VA, 2016, NEUROSCI BIOBEHAV R, V67, P102, DOI 10.1016/j.neubiorev.2015.08.021; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Nam KN, 2018, BBA-MOL BASIS DIS, V1864, P152, DOI 10.1016/j.bbadis.2017.10.018; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; O'Brien PD, 2017, LANCET NEUROL, V16, P465, DOI 10.1016/S1474-4422(17)30084-4; Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827; Profenno LA, 2008, AM J MED GENET B, V147B, P822, DOI 10.1002/ajmg.b.30694; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Ramsden M, 2003, NEUROSCIENCE, V122, P573, DOI 10.1016/j.neuroscience.2003.08.048; Rettberg JR, 2016, NEUROBIOL AGING, V40, P155, DOI 10.1016/j.neurobiolaging.2016.01.011; Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228; Tai LM, 2017, J LIPID RES, V58, P1733, DOI 10.1194/jlr.R076315; Tai LM, 2015, J NEUROCHEM, V133, P465, DOI 10.1111/jnc.13072; Trumble BC, 2017, FASEB J, V31, P1508, DOI 10.1096/fj.201601084R; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Wu L, 2018, J NEUROSCI, V38, P6665, DOI 10.1523/JNEUROSCI.2262-17.2018; Yang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125922; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Yu JT, 2014, ANNU REV NEUROSCI, V37, P79, DOI 10.1146/annurev-neuro-071013-014300	70	7	7	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4054	4066		10.1096/fj.201801756R	http://dx.doi.org/10.1096/fj.201801756R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509127	Bronze, Green Published			2022-12-28	WOS:000459794800076
J	Peigneur, S; Cheneval, O; Maiti, M; Leipold, E; Heinemann, SH; Lescrinier, E; Herdewijn, P; De Lima, ME; Craik, DJ; Schroeder, CI; Tytgat, J				Peigneur, Steve; Cheneval, Olivier; Maiti, Mohitosh; Leipold, Enrico; Heinemann, Stefan H.; Lescrinier, Eveline; Herdewijn, Piet; De Lima, Maria Elena; Craik, David J.; Schroeder, Christina I.; Tytgat, Jan			Where cone snails and spiders meet: design of small cyclic sodium-channel inhibitors	FASEB JOURNAL			English	Article						voltage-gated sodium channel; peptide cyclization; toxin-based therapeutics; peptide toxin	MU-CONOTOXIN-KIIIA; BRAZILIAN ARMED SPIDER; LETHAL NEUROTOXIN TX1; DE-NOVO DESIGN; FUNCTIONAL EXPRESSION; SUBTYPE SPECIFICITY; PEPTIDES; VENOM; BLOCKER; TETRODOTOXIN	A 13 aa residue voltage-gated sodium (Na-V) channel inhibitor peptide, Pn, containing 2 disulfide bridges was designed by using a chimeric approach. This approach was based on a common pharmacophore deduced from sequence and secondary structural homology of 2 Na-V inhibitors: Conus kinoshitai toxin IIIA, a 14 residue cone snail peptide with 3 disulfide bonds, and Phoneutria nigriventer toxin 1, a 78 residue spider toxin with 7 disulfide bonds. As with the parent peptides, this novel Na-V channel inhibitor was active on Na(V)1.2. Through the generation of 3 series of peptide mutants, we investigated the role of key residues and cyclization and their influence on Na-V inhibition and subtype selectivity. Cyclic PnCS1, a 10 residue peptide cyclized via a disulfide bond, exhibited increased inhibitory activity toward therapeutically relevant Na-V channel subtypes, including Na(V)1.7 and Na(V)1.9, while displaying remarkable serum stability. These peptides represent the first and the smallest cyclic peptide Na-V modulators to date and are promising templates for the development of toxin-based therapeutic agents.Peigneur, S., Cheneval, O., Maiti, M., Leipold, E., Heinemann, S. H., Lescrinier, E., Herdewijn, P., De Lima, M. E., Craik, D. J., Schroeder, C. I., Tytgat, J. Where cone snails and spiders meet: design of small cyclic sodium-channel inhibitors.	[Peigneur, Steve; Tytgat, Jan] Katholieke Univ KU Leuven, Toxicol & Pharmacol, Campus Gasthuisberg, Leuven, Belgium; [Peigneur, Steve; De Lima, Maria Elena] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Venenos & Toxinas Anim, Belo Horizonte, MG, Brazil; [Cheneval, Olivier; Craik, David J.; Schroeder, Christina I.] Univ Queensland, Inst Mol Biolsci, Brisbane, Qld 4072, Australia; [Maiti, Mohitosh; Lescrinier, Eveline; Herdewijn, Piet] Katholieke Univ Leuven, Rega Inst Med Res, Lab Med Chem, Leuven, Belgium; [Leipold, Enrico; Heinemann, Stefan H.] Friedrich Schiller Univ Jena, Jena Univ Hosp, Ctr Mol Biomed, Dept Biophys, Jena, Germany; [De Lima, Maria Elena] Grp Santa Casa Belo Horizonte, Inst Ensino & Pesquisa Santa Casa Belo Horizonte, Programa Posgrad Ciencias Saude Biomed & Med, Belo Horizonte, MG, Brazil; [Leipold, Enrico] Univ Lubeck, CBBM, Lubeck, Germany; [Leipold, Enrico] Univ Lubeck, Clin Anesthesiol & Intens Care, Lubeck, Germany	KU Leuven; Universidade Federal de Minas Gerais; University of Queensland; KU Leuven; Friedrich Schiller University of Jena; Instituto de Ensino Superior e Pesquisa da Santa Casa; University of Lubeck; University of Lubeck	Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biolsci, Brisbane, Qld 4072, Australia.; Tytgat, J (corresponding author), Univ Leuven, Toxicol, Campus Gasthuisberg,POB 922, B-3000 Louvain, Belgium.	c.schroeder@imb.uq.edu.au; jan.tytgat@pharm.kuleuven.be	Lima, Maria E/P-1707-2017; Lescrinier, Eveline/G-9339-2016; de Lima, Maria Elena/GQH-4440-2022; Craik, David/B-1695-2010; Schroeder, Christina/K-2042-2014; Cheneval, Olivier/O-1384-2017	Lima, Maria E/0000-0001-6185-4032; Lescrinier, Eveline/0000-0001-7066-4329; Craik, David/0000-0003-0007-6796; Herdewijn, Piet/0000-0003-3589-8503; Peigneur, Steve/0000-0003-0504-5702; Schroeder, Christina/0000-0002-6737-6374; Cheneval, Olivier/0000-0003-0109-7767; Heinemann, Stefan H./0000-0002-4144-0251	CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Australian Research Council [FL150100146, FT160100055]; CAPES, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FundacAo de Pesquisa do Estado de Minas Gerais;  [CELSA/17/047-BOF/ISP]	CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Australian Research Council(Australian Research Council); CAPES, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FundacAo de Pesquisa do Estado de Minas Gerais; 	The authors thank John N. Wood (University College London, London, United Kingdom) for sharing rNa<INF>V</INF>1.8; A. L. Goldin (University of California, Irvine, Irvine, CA, USA) for sharing rNa<INF>V</INF>1.1, rNa<INF>V</INF>1.2, rNa<INF>V</INF>1.3, and mNa<INF>V</INF>1.6; G. Mandel (State University of New York, Stony Brook, NY, USA) for sharing rNa<INF>V</INF>1.4; R. G. Kallen (Roche Institute of Molecular Biology, Nutley, NJ, USA) for sharing hNa<INF>V</INF>1.5; K. Dong (Michigan State University, East Lansing, MI, USA) for sharing the BgNa<INF>V</INF>1.1 and VdNa<INF>V</INF>1 clones; S. C. Cannon (University of Texas Southwestern Medical Center, Dallas, TX, USA) for sharing the h1 subunit; and Martin S. Williamson (Rothhamsted Research, Harpenden, United Kingdom) for providing the Para and tipE clone. The Na<INF>V</INF>1.7 clone was kindly provided by F. Bosmans (Johns Hopkins University, Baltimore, MD, USA). J.T. was supported by Grant CELSA/17/047-BOF/ISP. S.P. is a Ph.D. fellow supported by CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). D.J.C. is an Australian Research Council Australian Laureate Fellow (FL150100146) and C.I.S. is an Institute for Molecular Bioscience Industry Fellow and Australian Research Council Future Fellow (FT160100055). M.E.D.L. was supported by grants from CAPES, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and FundacAo de Pesquisa do Estado de Minas Gerais. The authors declare no conflicts of interest.	Abdelsayed M, 2013, CHANNELS, V7, P146, DOI 10.4161/chan.24380; Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Almeida Flavia De Marco, 2015, Shengli Xuebao, V67, P261; Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Brady RM, 2013, BIOORG MED CHEM LETT, V23, P4892, DOI 10.1016/j.bmcl.2013.06.086; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Lima M. E., 2015, SPIDER VENOMS, P1, DOI [10.1007/978-94-007-6646-4, DOI 10.1007/978-94-007-6646-4]; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; DINIZ CR, 1990, FEBS LETT, V263, P251, DOI 10.1016/0014-5793(90)81386-3; Diniz MRV, 2006, PROTEIN EXPRES PURIF, V50, P18, DOI 10.1016/j.pep.2006.06.012; DINIZ MRV, 1993, J BIOL CHEM, V268, P15340; French RJ, 2010, MAR DRUGS, V8, P2153, DOI 10.3390/md8072153; Goral RO, 2015, PFLUG ARCH EUR J PHY, V467, P2423, DOI 10.1007/s00424-015-1709-1; Green BR, 2014, FUTURE MED CHEM, V6, P1677, DOI [10.4155/fmc.14.107, 10.4155/FMC.14.107]; Han TS, 2009, CHEMMEDCHEM, V4, P406, DOI 10.1002/cmdc.200800292; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; Khoo KK, 2012, BIOCHEMISTRY-US, V51, P9826, DOI 10.1021/bi301256s; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leao RM, 2000, NEUROPHARMACOLOGY, V39, P1756, DOI 10.1016/S0028-3908(99)00267-1; Lebbe EKM, 2014, PEPTIDES, V53, P300, DOI 10.1016/j.peptides.2013.07.005; Leipold E, 2011, NEUROPHARMACOLOGY, V61, P105, DOI 10.1016/j.neuropharm.2011.03.008; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu M, 2011, PAIN MED, V12, pS93, DOI 10.1111/j.1526-4637.2011.01158.x; Markgraf R, 2012, BRIT J PHARMACOL, V167, P576, DOI 10.1111/j.1476-5381.2012.02004.x; Martin-Moutot N, 2006, MOL PHARMACOL, V69, P1931, DOI 10.1124/mol.105.021147; Moreau A, 2015, CHANNELS, V9, P139, DOI 10.1080/19336950.2015.1031937; Prashanth JR, 2017, MOL BIOSYST, V13, P2453, DOI 10.1039/c7mb00511c; Schroeder CI, 2012, BIOPOLYMERS, V98, P161, DOI 10.1002/bip.22032; Silva AO, 2012, BIOCHIMIE, V94, P2756, DOI 10.1016/j.biochi.2012.08.016; Spronk CAEM, 2002, J BIOMOL NMR, V22, P281, DOI 10.1023/A:1014971029663; Stevens M, 2012, J BIOL CHEM, V287, P31382, DOI 10.1074/jbc.M112.375733; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Torres FS, 2010, TOXICON, V56, P1172, DOI 10.1016/j.toxicon.2010.04.010; Van Der Haegen A, 2011, FEBS J, V278, P3408, DOI 10.1111/j.1742-4658.2011.08264.x; Walewska A, 2008, J AM CHEM SOC, V130, P14280, DOI 10.1021/ja804303p; Walewska A, 2013, EUR J MED CHEM, V65, P144, DOI 10.1016/j.ejmech.2013.04.041; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2010, J NEUROPHYSIOL, V104, P88, DOI 10.1152/jn.00145.2010; Zhang MM, 2009, CHANNELS, V3, P32, DOI 10.4161/chan.3.1.7500	47	20	20	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3693	3703		10.1096/fj.201801909R	http://dx.doi.org/10.1096/fj.201801909R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509130	Green Accepted, Bronze			2022-12-28	WOS:000459794800049
J	Xu, XH; Hirata, H; Shiraki, M; Kamohara, A; Nishioka, K; Miyamoto, H; Kukita, T; Kukita, A				Xu, Xianghe; Hirata, Hirohito; Shiraki, Makoto; Kamohara, Asana; Nishioka, Kenichi; Miyamoto, Hiroshi; Kukita, Toshio; Kukita, Akiko			Prostate transmembrane protein androgen induced 1 is induced by activation of osteoclasts and regulates bone resorption	FASEB JOURNAL			English	Article						membrane trafficking; arthritis; Nedd4; TGF-; lysosome	UBIQUITIN LIGASE NEDD4; TGF-BETA; VESICULAR TRAFFICKING; CANCER CELLS; PMEPA1; TMEPAI; RECEPTOR; GENE; GROWTH; DIFFERENTIATION	Osteoclasts derived from hematopoietic cells are activated on bone surface. To resorb bone, osteoclasts release acid and lysosome acid hydrolase via membrane transport. Prostate transmembrane protein androgen induced 1 (Pmepa1) is a type I transmembrane protein that regulates proliferation, migration, and metastasis of cancer cells. Because recent reports showed that Pmepa1 is involved in membrane transport in cancer cells, we investigated the role of Pmepa1 in osteoclast function. Pmepa1 expression was barely detected in osteoclasts formed on plastic surfaces in vitro, but was markedly increased in activated osteoclasts formed on calcified matrix. Inhibitors of bone resorption, such as alendronate, bafilomycin A1, and the PI3K inhibitor LY294002, suppressed the expression of Pmepa1 in osteoclasts. Knockdown of Pmepa1 expression impaired bone resorption activity and inhibited formation of a ring-like, actin-rich podosome belt that is essential for osteoclast function. Pmepa1 protein localized to lysosomes in osteoclasts. In addition, in sites of bone destruction observed in rats with adjuvant-induced arthritis, a marked high level of Pmepa1 expression was associated with the osteoclasts' resorbing bone. Our results suggest that Pmepa1 is a critical regulator of bone resorption and is a promising marker for activated osteoclasts and a potential therapeutic target in pathologic bone destruction.Xu, X., Hirata, H., Shiraki, M., Kamohara, A., Nishioka, K., Miyamoto, H., Kukita, T., Kukita, A. Prostate transmembrane protein androgen induced 1 is induced by activation of osteoclasts and regulates bone resorption.	[Xu, Xianghe; Hirata, Hirohito; Shiraki, Makoto; Kamohara, Asana; Miyamoto, Hiroshi; Kukita, Akiko] Saga Univ, Dept Pathol & Microbiol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan; [Xu, Xianghe; Kukita, Toshio] Kyushu Univ, Fac Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka, Fukuoka, Japan; [Nishioka, Kenichi] RIKEN Ctr Integrat Med Sci IMS, Lab Dev Genet, Yokohama, Kanagawa, Japan	Saga University; Kyushu University; RIKEN	Kukita, A (corresponding author), Saga Univ, Dept Pathol & Microbiol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	kukita@cc.saga-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [P15K11046]; Medical Care Education Research Foundation	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Care Education Research Foundation	The authors thank Dr. Eric Milner (BioMedical Science Writers, Hamilton, MT, USA) for English language editing of the manuscript. This work was supported by the Japan Society for the Promotion of Science (KAKENHI) Grant-in-Aid for Scientific Research (C) (P15K11046 to A.K.) and a grant awarded by the Medical Care Education Research Foundation (to A.K). The authors declare no conflicts of interest.	Alford AI, 2015, INT J BIOCHEM CELL B, V65, P20, DOI 10.1016/j.biocel.2015.05.008; Bai XL, 2014, CELL SIGNAL, V26, P2030, DOI 10.1016/j.cellsig.2014.06.001; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunschwig EB, 2003, CANCER RES, V63, P1568; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chung YH, 2014, INT J BIOCHEM CELL B, V54, P198, DOI 10.1016/j.biocel.2014.07.018; Chung YH, 2012, INT J BIOCHEM CELL B, V44, P989, DOI 10.1016/j.biocel.2012.03.007; Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Fujiwara T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86330; Funakubo N, 2018, J CELL PHYSIOL, V233, P3105, DOI 10.1002/jcp.26147; Giannini G, 2003, MOL CARCINOGEN, V38, P188, DOI 10.1002/mc.10162; Han ZY, 2014, J VIROL, V88, P7294, DOI 10.1128/JVI.00591-14; Hu Y, 2013, CARCINOGENESIS, V34, P1764, DOI 10.1093/carcin/bgt132; Kukita A, 2011, ARTHRITIS RHEUM-US, V63, P2744, DOI 10.1002/art.30455; Kuratani T, 1998, HISTOL HISTOPATHOL, V13, P751, DOI 10.14670/HH-13.751; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Li H, 2015, ONCOTARGET, V6, P15137, DOI 10.18632/oncotarget.3526; Li YJ, 2009, LAB INVEST, V89, P26, DOI 10.1038/labinvest.2008.111; Li YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16124; Luo SH, 2016, INT J BIOCHEM CELL B, V76, P98, DOI 10.1016/j.biocel.2016.05.004; Nakayama T, 2011, BONE, V49, P1331, DOI 10.1016/j.bone.2011.09.045; Oh Y, 2014, J CELL BIOCHEM, V115, P585, DOI 10.1002/jcb.24695; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Rae FK, 2001, MOL CARCINOGEN, V32, P44, DOI 10.1002/mc.1063; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Schnoor M, 2018, TRENDS CELL BIOL, V28, P79, DOI 10.1016/j.tcb.2017.10.009; SHANKAR G, 1993, J CELL SCI, V105, P61; Shinohara M, 2012, J BONE MINER RES, V27, P2464, DOI 10.1002/jbmr.1703; Shugg RPP, 2013, J BIOL CHEM, V288, P35346, DOI 10.1074/jbc.M113.507525; Singha Prajjal K, 2014, Genes Cancer, V5, P320; Singha PK, 2010, CANCER RES, V70, P6377, DOI 10.1158/0008-5472.CAN-10-1180; Stenbeck G, 2014, CURR OPIN PHARMACOL, V16, P7, DOI 10.1016/j.coph.2014.01.003; Sun AQ, 2017, AUTOPHAGY, V13, P522, DOI 10.1080/15548627.2016.1268301; SUNDQUIST K, 1990, BIOCHEM BIOPH RES CO, V168, P309, DOI 10.1016/0006-291X(90)91709-2; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Tharmalingam S, 2011, J BIOL CHEM, V286, P40922, DOI 10.1074/jbc.M111.265454; Tilli TM, 2015, ONCOL LETT, V9, P1845, DOI 10.3892/ol.2015.2939; Touaitahuata Heiani, 2014, Small GTPases, V5, pe28119, DOI 10.4161/sgtp.28119; Tow K, 2004, LAB INVEST, V84, P1092, DOI 10.1038/labinvest.3700132; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu QQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45375; Zalli D, 2016, J BONE MINER RES, V31, P1701, DOI 10.1002/jbmr.2851; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	50	8	8	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4365	4375		10.1096/fj.201801573R	http://dx.doi.org/10.1096/fj.201801573R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30557043	Bronze			2022-12-28	WOS:000459794800101
J	Zhou, J; Chen, Q				Zhou, Jie; Chen, Qing			Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway	FASEB JOURNAL			English	Article						miR-135b; CDDP; MKN28; MKN45	TUMOR-SUPPRESSOR; MDR1; MST1; PACLITAXEL; MIR-135B; KINASE; TRAIL; DRUGS	Gastric cancer (GC) has been classified as the fourth leading cause of cancer-related deaths worldwide. Due to their ability to suppress the expression of target genes, microRNAs (miRNAs) are listed as one of the key elements involved in the formation and development of tumors. This study was therefore conducted to investigate the effects of microRNA-135b (miR-135b) on cisplatin [cis-diamminedichloroplatinum (CDDP)] resistance of GC cells through the MAPK signaling pathway by targeting mammalian ste20-like kinase 1 (MST1). A microarray-based gene expression analysis was performed to screen the GC-related differentially expressed genes. The 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide assay was performed to determine the sensitivity of GC cells to CDDP. The bioinformatics database and dual luciferase reporter gene assay were used to check whether MST1 was a direct target gene of miR-135b. GC cell lines were prepared with high CDDP resistance, after which they were cultured and transfected respectively, followed by the administration of transfected cells into nude mice and subsequent treatment with CDDP in an attempt to identify the underlying mechanisms and functions of miR-135b in relation to MST1 in GC progression. The results were highly indicative of the crucial role played by MST1 in the development of GC and the sensitivity of GC to CDDP. miR-135b was found to regulate MST1, which in turn had an impact on the development of GC. MKN28 was observed to be most sensitive to CDDP, whereas MKN45 presented with the poorest sensitivity to CDDP. Furthermore, the down-regulation of miR-135b resulted in inactivation of the MAPK signaling pathway; increased the expression of MST1 and Bax; and decreased expression of p-p38MAPK, p-ERK1/2, P-glycoprotein, p38MAPK, ERK1/2, multidrug resistance protein 1, multidrug resistance-associated protein 1, lung resistance-related protein, and Bcl-2, thus inhibiting CDDP resistance of GC cells. The down-regulation of miR-135b also restrained cell proliferation and induced the apoptosis rate of GC cells. In summary, the results of this study showed that the down-regulation of miR-135b induced apoptosis, and it inhibited proliferation and CDDP resistance of GC cells by inactivating the MAPK signaling pathway and increasing the expression of MST1.Zhou, J., Chen, Q. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.	[Zhou, Jie] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan, Hubei, Peoples R China; [Chen, Qing] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	ch_enqing0322@163.com			National Natural Science Foundation of China [81572985, 81371508, 31000471]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge the reviewers for their helpful comments on this paper. This research was supported by the National Natural Science Foundation of China (81572985, 81371508, and 31000471). The authors declare no conflicts of interest.	Cervantes A, 2013, CANCER TREAT REV, V39, P60, DOI 10.1016/j.ctrv.2012.09.007; Chen L, 2015, CANCER RES, V75, P3832, DOI 10.1158/0008-5472.CAN-14-3690; Chen SH, 2014, BIOCHIMIE, V103, P71, DOI 10.1016/j.biochi.2014.04.004; Figueiredo C, 2013, HELICOBACTER, V18, P28, DOI 10.1111/hel.12083; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Guo CC, 2005, INT J CANCER, V116, P155, DOI 10.1002/ijc.20919; Holleman A, 2011, ONCOGENE, V30, P4386, DOI 10.1038/onc.2011.148; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Li P, 2016, AM J TRANSL RES, V8, P3522; Liang B, 2005, WORLD J GASTROENTERO, V11, P623, DOI 10.3748/wjg.v11.i5.623; Lu MD, 2018, INT J ONCOL, V52, P589, DOI 10.3892/ijo.2017.4222; Morinaka A, 2011, ONCOGENE, V30, P4208, DOI 10.1038/onc.2011.139; Nishide N, 2012, ENDOSCOPY, V44, P577, DOI 10.1055/s-0031-1291712; Park SR, 2004, ONCOL REP, V12, P1059; Shimazu T, 2015, CARCINOGENESIS, V36, P1291, DOI 10.1093/carcin/bgv125; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Song JJ, 2008, CELL SIGNAL, V20, P892, DOI 10.1016/j.cellsig.2008.01.001; Su WM, 2016, BIOMED PHARMACOTHER, V84, P123, DOI 10.1016/j.biopha.2016.09.027; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Vidal AF, 2016, WORLD J GASTROENTERO, V22, P2060, DOI 10.3748/wjg.v22.i6.2060; Wang Lin-pei, 2012, Zhonghua Yi Xue Za Zhi, V92, P3269; Wu H, 2003, CANCER RES, V63, P1515; Xie Xiang-Quan, 2014, J Prev Med Public Health, V47, P281, DOI 10.3961/jpmph.14.018; Xu XM, 2012, ONCOL LETT, V4, P339, DOI 10.3892/ol.2012.714; Xu ZP, 2011, HEPATO-GASTROENTEROL, V58, P1611, DOI 10.5754/hge10669; Yang M, 2015, J CANCER RES CLIN, V141, P1037, DOI 10.1007/s00432-014-1865-2; Yu JK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14539-x; Zhang CL, 2016, ONCOTARGETS THER, V9, P3555, DOI 10.2147/OTT.S105736; Zhang KG, 2012, HEPATO-GASTROENTEROL, V59, P2672, DOI 10.5754/hge11850; Zhou L, 2013, PATHOL ONCOL RES, V19, P677, DOI 10.1007/s12253-013-9630-4; Zhou XM, 2001, CARCINOGENESIS, V22, P1393, DOI 10.1093/carcin/22.9.1393	32	31	31	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3420	3436		10.1096/fj.201800618RRR	http://dx.doi.org/10.1096/fj.201800618RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30576232	Bronze, Green Published			2022-12-28	WOS:000459794800028
J	Yao, YX; Bi, Z; Wu, RF; Zhao, YL; Liu, YH; Liu, Q; Wang, YZ; Wang, XX				Yao, Yongxi; Bi, Zhen; Wu, Ruifan; Zhao, Yuanling; Liu, Youhua; Liu, Qing; Wang, Yizhen; Wang, Xinxia			METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBP beta pathway via an m(6)A-YTHDF2-dependent manner	FASEB JOURNAL			English	Article						m(6)A methylation; adipogenesis; porcine model; stem cells	MESENCHYMAL STEM-CELLS; MESSENGER-RNA; REGULATES ADIPOGENESIS; SIGNAL TRANSDUCERS; CALVARIAL DEFECTS; M(6)A METHYLATION; BINDING-PROTEIN; 3T3-L1 CELLS; NUCLEAR-RNA; EXPRESSION	Bone marrow stem cells (BMSCs) are multipotent stem cells that can regenerate mesenchymal tissues, such as adipose tissue, bone, and muscle. Recent studies have shown that N-6-methyladenosine (m(6)A) methylation, one of the most prevalent epigenetic modifications, is involved in the development process. However, whether it plays roles in BMSC differentiation is still elusive. Here, we found that the deletion of m(6)A "writer" protein methyltransferase-like (METTL)3 in porcine BMSCs (pBMSCs) could promote adipogenesis and janus kinase (JAK)1 protein expression via an m(6)A-dependent way. Knockdown of METTL3 decreased mRNA m(6)A levels of JAK1, leading to enhanced YTH m(6)A RNA binding protein 2 (YTHDF2)-dependent JAK1 mRNA stability. We further demonstrated that JAK1 activated signal transducer and activator of transcription (STAT) 5 through regulation of its phosphorylation to bind to the promoter of CCAAT/enhancer binding protein (C/EBP) beta, which could ultimately lead to a modulated adipogenic process. Collectively, our results reveal an orchestrated network linking the m(6)A methylation and JAK1/STAT5/C/EBP beta pathway in pBMSCs adipogenic differentiation. Our findings provide novel insights into the underlying molecular mechanisms of m(6)A modification in the regulation of BMSCs differentiating into adipocytes, which may pave a way to develop more effective therapeutic strategies in stem cell regenerative medicine and the treatment of obesity.-Yao, Y., Bi, Z., Wu, R., Zhao, Y., Liu, Y., Liu, Q., Wang, Y., Wang, X. METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBP beta pathway via an m(6)A-YTHDF2-dependent manner.	[Yao, Yongxi; Bi, Zhen; Wu, Ruifan; Zhao, Yuanling; Liu, Youhua; Liu, Qing; Wang, Yizhen; Wang, Xinxia] Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Yizhen; Wang, Xinxia] Minist Agr, Key Lab Anim Nutr & Feed Sci Eastern China, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs	Wang, XX (corresponding author), Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	xinxiawang@zju.edu.cn	Wu, Ruifan/AHH-6097-2022	Wu, Ruifan/0000-0003-4917-5197; wang, yizhen/0000-0002-3908-7102	National Natural Science Foundation of China [31572413]; Natural Science Foundation of Zhejiang Province [LZ17C17001]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant 31572413), the Natural Science Foundation of Zhejiang Province (Grant LZ17C17001), and the Fundamental Research Funds for the Central Universities. The authors declare no conflicts of interest.	Babaei R, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aai7838; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Caplan AI, 2017, STEM CELL TRANSL MED, V6, P1445, DOI 10.1002/sctm.17-0051; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; Derecka M, 2012, CELL METAB, V16, P814, DOI 10.1016/j.cmet.2012.11.005; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fuentes L, 2016, CONTRACEPTION, V93, P292, DOI 10.1016/j.contraception.2015.12.017; Gao P, 2015, CELL SIGNAL, V27, P2434, DOI 10.1016/j.cellsig.2015.09.010; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Harp JB, 2001, BIOCHEM BIOPH RES CO, V281, P907, DOI 10.1006/bbrc.2001.4460; Hellgren G, 2001, J INTERF CYTOK RES, V21, P75, DOI 10.1089/107999001750069935; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Huang JB, 2018, GENOM PROTEOM BIOINF, V16, P85, DOI 10.1016/j.gpb.2018.03.001; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jia YY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111085; Kawai M, 2007, J MOL ENDOCRINOL, V38, P19, DOI 10.1677/jme.1.02154; Kim KS, 2010, BIOMATERIALS, V31, P1104, DOI 10.1016/j.biomaterials.2009.10.020; Kusuyama J, 2018, J CELL PHYSIOL, V233, P2549, DOI 10.1002/jcp.26130; Lee K, 2016, BBA-GEN SUBJECTS, V1860, P2416, DOI 10.1016/j.bbagen.2016.07.009; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li SW, 2015, STEM CELL TRANSL MED, V4, P359, DOI 10.5966/sctm.2014-0150; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; Song XB, 2011, ACTA BIOCH BIOPH SIN, V43, P796, DOI 10.1093/abbs/gmr074; Stephens JM, 1996, J BIOL CHEM, V271, P10441, DOI 10.1074/jbc.271.18.10441; Stewart WC, 1999, BBA-MOL CELL RES, V1452, P188, DOI 10.1016/S0167-4889(99)00129-9; Tanaka Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30929-1; Wakao Hiroshi, 2011, Environmental Health and Preventive Medicine, V16, P247, DOI 10.1007/s12199-010-0193-7; Wang L, 2018, FASEB J, V32, P4714, DOI 10.1096/fj.201701314R; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang XX, 2018, INT J OBESITY, V42, P1912, DOI 10.1038/s41366-018-0027-z; Wang XX, 2015, BIOCHEM BIOPH RES CO, V459, P201, DOI 10.1016/j.bbrc.2015.02.048; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wei XJ, 2016, INT J BIOCHEM CELL B, V77, P109, DOI 10.1016/j.biocel.2016.06.003; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Wu RF, 2018, BBA-MOL CELL BIOL L, V1863, P1323, DOI 10.1016/j.bbalip.2018.08.008; Wu RF, 2018, INT J OBESITY, V42, P1378, DOI 10.1038/s41366-018-0082-5; Wu RF, 2016, MOL BIOTECHNOL, V58, P450, DOI 10.1007/s12033-016-9947-9; Xiao W, 2016, MOL CELL, V61, P925, DOI 10.1016/j.molcel.2016.03.004; Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Yuan YY, 2017, BIOCHEM BIOPH RES CO, V482, P1360, DOI 10.1016/j.bbrc.2016.12.042; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhang KM, 2011, J CELL BIOCHEM, V112, P488, DOI 10.1002/jcb.22936; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhao X, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0486-0; Zong C, 2010, EUR CELLS MATER, V20, P109; Zou DH, 2011, BIOMATERIALS, V32, P9707, DOI 10.1016/j.biomaterials.2011.09.005	64	67	75	6	48	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7529	7544		10.1096/fj.201802644R	http://dx.doi.org/10.1096/fj.201802644R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30865855	Bronze			2022-12-28	WOS:000476114200069
J	Xiong, Y; Wu, ZH; Zhang, B; Wang, C; Mao, FY; Liu, X; Hu, KP; Sun, XB; Jin, W; Kuang, SH				Xiong, Yan; Wu, Zihuan; Zhang, Bin; Wang, Chao; Mao, Fengyi; Liu, Xiao; Hu, Keping; Sun, Xiaobo; Jin, Wen; Kuang, Shihuan			Fndc5 loss-of-function attenuates exercise-induced browning of white adipose tissue in mice	FASEB JOURNAL			English	Article						irisin; WAT; metabolism; Ucp1; beige adipocyte	TYPE-2 DIABETES-MELLITUS; SPIEGELMAN IRISIN ERKS; HUMAN SKELETAL-MUSCLE; MAXIMAL OXYGEN-UPTAKE; INSULIN SENSITIVITY; CIRCULATING IRISIN; GLUCOSE-UPTAKE; WEIGHT-LOSS; OBESITY; FAT	Fibronectin type III domain containing 5 (Fndc5) is a transmembrane protein highly expressed in the skeletal muscle. It was reported that exercise promotes the shedding of the extracellular domain of Fndc5, generating a circulating peptide (irisin) that cross-talks to adipose tissues to convert lipid-storing white adipocytes to energy-catabolizing beige adipocytes. However, the requirement of Fndc5 in mediating the beneficial effect of exercise remains to be determined. Here, we created a mouse model of Fndc5 mutation through transcription activator-like effector nuclease-mediated DNA targeting. The Fndc5 mutant mice have normal skeletal muscle development, growth, regeneration, as well as glucose and lipid metabolism at resting state, even when fed a high-fat diet. In response to running exercise, however, the Fndc5 mutant mice exhibit reduced glucose tolerance and insulin sensitivity and have lower maximal oxygen consumption compared with the exercised wild-type mice. Mechanistically, Fndc5 mutation attenuates exercise-induced browning of white adipose tissue that is crucial for the metabolic benefits of physical activities. These data provide genetic evidence that Fndc5 is dispensable for muscle development and basal metabolism but essential for exercise-induced browning of white adipose tissues in mice.Xiong, Y., Wu, Z., Zhang, B., Wang, C., Mao, F., Liu, X., Hu, K., Sun, X., Jin, W., Kuang, S. Fndc5 loss-of-function attenuates exercise-induced browning of white adipose tissue in mice.	[Xiong, Yan; Wu, Zihuan; Zhang, Bin; Mao, Fengyi; Hu, Keping; Sun, Xiaobo; Jin, Wen] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Xiong, Yan] Southwest Minzu Univ, Coll Life Sci & Technol, Key Lab Qinghai Tibetan Plateau Anim Genet Resour, Minist Educ, Chengdu, Sichuan, Peoples R China; [Wang, Chao; Mao, Fengyi; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, 270 S Russell St,2070 CRTN, W Lafayette, IN 47907 USA; [Liu, Xiao] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Shandong, Peoples R China; [Liu, Xiao] Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Shandong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Southwest Minzu University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences	Jin, W (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.; Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, 270 S Russell St,2070 CRTN, W Lafayette, IN 47907 USA.	wjin@implad.ac.cn; skuang@purdue.edu	Wang, Chao/V-8994-2019	Wang, Chao/0000-0002-4051-364X; Kuang, Shihuan/0000-0001-9180-3180	National Natural Science Foundation of China [81471070, 41676152]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-012]; Fundamental Research Funds for the Central Universities [2018NQN34]; U.S. Department of Agriculture [NC1184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); U.S. Department of Agriculture(United States Department of Agriculture (USDA))	The authors thank Pengpeng Zhang, Wenjie Li, and Qing Wang (all of the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences) for discussion and technical support. This work was supported by National Natural Science Foundation of China (81471070, 41676152), the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS; 2016-I2M-1-012), Fundamental Research Funds for the Central Universities (2018NQN34), and the U.S. Department of Agriculture (NC1184). The authors declare no conflicts of interest.	Adachi H, 2007, DIABETES RES CLIN PR, V77, pS258, DOI 10.1016/j.diabres.2007.01.068; Aldiss P, 2018, METABOLISM, V81, P63, DOI 10.1016/j.metabol.2017.11.009; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; BERGH U, 1978, MED SCI SPORT EXER, V10, P151; Biniaminov N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189254; Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Bosma M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11314; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Burch N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010970; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Castro B, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2237; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Colaianni G, 2015, P NATL ACAD SCI USA, V112, pE5763, DOI 10.1073/pnas.1519137112; Rodrigues KCD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00088; Ellefsen S, 2014, EUR J APPL PHYSIOL, V114, P1875, DOI 10.1007/s00421-014-2922-x; Elsen M, 2014, DIABETES, V63, pE16, DOI 10.2337/db14-0776; Elsen M, 2014, J ENDOCRINOL, V222, pR25, DOI 10.1530/JOE-14-0189; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher G, 2017, EUR J APPL PHYSIOL, V117, P1413, DOI 10.1007/s00421-017-3634-9; Fruchter O, 2001, NEW ENGL J MED, V345, P696; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gorgens SW, 2015, PROG MOL BIOL TRANSL, V135, P313, DOI 10.1016/bs.pmbts.2015.07.002; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Huh JY, 2014, INT J OBESITY, V38, P1538, DOI 10.1038/ijo.2014.42; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Huh JY, 2014, J CLIN ENDOCR METAB, V99, pE2154, DOI 10.1210/jc.2014-1437; Huh JY, 2014, METABOLISM, V63, P918, DOI 10.1016/j.metabol.2014.04.001; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ikeda S, 2016, BIOCHEM BIOPH RES CO, V473, P947, DOI 10.1016/j.bbrc.2016.03.159; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lee HJ, 2015, MOL ENDOCRINOL, V29, P873, DOI 10.1210/me.2014-1353; Lee W, 2018, BIOCHEM BIOPH RES CO, V502, P129, DOI 10.1016/j.bbrc.2018.05.133; Lehr L, 2006, FEBS LETT, V580, P4661, DOI 10.1016/j.febslet.2006.07.037; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin SC, 2004, TRENDS MOL MED, V10, P434, DOI 10.1016/j.molmed.2004.07.005; Liu JJ, 2014, J DIABETES COMPLICAT, V28, P208, DOI 10.1016/j.jdiacomp.2013.09.011; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Ma YJ, 2015, BBA-MOL BASIS DIS, V1852, P1001, DOI 10.1016/j.bbadis.2015.01.017; Mann S, 2014, DIABETES-METAB RES, V30, P257, DOI 10.1002/dmrr.2488; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Montero D, 2016, EUR J PREV CARDIOL, V23, P733, DOI 10.1177/2047487315617118; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Perakakis N, 2017, NAT REV ENDOCRINOL, V13, P324, DOI 10.1038/nrendo.2016.221; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Reza MM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01131-0; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Ross R, 2003, DIABETES CARE, V26, P944, DOI 10.2337/diacare.26.3.944; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seibaek M, 2003, CLIN CARDIOL, V26, P515, DOI 10.1002/clc.4960261107; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Skorobogatko Y, 2018, P NATL ACAD SCI USA, V115, P7819, DOI 10.1073/pnas.1801050115; Speakman JR, 2010, NATURE, V464, pE1, DOI 10.1038/nature08807; Spiegelman BM, 2014, DIABETES, V63, pE17, DOI 10.2337/db14-0898; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; van der Zwaard S, 2016, J APPL PHYSIOL, V121, P636, DOI 10.1152/japplphysiol.00355.2016; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang C, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2279; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu J, 2014, DIABETES, V63, P381, DOI 10.2337/db13-1586; Wu Z., 2016, CHINESE J COMP MED, V26, P37; Xiong XQ, 2015, BBA-MOL BASIS DIS, V1852, P1867, DOI 10.1016/j.bbadis.2015.06.017; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yue F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14328; Zhang Y, 2016, AM J PHYSIOL-ENDOC M, V311, pE530, DOI 10.1152/ajpendo.00094.2016; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	78	25	26	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5876	5886		10.1096/fj.201801754RR	http://dx.doi.org/10.1096/fj.201801754RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30721625	Bronze			2022-12-28	WOS:000466932600007
J	Cheng, JY; Li, Y; Liu, SQ; Jiang, YJ; Ma, J; Wan, L; Li, QH; Pang, TX				Cheng, Jingying; Li, Ying; Liu, Shiqi; Jiang, Yajing; Ma, Jiao; Wan, Li; Li, Qinghua; Pang, Tianxiang			CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway	FASEB JOURNAL			English	Article						cytokines; cancer; bone marrow microenvironment; crosstalk	BONE-MARROW MICROENVIRONMENT; STEM-CELLS; GENETIC ABERRATIONS; INTERLEUKIN-8; EXPRESSION; CANCER; ANGIOGENESIS; MALIGNANCIES; INHIBITION; SECRETION	The role of proinflammatory cytokines secreted by the bone marrow mesenchymal stromal cells (BM-MSCs) in the progression of acute myeloid leukemia (AML) is poorly understood. We compared C-X-C motif chemokine ligand (CXCL)8 expression levels in the BM-MSCs of patients with AML and normal control subjects and detected significantly higher levels in the former. Furthermore, CXCL8 was up-regulated in cocultures of BM-MSCs and leukemic cell lines compared with either monoculture. CXCL8 expression was significantly higher in MSCs compared with mononuclear cells in patients with de novo AML. To elucidate the function of paracrine CXCL8 in AML, we blocked CXCL8 binding to the C-X-C motif chemokine receptor (CXCR)2 in the AML cells using SB225002. Inhibition of CXCL8/CXCR2 binding decreased proliferation in the AML cells by inducing cell cycle arrest at the G(0)/G(1) phase and apoptosis via decreased AKT phosphorylation. Blocking the PI3K/AKT signaling pathway by a specific inhibitor induced similar apoptosis induction and lower proliferation, suggesting that the PI3K/AKT signaling pathway was also involved in CXCL8 action. Taken together, our findings demonstrate that BM-MSCs are the main source of CXCL8 in the AML bone marrow microenvironment and promote leukemogenesis via the PI3K/AKT signaling pathway, indicating a novel therapeutic target.	[Cheng, Jingying; Li, Ying; Liu, Shiqi; Jiang, Yajing; Ma, Jiao; Wan, Li; Li, Qinghua; Pang, Tianxiang] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Nanjing Rd 288, Tianjin 300020, Peoples R China; [Cheng, Jingying; Li, Ying; Liu, Shiqi; Jiang, Yajing; Ma, Jiao; Wan, Li; Li, Qinghua; Pang, Tianxiang] Chinese Acad Med Sci, Blood Dis Hosp, Nanjing Rd 288, Tianjin 300020, Peoples R China; [Cheng, Jingying; Li, Ying; Liu, Shiqi; Jiang, Yajing; Ma, Jiao; Wan, Li; Li, Qinghua; Pang, Tianxiang] Peking Union Med Coll, Nanjing Rd 288, Tianjin 300020, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Pang, TX (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Nanjing Rd 288, Tianjin 300020, Peoples R China.; Pang, TX (corresponding author), Chinese Acad Med Sci, Blood Dis Hosp, Nanjing Rd 288, Tianjin 300020, Peoples R China.; Pang, TX (corresponding author), Peking Union Med Coll, Nanjing Rd 288, Tianjin 300020, Peoples R China.	pang@ihcams.ac.cn			Chinese Academy of Medical Sciences Initiative for Innovative Medicine [CAMS-I2M-2016-1-017]; National Natural Science Foundation of China [81170510]	Chinese Academy of Medical Sciences Initiative for Innovative Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Medical Sciences Initiative for Innovative Medicine (CAMS-I2M-2016-1-017) and the National Natural Science Foundation of China (81170510). The authors declare no conflicts of interest.	Abdul-Aziz AM, 2017, CANCER RES, V77, P303, DOI 10.1158/0008-5472.CAN-16-1095; Blau O, 2011, BLOOD, V118, P5583, DOI 10.1182/blood-2011-03-343467; Brenner AK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00106; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Civini S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-298; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Denizot Y, 1996, BLOOD, V87, P4016, DOI 10.1182/blood.V87.9.4016.bloodjournal8794016; Du L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0745-0; Du MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054572; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058; Jacamo R, 2014, BLOOD, V123, P2691, DOI 10.1182/blood-2013-06-511527; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Kawano Y, 2015, IMMUNOL REV, V263, P160, DOI 10.1111/imr.12233; Li W, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0172-3; Li X, 2015, ARCH TOXICOL, V89, P121, DOI 10.1007/s00204-014-1226-6; Li YY, 2018, BIOCHEM BIOPH RES CO, V499, P524, DOI 10.1016/j.bbrc.2018.03.181; Li ZL, 2018, FASEB J, V32, P2197, DOI 10.1096/fj.201700895R; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Moudra A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1183860; Mullally A, 2013, CELL STEM CELL, V13, P257, DOI 10.1016/j.stem.2013.08.009; Parmar A, 2011, CANCER RES, V71, P4696, DOI 10.1158/0008-5472.CAN-10-4136; Reikvam H, 2015, STEM CELL RES, V15, P530, DOI 10.1016/j.scr.2015.09.008; Rodriguez-Abreu D, 2007, ANN ONCOL, V18, pI3, DOI 10.1093/annonc/mdl443; Rotondi M, 2013, J CLIN ENDOCR METAB, V98, P308, DOI 10.1210/jc.2012-2555; Sanmamed MF, 2014, CLIN CANCER RES, V20, P5697, DOI 10.1158/1078-0432.CCR-13-3203; Schinke C, 2015, BLOOD, V125, P3144, DOI 10.1182/blood-2015-01-621631; Shalapour S, 2010, J MOL MED, V88, P249, DOI 10.1007/s00109-009-0583-8; Shao N, 2015, CANCER LETT, V364, P165, DOI 10.1016/j.canlet.2015.05.009; Sharma B, 2013, MOL CANCER THER, V12, P799, DOI 10.1158/1535-7163.MCT-12-0529; Shi Q, 2001, J INTERF CYTOK RES, V21, P553, DOI 10.1089/10799900152547812; Singh JK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3436; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; von der Heide E, 2017, LEUKEMIA, V31, P1069, DOI 10.1038/leu.2016.324; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang JC, 2015, ONCOTARGET, V6, P42825, DOI 10.18632/oncotarget.5739; Wang S, 2013, TRANSL ONCOL, V6, P216, DOI 10.1593/tlo.13133; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yang LL, 2015, CELL MOL LIFE SCI, V72, P1959, DOI 10.1007/s00018-015-1846-x	44	21	24	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4755	4764		10.1096/fj.201801931R	http://dx.doi.org/10.1096/fj.201801931R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592634	Bronze			2022-12-28	WOS:000462888500010
J	Kayser, BD; Lhomme, M; Prifti, E; Da Cunha, C; Marquet, F; Chain, F; Naas, I; Pelloux, V; Dao, MC; Kontush, A; Rizkalla, SW; Aron-Wisnewsky, J; Bermudez-Humaran, LG; Oakley, F; Langella, P; Clement, K; Dugail, I				Kayser, Brandon D.; Lhomme, Marie; Prifti, Edi; Da Cunha, Carla; Marquet, Florian; Chain, Florian; Naas, Isabelle; Pelloux, Veronique; Dao, Maria-Carlota; Kontush, Anatol; Rizkalla, Salwa W.; Aron-Wisnewsky, Judith; Bermudez-Humaran, Luis G.; Oakley, Fiona; Langella, Philippe; Clement, Karine; Dugail, Isabelle			Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity	FASEB JOURNAL			English	Article						phosphatidylglycerol synthesis; adipocyte lipolysis; lipidomic profiling; serum phospholipidome	LIPIDOMICS REVEALS; PHOSPHOLIPIDS; EXPRESSION; DISEASE; MICROBIOME; METABOLISM; MECHANISMS; SYSTEM; LIPIDS; LIVER	Lipidomic techniques can improve our understanding of complex lipid interactions that regulate metabolic diseases. Here, a serum phospholipidomics analysis identified associations between phosphatidylglycerols (PGs) and gut microbiota dysbiosis. Compared with the other phospholipids, serum PGs were the most elevated in patients with low microbiota gene richness, which were normalized after a dietary intervention that restored gut microbial diversity. Serum PG levels were positively correlated with metagenomic functional capacities for bacterial LPS synthesis and host markers of low-grade inflammation; transcriptome databases identified PG synthase, the first committed enzyme in PG synthesis, as a potential mediator. Experiments in mice and cultured human-derived macrophages demonstrated that LPS induces PG release. Acute PG treatment in mice altered adipose tissue gene expression toward remodeling and inhibited ex vivo lipolysis in adipose tissue, suggesting that PGs favor lipid storage. Indeed, several PG species were associated with the severity of obesity in mice and humans. Finally, despite enrichment in PGs in bacterial membranes, experiments employing gnotobiotic mice colonized with recombinant PG overproducing Lactococcus lactis showed limited direct contribution of microbial PGs to the host. In summary, PGs are inflammation-responsive lipids indirectly regulated by the gut microbiota via endotoxins and regulate adipose tissue homeostasis in obesity.	[Kayser, Brandon D.; Prifti, Edi; Da Cunha, Carla; Marquet, Florian; Pelloux, Veronique; Dao, Maria-Carlota; Rizkalla, Salwa W.; Aron-Wisnewsky, Judith; Clement, Karine; Dugail, Isabelle] Sorbonne Univ, INSERM, Unite 11662, Nutri Team, Paris, France; [Kontush, Anatol] Sorbonne Univ, INSERM, Unite 11662, Integrat Biol Atherosclerosis Team, Paris, France; [Lhomme, Marie; Prifti, Edi] Inst Cardiometab & Nutr ICAN, ICANalyt Team, Paris, France; [Lhomme, Marie] Inst Cardiometab & Nutr ICAN, Integr Team, Paris, France; [Chain, Florian; Naas, Isabelle; Bermudez-Humaran, Luis G.; Langella, Philippe] Univ Paris Saclay, AgroParisTech, Micalis Inst, Jouy En Josas, France; [Aron-Wisnewsky, Judith; Clement, Karine] Pitie Salpetriere Hop, AP HP, Ctr Rech Nutr Humaine CRNH Ile France, Nutr Dept, Paris, France; [Oakley, Fiona] Newcastle Univ, Inst Cellular Med, Newcastle Fibrosis Res Grp, Newcastle Upon Tyne, Tyne & Wear, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Newcastle University - UK	Clement, K (corresponding author), Sorbonne Univ, INSERM, UMR S1166, Nutri Team, 43-83 Blvd Hop,IE3M, F-75013 Paris, France.; Dugail, I (corresponding author), Sorbonne Univ, INSERM, UMR S1166, Nutri Team, 91 Blvd Hop, F-75013 Paris, France.	karine.clement@inserm.fr; isabelle.dugail@inserm.fr	Dugail, Isabelle/L-1567-2017; Prifti, Edi/F-3967-2019; BERMUDEZ, Luis/AAE-8917-2021; ARON-WISNEWSKY, judith/AAH-7608-2020	Dugail, Isabelle/0000-0003-3631-2252; Prifti, Edi/0000-0001-8861-1305; LHOMME, MARIE/0000-0002-6335-4506; Chain, Florian/0000-0001-8787-3311; Oakley, Fiona/0000-0001-8692-1836; Bermudez Humaran, Luis G./0000-0001-7525-3131	Agence Nationale de la Recherche (ANR MicrObes); Programme Hospitalier de Reserche Clinique (PHRC Microbaria) [AOM10285/P100111]; KOT-Ceprodi; Societe Francaise de Nutrition; Institut Benjamin Delessert; European Union's Seventh Framework Program Metacardis [HEALTH-F4-2012-305312]; European Union's Horizon 2020 Framework Program (EPoS) [634413]; European Foundation; Foundation de France; MRC [G0900535] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL130357] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR MicrObes); Programme Hospitalier de Reserche Clinique (PHRC Microbaria); KOT-Ceprodi; Societe Francaise de Nutrition; Institut Benjamin Delessert; European Union's Seventh Framework Program Metacardis; European Union's Horizon 2020 Framework Program (EPoS); European Foundation(European Science Foundation (ESF)); Foundation de France; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the nurses and technicians and, of course, the patients themselves for their invaluable contribution to this work. The authors also acknowledge Kavya Anjani (INSERM, Paris, Franc) for her contributions, as well as J. C. Bichet (Pitie Salpetriere Hospital) for providing liposuction-derived adipose tissue samples. This work was supported by Agence Nationale de la Recherche (ANR MicrObes), Programme Hospitalier de Reserche Clinique (PHRC Microbaria AOM10285/P100111), KOT-Ceprodi, Association Foundation Coeur et Arteres (clinical investigation), Societe Francaise de Nutrition, and Institut Benjamin Delessert. Support was obtained from European Union's Seventh Framework Program Metacardis under Grant HEALTH-F4-2012-305312, and Horizon 2020 Framework Program (EPoS, Grant 634413). The European Foundation for the Study of Diabetes Albert Renold Travel Fellowship has contributed to the work of B.D.K., and Danone Research to the work of M.-C.D. and K.C. Funding from Foundation de France (to K.C.) was also obtained. MicrObes Consortium collaborators: Aurelie Cotillard; Sean P. Kennedy; Nicolas Pons; Emmanuelle Le Chatelier; Mathieu Almeida; Benoit Quinquis; Nathalie Galleron; Jean-Michel Batto; Pierre Renault; Stanislav Dusko Ehrlich; Herve Blottiere; Marion Leclerc; Tomas de Wouters; Patricia Lepage, Jean-Daniel Zucker, Joel Dore, Salwa W. Rizkalla. The authors declare no conflicts of interest.	Anjani K, 2015, J HEPATOL, V62, P905, DOI 10.1016/j.jhep.2014.11.002; Aron-Wisnewsky J, 2019, GUT, V68, P70, DOI 10.1136/gutjnl-2018-316103; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Benbouziane B, 2013, J BIOTECHNOL, V168, P120, DOI 10.1016/j.jbiotec.2013.04.019; Bernhard W, 2016, ANN ANAT, V208, P146, DOI 10.1016/j.aanat.2016.08.003; Borgeson E, 2015, CELL METAB, V22, P125, DOI 10.1016/j.cmet.2015.05.003; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Caesar R, 2012, GUT, V61, P1701, DOI 10.1136/gutjnl-2011-301689; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Camont L, 2013, ARTERIOSCL THROM VAS, V33, P2715, DOI 10.1161/ATVBAHA.113.301468; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Dugail I, 2017, BIOCHIMIE, V141, P47, DOI 10.1016/j.biochi.2017.05.005; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Kayser BD, 2017, INT J OBESITY, V41, P917, DOI 10.1038/ijo.2017.63; Kong LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109434; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Meikle PJ, 2008, BIOCHEM J, V411, P71, DOI 10.1042/BJ20071043; Meikle PJ, 2017, NAT REV ENDOCRINOL, V13, P79, DOI 10.1038/nrendo.2016.169; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pallister T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13722-4; Prifti E., 2013, 4 INT HUM MICR C, V4; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Titos E, 2016, J IMMUNOL, V197, P3360, DOI 10.4049/jimmunol.1502522; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Wu YZ, 2003, AM J RESP CRIT CARE, V168, P692, DOI 10.1164/rccm.200304-467OC; Wynn JL, 2011, MOL MED, V17, P1146, DOI 10.2119/molmed.2011.00169	42	15	15	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4741	4754		10.1096/fj.201801897R	http://dx.doi.org/10.1096/fj.201801897R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30608881	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000462888500009
J	Assali, EA; Shlomo, D; Zeng, JL; Taddeo, EP; Trudeau, KM; Erion, KA; Colby, AH; Grinstaff, MW; Liesa, M; Las, G; Shirihai, OS				Assali, Essam A.; Shlomo, Dovi; Zeng, Jialiu; Taddeo, Evan P.; Trudeau, Kyle M.; Erion, Karel A.; Colby, Aaron H.; Grinstaff, Mark W.; Liesa, Marc; Las, Guy; Shirihai, Orian S.			Nanoparticle-mediated lysosomal reacidification restores mitochondrial turnover and function in cells under lipotoxicity	FASEB JOURNAL			English	Article						autophagy; islets; bioenergetics; free fatty acids; photoactivated nanoparticles	AUTOPHAGY; GLUCOSE; FUSION; DYSFUNCTION; MITOTIMER; FISSION	Chronic exposure of pancreatic cells to high concentrations of free fatty acids leads to lipotoxicity (LT)-mediated suppression of glucose-stimulated insulin secretion. This effect is in part caused by a decline in mitochondrial function as well as by a reduction in lysosomal acidification. Because both mitochondria and lysosomes can alter one another's function, it remains unclear which initiating dysfunction sets off the detrimental cascade of LT, ultimately leading to -cell failure. Here, we investigated the effects of restoring lysosomal acidity on mitochondrial function under LT. Our results show that LT induces a dose-dependent lysosomal alkalization accompanied by an increase in mitochondrial mass. This increase is due to a reduction in mitochondrial turnover as analyzed by MitoTimer, a fluorescent protein for which the emission is regulated by mitochondrial clearance rate. Mitochondrial oxygen consumption rate, citrate synthase activity, and ATP content are all reduced by LT. Restoration of lysosomal acidity using lysosome-targeted nanoparticles is accompanied by stimulation of mitochondrial turnover as revealed by mitophagy measurements and the recovery of mitochondrial mass. Remarkably, re-acidification restores citrate synthase activity and ATP content in an insulin secreting -cell line (INS-1). Furthermore, nanoparticle-mediated lysosomal reacidification rescues mitochondrial maximal respiratory capacity in both INS-1 cells and primary mouse islets. Therefore, our results indicate that mitochondrial dysfunction is downstream of lysosomal alkalization under lipotoxic conditions and that recovery of lysosomal acidity is sufficient to restore the bioenergetic defects.Assali, E. A., Shlomo, D., Zeng, J., Taddeo, E. P., Trudeau, K. M., Erion, K. A., Colby, A. H., Grinstaff, M. W., Liesa, M., Las, G., Shirihai, O. S. Nanoparticle-mediated lysosomal reacidification restores mitochondrial turnover and function in cells under lipotoxicity.	[Assali, Essam A.; Shlomo, Dovi; Las, Guy; Shirihai, Orian S.] Ben Gurion Univ Negev, Dept Clin Biochem, Fac Hlth Sci, Beer Sheva, Israel; [Assali, Essam A.; Taddeo, Evan P.; Erion, Karel A.; Liesa, Marc; Shirihai, Orian S.] Univ Calif Los Angeles, Dept Med, Div Endocrinol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Liesa, Marc] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Liesa, Marc] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90024 USA; [Zeng, Jialiu; Colby, Aaron H.; Grinstaff, Mark W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Zeng, Jialiu; Grinstaff, Mark W.] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA; [Zeng, Jialiu; Grinstaff, Mark W.] Boston Univ, Dept Med, Boston, MA 02215 USA; [Trudeau, Kyle M.] Boston Univ, Sch Med, Dept Med, Obes & Nutr Sect,Evans Biomed Res Ctr, Boston, MA 02118 USA	Ben Gurion University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Boston University; Boston University; Boston University; Boston University	Las, G (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84103 Beer Sheva, Israel.; Shirihai, OS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Hlth Sci 33 131, 650 Charles E Young St, Los Angeles, CA 90095 USA.	las@post.bgu.ac.il; oshirihai@mednet.ucla.edu	Assali, Essam/AAA-7601-2021; Zeng, Jialiu/AAB-3039-2019; Liesa, Marc/K-8590-2019	Zeng, Jialiu/0000-0001-7802-1432; Liesa, Marc/0000-0002-5909-8570	Azrieli Foundation; Kreitman Predoctoral Scholarship from Ben Gurion University; Israeli Council for Higher Education Fellowship; Israel Science Foundation [2018/13]; National Institute for Biotechnology in the Negev; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1-DK35914, R01-DK56690, R01-DK074778]; Diabetes Research Center at UCLA; University of California, San Diego (UCSD) [NIH NIDDK P30-DK063491]; Department of Medicine Chair at UCLA	Azrieli Foundation; Kreitman Predoctoral Scholarship from Ben Gurion University; Israeli Council for Higher Education Fellowship; Israel Science Foundation(Israel Science Foundation); National Institute for Biotechnology in the Negev; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Research Center at UCLA; University of California, San Diego (UCSD); Department of Medicine Chair at UCLA	The authors thank those who contributed helpful discussions, insight, and support of the research, including Drs. Assaf Rudich (Ben-Gurion University), Alicia Kowaltowski (Universidade de Sao Paulo, Sao Paulo, Brazil), Fernanda Cerqueirra (Ben-Gurion University), Eleni Ritou [University of California, Los Angeles (UCLA)], Kiana Mahdaviani (Boston University), Michael Shum (UCLA), Nathanael Miller (UCLA), Siyouneh Baghdasarian (UCLA), Dani Dagan (Technion-Israel Institute of Technology, Haifa, Israel), Jeniffer Ngo (UCLA), and Michaela Veliova (UCLA). E.A.A. is supported by the Azrieli Foundation, the Kreitman Predoctoral Scholarship from Ben Gurion University, and the Israeli Council for Higher Education Fellowship. G.L. was supported by the Israel Science Foundation under Grant 2018/13, and by the National Institute for Biotechnology in the Negev. O.S.S. is funded by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants RO1-DK35914, R01-DK56690, and R01-DK074778. M.L. is funded by a pilot grant from the Diabetes Research Center at UCLA, and University of California, San Diego (UCSD) (NIH NIDDK P30-DK063491), and the Department of Medicine Chair at UCLA. The authors declare no conflicts of interest.	Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Alsabeeh N, 2018, BBA-MOL CELL BIOL L, V1863, P143, DOI 10.1016/j.bbalip.2017.11.006; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Bachar-Wikstrom E, 2013, AUTOPHAGY, V9, P626, DOI 10.4161/auto.23642; Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079; Elmore SP, 2004, ARCH BIOCHEM BIOPHYS, V422, P145, DOI 10.1016/j.abb.2003.12.031; Ferree AW, 2013, AUTOPHAGY, V9, P1887, DOI 10.4161/auto.26503; Frudd K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02352-z; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Guan J, 2015, EMBO MOL MED, V7, P688, DOI 10.15252/emmm.201505318; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022; Presley AD, 2003, J CHROMATOGR B, V793, P141, DOI 10.1016/S1570-0232(03)00371-4; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Taddeo EP, 2018, MOL METAB, V16, P150, DOI 10.1016/j.molmet.2018.07.003; Trudeau KM, 2016, J CELL BIOL, V214, P25, DOI 10.1083/jcb.201511042; Trudeau KM, 2014, METHOD ENZYMOL, V547, P21, DOI 10.1016/B978-0-12-801415-8.00002-3; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	28	21	21	6	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4154	4165		10.1096/fj.201801292R	http://dx.doi.org/10.1096/fj.201801292R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30550357	Green Published, Bronze			2022-12-28	WOS:000459794800084
J	Kakihana, A; Oto, Y; Saito, Y; Nakayama, Y				Kakihana, Ayana; Oto, Yui; Saito, Youhei; Nakayama, Yuji			Heat shock-induced mitotic arrest requires heat shock protein 105 for the activation of spindle assembly checkpoint	FASEB JOURNAL			English	Article						Hsp105; mitosis; misorientation; spindle assembly checkpoint; heat shock	ORIENTATION; CELLS; CENTROSOME; EXPRESSION; KINASE; HSP105; CANCER; HSP70; PHOSPHORYLATION; HYPERTHERMIA	Heat shock causes proteotoxic stress that induces various cellular responses, including delayed mitotic progression and the generation of an aberrant number of chromosomes. In this study, heat shock delayed the onset of anaphase by increasing the number of misoriented cells, accompanied by the kinetochore localization of budding uninhibited by benzimidazole-related (BubR)1 in a monopolar spindle (Mps)1-dependent manner. The mitotic delay was canceled by knockdown of mitotic arrest defect (Mad)2. Knockdown of heat shock protein (Hsp)105 partially abrogated the mitotic delay with the loss of the kinetochore localization of BubR1 under heat shock conditions and accelerated mitotic progression under nonstressed conditions. Consistent with this result, Hsp105 knockdown increased the number of anaphase cells with lagging chromosomes, through mitotic slippage, and decreased taxol sensitivity more than Mad2 knockdown. Hsp105 was coprecipitated with cell division cycle (Cdc)20 in an Mps1-dependent manner; however, its knockdown did not affect coprecipitation of Mad2 and BubR1 with Cdc20. We propose that heat shock delays the onset of anaphase via the activation of the spindle assembly checkpoint (SAC). Hsp105 prevents abnormal cell division by contributing to SAC activation under heat shock and nonstressed conditions by interacting with Cdc20 but not affecting formation of the mitotic checkpoint complex.Kakihana, A., Oto, Y., Saito, Y., Nakayama, Y. Heat shock-induced mitotic arrest requires heat shock protein 105 for the activation of spindle assembly checkpoint.	[Kakihana, Ayana; Oto, Yui; Saito, Youhei; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto, Japan	Kyoto Pharmaceutical University	Nakayama, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Yamashina Ku, 5 Misasagi Nakauchi Cho, Kyoto 6078414, Japan.	nakayama@mb.kyoto-phu.ac.jp		Saito, Youhei/0000-0002-8545-6925; Nakayama, Yuji/0000-0001-7882-0066	Japan Society for the Promotion of Science [16K08253, 25460076, 18K06672, 26870701]; Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1311035]; Nagai Memorial Research Scholarship from Pharmaceutical Society of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagai Memorial Research Scholarship from Pharmaceutical Society of Japan	The authors thank Dr. Takeshi Tomonaga (Chiba University, Chiba, Japan) for HCT116 cells and Dr. Hideyuki Saya (Kumamoto University, Kumamoto, Japan), Dr. Teru Kanda (Aichi Cancer Center Research Institute, Aichi, Japan), and Dr. Geoffrey M. Wahl (Salk Institute for Biological Studies, La Jolla, CA, USA) for HeLa cells expressing histone H2B-GFP. This work was supported, in part, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science 16K08253 (to Y.N.), 25460076 (to Y.N.), 18K06672 (to Y.S.), and 26870701 (to Y.S.) and grants from the Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University and Chiba University) (to Y.N.); the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research (to Y.S.); the MEXT-Supported Program for the Strategic Research Foundation at Private Universities Grant S1311035 (to Y.S.); and Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan (to A.K.). The authors declare no conflicts of interest.	Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Chen YJ, 2014, ARCH TOXICOL, V88, P1711, DOI 10.1007/s00204-014-1222-x; COSS RA, 1982, CANCER RES, V42, P1059; Dai BB, 2013, J BIOL CHEM, V288, P1634, DOI 10.1074/jbc.M112.379362; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Erenpreisa JE, 2000, CELL BIOL INT, V24, P61, DOI 10.1006/cbir.1999.0466; Fuchs M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005582; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Furlong F, 2012, J PATHOL, V226, P746, DOI 10.1002/path.3035; Furusawa Y, 2012, APOPTOSIS, V17, P102, DOI 10.1007/s10495-011-0660-7; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Giovinazzi S, 2013, CELL CYCLE, V12, P2598, DOI 10.4161/cc.25591; Gupta RK, 2008, CANCER BIOL THER, V7, P1473, DOI 10.4161/cbt.7.9.6428; Hatayama T, 1997, CELL STRUCT FUNCT, V22, P517, DOI 10.1247/csf.22.517; Held T, 2011, REPRODUCTION, V142, P133, DOI 10.1530/REP-11-0023; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; HONDA K, 1989, BIOCHEM BIOPH RES CO, V160, P60, DOI 10.1016/0006-291X(89)91620-3; Hut HMJ, 2005, MOL BIOL CELL, V16, P3776, DOI 10.1091/mbc.E05-01-0038; IZUMI M, 1991, EXP CELL RES, V197, P229, DOI 10.1016/0014-4827(91)90427-V; Jia LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10818; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Katschinski DM, 2000, J BIOL CHEM, V275, P21094, DOI 10.1074/jbc.M001629200; Kimura A, 2016, ONCOTARGET, V7, P18415, DOI 10.18632/oncotarget.7821; Krenn V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00225; Lagos-Cabre R, 2008, REPRODUCTION, V135, P471, DOI 10.1530/REP-07-0389; LAMBOWITZ AM, 1983, NATURE, V303, P806, DOI 10.1038/303806a0; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627; Madlener S, 2009, HUM MOL GENET, V18, P1990, DOI 10.1093/hmg/ddp123; Maeshima K, 2018, CURR BIOL, V28, P444, DOI 10.1016/j.cub.2017.12.035; Makhnevych T, 2012, J CELL BIOL, V198, P623, DOI 10.1083/jcb.201111105; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Mikami H, 2017, EXP CELL RES, V352, P225, DOI 10.1016/j.yexcr.2017.02.004; Miyazaki M, 2005, CANCER SCI, V96, P695, DOI 10.1111/j.1349-7006.2005.00093.x; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nakahata K, 2002, INT J HYPERTHER, V18, P332, DOI 10.1080/02656730210129736; Nitta M, 1997, ONCOGENE, V15, P561, DOI 10.1038/sj.onc.1201210; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; O'Regan L, 2015, J CELL BIOL, V209, P349, DOI 10.1083/jcb.201409151; Park YY, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0069-2; PATRIARCA EJ, 1990, EXP CELL RES, V190, P57, DOI 10.1016/0014-4827(90)90143-X; Pawlik A, 2013, ACTA HISTOCHEM, V115, P8, DOI 10.1016/j.acthis.2012.02.006; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rogon C, 2014, MOL BIOL CELL, V25, P2260, DOI 10.1091/mbc.E14-02-0742; Saito Y, 2003, EXP CELL RES, V286, P233, DOI 10.1016/S0014-4827(03)00054-5; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seldin L, 2013, MOL BIOL CELL, V24, P3651, DOI 10.1091/mbc.E13-05-0277; Senju M, 2006, J CANCER RES CLIN, V132, P150, DOI 10.1007/s00432-005-0047-7; Singh D, 2016, GENESIS, V54, P220, DOI 10.1002/dvg.22930; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Vertii A, 2015, MOL BIOL CELL, V26, P3451, DOI 10.1091/mbc.E15-03-0158; VIDAIR CA, 1993, J CELL PHYSIOL, V154, P443, DOI 10.1002/jcp.1041540302; Wang G, 2014, J CELL SCI, V127, P4111, DOI 10.1242/jcs.151753; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Woodford MR, 2016, CELL REP, V14, P872, DOI 10.1016/j.celrep.2015.12.084; Yamagishi N, 2000, BIOCHEM BIOPH RES CO, V272, P850, DOI 10.1006/bbrc.2000.2864; Yamagishi N, 2003, FEBS LETT, V555, P390, DOI 10.1016/S0014-5793(03)01292-4; Yamagishi N, 2006, EXP CELL RES, V312, P3215, DOI 10.1016/j.yexcr.2006.06.007; Yang YF, 2014, P NATL ACAD SCI USA, V111, P2158, DOI 10.1073/pnas.1319341111; YASUDA K, 1995, J BIOL CHEM, V270, P29718, DOI 10.1074/jbc.270.50.29718; Zhu DH, 1997, DEVELOPMENT, V124, P3007	71	8	8	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3936	3953		10.1096/fj.201801369R	http://dx.doi.org/10.1096/fj.201801369R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496702	Bronze			2022-12-28	WOS:000459794800067
J	Tan, S; Shan, YL; Lin, YY; Liao, SY; Zhang, BJ; Zeng, Q; Wang, YG; Deng, ZZ; Chen, C; Hu, XQ; Peng, LS; Qiu, W; Lu, ZQ				Tan, Sha; Shan, Yilong; Lin, Yinyao; Liao, Siyuan; Zhang, Bingjun; Zeng, Qin; Wang, Yuge; Deng, Zhezhi; Chen, Chen; Hu, Xueqiang; Peng, Lisheng; Qiu, Wei; Lu, Zhengqi			Neutralization of interleukin-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A	FASEB JOURNAL			English	Article						IL-9; ischemic stroke; BBB	MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; NF-KAPPA-B; MEDIATED DISRUPTION; CELLS; INFLAMMATION; PERMEABILITY; MODEL; IL-9; ENCEPHALOMYELITIS	Astrocytes mediate the destruction of the blood-brain barrier (BBB) during ischemic stroke (IS). IL-9 is a pleiotropic cytokine that we previously found to be highly expressed in peripheral blood mononuclear cells from patients with IS, and the presence of IL-9 receptors on astrocytes has been reported in the literature. Here, we detected the effect of IL-9 on astrocytes using an anti-IL-9-neutralizing antibody to treat rats with experimental stroke. Supernatants from astrocytes treated with or without oxygen-glucose deprivation and/or IL-9 were incubated with bEnd.3 cell monolayers after blocking the IL-9 receptor on the endothelium. Immunofluorescence staining and Western blot analyses were conducted to observe the change in tight junction proteins (TJPs) in bEnd.3 cells as well as the level of VEGF-A and possible signal pathways in astrocytes. We also applied middle cerebral artery occlusion (MCAO) models to determine the effect of anti-IL-9-neutralizing antibodies on IS. As a result, astrocyte-conditioned medium treated with IL-9 aggravated the disruption of the BBB accomplished by the degradation of TJPs in endothelial cells. In addition, IL-9 increased the level of VEGF-A in astrocytes, and blocking the effect of VEGF-A reversed the breakdown of the BBB. In the MCAO model, anti-IL-9-neutralizing antibody reduced the infarct volume and BBB destruction. Mechanistically, the anti-IL-9-neutralizing antibody repaired the damaged TJPs (zonula occludens 1, occludin, and claudin-5) and induced a decrease in VEGF-A expression in ischemic lateral brain tissue. In contrast, a local injection of recombinant murine IL-9 to the brain resulted in a marked up-regulation of VEGF-A in the striatum. In conclusion, anti-IL-9-neutralizing antibody can reduce the severity of IS partially by alleviating the destruction of the BBB via down-regulation of astrocyte-derived VEGF-A. This finding suggests that targeting IL-9 or VEGF-A could provide a new direction for the treatment of IS.Tan, S., Shan, Y., Lin, Y., Liao, S., Zhang, B., Zeng, Q., Wang, Y., Deng, Z., Chen, C., Hu, X., Peng, L., Qiu, W., Lu, Z. Neutralization of IL-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A.	[Tan, Sha; Shan, Yilong; Lin, Yinyao; Liao, Siyuan; Zhang, Bingjun; Zeng, Qin; Wang, Yuge; Deng, Zhezhi; Chen, Chen; Hu, Xueqiang; Peng, Lisheng; Qiu, Wei; Lu, Zhengqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, 600 Tianhe Rd, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Qiu, W; Lu, ZQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, 600 Tianhe Rd, Guangzhou, Guangdong, Peoples R China.	qiuwei120@vip.163.com; lzq1828@163.com		Zhang, Bingjun/0000-0002-9641-2485	National Natural Science Foundation of China [81671178]; Natural Science Foundation of Guangdong Province [2017A030311013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (Grant 81671178) and the Natural Science Foundation of Guangdong Province (Grant 2017A030311013). The authors declare no conflicts of interest.	Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Begum G, 2018, GLIA, V66, P126, DOI 10.1002/glia.23232; Blecharz-Lang KG, 2018, TRANSL STROKE RES, V9, P631, DOI 10.1007/s12975-018-0614-2; Chen XD, 2015, NEUROBIOL DIS, V73, P118, DOI 10.1016/j.nbd.2014.09.007; Correale J, 2009, NEUROCHEM RES, V34, P2067, DOI 10.1007/s11064-009-0081-y; Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538; Ding XL, 2015, EXP MOL PATHOL, V99, P570, DOI 10.1016/j.yexmp.2015.07.010; Dobrogowska DH, 1998, J NEUROCYTOL, V27, P163, DOI 10.1023/A:1006907608230; Elyaman W, 2017, SEMIN IMMUNOPATHOL, V39, P79, DOI 10.1007/s00281-016-0604-y; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Lee H, 2017, ONCOTARGET, V8; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Li YN, 2014, J NEUROCHEM, V129, P120, DOI 10.1111/jnc.12611; Ni YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170346; NISHINO H, 1994, BRAIN RES BULL, V35, P51, DOI 10.1016/0361-9230(94)90215-1; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Park SJ, 2012, INFLAMM RES, V61, P1069, DOI 10.1007/s00011-012-0499-6; Parker JM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-14; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; Remmers M, 1999, BRAIN RES, V827, P237, DOI 10.1016/S0006-8993(99)01304-9; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Rost NS, 2018, J CEREBR BLOOD F MET, V38, P75, DOI 10.1177/0271678X17706449; Ruocco G, 2015, CLIN SCI, V129, P291, DOI 10.1042/CS20140608; Seifert HA, 2014, TRANSL STROKE RES, V5, P543, DOI 10.1007/s12975-014-0349-7; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Tan S, 2017, CLIN SCI, V131, P1499, DOI 10.1042/CS20170984; Thirupathi A, 2017, J PHYSIOL BIOCHEM, V73, P487, DOI 10.1007/s13105-017-0576-y; Tian YL, 2016, MOL CELL BIOCHEM, V422, P75, DOI 10.1007/s11010-016-2807-x; Wang W, 2018, MOL MED REP, V17, P3146, DOI 10.3892/mmr.2017.8203; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yang Y, 2018, NEUROBIOL DIS, V114, P95, DOI 10.1016/j.nbd.2018.02.012; Yao XH, 2014, IMMUNOLOGY, V143, P396, DOI 10.1111/imm.12322; Yu XF, 2016, CEREBROVASC DIS, V42, P49, DOI 10.1159/000444809; Zhang HM, 2015, CYTOKINE, V76, P549, DOI 10.1016/j.cyto.2015.06.019; Zhang L, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0610-y; Zhou Y, 2011, J IMMUNOL, V186, P4415, DOI 10.4049/jimmunol.1003307	45	19	24	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4376	4387		10.1096/fj.201801595RR	http://dx.doi.org/10.1096/fj.201801595RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30694693				2022-12-28	WOS:000459794800102
J	Hu, Y; French, SW; Chau, T; Liu, HX; Sheng, LL; Wei, F; Stondell, J; Garcia, JC; Du, YL; Bowlus, CL; Wan, YJY				Hu, Ying; French, Samuel W.; Chau, Thinh; Liu, Hui-Xin; Sheng, Lili; Wei, Fang; Stondell, Jesse; Garcia, Juan C.; Du, Yanlei; Bowlus, Christopher L.; Wan, Yu-Jui Yvonne			RAR acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells	FASEB JOURNAL			English	Article						nuclear receptor; protein deacetylase; butyrate; propionate; short-chain fatty acid	ORPHAN RECEPTOR TR3; BILE-ACID; RETINOIC ACID; HEPATOCELLULAR-CARCINOMA; HISTONE DEACETYLASE-1; NUCLEAR EXPORT; VITAMIN-D; PROLIFERATION; EXPRESSION; MICRORNA-22	This study investigates the mechanism and consequences of microRNA-22 (miR-22) induction. Our data revealed for the first time that retinoic acid (RA) and histone deacetylase (HDAC) inhibitors, including short-chain fatty acids and suberanilohydroxamic acid (SAHA), could individually or in combination induce miR-22. This induction was mediated via RA receptor (RAR) binding to a direct repeat 5 (DR5) motif. In addition, we uncovered HDAC1 as a novel miR-22 target. In an miR-22-dependent manner, HDAC inhibitors and RA reduced HDAC1, HDAC4, and sirtuin 1 (SIRT1), which were involved in chromatin remodeling of the RAR and nerve growth factor IB (NUR77). Thus, HDAC inhibitors and RA-induced miR-22 resulted in simultaneous induction of cytoplasmic RAR and NUR77, leading to apoptosis of colon cancer cells. In mice, miR-22 and its inducers inhibited the growth of xenograft colon cancer. Moreover, tumor size reduction was accompanied by elevated miR-22, NUR77, and RAR and by reduced HDACs. In human colon polyps and adenocarcinomas, miR-22 and RAR were consistently reduced, which was associated with elevated HDAC1, HDAC4, and SIRT1 in colon adenocarcinomas. Results from this study revealed a novel anticancer mechanism of RAR viamiR-22 induction to epigenetically regulate itself and NUR77, providing a promising cancer treatment modality using miR-22 and its inducers.Hu, Y., French, S. W., Chau, T., Liu, H.-X., Sheng, L., Wei, F., Stondell, J., Garcia, J. C., Du, Y., Bowlus, C. L., Wan, Y.-J. Y. RAR acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells.	[Hu, Ying; Chau, Thinh; Liu, Hui-Xin; Sheng, Lili; Wan, Yu-Jui Yvonne] Univ Calif, Davis Hlth Syst, Dept Med Pathol & Lab Med, Room 3400B,4645 Second Ave,Res Bldg 3, Sacramento, CA 95817 USA; [Stondell, Jesse; Garcia, Juan C.; Bowlus, Christopher L.] Univ Calif, Davis Hlth Syst, Div Gastroenterol, Sacramento, CA USA; [French, Samuel W.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Wei, Fang; Du, Yanlei] First Municipal Peoples Hosp Guangzhou, Guangzhou Med Coll, Dept Gastroenterol & Hepatol, Guangzhou, Guangdong, Peoples R China	University of California System; University of California Los Angeles; Guangzhou Medical University; South China University of Technology	Wan, YJY (corresponding author), Univ Calif, Davis Hlth Syst, Dept Med Pathol & Lab Med, Room 3400B,4645 Second Ave,Res Bldg 3, Sacramento, CA 95817 USA.	yjywan@ucdavis.edu	; Bowlus, Christopher/N-9276-2016	Liu, Hui-Xin/0000-0002-8981-9981; Bowlus, Christopher/0000-0002-3906-6811	U.S. National Institutes of Health (NIH) National Cancer Institute [R01CA222490]; Science Translation and Innovative Research (STAIR) Grant; National Natural Science Foundation of China [81772572]; NATIONAL CANCER INSTITUTE [U01CA179582, R01CA222490] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Science Translation and Innovative Research (STAIR) Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Prasant Kumar Jena and Nidhi Nagar (University of California, Davis Health System) for their assistance in preparation of this manuscript. This study was supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant R01CA222490 (to Y.-J.Y.W.); a Science Translation and Innovative Research (STAIR) Grant (to Y.-J.Y.W.); and National Natural Science Foundation of China Grant 81772572 (to Y.D.). The authors declare no conflicts of interest.	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Chen B, 2015, CANCER LETT, V356, P410, DOI 10.1016/j.canlet.2014.09.028; Ding L, 2015, ACTA PHARM SIN B, V5, P135, DOI 10.1016/j.apsb.2015.01.004; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; He YQ, 2014, AM J PHYSIOL-GASTR L, V307, pG205, DOI 10.1152/ajpgi.00105.2014; Hedrick E, 2017, MOL CELL BIOL, V37; Hu Y, 2015, MOL CANCER RES, V13, P281, DOI 10.1158/1541-7786.MCR-14-0230; Hu Y, 2013, BIOCHEM PHARMACOL, V85, P1007, DOI 10.1016/j.bcp.2013.01.023; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Kang SA, 2010, BIOCHEM PHARMACOL, V80, P867, DOI 10.1016/j.bcp.2010.04.026; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee SO, 2014, MOL CANCER RES, V12, P527, DOI 10.1158/1541-7786.MCR-13-0567; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Ling B, 2012, J CANCER RES CLIN, V138, P1355, DOI 10.1007/s00432-012-1194-2; Lionetti M, 2009, GENE CHROMOSOME CANC, V48, P521, DOI 10.1002/gcc.20660; Liu HX, 2016, ONCOTARGET, V7, P1096, DOI 10.18632/oncotarget.6665; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Minucci S, 1997, P NATL ACAD SCI USA, V94, P11295, DOI 10.1073/pnas.94.21.11295; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Niu YD, 2017, HEPATOLOGY, V65, P893, DOI 10.1002/hep.28924; Pant K, 2017, REDOX BIOL, V12, P340, DOI 10.1016/j.redox.2017.03.006; Quint K, 2011, VIRCHOWS ARCH, V459, P129, DOI 10.1007/s00428-011-1103-0; Rikimaru T, 2007, ONCOLOGY-BASEL, V72, P69, DOI 10.1159/000111106; Saeed A, 2017, BBA-MOL CELL BIOL L, V1862, P496, DOI 10.1016/j.bbalip.2017.01.007; Schilderink R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00226; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sun J, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.31; Tang HL, 2013, CANCER LETT, V340, P72, DOI 10.1016/j.canlet.2013.06.027; Tenga A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148433; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Touma SE, 2005, CLIN CANCER RES, V11, P3558, DOI 10.1158/1078-0432.CCR-04-1155; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Tsuei J, 2014, EXP BIOL MED, V239, P1489, DOI 10.1177/1535370214538743; Wang CG, 2011, J STEROID BIOCHEM, V123, P91, DOI 10.1016/j.jsbmb.2010.12.003; Wang JY, 2017, INT J ONCOL, V50, P345, DOI 10.3892/ijo.2016.3811; Wang LG, 2009, AM J TRANSL RES, V1, P62; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Yamakuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020291; Yang F, 2015, J BIOL CHEM, V290, P6507, DOI 10.1074/jbc.M114.620369; Yang F, 2014, BIOCHEM PHARMACOL, V91, P483, DOI 10.1016/j.bcp.2014.08.018; Yang H, 2011, BIOCHEM PHARMACOL, V81, P910, DOI 10.1016/j.bcp.2011.01.005; Yang H, 2011, HEPATOLOGY, V53, P865, DOI 10.1002/hep.24101; Yang QQ, 2015, ONCOL REP, V34, P1771, DOI 10.3892/or.2015.4167; Yao LM, 2012, CARCINOGENESIS, V33, P301, DOI 10.1093/carcin/bgr287; Zhan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050013; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895	58	9	9	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2314	2326		10.1096/fj.201801390R	http://dx.doi.org/10.1096/fj.201801390R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252536	Green Published			2022-12-28	WOS:000457296600063
J	Wang, QR; Zhu, CQ; Sun, MM; Maimaiti, R; Ford, SP; Nathanielsz, PW; Ren, J; Guo, W				Wang, Qiurong; Zhu, Chaoqun; Sun, Mingming; Maimaiti, Rexiati; Ford, Stephen P.; Nathanielsz, Peter W.; Ren, Jun; Guo, Wei			Maternal obesity impairs fetal cardiomyocyte contractile function in sheep	FASEB JOURNAL			English	Article						cardiac programming; myofilament; Ca2+ sensitivity	MYOSIN HEAVY-CHAIN; TROPONIN-T ISOFORMS; BODY-MASS INDEX; CARDIAC RYANODINE RECEPTOR; CONGENITAL HEART-DEFECTS; DIET-INDUCED OBESITY; CALCIUM OVERLOAD; ALPHA-MYOSIN; INSULIN-RESISTANCE; GENE-EXPRESSION	Obesity is a major public health problem worldwide. In the United States, one-third of women of reproductive age are obese. Human studies show that maternal obesity (MO) predisposes offspring to cardiovascular disease. However, the underlying mechanisms remain unclear. Given the similarities between pregnancy in sheep and humans, we studied sheep to examine the impact of MO on fetal cardiomyocyte contractility at term. We observed that MO impaired cardiomyocyte contractility by reducing peak shortening and shortening/relengthening velocity, prolonging time to relengthening. MO disrupted Ca2+ homeostasis in fetal cardiomyocytes, increasing intracellular Ca2+ and inducing cellular Ca2+ insensitivity. The Ca2+-release channel was impaired, but Ca2+ uptake was unaffected by MO. The upstream kinases that phosphorylate the Ca2+-release channelryanodine receptor-2, PKA, and calmodulin-dependent protein kinase IIwere activated in MO fetuses. Contractile dysfunction was associated with an increased ratio of myosin heavy chain (MHC)- to MHC- and upregulated cardiac troponin (cTn)-T and tropomyosin, as well as cTn-I phosphorylation. In summary, this is the first characterization of the effects of MO on fetal cardiomyocyte contractility. Our findings indicate that MO impairs fetal cardiomyocyte contractility through altered intracellular Ca2+ handling, overloading fetal cardiomyocyte intracellular Ca2+ and aberrant myofilament protein composition. These mechanisms may contribute to developmental programming by MO of offspring cardiac function and predisposition to later life cardiovascular disease in the offspring.Wang, Q., Zhu, C., Sun, M., Maimaiti, R., Ford, S. P., Nathanielsz, P. W., Ren, J., Guo, W. Maternal obesity impairs fetal cardiomyocyte contractile function in sheep.	[Wang, Qiurong; Ford, Stephen P.; Nathanielsz, Peter W.; Guo, Wei] Univ Wyoming, Ctr Study Fetal Programming, Laramie, WY 82071 USA; [Wang, Qiurong; Zhu, Chaoqun; Sun, Mingming; Maimaiti, Rexiati; Ford, Stephen P.; Nathanielsz, Peter W.; Guo, Wei] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Ren, Jun; Guo, Wei] Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming; University of Wyoming	Guo, W (corresponding author), Univ Wyoming, 1000 E Univ Ave, Laramie, WY 82071 USA.	wguo3@uwyo.edu	Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783; Nathanielsz, Peter/0000-0001-8410-6280; Wang, Qiurong/0000-0001-9654-9126	National Institutes of Health (NIH), National Institute of General Medical Sciences [GMSP20GM103432]; American Heart Association [16BGIA27790136]; U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Project [1009266]; NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development [1R01HD070096-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103432] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Project; NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. John F. Odhiambo, Dr. Adel Ghnenis, Dr. Shuyi Wang, Dr. Guorong Ruan, Dr. Zhilong Chen, Christopher Pankey, Dallas Sturdevant, and Ashley Smith (all from the University of Wyoming) for performing tissue collection and sheep necropsy; and Pan Chen (University of Wyoming) for help in obtaining immunofluorescence microscopic images of fetal sheep LV sections. The authors dedicate this work to the late Stephen P. Ford, M.D., a cofounder of the University of Wyoming Fetal Programming Center. This work was supported by National Institutes of Health (NIH), National Institute of General Medical Sciences Grant GMSP20GM103432; American Heart Association, Beginning Grant-in-Aid award to 16BGIA27790136 (to W.G.); a U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Project 1009266 (to WG); NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant 1R01HD070096-01A1 (to S.P.F. and P.W.N.). The authors declare no conflicts of interest.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P671; Anderson MS, 2001, AM J PHYSIOL-REG I, V281, pR1256, DOI 10.1152/ajpregu.2001.281.4.R1256; Anderson MS, 2001, AM J PHYSIOL-REG I, V281, pR1545, DOI 10.1152/ajpregu.2001.281.5.R1545; ANDERSON PAW, 1995, CIRC RES, V76, P681, DOI 10.1161/01.RES.76.4.681; Anthony RV, 2003, REPRODUCTION, P183; Barbera A, 2000, AM J PHYSIOL-REG I, V279, pR1157, DOI 10.1152/ajpregu.2000.279.4.R1157; BARRY WH, 1993, CIRCULATION, V87, P1806, DOI 10.1161/01.CIR.87.6.1806; Bers Donald M, 2006, Biochem J, V396, pe1; Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383; Brite J, 2014, INT J OBESITY, V38, P878, DOI 10.1038/ijo.2013.244; Cai GJ, 2014, AM J OBSTET GYNECOL, V211, P91, DOI 10.1016/j.ajog.2014.03.028; Chandrashekhar Y, 1999, J AM COLL CARDIOL, V34, P594, DOI 10.1016/S0735-1097(99)00222-3; CLUSIN WT, 1983, LANCET, V1, P272, DOI 10.1016/S0140-6736(83)91688-4; DIGIACOMO JE, 1990, AM J PHYSIOL, V259, pE506; Dong F, 2005, GROWTH HORM IGF RES, V15, P291, DOI 10.1016/j.ghir.2005.05.003; Dong F, 2008, J NUTR BIOCHEM, V19, P409, DOI 10.1016/j.jnutbio.2007.06.003; Dong ML, 2013, J MOL CELL CARDIOL, V55, P111, DOI 10.1016/j.yjmcc.2012.08.023; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Fan XJ, 2011, J NUTR BIOCHEM, V22, P30, DOI 10.1016/j.jnutbio.2009.11.006; Fernandez-Twinn DS, 2012, ENDOCRINOLOGY, V153, P5961, DOI 10.1210/en.2012-1508; Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009; George LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-75; Ghnenis AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189977; Giraud GD, 2006, ENDOCRINOLOGY, V147, P3643, DOI 10.1210/en.2006-0061; Gomes AV, 2004, J BIOL CHEM, V279, P49579, DOI 10.1074/jbc.M407340200; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Griffiths EJ, 2000, CARDIOVASC RES, V47, P116, DOI 10.1016/S0008-6363(00)00061-4; Guo W, 2018, INT J BIOL SCI, V14, P369, DOI 10.7150/ijbs.24117; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200; HAY WW, 1995, REPROD FERT DEVELOP, V7, P365, DOI 10.1071/RD9950365; HAY WW, 1989, AM J PHYSIOL, V256, pE704; HIGGINS TJC, 1980, J MOL CELL CARDIOL, V12, P909, DOI 10.1016/0022-2828(80)90059-0; Hillemeier MM, 2011, J WOMENS HEALTH, V20, P703, DOI 10.1089/jwh.2010.2397; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE968, DOI 10.1152/ajpendo.00434.2010; Ingul CB, 2016, ULTRASOUND OBST GYN, V47, P433, DOI 10.1002/uog.14841; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; Jonker SS, 2007, AM J PHYSIOL-REG I, V292, pR913, DOI 10.1152/ajpregu.00484.2006; JOSEPHSON RA, 1991, J BIOL CHEM, V266, P2354; Kandadi MR, 2013, J NUTR BIOCHEM, V24, P1982, DOI 10.1016/j.jnutbio.2013.07.003; Karachaliou M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.038; Katz AM, 2000, CIRCULATION, V102, P69; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; KITAZAWA T, 1984, J PHYSIOL-LONDON, V355, P635, DOI 10.1113/jphysiol.1984.sp015443; Klabunde R. E., 2010, CARDIOVASCULAR PHYSL; Ku PM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-57; Kushnir A, 2010, P NATL ACAD SCI USA, V107, P10274, DOI 10.1073/pnas.1005843107; KUSUOKA H, 1987, J CLIN INVEST, V79, P950, DOI 10.1172/JCI112906; Lee KK, 2015, HYPERTENSION, V66, P938, DOI 10.1161/HYPERTENSIONAHA.115.05920; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Limesand SW, 2007, AM J PHYSIOL-ENDOC M, V293, pE1716, DOI 10.1152/ajpendo.00459.2007; Loche E, 2018, CARDIOVASC RES, V114, P1372, DOI 10.1093/cvr/cvy082; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; MALHOTRA A, 1995, MOL CELL BIOCHEM, V151, P165, DOI 10.1007/BF01322339; MCAULIFFE JJ, 1991, PEDIATR RES, V29, P580, DOI 10.1203/00006450-199106010-00012; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; MORGAN JP, 1991, NEW ENGL J MED, V325, P625; Morrison JL, 2007, AM J PHYSIOL-REG I, V293, pR306, DOI 10.1152/ajpregu.00798.2006; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Nathanielsz PW, 2013, NUTR REV, V71, pS78, DOI 10.1111/nure.12062; National Research Council, 1985, NUTR REQ SHEEP; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Norby FL, 2002, AM J PHYSIOL-ENDOC M, V283, pE658, DOI 10.1152/ajpendo.00003.2002; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ogden Cynthia L, 2007, NCHS Data Brief, P1; Rabadan-Diehl C, 2013, J DEV ORIG HLTH DIS, V4, P3, DOI 10.1017/S2040174412000487; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Rankin J, 2010, INT J OBESITY, V34, P1371, DOI 10.1038/ijo.2010.66; Reiffert SU, 1998, BIOCHEMISTRY-US, V37, P13516, DOI 10.1021/bi980280j; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Ren J, 2008, CRIT CARE MED, V36, P2106, DOI 10.1097/CCM.0b013e31817bf925; Ren Jun, 2001, Biological Procedures Online, V3, P43, DOI 10.1251/bpo22; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Sucharov CC, 2004, MOL CELL BIOL, V24, P8705, DOI 10.1128/MCB.24.19.8705-8715.2004; Sundgren NC, 2003, AM J PHYSIOL-REG I, V285, pR1481, DOI 10.1152/ajpregu.00232.2003; Sundgren NC, 2003, J PHYSIOL-LONDON, V548, P881, DOI 10.1113/jphysiol.2003.038778; Thompson M, 2000, PEDIATR RES, V47, P669, DOI 10.1203/00006450-200005000-00019; Thornburg KL, 2015, J DEV ORIG HLTH DIS, V6, P366, DOI 10.1017/S2040174415001300; Toemen L, 2016, INT J OBESITY, V40, P1070, DOI 10.1038/ijo.2016.86; Tuersunjiang N, 2013, AM J PHYSIOL-ENDOC M, V305, pE868, DOI 10.1152/ajpendo.00117.2013; Uchinoumi H, 2016, J MOL CELL CARDIOL, V98, P62, DOI 10.1016/j.yjmcc.2016.06.007; Vassalle M, 2004, J BIOMED SCI, V11, P542, DOI 10.1159/000079666; Vega CC, 2015, INT J OBESITY, V39, P712, DOI 10.1038/ijo.2013.150; Wallace JM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1233, DOI 10.1152/ajpendo.00294.2007; Wang JY, 2010, FASEB J, V24, P2066, DOI 10.1096/fj.09-142315; Wang KCW, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.100388; Wang QR, 2016, PHARMACOL RES, V111, P357, DOI 10.1016/j.phrs.2016.06.024; Wang QR, 2014, TOXICOL SCI, V142, P6, DOI 10.1093/toxsci/kfu158; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; World Health Organization,, 2015, OB OV; Yin ZY, 2015, BBA-MOL BASIS DIS, V1852, P47, DOI 10.1016/j.bbadis.2014.11.003; Zambrano E, 2010, J PHYSIOL-LONDON, V588, P1791, DOI 10.1113/jphysiol.2010.190033; Zambrano E, 2013, NUTR REV, V71, pS42, DOI 10.1111/nure.12068; Zhang S, 2011, PROG BIOPHYS MOL BIO, V106, P307, DOI 10.1016/j.pbiomolbio.2010.12.004; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633	105	24	25	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2587	2598		10.1096/fj.201800988R	http://dx.doi.org/10.1096/fj.201800988R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30289749	Green Submitted, Green Published			2022-12-28	WOS:000457296600084
J	Carneros, D; Santamaria, EM; Larequi, E; Velez-Ortiz, JM; Reboredo, M; Mancheno, U; Perugorria, MJ; Navas, P; Romero-Gomez, M; Prieto, J; Hervas-Stubbs, S; Bustos, M				Carneros, David; Santamaria, Eva M.; Larequi, Eduardo; Miguel Velez-Ortiz, Jose; Reboredo, Mercedes; Mancheno, Uxua; Jesus Perugorria, Maria; Navas, Placido; Romero-Gomez, Manuel; Prieto, Jesus; Hervas-Stubbs, Sandra; Bustos, Matilde			Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization	FASEB JOURNAL			English	Article						interleukin-6; gp130; M1; IL-6; STAT3	ALTERNATIVE ACTIVATION; ONCOSTATIN M; INTERLEUKIN-6; RECEPTOR; INJURY; IL-6; EXPRESSION; MICE; ENDOTOXEMIA; MECHANISMS	Macrophages play a central role in tissue remodeling, repair, and resolution of inflammation. Macrophage polarization to M1 or M2 activation status may determine the progression or resolution of the inflammatory response. We have previously reported that cardiotrophin-1 (CT-1) displays both cytoprotective and metabolic activities. The role of CT-1 in inflammation remains poorly understood. Here, we employed recombinant CT-1 (rCT-1) and used CT-1-null mice and myeloid-specific CT-1 transgenic mice to investigate whether CT-1 might play a role in the modulation of the inflammatory response. We observed that CT-1 deficiency was associated with enhanced release of inflammatory mediators and with stronger activation of NF-kappa B in response to LPS, whereas the inflammatory response was attenuated in CT-1 transgenic mice or by administering rCT-1 to wild-type animals prior to LPS challenge. We found that CT-1 promoted IL-6 expression only by nonhematopoietic cells, whereas LPS up-regulated IL-6 expression in both hematopoietic and nonhematopoietic cells. Notably, rCT-1 inhibited LPS-mediated soluble IL-6R induction. Using IL-6(-/-) mice, we showed that rCT-1 inhibited LPS-induced TNF-alpha and IFN-gamma response in an IL-6-independent manner. Importantly, we demonstrated that CT-1 primes macrophages for IL-4-dependent M2 polarization by inducing IL-4 receptor expression. Mechanistic analyses showed that the signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 axis mediates this effect. Our findings support the notion that CT-1 is a critical regulator of inflammation and suggest that rCT-1 could be a molecule with potential therapeutic application in inflammatory conditions.-Carneros, D., Santamaria, E. M., Larequi, E., Velez-Ortiz, J. M., Reboredo, M., Mancheno, U., Perugorria, M. J., Navas, P., Romero-Gomez, M., Prieto, J., Hervas-Stubbs, S., Bustos, M. Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization.	[Carneros, David; Miguel Velez-Ortiz, Jose; Romero-Gomez, Manuel; Bustos, Matilde] Univ Seville, Virgen del Rocio Univ Hosp, CSIC, Inst Biomed Seville IBiS, Avda Manuel Siurot S-N, Seville 41013, Spain; [Santamaria, Eva M.; Larequi, Eduardo; Reboredo, Mercedes; Prieto, Jesus] Univ Navarra, Ctr Appl Med Res CIMA, Div Hepatol, Pamplona, Spain; [Mancheno, Uxua; Hervas-Stubbs, Sandra] Univ Navarra, Ctr Appl Med Res CIMA, Div Immunol & Immunotherapy, Pamplona, Spain; [Santamaria, Eva M.; Reboredo, Mercedes; Jesus Perugorria, Maria; Romero-Gomez, Manuel; Prieto, Jesus] Inst Salud Carlos III, CIBEREHD, Madrid, Spain; [Navas, Placido] Inst Salud Carlos III, CIBERER, Madrid, Spain; [Mancheno, Uxua; Hervas-Stubbs, Sandra] Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain; [Jesus Perugorria, Maria] Univ Basque Country, Donostia Univ Hosp, Biodonostia Hlth Res Inst, UPV EHU, San Sebastian, Spain; [Navas, Placido] Univ Pablo Olavide, CSIC, CABD, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Bustos, M (corresponding author), Univ Seville, Virgen del Rocio Univ Hosp, CSIC, Inst Biomed Seville IBiS, Avda Manuel Siurot S-N, Seville 41013, Spain.	mbustos-ibis@us.es	NAVAS, PLACIDO/R-5943-2019; Romero-Gomez, Manuel/L-8030-2014; Santa María Monasteri, Eva/Z-4537-2019; Hervas-Stubbs, Sandra/C-9053-2018; Mancheno, Uxua/D-2873-2018	NAVAS, PLACIDO/0000-0002-4115-7966; Romero-Gomez, Manuel/0000-0001-8494-8947; Santa María Monasteri, Eva/0000-0003-0629-6175; Hervas-Stubbs, Sandra/0000-0003-3391-1516; Bustos, Matilde/0000-0003-2306-9548; Velez-Ortiz, Jose Miguel/0000-0002-4861-3856; Mancheno, Uxua/0000-0003-1533-0371	Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion Sanitaria [PI13/01851, PI16/01791, PI15/02027]; Federacion Espanola de Enfermedades Raras (FEDER) funds	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Federacion Espanola de Enfermedades Raras (FEDER) funds	The authors thank Dr. Bettina Holtmann (University of Wurzburg, Wurzburg, Germany) who donated the CT-1-null mice. The authors also thank Dr. J. Vitorica (University of Seville) for providing the IL-4 knockout mice. This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) and the Fondo de Investigacion Sanitaria (PI13/01851 and PI16/01791 to M.B. and PI15/02027 to S.H.-S.). Centro de Investigacion Biomedica en Red Enfermedades Raras (CIBERER) and Enfermedades Hepaticas y Digestivas (CIBEREHD) are initiatives of the ISCIII of Spain, supported by Federacion Espanola de Enfermedades Raras (FEDER) funds. M.B. and S.H.-S. share senior authorship. The authors declare no conflicts of interest.	Aguilar-Melero P, 2013, J SURG RES, V181, pE83, DOI 10.1016/j.jss.2012.07.046; Alisi A, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8162421; Appari M, 2018, ANTIOXID REDOX SIGN, V29, P297, DOI 10.1089/ars.2017.7060; Benigni F, 1996, AM J PATHOL, V149, P1847; Beraza N, 2005, HEPATOLOGY, V41, P460, DOI 10.1002/hep.20590; Castano D, 2014, J HEPATOL, V60, P1017, DOI 10.1016/j.jhep.2013.12.012; Cichy J, 1997, J IMMUNOL, V159, P5648; Cron L, 2016, J EXP BIOL, V219, P259, DOI 10.1242/jeb.129213; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Garcia-Cenador MB, 2013, TRANSPLANTATION, V96, P1034, DOI 10.1097/TP.0b013e3182a74db4; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lopez-Yoldi M, 2015, CYTOKINE GROWTH F R, V26, P523, DOI 10.1016/j.cytogfr.2015.07.009; Makita N, 2015, INT IMMUNOL, V27, P131, DOI 10.1093/intimm/dxu090; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mauer J, 2015, TRENDS IMMUNOL, V36, P92, DOI 10.1016/j.it.2014.12.008; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; McCormick SM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00549; McLaughlin T, 2017, J CLIN INVEST, V127, P5, DOI 10.1172/JCI88876; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Pal M, 2014, IMMUNOL CELL BIOL, V92, P331, DOI 10.1038/icb.2014.16; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; Perugorria MJ, 2013, HEPATOLOGY, V57, P1238, DOI 10.1002/hep.26108; Pulido EJ, 1999, J SURG RES, V84, P240, DOI 10.1006/jsre.1999.5655; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Richards CD, 1996, J INTERF CYTOK RES, V16, P69, DOI 10.1089/jir.1996.16.69; Rose-John S, 2017, CLIN PHARMACOL THER, V102, P591, DOI 10.1002/cpt.782; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tanimoto K, 2005, CIRC J, V69, P1412, DOI 10.1253/circj.69.1412; Vinay DS, 2004, J IMMUNOL, V173, P4218, DOI 10.4049/jimmunol.173.6.4218; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; WARING PM, 1995, P NATL ACAD SCI USA, V92, P1337, DOI 10.1073/pnas.92.5.1337; Weber MA, 2005, LAB INVEST, V85, P276, DOI 10.1038/labinvest.3700216; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yan CG, 2013, FASEB J, V27, P2967, DOI 10.1096/fj.12-225797; Zaki OS, 2018, INFLAMMATION, V41, P20, DOI 10.1007/s10753-017-0659-5; Zhao JP, 2016, AM J PHYSIOL-LUNG C, V311, pL868, DOI 10.1152/ajplung.00281.2016	45	6	6	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7578	7587		10.1096/fj.201801563R	http://dx.doi.org/10.1096/fj.201801563R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30892966				2022-12-28	WOS:000476114200073
J	Kim, HK; Garcia, AB; Siu, E; Tilstam, P; Das, R; Roberts, S; Leng, L; Bucala, R				Kim, Hee Kyung; Garcia, Alvaro Baeza; Siu, Edwin; Tilstam, Pathricia; Das, Rita; Roberts, Scott; Leng, Lin; Bucala, Richard			Macrophage migration inhibitory factor regulates innate gamma delta T-cell responses via IL-17 expression	FASEB JOURNAL			English	Article						MIF; TSST-1; M; bovis	SHOCK-SYNDROME TOXIN-1; FACTOR GENE; FACTOR MIF; LISTERIA-MONOCYTOGENES; CRITICAL MEDIATOR; PRIMARY INFECTION; DISEASE SEVERITY; IMMUNE-RESPONSE; PROTECTIVE ROLE; ALPHA-BETA	T cells expressing invariant gamma delta antigen receptors (gamma delta T cells) bridge innate and adaptive immunity and facilitate barrier responses to pathogens. Macrophage migration inhibitory factor (MIF) is an upstream mediator of host defense that up-regulates the expression of pattern recognition receptors and sustains inflammatory responses by inhibiting activation-induced apoptosis in monocytes and macrophages. Surprisingly, Mif(-/-) gamma delta T cells, when compared with wild type, were observed to produce >10-fold higher levels of the proinflammatory cytokine IL-17 after stimulation with gram-positive exotoxins. High-IL-17 expression was associated with the characteristic features of IL-17-producing gamma delta T (gamma delta 17) cells, including expression of IL-23R, IL-1R1, and the transcription factors ROR gamma t and Sox13. In the gram-positive model of shock mediated by toxic shock syndrome toxin (TSST-1), Mif(-/-) mice succumbed to death more quickly with increased pulmonary neutrophil accumulation and higher production of cytokines, including IL-1 beta and IL-23. Mif(-/-) gamma delta T cells also produced high levels of IL-17 in response to Mycobacterium lipomannan, and depletion of gamma delta T cells improved survival from acutely lethal Mycobacterium infection or TSST-1 administration. These data indicate that MIF deficiency is associated with a compensatory amplification of gamma delta 17 cell responses, with implications for innate immunity and IL-17-mediated pathology in situations such as gram-positive toxic shock or Mycobacterium infection.-Kim, H. K., Garcia, A. B., Siu, E., Tilstam, P., Das, R., Roberts, S., Leng, L., Bucala, R. Macrophage migration inhibitory factor regulates innate gamma delta T-cell responses via IL-17 expression.	[Kim, Hee Kyung; Garcia, Alvaro Baeza; Siu, Edwin; Tilstam, Pathricia; Das, Rita; Roberts, Scott; Leng, Lin] Yale Sch Med, Dept Med, New Haven, CT USA; [Das, Rita; Bucala, Richard] Yale Sch Med, Dept Pathol, New Haven, CT USA	Yale University; Yale University	Bucala, R (corresponding author), Yale Univ, Sch Med, TAC S521,POB 208031,300 Cedar St, New Haven, CT 06520 USA.	richard.bucala@yale.edu	Garcia, Alvaro Baeza/AAB-7387-2021	Garcia, Alvaro Baeza/0000-0001-6032-7847; Leng, Lin/0000-0002-0605-358X; Siu, Edwin/0000-0003-1046-2279	U.S. National Institutes of Health (NIH) [AR049610, HL130669]; Arthritis Foundation [548970]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049610] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institutes of Health (NIH) Grants AR049610 (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and HL130669 (National Heart, Lung, and Blood Institute) and Arthritis Foundation Grant 548970. The authors declare no conflicts of interest.	Akitsu A, 2018, IMMUNOLOGY, V155, P418, DOI 10.1111/imm.12993; Avau A, 2014, ARTHRITIS RHEUMATOL, V66, P1340, DOI 10.1002/art.38359; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Benedek G, 2017, P NATL ACAD SCI USA, V114, pE8421, DOI 10.1073/pnas.1712288114; Bezdek S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02262; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Das R, 2013, P NATL ACAD SCI USA, V110, pE2997, DOI 10.1073/pnas.1301128110; De Benedetti F, 2003, ARTHRITIS RHEUM, V48, P1398, DOI 10.1002/art.10882; Dieli F, 2003, J IMMUNOL, V170, P463, DOI 10.4049/jimmunol.170.1.463; Doernberg S, 2011, CYTOKINE, V53, P292, DOI 10.1016/j.cyto.2010.12.010; Donn R, 2002, ARTHRITIS RHEUM-US, V46, P2402, DOI 10.1002/art.10492; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Eberl M, 2002, IMMUNOLOGY, V106, P200, DOI 10.1046/j.1365-2567.2002.01414.x; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666; Floret D, 2001, ARCH PEDIATRIE, V8, p70S; Fogli LK, 2013, J IMMUNOL, V191, P3100, DOI 10.4049/jimmunol.1301360; Fox RJ, 2018, NEW ENGL J MED, V379, P846, DOI 10.1056/NEJMoa1803583; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; IKEJIMA T, 1988, J INFECT DIS, V158, P1017, DOI 10.1093/infdis/158.5.1017; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kessel C, 2017, ARTHRITIS RHEUMATOL, V69, P1480, DOI 10.1002/art.40099; Kevill KA, 2008, J IMMUNOL, V180, P601, DOI 10.4049/jimmunol.180.1.601; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P975, DOI 10.1002/art.20885; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEE J, 1995, J IMMUNOL, V155, P2158; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGill JL, 2014, J IMMUNOL, V192, P2756, DOI 10.4049/jimmunol.1302567; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Ness-Schwickerath KJ, 2011, CELL MOL LIFE SCI, V68, P2371, DOI 10.1007/s00018-011-0700-z; Nigrovic PA, 2014, ARTHRITIS RHEUMATOL, V66, P1405, DOI 10.1002/art.38615; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; PARSONNET J, 1985, J INFECT DIS, V151, P514, DOI 10.1093/infdis/151.3.514; Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285; Renner P, 2012, FASEB J, V26, P907, DOI 10.1096/fj.11-195065; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; Savva A, 2016, P NATL ACAD SCI USA, V113, P3597, DOI 10.1073/pnas.1520727113; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sreih A, 2011, ARTHRITIS RHEUM-US, V63, P3942, DOI 10.1002/art.30624; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; UCHIYAMA T, 1986, MICROBIOL IMMUNOL, V30, P469, DOI 10.1111/j.1348-0421.1986.tb02973.x; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; USAMI J, 1995, IMMUNOLOGY, V86, P199; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yende S, 2009, FASEB J, V23, P2403, DOI 10.1096/fj.09-129445; YOO ZB, 1995, J IMMUNOL, V155, P5483; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zachariadis O, 2006, INFECT IMMUN, V74, P1837, DOI 10.1128/IAI.74.3.1837-1845.2006	62	5	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6919	6932		10.1096/fj.201802433R	http://dx.doi.org/10.1096/fj.201802433R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30817226	Green Published			2022-12-28	WOS:000476114200020
J	Li, XF; Yu, XJ; Chen, XB; Liu, ZZ; Wang, GQ; Li, C; Wong, EYM; Sham, MH; Tang, J; He, JF; Xiong, W; Liu, ZY; Huang, PB				Li, Xiaofen; Yu, Xiaojie; Chen, Xibing; Liu, Zhengzhao; Wang, Guangqin; Li, Chao; Wong, Elaine Y. M.; Sham, Mai Har; Tang, Jie; He, Jufang; Xiong, Wei; Liu, Zhiyong; Huang, Pingbo			Localization of TMC1 and LHFPL5 in auditory hair cells in neonatal and adult mice	FASEB JOURNAL			English	Article						mechanotransduction channel; mechanotransduction complex; tip link; stereocilia; hearing	MECHANOTRANSDUCTION MACHINERY; ESSENTIAL COMPONENT; INNER; PROTOCADHERIN-15; DEAFNESS; CHANNEL; MUTATIONS; DOMINANT; COMPLEX; PROTEIN	The channel that governs mechanotransduction (MT) by hair cells in the inner ear has been investigated intensively for 4 decades, but its precise molecular composition remains enigmatic. Transmembrane channel-like protein 1 (TMC1) was recently identified as a component of the MT channel, and lipoma HMGIC fusion partner-like 5 (LHFPL5) is considered to be part of the MT complex and may functionally couple the tip link to the MT channel. As components of the MT complex, TMC1 and LHFPL5 are expected to localize at the lower end of the tip link in hair cells, a notion generally supported by previous studies on neonatal mice. However, the localization of these 2 proteins, particularly in the hair cells of adult mice, remains incompletely elucidated. Because determination of TMC1 and LHFPL5 localization at distinct developmental stages is essential for understanding their function and regulation, we used several approaches to examine the localization of these proteins in neonatal and adult hair cells in the mouse. We report several notable findings: 1) TMC1 and LHFPL5 predominantly localize at the tip of the shorter rows of stereocilia in neonatal hair cells, which largely verifies the previously published findings in neonatal hair cells; 2) LHFPL5 persists in the hair bundle of hair cells after postnatal day (P)7, which clarifies the previously reported unexpected absence of LHFPL5 after P7 and supports the view that LHFPL5 is a permanent component in the MT complex; and 3) TMC1 and LHFPL5 remain at the tip of the shorter rows of stereocilia in adult outer hair cells, but in adult inner hair cells, TMC1 is uniformly distributed in both the tallest row and the shorter rows of stereocilia, whereas LHFPL5 is uniformly distributed in the shorter rows of stereocilia. These findings raise intriguing questions regarding the turnover rate, regulation, additional functions, and functional interaction of TMC1 and LHFPL5. Our study confirms the previous findings in neonatal hair cells and reveals several previously unidentified aspects of TMC1 and LHFPL5 localization in more mature hair cells.-Li, X., Yu, X., Chen, X., Liu, Z., Wang, G., Li, C., Wong, E. Y. M., Sham, M. H., Tang, J., He, J., Xiong, W., Liu, Z., Huang, P. Localization of TMC1 and LHFPL5 in auditory hair cells in neonatal and adult mice.	[Li, Xiaofen; Huang, Pingbo] HKUST, Dept Chem & Biol Engn, Hong Kong, Peoples R China; [Yu, Xiaojie; Chen, Xibing; Liu, Zhengzhao; Huang, Pingbo] HKUST, Div Life Sci, Hong Kong, Peoples R China; [Huang, Pingbo] HKUST, State Key Lab Mol Neurosci, Hong Kong, Peoples R China; [Huang, Pingbo] HKUST, Shenzhen Res Inst, Hong Kong, Peoples R China; [Wang, Guangqin; Li, Chao; Liu, Zhiyong] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Wong, Elaine Y. M.; Sham, Mai Har] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China; [Wong, Elaine Y. M.] Ear Sci Inst Australia, Subiaco, WA, Australia; [Tang, Jie] Southern Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou, Guangdong, Peoples R China; [He, Jufang] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Xiong, Wei] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; University of Hong Kong; Ear Science Institute Australia; Southern Medical University - China; City University of Hong Kong; Tsinghua University	Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Kowloon, Clear Water Bay, Hong Kong, Peoples R China.	bohuangp@ust.hk	Xiong, Wei/AAY-5944-2020; Tang, Jie/GNW-2318-2022; Sham, Mai Har/AAX-3781-2020; Liu, Zheng-Zhao/ADR-0038-2022; yu, xiaojie/GSI-9676-2022	Xiong, Wei/0000-0002-2784-7696; Sham, Mai Har/0000-0003-1179-7839; Liu, Zheng-Zhao/0000-0003-0659-2775; WANG, GUANGQIN/0000-0002-8613-7619; Huang, Pingbo/0000-0002-4560-8760; Li, Xiaofen/0000-0002-2079-9038; Tang, Jie/0000-0001-7882-4462	Hong Kong Research Grants Council [GRF16111616, GRF16102417]; Innovation and Technology Commission [ITCPD/17-9]; Chinese Major National Science and Technology Project [2017YFA0103900/2017YFA0103901]; National Natural Science Foundation of China [81771012, 31571080, 3181101148]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Innovation and Technology Commission; Chinese Major National Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Hong Kong Research Grants Council (GRF16111616 and GRF16102417 to P.H.); in part, by the Innovation and Technology Commission (ITCPD/17-9); by the Chinese Major National Science and Technology Project 2017YFA0103900/2017YFA0103901 (to Zhiyong Liu); and by the National Natural Science Foundation of China (Grants 81771012 to Zhiyong Liu, and 31571080, and 3181101148 to W.X.). The authors declare no conflicts of interest.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Beurg M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04589-8; Beurg M, 2015, P NATL ACAD SCI USA, V112, P1589, DOI 10.1073/pnas.1420906112; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Fang J, 2012, GENESIS, V50, P124, DOI 10.1002/dvg.20810; Giese APJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00061-1; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Hu WB, 2017, ELIFE, V6, DOI 10.7554/eLife.28021; Hughes AJ, 2014, NAT METHODS, V11, P749, DOI [10.1038/NMETH.2992, 10.1038/nmeth.2992]; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kim KX, 2013, J GEN PHYSIOL, V141, P141, DOI 10.1085/jgp.201210913; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Kurima K, 2015, CELL REP, V12, P1606, DOI 10.1016/j.celrep.2015.07.058; Li C, 2018, HEARING RES, V364, P12, DOI 10.1016/j.heares.2018.04.006; Liu XP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11508; Liu ZY, 2015, SCIENCE, V350, P317, DOI 10.1126/science.aad1886; Longo-Guess CM, 2007, MAMM GENOME, V18, P646, DOI 10.1007/s00335-007-9049-x; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mahendrasingam S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185285; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Michel V, 2017, EMBO MOL MED, V9, P1711, DOI 10.15252/emmm.201708087; Pan BF, 2018, NEURON, V99, P736, DOI 10.1016/j.neuron.2018.07.033; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Pepermans E, 2014, EMBO MOL MED, V6, P984, DOI 10.15252/emmm.201403976; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Xiong W, 2012, CELL, V151, P1283, DOI 10.1016/j.cell.2012.10.041; Zhao B, 2014, NEURON, V84, P954, DOI 10.1016/j.neuron.2014.10.041	32	11	11	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6838	6851		10.1096/fj.201802155RR	http://dx.doi.org/10.1096/fj.201802155RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30808210				2022-12-28	WOS:000476114200014
J	Zhang, JJ; Kong, XQ; Wang, ZM; Gao, XF; Ge, Z; Gu, Y; Ye, P; Chao, YL; Zhu, LL; Li, XB; Chen, SL				Zhang, Junjie; Kong, Xiangquan; Wang, Zhimei; Gao, Xiaofei; Ge, Zhen; Gu, Yue; Ye, Peng; Chao, Yuelin; Zhu, Linlin; Li, Xiaobo; Chen, Shaoliang			AMP-activated protein kinase regulates glycocalyx impairment and macrophage recruitment in response to low shear stress	FASEB JOURNAL			English	Article						Na+-H+ exchanger 1; hyaluronidase 2; endothelial inflammatory	ENDOTHELIAL-CELL GLYCOCALYX; B ACTIVATION; HYALURONAN; INCREASES; ATHEROSCLEROSIS; DECREASE; ISOFORM	Low shear stress (LSS) increases degradation of the endothelial glycocalyx, leading to production of endothelial inflammation and atherosclerosis. However, the underlying mechanisms of how LSS diminishes the endothelial glycocalyx remain unclear. We showed that LSS inactivated AMPK, enhanced Na+-H+ exchanger (NHE)1 activity, and induced glycocalyx degradation. Activation of AMPK prevented LSS-induced NHE1 activity and endothelial glycocalyx impairment. We further identified hyaluronidase 2 (HYAL2) as a mediator of endothelial glycocalyx impairment in HUVECs exposed to LSS. Inactivation of AMPK by LSS up-regulates the activity of HYAL2, which acts downstream of NHE1. We characterized a left common carotid artery partial ligation (PL) model of LSS in C57BL/6 mice. The results showed decreased expression of hyaluronan (HA) in the endothelial glycocalyx and decreased thickness of the endothelial glycocalyx in PL mice. Pharmacological activation of AMPK by ampkinone not only attenuated glycocalyx impairment due to HA degradation but also blocked vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 expression increase and macrophage recruitment in the endothelia of PL mice. Our results revealed that AMPK dephosphorylation induced by LSS activates NHE1 and HYAL2 to promote HA degradation and glycocalyx injury, which may contribute to endothelial inflammatory reaction and macrophage recruitment.-Zhang, J., Kong, X., Wang, Z., Gao, X., Ge, Z., Gu, Y., Ye, P., Chao, Y., Zhu, L., Li, X., Chen, S. AMP-activated protein kinase regulates glycocalyx impairment and macrophage recruitment in response to low shear stress.	[Zhang, Junjie; Kong, Xiangquan; Wang, Zhimei; Gao, Xiaofei; Ge, Zhen; Gu, Yue; Ye, Peng; Chao, Yuelin; Zhu, Linlin; Li, Xiaobo; Chen, Shaoliang] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China	Nanjing Medical University	Chen, SL (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China.	chmengx@126.com			National Natural Science Foundation of China [91439118, 91639303, 81770441, 81770342]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. Xiaonan Ma (China Pharmaceutical University, Nanjing, China) and Dr. Yulin Gu (3Think) for expert technical assistance. This work was supported by the National Natural Science Foundation of China under Grants 91439118 (to S.C.), 91639303 (to S.C.), 81770441 (to S.C.), and 81770342 (to J.Z.). The authors declare no conflicts of interest.	Annecke T, 2012, J INVEST SURG, V25, P162, DOI 10.3109/08941939.2011.618524; Bai K, 2012, J R SOC INTERFACE, V9, P2290, DOI 10.1098/rsif.2011.0901; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Cancel LM, 2016, ATHEROSCLEROSIS, V252, P136, DOI 10.1016/j.atherosclerosis.2016.07.930; Chao YL, 2018, J CELL PHYSIOL, V233, P1384, DOI 10.1002/jcp.26016; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; DESJARDINS C, 1990, AM J PHYSIOL, V258, pH647, DOI 10.1152/ajpheart.1990.258.3.H647; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; Dixit M, 2008, CARDIOVASC RES, V77, P160, DOI 10.1093/cvr/cvm017; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Gordts PLSM, 2014, CELL METAB, V20, P813, DOI 10.1016/j.cmet.2014.09.016; Gouverneur M, 2006, J INTERN MED, V259, P393, DOI 10.1111/j.1365-2796.2006.01625.x; Gouverneur M, 2006, AM J PHYSIOL-HEART C, V290, pH458, DOI 10.1152/ajpheart.00592.2005; Grundmann S, 2009, J CELL MOL MED, V13, P3463, DOI 10.1111/j.1582-4934.2009.00735.x; Hendus-Altenburger R, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0252-7; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Jinadasa T, 2014, J BIOL CHEM, V289, P20879, DOI 10.1074/jbc.M114.555284; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Kong XQ, 2016, MOL BIOL CELL, V27, P3972, DOI 10.1091/mbc.E16-04-0241; Maroski J, 2011, EXP PHYSIOL, V96, P977, DOI 10.1113/expphysiol.2010.056051; Merino H, 2013, MOL CELL BIOCHEM, V372, P267, DOI 10.1007/s11010-012-1468-7; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Okayasu T, 2008, LIFE SCI, V82, P884, DOI 10.1016/j.lfs.2008.02.002; Padberg JS, 2014, ATHEROSCLEROSIS, V234, P335, DOI 10.1016/j.atherosclerosis.2014.03.016; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Soltes L, 2006, BIOMACROMOLECULES, V7, P659, DOI 10.1021/bm050867v; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Suzuki K, 2008, AM J HYPERTENS, V21, P451, DOI 10.1038/ajh.2008.6; Tsai IY, 2011, SOFT MATTER, V7, P3599, DOI 10.1039/c0sm01353f; van den Berg BM, 2009, PFLUG ARCH EUR J PHY, V457, P1199, DOI 10.1007/s00424-008-0590-6; van den Berg BM, 2006, AM J PHYSIOL-HEART C, V290, pH915, DOI 10.1152/ajpheart.00051.2005; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x	40	11	11	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7202	7212		10.1096/fj.201801869RRR	http://dx.doi.org/10.1096/fj.201801869RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30860864	Bronze			2022-12-28	WOS:000476114200044
J	Kienzl, P; Polacek, R; Reithofer, M; Reitermaier, R; Hagenbach, P; Tajpara, PA; Vierhapper, M; Gschwandtner, M; Mildner, M; Jahn-Schmid, B; Elbe-Burger, A				Kienzl, Philip; Polacek, Romana; Reithofer, Manuel; Reitermaier, Rene; Hagenbach, Pia; Tajpara, Pooj A.; Vierhapper, Martin; Gschwandtner, Maria; Mildner, Michael; Jahn-Schmid, Beatrice; Elbe-Buerger, Adelheid			The cytokine environment influence on human skin-derived T cells	FASEB JOURNAL			English	Article						T-cell plasticity; IL-9; neutrophil; IL-8; CXCL13	TRANSCRIPTION FACTOR PU.1; TGF-BETA; T(H)9 CELLS; MAST-CELLS; IL-9; EXPRESSION; DIFFERENTIATION; RECEPTOR; INTERLEUKIN-4; LYMPHOCYTES	Skin resident T cells provide immediate immunologic responses at their specific location and play a role in the pathogenesis of skin diseases such as psoriasis. Recently, IL-9-producing T cells were described as a major T-cell subtype present in the skin, but knowledge on the biology and in situ regulation of this T-cell subtype is scarce. Here, we investigated the cytokine influence on skin T cells with focus on IL-9-producing T cells because a better understanding of their biology may identify novel therapeutic approaches. Healthy human skin biopsies were cultured either in the presence of IL-2, IL-4, and TGF- [T helper (T-h)9-promoting condition (T(h)9-PC)] or IL-2 and IL-15 [standard condition (SC)]. Paired analysis of enzymatically isolated skin T cells and emigrated T cells after 4 wk of skin culture showed significant alterations of T-cell phenotypes, cytokine production, and IL-9-producing T-cell frequency. RNA sequencing analysis revealed differentially regulated pathways and identified CXCL8 and CXCL13 as top up-regulated genes in T(h)9-PC compared with SC. Functionally supernatant of stimulated skin-derived T cells, CXCL8 and CXCL13 increased neutrophil survival. We report that the cytokine environment alters skin-derived T-cell phenotype and functional properties.Kienzl, P., Polacek, R., Reithofer, M., Reitermaier, R., Hagenbach, P., Tajpara, P., Vierhapper, M., Gschwandtner, M., Mildner, M. Jahn-Schmid, B., Elbe-Burger, A. The cytokine environment influence on human skin-derived T cells.	[Kienzl, Philip; Polacek, Romana; Reitermaier, Rene; Hagenbach, Pia; Tajpara, Pooj A.; Elbe-Buerger, Adelheid] Med Univ Vienna, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria; [Reithofer, Manuel; Jahn-Schmid, Beatrice] Med Univ Vienna, Inst Pathophysiol & Allergy Res, Vienna, Austria; [Vierhapper, Martin] Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria; [Gschwandtner, Maria; Mildner, Michael] Med Univ Vienna, Res Div Biol & Pathobiol Skin, Dept Dermatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Elbe-Burger, A (corresponding author), Med Univ Vienna, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	adelheid.elbe-buerger@meduniwien.ac.at		Mildner, Michael/0000-0002-6892-925X; Lazki-Hagenbach, Pia/0000-0003-0521-7981; Kienzl, Philip/0000-0002-0114-6904; Reithofer, Manuel/0000-0003-2845-1826	Austrian Science Fund (FWK) [DK W1248-B30]	Austrian Science Fund (FWK)	The authors thank Wolfgang Bauer, Barbel Reininger, Johanna Strobl, Christopher Schuster (Medical University of Vienna), and Robert Sabat (University Hospital Charite, Berlin, Germany) for excellent help and valuable discussions and for providing reagents. The authors thank Rachel Clark, Jessica E. Teague (Harvard University, Boston, MA, USA), and Emmanuella Guenova (University of Zurich, Zurich, Switzerland) for the skin explant protocols. The authors thank Christian Schneeberger and Iveta Yotova (Medical Univerity of Vienna) for access to the BD FacsVerse instrument. RNA sequencing was carried out by Markus Jeitler and Martin Bilban (Medical University of Vienna). The authors also thank Barbara Bohle and Dominika Polak (Medical University of Vienna) for the human blood neutrophil isolation protocol. This work was supported by the Austrian Science Fund (FWF; DK W1248-B30). The authors declare no conflicts of interest.	Aratani Y, 2018, ARCH BIOCHEM BIOPHYS, V640, P47, DOI 10.1016/j.abb.2018.01.004; Bang K, 2005, EXP DERMATOL, V14, P391, DOI 10.1111/j.0906-6705.2005.00294.x; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; BOS JD, 1986, IMMUNOL TODAY, V7, P235, DOI 10.1016/0167-5699(86)90111-8; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2017, SEMIN IMMUNOPATHOL, V39, P47, DOI 10.1007/s00281-016-0607-8; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; El Kebir D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00060; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; GEROSA F, 1992, CELL IMMUNOL, V141, P342, DOI 10.1016/0008-8749(92)90153-G; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Gschwandtner M, 2018, J INVEST DERMATOL, V138, P1318, DOI 10.1016/j.jid.2018.01.002; Guo S, 2014, CELL DEATH DIFFER, V21, P888, DOI 10.1038/cdd.2014.9; Hebel K, 2011, J IMMUNOL, V187, P5627, DOI 10.4049/jimmunol.1003998; Hirahara K, 2013, J ALLERGY CLIN IMMUN, V131, P1276, DOI 10.1016/j.jaci.2013.03.015; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Humblin E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01070-w; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kaplan MH, 2017, SEMIN IMMUNOPATHOL, V39, P11, DOI 10.1007/s00281-016-0600-2; Kieffer JD, 2001, BIOCHEM BIOPH RES CO, V285, P577, DOI 10.1006/bbrc.2001.5230; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Liu J, 2014, J INVEST DERMATOL, V134, P1903, DOI 10.1038/jid.2014.61; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Michalak-Stoma A, 2011, EUR CYTOKINE NETW, V22, P160, DOI 10.1684/ecn.2011.0294; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Norii M, 2006, ACTA MED OKAYAMA, V60, P149; PARTRIDGE M, 1989, BRIT J CANCER, V60, P542, DOI 10.1038/bjc.1989.310; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Polak D, 2019, J ALLERGY CLIN IMMUN, V143, P1143, DOI 10.1016/j.jaci.2018.06.005; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009; Salgado FJ, 2002, IMMUNOL CELL BIOL, V80, P138, DOI 10.1046/j.1440-1711.2002.01055.x; Salimi M, 2016, CLIN EXP DERMATOL, V41, P552, DOI 10.1111/ced.12802; Schlapbach C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007828; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schuster C, 2009, J EXP MED, V206, P169, DOI 10.1084/jem.20081747; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Stassen M, 2000, J IMMUNOL, V164, P5549, DOI 10.4049/jimmunol.164.11.5549; Stassen M, 2007, MOL IMMUNOL, V44, P926, DOI 10.1016/j.molimm.2006.03.019; STREILEIN JW, 1983, J INVEST DERMATOL, V80, pS12, DOI 10.1111/1523-1747.ep12536743; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Teague TK, 1997, J IMMUNOL, V158, P5791; van der Graaf CAA, 2006, CLIN VACCINE IMMUNOL, V13, P423, DOI 10.1128/CVI.13.3.423-425.2006; Vieyra-Garcia PA, 2016, CLIN CANCER RES, V22, P3328, DOI 10.1158/1078-0432.CCR-15-1784; Wang DH, 2004, J IMMUNOL, V172, P214, DOI 10.4049/jimmunol.172.1.214; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Yoshie O, 2015, INT IMMUNOL, V27, P11, DOI 10.1093/intimm/dxu079; Zhu JF, 2015, CYTOKINE, V75, P14, DOI 10.1016/j.cyto.2015.05.010	65	3	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6514	6525		10.1096/fj.201801416R	http://dx.doi.org/10.1096/fj.201801416R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807238	hybrid, Green Published			2022-12-28	WOS:000466932600055
J	Qin, S; Dorschner, RA; Masini, I; Lavoie-Gagne, O; Stahl, PD; Costantini, TW; Baird, A; Eliceiri, BP				Qin, Shu; Dorschner, Robert A.; Masini, Irene; Lavoie-Gagne, Ophelia; Stahl, Philip D.; Costantini, Todd W.; Baird, Andrew; Eliceiri, Brian P.			TBC1D3 regulates the payload and biological activity of extracellular vesicles that mediate tissue repair	FASEB JOURNAL			English	Article						macrophage activation; wound healing; exosome; RabGAP; foreign body response	CELL-DERIVED EXOSOMES; DENDRITIC CELLS; INFLAMMATORY RESPONSE; TRANSFERRIN RECEPTOR; IMMUNE-RESPONSES; IN-VITRO; ANTIGEN; MACROPHAGES; INDUCE; MACROPINOCYTOSIS	Healthy repair of cutaneous injury is a coordinated response of inflammatory cells, secreted factors, and biologically active extracellular vesicles (EVs). Although constitutive release of EVs into biologic fluids is a hallmark of cultured cells and tumors, their payload and biologic activity appears to be tightly regulated. We show that Tre-2/Bub2/Cdc16 (TBC1) domain family member 3 (TBC1D3) drives the release of an EV population that causes a decrease in phosphorylation of the transcription factor signal transducer and activator of transcription 3 in naive recipient cells. To explore the biologic activity of EVs in vivo, we used a mouse model of sterile subcutaneous inflammation to determine the payload and biologic activity of EVs released into the microenvironment by committed myeloid lineages and stroma. Expression of TBC1D3 in macrophages altered the payload of their released EVs, including RNA-binding proteins, molecular motors, and proteins regulating secretory pathways. A wound-healing model demonstrated that closure was delayed by EVs released under the control of TBC1D3. We show that modulating the secretory repertoire of a cell regulates EV payload and biologic activity that affects outcomes in tissue repair and establishes a strategy for modifying EVs mediating specific biologic responses.Qin, S., Dorschner, R. A., Masini, I., Lavoie-Gagne, O., Stahl, P. D., Costantini, T. W., Baird, A., Eliceiri, B. P. TBC1D3 regulates the payload and biological activity of extracellular vesicles that mediate tissue repair.	[Qin, Shu; Dorschner, Robert A.; Masini, Irene; Lavoie-Gagne, Ophelia; Costantini, Todd W.; Baird, Andrew; Eliceiri, Brian P.] Univ Calif San Diego, Dept Surg, 212 Dickinson St,MC8236, La Jolla, CA 92103 USA; [Qin, Shu] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Plast Surg, Shanghai, Peoples R China; [Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	University of California System; University of California San Diego; Shanghai Jiao Tong University; Washington University (WUSTL)	Eliceiri, BP (corresponding author), Univ Calif San Diego, Dept Surg, 212 Dickinson St,MC8236, La Jolla, CA 92103 USA.	beliceiri@ucsd.edu	Lavoie-Gagne, Ophelie/AAG-1784-2021	Lavoie-Gagne, Ophelie/0000-0002-1197-747X; Eliceiri, Brian/0000-0003-1811-1916	U.S. National Institutes of Health, National Institute of General Medical Sciences [1R01GM121530]; UCSD Academic Senate; UCSD Department of Surgery Reinvestment Fund; Shock Society; Surgical Infection Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121530] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021724] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCSD Academic Senate; UCSD Department of Surgery Reinvestment Fund; Shock Society; Surgical Infection Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Ann-Marie Hageny [University of California-San Diego (UCSD)] for expert technical support, and Dr. Antonio DeMaio (UCSD) for use of the Nanoparticle Tracking Analysis Instrument; Dr. Majid Ghassemian (UCSD Biomolecular and Proteomics Mass Spectrometry Facility) provided expert support and analysis for the proteomics studies; Dr. John Nolan (Scintillon Institute, San Diego, CA, USA) provided expert advice on the design of vesicle flow cytometry assays; Dr. Chen Kong (Washington University) helped with consultation on the molecular biology of TBC1D3; and Dr. Lisa A. Hannan provided expert editorial review of the study. Research was supported by operating grants from the U.S. National Institutes of Health, National Institute of General Medical Sciences (1R01GM121530), the UCSD Academic Senate, the UCSD Department of Surgery Reinvestment Fund, the Shock Society, and the Surgical Infection Society. The authors declare no conflicts of interest.	Abramowicz A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205496; Aline F, 2004, INFECT IMMUN, V72, P4127, DOI 10.1128/IAI.72.7.4127-4137.2004; Baird A, 2016, WOUND REPAIR REGEN, V24, P1004, DOI 10.1111/wrr.12471; Bakhtyar N, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0921-2; Bianco Nicole R, 2007, Methods Mol Biol, V380, P443; Bianco NR, 2009, ARTHRITIS RHEUM-US, V60, P380, DOI 10.1002/art.24229; Cheng L, 2017, INT J BIOL SCI, V13, P723, DOI 10.7150/ijbs.19642; Choi EW, 2018, EXP DERMATOL, V27, P1170, DOI 10.1111/exd.13451; Colino J, 2007, INFECT IMMUN, V75, P220, DOI 10.1128/IAI.01217-06; Colino J, 2006, J IMMUNOL, V177, P3757, DOI 10.4049/jimmunol.177.6.3757; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Deskins DL, 2012, JOVE-J VIS EXP, V62, P3885; Dorayappan KDP, 2018, ONCOGENE, V37, P3806, DOI 10.1038/s41388-018-0189-0; Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Frangsmyr L, 2005, MOL HUM REPROD, V11, P35, DOI 10.1093/molehr/gah129; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Garzetti L, 2014, J LEUKOCYTE BIOL, V95, P817, DOI 10.1189/jlb.0913485; Geiger A, 2015, BIOCHEM BIOPH RES CO, V467, P303, DOI 10.1016/j.bbrc.2015.09.166; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; Hao SG, 2006, CELL MOL IMMUNOL, V3, P205; Hao SG, 2007, IMMUNOLOGY, V120, P90, DOI 10.1111/j.1365-2567.2006.02483.x; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Harding CV, 2013, J CELL BIOL, V200, P367, DOI 10.1083/jcb.201212113; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Kim SH, 2006, MOL THER, V13, P289, DOI 10.1016/j.ymthe.2005.09.015; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; Kim YJ, 2017, BIOCHEM BIOPH RES CO, V493, P1102, DOI 10.1016/j.bbrc.2017.09.056; Kojima M, 2018, FASEB J, V32, P97, DOI 10.1096/fj.201700488R; Kojima M, 2017, J TRAUMA ACUTE CARE, V82, P42, DOI 10.1097/TA.0000000000001296; Latterich M, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-8; Lee HD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35250; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mittelbrunn M, 2015, TRAFFIC, V16, P327, DOI 10.1111/tra.12258; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nolan JP, 2018, METHODS MOL BIOL, V1678, P79, DOI 10.1007/978-1-4939-7346-0_5; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Patel DB, 2018, BIOTECHNOL ADV, V36, P2051, DOI 10.1016/j.biotechadv.2018.09.001; Peche H, 2006, AM J TRANSPLANT, V6, P1541, DOI 10.1111/j.1600-6143.2006.01344.x; Peche H, 2003, TRANSPLANTATION, V76, P1503, DOI 10.1097/01.TP.0000092494.75313.38; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pitt JM, 2014, J IMMUNOL, V193, P1006, DOI 10.4049/jimmunol.1400703; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Quah BJC, 2005, BLOOD CELL MOL DIS, V35, P94, DOI 10.1016/j.bcmd.2005.05.002; Rak J, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00021; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P1364, DOI 10.1189/jlb.0208092; Shenoda BB, 2016, CLIN MED INSIGHTS-PA, V9, P1, DOI 10.4137/CPath.S39925; Silva AM, 2017, EUR J PHARM SCI, V98, P86, DOI 10.1016/j.ejps.2016.09.017; Speth JM, 2016, J IMMUNOL, V196, P5112, DOI 10.4049/jimmunol.1502153; Stahl PD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.289pe59; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Truman JP, 2012, IMMUNOLOGY, V136, P30, DOI 10.1111/j.1365-2567.2012.03552.x; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Viaud S, 2010, CANCER RES, V70, P1281, DOI 10.1158/0008-5472.CAN-09-3276; Viaud S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004942; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Wainszelbaum MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031225; Yang XJ, 2011, J SURG RES, V171, P826, DOI 10.1016/j.jss.2010.05.021; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhao H, 2018, DIABETES, V67, P235, DOI 10.2337/db17-0356	74	14	14	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6129	6139		10.1096/fj.201802388R	http://dx.doi.org/10.1096/fj.201802388R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30715917	Green Published, Bronze			2022-12-28	WOS:000466932600027
J	Wang, M; Hu, J; Yan, LL; Yang, YP; He, M; Wu, M; Li, Q; Gong, W; Yang, Y; Wang, Y; Handy, DE; Lu, B; Hao, CM; Wang, QH; Li, YM; Hu, RG; Stanton, RC; Zhang, ZY				Wang, Meng; Hu, Ji; Yan, Linling; Yang, Yeping; He, Min; Wu, Meng; Li, Qin; Gong, Wei; Yang, Yang; Wang, Yi; Handy, Diane E.; Lu, Bin; Hao, Chuanming; Wang, Qinghua; Li, Yiming; Hu, Ronggui; Stanton, Robert C.; Zhang, Zhaoyun			High glucose-induced ubiquitination of G6PD leads to the injury of podocytes	FASEB JOURNAL			English	Article						diabetic kidney disease; G6PD; reactive oxygen species; ubiquitin proteasome pathway; von Hippel-Lindau	CAPILLARY ENDOTHELIAL FENESTRATION; INCREASED OXIDATIVE STRESS; PENTOSE-PHOSPHATE PATHWAY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY; DIABETIC-NEPHROPATHY; INSULIN-RESISTANCE; KIDNEY-DISEASE; GROWTH-FACTOR; OVEREXPRESSION; PROTEIN	Oxidative stress contributes substantially to podocyte injury, which plays an important role in the development of diabetic kidney disease. The mechanism of hyperglycemia-induced oxidative stress in podocytes is not fully understood. Glucose-6-phosphate dehydrogenase (G6PD) is critical in maintaining NADPH, which is an important cofactor for the antioxidant system. Here, we hypothesized that high glucose induced ubiquitination and degradation of G6PD, which injured podocytes by reactive oxygen species (ROS) accumulation. We found that G6PD protein expression was decreased in kidneys of both diabetic patients and diabetic rodents. G6PD activity was also reduced in diabetic mice. Overexpressing G6PD reversed redox imbalance and podocyte apoptosis induced by high glucose and palmitate. Inhibition of G6PD with small interfering RNA induced podocyte apoptosis. In kidneys of G6PD-deficient mice, podocyte apoptosis was significantly increased. Interestingly, high glucose had no effect on G6PD mRNA expression. Decreased G6PD protein expression was mediated by the ubiquitin proteasome pathway. We found that the von Hippel-Lindau (VHL) protein, an E3 ubiquitin ligase subunit, directly bound to G6PD and degraded G6PD through ubiquitylating G6PD on K-366 and K-403. In summary, our data suggest that high glucose induces ubiquitination of G6PD by VHL E3 ubiquitin ligase, which leads to ROS accumulation and podocyte injury.Wang, M., Hu, J., Yan, L., Yang, Y., He, M., Wu, M., Li, Q., Gong, W., Yang, Y., Wang, Y., Handy, D. E., Lu, B., Hao, C., Wang, Q., Li, Y., Hu, R., Stanton, R. C., Zhang, Z. High glucose-induced ubiquitination of G6PD leads to the injury of podocytes.	[Wang, Meng; Yang, Yeping; He, Min; Gong, Wei; Wang, Yi; Lu, Bin; Wang, Qinghua; Li, Yiming; Zhang, Zhaoyun] Fudan Univ, Div Endocrinol & Metab, Shanghai, Peoples R China; [Hao, Chuanming] Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai, Peoples R China; [Hu, Ji; Wu, Meng] Soochow Univ, Affiliated Hosp 2, Dept Endocrinol, Suzhou, Peoples R China; [Yan, Linling] First Peoples Hosp Taicang, Dept Endocrinol, Suzhou, Peoples R China; [Li, Qin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Yang, Yang; Hu, Ronggui] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Handy, Diane E.] Harvard Med Sch, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Stanton, Robert C.] Harvard Med Sch, Res Div, Joslin Diabet Ctr, Boston, MA 02115 USA; [Li, Yiming] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Endocrinol & Metab, Toronto, ON, Canada	Fudan University; Fudan University; Soochow University - China; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Zhang, ZY (corresponding author), Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	zhaoyunzhang@fudan.edu.cn	Stanton, Robert C/AAG-7584-2020; Wang, Qinghua/GVT-3252-2022	Stanton, Robert C/0000-0002-3056-1277; Handy, Diane/0000-0002-4310-8527	National Natural Science Foundation of China [81370938, 81471041, 81400796]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Zhihong Yang at the Joslin Diabetes Center for supplying podocytes. The authors thank Min Zhang (Huashan Hospital) for cell culturing guidance. The authors thank Wei Huang (Fudan University) for helpful comments with the manuscript. The authors also acknowledge the excellent support from all members of R.H.'s laboratory. This study was supported by the National Natural Science Foundation of China (Grants 81370938, 81471041, and 81400796). The authors declare no conflicts of interest.	Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Arias-Gonzalez L, 2013, NEOPLASIA, V15, P649, DOI 10.1593/neo.121896; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Chen JC, 2015, J AM SOC NEPHROL, V26, P1115, DOI 10.1681/ASN.2014020192; Chen JX, 2015, CELL SIGNAL, V27, P2314, DOI 10.1016/j.cellsig.2015.08.011; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Damjanovic SS, 2016, EXP MOL PATHOL, V101, P323, DOI 10.1016/j.yexmp.2016.11.003; Diaz-Flores M, 2006, LIFE SCI, V78, P2601, DOI 10.1016/j.lfs.2005.10.022; Ding M, 2013, AM J PHYSIOL-RENAL, V304, pF120, DOI 10.1152/ajprenal.00416.2012; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Filosa S, 2003, BIOCHEM J, V370, P935, DOI 10.1042/BJ20021614; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Hartner A, 2014, BBA-MOL BASIS DIS, V1842, P558, DOI 10.1016/j.bbadis.2014.01.001; Jiang XS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42764; Johnson SA, 2015, AM J PHYSIOL-RENAL, V309, pE807, DOI 10.1152/ajprenal.00266.2015; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirkman HN, 1999, J BIOL CHEM, V274, P13908, DOI 10.1074/jbc.274.20.13908; Kitada M, 2016, INT J NEPHROL RENOV, V9, P279, DOI 10.2147/IJNRD.S103784; Kumar PA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00151; Kuo WY, 1998, FREE RADICAL BIO MED, V24, P1130, DOI 10.1016/S0891-5849(97)00413-9; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee JW, 2011, ENDOCRINOLOGY, V152, P793, DOI 10.1210/en.2010-0606; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; Leopold JA, 2003, ARTERIOSCL THROM VAS, V23, P411, DOI 10.1161/01.ATV.0000056744.26901.BA; Li CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089233; Lin JS, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0735-5; Liu WJ, 2016, KIDNEY INT, V90, P1023, DOI 10.1016/j.kint.2016.06.018; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Mahmood DFD, 2013, ANTIOXID REDOX SIGN, V19, P1266, DOI 10.1089/ars.2012.4757; Mima A, 2012, FASEB J, V26, P2963, DOI 10.1096/fj.11-202994; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; PRETSCH W, 1988, BIOCHEM GENET, V26, P89, DOI 10.1007/BF00555491; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; Scarpa A, 2017, NATURE, V543, P65, DOI 10.1038/nature21063; Siddiqi FS, 2016, J AM SOC NEPHROL, V27, P2021, DOI 10.1681/ASN.2014090898; Stanton RC, 2011, CURR DIABETES REP, V11, P330, DOI 10.1007/s11892-011-0196-9; Sun J, 2017, BIOCHEM BIOPH RES CO, V483, P318, DOI 10.1016/j.bbrc.2016.12.145; Tao RK, 2017, NAT METHODS, V14, P720, DOI 10.1038/nmeth.4306; Thilo F, 2014, BIOCHEM BIOPH RES CO, V450, P312, DOI 10.1016/j.bbrc.2014.05.116; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Xu J, 2012, CELL STRESS CHAPERON, V17, P485, DOI 10.1007/s12192-012-0325-7; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731; Xu YZ, 2005, AM J PHYSIOL-RENAL, V289, pF1040, DOI 10.1152/ajprenal.00076.2005; YOSHIMOTO K, 1983, J BIOL CHEM, V258, P2355; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064601, 10.1371/journal.pone.0071243, 10.1371/journal.pone.0067564]; Zhang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049128; Zhang ZY, 2010, FASEB J, V24, P1497, DOI 10.1096/fj.09-136572; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643	63	20	22	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6296	6310		10.1096/fj.201801921R	http://dx.doi.org/10.1096/fj.201801921R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30785802	Bronze			2022-12-28	WOS:000466932600039
J	Fan, HH; Yu, IS; Lin, YH; Wang, SY; Liaw, YH; Chen, PL; Yang, TL; Lin, SW; Chen, YT				Fan, Hsiang-Hsuan; Yu, I-Shing; Lin, Yin-Hung; Wang, Shin-Yu; Liaw, Ying-Hsuan; Chen, Pei-Lung; Yang, Tsung-Lin; Lin, Shu-Wha; Chen, You-Tzung			P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies	FASEB JOURNAL			English	Article						genome editing; somatic mutagenesis; genetic screen	P53 GAIN; GROWTH-CHARACTERISTICS; IN-VITRO; TUMORIGENESIS; MODEL; MICE; DEFICIENT; MUTATIONS; CRISPR/CAS9; GENOMICS	The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 technology facilitates somatic genome editing to reveal cooperative genetic interactions at the cellular level without extensive breeding between different mutant animals. Here we propose a transgenic inducible Cas9 effector-CRISPR mutagen (ICE CRIM) mouse model in which CRISPR/Cas9-mediated somatic mutagenesis events can occur in response to Cre expression. The well-known tumor suppressor gene, Trp53, and 2 important DNA mismatch repair genes, Mlh1 and Msh2, were selected to be our somatic mutagenesis targets. Amplicon-based sequencing was performed to validate the editing efficiency and to identify the mutant allelic series. Crossed with various Cre lines, the Trp53 ICE CRIM alleles were activated to generate targeted cancer gene somatic or germ line mutant variants. We provide experimental evidence to show that an activated ICE CRIM can mutate both targeted alleles within a cell. Simultaneous disruption of multiple genes was also achieved when there were multiple single-guide RNA expression cassettes embedded within an activated ICE CRIM. Our mouse model can be used to generate mutant pools in vivo, which enables a functional screen to be performed in situ. Our results also provide evidence to support a monoclonal origin of hematopoietic neoplasms and to indicate that DNA mismatch repair deficiency accelerates tumorigenesis in Trp53 mutant genetic background.	[Fan, Hsiang-Hsuan; Lin, Yin-Hung; Wang, Shin-Yu; Liaw, Ying-Hsuan; Chen, Pei-Lung; Chen, You-Tzung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Grad Inst Med Genom & Prote, Taipei, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Lab Anim Ctr, Taipei, Taiwan; [Yang, Tsung-Lin; Chen, You-Tzung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Shu-Wha] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan; [Yang, Tsung-Lin; Chen, You-Tzung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan; [Lin, Shu-Wha; Chen, You-Tzung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Ctr Genom Med, Taipei, Taiwan; [Chen, Pei-Lung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan; [Chen, Pei-Lung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Yang, Tsung-Lin] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Yu, IS (corresponding author), Natl Taiwan Univ, Coll Med, Lab Anim Ctr, 10F 2,Xuzhou Rd, Taipei 100, Taiwan.; Chen, YT (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, 5F 2,Xuzhou Rd, Taipei 100, Taiwan.	isyu@ntu.edu.tw; youtzungchen@ntu.edu.tw	; Chen, Pei-Lung/A-3520-2010	CHEN, YOU-TZUNG/0000-0001-6510-3420; Chen, Pei-Lung/0000-0002-5640-3074	Ministry of Science and Technology [104-2311-B-002-016, 105-2311-B-002-006, 106-2320-B-002-048-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The authors are thankful for the technical services provided by the Transgenic Mouse Model Core Facility of the National Core Facility for Biopharmaceuticals, Ministry of Science and Technology (Taipei, Taiwan). The authors also appreciate technical assistance provided by Dr. Cheng-Yen Huang (The First Core Laboratory, Branch Office of Medical Research and Development, National Taiwan University College of Medicine). This work was supported by the Ministry of Science and Technology (Grants 104-2311-B-002-016, 105-2311-B-002-006, and 106-2320-B-002-048-MY2 to Y.-T.C.). The authors declare no conflicts of interest.	Alemany A, 2018, NATURE, V556, P108, DOI 10.1038/nature25969; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Beil-Wagner J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21377; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00654-2; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Halperin SO, 2018, NATURE, V560, P248, DOI 10.1038/s41586-018-0384-8; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, ONCOGENE, V8, P2457; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Jones SN, 1996, P NATL ACAD SCI USA, V93, P14106, DOI 10.1073/pnas.93.24.14106; Knudson CM, 2001, CANCER RES, V61, P659; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kubicka S, 2002, DIGEST DIS SCI, V47, P114, DOI 10.1023/A:1013275706401; Kucera GT, 1996, DEV BIOL, V173, P162, DOI 10.1006/dbio.1996.0014; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee MK, 2008, J CELL SCI, V121, P1899, DOI 10.1242/jcs.022822; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Masciarelli S, 2014, ONCOGENE, V33, P1601, DOI 10.1038/onc.2013.106; McCarthy A, 2007, J PATHOL, V211, P389, DOI 10.1002/path.2124; MILLER CW, 1992, CANCER RES, V52, P1695; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PURDIE CA, 1994, ONCOGENE, V9, P603; Roper J, 2017, NAT BIOTECHNOL, V35, P569, DOI 10.1038/nbt.3836; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Shafarenko M, 1997, CARCINOGENESIS, V18, P1423, DOI 10.1093/carcin/18.7.1423; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Slatter TL, 2010, CELL DEATH DIFFER, V17, P540, DOI 10.1038/cdd.2009.136; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; South AP, 2014, J INVEST DERMATOL, V134, P2630, DOI 10.1038/jid.2014.154; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Toft NJ, 2002, ONCOGENE, V21, P6299, DOI 10.1038/sj.onc.1205727; Ueki K, 2002, CLIN CANCER RES, V8, P196; van Oers JMM, 2014, ONCOGENE, V33, P3939, DOI 10.1038/onc.2013.365; Voskamp P, 2012, INT J CANCER, V131, P1267, DOI 10.1002/ijc.27391; Weber J, 2015, P NATL ACAD SCI USA, V112, P13982, DOI 10.1073/pnas.1512392112; Whibley C, 2010, J BIOL CHEM, V285, P11326, DOI 10.1074/jbc.M109.064444; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Young LC, 2007, CARCINOGENESIS, V28, P2131, DOI 10.1093/carcin/bgm153; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646	69	1	1	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5571	5584		10.1096/fj.201802027R	http://dx.doi.org/10.1096/fj.201802027R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30640520	Bronze			2022-12-28	WOS:000462888500075
J	Liu, MH; Wang, Z; Ren, MM; Yang, X; Liu, BY; Qi, H; Yu, M; Song, S; Chen, SY; Liu, L; Zhang, Y; Zou, JH; Zhu, WG; Yin, YX; Luo, JY				Liu, Minghui; Wang, Zhe; Ren, Mengmeng; Yang, Xin; Liu, Boya; Qi, Hao; Yu, Miao; Song, Shi; Chen, Shuaiyi; Liu, Lu; Zhang, Yu; Zou, Junhua; Zhu, Wei-Guo; Yin, Yuxin; Luo, Jianyuan			SIRT4 regulates PTEN stability through IDE in response to cellular stresses	FASEB JOURNAL			English	Article						sirtuin 4; protein stability; insulin degrading enzyme; autophagy	INSULIN-DEGRADING ENZYME; TUMOR-SUPPRESSOR; PHOSPHATASE-ACTIVITY; INDUCED AUTOPHAGY; NUCLEAR PTEN; MALONYL-COA; METABOLISM; UBIQUITINATION; GENE; SIRTUINS	Tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) plays a critical role in regulating cell survival, cell growth, and proliferation by antagonizing the PI3K-AKT-mTOR pathway. The regulatory mechanism of PTEN protein is still not completely understood. Here, we found that Sirtuin 4 (SIRT4) interacts with PTEN and regulates its stability. Overexpression of SIRT4 in cells causes down-regulation of PTEN. This regulation is independent of PTEN acetylation and ubiquitination. We further found that SIRT4 degrades PTEN through lysosome pathway mediated by insulin degrading enzyme (IDE). SIRT4 bridges PTEN and IDE for degradation in response to nutritional starvation stresses. Our results suggest that when cells were exposed to nutritional starvation, SIRT4 was induced and cooperated with IDE to degrade PTEN; low levels of PTEN promote cells to survive from cellular stress. Our findings provide a new regulation of PTEN in response to cellular stresses.	[Liu, Minghui; Wang, Zhe; Ren, Mengmeng; Yang, Xin; Liu, Boya; Qi, Hao; Yu, Miao; Song, Shi; Chen, Shuaiyi; Liu, Lu; Zhang, Yu; Zou, Junhua; Luo, Jianyuan] Peking Univ, Ctr Med Genet, Dept Med Genet, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Beijing, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen, Peoples R China; [Luo, Jianyuan] Univ Maryland, Sch Med, Dept Med & Res Technol, Baltimore, MD 21201 USA	Peking University; Peking University; Shenzhen University; University System of Maryland; University of Maryland Baltimore	Luo, JY (corresponding author), Peking Univ, Ctr Med Genet, Dept Med Genet, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	luojianyuan@bjmu.edu.cn	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Zhu, Wei-Guo/0000-0001-8385-6581; Yang, Xin/0000-0003-0222-5839	National Natural Science Foundation of China [81671389, 81874147, 81621063, 81270427, 81471405]; National Research Program of China (973 Program) [2013CB530801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (81671389, 81874147, 81621063, 81270427, 81471405) and the National Research Program of China (973 Program, 2013CB530801). The authors declare no conflicts of interest.	Adey NB, 2000, CANCER RES, V60, P35; Alam N, 1998, BIOCHEM J, V334, P233, DOI 10.1042/bj3340233; Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Araki S, 2015, CIRCULATION, V132, P1081, DOI 10.1161/CIRCULATIONAHA.114.014821; Cao JX, 2013, MOL CELL, V51, P409, DOI 10.1016/j.molcel.2013.08.010; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cho CS, 2017, HEPATOLOGY, V66, P700, DOI 10.1002/hep.29271; De Melo J, 2014, INT J MOL MED, V34, P835, DOI 10.3892/ijmm.2014.1840; de Tullio MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059113; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Georgescu MM, 2000, CANCER RES, V60, P7033; Guarente L, 2000, GENE DEV, V14, P1021; Guo J, 2017, SCI REP-UK, V7, DOI 10.1038/srep39899; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; He LZ, 2010, J CLIN INVEST, V120, P2094, DOI 10.1172/JCI40778; Ho J, 2015, METHODS, V77-78, P104, DOI 10.1016/j.ymeth.2015.01.006; Huynh FK, 2018, J INHERIT METAB DIS, V41, P59, DOI 10.1007/s10545-017-0069-8; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; KIRSCHNER RJ, 1983, J BIOL CHEM, V258, P967; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee JT, 2013, CELL RES, V23, P552, DOI 10.1038/cr.2013.27; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Liang H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14771; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Ho L, 2013, AGING-US, V5, P835, DOI 10.18632/aging.100616; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malaney P, 2013, MOL BIOSYST, V9, P2877, DOI 10.1039/c3mb70267g; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; Salcher S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0661-4; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Steneberg P, 2013, DIABETES, V62, P2004, DOI 10.2337/db12-1045; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wood JG, 2018, P NATL ACAD SCI USA, V115, P1564, DOI 10.1073/pnas.1720673115; Yang X, 2018, CANCER RES, V78, P372, DOI 10.1158/0008-5472.CAN-17-1912; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	58	22	22	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5535	5547		10.1096/fj.201801987R	http://dx.doi.org/10.1096/fj.201801987R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30649986				2022-12-28	WOS:000462888500072
J	Grane-Boladeras, N; Williams, D; Tarmakova, Z; Stevanovic, K; Villani, LA; Mehrabi, P; Siu, KWM; Pastor-Anglada, M; Coe, IR				Grane-Boladeras, Natalia; Williams, Declan; Tarmakova, Zlatina; Stevanovic, Katarina; Villani, Linda A.; Mehrabi, Pedram; Siu, K. W. Michael; Pastor-Anglada, Marcal; Coe, Imogen R.			Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1	FASEB JOURNAL			English	Article						MYTH; NanoBiT; hENT1; hENT2; adenosine	PROTEIN-KINASE CK2; ADENOSINE; ENT1; MODULATION; NANOLUC; GLUCOSE; CELLS	Equilibrative nucleoside transporters (ENTs) translocate nucleosides and nucleobases across plasma membranes, as well as a variety of anti-cancer, -viral, and -parasite nucleoside analogs. They are also key members of the purinome complex and regulate the protective and anti-inflammatory effects of adenosine. Despite their important role, little is known about the mechanisms involved in their regulation. We conducted membrane yeast 2-hybrid and coimmunoprecipitation studies and identified, for the first time to our knowledge, the existence of protein-protein interactions between human ENT1 and ENT2 (hENT1 and hENT2) proteins in human cells and the formation of hetero- and homo-oligomers at the plasma membrane and the submembrane region. The use of NanoLuc Binary Technology allowed us to analyze changes in the oligomeric status of hENT1 and hENT2 and how they rapidly modify the uptake profile for nucleosides and nucleobases and allow cells to respond promptly to external signals or changes in the extracellular environment. These changes in hENTs oligomerization are triggered by PKC activation and subsequent action of protein phosphatase 1.Grane-Boladeras, N., Williams, D., Tarmakova, Z., Stevanovic, K., Villani, L. A., Mehrabi, P., Siu, K. W. M., Pastor-Anglada, M., Coe, I. R. Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1.	[Grane-Boladeras, Natalia; Tarmakova, Zlatina; Stevanovic, Katarina; Coe, Imogen R.] Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 0A1, Canada; [Grane-Boladeras, Natalia; Pastor-Anglada, Marcal] Univ Barcelona, Inst Biomed, Dept Biochem & Mol Biomed, Barcelona, Spain; [Grane-Boladeras, Natalia; Pastor-Anglada, Marcal] Natl Biomed Res Inst Liver & Gastrointestinal Dis, Barcelona, Spain; [Williams, Declan; Siu, K. W. Michael] York Univ, Dept Chem, Toronto, ON, Canada; [Villani, Linda A.; Mehrabi, Pedram] York Univ, Dept Biol, Toronto, ON, Canada	Toronto Metropolitan University; University of Barcelona; York University - Canada; York University - Canada	Grane-Boladeras, N (corresponding author), Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 0A1, Canada.	nataliagrane@ryerson.ca	; Pastor Anglada, Marcal/C-3730-2017	Williams, Declan/0000-0002-6754-1624; Pastor Anglada, Marcal/0000-0003-3712-1773	Instituto de Salud Carlos III (Madrid, Spain); Ryerson University; Natural Science and Engineering Research Council of Canada; Ministry of Economy and Competitiveness (National Biomedicine Program, Ministry of Economy, Industry and Competiveness); Government of Spain [SAF2014-52067-R]; National Biomedical Research Institute (CIBER) of Liver and Gastrointestinal Diseases	Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); Ryerson University; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministry of Economy and Competitiveness (National Biomedicine Program, Ministry of Economy, Industry and Competiveness); Government of Spain(Spanish Government); National Biomedical Research Institute (CIBER) of Liver and Gastrointestinal Diseases	This work was supported by an Instituto de Salud Carlos III (Madrid, Spain), Predoctoral Contracts of Training in Health Research Doctoral Fellowship; a Ryerson University Postdoctoral Fellowship (to N.G.B.); Natural Science and Engineering Research Council of Canada; Ryerson University (to I.R.C.); Ministry of Economy and Competitiveness (National Biomedicine Program, Ministry of Economy, Industry and Competiveness); Government of Spain (SAF2014-52067-R); and National Biomedical Research Institute (CIBER) of Liver and Gastrointestinal Diseases (to M.P.-A.). CIBER is an initiative of Instituto de Salud Carlos III. The authors declare no conflicts of interest.	Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Balse E, 2009, P NATL ACAD SCI USA, V106, P14681, DOI 10.1073/pnas.0902809106; Bicket A, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160063; Bicket A, 2016, AM J PHYSIOL-CELL PH, V310, pC808, DOI 10.1152/ajpcell.00243.2015; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cabrita MA, 2002, BIOCHEM CELL BIOL, V80, P623, DOI 10.1139/O02-153; Coe I, 2002, FEBS LETT, V517, P201, DOI 10.1016/S0014-5793(02)02622-4; DELICADO EG, 1991, BIOCHEM J, V279, P651, DOI 10.1042/bj2790651; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; dos Santos-Rodrigues A, 2014, NEUROCHEM INT, V73, P229, DOI 10.1016/j.neuint.2014.03.014; Elsherbiny NM, 2015, LIFE SCI, V143, P8, DOI 10.1016/j.lfs.2015.10.026; Grane-Boladeras N, 2012, THESIS; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Kipp H, 2002, ANNU REV PHYSIOL, V64, P595, DOI 10.1146/annurev.physiol.64.081501.155793; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; Longhi MS, 2013, J MOL MED, V91, P165, DOI 10.1007/s00109-012-0991-z; Lu G, 2010, J NEUROSCI, V30, P5058, DOI 10.1523/JNEUROSCI.0148-10.2010; Montecinos VP, 2000, J PHYSIOL-LONDON, V529, P777, DOI 10.1111/j.1469-7793.2000.00777.x; Nishio R, 2011, CANCER SCI, V102, P622, DOI 10.1111/j.1349-7006.2010.01837.x; Oh-hashi K, 2016, CELL BIOCHEM FUNCT, V34, P497, DOI 10.1002/cbf.3222; Olsen BB, 2010, METHOD ENZYMOL, V484, P515, DOI [10.1016/B978-0-12-381298-8.00025-3, 10.1016/S0076-6879(10)84025-X]; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Pinto-Duarte A, 2005, J NEUROCHEM, V93, P595, DOI 10.1111/j.1471-4159.2005.03071.x; Ramadan A, 2014, PURINERG SIGNAL, V10, P305, DOI 10.1007/s11302-013-9391-2; Ramakers BP, 2011, CRIT CARE, V15, DOI 10.1186/cc10576; Reyes G, 2011, MOL MEMBR BIOL, V28, P412, DOI 10.3109/09687688.2011.604861; Roma MG, 2008, WORLD J GASTROENTERO, V14, P6786, DOI 10.3748/wjg.14.6786; Rose JB, 2010, AM J PHYSIOL-HEART C, V298, pH771, DOI 10.1152/ajpheart.00711.2009; Sen RP, 1999, NEUROPHARMACOLOGY, V38, P1009, DOI 10.1016/S0028-3908(99)00029-5; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Stecula A, 2017, BIOCHEMISTRY-US, V56, P3475, DOI 10.1021/acs.biochem.7b00339; Turowec JP, 2010, METHOD ENZYMOL, V484, P471, DOI [10.1016/S0076-6879(10)84023-6, 10.1016/B978-0-12-381298-8.00023-X]; Wang HJ, 2014, PEDIATR BLOOD CANCER, V61, P2230, DOI 10.1002/pbc.25221; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Weber S, 2016, J MOL CELL CARDIOL, V101, P116, DOI 10.1016/j.yjmcc.2016.09.007; Zhang SY, 1997, ARCH BIOCHEM BIOPHYS, V338, P227, DOI 10.1006/abbi.1996.9809	36	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3841	3850		10.1096/fj.201800440RR	http://dx.doi.org/10.1096/fj.201800440RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521377	Bronze			2022-12-28	WOS:000459794800060
J	Newberry, EP; Xie, Y; Lodeiro, C; Solis, R; Moritz, W; Kennedy, S; Barron, L; Onufer, E; Alpini, G; Zhou, TH; Blaner, WS; Chen, AP; Davidson, NO				Newberry, Elizabeth P.; Xie, Yan; Lodeiro, Carlos; Solis, Roberto; Moritz, William; Kennedy, Susan; Barron, Lauren; Onufer, Emily; Alpini, Gianfranco; Zhou, Tianhao; Blaner, William S.; Chen, Anping; Davidson, Nicholas O.			Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveals distinct roles in fibrogenic injury	FASEB JOURNAL			English	Article						fibrogenesis; steatohepatitis; mouse models; cell-specific Cre-deletion	PERILIPIN 5; HEPATIC STEATOSIS; METABOLISM; KNOCKOUT; MICE; FIBROSIS; ACCUMULATION; HOMEOSTASIS; STORES	Liver fatty acid binding protein (L-Fabp) modulates lipid trafficking in enterocytes, hepatocytes, and hepatic stellate cells (HSCs). We examined hepatocyte vs. HSC L-Fabp deletion in hepatic metabolic adaptation and fibrotic injury. Floxed L-Fabp mice were bred to different transgenic Cre mice or injected with adeno-associated virus type 8 (AAV8) Cre and fed diets to promote steatosis and fibrosis or were subjected to either bile duct ligation or CCl4 injury. Albumin-Cre-mediated L-Fabp deletion revealed recombination in hepatocytes and HSCs; these findings were confirmed with 2 other floxed alleles. Glial fibrillary acid protein-Cre and platelet-derived growth factor receptor -Cre-mediated L-Fabp deletion demonstrated recombination only in HSCs. Mice with albumin promoter-driven Cre recombinase (Alb-Cre)-mediated or AAV8-mediated L-Fabp deletion were protected against food withdrawal-induced steatosis. Mice with Alb-Cre-mediated L-Fabp deletion were protected against high saturated fat-induced steatosis and fibrosis, phenocopying germline L-Fabp(-/-) mice. Mice with HSC-specific L-Fabp deletion exhibited retinyl ester depletion yet demonstrated no alterations in fibrosis. On the other hand, fibrogenic resolution after CCl4 administration was impaired in mice with Alb-Cre-mediated L-Fabp deletion. These findings suggest cell type-specific roles for L-Fabp in mitigating hepatic steatosis and in modulating fibrogenic injury and reversal.Newberry, E. P., Xie, Y., Lodeiro, C., Solis, R., Moritz, W., Kennedy, S., Barron, L., Onufer, E., Alpini, G., Zhou, T., Blaner, W. S., Chen, A., Davidson, N. O. Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveal distinct roles in fibrogenic injury.	[Newberry, Elizabeth P.; Xie, Yan; Lodeiro, Carlos; Solis, Roberto; Moritz, William; Kennedy, Susan; Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, Gastroenterol Div, St Louis, MO 63110 USA; [Barron, Lauren; Onufer, Emily] Washington Univ, Sch Med, Dept Surg, Pediat Surg Div, St Louis, MO 63110 USA; [Alpini, Gianfranco; Zhou, Tianhao] Texas A&M Univ, Dept Med Physiol, Temple, TX USA; [Zhou, Tianhao] Texas A&M Univ, Dept Internal Med, Temple, TX USA; [Blaner, William S.] Columbia Univ, Dept Med, New York, NY USA; [Chen, Anping] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA	Washington University (WUSTL); Washington University (WUSTL); Texas A&M University System; Texas A&M University System; Columbia University; Saint Louis University	Davidson, NO (corresponding author), Washington Univ, Dept Med, Gastroenterol Div, 425 South Euclid Ave,Campus Box 8124, St Louis, MO 63110 USA.	nod@wustl.edu	Solis, Roberto/AAI-8360-2020; Zhou, Tianhao/AAO-3542-2021	Solis, Roberto/0000-0003-3786-1712; Zhou, Tianhao/0000-0002-5722-6954	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK 56260, DK 52574]; NIH National Heart, Lung, and Blood Institute [HL 38180]; Veterans Affairs (VA) Research Career Scientist Award; VA Merit Award from the United States Department of Veteran's Affairs [5I01BX000574]; Biomedical Laboratory Research and Development Service Grants [DK 068437, DK 101251]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK119437, P30DK056341, P30DK052574] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000574] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs (VA) Research Career Scientist Award; VA Merit Award from the United States Department of Veteran's Affairs(US Department of Veterans Affairs); Biomedical Laboratory Research and Development Service Grants; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (DK 56260, and DK 52574, to N.O.D), and NIH National Heart, Lung, and Blood Institute (HL 38180, to N.O.D.); Veterans Affairs (VA) Research Career Scientist Award and VA Merit Award 5I01BX000574 from the United States Department of Veteran's Affairs (to G.A.); and Biomedical Laboratory Research and Development Service Grants DK 068437 and DK 101251 (to W.S.B.). Portions of this material are the result of work supported with resources and the use of facilities at the Central Texas Veterans Health Care System, Temple, Texas. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Veterans Affairs or the United States Government. The authors declare no conflicts of interest.	Beaven SW, 2011, GASTROENTEROLOGY, V140, P1052, DOI 10.1053/j.gastro.2010.11.053; Chen AP, 2013, HEPATOLOGY, V57, P2202, DOI 10.1002/hep.26318; Cinar R, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87336; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, CELL METAB, V7, P187, DOI 10.1016/j.cmet.2008.02.002; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Glaser S, 2011, AM J PHYSIOL-GASTR L, V301, pG297, DOI 10.1152/ajpgi.00418.2010; Greenhalgh SN, 2015, HEPATOLOGY, V61, P2091, DOI 10.1002/hep.27606; Greuter T, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95354; Harrison SA, 2018, LANCET, V391, P1174, DOI 10.1016/S0140-6736(18)30474-4; Huang H, 2016, BIOCHEMISTRY-US, V55, P5243, DOI 10.1021/acs.biochem.6b00446; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Hyun J, 2014, J MOL HISTOL, V45, P103, DOI 10.1007/s10735-013-9532-5; Kakazu E, 2016, J LIPID RES, V57, P233, DOI 10.1194/jlr.M063412; Kim N, 2009, GUT, V58, P1382, DOI 10.1136/gut.2008.170233; Kimmel AR, 2014, CURR OPIN LIPIDOL, V25, P110, DOI 10.1097/MOL.0000000000000057; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Lin JG, 2018, J LIPID RES, V59, P416, DOI 10.1194/jlr.M077487; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Martin GG, 2005, BIOCHEM J, V391, P549, DOI 10.1042/BJ20050296; Martin GG, 2006, AM J PHYSIOL-GASTR L, V290, pG36, DOI 10.1152/ajpgi.00510.2004; Martin GG, 2008, J NUTR, V138, P1859, DOI 10.1093/jn/138.10.1859; Mason RR, 2015, TRENDS ENDOCRIN MET, V26, P144, DOI 10.1016/j.tem.2015.01.005; Mason RR, 2014, MOL METAB, V3, P652, DOI 10.1016/j.molmet.2014.06.002; Meivar-Levy I, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/252387; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2017, HEPATOLOGY, V65, P836, DOI 10.1002/hep.28941; Newberry EP, 2015, AM J PHYSIOL-GASTR L, V309, pG648, DOI 10.1152/ajpgi.00170.2015; Newberry EP, 2012, J LIPID RES, V53, P744, DOI 10.1194/jlr.M020966; Newberry EP, 2009, MOL CELL BIOCHEM, V326, P79, DOI 10.1007/s11010-008-0002-4; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Nguyet NM, 2005, DEV BIOL, V282, P111, DOI 10.1016/j.ydbio.2005.02.031; O'Mahony F, 2015, HEPATOLOGY, V62, P615, DOI 10.1002/hep.27645; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Shmarakov IO, 2013, J LIPID RES, V54, P893, DOI 10.1194/jlr.M029801; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Thompson MD, 2018, HEPATOLOGY, V67, P955, DOI 10.1002/hep.29371; Tsukamoto H, 2008, J GASTROEN HEPATOL, V23, pS104, DOI 10.1111/j.1440-1746.2007.05294.x; Tsukamoto H, 2006, J GASTROEN HEPATOL, V21, pS102, DOI 10.1111/j.1440-1746.2006.04573.x; Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138; Wang C, 2015, HEPATOLOGY, V61, P870, DOI 10.1002/hep.27409; Xie Y, 2014, J LIPID RES, V55, P540, DOI 10.1194/jlr.M046342; Xie Y, 2009, J LIPID RES, V50, P977, DOI 10.1194/jlr.M800645-JLR200; Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115; Zhang XJ, 2018, HEPATOLOGY, V67, P2068, DOI 10.1002/hep.29845; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	51	13	14	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4610	4625		10.1096/fj.201801976R	http://dx.doi.org/10.1096/fj.201801976R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30576225	Bronze, Green Published			2022-12-28	WOS:000459794800120
J	Qian, Q; Zhang, J; He, FP; Bao, WX; Zheng, TT; Zhou, DM; Pan, HY; Zhang, H; Zhang, XQ; He, X; Sun, BG; Luo, BY; Chen, C; Peng, GP				Qian, Qi; Zhang, Jian; He, Fang-Ping; Bao, Wang-Xiao; Zheng, Ting-Ting; Zhou, Dong-Ming; Pan, Hong-Yu; Zhang, Heng; Zhang, Xiao-Qin; He, Xiao; Sun, Bing-Gui; Luo, Ben-Yan; Chen, Chu; Peng, Guo-Ping			Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease	FASEB JOURNAL			English	Article						BACE1; neuroinflammation; NF-B; noncoding small RNA; epigenetics	NF-KAPPA-B; AMYLOID PRECURSOR PROTEIN; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; GENE-EXPRESSION; MOUSE MODEL; ROBUSTNESS; GLUTAMATE; RECEPTOR; ROLES	Alzheimer's disease (AD) is a leading cause of dementia. However, the mechanisms responsible for development of AD, especially for the sporadic variant, are still not clear. In our previous study, we discovered that a small noncoding RNA (miR-188-3p) targeting -site amyloid precursor protein cleaving enzyme (BACE)-1, a key enzyme responsible for A formation, plays an important role in the development of neuropathology in AD. In the present study, we identified that miR-338-5p, a new miRNA that also targets BACE1, contributes to AD neuropathology. We observed that expression of miR-338-5p was significantly down-regulated in the hippocampus of patients with AD and 5XFAD transgenic (TG) mice, an animal model of AD. Overexpression of miR-338-5p in the hippocampus of TG mice reduced BACE1 expression, A formation, and neuroinflammation. Overexpression of miR-338-5p functionally prevented impairments in long-term synaptic plasticity, learning ability, and memory retention in TG mice. In addition, we provide evidence that down-regulated expression of miR-338-5p in AD is regulated through the NF-B signaling pathway. Our results suggest that down-regulated expression of miR-338-5p plays an important role in the development of AD.Qian, Q., Zhang, J., He, F.-P., Bao, W.-X., Zheng, T.-T., Zhou, D.-M., Pan, H.-Y., Zhang, H., Zhang, X.-Q., He, X., Sun, B.-G., Luo, B.-Y., Chen, C., Peng, G.-P. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.	[Qian, Qi; He, Fang-Ping; Bao, Wang-Xiao; Luo, Ben-Yan; Peng, Guo-Ping] Zhejiang Univ, Affiliated Hosp 1, Ctr Brain Sci, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Zheng, Ting-Ting; Zhou, Dong-Ming; Pan, Hong-Yu; Zhang, Heng; Zhang, Xiao-Qin; He, Xiao; Sun, Bing-Gui] Zhejiang Univ, Dept Neurobiol, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Qian, Qi; Zhang, Jian; Chen, Chu] Louisiana State Univ, Sch Med, Neurosci Ctr Excellence, Hlth Sci Ctr, New Orleans, LA USA; [Qian, Qi] Zhejiang Chinese Med Univ, Coll Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Zheng, Ting-Ting] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Chen, C (corresponding author), LSU Hlth Sci Ctr, Neurosci Ctr, 2020 Gravier St, New Orleans, LA 70112 USA.; Peng, GP (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	cchen@lsuhsc.edu; guopingpeng@zju.edu.cn	Sun, Binggui/J-9028-2016	Sun, Binggui/0000-0002-0386-6569	National Natural Science Fund of China [81471284]; U.S. National Institutes of Health (from the National Institute of Neurological Disorders and Stroke) [R01NS076815]; U.S. National Institutes of Health (from the National Institute on Aging) [R01AG058621]; National Key Technology Research and Development Program of China [2016YFC1306402]; Research fund of Zhejiang Chinese Medical University [2018ZR04]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG058621] Funding Source: NIH RePORTER	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health (from the National Institute of Neurological Disorders and Stroke); U.S. National Institutes of Health (from the National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Research fund of Zhejiang Chinese Medical University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. XiaodongWang for suggestions on data analysis and for providing some of the reagents, and Dr. Sanhua Fang and Qiaoling Ding (all from Zhejiang University School of Medicine) for help with the experimental process. This work was supported by the National Natural Science Fund of China (81471284, to G.-P.P.), U.S. National Institutes of Health Grants (R01NS076815 from the National Institute of Neurological Disorders and Stroke and R01AG058621 from the National Institute on Aging, to C.C.), the National Key Technology Research and Development Program of China (2016YFC1306402, to B.-Y.L.), and the Research fund of Zhejiang Chinese Medical University (2018ZR04 to Q.Q.). C.C. and G.-P.P. conceived the study and designed the experiments as well as analyzed the data. Dr. Benyan Luo made constructive amendments to the project. Also, the majority of the experiments were performed in Dr. Luo's laboratory. The authors declare no conflicts of interest.	Ahmed T, 2011, BRAIN RES, V1400, P1, DOI 10.1016/j.brainres.2011.05.022; Beveridge NJ, 2012, NEUROBIOL DIS, V46, P263, DOI 10.1016/j.nbd.2011.12.029; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Chen RQ, 2013, CELL, V155, P1154, DOI 10.1016/j.cell.2013.10.042; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Dajas-Bailador F, 2012, NAT NEUROSCI, V15, P697, DOI 10.1038/nn.3082; Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Emmanouil M, 2011, ADV EXP MED BIOL, V691, P575, DOI 10.1007/978-1-4419-6612-4_60; Gaughwin P, 2011, CEREB CORTEX, V21, P1857, DOI 10.1093/cercor/bhq262; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hydbring Per, 2013, F1000Res, V2, P136, DOI 10.12688/f1000research.2-136.v1; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Iranifar E., 2018, J CELL PHYSL; Jones SV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01805; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim JH, 2001, J NEUROSCI, V21, P1327; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Lee K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34433; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Li GF, 2017, J MOL NEUROSCI, V61, P159, DOI 10.1007/s12031-016-0873-x; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Long JM, 2014, J BIOL CHEM, V289, P5184, DOI 10.1074/jbc.M113.518241; Lukiw WJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt150; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Prasad KN, 2017, MECH AGEING DEV, V162, P63, DOI 10.1016/j.mad.2016.12.003; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Rago L, 2014, EMBO J, V33, P906, DOI 10.1002/embj.201386591; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Santosa C, 2011, NEUROBIOL DIS, V43, P176, DOI 10.1016/j.nbd.2011.03.009; Satoh J, 2012, EXP NEUROL, V235, P436, DOI 10.1016/j.expneurol.2011.09.003; Schaeffer V, 2008, NEUROCHEM INT, V52, P948, DOI 10.1016/j.neuint.2008.01.010; Schonrock N, 2012, CELL MOL LIFE SCI, V69, P3543, DOI 10.1007/s00018-012-1125-z; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shadfar S, 2015, ARCH PHARM RES, V38, P2106, DOI 10.1007/s12272-015-0648-x; Shaik MM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040174; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Snow WM, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00118; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Valles A, 2014, J PSYCHIATR NEUROSCI, V39, P312, DOI 10.1503/jpn.130269; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wong J, 2013, SCHIZOPHRENIA BULL, V39, P396, DOI 10.1093/schbul/sbr177; Zhang J, 2014, J NEUROSCI, V34, P14919, DOI 10.1523/JNEUROSCI.1165-14.2014; Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	64	28	32	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4404	4417		10.1096/fj.201801846R	http://dx.doi.org/10.1096/fj.201801846R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30576233	Green Published			2022-12-28	WOS:000459794800104
J	Ruegsegger, GN; Manjunatha, S; Summer, P; Gopala, S; Zabeilski, P; Dasari, S; Vanderboom, PM; Lanza, IR; Klaus, KA; Nair, KS				Ruegsegger, Gregory N.; Manjunatha, Shankarappa; Summer, Priska; Gopala, Srinivas; Zabeilski, Piotr; Dasari, Surendra; Vanderboom, Patrick M.; Lanza, Ian R.; Klaus, Katherine A.; Nair, K. Sreekumaran			Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes	FASEB JOURNAL			English	Article						ketones; mitochondrial biogenesis; proteomics; reactive oxygen species	ALZHEIMERS-DISEASE; PROTEIN-SYNTHESIS; BARRIER PERMEABILITY; IMPROVES COGNITION; OXIDATIVE STRESS; ATP PRODUCTION; CHOLESTEROL; HYPERGLYCEMIA; DYSFUNCTION; SYSTEM	Despite the strong association between diabetes and dementia, it remains to be fully elucidated how insulin deficiency adversely affects brain functions. We show that insulin deficiency in streptozotocin-induced diabetic mice decreased mitochondrial ATP production and/or citrate synthase and cytochrome oxidase activities in the cerebrum, hypothalamus, and hippocampus. Concomitant decrease in mitochondrial fusion proteins and increased fission proteins in these brain regions likely contributed to altered mitochondrial function. Although insulin deficiency did not cause any detectable increase in reactive oxygen species (ROS) emission, inhibition of monocarboxylate transporters increased ROS emission and further reduced ATP production, indicating the causative roles of elevated ketones and lactate in counteracting oxidative stress and as a fuel source for ATP production during insulin deficiency. Moreover, in healthy mice, intranasal insulin administration increased mitochondrial ATP production, demonstrating a direct regulatory role of insulin on brain mitochondrial function. Proteomics analysis of the cerebrum showed that although insulin deficiency led to oxidative post-translational modification of several proteins that cause tau phosphorylation and neurofibrillary degeneration, insulin administration enhanced neuronal development and neurotransmission pathways. Together these results render support for the critical role of insulin to maintain brain mitochondrial homeostasis and provide mechanistic insight into the potential therapeutic benefits of intranasal insulin.Ruegsegger, G. N., Manjunatha, S., Summer, P., Gopala, S., Zabeilski, P., Dasari, S., Vanderboom, P. M., Lanza, I. R., Klaus, K. A., Nair, K. S. Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes.	[Ruegsegger, Gregory N.; Manjunatha, Shankarappa; Summer, Priska; Gopala, Srinivas; Zabeilski, Piotr; Vanderboom, Patrick M.; Lanza, Ian R.; Klaus, Katherine A.; Nair, K. Sreekumaran] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA; [Dasari, Surendra] Mayo Clin, Div Biomed Stat & Informat, 200 First St SW,Joseph 5-194, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Nair, KS (corresponding author), Mayo Clin, Div Biomed Stat & Informat, 200 First St SW,Joseph 5-194, Rochester, MN 55905 USA.	nair@mayo.edu		Gopala, Srinivas/0000-0001-5885-6256; Summer, Priska/0000-0002-3779-2895	U.S. National Institutes of Health, National Institute of Aging [P50-AG-016574, T32-AG-49672]; Mayo Clinic Metabolomics Resource Core Grant [U24-DK-100469]; Molecular Transducers of Physical Activity (MoTrPAC) Chemical Analysis Center Grant [U24-DK-112326]; American Diabetes Association; Indian Council of Medical Research (ICMR) International Fellowship [INDO/FRC/(Y-17)/2013-IHD]; David H. Murdock-Dole Food Company Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK100469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG049672] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mayo Clinic Metabolomics Resource Core Grant; Molecular Transducers of Physical Activity (MoTrPAC) Chemical Analysis Center Grant; American Diabetes Association(American Diabetes Association); Indian Council of Medical Research (ICMR) International Fellowship; David H. Murdock-Dole Food Company Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this work was provided by U.S. National Institutes of Health, National Institute of Aging Grants P50-AG-016574 and T32-AG-49672; Mayo Clinic Metabolomics Resource Core Grant U24-DK-100469; Molecular Transducers of Physical Activity (MoTrPAC) Chemical Analysis Center Grant U24-DK-112326; an American Diabetes Association mentor-based fellowship grant (to S.M.); the Indian Council of Medical Research (ICMR) International Fellowship Grant INDO/FRC/(Y-17)/2013-IHD (to S.G.); and the David H. Murdock-Dole Food Company Professorship (to K.S.N.). The authors declare no conflicts of interest.	Banks WA, 1997, PEPTIDES, V18, P1577, DOI 10.1016/S0196-9781(97)00238-6; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blachnio-Zabielska AU, 2012, RAPID COMMUN MASS SP, V26, P1134, DOI 10.1002/rcm.6216; Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652; Bouchard P, 2002, DIABETOLOGIA, V45, P1017, DOI 10.1007/s00125-002-0853-2; Cardoso S, 2010, BBA-MOL BASIS DIS, V1802, P942, DOI 10.1016/j.bbadis.2010.07.001; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gellerich FN, 2008, J BIOL CHEM, V283, P30715, DOI 10.1074/jbc.M709555200; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Gouspillou G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020709; Gratuze M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46359; Guo ZY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45971; Hanson Leah R, 2013, J Vis Exp, DOI 10.3791/4440; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; Huang SB, 2015, DIABETES, V64, P1728, DOI 10.2337/db14-0758; Huber JD, 2006, AM J PHYSIOL-HEART C, V291, pH2660, DOI 10.1152/ajpheart.00489.2006; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Karakelides H, 2007, DIABETES, V56, P2683, DOI 10.2337/db07-0378; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Kornhuber J, 2014, TRENDS PHARMACOL SCI, V35, P293, DOI 10.1016/j.tips.2014.04.003; Krumschnabel Gerhard, 2015, Methods Mol Biol, V1264, P245, DOI 10.1007/978-1-4939-2257-4_22; Kullmann S, 2016, PHYSIOL REV, V96, P1169, DOI 10.1152/physrev.00032.2015; Lacy ME, 2018, DIABETES CARE, V41, P2339, DOI 10.2337/dc18-0073; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lark DS, 2016, AM J PHYSIOL-CELL PH, V311, pC239, DOI 10.1152/ajpcell.00124.2016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Martin DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23658; Mason GF, 2006, DIABETES, V55, P929, DOI 10.2337/diabetes.55.04.06.db05-1325; Mattson MP, 2018, NAT REV NEUROSCI, V19, P81, DOI 10.1038/nrn.2017.156; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; MOORADIAN AD, 1987, DIABETES, V36, P1094, DOI 10.2337/diabetes.36.10.1094; Moreira PI, 2004, J NEUROENDOCRINOL, V16, P32, DOI 10.1111/j.1365-2826.2004.01107.x; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Osorio-Paz I, 2018, MOL BIOL REP, V45, P871, DOI 10.1007/s11033-018-4233-5; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Price TO, 2012, ENDOCRINOLOGY, V153, P362, DOI 10.1210/en.2011-1638; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Robinson MM, 2014, J CLIN ENDOCR METAB, V99, pE2574, DOI 10.1210/jc.2014-2736; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ruegsegger GN, 2018, J CLIN INVEST, V128, P3671, DOI 10.1172/JCI120843; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Suzuki R, 2010, CELL METAB, V12, P567, DOI 10.1016/j.cmet.2010.11.006; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Wang XT, 2012, ACTA PHARMACOL SIN, V33, P909, DOI 10.1038/aps.2012.50; Ye J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004754; Zabielski P, 2016, DIABETES, V65, P561, DOI 10.2337/db15-0823; Zabielski P, 2014, AM J PHYSIOL-ENDOC M, V306, pE529, DOI 10.1152/ajpendo.00610.2012; Zhao N, 2017, NEURON, V96, P115, DOI 10.1016/j.neuron.2017.09.003	67	28	29	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4458	4472		10.1096/fj.201802043R	http://dx.doi.org/10.1096/fj.201802043R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30676773	Green Published, Bronze			2022-12-28	WOS:000459794800108
J	Tang, W; Li, MM; Liu, YJ; Liang, N; Yang, Z; Zhao, YX; Wu, S; Lu, SW; Li, YL; Liu, FY				Tang, Wei; Li, Manmei; Liu, Yujun; Liang, Ning; Yang, Zhu; Zhao, Yanxiang; Wu, Shuai; Lu, Sangwei; Li, Yaolan; Liu, Fenyong			Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane	FASEB JOURNAL			English	Article						RSV; viral entry; antiviral; mice; drug resistance	ANTIVIRAL ACTIVITY; RNASE P; RSV; GLYCOPROTEIN; REPLICATION; RECEPTOR; BINDING; IDENTIFICATION; ATTACHMENT; ANTIBODIES	Antiviral drug development against respiratory syncytial virus (RSV) is urgently needed due to the public health significance of the viral infection. Here, we report the anti-RSV activity of a small molecule, (1S,3R,4R,5R)-3,4-bis{[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,5-dihydroxycyclohexane-1-carboxylic methyl ester (3,4-DCQAME) or 3,4-O-Dicaffeoylquinic acid methyl ester, which can be isolated from several plants of traditional Chinese medicine. We showed for the first time that compound 3,4-DCQAME potently inhibits RSV entry and infection. In vitro, 3,4-DCQAME can interact with F(ecto), the ectodomain of RSV fusion (F) protein. In cultured cells, the compound can block the interaction of F(ecto) protein with the cellular membrane and inhibit viral fusion during RSV entry, leading to inhibition of viral gene expression and infection. In RSV-infected mice that were treated with 3,4-DCQAME, we observed a reduction of RSV-induced pathologic changes and substantial inhibition of viral infection and growth in the lung tissues. Our results provide the first direct evidence of the anti-RSV activity of 3,4-DCQAME. Furthermore, these results suggest that 3,4-DCQAME represents a promising lead compound for anti-RSV therapeutic development.Tang, W., Li, M., Liu, Y., Liang, N., Yang, Z., Zhao, Y., Wu, S., Lu, S., Li, Y., Liu, F. Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane.	[Tang, Wei; Li, Manmei; Liang, Ning; Li, Yaolan; Liu, Fenyong] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China; [Tang, Wei; Liu, Yujun; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, 326 Barker Hall,MC 7354, Berkeley, CA 94720 USA; [Liu, Yujun] St Georges Univ, Sch Med, True Blue, Grenada; [Liu, Yujun; Yang, Zhu] Guangzhou Qinheli Biotechnolgies Inc, Guangzhou, Guangdong, Peoples R China; [Yang, Zhu] Jiangsu Affynigen Biotechnolgies Inc, Taizhou, Jiangsu, Peoples R China; [Yang, Zhu] Taizhou Inst Virol, Taizhou, Jiangsu, Peoples R China; [Yang, Zhu] Shandong Univ Tradit Chinese Med, Sch Pharm, Jinan, Shandong, Peoples R China; [Zhao, Yanxiang; Wu, Shuai] Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Jinan University; University of California System; University of California Berkeley; Shandong University of Traditional Chinese Medicine; Hong Kong Polytechnic University	Li, YL (corresponding author), Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China.; Liu, FY (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 326 Barker Hall,MC 7354, Berkeley, CA 94720 USA.	tliyl@jnu.edu.cn; liu_fy@berkeley.edu	Li, Yao/AAE-3550-2019		National Natural Science Foundation of China [81473116]; Guangdong Innovative and Entrepreneurial Research Team Program [2014ZT05S136]; Science and Technology Planning Project of Guangdong Province [2016A030303011]; National Mega Project on Major Infectious Disease Prevention [2012ZX10002006-003, 2012ZX10004-207]; National Mega Project on Major Drug Development [2009ZX09103-678, 2012ZX09102301-004, 2012ZX09103301-20, 2013ZX09102-031, 2014ZX09509001-001]; Antiviral Cooperative Innovation Center of Traditional Chinese Medicine at Shandong Province [XTCX2014B01-09]; Project for Construction of Guangzhou Key Laboratory of Virology [201705030003]; National Small Business Innovation and Research (SBIR) Program of China; Technology Research and Development Program of Jiangsu Province [BG2007035, BG2008662]; Open Research Fund Program of the State Key Laboratory of Virology of China [2018IOV006, 2013005, 2015KF011]; Science and Technology Program of Guangzhou [201707010399]; Open Fund of Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine (TCM) and New Drugs Research [2016B 030301004]; U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases [RO1-AI041927, RO1-AI091536]; NIH National Institute of Dental and Craniofacial Research [RO1-DE023935, RO1-DE025462]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023935, R01DE025462] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative and Entrepreneurial Research Team Program; Science and Technology Planning Project of Guangdong Province; National Mega Project on Major Infectious Disease Prevention; National Mega Project on Major Drug Development; Antiviral Cooperative Innovation Center of Traditional Chinese Medicine at Shandong Province; Project for Construction of Guangzhou Key Laboratory of Virology; National Small Business Innovation and Research (SBIR) Program of China; Technology Research and Development Program of Jiangsu Province; Open Research Fund Program of the State Key Laboratory of Virology of China; Science and Technology Program of Guangzhou; Open Fund of Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine (TCM) and New Drugs Research; U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases; NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Phong Trang, Marco Paliza-Carre, Adam Smith, (all from University of California-Berkeley) and Ting Wang (Jinan University) for critical comments, reagents, and technical assistance. This research has been supported by grants from National Natural Science Foundation of China (81473116), the Guangdong Innovative and Entrepreneurial Research Team Program (2014ZT05S136), the Science and Technology Planning Project of Guangdong Province (2016A030303011), the National Mega Project on Major Infectious Disease Prevention (2012ZX10002006-003 and 2012ZX10004-207), the National Mega Project on Major Drug Development (2009ZX09103-678, 2012ZX09102301-004, 2012ZX09103301-20, 2013ZX09102-031, and 2014ZX09509001-001), the Antiviral Cooperative Innovation Center of Traditional Chinese Medicine at Shandong Province (XTCX2014B01-09), the Project for Construction of Guangzhou Key Laboratory of Virology (201705030003), the National Small Business Innovation and Research (SBIR) Program of China, the Technology Research and Development Program of Jiangsu Province (BG2007035 and BG2008662), the Open Research Fund Program of the State Key Laboratory of Virology of China (2018IOV006, 2013005, and 2015KF011), the Science and Technology Program of Guangzhou (No. 201707010399), the Open Fund of Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine (TCM) and New Drugs Research (2016B 030301004), and the U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (RO1-AI041927, RO1-AI091536), and NIH National Institute of Dental and Craniofacial Research (RO1-DE023935, and RO1-DE025462). The authors declare that Y.L. and Z.Y., are employed by Guangzhou Qinheli Biotechnologies and Jiangsu Affynigen Biotechnologies. The authors declare no other conflicts of interest.	Andries K, 2003, ANTIVIR RES, V60, P209, DOI 10.1016/j.antiviral.2003.07.004; Bai Y, 2011, P NATL ACAD SCI USA, V108, P3222, DOI 10.1073/pnas.1014975108; Battles MB, 2016, NAT CHEM BIOL, V12, P87, DOI [10.1038/nchembio.1982, 10.1038/NCHEMBIO.1982]; Budge PJ, 2004, J VIROL, V78, P5015, DOI 10.1128/JVI.78.10.5015-5022.2004; Chaiwatpongsakorn S, 2011, J VIROL, V85, P3968, DOI 10.1128/JVI.01813-10; Chu HY, 2013, CURR TOP MICROBIOL, V372, P235, DOI 10.1007/978-3-642-38919-1_12; Cianci C, 2005, J ANTIMICROB CHEMOTH, V55, P289, DOI 10.1093/jac/dkh558; Cianci C, 2004, ANTIMICROB AGENTS CH, V48, P413, DOI 10.1128/AAC.48.2.413-422.2004; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Crim RL, 2007, J VIROL, V81, P261, DOI 10.1128/JVI.01226-06; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; Fan L, 2013, PLANTA MED, V79, P1558, DOI 10.1055/s-0033-1350804; German P, 2018, J CLIN PHARMACOL, V58, P1025, DOI 10.1002/jcph.1112; Graham BS, 2013, CURR TOP MICROBIOL, V372, P391, DOI 10.1007/978-3-642-38919-1_20; Hernandez LD, 1997, J CELL BIOL, V139, P1455, DOI 10.1083/jcb.139.6.1455; Hicks SN, 2018, J VIROL, V92, DOI 10.1128/JVI.00621-18; Karger A, 2001, J GEN VIROL, V82, P631, DOI 10.1099/0022-1317-82-3-631; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Krilov LR, 2002, PEDIATR INFECT DIS J, V21, P479, DOI 10.1097/00006454-200205000-00037; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Mejias A, 2005, ANTIMICROB AGENTS CH, V49, P4700, DOI 10.1128/AAC.49.11.4700-4707.2005; Olszewska W, 2011, EUR RESPIR J, V38, P401, DOI 10.1183/09031936.00005610; Olszewska W, 2009, EXPERT OPIN EMERG DR, V14, P207, DOI 10.1517/14728210902946399; Perron M, 2016, ANTIMICROB AGENTS CH, V60, P1264, DOI 10.1128/AAC.01497-15; Plotnicky-Gilquin H, 2002, VIROLOGY, V303, P130, DOI 10.1006/viro.2002.1563; Roymans D, 2010, P NATL ACAD SCI USA, V107, P308, DOI 10.1073/pnas.0910108106; Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006; Samuel D, 2015, ANTIMICROB AGENTS CH, V59, P7109, DOI 10.1128/AAC.00761-15; San-Juan-Vergara H, 2012, J VIROL, V86, P1832, DOI 10.1128/JVI.06274-11; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Simoes EAF, 2015, PEDIATR INFECT DIS J, V34, P1086, DOI 10.1097/INF.0000000000000813; Sun ZW, 2013, VIRUSES-BASEL, V5, P211, DOI 10.3390/v5010211; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Xin Y, 2018, J CLIN PHARMACOL, V58, P771, DOI 10.1002/jcph.1073; Xu JJ, 2015, J AGR FOOD CHEM, V63, P9520, DOI 10.1021/acs.jafc.5b03482; Xu JJ, 2014, J AGR FOOD CHEM, V62, P2182, DOI 10.1021/jf404310y; Zhao X, 2000, P NATL ACAD SCI USA, V97, P14172, DOI 10.1073/pnas.260499197	44	16	16	3	38	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4287	4299		10.1096/fj.201800579R	http://dx.doi.org/10.1096/fj.201800579R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30571312	Bronze, Green Published			2022-12-28	WOS:000459794800095
J	You, JS; McNally, RM; Jacobs, BL; Privett, RE; Gundermann, DM; Lin, KH; Steinert, ND; Goodman, CA; Hornberger, TA				You, Jae-Sung; McNally, Rachel M.; Jacobs, Brittany L.; Privett, Rachel E.; Gundermann, David M.; Lin, Kuan-Hung; Steinert, Nate D.; Goodman, Craig A.; Hornberger, Troy A.			The role of raptor in the mechanical load-induced regulation of mTOR signaling, protein synthesis, and skeletal muscle hypertrophy	FASEB JOURNAL			English	Article						mTORC1; rapamycin; mechanotransduction; exercise; growth	MAMMALIAN TARGET; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDIC-ACID; MESSENGER-RNA; RODENT MODEL; RAPAMYCIN; ACTIVATION; EXERCISE; ABLATION; MASS	It is well known that an increase in mechanical loading can induce skeletal muscle hypertrophy, and a long standing model in the field indicates that mechanical loads induce hypertrophy via a mechanism that requires signaling through the mechanistic target of rapamycin complex 1 (mTORC1). Specifically, it has been widely proposed that mechanical loads activate signaling through mTORC1 and that this, in turn, promotes an increase in the rate of protein synthesis and the subsequent hypertrophic response. However, this model is based on a number of important assumptions that have not been rigorously tested. In this study, we created skeletal muscle specific and inducible raptor knockout mice to eliminate signaling by mTORC1, and with these mice we were able to directly demonstrate that mechanical stimuli can activate signaling by mTORC1, and that mTORC1 is necessary for mechanical load-induced hypertrophy. Surprisingly, however, we also obtained multiple lines of evidence that indicate that mTORC1 is not required for a mechanical load-induced increase in the rate of protein synthesis. This observation highlights an important shortcoming in our understanding of how mechanical loads induce hypertrophy and illustrates that additional mTORC1-independent mechanisms play a critical role in this process.You, J.-S., McNally, R. M., Jacobs, B. L., Privett, R. E., Gundermann, D. M., Lin, K.-H., Steinert, N. D., Goodman, C. A., Hornberger, T. A. The role of raptor in the mechanical load-induced regulation of mTOR signaling, protein synthesis, and skeletal muscle hypertrophy.	[You, Jae-Sung; McNally, Rachel M.; Jacobs, Brittany L.; Privett, Rachel E.; Gundermann, David M.; Lin, Kuan-Hung; Steinert, Nate D.; Goodman, Craig A.; Hornberger, Troy A.] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA; [You, Jae-Sung; McNally, Rachel M.; Jacobs, Brittany L.; Privett, Rachel E.; Gundermann, David M.; Lin, Kuan-Hung; Steinert, Nate D.; Goodman, Craig A.; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, 2015 Linden Dr, Madison, WI 53706 USA; [Goodman, Craig A.] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Goodman, Craig A.] Victoria Univ, Australian Inst Musculoskeletal Sci, St Albans, Vic, Australia	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Victoria University; Victoria University	Hornberger, TA (corresponding author), Univ Wisconsin, Sch Vet Med, 2015 Linden Dr, Madison, WI 53706 USA.	troy.hornberger@wisc.edu	You, Jae-Sung/ABF-6763-2020; lin, ke/GZM-8300-2022	You, Jae-Sung/0000-0001-7791-8563; Goodman, Craig/0000-0002-5874-7743	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057347]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR057347 (to T.A.H.). The authors declare no conflicts of interest.	Adams GR, 2012, COMPR PHYSIOL, V2, P2829, DOI 10.1002/cphy.c110066; Astratenkova I V, 2014, Ross Fiziol Zh Im I M Sechenova, V100, P649; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; Bi PP, 2016, ELIFE, V5, DOI 10.7554/eLife.17355; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; COX RD, 1990, DIFFERENTIATION, V43, P183, DOI 10.1111/j.1432-0436.1990.tb00445.x; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Ge YJ, 2012, J BIOL CHEM, V287, P43928, DOI 10.1074/jbc.R112.406942; Goodman CA, 2014, REV PHYSIOL BIOCH P, V166, P43, DOI 10.1007/112_2013_17; Goodman CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037890; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Gordon BS, 2014, AM J PHYSIOL-ENDOC M, V307, pE703, DOI 10.1152/ajpendo.00250.2014; Gundermann DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1198, DOI 10.1152/ajpendo.00600.2013; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Jacobs BL, 2014, J MUSCLE RES CELL M, V35, P11, DOI 10.1007/s10974-013-9367-4; Jacobs BL, 2013, J PHYSIOL-LONDON, V591, P4611, DOI 10.1113/jphysiol.2013.256339; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kirby TJ, 2016, METHODS MOL BIOL, V1460, P43, DOI 10.1007/978-1-4939-3810-0_4; Kubica N, 2005, J BIOL CHEM, V280, P7570, DOI 10.1074/jbc.M413732200; Terena SMT, 2017, REV ASSOC MED BRAS, V63, P164, DOI 10.1590/1806-9282.63.02.164; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Marcotte GR, 2015, CALCIFIED TISSUE INT, V96, P196, DOI 10.1007/s00223-014-9925-9; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Murach KA, 2018, PHYSIOLOGY, V33, P26, DOI 10.1152/physiol.00019.2017; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Ogasawara R, 2018, FASEB J, V32, P5824, DOI 10.1096/fj.201701422R; Ogasawara R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31142; Pahor M, 1998, J Nutr Health Aging, V2, P97; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pasiakos SM, 2012, NUTRIENTS, V4, P740, DOI 10.3390/nu4070740; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Seguin R, 2003, AM J PREV MED, V25, P141, DOI 10.1016/S0749-3797(03)00177-6; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Spangenburg EE, 2009, APPL PHYSIOL NUTR ME, V34, P328, DOI 10.1139/H09-010; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; Yamada AK, 2012, J RECEPT SIG TRANSD, V32, P42, DOI 10.3109/10799893.2011.641978; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yonezawa K, 2003, CURR TOP MICROBIOL, V279, P271; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; You JS, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6847; You JS, 2014, J BIOL CHEM, V289, P1551, DOI 10.1074/jbc.M113.531392; You J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048613; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093	56	66	66	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4021	4034		10.1096/fj.201801653RR	http://dx.doi.org/10.1096/fj.201801653RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509128	Green Published			2022-12-28	WOS:000459794800073
J	Li, HW; Cui, Y; Wei, J; Liu, C; Chen, YH; Cui, CP; Li, L; Zhang, XL; Zhang, LQ				Li, Haiwen; Cui, Yu; Wei, Jun; Liu, Chao; Chen, Yuhan; Cui, Chun-Ping; Li, Lei; Zhang, Xueli; Zhang, Lingqiang			VCP/p97 increases BMP signaling by accelerating ubiquitin ligase Smurf1 degradation	FASEB JOURNAL			English	Article						PDB; osteoblast; E3 ubiquitin ligase	PAGETS-DISEASE; AAA-ATPASE; BONE; PROTEIN; DOMAIN; MUTATIONS; P97; FAM/USP9X; VCP	The bone morphogenetic protein (BMP)-Smad signaling pathway plays a crucial role in the control of bone homeostasis by regulating osteoblast activity. It is known that the ubiquitin ligase Smad ubiquitination regulatory factor (Smurf)1 is a master negative regulator of BMP signaling, but how its stability and activity are regulated remains poorly understood. Our study showed that valosin-containing protein/p97, the mutations of which lead to rare forms of Paget's disease of bone (PDB)-like syndromesuch as inclusion body myopathy (IBM) associated with Paget's disease of bone and frontotemporal dementia (IBM-PFD)together with its adaptor nuclear protein localization (NPL)4, specifically interact with Smurf1 and deliver the ubiquitinated Smurf1 for degradation. Depletion of either p97 or NPL4 resulted in the elevation of Smurf1 protein level and decreased BMP signaling accordingly. Mechanically, a typical proline, glutamic acid, serine, and threonine motif specifically existing in Smurf1 is necessary for its recognition and degradation by p97, and this process is dependent on p97 ATPase activity. More importantly, compared with p97 WT, PDB-associated mutation of p97 (mainly A232E) harboring the higher ATPase activity of p97 further promoted Smurf1 degradation, thus increasing BMP signaling activity. Our findings first establish a link between p97 and Smurf1, providing an in-depth understanding of how Smurf1 is regulated, as well as the mechanism of p97-related bone diseases.Li, H., Cui, Y., Wei, J., Liu, C., Chen, Y., Cui, C.-P., Li, L., Zhang, X., Zhang, L. VCP/p97 increases BMP signaling by accelerating ubiquitin ligase Smurf1 degradation.	[Li, Haiwen; Cui, Yu; Liu, Chao; Chen, Yuhan; Cui, Chun-Ping; Li, Lei; Zhang, Lingqiang] Beijing Inst Life, Natl Ctr Prot Sci, State Key Lab Prote, Beijing, Peoples R China; [Li, Haiwen] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Wei, Jun; Zhang, Xueli] Southern Med Univ, Fengxian Hosp, Shanghai Fengxian Cent Hosp, Dept Gen Surg,Grad Training Base, Shanghai 201400, Peoples R China	Case Western Reserve University; Southern Medical University - China	Zhang, XL (corresponding author), Southern Med Univ, Fengxian Hosp, Shanghai Fengxian Cent Hosp, Dept Gen Surg,Grad Training Base, Shanghai 201400, Peoples R China.; Zhang, LQ (corresponding author), Beijing Inst Life, 27 Taiping Rd, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn; zhanglq@nic.bmi.ac.cn		Chen, Yuhan/0000-0003-3674-1516	Chinese National Natural Science Foundation [81772959, 81521064]; Beijing Science Program for the Top Young Grant [2015000021223TD04]; Beijing Natural Science Foundation [Z151100003915083]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Science Program for the Top Young Grant; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	The authors thank their laboratory members for critical reading of the manuscript and helpful discussions, and Dr. Ping Wang (Tongji University, Shanghai, China) for generously providing the Smurf1 KO mice. This research was partially supported by Chinese National Natural Science Foundation Project Grants 81772959 (to X.Z.) and 81521064 (to L.Z.), Beijing Science Program for the Top Young Grant 2015000021223TD04, and Beijing Natural Science Foundation Project Grant Z151100003915083 (to L.Z.). The authors declare no conflicts of interest.	Al-Salihi MA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120082; Albagha OME, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.125; Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Baek G.H., 2013, J AMINO ACIDS, V2013, DOI DOI 10.1155/2013/183421; Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Cao Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04965; Chan NC, 2014, J BIOL CHEM, V289, P19789, DOI 10.1074/jbc.M114.569392; Cui Y, 2011, EMBO J, V30, P2675, DOI 10.1038/emboj.2011.155; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; David D, 2013, BBA-REV CANCER, V1835, P119, DOI 10.1016/j.bbcan.2012.11.003; De Boeck M, 2012, UPSALA J MED SCI, V117, P153, DOI 10.3109/03009734.2012.654858; Divisato G, 2018, CLIN GENET, V93, P1240, DOI 10.1111/cge.13247; Divisato G, 2016, AM J HUM GENET, V98, P275, DOI 10.1016/j.ajhg.2015.12.016; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Gibbs-Seymour I, 2015, MOL CELL, V57, P150, DOI 10.1016/j.molcel.2014.12.001; Greenblatt MB, 2015, J EXP MED, V212, P1283, DOI 10.1084/jem.20150407; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kannan M, 2012, DEVELOPMENT, V139, P3600, DOI 10.1242/dev.081786; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Li HW, 2016, CELL SIGNAL, V28, P1186, DOI 10.1016/j.cellsig.2016.05.016; Li JM, 2014, MOL CELL BIOL, V34, P335, DOI 10.1128/MCB.01190-13; Li LY, 2004, MOL CELL BIOL, V24, P856, DOI 10.1128/MCB.24.2.856-864.2004; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Menaa C, 2000, J CLIN INVEST, V105, P1833, DOI 10.1172/JCI9133; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Ralston SH, 2008, BONE, V43, P819, DOI 10.1016/j.bone.2008.06.015; Ralston SH, 2013, NEW ENGL J MED, V368, P644, DOI 10.1056/NEJMcp1204713; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584; Sanchez-Duffhues G, 2015, BONE, V80, P43, DOI 10.1016/j.bone.2015.05.025; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Soysa NS, 2009, BIOCHEM BIOPH RES CO, V378, P1, DOI 10.1016/j.bbrc.2008.10.146; Wan LX, 2011, MOL CELL, V44, P721, DOI 10.1016/j.molcel.2011.09.024; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Xu PL, 2012, FEBS LETT, V586, P1871, DOI 10.1016/j.febslet.2012.05.010; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zeng Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114475; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zhang L, 2014, CELL RES, V24, P742, DOI 10.1038/cr.2014.53; Zhang YC, 2016, INT J INTERDISCIP TE, V8, P1, DOI 10.4018/IJITN.2016040101; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	54	6	6	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2928	2943		10.1096/fj.201801173R	http://dx.doi.org/10.1096/fj.201801173R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30335548	Bronze			2022-12-28	WOS:000457296600111
J	Alibhai, JD; Diack, AB; Manson, JC				Alibhai, James D.; Diack, Abigail B.; Manson, Jean C.			Unravelling the glial response in the pathogenesis of Alzheimer's disease	FASEB JOURNAL			English	Review						microglia; astrocyte; neurodegeneration; protein misfolding disease	BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; MICROGLIAL ACTIVATION; ASTROCYTE TRANSCRIPTOME; BIOCHEMICAL-DIAGNOSIS; CORTICAL ASTROCYTES; POTASSIUM CHANNELS; ALPHA-SYNUCLEIN; GENE-EXPRESSION; MOUSE MODEL	Alzheimer's disease is a progressive, incurable neurodegenerative disease targeting specific neuronal populations within the brain while neighboring neurons appear unaffected. The focus for defining mechanisms has therefore been on the pathogenesis in affected neuronal populations and developing intervention strategies to prevent their cell death. However, there is growing recognition of the importance of glial cells in the development of pathology. Determining exactly how glial cells are involved in the disease process and the susceptibility of the aging brain provides unprecedented challenges. The present review examines recent studies attempting to unravel the glial response during the course of disease and how this action may dictate the outcome of neurodegeneration. The importance of regional heterogeneity of glial cells within the CNS during healthy aging and disease is examined to understand how the glial cells may contribute to neuronal susceptibility or resilience during the neurodegenerative process.Alibhai, J. D., Diack, A. B., Manson, J. C. Unravelling the glial response in the pathogenesis of Alzheimer's disease.	[Alibhai, James D.] Univ Edinburgh, Natl Creutzfeldt Jakob Dis CJD Res & Surveillance, Edinburgh, Midlothian, Scotland; [Alibhai, James D.] Univ Edinburgh, UK Dementia Res Inst, Edinburgh, Midlothian, Scotland; [Manson, Jean C.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Diack, Abigail B.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Diack, Abigail B.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Manson, JC (corresponding author), Univ Edinburgh, 9A Bioquarter,9 Little France Rd, Edinburgh, Midlothian, Scotland.	jean.manson@roslin.ed.ac.uk	Diack, Abigail/V-9652-2019		MRC Project [STFC-ST\P002447\1]; BBSRC Project [BBS/E/D/20002173]; BBSRC [BBS/E/D/10002071, BBS/E/D/20251969] Funding Source: UKRI	MRC Project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC Project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Financial support was provided by MRC Project STFC-ST\P002447\1 (to J.D.A.) and BBSRC Project BBS/E/D/20002173 (to A.B.D.). The authors declare no conflicts of interest.	Alibhai J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002579; Alzheimer A, 1910, Z GESAMTE NEUROL PSY, V1, P1, DOI 10.1007/BF02895916; Alzheimer's Disease International, 2018, DEM STAT; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Back SA, 2014, GLIA, V62, P1790, DOI 10.1002/glia.22658; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bruck D, 2016, NEUROBIOL DIS, V85, P262, DOI 10.1016/j.nbd.2015.03.003; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Cai ZY, 2016, INT J NEUROSCI, V126, P97, DOI 10.3109/00207454.2015.1025778; Cali I, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-017-0503-z; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Clavaguera F, 2014, ACTA NEUROPATHOL, V127, P299, DOI 10.1007/s00401-013-1231-5; Cole KLH, 2017, GLIA, V65, P1565, DOI 10.1002/glia.23166; Coleman P, 2004, NEUROLOGY, V63, P1155, DOI 10.1212/01.WNL.0000140626.48118.0A; Combrinck MI, 2002, NEUROSCIENCE, V112, P7, DOI 10.1016/S0306-4522(02)00030-1; Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Currais A, 2017, FASEB J, V31, P5, DOI 10.1096/fj.201601184; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Biase LM, 2017, NEURON, V95, P341, DOI 10.1016/j.neuron.2017.06.020; De Haas AH, 2008, GLIA, V56, P888, DOI 10.1002/glia.20663; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Di Fede G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21641-1; Duyckaerts C, 2018, ACTA NEUROPATHOL, V135, P201, DOI 10.1007/s00401-017-1791-x; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Erana H, 2017, BIOCHEM BIOPH RES CO, V483, P1125, DOI 10.1016/j.bbrc.2016.08.166; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Fan Z, 2017, BRAIN, V140, P792, DOI 10.1093/brain/aww349; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Flowers A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0840-7; Friedman BA, 2018, CELL REP, V22, P832, DOI 10.1016/j.celrep.2017.12.066; Frontzek K, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14287; Furube E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20643-3; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Gannon M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00220; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Gold Michael, 2017, Alzheimers Dement (N Y), V3, P402, DOI 10.1016/j.trci.2017.04.005; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hamaguchi T, 2016, ACTA NEUROPATHOL, V132, P313, DOI 10.1007/s00401-016-1588-3; Hamelin L, 2016, BRAIN, V139, P1252, DOI 10.1093/brain/aww017; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hart AD, 2012, BRAIN BEHAV IMMUN, V26, P754, DOI 10.1016/j.bbi.2011.11.006; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kamphuis W, 2016, BBA-MOL BASIS DIS, V1862, P1847, DOI 10.1016/j.bbadis.2016.07.007; Kamphuis W, 2014, NEUROBIOL AGING, V35, P492, DOI 10.1016/j.neurobiolaging.2013.09.035; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kang SH, 2008, NAT NEUROSCI, V11, P1365, DOI 10.1038/nn1208-1365; Kasahara Y, 2016, NEUROSCI RES, V111, P64, DOI 10.1016/j.neures.2016.05.001; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11634-x; Kleene R, 2007, J NEUROSCI, V27, P12331, DOI 10.1523/JNEUROSCI.1358-07.2007; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kozai TDY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/066001; KUFFLER SW, 1966, J NEUROPHYSIOL, V29, P768; Kulijewicz-Nawrot M, 2013, ASN NEURO, V5, P273, DOI 10.1042/AN20130017; Kulijewicz-Nawrot M, 2012, J ANAT, V221, P252, DOI 10.1111/j.1469-7580.2012.01536.x; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liebner S, 2018, ACTA NEUROPATHOL, V135, P311, DOI 10.1007/s00401-018-1815-1; Lu PH, 2013, BRAIN COGNITION, V81, P131, DOI 10.1016/j.bandc.2012.09.006; Lunnon K, 2011, J IMMUNOL, V186, P7215, DOI 10.4049/jimmunol.0903833; Macnab LT, 2007, NEUROSCIENCE, V150, P705, DOI 10.1016/j.neuroscience.2007.09.049; Marella M, 2004, J NEUROSCI, V24, P620, DOI 10.1523/JNEUROSCI.4303-03.2004; Martin E, 2017, AGING CELL, V16, P27, DOI 10.1111/acel.12522; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Mitew S, 2010, ACTA NEUROPATHOL, V119, P567, DOI 10.1007/s00401-010-0657-2; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Murray CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-50; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379; Olsen ML, 2007, J NEUROPHYSIOL, V98, P786, DOI 10.1152/jn.00340.2007; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Palin K, 2008, NEUROBIOL DIS, V30, P19, DOI 10.1016/j.nbd.2007.11.012; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; Pannell M, 2014, GLIA, V62, P667, DOI 10.1002/glia.22633; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pennisi M, 2017, J NEUROSCI RES, V95, P1360, DOI 10.1002/jnr.23986; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; RANSOM BR, 1992, J CLIN NEUROPHYSIOL, V9, P224, DOI 10.1097/00004691-199204010-00005; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Ritchie DL, 2017, ACTA NEUROPATHOL, V134, P221, DOI 10.1007/s00401-017-1703-0; Salvadores N, 2014, CELL REP, V7, P261, DOI 10.1016/j.celrep.2014.02.031; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Scheffel J, 2012, GLIA, V60, P1930, DOI 10.1002/glia.22409; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Scott HA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.008; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Shahnawaz M, 2017, JAMA NEUROL, V74, P163, DOI 10.1001/jamaneurol.2016.4547; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Simpson JE, 2011, NEUROBIOL AGING, V32, P1795, DOI 10.1016/j.neurobiolaging.2011.04.013; Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011; Spangenberg EE, 2017, BRAIN BEHAV IMMUN, V61, P1, DOI 10.1016/j.bbi.2016.07.003; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Taipa R, 2018, NEUROPATH APPL NEURO, V44, P298, DOI 10.1111/nan.12445; Tan MG, 2010, J NEUROSCI RES, V88, P1157, DOI 10.1002/jnr.22290; Terry RD, 2000, J NEUROPATH EXP NEUR, V59, P1118, DOI 10.1093/jnen/59.12.1118; Thomson CA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-73; Venegas C, 2017, J LEUKOCYTE BIOL, V101, P87, DOI 10.1189/jlb.3MR0416-204R; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Vincenti JE, 2016, J VIROL, V90, P3003, DOI 10.1128/JVI.02613-15; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Walker LR, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-015-0066-2; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Wu Y, 2017, NEUROSCI LETT, V642, P102, DOI 10.1016/j.neulet.2017.02.007; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang T, 2017, J NEUROSCI, V37, P152, DOI 10.1523/JNEUROSCI.1698-16.2016; Yeh CY, 2011, ASN NEURO, V3, DOI 10.1042/AN20110025; Yin ZR, 2017, NEUROBIOL AGING, V55, P115, DOI 10.1016/j.neurobiolaging.2017.03.021; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zlokovic BV, 2011, TRENDS NEUROSCI, V34, P198, DOI 10.1016/j.tins.2011.01.005	158	15	15	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5766	5777		10.1096/fj.201801360R	http://dx.doi.org/10.1096/fj.201801360R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	30376380	hybrid, Green Published			2022-12-28	WOS:000447172000002
J	Yamamura, A; Nayeem, MJ; Al Mamun, A; Takahashi, R; Hayashi, H; Sato, M				Yamamura, Aya; Nayeem, Md Junayed; Al Mamun, Abdullah; Takahashi, Rie; Hayashi, Hisaki; Sato, Motohiko			Platelet-derived growth factor up-regulates Ca2+-sensing receptors in idiopathic pulmonary arterial hypertension	FASEB JOURNAL			English	Article						imatinib; NPS2143; pulmonary hypertension; STAT1; 3; vascular remodeling	SMOOTH-MUSCLE-CELLS; ION CHANNELS; SILDENAFIL; EXPRESSION; CA2+; ANTIPROLIFERATION; ACTIVATION; STRATEGIES; TARGETS; LUNG	Pulmonary arterial hypertension (PAH) is a progressive and fatal disease associated with remodeling of the pulmonary artery. We previously reported that the Ca2+-sensing receptor (CaSR) is up-regulated in pulmonary arterial smooth muscle cells (PASMCs) from patients with idiopathic PAH (IPAH) and contributes to enhanced Ca2+ responses and excessive cell proliferation. However, the mechanisms underlying the up-regulation of CaSR have not yet been elucidated. We herein examined involvement of platelet-derived growth factor (PDGF) on CaSR expression, Ca2+ responses, and proliferation in PASMCs. The expression of PDGF receptors was higher in PASMCs from patients with IPAH than in PASMCs from normal subjects. In addition, PDGF-induced activation of PDGF receptors and their downstream molecules [ERK1/2, p38, protein kinase B, and signal transducer and activator of transcription (STAT) 1/3] were sustained longer in PASMCs from patients with IPAH. The PDGF-induced CaSR up-regulation was attenuated by small interfering RNA knockdown of PDGF receptors and STAT1/3, and by the treatment with imatinib. In monocrotaline-induced pulmonary hypertensive rats, the up-regulation of CaSR was reduced by imatinib. The combination of NPS2143 and imatinib additively inhibited the development of pulmonary hypertension. These results suggest that enhanced PDGF signaling is involved in CaSR up-regulation, leading to excessive PASMC proliferation and vascular remodeling in patients with IPAH. The linkage between CaSR and PDGF signals is a novel pathophysiological mechanism contributing to the development of PAH.-Yamamura, A., Nayeem, M. J., Al Mamun, A., Takahashi, R., Hayashi, H., Sato, M. Platelet-derived growth factor up-regulates Ca2+-sensing receptors in idiopathic pulmonary arterial hypertension.	[Yamamura, Aya; Nayeem, Md Junayed; Al Mamun, Abdullah; Takahashi, Rie; Hayashi, Hisaki; Sato, Motohiko] Aichi Med Univ, Dept Physiol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan	Aichi Medical University	Yamamura, A; Sato, M (corresponding author), Aichi Med Univ, Dept Physiol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	ayamamur@aichi-med-u.ac.jp; motosato@aichi-med-u.ac.jp	Mamun, Abdullah/HHM-9898-2022	Al Mamun, Md. Abdullah/0000-0003-3839-9603	Japan Society for the Promotion of Science [17K08320]; YOKOYAMA Foundation for Clinical Pharmacology [YRY-1710]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); YOKOYAMA Foundation for Clinical Pharmacology(Yokoyama Foundation for Clinical Pharmacology)	The authors thank Dr. Jason X.-J. Yuan (University of Arizona, Tucson, AZ, USA) for providing pulmonary arterial smooth muscle cell lines from patients with idiopathic pulmonary arterial hypertension. The authors also thank Dr. Hisao Yamamura (Nagoya City University, Nagoya, Japan) for valuable comments. This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (17K08320; to A.Y.). This investigation was also supported by a grant-in-aid from the YOKOYAMA Foundation for Clinical Pharmacology (YRY-1710; to A.Y.). The authors declare no conflicts of interest.	Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Cao YH, 2013, TRENDS MOL MED, V19, P460, DOI 10.1016/j.molmed.2013.05.002; Chiarini A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00134; Ciuclan L, 2013, AM J RESP CRIT CARE, V187, P78, DOI 10.1164/rccm.201206-1028OC; Dahal Bhola K, 2011, Pulm Circ, V1, P259, DOI 10.4103/2045-8932.83448; Frumkin LR, 2012, PHARMACOL REV, V64, P583, DOI 10.1124/pr.111.005587; Guibert C, 2007, CURR PHARM DESIGN, V13, P2443; Hendy GN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00394; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Kunichika N, 2004, AM J RESP CRIT CARE, V170, P1101, DOI 10.1164/rccm.200312-1668OC; Li B, 2007, ANESTH ANALG, V105, P1034, DOI 10.1213/01.ane.0000278736.81133.26; Lythgoe MP, 2016, PHARMACOL THERAPEUT, V164, P195, DOI 10.1016/j.pharmthera.2016.04.012; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; McLaughlin VV, 2015, J AM COLL CARDIOL, V65, P1976, DOI 10.1016/j.jacc.2015.03.540; Montani D, 2014, PHARMACOL THERAPEUT, V141, P172, DOI 10.1016/j.pharmthera.2013.10.002; Montani D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-97; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nakamura K, 2012, INT J CARDIOL, V159, P100, DOI 10.1016/j.ijcard.2011.02.024; Noskovicova N, 2015, AM J RESP CELL MOL, V52, P263, DOI 10.1165/rcmb.2014-0294TR; Ogawa A, 2012, AM J PHYSIOL-CELL PH, V302, pC405, DOI 10.1152/ajpcell.00337.2011; Olschewski A, 2014, PHARMACOL THERAPEUT, V144, P349, DOI 10.1016/j.pharmthera.2014.08.001; Pankey EA, 2013, AM J PHYSIOL-HEART C, V305, pH1288, DOI 10.1152/ajpheart.00329.2013; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Sato M, 2011, J BIOL CHEM, V286, P17766, DOI 10.1074/jbc.M111.219816; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Selimovic N, 2009, EUR RESPIR J, V34, P662, DOI 10.1183/09031936.00174908; Tang HY, 2016, AM J PHYSIOL-LUNG C, V310, pL846, DOI 10.1152/ajplung.00050.2016; Tantini B, 2005, BASIC RES CARDIOL, V100, P131, DOI 10.1007/s00395-004-0504-5; ten Freyhaus H, 2015, ARTERIOSCL THROM VAS, V35, P1236, DOI 10.1161/ATVBAHA.114.304864; Tu L, 2013, HANDB EXP PHARMACOL, V218, P409, DOI 10.1007/978-3-642-38664-0_17; Yamamura A, 2017, EUR J PHARMACOL, V810, P44, DOI 10.1016/j.ejphar.2017.06.010; Yamamura A, 2016, EUR J PHARMACOL, V784, P15, DOI 10.1016/j.ejphar.2016.04.059; Yamamura A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138384; Yamamura A, 2013, CIRC RES, V112, P640, DOI 10.1161/CIRCRESAHA.113.300897; Yamamura A, 2012, CIRC RES, V111, P469, DOI 10.1161/CIRCRESAHA.112.266361; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400	40	16	21	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7363	7374		10.1096/fj.201802620R	http://dx.doi.org/10.1096/fj.201802620R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30865840	Bronze			2022-12-28	WOS:000476114200056
J	Maclean, KN; Jiang, H; Phinney, WN; Keating, AK; Hurt, KJ; Stabler, SP				Maclean, Kenneth N.; Jiang, Hua; Phinney, Whitney N.; Keating, Amy K.; Hurt, K. Joseph; Stabler, Sally P.			Taurine alleviates repression of betaine-homocysteine S-methyltransferase and significantly improves the efficacy of long-term betaine treatment in a mouse model of cystathionine -synthase-deficient homocystinuria	FASEB JOURNAL			English	Article						transsulfuration; coagulation; homocysteine; TNF-; glutathione	CYSTEINE METABOLISM; MICE; METHIONINE; EXPRESSION; THERAPY; HYPERHOMOCYSTEINEMIA; INDUCTION; OXIDATION; FIBROSIS; TISSUES	Classical cystathionine -synthase-deficient homocystinuria (HCU) is a life-threatening inborn error of sulfur metabolism. Treatment for pyridoxine-nonresponsive HCU involves lowering homocysteine (Hcy) with a methionine (Met)-restricted diet and betaine supplementation. Betaine treatment efficacy diminishes significantly over time due to impairment of betaine-Hcy S-methyltransferase (BHMT) function. Little is known regarding the regulation of BHMT in HCU. Using a betaine-responsive preclinical mouse model of HCU, we observed that this condition induces a 75% repression of BHMT mRNA, protein and enzyme activity, and significant depletion of hepatic betaine levels. BHMT repression was proportional to plasma Hcy levels but was not observed in mouse models of homocystinuria due to either methylenetetrahydrofolate reductase or Met synthase deficiency. Both Met supplementation and chemically induced glutathione depletion exacerbated hepatic BHMT repression in HCU mice but not wild-type (WT) controls. Conversely, cysteine treatment normalized hepatic BHMT expression in HCU mice but had no effect in WT control animals. Taurine treatment induced BHMT expression in HCU mice by 5-fold and restored maximal lowering of Hcy levels during long-term betaine treatment with a concomitant normalization of inflammatory cytokine expression and a significantly improved coagulative phenotype. Collectively, our findings indicate that adjuvantial taurine treatment has the potential to significantly improve clinical outcomes in HCU.Maclean, K. N., Jiang, H, Phinney, W. N., Keating, A. K., Hurt, K. J., Stabler, S. P. Taurine alleviates repression of betaine-homocysteine S-methyltransferase and significantly improves the efficacy of long-term betaine treatment in a mouse model of cystathionine -synthase-deficient homocystinuria.	[Maclean, Kenneth N.; Jiang, Hua; Keating, Amy K.] Univ Colorado, Sch Med, Dept Pediat, Mail Stop 8313,POB 6511, Aurora, CO 80045 USA; [Phinney, Whitney N.; Stabler, Sally P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Hurt, K. Joseph] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Maclean, KN (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Mail Stop 8313,POB 6511, Aurora, CO 80045 USA.	ken.maclean@ucdenver.edu	Hurt, K. Joseph/J-8266-2019	Hurt, K. Joseph/0000-0001-6906-350X	William R. Hummel Homocystinuria Research Fund	William R. Hummel Homocystinuria Research Fund	K.N.M. gratefully acknowledges financial support from the William R. Hummel Homocystinuria Research Fund and holds the Ehst-Hummel-Kaufmann Family Endowed Chair in Inherited Metabolic Disease. The authors declare no conflicts of interest.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; ATLAS M, 1984, J MOL CELL CARDIOL, V16, P311, DOI 10.1016/S0022-2828(84)80602-1; Baric I, 2005, J INHERIT METAB DIS, V28, P885, DOI 10.1007/s10545-005-0192-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonhaus D W, 1983, Prog Clin Biol Res, V125, P195; Broze GJ, 2001, THROMB HAEMOSTASIS, V85, P747; CARSON NAJ, 1965, J PEDIATR-US, V66, P565, DOI 10.1016/S0022-3476(65)80121-4; Castro C, 2008, ARCH BIOCHEM BIOPHYS, V472, P26, DOI 10.1016/j.abb.2008.01.017; CHANDA R, 1970, Developmental Psychobiology, V3, P191, DOI 10.1002/dev.420030306; CRITCHLE.M, 1966, P ROY SOC MED, V59, P484, DOI 10.1177/003591576605900604; El Idrissi A, 2008, NEUROSCI LETT, V436, P19, DOI 10.1016/j.neulet.2008.02.070; Eyring KR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190916; Faverzani JL, 2017, CELL MOL NEUROBIOL, V37, P1477, DOI 10.1007/s10571-017-0478-0; FINKELSTEIN JD, 1982, BIOCHEM BIOPH RES CO, V108, P344, DOI 10.1016/0006-291X(82)91872-1; GAHL WA, 1988, J INHERIT METAB DIS, V11, P291, DOI 10.1007/BF01800372; GORDON RE, 1986, AM J PATHOL, V125, P585; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; GUREVICH VS, 1980, B EXP BIOL MED+, V89, P436, DOI 10.1007/BF00830891; HAYES KC, 1989, AM J CLIN NUTR, V49, P1211, DOI 10.1093/ajcn/49.6.1211; Hogg N, 1999, FREE RADICAL BIO MED, V27, P28, DOI 10.1016/S0891-5849(99)00029-5; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Imbard A, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150094; Jiang H, 2015, BIOL OPEN, V4, P1154, DOI 10.1242/bio.013433; Jiang H, 2014, FASEB J, V28, P4044, DOI 10.1096/fj.14-253633; Jiang H, 2012, MOL GENET METAB, V107, P55, DOI 10.1016/j.ymgme.2012.04.025; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; Jurkowska H, 2016, AMINO ACIDS, V48, P665, DOI 10.1007/s00726-015-2108-9; Kang KW, 1999, NITRIC OXIDE-BIOL CH, V3, P265, DOI 10.1006/niox.1999.0233; Keating AK, 2011, MOL GENET METAB, V103, P330, DOI 10.1016/j.ymgme.2011.04.012; Knock E, 2008, J NUTR, V138, P653, DOI 10.1093/jn/138.4.653; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; KOMROWER GM, 1966, ARCH DIS CHILD, V41, P666, DOI 10.1136/adc.41.220.666; Lawson-Yuen A, 2006, MOL GENET METAB, V88, P201, DOI 10.1016/j.ymgme.2006.02.004; LEFAUCONNIER JM, 1976, BRAIN RES, V117, P105, DOI 10.1016/0006-8993(76)90559-X; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Maclean KN, 2018, FASEB J, V32, P1265, DOI 10.1096/fj.201700586R; Maclean KN, 2012, MOL GENET METAB, V105, P395, DOI 10.1016/j.ymgme.2011.11.190; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; MALCANGIO M, 1989, PSYCHOPHARMACOLOGY, V98, P316, DOI 10.1007/BF00451681; Maynard L. A., 1962, ANIMAL NUTRITION, P283; Miller CM, 2005, BIOCHEM J, V392, P443, DOI 10.1042/BJ20050356; Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19; Mudd SH, 2012, MOL GENET METAB, V105, P228, DOI 10.1016/j.ymgme.2011.11.006; MUDD SH, 1985, AM J HUM GENET, V37, P1; Mudd SH, 2003, MOL GENET METAB, V79, P6, DOI 10.1016/S1096-7192(03)00066-0; Mulligan JD, 1998, J NUTR BIOCHEM, V9, P351, DOI 10.1016/S0955-2863(98)00025-4; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; MURPHY JV, 1985, J INHERIT METAB DIS, V8, P109, DOI 10.1007/BF01811482; Orendac M, 2003, J INHERIT METAB DIS, V26, P761, DOI 10.1023/B:BOLI.0000009963.88420.c2; Ou XP, 2007, BIOCHEM J, V401, P87, DOI 10.1042/BJ20061119; PERRY TL, 1968, LANCET, V2, P474; Pullin CH, 2002, J INHERIT METAB DIS, V25, P107, DOI 10.1023/A:1015672625913; Roman HB, 2013, ANTIOXID REDOX SIGN, V19, P1321, DOI 10.1089/ars.2012.5010; Sakamoto A, 2003, PEDIATR INT, V45, P333, DOI 10.1046/j.1442-200X.2003.01714.x; Soupart P., 1962, AMINO ACID POOLS, P220; Stabler SP, 2017, JIMD REP, V37, P55, DOI 10.1007/8904_2017_15; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; STURMAN JA, 1977, LIFE SCI, V21, P1, DOI 10.1016/0024-3205(77)90420-9; Suarez LM, 2014, NEUROPHARMACOLOGY, V79, P101, DOI 10.1016/j.neuropharm.2013.10.035; Swanson DA, 2001, MOL CELL BIOL, V21, P1058, DOI 10.1128/MCB.21.4.1058-1065.2001; van Gelder N M, 1985, Prog Clin Biol Res, V179, P149; WANG QJ, 1989, P SOC EXP BIOL MED, V190, P330; WILCKEN DEL, 1983, NEW ENGL J MED, V309, P448, DOI 10.1056/NEJM198308253090802; WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yokoi K, 2008, PEDIATR INT, V50, P694, DOI 10.1111/j.1442-200X.2008.02717.x	71	8	9	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6339	6353		10.1096/fj.201802069RR	http://dx.doi.org/10.1096/fj.201802069RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768359				2022-12-28	WOS:000466932600042
J	Rubio, K; Dobersch, S; Barreto, G				Rubio, Karla; Dobersch, Stephanie; Barreto, Guillermo			Functional interactions between scaffold proteins, noncoding RNAs, and genome loci induce liquid-liquid phase separation as organizing principle for 3-dimensional nuclear architecture: implications in cancer	FASEB JOURNAL			English	Review						nuclear subcompartments; nucleolus; chromosome territories; biomolecular aggregates; nuclear miRNAs	EMBRYONIC STEM-CELLS; SPATIAL-ORGANIZATION; CHROMOSOMAL TRANSLOCATIONS; OVARIAN-CANCER; NUCLEOLAR; MICRORNAS; DOMAINS; HETEROCHROMATIN; CONTRIBUTES; MECHANISMS	The eukaryotic cell nucleus consists of functionally specialized subcompartments. These nuclear subcompartments are biomolecular aggregates built of proteins, transcripts, and specific genome loci. The structure and function of each nuclear subcompartment are defined by the composition and dynamic interaction between these 3 components. The spatio-temporal localization of biochemical reactions into membraneless nuclear subcompartments can be achieved through liquid-liquid phase separation. Based on this organizing principle, nuclear subcompartments are droplet-like structures that adopt spherical shapes, flow, and fuse like liquids or gels. In the present review, we bring into the spotlight seminal works elucidating the functional interactions between scaffold proteins, noncoding RNAs, and genomic loci, thereby inducing liquid-liquid phase separation as an organizing principle for 3-dimensional nuclear architecture. We also discuss the implications in different cancer types as well as the potential use of this knowledge to develop novel therapeutic strategies against cancer.Rubio, K., Dobersch, S., Barreto, G. Functional interactions between scaffold proteins, noncoding RNAs, and genome loci induce liquid-liquid phase separation as organizing principle for 3-dimensional nuclear architecture: implications in cancer.	[Rubio, Karla; Dobersch, Stephanie; Barreto, Guillermo] Max Planck Inst Heart & Lung Res, Lung Canc Epigenet, Bad Nauheim, Germany; [Barreto, Guillermo] Univ Paris Est Creteil, Equipe Rech Labellisee ERL 9215, CNRS, Lab Croissance Reparat & Regenerat Tissulaires CR, Creteil, France; [Barreto, Guillermo] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Barreto, Guillermo] Univ Giessen, Marburg Lung Ctr, ECCPS, Giessen, Germany; [Barreto, Guillermo] German Ctr Lung Res, Giessen, Germany	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Kazan Federal University; Justus Liebig University Giessen	Barreto, G (corresponding author), Max Planck Inst Heart & Lung Res, Parkstr 1, D-61231 Bad Nauheim, Germany.	guillermo.barreto@mpi-bn.mpg.de	Rubio, Karla/AAP-1385-2021; Barreto, Guillermo/U-5718-2017	Rubio, Karla/0000-0002-8337-3106; Barreto, Guillermo/0000-0002-7777-4712	Max Planck Society [Max-Planck-Gesellschaft (MPG), Munich, Germany]; German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)] [BA 4036/4-1]; Excellence Cluster Cardio Pulmonary System (ECCPS)	Max Planck Society [Max-Planck-Gesellschaft (MPG), Munich, Germany]; German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)](German Research Foundation (DFG)); Excellence Cluster Cardio Pulmonary System (ECCPS)(German Research Foundation (DFG))	The authors thank Dr. Aditi Mehta (Pharmaceutical Technology and Biopharmaceutics, Department of Pharmacy, Ludwig-Maximilians-University of Munich, Germany), Dr. Indrabahadur Singh [Division Chronic Inflammation and Cancer (F180), German Cancer Research Center (DKFZ), Heidelberg, Germany], and Rafael Castillo (Negrete School of Medicine, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico) for helpful discussions. G.B. was funded by the Max Planck Society [Max-Planck-Gesellschaft (MPG), Munich, Germany], the German Research Foundation [Deutsche Forschungsgemeinschaft (DFG); BA 4036/4-1], and the Excellence Cluster Cardio Pulmonary System (ECCPS). This work was done according to the program of competitive growth of the Kazan Federal University and the Russian Government. G.B. is scientific advisor for Hawkeye Bio. The authors declare no conflicts of interest.	Alekseyenko AA, 2015, GENE DEV, V29, P1507, DOI 10.1101/gad.267583.115; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Arribas-Layton M, 2016, MOL CELL BIOL, V36, P2226, DOI 10.1128/MCB.01102-15; Aumiller WM, 2016, NAT CHEM, V8, P129, DOI [10.1038/NCHEM.2414, 10.1038/nchem.2414]; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Barutcu AR, 2016, BBA-GENE REGUL MECH, V1859, P1389, DOI 10.1016/j.bbagrm.2016.08.003; Biamonti G, 2004, NAT REV MOL CELL BIO, V5, P493, DOI 10.1038/nrm1405; Biamonti G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000695; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Carvalho C, 2001, MOL BIOL CELL, V12, P3563, DOI 10.1091/mbc.12.11.3563; Caudron-Herger M, 2016, NUCLEUS-PHILA, V7, P308, DOI 10.1080/19491034.2016.1190890; Caudron-Herger M, 2012, CURR OPIN GENET DEV, V22, P179, DOI 10.1016/j.gde.2011.12.005; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen Q, 2018, CLIN CANCER RES, V24, P684, DOI 10.1158/1078-0432.CCR-17-0605; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cooper C, 2009, NUCLEIC ACIDS RES, V37, P4518, DOI 10.1093/nar/gkp441; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DANG CV, 1989, J BIOL CHEM, V264, P18019; Daoud A, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00222; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Derenzini M, 2000, J PATHOL, V191, P181, DOI 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Dhamija S, 2016, INT J CANCER, V139, P269, DOI 10.1002/ijc.30039; Ding N, 2017, ONCOTARGETS THER, V10, P4905, DOI 10.2147/OTT.S142446; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dutta P, 2013, MOL ONCOL, V7, P647, DOI 10.1016/j.molonc.2013.02.008; Evich M, 2016, PROTEIN SCI, V25, P479, DOI 10.1002/pro.2838; Farley KI, 2015, CHROMOSOMA, V124, P323, DOI 10.1007/s00412-015-0507-z; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fischer AH, 2004, J CELL BIOCHEM, V91, P170, DOI 10.1002/jcb.10735; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.e05-06-0587; Fox AH, 2018, TRENDS BIOCHEM SCI, V43, P124, DOI 10.1016/j.tibs.2017.12.001; Frankowski KJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8307; Ganem NS, 2017, RNA BIOL, V14, P1690, DOI 10.1080/15476286.2017.1364830; Gao L, 2015, INT J CANCER, V136, pE623, DOI 10.1002/ijc.29169; Ghule PN, 2009, J CELL PHYSIOL, V220, P129, DOI 10.1002/jcp.21740; Goradel NH, 2019, J CELL PHYSIOL, V234, P1099, DOI 10.1002/jcp.27051; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grummt I, 2013, CHROMOSOMA, V122, P487, DOI 10.1007/s00412-013-0430-0; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hsu KS, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0204-8; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Isogai Y, 2003, CURR OPIN CELL BIOL, V15, P296, DOI 10.1016/S0955-0674(03)00052-8; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kamath RV, 2005, CANCER RES, V65, P246; Kanis Margaux J, 2018, Gynecol Oncol Res Pract, V5, P7, DOI 10.1186/s40661-018-0064-2; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kohn M, 2016, RNA BIOL, V13, P367, DOI 10.1080/15476286.2016.1152439; Kundu S, 2017, MOL CELL, V65, P432, DOI 10.1016/j.molcel.2017.01.009; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; LEGER I, 1994, CYTOMETRY, V16, P313, DOI 10.1002/cyto.990160405; Leucci E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02535; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070869; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu HY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0765-5; Loughlin FE, 2019, MOL CELL, V73, P490, DOI 10.1016/j.molcel.2018.11.012; Ma YL, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0799-3; Martin-Subero JI, 2003, ANTICANCER RES, V23, P1139; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mayr C, 2006, BLOOD, V107, P742, DOI 10.1182/blood-2005-05-2093; Melo SA, 2014, SEMIN CANCER BIOL, V27, P46, DOI 10.1016/j.semcancer.2014.02.012; Muhlmann Maria, 2002, Genetics and Molecular Research, V1, P117; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; OCHS RL, 1992, EXP CELL RES, V200, P339, DOI 10.1016/0014-4827(92)90181-7; Onciu M, 2006, CANCER-AM CANCER SOC, V107, P1084, DOI 10.1002/cncr.22089; Orsztynowicz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182398; Ottaviani A, 2009, EMBO J, V28, P2428, DOI 10.1038/emboj.2009.201; Park CW, 2010, RNA BIOL, V7, P606, DOI 10.4161/rna.7.5.13215; Pederson T, 2004, CURR OPIN GENET DEV, V14, P203, DOI 10.1016/j.gde.2004.02.008; Pederson T, 2000, J CELL BIOL, V148, P1091, DOI 10.1083/jcb.148.6.1091; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Pederson T, 2010, NUCLEUS-PHILA, V1, P444, DOI 10.4161/nucl.1.5.13056; Pirrotta V, 2012, CURR OPIN GENET DEV, V22, P101, DOI 10.1016/j.gde.2011.11.004; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Powell K, 2015, J CELL BIOL, V208, P384, DOI 10.1083/jcb.2084pi; Ray MK, 2016, J BIOL CHEM, V291, P19558, DOI 10.1074/jbc.M116.730853; Reyes-Gutierrez P, 2014, NUCLEUS-PHILA, V5, P636, DOI 10.4161/19491034.2014.990864; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; Savic N, 2014, CELL STEM CELL, V15, P720, DOI 10.1016/j.stem.2014.10.005; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schuller R, 2016, TRENDS BIOCHEM SCI, V41, P894, DOI 10.1016/j.tibs.2016.05.010; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P2298, DOI 10.1093/hmg/ddt622; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Singh I, 2018, NAT GENET, V50, P990, DOI 10.1038/s41588-018-0139-3; Sloutsky R, 2018, J MOL BIOL, V430, P41, DOI 10.1016/j.jmb.2017.11.001; Smolle MA, 2015, INT J MOL SCI, V16, P26463, DOI 10.3390/ijms161125962; Spector DL, 2001, J CELL SCI, V114, P2891; Towbin BD, 2013, TRENDS BIOCHEM SCI, V38, P356, DOI 10.1016/j.tibs.2013.04.004; Tsai RYL, 2014, FASEB J, V28, P3290, DOI 10.1096/fj.14-254680; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Valton AL, 2016, CURR OPIN GENET DEV, V36, P34, DOI 10.1016/j.gde.2016.03.008; Van Treeck B, 2018, CELL, V174, P791, DOI 10.1016/j.cell.2018.07.023; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Wang CF, 2016, RNA BIOL, V13, P940, DOI 10.1080/15476286.2016.1215796; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wesierska-Gadek J, 2003, ANN NY ACAD SCI, V1010, P266, DOI 10.1196/annals.1299.046; West JA, 2016, J CELL BIOL, V214, P817, DOI 10.1083/jcb.201601071; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang JS, 2017, ONCOL LETT, V14, P4983, DOI 10.3892/ol.2017.6769; Zhang XY, 2018, J CELL BIOCHEM, V119, P5426, DOI 10.1002/jcb.26697	121	9	9	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5814	5822		10.1096/fj.201802715R	http://dx.doi.org/10.1096/fj.201802715R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30742773	Green Submitted			2022-12-28	WOS:000466932600002
J	Schnittert, J; Bansal, R; Mardhian, DF; van Baarlen, J; Ostman, A; Prakash, J				Schnittert, Jonas; Bansal, Ruchi; Mardhian, Deby F.; van Baarlen, Joop; Ostman, Arne; Prakash, Jai			Integrin 11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer	FASEB JOURNAL			English	Article						tumor microenvironment; cancer-associated fibroblasts; transforming growth factor; cell migration; metastasis	FIBROBLASTS; FIBROSIS; CARCINOMA; MYOFIBROBLASTS; EXPRESSION; TARGETS; BIOLOGY; TISSUE	Pancreatic ductal adenocarcinoma (PDAC) is the deadliest tumor due to its highly abundant tumor stroma. Pancreatic stellate cells (PSCs) are considered precursor cells of cancer-associated fibroblasts (CAFs), which induce tumor progression, invasion, and metastasis. In this study, we investigated the role of integrin subunit (ITGA) 11, the receptor for collagen type I, in tumor stroma interaction. Clinical sample analysis showed that ITGA11 was overexpressed by CAFs in PDAC stroma, as shown with colocalization immunostaining with -smooth muscle actin. In contrast, there was no expression in healthy pancreas. Public transcriptomic data confirmed a reduced expression of ITGA11 in healthy pancreas and adjacent nontumoral tissues compared with human tumor tissues. Primary human PSCs (hPSCs) activated with either TGF- or pancreatic cancer cell (PANC-1)-conditioned medium (CM) resulted in the significant up-regulation of ITGA11 and various CAF markers. Furthermore, short hairpin RNA (shRNA)-mediated stable ITGA11 knockdown (shITGA11) in hPSCs significantly inhibited TGF-- and PANC-1 CM-mediated activation at both gene and protein levels of extracellular matrix, cytokines, and adhesion molecules. Additionally, shITGA11 hPSCs had a reduced migration and contractility compared with shRNA control (shCTR) PSCs. Furthermore, we investigated the effect of ITGA11 on the paracrine effects of hPSCs. Interestingly, the CM from shITGA11 hPSCs, activated with either TGF- or PANC-1 CM, caused tumor cells to migrate and invade lesser compared with their counterpart, activated shCTR PSCs. In summary, this study presents ITGA11 as an interesting stromal therapeutic target that plays a crucial role in the regulation of the differentiation of PSCs into CAFs and paracrine effects.Schnittert, J., Bansal, R., Mardhian, D. F., van Baarlen, J., ostman, A., Prakash, J. Integrin 11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.	[Schnittert, Jonas; Bansal, Ruchi; Mardhian, Deby F.; Prakash, Jai] Univ Twente, Dept Biomat Sci & Technol, TechMed Ctr, Targeted Therapeut Sect,Fac Sci & Technol, Zuidhorst 254, NL-7500 AE Enschede, Netherlands; [van Baarlen, Joop] Lab Pathol East Netherlands LabPON, Hengelo, Netherlands; [Ostman, Arne; Prakash, Jai] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden	University of Twente; Karolinska Institutet	Prakash, J (corresponding author), Univ Twente, Dept Biomat Sci & Technol, TechMed Ctr, Targeted Therapeut Sect,Fac Sci & Technol, Zuidhorst 254, NL-7500 AE Enschede, Netherlands.	j.prakash@utwente.nl	Mardhian, Deby/AAD-6215-2022; Prakash, Jai/C-8015-2014; Bansal, Ruchi/D-4796-2016	Prakash, Jai/0000-0003-1050-650X; Bansal, Ruchi/0000-0003-2470-5876; Mardhian, Deby/0000-0003-0162-4926	Swedish Research Council [2011-5389]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Swedish Research Council (Project 2011-5389). J.P. is a founder and stakeholder of ScarTec Therapeutics (Enschede). The remaining authors declare no conflicts of interest.	Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Apte MV, 2012, J GASTROEN HEPATOL, V27, P69, DOI 10.1111/j.1440-1746.2011.07000.x; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Bansal R, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.213; Bansal R, 2011, J CONTROL RELEASE, V154, P233, DOI 10.1016/j.jconrel.2011.05.027; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Conroy KP, 2016, CELL TISSUE RES, V365, P511, DOI 10.1007/s00441-016-2407-9; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Habisch Hansjorg, 2010, Cancers (Basel), V2, P1661, DOI 10.3390/cancers2031661; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Juuti A, 2004, J CLIN PATHOL, V57, P1151, DOI 10.1136/jcp.2003.015818; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kuninty PR, 2016, ONCOTARGET, V7, P16396, DOI 10.18632/oncotarget.7651; Kuninty PR, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00003; Lu N, 2010, MATRIX BIOL, V29, P166, DOI 10.1016/j.matbio.2009.11.003; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Navab R, 2016, ONCOGENE, V35, P1899, DOI 10.1038/onc.2015.254; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Netti PA, 2000, CANCER RES, V60, P2497; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Parajuli H, 2017, J ORAL PATHOL MED, V46, P267, DOI 10.1111/jop.12493; Prakash J, 2016, TRENDS CANCER, V2, P277, DOI 10.1016/j.trecan.2016.04.005; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Reed NI, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5094; Sarper M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27639; Schnittert J, 2018, ADV DRUG DELIVER REV, V129, P37, DOI 10.1016/j.addr.2018.01.020; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Xie DH, 2015, GENES DIS, V2, P133, DOI 10.1016/j.gendis.2015.01.002; Yazdani S, 2017, ADV DRUG DELIVER REV, V121, P101, DOI 10.1016/j.addr.2017.07.010; Zhang G, 2013, CLIN CANCER RES, V19, P4983, DOI 10.1158/1078-0432.CCR-13-0209; Zhang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031507	44	27	27	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6609	6621		10.1096/fj.201802336R	http://dx.doi.org/10.1096/fj.201802336R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30808244				2022-12-28	WOS:000466932600063
J	Wang, P; Tian, HL; Zhang, JY; Qian, JJ; Li, L; Shi, L; Zhao, Y				Wang, Peng; Tian, Hongling; Zhang, Jiayu; Qian, Juanjuan; Li, Ling; Shi, Lu; Zhao, Yong			Spaceflight/microgravity inhibits the proliferation of hematopoietic stem cells by decreasing Kit-Ras/cAMP-CREB pathway networks as evidenced by RNA-Seq assays	FASEB JOURNAL			English	Article						HSPCs; signaling pathway; SJ-10 satellite; Tianzhou-1 cargo ship	BONE-MARROW; MACROPHAGE POLARIZATION; CYCLE CONTROL; SPACE; MICROGRAVITY; ERYTHROPOIESIS; ASTRONAUTS; EXPRESSION; INDUCTION; ANEMIA	Exposure to spaceflight and microgravity causes physiologic and psychologic changes including bone loss, cardiovascular dysfunction, and immune dysfunction. Anemia and hematopoietic disorders are observed in astronauts after spaceflight. Hematopoietic stem and progenitor cells (HSPCs), which can self-renew and give rise to all blood cells, play vital roles in hematopoiesis and homeostasis; however, the molecular mechanisms responsible for the impacts of microgravity on the proliferation of HSPCs remain unclear. We maintained mouse bone marrow HSPCs in the presence of stem cell factor for 12 d under spaceflight and simulated microgravity conditions, respectively, and analyzed cell proliferation and gene expression. Both spaceflight and simulated microgravity significantly decreased the number of HSPCs, mainly by blocking cell cycle at G(1)/S transition, but did not affect their differentiation abilities. RNA-sequencing data indicated that genes related to cell proliferation were down-regulated, whereas the genes related to cell death were up-regulated under microgravity. Among the gene signatures, we identified that the Kit-Ras/cAMP-cAMP response element-binding protein pathway might be one of the major microgravity-regulated pathways during HSPC proliferation. Furthermore, the quantification of notable genes was validated at the mRNA levels under simulated microgravity condition. Overall, these results would help us to understand the intracellular molecular mechanisms regulating microgravity-inhibited proliferation of HSPCs.Wang, P., Tian, H., Zhang, J., Qian, J., Li, L., Shi, L., Zhao, Y. Spaceflight/microgravity inhibits the proliferation of hematopoietic stem cells by decreasing Kit-Ras/cAMP-CREB pathway networks as evidenced by RNA-Seq assays.	[Wang, Peng; Tian, Hongling; Zhang, Jiayu; Qian, Juanjuan; Li, Ling; Shi, Lu; Zhao, Yong] Chinese Acad Sci, State Key Lab Membrane Biol, Inst Zool, Beijing, Peoples R China; [Zhao, Yong] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China; [Zhang, Jiayu; Zhao, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, L; Zhao, Y (corresponding author), Chinese Acad Sci, Inst Zool, Transplantat Biol Res Div, State Key Lab Membrane Biol, Beichen West Rd 1-5, Beijing 100101, Peoples R China.	shilu@ioz.ac.cn; zhaoy@ioz.ac.cn		wang, peng/0000-0003-1845-7589	Program of National Natural Science Foundation of China [U1738111, 81530049, 31470860]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16030301]; Mega-Projects of National Science Research for the 13th Five-Year Plan; China Manned Space Flight Technology Project [TZ-1]	Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Mega-Projects of National Science Research for the 13th Five-Year Plan; China Manned Space Flight Technology Project	The authors thank Dr. Huiting Su (State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences) for critical reading of the manuscript. This work was supported by grants from the Program of National Natural Science Foundation of China (U1738111 to Y.Z.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16030301 to Y.Z.), the Mega-Projects of National Science Research for the 13th Five-Year Plan (to L.L.), the Program of National Natural Science Foundation of China (81530049 and 31470860 to Y.Z.), and the China Manned Space Flight Technology Project (TZ-1). The raw RNA-Seq data from this study have been deposited at the Big Data (BIGD) Genome Sequence Archive under accession number CRA001198. The authors declare no conflicts of interest.	Bedessem B, 2014, MATH BIOSCI, V248, P31, DOI 10.1016/j.mbs.2013.11.007; Berridge MJ, 2014, CELL SIGNAL BIOL, V6, P1, DOI DOI 10.1042/CSB0001002; Blaber E, 2014, STEM CELLS DEV, V23, P73, DOI 10.1089/scd.2014.0408; Borchers AT, 2002, NUTRITION, V18, P889, DOI 10.1016/S0899-9007(02)00913-9; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Connell-Crowley L, 1998, CURR BIOL, V8, P65, DOI 10.1016/S0960-9822(98)70021-1; Davis TA, 1996, J LEUKOCYTE BIOL, V60, P69, DOI 10.1002/jlb.60.1.69; De Santo NG, 2005, SEMIN NEPHROL, V25, P379, DOI 10.1016/j.semnephrol.2005.05.006; Delp MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep29901; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Domaratskaya EI, 2002, ADV SPACE RES, V30, P771, DOI 10.1016/S0273-1177(02)00394-0; Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x; Graebe A, 2004, J CLIN PHARMACOL, V44, P837, DOI 10.1177/0091270004267193; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Guo Yong, 2016, Chinese Medical Sciences Journal, V31, P100; Hou YZ, 2018, PROTEIN CELL, V9, P1027, DOI 10.1007/s13238-018-0505-z; Hsu P, 2013, CURR OPIN HEMATOL, V20, P289, DOI 10.1097/MOH.0b013e328360ab4d; Hu WR, 2014, MICROGRAVITY SCI TEC, V26, P159, DOI 10.1007/s12217-014-9390-0; LANGE RD, 1994, AVIAT SPACE ENVIR MD, V65, P730; Laresgoiti U, 2013, NUCLEIC ACIDS RES, V41, P10185, DOI 10.1093/nar/gkt821; Li Y, 2018, CELL MOL IMMUNOL, V15, P518, DOI 10.1038/cmi.2017.39; Liang ZF, 2018, AUTOPHAGY, V14, P505, DOI 10.1080/15548627.2017.1376161; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P827, DOI 10.1038/icb.2011.65; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Meng D, 2017, AEROSPACE CHINA, V3, P62; Morettini S, 2008, FRONT BIOSCI-LANDMRK, V13, P5522; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Plett RA, 2001, IN VITRO CELL DEV-AN, V37, P73, DOI 10.1290/1071-2690(2001)037<0073:POHHBM>2.0.CO;2; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sergushichev AA, 2016, NUCLEIC ACIDS RES, V44, pW194, DOI 10.1093/nar/gkw266; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sholl-Franco A, 2010, INT J DEV NEUROSCI, V28, P63, DOI 10.1016/j.ijdevneu.2009.09.004; Sun B, 2018, CELL MOL IMMUNOL, V15, P782, DOI 10.1038/cmi.2017.163; TAVASSOLI M, 1982, BLOOD, V60, P1059; UDDEN MM, 1995, AVIAT SPACE ENVIR MD, V66, P557; VACEK A, 1982, CELL TISSUE KINET, V15, P643, DOI 10.1111/j.1365-2184.1982.tb01070.x; Vajravelu BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140798; Vernikos J, 1996, BIOESSAYS, V18, P1029, DOI 10.1002/bies.950181215; Wakabayashi K, 2017, PHYSIOL PLANTARUM, V161, P285, DOI 10.1111/ppl.12591; Wang CZ, 2015, INFLAMM RES, V64, P303, DOI 10.1007/s00011-015-0811-3; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu XR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00315; Wu XL, 2017, ONCOTARGET, V8, P82968, DOI 10.18632/oncotarget.20897; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Zhang C, 2018, FASEB J, V32, P4444, DOI 10.1096/fj.201700208RR; Zhao H., 2016, J SPACE EXPLOR, V5, P101; Zhao QJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00637; Zhao Y, 2018, BLOOD, V131, P1587, DOI 10.1182/blood-2017-04-777128; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	52	14	14	3	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5903	5913		10.1096/fj.201802413R	http://dx.doi.org/10.1096/fj.201802413R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30721627	Green Published			2022-12-28	WOS:000466932600009
J	Zhang, HZ; Ren, LL; Ding, Y; Li, FY; Chen, XF; Ouyang, Y; Zhang, Y; Zhang, DS				Zhang, Huizhong; Ren, Liangliang; Ding, Ya; Li, Fengyan; Chen, Xiangfu; Ouyang, Ying; Zhang, Yan; Zhang, Dongsheng			Hyaluronan-mediated motility receptor confers resistance to chemotherapy via TGF/Smad2-induced epithelial-mesenchymal transition in gastric cancer	FASEB JOURNAL			English	Article						HMMR; chemoresistance; EMT; cancer stem cell	TGF-BETA; STEM-CELLS; RHAMM; METASTASIS; CHEMORADIOTHERAPY; CHEMORESISTANCE; ADENOCARCINOMA; TUMORIGENICITY; IDENTIFICATION; HETEROGENEITY	Chemotherapy is one of the vital treatments for gastric cancer (GC) patients, especially those suffering advanced stages. Chemoresistance results in tumor relapse, leading to poor prognosis in GC patients; thus, identifying key regulators in this process might provide novel clues for GC therapy. Herein, we identify hyaluronan-mediated motility receptor (HMMR) as a key regulator of chemoresistance in GC. HMMR was found to be substantially up-regulated in 5-fluorouracil (5-Fu)-resistant GC biopsies and cell lines. High expression of HMMR significantly correlates with tumor relapse and predicts poorer prognosis in GC patients. Moreover, we observed that HMMR induced epithelial-mesenchymal transition and increased the cancer stem cell properties of GC, thus rendering resistance to chemotherapy. Importantly, silencing of HMMR effectively increased the susceptibility to 5-Fu therapy both in vitro and in vivo. Furthermore, we demonstrated that HMMR activates the TGF-/Smad2 signaling pathway, which was required for the HMMR-mediated oncogenic effects and exhibited significant clinical relevance with HMMR expression. These findings reveal a critical role for HMMR in the chemoresistance of GC and suggest that HMMR might be a potential prognostic marker or therapeutic target against the disease.Zhang, H., Ren, L., Ding, Y., Li, F., Chen, X., Ouyang, Y., Zhang, Y., Zhang, D. Hyaluronan-mediated motility receptor confers resistance to chemotherapy via TGF/Smad2-induced epithelial-mesenchymal transition in gastric cancer.	[Zhang, Huizhong; Ren, Liangliang; Ding, Ya; Li, Fengyan; Chen, Xiangfu; Ouyang, Ying; Zhang, Dongsheng] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, 651 Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China; [Zhang, Huizhong] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Ding, Ya] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Biotherapy, Guangzhou, Guangdong, Peoples R China; [Li, Fengyan] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Zhang, Dongsheng] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Ren, Liangliang] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Biochem, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Yan] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, 26 Yuancun Erheng Rd, Guangzhou 510655, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhang, DS (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, 651 Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China.; Zhang, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, 26 Yuancun Erheng Rd, Guangzhou 510655, Guangdong, Peoples R China.	zhangy338@mail.sysu.edu.cn; zhangdsh@sysucc.org.cn	LI, feng/HIR-1703-2022; Ren, Liangliang/AAR-6436-2020	Ren, Liangliang/0000-0001-6219-4304	China Cancer Society Fund [201606]; Nature Science Foundation of China [81602141]; Natural Science Foundation of Guangdong Province [2016A030308002]	China Cancer Society Fund; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the China Cancer Society Fund (201606), Nature Science Foundation of China (81602141), and the Natural Science Foundation of Guangdong Province (2016A030308002). The authors declare no conflict of interest.	Abraham I, 2002, NEW ENGL J MED, V346, P210; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Assmann V, 1999, J CELL SCI, V112, P3943; Bekaii-Saab T, 2017, CANCER-AM CANCER SOC, V123, P1303, DOI 10.1002/cncr.30538; Blanco I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120020; Buttermore ST, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0360-1; Cai JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15870; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Corso S, 2016, TRENDS MOL MED, V22, P534, DOI 10.1016/j.molmed.2016.05.004; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Gust KM, 2009, NEOPLASIA, V11, P956, DOI 10.1593/neo.09694; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Huang Hao, 2016, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V38, P739, DOI 10.3881/j.issn.1000-503X.2016.06.020; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kim TY, 2015, EXPERT REV GASTROENT, V9, P1471, DOI 10.1586/17474124.2015.1096774; Koelzer VH, 2015, HUM PATHOL, V46, P1573, DOI 10.1016/j.humpath.2015.07.010; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Li CY, 2016, MED SCI MONITOR, V22, P4509, DOI 10.12659/MSM.898415; Lloyd DAJ, 2006, NEW ENGL J MED, V355, P1387; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MAXWELL C, 2011, S B, V9, DOI DOI 10.1371/JOURNAL.PBIO.1001199; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Mitra T, 2018, J CELL BIOCHEM, V119, P5775, DOI 10.1002/jcb.26753; Niedworok C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075681; Orditura M, 2014, WORLD J GASTROENTERO, V20, P1635, DOI 10.3748/wjg.v20.i7.1635; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Peitzsch C, 2017, SEMIN CANCER BIOL, V44, P10, DOI 10.1016/j.semcancer.2017.02.011; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Purnell MC, 2017, DISCOV MED, V23, P259; Qiu Zhen-Qin, 2015, Asian Pac J Cancer Prev, V16, P3447; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schutze A, 2016, ONCOTARGET, V7, P21428, DOI 10.18632/oncotarget.7258; Shah MA, 2015, J CLIN ONCOL, V33, P1760, DOI 10.1200/JCO.2014.60.1799; Stavropoulou V, 2016, CANCER CELL, V30, P43, DOI 10.1016/j.ccell.2016.05.011; Stevens LE, 2017, CANCER RES, V77, P1905, DOI 10.1158/0008-5472.CAN-16-1978; Sun WJ, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0147-6; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tang YA, 2018, P NATL ACAD SCI USA, V115, pE5990, DOI 10.1073/pnas.1801348115; Tilghman J, 2014, CANCER RES, V74, P3168, DOI 10.1158/0008-5472.CAN-13-2103; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Tolg C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/103923; Unternaehrer JJ, 2014, STEM CELL REP, V3, P691, DOI 10.1016/j.stemcr.2014.09.008; Xiao YB, 2018, MOL MED REP, V17, P6379, DOI 10.3892/mmr.2018.8726; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhuang JL, 2017, THERANOSTICS, V7, P3053, DOI 10.7150/thno.19542	52	33	34	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6365	6377		10.1096/fj.201802186R	http://dx.doi.org/10.1096/fj.201802186R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30802150	Bronze			2022-12-28	WOS:000466932600044
J	Xie, BC; Nguyen, PM; Idevall-Hagren, O				Xie, Beichen; Phuoc My Nguyen; Idevall-Hagren, Olof			Feedback regulation of insulin secretion by extended synaptotagmin-1	FASEB JOURNAL			English	Article						Ca2+; beta-cell; membrane contact sites; TMEM24; PKC	PROTEIN-KINASE-C; BETA-CELLS; MOUSE DEVELOPMENT; CA2+ CHANNEL; ACTIVATION; RELEASE; MECHANISMS; EXOCYTOSIS; VIABILITY; COMPONENT	Endoplasmic reticulum (ER)-plasma membrane (PM) contacts are dynamic structures with important roles in the regulation of calcium (Ca2+) and lipid homeostasis. The extended synaptotagmins (E-Syts) are ER-localized lipid transport proteins that interact with PM phosphatidylinositol 4,5-bisphosphate in a Ca2+-dependent manner. E-Syts bidirectionally transfer glycerolipids, including diacylglycerol (DAG), between the 2 juxtaposed membranes, but the biologic significance of this transport is still unclear. Using insulin-secreting cells and live-cell imaging, we now show that Ca2+-triggered exocytosis of insulin granules is followed, in sequence, by PM DAG formation and E-Syt1 recruitment. E-Syt1 counteracted the depolarization-induced DAG formation through a mechanism that required both voltage-dependent Ca2+ influx and Ca2+ release from the ER. E-Syt1 knockdown resulted in prolonged accumulation of DAG in the PM, resulting in increased glucose-stimulated insulin secretion. We conclude that Ca2+-triggered exocytosis is temporally coupled to Ca2+-triggered E-Syt1 PM recruitment and removal of DAG to negatively regulate the same process.	[Xie, Beichen; Phuoc My Nguyen; Idevall-Hagren, Olof] Uppsala Univ, Dept Med Cell Biol, BMC Box 571, S-75123 Uppsala, Sweden	Uppsala University	Idevall-Hagren, O (corresponding author), Uppsala Univ, Dept Med Cell Biol, BMC Box 571, S-75123 Uppsala, Sweden.	olof.idevall@mcb.uu.se		Nguyen, Phuoc My/0000-0003-1396-571X; Idevall Hagren, Olof/0000-0002-0241-6304	Swedish Research Council; Goran Gustafsson Foundation; Malin and Lennart Philipson Foundation; Excellence of Diabetes Research in Sweden; Ake Wiberg Foundation; Novo-Nordisk Foundation; Magnus Bergwall Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson Foundation; Malin and Lennart Philipson Foundation; Excellence of Diabetes Research in Sweden; Ake Wiberg Foundation; Novo-Nordisk Foundation(Novo Nordisk Foundation); Magnus Bergwall Foundation	The authors thank Antje Thonig (Uppsala University) for expert technical assistance and Prof. Anders Tengholm (Uppsala University) for discussions. This study was funded by the Swedish Research Council, the Goran Gustafsson Foundation, the Malin and Lennart Philipson Foundation, Excellence of Diabetes Research in Sweden, Ake Wiberg Foundation, The Novo-Nordisk Foundation, and Magnus Bergwall Foundation (to O.I.-H.). The authors declare no conflicts of interest.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; ARKHAMMAR P, 1989, BIOCHEM J, V264, P207, DOI 10.1042/bj2640207; Bian X, 2018, EMBO J, V37, P219, DOI 10.15252/embj.201797359; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Estevez-Herrera J, 2016, P NATL ACAD SCI USA, V113, pE4098, DOI 10.1073/pnas.1600690113; Fan F, 2015, J CLIN INVEST, V125, P4026, DOI 10.1172/JCI80652; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Frank JA, 2016, NAT CHEM BIOL, V12, P755, DOI 10.1038/nchembio.2141; Gandasi NR, 2017, J CLIN INVEST, V127, P2353, DOI 10.1172/JCI88491; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Henne WM, 2015, CURR OPIN CELL BIOL, V35, P123, DOI 10.1016/j.ceb.2015.05.001; Herdman C, 2014, CELL CYCLE, V13, P2616, DOI 10.4161/15384101.2014.943573; Idevall-Hagren O, 2015, EMBO J, V34, P2291, DOI 10.15252/embj.201591565; Idevall-Hagren O, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003932; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Kaneko YK, 2015, BIOL PHARM BULL, V38, P669, DOI 10.1248/bpb.b15-00060; Kaneko YK, 2013, ENDOCRINOLOGY, V154, P4089, DOI 10.1210/en.2013-1356; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Khan S, 2014, DIABETOLOGIA, V57, P2535, DOI 10.1007/s00125-014-3368-8; Lees JA, 2017, SCIENCE, V355, DOI 10.1126/science.aah6171; Liang K, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00109; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Pottekat A, 2013, CELL REP, V4, P921, DOI 10.1016/j.celrep.2013.07.050; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Santo-Domingo J, 2017, FASEB J, V31, P1028, DOI 10.1096/fj.201600837R; Schauder CM, 2014, NATURE, V510, P552, DOI 10.1038/nature13269; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Tremblay MG, 2016, CELL CYCLE, V15, P2360, DOI 10.1080/15384101.2016.1203494; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; VIRJI MAG, 1978, ENDOCRINOLOGY, V102, P706, DOI 10.1210/endo-102-3-706; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wuttke A, 2016, J BIOL CHEM, V291, P14986, DOI 10.1074/jbc.M115.698456; Wuttke A, 2013, FASEB J, V27, P1610, DOI 10.1096/fj.12-221499; Yu HJ, 2016, P NATL ACAD SCI USA, V113, P4362, DOI 10.1073/pnas.1517259113; Yuan TY, 2015, DEV CELL, V35, P120, DOI 10.1016/j.devcel.2015.09.004; Zawalich WS, 2001, MOL CELL ENDOCRINOL, V177, P95, DOI 10.1016/S0303-7207(01)00422-1; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	46	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4716	4728		10.1096/fj.201801878R	http://dx.doi.org/10.1096/fj.201801878R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30589572				2022-12-28	WOS:000462888500007
J	Ali, A; Biswas, A; Pal, M				Ali, Asif; Biswas, Anindya; Pal, Mahadeb			HSF1 mediated TNF- production during proteotoxic stress response pioneers proinflammatory signal in human cells	FASEB JOURNAL			English	Article						heat shock response; NF-B; heat shock elements; LEF1; TNFR1	NF-KAPPA-B; FACTOR-ALPHA GENE; HEAT-SHOCK RESPONSE; PROTEIN-QUALITY CONTROL; TRANSCRIPTION FACTOR; NUCLEAR-FACTOR; DNA-BINDING; ACTIVATION; EXPRESSION; INFLAMMATION	The proteotoxic stress response that safeguards the cellular proteome from various stressors was shown to activate NF-B signaling pathways (NBS) with an underlying mechanism that is poorly understood. We show here that the TNF- gene, a pleiotropic NBS inducer, is a direct target of heat shock factor 1 (HSF1). Human HSF1 drives this process by assembling a multiprotein activation complex at a heat shock element (HSE) located at the 3-UTR of the TNF- gene (HSE5). HSF1 associated with the HSE5 at the TNF- 3-UTR communicates with the promoter through chromatin looping by recruiting lymphoid enhancer-binding factor 1 at an adjacent Wnt-responsive element through its transactivation domain. TNF- thus produced guides the activation of NBS by acting through TNF- receptor 1 (TNFR1). Notably, cells with TNFR1(-/-) background or masked HSE5 through Clustered Regularly Interspaced Short Palindromic Repeats/dead CRISPR-associated protein 9 were defective in NBS and exhibited marked alteration in cellular biology, which includes loss of ability of cancer cells to migrate, to clear the protein aggregates, and associated toxicity upon heat shock. For the first time, our results suggest that TNF- thus produced pioneers the proinflammatory signal during proteotoxic stress response with an important implication for inflammation and cancer.Ali, A., Biswas, A., Pal, M. HSF1 mediated TNF- production during proteotoxic stress response pioneers proinflammatory signal in human cells.	[Ali, Asif; Pal, Mahadeb] Bose Inst, Div Mol Med, Kolkata, India; [Biswas, Anindya] Bose Inst, Dept Biochem, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Pal, M (corresponding author), Bose Inst, P1-12 CIT Scheme VIIM, Kolkata 700054, India.	mahadeb@jcbose.ac.in		Biswas, Anindya/0000-0003-1645-2856; ali, asif/0000-0001-8520-857X	SERB, DBT; Bose Institute plan program IV	SERB, DBT; Bose Institute plan program IV(Department of Science & Technology (India))	The authors thank Christian Buske (University Hospital Ulm, Ulm, Germany) for LEF1 shRNA construct, Jia-Da Li (Central South University, Changsha, China) for HA-LEF1 expression construct, Lajos Haracska (Institute of Genetics, Biological Research Center, Szeged, Hungary) for HLTF shRNA construct, Akira Nakai (Osaka University, Osaka, Japan) for human GST-HSF1 fusion constructs, and Jin-Soo Kim (Seoul University, Seoul, Korea) for the HEK293 TNFR1<SUP>-/-</SUP> cell line. Kind help from Subrata Sau (Bose Institute) during DNA footprinting experiment is appreciated. Thanks are due to Don Luse (Cleveland Clinic, Cleveland, OH, USA), George Stark (Cleveland Clinic, Cleveland, OH, USA), and Katerina Gurova (Roswell Park Cancer Institute, Buffalo, NY, USA) for their comments on this work. The authors appreciate the valuable comments from Shamila Sarwar (Bose Institute) on the manuscript editing. The authors thank Katerina Gurova for SSRP1 siRNA and Vinod Kumar Nelson (Bose Institute) for azadiradione. The authors thank Srabani Pal (BioBharati LifeScience) for her expert help during some plasmid construction used in the study. The authors also thank R. Chattopadhyay (Bose Institute), Zhumur Ghosh (Bose Institute), and Koustav Pal (Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India) for their comments. The work was supported by funding from SERB, DBT, and Bose Institute plan program IV. A.A. is a CSIR ad hoc fellow. The authors declare no conflicts of interest.	AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Brunquell J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2837-5; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Chen K, 2017, MOL ONCOL, V11, P1475, DOI 10.1002/1878-0261.12116; Chowdhary S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00292-17; Coccia M, 2017, P NATL ACAD SCI USA, V114, P1045, DOI 10.1073/pnas.1616112114; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Fujimoto M, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00051-18; Fujimoto M, 2012, MOL CELL, V48, P182, DOI 10.1016/j.molcel.2012.07.026; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Grossi V, 2018, NUCLEIC ACIDS RES, V46, P5587, DOI 10.1093/nar/gky331; Grumolato L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003603; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hazra J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168165; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Holwerda Sjoerd, 2012, Frontiers in Genetics, V3, P217, DOI 10.3389/fgene.2012.00217; Hunter P, 2012, EMBO REP, V13, P968, DOI 10.1038/embor.2012.142; Janus P, 2015, MOL GENET GENOMICS, V290, P1979, DOI 10.1007/s00438-015-1055-1; Jash A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040828; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; KRAMER B, 1995, J BIOL CHEM, V270, P6577; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Kretz-Remy C, 2001, J BIOL CHEM, V276, P43723, DOI 10.1074/jbc.M010821200; Kwon J, 1996, J BIOL CHEM, V271, P22383, DOI 10.1074/jbc.271.37.22383; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Laramie JM, 2008, SHOCK, V29, P623, DOI 10.1097/SHK.0b013e318157f33c; Li L, 2015, MOL CELL, V58, P216, DOI 10.1016/j.molcel.2015.02.023; Li Y, 2015, ONCOTARGET, V6, P2421, DOI 10.18632/oncotarget.2965; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lis JT, 2000, GENE DEV, V14, P792; Liu YN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13547; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nivon M, 2016, MOL BIOL CELL, V27, P1712, DOI 10.1091/mbc.E15-12-0835; Nivon M, 2012, J CELL SCI, V125, P1141, DOI 10.1242/jcs.091041; Pal S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-23; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; Ramesh V, 1996, J MOL BIOL, V260, P22, DOI 10.1006/jmbi.1996.0379; Rao R, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.5297.5297; Rossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031304; Rossi A, 2010, J BIOL CHEM, V285, P13607, DOI 10.1074/jbc.M109.082693; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Ting AT, 2016, TRENDS IMMUNOL, V37, P535, DOI 10.1016/j.it.2016.06.002; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Tsytsykova AV, 2002, MOL CELL BIOL, V22, P2620, DOI 10.1128/MCB.22.8.2620-2631.2002; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Vihervaara A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00151-0; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xu WP, 2011, CANCER CELL, V20, P281, DOI 10.1016/j.ccr.2011.08.020; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x; Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744; Zhou Z., 2017, CELL PROLIF, V50	79	7	7	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2621	2635		10.1096/fj.201801482R	http://dx.doi.org/10.1096/fj.201801482R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307772				2022-12-28	WOS:000457296600087
J	Back, M; Hansson, GK				Back, Magnus; Hansson, Goran K.			Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation	FASEB JOURNAL			English	Article						atherosclerosis; leukotrienes; resolvins	ANTIINFLAMMATORY ACTIONS; LIPID MEDIATORS; LEUKOTRIENE	Although a high marine food intake is considered cardioprotective, randomized trials of -3 fatty acids initially generated conflicting results in terms of the role of -3 supplementation in cardiovascular prevention. This work demonstrates the results of the 3 most recent clinical trials with -3 fatty acids are put into the context of possible mechanisms mediating their beneficial cardiovascular effects. In particular, the randomized Reduction of Cardiovascular Events with EPA Intervention Trial (REDUCE-IT) showed that icosapent ethyl, which is the ethyl ester form of the -3 fatty acid eicosapentaenoic acid (EPA), induced a significant reduction of cardiovascular events. Importantly, EPA serves as a substrate for the formation of the specialized proresolving mediator resolvin E1 (RvE1), which stimulates the resolution of inflammation. RvE1 reduces atherosclerosis and intimal hyperplasia by means of its specific receptor ERV1/ChemR23. The decreased levels of proinflammatory and proatherosclerotic leukotrienes by -3 fatty acids may further contribute to a beneficial inflammatory balance. Consequently, the Rv/leukotriene ratio is emerging as a marker of nonresolving vascular inflammation. Recent experimental studies have shown that anti-inflammatory and proresolving effects of lipid mediators derived from -3 fatty acids inhibit atherosclerosis independently of cholesterol and triglyceride levels. The results of the 3 most recent clinical trials of -3 fatty acid supplementation indicate an importance of the type and dose of -3 supplementation and highlight the need for risk stratification in the patient selection for -3 supplementation for either primary or secondary prevention of cardiovascular disease.Back, M., Hansson, G. K. Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation.	[Back, Magnus; Hansson, Goran K.] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Back, Magnus] Karolinska Univ Hosp, Div Coronary & Valvular Heart Dis, Theme Heart & Vessels, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Back, M (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, S1 02, S-17176 Stockholm, Sweden.	magnus.back@ki.se		Hansson, Goran/0000-0003-4148-5190				Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Artiach G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01327; Back M, 2006, ANN MED, V38, P493, DOI 10.1080/07853890600982737; Back M, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0067; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Bowman L, 2018, NEW ENGL J MED, V379, P1540, DOI 10.1056/NEJMoa1804989; Hamilton JA, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0696-4; Ingelsson E, 2012, J ALLERGY CLIN IMMUN, V129, P702, DOI 10.1016/j.jaci.2011.11.052; Kasikara C, 2018, J CLIN INVEST, V128, P2713, DOI 10.1172/JCI97950; Laguna-Fernandez A, 2018, CIRCULATION, V138, P1693, DOI 10.1161/CIRCULATIONAHA.117.032801; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu GZ, 2018, FASEB J, V32, P5413, DOI 10.1096/fj.201800173R; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Pirault J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01273; Prescott SM, 2005, NAT MED, V11, P596, DOI 10.1038/nm0605-596; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Thul S, 2017, EUR J PREV CARDIOL, V24, P903, DOI 10.1177/2047487317694464; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011	25	43	43	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1536	1539		10.1096/fj.201802445R	http://dx.doi.org/10.1096/fj.201802445R			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30703872	Bronze			2022-12-28	WOS:000457296600003
J	Wu, D; Kanda, A; Liu, Y; Kase, S; Noda, K; Ishida, S				Wu, Di; Kanda, Atsuhiro; Liu, Ye; Kase, Satoru; Noda, Kousuke; Ishida, Susumu			Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						AMD; RPE; SMAD family member 2; TGF-; VEGF	ENDOTHELIAL GROWTH-FACTOR; FACTOR-KAPPA-B; MACULAR DEGENERATION; EXPRESSION; HYPOXIA; CANCER; ICAM-1; CELLS; NONRESPONDERS; INFLAMMATION	VEGFA and TGF- are known major angiogenic and fibrogenic factors. Galectin-1, encoded by lectin, galactoside-binding, soluble (LGALS)1, has attracted growing attention for its facilitatory role in angiogenesis and fibrosis through its modification of VEGFA and TGF- receptor signaling pathways. We reveal galectin-1 involvement in the mouse model of laser-induced choroidal neovascularization (CNV) and subretinal fibrosis, both of which represent the pathogenesis of age-related macular degeneration (AMD). Neither deletion nor overexpression of Lgals1 affected physiologic retinal development or visual function. Galectin-1/Lgals1 was upregulated by CNV induction, whereas deletion of Lgals1 suppressed CNV together with downstream molecules of VEGF receptor (VEGFR)2. Loss of Lgals1 also attenuated subretinal fibrosis, expression of epithelial-mesenchymal transition (EMT) markers including Snai1, and phosphorylation of SMAD family member 2. Supporting these in vivo findings, silencing of LGALS1 in human retinal pigment epithelial (RPE) cells inhibited TGF-1-induced EMT-related molecules and cell motilities. Conversely, overexpression of Lgals1 enhanced CNV and subretinal fibrosis. Specimens from patients with AMD demonstrated colocalization of galectin-1 with VEGFR2 in neovascular endothelial cells and with phosphorylated SMAD2 in RPE cells. These results suggested a biologic significance of galectin-1 as a key promotor for both angiogenesis and fibrosis in eyes with AMD.Wu, D., Kanda, A., Liu, Y., Kase, S., Noda, K., Ishida, S. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition.	Hokkaido Univ, Lab Ocular Cell Biol & Visual Sci, Dept Ophthalmol, Fac Med, Sapporo, Hokkaido, Japan; Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kanda, A (corresponding author), Hokkaido Univ, Lab Ocular Cell Biol & Visual Sci, Dept Ophthalmol, Fac Med,Kita Ku, N-15 W-7, Sapporo, Hokkaido 0608638, Japan.; Kanda, A (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, N-15 W-7, Sapporo, Hokkaido 0608638, Japan.	kanda@med.hokudai.ac.jp			Bayer Yakuhin Ltd.; Uehara Memorial Foundation; Eye Research Foundation for the Aged; Japan National Society for the Prevention of Blindness; Otsuka Toshimi Scholarship Foundation; China Scholarship Council	Bayer Yakuhin Ltd.; Uehara Memorial Foundation(Uehara Memorial Foundation); Eye Research Foundation for the Aged; Japan National Society for the Prevention of Blindness(Japan National Society for the Prevention of Blindness); Otsuka Toshimi Scholarship Foundation(Otsuka Pharmaceutical); China Scholarship Council(China Scholarship Council)	The authors thank Ikuyo Hirose, Shiho Yoshida, and Miyuki Murata (Hokkaido University) for skilled technical assistance. This work was supported, in part, by Bayer Yakuhin Ltd., the Uehara Memorial Foundation, the Eye Research Foundation for the Aged, and the Japan National Society for the Prevention of Blindness (to A.K.). D.W. and Y.L. are recipients of scholarships from the Otsuka Toshimi Scholarship Foundation and China Scholarship Council, respectively. The authors declare no conflicts of interest.	AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Ashraf M, 2016, BRIT J OPHTHALMOL, V100, P1596, DOI 10.1136/bjophthalmol-2016-308388; Bloch SB, 2013, AM J OPHTHALMOL, V156, P116, DOI 10.1016/j.ajo.2013.02.012; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Cao JT, 2010, INVEST OPHTH VIS SCI, V51, P6009, DOI 10.1167/iovs.09-4956; Chao HH, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0393-1; Chung LY, 2012, CLIN CANCER RES, V18, P4037, DOI 10.1158/1078-0432.CCR-11-3348; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Daniel E, 2014, OPHTHALMOLOGY, V121, P656, DOI 10.1016/j.ophtha.2013.10.019; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Hirasawa M, 2011, MOL VIS, V17, P1222; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Ishikawa K, 2016, EXP EYE RES, V142, P19, DOI 10.1016/j.exer.2015.03.009; Iwanishi H, 2016, LAB INVEST, V96, P641, DOI 10.1038/labinvest.2016.30; Jiang SJ, 2013, MICROCIRCULATION, V20, P190, DOI 10.1111/micc.12024; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanda A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16499-8; Kanda A, 2017, MOL THER-NUCL ACIDS, V7, P116, DOI 10.1016/j.omtn.2017.01.001; Kanda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17946; Kathiriya JJ, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.10; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lim MJ, 2014, EXP CELL RES, V326, P125, DOI 10.1016/j.yexcr.2014.06.001; Lin MK, 2012, INVEST OPHTH VIS SCI, V53, P6197, DOI 10.1167/iovs.11-8936; Lux A, 2007, BRIT J OPHTHALMOL, V91, P1318, DOI 10.1136/bjo.2006.113902; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Connor JW, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-23; Otsuji T, 2013, CLIN OPHTHALMOL, V7, P1487, DOI 10.2147/OPTH.S46317; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Ridano ME, 2017, ONCOTARGET, V8, P32505, DOI 10.18632/oncotarget.17129; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tang D, 2018, ONCOL REP, V39, P1347, DOI 10.3892/or.2018.6202; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Uehara F, 2001, INVEST OPHTH VIS SCI, V42, P2164; Willoughby AS, 2015, OPHTHALMOLOGY, V122, P1846, DOI 10.1016/j.ophtha.2015.05.042; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Xu FY, 2016, J HISTOCHEM CYTOCHEM, V64, P157, DOI 10.1369/0022155415627681; Yang N, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/5053035; Yang N, 2017, EXP EYE RES, V159, P1, DOI 10.1016/j.exer.2017.02.015; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116; Zheng LY, 2016, AM J TRANSL RES, V8, P1641; Zhong X, 2012, BIOCHEM BIOPH RES CO, V425, P401, DOI 10.1016/j.bbrc.2012.07.110; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	54	34	35	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2498	2513		10.1096/fj.201801227R	http://dx.doi.org/10.1096/fj.201801227R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277820				2022-12-28	WOS:000457296600077
J	Potikha, T; Pappo, O; Mizrahi, L; Olam, D; Maller, SM; Rabinovich, GA; Galun, E; Goldenberg, DS				Potikha, Tamara; Pappo, Orit; Mizrahi, Lina; Olam, Devorah; Maller, Sebastian M.; Rabinovich, Gabriel A.; Galun, Eithan; Goldenberg, Daniel S.			Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model	FASEB JOURNAL			English	Article						HCC; Mdr2; Spp1; Ntrk2; S100a4	OSTEOPONTIN; CELLS; CANCER; OVEREXPRESSION; METASTASIS; ACTIVATION; INDUCTION; EFFECTOR; GENE; GLYCOSYLATION	Chronic liver inflammation (CLI) is a risk factor for development of hepatocellular carcinoma (HCC). Galectin-1 (Gal1) is involved in the regulation of inflammation, angiogenesis, and tumorigenesis, exhibiting multiple anti-inflammatory and protumorigenic activities. We aimed to explore its regulatory role in CLI and HCC progression using an established model of CLI-mediated HCC development, Abcb4 [multidrug-resistance 2 (Mdr2)]-knockout (KO) mice, which express high levels of Gal1 in the liver. We generated double-KO (dKO) Gal1-KO/Mdr2-KO mice on C57BL/6 and FVB/N genetic backgrounds and compared HCC development in the generated strains with their parental Mdr2-KO strains. Loss of Gal1 increased liver injury, inflammation, fibrosis, and ductular reaction in dKO mice of both strains starting from an early age. Aged dKO mutants displayed earlier hepatocarcinogenesis and increased tumor size compared with control Mdr2-KO mice. We found that osteopontin, a well-known modulator of HCC development, and oncogenic proteins Ntrk2 (TrkB) and S100A4 were overexpressed in dKO compared with Mdr2-KO livers. Our results demonstrate that in Mdr2-KO mice, a model of CLI-mediated HCC, Gal1-mediated protection from hepatitis, liver fibrosis, and HCC initiation dominates over its known procarcinogenic activities at later stages of HCC development. These findings suggest that anti-Gal1 treatments may not be applicable at all stages of CLI-mediated HCC.-Potikha, T., Pappo, O., Mizrahi, L., Olam, D., Maller, S. M., Rabinovich, G. A., Galun, E., Goldenberg, D. S. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.	[Potikha, Tamara; Mizrahi, Lina; Olam, Devorah; Galun, Eithan; Goldenberg, Daniel S.] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, POB 12000, IL-91120 Jerusalem, Israel; [Pappo, Orit] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel; [Maller, Sebastian M.; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, Lab Immunopathol, Inst Biol & Expt Med IBYME, Argentinean Natl Res Council, Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Exact & Nat Sci, Buenos Aires, DF, Argentina	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Goldenberg, DS (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, POB 12000, IL-91120 Jerusalem, Israel.	goldenberg@hadassah.org.il	Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702; Maller, Sebastian M./0000-0001-5536-7596; Goldenberg, Daniel/0000-0002-1618-4145	Kamea Scientific Foundation of the Israeli Government; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2014-3087]; Fundacion Sales; Fundacion Bunge Born; Kenneth Rainin Foundation; U.S. National Institutes of Health, National Cancer Institute Grant [CA197081-02]; Ministry Of Science and Technology (MOST); Israeli Science Foundation (ISF); personal ISF [486/2017]; Israeli Centers Of Research Excellence (ICORE)-ISF [41/2011]; Kron foundation; Raskin foundation; Benson foundation; Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB841];  [2473/2017]	Kamea Scientific Foundation of the Israeli Government; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Sales; Fundacion Bunge Born; Kenneth Rainin Foundation; U.S. National Institutes of Health, National Cancer Institute Grant; Ministry Of Science and Technology (MOST)(Ministry of Science and Technology, China); Israeli Science Foundation (ISF)(Israel Science Foundation); personal ISF; Israeli Centers Of Research Excellence (ICORE)-ISF; Kron foundation; Raskin foundation; Benson foundation; Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); 	The authors thank J. P. Cerliani [Argentinean National Research Council (CONICET)] for advice, and Marion Richardson (Hadassah-Hebrew University Medical Center) for assistance in manuscript preparation. T.P. and D.S.G. were supported by the Kamea Scientific Foundation of the Israeli Government. Work in G.A.R.'s laboratory was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2014-3087), Fundacion Sales, Fundacion Bunge & Born and the Kenneth Rainin Foundation. The work of E.G. was supported by U.S. National Institutes of Health, National Cancer Institute Grant CA197081-02, the Ministry Of Science and Technology (MOST), the Israeli Science Foundation (ISF) collaboration with Canada (2473/2017), the personal ISF (486/2017), the Israeli Centers Of Research Excellence (ICORE)-ISF (41/2011), and by the Kron, Raskin, and Benson foundations. This work was also supported by the Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB841, Project C3). The authors declare no conflicts of interest.	Alhabbab R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19965-z; Baker GJ, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1163461; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Bao W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070616; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Chiodoni C, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.978711; Cimmino F, 2009, ONCOGENE, V28, P2015, DOI 10.1038/onc.2009.70; Croci DO, 2013, LEUKEMIA, V27, P1413, DOI 10.1038/leu.2012.315; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Dalotto-Moreno T, 2013, CANCER RES, V73, P1107, DOI 10.1158/0008-5472.CAN-12-2418; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Espelt MV, 2011, HEPATOLOGY, V53, P2097, DOI 10.1002/hep.24294; Fan XY, 2015, CANCER RES, V75, P86, DOI 10.1158/0008-5472.CAN-14-0615; Fei F, 2017, ONCOTARGET, V8, P73219, DOI 10.18632/oncotarget.18016; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Ge XD, 2014, HEPATOLOGY, V59, P1600, DOI 10.1002/hep.26931; Gotoh M, 2002, PATHOL INT, V52, P19, DOI 10.1046/j.1440-1827.2002.01316.x; Hou SS, 2018, LAB INVEST, V98, P1025, DOI 10.1038/s41374-018-0067-y; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Kim MS, 2015, ONCOTARGET, V6, P40158, DOI 10.18632/oncotarget.5522; Kondoh N, 2003, INT J ONCOL, V23, P1575; Lam CT, 2011, CLIN CANCER RES, V17, P3123, DOI 10.1158/1078-0432.CCR-10-2802; Lee SH, 2016, ONCOTARGET, V7, P87219, DOI 10.18632/oncotarget.13529; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Mochida S, 2004, BIOCHEM BIOPH RES CO, V317, P114, DOI 10.1016/j.bbrc.2004.02.180; Orozco CA, 2018, P NATL ACAD SCI USA, V115, pE3769, DOI 10.1073/pnas.1722434115; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Potikha T, 2016, ONCOTARGET, V7, P31738, DOI 10.18632/oncotarget.9194; Potikha T, 2013, HEPATOLOGY, V58, P192, DOI 10.1002/hep.26335; Rabinovich GA, 2016, J MOL BIOL, V428, P3266, DOI 10.1016/j.jmb.2016.03.021; Roderfeld M, 2010, HEPATOLOGY, V51, P267, DOI 10.1002/hep.23274; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Scott K, 2002, GLYCOCONJUGATE J, V19, P467, DOI 10.1023/B:GLYC.0000014076.43288.89; Spano D, 2010, MOL MED, V16, P102, DOI 10.2119/molmed.2009.00119; Stannard KA, 2010, CANCER LETT, V299, P95, DOI 10.1016/j.canlet.2010.08.005; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Strazzabosco M, 2014, GUT, V63, P1693, DOI 10.1136/gutjnl-2014-307712; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Sundblad V, 2017, J IMMUNOL, V199, P3721, DOI 10.4049/jimmunol.1701172; Tesone AJ, 2016, CELL REP, V14, P1774, DOI 10.1016/j.celrep.2016.01.056; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Van Woensel M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01279-1; Wen YK, 2016, INT J BIOL SCI, V12, P1121, DOI 10.7150/ijbs.16445; Yan XL, 2013, HEPATOLOGY, V57, P2274, DOI 10.1002/hep.26257; Zhao J, 2008, GASTROENTEROLOGY, V135, P956, DOI 10.1053/j.gastro.2008.05.025	52	12	12	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7995	8007		10.1096/fj.201900017R	http://dx.doi.org/10.1096/fj.201900017R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30897344	Green Published			2022-12-28	WOS:000476234700016
J	Shi, JJ; Surma, M; Yang, Y; Wei, L				Shi, Jianjian; Surma, Michelle; Yang, Yang; Wei, Lei			Disruption of both ROCK1 and ROCK2 genes in cardiomyocytes promotes autophagy and reduces cardiac fibrosis during aging	FASEB JOURNAL			English	Article						Rho kinase; cytoskeleton; mTOR	RHO-ASSOCIATED KINASE; HEART-FAILURE; PROTEIN; ACTIVATION; MICE; TARGET; ALPHA; MTOR; HYPERTROPHY; EXPRESSION	In this study, we investigated the pathophysiological impact of Rho-associated coiled-coil-containing protein kinase (ROCK)1 and ROCK2 double deletion vs. single deletion on cardiac remodeling. Utilizing a cardiomyocyte-specific and tamoxifen-inducible MerCreMer recombinase (MCM), 3 mouse lines (MCM/ROCK1(fl/fl)/ROCK2(fl/fl), MCM/ROCK1(fl/fl), and MCM/ROCK2(fl/fl)) were generated. As early as 5 d after inducible deletion, the double ROCK knockout hearts exhibited reduced phosphorylation of myosin light chain (MLC) and focal adhesion kinase (FAK), supporting a role for ROCK activity in regulating the nonsarcomeric cytoskeleton. Moreover, the autophagy marker microtubule-associated proteins 1A-1B light chain 3B was increased in the double ROCK knockout, and these early molecular features persisted throughout aging. Mechanistically, the double ROCK knockout promoted age-associated or starvation-induced autophagy concomitant with reduced protein kinase B (AKT), mammalian target of rapamycin (mTOR), Unc-51-like kinase signaling, and cardiac fibrosis. In contrast, ROCK2 knockout hearts showed increased phosphorylated (p)-MLC and p-FAK levels, which were mostly attributable to a compensatory ROCK1 overactivation. Autophagy was inhibited at the baseline accompanying increased mTOR activity, leading to increased cardiac fibrosis in the ROCK2 knockout hearts. Finally, the loss of ROCK1 had no significant effect on p-MLC and p-FAK levels, mTOR signaling, or autophagy at baseline. In summary, deletions of ROCK isoforms in cardiomyocytes have different, even opposite, effects on endogenous ROCK activity and the MLC/FAK/AKT/mTOR signaling pathway, which is involved in autophagy and fibrosis of the heart.-Shi, J., Surma, M., Yang, Y., Wei, L. Disruption of both ROCK1 and ROCK2 genes in cardiomyocytes promotes autophagy and reduces cardiac fibrosis during aging.	[Shi, Jianjian; Surma, Michelle; Yang, Yang; Wei, Lei] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, 1044 West Walnut St,R4-240, Indianapolis, IN 46202 USA; [Yang, Yang] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Wei, Lei] Cent S Univ, Xiangya Hosp, Dept Cardiovasc Surg, Sch Med, Changsha, Hunan, Peoples R China	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Central South University	Shi, JJ; Wei, L (corresponding author), Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, 1044 West Walnut St,R4-240, Indianapolis, IN 46202 USA.	jishi@iu.edu; lewei@iu.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL107537, HL134599]; American Heart Association, Midwest Affiliate [12GRNT12060525]; Riley Children's Foundation; Biomedical Research Grant from the Indiana University School of Medicine [2286128ZJ]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107537, P01HL134599] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association, Midwest Affiliate(American Heart Association); Riley Children's Foundation; Biomedical Research Grant from the Indiana University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the Transgenic and Knock-Out Mouse Core, the Small Animal Ultrasound Core, and the Electron Microscopy Center at the Indiana University School of Medicine for assistance in the generation of Rho-associated coiled-coilcontaining protein kinase (ROCK1) fl/fl and ROCK2<SUP>fl/fl</SUP> mice, echocardiography imaging, and electron microscopy imaging. This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL107537 and HL134599; a Grant-in-Aid award from the American Heart Association, Midwest Affiliate (12GRNT12060525); and the Riley Children's Foundation (to L. W.). It was also supported by a Biomedical Research Grant from the Indiana University School of Medicine (2286128ZJ to J.S.) The authors declare no conflicts of interest.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Bersell K, 2013, DIS MODEL MECH, V6, P1459, DOI 10.1242/dmm.010447; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Ehler Elisabeth, 2018, Biophys Rev, V10, P1121, DOI 10.1007/s12551-018-0428-1; Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222; Gurkar AU, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3189; Hall ME, 2011, AM J PHYSIOL-HEART C, V301, pH253, DOI 10.1152/ajpheart.00786.2010; Henderson CA, 2017, COMPR PHYSIOL, V7, P891, DOI 10.1002/cphy.c160033; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kee AJ, 2009, J MUSCLE RES CELL M, V30, P187, DOI 10.1007/s10974-009-9193-x; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lauriol J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005262; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mleczak A, 2013, CELL SIGNAL, V25, P1, DOI 10.1016/j.cellsig.2012.09.010; Nacarelli T, 2015, EXP GERONTOL, V68, P66, DOI 10.1016/j.exger.2014.11.004; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Okamoto R, 2013, FASEB J, V27, P1439, DOI 10.1096/fj.12-217018; Aguilera MO, 2012, AUTOPHAGY, V8, P1590, DOI 10.4161/auto.21459; Pugach EK, 2015, J MOL CELL CARDIOL, V86, P54, DOI 10.1016/j.yjmcc.2015.06.019; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Sciarretta S, 2018, CIRC RES, V122, P489, DOI 10.1161/CIRCRESAHA.117.311147; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Shi JJ, 2008, J MOL CELL CARDIOL, V44, P551, DOI 10.1016/j.yjmcc.2007.11.018; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Shi Jianjian, 2018, Oncotarget, V9, P12995, DOI 10.18632/oncotarget.24457; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shi JJ, 2012, AM J PHYSIOL-HEART C, V302, pH1603, DOI 10.1152/ajpheart.00844.2011; Shi JJ, 2011, PEDIATR CARDIOL, V32, P297, DOI 10.1007/s00246-011-9920-0; Shi JJ, 2010, J MOL CELL CARDIOL, V49, P819, DOI 10.1016/j.yjmcc.2010.08.008; Shirakabe A, 2016, CIRC RES, V118, P1563, DOI 10.1161/CIRCRESAHA.116.307474; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Sunamura S, 2018, P NATL ACAD SCI USA, V115, pE7129, DOI 10.1073/pnas.1721298115; Takefuji M, 2013, J EXP MED, V210, P665, DOI 10.1084/jem.20122126; Torsoni AS, 2005, AM J PHYSIOL-HEART C, V289, pH1488, DOI 10.1152/ajpheart.00692.2004; Wei L, 2016, ARCH IMMUNOL THER EX, V64, P259, DOI 10.1007/s00005-015-0382-6; Yang XS, 2012, FASEB J, V26, P2105, DOI 10.1096/fj.11-201319; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	45	26	29	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7348	7362		10.1096/fj.201802510R	http://dx.doi.org/10.1096/fj.201802510R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30848941	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000476114200055
J	Kwon, E; Li, X; Deng, YF; Chang, HW; Kim, DY				Kwon, Eunju; Li, Xian; Deng, Yifeng; Chang, Hyeun Wook; Kim, Dong Young			AMPK is down-regulated by the CRL4A-CRBN axis through the polyubiquitination of AMPK isoforms	FASEB JOURNAL			English	Article						proteasomal degradation; BMMC; allergy	ACTIVATED PROTEIN-KINASE; E3 UBIQUITIN LIGASE; STRUCTURAL BASIS; BETA; IDENTIFICATION; DEGRADATION; CELL; BINDING; THALIDOMIDE; EXPRESSION	As a master regulator for metabolic and energy homeostasis, AMPK controls the activity of metabolic enzymes and transcription factors in response to cellular ATP status. AMPK has been thus recognized as a main target for the regulation of cellular energy metabolism. Here, we report that AMPK can be down-regulated by the cullin-RING ubiquitin E3 ligase 4A (CRL4A) with cereblon (CRBN). CRL4A interacted with AMPK holoenzymes and mediated AMPK-specific polyubiquitination for its proteasomal degradation through non-K48 polyubiquitin linkages. In the ubiquitination system, CRBN was required for efficient polyubiquitination of AMPK subunits. Consistently, polyubiquitination of AMPK subunits was reduced by inhibitors of CRL4A-CRBN. Physiologic function of AMPK down-regulation by CRL4-CRBN was also confirmed using mouse bone marrow-derived mast cells (BMMCs). The inactivation of CRL4A-CRBN in BMMC increased AMPK stability and suppressed secretion of allergic mediators via AMPK activation followed by MAPK inhibition. In addition, CRBN knockout of BMMC also decreased allergic responses in mice. Our results suggest that the CRL4A-CRBN axis could be a target for the regulation of AMPK-dependent responses.Kwon, E., Li, X., Deng, Y., Chang, H. W., Kim, D. Y. AMPK is down-regulated by the CRL4A-CRBN axis through the polyubiquitination of AMPK isoforms.	[Kwon, Eunju; Li, Xian; Deng, Yifeng; Chang, Hyeun Wook; Kim, Dong Young] Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, South Korea	Yeungnam University	Chang, HW; Kim, DY (corresponding author), Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, South Korea.	hwchang@ynu.ac.kr; dyokim@ynu.ac.kr		Kim, Dong Young/0000-0001-7594-9083	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science and Information and Communications Technology (ICT) [2014R1A4A1071040]; Ministry of Education [2017R1A6A3A11029218, 2017R1D1A1B03034088]	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science and Information and Communications Technology (ICT); Ministry of Education	The authors thank Prof. John D. Gross (University of California-San Francisco, San Francisco, CA, USA), for the helpful discussion. This work was supported by Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and Information and Communications Technology (ICT) (2014R1A4A1071040), and the Ministry of Education (2017R1A6A3A11029218; 2017R1D1A1B03034088). The authors declare no conflicts of interest.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Chen YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10667; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Fionda C, 2015, ONCOTARGET, V6, P23609, DOI 10.18632/oncotarget.4603; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hwang SL, 2014, J ALLERGY CLIN IMMUN, V134, P714, DOI 10.1016/j.jaci.2014.05.001; Hwang SL, 2013, J ALLERGY CLIN IMMUN, V132, P729, DOI 10.1016/j.jaci.2013.02.018; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee JO, 2013, J BIOL CHEM, V288, P4673, DOI 10.1074/jbc.M112.406009; Lee KM, 2013, DIABETES, V62, P1855, DOI 10.2337/db12-1030; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Li X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00596-9; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Quentin T, 2011, HISTOL HISTOPATHOL, V26, P589, DOI 10.14670/HH-26.589; Rubio T, 2013, MOL BIOL CELL, V24, P1801, DOI 10.1091/mbc.E12-11-0806; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819	51	20	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6539	6550		10.1096/fj.201801766RRR	http://dx.doi.org/10.1096/fj.201801766RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807229				2022-12-28	WOS:000466932600057
J	Vicen, M; Vitverova, B; Havelek, R; Blazickova, K; Machacek, M; Rathouska, J; Najmanova, I; Dolezelova, E; Prasnicka, A; Sternak, M; Bernabeu, C; Nachtigal, P				Vicen, Matej; Vitverova, Barbora; Havelek, Radim; Blazickova, Katerina; Machacek, Miloslav; Rathouska, Jana; Najmanova, Iveta; Dolezelova, Eva; Prasnicka, Alena; Sternak, Magdalena; Bernabeu, Carmelo; Nachtigal, Petr			Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro	FASEB JOURNAL			English	Article						hypercholesterolemia; oxysterols; endothelial cells; mice	DENSITY-LIPOPROTEIN RECEPTOR; SOLUBLE ENDOGLIN; APOLIPOPROTEIN-B; KAPPA-B; EXPRESSION; CELLS; RELEASE; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; TRANSCRIPTION	Our objective was to investigate the effect of cholesterol [hypercholesterolemia and 7-ketocholesterol (7K)] on endoglin (Eng) expression and regulation with respect to endothelial or vascular dysfunction in vivo and in vitro. In vivo experiments were performed in 2-mo-old atherosclerosis-prone apolipoprotein E-deficient/LDL receptor-deficient (ApoE(-/-)/LDLR-/-) female mice and their wild-type C57BL/6J littermates. In in vitro experiments, human aortic endothelial cells (HAECs) were treated with 7K. ApoE(-/-)/LDLR-/- mice developed hypercholesterolemia accompanied by increased circulating levels of P-selectin and Eng and a disruption of NO metabolism. Functional analysis of the aorta demonstrated impaired vascular reactivity, and Western blot analysis revealed down-regulation of membrane Eng/Smad2/3/eNOS signaling in ApoE(-/-)/LDLR-/- mice. 7K increased Eng expression via Kruppel-like factor 6 (KLF6), liver X nuclear receptor, and NF-B in HAECs. 7K-induced Eng expression was prevented by the treatment with 2-hydroxypropyl--cyclodextrin; 8-{[5-chloro-2-(4-methylpiperazin-1-yl) pyridine-4-carbonyl] amino}-1-(4-fluorophenyl)-4, 5-dihydrobenzo[g]indazole-3-carboxamide; or by KLF6 silencing. 7K induced increased adhesion and transmigration of monocytic human leukemia promonocytic cell line cells and was prevented by Eng silencing. We concluded that hypercholesterolemia altered Eng expression and signaling, followed by endothelial or vascular dysfunction before formation of atherosclerotic lesions in ApoE(-/-)/LDLR-/- mice. By contrast, 7K increased Eng expression and induced inflammation in HAECs, which was followed by an increased adhesion and transmigration of monocytes via endothelium, which was prevented by Eng inhibition. Thus, we propose a relevant role for Eng in endothelial or vascular dysfunction or inflammation when exposed to cholesterol.Vicen, M., Vitverova, B., Havelek, R., Blazickova, K., Machacek, M., Rathouska, J., Najmanova, I., Dolezelova, E., Prasnicka, A., Sternak, M., Bernabeu, C., Nachtigal, P. Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro.	[Vicen, Matej; Vitverova, Barbora; Blazickova, Katerina; Rathouska, Jana; Najmanova, Iveta; Dolezelova, Eva; Prasnicka, Alena; Nachtigal, Petr] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic; [Machacek, Miloslav] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem Sci, Hradec Kralove, Czech Republic; [Havelek, Radim] Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biochem, Hradec Kralove, Czech Republic; [Sternak, Magdalena] JCET, Krakow, Poland; [Bernabeu, Carmelo] CSIC, Ctr Biol Res, Madrid, Spain; [Bernabeu, Carmelo] Biomed Res Networking Ctr Rare Dis CIBERER, Madrid, Spain	Charles University Prague; Charles University Prague; Charles University Prague; University Hospital Hradec Kralove; Jagiellonian University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Nachtigal, P (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic.	petr.nachtigal@faf.cuni.cz	Havelek, Radim/S-5723-2016; Vicen, Matej/S-8443-2017; Prašnická, Alena/A-8903-2017; Najmanová, Iveta/T-5295-2017; Machacek, Miloslav/T-3378-2017; Vitverova, Barbora/T-4468-2017; Bernabeu, Carmelo/L-3226-2014; Rathouska, Jana/Q-2796-2016	Havelek, Radim/0000-0003-0528-1334; Vicen, Matej/0000-0002-7568-6989; Prašnická, Alena/0000-0002-6671-0318; Najmanová, Iveta/0000-0002-8443-0512; Machacek, Miloslav/0000-0001-7221-5914; Vitverova, Barbora/0000-0002-4446-2712; Bernabeu, Carmelo/0000-0002-1563-6162; Rathouska, Jana/0000-0001-6363-9715	Project Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods-New Challenges (EFSA-CDN) - European Regional Development Fund (ERDF) [CZ.02.1.01/0.0/0.0/16_019/0000841]; Charles University Grant Agency [GAUK 1158413C, 1216217]; Specific University Research [SVV260414]; Czech Health Research Council [AZV CR 17-31754A]; Consejo Superior de Investigaciones Cientificas [201420E039]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) [ISCIII-CB06/07/0038]; Fonds Europeen de Developpement Economique et Regional (FEDER) funds	Project Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods-New Challenges (EFSA-CDN) - European Regional Development Fund (ERDF); Charles University Grant Agency; Specific University Research; Czech Health Research Council; Consejo Superior de Investigaciones Cientificas; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Fonds Europeen de Developpement Economique et Regional (FEDER) funds	The authors thank Dr. Alena Mrkvicova and Milena Hajzlerova (both from the Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic) for assistance during PCR analysis, Dr. Veronika Skarkova (Department of Medical Biology and Genetics, Faculty of Medicine in Hradec Kralove, Charles University) for assistance during Elisa analysis and preparation of samples for Western blots, Drs. Soa ejkova (Institute of Clinical and Experimental Medicine, Prague, Czech Republic) and Feroz Ahmad (Department of Biomedical Sciences, University of Reading, Reading, United Kingdom) for help with the human acute monocytic leukemia cell line, Dr. Petra Hirova (Liver Pathobiology Laboratory, Mayo Clinic, Rochester, Minnesota) for information about immunocytochemistry, Dr. Hana Jansova (Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University) for help with preparation of substances for cell treatments, Dr. Vera Kralova (Department of Medical Biology and Genetics, Faculty of Medicine in Hradec Kralove, Charles University) for help with flow cytometry, and Pavlina Lukeova (Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University) for help during chamber slide preparation. This work was supported by Project Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods-New Challenges (EFSA-CDN; CZ.02.1.01/0.0/0.0/16_019/0000841) cofunded by the European Regional Development Fund (ERDF), grants of Charles University Grant Agency (GAUK 1158413C and 1216217), Specific University Research (SVV260414), and Czech Health Research Council (AZV CR 17-31754A). C.B. was supported by grants from Consejo Superior de Investigaciones Cientificas (201420E039) and Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER; ISCIII-CB06/07/0038). CIBERER is an initiative of the Instituto de Salud Carlos III (ISCIII) of Spain supported by Fonds Europeen de Developpement Economique et Regional (FEDER) funds. The authors declare no conflicts of interest.	Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Brown AJ, 2000, J LIPID RES, V41, P226; Brownfoot FC, 2014, PLACENTA, V35, P724, DOI 10.1016/j.placenta.2014.06.374; Carman CV, 2008, BLOOD, V112, P929, DOI 10.1182/blood-2008-05-153601; Chalubinski M, 2013, INFLAMM RES, V62, P1015, DOI 10.1007/s00011-013-0660-x; Coisne C, 2016, MOLECULES, V21, DOI 10.3390/molecules21121748; Coisne C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00185; Csanyi G, 2012, PROSTAG OTH LIPID M, V98, P107, DOI 10.1016/j.prostaglandins.2012.02.002; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Deckert V, 1997, CIRCULATION, V95, P723, DOI 10.1161/01.CIR.95.3.723; Dopico AM, 2018, PFLUG ARCH EUR J PHY, V470, P1271, DOI 10.1007/s00424-018-2151-y; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; Gallardo-Vara E, 2016, ANGIOGENESIS, V19, P155, DOI 10.1007/s10456-016-9495-8; Gojova A, 2003, BLOOD, V102, P4052, DOI 10.1182/blood-2003-05-1729; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hayden JM, 2002, J LIPID RES, V43, P26; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Henry-Berger J, 2008, BIOL REPROD, V78, P968, DOI 10.1095/biolreprod.107.066498; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Jawien J, 2007, EUR J PHARMACOL, V556, P129, DOI 10.1016/j.ejphar.2006.11.028; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kaczara P, 2018, FEBS J, V285, P1346, DOI 10.1111/febs.14411; Kaitu'u-Lino TJ, 2012, AM J PATHOL, V180, P888, DOI 10.1016/j.ajpath.2011.11.014; Kij A, 2016, J PHARMACEUT BIOMED, V129, P148, DOI 10.1016/j.jpba.2016.06.050; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5; Nachtigal P, 2012, ATHEROSCLEROSIS, V224, P4, DOI 10.1016/j.atherosclerosis.2012.03.001; Nemeckova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119665; Olkkonen VM, 2012, BIOMOLECULES, V2, P76, DOI 10.3390/biom2010076; Ollauri-Ibanez C, 2017, EXPERT OPIN BIOL TH, V17, P1053, DOI 10.1080/14712598.2017.1346607; Przyborowski K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130908; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Rathouska J, 2015, ATHEROSCLEROSIS, V243, P383, DOI 10.1016/j.atherosclerosis.2015.10.003; Rossi E, 2018, CELL MOL LIFE SCI, V75, P1269, DOI 10.1007/s00018-017-2694-7; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Ruiz-Remolina L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188204; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; SOMLYO AP, 1994, NATURE, V372, P812; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Strasky Z, 2011, CIRC J, V75, P1747, DOI 10.1253/circj.CJ-10-1285; Testa G, 2018, BIOCHIMIE, V153, P220, DOI 10.1016/j.biochi.2018.06.006; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Valbuena-Diez AC, 2012, CIRCULATION, V126, P2612, DOI 10.1161/CIRCULATIONAHA.112.101261; van Laake LW, 2006, CIRCULATION, V114, P2288, DOI 10.1161/CIRCULATIONAHA.106.639161; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Vaya J, 2001, FREE RADICAL RES, V34, P485, DOI 10.1080/10715760100300431; Vecerova L, 2012, J ATHEROSCLER THROMB, V19, P115, DOI 10.5551/jat.8185; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vitverova B, 2018, ATHEROSCLEROSIS, V271, P15, DOI 10.1016/j.atherosclerosis.2018.02.008; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Yamagata K, 2013, MICROVASC RES, V88, P25, DOI 10.1016/j.mvr.2013.03.006; Yu Q, 2015, EUR J PHARMACOL, V748, P166, DOI 10.1016/j.ejphar.2014.08.037; Zemankova L, 2015, J PHYSIOL PHARMACOL, V66, P403; Zhang YP, 2014, EUR J PHARMACOL, V725, P10, DOI 10.1016/j.ejphar.2014.01.008; Zhang Y, 2014, J BIOL CHEM, V289, P12876, DOI 10.1074/jbc.M113.535831	61	16	16	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6099	6114		10.1096/fj.201802245R	http://dx.doi.org/10.1096/fj.201802245R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753095	Green Submitted			2022-12-28	WOS:000466932600025
J	Icli, B; Wu, W; Ozdemir, D; Li, H; Haemmig, S; Liu, X; Giatsidis, G; Cheng, HS; Avci, SN; Kurt, M; Lee, N; Guimaraes, RB; Manica, A; Marchini, JF; Rynning, SE; Risnes, I; Hollan, I; Croce, K; Orgill, DP; Feinberg, MW				Icli, Basak; Wu, Winona; Ozdemir, Denizhan; Li, Hao; Haemmig, Stefan; Liu, Xin; Giatsidis, Giorgio; Cheng, Henry S.; Avci, Seyma Nazli; Kurt, Merve; Lee, Nathan; Guimaraes, Raphael Boesche; Manica, Andre; Marchini, Julio F.; Rynning, Stein Erik; Risnes, Ivar; Hollan, Ivana; Croce, Kevin; Orgill, Dennis P.; Feinberg, Mark W.			MicroRNA-135a-3p regulates angiogenesis and tissue repair by targeting p38 signaling in endothelial cells	FASEB JOURNAL			English	Article						VEGF; diabetic wounds; human organoid	HUNTINGTIN-INTERACTING PROTEIN-1; CRITICAL LIMB ISCHEMIA; GROWTH-FACTOR; DOUBLE-BLIND; INTERMITTENT CLAUDICATION; MYOCARDIAL-INFARCTION; IMPAIRED ANGIOGENESIS; DIABETES-MELLITUS; GENE-THERAPY; KINASE	Angiogenesis is a critical process in repair of tissue injury that is regulated by a delicate balance between pro- and antiangiogenic factors. In disease states associated with impaired angiogenesis, we identified that miR-135a-3p is rapidly induced and serves as an antiangiogenic microRNA (miRNA) by targeting endothelial cell (EC) p38 signaling in vitro and in vivo. MiR-135a-3p overexpression significantly inhibited EC proliferation, migration, and network tube formation in matrigel, whereas miR-135-3p neutralization had the opposite effects. Mechanistic studies using transcriptomic profiling, bioinformatics, 3'-UTR reporter and miRNA ribonucleoprotein complex -immunoprecipitation assays, and small interfering RNA dependency studies revealed that miR-135a-3p inhibits the p38 signaling pathway in ECs by targeting huntingtin-interacting protein 1 (HIP1). Local delivery of miR-135a-3p inhibitors to wounds of diabetic db/db mice markedly increased angiogenesis, granulation tissue thickness, and wound closure rates, whereas local delivery of miR-135a-3p mimics impaired these effects. Finally, through gain- and loss-of-function studies in human skin organoids as a model of tissue injury, we demonstrated that miR-135a-3p potently modulated p38 signaling and angiogenesis in response to VEGF stimulation by targeting HIP1. These findings establish miR-135a-3p as a pivotal regulator of pathophysiological angiogenesis and tissue repair by targeting a VEGF-HIP1-p38K signaling axis, providing new targets for angiogenic therapy to promote tissue repair.	[Icli, Basak; Wu, Winona; Ozdemir, Denizhan; Li, Hao; Haemmig, Stefan; Liu, Xin; Cheng, Henry S.; Avci, Seyma Nazli; Kurt, Merve; Lee, Nathan; Hollan, Ivana; Croce, Kevin; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, 77 Ave Louis Pasteur,NRB-742F, Boston, MA 02115 USA; [Giatsidis, Giorgio; Orgill, Dennis P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Plast Surg, Boston, MA 02115 USA; [Ozdemir, Denizhan] Hacettepe Univ, Dept Med Biol, Ankara, Turkey; [Guimaraes, Raphael Boesche; Manica, Andre] Fundacao Univ Cardiol ICFUC, Inst Cardiol Rio Grande Sul, Porto Alegre, RS, Brazil; [Marchini, Julio F.] Univ Sao Paulo, Med Sch, Heart Inst, Sao Paulo, Brazil; [Rynning, Stein Erik; Risnes, Ivar] LHL Hosp Gardermoen, Dept Cardiac Surg, Jessheim, Norway; [Hollan, Ivana] Lillehamer Hosp Rheumat Dis, Rheumatol Dept, Lillehamer, Norway; [Hollan, Ivana] Innlandet Hosp Trust, Res Dept, Brumunddal, Norway	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Hacettepe University; Fundacao Universitaria de Cardiologia; Universidade de Sao Paulo; Innlandet Hospital Trust	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, 77 Ave Louis Pasteur,NRB-742F, Boston, MA 02115 USA.	mfeinberg@bwh.harvard.edu	Marchini, Júlio F./G-7569-2012; Haemmig, Stefan/V-6585-2019	Marchini, Júlio F./0000-0002-2279-1945; Haemmig, Stefan/0000-0001-5014-4393; Guimaraes, Raphael/0000-0002-7883-828X; Ozdemir, Denizhan/0000-0002-8822-6842; Cheng, Henry/0000-0002-4254-962X; Feinberg, Mark/0000-0001-9523-3859	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [P30DK034854]; NIH National Heart, Lung, and Blood Institute [HL115141, HL117994, HL134849]; NIH National Institute of General Medical Sciences [GM115605]; Arthur K. Watson Charitable Trust; Dr. Ralph and Marian Falk Medical Research Trust (Bank of America); American Heart Association [18SFRN33900144]; American Diabetes Association [1-16-JDF-046]; Watkins Discovery Award; Lerner Young Investigator Award; Tubitak Predoctoral Scholarship; South-Eastern Regional Health Authorities; Norwegian Women's Public Health Association, Norway; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115141, R01HL117994, R01HL134849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115605] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Arthur K. Watson Charitable Trust; Dr. Ralph and Marian Falk Medical Research Trust (Bank of America); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); Watkins Discovery Award; Lerner Young Investigator Award; Tubitak Predoctoral Scholarship(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); South-Eastern Regional Health Authorities; Norwegian Women's Public Health Association, Norway; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Lay-Hong Ang (Beth Israel Deaconess Medical Center, Boston, MA, USA) for confocal microscopy technical assistance, and the Harvard Digestive Disease Center and U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant P30DK034854 This work was supported by the NIH National Heart, Lung, and Blood Institute Grants HL115141, HL117994, and HL134849, and NIH National Institute of General Medical Sciences Grant GM115605 (to M.W.F.); the Arthur K. Watson Charitable Trust (to M.W.F.); the Dr. Ralph and Marian Falk Medical Research Trust (Bank of America, N.A., Trustee; to M.W.F.); the American Heart Association Grant 18SFRN33900144 (to M.W.F.); the American Diabetes Association Grant 1-16-JDF-046 (to B.I.); the Watkins Discovery Award (to B.I.); the Lerner Young Investigator Award (to B.I.); a Tubitak Predoctoral Scholarship (to D.O.); and a grant from South-Eastern Regional Health Authorities and from Norwegian Women's Public Health Association, Norway (to I.H.). The authors declare no conflicts of interest.	Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Balaji S, 2014, J SURG RES, V190, P358, DOI 10.1016/j.jss.2014.02.027; Belch J, 2011, LANCET, V377, P1929, DOI 10.1016/S0140-6736(11)60394-2; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Bradley SV, 2007, CANCER RES, V67, P3609, DOI 10.1158/0008-5472.CAN-06-4803; Cannizzo CM, 2018, FASEB J, V32, P2911, DOI 10.1096/fj.201700617R; Caputo M, 2015, ADV DRUG DELIVER REV, V88, P78, DOI 10.1016/j.addr.2015.05.003; Chamorro-Jorganes A, 2013, PHARMACOL RES, V75, P15, DOI 10.1016/j.phrs.2013.04.002; Creager MA, 2011, CIRCULATION, V124, P1765, DOI 10.1161/CIRCULATIONAHA.110.009407; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Erba P, 2011, ANN SURG, V253, P402, DOI 10.1097/SLA.0b013e31820563a8; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Findley CM, 2008, J AM COLL CARDIOL, V52, P387, DOI 10.1016/j.jacc.2008.02.045; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Goligorsky MS, 2005, AM J PHYSIOL-RENAL, V288, pF871, DOI 10.1152/ajprenal.00333.2004; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Greene AK, 2006, ANN PLAS SURG, V56, P418, DOI 10.1097/01.sap.0000202831.43294.02; Grossman PM, 2007, AM HEART J, V153, P874, DOI 10.1016/j.ahj.2007.01.038; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; Hojo Y, 2000, J AM COLL CARDIOL, V35, P968, DOI 10.1016/S0735-1097(99)00632-4; Icli B, 2016, J MOL CELL CARDIOL, V91, P151, DOI 10.1016/j.yjmcc.2016.01.007; Icli B, 2013, CIRC RES, V113, P1231, DOI 10.1161/CIRCRESAHA.113.301780; Iyer Sunil R, 2017, JACC Basic Transl Sci, V2, P503, DOI 10.1016/j.jacbts.2017.07.012; Jones WS, 2007, CURR OPIN CARDIOL, V22, P458, DOI 10.1097/HCO.0b013e328236741b; Kawamoto A, 1998, INT J CARDIOL, V67, P47, DOI 10.1016/S0167-5273(98)00251-4; Kir D, 2018, ANGIOGENESIS, V21, P699, DOI 10.1007/s10456-018-9632-7; Krishna SM, 2015, INT J MOL SCI, V16, P11294, DOI 10.3390/ijms160511294; Kusumanto YH, 2006, HUM GENE THER, V17, P683, DOI 10.1089/hum.2006.17.683; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Laragione T, 2018, ANN RHEUM DIS, V77, P1627, DOI 10.1136/annrheumdis-2018-213498; Lee R, 2012, CURR VASC PHARMACOL, V10, P77, DOI 10.2174/157016112798829751; Li J, 1996, AM J PHYSIOL-HEART C, V270, pH1803, DOI 10.1152/ajpheart.1996.270.5.H1803; Ma N, 2013, GENETICS, V195, P457, DOI 10.1534/genetics.113.154674; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Medicherla S, 2009, DIABET METAB SYND OB, V2, P91; Melero-Martin JM, 2008, METHOD ENZYMOL, V445, P303, DOI 10.1016/S0076-6879(08)03013-9; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Nakajima K, 2004, CLIN CARDIOL, V27, P281, DOI 10.1002/clc.4960270509; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Ozdemir D, 2019, TRENDS CARDIOVAS MED, V29, P131, DOI 10.1016/j.tcm.2018.08.002; Peng C, 2011, PLAST RECONSTR SURG, V128, p673E, DOI 10.1097/PRS.0b013e318230c521; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Powell RJ, 2008, CIRCULATION, V118, P58, DOI 10.1161/CIRCULATIONAHA.107.727347; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Rao DS, 2003, CANCER CELL, V3, P471, DOI 10.1016/S1535-6108(03)00107-7; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; Rose BA, 2017, J BIOL CHEM, V292, P12787, DOI 10.1074/jbc.M117.784553; Sacilotto N, 2016, GENE DEV, V30, P2297, DOI 10.1101/gad.290619.116; Song GD, 2010, WOUND REPAIR REGEN, V18, P426, DOI 10.1111/j.1524-475X.2010.00595.x; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Sun L, 2009, AGEING RES REV, V8, P306, DOI 10.1016/j.arr.2009.04.003; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Wara AK, 2011, BLOOD, V118, P6461, DOI 10.1182/blood-2011-06-363457; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Yoshizuka N, 2012, MOL CELL BIOL, V32, P606, DOI 10.1128/MCB.06301-11; Yu JQ, 2004, J BIOL CHEM, V279, P50446, DOI 10.1074/jbc.M409221200	65	37	38	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5599	5614		10.1096/fj.201802063RR	http://dx.doi.org/10.1096/fj.201802063RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668922	Green Published, Bronze			2022-12-28	WOS:000462888500077
J	Mackenzie, AE; Quon, T; Lin, LC; Hauser, AS; Jenkins, L; Inoue, A; Tobin, AB; Gloriam, DE; Hudson, BD; Milligan, G				Mackenzie, Amanda E.; Quon, Tezz; Lin, Li-Chiung; Hauser, Alexander S.; Jenkins, Laura; Inoue, Asuka; Tobin, Andrew B.; Gloriam, David E.; Hudson, Brian D.; Milligan, Graeme			Receptor selectivity between the G proteins G alpha(12) and G alpha(13) is defined by a single leucine-to-isoleucine variation	FASEB JOURNAL			English	Article						GPCR; GPR35; G protein barcode; genome editing	CRYO-EM STRUCTURE; GPR35; AGONIST; IDENTIFICATION; PHARMACOLOGY; ACTIVATION; MIGRATION; POTENT; MODES; GPCRS	Despite recent advances in structural definition of GPCR-G protein complexes, the basis of receptor selectivity between G proteins remains unclear. The G alpha(12) and G alpha(13) subtypes together form the least studied group of heterotrimeric G proteins. G protein-coupled receptor 35 (GPR35) has been suggested to couple efficiently to G alpha(13) but weakly to G alpha(12). Using combinations of cells genome-edited to not express G proteins and bioluminescence resonance energy transfer-based sensors, we confirmed marked selectivity of GPR35 for G alpha(13). Incorporating G alpha(12)/G alpha(13) chimeras and individual residue swap mutations into these sensors defined that selectivity between G alpha(13) and G alpha(12) was imbued largely by a single leucine-to-isoleucine variation at position G.H5.23. Indeed, leucine could not be substituted by other amino acids in G alpha(13) without almost complete loss of GPR35 coupling. The critical importance of leucine at G.H5.23 for GPR35-G protein interaction was further demonstrated by introduction of this leucine into G alpha(q), resulting in the gain of coupling to GPR35. These studies demonstrate that G alpha(13) is markedly the most effective G protein for interaction with GPR35 and that selection between G alpha(13) and G alpha(12) is dictated largely by a single conservative amino acid variation.	[Mackenzie, Amanda E.; Quon, Tezz; Lin, Li-Chiung; Jenkins, Laura; Tobin, Andrew B.; Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow, Lanark, Scotland; [Hauser, Alexander S.; Gloriam, David E.] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan	University of Glasgow; University of Copenhagen; Tohoku University	Hudson, BD; Milligan, G (corresponding author), Univ Glasgow, Ctr Translat Pharmacol, Wolfson Link Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	brian.hudson@glasgow.ac.uk; graeme.milligan@glasgow.ac.uk	Hauser, Alexander/AAV-3436-2020; Gloriam, David E./A-1904-2011; Hudson, Brian/H-4845-2013	Hauser, Alexander/0000-0003-1098-6419; Gloriam, David E./0000-0002-4299-7561; Hudson, Brian/0000-0001-7059-0091	Novo Nordisk Foundation [NNF17OC0031226]; European Research Council [639125]; U.K. Medical Research Council; Glasgow University Leadership Fellowship; U.K. Biotechnology and Biosciences Research Council [BB/P000649/1, BB/P00069X/1]; Japanese Society for the Promotion of Science [17K08264]; Japan Agency for Medical Research and Development Grant [PRIME JP17gm5910013]; BBSRC [BB/P000649/1, BB/P00069X/1] Funding Source: UKRI; MRC [MC_UP_A600_1110, MR/P019366/1] Funding Source: UKRI	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Glasgow University Leadership Fellowship; U.K. Biotechnology and Biosciences Research Council; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development Grant(Japan Agency for Medical Research and Development (AMED)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.E.G. thanks the Novo Nordisk Foundation for Supporting Grant NNF17OC0031226 and the European Research Council for Starting Grant 639125. A.E.M. thanks the U.K. Medical Research Council for an Industrial Collaborative Awards in Science and Engineering Studentship, and B.D.H. was supported by a Glasgow University Leadership Fellowship. These studies were supported by U.K. Biotechnology and Biosciences Research Council Grants BB/P000649/1 (to G.M.) and BB/P00069X/1 (to A.B.T.), Japanese Society for the Promotion of Science Grant-in-Aid for Scientific Research (KAKANHI) 17K08264 (to A.I.), and Japan Agency for Medical Research and Development Grant PRIME JP17gm5910013 (to A.I.). The authors declare no conflicts of interest.	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Amir NASBM, 2018, J IMMUNOL, V201, P714, DOI 10.4049/jimmunol.1700884; Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Berlinguer-Palmini R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082180; Bolognini D, 2016, J BIOL CHEM, V291, P18915, DOI 10.1074/jbc.M116.736157; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Carpenter B, 2017, CURR OPIN STRUC BIOL, V45, P124, DOI 10.1016/j.sbi.2017.04.010; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Cooke RM, 2015, DRUG DISCOV TODAY, V20, P1355, DOI 10.1016/j.drudis.2015.08.003; Draper-Joyce CJ, 2018, NATURE, V558, P559, DOI 10.1038/s41586-018-0236-6; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Funke M, 2013, J MED CHEM, V56, P5182, DOI 10.1021/jm400587g; Garcia-Nafria J, 2018, NATURE, V558, P620, DOI 10.1038/s41586-018-0241-9; Grisshammer R, 2017, PROTEIN SCI, V26, P1493, DOI 10.1002/pro.3200; Guo YJ, 2017, BIOCHEM BIOPH RES CO, V493, P1159, DOI 10.1016/j.bbrc.2017.09.113; Hauser AS, 2018, CELL, V172, P41, DOI 10.1016/j.cell.2017.11.033; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Jenkins L, 2012, J PHARMACOL EXP THER, V343, P683, DOI 10.1124/jpet.112.198945; Jenkins L, 2011, BRIT J PHARMACOL, V162, P733, DOI 10.1111/j.1476-5381.2010.01082.x; Jenkins L, 2010, BIOCHEM J, V432, P451, DOI 10.1042/BJ20101287; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Kamato D, 2017, CELL MOL LIFE SCI, V74, P1379, DOI 10.1007/s00018-016-2405-9; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; MacKenzie AE, 2014, MOL PHARMACOL, V85, P91, DOI 10.1124/mol.113.089482; Malik RU, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08029-3; Manglik A, 2017, BIOCHEMISTRY-US, V56, P5628, DOI 10.1021/acs.biochem.7b00747; Maravillas-Montero JL, 2015, J IMMUNOL, V194, P29, DOI 10.4049/jimmunol.1401704; Mastop M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193705; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 2018, TRENDS PHARMACOL SCI, V39, P481, DOI 10.1016/j.tips.2018.02.005; Milligan G, 2011, TRENDS PHARMACOL SCI, V32, P317, DOI 10.1016/j.tips.2011.02.002; Moreira IS, 2014, BBA-GEN SUBJECTS, V1840, P16, DOI 10.1016/j.bbagen.2013.08.027; Neetoo-Isseljee Z, 2013, J PHARMACOL EXP THER, V344, P568, DOI 10.1124/jpet.112.201798; Pandy-Szekeres G, 2018, NUCLEIC ACIDS RES, V46, pD440, DOI 10.1093/nar/gkx1109; Park SJ, 2018, BRIT J PHARMACOL, V175, P154, DOI 10.1111/bph.14082; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Semack A, 2016, J BIOL CHEM, V291, P17929, DOI 10.1074/jbc.M116.735720; Sergeev E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14096-3; Shore DM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00069; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Thal DM, 2018, CURR OPIN STRUC BIOL, V51, P28, DOI 10.1016/j.sbi.2018.03.002; Tsukahara T, 2017, PHARMACOL RES, V123, P27, DOI 10.1016/j.phrs.2017.06.009; Van Eps N, 2018, P NATL ACAD SCI USA, V115, P2383, DOI 10.1073/pnas.1721896115; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Zhao PW, 2010, MOL PHARMACOL, V78, P560, DOI 10.1124/mol.110.066746	54	11	11	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5005	5017		10.1096/fj.201801956R	http://dx.doi.org/10.1096/fj.201801956R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601679	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000462888500030
J	Michael, JV; Gavrila, A; Nayak, AP; Pera, T; Liberato, JR; Polischak, SR; Shah, SD; Deshpande, DA; Penn, RB				Michael, James V.; Gavrila, Adelina; Nayak, Ajay P.; Pera, Tonio; Liberato, Jennifer R.; Polischak, Steven R.; Shah, Sushrut D.; Deshpande, Deepak A.; Penn, Raymond B.			Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle	FASEB JOURNAL			English	Article						airway remodeling; prostaglandin; asthma; EP receptor	PROTEIN-KINASE-A; PROSTAGLANDIN E-2; EP2 RECEPTOR; AGONISTS; PGE(2); CELLS; PHOSPHOPROTEIN; SENSITIVITY; ACTIVATION; MECHANISMS	Prostaglandin E2 (PGE(2)) is produced in the airway during allergic lung inflammation and both promotes and inhibits features of asthma pathology. These mixed effects relate to 4 E-prostanoid (EP) receptor subtypes (EP1, 2, 3 and 4) expressed at different levels on different resident and infiltrating airway cells. Although studies have asserted both EP2 and EP4 expression in human airway smooth muscle (HASM), a recent study asserted EP4 to be the functionally dominant EP subtype in HASM. Herein, we employ recently-developed subtype-selective ligands to investigate singular or combined EP2 and EP4 receptor activation in regulating HASM signaling and proliferation. The subtype specificity of ONO-AE1-259-01 (EP2 agonist) and ONO-AE1-329 (EP4 agonist) was first demonstrated in human embryonic kidney 293 cells stably expressing different EP receptor subtypes. EP receptor knockdown and subtype-selective antagonists demonstrated EP2 and EP4 receptor responsiveness in HASM cells to the specific ONO compounds, whereas PGE(2) appeared to preferentially signal via the EP4 receptor. Both singular EP2 and EP4 receptor agonists inhibited HASM proliferation, and combined EP2 and EP4 receptor agonism exhibited positive cooperativity in both chronic G(s)-mediated signaling and inhibiting HASM proliferation. These findings suggest both EP2 and EP4 are functionally important in HASM, and their combined targeting optimally inhibits airway smooth muscle proliferation.	[Michael, James V.; Gavrila, Adelina; Nayak, Ajay P.; Pera, Tonio; Liberato, Jennifer R.; Polischak, Steven R.; Shah, Sushrut D.; Deshpande, Deepak A.; Penn, Raymond B.] Thomas Jefferson Univ, Dept Med, Jane & Leonard Korman Lung Ctr, Div Pulm & Crit Care Med,Ctr Translat Med, Philadelphia, PA 19107 USA	Jefferson University	Penn, RB (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Room 543 JAH,1020 Locust St, Philadelphia, PA 19107 USA.	raymond.penn@jefferson.edu		Shah, Sushrut/0000-0002-4201-6532; Michael, James/0000-0001-8796-5259	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL136209, HL58506, HL139035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058506, F32HL139035, R01HL137030, R01HL136209] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL136209 (to R.B.P.), HL58506 (to R.B.P.), and HL139035 (to J.V.M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Aso H, 2013, AM J RESP CELL MOL, V48, P322, DOI 10.1165/rcmb.2012-0158OC; Belvisi MG, 1998, BRIT J PHARMACOL, V125, P1102, DOI 10.1038/sj.bjp.0702104; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Birrell MA, 2015, THORAX, V70, P740, DOI 10.1136/thoraxjnl-2014-206592; Birrell MA, 2013, BRIT J PHARMACOL, V168, P129, DOI 10.1111/j.1476-5381.2012.02088.x; Bogard AS, 2012, J PHARMACOL EXP THER, V342, P586, DOI 10.1124/jpet.112.193425; Buckley J, 2011, THORAX, V66, P1029, DOI 10.1136/thx.2010.158568; Burgess JK, 2004, J ALLERGY CLIN IMMUN, V113, P876, DOI 10.1016/j.jaci.2004.02.029; BUTT E, 1994, J BIOL CHEM, V269, P14509; Bygdeman M, 2003, BEST PRACT RES CL OB, V17, P707, DOI 10.1016/S1521-6934(03)00043-9; Claar D, 2015, EXPERT REV RESP MED, V9, P55, DOI 10.1586/17476348.2015.992783; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Feng CL, 2006, BLOOD, V107, P3243, DOI 10.1182/blood-2005-07-2772; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; HALBRUGGE M, 1989, EUR J BIOCHEM, V185, P41, DOI 10.1111/j.1432-1033.1989.tb15079.x; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; KAWAKAMI Y, 1973, EUR J CLIN PHARMACOL, V6, P127, DOI 10.1007/BF00562439; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Lazzeri N, 2001, AM J RESP CELL MOL, V24, P44, DOI 10.1165/ajrcmb.24.1.4027; Liu T, 2013, P NATL ACAD SCI USA, V110, P16987, DOI 10.1073/pnas.1313185110; Lundequist A, 2010, J IMMUNOL, V184, P433, DOI 10.4049/jimmunol.0902835; Maher SA, 2009, AM J RESP CRIT CARE, V180, P923, DOI 10.1164/rccm.200903-0388OC; Markovic T, 2017, DRUG DISCOV TODAY, V22, P57, DOI 10.1016/j.drudis.2016.08.003; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; MELILLO E, 1994, AM J RESP CRIT CARE, V149, P1138, DOI 10.1164/ajrccm.149.5.8173753; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; NIALS AT, 1993, CARDIOVASC DRUG REV, V11, P165, DOI 10.1111/j.1527-3466.1993.tb00274.x; Pan S, 2017, AM J PHYSIOL-LUNG C, V313, pL154, DOI 10.1152/ajplung.00106.2017; Pascual RM, 2001, AM J PHYSIOL-LUNG C, V281, pL1425, DOI 10.1152/ajplung.2001.281.6.L1425; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Pera T, 2018, FASEB J, V32, P862, DOI 10.1096/fj.201700555R; Pera T, 2015, FASEB J, V29, P4227, DOI 10.1096/fj.15-273094; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Samuchiwal SK, 2017, J BIOL CHEM, V292, P8195, DOI 10.1074/jbc.M116.769422; Sastre B, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/645383; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Sharma P, 2016, AM J PHYSIOL-LUNG C, V310, P1365, DOI 10.1152/ajplung.00373.2015; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tanaka H, 2005, CHEST, V128, P3717, DOI 10.1378/chest.128.5.3717; Tilley SL, 2003, AM J PHYSIOL-LUNG C, V284, pL599, DOI 10.1152/ajplung.00324.2002; WALTERS EH, 1982, THORAX, V37, P438, DOI 10.1136/thx.37.6.438; WALTERS EH, 1982, THORAX, V37, P918, DOI 10.1136/thx.37.12.918; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798	48	12	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4780	4789		10.1096/fj.201801959R	http://dx.doi.org/10.1096/fj.201801959R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601680	Bronze, Green Published			2022-12-28	WOS:000462888500012
J	Tan, AN; Ke, SY; Chen, Y; Chen, L; Lu, XS; Ding, F; Yang, LH; Tang, Y; Yu, YH				Tan, Anni; Ke, Shiyun; Chen, Yao; Chen, Lei; Lu, Xiaosheng; Ding, Fei; Yang, Liuhong; Tang, Yan; Yu, Yanhong			Expression patterns of C1ql4 and its cell-adhesion GPCR Bai3 in the murine testis and functional roles in steroidogenesis	FASEB JOURNAL			English	Article						testosterone; Leydig cells; ERK1/2; cAMP	COUPLED RECEPTOR BAI3; LEYDIG-CELLS; PROTEIN-KINASE; PATHWAY; BRAIN; ANGIOGENESIS; ADIPONECTIN; ENDOCRINE	C1q-like 4 (C1QL4), a novel member of the C1q- and TNF-related protein family, was found to be highly expressed in rodent and human testis. However, the localization, developmental, and hormonally regulated expression and biologic function of C1ql4 in the testis have not been investigated. Here, we demonstrated that C1ql4 mRNA and protein levels in murine testes gradually increased from the postnatal period to the adult stage and were up-regulated by LH in vivo. In situ hybridization demonstrated that the distribution and expression levels of C1ql4 mRNA varied at different developmental stages, although C1ql4 mRNA was detected in the seminiferous tubule and interstitial Leydig cells. Recombinant C1QL4 did not affect cell proliferation but did increase testosterone production in TM3 Leydig cells, as well as in cultured seminiferous tubules. C1QL4-induced testosterone secretion in Leydig cells was accompanied by increased expression of steroidogenic acute regulatory (StAR) protein and steroidogenic enzymes. During this process, the c-Raf/extracellular signal-regulated protein kinase kinases 1 and 2/ERK1/2/mitogen- and stress-activated protein kinase-1 and cAMP/PKA/cAMP-responsive element binding protein signaling cascades were activated by C1QL4. The cell-adhesion GPCR brain-specific angiogenesis inhibitor 3 (BAI3), a putative receptor of C1QL4, was detected in the seminiferous tubule and interstitial Leydig cells during testicular development. Knockdown of Bai3 expression in Leydig cells led to a reduction in Star expression, accompanied by increases in phosphorylation of ERK1/2 and intercellular cAMP levels. However, C1QL4-induced StAR expression was not completely suppressed in the Bai3-deficient Leydig cells, and phosphorylation of ERK1/2 and intercellular cAMP levels were not significantly changed before and after C1QL4 stimulation. Our results suggested that although BAI3 played a role in C1QL4-induced steroidogenesis, there was an unidentified receptor that mediated C1QL4-activated testosterone secretion in Leydig cells through phosphorylation of ERK1/2 and up-regulation of intracellular cAMP levels. Taken together, our results showed, for the first time to our knowledge, that C1QL4 served as a novel acute regulator of testosterone secretion, and BAI3 functioned as a new receptor that is involved in steroidogenesis in Leydig cells. BAI3-independent ERK1/2 activation and cAMP activation mediated C1QL4-induced testosterone secretion. This study expanded the reproductive roles and mechanisms of C1QL4 and BAI3 signaling pathways.	[Tan, Anni; Ke, Shiyun; Chen, Yao; Lu, Xiaosheng; Ding, Fei; Yang, Liuhong; Tang, Yan; Yu, Yanhong] Chinese Univ Hong Kong, Jinan Univ, Dept Dev & Regenerat Biol, Key Lab Regenerat Med,Minist Educ,Coll Life Sci &, Hong Kong, Peoples R China; [Chen, Lei] Jinan Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Jinan University	Yu, YH (corresponding author), Jinan Univ, Coll Life Sci & Technol, Dept Dev & Regenerat Biol, 601 Huangpu Rd West, Guangzhou 510632, Guangdong, Peoples R China.	yuyhong79@gmail.com		Yu, Yanhong/0000-0002-1652-201X; Tong, Yin Selina/0000-0002-6712-9752	National Natural Science Foundation of China [30900232]; Fundamental Research Funds for the Central Universities [21610202]; Postdoctoral Science Foundation, Funded Project of China [200801259]; Science and Technology Star of Pearl River (Guangzhou City, China) [2013J2200026]; Natural Science Foundation of Guangdong Province [8451063201000105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Postdoctoral Science Foundation, Funded Project of China; Science and Technology Star of Pearl River (Guangzhou City, China); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (30900232), the Fundamental Research Funds for the Central Universities (21610202), the Postdoctoral Science Foundation, Funded Project of China (200801259), the Science and Technology Star of Pearl River (Guangzhou City, China; 2013J2200026), and the Natural Science Foundation of Guangdong Province (8451063201000105). The authors declare no conflicts of interest.	Abdou HS, 2013, ENDOCRINOLOGY, V154, P511, DOI 10.1210/en.2012-1767; Andric SA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1399, DOI 10.1152/ajpendo.00482.2007; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Arakane F, 1998, J BIOL CHEM, V273, P16339, DOI 10.1074/jbc.273.26.16339; Bari MF, 2014, HISTOPATHOLOGY, V64, P547, DOI 10.1111/his.12278; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Caminos JE, 2008, ENDOCRINOLOGY, V149, P3390, DOI 10.1210/en.2007-1582; DUFAU ML, 1977, P NATL ACAD SCI USA, V74, P3419, DOI 10.1073/pnas.74.8.3419; Ge RS, 2005, ENDOCRINOLOGY, V146, P2657, DOI 10.1210/en.2005-0046; Gupta R, 2018, J BIOL CHEM, V293, P18086, DOI 10.1074/jbc.RA118.005403; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Hamoud N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06897-5; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Lanoue V, 2013, MOL PSYCHIATR, V18, P943, DOI 10.1038/mp.2013.46; Liu F, 2017, MOL CELL BIOCHEM, V424, P57, DOI 10.1007/s11010-016-2842-7; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; Matsuda K, 2016, NEURON, V90, P752, DOI 10.1016/j.neuron.2016.04.001; Matzkin ME, 2013, MOL CELL ENDOCRINOL, V370, P130, DOI 10.1016/j.mce.2013.02.017; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Otani M, 2012, CYTOKINE, V58, P238, DOI 10.1016/j.cyto.2012.01.018; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; Sigoillot SM, 2015, CELL REP, V10, P820, DOI 10.1016/j.celrep.2015.01.034; Smith LB, 2014, SEMIN CELL DEV BIOL, V30, P2, DOI 10.1016/j.semcdb.2014.02.012; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; SYED V, 1985, MOL CELL ENDOCRINOL, V40, P257, DOI 10.1016/0303-7207(85)90181-9; Tremblay JJ, 2015, STEROIDS, V103, P3, DOI 10.1016/j.steroids.2015.08.001; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Yamashita S, 2011, MOL ENDOCRINOL, V25, P1211, DOI 10.1210/me.2011-0059; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024	35	7	7	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4893	4906		10.1096/fj.201801620RR	http://dx.doi.org/10.1096/fj.201801620RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30608882	Bronze			2022-12-28	WOS:000462888500021
J	Fang, JD; Tung, HH; Lee, SL				Fang, Jung-Da; Tung, Hsiu-Hui; Lee, Sheau-Ling			Mitochondrial localization of St14-encoding transmembrane serine protease is involved in neural stem/progenitor cell bioenergetics through binding to F0F1-ATP synthase complex	FASEB JOURNAL			English	Article						ETC complex; oxygen consumption; reserve capacity; membrane potential; mitochondria	HEPATOCYTE GROWTH-FACTOR; ATP SYNTHASE; ACTIVATION; MATRIPTASE; SURFACE; MET	Knockdown of the suppression of tumorigenicity 14-encoding type II transmembrane serine protease matriptase (MTP) in neural stem/progenitor (NS/P) cells impairs cell mobility, response to chemo-attractants, and neurovascular niche interaction. In the present study, we showed by Western blot that a portion of MTP can be detected in the mitochondrial fraction of mouse NS/P cells by immunostaining that it is co-stained with the mitochondrial dye MitoTracker (Thermo Fisher Scientific, Waltham, MA, USA) inside the cells. Co-immunoprecipitation showed that MTP is bound to the subunit of mitochondrial F0F1-ATP synthase complex (ATP-). Cyto-immunofluorescence staining and an in situ proximity ligation assay further confirmed a physical interaction between MTP and ATP-. This interaction relied on the presence of both Cls/Clr urchin embryonic growth factor, bone morphogenic protein 1 and low-density lipoprotein receptor motifs of MTP. We found that NS/P cell mitochondrial membrane potential is impaired by MTP knockdown, and ATP synthesis and oxygen consumption rate are significantly reduced in MTP-knockdown NS/P cells. Among the oxidative phosphorylation functions, the greatest effect of MTP knockdown is the reduction by over 50% in the mitochondrial energy reserve capacity. This made MTP-knockdown NS/P cells unable to overcome hydrogen peroxide stress, which leads to cessation of cell growth. This work identifies 2 previously unknown functions for MTP: first as a binding protein in the mitochondrial F1F0-ATP synthase complex and second as a regulatory mechanism of mitochondrial bioenergetics. Mitochondrial MTP may serve a protective function for NS/P cells in response to stress.Fang, J.-D., Tung, H.-H., Lee, S.-L. Mitochondrial localization of St14-encoding transmembrane serine protease is involved in neural stem/progenitor cell bioenergetics through binding to F0F1-ATP synthase complex.	[Fang, Jung-Da; Tung, Hsiu-Hui; Lee, Sheau-Ling] Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.org.tw			National Health Research Institutes Grants [06A1-CSPP10-014, 05A1-CSPP10-014]; National Health Research Institutes; Central Government Science and Technology Grant [NP106-SP-06]	National Health Research Institutes Grants; National Health Research Institutes(National Health Research Institutes, Japan); Central Government Science and Technology Grant	This work was supported by National Health Research Institutes Grants 06A1-CSPP10-014 and 05A1-CSPP10-014, and National Health Research Institutes and Central Government Science and Technology Grant NP106-SP-06 (to S.-L.L.). The authors declare no conflicts of interest.	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Arakaki N, 2003, MOL CANCER RES, V1, P931; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Chen CY, 2016, J DERMATOL SCI, V83, P34, DOI 10.1016/j.jdermsci.2016.03.006; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Fang JD, 2014, BBA-MOL CELL RES, V1843, P1285, DOI 10.1016/j.bbamcr.2014.03.020; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Lee D, 2011, BIOCHEM BIOPH RES CO, V405, P644, DOI 10.1016/j.bbrc.2011.01.084; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Maniam S, 2015, CELL DEATH DIFFER, V22, P156, DOI 10.1038/cdd.2014.135; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Sanders Andrew J, 2006, J Exp Ther Oncol, V6, P39; Schmidt C, 2008, MOL PSYCHIATR, V13, P953, DOI 10.1038/sj.mp.4002077; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Tung HH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05131-4; Tung HH, 2012, J BIOL CHEM, V287, P22497, DOI 10.1074/jbc.M111.330589; Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117; Zoratti GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7776	33	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4327	4340		10.1096/fj.201801307R	http://dx.doi.org/10.1096/fj.201801307R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566397				2022-12-28	WOS:000459794800098
J	Igarashi, M; Watanabe, K; Tsuduki, T; Kimura, I; Kubota, N				Igarashi, Miki; Watanabe, Kazuhide; Tsuduki, Tsuyoshi; Kimura, Ikuo; Kubota, Naoto			NAPE-PLD controls OEA synthesis and fat absorption by regulating lipoprotein synthesis in an in vitro model of intestinal epithelial cells	FASEB JOURNAL			English	Article						NAPE-PLD; Caco-2; fatty acid ethanolamide	N-ACYL-PHOSPHATIDYLETHANOLAMINE; HYDROLYZING ACID AMIDASE; GENE-EXPRESSION; FOOD-INTAKE; MOLECULAR CHARACTERIZATION; ANANDAMIDE; CACO-2; ACYLETHANOLAMINES; BIOSYNTHESIS; MECHANISMS	Oleoylethanolamide (OEA), a fatty acid ethanolamide (FAE), is a lipid mediator that controls food intake and lipid metabolism. Accumulating data imply the importance of intestinal OEA in controlling satiety in addition to gastrointestinal peptide hormones. Although the biochemical pathway of FAE production has been illustrated, the enzymes responsible for the cleavage of OEA from its precursor N-acyl-phosphatidylethanolamine (NAPE) must be identified among reported candidates in the gut. In this study, we assessed the involvement of NAPE-specific phospholipase D (NAPE-PLD), which can directly release FAEs from NAPE, in intestinal OEA synthesis and lipid metabolism. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPER-associated protein 9 (Cas9)-mediated deletion of the NAPE-PLD gene in intestinal epithelial-like Caco-2 cells reduced OEA levels, regardless of their differentiation states. Transcriptome analysis revealed that deletion of NAPE-PLD activates a transcriptional program for nutrient transportation, including lipids and lipoproteins, and inactivates cell-cycle or mitosis-related genes in Caco-2 cells. In addition, the basolateral secretion of lipoproteins was increased in NAPE-PLD-deleted cells although lipoprotein size was not affected. By contrast, cellular lipid levels were reduced in NAPE-PLD-deleted cells. Overall, these results indicate that NAPE-PLD plays important roles in OEA synthesis and fat absorption by regulating lipoprotein production in the intestinal epithelial cells.Igarashi, M., Watanabe, K., Tsuduki, T., Kimura, I., Kubota, N. NAPE-PLD controls OEA synthesis and fat absorption by regulating lipoprotein synthesis in an in vitro model of intestinal epithelial cells.	[Igarashi, Miki; Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, 3-5-8 Saiwai, Fuchu, Tokyo 1838509, Japan; [Igarashi, Miki; Watanabe, Kazuhide; Kubota, Naoto] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr Sci, Dept Biosci & Biotechnol Future Bioind, Sendai, Miyagi, Japan; [Kubota, Naoto] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Kubota, Naoto] Univ Tokyo, Dept Clin Nutr Therapy, Tokyo, Japan; [Kubota, Naoto] Natl Inst Hlth & Nutr, Dept Clin Nutr, Tokyo, Japan; [Igarashi, Miki] Tokyo Univ Agr & Technol, Tokyo, Japan	Tokyo University of Agriculture & Technology; RIKEN; Tohoku University; University of Tokyo; University of Tokyo; National Institute of Health & Nutrition - Japan; Tokyo University of Agriculture & Technology	Igarashi, M (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, 3-5-8 Saiwai, Fuchu, Tokyo 1838509, Japan.	mikiigarashi@go.tuat.ac.jp	Watanabe, Kazuhide/C-9667-2017; Tsuduki, Tsuyoshi/T-2697-2019; Kimura, Ikuo/B-4193-2015	Watanabe, Kazuhide/0000-0002-5331-0593; Tsuduki, Tsuyoshi/0000-0001-7810-0528; 	Japan Society for the Promotion of Science [17K07809]; Kao Research Council for the Study of Healthcare Science; Project of the National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kao Research Council for the Study of Healthcare Science; Project of the National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution	The authors thank Dr. Tatsuya Sugawara (Kyoto University, Kyoto, Japan) for help in drafting the manuscript. The authors also thank Ms. Kumiko Tachikawa (Tokyo University of Agriculture and Technology, Tokyo, Japan) for excellent technical assistance. This research was supported by Grants-in-Aid for Scientific Research (KAKENHI), the Japan Society for the Promotion of Science 17K07809 (to M.I.), the Kao Research Council for the Study of Healthcare Science (2016) (to M.I.), and the Project of the National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution (advanced integration research for agriculture and interdisciplinary fields) (to M.I. and T.T.). The authors declare no conflicts of interest.	Boger DL, 2000, BIOORG MED CHEM LETT, V10, P2613, DOI 10.1016/S0960-894X(00)00528-X; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu J, 2008, AM J PHYSIOL-REG I, V295, pR45, DOI 10.1152/ajpregu.00126.2008; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; Grimaldi C, 2006, EXP CELL RES, V312, P363, DOI 10.1016/j.yexcr.2005.10.024; Guijarro A, 2010, PHARMACOL RES, V61, P27, DOI 10.1016/j.phrs.2009.09.003; Hasegawa A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-144; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Igarashi M, 2004, J NUTR SCI VITAMINOL, V50, P121, DOI 10.3177/jnsv.50.121; Igarashi M, 2015, BBA-MOL CELL BIOL L, V1851, P1218, DOI 10.1016/j.bbalip.2015.05.006; Inoue M, 2017, J BIOCHEM, V162, P449, DOI 10.1093/jb/mvx054; Joseph J, 2004, CANCER IMMUNOL IMMUN, V53, P723, DOI 10.1007/s00262-004-0509-9; Karwad MA, 2017, FASEB J, V31, P3267, DOI 10.1096/fj.201601346R; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Linsalata M, 2010, ANTICANCER RES, V30, P2583; Liu J, 2008, NEUROPHARMACOLOGY, V54, P1, DOI 10.1016/j.neuropharm.2007.05.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Nauli AM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12018; Nielsen MJ, 2004, J LIPID RES, V45, P1027, DOI 10.1194/jlr.C300008-JLR200; Ogura Y, 2016, NAT CHEM BIOL, V12, P669, DOI 10.1038/nchembio.2127; Okazaki M, 2016, J OLEO SCI, V65, P265, DOI 10.5650/jos.ess16020; Oveisi F, 2004, PHARMACOL RES, V49, P461, DOI 10.1016/j.phrs.2003.12.006; PINTO M, 1983, BIOL CELL, V47, P323; Piomelli D, 2013, TRENDS ENDOCRIN MET, V24, P332, DOI 10.1016/j.tem.2013.03.001; Proulx K, 2005, AM J PHYSIOL-REG I, V289, pR729, DOI 10.1152/ajpregu.00029.2005; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Suzuki R, 1998, LIFE SCI, V62, P861, DOI 10.1016/S0024-3205(98)00003-4; Tai T, 2012, ACS CHEM NEUROSCI, V3, P379, DOI 10.1021/cn300007s; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2011, BBA-MOL CELL BIOL L, V1811, P565, DOI 10.1016/j.bbalip.2011.07.009; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Usui S, 2002, J LIPID RES, V43, P805; VANBEERS EH, 1995, BIOCHEM J, V308, P769, DOI 10.1042/bj3080769	47	5	5	1	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3167	3179		10.1096/fj.201801408R	http://dx.doi.org/10.1096/fj.201801408R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30399323	Bronze			2022-12-28	WOS:000459794800008
J	Kang, M; Kim, S; Ko, J				Kang, Minsoo; Kim, Suhyun; Ko, Jesang			Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer	FASEB JOURNAL			English	Article						extracellular vesicles; KRAS mutant; chemoresistance	EXTRACELLULAR VESICLES; TUMOR MICROENVIRONMENT; CELLS; MUTATIONS; PROMOTES; RELEASE; GROWTH; DIFFERENTIATION; EXOSOMES; GENE	Extracellular vesicles contain various cellular components that are involved in tumor growth, metastasis, and immune escape. Extracellular vesicles are classified into 2 groups, namely, exosomes and microvesicles (MV). Although the formation and roles of exosomes have been studied, the exact functions of MVs and mechanisms underlying MV release are not fully understood. We found that epidermal growth factor accelerates the release of MVs from the plasma membrane by inducing NF-B activation and CD133 expression. The amount and sizes of budding MVs were found to be dependent on the expression level of CD133, which regulates the activities of the small guanosine 5'-triphosphatases RhoA and Rac1. CD133-containing MVs released from KRAS mutant colon cancer cells delivered KRAS mutant to adjacent nontumorigenic cells and activated KRAS downstream signaling. CD133-containing MVs were found to promote the migration and invasion of adjacent cells. CD133-containing MVs induced the development of chemoresistance by abolishing the inhibitory effects of anti-epidermal growth factor receptor (EGFR) drugs on cell proliferation and motility in colon cancer. These results suggest that CD133 acts as a novel modulator in MV release and in oncoprotein trafficking. CD133 can serve as a therapeutic target for treatment of anti-EGFR drug-resistant colon cancer.Kang, M., Kim, S., Ko, J. Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer.	[Kang, Minsoo; Kim, Suhyun; Ko, Jesang] Korea Univ, Div Life Sci, 1 Anam Dong, Seoul 136701, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Div Life Sci, 1 Anam Dong, Seoul 136701, South Korea.	jesangko@korea.ac.kr			Tunneling Nanotube Research Center through the National Research Foundation of Korea (NRF) - Korea government [NRF-2015R1A5A1009024]	Tunneling Nanotube Research Center through the National Research Foundation of Korea (NRF) - Korea government	This work was supported by the Tunneling Nanotube Research Center (NRF-2015R1A5A1009024) through the National Research Foundation of Korea (NRF) grant funded by the Korea government. The authors declare no conflicts of interest.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Chao OS, 2017, J CELL BIOCHEM, V118, P4414, DOI 10.1002/jcb.26095; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Imamura Y, 2012, CLIN CANCER RES, V18, P4753, DOI 10.1158/1078-0432.CCR-11-3210; Krasinskas A. M., 2011, PATHOLOG RES INT, V2011, P6, DOI DOI 10.4061/2011/932932; Latorre E, 2016, CANCER RES, V76, P2626, DOI 10.1158/0008-5472.CAN-15-2018; Lim SH, 2014, J GASTROINTEST ONCOL, V5, P447, DOI 10.3978/j.issn.2078-6891.2014.071; Lucchetti D, 2017, AM J PATHOL, V187, P1633, DOI 10.1016/j.ajpath.2017.03.015; Maguire CA, 2012, MOL THER, V20, P960, DOI 10.1038/mt.2011.303; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Moon BS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt373; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rappa G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-62; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Santi A, 2015, BBA-MOL CELL RES, V1853, P3211, DOI 10.1016/j.bbamcr.2015.09.013; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Schneider M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-96; Sedgwick AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14748; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Wang MN, 2017, J CANCER, V8, P761, DOI 10.7150/jca.17648; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Won C, 2015, HEPATOLOGY, V62, P1160, DOI 10.1002/hep.27968; Yang ZL, 2011, WORLD J GASTROENTERO, V17, P932, DOI 10.3748/wjg.v17.i7.932; Zhang LH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02992; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	46	13	14	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4248	4260		10.1096/fj.201802018R	http://dx.doi.org/10.1096/fj.201802018R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521383	Bronze			2022-12-28	WOS:000459794800092
J	Li, WW; Wang, WH; Liu, L; Qu, RZ; Chen, XM; Qiu, C; Li, JY; Hayball, J; Liu, L; Chen, JY; Wang, X; Pan, X; Zhao, YP				Li, Weiwei; Wang, Wenhan; Liu, Long; Qu, Ruize; Chen, Xiaomin; Qiu, Cheng; Li, Jiayi; Hayball, John; Liu, Liang; Chen, Jianying; Wang, Xia; Pan, Xin; Zhao, Yunpeng			GDF11 antagonizes TNF--induced inflammation and protects against the development of inflammatory arthritis in mice	FASEB JOURNAL			English	Article						rheumatoid arthritis; NF-B signaling pathway; synovitis; growth differentiation factor 11	DIFFERENTIATION FACTOR 11; NF-KAPPA-B; GENE; ANTIBODY; ALPHA; CELLS; AGE; OSTEOARTHRITIS; INTEGRATION; INHIBITORS	Growth differentiation factor 11 (GDF11), a key member of the TGF- superfamily, plays critical roles in various medical conditions. Recently, GDF11 was found to suppress the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) signaling pathway and protect against inflammation. This study aimed to investigate the role of GDF11 in the development of rheumatoid arthritis (RA). We demonstrated that GDF11 treatment antagonized TNF--induced inflammation in macrophages. Moreover, GDF11 inhibited the development of arthritis in the collagen-induced arthritis and collagen antibody-induced arthritis models. Local gene transfer of GDF11 via adeno-associated virus exerted therapeutic effects, while local knockdown of GDF11 exaggerated inflammation in our collagen-induced arthritis model, as detected by expression levels of inflammatory biomarkers and the destruction of joint structures. Additionally, the results from both in vitro experiments and luciferase reporter gene mouse experiments implied that the NF-B pathway might play a critical role in the therapeutic effect of GDF11 in RA. This study presents GDF11 as a potential target for the treatment of inflammatory arthritis, including RA.Li, W., Wang, W., Liu, L., Qu, R., Chen, X., Qiu, C., Li, J., Hayball, J., Liu, L., Chen, J., Wang, X., Pan, X., Zhao, Y. GDF11 antagonizes TNF--induced inflammation and protects against the development of inflammatory arthritis in mice.	[Li, Weiwei; Liu, Long] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Shandong, Peoples R China; [Wang, Wenhan; Wang, Xia; Pan, Xin; Zhao, Yunpeng] Shandong Univ, Qilu Hosp, Dept Orthoped, 107 West Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Wang, Wenhan; Qu, Ruize; Chen, Xiaomin; Qiu, Cheng; Li, Jiayi] Shandong Univ, Med Sch, Jinan, Shandong, Peoples R China; [Hayball, John; Liu, Liang] Univ South Australia, Hanson Inst, Sch Pharm & Med Sci, Expt Therapeut Lab, Adelaide, SA, Australia; [Hayball, John; Liu, Liang] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia; [Hayball, John; Liu, Liang] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Hayball, John; Liu, Liang] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Chen, Jianying] Inst Biopharmaceut Shandong Prov, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Hanson Institute; University of South Australia; University of South Australia; Robinson Research Institute; University of Adelaide; University of Adelaide	Pan, X; Zhao, YP (corresponding author), Shandong Univ, Qilu Hosp, Dept Orthoped, 107 West Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.	xinpanqlyy@126.com; miraculously2008@163.com	chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022		Key Research and Development Projects of Shandong Province [2015GSF118115]; Natural Science Foundation of Shandong Province [BS2014YY048, ZR2016HM53, BS2015SW028]; Major Project of Science and Technology of Shandong Province [2015ZDJS04001]; National Natural Science Foundation of China [81501880, 81602761]	Key Research and Development Projects of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Major Project of Science and Technology of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank C. Liu and S. Liu for their scientific input and advice. The authors thank H. Zhao, H. Li, and S. Wang for providing secretarial assistance and technical support. This work was supported in part by the Key Research and Development Projects of Shandong Province (2015GSF118115), the Natural Science Foundation of Shandong Province (BS2014YY048, ZR2016HM53, and BS2015SW028), the Major Project of Science and Technology of Shandong Province (2015ZDJS04001), and the National Natural Science Foundation of China (81501880 and 81602761). The authors declare no conflicts of interest.	Batra R, 2017, CELL, V170, P899, DOI 10.1016/j.cell.2017.07.010; Boutet MA, 2017, ANN RHEUM DIS, V76, P1300, DOI 10.1136/annrheumdis-2016-210630; DEGRAEFFMEEDER ER, 1991, LANCET, V337, P1368, DOI 10.1016/0140-6736(91)93057-G; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; El-Shami K, 2015, CA-CANCER J CLIN, V65, P427, DOI 10.3322/caac.21286; Fadini GP, 2015, DIABETES CARE, V38, pE118, DOI 10.2337/dc15-0868; Gamer LW, 2001, DEV BIOL, V229, P407, DOI 10.1006/dbio.2000.9981; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Jin C. H., MOLECULES, V22; Jin XN, 2016, ACTA PHARMACOL SIN, V37, P674, DOI 10.1038/aps.2016.7; Kafer R, 2017, MOL IMMUNOL, V87, P207, DOI 10.1016/j.molimm.2017.05.003; Kaiser J, 2015, SCIENCE, V348, P849, DOI 10.1126/science.348.6237.849; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kim DH, 2015, ARTHRITIS RHEUMATOL, V67, P3058, DOI 10.1002/art.39284; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Li WW, 2015, FEBS J, V282, P2317, DOI 10.1111/febs.13278; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Mei W, 2016, MOL THER, V24, P1926, DOI 10.1038/mt.2016.160; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Ohmi Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11205; Pawlowska J, 2011, CLIN EXP IMMUNOL, V163, P157, DOI 10.1111/j.1365-2249.2010.04294.x; Poggioli T, 2016, CIRC RES, V118, P29, DOI 10.1161/CIRCRESAHA.115.307521; Roark Anne C, 1977, Chron High Educ, V15, P7; Robbins D, 2011, METHODS MOL BIOL, V716, P169, DOI 10.1007/978-1-61779-012-6_10; Scudellari M, 2015, NATURE, V517, P426, DOI 10.1038/517426a; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Suzuki T, 2018, THER CLIN RISK MANAG, V14, P453, DOI 10.2147/TCRM.S156350; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tao YX, 2017, RHEUMATOLOGY, V56, P1804, DOI 10.1093/rheumatology/kex233; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang QH, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8134321; Wang WH, 2016, INFLAMMATION, V39, P1624, DOI 10.1007/s10753-016-0396-1; Widdifield J, 2015, ARTHRIT CARE RES, V67, P1047, DOI 10.1002/acr.22553; Zhang Weidong, 2004, Genet Vaccines Ther, V2, P8, DOI 10.1186/1479-0556-2-8; Zhang Y, 2016, BIOTECHNOL LETT, V38, P1423, DOI 10.1007/s10529-016-2139-7; Zhao YP, 2015, ANN RHEUM DIS, V74, P2244, DOI 10.1136/annrheumdis-2014-205779; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	47	18	18	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3317	3329		10.1096/fj.201801375RR	http://dx.doi.org/10.1096/fj.201801375RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30407878				2022-12-28	WOS:000459794800020
J	Poble, PB; Phan, C; Quatremare, T; Bordenave, J; Thuillet, R; Cumont, A; Huertas, A; Tu, L; Dorfmuller, P; Humbert, M; Ghigna, MR; Savale, L; Guignabert, C				Poble, Paul-Benoit; Phan, Carole; Quatremare, Timothee; Bordenave, Jennifer; Thuillet, Raphael; Cumont, Amelie; Huertas, Alice; Tu, Ly; Dorfmueller, Peter; Humbert, Marc; Ghigna, Maria-Rosa; Savale, Laurent; Guignabert, Christophe			Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension	FASEB JOURNAL			English	Article						pulmonary arterial hypertension; pulmonary vascular remodeling; extracellular matrix; FoxO1	SERINE ELASTASE INHIBITOR; TRANSCRIPTION FACTOR; FIBROSIS; TARGETS; PREVENTS	Heightened pulmonary artery smooth muscle cell (PA-SMC) proliferation and migration and dynamic remodeling of the extracellular matrix are hallmark pathogenic features of pulmonary arterial hypertension (PAH). Pirfenidone (PFD) is an orally bioavailable pyridone derivative with antifibrotic, antiinflammatory, and antioxidative properties currently used in the treatment of idiopathic pulmonary fibrosis. We therefore evaluated the efficacy of curative treatments with PFD in the sugen/hypoxia (SuHx) rat model of severe pulmonary hypertension. Treatment with PFD (30 mg/kg per day by mouth 3 times a day for 3 wk) started 5 wk after sugen injection partially reversed established pulmonary hypertension, reducing total pulmonary vascular resistance and remodeling. Consistent with these observations, we found that continued PFD treatment decreases PA-SMC proliferation and levels of extracellular matrix deposition in lungs and right ventricles in SuHx rats. Importantly, PFD attenuated the proproliferative and promigratory potentials of cultured PA-SMCs from patients with idiopathic PAH and their capacity to produce extracellular matrix components. Finally, we found that PFD dose dependently enhanced forkhead box O1 protein levels and its nuclear translocation in cultured idiopathic PAH PA-SMCs and in PFD-treated SuHx rats. PFD appears to be a potential therapy for PAH worthy of investigation and evaluation for clinical use in conjunction with current PAH treatments.Poble, P.-B., Phan, C., Quatremare, T., Bordenave, J., Thuillet, R., Cumont, A., Huertas, A., Tu, L., Dorfmuller, P., Humbert, M., Ghigna, M.-R., Savale, L., Guignabert, C. Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension.	[Poble, Paul-Benoit; Phan, Carole; Quatremare, Timothee; Bordenave, Jennifer; Thuillet, Raphael; Cumont, Amelie; Huertas, Alice; Tu, Ly; Dorfmueller, Peter; Humbert, Marc; Ghigna, Maria-Rosa; Savale, Laurent; Guignabert, Christophe] INSERM, UMR S 999, Le Plessis Robinson, France; [Poble, Paul-Benoit; Phan, Carole; Quatremare, Timothee; Bordenave, Jennifer; Thuillet, Raphael; Cumont, Amelie; Huertas, Alice; Tu, Ly; Dorfmueller, Peter; Humbert, Marc; Ghigna, Maria-Rosa; Savale, Laurent; Guignabert, Christophe] Univ Paris Saclay, Univ Paris Sud, Le Kremlin Bicetre, France; [Huertas, Alice; Humbert, Marc; Savale, Laurent] Hop Bicetre, AP HP, DHU Thorax Innovat, Ctr Reference Hypertens Pulm Severe,Serv Pneumol, Le Kremlin Bicetre, France; [Dorfmueller, Peter; Ghigna, Maria-Rosa] Hop Marie Lannelongue, Pathol Dept, Le Plessis Robinson, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue	Guignabert, C (corresponding author), Hop Marie Lannelongue, INSERM, UMR S 999, 133 Ave Resistance, F-92350 Le Plessis Robinson, France.	christophe.guignabert@inserm.fr	GUIGNABERT, Christophe/G-3873-2013; Humbert, Marc/ABD-5112-2021; Savale, Laurent/AAJ-9781-2020; TU, Ly/G-4035-2013; GUIGNABERT, Christophe/AGI-2488-2022; Humbert, Marc/AAC-8459-2019; Huertas, Alice/E-8244-2017; TU, Ly/AAK-4996-2020	GUIGNABERT, Christophe/0000-0002-8545-4452; TU, Ly/0000-0003-2336-5099; GUIGNABERT, Christophe/0000-0002-8545-4452; Humbert, Marc/0000-0003-0703-2892; Huertas, Alice/0000-0001-8545-747X; TU, Ly/0000-0003-2336-5099; bordenave, jennifer/0000-0001-8866-3666; Dorfmuller, Peter/0000-0003-2499-6829	INSERM, the University of Paris-Sud; University Paris-Saclay, Marie Lannelongue Hospital; French National Agency for Research (ANR) [ANR-16-CE17-0014]; Fondation de la Recherche Medicale (FRM) [DEQ20150331712]; Departement Hospitalo-Universitaire Thorax Innovation; Assistance Publique-Hopitaux de Paris, Service de Pneumologie, Centre de Reference de l'Hypertension Pulmonaire Severe; LabEx LERMIT [ANR-10-LABX-0033]; French PAH patient association (HTAP France); French Fonds de Dotation "Recherche en Sante Respiratoire" (FRSR); Fondation du Souffle (FdS); FRSR-FdS; FRM	INSERM, the University of Paris-Sud; University Paris-Saclay, Marie Lannelongue Hospital; French National Agency for Research (ANR)(French National Research Agency (ANR)); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Departement Hospitalo-Universitaire Thorax Innovation; Assistance Publique-Hopitaux de Paris, Service de Pneumologie, Centre de Reference de l'Hypertension Pulmonaire Severe; LabEx LERMIT; French PAH patient association (HTAP France); French Fonds de Dotation "Recherche en Sante Respiratoire" (FRSR); Fondation du Souffle (FdS); FRSR-FdS; FRM(Fondation pour la Recherche Medicale)	This research was supported by grants from INSERM, the University of Paris-Sud, the University Paris-Saclay, Marie Lannelongue Hospital, the French National Agency for Research (ANR; Grant ANR-16-CE17-0014, TAMIRAH), the Fondation de la Recherche Medicale (FRM; Grant DEQ20150331712, Equipe FRM 2015), and in part by the Departement Hospitalo-Universitaire Thorax Innovation, the Assistance Publique-Hopitaux de Paris, Service de Pneumologie, Centre de Reference de l'Hypertension Pulmonaire Severe, the LabEx LERMIT (Grant ANR-10-LABX-0033), the French PAH patient association (HTAP France), and the French Fonds de Dotation "Recherche en Sante Respiratoire" (FRSR), Fondation du Souffle (FdS). P.-B.P. and C.P. are supported by the FRSR-FdS and J.B. is supported by the FRM. P.-B.P., C.P., T.Q., J.B., R.T., A.C., A.H., L.T., P.D., M.-R.G., and C.G. have no conflicts of interest to disclose. In the past 3 yr, M.H. and L.S. report grants, personal fees, and nonfinancial support from Actelion, Pfizer, Bayer, GlaxoSmithKline, and MSD outside of the submitted work.	Al-Tamari HM, 2018, EMBO MOL MED, V10, P276, DOI 10.15252/emmm.201606261; Avouac J, 2017, ARTHRITIS RHEUMATOL, V69, P2209, DOI 10.1002/art.40229; Bertero T, 2016, J CLIN INVEST, V126, P3313, DOI 10.1172/JCI86387; Bonniaud P, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02133-2017; Boucly A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00889-2017; Cowan KN, 2000, NAT MED, V6, P698, DOI 10.1038/76282; Egemnazarov B, 2018, MATRIX BIOL, V68-69, P507, DOI 10.1016/j.matbio.2018.01.010; Golob MJ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12815; Guignabert C, 2016, J CLIN INVEST, V126, P3207, DOI 10.1172/JCI86249; Guignabert C, 2015, CHEST, V147, P529, DOI 10.1378/chest.14-0862; Huertas A, 2017, CURR OPIN PULM MED, V23, P377, DOI 10.1097/MCP.0000000000000404; Huertas A, 2015, EUR RESPIR J, V45, P1066, DOI 10.1183/09031936.00193014; ILKIW R, 1989, CIRC RES, V64, P814, DOI 10.1161/01.RES.64.4.814; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Lee KW, 2006, CIRCULATION, V114, P1703, DOI 10.1161/CIRCULATIONAHA.106.624320; Tu L, 2012, AM J RESP CRIT CARE, V186, P666, DOI 10.1164/rccm.201202-0309OC; Tu L, 2011, AM J RESP CELL MOL, V45, P311, DOI 10.1165/rcmb.2010-0317OC; MARUYAMA K, 1991, AM J PHYSIOL, V261, pH1716, DOI 10.1152/ajpheart.1991.261.6.H1716; Mirkovic S, 2002, BRIT J PHARMACOL, V135, P961, DOI 10.1038/sj.bjp.0704539; Nguyen DT, 2010, HEART RHYTHM, V7, P1438, DOI 10.1016/j.hrthm.2010.04.030; Noble PW, 2016, EUR RESPIR J, V47, P243, DOI 10.1183/13993003.00026-2015; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Richter MJ, 2018, AM J RESP CRIT CARE, V198, P808, DOI 10.1164/rccm.201801-0195LE; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Tamura Y, 2018, J CLIN INVEST, V128, P1956, DOI 10.1172/JCI96462; Vieillard-Baron A, 2003, HUM GENE THER, V14, P861, DOI 10.1089/104303403765701150; Vivar R, 2016, BBA-MOL CELL RES, V1863, P128, DOI 10.1016/j.bbamcr.2015.10.019; Wang YL, 2013, CARDIOLOGY, V126, P1, DOI 10.1159/000351179; Yadav H, 2017, J BIOL CHEM, V292, P3420, DOI 10.1074/jbc.M116.764910; Yoshida M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7653; Zaidi SHE, 2002, CIRCULATION, V105, P516, DOI 10.1161/hc0402.102866	33	14	14	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3670	3679		10.1096/fj.201801659R	http://dx.doi.org/10.1096/fj.201801659R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481487	Green Submitted, Bronze			2022-12-28	WOS:000459794800047
J	Liu, L; Yang, N; Xu, GY; Liu, SL; Wang, D; Song, JZ; Duan, ZY; Yang, S; Yu, Y				Liu, Lei; Yang, Ning; Xu, Guiyun; Liu, Shuli; Wang, Di; Song, Jiuzhou; Duan, Zhongyi; Yang, Shuang; Yu, Ying			Transgenerational transmission of maternal stimulatory experience in domesticated birds	FASEB JOURNAL			English	Article						epigenetic regulation; transcriptome; chicken	PRENATAL IMMUNE ACTIVATION; LARGE GENE LISTS; DNA METHYLATION; ENERGY-BALANCE; EARLY-LIFE; I-C; STRESS; EXPOSURE; INHERITANCE; EXPRESSION	The environmental stimuli experienced by a female can influence phenotypes and gene expression in the subsequent generations. We used a specifically designed domesticated-bird model to examine the transgenerational transmission of maternal stimulus exposure, a phenomenon that has been observed but has not been understood in noninbred animals. We subjected parental generation [filial (F)(0)] hens to viral- or bacterial-like stimulation after artificial insemination. Subsequent filial generations F-1 and F-2 transmitted growth or fertility variations without further stimulation in contrast to the controls. The whole-genome bisulfite sequence and next-generation mRNA sequencing of peripheral blood lymphocytes (PBLs) from the F-1 generation revealed DNA methylome and transcriptome differences in the F-1 polyriboinosinic:polyribocytidylic [poly(I:C)] acid or LPS offspring, compared with the F-1 controls. In the F-1 offspring, DNA methylation changes induced by maternal immune stimulation may have contributed to transcriptional variation. Pathways analysis indicated that the metabolic processes of xenobiotics and drug metabolism pathways, as well as reproduction-related pathways, were involved in the transgenerational transmission of maternal stimulatory experience. Furthermore, LPS-induced transcriptional transmission may have contributed to subfertility, as indicated by the results of comparative analysis between the transcriptomes of spleen tissues across the F-0 and F-1 generations, as well as the correlative analysis between the transcriptome and reproductive phenotypes. Our findings provide a framework for determining the mechanisms by which maternal stimulatory factors can be inherited transgenerationally with respect to growth, fertility, DNA methylation, and transcriptional levels in outbred animals.Liu, L., Yang, N., Xu, G., Liu, S., Wang, D., Song, J., Duan, Z., Yang, S., Yu, Y. Transgenerational transmission of maternal stimulatory experience in domesticated birds.	[Liu, Lei; Yang, Ning; Xu, Guiyun; Liu, Shuli; Wang, Di; Duan, Zhongyi; Yang, Shuang; Yu, Ying] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Minist Agr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Liu, Lei; Yang, Ning; Xu, Guiyun; Liu, Shuli; Wang, Di; Duan, Zhongyi; Yang, Shuang; Yu, Ying] China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Minist Agr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs; University System of Maryland; University of Maryland College Park	Yu, Y (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Minist Agr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.; Yu, Y (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Minist Agr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	yuying@cau.edu.cn	Song, Jiuzhou/AAD-6440-2020	Liu, Lei/0000-0002-0839-0678; Yang, Ning/0000-0001-5772-3320	National Natural Science Foundation of Major International Cooperation Project [31320103905]; Program for Changjiang Scholar and Innovation Research Team in University [IRT-15R62]; Modern Agro-Industry Technology Research System Grant [CARS-40]	National Natural Science Foundation of Major International Cooperation Project; Program for Changjiang Scholar and Innovation Research Team in University; Modern Agro-Industry Technology Research System Grant	The authors thank 2 anonymous reviewers for constructive comments and suggestions on the manuscript; Siyuan Mi and all the members of the Livestock Epigenetic Laboratory (China Agricultural University) for helpful discussions; Novogene Technology (Beijng, China) for sequencing services; and Jingwei Yuan, Xingzheng Li, Zhuang Liu, Changsheng Nie, Zhenfei Jiang, Wenbo Li, and Ting Yang (all from China Agricultural University), as well as, Xiaoyu Zhao and Tianzeng Li (both from Dawu Breeding Poultry Co., Hebei, China), for sample collection. This research was financially supported by the National Natural Science Foundation of Major International Cooperation Project 31320103905 (to N.Y., J.S. and Y.Y.), the Program for Changjiang Scholar and Innovation Research Team in University Grant IRT-15R62 (to N.Y. and Y.Y.); and Modern Agro-Industry Technology Research System Grant CARS-40 (to G.X.). The authors declare no conflicts of interest.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Arsenault D, 2014, BRAIN BEHAV IMMUN, V38, P77, DOI 10.1016/j.bbi.2013.12.016; Azevedo CC, 2015, MAR ENVIRON RES, V110, P152, DOI 10.1016/j.marenvres.2015.08.008; Bale TL, 2015, NAT REV NEUROSCI, V16, P332, DOI 10.1038/nrn3818; Basil P, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.80; Bohacek J, 2015, NAT REV GENET, V16, P641, DOI 10.1038/nrg3964; Butler WR, 2003, LIVEST PROD SCI, V83, P211, DOI 10.1016/S0301-6226(03)00112-X; BUTLER WR, 1989, J DAIRY SCI, V72, P767, DOI 10.3168/jds.S0022-0302(89)79169-4; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Chen YH, 2005, TOXICOLOGY, V211, P242, DOI 10.1016/j.tox.2005.03.011; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Daryabari H, 2014, POULTRY SCI, V93, P2289, DOI 10.3382/ps.2013-03862; Dernedde J, 2010, P NATL ACAD SCI USA, V107, P19679, DOI 10.1073/pnas.1003103107; Entrican G, 2002, J COMP PATHOL, V126, P79, DOI 10.1053/jcpa.2001.0539; Gapp K, 2014, BIOESSAYS, V36, P491, DOI 10.1002/bies.201300116; GINSBURG M, 1987, DEVELOPMENT, V101, P209; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Groger N, 2016, J NEURAL TRANSM, V123, P1037, DOI 10.1007/s00702-016-1570-1; He HQ, 2007, MOL IMMUNOL, V44, P3234, DOI 10.1016/j.molimm.2007.01.034; HOMAN ER, 1972, TOXICOL APPL PHARM, V23, P579, DOI 10.1016/0041-008X(72)90098-1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johansson HKL, 2017, NAT REV ENDOCRINOL, V13, P400, DOI 10.1038/nrendo.2017.36; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kinsey-Jones JS, 2009, J NEUROENDOCRINOL, V21, P20, DOI 10.1111/j.1365-2826.2008.01807.x; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Le QM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15527; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0; Lv F, 2018, ENDOCRINOLOGY, V159, P1401, DOI 10.1210/en.2018-00044; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Norouzitallab P, 2014, FASEB J, V28, P3552, DOI 10.1096/fj.14-252049; Po BHK, 2018, ENVIRON POLLUT, V235, P730, DOI 10.1016/j.envpol.2017.12.087; Pocar P, 2017, TOXICOL APPL PHARM, V322, P113, DOI 10.1016/j.taap.2017.03.008; Quan DN, 2008, MUCOSAL IMMUNOL, V1, P229, DOI 10.1038/mi.2008.1; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Razoux F, 2017, MOL PSYCHIATR, V22, P519, DOI 10.1038/mp.2016.146; Reijrink IAM, 2009, POULTRY SCI, V88, P2649, DOI 10.3382/ps.2008-00523; Rousset CI, 2013, DEV NEUROSCI-BASEL, V35, P172, DOI 10.1159/000346579; Schneider D, 2016, CURR BIOL, V26, pR503, DOI 10.1016/j.cub.2016.05.016; Sharma A, 2015, TRENDS MOL MED, V21, P269, DOI 10.1016/j.molmed.2015.02.010; Shoemaker KL, 2007, PHYSIOL ENTOMOL, V32, P113, DOI 10.1111/j.1365-3032.2006.00552.x; Tsukada T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129011; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Walker AK, 2012, PSYCHONEUROENDOCRINO, V37, P1320, DOI 10.1016/j.psyneuen.2012.01.005; Walker DM, 2011, NAT REV ENDOCRINOL, V7, P197, DOI 10.1038/nrendo.2010.215; Weber-Stadlbauer U, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.78; Weber-Stadlbauer U, 2017, MOL PSYCHIATR, V22, P102, DOI 10.1038/mp.2016.41; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yuan TF, 2016, MOL NEUROBIOL, V53, P6367, DOI 10.1007/s12035-015-9526-2	55	9	10	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					7002	7017		10.1096/fj.201800762RR	http://dx.doi.org/10.1096/fj.201800762RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	30260701				2022-12-28	WOS:000449359700049
J	Fang, C; Du, H; Zheng, XJ; Zhao, AH; Jia, W; Xu, Y				Fang, Cheng; Du, Hai; Zheng, Xiaojiao; Zhao, Aihua; Jia, Wei; Xu, Yan			Solid-state fermented Chinese alcoholic beverage (baijiu) and ethanol resulted in distinct metabolic and microbiome responses	FASEB JOURNAL			English	Article						alcoholic liver disease; gut microbiota; metabolomics	CHAIN FATTY-ACIDS; GUT MICROBIOTA; MUSCODOR-ALBUS; GLOBAL BURDEN; LIVER-DISEASE; CONSUMPTION; VOLATILE; INJURY; SUPPLEMENTATION; INFLAMMATION	Alcoholic beverages, which are consumed widely in most parts of the world, have long been identified as a major risk factor for all liver diseases, particularly alcoholic liver disease (ALD). Recent compositional analyses suggest that Chinese baijiu (CB), a clear alcoholic liquid distilled from fermented grains, contains large amounts of small molecule bioactive compounds in addition to a significant amount of ethanol (EtOH). Here, in an experimental mouse model, we show that CB caused lower degrees of liver injury than pure EtOH by protecting against the decrease of the relative abundance of Akkermansia and increase of the relative abundance of Prevotella in the gut, thereby preventing the destruction of the intestinal barrier. Furthermore, we demonstrated that EtOH-induced alteration of the gut microbiota profoundly affected the host metabolome. Compared with EtOH feeding, CB feeding resulted in higher concentrations of functional saturated long-chain fatty acids and short-chain fatty acids. The additional mouse models of low dosages of EtOH and of blending baijiu validated that volatile compounds in CB can attenuate EtOH-induced liver damages. Our results provide supporting evidence that ALD was profoundly influenced by host-gut microbiota metabolic interactions and that small molecule organic compounds in CB could attenuate ALD.-Fang, C., Du, H., Zheng, X., Zhao, A., Jia, W., Xu, Y. Solid-state fermented Chinese alcoholic beverage (baijiu) and ethanol resulted in distinct metabolic and microbiome responses.	[Fang, Cheng; Du, Hai; Xu, Yan] Jiangnan Univ, Sch Biotechnol, State Key Lab Food Sci & Technol, 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China; [Zheng, Xiaojiao; Zhao, Aihua; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Jia, Wei] Univ Hawaii, Canc Ctr, Honolulu, HI 96822 USA	Jiangnan University; Shanghai Jiao Tong University; Cancer Research Center of Hawaii; University of Hawaii System	Xu, Y (corresponding author), Jiangnan Univ, Sch Biotechnol, State Key Lab Food Sci & Technol, 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China.; Jia, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, 600 Yishan Rd, Shanghai 200233, Peoples R China.	wjia@cc.hawaii.edu; yxu@jiangnan.edu.cn	Jia, Wei/AAN-5102-2020	Jia, Wei/0000-0002-3739-8994	National Natural Science Foundation of China [31530055]; National First-Class Discipline Program of Light Industry Technology and Engineering [LITE2018-12]; Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX17_1418]; Beijing Advanced Innovation Center for Food Nutrition and Human Health; Beijing Technology and Business University (BTBU) [20182033]; Institute of Renhuai Jiang-Flavor Liquor; Chinese Liquor Industrial Technology Innovation Strategic Alliance; Institute for Health Research of Chinese Baijiu	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National First-Class Discipline Program of Light Industry Technology and Engineering; Postgraduate Research and Practice Innovation Program of Jiangsu Province; Beijing Advanced Innovation Center for Food Nutrition and Human Health; Beijing Technology and Business University (BTBU); Institute of Renhuai Jiang-Flavor Liquor; Chinese Liquor Industrial Technology Innovation Strategic Alliance; Institute for Health Research of Chinese Baijiu	This work was supported by the National Natural Science Foundation of China (Grant 31530055), the National First-Class Discipline Program of Light Industry Technology and Engineering (LITE2018-12), and the Postgraduate Research and Practice Innovation Program of Jiangsu Province (Grant KYCX17_1418). The authors give special thanks to the Beijing Advanced Innovation Center for Food Nutrition and Human Health, the Beijing Technology and Business University (BTBU; Grant 20182033), the Institute of Renhuai Jiang-Flavor Liquor, the Chinese Liquor Industrial Technology Innovation Strategic Alliance, and the Institute for Health Research of Chinese Baijiu for their financial support. The authors declare no conflicts of interest.	Acevedo F, 2017, FOOD RES INT, V94, P20, DOI 10.1016/j.foodres.2017.01.021; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atmosukarto I, 2005, PLANT SCI, V169, P854, DOI 10.1016/j.plantsci.2005.06.002; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen P, 2015, GASTROENTEROLOGY, V148, P203, DOI 10.1053/j.gastro.2014.09.014; Cresci GA, 2014, ALCOHOL CLIN EXP RES, V38, P1489, DOI 10.1111/acer.12428; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Dubinkina VB, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0359-2; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Elamin EE, 2013, NUTR REV, V71, P483, DOI 10.1111/nure.12027; Ezra D, 2004, MICROBIOL-SGM, V150, P4023, DOI 10.1099/mic.0.27334-0; Fang C, 2019, METABOLITES, V9, DOI 10.3390/metabo9010002; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gao XF, 2010, ANAL CHEM, V82, P6447, DOI 10.1021/ac1006552; Goldberg DM, 1999, J AGR FOOD CHEM, V47, P3978, DOI 10.1021/jf9811626; Grander C, 2018, GUT, V67, P892, DOI 10.1136/gutjnl-2016-313432; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hartmann P, 2015, ALCOHOL CLIN EXP RES, V39, P763, DOI 10.1111/acer.12704; Jiang ZL, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700547; Jin GY, 2017, TRENDS FOOD SCI TECH, V63, P18, DOI 10.1016/j.tifs.2017.02.016; Kemperman RA, 2013, FOOD RES INT, V53, P659, DOI 10.1016/j.foodres.2013.01.034; Kew W, 2017, J AM SOC MASS SPECTR, V28, P200, DOI 10.1007/s13361-016-1513-y; Koppes LLJ, 2006, DIABETOLOGIA, V49, P648, DOI 10.1007/s00125-005-0127-x; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mitchell AM, 2010, MICROBIOL-SGM, V156, P270, DOI 10.1099/mic.0.032540-0; Mukamal KJ, 2016, ALCOHOL CLIN EXP RES, V40, P2283, DOI 10.1111/acer.13231; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt R, 2015, ISME J, V9, P2329, DOI 10.1038/ismej.2015.42; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Schwarz M, 2009, FOOD CHEM, V116, P29, DOI 10.1016/j.foodchem.2009.01.096; Selim HMM, 2017, BIOCONTROL SCI TECHN, V27, P81, DOI 10.1080/09583157.2016.1258452; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z; Ullah I, 2015, J MICROBIOL, V53, P127, DOI 10.1007/s12275-015-4632-4; Wang DX, 2017, FOOD FUNCT, V8, P3165, DOI 10.1039/c7fo00791d; Wang YH, 2013, J NUTR BIOCHEM, V24, P1609, DOI 10.1016/j.jnutbio.2013.02.001; Wang YH, 2011, AM J PATHOL, V179, P2866, DOI 10.1016/j.ajpath.2011.08.039; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Xie GX, 2013, J PROTEOME RES, V12, P3297, DOI 10.1021/pr400362z; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Yanagimoto K, 2002, J AGR FOOD CHEM, V50, P5480, DOI 10.1021/jf025616h; Yao F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09553; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zheng XJ, 2013, METABOLOMICS, V9, P818, DOI 10.1007/s11306-013-0500-6; Zheng XJ, 2011, J PROTEOME RES, V10, P5512, DOI 10.1021/pr2007945; 2014, GLOB STAT REP VIOL, P1	68	13	16	8	98	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7274	7288		10.1096/fj.201802306R	http://dx.doi.org/10.1096/fj.201802306R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30857422	Bronze			2022-12-28	WOS:000476114200050
J	Cai, MX; Han, LC; Liu, LS; He, F; Chu, WY; Zhang, JS; Tian, ZJ; Du, SJ				Cai, Mengxin; Han, Lichen; Liu, Lusha; He, Feng; Chu, Wuying; Zhang, Jianshe; Tian, Zhenjun; Du, Shaojun			Defective sarcomere assembly in smyd1a and smyd1b zebrafish mutants	FASEB JOURNAL			English	Article						muscle development; myofibrillogenesis; CRISPR; chaperone	CARDIAC-MUSCLE FUNCTION; LYSINE-METHYLATION; MYOFIBRIL ORGANIZATION; HEAVY-CHAIN; SKELETAL; PROTEIN; SKNAC; METHYLTRANSFERASE; EXPRESSION; HEART	Two smyd1 paralogues, smyd1a and smyd1b, have been identified in zebrafish. Although Smyd1b function has been reported in fast muscle, its function in slow muscle and the function of Smyd1a, in general, are uncertain. In this study, we generated 2 smyd1a mutant alleles and analyzed the muscle defects in smyd1a and smyd1b single and double mutants in zebrafish. We demonstrated that knockout of smyd1a alone had no visible effect on muscle development and fish survival. This was in contrast to the smyd1b mutant, which exhibited skeletal and cardiac muscle defects, leading to early embryonic lethality. The smyd1a and smyd1b double mutants, however, showed a stronger muscle defect compared with smyd1a or smyd1b mutation alone, namely, the complete disruption of sarcomere organization in slow and fast muscles. Immunostaining revealed that smyd1a; smyd1b double mutations had no effect on myosin gene expression but resulted in a dramatic reduction of myosin protein levels in muscle cells of zebrafish embryos. This was accompanied by the up-regulation of hsp40 and hsp90-1 gene expression. Together, our studies indicate that both Smyd1a and Smyd1b partake in slow and fast muscle development although Smyd1b plays a dominant role compared with Smyd1a.Cai, M., Han, L., Liu, L., He, F., Chu, W., Zhang, J., Tian, Z., Du, S. Defective sarcomere assembly in smyd1a and smyd1b zebrafish mutants.	[Cai, Mengxin; Han, Lichen; Liu, Lusha; He, Feng; Du, Shaojun] Univ Maryland, Sch Med, Inst Marine & Environm Technol, Dept Biochem & Mol Biol, Baltimore, MD 21202 USA; [Cai, Mengxin; Tian, Zhenjun] Shaanxi Normal Univ, Inst Sports & Exercise Biol, Xian, Shaanxi, Peoples R China; [He, Feng] Ocean Univ China, Sch Fisheries, Qingdao, Shandong, Peoples R China; [Chu, Wuying; Zhang, Jianshe] Changsha Univ, Dept Bioengn & Environm Sci, Changsha, Hunan, Peoples R China	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Shaanxi Normal University; Ocean University of China; Changsha University	Du, SJ (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, 701 East Pratt St, Baltimore, MD 21202 USA.	sdu@som.umaryland.edu			U.S. National Institute of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR072703-01A1]; National Natural Science Foundation of China [31701039, 31820103016]; NIH Shared Instrument Grant [1S10 RR26870]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072703] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH Shared Instrument Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Ming-Yuan Liu (University of Maryland, Baltimore) for fish care, Siping Li (University of Maryland, Baltimore) for statistical analysis of the qRT-PCR data, and Nick Du (University of Washington, Seattle, WA, USA) for proofreading the manuscript. This research was supported by funding from the U.S. National Institute of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR072703-01A1 to S.D.), and National Natural Science Foundation of China (Grants 31701039 to M.C. and 31820103016 to J.Z.). The authors also acknowledge the contribution of Electron Microscopy Core Imaging Facility of the University of Maryland. This work utilized electron microscopy sample preparation instruments purchased with funding from the NIH Shared Instrument Grant (1S10 RR26870). The authors declare no conflicts of interest.	Anderson JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007105; Berkholz J, 2018, MICRON, V108, P6, DOI 10.1016/j.micron.2018.02.009; Berkholz J, 2015, EXP CELL RES, V336, P182, DOI 10.1016/j.yexcr.2015.06.019; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Cai MX, 2018, MAR BIOTECHNOL, V20, P168, DOI 10.1007/s10126-018-9794-8; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Coda DM, 2015, CELL CYCLE, V14, P1389, DOI 10.1080/15384101.2015.1005993; de Winter Josine M, 2017, J Neuromuscul Dis, V4, P99, DOI 10.3233/JND-160200; Dooley C.M., 2013, SANGER I ZEBRAFISH M; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Du SJ, 2014, ANAT REC, V297, P1650, DOI 10.1002/ar.22972; Du SJ, 2006, DEV DYNAM, V235, P3306, DOI 10.1002/dvdy.20984; Egorova KS, 2010, BIOCHEMISTRY-MOSCOW+, V75, P535, DOI 10.1134/S0006297910050019; Ehler E, 2008, ADV EXP MED BIOL, V642, P1; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Franklin S, 2016, AM J PHYSIOL-HEART C, V311, pH1234, DOI 10.1152/ajpheart.00235.2016; Gao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086808; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Hwang PM, 2015, NAT REV DRUG DISCOV, V14, P313, DOI 10.1038/nrd4554; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iwabata H, 2005, PROTEOMICS, V5, P4653, DOI 10.1002/pmic.200500042; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Laing N. G., 2008, ADV EXPT MED BIOL, V642; Lalonde S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178700; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Nagandla H, 2016, DEV BIOL, V410, P86, DOI 10.1016/j.ydbio.2015.12.005; Paone C, 2018, BIOCHEM BIOPH RES CO, V496, P339, DOI 10.1016/j.bbrc.2018.01.060; Park CY, 2010, P NATL ACAD SCI USA, V107, P20750, DOI 10.1073/pnas.1013493107; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Prill K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142528; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sanger JW, 2005, J MUSCLE RES CELL M, V26, P343, DOI 10.1007/s10974-005-9016-7; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Stewart MD, 2016, DIS MODEL MECH, V9, P347, DOI 10.1242/dmm.022491; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; TONG SW, 1983, J BIOL CHEM, V258, P3100; Warren JS, 2018, P NATL ACAD SCI USA, V115, pE7871, DOI 10.1073/pnas.1800680115; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Xu J, 2012, J GENET GENOMICS, V39, P69, DOI 10.1016/j.jgg.2012.01.005; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	48	9	9	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6209	6225		10.1096/fj.201801578R	http://dx.doi.org/10.1096/fj.201801578R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817176	Bronze, Green Published			2022-12-28	WOS:000466932600033
J	Kain, V; Van Der Pol, W; Mariappan, N; Ahmad, A; Eipers, P; Gibson, DL; Gladine, C; Vigor, C; Durand, T; Morrow, C; Halade, GV				Kain, Vasundhara; Van Der Pol, William; Mariappan, Nithya; Ahmad, Aftab; Eipers, Peter; Gibson, Deanna L.; Gladine, Cecile; Vigor, Claire; Durand, Thierry; Morrow, Casey; Halade, Ganesh, V			Obesogenic diet in aging mice disrupts gut microbe composition and alters neutrophil:lymphocyte ratio, leading to inflamed milieu in acute heart failure	FASEB JOURNAL			English	Article						inflammation; leukocytes; myocardial infarction; resolution of inflammation; nonresolving inflammation	FATTY-ACIDS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; OBESITY; INFLAMMATION; SUPPLEMENTATION; PHYTOPROSTANES; DYSREGULATION; ISOPROSTANES; DYSBIOSIS	Calorie-dense obesogenic diet (OBD) is a prime risk factor for cardiovascular disease in aging. However, increasing age coupled with changes in the diet can affect the interaction of intestinal microbiota influencing the immune system, which can lead to chronic inflammation. How age and calorie-enriched OBD interact with microbial flora and impact leukocyte profiling is currently under investigated. Here, we tested the interorgan hypothesis to determine whether OBD in young and aging mice alters the gut microbe composition and the splenic leukocyte profile in acute heart failure (HF). Young (2-mo-old) and aging (18-mo-old) mice were supplemented with standard diet (STD, approximate to 4% safflower oil diet) and OBD (10% safflower oil) for 2 mo and then subjected to coronary artery ligation to induce myocardial infarction. Fecal samples were collected pre- and post-diet intervention, and the microbial flora were analyzed using 16S variable region 4 rRNA gene DNA sequencing and Quantitative Insights Into Microbial Ecology informatics. The STD and OBD in aging mice resulted in an expansion of the genus Allobaculum in the fecal microbiota. However, we found a pathologic change in the neutrophil:lymphocyte ratio in aging mice in comparison with their young counterparts. Thus, calorie-enriched OBD dysregulated splenic leukocytes by decreasing immune-responsive F4/80(+) and CD169(+) macrophages in aging mice. OBD programmed neutrophil swarming with an increase in isoprostanoid levels, with dysregulation of lipoxygenases, cytokines, and metabolite-sensing receptor expression. In summary, calorie-dense OBD in aging mice disrupted the composition of the gut microbiome, which correlates with the development of integrative and system-wide nonresolving inflammation in acute HF.Kain, V., Van Der Pol, W., Mariappan, N., Ahmad, A., Eipers, P., Gibson, D. L., Gladine, C., Vigor, C., Durand, T., Morrow, C., Halade, G. V. Obesogenic diet in aging mice disrupts gut microbe composition and alters neutrophil:lymphocyte ratio, leading to inflamed milieu in acute heart failure.	[Kain, Vasundhara; Halade, Ganesh, V] Univ Alabama Birmingham, Div Cardiovasc Dis, Dept Med, 310A Zeigler Res Bldg,703 19th St South, Birmingham, AL 35294 USA; [Van Der Pol, William] Univ Alabama Birmingham, Biomed Informat, Ctr Clin & Translat Sci, Birmingham, AL 35294 USA; [Mariappan, Nithya; Ahmad, Aftab] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35294 USA; [Eipers, Peter; Morrow, Casey] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Gibson, Deanna L.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada; [Gladine, Cecile] Univ Clermont Ferrand, UNH, INRA, Ctr Rech Nutr Humaine CRNH Auvergne, Clermont Ferrand, France; [Vigor, Claire; Durand, Thierry] Univ Montpellier, Unite Mixte Rech UMR 247, IBMM, CNRS,ENSCM, Montpellier, France	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of British Columbia; University of British Columbia Okanagan; INRAE; Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Halade, GV (corresponding author), Univ Alabama Birmingham, Div Cardiovasc Dis, Dept Med, 310A Zeigler Res Bldg,703 19th St South, Birmingham, AL 35294 USA.	ganeshhalade@uabmc.edu	Ahmad, Aftab/ABC-2734-2020; Gibson, Deanna L/CAF-4166-2022; Kain, Vasundhara/AAL-7371-2021	Ahmad, Aftab/0000-0003-0686-0987; Gibson, Deanna L/0000-0003-0052-7550; VIGOR, Claire/0000-0002-1569-0425	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH) [AT006704, HL132989]; University of Alabama at Birmingham (UAB) Pittman Scholar Award; American Heart Association postdoctoral fellowship [POST31000008]; Microbiome Resource, Comprehensive Cancer Center [P30AR050948]; Center for Clinical Translational Science [UL1TR001417]; University-Wide Institutional Core; Heflin Center for Genomic Sciences; Microbiome Center at the University of Alabama at Birmingham; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417, UL1TR003096] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132989] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham (UAB) Pittman Scholar Award; American Heart Association postdoctoral fellowship(American Heart Association); Microbiome Resource, Comprehensive Cancer Center; Center for Clinical Translational Science; University-Wide Institutional Core; Heflin Center for Genomic Sciences; Microbiome Center at the University of Alabama at Birmingham; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge support from U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH) (formerly known as NCCAM) Grants AT006704 and HL132989, a University of Alabama at Birmingham (UAB) Pittman Scholar Award (to G.V.H.), and an American Heart Association postdoctoral fellowship (POST31000008 to V.K.). The authors also acknowledge the support of the Microbiome Resource, Comprehensive Cancer Center (P30AR050948), Center for Clinical Translational Science (UL1TR001417), University-Wide Institutional Core, Heflin Center for Genomic Sciences, and Microbiome Center at the University of Alabama at Birmingham. The authors declare no conflicts of interest.	Ander Bradley P, 2003, Exp Clin Cardiol, V8, P164; Arora T, 2012, BRIT J NUTR, V108, P1382, DOI 10.1017/S0007114511006957; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Bauer J, 2014, BRIT J PHARMACOL, V171, P3115, DOI 10.1111/bph.12677; Beam J, 2015, J BIOL CHEM, V290, P23371, DOI 10.1074/jbc.M115.682195; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang DH, 2015, ANTON LEEUW INT J G, V108, P1309, DOI 10.1007/s10482-015-0583-3; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; DeGruttola AK, 2016, INFLAMM BOWEL DIS, V22, P1137, DOI 10.1097/MIB.0000000000000750; Galano JM, 2017, PROG LIPID RES, V68, P83, DOI 10.1016/j.plipres.2017.09.004; Ghosh S, 2013, BRIT J NUTR, V110, P515, DOI 10.1017/S0007114512005326; Gill HS, 2001, AM J CLIN NUTR, V74, P833; Gill HS, 2001, J CLIN IMMUNOL, V21, P264, DOI 10.1023/A:1010979225018; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Gupta P, 2016, CELL REP, V16, P1749, DOI 10.1016/j.celrep.2016.07.010; Halade GV, 2018, J LEUKOCYTE BIOL, V104, P1173, DOI 10.1002/JLB.3A0618-223R; Halade GV, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1818; Halade GV, 2018, AM J PHYSIOL-HEART C, V314, pH255, DOI 10.1152/ajpheart.00528.2017; Halade GV, 2017, COMPR PHYSIOL, V7, P1463, DOI 10.1002/cphy.c170011; Halade GV, 2016, AGING-US, V8, P2611, DOI 10.18632/aging.101077; Haley PJ, 2003, TOXICOLOGY, V188, P49, DOI 10.1016/S0300-483X(03)00043-X; Haumer M, 2005, J VASC SURG, V41, P610, DOI 10.1016/j.jvs.2005.01.013; Jadapalli JK, 2018, AM J PHYSIOL-HEART C, V315, pH1091, DOI 10.1152/ajpheart.00290.2018; Kain V, 2018, J MOL CELL CARDIOL, V118, P70, DOI 10.1016/j.yjmcc.2018.03.004; Kain V, 2018, AM J PHYSIOL-HEART C, V314, pH160, DOI 10.1152/ajpheart.00297.2017; Kain V, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0444-7; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505; Kitai Takeshi, 2016, Curr Heart Fail Rep, V13, P103, DOI 10.1007/s11897-016-0285-9; Kumar Ranjit, 2014, Curr Protoc Hum Genet, V82, DOI 10.1002/0471142905.hg1808s82; Leung KS, 2014, CHEM PHYS LIPIDS, V180, P53, DOI 10.1016/j.chemphyslip.2014.02.004; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lopez EF, 2015, AM J PHYSIOL-HEART C, V308, pH269, DOI 10.1152/ajpheart.00604.2014; Ludwig DS, 2018, SCIENCE, V362, P764, DOI 10.1126/science.aau2096; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; MEHTA J, 1989, CIRCULATION, V79, P549, DOI 10.1161/01.CIR.79.3.549; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Perez OA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5520; Ponnappan S, 2011, ANTIOXID REDOX SIGN, V14, P1551, DOI 10.1089/ars.2010.3228; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vigen Rebecca, 2012, Curr Heart Fail Rep, V9, P369, DOI 10.1007/s11897-012-0114-8; Willett WC, 2007, J CARDIOVASC MED, V8, pS42, DOI 10.2459/01.JCM.0000289275.72556.13; Wong CK, 2015, J NUTR BIOCHEM, V26, P319, DOI 10.1016/j.jnutbio.2014.11.004; Yonny ME, 2016, J AGR FOOD CHEM, V64, P8296, DOI 10.1021/acs.jafc.6b03011	55	28	29	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6456	6469		10.1096/fj.201802477R	http://dx.doi.org/10.1096/fj.201802477R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768364	Green Published, Green Submitted			2022-12-28	WOS:000466932600051
J	Lee, BJ; Jun, HO; Kim, JH; Kim, JH				Lee, Byung Joo; Jun, Hyoung Oh; Kim, Jin Hyoung; Kim, Jeong Hun			Astrocytic cystine/glutamate antiporter is a key regulator of erythropoietin expression in the ischemic retina	FASEB JOURNAL			English	Article						ischemic optic neuropathy; ischemic retinopathy; system xc(-)	GLUTAMATE NEUROTOXICITY; SYSTEM X(C)(-); BRAIN; NEUROPROTECTION; CONTRIBUTES; HIF-1-ALPHA; TOXICITY; RELEASE; HIF-1	Ischemic retinopathies and optic neuropathies are important causes of vision loss. The neuroprotective effect of erythropoietin (EPO) in ischemic neuronal injury and the expression of EPO and its receptor in retinal tissue have been well documented. However, the exact regulatory mechanism of EPO expression in retinal ischemia still remains to be elucidated. In this study, we investigated the role of cystine/glutamate antiporter (system xc(-)) in the regulation of astrocytic EPO expression by using both in vitro and in vivo models. Under hypoxia, the expression of astrocytic system xc(-) is up-regulated both in vitro and in vivo. Inhibition of system xc(-) resulted in depletion of intracellular glutathione (GSH) and decrement of GSH disulfide ratios in human brain astrocytes (HBAs). In HBAs, hypoxia-induced stabilization of hypoxia-inducible factor (Hif)-2 is nearly completely abolished by inhibition of system xc(-). Hypoxia-induced up-regulation of astrocytic EPO expression is suppressed by both pharmacological inhibition and siRNA-mediated knockdown of system xc(-). In contrast, basal EPO expression under normoxia is not affected by system xc(-) modulation. In summary, under hypoxia, increased system xc(-) acts as the major source of intracellular GSH, which helps in stabilizing Hif-2 and subsequent up-regulation of EPO in astrocytes.Lee, B. J., Jun, H. O., Kim, J. H., Kim, J. H. Astrocytic cystine/glutamate antiporter is a key regulator of erythropoietin expression in the ischemic retina.	[Lee, Byung Joo; Jun, Hyoung Oh; Kim, Jin Hyoung; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul, South Korea; [Lee, Byung Joo; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, 101 Daehak Ro, Seoul 03080, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, 101 Daehak Ro, Seoul 03080, South Korea.	steph25@snu.ac.kr		Kim, Jeong Hun/0000-0003-2957-1766	Bio and Medical Technology Development Program of the National Research Foundation of Korea (NRF) - Korean Ministry of Science, Information and Communications Technology and Future Planning (MSIP) [NRF-2015M3A9E6028949]; Korea Research Institute of Standards and Science [KRISS-2018-GP2018-0018]; Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - MSIP [2018M3D1A1058826]; National Research Foundation of Korea; Ministry of Education, Science, and Technology [2015M3A7B6027946]	Bio and Medical Technology Development Program of the National Research Foundation of Korea (NRF) - Korean Ministry of Science, Information and Communications Technology and Future Planning (MSIP)(National Research Foundation of Korea); Korea Research Institute of Standards and Science; Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - MSIP(National Research Foundation of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Bio and Medical Technology Development Program of the National Research Foundation of Korea (NRF), funded by the Korean Ministry of Science, Information and Communications Technology and Future Planning (MSIP) (NRF-2015M3A9E6028949 to J.H.K.); the Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science (KRISS-2018-GP2018-0018 to J.H.K.); the Creative Materials Discovery Program through the National Research Foundation of Korea (NRF), funded by the MSIP (2018M3D1A1058826 to J.H.K.); and a research grant from the National Research Foundation of Korea and the Ministry of Education, Science, and Technology (2015M3A7B6027946 to J.H.K.). The authors declare no conflict of interests.	Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen H, 2008, FEBS LETT, V582, P3899, DOI 10.1016/j.febslet.2008.10.031; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03038.x; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; Gu LM, 2014, INVEST OPHTH VIS SCI, V55, P8208, DOI 10.1167/iovs.14-14435; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hsieh CH, 2017, J PATHOL, V241, P337, DOI 10.1002/path.4838; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Komnig D, 2018, J NEUROCHEM, V145, P258, DOI 10.1111/jnc.14296; Lewerenz J, 2012, AMINO ACIDS, V42, P171, DOI 10.1007/s00726-011-0862-x; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Nikinmaa M, 2004, J CELL SCI, V117, P3201, DOI 10.1242/jcs.01192; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; REGAN RF, 1991, NEUROSCIENCE, V43, P585, DOI 10.1016/0306-4522(91)90317-H; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Soria FN, 2014, J CLIN INVEST, V124, P3645, DOI 10.1172/JCI71886; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Watanabe Y, 2016, P NATL ACAD SCI USA, V113, P6011, DOI 10.1073/pnas.1524198113; Yamasaki M, 2005, BRAIN RES, V1050, P15, DOI 10.1016/j.brainres.2005.05.037; Yoo SJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.381	30	9	10	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6045	6054		10.1096/fj.201802144R	http://dx.doi.org/10.1096/fj.201802144R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30742774				2022-12-28	WOS:000466932600021
J	Zeng, Y; Li, BH; Liang, YY; Reeves, PM; Qu, XY; Ran, CZ; Liu, QY; Callahan, MV; Studer, AE; Gelfand, JA; Chen, HB; Poznansky, MC				Zeng, Yang; Li, Binghao; Liang, Yingying; Reeves, Patrick M.; Qu, Xiying; Ran, Chongzhao; Liu, Qiuyan; Callahan, Michael, V; Studer, Ann E.; Gelfand, Jeffrey A.; Chen, Huabiao; Poznansky, Mark C.			Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment	FASEB JOURNAL			English	Article						CXCR4 antagonist; immune checkpoint inhibitor; combination immunotherapy	REGULATORY T-CELLS; VACCINE STRATEGIES; CHEMOKINE CXCL12; CXCR4 INHIBITION; IMMUNE EVASION; MOUSE MODEL; CANCER; IMMUNOTHERAPY; PD-1; MACROPHAGES	Blockade of immune-checkpoint programmed cell death protein 1 (PD-1) or programmed cell death ligand 1 can enhance effector T-cell responses. However, the lack of response in many patients to checkpoint-inhibitor therapies emphasizes the need for combination immunotherapies to pursue maximal antitumor efficacy. We have previously demonstrated that antagonism of C-X-C chemokine receptor type 4 (CXCR4) by plerixafor (AMD3100) can decrease regulatory T (T-reg)-cell intratumoral infiltration. Therefore, a combination of these 2 therapies might increase antitumor effects. Here, we evaluated the antitumor efficacy of AMD3100 and anti-PD-1 (PD-1) antibody alone or in combination in an immunocompetent syngeneic mouse model of ovarian cancer. We found that AMD3100, a highly specific CXCR4 antagonist, directly down-regulated the expression of both C-X-C motif chemokine 12 (CXCL12) and CXCR4 in vitro and in vivo in tumor cells. AMD3100 and PD-1 significantly inhibited tumor growth and prolonged the survival of tumor-bearing mice when given as monotherapy. Combination of these 2 agents significantly enhanced antitumor effects compared with single-agent administration. Benefits of tumor control and animal survival were associated with immunomodulation mediated by these 2 agents, which were characterized by increased effector T-cell infiltration, increased effector T-cell function, and increased memory T cells in tumor microenvironment. Intratumoral T-reg cells were decreased, and conversion of T-reg cells into T helper cells was increased by AMD3100 treatment. Intratumoral myeloid-derived suppressor cells were decreased by the combined treatment, which was associated with decreased IL-10 and IL-6 in the ascites. Also, the combination therapy decreased suppressive leukocytes and facilitated M2-to-M1 macrophage polarization in the tumor. These results suggest that AMD3100 could be used to target the CXCR4-CXCL12 axis to inhibit tumor growth and prevent multifaceted immunosuppression alone or in combination with PD-1 in ovarian cancer, which could be clinically relevant to patients with this disease.Zeng, Y., Li, B., Liang, Y., Reeves, P. M., Qu, X., Ran, C., Liu, Q., Callahan, M. V., Sluder, A. E., Gelfand, J. A., Chen, H., Poznansky, M. C. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.	[Zeng, Yang; Li, Binghao; Liang, Yingying; Reeves, Patrick M.; Qu, Xiying; Callahan, Michael, V; Studer, Ann E.; Gelfand, Jeffrey A.; Chen, Huabiao; Poznansky, Mark C.] Harvard Med Sch, Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Charlestown, MA USA; [Ran, Chongzhao] Harvard Med Sch, Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Liu, Qiuyan] Second Mil Med Univ, Natl Key Lab Med Immunol Second, Shanghai, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Naval Medical University	Chen, HB (corresponding author), Massachusetts Gen Hosp East, Vaccine & Immunotherapy Ctr, 149 13th St, Charlestown, MA 02129 USA.	huabiao.chen@mgh.harvard.edu	Poznansky, Mark C/M-4996-2015; Gelfand, Jeffrey A/G-1885-2018; Reeves, Patrick/I-1066-2018	Poznansky, Mark C/0000-0003-1344-7103; Gelfand, Jeffrey A/0000-0002-4118-5676; Reeves, Patrick/0000-0001-8202-0723	Vaccine and Immunotherapy Center (VIC) Innovation Fund; Massachusetts General Hospital (MGH) Research Scholar Award; U.S. National Institutes of Health (NIH) [1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, 1S10RR023440-01A1]	Vaccine and Immunotherapy Center (VIC) Innovation Fund; Massachusetts General Hospital (MGH) Research Scholar Award; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The ID8 cell line was a kind gift from Dr. Kathy Roby (University of Kansas Medical Center, Kansas City, KS, USA). This work was supported by the Vaccine and Immunotherapy Center (VIC) Innovation Fund and the Massachusetts General Hospital (MGH) Research Scholar Award (to H.C., Y.Z., and M.C.P.). Cytometric findings reported here were performed in the MGH Department of Pathology Flow and Image Cytometry Research Core, which is supported by the U.S. National Institutes of Health (NIH) Shared Instrumentation Grants 1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, and 1S10RR023440-01A1. M.C.P. is the Scientific Founder of AperiSys. The remaining authors declare no conflicts of interest.	Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Benslimane-Ahmim Z, 2017, CANCER LETT, V395, P11, DOI 10.1016/j.canlet.2017.02.032; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Berzofsky JA, 2004, J CLIN INVEST, V113, P1515, DOI 10.1172/JCI200421926; Berzofsky JA, 2012, SEMIN ONCOL, V39, P348, DOI 10.1053/j.seminoncol.2012.02.002; Bu XN, 2018, CARCINOGENESIS, V39, P242, DOI 10.1093/carcin/bgx137; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Che FY, 2017, CANCER IMMUNOL IMMUN, V66, P717, DOI 10.1007/s00262-017-1961-7; Chen YC, 2015, HEPATOLOGY, V61, P1591, DOI 10.1002/hep.27665; Chodon T, 2018, HEMATOL ONCOL CLIN N, V32, P1025, DOI 10.1016/j.hoc.2018.07.011; Chowdhury PS, 2018, J INTERN MED, V283, P110, DOI 10.1111/joim.12708; Conrad C, 2012, CANCER RES, V72, P5240, DOI 10.1158/0008-5472.CAN-12-2271; Deng J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111713; Domanska UM, 2012, NEOPLASIA, V14, P709, DOI 10.1593/neo.12324; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Drake CG, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds262; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Flint TR, 2016, CELL METAB, V24, P672, DOI 10.1016/j.cmet.2016.10.010; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Georgoudaki AM, 2016, CELL REP, V15, P2000, DOI 10.1016/j.celrep.2016.04.084; Guo ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087029; Hart KM, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00029; Heckmann D, 2013, TRANSL ONCOL, V6, P124, DOI 10.1593/tlo.12268; Hu YP, 2012, LEUKEMIA LYMPHOMA, V53, P130, DOI 10.3109/10428194.2011.601698; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jiang CM, 2017, BIOMED PHARMACOTHER, V86, P677, DOI 10.1016/j.biopha.2016.12.055; Kaka AS, 2009, J IMMUNOTHER, V32, P726, DOI 10.1097/CJI.0b013e3181ad4071; Karakasheva TA, 2015, CANCER RES, V75, P4074, DOI 10.1158/0008-5472.CAN-14-3639; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Li BH, 2018, CANCER IMMUNOL RES, V6, P539, DOI 10.1158/2326-6066.CIR-17-0530; Li HP, 2017, ACTA BIOMATER, V53, P399, DOI 10.1016/j.actbio.2017.01.070; Liao YX, 2015, ONCOL REP, V34, P33, DOI 10.3892/or.2015.3992; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Mantia-Smaldone GM, 2012, HUM VACC IMMUNOTHER, V8, P1179, DOI 10.4161/hv.20738; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913; Mittica G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071169; Peng LS, 2012, CANCER IMMUNOL IMMUN, V61, P2183, DOI 10.1007/s00262-012-1277-6; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Sarchio SNE, 2014, J INVEST DERMATOL, V134, P1091, DOI 10.1038/jid.2013.424; Scala S, 2015, CLIN CANCER RES, V21, P4278, DOI 10.1158/1078-0432.CCR-14-0914; Scotton CJ, 2002, CANCER RES, V62, P5930; Shaaban S, 2016, Int J Cancer Res, V12, P69; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spranger S, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-16; Szebeni GJ, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9294018; Tabouret E, 2015, ONCOTARGET, V6, P11664, DOI 10.18632/oncotarget.3256; Terabe M, 2004, CURR OPIN IMMUNOL, V16, P157, DOI 10.1016/j.coi.2004.01.010; Wang SC, 2012, LAB INVEST, V92, P151, DOI 10.1038/labinvest.2011.128; Xu DS, 2016, CURR TOP MED CHEM, V16, P1441, DOI 10.2174/1568026615666150915120218; Yan M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2869; Zboralski D, 2017, CANCER IMMUNOL RES, V5, P950, DOI 10.1158/2326-6066.CIR-16-0303; Zeng Y., 2016, INT J CANC CLIN RES, V3, P51; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhu XX, 2016, GYNECOL ONCOL, V142, P184, DOI 10.1016/j.ygyno.2016.04.002; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	65	86	93	2	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6596	6608		10.1096/fj.201802067RR	http://dx.doi.org/10.1096/fj.201802067RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30802149	Green Published, Bronze			2022-12-28	WOS:000466932600062
J	Biswas, M; Chatterjee, SS; Boila, LD; Chakraborty, S; Banerjee, D; Sengupta, A				Biswas, Mayukh; Chatterjee, Shankha Subhra; Boila, Liberalis Debraj; Chakraborty, Sayan; Banerjee, Debasis; Sengupta, Amitava			MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia	FASEB JOURNAL			English	Article						chromatin remodeling; KDM6A; epistasis	HISTONE DEMETHYLASE UTX; CHROMATIN REMODELER MI-2-BETA; CANCER CELLS; NURD; DEACETYLATION; INHIBITION; COMPLEX; TARGETS; BINDING; PLURIPOTENCY	Cancer genome sequencing studies have focused on identifying oncogenic mutations. However, mutational profiling alone may not always help dissect underlying epigenetic dependencies in tumorigenesis. Nucleosome remodeling and deacetylase (NuRD) is an ATP-dependent chromatin remodeling complex that regulates transcriptional architecture and is involved in cell fate commitment. We demonstrate that loss of MBD3, an important NuRD scaffold, in human primary acute myeloid leukemia (AML) cells associates with leukemic NuRD. Interestingly, CHD4, an intact ATPase subunit of leukemic NuRD, coimmunoprecipitates and participates with H3K27Me3/2-demethylase KDM6A to induce expression of atypical guanine nucleotide exchange factors, dedicator of cytokinesis (DOCK) 5 and 8 (DOCK5/8), promoting Rac GTPase signaling. Mechanistically, MBD3 deficiency caused loss of histone deacytelase 1 occupancy with a corresponding increase in KDM6A, CBP, and H3K27Ac on DOCK5/8 loci, leading to derepression of gene expression. Importantly, the Cancer Genome Atlas AML cohort reveals that DOCK5/8 levels are correlated with MBD3 and KDM6A, and DOCK5/8 expression is significantly increased in patients who are MBD3 low and KDM6A high with a poor survival. In addition, pharmacological inhibition of DOCK signaling selectively attenuates AML cell survival. Because MBD3 and KDM6A have been implicated in metastasis, our results may suggest a general phenomenon in tumorigenesis. Collectively, these findings provide evidence for MBD3-deficient NuRD in leukemia pathobiology and inform a novel epistasis between NuRD and KDM6A toward maintenance of oncogenic gene expression in AML.	[Biswas, Mayukh; Chatterjee, Shankha Subhra; Boila, Liberalis Debraj; Chakraborty, Sayan; Sengupta, Amitava] IICB, CSIR, TRUE, Stem Cell & Leukemia Lab, Kolkata, W Bengal, India; [Biswas, Mayukh; Chatterjee, Shankha Subhra; Boila, Liberalis Debraj; Chakraborty, Sayan; Sengupta, Amitava] IICB, CSIR, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India; [Banerjee, Debasis] Pk Clin, Gorky Terrace, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Sengupta, A (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, CN-6,Sect 5, Kolkata 700091, India.	amitava.iicb@gmail.com		Biswas, Mayukh/0000-0003-1670-8161	Council of Scientific and Industrial Research (CSIR) [BSC 0120]; Department of Biotechnology (DBT) [BT/RLF/RE-ENTRY/06/2010]; Ramalingaswami Fellowship; DBT [BT/PR13023/MED/31/311/2015]; Department of Science and Technology (DST), Government of India [SB/SO/HS-053/2013]; University Grants Commission (UGC); CSIR	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Ramalingaswami Fellowship; DBT(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); University Grants Commission (UGC)(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Dr. Prasanta Mukhopadhyay for providing umbilical cord blood samples; Dr. Jose Silva (University of Cambridge, Cambridge, United Kingdom), Dr. Keisuke Kaji (The University of Edinburgh, Edinburgh, United Kingdom), and Dr. Jose Cancelas (Cincinnati Children's Hospital, OH, USA) for sharing plasmids; and Addgene (Watertown, MA, USA) for shipping DNA constructs. CB-AE and CB-MA9 acute myeloid leukemia cells were generous gifts from Dr. James Mulloy (Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA). MDS-L cells were obtained from Dr. Daniel Starczynowski (Cincinnati Children's Hospital Medical Center) with consent from Dr. Kaoru Tohyama (Kawasaki Medical School, Kurashiki, Japan). The authors thank Dr. Arindam Maitra and Dr. Subrata Patra [Core Technologies Research Initiative (CoTERI), National Institute of Biomedical Genomics (NIBMG), Kalyani, India] for chromatin immunoprecipitation sequencing (ChIP-seq) and next-generation sequencing experiments and Dr. Madavan Vasudevan and Shemi Ramesh (Bionivid Technology, Bangalore, India) for RNA sequencing (RNA-seq) experiments, ChIP-seq, and RNA-seq analysis; and Indian Institute of Chemical Biology (IICB) flow cytometry and mass spectrometry cores for services. This study is supported by funding from the Council of Scientific and Industrial Research (CSIR) (NWP/BioDiscovery, BSC 0120), Department of Biotechnology (DBT) (BT/RLF/RE-ENTRY/06/2010), Ramalingaswami Fellowship (to A.S.), DBT (BT/PR13023/MED/31/311/2015) (to A.S.), and Department of Science and Technology (DST) (SB/SO/HS-053/2013), Government of India (to A.S.). M.B., S.C., and S.S.C. acknowledge fellowships from the University Grants Commission (UGC) and CSIR, respectively. L.D.B. is CSIR-Shyama Prasad Mukherjee Fellow. The authors declare no conflicts of interest.	Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Benyoucef A, 2016, GENE DEV, V30, P508, DOI 10.1101/gad.276790.115; Boila L. D., 2017, EXP HEMATOL; Boila LD, 2018, EXP HEMATOL, V58, P44, DOI 10.1016/j.exphem.2017.10.002; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Chatterjee SS, 2018, MOL CANCER RES, V16, P791, DOI 10.1158/1541-7786.MCR-17-0493; Dhar SS, 2016, NUCLEIC ACIDS RES, V44, P3659, DOI 10.1093/nar/gkv1516; dos Santos RL, 2014, CELL STEM CELL, V15, P102, DOI 10.1016/j.stem.2014.04.019; Ezponda T, 2017, CELL REP, V21, P628, DOI 10.1016/j.celrep.2017.09.078; Fang J, 2016, NAT MED, V22, P727, DOI 10.1038/nm.4127; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gozdecka M, 2018, NAT GENET, V50, P883, DOI 10.1038/s41588-018-0114-z; Greif PA, 2018, CLIN CANCER RES, V24, P1716, DOI 10.1158/1078-0432.CCR-17-2344; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Hwei LS, 2016, BLOOD, V128; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Laurin M, 2013, P NATL ACAD SCI USA, V110, P7434, DOI 10.1073/pnas.1213050110; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Li QT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6780; Li RZ, 2017, ONCOTARGET, V8, P6067, DOI 10.18632/oncotarget.13496; Loughran SJ, 2017, J EXP MED, V214, P3085, DOI 10.1084/jem.20161827; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Mizukawa B, 2011, BLOOD, V118, P5235, DOI 10.1182/blood-2011-04-351817; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nishikimi A, 2012, CHEM BIOL, V19, P488, DOI 10.1016/j.chembiol.2012.03.008; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Priam P, 2017, NAT GENET, V49, P753, DOI 10.1038/ng.3812; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rath BH, 2018, MOL CANCER THER, V17, P1070, DOI 10.1158/1535-7163.MCT-17-1053; Raza A, 2012, NAT REV CANCER, V12, P849, DOI 10.1038/nrc3321; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Rhyasen GW, 2014, LEUKEMIA, V28, P1142, DOI 10.1038/leu.2013.372; Sengupta A, 2010, BLOOD, V116, P81, DOI 10.1182/blood-2009-10-247437; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Sinha S, 2018, EXP HEMATOL, V62, P39, DOI 10.1016/j.exphem.2018.03.005; Spensberger D, 2008, BIOCHEMISTRY-US, V47, P6418, DOI 10.1021/bi800267f; Sperlazza J, 2015, BLOOD, V126, P1462, DOI 10.1182/blood-2015-03-631606; Tajiri H, 2017, CELL REP, V19, P969, DOI 10.1016/j.celrep.2017.04.016; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; Vishwakarma BA, 2016, LEUKEMIA, V30, P200, DOI 10.1038/leu.2015.200; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Watanabe M, 2014, J IMMUNOL, V193, P5660, DOI 10.4049/jimmunol.1400885; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wei Y, 2013, LEUKEMIA, V27, P2177, DOI 10.1038/leu.2013.91; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Witzel M, 2017, NAT GENET, V49, P742, DOI 10.1038/ng.3833; Xu M, 2017, BRIT J CANCER, V116, P91, DOI 10.1038/bjc.2016.397; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zha L, 2015, J BIOL CHEM, V290, P25151, DOI 10.1074/jbc.M115.662650; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	60	20	21	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5268	5286		10.1096/fj.201801035R	http://dx.doi.org/10.1096/fj.201801035R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668141	Bronze			2022-12-28	WOS:000462888500052
J	Chang, SY; Lu, XL; Wang, S; Wang, ZG; Huo, JS; Huang, J; Shangguan, SF; Li, S; Zou, JZ; Bao, YH; Guo, J; Wang, F; Niu, B; Zhang, T; Qiu, ZY; Wu, JX; Wang, L				Chang, Shaoyan; Lu, Xiaolin; Wang, Shan; Wang, Zhigang; Huo, Junsheng; Huang, Jian; Shangguan, Shaofang; Li, Shen; Zou, Jizhen; Bao, Yihua; Guo, Jin; Wang, Fang; Niu, Bo; Zhang, Ting; Qiu, Zhiyong; Wu, Jianxin; Wang, Li			The effect of folic acid deficiency on FGF pathway via Brachyury regulation in neural tube defects	FASEB JOURNAL			English	Article						T-box transcription factor; encephalocele; mouse model; neural development; methylation modification	INTERSPERSED NUCLEOTIDE ELEMENT-1; FIBROBLAST-GROWTH-FACTOR; NOVO DNA METHYLATION; FATE SPECIFICATION; CELL FATE; GENE; EXPRESSION; INDUCTION; TISSUE; HYPOMETHYLATION	Folate deficiency in early development leads to disturbance in multiple processes, including neurogenesis during which fibroblast growth factor (FGF) pathway is one of the crucial pathways. Whether folic acid (FA) directly affects FGF pathways to influence neurodevelopment and the possible mechanism remains unclear. In this study, we presented evidence that in human FA-insufficient encephalocele, the FGF pathway was interfered. Furthermore, in Brachyury knockout mice devoid of such T-box transcription factors regulating embryonic neuromesodermal bipotency and a key component of FGF pathway, change in expression of Brachyury downstream targets, activator Fgf8 and suppressor dual specificity phosphatase 6 was detected, along with the reduction in expression of other key FGF pathway genes. By using a FA-deficient cell model, we further demonstrated that decrease in Brachyury expression was through alteration in hypermethylation at the Brachyury promoter region under FA deficiency conditions, and suppression of Brachyury promoted the inactivation of the FGF pathway. Correspondingly, FA supplementation partially reverses the effects seen in FA-deficient embryoid bodies. Lastly, in mice with maternal folate-deficient diets, aberrant FGF pathway activity was found in fetal brain dysplasia. Taken together, our findings highlight the effect of FA on FGF pathways during neurogenesis, and the mechanism may be due to the low expression of Brachyury gene via hypermethylation under FA-insufficient conditions.	[Chang, Shaoyan; Lu, Xiaolin; Wang, Shan; Shangguan, Shaofang; Li, Shen; Zou, Jizhen; Bao, Yihua; Guo, Jin; Wang, Fang; Niu, Bo; Zhang, Ting; Qiu, Zhiyong; Wu, Jianxin; Wang, Li] Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, 2 Yabao Rd, Beijing 100020, Peoples R China; [Wang, Zhigang] Peking Union Med Coll, Chinese Acad Med Sci, Beijing, Peoples R China; [Huo, Junsheng; Huang, Jian] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Key Lab Trace Element Nutr, Natl Hlth & Family Planning Commiss Peoples Repub, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Nutrition & Health, Chinese Center for Disease Control & Prevention	Wu, JX; Wang, L (corresponding author), Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, 2 Yabao Rd, Beijing 100020, Peoples R China.	jianxinwu_2000@163.com; lily_wang@yeah.net	lu, xl/HDO-8340-2022; wang, fang/GYD-4295-2022	Wang, Li/0000-0003-1918-0040	National Key Research and Development Program [2016YFC1000502, 2018YFC1002503]; National Natural Science Fund of China [81670802/H0724,81741023]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2016-I2M-1-008]; Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Municipal Administration [XTZD20180402]	National Key Research and Development Program; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences Initiative for Innovative Medicine; Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Municipal Administration	The authors thank the Department of Cell Therapy Center of Xuanwu Hospital for ESCs. This project was supported by the National Key Research and Development Program (2016YFC1000502, 2018YFC1002503), the National Natural Science Fund of China (81670802/H0724,81741023), the Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2016-I2M-1-008), and the Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Municipal Administration (XTZD20180402). The authors declare no conflicts of interest.	Akagi T, 2015, J BIOL CHEM, V290, P22460, DOI 10.1074/jbc.M115.675595; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Andoniadou CL, 2013, CELL MOL LIFE SCI, V70, P3739, DOI 10.1007/s00018-013-1269-5; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Briscoe J, 2015, BMC BIOL, V13, DOI 10.1186/s12915-014-0105-1; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chang SY, 2013, J CELL BIOCHEM, V114, P1549, DOI 10.1002/jcb.24496; Chen YJ, 2012, DEV BIOL, V361, P125, DOI 10.1016/j.ydbio.2011.10.019; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; Dansranjavin T, 2009, CELL CYCLE, V8, P916, DOI 10.4161/cc.8.6.7934; Doniach T, 1995, CELL, V83, P1067, DOI 10.1016/0092-8674(95)90133-7; Dunlevy LPE, 2006, BIRTH DEFECTS RES A, V76, P544, DOI 10.1002/bdra.20286; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Eom DS, 2012, BIRTH DEFECTS RES A, V94, P804, DOI 10.1002/bdra.23052; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033346; Gentsch GE, 2013, CELL REP, V4, P1185, DOI 10.1016/j.celrep.2013.08.012; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Imbard A, 2013, INT J ENV RES PUB HE, V10, P4352, DOI 10.3390/ijerph10094352; Kimura-Yoshida C, 2015, EBIOMEDICINE, V2, P513, DOI 10.1016/j.ebiom.2015.04.012; Kirillova I, 2000, TERATOLOGY, V61, P347, DOI 10.1002/(SICI)1096-9926(200005)61:5<347::AID-TERA6>3.3.CO;2-R; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; Koch F, 2017, DEV CELL, V42, P514, DOI 10.1016/j.devcel.2017.07.021; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; LAMB TM, 1995, DEVELOPMENT, V121, P3627; Lolas M, 2014, P NATL ACAD SCI USA, V111, P4478, DOI 10.1073/pnas.1402612111; Main H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062959; Martin BL, 2016, SEMIN CELL DEV BIOL, V49, P59, DOI 10.1016/j.semcdb.2015.11.014; Massarwa R, 2014, WIRES DEV BIOL, V3, P59, DOI 10.1002/wdev.120; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Osterhues A, 2013, CRIT REV FOOD SCI, V53, P1180, DOI 10.1080/10408398.2011.575966; Park JC, 2008, BIOCHEM BIOPH RES CO, V365, P221, DOI 10.1016/j.bbrc.2007.10.144; Pfuhlmann K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183488; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Richter B, 2002, J Med Genet, V39, pE14, DOI 10.1136/jmg.39.3.e14; Rochtus A, 2015, MINI-REV MED CHEM, V15, P1095, DOI 10.2174/1389557515666150909144828; Ruan JW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.220; Shimoda N, 2005, DEV DYNAM, V233, P1509, DOI 10.1002/dvdy.20455; Stancheva I, 2002, DEV BIOL, V243, P155, DOI 10.1006/dbio.2001.0560; Storey KG, 1998, DEVELOPMENT, V125, P473; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1998, DEVELOPMENT, V125, P507; Wang L, 2015, CURR MOL MED, V15, P497, DOI 10.2174/1566524015666150630130229; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Yamakoshi K, 2003, GENESIS, V37, P195, DOI 10.1002/gene.10245; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	49	5	7	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4688	4702		10.1096/fj.201801536R	http://dx.doi.org/10.1096/fj.201801536R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592646	Bronze			2022-12-28	WOS:000462888500005
J	Gong, SP; Chen, YN; Meng, FL; Zhang, YD; Wu, H; Li, CY; Zhang, GP				Gong, Shipeng; Chen, Yongning; Meng, Fanliang; Zhang, Yadi; Wu, Huan; Li, Chanyuan; Zhang, Guangping			RCC2, a regulator of the RalA signaling pathway, is identified as a novel therapeutic target in cisplatin-resistant ovarian cancer	FASEB JOURNAL			English	Article						DDP; bioinformatics analysis; RalBP1; proliferation and apoptosis	RAS; GTPASES; TRANSFORMATION; INHIBITION; EXPRESSION; CELLS; APOPTOSIS; SURVIVAL; LUNG	Currently, cisplatin (DDP) is the first-line chemotherapeutic agent used for treatment of ovarian cancer, but gradually acquired drug resistance minimizes its therapeutic outcomes. We aimed to identify crucial genes associated with DDP resistance in ovarian cancer and uncover potential mechanisms. Two sets of gene expression data were downloaded from Gene Expression Omnibus, and bioinformatics analysis was conducted. In our study, the differentially expressed genes between DDP-sensitive and DDP-resistant ovarian cancer were screened in GSE15709 and GSE51373 database, and chromosome condensation 2 regulator (RCC2) and nucleoporin 160 were identified as 2 genes that significantly up-regulated in DDP-resistant ovarian cancer cell lines compared with DDP-sensitive cell lines. Moreover, RCC2, Ral small GTPase (RalA), and Ral binding protein-1 (RalBP1) expression was found to be significantly higher in DDP-resistant ovarian cancer tissues than in DDP-sensitive tissues. RCC2 plays a positive role in cell proliferation, apoptosis, and migration in DDP-resistant ovarian cancer cell lines in vitro and in vivo. Furthermore, RCC2 could interact with RalA, thus promoting its downstream effector RalBP1. RalA knockdown could reverse the effects of RCC2 overexpression on DDP-resistant ovarian cancer cell proliferation, apoptosis, and migration. Similarly, RalA overexpression could alleviate the effects of RCC2 knockdown in DDP-resistant ovarian cancer cells. Taken together, RCC2 may function as an oncogene, regulating the RalA signaling pathway, and intervention of RCC2 expression might be a promising therapeutic strategy for DDP-resistant ovarian cancer.	[Gong, Shipeng; Chen, Yongning; Meng, Fanliang; Zhang, Yadi; Li, Chanyuan] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China; [Wu, Huan] Chongqing Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Chongqing, Peoples R China; [Zhang, Guangping] Peoples Hosp Huadu Dist, Dept Gynecol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Chongqing Medical University	Gong, SP (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.	gsp2103@163.com	Zhang, Guang-Ping/T-2664-2019; Zhang, Guang-Ping/C-8300-2011	Zhang, Guang-Ping/0000-0002-1620-0221; Zhang, Guang-Ping/0000-0002-1620-0221	Guangdong Science and Technology Department [2016A020215115]; National Natural Science Foundation of China [81402127]; Science and Technology Bureau of Huadu District [HD15CXY006]; Tianhe District [201604KW010]	Guangdong Science and Technology Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Huadu District; Tianhe District	This work was supported by grants from the Guangdong Science and Technology Department (2016A020215115, to S.G.), the National Natural Science Foundation of China (81402127, to S.G.), and the Science and Technology Bureau of Huadu District (HD15CXY006, to S.G.) and Tianhe District (201604KW010, to S.G.). The authors declare no conflicts of interest.	Ali AA, 2017, NANOMED-NANOTECHNOL, V13, P921, DOI 10.1016/j.nano.2016.11.019; ANDREASSEN PR, 1991, J CELL SCI, V99, P523; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bruun J, 2015, CLIN CANCER RES, V21, P3759, DOI 10.1158/1078-0432.CCR-14-3294; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Dennis G, 2003, GENOME BIOL, V4; Drake KJ, 2007, INT J ONCOL, V30, P139; Ezzeldin M, 2014, MOL ONCOL, V8, P1043, DOI 10.1016/j.molonc.2014.03.020; Feng X, 2017, ONCOTARGETS THER, V10, P5899, DOI 10.2147/OTT.S145833; Foster T, 2009, GYNECOL ONCOL, V115, P290, DOI 10.1016/j.ygyno.2009.07.026; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Fujii K, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201800015; Gu CM, 2016, ONCOTARGET, V7, P20561, DOI 10.18632/oncotarget.7987; Gupta AK, 2001, METHOD ENZYMOL, V333, P284; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Kashatus DF, 2013, EXP CELL RES, V319, P2337, DOI 10.1016/j.yexcr.2013.06.020; Kidd AR, 2010, INT J RADIAT ONCOL, V78, P205, DOI 10.1016/j.ijrobp.2010.03.023; Kim IA, 2004, CANCER METAST REV, V23, P227, DOI 10.1023/B:CANC.0000031763.95152.09; Kirschner K, 2010, ANTICANCER RES, V30, P3223; Knizhnik A V, 2011, Mol Biol (Mosk), V45, P307; Li Y, 2018, GENE, V663, P9, DOI 10.1016/j.gene.2018.04.033; Male H, 2012, LUNG CANCER, V77, P252, DOI 10.1016/j.lungcan.2012.03.007; Martin Timothy D, 2012, Small GTPases, V3, P126, DOI 10.4161/sgtp.19571; Matchett KB, 2014, ADV EXP MED BIOL, V773, P323, DOI 10.1007/978-1-4899-8032-8_15; Materon EM, 2014, BIOSENS BIOELECTRON, V58, P232, DOI 10.1016/j.bios.2014.02.070; Matsuo M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-15; McCrudden CM, 2017, MOL THER-NUCL ACIDS, V6, P249, DOI 10.1016/j.omtn.2016.12.010; McKenna WG, 2003, ONCOGENE, V22, P5866, DOI 10.1038/sj.onc.1206699; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Musella A, 2015, ANN SURG ONCOL, V22, P4211, DOI 10.1245/s10434-015-4523-2; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Nguyen-Ba G, 1999, ONCOL REP, V6, P925; Pang B, 2017, CLIN CANCER RES, V23, P5598, DOI 10.1158/1078-0432.CCR-16-2909; Papini D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8678; Qin XY, 2017, CELL BIOL INT, V41, P1110, DOI 10.1002/cbin.10819; Shimozono N, 2015, CANCER RES, V75, P4458, DOI 10.1158/0008-5472.CAN-15-0418; Singhal SS, 2007, CANCER RES, V67, P4382, DOI 10.1158/0008-5472.CAN-06-4124; Sun Y, 2016, CANCER BIOTHER RADIO, V31, P246, DOI 10.1089/cbr.2016.2034; Wang HX, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0130-x; Wei W, 2017, ANN ONCOL, V28, P16, DOI 10.1093/annonc/mdx447; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Wu N, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3908-y; Xu ZZ, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0840-y	45	15	16	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5350	5365		10.1096/fj.201801529RR	http://dx.doi.org/10.1096/fj.201801529RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30768358	Bronze			2022-12-28	WOS:000462888500058
J	Jiang, EH; Xu, Z; Wang, M; Yan, TL; Huang, CM; Zhou, XC; Liu, Q; Wang, L; Chen, Y; Wang, H; Liu, K; Shao, Z; Shang, ZJ				Jiang, Erhui; Xu, Zhi; Wang, Meng; Yan, Tinglin; Huang, Chunming; Zhou, Xiaocheng; Liu, Qing; Wang, Lin; Chen, Yang; Wang, Hui; Liu, Ke; Shao, Zhe; Shang, Zhengjun			Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma	FASEB JOURNAL			English	Article						OSCC; reverse Warburg effect; metabolism; tumor-stroma interaction; tumor microenvironment	CANCER-ASSOCIATED FIBROBLASTS; EXTRACELLULAR VESICLES; PANCREATIC-CANCER; MEMBRANE MICROVESICLES; EMERGING ROLE; STROMA; MICROENVIRONMENT; COMMUNICATION; METABOLISM; CONVERSION	Metabolic reprogramming is a hallmark of cancer. Stromal cells could function as providers of energy metabolites for tumor cells by undergoing the "reverse Warburg effect," but the mechanism has not been fully elucidated. The interaction between the tumoral microvesicles (TMVs) and stroma in the tumor microenvironment plays a critical role in facilitating cancer progression. In this study, we demonstrated a novel mechanism for the TMV-mediated glycometabolic reprogramming of stromal cells. After being incubated with TMVs, normal human gingival fibroblasts exhibited a phenotype switch to cancer-associated fibroblasts and underwent a degradation of caveolin 1 (CAV1) through the ERK1/2-activation pathway. CAV1 degradation further induced the metabolic switch to aerobic glycolysis in the fibroblasts. The microvesicle-activated fibroblasts absorbed more glucose and produced more lactate. The migration and invasion of oral squamous cell carcinoma (OSCC) were promoted after being cocultured with the activated fibroblasts. Fibroblast-cancer cell glycometabolic coupling ring mediated by monocarboxylate transporter (MCT) 4 and MCT1 was then proved in the tumor microenvironment. Results indicated a mechanism for tumor progression by the crosstalk between tumor cells and stromal cells through the reverse Warburg effect via TMVs, thereby identifying potential targets for OSCC prevention and treatment.	[Jiang, Erhui; Yan, Tinglin; Huang, Chunming; Zhou, Xiaocheng; Liu, Qing; Wang, Lin; Chen, Yang; Wang, Hui; Liu, Ke; Shao, Zhe; Shang, Zhengjun] Minist Educ KLOBME, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan, Hubei, Peoples R China; [Jiang, Erhui; Yan, Tinglin; Huang, Chunming; Zhou, Xiaocheng; Liu, Qing; Wang, Lin; Chen, Yang; Wang, Hui; Liu, Ke; Shao, Zhe; Shang, Zhengjun] Minist Educ KLOBME, Key Lab Oral Biomed Engn, Wuhan, Hubei, Peoples R China; [Xu, Zhi] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Stomatol, Wuhan, Hubei, Peoples R China; [Wang, Meng] Shandong Univ, Sch Stomatol, Shandong Prov Key Lab Oral Tissue Regenerat, Jinan, Shandong, Peoples R China; [Liu, Ke; Shao, Zhe; Shang, Zhengjun] Wuhan Univ, Sch Stomatol, Hosp Stomatol, Dept Oral & Maxillofacial Head & Neck Oncol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Shandong University; Wuhan University	Shao, Z; Shang, ZJ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol,Minist Educ KLOBME, Dept Oral & Maxillofacial Head & Neck Oncol, State Key Lab Breeding Base Basic Sci Stomatol Hu, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.; Shao, Z; Shang, ZJ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol,Minist Educ KLOBME, Dept Oral & Maxillofacial Head & Neck Oncol, Key Lab Oral Biomed Engn, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.	shaozhe@whu.edu.cn; shangzhengjun@whu.edu.cn		Jiang, Erhui/0000-0003-4668-026X; shang, zhengjun/0000-0002-4884-8129	National Natural Science Foundation of China [81672666, 81372879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Xiaoxuan Wang (Wuhan University) and Xiaoping Zhao (Huazhong University of Science and Technology) for their kind help in the experimental research. The authors thank Pei Zhang (Wuhan Institute of Virology, Wuhan, China), for help with producing transmission electron microscopy micrographs. This study was supported by the National Natural Science Foundation of China (Grants 81672666, 81372879 to Z. Shang). The authors declare no conflicts of interest.	Achreja A, 2017, METAB ENG, V43, P156, DOI 10.1016/j.ymben.2017.01.001; Almangush A, 2018, HISTOPATHOLOGY, V72, P1128, DOI 10.1111/his.13481; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Bussard KM, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0740-2; Castellana D, 2009, CANCER RES, V69, P785, DOI 10.1158/0008-5472.CAN-08-1946; Chen G, 2015, ANGEW CHEM INT EDIT, V54, P1036, DOI 10.1002/anie.201410223; Chiarugi P, 2016, CANCER LETT, V380, P272, DOI 10.1016/j.canlet.2015.10.027; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Corbet C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03525-0; Crewe C, 2018, CELL, V175, P695, DOI 10.1016/j.cell.2018.09.005; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Leef G, 2013, ORAL ONCOL, V49, P381, DOI 10.1016/j.oraloncology.2012.12.014; Martinez-Outschoorn UE, 2014, SEMIN CANCER BIOL, V25, P47, DOI 10.1016/j.semcancer.2014.01.005; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P2423, DOI 10.4161/cc.9.12.12048; Milani G, 2017, MOL CANCER RES, V15, P683, DOI 10.1158/1541-7786.MCR-16-0307; Minciacchi VR, 2015, SEMIN CELL DEV BIOL, V40, P41, DOI 10.1016/j.semcdb.2015.02.010; Moore C, 2017, INT J CANCER, V141, P428, DOI 10.1002/ijc.30672; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; NAITO S, 1986, CANCER RES, V46, P4109; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; Nwosu ZC, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0558-7; Orr B, 2012, ONCOGENE, V31, P1130, DOI 10.1038/onc.2011.312; Pang WJ, 2015, CANCER SCI, V106, P1362, DOI 10.1111/cas.12747; Patel BB, 2017, EXP CELL RES, V352, P20, DOI 10.1016/j.yexcr.2017.01.013; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pertega-Gomes N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-352; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Shan T, 2017, ONCOL REP, V37, P1971, DOI 10.3892/or.2017.5479; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Sung MS, 2018, SMALL, V14, DOI 10.1002/smll.201802358; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Vader P, 2014, TRENDS MOL MED, V20, P385, DOI 10.1016/j.molmed.2014.03.002; Wang X, 2016, BIOMATERIALS, V83, P207, DOI 10.1016/j.biomaterials.2016.01.001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu MH, 2011, CLIN CANCER RES, V17, P1306, DOI 10.1158/1078-0432.CCR-10-1824; Yan W, 2018, NAT CELL BIOL, V20, P597, DOI 10.1038/s41556-018-0083-6; Yang XG, 2016, CANCER RES, V76, P4124, DOI 10.1158/0008-5472.CAN-15-2973; Yang ZT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145807; Yogev O, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006524; Zhan HX, 2017, CANCER LETT, V392, P83, DOI 10.1016/j.canlet.2017.01.041; Zhang J, 2013, PHARMACOL THERAPEUT, V137, P200, DOI 10.1016/j.pharmthera.2012.10.003; Zhao HY, 2016, ELIFE, V5, DOI 10.7554/eLife.10250; Zhao XP, 2015, CANCER LETT, V360, P125, DOI 10.1016/j.canlet.2015.01.032; Zhou XC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0911-3	49	38	40	1	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5690	5703		10.1096/fj.201802226R	http://dx.doi.org/10.1096/fj.201802226R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30698991	Bronze			2022-12-28	WOS:000462888500084
J	Liang, XL; Jin, YM; Wang, H; Meng, XL; Tan, ZZ; Huang, T; Fan, SR				Liang, Xiaoling; Jin, Yimei; Wang, Hao; Meng, Xinlu; Tan, Zhongzhou; Huang, Tao; Fan, Shangrong			Transgelin 2 is required for embryo implantation by promoting actin polymerization	FASEB JOURNAL			English	Article						TAGLN2; blastocyst implantation; cell migration; cell invasion	LASER CAPTURE MICRODISSECTION; ADHESION MOLECULES; TROPHOBLAST; IDENTIFICATION; CYTOSKELETON; ADHESIVENESS; BIOMARKER; PROTEIN; WINDOW; TAGLN2	Infertility has been a great challenge in reproductive medicine. At least 40% of human pregnancy losses are clinically unrecognized and occur because of embryo implantation failure. Identification of the proteins and biochemical factors involved in embryo implantation and that are essential for crosstalk between the embryo and uterus can further increase female fertility rates. The actin cytoskeleton and actin-binding proteins (ABPs) are of great importance for cell morphology and rearrangement, which is crucial for trophoblast adhesion and invasion. However, the research on ABPs in embryo implantation is insufficient. In this report, we found that transgelin (TAGLN)2 is highly expressed in mouse blastocyst trophoblasts. Notably, inhibition of mouse blastocyst trophoblast TAGLN2 by lentivirus-mediated RNA interference significantly impaired embryo adhesion and implantation ability. Further in vitro experiments demonstrated that TAGLN2 knockdown with small interfering RNA observably decreased the invasion and migration abilities of human trophoblast cells. Immunofluorescence colocalization and microscale thermophoresis analysis showed that TAGLN2 directly binds to actin. In addition, knockdown of TAGLN2 in trophoblast cells resulted in a remarkable reduction in F-actin rather than G-actin. Our findings reveal an unidentified role of TAGLN2 in regulation of trophoblast invasion and adhesion by promoting actin polymerization.	[Liang, Xiaoling; Wang, Hao; Fan, Shangrong] Peking Univ, Shenzhen Hosp, Dept Obstet & Gynecol, 1120 Lianhua Rd, Shenzhen 518036, Peoples R China; [Liang, Xiaoling; Fan, Shangrong] Shenzhen Key Lab Technol Early Diag Major Gynecol, Shenzhen, Peoples R China; [Jin, Yimei; Meng, Xinlu] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing, Peoples R China; [Tan, Zhongzhou; Huang, Tao] Peking Univ, Sch Basic Med Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University	Fan, SR (corresponding author), Peking Univ, Shenzhen Hosp, Dept Obstet & Gynecol, 1120 Lianhua Rd, Shenzhen 518036, Peoples R China.	fanshangrong@163.com		Jin, Yimei/0000-0001-7599-7042; meng, xin lu/0000-0003-3731-9536; Liang, Xiaoling/0000-0002-9436-8476	Shenzhen Science and Technology Plan [JCYJ20160428175005906]	Shenzhen Science and Technology Plan	The authors are grateful to Prof. Mo Li and Dr. Bingteng Xie (both from the Center for Reproductive Medicine, Peking University Third Hospital) for the insightful comments and suggestions on the manuscript. This research was supported by the Shenzhen Science and Technology Plan (Grant JCYJ20160428175005906 to S. Fan). The authors declare no conflicts of interest.	Aplin JD, 2017, J CELL SCI, V130, P15, DOI 10.1242/jcs.175943; Armant DR, 2011, CELL CYCLE, V10, P574, DOI 10.4161/cc.10.4.14846; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Chen Q, 2011, J BIOL CHEM, V286, P4349, DOI 10.1074/jbc.M110.197202; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Dvorakova M, 2016, J PROTEOMICS, V132, P103, DOI 10.1016/j.jprot.2015.11.025; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; Forti G, 1998, J CLIN ENDOCR METAB, V83, P4177, DOI 10.1210/jc.83.12.4177; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Han MZ, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0619-9; Heneweer C, 2002, MOL HUM REPROD, V8, P1014, DOI 10.1093/molehr/8.11.1014; Hill JJ, 2011, J PROTEOME RES, V10, P2479, DOI 10.1021/pr101267k; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huang QJ, 2008, J CANCER RES CLIN, V134, P1219, DOI 10.1007/s00432-008-0398-y; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Jauniaux E, 2005, PLACENTA, V26, P114, DOI 10.1016/j.placenta.2004.05.011; Kim HR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09144-x; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Na BR, 2015, J CELL BIOL, V209, P143, DOI 10.1083/jcb.201407130; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Pei J, 2018, EUR REV MED PHARMACO, V22, P307, DOI 10.26355/eurrev_201801_14173; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Rho JH, 2009, J PROTEOME RES, V8, P5610, DOI 10.1021/pr900705r; Singh H, 2009, J ANAT, V215, P3, DOI 10.1111/j.1469-7580.2008.01034.x; Thie M, 1997, MOL HUM REPROD, V3, P275, DOI 10.1093/molehr/3.4.275; van Mourik MSM, 2009, J LEUKOCYTE BIOL, V85, P4, DOI 10.1189/jlb.0708395; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Xie BT, 2018, CELL RES, V28, P462, DOI 10.1038/s41422-018-0009-7; Yekani F, 2018, J CELL PHYSIOL, V233, P9070, DOI 10.1002/jcp.26879; Zhang HJ, 2018, ONCOL LETT, V16, P6355, DOI 10.3892/ol.2018.9436; Zhang YB, 2010, CANCER SCI, V101, P523, DOI 10.1111/j.1349-7006.2009.01424.x	40	19	20	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5667	5675		10.1096/fj.201802158RRR	http://dx.doi.org/10.1096/fj.201802158RRR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702937	Bronze			2022-12-28	WOS:000462888500082
J	Townsend, LK; Medak, KD; Knuth, CM; Peppler, WT; Charron, MJ; Wright, DC				Townsend, Logan K.; Medak, Kyle D.; Knuth, Carly M.; Peppler, Willem T.; Charron, Maureen J.; Wright, David C.			Loss of glucagon signaling alters white adipose tissue browning	FASEB JOURNAL			English	Article						WAT; brown adipose tissue; cold	GENE-EXPRESSION; FAT-CELLS; THERMOGENESIS; FGF21; EXERCISE; MICE; GLUCOSE; OBESITY; BEIGE; PGC-1-ALPHA	Various endocrine factors contribute to cold-induced white adipose tissue (WAT) browning, but glucagon has largely been ignored. The purpose of the current investigation was to determine if glucagon was required for the effects of cold on WAT browning. Utilizing whole-body glucagon receptor knockout (Gcgr(-/-)) mice and their wild-type (WT) littermate controls, we examined the response of inguinal WAT (iWAT) and interscapular brown adipose tissue (BAT) to an acute (48 h) cold stress or challenge with the beta 3-adrenergic agonist CL316,243. The effects of glucagon alone on the induction of thermogenic genes in adipose tissue from C57BL6/J mice were also examined. Gcgr(-/-) mice displayed modest increases in indices of browning at room temperature while displaying a blunted induction of Ucp1, Cidea, and Ffg21 mRNA expression in iWAT following cold exposure. Similarly, cold induced increases in mitochondrial DNA copy number, and the protein content of mitochondrial respiratory chain complexes, UCP1, and PGC1 were attenuated in iWAT from Gcgr(-/-) mice. In BAT, the induction of thermogenic markers following cold exposure was reduced, but the effect was less pronounced than in iWAT. Glucagon treatment increased the expression of thermogenic genes in both iWAT and BAT of C57BL6/J mice. In response to CL316,243, circulating fatty acids, glycerol, and the phosphorylation of hormone-sensitive lipase were attenuated in iWAT of Gcgr(-/-) mice. We provide evidence that glucagon is sufficient for the induction of thermogenic genes in iWAT, and the absence of intact glucagon signaling blunts the cold-induced browning of WAT, possibly due, in part, to impaired adrenergic signaling.	[Townsend, Logan K.; Medak, Kyle D.; Knuth, Carly M.; Peppler, Willem T.; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada; [Charron, Maureen J.] Albert Einstein Coll Med, Dept Biochem, New York, NY USA; [Charron, Maureen J.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, New York, NY USA; [Charron, Maureen J.] Albert Einstein Coll Med, Dept Med, Div Endocrinol & Diabet, New York, NY USA	University of Guelph; Yeshiva University; Yeshiva University; Yeshiva University	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca		Wright, David/0000-0003-3867-8901	Natural Sciences and Engineering Research Council of Canada (NSERC); Queen Elizabeth II Graduate Scholarship in Science and Technology; Ontario Graduate Scholarship; Dairy Farmers of Ontario Doctoral Research Assistantship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship in Science and Technology; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Dairy Farmers of Ontario Doctoral Research Assistantship	This work was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to D.C.W., who is a Tier 2 Canada Research Chair in Lipids, Metabolism and Health. W.T.P. was supported by a Queen Elizabeth II Graduate Scholarship in Science and Technology. L.K.T. was supported by an Ontario Graduate Scholarship, a Dairy Farmers of Ontario Doctoral Research Assistantship, and a Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship. The authors declare no conflicts of interest.	Atgie C, 1997, AM J PHYSIOL-CELL PH, V273, pC1136, DOI 10.1152/ajpcell.1997.273.4.C1136; Banfi S, 2018, P NATL ACAD SCI USA, V115, pE1249, DOI 10.1073/pnas.1717420115; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; BILLINGTON CJ, 1991, AM J PHYSIOL, V261, pR501, DOI 10.1152/ajpregu.1991.261.2.R501; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; BURCELIN R, 1995, GENE, V164, P305, DOI 10.1016/0378-1119(95)00472-I; Buzelle SL, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12312; Castellani LN, 2017, PSYCHONEUROENDOCRINO, V82, P38, DOI 10.1016/j.psyneuen.2017.05.005; Defour M, 2018, MOL METAB, V10, P39, DOI 10.1016/j.molmet.2018.01.023; Douris N, 2017, MOL METAB, V6, P854, DOI 10.1016/j.molmet.2017.05.017; Douris N, 2015, ENDOCRINOLOGY, V156, P2470, DOI 10.1210/en.2014-2001; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Fischer AW, 2016, AM J PHYSIOL-ENDOC M, V311, pE202, DOI 10.1152/ajpendo.00093.2016; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Foster MT, 2012, ADIPOCYTE, V1, P192, DOI 10.4161/adip.21756; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; HAGEN JH, 1961, J BIOL CHEM, V236, P1023; Hansen JS, 2015, MOL METAB, V4, P551, DOI 10.1016/j.molmet.2015.06.001; HARVEY WD, 1974, ENDOCRINOLOGY, V94, P1254; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Jay O, 2016, AM J PHYSIOL-ENDOC M, V311, pE638, DOI 10.1152/ajpendo.00265.2016; Kazak L, 2017, CELL METAB, V26, P660, DOI 10.1016/j.cmet.2017.08.009; Keipert S, 2017, CELL METAB, V26, P437, DOI 10.1016/j.cmet.2017.07.016; Keipert S, 2015, MOL METAB, V4, P537, DOI 10.1016/j.molmet.2015.04.006; Kinoshita K, 2014, ENDOCRINOLOGY, V155, P3484, DOI 10.1210/en.2014-1175; Knuth CM, 2018, J PHYSIOL-LONDON, V596, P4375, DOI 10.1113/JP276228; Labbe SM, 2016, AM J PHYSIOL-ENDOC M, V311, pE260, DOI 10.1152/ajpendo.00545.2015; Mo QX, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93166; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Omar BA, 2014, DIABETES, V63, P101, DOI 10.2337/db13-0710; Patsouris D, 2015, CELL REP, V13, P1538, DOI 10.1016/j.celrep.2015.10.028; Peppler WT, 2018, AM J PHYSIOL-ENDOC M, V314, pE66, DOI 10.1152/ajpendo.00226.2017; Peppler WT, 2017, ADIPOCYTE, V6, P1, DOI 10.1080/21623945.2016.1259778; PEREA A, 1995, HORM METAB RES, V27, P372, DOI 10.1055/s-2007-979981; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Richard JE, 2017, AM J PHYSIOL-ENDOC M, V313, pE344, DOI 10.1152/ajpendo.00418.2016; Salem V, 2016, DIABETES OBES METAB, V18, P72, DOI 10.1111/dom.12585; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; SEITZ HJ, 1981, PFLUG ARCH EUR J PHY, V389, P115, DOI 10.1007/BF00582100; Sepa-Kishi DM, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13592; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stanford KI, 2015, DIABETES, V64, P2002, DOI 10.2337/db14-0704; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Townsend LK, 2019, PFLUG ARCH EUR J PHY, V471, P455, DOI 10.1007/s00424-018-2177-1; Townsend LK, 2018, PSYCHONEUROENDOCRINO, V88, P121, DOI 10.1016/j.psyneuen.2017.12.004; Veniant MM, 2015, CELL METAB, V21, P731, DOI 10.1016/j.cmet.2015.04.019; Wainright KS, 2015, AM J PHYSIOL-REG I, V309, pR594, DOI 10.1152/ajpregu.00042.2015; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110	55	17	17	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4824	4835		10.1096/fj.201802048RR	http://dx.doi.org/10.1096/fj.201802048RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30615494				2022-12-28	WOS:000462888500016
J	Vitzthum, C; Stein, L; Brunner, N; Knittel, R; Fallier-Becker, P; Amasheh, S				Vitzthum, Constanze; Stein, Laura; Brunner, Nora; Knittel, Ria; Fallier-Becker, Petra; Amasheh, Salah			Xenopus oocytes as a heterologous expression system for analysis of tight junction proteins	FASEB JOURNAL			English	Article						tissue barrier; claudins; freeze-fracture electron microscopy; TJ strand formation	BLOOD-BRAIN-BARRIER; EPITHELIAL BARRIER; TRANSPORT; DETERMINANTS; CHANNELS; CLAUDINS; CATION	Claudins (cldns) represent the largest family of transmembrane tight junction (TJ) proteins, determining organ-specific epithelial barrier properties. Because methods for the analysis of multiple cldn interaction are limited, we have established the heterologous Xenopus laevis oocyte expression system for TJ protein assembly and interaction analysis. Oocytes were injected with cRNA encoding human cldn-1, -2, or -3 or with a combination of these and were incubated in pairs for interaction analysis. Immunoblotting and immunohistochemistry were performed, and membrane contact areas were analyzed morphometrically and by freeze fracture electron microscopy. Cldns were specifically detected in membranes of expressing oocytes, and coincubation of oocytes resulted in adhesive contact areas that increased with incubation time. Adjacent membrane areas revealed specific cldn signals, including "kissing-point"-like structures representing homophilic trans-interactions of cldns. Contact areas of oocytes expressing a combination markedly exceeded those expressing single cldns, indicating effects on adhesion. Ultrastructural analysis revealed a self-assembly of TJ strands and a cldn-specific strand morphology.	[Vitzthum, Constanze; Stein, Laura; Brunner, Nora; Amasheh, Salah] Free Univ Berlin, Inst Vet Physiol, Oertzenweg 19b, D-14163 Berlin, Germany; [Knittel, Ria; Fallier-Becker, Petra] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany	Free University of Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Amasheh, S (corresponding author), Free Univ Berlin, Inst Vet Physiol, Oertzenweg 19b, D-14163 Berlin, Germany.	salah.amasheh@fu-berlin.de	Amasheh, Salah/AAG-4035-2021		Deutsche Forschungsgemeinschaft [AM141/4-3, AM141/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank their colleagues at the Institute of Veterinary Physiology, Freie Universitat Berlin, for technical assistance and support and Barbara Drewes and Karin Briest-Forch from the Institute of Veterinary Anatomy as well as the colleagues at the Institute of Veterinary Pathology for excellent help with paraffin embedding. This study was supported by Deutsche Forschungsgemeinschaft Grants AM141/4-3 and AM141/11-1. The authors declare no conflicts of interest.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Amasheh S, 1999, J MEMBRANE BIOL, V172, P169, DOI 10.1007/s002329900594; Amasheh S, 1997, J MEMBRANE BIOL, V155, P247, DOI 10.1007/s002329900177; Amasheh S, 2009, INT J COLORECTAL DIS, V24, P1149, DOI 10.1007/s00384-009-0737-8; Angelow S, 2009, ANN NY ACAD SCI, V1165, P143, DOI 10.1111/j.1749-6632.2009.04038.x; Chai ZF, 2011, MOL BIOL CELL, V22, P4503, DOI 10.1091/mbc.E11-05-0438; Doring F, 1996, J PHYSIOL-LONDON, V497, P773; Doring F, 1998, J CLIN INVEST, V101, P2761, DOI 10.1172/JCI1909; Doring F, 1998, J BIOL CHEM, V273, P23211, DOI 10.1074/jbc.273.36.23211; EBIHARA L, 1992, METHOD ENZYMOL, V207, P376; Florian P, 2003, BIOCHEM BIOPH RES CO, V304, P5, DOI 10.1016/S0006-291X(03)00498-4; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Leduc-Nadeau A, 2007, AM J PHYSIOL-CELL PH, V292, pC1132, DOI 10.1152/ajpcell.00136.2006; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Markov AG, 2017, IUBMB LIFE, V69, P290, DOI 10.1002/iub.1622; Markov AG, 2015, IUBMB LIFE, V67, P29, DOI 10.1002/iub.1347; Markov AG, 2011, RESP PHYSIOL NEUROBI, V175, P331, DOI 10.1016/j.resp.2010.12.012; Milatz S, 2015, BIOCHEM J, V468, P449, DOI 10.1042/BJ20150148; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Noell S, 2009, CELL TISSUE RES, V337, P185, DOI 10.1007/s00441-009-0812-z; Pal JD, 2000, AM J PHYSIOL-CELL PH, V279, pC596, DOI 10.1152/ajpcell.2000.279.3.C596; Radloff J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00579; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Tebbe B, 2002, ARCH DERMATOL RES, V294, P14, DOI 10.1007/s00403-001-0290-y; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Vitzthum C, 2015, BBA-BIOMEMBRANES, V1848, P2942, DOI 10.1016/j.bbamem.2015.09.009; Vivaudou M, 2017, METHODS MOL BIOL, V1635, P283, DOI 10.1007/978-1-4939-7151-0_15	31	6	6	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5312	5319		10.1096/fj.201801451RR	http://dx.doi.org/10.1096/fj.201801451RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30645152	Bronze			2022-12-28	WOS:000462888500055
J	Behura, SK; Kelleher, AM; Spencer, TE				Behura, Susanta K.; Kelleher, Andrew M.; Spencer, Thomas E.			Evidence for functional interactions between the placenta and brain in pregnant mice	FASEB JOURNAL			English	Article						fetus; paralog; Foxa2; regulation; uterine	NEUROTROPHIC FACTOR BDNF; FETAL-BRAIN; MATERNAL-BEHAVIOR; SIGNALING PATHWAY; PROLACTIN FAMILY; EVOLUTION; EXPRESSION; IMPLANTATION; SEROTONIN; GENES	The placenta plays a pivotal role in the development of the fetal brain and also influences maternal brain function, but our understanding of communication between the placenta and brain remains limited. Using a gene expression and network analysis approach, we provide evidence that the placenta transcriptome is tightly interconnected with the maternal brain and fetal brain in d 15 pregnant C57BL/6J mice. Activation of serotonergic synapse signaling and inhibition of neurotrophin signaling were identified as potential mediators of crosstalk between the placenta and maternal brain and fetal brain, respectively. Genes encoding specific receptors and ligands were predicted to affect functional interactions between the placenta and brain. Paralogous genes, such as sex comb on midleg homolog 1/scm-like with 4 mbt domains 2 and polycomb group ring finger (Pcgf) 2/Pcgf5, displayed antagonistic regulation between the placenta and brain. Additionally, conditional ablation of forkhead box a2 (Foxa2) in the glands of the uterus altered the transcriptome of the d 15 placenta, which provides novel evidence of crosstalk between the uterine glands and placenta. Furthermore, expression of cathepsin 6 and monocyte to macrophage differentiation associated 2 was significantly different in the fetal brain of Foxa2 conditional knockout mice compared with control mice. These findings provide a better understanding of the intricacies of uterus-placenta-brain interactions during pregnancy and provide a foundation and model system for their exploration.Behura, S. K., Kelleher, A. M., Spencer, T. E. Evidence for functional interactions between the placenta and brain in pregnant mice.	[Behura, Susanta K.; Kelleher, Andrew M.; Spencer, Thomas E.] Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA; [Behura, Susanta K.] Univ Missouri, Informat Inst, Columbia, MO USA; [Spencer, Thomas E.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Behura, SK (corresponding author), Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA.	behuras@missouri.edu	Spencer, Thomas/AAD-6434-2020	Kelleher, Andrew/0000-0002-1484-4998; behura, Susanta/0000-0003-1057-2435	University of Missouri's Research Council; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Development [R21 HD076347, R01 HD096266]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD096266] Funding Source: NIH RePORTER	University of Missouri's Research Council; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Dr. Gregory W. Burns (Grand Rapids Research Center, Michigan State University College of Human Medicine, Grand Rapids, MI, USA) for reading the manuscript. This work was supported, in part, by the University of Missouri's Research Council Grant (to S.K.B.), and by Grants R21 HD076347 and R01 HD096266 from the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Development (to T.E.S.) The authors declare no conflicts of interest.	Ain R, 2004, P NATL ACAD SCI USA, V101, P16543, DOI 10.1073/pnas.0406185101; Arora R, 2016, DEVELOPMENT, V143, P4749, DOI 10.1242/dev.144386; Belnoue L, 2016, SCI REP-UK, V6, DOI 10.1038/srep37615; Bonnin A, 2011, NEUROSCIENCE, V197, P1, DOI 10.1016/j.neuroscience.2011.10.005; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Brown CH, 2007, TRENDS ENDOCRIN MET, V18, P225, DOI 10.1016/j.tem.2007.04.003; Bu PL, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.138032; Budden DM, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0331-y; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Cameron EL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00067; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chakraborty G, 2012, ENDOCRINOLOGY, V153, P1311, DOI 10.1210/en.2011-1437; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; Daikoku T, 2014, ENDOCRINOLOGY, V155, P2718, DOI 10.1210/en.2014-1265; Das SK, 2009, REPRODUCTION, V137, P889, DOI 10.1530/REP-08-0539; Eisinger BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063824; Elyada YM, 2015, CURR OPIN NEUROBIOL, V35, P49, DOI 10.1016/j.conb.2015.06.007; Filant J, 2014, FASEB J, V28, P230, DOI 10.1096/fj.13-237446; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Galea LAM, 2014, J NEUROENDOCRINOL, V26, P641, DOI 10.1111/jne.12177; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gentleman R, 2005, STAT BIOL HEALTH, P189; Goasdoue K, 2017, PLACENTA, V54, P111, DOI 10.1016/j.placenta.2016.12.005; Goldman-Wohl D, 2004, PLACENTA, V25, P623, DOI 10.1016/j.placenta.2004.01.016; Gonez LJ, 2008, MOL MED, V14, P697, DOI 10.2119/2008-00072.Gonez; Guschanski K, 2017, GENOME RES, V27, P1461, DOI 10.1101/gr.215566.116; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Hillerer KM, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/574159; Hoekzema E, 2017, NAT NEUROSCI, V20, P287, DOI 10.1038/nn.4458; Hou ZC, 2012, GENOME BIOL EVOL, V4, P713, DOI 10.1093/gbe/evs045; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ihnatova I, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0763-1; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kelleher AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04848-8; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kelleher AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38078; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kinsley CH, 2011, J NEUROENDOCRINOL, V23, P974, DOI 10.1111/j.1365-2826.2011.02194.x; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; Kodomari I, 2009, NEUROCHEM INT, V54, P95, DOI 10.1016/j.neuint.2008.11.005; KORPEINEN T, 1982, J NEUROCHEM, V39, P1737, DOI 10.1111/j.1471-4159.1982.tb08011.x; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Makieva S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092477; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Mozzi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10245-w; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nakajima A, 2000, BIOCHEM J, V349, P689, DOI 10.1042/bj3490689; Napso T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01091; Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019; Prince CS, 2017, PLACENTA, V49, P55, DOI 10.1016/j.placenta.2016.11.010; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Ray S, 2016, G3-GENES GENOM GENET, V6, P221, DOI [10.1534/g3.115.020982/-/DC1, 10.1534/g3.115.020982]; Roberts RM, 2016, REPRODUCTION, V152, pR179, DOI 10.1530/REP-16-0325; ROBINSON J, 1995, REPROD FERT DEVELOP, V7, P333, DOI 10.1071/RD9950333; Saenen ND, 2015, ENVIRON HEALTH PERSP, V123, P834, DOI 10.1289/ehp.1408549; Scrucca L, 2016, R J, V8, P289; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SLOTNICK BM, 1975, J COMP PHYSIOL PSYCH, V88, P118, DOI 10.1037/h0076200; Soares MJ, 2007, TRENDS ENDOCRIN MET, V18, P114, DOI 10.1016/j.tem.2007.02.005; Soares MJ, 2018, BIOL REPROD, V99, P196, DOI 10.1093/biolre/ioy049; Spencer TE, 2014, SEMIN REPROD MED, V32, P346, DOI 10.1055/s-0034-1376354; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Stolzenberg DS, 2012, HORM BEHAV, V62, P128, DOI 10.1016/j.yhbeh.2012.05.012; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; VADAKKADATH MS, 2005, CELL MOL LIFE SCI, V62, P257, DOI DOI 10.1007/S00018-004-4381-3; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wessels JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094036; Wildman DE, 2011, PLACENTA, V32, pS142, DOI 10.1016/j.placenta.2011.01.005; Woods L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00570; Yuan JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03092-4; Zeltser LM, 2011, P NATL ACAD SCI USA, V108, P15667, DOI 10.1073/pnas.1112239108; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038602; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	85	18	18	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4261	4272		10.1096/fj.201802037R	http://dx.doi.org/10.1096/fj.201802037R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521381	Green Published			2022-12-28	WOS:000459794800093
J	Gonzalez-Ramos, S; Paz-Garcia, M; Rius, C; del Monte-Monge, A; Rodriguez, C; Fernandez-Garcia, V; Andres, V; Martinez-Gonzalez, J; Lasuncion, MA; Martin-Sanz, P; Soehnlein, O; Bosca, L				Gonzalez-Ramos, Silvia; Paz-Garcia, Marta; Rius, Cristina; del Monte-Monge, Alberto; Rodriguez, Cristina; Fernandez-Garcia, Victoria; Andres, Vicente; Martinez-Gonzalez, Jose; Lasuncion, Miguel A.; Martin-Sanz, Paloma; Soehnlein, Oliver; Bosca, Lisardo			Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1	FASEB JOURNAL			English	Article						cardiovascular disease; innate immunity; leukocyte	NF-KAPPA-B; ADHESION MOLECULES; DYSFUNCTION; ACTIVATION; EXPRESSION; HYPERCHOLESTEROLEMIA; PROLIFERATION; PEPTIDOGLYCAN; INFLAMMATION; MECHANISMS	Atherosclerosis is a chronic disease characterized by vascular lipid retention and inflammation, and pattern recognition receptors (PRRs) are important contributors in early stages of the disease. Given the implication of the intracellular PRR nucleotide-binding oligomerization domain 1 (NOD1) in cardiovascular diseases, we investigated its contribution to early atherosclerosis. We evidenced NOD1 induction in atherosclerotic human and mouse tissues, predominantly in vascular endothelial cells. Accordingly, NOD1 genetic inactivation in Apoe(-/-) mice reduced not only atherosclerosis burden, but also monocyte and neutrophil accumulation in atheromata. Of note, in the presence of either peptidoglycan or oxidized LDLs, endothelial NOD1 triggered VCAM-1 up-regulation through the RIP2-NF-B axis in an autocrine manner, enhancing firm adhesion of both sets of myeloid cells to the inflamed micro- and macrovasculature in vivo. Our data define a major proatherogenic role for endothelial NOD1 in early leukocyte recruitment to the athero-prone vasculature, thus introducing NOD1 as an innovative therapeutic target and potential prognostic molecule.Gonzalez-Ramos, S., Paz-Garcia, M., Rius, C., del Monte-Monge, A., Rodriguez, C., Fernandez-Garcia, V., Andres, V., Martinez-Gonzalez, J., Lasuncion, M. A., Martin-Sanz, P., Soehnlein, O., Bosca, L. Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1.	[Gonzalez-Ramos, Silvia; Paz-Garcia, Marta; Fernandez-Garcia, Victoria; Martin-Sanz, Paloma; Bosca, Lisardo] UAM, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain; [Gonzalez-Ramos, Silvia; Paz-Garcia, Marta; del Monte-Monge, Alberto; Rodriguez, Cristina; Fernandez-Garcia, Victoria; Andres, Vicente; Martinez-Gonzalez, Jose; Martin-Sanz, Paloma; Bosca, Lisardo] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Rius, Cristina; del Monte-Monge, Alberto; Andres, Vicente] CNIC, Madrid, Spain; [Rodriguez, Cristina] Hosp Santa Creu & Sant Pau, Inst Recerca, ICCC, Barcelona, Spain; [Martinez-Gonzalez, Jose] CSIC, IIBB, St Pau Biomed Res Inst IIB St Pau, Barcelona, Spain; [Lasuncion, Miguel A.] Hosp Univ Ramon & Cajal IRyCIS, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Soehnlein, Oliver] Ludwig Maximilians Univ LMU, Inst Cardiovasc Prevent, Munich, Germany; [Soehnlein, Oliver] Karolinska Inst, Stockholm, Sweden; [Soehnlein, Oliver] Partner Site Munich Heart Alliance MHA, German Ctr Cardiovasc Res DZHK, Berlin, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Hospital Universitario Ramon y Cajal; University of Munich; Karolinska Institutet; German Centre for Cardiovascular Research; Munich Heart Alliance	Bosca, L (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.; Soehnlein, O (corresponding author), Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Pettenkoferstr 9, D-80336 Munich, Germany.	oliver.soehnlein@gmail.com; lbosca@iib.uam.es	Lasunción, Miguel A./K-6167-2014; Del Monte Monge, Alberto/AAB-6859-2021; Andres, Vicente/I-6440-2014; Rodriguez, Cristina/D-3099-2011	Lasunción, Miguel A./0000-0003-0299-9391; Del Monte Monge, Alberto/0000-0002-6382-9639; Andres, Vicente/0000-0002-0125-7209; Rodriguez, Cristina/0000-0002-6472-5647; Fernandez-Garcia, PhD, Victoria/0000-0003-2521-0146	Ministry of Science, Innovation and Universities [SAF2015-64767-R, SAF2016-79490-R, SAF2015-70747-R, SAF2016-75004-R, SAF2017-82436-R/RTC2017-6283-1]; Center for Biomedical Research Network Consortium in Cardiovascular Diseases [CB16/11/00257, CB16/11/00405, CB/11/00222]; Community of Madrid Grant [BMD/3686]; German Research Foundation [SFB914 TP A02/B08/B09/Z03, SFB1123 TP A06/B05/B08/Z01]; Netherlands Organization for Scientific Research [91712303]; European Regional Development Fund	Ministry of Science, Innovation and Universities; Center for Biomedical Research Network Consortium in Cardiovascular Diseases; Community of Madrid Grant; German Research Foundation(German Research Foundation (DFG)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Regional Development Fund(European Commission)	The authors thank Gabriel Nunez (Department of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA) for providing Nod1<SUP>-/-</SUP> mice and Javier Perez (Instituto de Investigaciones Biomedicas Alberto) for preparing scientific drawings. This work was supported by the the Ministry of Science, Innovation and Universities (Grants SAF2015-64767-R, SAF2016-79490-R, SAF2015-70747-R, SAF2016-75004-R, SAF2017-82436-R/RTC2017-6283-1), the Center for Biomedical Research Network Consortium in Cardiovascular Diseases (Grants CB16/11/00257, CB16/11/00405, CB/11/00222), Community of Madrid Grant BMD/3686, the German Research Foundation (Grants SFB914 TP A02/B08/B09/Z03, SFB1123 TP A06/B05/B08/Z01), and the Netherlands Organization for Scientific Research (VIDI project 91712303). This project was also financed, in part, by the European Regional Development Fund. O.S. and L.B. contributed equally as senior authors. The authors declare no conflicts of interest.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Brown RA, 2017, AM J MED, V130, P268, DOI 10.1016/j.amjmed.2016.10.022; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Cid MC, 2000, ARTHRITIS RHEUM-US, V43, P184, DOI 10.1002/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Fueger BJ, 2006, J NUCL MED, V47, P999; Fuster JJ, 2011, ARTERIOSCL THROM VAS, V31, P2455, DOI 10.1161/ATVBAHA.111.235580; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gopal K, 2010, J THROMB THROMBOLYS, V30, P154, DOI 10.1007/s11239-010-0446-8; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Kanno S, 2015, J IMMUNOL, V194, P773, DOI 10.4049/jimmunol.1302841; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lee ES, 2012, J SURG RES, V177, P373, DOI 10.1016/j.jss.2012.06.021; Lee IT, 2014, CLIN SCI, V127, P375, DOI 10.1042/CS20130816; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lichtenstein L, 2015, CARDIOVASC RES, V106, P314, DOI 10.1093/cvr/cvv109; Liu JR, 2014, INFLAMMATION, V37, P522, DOI 10.1007/s10753-013-9766-0; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Martin BJ, 2009, CAN J CARDIOL, V25, p15A, DOI 10.1016/S0828-282X(09)71049-9; Motomura Y, 2015, ARTERIOSCL THROM VAS, V35, P1423, DOI 10.1161/ATVBAHA.114.304846; Ogawa H, 2003, J IMMUNOL, V170, P5956, DOI 10.4049/jimmunol.170.12.5956; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ortega-Gomez A, 2016, CIRCULATION, V134, P1176, DOI 10.1161/CIRCULATIONAHA.116.024790; Pirillo A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152786; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Prieto P, 2014, CLIN SCI, V127, P665, DOI 10.1042/CS20140180; Rius C, 2015, METHODS MOL BIOL, V1339, P357, DOI 10.1007/978-1-4939-2929-0_26; Schmidt EP, 2016, COMPR PHYSIOL, V6, P945, DOI 10.1002/cphy.c150020; Swirski FK, 2013, CIRC RES, V112, P744, DOI 10.1161/CIRCRESAHA.113.300867; Val-Blasco A, 2017, J AM COLL CARDIOL, V69, P423, DOI 10.1016/j.jacc.2016.10.073; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Yang H, 2015, APOPTOSIS, V20, P512, DOI 10.1007/s10495-015-1089-1; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zimmer S, 2015, CIRC RES, V116, P323, DOI 10.1161/CIRCRESAHA.116.301135	44	19	19	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3912	3921		10.1096/fj.201801231RR	http://dx.doi.org/10.1096/fj.201801231RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496704	Green Submitted, Bronze			2022-12-28	WOS:000459794800065
J	Jo, YJ; Lee, IW; Jung, SM; Kwon, J; Kim, NH; Namgoong, S				Jo, Yu-Jin; Lee, In-Won; Jung, Seung-Min; Kwon, JeongWoo; Kim, Nam-Hyung; Namgoong, Suk			Spire localization via zinc finger-containing domain is crucial for the asymmetric division of mouse oocyte	FASEB JOURNAL			English	Article						asymmetric division; Soire; zinc finger	2 ACTIN NUCLEATORS; MEIOTIC SPINDLE; FERTILIZATION; TRANSPORTERS; FORMIN-2; MEIOSIS; DRIVE; MIGRATION; PROTEINS; INDUCE	Zinc plays an essential role in mammalian oocyte maturation, fertilization, and early embryogenesis, and depletion of zinc impairs cell cycle control, asymmetric division, and cytokinesis in oocyte. We report that zinc, via the actin nucleator Spire, acts as an essential regulator of the actin cytoskeleton remodeling during mouse oocyte maturation and fertilization. Depletion of zinc in the mouse oocyte impaired cortical and cytoplasmic actin formation. Spire is colocalized with zinc-containing vesicles via its zinc finger-containing Fab1, YOTB, Vac 1, EEA1 (FYVE) domain. Improper localization of Spire by zinc depletion or mutations in the FYVE domain impair cytoplasmic actin mesh formations and asymmetric division and cytokinesis of oocyte. All 3 major domains of the Spire are required for its proper localization and activity. After fertilization or parthenogenetic activation, Spire localization was dramatically altered following zinc release from the oocyte. Collectively, our data reveal novel roles for zinc in the regulation of the actin nucleator Spire by controlling its localization in mammalian oocyte.Jo, Y.-J., Lee, I.-W., Jung, S.-M., Kwon, J., Kim, N.-H., Namgoong, S. Spire localization via zinc finger-containing domain is crucial for the asymmetric division of mouse oocyte.	[Jo, Yu-Jin; Lee, In-Won; Jung, Seung-Min; Kwon, JeongWoo; Kim, Nam-Hyung; Namgoong, Suk] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, North Chungcheo, South Korea	Chungbuk National University	Kim, NH; Namgoong, S (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Chungdae Ro 1, Cheongju 28644, Chungcheongbuk, South Korea.	nhkim@chungbuk.ac.kr; suknamgoong@chungbuk.ac.kr		Lee, In-won/0000-0003-4336-5897	Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, South Korea [PJ01322102]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2018R1A6A3A11049229]	Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, South Korea; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education	This work was carried out with the support of the Cooperative Research Program for Agriculture Science and Technology Development (Project PJ01322102), Rural Development Administration, South Korea, and Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2018R1A6A3A11049229). The authors declare no conflicts of interest.	Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bernhardt ML, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097253; Bernhardt ML, 2011, BIOL REPROD, V84, P526, DOI 10.1095/biolreprod.110.086488; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Chaigne A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7027; Chaigne A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10253; Chaigne A, 2013, NAT CELL BIOL, V15, P958, DOI 10.1038/ncb2799; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Duncan FE, 2016, SCI REP-UK, V6, DOI 10.1038/srep24737; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Jo YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29204; Jo YJ, 2015, J CELL SCI, V128, P160, DOI 10.1242/jcs.163576; Kerkhoff E, 2001, CURR BIOL, V11, P1963, DOI 10.1016/S0960-9822(01)00602-9; Kim AM, 2011, ACS CHEM BIOL, V6, P716, DOI 10.1021/cb200084y; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Kong BY, 2014, MOL HUM REPROD, V20, P1077, DOI 10.1093/molehr/gau066; Kong BY, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099390; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Lisle RS, 2013, REPRODUCTION, V145, P381, DOI 10.1530/REP-12-0338; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MARO B, 1984, J EMBRYOL EXP MORPH, V81, P211; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Meng QG, 2007, ACTA VET HUNG, V55, P369, DOI 10.1556/AVet.55.2007.3.11; Namgoong S, 2016, CELL CYCLE, V15, P1830, DOI 10.1080/15384101.2016.1181239; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pitt SJ, 2015, BIOCHEM SOC T, V43, P359, DOI 10.1042/BST20140285; Pylypenko O, 2016, ELIFE, V5, DOI [10.7554/elife.17523, 10.7554/eLife.17523]; Que EL, 2017, INTEGR BIOL-UK, V9, P135, DOI 10.1039/c6ib00212a; Que EL, 2015, NAT CHEM, V7, P130, DOI [10.1038/NCHEM.2133, 10.1038/nchem.2133]; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2013, DEVELOPMENT, V140, P4417, DOI 10.1242/dev.097337; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Schmitt A, 2002, J CELL SCI, V115, P2457; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Suzuki T, 2010, DEVELOPMENT, V137, P2659, DOI 10.1242/dev.049791; Tittel J, 2015, J BIOL CHEM, V290, P6428, DOI 10.1074/jbc.M114.602672; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yang Q, 2012, J CELL BIOL, V197, P939, DOI 10.1083/jcb.201111052; Yi KX, 2013, J CELL BIOL, V200, P567, DOI 10.1083/jcb.201211068; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zhang N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22772	60	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4432	4447		10.1096/fj.201801905R	http://dx.doi.org/10.1096/fj.201801905R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30557038				2022-12-28	WOS:000459794800106
J	Turpaev, K; Krizhanovskii, C; Wang, X; Sargsyan, E; Bergsten, P; Welsh, N				Turpaev, Kyril; Krizhanovskii, Camilla; Wang, Xuan; Sargsyan, Ernest; Bergsten, Peter; Welsh, Nils			The protein synthesis inhibitor brusatol normalizes high-fat diet-induced glucose intolerance in male C57BL/6 mice: role of translation factor eIF5A hypusination	FASEB JOURNAL			English	Article						iNOS; insulin release; -cell death	BETA-CELLS; QUASSINOIDS; CYTOKINES; INFLAMMATION; DYSFUNCTION; SURVIVAL; MODELS; LINE; MASS	The naturally occurring quassinoid compound brusatol improves the survival of insulin-producing cells when exposed to the proinflammatory cytokines IL-1b and IFN-g in vitro. The aim of the present study was to investigatewhetherbrusatol also promotes beneficial effects inmice fed a high-fat diet (HFD), and if so, to study the mechanisms by which brusatol acts. In vivo, we observed that the impaired glucose tolerance of HFD-fed male C57BL/ 6micewas counteracted by a 2wk treatmentwith brusatol. Brusatol treatment improvedbothb-cell function and peripheral insulin sensitivity of HFD-fed mice. In vitro, brusatol inhibited b-cell total protein and proinsulin biosynthesis, withanED50 of 40nM. In linewith this, brusatol blocked cytokine-inducediNOSprotein expression via inhibition of iNOS mRNA translation. Brusatol may have affected protein synthesis, at least in part, via inhibition of eukaryotic initiation factor 5A (eIF5A) hypusination, as eIF5A spermidine association and hypusinationin RIN-5AHcellswas reducedinadose-andtime-dependentmanner. The eIF5AhypusinationinhibitorGC7 promoted a similar effect. Both brusatol and GC7 protected rat RIN-5AH cells against cytokine-induced cell death. Brusatol reduced eIF5A hypusination and cytokine-induced cell death in EndoC-bH1 cells as well. Finally, hypusinated eIF5A was reduced in vivo by brusatol in islet endocrine and endothelial islet cells of mice fed anHFD. The results of the present study suggest that brusatol improves glucose intolerance in mice fed an HFD, possibly by inhibiting protein biosynthesis and eIF5A hypusination.-Turpaev, K., Krizhanovskii, C., Wang, X., Sargsyan, E., Bergsten, P., Welsh, N. The protein synthesis inhibitor brusatol normalizes high-fat diet-induced glucose intolerance in male C57BL/ 6 mice: role of translation factor eIF5A hypusination. FASEB J. 33, 3510-3522 (2019). www.fasebj.org	[Turpaev, Kyril; Krizhanovskii, Camilla; Wang, Xuan; Sargsyan, Ernest; Bergsten, Peter; Welsh, Nils] Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden; [Turpaev, Kyril] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia	Uppsala University; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences	Welsh, N (corresponding author), Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, BMC, Box 571,Husargatan 3, SE-75123 Uppsala, Sweden.	nils.welsh@mcb.uu.se		, camilla/0000-0003-2195-165X	Genentech (San Francisco, CA, USA) [mAbHpu98.61]; Diabetes Wellness Sweden Foundation; Swedish Diabetes Association; family Ernfors Fund; Barndiabetesfonden; Exodiab	Genentech (San Francisco, CA, USA); Diabetes Wellness Sweden Foundation; Swedish Diabetes Association; family Ernfors Fund; Barndiabetesfonden; Exodiab	The anti-hypusinated eIF5A antibody mAbHpu98.61 was kindly provided by Genentech (San Francisco, CA, USA). This work was supported by the Diabetes Wellness Sweden Foundation, the Swedish Diabetes Association, the family Ernfors Fund, Barndiabetesfonden, and Exodiab. The authors declare no conflicts of interest.	Ablat A, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1610-x; Bawm S, 2008, VET PARASITOL, V158, P288, DOI 10.1016/j.vetpar.2008.09.021; Caraglia M, 2013, AMINO ACIDS, V44, P103, DOI 10.1007/s00726-011-1182-x; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Fiaschetti G, 2011, CURR MED CHEM, V18, P316, DOI 10.2174/092986711794839205; Fukamiya N, 2005, CANCER LETT, V220, P37, DOI 10.1016/j.canlet.2004.04.023; Guo N, 2017, J CHROMATOGR B, V1053, P20, DOI 10.1016/j.jchromb.2017.04.012; Guo Z, 2005, CURR MED CHEM, V12, P173, DOI 10.2174/0929867053363351; Kristinsson H, 2015, BBA-MOL CELL RES, V1853, P3248, DOI 10.1016/j.bbamcr.2015.09.022; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Lopes M, 2014, GENOMICS, V103, P264, DOI 10.1016/j.ygeno.2013.12.007; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Mata-Greenwood E, 2002, LEUKEMIA, V16, P2275, DOI 10.1038/sj.leu.2402696; Moore CC, 2008, J INFECT DIS, V198, P1407, DOI 10.1086/592222; Olayanju A, 2015, FREE RADICAL BIO MED, V78, P202, DOI 10.1016/j.freeradbiomed.2014.11.003; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Pallmann N, 2015, J BIOL CHEM, V290, P18343, DOI 10.1074/jbc.M115.664490; Park JH, 2011, METHODS MOL BIOL, V720, P207, DOI 10.1007/978-1-61779-034-8_13; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pirot P, 2008, ARQ BRAS ENDOCRINOL, V52, P156, DOI 10.1590/S0004-27302008000200003; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Silva RL, 2015, J NAT PROD, V78, P241, DOI 10.1021/np500796f; Staaf J, 2016, PEDIATR RES, V80, P267, DOI 10.1038/pr.2016.80; Tang WB, 2014, J MED CHEM, V57, P7600, DOI 10.1021/jm5007534; Templin AT, 2011, CELL CYCLE, V10, P1043, DOI 10.4161/cc.10.7.15206; Tersey SA, 2014, AMINO ACIDS, V46, P633, DOI 10.1007/s00726-013-1560-7; Tsonkova VG, 2018, MOL METAB, V8, P144, DOI 10.1016/j.molmet.2017.12.007; Turpaev K, 2015, BIOCHEM BIOPH RES CO, V460, P868, DOI 10.1016/j.bbrc.2015.03.124; Vartanian S, 2016, MOL CELL PROTEOMICS, V15, P1220, DOI 10.1074/mcp.M115.055509; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; WELSH N, 1995, MOL MED, V1, P806, DOI 10.1007/BF03401895; Ye QM, 2015, FITOTERAPIA, V105, P66, DOI 10.1016/j.fitote.2015.06.004; Zhai QT, 2016, J MOL BIOL, V428, P603, DOI 10.1016/j.jmb.2016.01.006	37	7	7	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3510	3522		10.1096/fj.201801698R	http://dx.doi.org/10.1096/fj.201801698R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30462531	Bronze			2022-12-28	WOS:000459794800034
J	Yan, TT; Jiang, XP; Lin, GA; Tang, D; Zhang, JH; Guo, XW; Zhang, DX; Zhang, Q; Jia, JZ; Huang, YS				Yan, Tiantian; Jiang, Xupin; Lin, Guoan; Tang, Di; Zhang, Junhui; Guo, Xiaowei; Zhang, Dongxia; Zhang, Qiong; Jia, Jiezhi; Huang, Yuesheng			Autophagy is required for the directed motility of keratinocytes driven by electric fields	FASEB JOURNAL			English	Article						wound healing; reepithelialization; autophagosome; directional electrical signals	MESENCHYMAL TRANSITION; CELL-MIGRATION; ADHESION; STIMULATION; APOPTOSIS; TRANSPORT; PATHWAYS; REPAIR; CA2+; CUE	Endogenous wound electric fields (EFs), an important and fundamental occurrence of wound healing, profoundly influence the directed migration of keratinocytes. Although numerous studies have unveiled the signals responsible for EF-biased direction, the mechanisms by which EFs promote keratinocyte motility remains to be elucidated. In our study, EFs enhanced the directed migratory speed of keratinocytes by inducing autophagic activity, thereby facilitating skin barrier restoration. Initially, we found that electrical signals directed keratinocytes to the cathode with enhanced motility parameters [i.e., trajectory distance, trajectory speed, displacement distance, and displacement speed (T-d/t)] and more efficient migration (directionality and T-d/t along the x axis, among others). Meanwhile, EFs induced a time-dependent increase in autophagic activity in keratinocytes, with constant autophagic flux, accompanied by increased transcription of numerous autophagy-related genes. Deficiency in Atg5, a key protein necessary for autophagosome formation, led to significant reduction of autophagy, which was accompanied by a substantial reduction in EF-stimulated directed motility. These results demonstrated a causal relationship between autophagy and EF-directed migratory speed. In addition, both cell migration under normal conditions and EF-biased directionality were autophagy independent. Thus, our findings define autophagy as an important functional regulator of electrically enhanced directed motility, adding to a growing understanding of EFs.Yan, T., Jiang, X., Lin, G., Tang, D., Zhang, J., Guo, X., Zhang, D., Zhang, Q., Jia, J., Huang, Y. Autophagy is required for the directed motility of keratinocytes driven by electric fields.	[Yan, Tiantian; Jiang, Xupin; Tang, Di; Zhang, Junhui; Zhang, Dongxia; Zhang, Qiong; Jia, Jiezhi; Huang, Yuesheng] Third Mil Med Univ, Army Med Univ, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res,Southwest Hosp, Gaotanyan Main St 30, Chongqing 400038, Peoples R China; [Yan, Tiantian; Lin, Guoan] Peoples Liberat Army, Mil Burn Ctr, Hosp 990 159, Zhumadian, Peoples R China; [Guo, Xiaowei] Peoples Liberat Army, Hosp 205, Dept Burns & Plast Surg, Jinzhou, Peoples R China	Army Medical University	Huang, YS (corresponding author), Third Mil Med Univ, Army Med Univ, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res,Southwest Hosp, Gaotanyan Main St 30, Chongqing 400038, Peoples R China.	yshuangtmmu@163.com			National Key Research and Development Program [2017YFC1103302]; Key Program of the National Natural Science Foundation of China [81430042]; Science Foundation for the Excellent Youth Scholars of the Third Military Medical University [2017MPRC-05]; Innovation Program of Southwest Hospital [SWH2016JSYB-02]	National Key Research and Development Program; Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for the Excellent Youth Scholars of the Third Military Medical University; Innovation Program of Southwest Hospital	This work was supported by National Key Research and Development Program Grant 2017YFC1103302 (to Y.H.); Key Program of the National Natural Science Foundation of China Grant 81430042 (to Y.H.); Science Foundation for the Excellent Youth Scholars of the Third Military Medical University Grant 2017MPRC-05 (to X.J.); and Innovation Program of Southwest Hospital Grant SWH2016JSYB-02 (to X.J.). The authors declare no conflicts of interest.	Abada A, 2014, EMBO REP, V15, P839, DOI 10.15252/embr.201439076; Allen GM, 2013, CURR BIOL, V23, P560, DOI 10.1016/j.cub.2013.02.047; Busschaert N, 2017, NAT CHEM, V9, P667, DOI [10.1038/nchem.2706, 10.1038/NCHEM.2706]; Cicchini M, 2015, CLIN CANCER RES, V21, P498, DOI 10.1158/1078-0432.CCR-13-2438; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; East DA, 2013, AUTOPHAGY, V9, P1710, DOI 10.4161/auto.25367; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Funk RHW, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00143; Galavotti S, 2013, ONCOGENE, V32, P699, DOI 10.1038/onc.2012.111; Guo AH, 2010, J INVEST DERMATOL, V130, P2320, DOI 10.1038/jid.2010.96; Guo XW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10289; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoare JI, 2016, J LEUKOCYTE BIOL, V99, P1141, DOI 10.1189/jlb.3A0815-390R; Huttenlocher A, 2007, NEW ENGL J MED, V356, P303, DOI 10.1056/NEJMcibr066496; Iglesia DDS, 1996, J EXP ZOOL, V274, P56, DOI 10.1002/(SICI)1097-010X(19960101)274:1<56::AID-JEZ6>3.0.CO;2-E; Kenific CM, 2016, J CELL SCI, V129, P3685, DOI 10.1242/jcs.188490; Kenific CM, 2016, J CELL BIOL, V212, P577, DOI 10.1083/jcb.201503075; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KLYCE SD, 1982, J MEMBRANE BIOL, V66, P133, DOI 10.1007/BF01868489; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kondratskyi A, 2018, AUTOPHAGY, V14, P3, DOI 10.1080/15548627.2017.1384887; La Rovere RML, 2016, CELL CALCIUM, V60, P74, DOI 10.1016/j.ceca.2016.04.005; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Li J, 2011, LAB CHIP, V11, P1298, DOI 10.1039/c0lc00371a; Liu H, 2017, AUTOPHAGY, V13, P900, DOI 10.1080/15548627.2017.1291479; Liu Q, 2014, INT J BIOCHEM CELL B, V55, P264, DOI 10.1016/j.biocel.2014.09.014; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Martin P, 2015, BRIT J DERMATOL, V173, P370, DOI 10.1111/bjd.13954; Martinet W, 2006, J HISTOCHEM CYTOCHEM, V54, P85, DOI 10.1369/jhc.5A6743.2005; MCGAHAN MC, 1982, BIOCHIM BIOPHYS ACTA, V689, P385, DOI 10.1016/0005-2736(82)90273-5; Messerli MA, 2011, BIOL BULL-US, V221, P79, DOI 10.1086/BBLv221n1p79; Nuccitelli R, 2008, WOUND REPAIR REGEN, V16, P432, DOI 10.1111/j.1524-475X.2008.00389.x; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; Reid B, 2007, NAT PROTOC, V2, P661, DOI 10.1038/nprot.2007.91; Rognoni E, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178174; Sharifi MN, 2016, CELL REP, V15, P1660, DOI 10.1016/j.celrep.2016.04.065; Simpson MJ, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0413-5; Singh SS, 2018, ONCOGENE, V37, P1142, DOI 10.1038/s41388-017-0046-6; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Sun YH, 2013, CURR BIOL, V23, P569, DOI 10.1016/j.cub.2013.02.026; Thulabandu V, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.307; Tuloup-Minguez V, 2013, CELL CYCLE, V12, P3317, DOI 10.4161/cc.26298; White E, 2015, CLIN CANCER RES, V21, P5037, DOI 10.1158/1078-0432.CCR-15-0490; Willenborg S, 2014, J DTSCH DERMATOL GES, V12, P214, DOI 10.1111/ddg.12290; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Yan TT, 2017, J DERMATOL SCI, V85, P96, DOI 10.1016/j.jdermsci.2016.11.007; Yan TT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169155; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2010, ADV WOUND CARE-SER, V1, P567, DOI 10.1089/awc.2009.0021; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	55	7	9	2	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3922	3935		10.1096/fj.201801294R	http://dx.doi.org/10.1096/fj.201801294R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509146	Bronze			2022-12-28	WOS:000459794800066
J	Zheng, WW; Li, XL; Liu, DQ; Li, J; Yang, S; Gao, Z; Wang, ZN; Yokota, H; Zhang, P				Zheng, Weiwei; Li, Xinle; Liu, Daquan; Li, Jie; Yang, Shuang; Gao, Zhe; Wang, Zhaonan; Yokota, Hiroki; Zhang, Ping			Mechanical loading mitigates osteoarthritis symptoms by regulating endoplasmic reticulum stress and autophagy	FASEB JOURNAL			English	Article						OA; eIF2alpha; P62; knee load; non-invasive physical therapy	UNFOLDED PROTEIN RESPONSE; BONE-FORMATION; MURINE TIBIAE; ER STRESS; KNEE; CARTILAGE; HISTOPATHOLOGY; STIMULATION; ACTIVATION; FREQUENCY	Osteoarthritis (OA) is a disease characterized by cartilage damage and abnormal remodeling of subchondral bone. Our previous study showed that in the early stage of OA, knee loading exerts protective effects by suppressing osteoclastogenesis through Wnt signaling, but little is known about loading effects at the late OA stage. Endoplasmic reticulum (ER) stress and autophagy are known to be involved in the late OA stage. We determined the effects of mechanical loading on ER stress and autophagy in OA mice. One hundred seventy-four mice were used for a surgery-induced OA model. In the first set of experiments, 60 mice were devoted to evaluation of the role of ER stress and autophagy in the development of OA. In the second set, 114 mice were used to assess the effect of knee loading on OA. Histologic, cellular, microcomputed tomography, and electron microscopic analyses were performed to evaluate morphologic changes, ER stress, and autophagy. Mechanical loading increased phosphorylation of eukaryotic translation initiation factor 2 (eIF2) and regulated expressions of autophagy markers LC3II/I and p62. Osteoarthritic mice also exhibited an elevated ratio of calcified cartilage to total articular cartilage (CC/TAC), and synovial hyperplasia with increased lining cells was found. At the early disease stage, subchondral bone plate thinning and reduced subchondral bone volume fraction (B.Ar/T.Ar) were observed. At the late disease stages, subchondral bone plate thickened concomitant with increased B.Ar/T.Ar. Mice subjected to mechanical loading exhibited resilience to cartilage destruction and a correspondingly reduced Osteoarthritis Research Society International score at 4 and 8 wk, as well as a decrease in synovitis and CC/TAC. While chondrocyte numbers in the OA group was notably decreased, mechanical loading restored chondrogenic differentiation. These results demonstrate that mechanical loading can retard the pathologic progression of OA at its early and late stages. The observed effects of loading are associated with the regulations of ER stress and autophagy.Zheng, W., Li, X., Liu, D., Li, J., Yang, S., Gao, Z., Wang, Z., Yokota, H., Zhang, P. Mechanical loading mitigates osteoarthritis symptoms by regulating endoplasmic reticulum stress and autophagy.	[Zheng, Weiwei; Li, Xinle; Liu, Daquan; Li, Jie; Yang, Shuang; Gao, Zhe; Wang, Zhaonan; Zhang, Ping] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Metab Dis, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Li, Xinle; Liu, Daquan; Li, Jie; Yang, Shuang; Zhang, Ping] Chinese Acad Med Sci, Int Cardiovasc Hosp, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China; [Li, Xinle; Liu, Daquan; Li, Jie; Yang, Shuang; Zhang, Ping] Peking Union Med Coll, Tianjin, Peoples R China; [Yokota, Hiroki; Zhang, Ping] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA	Tianjin Medical University; Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Indiana University System; Indiana University-Purdue University Indianapolis	Zhang, P (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	pizhang2008@163.com			National Natural Science Foundation of China [81772405, 81572100, 81601863]; China Postdoctoral Science Foundation [2016M601275]; Tianjin Binhai New Area Health and Family Planning Commission [2016BWKL002, 2016BWKZ005]; Science and Technology Development Fund of Tianjin Education Commission for Higher Education [2017KJ223]; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR052144]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052144] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tianjin Binhai New Area Health and Family Planning Commission; Science and Technology Development Fund of Tianjin Education Commission for Higher Education; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Natural Science Foundation of China (81772405 and 81572100 to P.Z.; 81601863 to X.L.), China Postdoctoral Science Foundation (2016M601275 to X.L.), Tianjin Binhai New Area Health and Family Planning Commission (2016BWKL002 to P.Z.; 2016BWKZ005 to D.L.), the Science and Technology Development Fund of Tianjin Education Commission for Higher Education (2017KJ223 to D.L.), and the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR052144 to H.Y.). The authors declare no conflicts of interest.	Binet F, 2015, CELL METAB, V22, P560, DOI 10.1016/j.cmet.2015.07.010; Binet F, 2013, CELL METAB, V17, P353, DOI 10.1016/j.cmet.2013.02.003; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Denny P, 2018, AUTOPHAGY, V14, P419, DOI 10.1080/15548627.2017.1415189; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2015, CURR OPIN PHARMACOL, V22, P51, DOI 10.1016/j.coph.2015.03.004; Hamamura K, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-312; Hang DH, 2012, CELLS TISSUES ORGANS, V195, P495, DOI 10.1159/000329502; Hendrickx G, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007321; Hilz FM, 2014, BIOELECTROMAGNETICS, V35, P116, DOI 10.1002/bem.21822; Hirasawa H, 2010, FEBS LETT, V584, P745, DOI 10.1016/j.febslet.2009.12.028; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Hu XH, 2018, J BONE MINER RES, V33, P945, DOI 10.1002/jbmr.3380; Huang ZY, 2016, NAT REV RHEUMATOL, V12, P123, DOI 10.1038/nrrheum.2015.158; Jayasuriya CT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25395-8; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Kaneko H, 2013, MATRIX BIOL, V32, P178, DOI 10.1016/j.matbio.2013.01.004; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kishino A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02960-1; Lapane KL, 2015, ARTHRITIS RHEUMATOL, V67, P724, DOI 10.1002/art.38933; Li CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18541-1; Li J, 2017, BONE, V97, P2, DOI 10.1016/j.bone.2016.12.009; Li XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24668; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Liu DQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05488-6; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109; MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Oliveira LC, 2016, OSTEOPOROSIS INT, V27, P2913, DOI 10.1007/s00198-016-3618-3; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Rhodes SD, 2013, J BONE MINER RES, V28, P2476, DOI 10.1002/jbmr.1992; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Sun HB, 2012, CONNECT TISSUE RES, V53, P180, DOI 10.3109/03008207.2011.628765; Tan N, 2018, HEPATOL RES, V48, P839, DOI 10.1111/hepr.13076; Tower RJ, 2015, BONE, V74, P171, DOI 10.1016/j.bone.2015.01.009; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vega-Rubin-de-Celis S, 2018, P NATL ACAD SCI USA, V115, P4176, DOI 10.1073/pnas.1717800115; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang CJ, 2012, J SURG RES, V178, P196, DOI 10.1016/j.jss.2012.01.010; Wang CJ, 2011, ARCH ORTHOP TRAUM SU, V131, P1153, DOI 10.1007/s00402-011-1289-2; Wang HL, 2014, SHOCK, V41, P324, DOI 10.1097/SHK.0000000000000122; Yamasaki Y, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0613-3; Yoboue ED, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0033-4; Zhang P, 2006, J APPL PHYSIOL, V100, P1452, DOI 10.1152/japplphysiol.00997.2005; Zhang P, 2007, J BONE MINER METAB, V25, P383, DOI 10.1007/s00774-007-0774-8; Zhang P, 2007, J BONE MINER RES, V22, P1979, DOI 10.1359/JBMR.070803; Zhang P, 2007, BONE, V40, P538, DOI 10.1016/j.bone.2006.09.018; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020; Zhang P, 2009, BONE, V44, P989, DOI 10.1016/j.bone.2009.01.367; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	54	30	31	1	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4077	4088		10.1096/fj.201801851R	http://dx.doi.org/10.1096/fj.201801851R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30485126	Green Published, Bronze			2022-12-28	WOS:000459794800078
J	Xu, WY; Jin, MM; Huang, WL; Wang, H; Hu, RK; Li, JY; Cao, Y				Xu, Wenyan; Jin, Miaomiao; Huang, Weilai; Wang, Hong; Hu, Ruikun; Li, Jingyu; Cao, Ying			Apical PtdIns(4,5)P-2 is required for ciliogenesis and suppression of polycystic kidney disease	FASEB JOURNAL			English	Article						cilium; Pip5k1; Inpp5e	PRIMARY CILIUM; PLASMA-MEMBRANE; BINDING-SITE; PHOSPHOINOSITIDES; INPP5E; MUTATIONS; TRAFFICKING; EZRIN; GENE; TRANSPORT	Cilia are hair-like structures that function like antennae to detect chemical and mechanical signals in the environment. Recently, phosphoinositides were shown to play an important role in cilia assembly and disassembly. However, the precise molecular and cellular mechanisms underlying this process remain unknown. Here, we report that suppression of apical phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P-2], by overexpressing apically targeted PtdIns(4,5)P-2 phosphatase or by knocking down type I phosphatidylinositol 4-phosphate 5-kinase (Pip5k1), leads to ciliogenesis defects and polycystic kidney disease (PKD) in zebrafish embryos that phenocopied inpp5e mutant, a Joubert syndrome model. We further demonstrate that decreased expression of apical PtdIns(4,5)P-2 disrupted apical ezrin recruitment, F-actin organization, and basal body docking. Moreover, the ciliogenesis and polycystic kidney defects in PtdIns(4,5)P-2-depleted embryos can be rescued by overexpression of ezrin. Finally, Pip5k1a overexpression rescued the ciliogenesis defects and PKD phenotypes in Inpp5e-depleted embryos. Taken together, our results reveal that apical PtdIns(4,5)P-2 is essential for ciliogenesis and the prevention of PKD and suggest a novel possibility for treating PKD and other human ciliopathies.Xu, W., Jin, M., Huang, W., Wang, H., Hu, R., Li, J., Cao, Y. Apical PtdIns(4,5)P-2 is required for ciliogenesis and suppression of polycystic kidney disease.	[Xu, Wenyan; Jin, Miaomiao; Huang, Weilai; Wang, Hong; Hu, Ruikun; Li, Jingyu; Cao, Ying] Tongji Univ, Matern & Infant Hosp 1, Sch Life Sci & Technol, Clin & Translat Res Ctr Shanghai, Shanghai, Peoples R China; [Xu, Wenyan] Yale Univ, Sch Med, New Haven, CT USA	Tongji University; Yale University	Cao, Y (corresponding author), Tongji Univ, 1239 Siping Rd,Med Bldg 1315, Shanghai 200092, Peoples R China.	yingcao@tongji.edu.cn	Li, Jing/GYU-5036-2022; Li, Jingyu/GSD-1924-2022		National Key Research and Development Program of China [2017YFA0104600]; National Natural Science Foundation of China [31771597, 31571515]; National Basic Research Program of China (973 Program) [2012CB966601, 2013CB945300]; Ministry of Science and Technology of China [2011DFB30010]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The authors thank Prof. Zhaoxia Sun (Yale University, New Haven, CT, USA), Dr. Kun Ling (Mayo Clinic, Rochester, MN, USA) and Dr. Lu Zhao (Zhejiang University, Hangzhou, China) for critically reading the manuscript, and the members of the Cao Laboratory for helpful discussions. This project was supported by grants from National Key Research and Development Program of China (2017YFA0104600), National Natural Science Foundation of China (31771597 and 31571515), National Basic Research Program of China (973 Program 2012CB966601 and 2013CB945300), and Ministry of Science and Technology of China (2011DFB30010). The authors declare no conflicts of interest.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; AUKEMA HM, 1995, J NUTR, V125, P1183; AUKEMA HM, 1992, EXP MOL PATHOL, V57, P39, DOI 10.1016/0014-4800(92)90047-F; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Cao Y, 2010, J AM SOC NEPHROL, V21, P1326, DOI 10.1681/ASN.2009091001; Castelli M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3658; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Epting D, 2015, DEVELOPMENT, V142, P174, DOI 10.1242/dev.112250; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Franco I, 2014, DEV CELL, V28, P647, DOI 10.1016/j.devcel.2014.01.022; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hakim S, 2016, HUM MOL GENET, V25, P2295, DOI 10.1093/hmg/ddw097; Hasegawa H, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.110.089896; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Luo N, 2012, VISION RES, V75, P98, DOI 10.1016/j.visres.2012.09.011; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Skwarek LC, 2009, DEV CELL, V16, P12, DOI 10.1016/j.devcel.2008.12.006; Thisse B, 2004, METHOD CELL BIOL, V77, P505; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Wei HC, 2008, J CELL SCI, V121, P1076, DOI 10.1242/jcs.024927; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xu QW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10777; Xu WY, 2017, J AM SOC NEPHROL, V28, P118, DOI 10.1681/ASN.2015080906; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF55, DOI 10.1152/ajprenal.00043.2010	43	6	6	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2848	2857		10.1096/fj.201800385RRR	http://dx.doi.org/10.1096/fj.201800385RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30321068	Bronze			2022-12-28	WOS:000457296600105
J	Kim, H; Williams, D; Qiu, YN; Song, ZF; Yang, Z; Kimler, V; Goldberg, A; Zhang, R; Yang, ZQ; Chen, XQ; Wang, L; Fang, DY; Lin, JD; Zhang, KZ				Kim, Hyunbae; Williams, Dreana; Qiu, Yining; Song, Zhenfeng; Yang, Zhao; Kimler, Victoria; Goldberg, Andrew; Zhang, Ren; Yang, Zengquan; Chen, Xuequn; Wang, Li; Fang, Deyu; Lin, Jiandie D.; Zhang, Kezhong			Regulation of hepatic autophagy by stress-sensing transcription factor CREBH	FASEB JOURNAL			English	Article						stress response; transcriptional regulation; hepatic lipid homeostasis	ELEMENT-BINDING PROTEIN; ACTIVATED RECEPTOR-ALPHA; LIPID-METABOLISM; BIOGENESIS; EXPRESSION; CAMP; FAMILY	Autophagy, a lysosomal degradative pathway in response to nutrient limitation, plays an important regulatory role in lipid homeostasis upon energy demands. Here, we demonstrated that the endoplasmic reticulum-tethered, stress-sensing transcription factor cAMP-responsive element-binding protein, hepatic-specific (CREBH) functions as a major transcriptional regulator of hepatic autophagy and lysosomal biogenesis in response to nutritional or circadian signals. CREBH deficiency led to decreased hepatic autophagic activities and increased hepatic lipid accumulation upon starvation. Under unfed or during energy-demanding phases of the circadian cycle, CREBH is activated to drive expression of the genes encoding the key enzymes or regulators in autophagosome formation or autophagic process, including microtubule-associated protein 1B-light chain 3, autophagy-related protein (ATG)7, ATG2b, and autophagosome formation Unc-51 like kinase 1, and the genes encoding functions in lysosomal biogenesis and homeostasis. Upon nutrient starvation, CREBH regulates and interacts with peroxisome proliferator-activated receptor alpha (PPAR alpha) and PPAR gamma coactivator 1 alpha to synergistically drive expression of the key autophagy genes and transcription factor EB, a master regulator of lysosomal biogenesis. Furthermore, CREBH regulates rhythmic expression of the key autophagy genes in the liver in a circadian-dependent manner. In summary, we identified CREBH as a key transcriptional regulator of hepatic autophagy and lysosomal biogenesis for the purpose of maintaining hepatic lipid homeostasis under nutritional stress or circadian oscillation.-Kim, H., Williams, D., Qiu, Y., Song, Z., Yang, Z., Kimler, V., Goldberg, A., Zhang, R., Yang, Z., Chen, X., Wang, L., Fang, D., Lin, J. D., Zhang, K. Regulation of hepatic autophagy by stress-sensing transcription factor CREBH.	[Kim, Hyunbae; Williams, Dreana; Song, Zhenfeng; Yang, Zhao; Zhang, Ren; Zhang, Kezhong] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 3202 Scott Hall,540 E Canfield Ave, Detroit, MI 48201 USA; [Chen, Xuequn] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Zhang, Kezhong] Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI 48201 USA; [Yang, Zengquan; Zhang, Kezhong] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Qiu, Yining] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Hubei, Peoples R China; [Kimler, Victoria; Goldberg, Andrew] Oakland Univ, Eye Res Inst, Rochester, MI USA; [Wang, Li] Univ Connecticut, Dept Physiol & Neurobiol, Inst Syst Genom, Storrs, CT 06269 USA; [Wang, Li] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; [Wang, Li] Yale Univ, Liver Ctr, Dept Internal Med, New Haven, CT USA; [Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lin, Jiandie D.] Univ Michigan, Med Sch, Life Sci Inst, Ann Arbor, MI USA	Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Huazhong University of Science & Technology; Oakland University; University of Connecticut; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan	Zhang, KZ (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 3202 Scott Hall,540 E Canfield Ave, Detroit, MI 48201 USA.	kzhang@med.wayne.edu		Zhang, Kezhong/0000-0002-6062-235X; Yang, Zhao/0000-0002-4133-3130	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases [DK090313, DK110314, DK102456]; NIH National Institute of Environmental Health Sciences [ES017829]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR066634]; NIH National Eye Institute [EY025291]; American Heart Association [0635423Z, 09GRNT2280479]; NATIONAL EYE INSTITUTE [R01EY025291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102456, P30DK020572, R01DK110314, R01DK090313] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Portions of this work were supported by U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grants DK090313 (to K.Z), DK110314 (to X.C.), and DK102456 (to J.D.L.); NIH National Institute of Environmental Health Sciences Grant ES017829 (to K.Z.); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR066634 (to D.F. and K.Z.); NIH National Eye Institute Grant EY025291 (to A.G.); and American Heart Association Grants 0635423Z and 09GRNT2280479 (to K.Z.). The authors declare no conflicts of interest.	Avila DV, 2016, J PATHOL, V240, P96, DOI 10.1002/path.4760; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cefalu AB, 2015, ARTERIOSCL THROM VAS, V35, P2694, DOI 10.1161/ATVBAHA.115.306170; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Ghosh A, 2015, J BIOL CHEM, V290, P10309, DOI 10.1074/jbc.M114.610659; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Holen I, 1996, EUR J BIOCHEM, V236, P163, DOI 10.1111/j.1432-1033.1996.00163.x; Johansen CT, 2012, CIRC-CARDIOVASC GENE, V5, P66, DOI 10.1161/CIRCGENETICS.111.960864; Kim H, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00048-17; Kim H, 2015, MOL CELL BIOL, V35, P4121, DOI 10.1128/MCB.00665-15; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Yamamoto S, 2018, CELL REP, V23, P3286, DOI 10.1016/j.celrep.2018.05.032; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zheng Z, 2016, DIABETES, V65, P3369, DOI 10.2337/db16-0298	38	15	15	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7896	7914		10.1096/fj.201802528R	http://dx.doi.org/10.1096/fj.201802528R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30912978	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000476234700009
J	Zhang, Y; Unnithan, RVM; Hamidi, A; Caja, L; Saupe, F; Moustakas, A; Cedervall, J; Olsson, AK				Zhang, Yanyu; Unnithan, Ragaseema Valsala Madhavan; Hamidi, Anahita; Caja, Laia; Saupe, Falk; Moustakas, Aristidis; Cedervall, Jessica; Olsson, Anna-Karin			TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells	FASEB JOURNAL			English	Article						platelets; cancer; TBK1; NF-kappa B; metastasis	EPITHELIAL-MESENCHYMAL TRANSITION; KAPPA-B ACTIVATION; CANCER-CELLS; THERAPEUTIC TARGET; TBK1; METASTASIS; INHIBITION; TRANSCRIPTION; EXPRESSION; MECHANISM	Platelets can promote several stages of the metastatic process and thus contribute to malignant progression. As an example, platelets promote invasive properties of tumor cells by induction of epithelial to mesenchymal transition (EMT). In this study, we show that tumor necrosis factor receptor-associated factor (TRAF) family member-associated NF-kappa B activator (TANK)-binding kinase 1 (TBK1) is a previously unknown mediator of platelet-induced EMT in mammary carcinoma cells. Coculture of 2 mammary carcinoma cell lines, Ep5 from mice and MCF10A(MII) from humans, with isolated platelets induced morphologic as well as molecular changes characteristic of EMT, which was paralleled with activation of TBK1. TBK1 depletion using small interfering RNA impaired platelet-induced EMT in both Ep5 and MCF10A(MII) cells. Furthermore, platelet-induced activation of the NF-kappa B subunit p65 was suppressed after TBK1 knockdown, demonstrating that TBK1 mediates platelet-induced NF-kappa B signaling and EMT. Using an in vivo metastasis assay, we found that depletion of TBK1 from mammary carcinoma cells during in vitro preconditioning with platelets subsequently suppressed the formation of lung metastases in mice. Altogether, these results suggest that TBK1 contributes to tumor invasiveness and may be a driver of metastatic spread in breast cancer.-Zhang, Y., Unnithan, R. V. M., Hamidi, A., Caja, L., Saupe, F., Moustakas, A., Cedervall, J., Olsson, A.-K. TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells.	[Zhang, Yanyu; Unnithan, Ragaseema Valsala Madhavan; Hamidi, Anahita; Caja, Laia; Saupe, Falk; Moustakas, Aristidis; Cedervall, Jessica; Olsson, Anna-Karin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Unnithan, Ragaseema Valsala Madhavan] Govt Arts Coll, Thiruvananthapuram, Kerala, India	Uppsala University	Cedervall, J (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Sci Life Lab, Box 582, SE-75123 Uppsala, Sweden.	jessica.cedervall@imbim.uu.se	Caja, Laia/J-4618-2019	Caja, Laia/0000-0002-8786-8763; Hamidi, Anahita/0000-0002-5445-2446; Zhang, Yanyu/0000-0001-9939-1838	Swedish Research Council [2016-03036]; Swedish Cancer Society [CAN 2017/522]; Swedish Society of Medicine [SLS-683851]; China Scholarship Council [2011687010]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Society of Medicine; China Scholarship Council(China Scholarship Council)	This work was supported by grants from the Swedish Research Council (2016-03036), the Swedish Cancer Society (CAN 2017/522 to A.-K.O.), and from the Swedish Society of Medicine to (SLS-683851 to J.C.), and from the China Scholarship Council (2011687010 to Y.Z.). The authors declare no conflicts of interest.	Allen DL, 2010, AM J PHYSIOL-REG I, V298, pR198, DOI 10.1152/ajpregu.00325.2009; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Cedervall J., 2012, TUMOR ANGIOGENESIS, V17, P115, DOI DOI 10.5772/29318; Cedervall J, 2013, ANGIOGENESIS, V16, P889, DOI 10.1007/s10456-013-9363-8; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Cooper JM, 2017, CANCER RES, V77, P5077, DOI 10.1158/0008-5472.CAN-17-0829; Cruz VH, 2018, J CELL COMMUN SIGNAL, V12, P83, DOI 10.1007/s12079-017-0438-y; Czabanka M, 2008, FRONT BIOSCI, V13, P7243, DOI 10.2741/3225; Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109; Deng T, 2014, CANCER RES, V74, P2119, DOI 10.1158/0008-5472.CAN-13-2138; Dovizio M, 2013, MOL PHARMACOL, V84, P25, DOI 10.1124/mol.113.084988; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Eskiocak B, 2017, CANCER DISCOV, V7, P832, DOI 10.1158/2159-8290.CD-16-0955; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Guillem-Llobat P, 2016, ONCOTARGET, V7, P32462, DOI 10.18632/oncotarget.8655; Hamidi A, 2012, J BIOL CHEM, V287, P123, DOI 10.1074/jbc.M111.285122; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lee SE, 2017, ONCOTARGET, V8, P16233, DOI 10.18632/oncotarget.9069; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lin J, 2013, J CELL BIOCHEM, V114, P606, DOI 10.1002/jcb.24398; Lip GYH, 2002, LANCET ONCOL, V3, P27, DOI 10.1016/S1470-2045(01)00619-2; Liu W, 2014, LAB INVEST, V94, P362, DOI 10.1038/labinvest.2013.153; MAKINO H, 1987, INT ARCH ALLER A IMM, V82, P66, DOI 10.1159/000234292; Miyashita T, 2015, J SURG RES, V193, P289, DOI 10.1016/j.jss.2014.07.037; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Olsson AK, 2018, PLATELETS, V29, P569, DOI 10.1080/09537104.2018.1453059; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Pillai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10072; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tang ML, 2017, ONCOTARGET, V8, P97464, DOI 10.18632/oncotarget.22136; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Vu HL, 2014, MOL CANCER RES, V12, P1509, DOI 10.1158/1541-7786.MCR-14-0204; Xiao YC, 2017, J EXP MED, V214, P1493, DOI 10.1084/jem.20161524; Yang KM, 2013, CANCER RES, V73, P6679, DOI 10.1158/0008-5472.CAN-13-0891; Yun SH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9060143; 1988, LAB ANIM, V22, P195	42	12	13	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7822	7832		10.1096/fj.201801936RRR	http://dx.doi.org/10.1096/fj.201801936RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30912981	Bronze			2022-12-28	WOS:000476234700004
J	Mallach, A; Weinert, M; Arthur, J; Gveric, D; Tierney, TS; Alavian, KN				Mallach, Anna; Weinert, Maria; Arthur, Joy; Gveric, Djordje; Tierney, Travis S.; Alavian, Kambiz N.			Post mortem examination of Parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus	FASEB JOURNAL			English	Article						metabolic plasticity; mitochondrial dysfunction; neurodegeneration; neuromodulation	GLUTAMATE EXCITOTOXICITY; OXIDATIVE STRESS; STN-DBS; BIOENERGETICS; DYSFUNCTION; MEDICATION	Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is the most commonly used surgical treatment for Parkinson's disease (PD). The disease-modifying aspects of DBS at a cellular level are not fully understood, and the key question of the effect of DBS on the degeneration of the dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) remains to be answered. A major technical hurdle in determining any neuroprotective effect by DBS is its use in mid- to late-stage patients with PD when a majority of the DA neurons have been lost. In this work, we hypothesized that the long-term clinical benefits of DBS are, at least in part, due to a neuromodulatory effect on the SNpc neurons. These changes would affect cellular energetics and mitochondrial metabolism. We examined the number and volume of mitochondria as well as their vicinity to the DA presynaptic terminals postmortem caudate and putamen of 3 healthy individuals, 4 PD cases, and 3 DBS-treated patients. PD seems to have caused an increase in the mean distance between mitochondria and presynaptic terminals as well as a decrease in mean mitochondrial volume and numbers in DA projections. Although there was no difference in distance between mitochondria and presynaptic terminals of SNpc neurons in PD brains vs. DBS-treated brains, DBS treatment seemed to have inhibited or reversed the reduction in mitochondrial volume and numbers caused by PD. These results suggest enhanced metabolic plasticity leading to neuroprotection in the SNpc as a result of STN-DBS.-Mallach, A., Weinert, M., Arthur, J., Gveric, D., Tierney, T. S., Alavian, K. N. Post mortem examination of Parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus.	[Mallach, Anna; Weinert, Maria; Arthur, Joy; Gveric, Djordje; Tierney, Travis S.; Alavian, Kambiz N.] Imperial Coll, Dept Med, Div Brain Sci, London, England; [Tierney, Travis S.] Nicklaus Childrens Hosp, Dept Neurosurg, Miami, FL USA; [Alavian, Kambiz N.] Yale Univ, Dept Internal Med, Sect Endocrinol, New Haven, CT USA	Imperial College London; Yale University	Alavian, KN (corresponding author), Imperial Coll London, Dept Med, Div Brain Sci, Hammersmith Hosp, E508,DuCane Rd, London W12 0NN, England.	k.alavian@imperial.ac.uk	Alavian, Kambiz N/D-7720-2012; Alavian, Kambiz/O-2831-2017	Weinert, Maria/0000-0001-6187-1000; Alavian, Kambiz/0000-0002-0653-3057; Mallach, Anna/0000-0001-7181-3429	Imperial College London	Imperial College London(General Electric)	The authors thank the Parkinson's UK Brain Bank at Imperial College London for providing post mortem human tissue samples. The authors are grateful to Steven Rothery (Imperial College London) for advice on image analysis and macro writing. The authors also thank Alan King Liu (Imperial College London) for advice on the immunohistochemistry protocol. This study was funded by the Imperial College London funds provided to K.N.A.	Abosch A, 2013, STEREOT FUNCT NEUROS, V91, P1, DOI 10.1159/000343207; Alavian KN, 2012, BRAIN RES, V1446, P1, DOI 10.1016/j.brainres.2012.01.046; Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Ashkan K, 2017, NAT REV NEUROL, V13, P548, DOI 10.1038/nrneurol.2017.105; Beal M Flint, 2007, Novartis Found Symp, V287, P183; BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Charles D, 2014, PARKINSONISM RELAT D, V20, P731, DOI 10.1016/j.parkreldis.2014.03.019; Charles D, 2012, J PARKINSON DIS, V2, P215, DOI 10.3233/JPD-2012-012095; Charles PD, 2008, NAT CLIN PRACT NEURO, V4, P424, DOI 10.1038/ncpneuro0848; Chen YC, 2017, ACTA NEUROL SCAND, V135, P491, DOI 10.1111/ane.12628; Chiken S, 2016, NEUROSCIENTIST, V22, P313, DOI 10.1177/1073858415581986; Chiken S, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00033; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Eijkholt M, 2017, NEUROMODULATION, V20, P411, DOI 10.1111/ner.12608; Filali M, 2004, EXP BRAIN RES, V156, P274, DOI 10.1007/s00221-003-1784-y; Guridi J, 1997, NEUROSURGERY, V41, P1169, DOI 10.1097/00006123-199711000-00029; Guridi J, 2008, NEUROSURGERY, V62, P311, DOI 10.1227/01.neu.0000315998.58022.55; Hacker ML, 2016, J PARKINSON DIS, V6, P125, DOI 10.3233/JPD-150712; Hinerfeld D, 2004, J NEUROCHEM, V88, P657, DOI 10.1046/j.1471-4159.2003.02195.x; Jonas EA, 2017, BIOPHYS J, V112, p180A, DOI 10.1016/j.bpj.2016.11.996; Jonas EA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00355; Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; MARSDEN CD, 1976, LANCET, V1, P292, DOI 10.1016/S0140-6736(76)91416-1; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Millan SH, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/7163801; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Musacchio T, 2017, ANN NEUROL, V81, P825, DOI 10.1002/ana.24947; Nantel J, 2012, PARKINSONISM RELAT D, V18, P285, DOI 10.1016/j.parkreldis.2011.11.005; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Pissadaki EK, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00013; Rodriguez MC, 1998, ANN NEUROL, V44, pS175, DOI 10.1002/ana.410440726; Sankar T, 2011, INT REV NEUROBIOL, V98, P151, DOI 10.1016/B978-0-12-381328-2.00006-7; Tagliati M, 2010, INT J NEUROSCI, V120, P717, DOI 10.3109/00207454.2010.518777; Tierney Travis S, 2013, Front Biosci (Elite Ed), V5, P490; Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137; Wang WZ, 2015, J BIOL CHEM, V290, P168, DOI 10.1074/jbc.M114.617167; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016	43	7	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6957	6961		10.1096/fj.201802628R	http://dx.doi.org/10.1096/fj.201802628R			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30862197	Bronze			2022-12-28	WOS:000476114200023
J	Gao, XT; Gao, SY; Guan, Y; Huang, L; Huang, JL; Lin, L; Liu, Y; Zhao, H; Huang, BJ; Yuan, TY; Liu, Y; Liang, DD; Zhang, YY; Ma, XE; Li, L; Li, J; Zhou, DZ; Shi, D; Xu, L; Chen, YH				Gao, Xueting; Gao, Siyun; Guan, Yi; Huang, Lin; Huang, Jiale; Lin, Li; Liu, Yuan; Zhao, Hong; Huang, Bijun; Yuan, Tianyou; Liu, Yi; Liang, Dandan; Zhang, Yangyang; Ma, Xiue; Li, Li; Li, Jun; Zhou, Daizhan; Shi, Dan; Xu, Liang; Chen, Yi-Han			Toll-like receptor 3 controls QT interval on the electrocardiogram by targeting the degradation of Kv4.2/4.3 channels in the endoplasmic reticulum	FASEB JOURNAL			English	Article						cardiac repolarization; transient outward potassium channel; degradation; ER retention	CURRENT I-TO; QUALITY-CONTROL; HEART-FAILURE; RECOGNITION; ACTIVATION; TLR3; REPOLARIZATION; STIMULATION; CONTRIBUTES; HOMEOSTASIS	TLRs have been proven to be essential mediators for the early innate immune response. Overactivation of TLR-mediated immune signaling promotes deterioration of cardiovascular diseases; however, the role of TLRs in the heart under physiologic conditions remains neglected. Here, we show that Tlr3 deficiency induced the endoplasmic reticulum (ER) retention of Kv4.2/4.3 proteins and consequent degradation via the ubiquitin-proteasome pathway. Knockout of Tlr3 resulted in a prolonged QT interval (the space between the start of the Q wave and the end of the T wave) in mice with no significant signs of inflammation and tissue abnormality in cardiac muscles. Prolongation of action potential duration resulted from the depression of transient outward potassium channel (I-to) currents in Tlr3-deficient ventricular myocytes mirrored the change in QT interval. Mechanistically, we found that Tlr3 was exclusively localized in the ER of cardiomyocytes where it interacted with Kv4.2/4.3 subunits of I-to channel. Thus, our data indicated that TLR3 directly regulates I-to channel protein dynamics to maintain cardiac repolarization, which may implicate a new molecular surveillance system for cardiac electrophysiological homeostasis.Gao, X., Gao, S., Guan, Y., Huang, L., Huang, J., Lin, L., Liu, Y., Zhao, H., Huang, B., Yuan, T., Liu, Y., Liang, D., Zhang, Y., Ma, X., Li, L., Li, J., Zhou, D., Shi, D., Xu, L., Chen, Y.-H. Toll-like receptor 3 controls QT interval on the electrocardiogram by targeting the degradation of Kv4.2/4.3 channels in the endoplasmic reticulum.	[Gao, Xueting; Gao, Siyun; Guan, Yi; Huang, Lin; Huang, Jiale; Lin, Li; Liu, Yuan; Huang, Bijun; Yuan, Tianyou; Liu, Yi; Liang, Dandan; Zhang, Yangyang; Ma, Xiue; Li, Li; Li, Jun; Zhou, Daizhan; Shi, Dan; Xu, Liang; Chen, Yi-Han] East Hosp, Heart Hlth Ctr, Shanghai, Peoples R China; [Gao, Siyun; Guan, Yi; Huang, Jiale; Lin, Li; Yuan, Tianyou; Liu, Yi; Liang, Dandan; Zhang, Yangyang; Ma, Xiue; Li, Jun; Zhou, Daizhan; Shi, Dan; Xu, Liang; Chen, Yi-Han] Minist Educ China, Key Lab Arrhythmias, East Hosp, Shanghai, Peoples R China; [Zhao, Hong] Tongji Hosp, Dept Pediat, Shanghai, Peoples R China; [Li, Jun; Chen, Yi-Han] Tongji Univ, Dept Pathol & Pathophysiol, Sch Med, Shanghai, Peoples R China; [Gao, Xueting; Gao, Siyun; Guan, Yi; Huang, Lin; Huang, Jiale; Lin, Li; Liu, Yuan; Huang, Bijun; Liang, Dandan; Zhang, Yangyang; Ma, Xiue; Li, Li; Li, Jun; Zhou, Daizhan; Shi, Dan; Xu, Liang; Chen, Yi-Han] Tongji Univ, Inst Med Genet, Shanghai, Peoples R China	Ministry of Education, China; Tongji University; Tongji University	Xu, L (corresponding author), Tongji Univ, East Hosp, Key Lab Arrhythmias, Minist Educ China,Sch Med, Jimo Rd 150, Shanghai 200120, Peoples R China.; Chen, YH (corresponding author), Tongji Univ, East Hosp, Heart Hlth Ctr, Sch Med, Jimo Rd 150, Shanghai 200120, Peoples R China.	xuliang_east@126.com; yihanchen@tongji.edu.cn	zhang, yangyang/GZG-7467-2022; Chen, Yi/HIR-2608-2022	Li, Li/0000-0003-0524-7515	Key Program of National Natural Science Foundation of China [81530017]; National Innovative Research Groups Program of the National Natural Science Foundation of China [81521061]; National Natural Science Foundation of China [81770397, 81670360, 81500252, 81770267, 81670295]; Outstanding Young Talent Training Program of Shanghai Municipal Commission of Health and Family Planning [2017YQ045]; Fundamental Research Funds for the Central Universities; National Key Research and Development Program [2018YFC1312504]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Innovative Research Groups Program of the National Natural Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Talent Training Program of Shanghai Municipal Commission of Health and Family Planning; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Research and Development Program	This work was funded by the Key Program of National Natural Science Foundation of China (81530017 to Y.-H.C.), the National Innovative Research Groups Program of the National Natural Science Foundation of China (81521061 to Y.-H.C.), the General Program of the National Natural Science Foundation of China (81770397 to Y.-H.C.; 81670360 to J.L.; 81500252 and 81770267 to D.L.; 81670295 to L.L.), the Outstanding Young Talent Training Program of Shanghai Municipal Commission of Health and Family Planning (2017YQ045 to D.L.), the Fundamental Research Funds for the Central Universities to Y.-H.C. and D.L., and the National Key Research and Development Program (2018YFC1312504 to L.X.). The authors declare no conflicts of interest.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Esmail S, 2016, J CELL BIOCHEM, V117, P2757, DOI 10.1002/jcb.25574; Farkas D, 2019, AM J RESP CRIT CARE, V199, P199, DOI 10.1164/rccm.201707-1370OC; Figarella-Branger D, 2003, MUSCLE NERVE, V28, P659, DOI 10.1002/mus.10462; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Gao M, 2012, CRIT CARE MED, V40, P2390, DOI 10.1097/CCM.0b013e3182535aeb; Gao T, 2018, J CELL MOL MED, V22, P395, DOI 10.1111/jcmm.13328; Garantziotis S, 2008, ANNU REV MED, V59, P343, DOI 10.1146/annurev.med.59.061206.112455; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Guo WN, 1999, J PHYSIOL-LONDON, V521, P587, DOI 10.1111/j.1469-7793.1999.00587.x; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hodgkinson CP, 2018, STEM CELLS, V36, P1198, DOI 10.1002/stem.2833; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Li J, 2015, CIRC RES, V116, P1655, DOI 10.1161/CIRCRESAHA.116.306287; Lim KH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011247; Liu L, 2015, J CELL MOL MED, V19, P2728, DOI 10.1111/jcmm.12659; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Monnerat-Cahli G, 2014, J MOL CELL CARDIOL, V76, P116, DOI 10.1016/j.yjmcc.2014.08.012; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Panama BK, 2016, J BIOL CHEM, V291, P4156, DOI 10.1074/jbc.M115.694984; Panama BK, 2011, CIRC RES, V108, P537, DOI 10.1161/CIRCRESAHA.110.229112; Ramnath D, 2017, SEMIN CELL DEV BIOL, V61, P22, DOI 10.1016/j.semcdb.2016.08.014; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Roth GM, 2014, JOVE-J VIS EXP, DOI 10.3791/51109; Saito T, 2009, CIRC RES, V105, P343, DOI 10.1161/CIRCRESAHA.108.190041; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Tian J, 2013, CARDIOVASC RES, V98, P391, DOI 10.1093/cvr/cvt047; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Wang XH, 2018, CELL DEATH DIFFER, V25, P966, DOI 10.1038/s41418-017-0036-9; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xu L, 2015, J MOL CELL BIOL, V7, P476, DOI 10.1093/jmcb/mjv054; Yang X, 2006, AM J PHYSIOL-HEART C, V291, pH2334, DOI 10.1152/ajpheart.00252.2006; Yin Q, 2015, ANNU REV IMMUNOL, V33, P393, DOI 10.1146/annurev-immunol-032414-112258	50	3	3	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6197	6208		10.1096/fj.201801464R	http://dx.doi.org/10.1096/fj.201801464R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30758987	Bronze			2022-12-28	WOS:000466932600032
J	Xiang, YX; Wei, XB; Du, PC; Zhao, H; Liu, AC; Chen, YG				Xiang, Yanxiao; Wei, Xinbing; Du, Pengchao; Zhao, Hua; Liu, Anchang; Chen, Yuguo			beta-Arrestin-2-ERK1/2 cPLA(2) axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain	FASEB JOURNAL			English	Article						stroke; ischemic injury; neuroinflammation; -arrestin-2; PGE(2)	INFLAMMATORY RESPONSE; PHOSPHOLIPASE A(2); BETA-ARRESTINS; NADPH OXIDASE; ACTIVATION; EXPRESSION; STROKE; GENERATION; RECEPTORS; RELEASE	LPS has been shown to elicit neuroinflammation associated with the up-regulation of the eicosanoid pathway in animal models; however, the regulatory mechanisms of TLR4 in brain neuroinflammatory conditions remain elusive. -Arrestins are key regulators of the GPCR signaling pathway and are involved in the leukotriene B4-induced leukocyte migration to initiate inflammatory response. However, the roles of -arrestins in eicosanoid regulation and related diseases are not clear. To address this issue, we conducted a study to investigate the effect of TLR4 on the eicosanoid pathway in ischemic stroke brain and to explore the underlying molecular regulation mechanism. Cerebral ischemia was produced by occlusion of the middle cerebral artery, followed by reperfusion for 24 h. We demonstrated that knockout of TLR4 improves ischemic stroke brain associated with eicosanoid down-regulation. Interestingly, genetic disruption of -arrestin-2 failed to decrease neuroinflammation in the damaged brain of TLR4(-/-) mice, which indicates the requirement of -arrestin-2 for TLR4 knockdown protection. Further study showed that the negative regulation of phosphorylated (phospho-)ERK1/2 and phospho-cytosolic phospholipase A(2) (cPLA(2)) by TLR4 deficiency was eliminated by genetic disruption of -arrestin-2. In addition, -arrestin-2 deficiency reversed the reduction of colocalization of phospho-ERK1/2 with phospho-cPLA(2) in TLR4(-/-) mice following ischemic stroke. Mechanistic studies indicated that -arrestin-2 specifically colocalized and associated with ERK1/2 to prevent ERK1/2-dependent cPLA(2) activation following ischemic injury, and -arrestin-2 deficiency blocked the negative regulation of phospho-ERK1/2, revived the association of phospho-ERK1/2 with phospho-cPLA(2), and subsequently increased the prostaglandin E2 and thromboxane A2 production remarkably. Our findings may provide novel insights that -arrestin-2 is responsible for ischemic brain improvement in TLR4(-/-) mice via negative regulation of eicosanoid production.Xiang, Y., Wei, X., Du, P., Zhao, H., Liu, A., Chen, Y. -Arrestin-2-ERK1/2 cPLA(2) axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain.	[Xiang, Yanxiao; Liu, Anchang] Shandong Univ, Inst Emergency & Crit Care Med, Dept Pharm, Jinan, Shandong, Peoples R China; [Xiang, Yanxiao; Chen, Yuguo] Shandong Univ, Inst Emergency & Crit Care Med, Dept Emergency Med, Jinan, Shandong, Peoples R China; [Zhao, Hua] Shandong Univ, Inst Emergency & Crit Care Med, Dept Orthoped, Jinan, Shandong, Peoples R China; [Chen, Yuguo] Shandong Univ, Inst Emergency & Crit Care Med, Clin Res Ctr Emergency & Crit Care Med Shandng Pr, Jinan, Shandong, Peoples R China; [Chen, Yuguo] Shandong Univ, Qilu Hosp, Key Lab Emergency & Crit Care Med Shandong Prov, Key Lab Cardiopulm Cerebral Resuscitat Shandong P, Jinan, Shandong, Peoples R China; [Chen, Yuguo] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res,State &, Chinese Minist Educ,Chinese Minist Hlth,Chinese A, Jinan, Shandong, Peoples R China; [Wei, Xinbing] Shandong Univ, Dept Pharmacol, Sch Med, Jinan, Shandong, Peoples R China; [Du, Pengchao] Binzhou Med Univ, Coll Basic Med, Yantai, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Binzhou Medical University	Xiang, YX; Liu, AC (corresponding author), Shandong Univ, Qilu Hosp, Dept Pharm, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.; Xiang, YX; Chen, YG (corresponding author), Shandong Univ, Qilu Hosp, Dept Emergency Med, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.; Xiang, YX; Chen, YG (corresponding author), Shandong Univ, Qilu Hosp, Chest Pain Ctr, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.	11xiaoxiao23@163.com; anchang.liu@gmail.com; chen919085@sdu.edu.cn			National Science Foundation of China [81503061, 81601067, 81500557, 81570401, 81772036, 81571934, 81671952]; China Postdoctoral Science Foundation [2018M630784]; Taishan Young Scholar Program of Shandong Province [tsqn20161065]; Key Research and Development Program of Shandong Province [2016GSF201235, 2016ZDJS07A14, 2018GSF118003]; Fundamental Research Funds of Shandong University [2014QLKY04]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Taishan Young Scholar Program of Shandong Province; Key Research and Development Program of Shandong Province; Fundamental Research Funds of Shandong University	This study was supported by the National Science Foundation of China (81503061, 81601067, 81500557, 81570401, 81772036, 81571934, and 81671952), the China Postdoctoral Science Foundation(2018M630784), the Taishan Young Scholar Program of Shandong Province (tsqn20161065), the Key Research and Development Program of Shandong Province (2016GSF201235, 2016ZDJS07A14, and 2018GSF118003), and the Fundamental Research Funds of Shandong University (2014QLKY04). The authors declare no conflicts of interest.	Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; Capra V, 2013, MED RES REV, V33, P364, DOI 10.1002/med.21251; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Diegelmann J, 2012, J BIOL CHEM, V287, P286, DOI 10.1074/jbc.M111.294355; FAGAN SC, 1986, CLIN EXP PHARMACOL P, V13, P629, DOI 10.1111/j.1440-1681.1986.tb00948.x; Fan HK, 2007, MOL IMMUNOL, V44, P3092, DOI 10.1016/j.molimm.2007.02.009; Jacobs AH, 2012, J CEREBR BLOOD F MET, V32, P1393, DOI 10.1038/jcbfm.2012.53; Jala V. R., 2010, JOVE-J VIS EXP, P2315; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Li XQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0246-3; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lindner SC, 2009, J LEUKOCYTE BIOL, V86, P389, DOI 10.1189/jlb.1008591; Liu HQ, 2015, INT J BIOL SCI, V11, P525, DOI 10.7150/ijbs.10927; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luttrell LM, 2002, J CELL SCI, V115, P455; Lyden P, 2008, NEW ENGL J MED, V359, P1393, DOI 10.1056/NEJMe0806335; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Naini SM, 2016, FASEB J, V30, P1155, DOI 10.1096/fj.15-278416; Nogawa S, 1997, J NEUROSCI, V17, P2746; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Rost NS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002433; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Sugimoto K, 2003, BRAIN RES, V960, P273, DOI 10.1016/S0006-8993(02)03805-2; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Wang ZY, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7191856; Xiang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077909; Yagami T, 2004, NEUROBIOL DIS, V16, P481, DOI 10.1016/j.nbd.2004.04.013; Yagami T, 2014, MOL NEUROBIOL, V49, P863, DOI 10.1007/s12035-013-8565-9; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yokota C, 2004, NEUROSCI LETT, V357, P219, DOI 10.1016/j.neulet.2003.12.109; Zaro-Weber O, 2010, STROKE, V41, P1939, DOI 10.1161/STROKEAHA.110.584029; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	39	2	2	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6584	6595		10.1096/fj.201802020R	http://dx.doi.org/10.1096/fj.201802020R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794438				2022-12-28	WOS:000466932600061
J	Flores, EM; Woeller, CF; Falsetta, ML; Susiarjo, M; Phipps, RP				Flores, E'Lissa M.; Woeller, Collynn F.; Falsetta, Megan L.; Susiarjo, Martha; Phipps, Richard P.			Thy1 (CD90) expression is regulated by DNA methylation during adipogenesis	FASEB JOURNAL			English	Article						3T3-L1; obesity; mesenchymal stem cells; 5-aza-dC; epigenetics	PPAR-GAMMA; STEM-CELLS; OBESITY; PROMOTER; MURINE; OSTEOBLASTOGENESIS; INDUCTION; GENES; BONE	The obesity epidemic is developing into the most costly health problem facing the world. Obesity, characterized by excessive adipogenesis and enlarged adipocytes, promotes morbidities, such as diabetes, cardiovascular disease, and cancer. Regulation of adipogenesis is critical to our understanding of how fat cell formation causes obesity and associated health problems. Thy1 (also called CD90), a widely used stem cell marker, blocks adipogenesis and reduces lipid accumulation. Thy1-knockout mice are prone to diet-induced obesity. Although the importance of Thy1 in adipogenesis and obesity is now evident, how its expression is regulated is not. We hypothesized that DNA methylation has a role in promoting adipogenesis and affects Thy1 expression. Using the methylation inhibitor 5-aza-2-deoxycytidine (5-aza-dC), we investigated whether DNA methylation alters Thy1 expression during adipogenesis in both mouse 3T3-L1 preadipocytes and mouse mesenchymal stem cells. Thy1 protein and mRNA levels were decreased dramatically during adipogenesis. However, 5-aza-dC treatment prevented that phenomenon. Methylation-sensitive pyrosequencing analysis showed that CpG sites at the Thy1 locus have increased methylation during adipogenesis, as well as increased methylation in adipose tissue from diet-induced obese mice. These new findings highlight the potential role of Thy1 and DNA methylation in adipogenesis and obesity.Flores, E. M., Woeller, C. F., Falsetta, M. L., Susiarjo, M., Phipps, R. P. Thy1 (CD90) expression is regulated by DNA methylation during adipogenesis.	[Flores, E'Lissa M.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Clin & Translat Sci Inst, Rochester, NY USA; [Woeller, Collynn F.; Falsetta, Megan L.; Susiarjo, Martha; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA; [Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Woeller, CF (corresponding author), Univ Rochester, Dept Environm Med, 601 Elmwood Ave,Box 850,Room 3-11001, Rochester, NY 14642 USA.	collynn_woeller@urmc.rochester.edu	Falsetta, Megan L./AAE-1586-2020; Woeller, Collynn/U-3877-2019	Woeller, Collynn/0000-0001-7197-5057	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [F31ES027767, ES001247, ES0023032]; NIH National Heart, Lung, and Blood Institute [HL133761]; University of Rochester Clinical and Translational Science Award from the NIH [TL1-TR000096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, F31ES027767] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Rochester Clinical and Translational Science Award from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Stephen Pollock (University of Rochester Medical Center) for assisting with figure preparation for the manuscript. This project is funded by U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grants F31ES027767 (to E.F.), ES001247, and ES0023032; NIH National Heart, Lung, and Blood Institute Grant HL133761; and University of Rochester Clinical and Translational Science Award TL1-TR000096 from the NIH. The authors declare no conflicts of interest.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Alipour R, 2010, INT J PREVENTIVE MED, V1, P164; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bearden RN, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0639-6; Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103; Broholm C, 2016, EPIGENOMICS-UK, V8, P1601, DOI 10.2217/epi-2016-0077; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chen YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25283; Chung MT, 2013, TISSUE ENG PT A, V19, P989, DOI [10.1089/ten.tea.2012.0370, 10.1089/ten.TEA.2012.0370]; Du JJ, 2016, BIOCHEM BIOPH RES CO, V475, P140, DOI 10.1016/j.bbrc.2016.05.057; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; GIGUERE V, 1985, EMBO J, V4, P2017, DOI 10.1002/j.1460-2075.1985.tb03886.x; GUNDERSEN G, 1992, GENE, V113, P207, DOI 10.1016/0378-1119(92)90397-8; Guo W, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.378; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hansen TC, 2017, PLAST RECONSTR SURG, V140, P316, DOI 10.1097/PRS.0000000000003542; He JT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079; Jing K, 2009, BBA-MOL CELL BIOL L, V1791, P816, DOI 10.1016/j.bbalip.2009.04.010; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; John E, 2012, NUCLEIC ACIDS RES, V40, P4446, DOI 10.1093/nar/gks025; Kasaai B, 2012, J HISTOCHEM CYTOCHEM, V60, P219, DOI 10.1369/0022155411432010; Keller M, 2017, MOL METAB, V6, P86, DOI 10.1016/j.molmet.2016.11.003; Kim CY, 2012, BIOCHEM BIOPH RES CO, V426, P551, DOI 10.1016/j.bbrc.2012.08.125; KOLSTO AB, 1986, NUCLEIC ACIDS RES, V14, P9667; Kumar A, 2012, ENDOCRINOLOGY, V153, P254, DOI 10.1210/en.2011-1169; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Lehmann GM, 2010, AM J PHYSIOL-CELL PH, V299, pC672, DOI 10.1152/ajpcell.00451.2009; Li MH, 2015, BIOL CHEM, V396, P235, DOI 10.1515/hsz-2014-0241; Liang XW, 2016, J PHYSIOL-LONDON, V594, P4453, DOI 10.1113/JP272123; Lim YC, 2016, MOL METAB, V5, P1033, DOI 10.1016/j.molmet.2016.08.006; MANN V, 1986, INT J CANCER, V37, P781, DOI 10.1002/ijc.2910370521; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Neveu WA, 2015, AM J PHYSIOL-CELL PH, V309, pC616, DOI 10.1152/ajpcell.00086.2015; Noer A, 2006, MOL BIOL CELL, V17, P3543, DOI 10.1091/mbc.E06-04-0322; Onate B, 2012, FASEB J, V26, P4327, DOI 10.1096/fj.12-207217; Orbay H, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/461718; Paine A, 2018, FASEB J, V32, P3174, DOI 10.1096/fj.201701379R; Parry PV, 2012, NEUROSURGERY, V70, pN23, DOI 10.1227/01.neu.0000413227.80467.92; Perri R, 2012, J DENT RES, V91, P33, DOI 10.1177/0022034511425045; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Rudnicki MA, 2015, BONE, V80, P60, DOI 10.1016/j.bone.2015.02.009; Sakamoto H, 2008, BIOCHEM BIOPH RES CO, V366, P360, DOI 10.1016/j.bbrc.2007.11.137; Sanders YY, 2008, AM J RESP CELL MOL, V39, P610, DOI 10.1165/rcmb.2007-0322OC; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; SPANOPOULOU E, 1991, MOL CELL BIOL, V11, P2216, DOI 10.1128/MCB.11.4.2216; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Volberg V, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-016-0365-4; Woeller CF, 2017, TOXICOL SCI, V157, P305, DOI 10.1093/toxsci/kfx046; Woeller CF, 2015, FASEB J, V29, P920, DOI 10.1096/fj.14-257121; Xu S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105940; Yang XS, 2016, MOL ENDOCRINOL, V30, P677, DOI 10.1210/me.2015-1135; Yin XH, 2015, EXP CELL RES, V335, P107, DOI 10.1016/j.yexcr.2015.04.020; Zhao QH, 2013, FEBS J, V280, P5801, DOI 10.1111/febs.12500	61	8	8	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3353	3363		10.1096/fj.201801481R	http://dx.doi.org/10.1096/fj.201801481R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30376360	Green Published, Green Submitted			2022-12-28	WOS:000459794800023
J	Xu, X; Pan, J; Li, HL; Li, XZ; Fang, F; Wu, DK; Zhou, Y; Zheng, PL; Xiong, L; Zhang, DS				Xu, Xuan; Pan, Jian; Li, Huiling; Li, Xiaozhou; Fang, Fang; Wu, Dengke; Zhou, Yu; Zheng, Peiling; Xiong, Li; Zhang, Dongshan			Atg7 mediates renal tubular cell apoptosis in vancomycin nephrotoxicity through activation of PKC-	FASEB JOURNAL			English	Article						vancomycin; autophagy; apoptosis; ERK1; 2; mTOR	AUTOPHAGY PROTECTS; KIDNEY INJURY; PATHWAY; MODELS; HEALTH; P53	Recent studies have shown that autophagy exhibits a renoprotective role in various models of acute kidney injury (AKI). However, its role in vancomycin (Van)-induced AKI remains largely unclarified. This study was the first to indicate that autophagy was rapidly activated in both human kidney-2 cells and renal tissues, and mammalian target of rapamycin (mTOR) was inactivated via the suppression of ERK1/2 and mTOR during Van treatment. Interestingly, for both in vitro and in vivo experiments, the suppression of autophagy via chloroquine and PT-Atg7-KO significantly ameliorated Van-induced kidney injury and renal tubular cell apoptosis. Global gene expression analysis indicated that the expression levels of 6159 genes were induced by Van treatment in the kidney cortical tissues of PT-Atg7 wild-type mice, and 18 of them were notably suppressed in PT-Atg7-KO mice. These 18 genes were further classified as programmed cell death, protein binding, signal transduction, E3 ubiquitin ligase, nucleoside diphosphate kinase activity, and E1-like activating enzyme. Unexpectedly, following Van treatment, PKC- expression was found to be highest among the 4 genes related to cell death, which was remarkably suppressed in vitro and in PT-Atg7-KO mice. In addition, Atg7 could induce renal cell apoptosis during Van treatment via binding to PKC-. Likewise, the inhibition of PKC ameliorated Van-induced apoptosis in human kidney-2 cells and kidney tissues. Furthermore, the data showed that PT-Atg7-KO exerted a renoprotective effect against Van-induced nephrotoxicity, but this effect was lost after injection with myc-tagged PKC. Taken altogether, these results indicate that Van induces autophagy by suppressing the activation of the ERK1/2 and mTOR signaling pathway. In addition, Atg7 mediates Van-induced AKI through the activation of PKC. In sum, autophagy inhibition may serve as a novel therapeutic target for treating nephrotoxic AKI induced by Van.Xu, X., Pan, J., Li, H., Li, X., Fang, F., Wu, D., Zhou, Y., Zheng, P., Xiong, L., Zhang, D. Atg7 mediates renal tubular cell apoptosis in vancomycin nephrotoxicity through activation of PKC-.	[Xu, Xuan; Pan, Jian; Li, Xiaozhou; Wu, Dengke; Zhou, Yu; Zhang, Dongshan] Cent S Univ, Xiangya Hosp 2, Dept Emergency Med, Renmin Rd, Changsha 410011, Hunan, Peoples R China; [Li, Huiling; Fang, Fang] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Zheng, Peiling] Cent S Univ, Xiangya Hosp 2, Dept Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Xiong, Li] Cent S Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Zhang, DS (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Emergency Med, Renmin Rd, Changsha 410011, Hunan, Peoples R China.	dongshanzhang@csu.edu.cn		, Dongshan/0000-0002-7387-4804	National Natural Science Foundation of China [81870475, 81570646, 81770951, 81500756]; Excellent Youth Foundation of Hu'nan Scientific Committee [2017JJ1035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Hu'nan Scientific Committee	The National Natural Science Foundation of China [Grants 81870475 and 81570646 (to D.Z.), 81770951 (to H.L.) and 81500756 (to F.F.)] and the Excellent Youth Foundation of Hu'nan Scientific Committee (2017JJ1035) supported this work. The authors declare no conflicts of interest.	Chen JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38868; Chien CT, 2007, TRANSPLANTATION, V84, P1183, DOI 10.1097/01.tp.0000287334.38933.e3; Cui J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11256; Hanrahan TP, 2015, ANAESTH INTENS CARE, V43, P594, DOI 10.1177/0310057X1504300507; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He Q, 2016, J MOL ENDOCRINOL, V57, P251, DOI 10.1530/JME-16-0139; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Inoue K, 2010, CLIN EXP NEPHROL, V14, P112, DOI 10.1007/s10157-009-0254-7; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Kaushal GP, 2016, KIDNEY INT, V89, P779, DOI 10.1016/j.kint.2015.11.021; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Leventhal JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150001; Ma ZN, 2016, ONCOTARGET, V7, P66558, DOI 10.18632/oncotarget.11684; Mei SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22171; Meije Y, 2014, J INFECTION, V68, P548, DOI 10.1016/j.jinf.2014.01.001; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Peng JP, 2015, KIDNEY INT, V87, P137, DOI 10.1038/ki.2014.226; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Takabatake Y, 2014, NEPHROL DIAL TRANSPL, V29, P1639, DOI 10.1093/ndt/gft535; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Wang J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.509; Wang ZB, 2014, ANTIOXID REDOX SIGN, V20, P519, DOI 10.1089/ars.2013.5363; Wu D, 2005, J AM SOC NEPHROL, V16, P646, DOI 10.1681/ASN.2004060445; Xu X, 2017, ONCOTARGET, V8, P91577, DOI 10.18632/oncotarget.21244; Yang RH, 2017, SCI REP-UK, V7, DOI 10.1038/srep43409; Zhan XQ, 2014, J NEUROCHEM, V128, P350, DOI 10.1111/jnc.12471; Zhang DS, 2017, AUTOPHAGY, V13, P631, DOI 10.1080/15548627.2016.1269990; Zhang DS, 2017, J AM SOC NEPHROL, V28, P1131, DOI 10.1681/ASN.2016030337; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902; Zhang DS, 2013, J PHARMACOL EXP THER, V345, P69, DOI 10.1124/jpet.112.202481; Zhang YL, 2015, EXP BIOL MED, V240, P1590, DOI 10.1177/1535370215581306	39	27	27	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4513	4524		10.1096/fj.201801515R	http://dx.doi.org/10.1096/fj.201801515R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30589566				2022-12-28	WOS:000459794800112
J	Zhao, F; Wu, WJ; Wei, QW; Shen, M; Li, BJ; Jiang, Y; Liu, KQ; Liu, HL				Zhao, Fang; Wu, Wangjun; Wei, Quanwei; Shen, Ming; Li, Bojiang; Jiang, Yi; Liu, Kaiqing; Liu, Honglin			Exogenous adrenocorticotropic hormone affects genome-wide DNA methylation and transcriptome of corpus luteum in sows	FASEB JOURNAL			English	Article						porcine; epigenetics; transcription	GLUCOSE-HOMEOSTASIS; FEMALE INFERTILITY; INSULIN-RECEPTOR; OVARIAN-FUNCTION; STRESS; ACTH; EXPRESSION; CORTISOL; SGLT2; LH	Stress is known to cause corpus luteum (CL) dysfunction, and stress hormones play a critical role in this process. However, the mechanism remains unclear. In this study, weaned sows were injected with synthetic adrenocorticotropic hormone (ACTH) for 7 d; whole-genome bisulfite sequencing (WGBS) and RNA sequencing was used respectively to investigate the systematic association between ACTH administration and DNA methylation in CL and its relationship to gene expression. Results showed that ACTH treatment significantly increased the concentrations of cortisol (P < 0.05). The genome-wide DNA methylation maps of CL were provided, and the global analysis showed the difference between the 2 groups exists in the chromosomes and feature regions of the genome. A total of 88,559 DMRs were identified and the most DMR-related genes were gathered in terms of metabolic biologic processes, and some DMR-related genes were involved in cellular differentiation. Nine differentially expressed genes were screened out of coexpressed genes and 4 DMR-associated genes that were also differentially expressed (P < 0.05). In summary, our study firstly provides insight into the regulation of ACTH administration on genomic DNA methylation and gene expression in CL. We revealed a remarkable alteration of DNA methylation in CL caused by ACTH treatment, and identified 4 DMR-related genes that may be involved in the CL function under stress conditions.Zhao, F., Wu, W., Wei, Q., Shen, M., Li, B., Jiang, Y., Liu, K., Liu, H. Exogenous adrenocorticotropic hormone affects genome-wide DNA methylation and transcriptome of corpus luteum in sows.	[Zhao, Fang; Wu, Wangjun; Shen, Ming; Li, Bojiang; Jiang, Yi; Liu, Kaiqing; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Anim Genet & Breeding, Nanjing 210095, Jiangsu, Peoples R China; [Wei, Quanwei] Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Anim Reprod, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Anim Genet & Breeding, Nanjing 210095, Jiangsu, Peoples R China.	liuhonglin@njau.edu.cn	Wu, Wangjun/AAA-9684-2019; WEI, QUANWEI/AIF-1424-2022; liu, honglin/HDN-0409-2022	WEI, QUANWEI/0000-0002-8545-2502; liu, honglin/0000-0002-1254-3163	National Key Basic Research Program of China 973 Grant [2014CB138502]; National Natural Science Foundation of China [31601939]	National Key Basic Research Program of China 973 Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China 973 Grant 2014CB138502 (to H.L.) and the National Natural Science Foundation of China Grant 31601939 (to H.L.). The authors declare no conflicts of interest.	Amweg AN, 2011, THERIOGENOLOGY, V75, P628, DOI 10.1016/j.theriogenology.2010.10.003; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Brandt Y, 2009, ANIM REPROD SCI, V110, P172, DOI 10.1016/j.anireprosci.2008.01.008; Brandt Y, 2007, REPROD DOMEST ANIM, V42, P118, DOI 10.1111/j.1439-0531.2006.00698.x; Breker M, 2013, J CELL BIOL, V200, P839, DOI 10.1083/jcb.201301120; Brown WM, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094073; Brussow KP, 2005, J REPROD DEVELOP, V51, P133, DOI 10.1262/jrd.51.133; Chen J, 2012, J NEUROENDOCRINOL, V24, P1055, DOI 10.1111/j.1365-2826.2012.02306.x; Chuang TJ, 2014, MOL BIOL EVOL, V31, P387, DOI 10.1093/molbev/mst208; Dafou D, 2010, NEOPLASIA, V12, P579, DOI 10.1593/neo.10340; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DEMYTTENAERE K, 1994, GYNECOL ENDOCRINOL, V8, P233, DOI 10.3109/09513599409023626; Dickinson RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027792; Einarsson S, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-48; Fernandez-Ruiz I, 2018, NAT REV CARDIOL, V15, P2, DOI 10.1038/nrcardio.2017.198; Guelfi G, 2011, MOL CELL ENDOCRINOL, V339, P63, DOI 10.1016/j.mce.2011.03.017; Duong HT, 2012, J REPROD DEVELOP, V58, P223, DOI 10.1262/jrd.11-122T; Hanson B, 2017, J ASSIST REPROD GEN, V34, P167, DOI 10.1007/s10815-016-0836-8; HORVATH E, 1991, ACTA PHYSIOL HUNG, V78, P69; Houtepen LC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10967; Huisman C, 2015, EPIGENETICS-US, V10, P384, DOI 10.1080/15592294.2015.1034415; Kerdelhue B, 2006, NEUROENDOCRINOL LETT, V27, P114; Komiyama J, 2008, BIOL REPROD, V78, P888, DOI 10.1095/biolreprod.107.065656; Kori M, 2016, SYST BIOL REPROD MED, V62, P266, DOI 10.1080/19396368.2016.1197982; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Kumar Balvinder, 2012, Front Biosci (Elite Ed), V4, P1759; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lay DC, 2011, J ANIM SCI, V89, P1787, DOI 10.2527/jas.2010-3612; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu B, 2017, DIABETES, V66, P689, DOI 10.2337/db16-1104; Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Lynch CD, 2014, HUM REPROD, V29, P1067, DOI 10.1093/humrep/deu032; Malhi PS, 2005, BIOL REPROD, V73, P45, DOI 10.1095/biolreprod.104.038745; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Neuvians TP, 2003, ENDOCRINE, V22, P93, DOI 10.1385/ENDO:22:2:93; Nishimoto H, 2006, J ENDOCRINOL, V188, P111, DOI 10.1677/joe.1.06210; Nishimura R, 2016, REPROD FERT DEVELOP, V28, P1479, DOI 10.1071/RD15010; O'Connor KA, 2011, AM J PHYS ANTHROPOL, V145, P629, DOI 10.1002/ajpa.21538; Richetto J, 2017, BIOL PSYCHIAT, V81, P265, DOI 10.1016/j.biopsych.2016.08.010; Schachtschneider KM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1938-x; Schweiger U, 2012, NERVENARZT, V83, P1442, DOI 10.1007/s00115-012-3662-y; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Suda Y, 2003, YEAST, V20, P995, DOI 10.1002/yea.1008; Tilbrook AJ, 2002, STRESS, V5, P83, DOI 10.1080/10253890290027912; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Viveiros MM, 2000, J ENDOCRINOL, V164, P255, DOI 10.1677/joe.0.1640255; Wang HF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10648-9; Wei QW, 2013, REPRODUCTION, V146, P593, DOI 10.1530/REP-13-0174; Weiss RV, 2014, ARQ BRAS ENDOCRINOL, V58, P144, DOI 10.1590/0004-2730000003021; Xu JW, 2016, ONCOTARGET, V7, P27899, DOI 10.18632/oncotarget.8544; Yang EV, 2000, BIOMED PHARMACOTHER, V54, P245, DOI 10.1016/S0753-3322(00)80066-9; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yuan XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04603-x; Yuan XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22138; Zhang S, 2017, BIOINFORMATICS, V33, P1591, DOI 10.1093/bioinformatics/btx040; Zhao Y, 2016, CELL METAB, V23, P699, DOI 10.1016/j.cmet.2016.02.019; Zhu HS, 2016, REPROD BIOL ENDOCRIN, V14, DOI 10.1186/s12958-016-0214-5	62	5	4	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3264	3278		10.1096/fj.201801081RRR	http://dx.doi.org/10.1096/fj.201801081RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30423262				2022-12-28	WOS:000459794800016
J	Ko, J; Kang, HJ; Kim, DA; Ryu, ES; Yu, M; Lee, H; Lee, HK; Ryu, HM; Park, SH; Kim, YL; Kang, DH				Ko, Jiyeon; Kang, Hyun-Jung; Kim, Dal-Ah; Ryu, Eun-Sun; Yu, Mina; Lee, Huisong; Lee, Hyeon Kook; Ryu, Hye-Myung; Park, Sun-Hee; Kim, Yong-Lim; Kang, Duk-Hee			Paricalcitol attenuates TGF-1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome	FASEB JOURNAL			English	Article						EMT; peritoneal dialysis; peritoneal fibrosis; NADPH oxidase; vitamin D agonist	TO-MESENCHYMAL TRANSITION; VITAMIN-D; TGF-BETA; RENAL INFLAMMATION; ANGIOTENSIN-II; HIGH GLUCOSE; ACTIVATION; DIALYSIS; ALDOSTERONE; MEMBRANE	Phenotype transition of mesothelial cells, such as epithelial-to-mesenchymal transition (EMT), is one of the early mechanisms of peritoneal fibrosis, which is mediated by oxidative stress and inflammation. Nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a multiprotein oligomer that promotes the maturation of IL-1 and IL-18. Paricalcitol is reported to exert an anti-inflammatory effect; however, there are no studies as to whether paricalcitol modulates the activation of NLRP3 inflammasome. We investigated the role of NLRP3 inflammasome in peritoneal EMT with an exploration of the effect of paricalcitol on oxidative stress, NLRP3 inflammasome, and EMT of mesothelial cells. TGF-1-induced EMT in human peritoneal mesothelial cells (HPMCs) was associated with an up-regulation of NLRP3, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), and procaspase-1, with an increased production of IL-1 and IL-18, which was ameliorated by small interfering (si)NLRP3, siASC, caspase inhibitors, or neutralizing antibodies for IL-1 and IL-18. TGF-1 enhanced reactive oxygen species generation with an increase in NADPH oxidase (NOX) activity and mitochondrial NOX4 production. Paricalcitol alleviated TGF-1-induced EMT and the NLRP3 inflammasome, which was associated with a down-regulation of NOX activity by interfering with p47phox and p22phox interaction and mitochondrial NOX4 production in HPMCs. Taken together, paricalcitol ameliorated EMT of HPMCs via modulating an NOX-dependent increase in the activity of NLRP3 inflammasome. Paricalcitol could be a novel approach to protect the peritoneum from the development of EMT and peritoneal fibrosis.Ko, J., Kang, H.-J., Kim, D.-A., Ryu, E.-S., Yu, M., Lee, H., Lee, H. K., Ryu, H.-M., Park, S.-H., Kim, Y.-L., Kang, D.-H. Paricalcitol attenuates TGF-1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.	[Ko, Jiyeon; Kang, Hyun-Jung; Kim, Dal-Ah; Ryu, Eun-Sun; Kang, Duk-Hee] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Lee, Huisong; Lee, Hyeon Kook] Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Dept Surg, Seoul, South Korea; [Yu, Mina] Seonam Hosp, Dept Internal Med, Seoul, South Korea; [Ryu, Hye-Myung; Park, Sun-Hee; Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Nephrol, Daegu, South Korea	Ewha Womans University; Ewha Womans University; Kyungpook National University	Kang, DH (corresponding author), Ewha Womans Univ, Coll Med, Ewha Med Res Ctr, Div Nephrol,Dept Internal Med, 911 Mok Dong, Seoul 158710, South Korea.	dhkang@ewha.ac.kr	Park, Sun/GSD-9620-2022		Korean Health Technology Research and Development Project (Ministry of Health and Welfare, Republic of Korea) [HI12C0050, HI15C0001, HC15C1129]; National Research Foundation of Korea (NRF) - Korean government [Ministry of Science and Information and Communications Technology (MSIT)] [NRF-2015R1A2A1A15053374, NRF-2017R1A2B2005849]; Ewha Womans University	Korean Health Technology Research and Development Project (Ministry of Health and Welfare, Republic of Korea); National Research Foundation of Korea (NRF) - Korean government [Ministry of Science and Information and Communications Technology (MSIT)]; Ewha Womans University	This work was supported by the Korean Health Technology Research and Development Project (Ministry of Health and Welfare, Republic of Korea Grants HI12C0050, HI15C0001, and HC15C1129); a National Research Foundation of Korea (NRF) grant funded by the Korean government [Ministry of Science and Information and Communications Technology (MSIT); NRF-2015R1A2A1A15053374 and NRF-2017R1A2B2005849]; and the Ewha Womans University Research Grant of 2016. The authors declare no conflicts of interest.	Ari E, 2012, BRIT J RADIOL, V85, P1038, DOI 10.1259/bjr/16327485; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Brown KD, 2017, INVEST OPHTH VIS SCI, V58, P3011, DOI 10.1167/iovs.16-20633; Cho YJ, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/909373; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; Gonzalez-Mateo GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108477; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guo JL, 2013, ARCH TOXICOL, V87, P1963, DOI 10.1007/s00204-013-1063-z; He T, 2015, MOL CELL ENDOCRINOL, V402, P13, DOI 10.1016/j.mce.2014.12.010; Hiraga R, 2013, ANTICANCER RES, V33, P4431; Jang YH, 2013, LAB INVEST, V93, P194, DOI 10.1038/labinvest.2012.166; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang SH, 2014, NEPHRON EXP NEPHROL, V126, P1, DOI 10.1159/000357156; Kim SH, 2012, LAB INVEST, V92, P488, DOI 10.1038/labinvest.2011.194; Lee JW, 2014, BIOCHEM BIOPH RES CO, V444, P121, DOI 10.1016/j.bbrc.2014.01.005; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Li YJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-87; Liang H, 2018, BIOMED PHARMACOTHER, V106, P879, DOI 10.1016/j.biopha.2018.07.031; Liu WC, 2016, CLIN CHIM ACTA, V453, P1, DOI 10.1016/j.cca.2015.11.029; Lopez-Cabrera M, 2014, ADV MED, V2014; Lorenz G, 2014, NEPHROL DIAL TRANSPL, V29, P41, DOI 10.1093/ndt/gft332; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Noh H, 2006, KIDNEY INT, V69, P2022, DOI 10.1038/sj.ki.5001506; Panizo S, 2013, NEPHROL DIAL TRANSPL, V28, P2735, DOI 10.1093/ndt/gft268; Park JW, 2010, AM J PHYSIOL-RENAL, V298, pF301, DOI 10.1152/ajprenal.00471.2009; Patel P, 2010, KIDNEY INT, V77, P319, DOI 10.1038/ki.2009.436; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Sahin I, 2014, EUR REV MED PHARMACO, V18, P2895; Sanchez-Nino MD, 2012, AM J PHYSIOL-RENAL, V302, pF647, DOI 10.1152/ajprenal.00090.2011; Segovia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029695; Shin HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05836-6; Shin HS, 2015, LAB INVEST, V95, P1157, DOI 10.1038/labinvest.2015.91; Stavenuiter A.W., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/468574266053304641933; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520; Gonzalez-Mateo GT, 2012, NEPHROL DIAL TRANSPL, V27, P478, DOI 10.1093/ndt/gfr543; Tobar N, 2010, BRIT J CANCER, V103, P1040, DOI 10.1038/sj.bjc.6605847; Wang AYM, 2011, SEMIN NEPHROL, V31, P159, DOI 10.1016/j.semnephrol.2011.01.005; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Wu J, 2016, EXP CELL RES, V341, P42, DOI 10.1016/j.yexcr.2016.01.014; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Yu MA, 2009, J AM SOC NEPHROL, V20, P567, DOI 10.1681/ASN.2008040424; Yu M, 2015, KIDNEY RES CLIN PRAC, V34, P83, DOI 10.1016/j.krcp.2015.03.005; Zhang LL, 2016, FREE RADICAL BIO MED, V97, P531, DOI 10.1016/j.freeradbiomed.2016.07.014; 이상협, 2013, [The Journal of Korea Robotics Society, 로봇학회 논문지], V8, P8, DOI 10.7746/jkros.2013.8.1.008	50	24	24	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3035	3050		10.1096/fj.201800292RR	http://dx.doi.org/10.1096/fj.201800292RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30354670	Bronze			2022-12-28	WOS:000457296600119
J	Le Menn, G; Sibille, B; Murdaca, J; Rousseau, AS; Squillace, R; Vergoni, B; Cormont, M; Niot, I; Grimaldi, PA; Mothe-Satney, I; Neels, JG				Le Menn, Gwenaelle; Sibille, Brigitte; Murdaca, Joseph; Rousseau, Anne-Sophie; Squillace, Raphaelle; Vergoni, Bastien; Cormont, Mireille; Niot, Isabelle; Grimaldi, Paul A.; Mothe-Satney, Isabelle; Neels, Jaap G.			Decrease in alpha beta/gamma T-cell ratio is accompanied by a reduction in high-fat diet-induced weight gain, insulin resistance, and inflammation	FASEB JOURNAL			English	Article						obesity; adipose tissue; immune cells	ADIPOSE-TISSUE; INDUCED OBESITY; ADIPOGENESIS; ACCUMULATION; ACTIVATION; IMMUNITY	The implication of and T cells in obesity-associated inflammation and insulin resistance (IR) remains uncertain. Mice lacking T cells show either no difference or a decrease in high-fat diet (HFD)-induced IR, whereas partial depletion in T cells does not protect from HFD-induced IR. T-cell deficiency leads to a decrease in white adipose tissue (WAT) inflammation and IR without weight change, but partial depletion of these cells has not been studied. We previously described a mouse model overexpressing peroxisome proliferator-activated receptor (PPAR-) specifically in T cells [transgenic (Tg) T-PPAR-] that exhibits a partial depletion in T cells and no change in T-cell number. This results in a decreased / T-cell ratio in lymphoid organs. We now show that Tg T-PPAR- mice are partially protected against HFD-induced weight gain and exhibit decreased IR and liver steatosis independently of animal weight. These mice display an alteration of WAT-depots distribution with an increased epididymal-WAT mass and a decreased subcutaneous WAT mass. Immune cell number is decreased in both WAT-depots, except for T cells, which are increased in epididymal-WAT. Overall, we show that decreasing / T-cell ratio in WAT-depots alters their inflammatory state and mass repartition, which might be involved in improvement of insulin sensitivity.Le Menn, G., Sibille, B., Murdaca, J., Rousseau, A.-S., Squillace, R., Vergoni, B., Cormont, M., Niot, I., Grimaldi, P. A., Mothe-Satney, I., Neels, J. G. Decrease in / T-cell ratio is accompanied by a reduction in high-fat diet-induced weight gain, insulin resistance, and inflammation.	[Le Menn, Gwenaelle; Sibille, Brigitte; Murdaca, Joseph; Rousseau, Anne-Sophie; Squillace, Raphaelle; Vergoni, Bastien; Cormont, Mireille; Grimaldi, Paul A.; Mothe-Satney, Isabelle; Neels, Jaap G.] Univ Cote Azur, INSERM, Ctr Mediterran Med Mol C3M, Nice, France; [Niot, Isabelle] Univ Bourgogne, INSERM, U866, Physiol Nutr & Toxicol NUTox,UMR,AgroSup Dijon, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Neels, JG (corresponding author), Univ Nice Sophia Antipolis, INSERM, Team 9 Metab Challenges Immune Cells Obes Diabet, Mediterranean Ctr Mol Med C3M,Unite 1065, Batiment Univ Archimed,Room M3-109bis, F-06204 Nice 3, France.	jaap.neels@unice.fr	Neels, Jaap G/F-5534-2010; Sibille, Brigitte/Q-8240-2016; MOTHE-SATNEY, ISABELLE/Q-6377-2016	Neels, Jaap G/0000-0002-5900-8395; Sibille, Brigitte/0000-0001-6806-0454; MOTHE-SATNEY, ISABELLE/0000-0002-2693-8385; Le Menn, Gwenaelle/0000-0001-5436-9397; Anne-Sophie, Rousseau/0000-0002-7672-0237; CORMONT, Mireille/0000-0001-6918-2410	INSERM; Universite Cote d'Azur; Fondation pour la Recherche Medicale (FRM) [DRM20101220437]; French National Research Agency (ANR) [ANR-14-CE12-0008-02]; Agence Francaise de Lutte contre le Dopage (AFLD)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Cote d'Azur; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French National Research Agency (ANR)(French National Research Agency (ANR)); Agence Francaise de Lutte contre le Dopage (AFLD)	The authors thank Veronique Corcelle and the INSERM Unite 1065 Animal Facility staff for their excellent care of mice. Image acquisition and image analysis were performed on the Centre Mediterraneen de Medecine Moleculaire (C3M) Imaging Core Facility [part of Microscopy and Imaging Platform Cote d'Azur (MICA)] with the help of Maeva Gesson. The authors thank Giulia Chinetti and Philippe Gual [Universite Cote d'Azur, Centre Hospitalier Universitaire (CHU), INSERM, C3M) for critical reading of the manuscript and scientific discussions, respectively. This work was financially supported by INSERM, the Universite Cote d'Azur, the Fondation pour la Recherche Medicale (FRM; Grant DRM20101220437), the French National Research Agency (ANR; No ANR-14-CE12-0008-02), and the Agence Francaise de Lutte contre le Dopage (AFLD). The authors declare no conflicts of interest.	Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hur KY, 2015, DIABETES METAB J, V39, P198, DOI 10.4093/dmj.2015.39.3.198; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jeffery E, 2016, CELL METAB, V24, P142, DOI 10.1016/j.cmet.2016.05.012; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Khan IM, 2014, ATHEROSCLEROSIS, V233, P419, DOI 10.1016/j.atherosclerosis.2014.01.011; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Le Thuc O, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00197; Liang XB, 2006, AM J PHYSIOL-ENDOC M, V290, pE103, DOI 10.1152/ajpendo.00605.2004; McLaughlin T, 2017, J CLIN INVEST, V127, P5, DOI 10.1172/JCI88876; Mehta P, 2015, J LEUKOCYTE BIOL, V97, P121, DOI 10.1189/jlb.3A0414-211RR; Montes VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067709; Mothe-Satney I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34317; Paul S, 2014, INT REV IMMUNOL, V33, P537, DOI 10.3109/08830185.2013.863306; Shin JH, 2009, BIOCHEM PHARMACOL, V77, P1835, DOI 10.1016/j.bcp.2009.03.008; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Yan LN, 2016, PHARM RES-DORDR, V33, P395, DOI 10.1007/s11095-015-1797-9; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	22	6	6	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2553	2562		10.1096/fj.201800696RR	http://dx.doi.org/10.1096/fj.201800696RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30285581	Green Submitted			2022-12-28	WOS:000457296600081
J	Michelsen, TM; Henriksen, T; Reinhold, D; Powell, TL; Jansson, T				Michelsen, Trond M.; Henriksen, Tore; Reinhold, Dominik; Powell, Theresa L.; Jansson, Thomas			The human placental proteome secreted into the maternal and fetal circulations in normal pregnancy based on 4-vessel sampling	FASEB JOURNAL			English	Article						placental physiology; proteomics; trophoblast; pregnancy proteins	GROWTH-FACTOR; GENE-EXPRESSION; PREECLAMPSIA; RAT; DIFFERENTIATION; TROPHOBLAST; RECEPTORS; SEROTONIN; DISCOVERY; HORMONE	We sought to identify proteins secreted by the human placenta into the maternal and fetal circulations. Blood samples from the maternal radial artery and uterine vein and umbilical artery and vein were obtained during cesarean section in 35 healthy women with term pregnancy. Slow off-rate modified aptamer (SOMA) protein-binding technology was used to quantify 1310 known proteins. The uteroplacental and umbilical venoarterial concentration differences were calculated. Thirty-four proteins were significantly secreted by the placenta into the maternal circulation, including placental growth factor, growth/differentiation factor 15, and matrix metalloproteinase 12. There were 341 proteins significantly secreted by the placenta into the fetal circulation. Only 7 proteins were secreted into both the fetal and maternal circulations, suggesting a distinct directionality in placental protein release. We examined changes across gestation in the proteins found to be significantly secreted by the placenta into the maternal circulation using serial blood samples from healthy women. Among the 34 proteins secreted into the maternal circulation, 8 changed significantly across gestation. The identified profiles of secreted placental proteins will allow us to identify novel minimally invasive biomarkers for human placental function across gestation and discover previously unknown proteins secreted by the human placenta that regulate maternal physiology and fetal development.Michelsen, T. M., Henriksen, T., Reinhold, D., Powell, T. L., Jansson, T. The human placental proteome secreted into the maternal and fetal circulations in normal pregnancy based on 4-vessel sampling.	[Michelsen, Trond M.; Jansson, Thomas] Univ Colorado, Dept Obstet & Gynecol, Div Reprod Sci, Anschutz Med Campus, Aurora, CO USA; [Powell, Theresa L.] Univ Colorado, Dept Pediat, Div Neonatol, Anschutz Med Campus, Aurora, CO USA; [Michelsen, Trond M.; Henriksen, Tore] Oslo Univ Hosp, Dept Obstet, Rikshosp, Div Obstet & Gynecol, Sognsvannsveien 20, N-0424 Oslo, Norway; [Reinhold, Dominik] PPD, Wilmington, NC USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oslo; National Hospital Norway	Michelsen, TM (corresponding author), Oslo Univ Hosp, Dept Obstet, Rikshosp, Div Obstet & Gynecol, Sognsvannsveien 20, N-0424 Oslo, Norway.	trmi1@ous-hf.no	Powell, Theresa/AAE-4249-2020		South-Eastern Norway Regional Health Authority	South-Eastern Norway Regional Health Authority	T.M.M. received a research grant from The South-Eastern Norway Regional Health Authority. The funders had no role in designing the study, analyzing the data, writing the paper or the decision to publish the paper. The authors declare no conflicts of interest.	Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Alsat E, 1998, MOL CELL ENDOCRINOL, V140, P121, DOI 10.1016/S0303-7207(98)00040-9; Alsat E, 1997, AM J OBSTET GYNECOL, V177, P1526, DOI 10.1016/S0002-9378(97)70103-0; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2017, TISS ATL; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Burton GJ, 2009, REPRODUCTION, V138, P895, DOI 10.1530/REP-09-0092; Clark DE, 1996, HUM REPROD, V11, P1090; Cole LA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-24; Conde-Agudelo A, 2013, BJOG-INT J OBSTET GY, V120, P681, DOI 10.1111/1471-0528.12172; Costa MA, 2016, REPROD BIOMED ONLINE, V32, P14, DOI 10.1016/j.rbmo.2015.10.005; De Falco M, 2007, PLACENTA, V28, P118, DOI 10.1016/j.placenta.2006.03.010; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Ganz P, 2016, JAMA-J AM MED ASSOC, V315, P2532, DOI 10.1001/jama.2016.5951; Goeden N, 2016, J NEUROSCI, V36, P6041, DOI 10.1523/JNEUROSCI.2534-15.2016; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Haider S, 2016, P NATL ACAD SCI USA, V113, pE7710, DOI 10.1073/pnas.1612335113; Handwerger S, 2000, J PEDIATR ENDOCR MET, V13, P343, DOI 10.1515/JPEM.2000.13.4.343; Harris LK, 2010, AM J PATHOL, V177, P2103, DOI 10.2353/ajpath.2010.100182; Hathout Y, 2015, P NATL ACAD SCI USA, V112, P7153, DOI 10.1073/pnas.1507719112; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Hewitt DP, 2006, BIOL REPROD, V75, P75, DOI 10.1095/biolreprod.105.047647; Holm MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185760; Holme AM, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.07.056; Ishii H, 2001, CIRC RES, V89, P1240, DOI 10.1161/hh2401.101066; Jung JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044572; Leguy MC, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-129; Lowe WL, 2014, DIABETIC MED, V31, P254, DOI 10.1111/dme.12352; Lynch AM, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.001; Major HD, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.024; Michelsen TM, 2017, PLACENTA, V59, pS26, DOI 10.1016/j.placenta.2017.03.014; Mifsud W, 2014, FETAL DIAGN THER, V36, P117, DOI 10.1159/000359969; Mitchell MD, 2015, AM J OBSTET GYNECOL, V213, pS173, DOI 10.1016/j.ajog.2015.07.001; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Muyan M, 1997, PLACENTA, V18, P237, DOI 10.1016/S0143-4004(97)80056-2; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Romero R., 2017, AM J OBSTET GYNECOL, V217, P67; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Rosario FJ, 2011, ENDOCRINOLOGY, V152, P1119, DOI 10.1210/en.2010-1153; SASAKI A, 1987, J CLIN ENDOCR METAB, V64, P224, DOI 10.1210/jcem-64-2-224; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Shillingford JM, 2002, MOL ENDOCRINOL, V16, P563, DOI 10.1210/me.16.3.563; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Sircar M, 2015, CURR OPIN NEPHROL HY, V24, P131, DOI 10.1097/MNH.0000000000000105; Sugulle M, 2009, HYPERTENSION, V54, P106, DOI 10.1161/HYPERTENSIONAHA.109.130583; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tanaka Y, 2007, BRAIN RES, V1165, P135, DOI 10.1016/j.brainres.2007.06.039; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang A, 2015, J CLIN INVEST, V125, P4021, DOI 10.1172/JCI80457; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xin H, 2012, THROMB RES, V129, P563, DOI 10.1016/j.thromres.2011.07.039; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	56	13	14	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2944	2956		10.1096/fj.201801193R	http://dx.doi.org/10.1096/fj.201801193R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30335547	Bronze			2022-12-28	WOS:000457296600112
J	Palygin, O; Miller, BS; Nishijima, Y; Zhang, DX; Staruschenko, A; Sorokin, A				Palygin, Oleg; Miller, Bradley S.; Nishijima, Yoshinori; Zhang, David X.; Staruschenko, Alexander; Sorokin, Andrey			Endothelin receptor A and p66Shc regulate spontaneous Ca2+ oscillations in smooth muscle cells controlling renal arterial spontaneous motion	FASEB JOURNAL			English	Article						calcium; ET-1; vasomotion; vascular tone; endothelium; cell signaling	VASOMOTOR RESPONSES; OXIDATIVE STRESS; LIFE-SPAN; P66(SHC); PROTEIN; HYPERTENSION; MECHANISMS; PHYSIOLOGY; PHOSPHORYLATION; AUTOREGULATION	Adaptor protein p66Shc is overexpressed in smooth muscle cells of renal resistance vessels of hypertensive salt-sensitive rats and is involved in the regulation of renal vascular tone. We applied 2-photon laser scanning fluorescence microscopy to analyze spontaneous dynamic fluctuations in intracellular calcium concentrations ([Ca2+](i)) in smooth muscle cells embedded in the walls of freshly isolated renal resistance arteries. The amplitude, number of events, and frequency of spontaneous [Ca2+](i) oscillations triggered by endogenously released endothelin-1 were recorded in smooth muscle cells of the renal arteries. Endothelin receptor A antagonist BQ123 dramatically reduced the amplitude and frequency of spontaneous Ca2+ events, producing marked inhibition of renal vessels spontaneous motion. Spontaneous Ca2+ fluctuations in smooth muscle cells of p66Shc knockout (p66ShcKO) rats had significantly higher amplitude than in control rats. The frequency of spontaneous [Ca2+](i) oscillations did not change in p66ShcKO rats, suggesting that p66Shc expression did not affect endothelin-1 release from resident endothelial cells. Acute application of endothelin-1 revealed significantly elevated production of the total [Ca2+](i) in p66ShcKO rats. Spontaneous cytosolic Ca2+ oscillations in smooth muscle cells of renal vessels mediate their spontaneous motion via the endothelin-1/endothelin receptor A pathway. p66Shc decreases the amplitude of individual changes in [Ca2+](i), which mitigates the spontaneous motion of renal vessels.Palygin, O., Miller, B. S., Nishijima, Y., Zhang, D. X., Staruschenko, A., Sorokin, A. Endothelin receptor A and p66Shc regulate spontaneous Ca2+ oscillations in smooth muscle cells controlling renal arterial spontaneous motion.	[Palygin, Oleg; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Palygin, Oleg; Miller, Bradley S.; Nishijima, Yoshinori; Zhang, David X.; Staruschenko, Alexander; Sorokin, Andrey] Med Coll Wisconsin, Cardiovasc Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Miller, Bradley S.; Sorokin, Andrey] Med Coll Wisconsin, Dept Med, Div Nephrol, Milwaukee, WI 53226 USA; [Nishijima, Yoshinori; Zhang, David X.] Med Coll Wisconsin, Div Cardiol, Milwaukee, WI 53226 USA; [Nishijima, Yoshinori; Zhang, David X.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Staruschenko, A (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Staruschenko, A; Sorokin, A (corresponding author), Med Coll Wisconsin, Cardiovasc Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	staruschenko@mcw.edu; sorokin@mcw.edu	Palygin, Oleg/AAT-3047-2020	Palygin, Oleg/0000-0002-3680-5527; Staruschenko, Alexander/0000-0002-5190-8356; , Yoshinori/0000-0002-5547-4508	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK098159]; NIH National Heart, Lung, and Blood Institute [R35 HL135749, P01 HL116264, R01 HL096647]; American Heart Association [17SDG33660149]; Wisconsin Breast Cancer Showhouse; Medical College of Wisconsin Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096647, R35HL135749, P01HL116264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098159] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Wisconsin Breast Cancer Showhouse; Medical College of Wisconsin Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Marie Schulte and William Cashdollar and the Northwestern Mutual Foundation Imaging Center (Blood Research Institute of Wisconsin, Milwaukee, WI, USA) for help with the imaging studies. This research was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK098159 (to A. Sorokin), NIH National Heart, Lung, and Blood Institute Grants R35 HL135749 (to A. Staruschenko), P01 HL116264 (to A. Staruschenko), and R01 HL096647 (to D.X.Z.), American Heart Association Grant 17SDG33660149 (to O.P.), and a grant from the Wisconsin Breast Cancer Showhouse and the Medical College of Wisconsin Cancer Center (to A. Sorokin). The authors declare no conflicts of interest.	Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; AKATA T, 1995, JPN J PHARMACOL, V68, P331, DOI 10.1254/jjp.68.331; Barton M, 2000, J CARDIOVASC PHARM, V36, pS153, DOI 10.1097/00005344-200036051-00048; Barton M, 2015, SEMIN NEPHROL, V35, P156, DOI 10.1016/j.semnephrol.2015.02.005; Bertero E, 2018, CIRC RES, V122, P1460, DOI 10.1161/CIRCRESAHA.118.310082; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Burke M, 2014, CURR VASC PHARMACOL, V12, P845, DOI 10.2174/15701611113116660149; Camici GG, 2008, J APPL PHYSIOL, V105, P1628, DOI 10.1152/japplphysiol.90579.2008; Cao S, 2018, J BIOL CHEM, V293, P5307, DOI 10.1074/jbc.M117.811075; Carlstrom M, 2015, PHYSIOL REV, V95, P405, DOI 10.1152/physrev.00042.2012; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Chahdi A, 2010, CELL SIGNAL, V22, P325, DOI 10.1016/j.cellsig.2009.09.039; Chen XP, 2010, J CELL MOL MED, V14, P2483, DOI 10.1111/j.1582-4934.2009.00890.x; Dubow J, 2011, CURR ATHEROSCLER REP, V13, P298, DOI 10.1007/s11883-011-0187-y; Foschi M, 2001, J BIOL CHEM, V276, P26640, DOI 10.1074/jbc.M102008200; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; Gustafsson F, 1999, ACTA PHYSIOL SCAND, V167, P11; Hall JE, 2012, COMPR PHYSIOL, V2, P2393, DOI 10.1002/cphy.c110058; Haller M, 2016, J BIOL CHEM, V291, P23557, DOI 10.1074/jbc.M116.752766; Imig JD, 2008, MICROCIRCULATION, V15, P137, DOI 10.1080/10739680701456960; Kohan DE, 2011, COMPR PHYSIOL, V1, P883, DOI 10.1002/cphy.c100039; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Kvernmo HD, 1999, MICROVASC RES, V57, P298, DOI 10.1006/mvre.1998.2139; LEVESQUE H, 1994, DRUG AGING, V4, P221, DOI 10.2165/00002512-199404030-00005; Levey AS, 2010, KIDNEY INT, V78, P19, DOI 10.1038/ki.2010.115; Levin ER, 1996, AM J NEPHROL, V16, P246, DOI 10.1159/000169004; Lukaszewicz KM, 2016, MICROCIRCULATION, V23, P540, DOI 10.1111/micc.12304; Maguire JJ, 2015, SEMIN NEPHROL, V35, P125, DOI 10.1016/j.semnephrol.2015.02.002; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller B, 2016, J CLIN INVEST, V126, P2533, DOI 10.1172/JCI75079; Nishijima Y, 2017, CIRC RES, V120, P658, DOI 10.1161/CIRCRESAHA.116.309491; Okada M, 2002, CARDIOVASC DRUG REV, V20, P53; Oshikawa J, 2012, AM J PHYSIOL-HEART C, V302, pH724, DOI 10.1152/ajpheart.00739.2011; Palygin O, 2016, LIFE SCI, V159, P140, DOI 10.1016/j.lfs.2015.12.022; Peng HL, 2001, CIRC RES, V88, P810, DOI 10.1161/hh0801.089603; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rahman A, 2005, J VASC RES, V42, P301, DOI 10.1159/000086002; Reho JJ, 2014, AM J PHYSIOL-HEART C, V306, pH163, DOI 10.1152/ajpheart.00493.2013; Ren YL, 2014, AM J PHYSIOL-RENAL, V307, pF533, DOI 10.1152/ajprenal.00283.2014; Schiffrin EL, 2001, AM J HYPERTENS, V14, p83S, DOI 10.1016/S0895-7061(01)02074-X; Sgouralis I, 2012, AM J PHYSIOL-RENAL, V303, pF229, DOI 10.1152/ajprenal.00589.2011; Sorokin A, 2003, AM J PHYSIOL-RENAL, V285, pF579, DOI 10.1152/ajprenal.00019.2003; Sorokin A, 2011, CONTRIB NEPHROL, V172, P50, DOI 10.1159/000328680; Szczech LA, 2004, KIDNEY INT, V66, pS3, DOI 10.1111/j.1523-1755.2004.09002.x; Tomilov AA, 2010, J BIOL CHEM, V285, P1153, DOI 10.1074/jbc.M109.017491; Trolliet MR, 2001, KIDNEY BLOOD PRESS R, V24, P116, DOI 10.1159/000054217; Tykocki NR, 2010, CLIN SCI, V119, P361, DOI 10.1042/CS20100145; Wright KD, 2018, AM J PHYSIOL-RENAL, V314, pF143, DOI 10.1152/ajprenal.00414.2017; Xu XL, 2017, AGING DIS, V8, P486, DOI 10.14336/AD.2017.0507; Zhao XY, 2005, HYPERTENSION, V46, P562, DOI 10.1161/01.HYP.0000179584.39937.41	52	4	4	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2636	2645		10.1096/fj.201800776RR	http://dx.doi.org/10.1096/fj.201800776RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303741	Green Published			2022-12-28	WOS:000457296600088
J	Zhang, GW; Isaji, T; Xu, ZW; Lu, X; Fukuda, T; Gu, JG				Zhang, Guowei; Isaji, Tomoya; Xu, Zhiwei; Lu, Xu; Fukuda, Tomohiko; Gu, Jianguo			N-acetylglucosaminyltransferase-I as a novel regulator of epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						cell adhesion; N-glycosylation; integrins	E-CADHERIN; SIGNALING PATHWAY; CELL-SURFACE; HIGH-MANNOSE; LUNG-CANCER; GLYCOSYLATION; EMT; SWAINSONINE; ACTIVATION; EXPRESSION	N-Glycans are involved in numerous biologic processes, such as cell adhesion, migration, and invasion. To distinguish the functions of complex high-mannose types of N-glycans, we used the clustered, regularly interspaced, short palindromic repeats/Cas9 system to establish N-acetylglucosaminyltransferase (GnT)-I-knockout (KO) cells. Loss of GnT-I greatly induced cell-cell adhesion and decreased cell migration. In addition, the expression levels of epithelial-mesenchymal transition (EMT) markers such as -SMA, vimentin, and N-cadherin were suppressed, whereas the expression of claudin-1 was promoted, suggesting a mesenchymal-epithelial transition-like phenotype, an opposite process to the EMT, was occurred in the KO cells. The phosphorylation levels of Smad-2, epidermal growth factor receptor, and integrin-mediated focal adhesion kinase (FAK) were consistently suppressed. Furthermore, the restoration of GnT-I in the KO cells suppressed the cell-cell adhesion and augmented the expression of EMT markers as well as that of FAK activation. The expression levels of integrins were upregulated in the KO cells, although their functions were decreased, whereas their expression levels were downregulated in the rescued cells, which suggests a negative feedback loop between function and expression. Finally, we also found that the expression of GnT-I was important for cell survival, resistance to cancer drugs, and increased colony formation. The results of the present study demonstrate that GnT-I works as a switch to turn on/off EMT, which further supports the notion that on most surface receptors, the N-glycans differentially play essential roles in biologic functions.Zhang, G., Isaji, T., Xu, Z., Lu, X., Fukuda, T., Gu, J. N-acetylglucosaminyltransferase-I as a novel regulator of epithelial-mesenchymal transition.	[Zhang, Guowei; Isaji, Tomoya; Xu, Zhiwei; Lu, Xu; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan	Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsusima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Japanese Society for the Promotion of Science [15H04354]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [18H04868]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by Grant-in-Aid for Scientific Research 15H04354 (to J.G.) from the Japanese Society for the Promotion of Science, and by Grant-in-Aid for Scientific Research on Innovative Areas 18H04868 (to J.G.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare no conflicts of interest.	Adhikary A, 2014, J BIOL CHEM, V289, P25431, DOI 10.1074/jbc.M113.527267; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Banerjee A, 2015, ADV EXP MED BIOL, V842, P355, DOI 10.1007/978-3-319-11280-0_22; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen QK, 2013, DIFFERENTIATION, V86, P126, DOI 10.1016/j.diff.2013.03.003; Cui J, 2018, J PATHOL, V245, P41, DOI 10.1002/path.5054; Davis FM, 2014, TRENDS PHARMACOL SCI, V35, P479, DOI 10.1016/j.tips.2014.06.006; de Leoz Maria Lorna A, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M110.002717; Draheim V, 2010, EUR J PHARM SCI, V41, P201, DOI 10.1016/j.ejps.2010.06.005; Du BW, 2016, MOLECULES, V21, DOI 10.3390/molecules21070965; DUBAND JL, 1987, DEVELOPMENT, V101, P461; Fanata WID, 2013, PLANT J, V73, P966, DOI 10.1111/tpj.12087; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Goh KL, 1997, DEVELOPMENT, V124, P4309; Goss PE, 1997, CLIN CANCER RES, V3, P1077; Gu JG, 2012, GLYCOCONJUGATE J, V29, P599, DOI 10.1007/s10719-012-9386-1; Gu W, 2013, FASEB J, V27, P3947, DOI 10.1096/fj.12-225805; Guo P, 2004, CELL MOL LIFE SCI, V61, P1795, DOI 10.1007/s00018-004-4122-z; He X, 2012, GLYCOBIOLOGY, V22, P492, DOI 10.1093/glycob/cwr157; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Ho WL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0334-6; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Huang CY, 2015, FEBS J, V282, P4295, DOI 10.1111/febs.13419; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Jin ZC, 2018, J BIOL CHEM, V293, P5572, DOI 10.1074/jbc.M117.813030; Jolly MK, 2017, MOL ONCOL, V11, P755, DOI 10.1002/1878-0261.12083; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li N, 2014, J CELL MOL MED, V18, P1975, DOI 10.1111/jcmm.12331; Li QH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15166; Li WL, 2018, ONCOGENE, V37, P4903, DOI 10.1038/s41388-018-0341-x; Li X, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00033; Li XL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40464; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Ma JX, 2018, ONCOL RES, V26, P1207, DOI 10.3727/096504017X15046134836575; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mittal A, 2010, MECH DEVELOP, V127, P472, DOI 10.1016/j.mod.2010.08.005; Mori S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137486; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; NEWGREEN D, 1980, CELL TISSUE RES, V211, P269; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; OLDEN K, 1991, PHARMACOL THERAPEUT, V50, P285, DOI 10.1016/0163-7258(91)90046-O; Ozcan S, 2014, CANCER PREV RES, V7, P226, DOI 10.1158/1940-6207.CAPR-13-0235; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Peiris D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43006; Pinho SS, 2013, BBA-GEN SUBJECTS, V1830, P2690, DOI 10.1016/j.bbagen.2012.10.021; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Pochec E, 2015, ANAL CELL PATHOL, V2015, DOI 10.1155/2015/324980; Porwoll S, 1998, J BIOL CHEM, V273, P1075, DOI 10.1074/jbc.273.2.1075; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Seres M, 2011, INT J MOL SCI, V12, P7772, DOI 10.3390/ijms12117772; Shaheen PE, 2005, INVEST NEW DRUG, V23, P577, DOI 10.1007/s10637-005-0793-z; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao K, 2016, GLYCOBIOLOGY, V26, P142, DOI 10.1093/glycob/cwv089; Stanley P, 2015, ESSENTIALS GLYCOBIOL, P99, DOI DOI 10.1101/GLYCOBIOLOGY.3E.009; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Thompson EW, 2011, NAT MED, V17, P1048, DOI 10.1038/nm.2437; Tu CF, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0904-8; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wojtowicz K, 2015, BIOMED PHARMACOTHER, V74, P49, DOI 10.1016/j.biopha.2015.07.001; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; You N, 2012, ONCOL REP, V28, P2091, DOI 10.3892/or.2012.2035; Zavareh RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043721; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	77	11	12	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2823	2835		10.1096/fj.201801478R	http://dx.doi.org/10.1096/fj.201801478R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307765	Bronze			2022-12-28	WOS:000457296600103
J	Du, W; Wang, N; Li, F; Jia, KQ; An, JH; Liu, YP; Wang, YX; Zhu, L; Zhao, S; Hao, J				Du, Wei; Wang, Na; Li, Fan; Jia, Keqi; An, Jiahui; Liu, Yaping; Wang, Yuxue; Zhu, Lin; Zhao, Song; Hao, Jun			STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy	FASEB JOURNAL			English	Article						histone deacetylase 1; JAK-STAT3 signaling; Atg3; P62; LC3	INHIBITION; JAK/STAT; PATHWAY; HDAC1; BIOENERGETICS; PATHOGENESIS; MECHANISMS	Schwann cells are the main supportive cells of the peripheral nerves. Schwann cells suffer inhibition of autophagy under hyperglycemia treatment in diabetic peripheral neuropathy (DPN). However, the exact mechanism is still not fully elucidated. We first observed the decrease of autophagy markers (LC3-II/LC3-I, P62) in the sciatic nerves of diabetic mice vs. normal mice, accompanied with the loss of myelinated nerve fibers and abnormal myelin sheath. In line with this, LC3-II/LC3-I and P62 were also significantly reduced in high glucose-treated rat Schwann cell 96 (RSC96) cells compared with normal glucose-treated cells. Furthermore, we found that trichostatin A [an inhibitor of histone deacetylase (HDAC)] evidently improved LC3-II/LC3-I in high glucose-treated RSC96 cells, without an effect on P62 expression. Again, HDAC1 and HDAC5 were revealed to be increased in RSC96 cells stimulated with high glucose. Inhibition of HDAC1 but not HDAC5 by small hairpin RNA vector enhanced LC3-II/LC3-I in high glucose-cultured RSC96 cells. In addition, LC3-II conversion regulators [autophagy-related protein (Atg)3, Atg5, and Atg7] were detected in high glucose-treated and HDAC1-knockdown RSC96 cells, and Atg3 was proven to be the key target of HDAC1. The presuppression of Atg3 offset the improvement of LC3-II/LC3-I resulting from HDAC1 inhibition in high glucose-treated RSC96 cells. The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway was activated in RSC96 cells treated with high glucose, which was indicated by increased STAT3 phosphorylation. Blocking STAT3 phosphorylation by chemical inhibitor AG490 induced HDAC1 down-regulation followed by increases in Atg3 and LC3-II/LC3-I. Interestingly, we also found that AG490 treatment enhanced P62 expression in high glucose-stimulated RSC96 cells. Taken together, our findings demonstrate that hyperglycemia inhibits LC3-II/LC3-I in an HDAC1-Atg3-dependent manner and decreases P62 expression in an HDAC-independent manner via the JAK-STAT3 signaling pathway in the Schwann cells of DPN.-Du, W., Wang, N., Li, F. Jia, K., An, J., Liu, Y., Wang, Y., Zhu, L., Zhao, S. Hao, J. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy.	[Du, Wei; Li, Fan; Jia, Keqi; An, Jiahui; Liu, Yaping; Wang, Yuxue; Zhao, Song; Hao, Jun] Hebei Med Univ, Dept Pathol, Zhongshan East Rd 361, Shijiazhuang 050017, Hebei, Peoples R China; [Wang, Na] Hebei Med Univ, Hosp 2, Dept Pediat, Shijiazhuang, Hebei, Peoples R China; [Zhu, Lin] Hebei Med Univ, Hosp 3, Dept Electromyogram, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Zhao, S; Hao, J (corresponding author), Hebei Med Univ, Dept Pathol, Zhongshan East Rd 361, Shijiazhuang 050017, Hebei, Peoples R China.	xljer606@163.com; haojun2004@hotmail.com			National Natural Science Foundation of China [81700715]; Foundation of Hebei Province Education Department [ZD2018251]; Natural Science Foundation of Hebei Province [H2018206096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Hebei Province Education Department; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This research was supported by grants from the National Natural Science Foundation of China (81700715), the Foundation of Hebei Province Education Department (ZD2018251), and the Natural Science Foundation of Hebei Province (H2018206096). The authors declare no conflicts of interest.	Al-Rasheed NM, 2016, DRUG DES DEV THER, V10, P2095, DOI 10.2147/DDDT.S109287; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bai Y, 2018, FASEB J, V32, P4573, DOI 10.1096/fj.201701411R; Candeias E, 2018, MOL NEUROBIOL, V55, P4030, DOI 10.1007/s12035-017-0622-3; Cao DJ, 2011, P NATL ACAD SCI USA, V108, P4123, DOI 10.1073/pnas.1015081108; Cheng MJ, 2018, NEUROCHEM RES, V43, P2141, DOI 10.1007/s11064-018-2637-1; Chowdhury SR, 2014, CELL MOL NEUROBIOL, V34, P643, DOI 10.1007/s10571-014-0054-9; Chung YC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1192-7; Dehdashtian E, 2018, LIFE SCI, V193, P20, DOI 10.1016/j.lfs.2017.12.001; Dodington DW, 2018, TRENDS ENDOCRIN MET, V29, P55, DOI 10.1016/j.tem.2017.11.001; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Gilardini Montani MS, 2017, CELL ONCOL, V40, P167, DOI 10.1007/s13402-017-0314-z; Gumy LF, 2008, MOL CELL NEUROSCI, V37, P298, DOI 10.1016/j.mcn.2007.10.004; Hao J, 2009, HISTOCHEM CELL BIOL, V131, P327, DOI 10.1007/s00418-008-0528-2; He XL, 2018, NAT MED, V24, P338, DOI 10.1038/nm.4483; Hur J, 2016, DIABETOLOGIA, V59, P1297, DOI 10.1007/s00125-016-3913-8; Jia LF, 2018, FASEB J, V32, P6911, DOI 10.1096/fj.201800597R; Jo YK, 2018, ANTICANCER RES, V38, P271, DOI 10.21873/anticanres.12218; Khangura RK, 2017, EUR J PHARMACOL, V795, P36, DOI 10.1016/j.ejphar.2016.12.001; Kim M, 2019, J MOL HISTOL, V50, P167, DOI 10.1007/s10735-019-09815-1; Koeneke E, 2015, CELLS-BASEL, V4, P135, DOI 10.3390/cells4020135; Kou ZZ, 2013, PAIN PHYSICIAN, V16, pE71; Kume S, 2014, SEMIN NEPHROL, V34, P9, DOI 10.1016/j.semnephrol.2013.11.003; Liu J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0374-7; Mrakovcic M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091883; Oh M, 2008, BIOCHEM BIOPH RES CO, V369, P1179, DOI 10.1016/j.bbrc.2008.03.019; Ortiz-Munoz G, 2010, J AM SOC NEPHROL, V21, P763, DOI 10.1681/ASN.2009060625; Qu L, 2014, NEURAL REGEN RES, V9, P1195, DOI 10.4103/1673-5374.135328; Reumann S, 2016, J CELL BIOCHEM, V117, P751, DOI 10.1002/jcb.25360; Rikiishi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/830260; Tang DF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22257-1; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wang FL, 2017, CAN J CARDIOL, V33, P850, DOI 10.1016/j.cjca.2017.01.002; Wang SY, 2018, J MOL CELL CARDIOL, V119, P40, DOI 10.1016/j.yjmcc.2018.04.009; Wang WJ, 2017, AUTOPHAGY, V13, P941, DOI 10.1080/15548627.2017.1293768; Wu S, 2013, J BIOL CHEM, V288, P35500, DOI 10.1074/jbc.M113.479865; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yerra VG, 2016, MED HYPOTHESES, V86, P120, DOI 10.1016/j.mehy.2015.11.004; Zhu L, 2019, J CELL BIOCHEM, V120, P5777, DOI 10.1002/jcb.27864; Zhu L, 2018, EXP CELL RES, V367, P186, DOI 10.1016/j.yexcr.2018.03.034; Zhu L, 2016, J CELL BIOCHEM, V117, P1187, DOI 10.1002/jcb.25402; Zimberlin CD, 2015, FASEB J, V29, P2070, DOI 10.1096/fj.14-257931	42	34	40	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8008	8021		10.1096/fj.201900127R	http://dx.doi.org/10.1096/fj.201900127R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30913399	Bronze			2022-12-28	WOS:000476234700017
J	Li, Y; Sun, Q; Jiang, MC; Li, S; Zhang, JY; Xu, ZQ; Guo, DY; Gu, TN; Wang, BY; Xiao, L; Zhou, TH; Zhuo, W				Li, Yang; Sun, Qiang; Jiang, Mingchun; Li, Shuang; Zhang, Jiayu; Xu, Zhangqi; Guo, Dongyang; Gu, Tianning; Wang, Boya; Xiao, Lei; Zhou, Tianhua; Zhuo, Wei			KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28	FASEB JOURNAL			English	Article						GSEA; transwell assay; MTT assay; stomach; pulmonary metastasis	KRUPPEL-LIKE FACTORS; MATRIX METALLOPROTEINASES; MESENCHYMAL TRANSITION; MICE LACKING; GROWTH; GENE; CARCINOMA; MMP-28; PROLIFERATION; ACTIVATION	Gastric cancer (GC) is among the most lethal human malignancies, and the leading cause of GC mortality is metastasis. However, the precise mechanism of GC metastasis remains unclear. To screen key transcriptional factors (TFs) involved in GC metastasis, we performed bioinformatics analysis of The Cancer Genome Atlas database and found that Kruppel-like factor 9 (KLF9) is a GC metastasis-associated TF. KLF9 is significantly decreased in patients with GC with distant metastasis compared with those patients without distant metastasis. Ectopic expression of KLF9 evidently inhibited the migration and invasion capabilities of GC cells. Conversely, knockdown of KLF9 endowed GC cells with stronger invasive capacity. Moreover, tail intravenous injection confirmed that KLF9 strongly inhibits the lung metastasis process of GC in vivo. Mechanistically, chromatin immunoprecipitation coupled with high-throughput sequencing data from Encyclopedia of DNA Elements revealed that KLF9 specifically binds to the promoter region of matrix metalloproteinase (MMP)28. Further quantitative real-time PCR and dual-luciferase assay indicated that KLF9 directly inhibited MMP28 transcription. Importantly, decreased invasion and metastasis capability of GC cells caused by ectopic KLF9 expression could be rescued via reinforcing MMP28 expression in vivo. Collectively, our study indicates that KLF9 significantly suppresses GC cell invasion and metastasis through inhibiting MMP28 transcription.-Li, Y., Sun, Q., Jiang, M., Li, S., Zhang, J., Xu, Z., Guo, D., Gu, T., Wang, B., Xiao, L., Zhou, T., Zhuo, W. KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28.	[Li, Yang; Xiao, Lei] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Zhou, Tianhua; Zhuo, Wei] Zhejiang Univ, Inst Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Li, Yang; Sun, Qiang; Jiang, Mingchun; Li, Shuang; Zhang, Jiayu; Xu, Zhangqi; Guo, Dongyang; Gu, Tianning; Xiao, Lei; Zhou, Tianhua; Zhuo, Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cell Biol, Hangzhou, Zhejiang, Peoples R China; [Li, Yang; Sun, Qiang; Jiang, Mingchun; Li, Shuang; Zhang, Jiayu; Xu, Zhangqi; Guo, Dongyang; Gu, Tianning; Xiao, Lei; Zhou, Tianhua; Zhuo, Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Canc Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Boya] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pharm, Hangzhou, Zhejiang, Peoples R China; [Zhou, Tianhua] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhou, TH; Zhuo, W (corresponding author), Zhejiang Univ, Sch Med, Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	tzhou@zju.edu.cn; 0012049@zju.edu.cn	sun, qiang/GQQ-9847-2022; Sun, Qiang/AAL-4865-2020; zhou, tianhua/K-4908-2013	sun, qiang/0000-0002-6621-7064; Sun, Qiang/0000-0002-6621-7064; zhou, tianhua/0000-0002-1791-2124; Zhuo, Wei/0000-0002-8251-4210; Gu, Tianning/0000-0003-1550-1011	National Natural Science Foundation of China [31771540, 91740205, 31620103911, 31571446, 31301149]; Natural Scientific Foundation of Zhejiang Province [LYY19H310011, LQ13H160013]; Fundamental Research Funds for the Central Universities [2017QNA7005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors thank Zhaocai Zhou (Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China) for providing the BGC-823 cells and Youyong Lu (Beijing Cancer Hospital, Beijing, China) for providing the SGC-7901 GC cell lines. The authors are grateful to Lydia Zhong (Princeton University, Princeton, NJ, USA) for help with editing the language of our manuscript. This work was supported by the National Natural Science Foundation of China (31771540, 91740205, 31620103911, 31571446, and 31301149), the Natural Scientific Foundation of Zhejiang Province (LYY19H310011, LQ13H160013), and Fundamental Research Funds for the Central Universities (2017QNA7005). The authors declare no conflicts of interest.	Bagamasbad P, 2012, ENDOCRINOLOGY, V153, P5334, DOI 10.1210/en.2012-1303; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bernards N, 2013, ANN ONCOL, V24, P3056, DOI 10.1093/annonc/mdt401; Bornschein J, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0449-z; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Illman SA, 2006, J CELL SCI, V119, P3856, DOI 10.1242/jcs.03157; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kang L, 2008, PATHOL INT, V58, P334, DOI 10.1111/j.1440-1827.2008.02233.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kubben FJGM, 2006, BRIT J CANCER, V94, P1035, DOI 10.1038/sj.bjc.6603041; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Limame R, 2013, ONCOSCIENCE, V1, P69, DOI DOI 10.18632/oncoscience.10; Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manicone AM, 2009, J IMMUNOL, V182, P3866, DOI 10.4049/jimmunol.0713949; Marchenko GN, 2001, GENE, V265, P87, DOI 10.1016/S0378-1119(01)00360-2; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Qiao F, 2016, MOL CARCINOGEN, V55, P280, DOI 10.1002/mc.22277; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shan YQ, 2015, CANCER GENE THER, V22, P101, DOI 10.1038/cgt.2014.61; Shen MH, 2013, CELL RES, V23, P1284, DOI 10.1038/cr.2013.127; Shen PL, 2014, PROSTATE, V74, P946, DOI 10.1002/pros.22812; Simmen FA, 2007, AM J PHYSIOL-GASTR L, V292, pG1757, DOI 10.1152/ajpgi.00013.2007; Simmen RCM, 2004, J BIOL CHEM, V279, P29286, DOI 10.1074/jbc.M403139200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JB, 2014, CANCER LETT, V355, P25, DOI 10.1016/j.canlet.2014.09.022; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063826; Wang Q, 2012, MED ONCOL, V29, P77, DOI 10.1007/s12032-010-9766-y; WU CW, 1989, CANCER, V64, P2552, DOI 10.1002/1097-0142(19891215)64:12&lt;2552::AID-CNCR2820641224&gt;3.0.CO;2-Y; Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang QH, 2015, ARCH GYNECOL OBSTET, V291, P377, DOI 10.1007/s00404-014-3405-3; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng HC, 2006, ANTICANCER RES, V26, P3579	51	32	33	5	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7915	7928		10.1096/fj.201802531R	http://dx.doi.org/10.1096/fj.201802531R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30913394	Bronze			2022-12-28	WOS:000476234700010
J	Pryce, KD; Powell, R; Agwa, D; Evely, KM; Sheehan, GD; Nip, A; Tomasello, DL; Gururaj, S; Bhattacharjee, A				Pryce, Kern D.; Powell, Rasheen; Agwa, Dalia; Evely, Katherine M.; Sheehan, Garrett D.; Nip, Allan; Tomasello, Danielle L.; Gururaj, Sushmitha; Bhattacharjee, Arin			Magi-1 scaffolds Na(V)1.8 and Slack K-Na channels in dorsal root ganglion neurons regulating excitability and pain	FASEB JOURNAL			English	Article						sodium channels; potassium channels; trafficking; nociception; peptidomimetics	GATED SODIUM-CHANNELS; ACTIVATED POTASSIUM CHANNELS; PROTEIN-KINASE-A; INDUCED INTERNALIZATION; TRAFFICKING; EXPRESSION; SCHIZOPHRENIA; LOCALIZATION; DOMAIN; DYSREGULATION	Voltage-dependent sodium (Na-V) 1.8 channels regulate action potential generation in nociceptive neurons, identifying them as putative analgesic targets. Here, we show that Na(V)1.8 channel plasma membrane localization, retention, and stability occur through a direct interaction with the postsynaptic density-95/discs large/zonula occludens-1-and WW domain-containing scaffold protein called membrane-associated guanylate kinase with inverted orientation (Magi)-1. The neurophysiological roles of Magi-1 are largely unknown, but we found that dorsal root ganglion (DRG)-specific knockdown of Magi-1 attenuated thermal nociception and acute inflammatory pain and produced deficits in Na(V)1.8 protein expression. A competing cell-penetrating peptide mimetic derived from the Na(V)1.8 WW binding motif decreased sodium currents, reduced Na(V)1.8 protein expression, and produced hypoexcitability. Remarkably, a phosphorylated variant of the very same peptide caused an opposing increase in Na(V)1.8 surface expression and repetitive firing. Likewise, in vivo, the peptides produced diverging effects on nocifensive behavior. Additionally, we found that Magi-1 bound to sequence like a calcium-activated potassium channel sodium-activated (Slack) potassium channels, demonstrating macrocomplexing with Na(V)1.8 channels. Taken together, these findings emphasize Magi-1 as an essential scaffold for ion transport in DRG neurons and a central player in pain.-Pryce, K. D., Powell, R., Agwa, D., Evely, K. M., Sheehan, G. D., Nip, A., Tomasello, D. L., Gururaj, S., Bhattacharjee, A. Magi-1 scaffolds Na(V)1.8 and Slack K-Na channels in dorsal root ganglion neurons regulating excitability and pain.	[Pryce, Kern D.; Powell, Rasheen; Agwa, Dalia; Evely, Katherine M.; Sheehan, Garrett D.; Nip, Allan; Tomasello, Danielle L.; Gururaj, Sushmitha; Bhattacharjee, Arin] Univ Buffalo State Univ New York, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bhattacharjee, A (corresponding author), Univ Buffalo State Univ New York, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA.	ab68@buffalo.edu		Pryce, Kerri/0000-0001-6771-2000; Powell, Rasheen/0000-0003-4423-6413	U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke [NS078184]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM095459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank undergraduate students Kimberly Nguyen (State University of New York at Buffalo) and Morgan Paladino (University of Notre Dame, Notre Dame, ID, USA) for scoring the formalin behavior. The authors thank Dr. Wade Sigurdson (Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo) for assistance with microscopy for the immunofluorescence experiments. The authors thank Dr. Elsa Daurignac (Jacobs School of Medicine and Biomedical Research, State University of New York at Buffalo) for critical reading of this manuscript. D.A., K.M.E., D.L.T., and A.B. are also affiliated with the Program for Neuroscience at The State University of New York at Buffalo. This work was supported by the U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke Grant NS078184 (to A.B.). The authors declare no conflicts of interest.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Bao L, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0065-7; Benn SC, 2001, J NEUROSCI, V21, P6077, DOI 10.1523/JNEUROSCI.21-16-06077.2001; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Brattacharjee A, 2005, J COMP NEUROL, V484, P80, DOI 10.1002/cne.20462; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Carroll LS, 2016, PSYCHIAT GENET, V26, P60, DOI 10.1097/YPG.0000000000000110; Chang MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep35612; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; DWORKIN RH, 1994, SCHIZOPHRENIA BULL, V20, P235, DOI 10.1093/schbul/20.2.235; Eisele F, 2002, CHEM-EUR J, V8, P3362, DOI 10.1002/1521-3765(20020802)8:15<3362::AID-CHEM3362>3.0.CO;2-0; Ferentinos P, 2014, J AFFECT DISORDERS, V155, P81, DOI 10.1016/j.jad.2013.10.027; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Francois-Moutal L, 2015, PAIN, V156, P1247, DOI 10.1097/j.pain.0000000000000147; Gold MS, 2003, J NEUROSCI, V23, P158; Gonzalez C, 2016, P NATL ACAD SCI USA, V113, P1823, DOI 10.1073/pnas.1514943113; Gururaj S, 2017, J BIOL CHEM, V292, P19304, DOI 10.1074/jbc.M117.804716; Gururaj S, 2016, NEUROPHARMACOLOGY, V103, P279, DOI 10.1016/j.neuropharm.2015.12.016; Hage TA, 2012, J NEUROSCI, V32, P2714, DOI 10.1523/JNEUROSCI.5088-11.2012; Hooley JM, 2001, SCHIZOPHR RES, V47, P265, DOI 10.1016/S0920-9964(00)00064-5; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Inan S, 2009, EUR J PHARMACOL, V616, P141, DOI 10.1016/j.ejphar.2009.06.026; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Ito H, 2012, J NEUROSCI RES, V90, P1776, DOI 10.1002/jnr.23074; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Karlsson R, 2012, BIOL PSYCHIAT, V71, P922, DOI 10.1016/j.biopsych.2012.01.020; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Kundu K, 2014, BIOINFORMATICS, V30, P2668, DOI 10.1093/bioinformatics/btu350; Kundu K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S5; Laedermann CJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00263; Laedermann CJ, 2013, J CLIN INVEST, V123, P3002, DOI 10.1172/JCI68996; Li J, 2018, SCHIZOPHR RES, V192, P194, DOI 10.1016/j.schres.2017.04.009; Liu C, 2010, TRAFFIC, V11, P405, DOI 10.1111/j.1600-0854.2009.01027.x; Lu RR, 2015, J NEUROSCI, V35, P1125, DOI 10.1523/JNEUROSCI.2423-14.2015; Martinez-Rodriguez S, 2015, J STRUCT BIOL, V191, P381, DOI 10.1016/j.jsb.2015.08.001; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Nelson AR, 2007, BIOCHEMISTRY-US, V46, P14771, DOI 10.1021/bi701295k; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Piluso G., 2017, WORLD J BIOL PSYCHIA, P1; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Ridgway LD, 2009, AM J PHYSIOL-CELL PH, V297, pC55, DOI 10.1152/ajpcell.00073.2009; Ritter DM, 2015, J NEUROSCI, V35, P1260, DOI 10.1523/JNEUROSCI.1594-14.2015; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; Shao D, 2009, MOL CELL NEUROSCI, V42, P219, DOI 10.1016/j.mcn.2009.07.003; Shirata N, 2017, J AM SOC NEPHROL, V28, P2655, DOI 10.1681/ASN.2016121356; Skouloudaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035735; Takahashi I, 2015, J NEUROPHYSIOL, V114, P2450, DOI 10.1152/jn.00087.2015; TAYLOR BK, 1995, J NEUROSCI, V15, P7575; Tibbs GR, 2016, TRENDS PHARMACOL SCI, V37, P522, DOI 10.1016/j.tips.2016.05.002; Tressel SL, 2011, METHODS MOL BIOL, V683, P259, DOI 10.1007/978-1-60761-919-2_19; Uchino S, 2003, BIOCHEM BIOPH RES CO, V310, P1140, DOI 10.1016/j.bbrc.2003.09.133; Vijayaragavan K, 2004, J NEUROPHYSIOL, V91, P1556, DOI 10.1152/jn.00676.2003; WARD NE, 1993, BIOCHEMISTRY-US, V32, P11903, DOI 10.1021/bi00095a020; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Yazicioglu MN, 2013, J BIOL CHEM, V288, P25908, DOI 10.1074/jbc.M113.484683; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Zou SW, 2011, J NEUROCHEM, V117, P833, DOI 10.1111/j.1471-4159.2011.07250.x	66	8	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7315	7330		10.1096/fj.201802454RR	http://dx.doi.org/10.1096/fj.201802454RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30860870	Green Published, Bronze			2022-12-28	WOS:000476114200053
J	Trigo, D; Goncalves, MB; Corcoran, JPT				Trigo, Diogo; Goncalves, Maria B.; Corcoran, Jonathan P. T.			The regulation of mitochondrial dynamics in neurite outgrowth by retinoic acid receptor beta signaling	FASEB JOURNAL			English	Article						neuron; retinoid; growth cone; energy metabolism	NERVE GROWTH-FACTOR; AXONAL-TRANSPORT; ENDOPLASMIC-RETICULUM; HYPOXIA; PROTEIN; DIFFERENTIATION; ACCUMULATION; REGENERATION; BIOGENESIS; PATHWAY	Neuronal regeneration is a highly energy-demanding process that greatly relies on axonal mitochondrial transport to meet the enhanced metabolic requirements. Mature neurons typically fail to regenerate after injury, partly because of mitochondrial motility and energy deficits in injured axons. Retinoic acid receptor (RAR)-beta signaling is involved in axonal and neurite regeneration. Here we investigate the effect of RAR-beta signaling on mitochondrial trafficking during neurite outgrowth and find that it enhances their proliferation, speed, and movement toward the growing end of the neuron via hypoxia-inducible factor 1 alpha signaling. We also show that RAR-beta signaling promotes the binding of the mitochondria to the anchoring protein, glucose-related protein 75, at the growing tip of neurite, thus allowing them to provide energy and metabolic roles required for neurite outgrowth.-Trigo, D., Goncalves, M. B., Corcoran, J. P. T. The regulation of mitochondrial dynamics in neurite outgrowth by retinoic acid receptor beta signaling.	[Trigo, Diogo; Goncalves, Maria B.; Corcoran, Jonathan P. T.] Kings Coll London, Wolfson Ctr Age Related Dis, Guys Campus, London SE1 1UL, England	University of London; King's College London	Corcoran, JPT (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Guys Campus, London SE1 1UL, England.	jonathan.corcoran@kcl.ac.uk	Trigo, Diogo/AAN-1689-2020	Trigo, Diogo/0000-0002-4432-0925	Wellcome Trust (London, United Kingdom) [WT092718]	Wellcome Trust (London, United Kingdom)(Wellcome Trust)	This work was supported by Grant WT092718 from the Wellcome Trust (London, United Kingdom). The authors declare no conflicts of interest.	Agudo M, 2010, NEUROBIOL DIS, V37, P147, DOI 10.1016/j.nbd.2009.09.018; Cartoni R, 2017, NEURON, V94, P689, DOI 10.1016/j.neuron.2017.04.028; Cho Y, 2015, NEURON, V88, P720, DOI 10.1016/j.neuron.2015.09.050; Corcoran J, 1999, NAT NEUROSCI, V2, P307, DOI 10.1038/7214; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Devine MJ, 2016, NEUROBIOL DIS, V90, P27, DOI 10.1016/j.nbd.2015.12.008; Dmetrichuk JM, 2006, DEV BIOL, V294, P39, DOI 10.1016/j.ydbio.2006.02.018; Gao ZH, 2017, ONCOTARGET, V8, P58536, DOI 10.18632/oncotarget.17234; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; Goncalves MB, 2013, EUR J NEUROSCI, V37, P1182, DOI 10.1111/ejn.12142; Han SM, 2016, NEURON, V92, P1308, DOI 10.1016/j.neuron.2016.11.025; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; Hoecker J, 2013, ORG BIOMOL CHEM, V11, P3314, DOI 10.1039/c3ob40106e; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Honrath B, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.76; Hutchins BI, 2011, DEV NEUROBIOL, V71, P269, DOI 10.1002/dneu.20846; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Kawai A, 2001, J CELL SCI, V114, P3565; Kiryu-Seo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28331; Lai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075625; Lathrop Kira L, 2013, J Ocul Biol, V1, P9; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Li Y, 2009, J CELL BIOL, V185, P1065, DOI 10.1083/jcb.200811033; Lin MY, 2017, NEURON, V94, P595, DOI 10.1016/j.neuron.2017.04.004; Liou JC, 2005, J CELL SCI, V118, P4721, DOI 10.1242/jcs.02603; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; Luarte A, 2018, DEV NEUROBIOL, V78, P181, DOI 10.1002/dneu.22560; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Mar FM, 2014, J NEUROSCI, V34, P5965, DOI 10.1523/JNEUROSCI.4680-13.2014; MASSA SM, 1995, J NEUROSCI RES, V40, P807, DOI 10.1002/jnr.490400612; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Mishra S, 2018, STEM CELL REP, V10, P1705, DOI 10.1016/j.stemcr.2018.04.024; MORRIS RL, 1993, J CELL SCI, V104, P917; Mylonis I, 2017, J CELL SCI, V130, P466, DOI 10.1242/jcs.195339; Notario B, 2003, MOL PHARMACOL, V63, P224, DOI 10.1124/mol.63.1.224; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Sajic M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001754; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Susalka SJ, 2000, J NEUROCYTOL, V29, P819, DOI 10.1023/A:1010995408343; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Trigo D, 2015, J PHYSIOL-LONDON, V593, P987, DOI 10.1113/jphysiol.2014.279331; Vaarmann A, 2016, DEVELOPMENT, V143, P1981, DOI 10.1242/dev.128926; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; Voos W, 1999, BBA-REV BIOMEMBRANES, V1422, P235, DOI 10.1016/S0304-4157(99)00007-6; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Williamson CL, 2008, AM J PHYSIOL-HEART C, V294, pH249, DOI 10.1152/ajpheart.00775.2007; Zhang J, 2008, HAEMATOL-HEMATOL J, V93, P1480, DOI 10.3324/haematol.13096; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101	57	16	16	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7225	7235		10.1096/fj.201802097R	http://dx.doi.org/10.1096/fj.201802097R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30857414	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000476114200046
J	Yuan, C; Freeman, BT; McArdle, TJ; Jung, JP; Ogle, BM				Yuan, Ce; Freeman, Brian T.; McArdle, Tanner J.; Jung, Jangwook P.; Ogle, Brenda M.			Conserved pathway activation following xenogeneic, heterotypic fusion	FASEB JOURNAL			English	Article						cell fusion; human growth hormone; mesenchymal stem cell; cardiomyocyte; ribosome	MESENCHYMAL STEM-CELLS; MARROW-DERIVED CELLS; MYOBLAST FUSION; MACROPHAGE FUSION; DIFFERENTIATION; CARDIOMYOCYTES; RECEPTOR; GENE; METASTASIS; MYOCARDIUM	Fusion between cells of different organisms (i.e., xenogeneic hybrids) can occur, and for humans this may occur in the course of tissue transplantation, animal handling, and food production. Previous work shows that conferred advantages are rare in xenogeneic hybrids, whereas risks of cellular dysregulation are high. Here, we explore the transcriptome of individual xenogeneic hybrids of human mesenchymal stem cells and murine cardiomyocytes soon after fusion and ask whether the process is stochastic or involves conserved pathway activation. Toward this end, single-cell RNA sequencing was used to analyze the transcriptomes of hybrid cells with respect to the human and mouse genomes. Consistent with previous work, hybrids possessed a unique transcriptome distinct from either fusion partner but were dominated by the cardiomyocyte transcriptome. New in this work is the documentation that a few genes that were latent in both fusion partners were consistently expressed in hybrids. Specifically, human growth hormone 1, murine ribosomal protein S27, and murine ATP synthase H+ transporting, mitochondrial Fo complex subunit C2 were expressed in nearly all hybrids. The consistent activation of latent genes between hybrids suggests conserved signaling mechanisms that either cause or are the consequence of fusion of these 2 cell types and might serve as a target for limiting unwanted xenogeneic fusion in the future.-Yuan, C., Freeman, B. T., McArdle, T. J., Jung, J. P., Ogle, B. M. Conserved pathway activation following xenogeneic, heterotypic fusion.	[Yuan, Ce] Univ Minnesota Twin Cities, Bioinformat & Computat Biol Program, Minneapolis, MN 55455 USA; [Yuan, Ce; Freeman, Brian T.; McArdle, Tanner J.; Jung, Jangwook P.; Ogle, Brenda M.] Univ Minnesota Twin Cities, Stem Cell Inst, Minneapolis, MN 55455 USA; [Freeman, Brian T.; McArdle, Tanner J.; Jung, Jangwook P.; Ogle, Brenda M.] Univ Minnesota Twin Cities, Dept Biomed Engn, 312 Church St SE, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Inst Engn Med, Minneapolis, MN 55455 USA; [Freeman, Brian T.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison	Ogle, BM (corresponding author), Univ Minnesota Twin Cities, Dept Biomed Engn, 312 Church St SE, Minneapolis, MN 55455 USA.	ogle@umn.edu	Yuan, Ce/AAI-2721-2020	Yuan, Ce/0000-0002-4323-7353	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL137204]; University of Minnesota Genomics Center New Investigator Award (NSF-GRFP) [2010105691]; Minnesota's Discover, Research, and Innovation Economy, University of Minnesota Informatics Institute Graduate Fellowship; Minnesota Stem Cell Institute	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Minnesota Genomics Center New Investigator Award (NSF-GRFP); Minnesota's Discover, Research, and Innovation Economy, University of Minnesota Informatics Institute Graduate Fellowship; Minnesota Stem Cell Institute	The authors thank Dr. Peiman Hematti (University of Wisconsin-Madison) for the kind donation of pluripotent stem cell-derived mesenchymal stem cells. The authors also thank Joshua Baller and John Garbe (University of Minnesota Supercomputing Institute) for assistance in setting up single-cell RNA sequencing workflow analyses for multiple genomes. This study was funded by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant HL137204); University of Minnesota Genomics Center New Investigator Award (NSF-GRFP, 2010105691); Minnesota's Discover, Research, and Innovation Economy, University of Minnesota Informatics Institute Graduate Fellowship; and the Minnesota Stem Cell Institute. The authors declare no conflicts of interest.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Chitwood CA, 2018, APL BIOENG, V2, DOI 10.1063/1.5024744; Perez-Ibave DC, 2014, GROWTH HORM IGF RES, V24, P47, DOI 10.1016/j.ghir.2014.01.005; de la Garza-Rodea AS, 2012, CELL TRANSPLANT, V21, P153, DOI 10.3727/096368911X580554; Dedja A, 2006, FASEB J, V20, P2534, DOI 10.1096/fj.06-6586fje; Degrelle SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42173; Deng S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005381; Ding Z, 2016, DISCOV MED, V21, P331; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019569; Freeman BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23270; Freeman BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20283; Freeman BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136199; Freeman BT, 2015, STEM CELL TRANSL MED, V4, P685, DOI 10.5966/sctm.2014-0198; Gauster M, 2009, PLACENTA, V30, pS49, DOI 10.1016/j.placenta.2008.10.011; Goh ELK, 1997, ENDOCRINOLOGY, V138, P3207, DOI 10.1210/en.138.8.3207; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Harvey S, 2010, ENDOCRINE, V38, P335, DOI 10.1007/s12020-010-9403-8; Ho Y, 2013, MOL CELL BIOL, V33, P1723, DOI 10.1128/MCB.01166-12; Huda F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164202; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Ishikawa F, 2006, FASEB J, V20, P950, DOI 10.1096/fj.05-4863fje; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; Kobayashi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36780; Kopchick JJ, 2000, MOL GENET METAB, V71, P293, DOI 10.1006/mgme.2000.3068; Kouris NA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/414038; Kruglyakov PV, 2006, B EXP BIOL MED+, V142, P503, DOI 10.1007/s10517-006-0403-x; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Li H, 2014, ONCOL REP, V32, P539, DOI 10.3892/or.2014.3264; Luo F, 2016, ONCOTARGET, V7, P30924, DOI 10.18632/oncotarget.9045; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Ogle BM, 2004, AM SCI, V92, P420; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Ogle Brenda M., 2004, FASEB Journal, V18, P548; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Pawelek JM, 2014, CHIN J CANCER, V33, P133, DOI 10.5732/cjc.013.10243; Pizza FX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05283-3; Sun C, 2015, ONCOL REP, V34, P2022, DOI 10.3892/or.2015.4135; Toufaily C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121468; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Verma SK, 2014, BIOCHEM J, V464, P293, DOI 10.1042/BJ20141233; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Willenbring H, 2004, CELL CYCLE, V3, P1489, DOI 10.4161/cc.3.12.1304; Zhang P, 2005, J BIOCHEM MOL BIOL, V38, P373; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	54	0	0	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6767	6777		10.1096/fj.201801700R	http://dx.doi.org/10.1096/fj.201801700R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30807240	Green Published			2022-12-28	WOS:000476114200008
J	Liu, YY; Harashima, SI; Wang, Y; Suzuki, K; Tokumoto, S; Usui, R; Tatsuoka, H; Tanaka, D; Yabe, D; Harada, N; Hayashi, Y; Inagaki, N				Liu, Yanyan; Harashima, Shin-ichi; Wang, Yu; Suzuki, Kazuyo; Tokumoto, Shinsuke; Usui, Ryota; Tatsuoka, Hisato; Tanaka, Daisuke; Yabe, Daisuke; Harada, Norio; Hayashi, Yoshitaka; Inagaki, Nobuya			Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion	FASEB JOURNAL			English	Article						inflammation; lipid metabolism; obesity	GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; RECEPTOR AGONISTS; ADIPOSE-TISSUE; ADIPONECTIN RECEPTORS; INFLAMMATORY MARKERS; OBESITY; LIPOPROTEIN; RESISTANCE; RESPONSES	Our previous study demonstrated that sphingosine kinase 1-interacting protein (SKIP, or Sphkap) is expressed in pancreatic -cells, and depletion of SKIP enhances glucose-stimulated insulin secretion. We find here that SKIP is also expressed in intestinal K- and L-cells and that secretion of gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) as well as insulin are significantly increased, and blood glucose levels are decreased in SKIP-deficient (SKIP-/-) mice compared with those in wild-type mice. Plasma triglyceride (Tg), LDL cholesterol, and mRNA levels of proinflammatory cytokines in adipose tissues, livers, and intestines were found to be significantly decreased in SKIP-/- mice. The phenotypic characteristics of SKIP-/- mice, including adiposity and attenuation of basal inflammation, were abolished by genetic depletion of GIP. The improvement of glucose tolerance and lipid profiles in SKIP-/- mice were cancelled by GLP-1 receptor antagonist exendin-(9-39) treatment. In summary, depletion of SKIP ameliorates glucose tolerance by enhancing secretion of insulin and incretins, improves lipid metabolism, and reduces basal inflammation levels. Thus, inhibition of SKIP action may emerge as a new option for treatment of type 2 diabetes mellitus with metabolic dysfunction.Liu, Y., Harashima, S., Wang, Y., Suzuki, K., Tokumoto, S., Usui, R., Tatsuoka, H., Tanaka, D., Yabe, D., Harada, N., Hayashi, Y., Inagaki, N. Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.	[Liu, Yanyan; Harashima, Shin-ichi; Wang, Yu; Suzuki, Kazuyo; Tokumoto, Shinsuke; Usui, Ryota; Tatsuoka, Hisato; Tanaka, Daisuke; Yabe, Daisuke; Harada, Norio; Inagaki, Nobuya] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Grad Sch Med, Kyoto, Japan; [Hayashi, Yoshitaka] Nagoya Univ, Div Stress Adaptat & Protect, Dept Genet, Res Inst Environm Med, Nagoya, Aichi, Japan	Kyoto University; Nagoya University	Inagaki, N (corresponding author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	inagaki@kuhp.kyoto-u.ac.jp	Yabe, Daisuke/J-6682-2014; Hayashi, Yoshitaka/I-6168-2014; tokumoto, shinsuke/AAF-7515-2020	Yabe, Daisuke/0000-0002-5334-7687; Hayashi, Yoshitaka/0000-0002-7557-4303; tokumoto, shinsuke/0000-0002-4070-6724; HARADA, NORIO/0000-0001-8720-1013; Tatsuoka, Hisato/0000-0002-0669-6825	Japan Society for the Promotion of Sciences; Japan Agency for Medical Research and Development (AMED); KAKENHI [24591325, 18K08474, 26111004, 17K09825, 17K19654, 16H05326]; AMED Grants [JP17lm0203006j0001, 19ek0210111h0002, 17ek0210079h0001]	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED Grants	This work was supported by grants from the Japan Society for the Promotion of Sciences and Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research (KAKENHI) Grants 24591325 (to S.H.), 18K08474 (to S.H.), 26111004 (to D.Y.), 17K09825 (to D.Y.), 17K19654 (to N.I.), and 16H05326 (to N.I.); and AMED Grants JP17lm0203006j0001 (to S.H.), 19ek0210111h0002 (to D.Y.), 17ek0210079h0001 (to N.I.). The authors declare no conflicts of interest.	Ballinger A, 2003, GUT, V52, P319, DOI 10.1136/gut.52.3.319; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bochud M, 2009, J CLIN ENDOCR METAB, V94, P3969, DOI 10.1210/jc.2008-2428; Chen S, 2015, AM J PHYSIOL-ENDOC M, V308, pE414, DOI 10.1152/ajpendo.00418.2014; Choi KM, 2007, DIABETES RES CLIN PR, V75, P235, DOI 10.1016/j.diabres.2006.06.019; Cote M, 2005, J CLIN ENDOCR METAB, V90, P1434, DOI 10.1210/jc.2004-1711; Creutzfeldt M, 1974, Gastroenterology, V67, P748; Dobrian AD, 2011, AM J PHYSIOL-ENDOC M, V300, pE410, DOI 10.1152/ajpendo.00463.2010; ECKEL RH, 1979, DIABETES, V28, P1141, DOI 10.2337/diabetes.28.12.1141; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Farr Sarah, 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P126; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hsieh J, 2010, DIABETOLOGIA, V53, P552, DOI 10.1007/s00125-009-1611-5; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Joo E, 2017, DIABETES, V66, P868, DOI 10.2337/db16-0758; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; KOMATSU R, 1989, DIABETES, V38, P902, DOI 10.2337/diabetes.38.7.902; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Lacana E, 2002, J BIOL CHEM, V277, P32947, DOI 10.1074/jbc.M202841200; Lee YS, 2012, DIABETOLOGIA, V55, P2456, DOI 10.1007/s00125-012-2592-3; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Marques C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/538737; Nasteska D, 2014, DIABETES, V63, P2332, DOI 10.2337/db13-1563; Nijhuis J, 2009, OBESITY, V17, P2014, DOI 10.1038/oby.2009.113; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Pennington KL, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0063-5; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; SCHMIDT WE, 1985, DIABETOLOGIA, V28, P704, DOI 10.1007/BF00291980; Scholten A, 2006, J PROTEOME RES, V5, P1435, DOI 10.1021/pr0600529; Shetty GK, 2004, DIABETES CARE, V27, P2450, DOI 10.2337/diacare.27.10.2450; Sun F, 2015, DIABETES RES CLIN PR, V110, P26, DOI 10.1016/j.diabres.2015.07.015; Sun F, 2015, CLIN THER, V37, P225, DOI 10.1016/j.clinthera.2014.11.008; Suzuki K, 2013, J BIOL CHEM, V288, P1929, DOI 10.1074/jbc.M112.423137; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tsukiyama K, 2006, MOL ENDOCRINOL, V20, P1644, DOI 10.1210/me.2005-0187; Usui S, 2002, J LIPID RES, V43, P805; Wang J, 2014, AM J PHYSIOL-ENDOC M, V306, pE756, DOI 10.1152/ajpendo.00549.2013; Wang XC, 2014, WORLD J GASTROENTERO, V20, P14821, DOI 10.3748/wjg.v20.i40.14821; Wang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03901-8; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; Yamane S, 2016, J DIABETES INVEST, V7, P20, DOI 10.1111/jdi.12467; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Zhong JX, 2015, CLIN LIPIDOL, V10, P103, DOI 10.2217/CLP.14.59	49	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6239	6253		10.1096/fj.201801783RR	http://dx.doi.org/10.1096/fj.201801783RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30789757	Bronze, Green Submitted			2022-12-28	WOS:000466932600035
J	Lodberg, A; van der Eerden, BCJ; Boers-Sijmons, B; Thomsen, JS; Bruel, A; van Leeuwen, JPTM; Eijken, M				Lodberg, Andreas; van der Eerden, Bram C. J.; Boers-Sijmons, Bianca; Thomsen, Jesper Skovhus; Bruel, Annemarie; van Leeuwen, Johannes P. T. M.; Eijken, Marco			A follistatin-based molecule increases muscle and bone mass without affecting the red blood cell count in mice	FASEB JOURNAL			English	Article						IASP; therapeutic; erythropoiesis; muscle anabolic; osteoporosis	ACTIVIN-A; PARATHYROID-HORMONE; ERYTHROID-DIFFERENTIATION; ANDROGEN DEPRIVATION; POSTMENOPAUSAL WOMEN; MINERAL DENSITY; II RECEPTORS; MOUSE MODEL; MYOSTATIN; PROTEIN	Inhibitors of the activin receptor signaling pathway (IASPs) have become candidate therapeutics for sarcopenia and bone remodeling disorders because of their ability to increase muscle and bone mass. However, IASPs utilizing activin type IIA and IIB receptors are also potent stimulators of erythropoiesis, a feature that may restrict their usage to anemic patients because of increased risk of venous thromboembolism. Based on the endogenous TGF- superfamily antagonist follistatin (FST), a molecule in the IASP class, FSTHBS-mFc, was generated and tested in both ovariectomized and naive BALB/c and C57BL/6 mice. In ovariectomized mice, FSTHBS-mFc therapy dose-dependently increased cancellous bone mass up to 42% and improved bone microstructural indices. For the highest dosage of FSTHBS-mFc (30 mg/kg, 2 times/wk), the increase in cancellous bone mass was similar to that observed with parathyroid hormone therapy (1-34, 80 mu g/kg, 5 times/wk). Musculus quadriceps femoris mass dose-dependently increased up to 21% in ovariectomized mice. In both ovariectomized and naive mice, FSTHBS-mFc therapy did not influence red blood cell count or hematocrit or hemoglobin levels. If the results are reproduced, a human FSTHBS-mFc version could be applicable in patients with musculoskeletal conditions irrespective of hematocrit status.Lodberg, A., van der Eerden, B. C. J., Boers-Sijmons, B., Thomsen, J. S., Bruel, A., van Leeuwen, J. P. T. M., Eijken, M. A follistatin-based molecule increases muscle and bone mass without affecting the red blood cell count in mice.	[Lodberg, Andreas] Aarhus Univ Hosp, Dept Pulm Med, Aarhus, Denmark; [Lodberg, Andreas; Thomsen, Jesper Skovhus; Bruel, Annemarie] Aarhus Univ Hosp, Dept Biomed, Aarhus, Denmark; [Eijken, Marco] Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark; [Eijken, Marco] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [van der Eerden, Bram C. J.; Boers-Sijmons, Bianca; van Leeuwen, Johannes P. T. M.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Erasmus University Rotterdam; Erasmus MC	Lodberg, A (corresponding author), Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 3, DK-8000 Aarhus C, Denmark.	andreaslodberg@gmail.com	Lodberg, Andreas/ABB-2541-2021; van der Eerden, Bram CJ/I-7496-2012; Bruel, Annemarie/AAT-2310-2020; van Leeuwen, Johannes/D-5015-2014	Lodberg, Andreas/0000-0001-9261-8753; van der Eerden, Bram CJ/0000-0003-4403-6497; Thomsen, Jesper Skovhus/0000-0001-9386-6679; Eijken, Marco/0000-0002-9043-3971; van Leeuwen, Johannes/0000-0002-2282-4006; Bruel, Annemarie/0000-0003-4833-0888				Attie KM, 2014, AM J HEMATOL, V89, P766, DOI 10.1002/ajh.23732; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Bhattacharya I, 2018, CLIN PHARM DRUG DEV, V7, P484, DOI 10.1002/cpdd.386; Bialek P, 2014, BONE, V60, P162, DOI 10.1016/j.bone.2013.12.002; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Braekkan SK, 2010, HAEMATOL-HEMATOL J, V95, P270, DOI 10.3324/haematol.2009.008417; Burton LA, 2010, CLIN INTERV AGING, V5, P217; Carrancio S, 2014, BRIT J HAEMATOL, V165, P870, DOI 10.1111/bjh.12838; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Chiu CS, 2013, J GERONTOL A-BIOL, V68, P1181, DOI 10.1093/gerona/glt030; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Datta-Mannan A, 2013, J PHARMACOL EXP THER, V344, P616, DOI 10.1124/jpet.112.201491; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; Fajardo RJ, 2010, BONE, V46, P64, DOI 10.1016/j.bone.2009.09.018; Fuller K, 2000, BIOCHEM BIOPH RES CO, V268, P2, DOI 10.1006/bbrc.2000.2075; Gaddy-Kurten D, 2002, ENDOCRINOLOGY, V143, P74, DOI 10.1210/en.143.1.74; Goh BC, 2017, J BIOL CHEM, V292, P13809, DOI 10.1074/jbc.M117.782128; Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231; Hirotani H, 2002, CALCIFIED TISSUE INT, V70, P330, DOI 10.1007/s00223-001-2037-3; Ikenoue T, 1999, J CELL BIOCHEM, V75, P206, DOI 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.3.CO;2-K; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Latres E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15153; Latres E, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0060-8; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee YS, 2013, P NATL ACAD SCI USA, V110, pE3713, DOI 10.1073/pnas.1309907110; Liu LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136968; Liu WQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12794; Lodberg A, 2018, BONE, V110, P326, DOI 10.1016/j.bone.2018.02.026; Lodberg Andreas, 2015, Bone Rep, V2, P59, DOI 10.1016/j.bonr.2015.04.001; Lotinun S, 2010, BONE, V46, P1082, DOI 10.1016/j.bone.2010.01.370; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24; Miller PD, 2016, JAMA-J AM MED ASSOC, V316, P722, DOI 10.1001/jama.2016.11136; Morvan F, 2017, P NATL ACAD SCI USA, V114, P12448, DOI 10.1073/pnas.1707925114; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Padhi D, 2014, J CLIN ENDOCR METAB, V99, pE1967, DOI 10.1210/jc.2014-1271; Pearsall RS, 2008, P NATL ACAD SCI USA, V105, P7082, DOI 10.1073/pnas.0711263105; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Platzbecker U, 2017, LANCET ONCOL, V18, P1338, DOI 10.1016/S1470-2045(17)30615-0; Polkey MI, 2019, AM J RESP CRIT CARE, V199, P313, DOI 10.1164/rccm.201802-0286OC; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; Rooks D, 2017, J AM GERIATR SOC, V65, P1988, DOI 10.1111/jgs.14927; Rooks DS, 2017, J CACHEXIA SARCOPENI, V8, P727, DOI 10.1002/jcsm.12205; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; SAKAI R, 1993, BIOCHEM BIOPH RES CO, V195, P39, DOI 10.1006/bbrc.1993.2006; Shen C, 2018, J PHARMACOL EXP THER, V366, P291, DOI 10.1124/jpet.118.248195; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; SHIOZAKI M, 1992, P NATL ACAD SCI USA, V89, P1553, DOI 10.1073/pnas.89.5.1553; Sidis Y, 2005, ENDOCRINOLOGY, V146, P130, DOI 10.1210/en.2004-1041; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thomsen JS, 2012, CALCIFIED TISSUE INT, V90, P294, DOI 10.1007/s00223-012-9576-7; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107; Vegger JB, 2014, BONE, V66, P287, DOI 10.1016/j.bone.2014.06.020; Virchow R. L. K., 1910, THROMBOSE EMBOLIE 18, V7; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Westbroek I, 2007, J CELL BIOCHEM, V101, P360, DOI 10.1002/jcb.21177; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Woodhouse L, 2016, J FRALITY AGING, V5, P62, DOI 10.14283/jfa.2016.81; Yaden BC, 2014, J PHARMACOL EXP THER, V349, P355, DOI 10.1124/jpet.113.211169; Yamawaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078076; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2; Zhu YX, 2016, BIOANALYSIS, V8, P193, DOI 10.4155/bio.15.238	82	10	11	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6001	6010		10.1096/fj.201801969RR	http://dx.doi.org/10.1096/fj.201801969RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30759349	Bronze			2022-12-28	WOS:000466932600017
J	Benedetto, R; Cabrita, I; Schreiber, R; Kunzelmann, K				Benedetto, Roberta; Cabrita, Ines; Schreiber, Rainer; Kunzelmann, Karl			TMEM16A is indispensable for basal mucus secretion in airways and intestine	FASEB JOURNAL			English	Article						anoctamin 1; cystic fibrosis; asthma; Ca2+ signaling	ACTIVATED CHLORIDE CHANNEL; GOBLET CELL HYPERPLASIA; BICARBONATE; MODULATION; MECHANISM; TRANSPORT; OVEREXPRESSION; ANOCTAMINS; REGULATOR; PROTEIN	Transmembrane member 16A (TMEM16A) is the Ca2+-activated chloride channel in airways and intestine. It has been associated with goblet cell metaplasia, as expression of TMEM16A is strongly up-regulated in cystic fibrosis and asthma during mucus hypersecretion. However, the possible role of TMEM16A for mucus production or mucus secretion remains obscure, and whether TMEM16A controls the function of intestinal goblet cells is entirely unknown. Basal mucus secretion in lungs occurs through low levels of ATP in the airway surface liquid. Here, we report for the first time that TMEM16A is essential for basal secretion of mucus in airways and intestine. Airway-ciliated and intestinal epithelial-specific knockout of TMEM16A (TMEM16A(flox/flox)FoxJ1, TMEM16A(flox/flox)Vil1) leads to accumulation of mucus in airway club (Clara) cells and intestinal goblet cells, respectively. Acute ATP-induced mucus secretion by airway club cells is inhibited when TMEM16A is knocked out in ciliated cells, possibly as a result of compromised release of prosecretory cytokines. Knockdown or inhibition of TMEM16A in human Calu3 airway epithelial cells indicates compromised IL-8 release. In intestinal goblet cells lacking expression of TMEM16A, mucus accumulates as a result of compromised ATP-induced secretion. In contrast, cholinergic mucus secretion by compound exocytosis is independent of TMEM16A. The data demonstrate a previously unrecognized role of TMEM16A for membrane exocytosis and describe a novel, ATP-driven pathway for intestinal mucus secretion. We conclude that ATP-dependent mucus secretion in both airways and intestine requires TMEM16A. The present results may form the basis for a novel, therapeutic approach for the treatment of mucus hypersecretion in inflammatory airway and intestinal disease.Benedetto, R., Cabrita, I., Schreiber, R., Kunzelmann, K. TMEM16A is indispensable for basal mucus secretion in airways and intestine.	[Benedetto, Roberta; Cabrita, Ines; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany	University of Regensburg	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@ur.de		Cabrita, Ines/0000-0002-1349-7605	Cystic Fibrosis Trust [SRC 013]; Gilead Stiftung; DFG [KU756/14-1]; Cystic Fibrosis Trust [SRC013] Funding Source: researchfish	Cystic Fibrosis Trust; Gilead Stiftung(Gilead Sciences); DFG(German Research Foundation (DFG)); Cystic Fibrosis Trust	The excellent technical assistance by P. Seeberger and E. Tartler (Institut fur Psychologie, Universitat Regensburg) is gratefully acknowledged. The authors thank Ernst Tamm and Margit Schimmel (Institute for Anatomy, University of Regensburg) for providing electron microscopy images. The supply of mice with a floxed TMEM16A gene by Jason R. Rock (Boston University School of Medicine, Boston, MA, USA) and FoxJ1-Cre mice by Michael J. Holtzman and Y. Zhang (Washington University School of Medicine, St. Louis, MO, USA) is gratefully acknowledged. This work was supported by Cystic Fibrosis Trust (SRC 013), Personalized Therapies for All (DFG KU756/14-1), and Gilead Stiftung. The authors declare no conflicts of interest.	Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Benedetto R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10910-0; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Cabrita I, 2017, FASEB J, V31, P2123, DOI 10.1096/fj.201600797RR; Caci E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131775; Chambers LA, 2007, RESP PHYSIOL NEUROBI, V159, P256, DOI 10.1016/j.resp.2007.06.005; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Gorrieri G, 2016, SCI REP-UK, V6, DOI 10.1038/srep36016; Gupta R, 2019, AM J RESP CELL MOL, V60, P209, DOI 10.1165/rcmb.2018-0156OC; He M, 2017, P NATL ACAD SCI USA, V114, pE11161, DOI 10.1073/pnas.1714448115; Houy S, 2017, ELIFE, V6, DOI 10.7554/eLife.27000; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Jeon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067989; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kondo M, 2017, CLIN EXP ALLERGY, V47, P795, DOI 10.1111/cea.12887; Kondo M, 2012, ALLERGOL INT, V61, P133, DOI 10.2332/allergolint.11-OA-0307; Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1; Kunzelmann K, 2017, J CYST FIBROS, V16, P653, DOI 10.1016/j.jcf.2017.06.005; KUROSUMI K, 1981, ARCH HISTOL JAPON, V44, P263, DOI 10.1679/aohc1950.44.263; Lin JC, 2015, EXP CELL RES, V334, P260, DOI 10.1016/j.yexcr.2015.02.026; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Matos JE, 2005, J PHYSIOL-LONDON, V564, P269, DOI 10.1113/jphysiol.2004.080002; Miner K, 2017, AM J RESP CRIT CARE, V195; MORRISON KJ, 1990, AM J PHYSIOL, V258, pL254, DOI 10.1152/ajplung.1990.258.6.L254; Neureither F, 2017, CEREBELLUM, V16, P929, DOI 10.1007/s12311-017-0867-4; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Rogers DF, 2006, ANN MED, V38, P116, DOI 10.1080/07853890600585795; Rossetto O, 2001, TOXICON, V39, P27, DOI 10.1016/S0041-0101(00)00163-X; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Schreiber R, 2015, PFLUG ARCH EUR J PHY, V467, P1203, DOI 10.1007/s00424-014-1559-2; Schreiber R, 2008, PFLUG ARCH EUR J PHY, V457, P431, DOI 10.1007/s00424-008-0543-0; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; Sirianant L, 2016, PFLUG ARCH EUR J PHY, V468, P805, DOI 10.1007/s00424-016-1789-6; SPECIAN RD, 1980, J CELL BIOL, V85, P626, DOI 10.1083/jcb.85.3.626; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Thorn Peter, 2012, Commun Integr Biol, V5, P61; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Wang P, 2018, J ALLERGY CLIN IMMUN, V141, P1259, DOI 10.1016/j.jaci.2017.05.053; Zhang CH, 2013, AM J RESP CRIT CARE, V187, P374, DOI 10.1164/rccm.201207-1303OC; Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	53	46	46	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4502	4512		10.1096/fj.201801333RRR	http://dx.doi.org/10.1096/fj.201801333RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30586313	Bronze			2022-12-28	WOS:000459794800111
J	Hillebrand, LE; Wickberg, SM; Gomez-Auli, A; Follo, M; Maurer, J; Busch, H; Boerries, M; Reinheckel, T				Hillebrand, Larissa E.; Wickberg, Sarah M.; Gomez-Auli, Alejandro; Follo, Marie; Maurer, Jochen; Busch, Hauke; Boerries, Melanie; Reinheckel, Thomas			MMP14 empowers tumor-initiating breast cancer cells under hypoxic nutrient-depleted conditions	FASEB JOURNAL			English	Article						mammary carcinoma; phenotypic plasticity; proteases	TYPE-1 MATRIX-METALLOPROTEINASE; IN-VITRO PROPAGATION; STEM-CELLS; EXPRESSION; PROMOTES; MT1-MMP; PROGRESSION; IDENTIFICATION; ANGIOGENESIS; METASTASIS	Tumor-initiating cells (TICs) existing in breast cancer are thought to be involved in initiation, progression, and relapse of tumors. In these processes, the epithelial-to-mesenchymal transition (EMT) and proteases are crucial factors that also dependent on the tumor milieu, including hypoxic nutrient-deprived, as well as normoxic nutrient-rich, environments. Therefore, we investigated EMT and proteases in TICs and their response to different environments by means of a newly generated immortalized TIC (iTIC) line. With the use of primary CD24(+)CD90(+)CD45(-) TICs from the mouse mammary tumor virus-polyoma middle T mouse breast cancer model, iTICs were generated by single cell-initiated sphere and subsequent 2-dimensional monolayer culture. Our data demonstrate the possibility to generate iTICs that are highly tumorigenic in culture and in mouse mammary fat pad. Contrasting environmental conditions provide these cells with a phenotypic and molecular plasticity that has a growth-promoting character in nutrient-rich normoxia and a motile character in nutrient-deprived hypoxia. Expression profiling revealed partial and dynamically changing EMT states, as well as a significantly up-regulated proteolytic signature, including many metalloproteinases, such as matrix metalloproteinase 14 (Mmp14). Inhibitor treatment of metalloproteinases, as well as short hairpin RNA-mediated knockdown of Mmp14 strongly impacted TIC characteristics, including tumor initiation, cell growth, migration, and invasion, especially in starved environments. We conclude that metalloproteinases empower TICs to adapt to changing environments.Hillebrand, L. E., Wickberg, S. M., Gomez-Auli, A., Follo, M., Maurer, J., Busch, H., Boerries, M., Reinheckel, T. MMP14 empowers tumor-initiating breast cancer cells under hypoxic nutrient-depleted conditions.	[Hillebrand, Larissa E.; Wickberg, Sarah M.; Gomez-Auli, Alejandro; Busch, Hauke; Boerries, Melanie; Reinheckel, Thomas] Univ Freiburg, Med Fac, Inst Mol Med & Cell Res, Freiburg, Germany; [Follo, Marie] Univ Freiburg, Med Ctr, Dept Med 1, Lighthouse Core Facil,Fac Med, Freiburg, Germany; [Hillebrand, Larissa E.; Reinheckel, Thomas] BIOSS Ctr Biol Signaling Studies, Freiburg, Germany; [Maurer, Jochen; Boerries, Melanie; Reinheckel, Thomas] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Boerries, Melanie; Reinheckel, Thomas] Comprehens Canc Ctr Freiburg, Freiburg, Germany; [Maurer, Jochen] Rheinisch Westfalische TH Aachen Univ, Aachen, Germany; [Busch, Hauke] Univ Lubeck, Lubeck, Germany	University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); RWTH Aachen University; University of Lubeck	Reinheckel, T (corresponding author), Albert Ludwigs Univ Freiburg, Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.reinheckel@mol-med.uni-freiburg.de	Reinheckel, Thomas/AAL-9761-2021; Maurer, Jochen/G-4832-2018; Boerries, Melanie/AAM-2602-2021; Busch, Hauke/R-6452-2016	Reinheckel, Thomas/0000-0001-9866-9105; Maurer, Jochen/0000-0003-3962-3128; Busch, Hauke/0000-0003-4763-4521	Deutsche Forschungsgemeinschaft [SFB850]; Excellence Initiative of the German Federal and State Governments [EXC 294, EXC 306]; German Cancer Consortium Program Oncogenic Pathways [L625, L627]; German Federal Ministry of Education and Research [FKZ 01ZX1409B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; German Cancer Consortium Program Oncogenic Pathways; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The authors thank Nicole Klemm (Institute of Molecular Medicine and Cell Research) for excellent technical support, and Dr. Melanie Bewerunge-Hudler and Dr. Stephan Wolf (German Cancer Research Center Genomics and Proteomics Core Facility, Heidelberg, Germany) for providing the Illumina Whole-Genome Expression BeadChips and related service. This work was supported by the Deutsche Forschungsgemeinschaft SFB850 Projects B7 (to T.R.) and Z1 (to M.B.), the Excellence Initiative of the German Federal and State Governments (EXC 294, BIOSS, Project B10 to T.R.; EXC 306 to H.B.), the German Cancer Consortium Program Oncogenic Pathways (Project L625 to M.B.; L627 to T.R.), and the German Federal Ministry of Education and Research, including the framework of the e:Med research and funding concept (FKZ 01ZX1409B to M.B.). The authors declare no conflicts of interest.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bengsch F, 2014, ONCOGENE, V33, P4474, DOI 10.1038/onc.2013.395; Bierie B, 2017, P NATL ACAD SCI USA, V114, pE2337, DOI 10.1073/pnas.1618298114; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carnero A, 2016, BIOESSAYS, V38, pS65, DOI 10.1002/bies.201670911; Castro DJ, 2013, STEM CELLS, V31, P12, DOI 10.1002/stem.1224; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fantozzi A, 2014, CANCER RES, V74, P1566, DOI 10.1158/0008-5472.CAN-13-1641; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hamdan FH, 2014, GENOMICS, V104, P477, DOI 10.1016/j.ygeno.2014.10.010; Hardee ME, 2009, CURR MOL MED, V9, P435, DOI 10.2174/156652409788167122; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hillebrand LE, 2016, ONCOTARGET, V7, P58244, DOI 10.18632/oncotarget.11309; Hong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004569; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Jiang WG, 2006, INT J MOL MED, V17, P583; Jolly MK, 2016, ONCOTARGET, V7, P27067, DOI 10.18632/oncotarget.8166; Kessenbrock K, 2015, MATRIX BIOL, V44-46, P184, DOI 10.1016/j.matbio.2015.01.022; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Ma J, 2012, TUMOR BIOL, V33, P1983, DOI 10.1007/s13277-012-0458-4; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; McMahon S, 2005, J BIOL CHEM, V280, P6561, DOI 10.1074/jbc.M413248200; Michor F, 2010, CANCER PREV RES, V3, P1361, DOI 10.1158/1940-6207.CAPR-10-0234; Miyoshi A, 2006, INT J ONCOL, V29, P1533; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ritchie ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002276; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Sevenich L, 2014, GENE DEV, V28, P2331, DOI 10.1101/gad.250647.114; Thompson EW, 2018, NATURE, V556, P442, DOI 10.1038/d41586-018-04403-x; Turunen SP, 2017, BBA-MOL CELL RES, V1864, P1974, DOI 10.1016/j.bbamcr.2017.04.002; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11459	56	19	21	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4124	4140		10.1096/fj.201801127R	http://dx.doi.org/10.1096/fj.201801127R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521382				2022-12-28	WOS:000459794800082
J	Liu, Y; Ren, HZ; Wang, JL; Yang, FJ; Li, J; Zhou, Y; Yuan, XW; Zhu, W; Shi, XL				Liu, Yang; Ren, Haozhen; Wang, Jinglin; Yang, Faji; Li, Jun; Zhou, Yuan; Yuan, Xianwen; Zhu, Wei; Shi, Xiaolei			Prostaglandin E-2 secreted by mesenchymal stem cells protects against acute liver failure via enhancing hepatocyte proliferation	FASEB JOURNAL			English	Article						cell proliferation; YAP; mTOR	HIPPO PATHWAY; STROMAL CELLS; YAP; GROWTH; PHOSPHORYLATION; TUMORIGENESIS; REGENERATION; INFLAMMATION; INHIBITION; EXPRESSION	Bone marrow-derived mesenchymal stem cells (MSCs) have been recently used in clinical trials as treatment for liver diseases. However, the underlying mechanism of their effectiveness remains largely unexplored. In the present study, we confirmed that the protective effects of MSCs on mouse model of acute liver failure (ALF) were based on MSC-secreted prostaglandin (PG)E-2. Our data confirmed that MSC-secreted PGE(2) not only inhibited apoptosis but also enhanced hepatocyte proliferation, thus attenuating ALF. Moreover, Yes-associated protein (YAP) played a major role in PGE(2)-triggered hepatocyte proliferation. In vitro studies showed that PGE(2) increased the expression of PGE(4) and enhanced the phosphorylation of cAMP response element binding protein, resulting in YAP activation and increased expression of YAP-related genes. Furthermore, the mammalian target of rapamycin, another major regulator of cell proliferation, was activated by YAP via suppressing phosphatase and tensin homolog through miR-29a-3p. These pathways coordinated to control cell proliferation. Collectively, MSCs could promote the recovery of ALF through PGE(2)-induced hepatocyte proliferation.Liu, Y., Ren, H., Wang, J., Yang, F., Li, J., Zhou, Y., Yuan, X., Zhu, W., Shi, X. Prostaglandin E-2 secreted by mesenchymal stem cells protects against acute liver failure via enhancing hepatocyte proliferation.	[Liu, Yang; Ren, Haozhen; Wang, Jinglin; Yang, Faji; Li, Jun; Zhou, Yuan; Yuan, Xianwen; Shi, Xiaolei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Hepatobiliary Surg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Wei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Anesthesiol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Shi, XL (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Hepatobiliary Surg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Zhu, W (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Anesthesiol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	chzhuwei118@qq.com; njsxl2000@163.com			National Natural Science Foundation of China [81670566]; Jiangsu Provincial Medical Talent Grant [ZDRCA2016066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Medical Talent Grant	This work was supported by National Natural Science Foundation of China Grant 81670566, and by Jiangsu Provincial Medical Talent Grant ZDRCA2016066. The authors declare no conflicts of interest.	Alfaifi M, 2018, J HEPATOL, V68, P1272, DOI 10.1016/j.jhep.2018.01.030; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Blenis J, 2017, CELL, V171, P10, DOI 10.1016/j.cell.2017.08.019; Chaulk SG, 2014, J BIOL CHEM, V289, P1886, DOI 10.1074/jbc.C113.529362; Chung Raymond T, 2012, Gastroenterology, V143, pe1, DOI 10.1053/j.gastro.2012.07.011; Detry O, 2017, J HEPATOL, V67, P47, DOI 10.1016/j.jhep.2017.03.001; Fan FQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2304; Hansen CG, 2015, CELL RES, V25, P1299, DOI 10.1038/cr.2015.140; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Hossain MA, 1999, BRIT J SURG, V86, P776, DOI 10.1046/j.1365-2168.1999.01098.x; Jiang JW, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12351; Kachaylo E, 2017, HEPATOLOGY, V66, P908, DOI 10.1002/hep.29226; Kim HB, 2017, GASTROENTEROLOGY, V152, P616, DOI 10.1053/j.gastro.2016.11.005; Kim HS, 2013, GASTROENTEROLOGY, V145, P1392, DOI 10.1053/j.gastro.2013.08.033; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kuzumoto Y, 2005, HEPATOLOGY, V42, P608, DOI 10.1002/hep.20827; Lin BL, 2017, HEPATOLOGY, V66, P209, DOI 10.1002/hep.29189; Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089; Mao YX, 2015, STEM CELLS, V33, P2331, DOI 10.1002/stem.1996; Matsumoto Y, 2016, MOL THER, V24, P1848, DOI 10.1038/mt.2016.127; Miyamura N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms16017; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nguyen HB, 2013, ONCOGENE, V32, P4100, DOI 10.1038/onc.2012.431; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542; Tiao MM, 2014, APOPTOSIS, V19, P30, DOI 10.1007/s10495-013-0909-4; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang JY, 2013, HEPATOLOGY, V58, P1011, DOI 10.1002/hep.26420; Yimlamai D, 2015, J HEPATOL, V63, P1491, DOI 10.1016/j.jhep.2015.07.008; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340	35	16	16	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2514	2525		10.1096/fj.201801349RR	http://dx.doi.org/10.1096/fj.201801349RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260707				2022-12-28	WOS:000457296600078
J	Shi, Y; Lv, X; Liu, YA; Li, BC; Liu, MM; Yan, M; Liu, YJ; Li, Q; Zhang, XJ; He, S; Zhu, MS; He, JL; Zhu, Y; Zhu, Y; Ai, D				Shi, Ying; Lv, Xue; Liu, Yanan; Li, Bochuan; Liu, Mingming; Yan, Meng; Liu, Yajin; Li, Qi; Zhang, Xuejiao; He, Shuang; Zhu, Mason; He, Jinlong; Zhu, Yan; Zhu, Yi; Ai, Ding			Elevating ATP-binding cassette transporter G1 improves re-endothelialization function of endothelial progenitor cells via Lyn/Akt/eNOS in diabetic mice	FASEB JOURNAL			English	Article						high glucose; cholesterol efflux; vasculogenesis; vascular repair	ACTIVATED PROTEIN-KINASE; ABCG1(-/-) BONE-MARROW; TYROSINE KINASE; CHOLESTEROL EFFLUX; ACCELERATES ATHEROSCLEROSIS; ANGIOGENESIS; DYSFUNCTION; DEFICIENCY; METABOLISM; MELLITUS	Endothelial progenitor cell (EPC) dysfunction contributes to diabetes-induced delay in endothelium repair after vessel injury, prominently associated with diabetic cardiovascular complications such as neointima formation. ATP-binding cassette transporter G1 (ABCG1) promotes cholesterol efflux to HDL, which may favorably affect EPC function. However, whether ABCG1 improves EPC function, especially in diabetes, remains unknown. Here we investigated the role of ABCG1 in EPCs by using Tie2-mediated ABCG1 transgenic (Tie2-ABCG1(Tg)) mice. Mice were injected with streptozotocin to induce diabetes mellitus. As compared with wild-type (WT) mice, in Tie2-ABCG1(Tg) mice, diabetes-impaired EPC migration and tube formation were reversed. In vitro gain-of-function and loss-of-function studies further revealed that ABCG1-overexpressing EPCs showed increased migration and tube formation and differentiation via the Lck/Yes-related novel protein tyrosine kinase /Akt/endothelial NO synthase pathway by enhancing cellular cholesterol efflux. Finally, type 1 and type 2 diabetic mouse models with arterial injury were intravenously injected with labeled EPCs from WT or Tie2-ABCG1(Tg) mice. Re-endothelialization in diabetic mice was improved to a greater extent by injection of ABCG1-overexpressing than WT EPCs. Our study demonstrated that ABCG1 in EPCs improved repair after vascular injury in diabetes by increasing EPC function such as migration, tube formation and differentiation, and subsequent re-endothelialization. ABCG1 might be a promising therapeutic target for diabetes-associated vascular diseases.Shi, Y., Lv, X., Liu, Y., Li, B., Liu, M., Yan, M., Liu, Y., Li, Q., Zhang, X., He, S., Zhu, M., He, J., Zhu, Y., Zhu, Y., Ai, D. Elevating ATP-binding cassette transporter G1 improves re-endothelialization function of endothelial progenitor cells via Lyn/Akt/eNOS in diabetic mice.	[Shi, Ying; Lv, Xue; Liu, Yanan; Li, Bochuan; Liu, Mingming; Yan, Meng; Liu, Yajin; Li, Qi; Zhang, Xuejiao; He, Jinlong; Zhu, Yi; Ai, Ding] Tianjin Med Univ, Dept Physiol & Pathophysiol, Tianjin Key Lab Metab Dis, Tianjin, Peoples R China; [Shi, Ying] Tianjin Chest Hosp, Tianjin Inst Cardiovasc Dis, Tianjin, Peoples R China; [He, Shuang; Zhu, Yan] Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Zhu, Mason] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA	Tianjin Medical University; Tianjin University of Traditional Chinese Medicine; University of California System; University of California San Diego	Ai, D (corresponding author), Tianjin Med Univ, Dept Physiol, Qixiangtai Rd 22, Tianjin 300070, Peoples R China.	dingai@tmu.edu.cn	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936; Ai, Ding/0000-0001-5992-9904	National Key Research and Development Program of China [2017YFC1307402]; National Natural Science Foundation of China [81420108003, 81670388, 81400320]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China Grant 2017YFC1307402, and by National Natural Science Foundation of China Grants 81420108003 (to Yi Z.), 81670388 (to D.A.), and 81400320 (to J.H.). The authors declare no conflicts of interest.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Brown RJ, 2013, ANAL BIOCHEM, V433, P56, DOI 10.1016/j.ab.2012.10.007; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cochran BJ, 2016, DIABETES, V65, P3610, DOI 10.2337/db16-0668; Ding JZ, 2015, DIABETES, V64, P3464, DOI 10.2337/db14-1314; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Georgescu A, 2011, EUR J PHARMACOL, V669, P1, DOI 10.1016/j.ejphar.2011.07.035; Ii M, 2006, CIRC RES, V98, P697, DOI 10.1161/01.RES.0000209948.50943.ea; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Kessler T, 2015, CIRCULATION, V131, P1191, DOI 10.1161/CIRCULATIONAHA.114.014072; Li XX, 2012, MICROCIRCULATION, V19, P547, DOI 10.1111/j.1549-8719.2012.00186.x; Ma FX, 2006, J LIPID RES, V47, P1227, DOI 10.1194/jlr.M500507-JLR200; Mao RF, 2017, CIRC RES, V120, P1727, DOI 10.1161/CIRCRESAHA.116.309754; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Pagler TA, 2011, CIRC RES, V108, P194, DOI 10.1161/CIRCRESAHA.110.228619; Psaltis PJ, 2015, CIRC RES, V116, P1392, DOI 10.1161/CIRCRESAHA.116.305368; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Song YM, 2013, CARDIOVASC RES, V99, P514, DOI 10.1093/cvr/cvt113; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Sturek JM, 2010, J CLIN INVEST, V120, P2575, DOI 10.1172/JCI41280; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; van Oostrom O, 2007, ARTERIOSCL THROM VAS, V27, P1864, DOI 10.1161/ATVBAHA.107.143875; Wei SP, 2015, J MOL CELL CARDIOL, V87, P17, DOI 10.1016/j.yjmcc.2015.08.004; Westerterp M, 2016, CIRC RES, V119, P13, DOI 10.1161/CIRCRESAHA.116.309116; Westerterp M, 2016, ARTERIOSCL THROM VAS, V36, P1328, DOI 10.1161/ATVBAHA.115.306670; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Xue SS, 2016, BIOCHEM BIOPH RES CO, V477, P247, DOI 10.1016/j.bbrc.2016.06.050; Ye L, 2015, WORLD J STEM CELLS, V7, P894, DOI 10.4252/wjsc.v7.i6.894; Yiu KH, 2014, ARTERIOSCL THROM VAS, V34, P1136, DOI 10.1161/ATVBAHA.114.302192; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang QH, 2010, EXP BIOL MED, V235, P1082, DOI 10.1258/ebm.2010.010060	48	15	16	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6525	6536		10.1096/fj.201800248RR	http://dx.doi.org/10.1096/fj.201800248RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	30495987				2022-12-28	WOS:000449359700014
J	Ferchaud-Roucher, V; Barner, K; Jansson, T; Powell, TL				Ferchaud-Roucher, Veronique; Barner, Kelsey; Jansson, Thomas; Powell, Theresa L.			Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory and insulin-sensitizing properties	FASEB JOURNAL			English	Article						POA synthesis; pregnancy; placenta; lipids	PRIMARY HUMAN TROPHOBLAST; BODY-MASS INDEX; ADIPOSE-TISSUE; METABOLISM; PREGNANCY; TERM; EXPRESSION; CHILDHOOD; TRANSPORT; MEMBRANE	The fetus is dependent on delivery of fatty acids (FAs) by the syncytiotrophoblast, the transporting epithelium of the human placenta. Obese pregnant women have dyslipidemia; however, whether obesity impacts placental lipid transport and metabolism remains to be fully established. Palmitoleic acid (POA), an FA with anti-inflammatory and insulin-sensitizing properties, is synthesized from palmitic acid (PA) catalyzed by stearoyl-coenzyme A desaturase (SCD) activity. We hypothesized that the uptake and incorporation of FAs and POA synthesis are reduced in primary human trophoblasts (PHTs) isolated from pregnancies complicated by maternal obesity. Villous cytotrophoblasts were isolated from 7 placentas of obese [body mass index (BMI) = 37.5 +/- 1.9] and 12 normal (BMI = 23.6 +/- 0.6) mothers. FA uptake and incorporation were assessed using uniformly labeled (U[C-13])-FA mixtures of PA, oleic acid (OA), linoleic acid, and docosahexaenoic acid. Cellular [C-13] FAs were quantified both in total cellular lipids and in lipid classes by GC-MS. Uptake and incorporation of [C-13] FAs in total cellular lipids were not different in PHTs isolated from obese mothers compared with normal mothers. Only the concentration of OA was increased in the triglyceride fraction (P < 0.05) if the mother was obese. We found an isotopic enrichment of POA after U[C-13]-PA treatment, demonstrating SCD activity in PHT cells. Labeled POA content and the POA:PA ratio were significantly lower in PHTs isolated from placentas of obese mothers compared with normal, healthy controls. Decreased syncytiotrophoblast POA synthesis may contribute to insulin resistance and low-grade inflammation in the mother, placenta, or fetus (or a combination of the 3) in pregnancies complicated by obesity.Ferchaud-Roucher, V., Barner, K., Jansson, T., Powell, T. L. Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory and insulin-sensitizing properties.	[Ferchaud-Roucher, Veronique; Barner, Kelsey; Jansson, Thomas; Powell, Theresa L.] Univ Colorado, Div Reprod Sci, Dept Obstet & Gynecol, Anschutz Med Campus, Aurora, CO 80045 USA; [Powell, Theresa L.] Univ Colorado, Sect Neonatol, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Ferchaud-Roucher, V (corresponding author), Univ Colorado, Dept Obstet & Gynecol, Anschutz Med Campus,Res Complex 2,Mail Stop 8613, Aurora, CO 80045 USA.	veronique.ferchaudroucher@ucdenver.edu	Powell, Theresa/AAE-4249-2020	FERCHAUD-ROUCHER, Veronique/0000-0001-6809-1488	Perinatal Clinical Translational Research Center at the University of Colorado Anschutz Medical Campus; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK048520-23]; NIH National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute Clinical and Translational Science Award [UL1 TR002535]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	Perinatal Clinical Translational Research Center at the University of Colorado Anschutz Medical Campus; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute Clinical and Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Placental collection was supported by the Perinatal Clinical Translational Research Center at the University of Colorado Anschutz Medical Campus. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant DK048520-23, and NIH National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute Clinical and Translational Science Award Grant UL1 TR002535. The authors declare no conflicts of interest.	Aye ILMH, 2014, MOL ENDOCRINOL, V28, P512, DOI 10.1210/me.2013-1401; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Brass E, 2013, PLACENTA, V34, P503, DOI 10.1016/j.placenta.2013.03.009; Calabuig-Navarro V, 2017, ENDOCRINOLOGY, V158, P2543, DOI 10.1210/en.2017-00152; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Chan KL, 2015, J BIOL CHEM, V290, P16979, DOI 10.1074/jbc.M115.646992; COBELLI C, 1992, AM J PHYSIOL, V262, pE968, DOI 10.1152/ajpendo.1992.262.6.E968; de Souza CO, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700504; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Ferchaud-Roucher V, 2019, BBA-MOL CELL BIOL L, V1864, P394, DOI 10.1016/j.bbalip.2018.12.007; Ferchaud-Roucher V, 2017, PROSTAG LEUKOTR ESS, V121, P14, DOI 10.1016/j.plefa.2017.06.001; Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015; Flanagan JL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-30; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; Frigolet ME, 2017, ADV NUTR, V8, p173S, DOI 10.3945/an.115.011130; Vazquez-Vela MEF, 2008, ARCH MED RES, V39, P715, DOI 10.1016/j.arcmed.2008.09.005; Gil-Sanchez A, 2010, AM J CLIN NUTR, V92, P115, DOI 10.3945/ajcn.2010.29589; Hanebutt FL, 2008, CLIN NUTR, V27, P685, DOI 10.1016/j.clnu.2008.05.010; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Hirschmugl B, 2017, INT J OBESITY, V41, P317, DOI 10.1038/ijo.2016.188; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Jarvie E, 2010, CLIN SCI, V119, P123, DOI 10.1042/CS20090640; Jones HN, 2010, DIABETES, V59, P1161, DOI 10.2337/db09-0824; Kusunoki J, 2006, ENDOCRINE, V29, P91, DOI 10.1385/ENDO:29:1:91; Lager S, 2014, PLACENTA, V35, P523, DOI 10.1016/j.placenta.2014.04.017; Lager S, 2011, PLACENTA, V32, P121, DOI 10.1016/j.placenta.2010.10.012; Lager S, 2016, PLACENTA, V40, P60, DOI 10.1016/j.placenta.2016.02.010; Lager S, 2013, J LIPID RES, V54, P725, DOI 10.1194/jlr.M033050; Lassance L, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.026; Lindegaard MLS, 2005, J LIPID RES, V46, P2339, DOI 10.1194/jlr.M500277-JLR200; Min Y, 2004, DIABETOLOGIA, V47, P75, DOI 10.1007/s00125-003-1275-5; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Parsons TJ, 2001, BRIT MED J, V323, P1331, DOI 10.1136/bmj.323.7325.1331; Pathmaperuma AN, 2010, PLACENTA, V31, P230, DOI 10.1016/j.placenta.2009.12.013; Perazzolo S, 2017, J LIPID RES, V58, P443, DOI 10.1194/jlr.P072355; Riserus U, 2005, DIABETES, V54, P1379, DOI 10.2337/diabetes.54.5.1379; Rosario FJ, 2013, J PHYSIOL-LONDON, V591, P609, DOI 10.1113/jphysiol.2012.238014; Rudolph MC, 2012, ANAL BIOCHEM, V428, P158, DOI 10.1016/j.ab.2012.06.013; Saben J, 2014, PLACENTA, V35, P171, DOI 10.1016/j.placenta.2014.01.003; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Sewell MF, 2006, AM J OBSTET GYNECOL, V195, P1100, DOI 10.1016/j.ajog.2006.06.014; Sharma Shruti, 2009, Drug Discov Today Dis Mech, V6, pe31; Talbot NA, 2014, MOL CELL ENDOCRINOL, V393, P129, DOI 10.1016/j.mce.2014.06.010; Uhl O, 2015, DIABETES RES CLIN PR, V109, P364, DOI 10.1016/j.diabres.2015.05.032	49	9	10	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6643	6654		10.1096/fj.201802444R	http://dx.doi.org/10.1096/fj.201802444R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30811959	Green Published, Bronze			2022-12-28	WOS:000466932600066
J	Liu, GL; Zhang, FF; Wang, RX; London, SD; London, L				Liu, Guangliang; Zhang, Fangfang; Wang, Ruixue; London, Steven D.; London, Lucille			Salivary gland immunization via Wharton's duct activates differential T-cell responses within the salivary gland immune system	FASEB JOURNAL			English	Article						mucosal immunity; vaccine development; T helper cells	ROR-GAMMA-T; SJOGRENS-SYNDROME; MURINE CYTOMEGALOVIRUS; PROMOTES ACCUMULATION; MUCOSAL; EXPRESSION; MEMORY; INFECTION; CYTOKINES; TRANSCRIPTION	Salivary glands are a major component of the mucosal immune system that confer adaptive immunity to mucosal pathogens. As previously demonstrated, immunization of the submandibular gland with tissue culture-derived murine cytomegalovirus (tcMCMV) or replication-deficient adenoviruses expressing individual murine cytomegalovirus (MCMV) genes protected mice against a lethal MCMV challenge. Here, we report that salivary gland inoculation of BALB/cByJ mice with tcMCMV or recombinant adenoviruses differentially activates T helper (T-h)1, -2, and -17 cells in the salivary glands vs. the associated lymph nodes. After inoculation with tcMCMV, lymphocytes from the submandibular gland preferentially express the transcription factor T-cell-specific T-box transcription factor (T-bet), which controls the expression of the hallmark T(h)1 cytokine, IFN-. Lymphocytes from the periglandular lymph nodes (PGLNs) express both T-bet and GATA-binding protein 3 (GATA3), which promotes the secretion of IL-4, -5, and -10 from T(h)2 cells. In contrast, after inoculation with replication-deficient adenoviruses, lymphocytes from the submandibular gland express T-bet, GATA3, and RAR-related orphan receptor , thymus-specific isoform (RORt) (required for differentiation of T(h)17 cells) and forkhead box P3 (Foxp3) (required for the differentiation of regulatory T cells). Lymphocytes from the PGLNs were not activated. The differential induction of T-h responses in the salivary gland vs. the PGLNs after inoculation with attenuated virus vs. a nominal protein antigen supports the use of the salivary as an alternative mucosal route for administering vaccines.Liu, G., Zhang, F., Wang, R., London, S. D., London, L. Salivary gland immunization via Wharton's duct activates differential T-cell responses within the salivary gland immune system.	[Liu, Guangliang; Zhang, Fangfang; Wang, Ruixue; London, Steven D.; London, Lucille] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, 231 Dutchess Hall, Stony Brook, NY 11794 USA; [Liu, Guangliang] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Sate Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Zhang, Fangfang] Lanzhou Univ, Sch Basic Sci, Inst Pathol, Lanzhou, Gansu, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Lanzhou University	London, L (corresponding author), SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, 231 Dutchess Hall, Stony Brook, NY 11794 USA.	lucille.london@stonybrook.edu	Zhang, Fang/HHN-2153-2022; Liu, Guangliang/I-8173-2013	Liu, Guangliang/0000-0001-8158-5749	U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research Grant [1R01 DE016652, 1R15DE024313]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R15DE024313] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr. John D. Shanley and Dr. Carol A. Wu (University of Connecticut, Farmington, CT, USA) for providing recombinant adenovirus vectors and cell lines. This project was supported by U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research Grant 1R01 DE016652 (to S.D.L.) and 1R15DE024313 (to S.D.L.). The authors declare no conflicts of interest.	Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Bikker A, 2010, ARTHRITIS RHEUM-US, V62, P969, DOI 10.1002/art.27318; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Brune W, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1907s43; Caldeira-Dantas S, 2018, J IMMUNOL, V200, P1133, DOI 10.4049/jimmunol.1701272; Campbell AE, 2008, MED MICROBIOL IMMUN, V197, P205, DOI 10.1007/s00430-008-0077-2; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cavanaugh VJ, 2003, J VIROL, V77, P1703, DOI 10.1128/JVI.77.3.1703-1717.2003; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Fu HM, 2013, FRONT BIOSCI-LANDMRK, V18, P422, DOI 10.2741/4111; Gagliani N, 2017, METHODS MOL BIOL, V1514, P19, DOI 10.1007/978-1-4939-6548-9_2; Geist LJ, 2001, J INVEST MED, V49, P434, DOI 10.2310/6650.2001.33788; Grewal JS, 2011, FASEB J, V25, P1680, DOI 10.1096/fj.10-174656; Guggino G, 2017, EUR J IMMUNOL, V47, P2002, DOI 10.1002/eji.201747140; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Hillen MR, 2016, ANN RHEUM DIS, V75, P1735, DOI 10.1136/annrheumdis-2016-209236; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Iizuka M, 2015, J IMMUNOL, V194, P56, DOI 10.4049/jimmunol.1401118; Ivetic A, 2013, INT J BIOCHEM CELL B, V45, P550, DOI 10.1016/j.biocel.2012.12.023; Kallies A, 2017, TRENDS IMMUNOL, V38, P287, DOI 10.1016/j.it.2017.02.003; Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319; Khor B, 2017, TRANSFUS MED REV, V31, P36, DOI 10.1016/j.tmrv.2016.07.003; Liu GL, 2014, FASEB J, V28, P1698, DOI 10.1096/fj.13-244178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Xiaojing, 2015, F1000Res, V4, DOI 10.12688/f1000research.7010.1; Maehara T, 2012, CLIN EXP IMMUNOL, V169, P89, DOI 10.1111/j.1365-2249.2012.04606.x; Mieliauskaite D, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/187258; Min B, 2017, J INTERF CYTOK RES, V37, P386, DOI 10.1089/jir.2017.0027; Na H, 2016, IMMUNE NETW, V16, P1, DOI 10.4110/in.2016.16.1.1; Nalbant Ayten, 2016, Front Biosci (Elite Ed), V8, P427; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Picarda G, 2018, J IMMUNOL, V200, P3881, DOI 10.4049/jimmunol.1800171; Pilgrim MJ, 2007, EXP MOL PATHOL, V82, P269, DOI 10.1016/j.yexmp.2006.12.010; Plitas G, 2016, CANCER IMMUNOL RES, V4, P721, DOI 10.1158/2326-6066.CIR-16-0193; Ponzio Todd A, 2017, Trop Dis Travel Med Vaccines, V3, P4, DOI 10.1186/s40794-017-0047-z; Qiao YC, 2017, AUTOIMMUN REV, V16, P1058, DOI 10.1016/j.autrev.2017.08.001; Sakai A, 2008, J IMMUNOL, V181, P2898, DOI 10.4049/jimmunol.181.4.2898; Sarigul M, 2010, LUPUS, V19, P138, DOI 10.1177/0961203309348234; Shanley JD, 2005, VACCINE, V23, P996, DOI 10.1016/j.vaccine.2004.07.041; Shanley JD, 2003, VACCINE, V21, P2632, DOI 10.1016/S0264-410X(03)00037-9; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Szodoray P, 2005, CLIN IMMUNOL, V117, P168, DOI 10.1016/j.clim.2005.06.016; Tahara M, 2017, CLIN EXP IMMUNOL, V187, P213, DOI 10.1111/cei.12868; Takahashi I, 2009, CURR OPIN IMMUNOL, V21, P352, DOI 10.1016/j.coi.2009.04.002; Tang-Feldman YJ, 2006, J VIROL METHODS, V131, P122, DOI 10.1016/j.jviromet.2005.07.013; Tessmer MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001254; Tucker SN, 2004, VACCINE, V22, P2500, DOI 10.1016/j.vaccine.2003.12.034; van Eden W, 2013, FEBS LETT, V587, P1951, DOI 10.1016/j.febslet.2013.05.024; Verma NK, 2017, J IMMUNOL, V199, P1213, DOI 10.4049/jimmunol.1700495; Wali S, 2016, CYTOKINE, V87, P9, DOI 10.1016/j.cyto.2016.06.010; Wang JJ, 2016, EUR J IMMUNOL, V46, P2444, DOI 10.1002/eji.201646300; Woyciechowski S, 2017, EUR J IMMUNOL, V47, P244, DOI 10.1002/eji.201646722; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Zhang LW, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12649; Zhao LL, 2017, RHEUMATOLOGY, V56, P303, DOI 10.1093/rheumatology/kew360; Zhu JF, 2015, CYTOKINE, V75, P14, DOI 10.1016/j.cyto.2015.05.010; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	60	0	0	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6011	6022		10.1096/fj.201801993R	http://dx.doi.org/10.1096/fj.201801993R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817215	Green Published, Bronze			2022-12-28	WOS:000466932600018
J	Ballaro, R; Beltra, M; De Lucia, S; Pin, F; Ranjbar, K; Hulmi, JJ; Costelli, P; Penna, F				Ballaro, Riccardo; Beltra, Marc; De Lucia, Serena; Pin, Fabrizio; Ranjbar, Kia; Hulmi, Juha J.; Costelli, Paola; Penna, Fabio			Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations	FASEB JOURNAL			English	Article						cancer cachexia; mitochondria; autophagy; PGC-1 alpha; survival	PROTEIN-SYNTHESIS; ANIMAL-MODEL; CACHEXIA; PREVENTION; RESISTANCE; MECHANISMS; ATROPHY; IMPACT	Cancer cachexia is a multifactorial syndrome characterized by anorexia, body wasting, and muscle and adipose tissue loss, impairing patient's tolerance to anticancer treatments and survival. The aim of the present study was to compare the effects induced in mice by tumor growth alone (C26) or in combination with chemotherapy [C26 oxaliplatin and 5-fluorouracil (oxfu)] and to evaluate the potential of moderate exercise. Oxfu administration to C26 mice exacerbated muscle wasting and triggered autophagy or mitophagy, decreased protein synthesis, and induced mitochondrial alterations. Exercise in C26 oxfu mice counteracted the loss of muscle mass and strength, partially rescuing autophagy and mitochondrial function. Nevertheless, exercise worsened survival in C26 oxfu mice in late stages of cachexia. In summary, chemotherapy further impinges on cancer-induced alterations, worsening muscle wasting. An ideal multifactorial and early intervention to prevent cancer cachexia could take advantage of exercise, improving patient's energy metabolism, mobility, and quality of life.	[Ballaro, Riccardo; Beltra, Marc; De Lucia, Serena; Costelli, Paola; Penna, Fabio] Univ Torino, Expt Med & Clin Pathol Unit, Dept Clin & Biol Sci, Turin, Italy; [Ballaro, Riccardo; Beltra, Marc; De Lucia, Serena; Costelli, Paola; Penna, Fabio] Interuniv Inst Myol, Assisi, Italy; [Pin, Fabrizio] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Ranjbar, Kia] Univ Tarbiat Modares, Fac Phys Educ & Sport Sci, Dept Exercise Physiol, Tehran, Iran; [Hulmi, Juha J.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Biol Phys Act, Neuromuscular Res Ctr, Jyvaskyla, Finland	University of Turin; Indiana University System; Indiana University Bloomington; Tarbiat Modares University; University of Jyvaskyla	Penna, F (corresponding author), Univ Torino, Dept Clin & Biol Sci, Corso Raffaello 30, I-10125 Turin, Italy.	fabio.penna@unito.it	Ballarò, Riccardo/ABC-1988-2020; Beltrà, Marc/AFR-7797-2022; Penna, Fabio/K-5090-2016	Ballarò, Riccardo/0000-0001-5505-9024; Beltrà, Marc/0000-0001-6070-9861; Penna, Fabio/0000-0002-2774-6027	Associazione Italiana per la Ricerca sul Cancro [AIRC], Milano [IG9153]; University of Torino; Academy of Finland [275922]	Associazione Italiana per la Ricerca sul Cancro [AIRC], Milano(Fondazione AIRC per la ricerca sul cancro); University of Torino; Academy of Finland(Academy of Finland)	The authors thank Juulia Lautaoja (Neuromuscular Research Center, Biology of Physical Activity, Faculty of Sport and Health Sciences, University of Jyvaskyla) for technical assistance. This work was supported by Associazione Italiana per la Ricerca sul Cancro [AIRC; Grant IG9153 (to P.C.)] Milano, University of Torino (ex-60% funds), and by Academy of Finland Grant 275922 (to J.J.H.). The authors declare no conflicts of interest.	Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Argiles JM, 2012, J CACHEXIA SARCOPENI, V3, P73, DOI 10.1007/s13539-012-0067-5; Aversa Z, 2017, THER ADV MED ONCOL, V9, P369, DOI 10.1177/1758834017698643; Ballaro R, 2016, CURR OPIN SUPPORT PA, V10, P281, DOI 10.1097/SPC.0000000000000233; Barreto R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00472; Barreto R, 2016, ONCOTARGET, V7, P43442, DOI 10.18632/oncotarget.9779; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106489; Bredahl EC, 2016, MED SCI SPORT EXER, V48, P1468, DOI 10.1249/MSS.0000000000000926; Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232; Cao SS, 1996, J NATL CANCER I, V88, P430, DOI 10.1093/jnci/88.7.430; Chacon-Cabrera A, 2017, J CELL PHYSIOL, V232, P3744, DOI 10.1002/jcp.25851; Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023; Damrauer J.S., 2008, BASIC APPL MYOL, V18, P139, DOI [10.4081/ejtm.2018.7590, DOI 10.4081/EJTM.2018.7590, DOI 10.4081/ejtm.2018.7590]; Engelen MPKJ, 2016, CURR OPIN CLIN NUTR, V19, P39, DOI 10.1097/MCO.0000000000000236; Gilliam LAA, 2016, AM J PHYSIOL-ENDOC M, V311, pE293, DOI 10.1152/ajpendo.00540.2015; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Grande AJ, 2015, J CACHEXIA SARCOPENI, V6, P208, DOI 10.1002/jcsm.12055; Hatakeyama S, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0098-2; Heywood R, 2018, ARCH PHYS MED REHAB, V99, P2595, DOI 10.1016/j.apmr.2018.04.008; Hojman P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109030; Kazemi-Bajestani SMR, 2016, SEMIN CELL DEV BIOL, V54, P2, DOI 10.1016/j.semcdb.2015.09.001; Keizman D, 2010, CANCER, V116, P251, DOI 10.1002/cncr.24710; Khamoui AV, 2016, METABOLISM, V65, P685, DOI 10.1016/j.metabol.2016.01.014; LEBRICON T, 1995, METABOLISM, V44, P1340, DOI 10.1016/0026-0495(95)90040-3; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MacDonald AJ, 2015, CLIN CANCER RES, V21, P1734, DOI 10.1158/1078-0432.CCR-14-2004; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Miyamoto Y, 2015, ANN SURG ONCOL, V22, P2663, DOI 10.1245/s10434-014-4281-6; Nissinen TA, 2018, J CACHEXIA SARCOPENI, V9, P514, DOI 10.1002/jcsm.12310; Padilha CS, 2017, APPL PHYSIOL NUTR ME, V42, P916, DOI 10.1139/apnm-2016-0436; Penna F, 2016, EXPERT OPIN INV DRUG, V25, P63, DOI 10.1517/13543784.2016.1117072; Penna F, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7153610; Penna F, 2016, J CACHEXIA SARCOPENI, V7, P345, DOI 10.1002/jcsm.12050; Penna F, 2016, SEMIN CELL DEV BIOL, V54, P20, DOI 10.1016/j.semcdb.2015.09.002; Penna F, 2013, AM J PATHOL, V182, P1367, DOI 10.1016/j.ajpath.2012.12.023; Penna F, 2011, J CACHEXIA SARCOPENI, V2, P95, DOI 10.1007/s13539-011-0028-4; Penna F, 2010, INT J CANCER, V127, P1706, DOI 10.1002/ijc.25146; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Pigna E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26991; Pin F, 2015, ONCOTARGET, V6, P43202, DOI 10.18632/oncotarget.6439; Robinson SM, 2013, J HEPATOL, V59, P318, DOI 10.1016/j.jhep.2013.04.014; Sandri M, 2016, SEMIN CELL DEV BIOL, V54, P11, DOI 10.1016/j.semcdb.2015.11.002; Toledo M, 2016, J CACHEXIA SARCOPENI, V7, P48, DOI 10.1002/jcsm.12035; von Haehling S, 2014, J CACHEXIA SARCOPENI, V5, P261, DOI 10.1007/s13539-014-0164-8; White JP, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-14; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599	50	46	46	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5482	5494		10.1096/fj.201801862R	http://dx.doi.org/10.1096/fj.201801862R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30653354	Bronze			2022-12-28	WOS:000462888500068
J	Fergie, N; Todd, N; McClements, L; McAuley, D; O'Kane, C; Krasnodembskaya, A				Fergie, Nicola; Todd, Naomi; McClements, Lana; McAuley, Danny; O'Kane, Cecilia; Krasnodembskaya, Anna			Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair	FASEB JOURNAL			English	Article						ARDS; hypercapnic acidosis; mitochondrial transfer; wound healing	STROMAL CELLS; IN-VITRO; ENDOTHELIAL-CELLS; EXPRESSION; INJURY; MODELS; INFLAMMATION; VENTILATION; CAVEOLIN-1; MORTALITY	Acute respiratory distress syndrome (ARDS) is a devastating disorder characterized by diffuse inflammation and edema formation. The main management strategy, low tidal volume ventilation, can be associated with the development of hypercapnic acidosis (HCA). Mesenchymal stem cells (MSCs) are a promising therapeutic candidate currently in early-phase clinical trials. The effects of HCA on the alveolar epithelium and capillary endothelium are not well established. The therapeutic efficacy of MSCs has never been reported in HCA. In the present study, we evaluated the effects of HCA on inflammatory response and reparative potential of the primary human small airway epithelial and lung microvasculature endothelial cells as well as on the capacity of bone marrow-derived MSCs to promote wound healing in vitro. We demonstrate that HCA attenuates the inflammatory response and reparative potential of primary human small airway epithelium and capillary endothelium and induces mitochondrial dysfunction. It was found that MSCs promote lung epithelial wound repair via the transfer of functional mitochondria; however, this proreparative effect of MSCs was lost in the setting of HCA. Therefore, HCA may adversely impact recovery from ARDS at the cellular level, whereas MSCs may not be therapeutically beneficial in patients with ARDS who develop HCA.	[Fergie, Nicola; Todd, Naomi; McClements, Lana; McAuley, Danny; O'Kane, Cecilia; Krasnodembskaya, Anna] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Expt Med, Room 2-059,Wellcome Wolfson Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Krasnodembskaya, A (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Expt Med, Room 2-059,Wellcome Wolfson Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	a.krasnodembskaya@qub.ac.uk	McClements, Lana/S-9458-2019; Krasnodembskaya, Anna D./I-1225-2019	McClements, Lana/0000-0002-4911-1014; Krasnodembskaya, Anna D./0000-0002-2380-5069; McAuley, Daniel/0000-0002-3283-1947; O'Kane, Cecilia/0000-0002-7138-5396	Medical Research Council (MRC) [MR/L017229/1]; MRC Queen's University of Belfast (QUB) [CD1516-CIC4]; Department for Education (DfE); National Institute of General Medical Sciences (NIGMS) of the U.S. National Institutes of Health [P40RR017447]; MRC [MR/M009149/1, MR/L017229/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Queen's University of Belfast (QUB); Department for Education (DfE); National Institute of General Medical Sciences (NIGMS) of the U.S. National Institutes of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (MRC) (MR/L017229/1), MRC Queen's University of Belfast (QUB) (CD1516-CIC4), and the Department for Education (DfE) (PhD studentship). Some of the materials employed in this work were provided by the Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Baylor Scott and White Hospital through a grant from the National Institute of General Medical Sciences (NIGMS) of the U.S. National Institutes of Health (Grant No. P40RR017447). The authors declare no conflicts of interest.	Akram KM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-9; Boyle AJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-166; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Burg J, 2002, AM J PHYSIOL-LUNG C, V283, pL460, DOI 10.1152/ajplung.00249.2001; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; Contreras M, 2012, CRIT CARE MED, V40, P2622, DOI 10.1097/CCM.0b013e318258f8b4; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; Curley GF, 2013, ANESTHESIOLOGY, V118, P924, DOI 10.1097/ALN.0b013e318287ba08; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Dada LA, 2015, MOL CELL BIOL, V35, P3962, DOI 10.1128/MCB.00813-15; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang XH, 2010, J BIOL CHEM, V285, P26211, DOI 10.1074/jbc.M110.119917; Fergie N., 2017, THORAX, V72, pA018; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; GEAR ARL, 1974, J BIOL CHEM, V249, P3628; Geys J, 2006, TOXICOL LETT, V160, P218, DOI 10.1016/j.toxlet.2005.07.005; Godfrey RWA, 1997, MICROSC RES TECHNIQ, V38, P488, DOI 10.1002/(SICI)1097-0029(19970901)38:5<488::AID-JEMT5>3.0.CO;2-E; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Higgins BD, 2009, ANESTHESIOLOGY, V111, P1317, DOI 10.1097/ALN.0b013e3181ba3c11; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Horie S, 2016, INTENS CARE MED, V42, P779, DOI 10.1007/s00134-015-4140-3; Horie Shahd, 2016, Intensive Care Med Exp, V4, P8, DOI 10.1186/s40635-016-0081-6; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Jackson MV, 2016, STEM CELLS, V34, P2210, DOI 10.1002/stem.2372; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Kregenow DA, 2006, CRIT CARE MED, V34, P1, DOI 10.1097/01.CCM.0000194533.75481.03; Laffey JG, 1999, LANCET, V354, P1283, DOI 10.1016/S0140-6736(99)02388-0; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Liu YL, 2008, CYTOKINE, V44, P108, DOI 10.1016/j.cyto.2008.06.016; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Matthay MA, 2019, LANCET RESP MED, V7, P154, DOI 10.1016/S2213-2600(18)30418-1; McAuley DF, 2014, AM J PHYSIOL-LUNG C, V306, pL809, DOI 10.1152/ajplung.00358.2013; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Morrison T, 2015, J Intensive Care Soc, V16, P320, DOI 10.1177/1751143715586420; Morrison TJ, 2017, AM J RESP CRIT CARE, V196, P1275, DOI 10.1164/rccm.201701-0170OC; Muller AM, 2002, EXP MOL PATHOL, V73, P171, DOI 10.1006/exmp.2002.2446; Nardelli LM, 2015, RESP PHYSIOL NEUROBI, V205, P1, DOI 10.1016/j.resp.2014.09.007; Niu ZD, 2016, ENVIRON TOXICOL PHAR, V45, P212, DOI 10.1016/j.etap.2016.06.006; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Patel AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121246; Piantadosi CA, 2017, ANNU REV PHYSIOL, V79, P495, DOI 10.1146/annurev-physiol-022516-034322; Rydkina E, 2010, INFECT IMMUN, V78, P2599, DOI 10.1128/IAI.01335-09; Scott BB, 2005, BIOCHEM BIOPH RES CO, V328, P409, DOI 10.1016/j.bbrc.2004.12.180; Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003; SMITH MF, 1994, J IMMUNOL, V153, P3584; Swain RJ, 2010, BIOPHYS J, V98, P1703, DOI 10.1016/j.bpj.2009.12.4289; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Tsuji Takao, 2013, Open Respir Med J, V7, P6, DOI 10.2174/1874306401307010006; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vadasz I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046696; Vohwinkel CU, 2011, J BIOL CHEM, V286, P37067, DOI 10.1074/jbc.M111.290056; Welch LC, 2010, FEBS LETT, V584, P3985, DOI 10.1016/j.febslet.2010.08.002; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/S2213-2600(14)70291-7, 10.1016/s2213-2600(14)70291-7]; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Wu GJ, 2005, ANN NY ACAD SCI, V1042, P168, DOI 10.1196/annals.1338.019; Wu SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074742; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zheng GP, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-39	61	25	25	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5585	5598		10.1096/fj.201802056R	http://dx.doi.org/10.1096/fj.201802056R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30649987	Green Published, hybrid			2022-12-28	WOS:000462888500076
J	Lahav-Ariel, L; Caspi, M; Nadar-Ponniah, PT; Zelikson, N; Hofmann, I; Hanson, KK; Franke, WW; Sklan, EH; Avraham, KB; Rosin-Arbesfeld, R				Lahav-Ariel, Lital; Caspi, Michal; Nadar-Ponniah, Prathamesh T.; Zelikson, Natalie; Hofmann, Ilse; Hanson, Kirsten K.; Franke, Werner W.; Sklan, Ella H.; Avraham, Karen B.; Rosin-Arbesfeld, Rina			Striatin is a novel modulator of cell adhesion	FASEB JOURNAL			English	Article						cell-cell junctions; Wnt signaling; epithelial cells; tight junctions	TIGHT JUNCTIONS; CALMODULIN-BINDING; NEGATIVE REGULATOR; PROTEIN; APC; ORGANIZATION; FAMILY; IDENTIFICATION; MICROTUBULES; MAINTENANCE	The adherens junctions (AJs) and tight junctions (TJs) provide critical adhesive contacts between neighboring epithelial cells and are crucial for epithelial adhesion, integrity, and barrier functions in a wide variety of tissues and organisms. The striatin protein family, which are part of the striatin interaction phosphatases and kinases complex, are multidomain scaffolding proteins that play important biologic roles. We have previously shown that striatin colocalizes with the tumor suppressor protein adenomatous polyposis coli in the TJs of epithelial cells. Here we show that striatin affects junction integrity and cell migration, probably through a mechanism that involves the adhesion molecule E-cadherin. Cells engaged in cell-cell adhesion expressed a high MW-modified form of striatin that forms stable associations with detergent-insoluble, membrane-bound cellular fractions. In addition, striatin has recently been suggested to be a target of the poly (ADP-ribose) polymerases Tankyrase 1, and we have found that striatin interacts with Tankyrase 1 and is subsequently poly-ADP-ribosylated. Taken together, our results suggest that striatin is a novel cell-cell junctional protein that functions to maintain correct cell adhesion and may have a role in establishing the relationship between AJs and TJs that is fundamental for epithelial cell-cell adhesion.	[Lahav-Ariel, Lital; Caspi, Michal; Nadar-Ponniah, Prathamesh T.; Zelikson, Natalie; Sklan, Ella H.; Rosin-Arbesfeld, Rina] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-6997801 Tel Aviv, Israel; [Nadar-Ponniah, Prathamesh T.; Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel; [Nadar-Ponniah, Prathamesh T.; Avraham, Karen B.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Hofmann, Ilse] German Canc Res Ctr DKFZ ZMBH Alliance, Ctr Mol Biol, Div Vasc Oncol & Metastasis, Heidelberg, Germany; [Franke, Werner W.] German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany; [Hofmann, Ilse] Heidelberg Univ, Med Fac Mannheim, Dept Vasc Biol & Tumor Angiogenesis CBTM, Heidelberg, Germany; [Hanson, Kirsten K.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Hanson, Kirsten K.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Rosin-Arbesfeld, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-6997801 Tel Aviv, Israel.	arina@tauex.tau.ac.il		Hanson, Kirsten/0000-0002-0154-0979; Franke, Werner W./0000-0002-4873-8448; Nadar Ponniah, Prathamesh Thangaraj/0000-0002-1087-9069	German-Israeli Foundation [1098]; Israel Science Foundation [829/14]; Rising Tide Foundation for Clinical Cancer Research; Gateway for Cancer Research Foundation; United States-Israel Binational Science Foundation [2017173]; U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders [R01DC011835]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011835] Funding Source: NIH RePORTER	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Rising Tide Foundation for Clinical Cancer Research; Gateway for Cancer Research Foundation; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the German-Israeli Foundation (1098), the Israel Science Foundation (829/14), the Rising Tide Foundation for Clinical Cancer Research, the Gateway for Cancer Research Foundation (to R.R.-A.), the United States-Israel Binational Science Foundation (2017173, to R.R.-A. and K.B.A.), and the U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders Grant R01DC011835 (to K.B.A.). The authors declare no conflicts of interest.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Bahmanyar S, 2009, ADV EXP MED BIOL, V656, P65, DOI 10.1007/978-1-4419-1145-2_6; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Breitman M, 2008, BBA-MOL CELL RES, V1783, P1792, DOI 10.1016/j.bbamcr.2008.04.017; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Ciarlet M, 2001, J VIROL, V75, P11834, DOI 10.1128/JVI.75.23.11834-11850.2001; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; DEJANA E, 1994, CLIN EXP RHEUMATOL, V12, pS25; Del Vecchio G, 2012, MOL PHARMACEUT, V9, P2523, DOI 10.1021/mp3001414; Fearon ER, 2009, CANCER CELL, V16, P366, DOI 10.1016/j.ccr.2009.10.007; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hamada F, 2002, NAT CELL BIOL, V4, P208, DOI 10.1038/ncb755; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Hori K, 2003, FEBS LETT, V554, P30, DOI 10.1016/S0014-5793(03)01074-3; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Liu JX, 2017, MOL MED REP, V16, P8076, DOI 10.3892/mmr.2017.7643; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; MANDEL LJ, 1993, NATURE, V361, P552, DOI 10.1038/361552a0; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Mortensen K, 2003, CELL MOL LIFE SCI, V60, P1007, DOI 10.1007/s00018-003-3022-x; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Nunes FD, 2006, J CELL SCI, V119, P4819, DOI 10.1242/jcs.03233; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Petrova YI, 2016, MOL BIOL CELL, V27, P3233, DOI 10.1091/mbc.E16-01-0058; Pfister AS, 2012, J BIOL CHEM, V287, P1734, DOI 10.1074/jbc.M111.308650; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Stern JA, 2015, RES VET SCI, V102, P182, DOI 10.1016/j.rvsc.2015.08.009; Valnickova Z, 2006, BIOCHEMISTRY-US, V45, P1525, DOI 10.1021/bi051956v; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; ZOU ZZ, 1989, J HISTOCHEM CYTOCHEM, V37, P15, DOI 10.1177/37.1.2461981	53	6	6	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4729	4740		10.1096/fj.201801882R	http://dx.doi.org/10.1096/fj.201801882R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592649	Green Published			2022-12-28	WOS:000462888500008
J	Le Barz, M; Daniel, N; Varin, TV; Naimi, S; Demers-Mathieu, V; Pilon, G; Audy, J; Laurin, E; Roy, D; Urdaci, MC; St-Gelais, D; Fliss, I; Marette, A				Le Barz, Melanie; Daniel, Noemie; Varin, Thibault V.; Naimi, Sabrine; Demers-Mathieu, Veronique; Pilon, Genevieve; Audy, Julie; Laurin, Emilie; Roy, Denis; Urdaci, Maria C.; St-Gelais, Daniel; Fliss, Ismail; Marette, Andre			In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lb102 and Bifidobacterium animalis ssp. lactis Bf141 as probiotics that improve metabolic disorders in a mouse model of obesity	FASEB JOURNAL			English	Article						gut integrity; insulin resistance; dairy products	DIET-INDUCED OBESITY; INSULIN-RESISTANCE; GUT MICROBIOTA; ADIPOSE-TISSUE; HIGH-FAT; INTESTINAL INFLAMMATION; SENSITIVITY; MECHANISMS; PREBIOTICS; SUPPLEMENTATION	Given the growing evidence that gut dysfunction, including changes in gut microbiota composition, plays a critical role in the development of inflammation and metabolic diseases, the identification of novel probiotic bacteria with immunometabolic properties has recently attracted more attention. Herein, bacterial strains were first isolated from dairy products and human feces and then screened in vitro for their immunomodulatory activity. Five selected strains were further analyzed in vivo, using a mouse model of diet-induced obesity. C57BL/6 mice were fed a high-fat high-sucrose diet, in combination with 1 of 3 Lactobacillus strains (Lb38, L. plantarum; L79, L. paracasei/casei; Lb102, L. rhamnosus) or Bifidobacterium strains (Bf26, Bf141, 2 different strains of B. animalis ssp. lactis species) administered for 8 wk at 10(9) colony-forming units/d. Whereas 3 strains showed only modest (Lb38, Bf26) or no (L79) effects, Lb102 and Bf141 reduced diet-induced obesity, visceral fat accretion, and inflammation, concomitant with improvement of glucose tolerance and insulin sensitivity. Further analysis revealed that Lb102 and Bf141 enhanced intestinal integrity markers in association with selective changes in gut microbiota composition. We have thus identified 2 new potential probiotic bacterial strains with immunometabolic properties to alleviate obesity development and associated metabolic disturbances.	[Le Barz, Melanie; Daniel, Noemie; Varin, Thibault V.; Pilon, Genevieve; Marette, Andre] Laval Univ, Quebec Heart & Lung Inst, Res Ctr, Cardiol Axis,Dept Med,Fac Med, Quebec City, PQ, Canada; [Le Barz, Melanie; Daniel, Noemie; Varin, Thibault V.; Naimi, Sabrine; Demers-Mathieu, Veronique; Pilon, Genevieve; Roy, Denis; St-Gelais, Daniel; Fliss, Ismail; Marette, Andre] Laval Univ, Inst Nutr & Funct Foods, Quebec City, PQ, Canada; [Naimi, Sabrine; Demers-Mathieu, Veronique; St-Gelais, Daniel; Fliss, Ismail] Laval Univ, Dairy Sci & Technol Res Ctr, Quebec City, PQ, Canada; [Le Barz, Melanie; Urdaci, Maria C.] Univ Bordeaux, Lab Microbiol & Appl Biochem, Unite Mixte Rech 5248, Gradignan, France; [Demers-Mathieu, Veronique; St-Gelais, Daniel] Agr & Agri Food Canada, St Hyacinthe Res & Dev Ctr, St Hyacinthe, PQ, Canada; [Audy, Julie] Agropur Cooperat, St Hubert, PQ, Canada; [Laurin, Emilie] Ultima Foods, Granby, PQ, Canada; [Le Barz, Melanie] Univ Claude Bernard Lyon1, Lyon Univ, INSA Lyon, CarMeN Lab,INSERM,U1060,INRA,U1235, Oullins, France	Laval University; Quebec Heart & Lung Institute; Laval University; Laval University; UDICE-French Research Universities; Universite de Bordeaux; Agriculture & Agri Food Canada; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Marette, A (corresponding author), Laval Univ, Hop Laval, Quebec Heart & Lung Inst, Cardiol Axis, Pavillon Marguerite dYouville,Bur Y4340, Ste Foy, PQ G1V 4G5, Canada.	andre.marette@criucpq.ulaval.ca	Demers-Mathieu, Veronique/I-1923-2016; Roy, Denis/H-4998-2011; Carmen, Team1/Y-7382-2019	Demers-Mathieu, Veronique/0000-0002-7937-6355; Roy, Denis/0000-0002-4229-9245; Carmen, Team1/0000-0003-4234-1746; Le Barz, Melanie/0000-0002-2112-5254; Naimi, Sabrine/0000-0001-6553-7560; Urdaci, Maria C/0000-0002-0868-0050; Lab, Carmen/0000-0002-5935-3236; Daniel, Noemie/0000-0003-4319-0054; Marette, Andre/0000-0003-3950-5973	Natural Sciences and Engineering Research Council of Canada (NSERC) [CRDPJ 402030-2010]; Agropur Cooperative Laitiere; Aliments Ultima Food	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agropur Cooperative Laitiere; Aliments Ultima Food	The authors thank B. Marcotte, V. Dumais, and C. Dallaire for their help and advice during the in vitro screening and animal protocols, as well as Dr. Benjamin A. H. Jensen for help in proofreading and revising the text; B.M., V.D., C.D. and B.A.H.J. work in the Laboratory of Andre Marette at the Cardiology Axis of the Quebec Heart and Lung Institute Research Centre (Laval University, QC, Canada). This project was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC; CRDPJ 402030-2010), Agropur Cooperative Laitiere, and Aliments Ultima Foods. J.A. and E.L. are employees of Agropur Cooperative Laitiere and Aliments Ultima Foods, respectively, and were involved in the initial isolation of bacterial strains used in this study. However, they have neither been involved in the in vitro and in vivo screening of the strains nor in the interpretation of the data. The remaining authors declare no conflicts of interest.	Alard J, 2016, ENVIRON MICROBIOL, V18, P1484, DOI 10.1111/1462-2920.13181; Alhamoruni A, 2012, BRIT J PHARMACOL, V165, P2598, DOI 10.1111/j.1476-5381.2011.01589.x; Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Cani PD, 2014, DIABETES METAB, V40, P246, DOI 10.1016/j.diabet.2014.02.004; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de LeBlanc AD, 2014, WORLD J GASTROENTERO, V20, P16518, DOI 10.3748/wjg.v20.i44.16518; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Demers-Mathieu V, 2016, J FUNCT FOODS, V24, P327, DOI 10.1016/j.jff.2016.04.025; Demers-Mathieu V, 2015, INT DAIRY J, V45, P31, DOI 10.1016/j.idairyj.2015.01.014; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Galdeano CM, 2004, J APPL MICROBIOL, V97, P673, DOI 10.1111/j.1365-2672.2004.02353.x; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074; Hulston CJ, 2015, BRIT J NUTR, V113, P596, DOI 10.1017/S0007114514004097; Jensen BAH, 2016, METABOLISM, V65, P1706, DOI 10.1016/j.metabol.2016.09.002; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Khan MT, 2014, CELL METAB, V20, P753, DOI 10.1016/j.cmet.2014.07.006; Krych L, 2015, GUT MICROBES, V6, P101, DOI 10.1080/19490976.2015.1011876; Le Barz M, 2015, DIABETES METAB J, V39, P291, DOI 10.4093/dmj.2015.39.4.291; Lee Y, 2016, AM J PHYSIOL-GASTR L, V311, pG655, DOI 10.1152/ajpgi.00294.2015; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Minami J, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.5; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nagpal R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30114-4; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; O'Shea EF, 2012, INT J FOOD MICROBIOL, V152, P189, DOI 10.1016/j.ijfoodmicro.2011.05.025; Orel R, 2014, WORLD J GASTROENTERO, V20, P11505, DOI 10.3748/wjg.v20.i33.11505; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Sanchez B, 2010, MICROBIOL-SGM, V156, P3232, DOI 10.1099/mic.0.044057-0; Sanchez M, 2014, BRIT J NUTR, V111, P1507, DOI 10.1017/S0007114513003875; Sarkar A, 2016, MICROBIOL RES, V192, P159, DOI 10.1016/j.micres.2016.07.001; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; van Greevenbroek Marleen M J, 2016, F1000Res, V5; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yan Fang, 2012, Funct Food Rev, V4, P77	63	36	36	5	52	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4921	4935		10.1096/fj.201801672R	http://dx.doi.org/10.1096/fj.201801672R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596521				2022-12-28	WOS:000462888500023
J	Du, LJ; Yang, F; Fang, HS; Sun, HY; Chen, Y; Xu, Y; Li, H; Zheng, L; Zhou, BBS				Du, Lijuan; Yang, Fan; Fang, Houshun; Sun, Huiying; Chen, Yao; Xu, Yan; Li, Hui; Zheng, Liang; Zhou, Bin-Bing S.			AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells	FASEB JOURNAL			English	Article						cell cycle; apoptosis; nucleotide imbalances	ACTIVATED PROTEIN-KINASE; ADENOSINE-REGULATING AGENT; DOUBLE-STRAND BREAKS; CYCLE REGULATION; CANCER CELLS; APOPTOSIS; AMPK; ACADESINE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE-1-BETA-D-RIBOFURANOSIDE; MAINTENANCE	It has been shown that 5-amino-4-imidazolecarboxamide riboside (AICAr) can inhibit cell proliferation and induce apoptosis in childhood acute lymphoblastic leukemia (ALL) cells. Although AICAr could regulate cellular energy metabolism by activating AMPK, the cytotoxic mechanisms of AICAr are still unclear. Here, we knocked out TP53 or PRKAA1 gene (encoding AMPK1) in NALM-6 and Reh cells by using the clustered regularly interspaced short palindromic repeats/Cas9 system and found that AICAr-induced proliferation inhibition was independent of AMPK activation but dependent on p53. Liquid chromatography-mass spectrometry analysis of nucleotide metabolites indicated that AICAr caused an increase in adenosine triphosphate, deoxyadenosine triphosphate, and deoxyguanosine triphosphate levels by up-regulating purine biosynthesis, while AICAr led to a decrease in cytidine triphosphate, uridine triphosphate, deoxycytidine triphosphate, and deoxythymidine triphosphate levels because of reduced phosphoribosyl pyrophosphate production, which consequently impaired the pyrimidine biosynthesis. Ribonucleoside triphosphate (NTP) pool imbalances suppressed the rRNA transcription efficiency. Furthermore, deoxy-ribonucleoside triphosphate (dNTP) pool imbalances induced DNA replication stress and DNA double-strand breaks, followed by cell cycle arrest and apoptosis in ALL cells. Exogenous uridine could rebalance the NTP and dNTP pools by supplementing pyrimidine and then attenuate AICAr-induced cytotoxicity. Our data indicate that RNA transcription inhibition and DNA replication stress induced by NTP and dNTP pool imbalances might play a key role in AICAr-mediated cytotoxic effects on ALL cells, suggesting a potential clinical application of AICAr in future ALL therapy.Du, L., Yang, F., Fang, H., Sun, H., Chen, Y., Xu, Y., Li, H., Zheng, L., Zhou, B.-B. S. AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells.	[Du, Lijuan; Yang, Fan; Fang, Houshun; Sun, Huiying; Chen, Yao; Xu, Yan; Li, Hui; Zheng, Liang; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Minist Hlth, Key Lab Pediat Hematol & Oncol, 1678 Dongfang Rd, Shanghai 200127, Peoples R China; [Du, Lijuan; Yang, Fan; Fang, Houshun; Sun, Huiying; Chen, Yao; Xu, Yan; Li, Hui; Zheng, Liang; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Pediat Translat Med Inst, 1678 Dongfang Rd, Shanghai 200127, Peoples R China; [Li, Hui; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Sch Basic Med, Dept Pharmacol & Chem Biol, Shanghai, Peoples R China; [Li, Hui; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Translat Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, F; Zhou, BBS (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Minist Hlth, Key Lab Pediat Hematol & Oncol, 1678 Dongfang Rd, Shanghai 200127, Peoples R China.; Yang, F; Zhou, BBS (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Pediat Translat Med Inst, 1678 Dongfang Rd, Shanghai 200127, Peoples R China.	yangfan@nibs.ac.cn; binbing_s_zhou@yahoo.com		Zheng, Liang/0000-0002-5346-4111; Du, Lijuan/0000-0001-6792-3684	National Natural Science Foundation of China [31530017, 81372349, 81800145]; National Basic Research Program of China (973 Program) [2015CB553904]; Science and Technology Commission of Shanghai Municipality [13431900502, 16XD1402100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The authors thank Dr. Renate Kirschner-Schwabe (Charite-Universitatsmedizin Berlin, Berlin, Germany) for kindly providing the ALL cell lines, Malwine Pogodzinski (Charite-Universitatsmedizin Berlin) for sequencing the TP53 gene in all the ALL cell lines, Fangfei Wei and N. Cauwenberghs (both from University of Leuven, Leuven, Belgium) for reviewing the manuscript, and Shanghai ChemPartner and Wuhan Metware for LC-MS services. This work was supported by grants from the National Natural Science Foundation of China (31530017 and 81372349 to B.-B.S.Z., and 81800145 to F.Y.), the National Basic Research Program of China (973 Program 2015CB553904 to B.-B.S.Z.), and the Science and Technology Commission of Shanghai Municipality (13431900502 and 16XD1402100 to B.-B.S.Z.). The authors declare no conflicts of interest.	Adachi S, 2011, BIOCHEM BIOPH RES CO, V414, P53, DOI 10.1016/j.bbrc.2011.09.020; Ahmad MF, 2013, PROG MOL BIOL TRANSL, V117, P389, DOI 10.1016/B978-0-12-386931-9.00014-3; Bardeleben C, 2013, MOL CANCER THER, V12, P1310, DOI 10.1158/1535-7163.MCT-12-1042; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Ceschin J, 2014, J BIOL CHEM, V289, P16844, DOI 10.1074/jbc.M114.551192; Chabosseau P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1363; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cui CH, 2004, BIOTECHNIQUES, V36, P134, DOI 10.2144/04361RR04; Daignan-Fornier B, 2012, METABOLITES, V2, DOI 10.3390/metabo2020292; Drew BG, 2008, EXPERT OPIN PHARMACO, V9, P2137, DOI [10.1517/14656566.9.12.2137, 10.1517/14656566.9.12.2137 ]; Esparza Samuel D, 2005, MedGenMed, V7, P23; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; HIROTA Y, 1989, CANCER RES, V49, P915; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Lopez JM, 2003, BIOCHEM J, V370, P1027, DOI 10.1042/BJ20021053; Ma HQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04227; MEUTH M, 1989, EXP CELL RES, V181, P305, DOI 10.1016/0014-4827(89)90090-6; Morishita M, 2017, INT J ONCOL, V50, P23, DOI 10.3892/ijo.2016.3775; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Newman MF, 2012, JAMA-J AM MED ASSOC, V308, P157, DOI 10.1001/jama.2012.7633; Pfister SX, 2015, CANCER CELL, V28, P557, DOI 10.1016/j.ccell.2015.09.015; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Santidrian AF, 2010, BLOOD, V116, P3023, DOI 10.1182/blood-2010-05-283960; Schmiegelow K, 2014, J PEDIAT HEMATOL ONC, V36, P503, DOI 10.1097/MPH.0000000000000206; Schwab RAV, 2011, JOVE-J VIS EXP, DOI 10.3791/3255; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; Van Den Neste E, 2013, CANCER CHEMOTH PHARM, V71, P581, DOI 10.1007/s00280-012-2033-5; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Yang F., 2017, ONCOTARGET, V9, P2268; YOSHIOKA A, 1987, BIOCHEM BIOPH RES CO, V146, P258, DOI 10.1016/0006-291X(87)90719-4	39	10	10	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4525	4537		10.1096/fj.201801559RR	http://dx.doi.org/10.1096/fj.201801559RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30702927	Bronze			2022-12-28	WOS:000459794800113
J	Khan, MI; Al Johani, A; Hamid, A; Ateeq, B; Manzar, N; Adhami, VM; Lall, RK; Rath, S; Sechi, M; Siddiqui, IA; Choudhry, H; Zamzami, MA; Havighurst, TC; Huang, W; Ntambi, JM; Mukhtar, H				Khan, Mohammad Imran; Al Johani, Ahmed; Hamid, Abid; Ateeq, Bushra; Manzar, Nishat; Adhami, Vaqar Mustafa; Lall, Rahul K.; Rath, Suvasmita; Sechi, Mario; Siddiqui, Imtiaz Ahmad; Choudhry, Hani; Zamzami, Mazin A.; Havighurst, Thomas C.; Huang, Wei; Ntambi, James M.; Mukhtar, Hasan			Proproliferative function of adaptor protein GRB10 in prostate carcinoma	FASEB JOURNAL			English	Article						GRB10; PTEN; PI3K; RTKs; mTOR	INSULIN-RECEPTOR; CELL-PROLIFERATION; PTEN; INHIBITION; GROWTH; CANCER; PI3K; PHOSPHORYLATION; DISRUPTION; ACTIVATION	Growth factor receptor-binding protein 10 (GRB10) is a well-known adaptor protein and a recently identified substrate of the mammalian target of rapamycin (mTOR). Depletion of GRB10 increases insulin sensitivity and overexpression suppresses PI3K/Akt signaling. Because the major reason for the limited efficacy of PI3K/Akt-targeted therapies in prostate cancer (PCa) is loss of mTOR-regulated feedback suppression, it is therefore important to assess the functional importance and regulation of GRB10 under these conditions. On the basis of these background observations, we explored the status and functional impact of GRB10 in PCa and found maximum expression in phosphatase and tensin homolog (PTEN)-deficient PCa. In human PCa samples, GRB10 inversely correlated with PTEN and positively correlated with pAKT levels. Knockdown of GRB10 in nontumorigenic PTEN null mouse embryonic fibroblasts and tumorigenic PCa cell lines reduced Akt phosphorylation and selectively activated a panel of receptor tyrosine kinases. Similarly, overexpression of GRB10 in PTEN wild-type PCa cell lines accelerated tumorigenesis and induced Akt phosphorylation. In PTEN wild-type PCa, GRB10 overexpression promoted mediated PTEN interaction and degradation. PI3K (but not mTOR) inhibitors reduced GRB10 expression, suggesting primarily PI3K-driven regulation of GRB10. In summary, our results suggest that GRB10 acts as a major downstream effector of PI3K and has tumor-promoting effects in prostate cancer.Khan, M. I., Al Johani, A., Hamid, A., Ateeq, B., Manzar, N., Adhami, V. M., Lall, R. K., Rath, S., Sechi, M., Siddiqui, I. A., Choudhry, H., Zamzami, M. A., Havighurst, T. C., Huang, W., Ntambi, J. M., Mukhtar, H. Proproliferatve function of adaptor protein GRB10 in prostate carcinoma.	[Khan, Mohammad Imran; Choudhry, Hani; Zamzami, Mazin A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia; [Khan, Mohammad Imran; Choudhry, Hani; Zamzami, Mazin A.] King Abdulaziz Univ, Fac Sci, Canc Metab & Epigenet Unit, Jeddah, Saudi Arabia; [Khan, Mohammad Imran; Hamid, Abid; Adhami, Vaqar Mustafa; Lall, Rahul K.; Rath, Suvasmita; Siddiqui, Imtiaz Ahmad; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI USA; [Al Johani, Ahmed; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Sch Med & Publ Hlth, 420 Henry Mall, Madison, WI 53705 USA; [Havighurst, Thomas C.] Univ Wisconsin, Dept Biostat & Med Informat, Sch Med & Publ Hlth, Madison, WI USA; [Huang, Wei] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI USA; [Ateeq, Bushra; Manzar, Nishat] Indian Inst Technol Kanpur, Dept Biol Sci & Bioengn, Mol Oncol Lab, Kanpur, Uttar Pradesh, India; [Sechi, Mario] Univ Sassari, Dept Chem & Pharm, Sassari, Italy; [Al Johani, Ahmed] King Saud Bin Abdulaziz Univ Hlth Sci, Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Hamid, Abid] Cent Univ Kashmir, Sch Life Sci, Dept Biotechnol, Kashmir, India	King Abdulaziz University; King Abdulaziz University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; University of Sassari; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia; Central University of Kashmir	Khan, MI (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia.	mad4res@gmail.com	Zamzami, Mazin A/D-9101-2017; Ateeq, Bushra/I-3967-2019; Rath, Suvasmita/N-7915-2017; Adhami, Vaqar/AAY-2837-2020; Khan, Mohammad Imran/AAH-3327-2020; Khan, Mohammad Dr/B-2030-2019; Aljohani, Ahmed/HHD-3455-2022	Ateeq, Bushra/0000-0003-4682-9773; Rath, Suvasmita/0000-0001-8738-1560; Adhami, Vaqar/0000-0002-2048-4570; Manzar, Nishat/0000-0003-3628-6832; Lall, Rahulkumar/0000-0002-0042-6103; Khan, Mohammad Imran/0000-0001-5832-5017	U.S. National Institutes of Health, National Cancer Institute [RO1CA160867]; Regione Autonoma dellaSardegna (Annualita 2010) within the frame of Leggeregionale [CRP-25920, 7/2007]; University of Wisconsin Translational Research Initiatives Pathology Laboratory - University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center [P30CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Regione Autonoma dellaSardegna (Annualita 2010) within the frame of Leggeregionale; University of Wisconsin Translational Research Initiatives Pathology Laboratory - University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Prof. John Blenis (Weill Cornell Medical College, New York, NY, USA), Dr. Yonghao Yu (University of Texas Southwestern Medical Center, Dallas, TX, USA), and Prof. Illena Illert (University Medical Center Freiburg, Freiburg, Germany) for providing plasmids used in this study, and Prof. Tak W. Mak (University of Toronto, Toronto, ON, Canada) for providing PTEN MEF<SUP>WT</SUP> and PTEN MEF<SUP>-/-</SUP> cells. The authors also thank Precision Antibody (Columbia, MD, USA) for their helpful technical assistance. This work was supported by the U.S. National Institutes of Health, National Cancer Institute Grant RO1CA160867 (to H.M.), Regione Autonoma dellaSardegna (Annualita 2010) within the frame of Leggeregionale n 7/2007 (Grant CRP-25920 to M.S.), and the University of Wisconsin Translational Research Initiatives Pathology Laboratory, supported, in part, by the University of Wisconsin Department of Pathology and Laboratory Medicine and the University of Wisconsin Carbone Cancer Center (P30CA014520), for use of its facilities and services. The authors declare no conflicts of interest.	Armstrong AJ, 2013, CLIN GENITOURIN CANC, V11, P397, DOI 10.1016/j.clgc.2013.05.007; Boot A, 2016, J PATHOL, V240, P72, DOI 10.1002/path.4756; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Brisbin S, 2009, DEV CELL, V17, P459, DOI 10.1016/j.devcel.2009.08.009; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Das TP, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.403; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Deng YP, 2007, J CELL BIOCHEM, V100, P557, DOI 10.1002/jcb.21030; Deng YP, 2003, J BIOL CHEM, V278, P39311, DOI 10.1074/jbc.M304599200; El Sheikh SS, 2008, NEOPLASIA, V10, P949, DOI 10.1593/neo.08582; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Jahn T, 2002, MOL CELL BIOL, V22, P979, DOI 10.1128/MCB.22.4.979-991.2002; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kabir NN, 2014, MOL BIOL REP, V41, P1985, DOI 10.1007/s11033-014-3046-4; Kazi JU, 2013, MOL ONCOL, V7, P402, DOI 10.1016/j.molonc.2012.11.003; Li Y, 2008, EXP MOL PATHOL, V84, P234, DOI 10.1016/j.yexmp.2008.03.013; Lim MA, 2004, FRONT BIOSCI-LANDMRK, V9, P387, DOI 10.2741/1226; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; Liu J, 2014, ONCOGENE, V33, P3878, DOI 10.1038/onc.2013.347; Liu ML, 2014, CELL METAB, V19, P967, DOI 10.1016/j.cmet.2014.03.018; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Mirmohammadsadegh A, 2004, CELLS TISSUES ORGANS, V177, P119, DOI 10.1159/000079985; Mohamed AM, 2006, DEV BIOL, V290, P164, DOI 10.1016/j.ydbio.2005.11.019; Moutoussamy S, 1998, J BIOL CHEM, V273, P15906, DOI 10.1074/jbc.273.26.15906; Ni J, 2012, CANCER DISCOV, V2, P425, DOI 10.1158/2159-8290.CD-12-0003; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Okino K, 2005, ONCOL REP, V13, P1069; R Development CoreTeam, 2014, R LANG ENV STAT COMP; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang JJ, 2012, DIABETES, V61, P3189, DOI 10.2337/db12-0249	48	7	8	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3198	3211		10.1096/fj.201800265RR	http://dx.doi.org/10.1096/fj.201800265RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30379590	Green Published, Bronze			2022-12-28	WOS:000459794800011
J	Pacheco-Quinto, J; Clausen, D; Perez-Gonzalez, R; Peng, H; Meszaros, A; Eckman, CB; Levy, E; Eckman, EA				Pacheco-Quinto, Javier; Clausen, Dana; Perez-Gonzalez, Rocio; Peng, Hui; Meszaros, Austin; Eckman, Christopher B.; Levy, Efrat; Eckman, Elizabeth A.			Intracellular metalloprotease activity controls intraneuronal A aggregation and limits secretion of A via exosomes	FASEB JOURNAL			English	Article						Alzheimer's disease; oligomer; ECE; multivesicular body	AMYLOID PRECURSOR PROTEIN; ENDOTHELIN-CONVERTING ENZYME; A-BETA ACCUMULATION; ALZHEIMERS-DISEASE; LYSOSOMAL DYSFUNCTION; COGNITIVE DEFICITS; TERMINAL FRAGMENTS; GAMMA-SECRETASE; MOUSE MODEL; WILD-TYPE	Accumulating evidence suggests that the abnormal aggregation of amyloid- () peptide in Alzheimer's disease (AD) begins intraneuronally, within vesicles of the endosomal-lysosomal pathway where A is both generated and degraded. Metalloproteases, including endothelin-converting enzyme (ECE)-1 and -2, reside within these vesicles and normally limit the accumulation of intraneuronally produced A. In this study, we determined whether disruption of A catabolism could trigger A aggregation within neurons and increase the amount of A associated with exosomes, small extracellular vesicles derived from endosomal multivesicular bodies. Using cultured cell lines, primary neurons, and organotypic brain slices from an AD mouse model, we found that pharmacological inhibition of the ECE family of metalloproteases increased intracellular and extracellular A levels and promoted the intracellular formation of A oligomers, a process that did not require internalization of secreted A. In vivo, the accumulation of intraneuronal A aggregates was accompanied by increased levels of both extracellular and exosome-associated A, including oligomeric species. Neuronal exosomes were found to contain both ECE-1 and -2 activities, suggesting that multivesicular bodies are intracellular sites of A degradation by these enzymes. ECE dysfunction could lead to the accumulation of intraneuronal A aggregates and their subsequent release into the extracellular space via exosomes.Pacheco-Quinto, J., Clausen, D., Perez-Gonzalez, R., Peng, H., Meszaros, A., Eckman, C. B., Levy, E., Eckman, E. A. Intracellular metalloprotease activity controls intraneuronal A aggregation and limits secretion of A via exosomes.	[Pacheco-Quinto, Javier; Clausen, Dana; Peng, Hui; Meszaros, Austin; Eckman, Christopher B.; Eckman, Elizabeth A.] Biomed Res Inst New Jersey, 140 East Hanover Ave, Cedar Knolls, NJ 07927 USA; [Pacheco-Quinto, Javier; Eckman, Elizabeth A.] Atlantic Hlth Syst, Morristown, NJ USA; [Perez-Gonzalez, Rocio; Levy, Efrat] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Perez-Gonzalez, Rocio; Levy, Efrat] NYU, Dept Psychiat, Langone Med Ctr, 550 1st Ave, New York, NY 10016 USA; [Levy, Efrat] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY USA; [Levy, Efrat] NYU, Inst Neurosci, Langone Med Ctr, New York, NY USA	Atlantic Health System; Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Pacheco-Quinto, J; Eckman, EA (corresponding author), Biomed Res Inst New Jersey, 140 East Hanover Ave, Cedar Knolls, NJ 07927 USA.	pacheco-quinto@brinj.org; lizeckman@brinj.org	Perez-Gonzalez, Rocio/GQH-7068-2022; Eckman, Elizabeth/AAL-7316-2021	Perez-Gonzalez, Rocio/0000-0002-0641-2001; Eckman, Elizabeth/0000-0002-5391-4960	Vanech Family Foundation; U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke [NS073512]; NIH National Institute on Aging [AG017617, AG056732, P30 AG19610]; NIH National Institute of Neurological Disorders and Stroke [U2418 NS072026]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056732, P30AG019610, P01AG017617] Funding Source: NIH RePORTER	Vanech Family Foundation; U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Luis Marcelino and Joaquim Vieira (Biomedical Research Institute of New Jersey) for assistance with the mice and the Banner Sun Health Research Institute Brain and Body Donation Program (Sun City, AZ, USA), for the provision of human brain tissue. Research reported in this publication was supported in part by a grant from the Vanech Family Foundation (to J.P.-Q.), by U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke Grant NS073512 (to E.A.E.) and NIH National Institute on Aging Grants AG017617 and AG056732 (to E.L.). The Brain and Body Donation Program was supported by the NIH National Institute of Neurological Disorders and Stroke Grant U2418 NS072026 (National Brain and Tissue Resource for Parkinson's Disease and Related Disorders); the NIH National Institute on Aging Grant P30 AG19610 (Arizona Alzheimer's Disease Core Center); the Arizona Department of Health Services Contract 211002 (Arizona Alzheimer's Research Center); the Arizona Biomedical Research Commission Contracts 4001, 0011, 05-901 and 1001 (Arizona Parkinson's Disease Consortium), and the Michael J. Fox Foundation for Parkinson's Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boland B, 2010, J BIOL CHEM, V285, P37415, DOI 10.1074/jbc.M110.186411; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bur D, 2001, PROTEIN ENG, V14, P337, DOI 10.1093/protein/14.5.337; BURDICK D, 1992, J BIOL CHEM, V267, P546; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cermak S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167428; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Colacurcio DJ, 2018, FREE RADICAL BIO MED, V114, P40, DOI 10.1016/j.freeradbiomed.2017.10.001; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Fahnoe DC, 2000, J CARDIOVASC PHARM, V36, pS22, DOI 10.1097/00005344-200036051-00009; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hafez D, 2011, AM J PATHOL, V178, P306, DOI 10.1016/j.ajpath.2010.11.012; Hanson LR, 2011, J MOL NEUROSCI, V43, P424, DOI 10.1007/s12031-010-9460-8; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Lai A. Y., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/548380; Lanz TA, 2006, J NEUROSCI METH, V157, P71, DOI 10.1016/j.jneumeth.2006.03.023; Levy E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00142; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Muller L, 2003, J BIOL CHEM, V278, P545, DOI 10.1074/jbc.M208949200; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; Novo M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19961-3; Pacheco-Quinto J, 2016, NEUROBIOL AGING, V48, P83, DOI 10.1016/j.neurobiolaging.2016.08.011; Pacheco-Quinto J, 2013, J BIOL CHEM, V288, P5606, DOI 10.1074/jbc.M112.422964; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Perez-Gonzalez R, 2017, METHODS MOL BIOL, V1545, P139, DOI 10.1007/978-1-4939-6728-5_10; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Puzzo D, 2015, NEUROSCIENCE, V307, P26, DOI 10.1016/j.neuroscience.2015.08.039; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shinohara M, 2010, J BIOL CHEM, V285, P22091, DOI 10.1074/jbc.M110.102277; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tien NT, 2016, J BIOL CHEM, V291, P10528, DOI 10.1074/jbc.M116.719286; Valdenaire O, 1999, EUR J BIOCHEM, V264, P341, DOI 10.1046/j.1432-1327.1999.00602.x; Valdenaire O, 1999, J CELL SCI, V112, P3115; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vingtdeux V, 2011, FASEB J, V25, P219, DOI 10.1096/fj.10-167361; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Youmans KL, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-8	62	18	18	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3758	3771		10.1096/fj.201801319R	http://dx.doi.org/10.1096/fj.201801319R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481490	Bronze, Green Published			2022-12-28	WOS:000459794800054
J	Song, DG; Kim, D; Jung, JW; Nam, SH; Kim, JE; Kim, HJ; Kim, JH; Lee, SJ; Pan, CH; Kim, S; Lee, JW				Song, Dae-Geun; Kim, Doyeun; Jung, Jae Woo; Nam, Seo Hee; Kim, Ji Eon; Kim, Hye-Jin; Kim, Jong Hyun; Lee, Seo-Jin; Pan, Cheol-Ho; Kim, Sunghoon; Lee, Jung Weon			Glutamyl-prolyl-tRNA synthetase induces fibrotic extracellular matrix via both transcriptional and translational mechanisms	FASEB JOURNAL			English	Article						fibrotic animal model; hepatic stellate cells; prolyl-tRNA-synthetase; signal transduction; STAT6	HEPATIC-FIBROSIS; GENE-EXPRESSION; STELLATE CELLS; TGF-BETA; HALOFUGINONE; FEBRIFUGINE; PROTEIN; LIVER; BINDING; MOUSE	Fibrosis is characterized by the increased accumulation of extracellular matrix (ECM), which drives abnormal cell proliferation and progressive organ dysfunction in many inflammatory and metabolic diseases. Studies have shown that halofuginone, a racemic halogenated derivative, inhibits glutamyl-prolyl-transfer RNA-synthetase (EPRS)-mediated fibrosis. However, the mechanism by which this occurs is unclear. We explored the mechanistic aspects of how EPRS could develop liver fibrotic phenotypes in cells and animal models. Treatment with TGF-1 up-regulated fibronectin and collagen I levels in LX2 hepatic stellate cells. This effect was inhibited in prolyl-transfer RNA synthetase (PRS)-suppressed LX2 cells. Using the promoter luciferase assay, TGF-1-mediated collagen I, 1 chain transcription and 2 basal laminin transcription in LX2 cells were down-regulated by EPRS suppression, suggesting that EPRS may play roles in ECM production at transcriptional levels. Furthermore, signal transducer and activator of transcription (STAT) signaling activation was involved in the effects of TGF-1 on ECM expression in a PRS-dependent manner. This was mediated via a protein-protein complex formation consisting of TGF-1 receptor, EPRS, Janus kinases, and STAT6. Additionally, ECM expression in fibrotic livers overlapped with EPRS expression along fibrotic septa regions and was positively correlated with STAT6 activation in carbon tetrachloride-treated mice. This was less obvious in livers of Eprs(-/+) mice. These findings suggest that, during fibrosis development, EPRS plays roles in nontranslational processes of ECM expression via intracellular signaling regulation upon TGF-1 stimulation.Song, D.-G., Kim, D., Jung, J. W., Nam, S. H., Kim, J. E., Kim, H.-J., Kim, J. H., Lee, S.-J., Pan, C.-H., Kim, S., Lee, J. W. Glutamyl-prolyl-tRNA synthetase induces fibrotic extracellular matrix via both transcriptional and translational mechanisms.	[Song, Dae-Geun; Nam, Seo Hee; Kim, Ji Eon; Kim, Hye-Jin; Lee, Jung Weon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Dept Pharm, Seoul, South Korea; [Kim, Doyeun; Kim, Jong Hyun; Kim, Sunghoon; Lee, Jung Weon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea; [Jung, Jae Woo; Lee, Jung Weon] Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul, South Korea; [Song, Dae-Geun; Pan, Cheol-Ho] KIST, Syst Biotechnol Res Ctr, Gangneung Si, South Korea; [Lee, Seo-Jin] Shingyeong Univ, Dept Life Sci & Biotechnol, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST)	Lee, JW (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea.	jwl@snu.ac.kr	Lee, Jung Weon/F-9149-2012; Kim, Sunghoon/AAE-8314-2020	Lee, Jung Weon/0000-0003-2722-8200	Korea Institute of Science and Technology Gangneung Institute Intramural Research Grant [2Z05310]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - (Ministry of Science); Information and Communications Technology (ICT) and Future Planning Grants [NRF-2018M3A9C8020027, NRF-2017R1A2B3005015]; Tumor Microenvironment Global Core Research Center (GCRC) Grant [2011-0030001]; Medicinal Bioconvergence Research Center Grant [NRF-2013M3A6A4044019]	Korea Institute of Science and Technology Gangneung Institute Intramural Research Grant; Basic Science Research Program through the National Research Foundation of Korea (NRF) - (Ministry of Science); Information and Communications Technology (ICT) and Future Planning Grants; Tumor Microenvironment Global Core Research Center (GCRC) Grant; Medicinal Bioconvergence Research Center Grant	The authors thank Dr. Myung Hee Kim (Korea Research Institute of Bioscience and Biotechnology) for EPRS constructs, Dr. Scott Friedman (Ichan School of Medicine, Mount Sinai, New York, NY, USA) for LX2 cells, and Dr. Jin Ho Chung (Seoul National University) for HFFs. This work was supported by Korea Institute of Science and Technology Gangneung Institute Intramural Research Grant 2Z05310 (to C.-H.P. and D.-G.S.); Basic Science Research Program through the National Research Foundation of Korea (NRF) (funded by the Ministry of Science); Information and Communications Technology (ICT) and Future Planning Grants NRF-2018M3A9C8020027 and NRF-2017R1A2B3005015; Tumor Microenvironment Global Core Research Center (GCRC) Grant 2011-0030001; and Medicinal Bioconvergence Research Center Grant NRF-2013M3A6A4044019 (to J.W.L.). The authors declare no conflicts of interest.	Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671; Delgoffe Greg M, 2013, JAKSTAT, V2, pe23060, DOI 10.4161/jkst.23060; Ghosh AK, 2013, EXP BIOL MED, V238, P461, DOI 10.1177/1535370213489441; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner OA, 2014, CLIN CHIM ACTA, V433, P111, DOI 10.1016/j.cca.2014.02.021; Halevy O, 1996, BIOCHEM PHARMACOL, V52, P1057, DOI 10.1016/0006-2952(96)00427-3; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Huang Y, 2017, EXP CELL RES, V352, P420, DOI 10.1016/j.yexcr.2017.02.038; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Jiang SP, 2005, ANTIMICROB AGENTS CH, V49, P1169, DOI 10.1128/AAC.49.3.1169-1176.2005; KAISER E, 1994, GENOMICS, V19, P280, DOI 10.1006/geno.1994.1059; Karsdal MA, 2015, AM J PHYSIOL-GASTR L, V308, pG807, DOI 10.1152/ajpgi.00447.2014; Katayama M, 2010, INTENS CARE MED, V36, P479, DOI 10.1007/s00134-009-1719-6; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kim HJ, 2017, FASEB J, V31, P1461, DOI 10.1096/fj.201600944RR; Kiyokawa H, 2017, CANCER SCI, V108, P1432, DOI 10.1111/cas.13261; Lareu RR, 2007, FEBS LETT, V581, P2709, DOI 10.1016/j.febslet.2007.05.020; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Li XY, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00855; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo Y, 2017, J LEUKOCYTE BIOL, V102, P1333, DOI 10.1189/jlb.3RU0417-148RR; Luzina IG, 2015, CYTOKINE, V74, P88, DOI 10.1016/j.cyto.2014.11.008; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; McLaughlin NP, 2014, BIOORGAN MED CHEM, V22, P1993, DOI 10.1016/j.bmc.2014.02.040; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pines M, 2015, MOLECULES, V20, P573, DOI 10.3390/molecules20010573; Roffe S, 2010, EXP CELL RES, V316, P1061, DOI 10.1016/j.yexcr.2010.01.003; Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006; Tag Carmen G, 2015, J Vis Exp, DOI 10.3791/52438; Tang LY, 2017, J BIOL CHEM, V292, P4302, DOI 10.1074/jbc.M116.773085; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Tu T, 2015, J GASTROEN HEPATOL, V30, P1696, DOI 10.1111/jgh.13065; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Zhang YE, 2018, CURR OPIN CELL BIOL, V51, P1, DOI 10.1016/j.ceb.2017.10.001; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	38	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4341	4354		10.1096/fj.201801344RR	http://dx.doi.org/10.1096/fj.201801344RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30592630	Bronze			2022-12-28	WOS:000459794800099
J	Song, ZY; Wang, W; Li, N; Yan, SS; Rong, K; Lan, T; Xia, P				Song, Ziyu; Wang, Wei; Li, Ning; Yan, Sishan; Rong, Kuan; Lan, Tian; Xia, Pu			Sphingosine kinase 2 promotes lipotoxicity in pancreatic -cells and the progression of diabetes	FASEB JOURNAL			English	Article						apoptosis; type 2 diabetes; -cell biology; sphingolipids	BETA-CELL; OXIDATIVE STRESS; PROTEIN; TYPE-2; APOPTOSIS; PHOSPHORYLATION; MELLITUS; CANCER; ROLES; DEATH	Loss of functional -cell mass caused by lipotoxicity is a key pathogenic factor in the development of type 2 diabetes mellitus (T2DM). We have previously reported that sphingosine kinase (SK)1 is an endogenous protector of -cells against lipotoxicity. The current study reports that SK2, another isoform of SK, is a crucial mediator of lipotoxicity in -cells. Exposure of -cells to palmitatic acid (PA), a saturated free fatty acid, resulted in a nearly 2-fold increase in SK2 expression, which paralleled the induction of cell death in a similar dose- and time-dependent fashion. Silencing SK2 expression by its specific small interfering RNAs significantly inhibited PA-induced cell death and caspase-3 activation, whereas overexpression of SK2 promoted lipotoxicity in -cells. Mechanistically, upon exposure to PA, endogenous SK2 was shuttled from the nucleus to the cytoplasm, where it interacted with B-cell lymphoma-extra-large (Bcl-xL), leading to mitochondrial apoptotic pathway activation and cell death. By blocking SK2 translocation and its interaction with Bcl-xL, either the nuclear export signal mutant (L423A/L425A) or the BH3 domain mutant (L219A) of SK2 significantly attenuated -cell lipotoxicity. Furthermore, SK2 deficiency in mice significantly prevented the loss of -cell mass, preserved insulin production, and ameliorated the diabetic phenotype in an established T2DM model induced by feeding a high-fat diet accompanied by administration of streptozotocin. These findings provide the first evidence, in vitro and in vivo, of a critical role for SK2 in mediating -cell lipotoxicity and the progression of diabetes.Song, Z., Wang, W., Li, N., Yan, S., Rong, K., Lan, T., Xia, P. Sphingosine kinase 2 promotes lipotoxicity in pancreatic -cells and the progression of diabetes.	[Song, Ziyu; Wang, Wei; Rong, Kuan; Xia, Pu] Fudan Univ, Zhongshan Hosp, Fudan Inst Metab Dis, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Xia, Pu] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China; [Li, Ning; Yan, Sishan; Lan, Tian; Xia, Pu] Guangdong Pharmaceut Univ, Sch Pharm, 280 Waihuan Dong Rd, Guangzhou 510006, Guangdong, Peoples R China	Fudan University; Fudan University; Guangdong Pharmaceutical University	Lan, T (corresponding author), Guangdong Pharmaceut Univ, Sch Pharm, 280 Waihuan Dong Rd, Guangzhou 510006, Guangdong, Peoples R China.; Xia, P (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Xia, P (corresponding author), Fudan Univ, Fudan Inst Metab Dis, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	lantian012345@163.com; xiapu_fudan@163.com	Xia, Pu/G-3090-2010	Xia, Pu/0000-0003-4705-8878	National Natural Science Foundation of China [81370937, 81561128014]; Fudan Distinguished Professorship	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan Distinguished Professorship	The authors thank Dr. Richard Proia (NIH, Bethesda, MD, USA) for providing SK2<SUP>-/-</SUP> and SK2<SUP>+/+</SUP> mouse colonies and Dr. Carol Wadham (South Australia Pathology, Adelaide, Australia) for reviewing and editing the manuscript. This work was supported by National Natural Science Foundation of China Grants 81370937 and 81561128014 (to P.X.) and by a Fudan Distinguished Professorship (to P.X.). The authors declare no conflicts of interest.	Adada MM, 2015, FASEB J, V29, P4654, DOI 10.1096/fj.15-274340; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; Dai L, 2014, MOL ENDOCRINOL, V28, P197, DOI 10.1210/me.2013-1237; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Islam Md Shahidul, 2012, Methods Mol Biol, V933, P161, DOI 10.1007/978-1-62703-068-7_10; Ji XQ, 2016, MOL CELL ENDOCRINOL, V437, P268, DOI 10.1016/j.mce.2016.06.029; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Song DD, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.289; Song Z., 2016, ENDOPLASMIC RETICULU, P25; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Sukocheva O, 2015, STEROIDS, V104, P237, DOI 10.1016/j.steroids.2015.10.009; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Xia P, 2011, CYTOKINE GROWTH F R, V22, P45, DOI 10.1016/j.cytogfr.2010.09.004; Zemann B, 2007, IMMUNOL LETT, V109, P56, DOI 10.1016/j.imlet.2007.01.001	32	17	17	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3636	3646		10.1096/fj.201801496R	http://dx.doi.org/10.1096/fj.201801496R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30452878	Bronze, Green Published			2022-12-28	WOS:000459794800044
J	Meyer, SK; Dunn, M; Vidler, DS; Porter, A; Blain, PG; Jowsey, PA				Meyer, Stephanie K.; Dunn, Michael; Vidler, Daniel S.; Porter, Andrew; Blain, Peter G.; Jowsey, Paul A.			Phosphorylation of MCPH1 isoforms during mitosis followed by isoform-specific degradation by APC/C-CDH1	FASEB JOURNAL			English	Article						cell cycle regulation; cyclin-dependent kinase-1; microcephalin-1; anaphase; promoting complex; cyclosome	DNA-DAMAGE RESPONSE; ANAPHASE-PROMOTING COMPLEX; MITOTIC ENTRY; CHROMOSOME CONDENSATION; MICROCEPHALIN; PROTEIN; STABILITY; PATHWAY; CYCLE	Microcephalin-1 (MCPH1) exists as 2 isoforms that regulate cyclin-dependent kinase-1 activation and chromosome condensation during mitosis, with MCPH1 mutations causing primary microcephaly. MCPH1 is also a tumor suppressor protein, with roles in DNA damage repair/checkpoints. Despite these important roles, there is little information on the cellular regulation of MCPH1. We show that both MCPH1 isoforms are phosphorylated in a cyclin-dependent kinase-1-dependent manner in mitosis and identify several novel phosphorylation sites. Upon mitotic exit, MCPH1 isoforms were degraded by the anaphase-promoting complex/cyclosome-CDH1 E3 ligase complex. Anaphase-promoting complex/cyclosome-CDH1 target proteins generally have D-Box or KEN-Box degron sequences. We found that MCPH1 isoforms are degraded independently, with the long isoform degradation being D-Box dependent, whereas the short isoform was KEN-Box dependent. Our research identifies several novel mechanisms regulating MCPH1 and also highlights important issues with several commercial MCPH1 antibodies, with potential relevance to previously published data.Meyer, S. K., Dunn, M., Vidler, D. S., Porter, A., Blain, P. G., Jowsey, P. A. Phosphorylation of MCPH1 isoforms during mitosis followed by isoform-specific degradation by APC/C-CDH1.	[Meyer, Stephanie K.; Dunn, Michael; Vidler, Daniel S.; Blain, Peter G.; Jowsey, Paul A.] Newcastle Univ, Inst Cellular Med, NIHR, Hlth Protect Res Unit Chem & Radiat Threats & Haz, Wolfson Bldg, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; [Porter, Andrew] Newcastle Univ, Newcastle Univ Prot & Proteome Anal, Newcastle Upon Tyne, Tyne & Wear, England; [Vidler, Daniel S.] Univ Liverpool, Ctr Genom Res, GeneMill, Liverpool, Merseyside, England	Newcastle University - UK; Newcastle University - UK; University of Liverpool	Jowsey, PA (corresponding author), Newcastle Univ, Inst Cellular Med, NIHR, Hlth Protect Res Unit Chem & Radiat Threats & Haz, Wolfson Bldg, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.	paul.jowsey@newcastle.ac.uk		Jowsey, Paul/0000-0003-2867-6857	National Institute for Health Research (NIHR) Health Protection Research Unit for Chemical and Radiation Threats and Hazards at Newcastle University [HPRU-2012-10076]; Public Health England; Newcastle University via the Wellcome Trust Institutional Strategic Support Fund	National Institute for Health Research (NIHR) Health Protection Research Unit for Chemical and Radiation Threats and Hazards at Newcastle University; Public Health England; Newcastle University via the Wellcome Trust Institutional Strategic Support Fund	P.A.J., S.K.M., M.D., and P.G.B. are affiliated with the National Institute for Health Research (NIHR) Health Protection Research Unit for Chemical and Radiation Threats and Hazards at Newcastle University (Grant HPRU-2012-10076) in partnership with Public Health England. Funding was provided by Newcastle University via the Wellcome Trust Institutional Strategic Support Fund. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, the Department of Health, or Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Arroyo M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12793-7; Chang LF, 2014, CURR OPIN STRUC BIOL, V29, P1, DOI 10.1016/j.sbi.2014.08.003; Cotto-Rios XM, 2011, J CELL BIOL, V194, P177, DOI 10.1083/jcb.201101062; de Boer HR, 2016, CELL MOL LIFE SCI, V73, P2985, DOI 10.1007/s00018-016-2279-x; Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4; Gavvovidis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040387; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Ha K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15751; Hainline SG, 2014, BIOL OPEN, V3, P669, DOI 10.1242/bio.20148318; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jo YS, 2017, INT J COLORECTAL DIS, V32, P161, DOI 10.1007/s00384-016-2675-6; Kucharski TJ, 2017, CELL REP, V18, P1982, DOI 10.1016/j.celrep.2017.01.080; Lafranchi L, 2014, EMBO J, V33, P2860, DOI 10.15252/embj.201489017; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Liu XQ, 2017, EMBO J, V36, P3666, DOI 10.15252/embj.201694443; Liu XQ, 2016, ACTA BIOCH BIOPH SIN, V48, P678, DOI 10.1093/abbs/gmw048; Mantere T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005816; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Richardson J, 2011, BREAST CANCER RES TR, V127, P639, DOI 10.1007/s10549-010-1019-4; Sivakumar S, 2015, NAT REV MOL CELL BIO, V16, P82, DOI 10.1038/nrm3934; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yamashita D, 2011, J CELL BIOL, V194, P841, DOI 10.1083/jcb.201106141	29	3	3	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2796	2808		10.1096/fj.201801353R	http://dx.doi.org/10.1096/fj.201801353R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303738	Green Accepted, Green Published			2022-12-28	WOS:000457296600101
J	Aiken, CE; Tarry-Adkins, JL; Spiroski, AM; Nuzzo, AM; Ashmore, TJ; Rolfo, A; Sutherland, MJ; Camm, EJ; Giussani, DA; Ozanne, SE				Aiken, Catherine E.; Tarry-Adkins, Jane L.; Spiroski, Ana-Mishel; Nuzzo, Anna M.; Ashmore, Thomas J.; Rolfo, Alessandro; Sutherland, Megan J.; Camm, Emily J.; Giussani, Dino A.; Ozanne, Susan E.			Chronic gestational hypoxia accelerates ovarian aging and lowers ovarian reserve in next-generation adult rats	FASEB JOURNAL			English	Article						ovary; follicles; reproductive aging; fetal hypoxia; developmental programming	INTRAUTERINE GROWTH RESTRICTION; PLACENTAL OXIDATIVE STRESS; POOR MATERNAL NUTRITION; HIGH-ALTITUDE; INSULIN-RESISTANCE; PRENATAL HYPOXIA; BIRTH-WEIGHT; BLOOD-FLOW; FETAL; MARKERS	Chronic fetal hypoxia is a common complication observed in human pregnancy, impacting pregnancies across global contexts. Exposure to chronic intrauterine hypoxia has major short- and long-term consequences for offspring health. However, the impact of chronic gestational hypoxia on female reproductive system development is unknown. We aimed to understand the impact of exposure to chronic fetal hypoxia on the developing female reproductive system. Wistar rat dams underwent normoxia (21%) or hypoxia (13%) during pregnancy. Postnatally, all female offspring were maintained in normoxic conditions into early adulthood. Female rats exposed to chronic gestational hypoxia (13%) during their intrauterine development had decreased ovarian primordial follicular reserve compared to controls (P < 0.05). Adult females who had been exposed to chronic fetal hypoxia had significantly reduced somatic ovarian telomere length (P < 0.05) and reduced ovarian protein expression of KU70, a critical component of the DNA-activated protein kinase repair complex (P < 0.01). Gene expression of NADPH oxidase 2-mediated oxidative stress markers was increased (P < 0.05). Exposure to chronic hypoxia during fetal development leads to accelerated aging of the somatic ovary and decreased ovarian reserve in adulthood. Ovarian aging is highly sensitive to gestational hypoxia, with implications for future fertility in next-generation offspring of high-risk pregnancies.-Aiken, C. E., Tarry-Adkins, J. L., Spiroski, A.-M., Nuzzo, A. M., Ashmore, T. J., Rolfo, A., Sutherland, M. J., Camm, E. J., Giussani, D. A., Ozanne, S. E. Chronic gestational hypoxia accelerates ovarian aging and lowers ovarian reserve in next-generation adult rats.	[Aiken, Catherine E.; Tarry-Adkins, Jane L.; Ashmore, Thomas J.; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Cambridge, England; [Aiken, Catherine E.; Tarry-Adkins, Jane L.; Ashmore, Thomas J.; Ozanne, Susan E.] Univ Cambridge, MRC, Metab Dis Unit,Addenbrookes Hosp, Wellcome Trust,Inst Metab Sci,Addenbrookes Treatm, Cambridge, England; [Aiken, Catherine E.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Spiroski, Ana-Mishel; Sutherland, Megan J.; Camm, Emily J.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Nuzzo, Anna M.; Rolfo, Alessandro] Univ Torino, Dipartimento Sci Chirurg, Turin, Italy	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Turin	Aiken, CE (corresponding author), Univ Cambridge, Hills Rd, Cambridge CB2 0QQ, England.	cema2@cam.ac.uk		Spiroski, Ana-Mishel/0000-0002-8584-8048; Sutherland, Megan/0000-0002-0841-1635; Ozanne, Susan/0000-0001-8753-5144	Addenbrooke's Charitable Trust (ACT) [RG94137]; Issac Newton Trust/Wellcome Trust ISSF/ University of Cambridge Joint Research Grant; Medical Research Council [MC_UU_12012/4]; British Heart Foundation [PG/14/5/30546]; MRC [MC_UU_12012/4, MC_UU_00014/4, MC_UU_12012/5] Funding Source: UKRI	Addenbrooke's Charitable Trust (ACT); Issac Newton Trust/Wellcome Trust ISSF/ University of Cambridge Joint Research Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	C.E.A. was supported by a Grant from the Addenbrooke's Charitable Trust (ACT; RG94137) and by an Issac Newton Trust/Wellcome Trust ISSF/ University of Cambridge Joint Research Grant. S.E.O. is supported by the Medical Research Council (MC_UU_12012/4). D.A.G. is supported by The British Heart Foundation (PG/14/5/30546). The authors declare no conflicts of interest.	Aiken CE, 2015, SCI REP-UK, V5, DOI 10.1038/srep16175; Aiken CE, 2016, FASEB J, V30, P1548, DOI 10.1096/fj.15-280800; Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Aiken CE, 2013, FASEB J, V27, P3959, DOI 10.1096/fj.13-234484; Allison BJ, 2016, FASEB J, V30, P1968, DOI 10.1096/fj.201500057; Alviggi C, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-101; Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; BEALL CM, 1983, ANN HUM BIOL, V10, P365, DOI 10.1080/03014468300006531; Bernal AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015558; Burton GJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00373; Camm EJ, 2011, FASEB J, V25, P420, DOI 10.1096/fj.10-158188; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; Castelo-Branco C, 2006, MENOPAUSE, V13, P850; Chan KA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124149; Cohen JE, 1998, P NATL ACAD SCI USA, V95, P14009, DOI 10.1073/pnas.95.24.14009; Depmann M, 2015, J CLIN ENDOCR METAB, V100, pE845, DOI 10.1210/jc.2015-1298; Ducsay CA, 2018, PHYSIOL REV, V98, P1241, DOI 10.1152/physrev.00043.2017; Ganzevoort W, 2017, ULTRASOUND OBST GYN, V49, P769, DOI 10.1002/uog.17433; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Giussani DA, 2016, J PHYSIOL-LONDON, V594, P1215, DOI 10.1113/JP271099; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; GONDOS B, 1986, AM J OBSTET GYNECOL, V155, P189, DOI 10.1016/0002-9378(86)90109-2; Gonzales GF, 1996, HUM BIOL, V68, P265; Gonzalez-Rodriguez P, 2013, INT J MED SCI, V10, P532, DOI 10.7150/ijms.5566; Herrera EA, 2012, J VASC RES, V49, P50, DOI 10.1159/000330666; Ho SM, 2017, REPROD TOXICOL, V68, P85, DOI 10.1016/j.reprotox.2016.07.011; Hoshino Y, 2018, REPROD MED BIOL, V17, P434, DOI 10.1002/rmb2.12245; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux Eric, 2003, Reprod Biomed Online, V7, P250; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Kuzmina IY, 2005, EUR J OBSTET GYN R B, V120, P139, DOI 10.1016/j.ejogrb.2004.09.001; Lawn JE, 2014, LANCET, V384, P132; LONGO LD, 1976, SCIENCE, V194, P523, DOI 10.1126/science.973133; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; Moore LG, 2011, RESP PHYSIOL NEUROBI, V178, P181, DOI 10.1016/j.resp.2011.04.017; Parks WT, 2017, BIRTH DEFECTS RES, V109, P1345, DOI 10.1002/bdr2.1143; Pelosi E, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127381; Picut CA, 2014, TOXICOL PATHOL, V42, P403, DOI 10.1177/0192623313484832; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; RICHARDSON SJ, 1990, ANN NY ACAD SCI, V592, P13; Richter HG, 2012, J PHYSIOL-LONDON, V590, P1377, DOI 10.1113/jphysiol.2011.226340; Roost M, 2009, BJOG-INT J OBSTET GY, V116, P1210, DOI 10.1111/j.1471-0528.2009.02209.x; Salam RA, 2014, CURR OPIN CLIN NUTR, V17, P249, DOI 10.1097/MCO.0000000000000051; Santhakumaran S, 2018, ARCH DIS CHILD-FETAL, V103, pF208, DOI 10.1136/archdischild-2017-312748; Staudacher JJ, 2015, NUCLEIC ACIDS RES, V43, P3219, DOI 10.1093/nar/gkv167; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Tarry-Adkins JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22383-w; Tarry-Adkins JL, 2015, ENDOCRINOLOGY, V156, P3528, DOI 10.1210/en.2015-1424; Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005; van Patot MCT, 2010, AM J PHYSIOL-REG I, V298, pR166, DOI 10.1152/ajpregu.00383.2009; Van Wassenaer-Leemhuis AG, 2017, BJOG-INT J OBSTET GY, V124, P1072, DOI 10.1111/1471-0528.14511; VanBlerkom J, 1997, HUM REPROD, V12, P1047; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Winship AL, 2018, REPRODUCTION, V156, P299, DOI 10.1530/REP-18-0247; Yamaji R, 2003, BBA-MOL CELL RES, V1593, P269, DOI 10.1016/S0167-4889(02)00397-X; Zhang LB, 2005, J SOC GYNECOL INVEST, V12, P2, DOI 10.1016/j.jsgi.2004.09.004	59	10	11	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7758	7766		10.1096/fj.201802772R	http://dx.doi.org/10.1096/fj.201802772R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30888848	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000476114200087
J	Singh, A; Zapata, RC; Pezeshki, A; Workentine, ML; Chelikani, PK				Singh, Arashdeep; Zapata, Rizaldy C.; Pezeshki, Adel; Workentine, Matthew L.; Chelikani, Prasanth K.			Host genetics and diet composition interact to modulate gut microbiota and predisposition to metabolic syndrome in spontaneously hypertensive stroke-prone rats	FASEB JOURNAL			English	Article						energy balance; glucose tolerance; obesity; hypertension	GENES CAUSING HYPERTENSION; INDUCED OBESITY; ENERGY-BALANCE; NORMAL-WEIGHT; EXPRESSION PROFILES; GLUCOSE-METABOLISM; PHYSICAL-ACTIVITY; ADIPOSE-TISSUE; HEALTHY OBESE; RENAL DAMAGE	Metabolic syndrome encompasses obesity, glucose intolerance, hypertension, and dyslipidemia; however, the interactions between diet and host physiology that predispose to metabolic syndrome are incompletely understood. Here, we explored the effects of a high-fat diet (HFD) on energy balance, gut microbiota, and risk factors of metabolic syndrome in spontaneously hypertensive stroke-prone (SHRSP) and Wistar-Kyoto (WKY) rats. We found that the SHRSP rats were hypertensive, hyperphagic, less sensitive to hypophagic effects of exendin-4, and expended more energy with diminished sensitivity to sympathetic blockade compared to WKY rats. Notably, key thermogenic markers in brown and retroperitoneal adipose tissues and skeletal muscle were up-regulated in SHRSP than WKY rats. Although HFD promoted weight gain, adiposity, glucose intolerance, hypertriglyceridemia, hepatic lipidosis, and hyperleptinemia in both SHRSP and WKY rats, the SHRSP rats weighed less but had comparable percent adiposity to WKY rats, which supports the use of HFD-fed SHRSP rats as a unique model for studying the metabolically obese normal weight (MONW) phenotype in humans. Despite distinct strain differences in gut microbiota composition, diet had a preponderant impact on gut flora with some of the taxa being strongly associated with key metabolic parameters. Together, we provide evidence that interactions between host genetics and diet modulate gut microbiota and predispose SHRSP rats to develop metabolic syndrome.-Singh, A., Zapata, R. C., Pezeshki, A., Workentine, M. L., Chelikani, P. K. Host genetics and diet composition interact to modulate gut microbiota and predisposition to metabolic syndrome in spontaneously hypertensive stroke-prone rats.	[Singh, Arashdeep; Zapata, Rizaldy C.; Workentine, Matthew L.; Chelikani, Prasanth K.] Univ Calgary, Dept Prod Anim Hlth, Fac Vet Med, HS 1871,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Chelikani, Prasanth K.] Univ Calgary, Snyder Inst Chron Dis, Gastrointestinal Res Grp, Calgary, AB, Canada; [Pezeshki, Adel] Oklahoma State Univ, Dept Anim & Food Sci, Stillwater, OK 74078 USA	University of Calgary; University of Calgary; Oklahoma State University System; Oklahoma State University - Stillwater	Chelikani, PK (corresponding author), Univ Calgary, Dept Prod Anim Hlth, Fac Vet Med, HS 1871,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pchelika@ucalgary.ca	Singh, Arashdeep/L-4795-2019; Chelikani, Prasanth/N-3462-2019; Chelikani, Prasanth/AAY-2145-2021	Singh, Arashdeep/0000-0002-2477-1438; Chelikani, Prasanth/0000-0002-7300-2918; Zapata, Rizaldy/0000-0003-4745-8513	Gerald L. (Jerry) Weber Cosmopolitan International Club of Calgary Graduate Scholarship; Heart and Stroke Foundation of Canada [G-18-0022205]; Canada Foundation for Innovation [18617]; Alberta Advanced Education and Technology [URSI-09-008-SEG]; International Microbiome Centre at the University of Calgary	Gerald L. (Jerry) Weber Cosmopolitan International Club of Calgary Graduate Scholarship; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Advanced Education and Technology; International Microbiome Centre at the University of Calgary	A.S. was supported by Gerald L. (Jerry) Weber Cosmopolitan International Club of Calgary Graduate Scholarship. The work was supported by a grant-in-aid from the Heart and Stroke Foundation of Canada (G-18-0022205), infrastructure support from the Canada Foundation for Innovation (18617), and Alberta Advanced Education and Technology (URSI-09-008-SEG) to P.K.C., and by the International Microbiome Centre at the University of Calgary. High-performance computation was provided by the University of Calgary Centre for Health Genomics and Informatics. The authors declare no conflicts of interest.	Abdel-latif RG, 2018, EUR J PHARMACOL, V833, P145, DOI 10.1016/j.ejphar.2018.05.045; Abrahamsen CT, 2002, J PHARMACOL EXP THER, V301, P21, DOI 10.1124/jpet.301.1.21; Adnan S, 2017, PHYSIOL GENOMICS, V49, P96, DOI 10.1152/physiolgenomics.00081.2016; Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Bailey EL, 2011, INT J STROKE, V6, P434, DOI 10.1111/j.1747-4949.2011.00659.x; Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; Barone FC, 2001, CARDIOVASC RES, V50, P525, DOI 10.1016/S0008-6363(01)00257-7; Barone FC, 1996, J PHARMACOL EXP THER, V279, P948; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthiaume N, 2002, METABOLISM, V51, P595, DOI 10.1053/meta.2002.31989; Blaak EE, 2007, OBESITY, V15, P653, DOI 10.1038/oby.2007.606; Blais A, 2018, AM J PHYSIOL-ENDOC M, V314, pE139, DOI 10.1152/ajpendo.00318.2017; Bradshaw PT, 2013, OBESITY, V21, P203, DOI 10.1002/oby.20248; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Carneiro IP, 2016, ADV NUTR, V7, P476, DOI 10.3945/an.115.008755; Covasa M, 1998, PEPTIDES, V19, P1407, DOI 10.1016/S0196-9781(98)00096-5; DAVIDSON AO, 1995, HYPERTENSION, V26, P452, DOI 10.1161/01.HYP.26.3.452; DeLany JP, 2013, INT J OBESITY, V37, P1006, DOI 10.1038/ijo.2012.172; Di Renzo L, 2006, Eur Rev Med Pharmacol Sci, V10, P191; Ding C, 2018, AM J PHYSIOL-ENDOC M, V314, pE494, DOI 10.1152/ajpendo.00382.2017; Ding C, 2016, CURR OPIN CLIN NUTR, V19, P408, DOI 10.1097/MCO.0000000000000317; Duca FA, 2015, OBESITY, V23, P2260, DOI 10.1002/oby.21231; Duca FA, 2013, HORM BEHAV, V64, P812, DOI 10.1016/j.yhbeh.2013.09.004; Duca FA, 2013, DIABETES, V62, P2410, DOI 10.2337/db12-1204; Durgan DJ, 2016, HYPERTENSION, V67, P469, DOI 10.1161/HYPERTENSIONAHA.115.06672; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Farley C, 2003, OBES RES, V11, P845, DOI 10.1038/oby.2003.116; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Furedi N, 2016, J MOL NEUROSCI, V59, P521, DOI 10.1007/s12031-016-0771-2; Gavini CK, 2018, OBESITY, V26, P885, DOI 10.1002/oby.22166; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Health Canada, 2006, DIET REF INT; Hojna S, 2012, HYPERTENS RES, V35, P279, DOI 10.1038/hr.2011.188; Jackman MR, 2010, AM J PHYSIOL-REG I, V299, pR1097, DOI 10.1152/ajpregu.00549.2009; Jan S, 2018, LANCET, V391, P2047, DOI 10.1016/S0140-6736(18)30323-4; Kim S, 2017, EXP NEUROBIOL, V26, P227, DOI 10.5607/en.2017.26.4.227; Krafft PR, 2012, INT J STROKE, V7, P398, DOI 10.1111/j.1747-4949.2012.00838.x; Lee SJ, 2018, MOL METAB, V11, P33, DOI 10.1016/j.molmet.2018.03.008; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Levin BE, 2002, AM J PHYSIOL-REG I, V283, pR941, DOI 10.1152/ajpregu.00245.2002; Levin BE, 2003, AM J PHYSIOL-REG I, V285, pR1184, DOI 10.1152/ajpregu.00267.2003; Levin BE, 2005, AM J PHYSIOL-REG I, V289, pR704, DOI 10.1152/ajpregu.00216.2005; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Li XL, 2017, J STROKE CEREBROVASC, V26, P2700, DOI 10.1016/j.jstrokecerebrovasdis.2017.03.014; Li XL, 2017, J CLIN NEUROSCI, V40, P34, DOI 10.1016/j.jocn.2017.01.018; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MAY RM, 1989, TRENDS ECOL EVOL, V4, P20, DOI 10.1016/0169-5347(89)90009-8; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nawrocki EP, 2009, THESIS; Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Palmer BF, 2017, OBES REV, V18, P819, DOI 10.1111/obr.12563; Papazzo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066655; Parkes D, 2001, DRUG DEVELOP RES, V53, P260, DOI 10.1002/ddr.1195; Pezeshki A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25145; Pezeshki A, 2015, J NUTR, V145, P2236, DOI 10.3945/jn.115.213843; Pirici D, 2017, BRAIN PATHOL, V27, P169, DOI 10.1111/bpa.12384; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prieto I, 2018, LIFE SCI, V192, P9, DOI 10.1016/j.lfs.2017.11.022; Ricci MR, 2003, AM J PHYSIOL-REG I, V285, pR610, DOI 10.1152/ajpregu.00235.2003; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; Samouda H, 2019, DIABETES METAB, V45, P140, DOI 10.1016/j.diabet.2017.11.007; Schreiber Stefanie, 2013, Exp Transl Stroke Med, V5, P4, DOI 10.1186/2040-7378-5-4; Schulz A, 2012, HYPERTENS RES, V35, P675, DOI 10.1038/hr.2012.77; Singh A, 2018, J NUTR BIOCHEM, V59, P142, DOI 10.1016/j.jnutbio.2018.05.017; Singh A, 2016, J NUTR BIOCHEM, V37, P47, DOI 10.1016/j.jnutbio.2016.07.011; Smeda JS, 1997, CAN J PHYSIOL PHARM, V75, P796, DOI 10.1139/cjpp-75-7-796; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Strahorn P, 2005, J HYPERTENS, V23, P2179, DOI 10.1097/01.hjh.0000191904.26853.b8; Stroeve JHM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0459-1; Tellechea ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05344-7; Teske JA, 2012, INT J OBESITY, V36, P603, DOI 10.1038/ijo.2011.108; Toop CR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090577; Trayhurn P, 2017, BIOCHIMIE, V134, P62, DOI 10.1016/j.biochi.2016.09.007; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; van Baak M A, 2001, Obes Rev, V2, P3; Wang B, 2015, HORM METAB RES, V47, P839, DOI 10.1055/s-0035-1559767; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe Y, 2015, INT J MOL MED, V36, P712, DOI 10.3892/ijmm.2015.2281; Weijs PJM, 2010, CLIN NUTR, V29, P347, DOI 10.1016/j.clnu.2009.09.009; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wong SK, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0123-9; Wong VY, 2001, BRIT J PHARMACOL, V134, P977, DOI 10.1038/sj.bjp.0704329; Woods SC, 2004, PHYSIOL BEHAV, V83, P573, DOI 10.1016/j.physbeh.2004.07.026; Xie ZY, 2018, NEUROPHARMACOLOGY, V128, P142, DOI 10.1016/j.neuropharm.2017.09.040; Yamamoto H, 2013, INT J MOL MED, V31, P1057, DOI 10.3892/ijmm.2013.1304; Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315; Yoshida M, 2014, INT J MOL MED, V33, P887, DOI 10.3892/ijmm.2014.1631; Zhang LY, 2018, HYPERTENS RES, V41, P414, DOI 10.1038/s41440-018-0033-5	100	13	13	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6748	6766		10.1096/fj.201801627RRR	http://dx.doi.org/10.1096/fj.201801627RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30821497	Bronze			2022-12-28	WOS:000476114200007
J	Nachmany, I; Bogoch, Y; Sivan, A; Amar, O; Bondar, E; Zohar, N; Yakubovsky, O; Fainaru, O; Klausner, JM; Pencovich, N				Nachmany, Ido; Bogoch, Yoel; Sivan, Ayelet; Amar, Omer; Bondar, Ekaterina; Zohar, Nitzan; Yakubovsky, Oran; Fainaru, Ofer; Klausner, Joseph M.; Pencovich, Niv			CD11b(+)Ly6G(+) myeloid-derived suppressor cells promote liver regeneration in a murine model of major hepatectomy	FASEB JOURNAL			English	Article						liver resection; immature myeloid cells; angiogenesis; immune suppression	ANGIOGENESIS; RECRUITMENT; EXPRESSION; PLATELETS; CANCER	Liver regeneration depends on sequential activation of pathways and cells involving the remaining organ in recovery of mass. Proliferation of parenchyma is dependent on angiogenesis. Understanding liver regeneration-associated neovascularization may be useful for development of clinical interventions. Myeloid-derived suppressor cells (MDSCs) promote tumor angiogenesis and play a role in developmental processes that necessitate rapid vascularization. We therefore hypothesized that the MDSCs could play a role in liver regeneration. Following partial hepatectomy, MDSCs were enriched within regenerating livers, and their depletion led to increased liver injury and postoperative mortality, reduced liver weights, decreased hepatic vascularization, reduced hepatocyte hypertrophy and proliferation, and aberrant liver function. Gene expression profiling of regenerating liver-derived MDSCs demonstrated a large-scale transcriptional response involving key pathways related to angiogenesis. Functionally, enhanced reactive oxygen species production and angiogenic capacities of regenerating liver-derived MDSCs were confirmed. A comparative analysis revealed that the transcriptional response of MDSCs during liver regeneration resembled that of peripheral blood MDSCs during progression of abdominal tumors, suggesting a common MDSC gene expression profile promoting angiogenesis. In summary, our study shows that MDSCs contribute to early stages of liver regeneration possibly by exerting proangiogenic functions using a unique transcriptional program.Nachmany, I., Bogoch, Y., Sivan, A., Amar, O., Bondar, E., Zohar, N., Yakubovsky, O., Fainaru, O., Klausner, J. M., Pencovich, N. CD11b(+)Ly6G(+) myeloid-derived suppressor cells promote liver regeneration in a murine model of major hepatectomy.	[Nachmany, Ido; Bogoch, Yoel; Sivan, Ayelet; Amar, Omer; Bondar, Ekaterina; Zohar, Nitzan; Yakubovsky, Oran; Klausner, Joseph M.; Pencovich, Niv] Tel Aviv Univ, Sackler Sch Med, Tel Aviv Sourasky Med Ctr,Dept Surg B,Surg Div, Hepatopancreato Biliary HPB Canc Res,Lab Mol Gene, Tel Aviv, Israel; [Fainaru, Ofer] Rambam Med Ctr, Dept Obstet & Gynecol, In Vitro Fertilizat IVF Unit, Haifa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology	Pencovich, N (corresponding author), Tel Aviv Sourasky Med Ctr, 6 Weizmarm St, IL-6423906 Tel Aviv, Israel.	Nivp@tlvmc.gov.il			Alexander Grass Foundation; "Reut" Foundation	Alexander Grass Foundation; "Reut" Foundation	This study was partially funded by the Alexander Grass Foundation and the "Reut" Foundation. The funders had no part in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the article for publication. The authors declare no conflicts of interest.	Beury DW, 2016, J IMMUNOL, V196, P3470, DOI 10.4049/jimmunol.1501785; Castellaneta A, 2006, HEPATOLOGY, V43, P807, DOI 10.1002/hep.21098; Cekic C, 2014, CANCER RES, V74, P7250, DOI 10.1158/0008-5472.CAN-13-3583; Chauhan A, 2016, HEPATOLOGY, V64, P1774, DOI 10.1002/hep.28526; Chung PY, 2003, LIVER TRANSPLANT, V9, P248, DOI 10.1053/jlts.2003.50053; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Das SK, 2007, LIFE SCI, V81, P1555, DOI 10.1016/j.lfs.2007.09.027; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Drixler TA, 2002, ANN SURG, V236, P703, DOI 10.1097/00000658-200212000-00002; Fainaru O, 2013, FERTIL STERIL, V99, P910, DOI 10.1016/j.fertnstert.2012.11.018; Fainaru O, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.060; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Harun N, 2007, J SURG RES, V138, P284, DOI 10.1016/j.jss.2006.06.024; Janakiram M, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026534; Kaur S, 2013, HEPATOL INT, V7, P959, DOI 10.1007/s12072-013-9483-7; Kim JA, 2010, BLOOD, V116, P1623, DOI 10.1182/blood-2009-08-237040; Kron P, 2016, HEPATOLOGY, V64, P2198, DOI 10.1002/hep.28809; Kwon YJ, 2015, CLIN MOL HEPATOL, V21, P7, DOI 10.3350/cmh.2015.21.1.7; Li N, 2017, ONCOTARGET, V8, P3628, DOI 10.18632/oncotarget.12275; Lisman T, 2016, BLOOD, V128, P625, DOI 10.1182/blood-2016-04-692665; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Mei-Dan E, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.025; Meirow Y, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00523; Melgar-Lesmes P, 2015, J HEPATOL, V63, P917, DOI 10.1016/j.jhep.2015.05.011; Meyer J, 2015, J HEPATOL, V63, P1263, DOI 10.1016/j.jhep.2015.07.002; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Momiyama M, 2012, J SURG RES, V178, P280, DOI 10.1016/j.jss.2012.03.020; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; Ostrand-Rosenberg S, 2018, J IMMUNOL, V200, P422, DOI 10.4049/jimmunol.1701019; Pencovich N, 2013, GENES IMMUN, V14, P90, DOI 10.1038/gene.2012.59; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; Shi JH, 2014, WORLD J GASTROENTERO, V20, P16167, DOI 10.3748/wjg.v20.i43.16167; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Siriwardena AK, 2014, NAT REV CLIN ONCOL, V11, P446, DOI 10.1038/nrclinonc.2014.90; Solito S, 2014, ANN NY ACAD SCI, V1319, P47, DOI 10.1111/nyas.12469; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Uda Y, 2013, SURGERY, V153, P70, DOI 10.1016/j.surg.2012.06.021; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Zaslavsky A, 2010, MOL CANCER RES, V8, P1198, DOI 10.1158/1541-7786.MCR-10-0047	48	5	5	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5967	5978		10.1096/fj.201801733R	http://dx.doi.org/10.1096/fj.201801733R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30730772	Bronze			2022-12-28	WOS:000466932600014
J	Cai, JR; Jiao, XY; Fang, Y; Yu, XF; Ding, XQ				Cai, Jieru; Jiao, Xiaoyan; Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang			The orphan nuclear receptor ROR alpha is a potential endogenous protector in renal ischemia/reperfusion injury	FASEB JOURNAL			English	Article						ROR; AKI; apoptosis	ACUTE KIDNEY INJURY; OXIDATIVE STRESS; CELL-DEATH; RAT MODEL; MELATONIN; ACTIVATION; EXPRESSION; APOPTOSIS; GAMMA	Emerging evidence indicates that retinoid-related orphan receptor (ROR)alpha, a member of the ROR nuclear receptor subfamily, mediates key cellular adaptions to hypoxia and contributes to the pathophysiology of many disease states. However, the effects of ROR alpha in renal ischemia/reperfusion (I/R) injury remain unclear. Wild-type (WT) C57 black 6 (C57BL/6) mice and ROR alpha-deficient stagger [ROR(sg/sg)] mice and their WT littermates were used for in vivo studies. The renal I/R injury model was induced by bilateral renal pedicle clamping for 35 min. Human proximal tubule cell line cells were treated with hypoxia (1% oxygen) to establish the cell hypoxia/reoxygenation (H/R) model. We investigated the renal expression and biologic function of ROR alpha, and we found that ROR alpha was significantly down-regulated after renal I/R injury. ROR(sg/sg) mice displayed dramatically augmented renal dysfunction and morphologic damage compared with WT mice at 24 h post-I/R. Further study revealed that the detrimental effects of ROR alpha deficiency were attributable to tubular epithelial cell apoptosis and, consequently, renal inflammation and oxidative stress. The proapoptotic effect of ROR alpha deficiency was associated with aggravated mitochondrial dysfunction in renal tubular cells after I/R. However, pretreatment of C57BL/6 mice with the ROR alpha agonist SR1078 ameliorated I/R-induced renal dysfunction and damage and elicited a concomitant decrease in tubular epithelial cell apoptosis. In summary, our study provides experimental evidence showing that ROR alpha is a novel endogenous protector against renal I/R injury and that ROR-alpha activation is a promising therapeutic strategy for the prevention of acute kidney injury.	[Cai, Jieru; Jiao, Xiaoyan; Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Dept Nephrol, Shanghai, Peoples R China; [Cai, Jieru; Jiao, Xiaoyan; Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang] Shanghai Key Lab Kidney & Blood Purificat, Shanghai, Peoples R China; [Cai, Jieru; Jiao, Xiaoyan; Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang] Shanghai Med Ctr Kidney Dis, Shanghai, Peoples R China; [Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang] Shanghai Inst Kidney & Dialysis, Shanghai, Peoples R China	Fudan University	Yu, XF; Ding, XQ (corresponding author), Fudan Univ, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	yu.xiaofang@zs-hospital.sh.cn; ding.xiaoqiang@zs-hospital.sh.cn			National Natural Science Foundation of China [81600517, 81570600]; Shanghai Sailing Plan [15YF1402100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Plan	The authors thank Dr. Ding Song (Renji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, China) for providing the retinoid-related orphan receptor -deficient stagger mice. This work was supported by National Natural Science Foundation of China Grants 81600517 and 81570600, and Shanghai Sailing Plan 15YF1402100. The authors declare no conflicts of interest.	Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Arici M, 2003, J AM SOC NEPHROL, V14, P17, DOI 10.1097/01.ASN.0000042167.66685.EA; Balasubramanian S, 2012, J AM SOC NEPHROL, V23, P674, DOI 10.1681/ASN.2011070646; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boukhtouche F, 2006, J NEUROCHEM, V96, P1778, DOI 10.1111/j.1471-4159.2006.03708.x; Cal JR, 2014, AM J NEPHROL, V39, P466, DOI 10.1159/000362623; Cook Donald N, 2015, Nucl Receptor Res, V2; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dong W, 2015, J AM SOC NEPHROL, V26, P2789, DOI 10.1681/ASN.2014080846; Fang Y, 2015, HEMODIAL INT, V19, P2, DOI 10.1111/hdi.12193; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Han YH, 2014, ANTIOXID REDOX SIGN, V21, P2083, DOI 10.1089/ars.2013.5655; He B, 2016, J PINEAL RES, V60, P313, DOI 10.1111/jpi.12312; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Julien O, 2017, CELL DEATH DIFFER, V24, P1380, DOI 10.1038/cdd.2017.44; Kaushal GP, 2014, J AM SOC NEPHROL, V25, P877, DOI 10.1681/ASN.2013070780; Kim EJ, 2008, ARTERIOSCL THROM VAS, V28, P1796, DOI 10.1161/ATVBAHA.108.171546; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kurcer Z, 2007, J PINEAL RES, V43, P172, DOI 10.1111/j.1600-079X.2007.00459.x; Lazar MA, 2017, J CLIN INVEST, V127, P1123, DOI 10.1172/JCI92949; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Li SY, 2009, KIDNEY INT, V76, P1049, DOI 10.1038/ki.2009.330; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Marciano DP, 2014, CELL METAB, V19, P193, DOI 10.1016/j.cmet.2013.12.009; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Opie LH, 2016, EUR HEART J-CARD PHA, V2, P258, DOI 10.1093/ehjcvp/pvv037; Sancho-Martinez SM, 2015, CLIN KIDNEY J, V8, P548, DOI 10.1093/ckj/sfv069; Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018; Tilley SL, 2007, J IMMUNOL, V178, P3208, DOI 10.4049/jimmunol.178.5.3208; Tomas-Zapico C, 2005, J PINEAL RES, V39, P21, DOI 10.1111/j.1600-079X.2005.00210.x; Vanmassenhove J, 2017, LANCET, V389, P2139, DOI 10.1016/S0140-6736(17)31329-6; Volt H, 2016, J PINEAL RES, V60, P193, DOI 10.1111/jpi.12303; Wagner J, 2000, J AM SOC NEPHROL, V11, P1479, DOI 10.1681/ASN.V1181479; Wang JL, 2015, CIRCULATION, V132, P1909, DOI 10.1161/CIRCULATIONAHA.115.016457; Wang YJ, 2010, ACS CHEM BIOL, V5, P1029, DOI 10.1021/cb100223d; Weidemann A, 2008, J AM SOC NEPHROL, V19, P486, DOI 10.1681/ASN.2007040419; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhao YC, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12378	44	9	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5704	5715		10.1096/fj.201802248R	http://dx.doi.org/10.1096/fj.201802248R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30673513				2022-12-28	WOS:000462888500085
J	Reyes, JL; Lopes, F; Leung, G; Jayme, TS; Matisz, CE; Shute, A; Burkhard, R; Carneiro, M; Workentine, ML; Wang, A; Petri, B; Beck, PL; Geuking, MB; McKay, DM				Reyes, Jose L.; Lopes, Fernando; Leung, Gabriella; Jayme, Timothy S.; Matisz, Chelsea E.; Shute, Adam; Burkhard, Regula; Carneiro, Matheus; Workentine, Matthew L.; Wang, Arthur; Petri, Bjorn; Beck, Paul L.; Geuking, Markus B.; McKay, Derek M.			Macrophages treated with antigen from the tapeworm Hymenolepis diminuta condition CD25(+) T cells to suppress colitis	FASEB JOURNAL			English	Article						helminth; intestine; inflammatory bowel disease; macrophage; interleukin-10	ALTERNATIVELY ACTIVATED MACROPHAGES; INFLAMMATORY RESPONSES; ADOPTIVE TRANSFER; DENDRITIC CELLS; TH2 RESPONSES; HELMINTH; INDUCTION; INFECTION; IMMUNITY; PROTECTS	Macrophages play central roles in immunity as early effectors and modulating adaptive immune reponses; we implicated macrophages in the anticolitic effect of infection with the tapeworm Hymenolepis diminuta. Here, gene arrays revealed that H. diminuta antigen (HdAg) evoked a program in murine macrophages distinct from that elicited by IL-4. Further, HdAg suppressed LPS-evoked release of TNF-alpha and IL-1 beta from macrophages via autocrine IL-10 signaling. In assessing the ability of macrophages treated in vitro with an extract of H. diminuta [M-(HdAg)] to affect disease, intravenous, but not peritoneal, injection of M-(HdAg) protected wild-type but not RAG1(-/-) mice from dinitrobenzene sulphonic acid (DNBS)-induced colitis. Administration of splenic CD4(+) T cells from in vitro cocultures with M-(HdAg), but not those cocultured with M(IL-4) cells, inhibited DNBS-induced colitis; fractionation of the T-cell population indicated that the CD4(+)CD25(+) T cells from cocultures with M-(HdAg) drove the suppression of DNBS-induced colitis. Use of IL-4(-/-) or IL-10(-/-) CD4(+) T cells revealed that neither cytokine alone from the donor cells was essential for the anticolitic effect. These data illustrate that HdAg evokes a unique regulatory program in macrophages, identifies HdAg-evoked IL-10 suppression of macrophage activation, and reveals the ability of HdAg-treated macrophages to educate (i.e., condition) and mobilize CD4(+)CD25(+) T cells, which could be deployed to treat colonic inflammation.	[Reyes, Jose L.; Lopes, Fernando; Leung, Gabriella; Jayme, Timothy S.; Matisz, Chelsea E.; Shute, Adam; Burkhard, Regula; Wang, Arthur; Beck, Paul L.; Geuking, Markus B.; McKay, Derek M.] Univ Calgary, Dept Physiol & Pharmacol, 1877 HSC,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Petri, Bjorn] Univ Calgary, Calvin Joan & Phoebe Snyder Inst Chron Dis, Mouse Phen Resource Lab, Calgary, AB, Canada; [Burkhard, Regula; Carneiro, Matheus; Petri, Bjorn; Geuking, Markus B.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Beck, Paul L.] Univ Calgary, Dept Med, Cumming Sch Med, Calgary, AB, Canada; [Workentine, Matthew L.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Reyes, Jose L.] UNAM, FES, Unidad Invest Biomed UBIMED, Lab Inmunol Expt & Regulac Inflamac Hepatointesti, Tlalnepantla de Baz, Mexico	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Universidad Nacional Autonoma de Mexico	McKay, DM (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, 1877 HSC,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	dmckay@ucalgary.ca	McKay, Derek/HCH-3240-2022; Wang, Arthur/AAE-3368-2019; Reyes, Jose Luis/D-8322-2018	Burkhard, Regula/0000-0002-5117-0937; Workentine, Matthew/0000-0002-6415-2797; Reyes, Jose Luis/0000-0003-0089-0261; Leung, Gabriella/0000-0002-8754-1621	Canadian Institutes for Health Research (CIHR)/Canadian Association of Gastroenterology (CAG)/Janssen; Alberta Innovates-Health Solutions (AI-HS); Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI) program at the University of Calgary; Beverly Philips Snyder Institute University of Calgary; Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI); Canadian Association of Gastroenterology (CAG); Calvin, Joan and Phoebe Snyder Institute for Chronic Diseases; Allergan	Canadian Institutes for Health Research (CIHR)/Canadian Association of Gastroenterology (CAG)/Janssen(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AI-HS); Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI) program at the University of Calgary; Beverly Philips Snyder Institute University of Calgary; Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI); Canadian Association of Gastroenterology (CAG); Calvin, Joan and Phoebe Snyder Institute for Chronic Diseases; Allergan(AbbVieAllergan)	J.L.R. and F.L. were recipients of Canadian Institutes for Health Research (CIHR)/Canadian Association of Gastroenterology (CAG)/Janssen or Allergan, and Alberta Innovates-Health Solutions (AI-HS) postdoctoral fellowships. C.E.M. held AI-HS and CIHR Ph.D. studentships. G.L. held an AI-HS Ph.D. studentship. T.S.J was supported, in part, by a stipend from the Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI) program at the University of Calgary. A.S. was supported by a Beverly Philips Snyder Institute University of Calgary, Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI), and Canadian Association of Gastroenterology (CAG) graduate studentships. D.M.M. holds a Canada Research Chair (Tier 1) in Intestinal Immunophysiology in Health and Disease. The Snyder Mouse Phenomics Resources Laboratory, funded by the Calvin, Joan and Phoebe Snyder Institute for Chronic Diseases and the Flow Cytometry supported this work. The authors declare no conflicts of interest.	Aira N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005390; [Anonymous], 2021, LANG ENV STAT COMP; Arora S, 2018, IMMUNOBIOLOGY, V223, P383, DOI 10.1016/j.imbio.2017.11.001; Cao Q, 2010, J AM SOC NEPHROL, V21, P933, DOI 10.1681/ASN.2009060592; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; DiNardo AR, 2016, J INFECT DIS, V214, P479, DOI 10.1093/infdis/jiw156; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Du LL, 2011, DIGEST DIS SCI, V56, P2810, DOI 10.1007/s10620-011-1689-8; Eason RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37276; Esser-von Bieren Julia, 2015, J Immunol, V194, P1154, DOI 10.4049/jimmunol.1401645; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Fernando ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099050; Figueiredo AS, 2009, FEBS J, V276, P3454, DOI 10.1111/j.1742-4658.2009.07068.x; Finlay CM, 2014, IMMUNOL REV, V259, P206, DOI 10.1111/imr.12164; Fleming BD, 2015, J LEUKOCYTE BIOL, V98, P395, DOI 10.1189/jlb.2A1114-560R; Fleming JO, 2013, INT J PARASITOL, V43, P259, DOI 10.1016/j.ijpara.2012.10.025; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Hang L, 2016, J IMMUNOL, V197, P2948, DOI 10.4049/jimmunol.1600063; Hang L, 2013, J IMMUNOL, V191, P1927, DOI 10.4049/jimmunol.1201457; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Heylen M, 2015, INFLAMM BOWEL DIS, V21, P48, DOI 10.1097/MIB.0000000000000246; Hunter MM, 2010, GASTROENTEROLOGY, V138, P1395, DOI 10.1053/j.gastro.2009.12.041; Hunter MM, 2005, J IMMUNOL, V174, P7368, DOI 10.4049/jimmunol.174.11.7368; Hussaarts L, 2013, IMMUNOL CELL BIOL, V91, P486, DOI 10.1038/icb.2013.31; Jenkins SJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/262609; Johnston MJG, 2010, INFECT IMMUN, V78, P1364, DOI 10.1128/IAI.01349-08; Klotz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001248; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Ledesma-Soto Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/563425; Leung G, 2015, MOL MED, V21, P924, DOI 10.2119/molmed.2015.00193; Leung G, 2013, AM J PHYSIOL-GASTR L, V304, pG781, DOI 10.1152/ajpgi.00055.2013; Cancado GGL, 2011, INFLAMM BOWEL DIS, V17, P2275, DOI 10.1002/ibd.21629; Lopes F, 2016, INFLAMM BOWEL DIS, V22, P2499, DOI 10.1097/MIB.0000000000000889; Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Matisz CE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40631; Matisz CE, 2015, EUR J IMMUNOL, V45, P3126, DOI 10.1002/eji.201545579; Nickles D., 2016, NANOSTRINGQCPRO QUAL; Pineda MA, 2014, MOL BIOCHEM PARASIT, V194, P1, DOI 10.1016/j.molbiopara.2014.03.003; Rausch S, 2009, EUR J IMMUNOL, V39, P3066, DOI 10.1002/eji.200939644; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Reyes JL, 2016, INFECT IMMUN, V84, P3471, DOI 10.1128/IAI.00681-16; Reyes JL, 2015, J IMMUNOL, V194, P364, DOI 10.4049/jimmunol.1400738; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizzo A, 2012, INFLAMM BOWEL DIS, V18, P449, DOI 10.1002/ibd.21799; Rolot M, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2790627; Sanin DE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004841; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Schuijs MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161885; Shepherd C, 2015, PARASITE IMMUNOL, V37, P293, DOI 10.1111/pim.12192; Smith H, 2018, EXPERT REV GASTROENT, V12, P997, DOI 10.1080/17474124.2018.1505498; Smith KA, 2016, MUCOSAL IMMUNOL, V9, P428, DOI 10.1038/mi.2015.73; Smits HH, 2010, CURR ALLERGY ASTHM R, V10, P3, DOI 10.1007/s11882-009-0085-3; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Terrazas CA, 2011, INT J BIOL SCI, V7, P1391, DOI 10.7150/ijbs.7.1391; Waggott D., 2015, NANOSTRINGNORML NORM; Weisser SB, 2014, EUR J IMMUNOL, V44, P3353, DOI 10.1002/eji.201343981; Wi HJ, 2012, CYTOKINE, V59, P237, DOI 10.1016/j.cyto.2012.04.021; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Zawistowska-Deniziak A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00148; Ziegler T, 2015, J IMMUNOL, V194, P1555, DOI 10.4049/jimmunol.1401217	66	5	6	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5676	5689		10.1096/fj.201802160R	http://dx.doi.org/10.1096/fj.201802160R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668930				2022-12-28	WOS:000462888500083
J	Arnold, C; Feldner, A; Zappe, M; Komljenovic, D; De La Torre, C; Ruzicka, P; Hecker, M; Neuhofer, W; Korff, T				Arnold, Caroline; Feldner, Anja; Zappe, Maren; Komljenovic, Dorde; De La Torre, Carolina; Ruzicka, Philipp; Hecker, Markus; Neuhofer, Wolfgang; Korff, Thomas			Genetic ablation of NFAT5/TonEBP in smooth muscle cells impairs flow- and pressure-induced arterial remodeling in mice	FASEB JOURNAL			English	Article						hypertension; wall stress; transcriptome	TENASCIN-C; REQUIRES TONEBP/NFAT5; BLOOD-PRESSURE; IN-VITRO; HYPERTENSION; TRANSCRIPTION; GROWTH; CYCLOOXYGENASE-2; PROLIFERATION; EXPRESSION	The arterial wall adapts to alterations in blood flow and pressure by remodeling the cellular and extracellular architecture. Biomechanical stress of vascular smooth muscle cells (VSMCs) in the media is thought to precede this process and promote their activation and subsequent proliferation. However, molecular determinants orchestrating the transcriptional phenotype under these conditions have been insufficiently studied. We identified the transcription factor, nuclear factor of activated T cells 5 (NFAT5; or tonicity enhancer-binding protein) as a crucial regulatory element of mechanical stress responses of VSMCs. Here, the relevance of NFAT5 for arterial growth and thickening is investigated in mice upon inducible smooth muscle cell (SMC)-specific genetic ablation of Nfat5. In cultured mouse VSMCs, loss of Nfat5 inhibits the expression of gene sets involved in the control of the cell cycle and the interaction with the extracellular matrix and cytoskeletal dynamics. In vivo, SMC-specific knockout of Nfat5 did not affect the general vascular architecture and blood pressure levels under baseline conditions. However, proliferation of VSMCs and the thickening of the arterial wall were inhibited during both flow-induced collateral remodeling and hypertension-mediated arterial hypertrophy. Whereas originally described as a hypertonicity-responsive transcription factor, these findings identify NFAT5 as a novel molecular determinant of biomechanically induced phenotype changes of VSMCs and wall stress-induced arterial remodeling processes.Arnold, C., Feldner, A., Zappe, M., Komljenovic, D., De La Torre, C., Ruzicka, P., Hecker, M., Neuhofer, W., Korff, T. Genetic ablation of NFAT5/TonEBP in smooth muscle cells impairs flow- and pressure-induced arterial remodeling in mice.	[Arnold, Caroline; Feldner, Anja; Zappe, Maren; Ruzicka, Philipp; Hecker, Markus; Korff, Thomas] Heidelberg Univ, Univ Hosp Mannheim, Inst Physiol & Pathophysiol, Dept Cardiovasc Physiol, Heidelberg, Germany; [De La Torre, Carolina] Heidelberg Univ, Univ Hosp Mannheim, Ctr Med Res, Heidelberg, Germany; [Korff, Thomas] Heidelberg Univ, Univ Hosp Mannheim, European Ctr Angiosci, Med Fac Mannheim, Heidelberg, Germany; [Neuhofer, Wolfgang] Heidelberg Univ, Univ Hosp Mannheim, Med Clin 5, Heidelberg, Germany; [Komljenovic, Dorde] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Korff, T (corresponding author), Heidelberg Univ, Dept Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [KO2344/8-1, SFB TR23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge the excellent technical assistance of Gudrun Scheib, Maria Harlacher, Yvonne Feuchter (all from Heidelberg University), and Melanie Muller (computed tomography 3-dimensional reconstructions; German Cancer Research Center). This work was supported by Deutsche Forschungsgemeinschaft Grant KO2344/8-1, SFB TR23, Projects C5, C6, and Z1. The authors declare no conflicts of interest.	Ahn JD, 2002, CIRC RES, V90, P1325, DOI 10.1161/01.RES.0000023200.19316.D5; AlGhatrif M, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0523-z; Arnold C, 2014, EMBO MOL MED, V6, P1075, DOI 10.15252/emmm.201403864; Avendano MS, 2016, BRIT J PHARMACOL, V173, P1541, DOI 10.1111/bph.13457; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Chan CT, 2012, HYPERTENSION, V60, P1207, DOI 10.1161/HYPERTENSIONAHA.112.201251; Chang KW, 2006, HEPATOL RES, V36, P33, DOI 10.1016/j.hepres.2006.05.003; Chang KW, 2011, ANTICANCER RES, V31, P2037; Choi S, 2017, J CLIN INVEST, V127, P954, DOI 10.1172/JCI87880; Cowan KN, 2000, J CLIN INVEST, V105, P21, DOI 10.1172/JCI6539; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782; Eitenmuller I, 2006, CIRC RES, V99, P656, DOI 10.1161/01.RES.0000242560.77512.dd; Favale NO, 2009, BIOCHEM BIOPH RES CO, V381, P301, DOI 10.1016/j.bbrc.2008.12.189; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; Ghosh S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001712; Golledge J, 2011, CARDIOVASC RES, V92, P19, DOI 10.1093/cvr/cvr183; Halterman JA, 2012, AM J PHYSIOL-CELL PH, V302, pC1, DOI 10.1152/ajpcell.00327.2011; Hamada K, 1998, J BIOL CHEM, V273, P6334, DOI 10.1074/jbc.273.11.6334; Han EJ, 2017, EBIOMEDICINE, V18, P261, DOI 10.1016/j.ebiom.2017.03.039; Heerkens EHJ, 2007, HYPERTENSION, V49, P1, DOI 10.1161/01.HYP.0000252753.63224.3b; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Helisch A, 2003, MICROCIRCULATION, V10, P83, DOI 10.1038/sj.mn.7800173; Hodebeck M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00467; Holschermann H, 2006, CARDIOVASC RES, V71, P527, DOI 10.1016/j.cardiores.2006.05.021; Huveneers S, 2015, CIRC RES, V116, P895, DOI 10.1161/CIRCRESAHA.116.305720; Ihida-Stansbury K, 2006, AM J PHYSIOL-LUNG C, V291, pL694, DOI 10.1152/ajplung.00119.2006; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Intengan HD, 2000, HYPERTENSION, V36, P312, DOI 10.1161/01.HYP.36.3.312; Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Jones PL, 1996, CIRC RES, V79, P1131, DOI 10.1161/01.RES.79.6.1131; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kawabe J, 2004, AM J PHYSIOL-HEART C, V286, pH1845, DOI 10.1152/ajpheart.00593.2003; Kuper C., 2015, FRONT PHYSIOL, V5, P507; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lee HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24921; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; MACKIE EJ, 1992, AM J PATHOL, V141, P377; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Mulvany MJ, 1996, HYPERTENSION, V28, P505; Mulvany MJ, 2002, CURR HYPERTENS REP, V4, P49, DOI 10.1007/s11906-002-0053-y; Numaguchi K, 1999, CIRC RES, V85, P5; Okumura T, 2002, HYPERTENS RES, V25, P927; Pfisterer L, 2012, CARDIOVASC RES, V96, P120, DOI 10.1093/cvr/cvs247; Sawada Y, 2007, CARDIOVASC RES, V74, P366, DOI 10.1016/j.cardiores.2007.02.028; Scherer C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000626; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Serr I, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aag1782; Wallner K, 1999, J AM COLL CARDIOL, V34, P871, DOI 10.1016/S0735-1097(99)00272-7; Wallner K, 1999, CIRCULATION, V99, P1284, DOI 10.1161/01.CIR.99.10.1284; Wharton J, 2000, CIRCULATION, V102, P3130; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yamamoto K, 2005, CARDIOVASC RES, V65, P737, DOI 10.1016/j.cardiores.2004.10.034; Yoon HJ, 2011, ARTHRITIS RHEUM-US, V63, P1843, DOI 10.1002/art.30229; Young W, 2000, CIRC RES, V86, P906, DOI 10.1161/01.RES.86.8.906; Yue ZC, 2015, AM J PHYSIOL-HEART C, V308, pH157, DOI 10.1152/ajpheart.00457.2014; Zappe M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01190; Zhao HG, 2009, BIOCHEM BIOPH RES CO, V389, P599, DOI 10.1016/j.bbrc.2009.09.028	67	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3364	3377		10.1096/fj.201801594R	http://dx.doi.org/10.1096/fj.201801594R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383452	Bronze			2022-12-28	WOS:000459794800024
J	Brehm, MA; Kenney, LL; Wiles, MV; Low, BE; Tisch, RM; Burzenski, L; Mueller, C; Greiner, DL; Shultz, LD				Brehm, Michael A.; Kenney, Laurie L.; Wiles, Michael V.; Low, Benjamin E.; Tisch, Roland M.; Burzenski, Lisa; Mueller, Christian; Greiner, Dale L.; Shultz, Leonard D.			Lack of acute xenogeneic graft-versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression	FASEB JOURNAL			English	Article						humanized; HU-PBL-SCID; GVHD; immunodeficient; humanized	NONOBESE DIABETIC MICE; COMPLEX CLASS-I; MOUSE MODELS; HUMAN CD4(+); IMMUNE-SYSTEM; IL-2; GENE; INTERLEUKIN-2; PREVENTION; INSULITIS	Immunodeficient mice engrafted with human peripheral blood mononuclear cells (PBMCs) support preclinical studies of human pathogens, allograft rejection, and human T-cell function. However, a major limitation of PBMC engraftment is development of acute xenogeneic graft-versus-host disease (GVHD) due to human T-cell recognition of murine major histocompatibility complex (MHC). To address this, we created 2 NOD-scid IL-2 receptor subunit (IL2rg)(null) (NSG) strains that lack murine MHC class I and II [NSG--2-microglobulin (B2M)(null) (IA IE)(null) and NSG-(K-b D-b)(null) (IA(null))]. We observed rapid human IgG clearance in NSG-B2M(null) (IA IE)(null) mice whereas clearance in NSG-(K-b D-b)(null) (IA(null)) mice and NSG mice was comparable. Injection of human PBMCs into both strains enabled long-term engraftment of human CD4(+) and CD8(+) T cells without acute GVHD. Engrafted human T-cell function was documented by rejection of human islet allografts. Administration of human IL-2 to NSG-(K-b D-b)(null) (IA(null)) mice via adeno-associated virus vector increased human CD45(+) cell engraftment, including an increase in human regulatory T cells. However, high IL-2 levels also induced the development of GVHD. These data document that NSG mice deficient in murine MHC support studies of human immunity in the absence of acute GVHD and enable evaluation of human antibody therapeutics targeting human T cells.Brehm, M. A., Kenney, L. L., Wiles, M. V., Low, B. E., Tisch, R. M., Burzenski, L., Mueller, C., Greiner, D. L., Shultz, L. D. Lack of acute xenogeneic graft-versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.	[Brehm, Michael A.; Kenney, Laurie L.; Greiner, Dale L.] Univ Massachusetts, Med Sch, Diabet Ctr Excellence, Worcester, MA USA; [Mueller, Christian] Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA USA; [Mueller, Christian] Univ Massachusetts, Med Sch, Horae Gene Therapy Ctr, Worcester, MA USA; [Wiles, Michael V.; Low, Benjamin E.; Burzenski, Lisa; Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Tisch, Roland M.] Univ N Carolina, Dept Immunol & Microbiol, Chapel Hill, NC 27515 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill	Brehm, MA (corresponding author), Univ Massachusetts, Med Sch, Program Mol Med, Diabet Ctr Excellence, 368 Plantat St,AS7-2053, Worcester, MA 01605 USA.	michael.brehm@umassmed.edu		Mueller, Christian/0000-0003-3589-8749; wiles, michael/0000-0002-3620-8386; Brehm, Michael/0000-0001-6813-3262	U.S. National Institutes of Health (NIH) Office of the Director Grant [1R24 OD018259]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [UC4 DK104218, CA034196, 1R01 AI132963, HL131471, 1DP3DK111898, DK098252, 1R01 DK1035486]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL131471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098252, DP3DK111898, U01DK104218, R01DK103546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD018259] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Office of the Director Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by U.S. National Institutes of Health (NIH) Office of the Director Grant 1R24 OD018259 and the NIH National Institute of Diabetes and Digestive and Kidney Diseases-supported Human Islet Research Network (https://hirnetwork.org) Grants UC4 DK104218 (to M.A.B., D.L.G., and L.D.S.), CA034196 (to L.D.S.), 1R01 AI132963 (to M.A.B. and L.D.S.), HL131471 (to C.M.), 1DP3DK111898 (to M.A.B.), DK098252 (to C.M.), and 1R01 DK1035486 (R.M.T. and M.A.B.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. M.A.B. and D.L.C. are consultants for The Jackson Laboratory. The authors declare no conflicts of interest.	Abraham S, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00276; Abraham S, 2015, CLIN IMMUNOL, V156, P58, DOI 10.1016/j.clim.2014.11.004; Akkina R, 2016, AIDS RES HUM RETROV, V32, P109, DOI [10.1089/aid.2015.0258, 10.1089/AID.2015.0258]; Ali N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044219; Ashizawa T, 2017, CLIN CANCER RES, V23, P149, DOI 10.1158/1078-0432.CCR-16-0122; Bevan MJ, 2010, J IMMUNOL, V184, P4585, DOI 10.4049/jimmunol.1090023; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; Brehm M, 2016, TRANSL IMMUNOL MECH, V2016, P285, DOI [DOI 10.1016/B978-0-12-801577-3.00012-5, 10.1016/B978-0-12-801577-3.00012-5]; Brehm MA, 2014, J IMMUNOL METHODS, V410, P3, DOI 10.1016/j.jim.2014.02.011; Bruck F, 2013, CYTOTHERAPY, V15, P267, DOI 10.1016/j.jcyt.2012.09.003; Christianson SW, 1997, J IMMUNOL, V158, P3578; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Covassin L, 2013, CLIN EXP IMMUNOL, V174, P372, DOI 10.1111/cei.12180; Dai CH, 2016, J CLIN INVEST, V126, P1857, DOI 10.1172/JCI83657; Durost PA, 2018, HUM GENE THER, V29, P352, DOI 10.1089/hum.2017.072; Ferrara JLM, 2006, SEMIN HEMATOL, V43, P1, DOI 10.1053/j.seminhematol.2005.11.028; Gregoire-Gauthier J, 2015, BIOL BLOOD MARROW TR, V21, P821, DOI 10.1016/j.bbmt.2015.01.006; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; HARLAN DM, 1995, DIABETES, V44, P816, DOI 10.2337/diabetes.44.7.816; Hatano R, 2013, BRIT J HAEMATOL, V162, P263, DOI 10.1111/bjh.12378; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; He Y, 2013, HUM GENE THER, V24, P545, DOI 10.1089/hum.2013.065; Hilger N, 2016, CYTOM PART A, V89A, P803, DOI 10.1002/cyto.a.22930; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2017, AM J TRANSPLANT, V17, P1216, DOI 10.1111/ajt.14116; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Johnson MC, 2013, DIABETES, V62, P3775, DOI 10.2337/db13-0669; Kenney LL, 2016, AM J TRANSPLANT, V16, P389, DOI 10.1111/ajt.13520; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P917, DOI 10.1016/j.dci.2005.03.003; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; MIYAZAKI T, 1992, P NATL ACAD SCI USA, V89, P9519, DOI 10.1073/pnas.89.20.9519; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Pino S, 2010, METHODS MOL BIOL, V602, P105, DOI 10.1007/978-1-60761-058-8_7; PODOLIN PL, 1993, J EXP MED, V178, P793, DOI 10.1084/jem.178.3.793; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; RAULET DH, 1994, ADV IMMUNOL, V55, P381; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Sim GC, 2014, CYTOKINE GROWTH F R, V25, P377, DOI 10.1016/j.cytogfr.2014.07.018; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Theocharides APA, 2016, HAEMATOLOGICA, V101, P5, DOI 10.3324/haematol.2014.115212; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; van den Broek T, 2018, NAT REV IMMUNOL, V18, P363, DOI 10.1038/s41577-018-0001-y; Wager EJ, 2000, J IMMUNOL, V165, P518, DOI 10.4049/jimmunol.165.1.518; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Yang CX, 2015, DIABET METAB SYND OB, V8, P387, DOI 10.2147/DMSO.S87253	56	55	56	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3137	3151		10.1096/fj.201800636R	http://dx.doi.org/10.1096/fj.201800636R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383447	Green Published			2022-12-28	WOS:000459794800006
J	Deng, YJ; Cai, Y; Liu, LL; Lin, XP; Lu, PF; Guo, YY; Han, M; Xu, G				Deng, Yuanjun; Cai, Yang; Liu, Lele; Lin, Xueping; Lu, Pingfan; Guo, Yiyan; Han, Min; Xu, Gang			Blocking Tyr265 nitration of protein phosphatase 2A attenuates nitrosative stress-induced endothelial dysfunction in renal microvessels	FASEB JOURNAL			English	Article						nitration; endothelial cells; peptide drugs	NITRIC-OXIDE; CELL; PEPTIDE; PP2A; INACTIVATION; FIBROBLASTS; MODULATION; INHIBITION; OXIDATION; JUNCTIONS	Protein tyrosine (Tyr) nitration, the covalent addition of a nitro group ((NO2)-N-center dot) to Tyr residues, is emerging as a candidate mechanism of endothelial dysfunction. Previous studies have shown that Tyr nitration is primarily induced by nitrosative stress, a process characterized by the production of reactive nitrogen species, especially peroxynitrite anion (ONOO-), which is considered a secondary product of NO in the presence of superoxide radicals (O-2(center dot-)). However, the impact of nitrosative stress-induced Tyr nitration on endothelial dysfunction has not been thoroughly elucidated to date. We developed an endothelial dysfunction model, a process called endothelial-to-mesenchymal transition (EndMT), and evaluated the production of NO, O-2(center dot-), and protein nitration during EndMT. The results showed that TGF-1 stimulation induced EndMT and elevated endothelial NO and O-2(center dot-) production as well as nitration of the catalytic subunit of protein phosphatase (PP)2A. Mass spectrometry analysis showed that Tyr265 was the nitration site in the catalytic subunit of protein phosphatase (PP)2A, and this Tyr nitration increased PP2A activity and disrupted endothelial integrity. To devise an endothelial-targeted anti-PP2Ac nitration strategy, a mimic peptide, tyrosine 265 wild type (Y265WT), conjugated with the cell-penetrating peptide HIV-1 TAT protein (TAT) was synthesized. PP2Ac nitration and PP2A activity were significantly inhibited by pretreatment with TAT-265WT, and the integrity of endothelial cells was maintained. Furthermore, injection of TAT-265WT attenuated renal nitration formation and caused anticapillary rarefaction in a unilateral urethral obstructive nephropathy model. Taken together, these results offer preclinical proof of concept for TAT-265WT as a tractable agent to protect against nitrosative stress-induced endothelial dysfunction in renal microvessels.Deng,Y., Cai, Y., Liu, L., Lin, X., Lu, P., Guo, Y., Han, M., Xu, G. Blocking Tyr265 nitration of protein phosphatase 2A attenuates nitrosative stress-induced endothelial dysfunction in renal microvessels.	[Deng, Yuanjun; Cai, Yang; Liu, Lele; Lin, Xueping; Lu, Pingfan; Guo, Yiyan; Han, Min; Xu, Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Nephrol,Dept Internal Med, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology	Han, M; Xu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Nephrol,Dept Internal Med, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	minhan@tjh.tjmu.edu.cn; xugang@tjh.tjmu.edu.cn			National Natural Science Foundation of China [81370798, 81670633, 81770686]; Huazhong University of Science and Technology [2017KFYXJJ101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong University of Science and Technology	The authors thank Yajun Ruan (Tongji Hospital, Huazhong University of Science and Technology) for technical assistance for the whole-body fluorescence imaging experiment. This research was supported by National Natural Science Foundation of China Grants 81370798, 81670633, and 81770686, and by Huazhong University of Science and Technology research funds for Self-Dependent Innovation (Grant 2017KFYXJJ101). The authors declare no conflicts of interest.	Bailey JC, 2014, PHARMACOL THERAPEUT, V144, P303, DOI 10.1016/j.pharmthera.2014.06.009; Bani-Hani AH, 2008, J UROLOGY, V180, P461, DOI 10.1016/j.juro.2008.04.001; Batthyany C, 2005, BIOCHEMISTRY-US, V44, P8038, DOI 10.1021/bi0474620; Bellmann-Sickert K, 2010, TRENDS PHARMACOL SCI, V31, P434, DOI 10.1016/j.tips.2010.06.003; Bohle A, 1996, KIDNEY BLOOD PRESS R, V19, P191, DOI 10.1159/000174072; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brovkovych V, 1999, J PHYSIOL PHARMACOL, V50, P575; Carlstrom M, 2015, PHYSIOL REV, V95, P405, DOI 10.1152/physrev.00042.2012; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Deng YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19821; Deshmukh PA, 2007, AM J PHYSIOL-HEART C, V292, pH792, DOI 10.1152/ajpheart.00225.2006; Dunagan M, 2012, AM J PHYSIOL-GASTR L, V303, pG1356, DOI 10.1152/ajpgi.00526.2011; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Fine LG, 1998, KIDNEY INT, pS74; Han F, 2011, J PINEAL RES, V50, P281, DOI 10.1111/j.1600-079X.2010.00838.x; Heigold S, 2002, J LEUKOCYTE BIOL, V72, P554; Ichikawa T, 2008, AM J PHYSIOL-LUNG C, V295, pL800, DOI 10.1152/ajplung.90264.2008; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jung HJ, 2006, BIOCHEM BIOPH RES CO, V345, P222, DOI 10.1016/j.bbrc.2006.04.059; Kasa A, 2013, MICROVASC RES, V89, P86, DOI 10.1016/j.mvr.2013.05.003; Kim DH, 2014, ENVIRON SCI TECHNOL, V48, P4030, DOI 10.1021/es500001q; Knepler JL, 2001, AM J PHYSIOL-CELL PH, V281, pC1064, DOI 10.1152/ajpcell.2001.281.3.C1064; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Liu RH, 2012, J CONTROL RELEASE, V161, P893, DOI 10.1016/j.jconrel.2012.05.002; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Malinski T, 2007, J ALZHEIMERS DIS, V11, P207; Mathews MT, 2008, ARTERIOSCL THROM VAS, V28, P711, DOI 10.1161/ATVBAHA.107.156406; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nakahata S, 2014, BLOOD, V124, P2163, DOI 10.1182/blood-2014-08-594093; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; Panth N., 2016, ADV MED, V2016, P9152732, DOI [10.1155/2016/9152732, DOI 10.1155/2016/9152732]; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Sun L, 2015, BIOMOLECULES, V5, P1284, DOI 10.3390/biom5031284; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; Wu F, 2009, CARDIOVASC RES, V81, P38, DOI 10.1093/cvr/cvn246; Yang D, 2013, EXP NEUROL, V247, P447, DOI 10.1016/j.expneurol.2013.01.015; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	41	4	4	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3718	3730		10.1096/fj.201800885RR	http://dx.doi.org/10.1096/fj.201800885RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521379	Bronze			2022-12-28	WOS:000459794800051
J	Jie, ZW; Shen, SY; Zhao, XD; Xu, WB; Zhang, XY; Huang, B; Tang, P; Qin, A; Fan, SW; Xie, Z				Jie, Zhiwei; Shen, Shuying; Zhao, Xiangde; Xu, Wenbin; Zhang, Xuyang; Huang, Bao; Tang, Pan; Qin, An; Fan, Shunwu; Xie, Ziang			Activating -catenin/Pax6 axis negatively regulates osteoclastogenesis by selectively inhibiting phosphorylation of p38/MAPK	FASEB JOURNAL			English	Article						bone loss; osteoclast; VX-745; SKL2001; therapeutic	P38 MAP KINASE; NF-KAPPA-B; BETA-CATENIN; ALKALINE-PHOSPHATASE; CROSS-TALK; RANKL; MECHANISMS; INDUCTION; NFATC1; GENES	Balance of osteoclast formation is regulated by the receptor activator of NF-B ligand and extracellular negative regulators such as IFN- and IFN-. However, very little is known about the intrinsic negative regulatory factors of osteoclast differentiation. Recently, the paired-box homeodomain transcription factor Pax6 was shown to negatively regulate receptor activator of NF-B ligand-mediated osteoclast differentiation. However, the mechanism underlying this regulation is still unclear. In this study, we show that a p38 inhibitor (VX-745) up-regulates the expression of Pax6 during osteoclast differentiation. Subsequently, we found that -catenin could bind to the proximal region of Pax6 promoter to induce its expression, and this action could be impaired by p38-induced ubiquitin-mediated degradation of -catenin. Our results suggest that Pax6 is regulated by a novel p38/-catenin pathway. Pax6 can further regulate the nuclear translocation of NF of activated T cells, cytoplasmic 1. Our study indicates that this novel p38/-catenin/Pax6 axis contributes to negative regulation of osteoclastogenesis. In addition, our study proposes a novel approach to treat osteoclast-related diseases through the use of VX-745 complemented with the -catenin activator SKL2001.Jie, Z., Shen, S., Zhao, X., Xu, W., Zhang, X., Huang, B., Tang, P., Qin, A., Fan, S., Xie, Z. Activating -catenin/Pax6 axis negatively regulates osteoclastogenesis by selectively inhibiting phosphorylation of p38/MAPK.	[Jie, Zhiwei; Shen, Shuying; Zhao, Xiangde; Xu, Wenbin; Zhang, Xuyang; Huang, Bao; Fan, Shunwu; Xie, Ziang] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Hangzhou, Zhejiang, Peoples R China; [Jie, Zhiwei; Shen, Shuying; Zhao, Xiangde; Xu, Wenbin; Zhang, Xuyang; Huang, Bao; Fan, Shunwu; Xie, Ziang] Key Lab Musculoskeletal Syst Degenerat & Regenera, Hangzhou, Zhejiang, Peoples R China; [Tang, Pan] Zhejiang Univ, Huzhou Hosp, Dept Orthopaed, Hangzhou, Zhejiang, Peoples R China; [Qin, An] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant, Dept Orthopaed,Sch Med, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; Shanghai Jiao Tong University	Fan, SW; Xie, Z (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed, 3rd Qingchun Rd, Hangzhou, Zhejiang, Peoples R China.	shunwu_fan@zju.edu.cn; ziang_xie@zju.edu.cn	zhang, xuyang/GQH-3712-2022; Tang, Pan/AIC-2118-2022	Jie, Zhiwei/0000-0002-9469-4490; Zhang, Xuyang/0000-0002-4665-3934	National Key Research and Development Program of China [2018YFC1105200]; Key Research and Development Plan in Zhejiang Province [2018C03060]; National Nature Science Fund of China [81871797, 81802680, 81772387]; Natural Science Fund of Zhejiang Province [Z15H060002]	National Key Research and Development Program of China; Key Research and Development Plan in Zhejiang Province; National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	The authors thank Dr. Xiangqian Fang (Sir Run Run Shaw Hospital) for contributing to revisions to the manuscript. This research was supported by the National Key Research and Development Program of China (2018YFC1105200 to S.F.), the Key Research and Development Plan in Zhejiang Province (2018C03060), the National Nature Science Fund of China [81871797, 81802680 (to S.F.), and 81772387], and the Natural Science Fund of Zhejiang Province (Z15H060002). The authors declare no conflicts of interest.	ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Bohm C, 2009, J IMMUNOL, V183, P5938, DOI 10.4049/jimmunol.0901026; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Cong Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep45964; Cott C, 2016, BBA-MOL CELL RES, V1863, P1106, DOI 10.1016/j.bbamcr.2016.02.004; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; Deepak V, 2015, BIOFACTORS, V41, P403, DOI 10.1002/biof.1241; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Gan QN, 2014, STEM CELLS, V32, P45, DOI 10.1002/stem.1561; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grabowski P, 2009, ENDOCR DEV, V16, P32, DOI 10.1159/000223687; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; Hinoi E, 2012, J BONE MINER RES, V27, P2526, DOI 10.1002/jbmr.1708; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Kim H, 2017, J BONE MINER RES, V32, P397, DOI 10.1002/jbmr.2974; Kogawa M, 2013, J BIOL CHEM, V288, P31299, DOI 10.1074/jbc.M113.461848; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Lin J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005867; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; McGuire VA, 2013, MOL CELL BIOL, V33, P4152, DOI 10.1128/MCB.01691-12; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Rey A, 2007, BONE, V41, P59, DOI 10.1016/j.bone.2007.02.031; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Suzuki A, 2002, BONE, V30, P91, DOI 10.1016/S8756-3282(01)00660-3; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Xie Z, 2018, J BONE MINER RES, V33, P667, DOI 10.1002/jbmr.3334; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yamashita T, 2008, BIOCHEM BIOPH RES CO, V365, P252, DOI 10.1016/j.bbrc.2007.10.169; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zhou FH, 2006, J BONE MINER RES, V21, P1075, DOI 10.1359/JBMR.060410	45	12	12	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4236	4247		10.1096/fj.201801977R	http://dx.doi.org/10.1096/fj.201801977R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526042	Bronze			2022-12-28	WOS:000459794800091
J	Shin, HW; Takatsu, H				Shin, Hye-Won; Takatsu, Hiroyuki			Substrates of P4-ATPases: beyond aminophospholipids (phosphatidylserine and phosphatidylethanolamine)	FASEB JOURNAL			English	Review						flippase; lipid bilayer; asymmetry; biological membrane; membrane curvature	P-TYPE ATPASES; INTRAHEPATIC CHOLESTASIS TYPE-1; MEMBRANE PHOSPHOLIPID ASYMMETRY; RED-BLOOD-CELLS; PLASMA-MEMBRANE; CANALICULAR MEMBRANE; TRANSBILAYER DISTRIBUTION; ATP8B1 DEFICIENCY; LIPID ASYMMETRY; SUBCELLULAR-LOCALIZATION	P4-ATPases, a subfamily of P-type ATPases, were initially identified as aminophospholipid translocases in eukaryotic membranes. These proteins generate and maintain membrane lipid asymmetry by translocating aminophospholipids (phosphatidylserine and phosphatidylethanolamine) from the exoplasmic/lumenal leaflet to the cytoplasmic leaflet. The human genome encodes 14 P4-ATPases, and the cellular localizations, substrate specificities, and cellular roles of these proteins were recently revealed. Numerous P4-ATPases, including ATP8A1, ATP8A2, ATP11A, ATP11B, and ATP11C, transport phosphatidylserine. By contrast, ATP8B1, ATP8B2, and ATP10A transport phosphatidylcholine but not aminophospholipids, although there is a discrepancy regarding the substrate of ATP8B1 in the literature. Some yeast and plant P4-ATPases can also translocate phosphatidylcholine. At least 2 P4-ATPases (ATP8A2 and ATP8B1) are associated with severe human diseases, and other P4-ATPases are implicated in various pathophysiologic conditions in mouse models. Here, we discuss the cellular functions of phosphatidylcholine flippases and suggest a model for the phenotype of progressive familial intrahepatic cholestasis 1 caused by a defect in ATP8B1.Shin, H.-W., Takatsu, H. Substrates of P4-ATPases: beyond aminophospholipids (phosphatidylserine and phosphatidylethanolamine).	[Shin, Hye-Won; Takatsu, Hiroyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan	Kyoto University	Shin, HW (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimo Adachi Cho, Kyoto 6068501, Japan.	shin@pharm.kyoto-u.ac.jp	Shin, Hye-Won/P-5398-2018	Shin, Hye-Won/0000-0002-9138-9554	JSPS KAKENHI [JP16H00764, JP17H03655, JP17K08270]; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors thank all laboratory members for ongoing discussions. This work was supported by JSPS KAKENHI (Grants JP16H00764 and JP17H03655 to H.-W.S; and JP17K08270 to H.T.) and the Takeda Science Foundation (to H.-W.S.). The authors declare no conflicts of interest.	Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Beer KB, 2018, P NATL ACAD SCI USA, V115, pE1127, DOI 10.1073/pnas.1714085115; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Bruurs LJM, 2015, J CELL BIOL, V210, P1055, DOI 10.1083/jcb.201505118; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cai SY, 2009, GASTROENTEROLOGY, V136, P1060, DOI 10.1053/j.gastro.2008.10.025; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Coleman JA, 2014, J CELL SCI, V127, P1138, DOI 10.1242/jcs.145052; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; COLLEAU M, 1991, CHEM PHYS LIPIDS, V57, P29, DOI 10.1016/0009-3084(91)90046-E; COMFURIUS P, 1990, BIOCHIM BIOPHYS ACTA, V1026, P153, DOI 10.1016/0005-2736(90)90058-V; CONNOR J, 1990, BIOCHIM BIOPHYS ACTA, V1025, P82, DOI 10.1016/0005-2736(90)90193-R; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Cornelius F, 2015, BBA-BIOMEMBRANES, V1848, P1729, DOI 10.1016/j.bbamem.2015.03.012; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; DALEKE DL, 1985, BIOCHEMISTRY-US, V24, P5406, DOI 10.1021/bi00341a019; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Davit-Spraul A, 2010, HEPATOLOGY, V51, P1645, DOI 10.1002/hep.23539; Davit-Spraul A, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-1; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Eppens EF, 2001, J HEPATOL, V35, P436, DOI 10.1016/S0168-8278(01)00158-1; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; Folmer DE, 2009, HEPATOLOGY, V50, P1597, DOI 10.1002/hep.23158; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gomes E, 2000, PLANT CELL, V12, P2441, DOI 10.1105/tpc.12.12.2441; Groen A, 2011, GASTROENTEROLOGY, V141, P1927, DOI 10.1053/j.gastro.2011.07.042; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HANADA K, 1995, J CELL BIOL, V128, P793, DOI 10.1083/jcb.128.5.793; Hayashi H, 2018, EBIOMEDICINE, V27, P187, DOI 10.1016/j.ebiom.2017.10.007; Hirayama H, 2013, J LIPID RES, V54, P496, DOI 10.1194/jlr.M033209; Hurst SE, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/152902; Irvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024052; Jacquemin E, 2012, CLIN RES HEPATOL GAS, V36, pS26, DOI 10.1016/S2210-7401(12)70018-9; Jensen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17742-y; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; Katoh Y, 2004, ONCOL REP, V12, P939; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Linton KJ, 2015, BIOCHEM SOC T, V43, P1003, DOI 10.1042/BST20150132; Lopez-Marques RL, 2015, BBA-GEN SUBJECTS, V1850, P461, DOI 10.1016/j.bbagen.2014.04.008; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Miyano R, 2016, FEBS LETT, V590, P2138, DOI 10.1002/1873-3468.12247; Murate M, 2015, J CELL SCI, V128, P1627, DOI 10.1242/jcs.163105; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Nicolaou M, 2012, J PATHOL, V226, P300, DOI 10.1002/path.3019; Osada N, 2007, GENE, V392, P151, DOI 10.1016/j.gene.2006.11.021; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; POMORSKI T, 1994, MOL MEMBR BIOL, V11, P39, DOI 10.3109/09687689409161028; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8649; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; Roland BP, 2016, CRIT REV BIOCHEM MOL, V51, P513, DOI 10.1080/10409238.2016.1237934; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Segawa K, 2016, J BIOL CHEM, V291, P762, DOI 10.1074/jbc.M115.690727; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shin HW, 2012, MEMBRANES-BASEL, V2, DOI 10.3390/membranes2010118; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; SMEETS EF, 1994, BBA-BIOMEMBRANES, V1195, P281, DOI 10.1016/0005-2736(94)90268-2; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Takada N, 2018, EMBO J, V37, DOI 10.15252/embj.201797705; Takada N, 2015, J LIPID RES, V56, P2151, DOI 10.1194/jlr.M062547; Takar M, 2016, J BIOL CHEM, V291, P15727, DOI 10.1074/jbc.M115.686253; Takatsu H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01338-1; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tanaka Y, 2016, MOL BIOL CELL, V27, P3883, DOI 10.1091/mbc.E16-08-0586; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Tsuchiya M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04436-w; Ujhazy P, 2001, HEPATOLOGY, V34, P768, DOI 10.1053/jhep.2001.27663; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van der Mark VA, 2014, BBA-MOL BASIS DIS, V1842, P2378, DOI 10.1016/j.bbadis.2014.09.003; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; Van Mil SWC, 2004, PEDIATR RES, V56, P981, DOI 10.1203/01.PDR.0000145564.06791.D1; Verhulst PM, 2010, HEPATOLOGY, V51, P2049, DOI 10.1002/hep.23586; Vestergaard AL, 2015, FEBS LETT, V589, P3908, DOI 10.1016/j.febslet.2015.11.031; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Wang J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29108-z; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Xu P, 2007, ACTA BIOCH BIOPH SIN, V39, P739, DOI 10.1111/j.1745-7270.2007.00342.x; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Yabas M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146774; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yamasaki K, 2017, J BIOL CHEM, V292, P20218, DOI 10.1074/jbc.M117.816702; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhao Y, 2015, J LIPID RES, V56, P644, DOI 10.1194/jlr.M056622; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	112	30	30	1	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3087	3096		10.1096/fj.201801873R	http://dx.doi.org/10.1096/fj.201801873R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509129	Bronze			2022-12-28	WOS:000459794800002
J	Xu, JY; Chang, NB; Rong, ZH; Li, T; Xiao, L; Yao, QP; Jiang, R; Jiang, J				Xu, Jia-Ying; Chang, Neng-Bin; Rong, Zhi-Hua; Li, Tao; Xiao, Ling; Yao, Qing-Ping; Jiang, Rui; Jiang, Jun			circDiaph3 regulates rat vascular smooth muscle cell differentiation, proliferation, and migration	FASEB JOURNAL			English	Article						intimal hyperplasia; vascular injury; vascular remodeling; VSMC; noncoding RNA	NONCODING RNA; BALLOON ANGIOPLASTY; CIRCULAR RNAS; EXPRESSION; ATHEROSCLEROSIS; APOPTOSIS; MICRORNA; DISEASE; MIRNAS; STENTS	Intimal hyperplasia is a reaction to vascular injury, which is the primary reason for vascular restenosis caused by the diagnostic or therapeutic procedure for cardiovascular diseases. Circular RNAs (circRNAs) are known to be associated with several cardiovascular conditions, but the expression of circRNAs in the neointima has not been reported in detail. In this study, we established the balloon-injured rat carotid artery model and detected the expression of circRNAs in the carotid arteries with a microarray. We found that the circRNA expression profile of the healthy carotid arteries and the injured arteries were significantly different. We investigated the role of rno-circ_005717 (circDiaph3) in the differentiation of rat vascular smooth muscle cells (VSMCs). We found that knockdown of circDiaph3 up-regulated the level of diaphanous-related formin-3 and promoted the differentiation of VSMCs to contractile type. In addition, circDiaph3 up-regulated the transcription of Igf1r and supported the proliferation and migration of VSMCs. circDiaph3 could be a molecular target to combat intimal hyperplasia.Xu, J.-Y., Chang, N.-B., Rong, Z.-H., Li, T., Xiao, L., Yao, Q.-P., Jiang, R., Jiang, J. circDiaph3 regulates rat vascular smooth muscle cell differentiation, proliferation, and migration.	[Xu, Jia-Ying; Rong, Zhi-Hua; Jiang, Rui; Jiang, Jun] Southwest Med Univ, Affiliated Hosp, Dept Surg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China; [Chang, Neng-Bin] Southwest Med Univ, Inst Cardiovasc Res, Collaborat Innovat Ctr Prevent & Treatment Cardio, Dept Anat,Minist Educ, Luzhou, Peoples R China; [Li, Tao] Southwest Med Univ, Inst Cardiovasc Res, Collaborat Innovat Ctr Prevent & Treatment Cardio, Key Lab Med Electrophysiol,Minist Educ, Luzhou, Peoples R China; [Xiao, Ling] Emergency Med Ctr Chongqing, Chongqing, Peoples R China; [Yao, Qing-Ping] Shanghai Jiao Tong Univ, Inst Mechanobiol & Med Engn, Sch Life Sci & Biotechnol, Shanghai, Peoples R China	Southwest Medical University; Southwest Medical University; Southwest Medical University; Shanghai Jiao Tong University	Jiang, R; Jiang, J (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Surg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China.	jiangrui@126.com; john978@163.com	xu, jia/GSD-6347-2022		Science and Technology-Department of Sichuan Province [2016JY0066]; Office of Science and Technology and Intellectual Property of Luzhou [14JC0176]; Institute of Cardiovascular Research, Southwest Medical University; Southwest Medical University/Affiliated Hospital of Southwest Medical University	Science and Technology-Department of Sichuan Province; Office of Science and Technology and Intellectual Property of Luzhou; Institute of Cardiovascular Research, Southwest Medical University; Southwest Medical University/Affiliated Hospital of Southwest Medical University	This research was supported by Science and Technology-Department of Sichuan Province Grant 2016JY0066; Office of Science and Technology and Intellectual Property of Luzhou Grant 14JC0176; the Institute of Cardiovascular Research, Southwest Medical University; and by the Southwest Medical University/Affiliated Hospital of Southwest Medical University. The authors declare no conflicts of interest.	Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Ballantyne MD, 2016, CIRCULATION, V133, P2050, DOI 10.1161/CIRCULATIONAHA.115.021019; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Deng L, 2016, CURR OPIN LIPIDOL, V27, P439, DOI 10.1097/MOL.0000000000000336; Gareri C, 2016, CIRC RES, V118, P1170, DOI 10.1161/CIRCRESAHA.115.308237; Geng HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151753; Grant MB, 1999, REGUL PEPTIDES, V79, P47, DOI 10.1016/S0167-0115(98)00027-5; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53; Holdt LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12429; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Katsanos K, 2016, J ENDOVASC THER, V23, P851, DOI 10.1177/1526602816671740; Lv JY, 2018, BIOCHEM BIOPH RES CO, V497, P1154, DOI 10.1016/j.bbrc.2017.01.011; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Polimeni A, 2013, TRENDS CARDIOVAS MED, V23, P9, DOI 10.1016/j.tcm.2012.08.004; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Shan K, 2017, CIRCULATION, V136, P1629, DOI 10.1161/CIRCULATIONAHA.117.029004; Song XW, 2014, SCI CHINA LIFE SCI, V57, P826, DOI 10.1007/s11427-014-4698-y; Staus DP, 2007, ARTERIOSCL THROM VAS, V27, P478, DOI 10.1161/01.ATV.0000255559.77687.c1; Staus DP, 2014, AM J PHYSIOL-HEART C, V307, pH379, DOI 10.1152/ajpheart.01002.2013; Staus DP, 2011, BIOCHEM J, V439, P57, DOI 10.1042/BJ20101700; Tang CY, 2017, SPR SER POLYM COMPOS, P1, DOI 10.1007/978-3-319-46458-9_1; Vausort M, 2016, J AM COLL CARDIOL, V68, P1247, DOI 10.1016/j.jacc.2016.06.040; Viereck J, 2017, CIRC RES, V120, P381, DOI 10.1161/CIRCRESAHA.116.308434; Wang K, 2016, EUR HEART J, V37, P2602, DOI 10.1093/eurheartj/ehv713; Weise-Cross L, 2015, ARTERIOSCL THROM VAS, V35, P2374, DOI 10.1161/ATVBAHA.115.305879; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Wu GZ, 2014, CIRCULATION, V130, P1452, DOI 10.1161/CIRCULATIONAHA.114.011675; Zhao ZZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39918; Zheng CF, 2015, MOL MED REP, V12, P6656, DOI 10.3892/mmr.2015.4264	32	32	35	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2659	2668		10.1096/fj.201800243RRR	http://dx.doi.org/10.1096/fj.201800243RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307766				2022-12-28	WOS:000457296600090
J	Login, FH; Jensen, HH; Pedersen, GA; Koffman, JS; Kwon, TH; Parsons, M; Nejsum, LN				Login, Frederic H.; Jensen, Helene H.; Pedersen, Gitte A.; Koffman, Jennifer S.; Kwon, Tae-Hwan; Parsons, Maddy; Nejsum, Lene N.			Aquaporins differentially regulate cell-cell adhesion in MDCK cells	FASEB JOURNAL			English	Article						cell migration; cancer; metastasis; junctional proteins	CANCER CELLS; WATER PERMEABILITY; BREAST-CANCER; MIGRATION; EXPRESSION; INCREASES; GROWTH; ACTIN; RAS; OVEREXPRESSION	Plasticity of epithelial cell-cell adhesion is vital in epithelial homeostasis and is regulated in multiple processes associated with cell migration, such as embryogenesis and wound healing. In cancer, cell-cell adhesion is compromised and is associated with increased cell migration and metastasis. Aquaporin (AQP) water channels facilitate water transport across cell membranes and are essential in the regulation of body water homeostasis. Increased expression of several AQPs, especially AQP5, is associated with increased cancer cell migration, metastasis, and poor prognosis. We found that AQP5 overexpression in normal epithelial cells induced cell detachment and dissemination from migrating cell sheets. AQP5 reduced both cell-cell coordination during collective migration and overall distance covered by the migrating cell sheets. AQP5 and the isoforms AQP1 and AQP4 decreased, whereas AQP3 increased, levels of plasma membrane-associated lateral junctional proteins. This regulation was mediated by the cytoplasmic domains of the AQPs. This shows that the AQPs have dual functions in epithelial physiology: as channel proteins and as differential regulators of cell-cell adhesiveness. This regulation may contribute to dynamic regulation of cell junctions in processes such as embryogenesis and wound healing and also explain the pivotal roles of AQPs in carcinogenesis and metastasis.-Login, F. H., Jensen, H. H., Pedersen, G. A., Koffman, J. S., Kwon, T.-H., Parsons, M., Nejsum, L. N. Aquaporins differentially regulate cell-cell adhesion in MDCK cells.	[Login, Frederic H.; Jensen, Helene H.; Pedersen, Gitte A.; Nejsum, Lene N.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Jensen, Helene H.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Koffman, Jennifer S.; Nejsum, Lene N.] Aarhus Univ, Interdisciplinary Nanosci Ctr, Bartholins Alle 6, DK-8000 Aarhus, Denmark; [Pedersen, Gitte A.; Parsons, Maddy] Kings Coll London, London, England; [Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu, South Korea	Aarhus University; Aarhus University; Aarhus University; University of London; King's College London; Kyungpook National University	Nejsum, LN (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr, Bartholins Alle 6, DK-8000 Aarhus, Denmark.	nejsum@clin.au.dk	Kwon, Tae-Hwan/ABA-1981-2020; Jensen, Helene/GZK-5914-2022; Jensen, Helene H/V-5038-2018; Parsons, Maddy/B-2203-2013	Jensen, Helene H/0000-0002-8426-9802; Nejsum, Lene Niemann/0000-0003-4368-8821; Parsons, Maddy/0000-0002-2021-8379	Independent Research Fund Denmark (Natural Sciences); Aarhus University Research Foundation (AUFF); Lundbeck Junior Group Leader fellowship from the Lundbeck Foundation; Carlsberg Foundation; Danish Cancer Society; Christian and Ottilia Brorsons Rejselegat; National Research Foundation of Korea (NRF) - Ministry of Science and Information and Communication Technology (ICT) [2014R1A5A2009242]; Lundbeck Foundation; MEMBRANES (Aarhus University, Denmark); Graduate School of Science and Technology at Aarhus University	Independent Research Fund Denmark (Natural Sciences); Aarhus University Research Foundation (AUFF); Lundbeck Junior Group Leader fellowship from the Lundbeck Foundation; Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); Christian and Ottilia Brorsons Rejselegat; National Research Foundation of Korea (NRF) - Ministry of Science and Information and Communication Technology (ICT); Lundbeck Foundation(Lundbeckfonden); MEMBRANES (Aarhus University, Denmark); Graduate School of Science and Technology at Aarhus University	The authors thank Prof. W. James Nelson (Stanford University, Stanford, CA, USA) for Madin-Darby canine kidney cells and the GP135/podocalyxin hybridoma supernatant; Prof. Anita Aperia (Karolinska Institutet, Solna, Sweden) for AQP 3, -4, and -5 cDNA constructs; and Prof. Peter Pohl (Johannes Kepler University, Linz, Austria) for the AQP1 cDNA construct. This work was supported by the Independent Research Fund Denmark (Natural Sciences), the Aarhus University Research Foundation (AUFF), and a Lundbeck Junior Group Leader fellowship from the Lundbeck Foundation (all to L.N.N.). Also, this work was funded by the Graduate School of Science and Technology at Aarhus University (to H.H.J. and J.S.K.), a postdoctoral fellowship from the Carlsberg Foundation (to G.A.P.), a travel grant from the Danish Cancer Society (to H.H.J.), a grant from Christian and Ottilia Brorsons Rejselegat (to H.H.J.), and a grant from the National Research Foundation of Korea (NRF), funded by the Ministry of Science and Information and Communication Technology (ICT) (2014R1A5A2009242, to T.-H.K.). The Nikon microscope was funded by the Lundbeck Foundation, the Carlsberg Foundation, and MEMBRANES (Aarhus University, Denmark). The authors declare no conflicts of interest.	Abu-Tayeh H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.387; Alaee M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154323; Arnspang EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073977; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Chen C, 2017, MOL CARCINOGEN, V56, P2692, DOI 10.1002/mc.22712; Chen J, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-38; Chen J, 2015, MOL MED REP, V11, P2882, DOI 10.3892/mmr.2014.3097; Dorward HS, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0310-6; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Ishida S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099655; Jensen HH, 2019, J PHYSIOL-LONDON, V597, P849, DOI 10.1113/JP277383; Jensen HH, 2018, AM J PHYSIOL-CELL PH, V314, pC654, DOI 10.1152/ajpcell.00186.2017; Jensen HH, 2017, BIOCHEM BIOPH RES CO, V493, P1210, DOI 10.1016/j.bbrc.2017.09.125; Jensen HH, 2016, INT J BIOCHEM CELL B, V79, P271, DOI 10.1016/j.biocel.2016.09.005; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kim NH, 2010, J INVEST DERMATOL, V130, P2231, DOI 10.1038/jid.2010.99; Lan YL, 2017, ONCOTARGET, V8, P32345, DOI 10.18632/oncotarget.16017; Lee SJ, 2014, ANN SURG ONCOL, V21, P375, DOI 10.1245/s10434-013-3317-7; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Machida Y, 2011, HUM PATHOL, V42, P669, DOI 10.1016/j.humpath.2010.07.022; Marlar S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102106; Marlar S, 2014, AM J PHYSIOL-CELL PH, V306, pC598, DOI 10.1152/ajpcell.00132.2013; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Monzani E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006167; Odenwald MA, 2017, J CELL SCI, V130, P243, DOI 10.1242/jcs.188185; Patil PU, 2015, J CELL SCI, V128, P4366, DOI 10.1242/jcs.173518; Pedersen GA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179122; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Rosso M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184439; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Scarpa E, 2016, J CELL BIOL, V212, P143, DOI 10.1083/jcb.201508047; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tsunoda SP, 2004, J BIOL CHEM, V279, P11364, DOI 10.1074/jbc.M310881200; Vedula SRK, 2012, P NATL ACAD SCI USA, V109, P12974, DOI 10.1073/pnas.1119313109; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Wang W, 2018, CYTOTECHNOLOGY, V70, P615, DOI 10.1007/s10616-017-0147-7; Wang WL, 2015, FASEB J, V29, P1551, DOI 10.1096/fj.14-260828; Woo J, 2008, CANCER LETT, V264, P54, DOI 10.1016/j.canlet.2008.01.029; Woo J, 2008, BIOCHEM BIOPH RES CO, V367, P291, DOI 10.1016/j.bbrc.2007.12.073; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	59	14	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6980	6994		10.1096/fj.201802068RR	http://dx.doi.org/10.1096/fj.201802068RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30840830	Bronze			2022-12-28	WOS:000476114200026
J	Lay, FT; Ryan, GF; Caria, S; Phan, TK; Veneer, PK; White, JA; Kvansakul, M; Hulett, MD				Lay, Fung T.; Ryan, Gemma F.; Caria, Sofia; Thanh Kha Phan; Veneer, Prem K.; White, Julie A.; Kvansakul, Marc; Hulett, Mark D.			Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis	FASEB JOURNAL			English	Article						antimicrobial peptide; cell permeabilization; X-ray crystallography; anticancer; innate immunity	CATIONIC ANTIMICROBIAL PEPTIDES; PLANT DEFENSIN; BELL PEPPER; INHIBITION; EXPRESSION; SEQUENCE; SYSTEM; FAMILY; GENE; NAD1	Defensins are an extensive family of host defense peptides found ubiquitously across plant and animal species. In addition to protecting against infection by pathogenic microorganisms, some defensins are selectively cytotoxic toward tumor cells. As such, defensins have attracted interest as potential antimicrobial and anticancer therapeutics. The mechanism of defensin action against microbes and tumor cells appears to be conserved and involves the targeting and disruption of cellular membranes. This has been best defined for plant defensins, which upon binding specific phospholipids, such as phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidic acid, form defensin-lipid oligomeric complexes that destabilize membranes, leading to cell lysis. In this study, to further define the anticancer and therapeutic properties of plant defensins, we have characterized a novel plant defensin, Nicotiana occidentalis defensin 173 (NoD173), from N. occidentalis. NoD173 at low micromolar concentrations selectively killed a panel of tumor cell lines over normal primary cells. To improve the anticancer activity of NoD173, we explored increasing cationicity by mutation, with NoD173 with the substitution of Q22 with lysine [NoD173(Q22K)], increasing the antitumor cell activity by 2-fold. NoD173 and the NoD173(Q22K) mutant exhibited only low levels of hemolytic activity, and both maintained activity against tumor cells in serum. The ability of NoD173 to inhibit solid tumor growth in vivo was tested in a mouse B16-F1 model, whereby injection of NoD173 into established subcutaneous tumors significantly inhibited tumor growth. Finally, we showed that NoD173 specifically targets PIP2 and determined by X-ray crystallography that a high-resolution structure of NoD173, which forms a conserved family-defining cysteine-stabilized- motif with a dimeric lipid-binding conformation, configured into an arch-shaped oligomer of 4 dimers. These data provide insights into the mechanism of how defensins target membranes to kill tumor cells and provide proof of concept that defensins are able to inhibit tumor growth in vivo.Lay, F. T., Ryan, G. F., Caria, S., Phan, T. K., Veneer, P. K., White, J. A., Kvansakul, M., Hulett M. D. Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis.	[Lay, Fung T.; Ryan, Gemma F.; Caria, Sofia; Thanh Kha Phan; Veneer, Prem K.; White, Julie A.; Kvansakul, Marc; Hulett, Mark D.] La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, LIMS1 Rm 518, Melbourne, Vic 3086, Australia	La Trobe University	Kvansakul, M; Hulett, MD (corresponding author), La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, LIMS1 Rm 518, Melbourne, Vic 3086, Australia.	m.kvansakul@latrobe.edu.au; m.hulett@latrobe.edu.au	Phan, Thanh Kha/AAD-4969-2019; Kvansakul, Marc/AAF-2453-2019; Lay, Fung T./A-9043-2010	Kvansakul, Marc/0000-0003-2639-2498; Caria, Sofia/0000-0001-7289-2093; Hulett, Mark/0000-0003-2072-5968; Lay, Fung T./0000-0002-3101-3782; Phan, Thanh Kha/0000-0001-5802-1603	Hexima; Australian Research Council [FT130101349]; Balmoral Proprietary	Hexima; Australian Research Council(Australian Research Council); Balmoral Proprietary	The authors thank the MX2 Beamline staff at the Australian Synchrotron (Clayton, VIC, Australia) for help with X-ray data collection and Janet Newman and Shane Seabrook at the Commonwealth Scientific and Industrial Research Organisation Collaborative Crystallisation Centre (Parkville, VIC, Australia) for assistance with crystallization. The authors thank Christopher Adda (La Trobe University) for the Nicotiana occidentalis defensin 173 antibody and staff at the Comprehensive Proteomic Platform (La Trobe Institute for Molecular Science, La Trobe University) for assistance with mass spectrometry analyses. The authors acknowledge funding from Hexima and Balmoral Proprietary. This work was supported, in part, by the Australian Research Council (Fellowship FT130101349 to M.K.). The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baxter AA, 2017, CELL MOL LIFE SCI, V74, P3809, DOI 10.1007/s00018-017-2604-z; Baxter AA, 2015, MOL CELL BIOL, V35, P1964, DOI 10.1128/MCB.00282-15; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; COLILLA FJ, 1990, FEBS LETT, V270, P191, DOI 10.1016/0014-5793(90)81265-P; Cools TL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02051; Dracatos PM, 2014, MOL PLANT PATHOL, V15, P67, DOI 10.1111/mpp.12066; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gaspar D., 2016, HOST DEFENSE PEPTIDE, P95; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Houlne G, 1998, MOL GEN GENET, V259, P504, DOI 10.1007/s004380050841; Islam KT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16508-w; Jarva M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0979; Jarva M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04434-y; Jarva M, 2017, FEBS LETT, V591, P2482, DOI 10.1002/1873-3468.12761; KARUNANANDAA B, 1994, PLANT MOL BIOL, V26, P459, DOI 10.1007/BF00039555; Komori T., 1997, PLANT PHYSIOL, V115, P314; Kushmerick C, 1998, FEBS LETT, V440, P302, DOI 10.1016/S0014-5793(98)01480-X; Kvansakul M, 2016, P NATL ACAD SCI USA, V113, P11202, DOI 10.1073/pnas.1607855113; Lay F. T, 2003, THESIS; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; Lay FT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-41; Lay FT, 2012, J BIOL CHEM, V287, P19961, DOI 10.1074/jbc.M111.331009; Lay FT, 2012, ACTA CRYSTALLOGR F, V68, P314, DOI 10.1107/S1744309112001510; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Mendez E, 1996, EUR J BIOCHEM, V239, P67, DOI 10.1111/j.1432-1033.1996.0067u.x; MENDEZ E, 1990, EUR J BIOCHEM, V194, P533, DOI 10.1111/j.1432-1033.1990.tb15649.x; Meyer B, 1996, PLANT PHYSIOL, V112, P615, DOI 10.1104/pp.112.2.615; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Mirouze M, 2006, PLANT J, V47, P329, DOI 10.1111/j.1365-313X.2006.02788.x; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Parisi K, 2019, SEMIN CELL DEV BIOL, V88, P107, DOI 10.1016/j.semcdb.2018.02.004; Phan TK, 2016, ONCOTARGET, V7, P2054, DOI 10.18632/oncotarget.6520; POON I, 2014, WHITE, V3, DOI DOI 10.7554/ELIFE.01808; Raschig J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006261; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Sagaram US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018550; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Shafee TMA, 2017, CELL MOL LIFE SCI, V74, P663, DOI 10.1007/s00018-016-2344-5; Shafee TMA, 2016, MOL BIOL EVOL, V33, P2345, DOI 10.1093/molbev/msw106; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Phan TK, 2018, IMMUNOL CELL BIOL, V96, P54, DOI 10.1111/imcb.1017; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Vriens K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32121; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yamada S., 1997, PLANT PHYSIOL, V115, P314	58	14	15	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6470	6482		10.1096/fj.201802540R	http://dx.doi.org/10.1096/fj.201802540R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794440	Bronze			2022-12-28	WOS:000466932600052
J	Mahajan, N; Hoover, B; Rajendram, M; Shi, HY; Kawasak, K; Weibel, DB; Zhang, M				Mahajan, Nitin; Hoover, Brandon; Rajendram, Manohary; Shi, Heidi Y.; Kawasak, Kiyoshi; Weibel, Douglas B.; Zhang, Ming			Maspin binds to cardiolipin in mitochondria and triggers apoptosis	FASEB JOURNAL			English	Article						diphosphatidylglycerol; cytochrome c; mitochondrial membranes; anionic phospholipids	CYTOCHROME-C RELEASE; TUMOR-CELL APOPTOSIS; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; RECOGNITION; LYMPHOCYTES; MECHANISMS; EXPRESSION; EXPOSURE; PROTEIN	A central question in cell biology is how cells respond to stress signals and biochemically regulate apoptosis. One critical pathway involves the change of mitochondrial function and release of cytochrome c to initiate apoptosis. In response to apoptotic stimuli, we found that maspina noninhibitory member of the serine protease inhibitor superfamilytranslocates from the cytosol to mitochondria and binds to cardiolipin in the inner mitochondrial membrane. Biolayer interferometry assay revealed that recombinant maspin binds cardiolipin with an apparent K-d,of approximate to 15.8 M and competes with cytochrome c (apparent K-d of approximate to 1.31 M) for binding to cardiolipin-enriched membranes. A hydrophobic, lysine-rich domain in maspin consists of 27 aa, is located at position 268-294, and is responsible for the interaction of this protein with cardiolipin. Depletion of cardiolipin in cells significantly prevents maspin binding to the inner mitochondrial membrane and decreases cytochrome c release and apoptosis. Alteration to maspin's cardiolipin binding domain changes its ability to bind cardiolipin, and tumor cells expressing this mutant have a low frequency of apoptosis. We propose a model of apoptosis in which maspin binds to cardiolipin, displaces cytochrome c from the membrane, and facilitates its release to the cytoplasm.Mahajan, N., Hoover, B., Rajendram, M., Shi, H. Y., Kawasaki, K., Weibel, D. B., Zhang, M. Maspin binds to cardiolipin in mitochondria and triggers apoptosis.	[Mahajan, Nitin; Shi, Heidi Y.; Zhang, Ming] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA; [Mahajan, Nitin; Shi, Heidi Y.; Zhang, Ming] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Olson 8-452,710 N Fairbanks Ct, Chicago, IL 60611 USA; [Hoover, Brandon; Rajendram, Manohary; Weibel, Douglas B.] Univ Wisconsin, Dept Biochem, 440 Henry Mall, Madison, WI 53706 USA; [Weibel, Douglas B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Kawasak, Kiyoshi] Doshisha Womens Univ, Fac Pharmaceut Sci, Kyoto, Japan	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, M (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Olson 8-452,710 N Fairbanks Ct, Chicago, IL 60611 USA.; Weibel, DB (corresponding author), Univ Wisconsin, Dept Biochem, 440 Henry Mall, Madison, WI 53706 USA.	douglas.weibel@wisc.edu; m-zhang@northwestern.edu			U.S. National Institutes of Health (NIH) National Cancer Institute [CA079736]; NIH Office of the Director [1DP2OD008735-01]; U.S. National Science Foundation [DMR-1121288]; NIH Molecular Biophysics Predoctoral Traineeship [T32 GM08293]; Northwestern University Zell Foundation; Dr. James Chieh-Hsia Mao Wisconsin Distinguished Graduate Fellowship	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); NIH Molecular Biophysics Predoctoral Traineeship; Northwestern University Zell Foundation; Dr. James Chieh-Hsia Mao Wisconsin Distinguished Graduate Fellowship	The authors thank Dr. M. Geiger (Medical University of Vienna, Vienna, Austria) for stimulating discussions and for providing the protein-lipid overlay assay protocol. This work was supported by the U.S. National Institutes of Health (NIH) National Cancer Institute (Grant CA079736 to M.Z.), NIH Office of the Director (Grant 1DP2OD008735-01 to D.B.W.) and the U.S. National Science Foundation (Grant DMR-1121288; University of Wisconsin-Madison). M.R. was supported by the Dr. James Chieh-Hsia Mao Wisconsin Distinguished Graduate Fellowship, B.H. by an NIH Molecular Biophysics Predoctoral Traineeship (T32 GM08293), and H.Y.S by the Northwestern University Zell Foundation. The authors declare no conflicts of interest.	ARNOLD M, 1995, BBA-BIOMEMBRANES, V1233, P198, DOI 10.1016/0005-2736(94)00251-J; Ashman RF, 1995, IMMUNOL LETT, V48, P159, DOI 10.1016/0165-2478(95)02471-9; Bailey CM, 2006, J CELL PHYSIOL, V209, P617, DOI 10.1002/jcp.20782; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; Dennison SM, 2014, J VIROL, V88, P9406, DOI 10.1128/JVI.01031-14; Domanov YA, 2005, BBA-BIOMEMBRANES, V1716, P49, DOI 10.1016/j.bbamem.2005.09.002; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Esposti MD, 2003, CELL DEATH DIFFER, V10, P1300, DOI 10.1038/sj.cdd.4401306; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; FADOK VA, 1992, J IMMUNOL, V148, P2207; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Hong YN, 2012, J AM CHEM SOC, V134, P18713, DOI 10.1021/ja307426k; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Kawasaki K, 1999, J BIOL CHEM, V274, P1828, DOI 10.1074/jbc.274.3.1828; KERTESZ Z, 1995, BIOCHEM J, V310, P315, DOI 10.1042/bj3100315; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Latha K, 2005, MOL CELL BIOL, V25, P1737, DOI 10.1128/MCB.25.5.1737-1748.2005; Li CH, 2010, NEOPLASIA, V12, P150, DOI 10.1593/neo.91500; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li JJ, 1998, CARCINOGENESIS, V19, P833, DOI 10.1093/carcin/19.5.833; Liu JY, 2004, CANCER RES, V64, P1703, DOI 10.1158/0008-5472.CAN-03-2568; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mahajan N, 2013, J BIOL CHEM, V288, P11611, DOI 10.1074/jbc.M112.410852; Merrick BA, 1996, BBA-PROTEIN STRUCT M, V1297, P57; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; NICHOLLS P, 1974, BIOCHIM BIOPHYS ACTA, V346, P261, DOI 10.1016/0304-4173(74)90003-2; O'Brien ES, 2015, J BIOL CHEM, V290, P30879, DOI 10.1074/jbc.M115.689406; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Ravenhill L, 2010, J BIOL CHEM, V285, P36285, DOI 10.1074/jbc.M110.177253; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlegel RA, 1996, ADV EXP MED BIOL, V406, P21; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Sheng SJ, 2006, J CELL PHYSIOL, V209, P631, DOI 10.1002/jcp.20786; Shi HY, 2001, CANCER RES, V61, P6945; Stepanov G, 2009, FEBS LETT, V583, P97, DOI 10.1016/j.febslet.2008.11.029; Talmard C, 2007, CHEMBIOCHEM, V8, P163, DOI 10.1002/cbic.200600319; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Zhang G, 1998, APOPTOSIS, V3, P27, DOI 10.1023/A:1009655018726; Zhang WG, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-50; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	58	7	7	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6354	6364		10.1096/fj.201802182R	http://dx.doi.org/10.1096/fj.201802182R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30786218	Green Published, Bronze			2022-12-28	WOS:000466932600043
J	Schmelzer, CEH; Heinz, A; Troilo, H; Lockhart-Cairns, MP; Jowitt, TA; Marchand, MF; Bidault, L; Bignon, M; Hedtke, T; Barret, A; McConnell, JC; Sherratt, MJ; Germain, S; Hulmes, DJS; Baldock, C; Muller, L				Schmelzer, Christian E. H.; Heinz, Andrea; Troilo, Helen; Lockhart-Cairns, Michael P.; Jowitt, Thomas A.; Marchand, Marion F.; Bidault, Laurent; Bignon, Marine; Hedtke, Tobias; Barret, Alain; McConnell, James C.; Sherratt, Michael J.; Germain, Stephane; Hulmes, David J. S.; Baldock, Clair; Muller, Laurent			Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin	FASEB JOURNAL			English	Article						matrix remodeling; elastin; protein structure; SAXS; proteomics	ELASTIN; PROTEIN; EXPRESSION; MATURATION; DOMAINS; COACERVATION; SCATTERING; PRECURSOR; SYSTEM; TISSUE	Lysyl oxidases (LOXs) play a central role in extracellular matrix remodeling during development and tumor growth and fibrosis through cross-linking of collagens and elastin. We have limited knowledge of the structure and substrate specificity of these secreted enzymes. LOXs share a conserved C-terminal catalytic domain but differ in their N-terminal region, which is composed of 4 repeats of scavenger receptor cysteine-rich (SRCR) domains in LOX-like (LOXL) 2. We investigated by X-ray scattering and electron microscopy the low-resolution structure of the full-length enzyme and the structure of a shorter form lacking the catalytic domain. Our data demonstrate that LOXL2 has a rod-like structure with a stalk composed of the SRCR domains and the catalytic domain at its tip. We detected direct interaction between LOXL2 and tropoelastin (TE) and also LOXL2-mediated deamination of TE. Using proteomics, we identified several allysines together with cross-linked TE peptides. The elastin-like material generated was resistant to trypsin proteolysis and displayed mechanical properties similar to mature elastin. Finally, we detected the codistribution of LOXL2 and elastin in the vascular wall. Altogether, these data suggest that LOXL2 could participate in elastogenesis in vivo and could be used as a means of cross-linking TE in vitro for biomimetic and cell-compatible tissue engineering purposes.	[Schmelzer, Christian E. H.; Hedtke, Tobias] IMWS, Halle, Saale, Germany; [Schmelzer, Christian E. H.; Heinz, Andrea; Hedtke, Tobias] Martin Luther Univ Halle Wittenberg, Inst Pharm, Halle, Saale, Germany; [Heinz, Andrea] Univ Copenhagen, Dept Pharm, Copenhagen, Denmark; [Troilo, Helen; Lockhart-Cairns, Michael P.; Jowitt, Thomas A.; Baldock, Clair] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Troilo, Helen; Lockhart-Cairns, Michael P.; Jowitt, Thomas A.; McConnell, James C.; Sherratt, Michael J.; Baldock, Clair] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England; [Marchand, Marion F.; Bidault, Laurent; Bignon, Marine; Barret, Alain; Germain, Stephane; Muller, Laurent] PSL Res Univ, CNRS, INSERM, Coll France,CIRB, Paris, France; [Marchand, Marion F.] Sorbonne Univ, Coll Doctoral, Paris, France; [Hulmes, David J. S.] Univ Lyon, Lab Biol Tissulaire & Ingenierie Therapeut LBTI, CNRS, UMR 5305, Lyon, France	Martin Luther University Halle Wittenberg; University of Copenhagen; University of Manchester; University of Manchester; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Muller, L (corresponding author), CNRS, Coll France, Ctr Interdisciplinary Res Biol, INSERM,U1050,UMR 7241, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	laurent.muller@college-de-france.fr	Germain, Stephane/E-2301-2016; Lockhart-Cairns, Michael/AAJ-3888-2021; Schmelzer, Christian/AAG-1246-2019; Heinz, Andrea/ABL-8318-2022; muller, laurent/S-1990-2016; Heinz, Andreas/ABB-7736-2020	Germain, Stephane/0000-0001-5992-1275; Lockhart-Cairns, Michael/0000-0003-2289-1281; Schmelzer, Christian/0000-0002-1180-0201; Heinz, Andrea/0000-0002-8609-4460; muller, laurent/0000-0001-9634-4323; Heinz, Andreas/0000-0001-5405-9065; Baldock, Clair/0000-0003-3497-1959; Hedtke, Tobias/0000-0002-2662-6576; marchand, marion/0000-0001-7247-5003; Jowitt, Thomas/0000-0002-4045-0933	European Synchrotron Radiation Facility (ESRF) [283570 Midland BAG MX1783]; Fraunhofer Internal Programs [069-608203]; European Regional Development Fund in Saxony-Anhalt; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L00612X/1]; LEO Foundation [LF17063]; Prevent Breast Cancer; Federation pour la Recherche Medicale [FRM-ECO2016-0736055]; BBSRC [BB/L00612X/1] Funding Source: UKRI	European Synchrotron Radiation Facility (ESRF); Fraunhofer Internal Programs; European Regional Development Fund in Saxony-Anhalt; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); LEO Foundation(LEO Pharma); Prevent Breast Cancer; Federation pour la Recherche Medicale(Fondation pour la Recherche Medicale); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the Structure Federative de Recherche Biosciences (UMS3444/CNRS), US8/INSERM, Ecole Normale Superieure de Lyon, Universite Claude Bernard Lyon 1 Protein Science Facility for access to the circular dichroism instrument. The authors thank Christian Ihling (Martin Luther University Halle-Wittenberg, Germany) for assistance with mass spectrometry measurements, Prof. Tony Weiss (University of Sydney, Sydney, NSW, Australia) for providing the recombinant tropoelastin used in surface plasmon resonance experiments, Markus Pietzsch (Martin Luther University Halle-Wittenberg) for providing the recombinant tropoelastin used in other experiments, and Jurgen Brinckmann (University of Lubeck, Germany) for the amino acid analysis, and Dr. Catherine Moali (Universite de Lyon, France) for helpful discussions and reading the manuscript, as well as providing BMP-1 and PCPE-1. The authors thank staff in the University of Manchester Biomolecular Analysis Core Facility and Electron Microscopy Centre for assistance and Diamond Light Source and European Synchrotron Radiation Facility (ESRF) (BioStruct-X FP7-Infractrustures Project 283570 Midland BAG MX1783) for beamtime. The work was supported by the Fraunhofer Internal Programs (Attract Grant 069-608203 to C.E.H.S.), the European Regional Development Fund in Saxony-Anhalt (project ElastoHEAL; to CEHS), the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/L00612X/1 to C.B.), the LEO Foundation (Grant LF17063 to A.H.), and Prevent Breast Cancer (to M.J.S.). M.F.M. was supported by Federation pour la Recherche Medicale (FRM-ECO2016-0736055). The authors declare no conflicts of interest.	Alsofi L, 2016, CALCIFIED TISSUE INT, V98, P172, DOI 10.1007/s00223-015-0076-4; Anazco C, 2016, J BIOL CHEM, V291, P25999, DOI 10.1074/jbc.M116.738856; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Borel A, 2001, J BIOL CHEM, V276, P48944, DOI 10.1074/jbc.M109499200; Bourhis JM, 2013, P NATL ACAD SCI USA, V110, P6394, DOI 10.1073/pnas.1300480110; BRESSAN GM, 1986, J ULTRA MOL STRUCT R, V94, P209, DOI 10.1016/0889-1605(86)90068-6; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gambichler T, 2019, CLIN EXP DERMATOL, V44, P47, DOI 10.1111/ced.13652; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Heinz A, 2014, MATRIX BIOL, V38, P12, DOI 10.1016/j.matbio.2014.07.006; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Iftikhar M, 2011, J BIOL CHEM, V286, P909, DOI 10.1074/jbc.M110.155622; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lopez-Jimenez AJ, 2017, J BIOL CHEM, V292, P16970, DOI 10.1074/jbc.M117.798603; Lopez-Luppo M, 2017, INVEST OPHTH VIS SCI, V58, P2832, DOI 10.1167/iovs.16-20312; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Martin A, 2015, EMBO J, V34, P1090, DOI 10.15252/embj.201489975; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; Moon HJ, 2014, BIOORG CHEM, V57, P231, DOI 10.1016/j.bioorg.2014.07.003; Petoukhov MV, 2006, EUR BIOPHYS J BIOPHY, V35, P567, DOI 10.1007/s00249-006-0063-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reichheld SE, 2014, J BIOL CHEM, V289, P10057, DOI 10.1074/jbc.M113.533893; Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060; Schmelzer CEH, 2012, FEBS J, V279, P4191, DOI 10.1111/febs.12012; Schrader CU, 2018, J BIOL CHEM, V293, P15107, DOI 10.1074/jbc.RA118.004322; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trackman PC, 2018, METHOD CELL BIOL, V143, P147, DOI 10.1016/bs.mcb.2017.08.009; Trackman PC, 2016, MATRIX BIOL, V52-54, P7, DOI 10.1016/j.matbio.2016.01.001; Urban Z, 2007, INVEST OPHTH VIS SCI, V48, P3209, DOI 10.1167/iovs.07-0107; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Xu L, 2013, J BIOL CHEM, V288, P5357, DOI 10.1074/jbc.C112.421768; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; Zhang X, 2018, P NATL ACAD SCI USA, V115, P3828, DOI 10.1073/pnas.1720859115	44	33	35	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5468	5481		10.1096/fj.201801860RR	http://dx.doi.org/10.1096/fj.201801860RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30676771	Green Published, hybrid			2022-12-28	WOS:000462888500067
J	Ke, YB; Karki, P; Kim, J; Son, S; Berdyshev, E; Bochkov, VN; Birukova, AA; Birukov, KG				Ke, Yunbo; Karki, Pratap; Kim, Junghyun; Son, Sophia; Berdyshev, Evgeny; Bochkov, Valery N.; Birukova, Anna A.; Birukov, Konstantin G.			Elevated truncated oxidized phospholipids as a factor exacerbating ALI in the aging lungs	FASEB JOURNAL			English	Article						lung injury; vascular permeability; inflammation	OXIDATIVE STRESS; PERMEABILITY; PATHWAY; ACETYLHYDROLASE; INHIBITION; INJURY	As mechanisms controlling redox homeostasis become impaired with aging, exaggerated oxidant stress may cause disproportional oxidation of cell membranes and circulating phospholipids (PLs), leading to the formation of truncated oxidized PL products (Tr-OxPLs), which exhibit deleterious effects. This study investigated the role of elevated Tr-OxPLs as a factor exacerbating inflammation and lung barrier dysfunction in an animal model of aging. Mass spectrometry analysis of Tr-OxPL species in young (2-4 mo) and aging (18-24 mo) mice revealed elevated basal levels of several products [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-phosphocholine (POVPC), 1-palmitoyl-2-glutaroyl-sn-glycero-phosphocholine, lysophosphocholine, 1-palmitoyl-2-(9-oxo-nonanoyl)-sn-glycero-3-phosphocholine, 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine, O-1-O-palmitoyl-2-O-(5,8-dioxo-8-hydroxy-6-octenoyl)-l-glycero-3-phosphocholine, and others] in the aged lungs. An intratracheal (i.t.) injection of bacterial LPS caused increased generation of Tr-OxPLs in the lungs but not in the liver, with higher levels detected in the aged group. In addition, OxPLs clearance from the lung tissue after LPS challenge was delayed in the aged group. The impact of Tr-OxPLs on endothelial cell (EC) barrier compromise under inflammatory conditions was further evaluated in the 2-hit cell culture model of acute lung injury (ALI). EC barrier dysfunction caused by cell treatment with a cytokine mixture (CM) was augmented by cotreatment with low-dose Tr-OxPLs, which did not significantly affect endothelial function when added alone. Deleterious effects of Tr-OxPLs on inflamed ECs stimulated with CM were associated with further weakening of cell junctions and more robust EC hyperpermeability. Aged mice injected intratracheally with TNF- exhibited a more pronounced elevation of cell counts and protein content in bronchoalveolar lavage (BAL) samples. Interestingly, intravenous administration of low POVPC doseswhich did not affect BAL parameters alone in young mice exposed to i.t. TNF- challengeaugmented lung injury to the levels observed in aged mice stimulated with TNF- alone. Inhibition of Tr-OxPL generation by ectopic expression of PL-specific platelet-activating factor acetylhydrolase 2 (PAFAH2) markedly reduced EC dysfunction induced by CM, whereas PAFAH2 pharmacologic inhibition augmented deleterious effects of cytokines on EC barrier function. Moreover, exacerbating effects of PAFAH2 inhibition on TNF--induced lung injury were observed in vivo. These results demonstrate an age-dependent increase in Tr-OxPL production under basal conditions and augmented Tr-OxPL generation upon inflammatory stimulation, suggesting a major role for elevated Tr-OxPLs in more severe ALI and delayed resolution in aging lungs.Ke, Y., Karki, P., Kim, J., Son, S., Berdyshev, E., Bochkov, V. N., Birukova, A. A., Birukov, K. G. Elevated truncated oxidized phospholipids as a factor exacerbating ALI in the aging lungs.	[Ke, Yunbo; Kim, Junghyun; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Karki, Pratap; Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Son, Sophia] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Berdyshev, Evgeny] Natl Jewish Hlth, Denver, CO USA; [Bochkov, Valery N.] Karl Franzens Univ Graz, Dept Pharmaceut Chem, Graz, Austria	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Chicago; National Jewish Health; University of Graz	Birukov, KG (corresponding author), Univ Maryland, Sch Med, UMSOM Lung Biol Program, Dept Anesthesiol, 20 Penn St,HSF 2,Room S145, Baltimore, MD 21201 USA.	kbirukov@som.umaryland.edu	Birukov, Konstantin/FJB-5755-2022		U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL076259, HL087823, HL107920, HL130431]; NIH National Institute on Aging Grant [AG048231]; NIH National Institute of General Medical Sciences [GM122940, GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076259, R01HL107920, R01HL130431, R01HL087823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171, R01GM122940] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Aging Grant; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL076259 (to K.G.B.), HL087823, HL107920, and HL130431; NIH National Institute on Aging Grant AG048231 (to K.G.B.); and NIH National Institute of General Medical Sciences Grants GM122940 (to K.G.B.) and GM114171 (to A.A.B.). The authors declare no conflicts of interest.	Akbaraly TN, 2009, BRIT J NUTR, V101, P86, DOI 10.1017/S0007114508998445; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016; Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008; Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957; Bochkov VN, 2006, CURR RESPIR MED REV, V2, P27, DOI 10.2174/157339806775486182; Cao LC, 2004, J STEROID BIOCHEM, V88, P61, DOI 10.1016/j.jsbmb.2003.10.007; Chabot F, 1998, EUR RESPIR J, V11, P745; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foulks JM, 2008, FREE RADICAL BIO MED, V45, P434, DOI 10.1016/j.freeradbiomed.2008.04.034; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Gruber F, 2012, J LIPID RES, V53, P1232, DOI 10.1194/jlr.D025270; Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009; Hecker L, 2018, AM J PHYSIOL-LUNG C, V314, P1642, DOI 10.1152/ajplung.00275.2017; Heffern CTR, 2013, CHEM PHYS LIPIDS, V175, P9, DOI 10.1016/j.chemphyslip.2013.07.003; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jozsef L, 2006, J IMMUNOL, V176, P1195, DOI 10.4049/jimmunol.176.2.1195; Kalyanaraman B, 2004, P NATL ACAD SCI USA, V101, P11527, DOI 10.1073/pnas.0404309101; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; McIntyre TM, 2012, BBA-BIOMEMBRANES, V1818, P2456, DOI 10.1016/j.bbamem.2012.03.004; Meliton AY, 2015, AM J PHYSIOL-LUNG C, V308, pL550, DOI 10.1152/ajplung.00248.2014; Morrow JD, 2002, AM J RESP CRIT CARE, V166, pS25, DOI 10.1164/rccm.2206011; Munoz Nilda M, 2012, Pulm Circ, V2, P182, DOI 10.4103/2045-8932.97604; Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Prauchner CA, 2017, BURNS, V43, P471, DOI 10.1016/j.burns.2016.09.023; Sprong RC, 1998, AM J RESP CRIT CARE, V157, P1283; Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC; Starr ME, 2011, FREE RADICAL BIO MED, V50, P371, DOI 10.1016/j.freeradbiomed.2010.11.013; Stengle J, 1994, Crit Care Nurs Clin North Am, V6, P421; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Tanaka K, 2017, AM J RESP CELL MOL, V56, P179, DOI 10.1165/rcmb.2016-0158OC; Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP; von Schlieffen E, 2009, ARTERIOSCL THROM VAS, V29, P356, DOI 10.1161/ATVBAHA.108.173799; Webster RG, 2000, VACCINE, V18, P1686, DOI 10.1016/S0264-410X(99)00507-1; Wu JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615312	41	15	15	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3887	3900		10.1096/fj.201800981R	http://dx.doi.org/10.1096/fj.201800981R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521374	Green Published, Bronze			2022-12-28	WOS:000459794800063
J	Kutil, Z; Skultetyova, L; Rauh, D; Meleshin, M; Snajdr, I; Novakova, Z; Mikesova, J; Pavlicek, J; Hadzima, M; Baranova, P; Havlinova, B; Majer, P; Schutkowski, M; Barinka, C				Kutil, Zsofia; Skultetyova, Lubica; Rauh, David; Meleshin, Marat; Snajdr, Ivan; Novakova, Zora; Mikesova, Jana; Pavlicek, Jiri; Hadzima, Martin; Baranova, Petra; Havlinova, Barbora; Majer, Pavel; Schutkowski, Mike; Barinka, Cyril			The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries	FASEB JOURNAL			English	Article						human acetylome; deacylation; deformylation; logo	2 CATALYTIC DOMAINS; ACETYLATION SITE; STRESS GRANULES; HDAC6; LYSINE; MICROTUBULES; PROTEINS; TUBULIN; ARRAYS; FORMYLATION	Histone deacetylase 6 (HDAC6) is a multidomain cytosolic hydrolase acting mostly on nonhistone protein substrates. Investigations of the substrate specificity of HDAC6 are confounded by the presence of 2 catalytically active deacetylase domains (DD1 and DD2). In this study, acetylome peptide microarrays and peptide libraries were used to map the substrate specificity of DD1 and DD2 of human HDAC6. The results show that DD1 is solely responsible for the deacetylation of substrates harboring the acetyllysine at their C terminus, whereas DD2 exclusively deacetylates peptides with an internal acetyllysine residue. Also, statistical analysis of the deacetylation data revealed amino acid preferences at individual positions flanking the acetyllysine, where glycine and arginine residues are favored at positions N-terminal to the central acetyllysine; negatively charged glutamate is strongly disfavored throughout the sequence. Finally, the deacylation activity of HDAC6 was profiled by using a panel of acyl derivatives of the optimized peptide substrate and showed that HDAC6 acts as a proficient deformylase. Our data thus offer a detailed insight into the substrate preferences of the individual HDAC6 domains at the peptide level, and these findings can in turn help in elucidating the biologic roles of the enzyme and facilitate the development of new domain-specific inhibitors as research tools or therapeutic agents.Kutil, Z., Skultetyova, L., Rauh, D., Meleshin, M., Snajdr, I., Novakova, Z., Mikesova, J., Pavlicek, J., Hadzima, M., Baranova, P., Havlinova, B., Majer, P., Schutkowski, M., Barinka, C. The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries.	[Kutil, Zsofia; Skultetyova, Lubica; Novakova, Zora; Mikesova, Jana; Pavlicek, Jiri; Baranova, Petra; Havlinova, Barbora; Barinka, Cyril] Czech Acad Sci, BIOCEV, Inst Biotechnol, Vestec, Czech Republic; [Rauh, David; Meleshin, Marat; Schutkowski, Mike] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Charles Tanford Prot Ctr, Dept Enzymol, Kurt Mothes Str 3a, D-06120 Halle, Saale, Germany; [Snajdr, Ivan; Hadzima, Martin; Majer, Pavel] CAS, Inst Organ Chem & Biochem, Prague, Czech Republic	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Martin Luther University Halle Wittenberg; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Schutkowski, M (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Charles Tanford Prot Ctr, Dept Enzymol, Kurt Mothes Str 3a, D-06120 Halle, Saale, Germany.; Barinka, C (corresponding author), CAS, Inst Biotechnol, Vvi, Struct Biol Lab, Prumyslova 595, Vestec 25250, Czech Republic.	mike.schutkowski@biochemtech.uni-halle.de; cyril.barinka@ibt.cas.cz	Kutil, Zsofia/O-1096-2013; Novakova, Zora/G-8665-2014; Škultétyová, Ľubica/H-3053-2014; Majer, Pavel/G-1141-2019	Novakova, Zora/0000-0001-9804-6346; Škultétyová, Ľubica/0000-0001-7627-5367; Snajdr, Ivan/0000-0002-0831-4034; Rauh, David/0000-0001-7499-1693; Hadzima, Martin/0000-0002-6479-3682; Barinka, Cyril/0000-0003-2751-3060	Czech Science Foundation [15-19640S]; Czech Academy of Sciences [RVO: 86652036]; Charles University from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; Biotechnology and Biomedicine Center of the Academy of Sciences	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences); Charles University from the European Regional Development Fund; Biotechnology and Biomedicine Center of the Academy of Sciences	The authors thank I. Jelinkova (Institute of Biotechnology of the Czech Academy of Sciences) and J. Barinkova (Institute of Organic Chemistry and Biochemistry of the CAS) for their excellent technical assistance. This work was supported by the Czech Science Foundation (Grant 15-19640S), the Czech Academy of Sciences (RVO: 86652036), and the Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University (CZ.1.05/1.1.00/02.0109) from the European Regional Development Fund. The authors declare no conflicts of interest.	AbouElfetouh A, 2015, MICROBIOLOGYOPEN, V4, P66, DOI 10.1002/mbo3.223; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Castaneda CA, 2017, J BIOL CHEM, V292, P21568, DOI 10.1074/jbc.M117.811026; Castaneda CA, 2017, BIOCHEMISTRY-US, V56, P5663, DOI 10.1021/acs.biochem.7b00851; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Di Fulvio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028563; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Gurard-Levin ZA, 2008, BIOCHEMISTRY-US, V47, P6242, DOI 10.1021/bi800053v; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Gurard-Levin ZA, 2009, CHEMBIOCHEM, V10, P2159, DOI 10.1002/cbic.200900417; Hai Y, 2016, NAT CHEM BIOL, V12, P741, DOI 10.1038/nchembio.2134; Han Y, 2009, BIOCHEM BIOPH RES CO, V383, P88, DOI 10.1016/j.bbrc.2009.03.147; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Jung HY, 2013, CANCER RES TREAT, V45, P134, DOI 10.4143/crt.2013.45.2.134; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kuo HY, 2013, ANAL CHEM, V85, P10635, DOI 10.1021/ac402614x; Kutil Z, 2018, ACS CHEM BIOL, V13, P685, DOI 10.1021/acschembio.7b00942; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Legros S, 2011, ONCOGENE, V30, P4050, DOI 10.1038/onc.2011.120; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Marino G, 2015, ACS CHEM BIOL, V10, P1754, DOI 10.1021/acschembio.5b00189; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McClure JJ, 2017, ACS CHEM BIOL, V12, P1644, DOI 10.1021/acschembio.7b00321; Miyake Y, 2016, NAT CHEM BIOL, V12, P748, DOI 10.1038/nchembio.2140; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Patel K, 2015, J BIOMOL SCREEN, V20, P842, DOI 10.1177/1087057115588512; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Reineke U., 2006, BIOMEMS BIOMEDICAL N, V2, P161; Riester D, 2007, BIOCHEM BIOPH RES CO, V357, P439, DOI 10.1016/j.bbrc.2007.03.158; Salemi LM, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3430-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Skultetyova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11739-3; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Thiele A, 2011, MOL BIOTECHNOL, V49, P283, DOI 10.1007/s12033-011-9402-x; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Wisniewski JR, 2008, NUCLEIC ACIDS RES, V36, P570, DOI 10.1093/nar/gkm1057; Wu JY, 2018, J BIOL CHEM, V293, P1976, DOI 10.1074/jbc.M117.795955; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764; Yu XD, 2002, J NATL CANCER I, V94, P504; Zhang LL, 2015, PROTEIN CELL, V6, P42, DOI 10.1007/s13238-014-0102-8; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	53	19	19	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4035	4045		10.1096/fj.201801680R	http://dx.doi.org/10.1096/fj.201801680R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496698	Bronze			2022-12-28	WOS:000459794800074
J	Lana, D; Ugolini, F; Wenk, GL; Giovannini, MG; Zecchi-Orlandini, S; Nosi, D				Lana, Daniele; Ugolini, Filippo; Wenk, Gary L.; Giovannini, Maria Grazia; Zecchi-Orlandini, Sandra; Nosi, Daniele			Microglial distribution, branching, and clearance activity in aged rat hippocampus are affected by astrocyte meshwork integrity: evidence of a novel cell-cell interglial interaction	FASEB JOURNAL			English	Article						neuroinflammation; aging; microglia dysregulation; neuronophagia; integrin-1	CHRONIC CEREBRAL HYPOPERFUSION; ALZHEIMERS-DISEASE; PROCESS EXTENSION; ACTIVATION; PHAGOCYTOSIS; FIBRONECTIN; INVOLVEMENT; CHEMOTAXIS; EXPRESSION; FORCES	Aging and neurodegenerative diseases share a condition of neuroinflammation entailing the production of endogenous cell debris in the CNS that must be removed by microglia (i.e., resident macrophages), to restore tissue homeostasis. In this context, extension of microglial cell branches toward cell debris underlies the mechanisms of microglial migration and phagocytosis. Amoeboid morphology and the consequent loss of microglial branch functionality characterizes dysregulated microglia. Microglial migration is assisted by another glial population, the astroglia, which forms a dense meshwork of cytoplasmic projections. Amoeboid microglia and disrupted astrocyte meshwork are consistent traits in aged CNS. In this study, we assessed a possible correlation between microglia and astroglia morphology in rat models of chronic neuroinflammation and aging, by 3-dimensional confocal analysis implemented with particle analysis. Our findings suggest that a microglia-astroglia interaction occurs in rat hippocampus via cell-cell contacts, mediating microglial cell branching in the presence of inflammation. In aged rats, the impairment of such an interaction correlates with altered distribution, morphology, and inefficient clearance by microglia. These data support the idea that generally accepted functional boundaries between microglia and astrocytes should be re-evaluated to better understand how their functions overlap and interact.Lana, D., Ugolini, F., Wenk, G. L., Giovannini, M. G., Zecchi-Orlandini, S., Nosi, D. Microglial distribution, branching, and clearance activity in aged rat hippocampus are affected by astrocyte meshwork integrity: evidence of a novel cell-cell interglial interaction.	[Lana, Daniele; Ugolini, Filippo; Giovannini, Maria Grazia] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy; [Zecchi-Orlandini, Sandra; Nosi, Daniele] Univ Florence, Dept Expt & Clin Med, Largo Brambilla 3, I-50134 Florence, Italy; [Wenk, Gary L.] Ohio State Univ, Dept Psychol, Columbus, OH USA	University of Florence; University of Florence; University System of Ohio; Ohio State University	Nosi, D (corresponding author), Univ Florence, Dept Expt & Clin Med, Largo Brambilla 3, I-50134 Florence, Italy.	daniele.nosi@unifi.it		Ugolini, Filippo/0000-0003-3603-2111	University of Florence	University of Florence	The authors thank Prof. Giovanni Delfino, University of Florence, and Prof. Diego Minciacchi, University of Florence, for their assistance in the preparation of the manuscript. This work was partially funded by grants to D. N. and S. Z.-O. by the University of Florence. The authors declare no conflicts of interest.	Barcia C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00809; Bollmann L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00363; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Chen YF, 2017, MOL BIOL CELL, V28, P3134, DOI 10.1091/mbc.E17-04-0228; Chitnis T, 2017, J CLIN INVEST, V127, P3577, DOI 10.1172/JCI90609; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Daria A, 2017, EMBO J, V36, P583, DOI 10.15252/embj.201694591; Deleidi M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00172; Elali A, 2016, BRAIN BEHAV IMMUN, V55, P138, DOI 10.1016/j.bbi.2015.07.021; Fan Y, 2017, MOL CELLS, V40, P163, DOI 10.14348/molcells.2017.0011; Fonseca RS, 2016, STEM CELLS DEV, V25, P542, DOI 10.1089/scd.2015.0319; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Giovannini MG, 2002, METHOD ENZYMOL, V345, P426; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Kanazawa H, 2002, J BIOL CHEM, V277, P20026, DOI 10.1074/jbc.M109218200; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kwon YH, 2017, FEBS LETT, V591, P1742, DOI 10.1002/1873-3468.12691; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lana D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00296; Lana D, 2017, EXP GERONTOL, V96, P46, DOI 10.1016/j.exger.2017.06.006; Lana D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00322; Lefort CT, 2011, J BIOL CHEM, V286, P3149, DOI 10.1074/jbc.M110.115733; Liu W, 2011, LIFE SCI, V89, P141, DOI 10.1016/j.lfs.2011.05.011; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Maldonado H, 2017, BBA-MOL CELL RES, V1864, P243, DOI 10.1016/j.bbamcr.2016.11.006; Mercatelli R, 2016, FASEB J, V30, P1480, DOI 10.1096/fj.15-275503; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Ohsawa K, 2000, J CELL SCI, V113, P3073; Ohsawa K, 2010, GLIA, V58, P790, DOI 10.1002/glia.20963; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Peng H, 2008, DEV NEUROBIOL, V68, P559, DOI 10.1002/dneu.20593; Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00566; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Tian L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-155; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; VanGuilder HD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-138; Vilalta A, 2018, FEBS J, V285, P3566, DOI 10.1111/febs.14323; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wes PD, 2016, GLIA, V64, P1710, DOI 10.1002/glia.22988; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; Yamaguchi N, 2015, SCI REP-UK, V5, DOI 10.1038/srep07656	62	16	17	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4007	4020		10.1096/fj.201801539R	http://dx.doi.org/10.1096/fj.201801539R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496700				2022-12-28	WOS:000459794800072
J	Lu, DY; Sun, SJ; Zhang, F; Luo, CH; Zheng, L; Wu, Y; Li, N; Zhang, C; Wang, CZ; Chen, Q; Long, M				Lu, Dongyuan; Sun, Shujin; Zhang, Fan; Luo, Chunhua; Zheng, Lu; Wu, Yi; Li, Ning; Zhang, Chen; Wang, Chengzhi; Chen, Qin; Long, Mian			Microgravity-induced hepatogenic differentiation of rBMSCs on board the SJ-10 satellite	FASEB JOURNAL			English	Article						mesenchymal stem cells; mechanotransduction; hepatocyte; signaling pathway	MESENCHYMAL STEM-CELLS; SIMULATED MICROGRAVITY; OSTEOGENIC DIFFERENTIATION; ENDOTHELIAL-CELLS; LIVER; HEPATOCYTES; EXPRESSION; GRAVITY; ACTIVATION; CAPACITY	Bone marrow-derived mesenchymal stem cells (BMSCs) are able to differentiate into functional hepatocytelike cells, which are expected to serve as a potential cell source in regenerative medicine, tissue engineering, and clinical treatment of liver injury. Little is known about whether and how space microgravity is able to direct the hepatogenic differentiation of BMSCs in the actual space microenvironment. In this study, we examined the effects of space microgravity on BMSC hepatogenic differentiation on board the SJ-10 Recoverable Scientific Satellite. Rat BMSCs were cultured and induced in hepatogenic induction medium for 3 and 10 d in custom-made space cell culture hardware. Cell growth was monitored periodically in orbit, and the fixed cells and collected supernatants were retrieved back to the Earth for further analyses. Data indicated that space microgravity improves the differentiating capability of the cells by up-regulating hepatocyte-specific albumin and cytokeratin 18. The resulting cells tended to be maturated, with an in-orbit period of up to 10 d. In space, mechanosensitive molecules of 1-integrin, -actin, -tubulin, and Ras homolog gene family member A presented enhanced expression, whereas those of cell-surface glycoprotein CD44, intercellular adhesion molecule 1, vascular cell adhesion molecule 1, vinculin, cell division control protein 42 homolog, and Rho-associated coiled-coil kinase yielded reduced expression. Also observed in space were the depolymerization of actin filaments and the accumulation of microtubules and vimentin through the altered expression and location of focal adhesion complexes, Rho guanosine 5'-triphosphatases, as well as the enhanced exosome-mediated mRNA transfer. This work furthers the understanding of the underlying mechanisms of space microgravity in directing hepatogenic differentiation of BMSCs.Lu, D., Sun, S., Zhang, F., Luo, C., Zheng, L., Wu, Y., Li, N., Zhang, C., Wang, C., Chen, Q., Long, M. Microgravity-induced hepatogenic differentiation of rBMSCs on board the SJ-10 satellite.	[Lu, Dongyuan; Sun, Shujin; Zhang, Fan; Luo, Chunhua; Zheng, Lu; Wu, Yi; Li, Ning; Zhang, Chen; Wang, Chengzhi; Chen, Qin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, Key Lab Micrograv, Beijing, Peoples R China; [Lu, Dongyuan; Sun, Shujin; Zhang, Fan; Luo, Chunhua; Zheng, Lu; Wu, Yi; Li, Ning; Zhang, Chen; Wang, Chengzhi; Chen, Qin; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing, Peoples R China; [Lu, Dongyuan; Sun, Shujin; Zhang, Fan; Zheng, Lu; Wu, Yi; Li, Ning; Wang, Chengzhi; Long, Mian] Univ Chinese Acad Sci, Sch Engn Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Long, M (corresponding author), Chinese Acad Sci, Inst Mech, 15 North 4th Ring Rd, Beijing 100190, Peoples R China.	mlong@imech.ac.cn			National Natural Science Foundation of China [U1738115, 31661143044]; Strategic Priority Research Program; Frontier Science Key Project of Chinese Academy of Sciences [XDA0402020219, XDA04020416, XDA04073800, QYZDJSSW-JSC018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program(Chinese Academy of Sciences); Frontier Science Key Project of Chinese Academy of Sciences	The authors thank Lei Zhang, Jianquan Zhang, Zhongfang Deng, Xiang Li, Teng Xie, and Namei Du (Technology and Engineering Center for Space Utilization, Chinese Academy of Sciences) for help in developing hardware and software; Juan Chen and Yuxin Gao (Institute of Mechanics, Chinese Academy of Sciences) for technical support; and Shenbao Chen, Luwen Zhou, Xiao Zhang, Yuzhen Bi, Bing Shangguan, and Hao Yang (Institute of Mechanics, Chinese Academy of Sciences) for contributions to implement the space experiment. The authors are grateful to the staff members from the National Space Science Center, Chinese Academy of Sciences, and from the China Academy of Space Technology, China Aerospace Science and Technology Corporation, for contributions to the mission of the SJ-10 Recoverable Scientific Satellite. This work was supported by National Natural Science Foundation of China Grants U1738115 and 31661143044, and Strategic Priority Research Program and Frontier Science Key Project of Chinese Academy of Sciences Grants XDA0402020219, XDA04020416, XDA04073800, and QYZDJSSW-JSC018. The authors declare no conflicts of interest.	Aldridge V, 2012, HEPATOLOGY, V56, P1063, DOI 10.1002/hep.25716; Aleshcheva G, 2015, FASEB J, V29, P2303, DOI 10.1096/fj.14-268151; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Bi HJ, 2017, J TISSUE ENG REGEN M, V11, P2685, DOI 10.1002/term.2161; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Chen Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep30322; Cipriano M, 2017, ARCH TOXICOL, V91, P2469, DOI 10.1007/s00204-016-1901-x; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Esmaeli S, 2017, BIOLOGICALS, V47, P52, DOI 10.1016/j.biologicals.2017.01.006; Godoy P, 2015, J HEPATOL, V63, P934, DOI 10.1016/j.jhep.2015.05.013; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Herrmann H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018242; Hu WR, 2014, MICROGRAVITY SCI TEC, V26, P159, DOI 10.1007/s12217-014-9390-0; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kiss C, 1997, CYTOGENET CELL GENET, V79, P228, DOI 10.1159/000134729; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Lee JW, 2004, BIOMATERIALS, V25, P1901, DOI 10.1016/j.biomaterials.2003.08.037; Lee SW, 2015, BIOCHEM BIOPH RES CO, V464, P1178, DOI 10.1016/j.bbrc.2015.07.100; Li N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01025; Li Z, 2013, BIOMATERIALS, V34, P7616, DOI 10.1016/j.biomaterials.2013.06.059; Liu HZ, 2010, SCAND J UROL NEPHROL, V44, P277, DOI 10.3109/00365599.2010.492787; Long M, 2015, MICROGRAVITY SCI TEC, V27, P505, DOI 10.1007/s12217-015-9464-7; Luna C, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.7; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Meyers VE, 2004, J CELL BIOCHEM, V93, P697, DOI 10.1002/jcb.20229; Miyazaki M, 2002, BIOCHEM BIOPH RES CO, V298, P24, DOI 10.1016/S0006-291X(02)02340-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Popov C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.71; Ratushnyy A, 2018, STEM CELLS DEV, V27, P831, DOI 10.1089/scd.2017.0262; Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017; Ronningen T, 2015, GENOME RES, V25, P1825, DOI 10.1101/gr.193748.115; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Sheyn D, 2010, TISSUE ENG PT A, V16, P3403, DOI 10.1089/ten.tea.2009.0834; Song K, 2014, MOL MED REP, V10, P755, DOI 10.3892/mmr.2014.2264; Speicher T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4862; Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7; Talbot NC, 2013, J ANIM SCI, V91, P66, DOI 10.2527/jas.2012-5748; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Wang ND, 2014, CYTOTECHNOLOGY, V66, P119, DOI 10.1007/s10616-013-9544-8; Wu HH, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0259-y; Yan CH, 2014, BIOMATERIALS, V35, P3035, DOI 10.1016/j.biomaterials.2013.12.037; Yin HY, 2016, ACTA BIOMATER, V33, P96, DOI 10.1016/j.actbio.2016.01.024; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zhang C, 2017, FASEB J, V31, P802, DOI 10.1096/fj.201600897RR; Zhang C, 2018, FASEB J, V32, P4444, DOI 10.1096/fj.201700208RR; Zhou LW, 2018, BIOMECH MODEL MECHAN, V17, P191, DOI 10.1007/s10237-017-0954-y; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	59	10	12	2	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4273	4286		10.1096/fj.201802075R	http://dx.doi.org/10.1096/fj.201802075R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521385	Bronze			2022-12-28	WOS:000459794800094
J	Makwana, K; Gosai, N; Poe, A; Kondratov, RV				Makwana, Kuldeep; Gosai, Neha; Poe, Allan; Kondratov, Roman V.			Calorie restriction reprograms diurnal rhythms in protein translation to regulate metabolism	FASEB JOURNAL			English	Article						ACOTs; lipid metabolism; mRNA-sequencing	ACYL-COA THIOESTERASE; CIRCADIAN-RHYTHM; LIPID-METABOLISM; GENE-EXPRESSION; ENERGY-INTAKE; CELL-SIZE; LIVER; CLOCKS; CONSEQUENCES; DISRUPTION	Calorie restriction (CR) delays aging and affects the circadian clocks by reprogramming circadian rhythms in gene expression. To expand on the circadian mechanisms in CR, we assayed rhythms in the protein translation by analyzing polysome-associated mRNAs in the liver of mice fed ad libitum (AL) and CR diets. Global comparison of the diets revealed that <1% of transcripts were differentially abundant in the polysomes. In contrast, the large differential, up to 10%, was detected when CR and AL diets were compared at individual times throughout the day. Most transcripts that were rhythmic under AL lost their rhythms, and many new transcripts gained rhythms under CR. Only a small fraction of transcripts, including the circadian clock genes, were rhythmic under both diets. Thus, CR strongly reprograms translation. CR affected translation of enzymes regulating long-chain acetyl-coenzyme A (Acyl-CoA) metabolism. The expression of the Acyl-CoA thioesterase (ACOT) family was induced upon CR, leading to the increased transcriptional activity of peroxisome proliferator-activated receptor , the transcriptional factor regulated by the ACOT products. We propose that the differential translation induced by CR leads to a temporal partition and reprogramming of metabolic processes and provides a link between CR, lipid metabolism, and the circadian clock.Makwana, K., Gosai, N., Poe, A., Kondratov, R. V. Calorie restriction reprograms diurnal rhythms in protein translation to regulate metabolism.	[Makwana, Kuldeep; Gosai, Neha; Poe, Allan; Kondratov, Roman V.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University	Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA.	r.kondratov@csuohio.edu	Makwana, Kuldeep/AAD-9386-2022	Makwana, Kuldeep/0000-0003-0890-8120; Kondratov, Roman/0000-0003-3449-745X	U.S. National Institues of Health, National Institute on Aging Grant [5RO1-AG039547]; NATIONAL INSTITUTE ON AGING [R01AG039547] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD025252] Funding Source: NIH RePORTER	U.S. National Institues of Health, National Institute on Aging Grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institues of Health, National Institute on Aging Grant 5RO1-AG039547 (to R.V.K.), and internal support by the Gene Regulation in Health and Diseases Department at Cleveland State University (to R.V.K.). The authors declare no conflicts of interest.	Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Astafev AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09289-9; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Barger JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120738; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Brocker Chad, 2010, Hum Genomics, V4, P411; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Hernandez-Rodas MC, 2015, INT J MOL SCI, V16, P25168, DOI 10.3390/ijms161025168; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chasse H, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw907; Chaudhari Amol, 2017, Nutr Healthy Aging, V4, P101, DOI 10.3233/NHA-160006; Chen SF, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1469-3; Chou SH, 2010, CARDIOVASC RES, V87, P751, DOI 10.1093/cvr/cvq095; DCOSTA AP, 1993, MECH AGEING DEV, V71, P59, DOI 10.1016/0047-6374(93)90035-P; Dermit M, 2017, MOL BIOSYST, V13, P2477, DOI 10.1039/c7mb00476a; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ellis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116587; Franklin MP, 2017, DIABETES, V66, P2112, DOI 10.2337/db16-1519; Froy O, 2013, AGEING RES REV, V12, P931, DOI 10.1016/j.arr.2013.09.002; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Hsiao YS, 2004, J BIOL CHEM, V279, P31584, DOI 10.1074/jbc.M403484200; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Iwasaki S, 2017, TRENDS BIOCHEM SCI, V42, P612, DOI 10.1016/j.tibs.2017.05.004; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Jove M, 2014, AGING CELL, V13, P828, DOI 10.1111/acel.12241; Karunadharma PP, 2015, AGING CELL, V14, P547, DOI 10.1111/acel.12317; Katewa SD, 2016, CELL METAB, V23, P143, DOI 10.1016/j.cmet.2015.10.014; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kulkarni SR, 2013, PHARM RES-DORDR, V30, P2221, DOI 10.1007/s11095-013-1138-9; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Lee C, 2016, F1000 RES, V5, P5, DOI DOI 10.12688/F1000RESEARCH.7136.1; Li Min-Dian, 2012, Yale Journal of Biology and Medicine, V85, P387; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006; Melamed D, 2007, METHOD ENZYMOL, V431, P177, DOI 10.1016/S0076-6879(07)31010-0; Miller BF, 2013, J GERONTOL A-BIOL, V68, P530, DOI 10.1093/gerona/gls219; Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027; Moffat C, 2014, J LIPID RES, V55, P2458, DOI 10.1194/jlr.M046961; Park CY, 2017, BIOCHEM BIOPH RES CO, V490, P636, DOI 10.1016/j.bbrc.2017.06.090; PARVIN R, 1970, J BIOL CHEM, V245, P5773; Patel SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25970; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Potter GDM, 2016, ENDOCR REV, V37, P584, DOI 10.1210/er.2016-1083; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Rhoads TW, 2018, CELL METAB, V27, P677, DOI 10.1016/j.cmet.2018.01.014; Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042; Savvidis C, 2012, MOL MED, V18, P1249, DOI 10.2119/molmed.2012.00077; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Sinturel F, 2017, CELL, V169, P651, DOI 10.1016/j.cell.2017.04.015; Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035; Swigonova Z, 2009, J MOL EVOL, V69, P176, DOI 10.1007/s00239-009-9263-0; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Tognini P, 2017, CELL METAB, V26, P523, DOI 10.1016/j.cmet.2017.08.015; van Eunen K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003186; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033	67	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4473	4489		10.1096/fj.201802167R	http://dx.doi.org/10.1096/fj.201802167R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566374	Green Published, Bronze			2022-12-28	WOS:000459794800109
J	Miyoshi, A; Koyama, S; Sasagawa-Monden, M; Kadoya, M; Konishi, K; Shoji, T; Inaba, M; Yamamoto, Y; Koyama, H				Miyoshi, Akio; Koyama, Sachie; Sasagawa-Monden, Masayo; Kadoya, Manabu; Konishi, Kosuke; Shoji, Takuhito; Inaba, Masaaki; Yamamoto, Yasuhiko; Koyama, Hidenori			JNK and ATF4 as two important platforms for tumor necrosis factor--stimulated shedding of receptor for advanced glycation end products	FASEB JOURNAL			English	Article						RAGE; soluble RAGE; inflammation; ER stress; endothelial cells	ENDOPLASMIC-RETICULUM STRESS; CELL-SURFACE RECEPTOR; SOLUBLE RECEPTOR; ATHEROSCLEROTIC PLAQUES; GROWTH-FACTOR; RAGE; INFLAMMATION; ACTIVATION; CLEAVAGE; ADAM10	Soluble receptor for advanced glycation end products (sRAGE), shed from cell surfaces, is found in human circulation and has been implicated in cardiovascular disease. Its pathophysiological regulation and underlying mechanisms are scarcely understood. In endothelium-specific human RAGE transgenic mice, human sRAGE was detected in circulation, whereas its level was markedly increased after LPS treatment. That increase was preceded by a rapid rise in TNF- level. Treatment with TNF- also significantly increased serum sRAGE. In human microvascular endothelial cells or human umbilical vein endothelial cells with RAGE overexpression, TNF- markedly induced RAGE shedding, which was dependent on MMP9 and ADAM10. TNF--stimulated MMP9 expression was completely dependent on JNK activation, with its inhibition partially effective in suppressing TNF--induced RAGE shedding. In contrast, TNF- transiently induced activation transcription factor (ATF)4, a major component in unfolded protein response (UPR), whereas knockdown of ATF4 abrogated TNF--stimulated RAGE shedding. Protein levels of the pro and activated forms of ADAM10 were also decreased by ATF4 knockdown, whereas inhibition of other components of UPR, including XBP1 and ATF6, failed to block TNF--stimulated RAGE shedding. Although the endoplasmic reticulum stressors thapsigargin and tunicamycin induced markedly and sustained expression of ATF4 and XBP-1, they did not induce RAGE shedding to the same level as TNF-, suggesting that ATF4 is necessary but not sufficient alone for TNF--mediated RAGE shedding. ATF4 inhibition did not affect TNF--stimulated MMP9 expression, whereas inhibition of JNK activity did not influence ADAM10 activation. Thus, inflammatory cascades including TNF- induced RAGE shedding in endothelial cells in vivo and in vitro. JNK and ATF4 may be 2 platforms for regulation of TNF--stimulated RAGE shedding.Miyoshi, A., Koyama, S., Sasagawa-Monden, M., Kadoya, M., Konishi, K., Shoji, T., Inaba, M., Yamamoto, Y., Koyama, H. JNK and ATF4 as two important platforms for tumor necrosis factor--stimulated shedding of receptor for advanced glycation end products.	[Miyoshi, Akio; Koyama, Sachie; Sasagawa-Monden, Masayo; Kadoya, Manabu; Konishi, Kosuke; Shoji, Takuhito; Koyama, Hidenori] Hyogo Coll Med, Div Diabet Endocrinol & Metab, Dept Internal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan; [Sasagawa-Monden, Masayo; Inaba, Masaaki] Osaka City Univ, Dept Endocrinol Metab & Mol Med, Grad Sch Med, Osaka, Japan; [Yamamoto, Yasuhiko] Kanazawa Univ, Dept Biochem & Mol Vasc Biol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Hyogo College of Medicine; Osaka Metropolitan University; Kanazawa University	Koyama, H (corresponding author), Hyogo Coll Med, Div Diabet Endocrinol & Metab, Dept Internal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	hkoyama@hyo-med.ac.jp	Koyama, Hidenori/AAU-2346-2020	Koyama, Hidenori/0000-0001-7930-2228	Hyogo College of Medicine; Japan Society for the Promotion of Science [23591329, JP18K08531, 15K09443, 18K16248]	Hyogo College of Medicine; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank all the members in the laboratory for assistance with the experiments and helpful discussion. This work was supported by Grant-in-Aid for Graduate Students, Hyogo College of Medicine (to A.M.), and Japan Society for the Promotion of Science Grants-in-Aid 23591329, JP18K08531 (to H.K.), 15K09443 (to T.S.), and 18K16248 (to K.K.). The authors declare no conflicts of interest.	Antonelli A, 2017, BBA-GEN SUBJECTS, V1861, P354, DOI 10.1016/j.bbagen.2016.11.040; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; Braley A, 2016, J BIOL CHEM, V291, P12057, DOI 10.1074/jbc.M115.702399; Burke AP, 2004, ARTERIOSCL THROM VAS, V24, P1266, DOI 10.1161/01.ATV.0000131783.74034.97; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Cao SS, 2016, J CELL PHYSIOL, V231, P288, DOI 10.1002/jcp.25098; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen Y, 2012, DIABETOLOGIA, V55, P2533, DOI 10.1007/s00125-012-2594-1; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Koyama H, 2005, ARTERIOSCL THROM VAS, V25, P2587, DOI 10.1161/01.ATV.0000190660.32863.cd; Koyama H, 2007, ARTERIOSCL THROM VAS, V27, P147, DOI 10.1161/01.ATV.0000251502.88818.4b; Koyama H, 2014, ATHEROSCLEROSIS, V234, P329, DOI 10.1016/j.atherosclerosis.2014.03.025; Lam JKY, 2013, DIABETIC MED, V30, P702, DOI 10.1111/dme.12166; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Lee Albert, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0123462; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Metz VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041823; Monden M, 2013, DIABETES, V62, P478, DOI 10.2337/db11-1116; Motoyoshi S, 2014, BIOCHEM J, V463, P75, DOI 10.1042/BJ20140084; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Quade-Lyssy P, 2013, J LIPID RES, V54, P3052, DOI 10.1194/jlr.M038968; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reinhardt S, 2014, FASEB J, V28, P978, DOI 10.1096/fj.13-234864; Ronicke V, 1996, CIRC RES, V79, P277, DOI 10.1161/01.RES.79.2.277; Rzymski T, 2012, ONCOGENE, V31, P3621, DOI 10.1038/onc.2011.522; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Selvin E, 2013, DIABETES, V62, P2116, DOI 10.2337/db12-1528; Shoji T, 2006, DIABETES, V55, P2245, DOI 10.2337/db05-1375; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tam HL, 2010, ATHEROSCLEROSIS, V209, P173, DOI 10.1016/j.atherosclerosis.2009.08.031; Tan KCB, 2007, DIABETOLOGIA, V50, P1819, DOI 10.1007/s00125-007-0759-0; Thomas MC, 2011, DIABETOLOGIA, V54, P2669, DOI 10.1007/s00125-011-2186-5; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; Ueno H, 2010, ATHEROSCLEROSIS, V211, P431, DOI 10.1016/j.atherosclerosis.2010.04.006; van Zoelen MAD, 2009, J INFECT DIS, V200, P765, DOI 10.1086/604730; Wang G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113983; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200	62	9	9	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3575	3589		10.1096/fj.201701553RR	http://dx.doi.org/10.1096/fj.201701553RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30452882	Bronze			2022-12-28	WOS:000459794800039
J	Wang, YS; Wang, C; Liu, N; Hou, J; Xiao, WJ; Wang, H				Wang, Yongsheng; Wang, Cong; Liu, Na; Hou, Jun; Xiao, Wenjing; Wang, Hui			HOXC6 promotes cervical cancer progression via regulation of Bcl-2	FASEB JOURNAL			English	Article						BCL2 apoptosis; HPV; invasion; cell cycle	GENE-EXPRESSION; IN-VITRO; APOPTOSIS; FAMILY	Homeobox C6 (HOXC6) is a transcription factor that plays an important role in the development of several cancers. However, it is unknown whether HOXC6 regulates cervical cancer progression. In this study, we used quantitative PCR and Western blots to demonstrate that HOXC6 overexpression is associated with cervical cancer progression. These results are also supported by the public RNA-seq data showing that HOXC6 overexpression is correlated with poor patient survival. In vitro and in vivo experiments revealed that enhanced HOXC6 expression results in cervical cancer cell proliferation, cell cycle progression, anchorage colony formation, and xenograft tumor growth. Mechanistically, we show that HOXC6 up-regulates BCL2 expression through transcription regulation. Together, these results led us to conclude that overexpression of HOXC6 expression can enhance BCL2-mediated antiapoptotic effects to promote cervical cancer cell cycle progression and proliferation.Wang, Y., Wang, C., Liu, N., Hou, J., Xiao, W., Wang, H. HOXC6 promotes cervical cancer progression via regulation of Bcl-2.	[Wang, Yongsheng; Wang, Cong; Liu, Na; Wang, Hui] Peoples Hosp Linyi City, Dept Obstet & Gynecol, 27 Jiefang Rd, Linyi 276000, Shandong, Peoples R China; [Hou, Jun; Xiao, Wenjing] Chengdu Mil Gen Hosp, Dept Pharm, Chengdu, Sichuan, Peoples R China		Wang, H (corresponding author), Peoples Hosp Linyi City, Dept Obstet & Gynecol, 27 Jiefang Rd, Linyi 276000, Shandong, Peoples R China.	591768560@qq.com			National Natural Science Foundation of China [81402507]; China Postdoctoral Science Foundation Grant [2014M552600]; Innovation Project of Medical Science and Research of Sichuan Province [Q14006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Grant(China Postdoctoral Science Foundation); Innovation Project of Medical Science and Research of Sichuan Province	This work was supported by National Natural Science Foundation of China Grant 81402507 (to W.X.), China Postdoctoral Science Foundation Grant 2014M552600 (to J.H.), and Innovation Project of Medical Science and Research of Sichuan Province Grant Q14006 (to J.H.). The authors declare no conflicts of interest.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Abe M, 2006, ONCOL REP, V15, P797; ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Ansari KI, 2011, J MOL BIOL, V411, P334, DOI 10.1016/j.jmb.2011.05.050; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Bhatlekar S, 2014, J MOL MED, V92, P811, DOI 10.1007/s00109-014-1181-y; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Jin Y, 2014, INT J CLIN EXP PATHO, V7, P8724; Moon SM, 2012, J BIOL CHEM, V287, P35678, DOI 10.1074/jbc.M112.361675; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906; Roura E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151427; Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shrestha B, 2012, FEBS J, V279, P3715, DOI 10.1111/j.1742-4658.2012.08733.x; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stein S, 1996, MECH DEVELOP, V55, P91, DOI 10.1016/0925-4773(95)00494-7; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Voigt A, 2003, MED PEDIATR ONCOL, V40, P205, DOI 10.1002/mpo.10250; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Yim Eun-Kyoung, 2005, Cancer Res Treat, V37, P319, DOI 10.4143/crt.2005.37.6.319; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	32	19	20	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3901	3911		10.1096/fj.201801099RR	http://dx.doi.org/10.1096/fj.201801099RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509141				2022-12-28	WOS:000459794800064
J	Mouzannar, K; Fusil, F; Lacombe, B; Ollivier, A; Menard, C; Lotteau, V; Cosset, FL; Ramiere, C; Andre, P				Mouzannar, Karim; Fusil, Floriane; Lacombe, Benoit; Ollivier, Anais; Menard, Camille; Lotteau, Vincent; Cosset, Francois-Loic; Ramiere, Christophe; Andre, Patrice			Farnesoid X receptor- is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo	FASEB JOURNAL			English	Article						bile acids; mouse model; rAAV-HBV; HBx; agonist	CLOSED-CIRCULAR DNA; BILE-ACIDS; EPIGENETIC REGULATION; FEEDBACK-REGULATION; HEPARG CELLS; HBV; CCCDNA; MICE; REPLICATION; TRANSCRIPTION	Hepatitis B virus (HBV) infection and bile acid (BA) metabolism are interdependent: infection modifies the expression of the BA nuclear receptor farnesoid X receptor (FXR)-, and modulation of FXR activity by ligands alters HBV replication. Mechanisms of HBV control by FXR remain to be unveiled. FXR silencing in HBV-infected HepaRG cells decreased the viral covalently closed circular (ccc)DNA pool size and transcriptional activity. Treatment with the FXR agonist GW4064 inhibited FXR proviral effect on cccDNA similarly for wild-type and hepatitis B viral X protein (HBx)-deficient virus, whereas agonist-induced inhibition of pregenomic and precore RNA transcription and viral DNA secretion was HBx dependent. These data indicated that FXR acts as a proviral factor by 2 different mechanisms, which are abolished by FXR stimulation. Finally, infection of C3H/HeN mice by a recombinant adeno-associated virus-2/8-HBV vector induced a sustained HBV replication in young mice in contrast with the transient decline in adult mice. Four-week GW4064 treatment of infected C3H/HeN mice decreased secretion of HBV DNA and HB surface antigen in adult mice only. These results suggest that the physiologic balance of FXR expression and activation by bile acid is a key host metabolic pathway in the regulation of HBV infection and that FXR can be envisioned as a target for HBV treatment.Mouzannar, K., Fusil, F., Lacombe, B., Ollivier, A., Menard, C., Lotteau, V., Cosset, F.-L., Ramiere, C., Andre, P. Farnesoid X receptor is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo.	[Mouzannar, Karim; Fusil, Floriane; Lacombe, Benoit; Ollivier, Anais; Menard, Camille; Lotteau, Vincent; Cosset, Francois-Loic; Ramiere, Christophe; Andre, Patrice] Univ Claude Bernard Lyon 1, CIRI, Univ Lyon,Ecole Normale Super ENS Lyon, INSERM,Unite 1111,CNRS,Unite Mixte Rech UMR 5308, Lyon, France; [Ramiere, Christophe] Hosp Civils Lyon, Lab Virol, Hop Croix Rousse, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Andre, P (corresponding author), Univ Claude Bernard Lyon 1, CIRI, Univ Lyon, 21 Ave Tony Garnier, F-69007 Lyon, France.	patrice.andre@inserm.fr	Cosset, François-Loïc/M-5862-2019; Sharma, Ashwani/AAK-3879-2020; André, Patrice/M-8139-2014; Ramière, Christophe/M-8083-2014	Cosset, François-Loïc/0000-0001-8842-3726; Sharma, Ashwani/0000-0001-9835-1973; André, Patrice/0000-0002-5834-7395; Ramière, Christophe/0000-0002-1981-7155; FUSIL, Floriane/0000-0002-1619-7333; Ollivier, Anais/0000-0003-1411-2348; Lotteau, Vincent/0000-0003-0997-3282	Biosafety Level-3 Laboratory of Structure Federative de Recherche (SFR) Biosciences (Gerland-Lyon Sud, France) [AMS3444/US8AniRA]; French Agence Nationale de la Recherche (ANR) sur le sida et les Hepatites Virales (ANRS); Universite de Lyon [ANR-11-LABX-0048LabEx Ecofect, ANR-11-IDEX-0007]; INSERM; EnyoPharma	Biosafety Level-3 Laboratory of Structure Federative de Recherche (SFR) Biosciences (Gerland-Lyon Sud, France); French Agence Nationale de la Recherche (ANR) sur le sida et les Hepatites Virales (ANRS); Universite de Lyon; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EnyoPharma	The authors acknowledge Grant AMS3444/US8AniRA from the Biosafety Level-3 Laboratory of Structure Federative de Recherche (SFR) Biosciences (Gerland-Lyon Sud, France). This work was supported by the French Agence Nationale de la Recherche (ANR) sur le sida et les Hepatites Virales (ANRS; to P.A. and F.L.-C.), and Grant ANR-11-LABX-0048LabEx Ecofect from the Universite de Lyon, within the "Investissements d'Avenir" (ANR-11-IDEX-0007) Program, operated by the ANR (to P.A. and F.L.-C.). P.A. and V.L. are cofounders and consultants for EnyoPharma. The wages of B.L. and C.M. are supported by a collaboration contract between INSERM and EnyoPharma. The remaining authors declare no conflicts of interest.	BELLE RCD, 1979, J PEDIATR-US, V94, P472, DOI 10.1016/S0022-3476(79)80604-6; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Bourlieu C, 2014, CRIT REV FOOD SCI, V54, P1427, DOI 10.1080/10408398.2011.640757; Chou HH, 2015, P NATL ACAD SCI USA, V112, P2175, DOI 10.1073/pnas.1424775112; Curtil C, 2014, FASEB J, V28, P1454, DOI 10.1096/fj.13-236372; Dion S, 2013, J VIROL, V87, P5554, DOI 10.1128/JVI.03134-12; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Hong XP, 2017, HEPATOLOGY, V66, P2066, DOI 10.1002/hep.29479; Izhar L, 2015, CELL REP, V11, P1486, DOI 10.1016/j.celrep.2015.04.053; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lucifora J, 2017, ANTIVIR RES, V145, P14, DOI 10.1016/j.antiviral.2017.07.006; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Nakai H, 2000, J VIROL, V74, P9451, DOI 10.1128/JVI.74.20.9451-9463.2000; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Naugler WE, 2015, GASTROENTEROLOGY, V149, P728, DOI 10.1053/j.gastro.2015.05.043; Niu YD, 2017, HEPATOLOGY, V65, P893, DOI 10.1002/hep.28924; Oehler N, 2014, HEPATOLOGY, V60, P1483, DOI 10.1002/hep.27159; Protzer U, 2017, NAT REV GASTRO HEPAT, V14, P327, DOI 10.1038/nrgastro.2017.44; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Radreau P, 2016, FASEB J, V30, P3146, DOI 10.1096/fj.201500134; Ramiere C, 2008, J VIROL, V82, P10832, DOI 10.1128/JVI.00883-08; Reese VC, 2012, J VIROL, V86, P2760, DOI 10.1128/JVI.06742-11; Ren J.-H., 2018, HEPATOLOGY; Riviere L, 2015, J HEPATOL, V63, P1093, DOI 10.1016/j.jhep.2015.06.023; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shao JB, 2003, J VIROL METHODS, V112, P45, DOI 10.1016/S0166-0934(03)00190-3; Slijepcevic D, 2015, HEPATOLOGY, V62, P207, DOI 10.1002/hep.27694; Song M, 2018, J VIROL, V92, DOI 10.1128/JVI.01771-17; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; WATKINS JB, 1973, NEW ENGL J MED, V288, P431, DOI 10.1056/NEJM197303012880902; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yu XM, 1997, J VIROL, V71, P9366, DOI 10.1128/JVI.71.12.9366-9374.1997	41	22	22	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2472	2483		10.1096/fj.201801181R	http://dx.doi.org/10.1096/fj.201801181R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30307769				2022-12-28	WOS:000457296600075
J	Paulsen, ME; Rosario, FJ; Wesolowski, SR; Powell, TL; Jansson, T				Paulsen, Megan E.; Rosario, Fredrick J.; Wesolowski, Stephanie R.; Powell, Theresa L.; Jansson, Thomas			Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring	FASEB JOURNAL			English	Article						fetal programming; insulin resistance; fatty liver	FULL-LENGTH ADIPONECTIN; INSULIN-RESISTANCE; FETAL OVERNUTRITION; MATERNAL OBESITY; UNITED-STATES; MOUSE MODEL; TRANSPORT; GLUCOSE; WOMEN; BIRTH	Infants of obese mothers have an increased risk of developing obesity, insulin resistance, and type 2 diabetes. The underlying mechanisms remain elusive, and no effective interventions to limit the transmission of metabolic disease from the obese mother to her infant are currently available. Obese pregnant women have decreased circulating levels of adiponectin, which is associated with increased placental nutrient transport and fetal overgrowth. We have reported that normalization of adiponectin levels during late gestation reversed placental dysfunction and fetal overgrowth in a mouse model of maternal obesity in pregnancy. In the current study, we hypothesized that adiponectin supplementation during pregnancy in obese mice attenuates the adverse metabolic outcomes in adult offspring. Adult male offspring of obese mice developed obesity, fatty liver, and insulin resistance, with adult female offspring of obese mice having a less pronounced metabolic phenotype. These metabolic abnormalities in offspring born to obese mice were largely prevented by normalization of maternal adiponectin levels in late pregnancy. We provide evidence that low circulating maternal adiponectin is a critical mechanistic link between maternal obesity and the development of metabolic disease in offspring. Strategies aimed at improving maternal adiponectin levels may prevent long-term metabolic dysfunction in offspring of obese mothers.Paulsen, M. E., Rosario, F. J., Wesolowski, S. R., Powell, T. L., Jansson, T. Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring.	[Paulsen, Megan E.; Wesolowski, Stephanie R.; Powell, Theresa L.] Univ Colorado, Dept Pediat, Sect Neonatol, Anschutz Med Campus, Aurora, CO USA; [Rosario, Fredrick J.; Powell, Theresa L.; Jansson, Thomas] Univ Colorado, Dept Obstet & Gynecol, Div Reprod Sci, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Paulsen, ME (corresponding author), Univ Minnesota, Med Sch, Dept Pediat, Div Neonatol, 2450 Riverside Ave,6th Floor,East Bldg, Minneapolis, MN 55455 USA.	mgosslin@umn.edu	Powell, Theresa/AAE-4249-2020	Paulsen, Megan/0000-0001-9187-4966	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK59630]; NIH Office of the Director [R24OD016724]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD065007, T32HD07186]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065007, T32HD007186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630, R01DK108910] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD016724] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank A. Kramer and N. Anderson (University of Colorado) for providing technical assistance in the acquisition of data, and the Mouse Metabolic Phenotyping Center at the University of Cincinnati (Cincinnati, OH, USA) [U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases; Grant DK59630] for performing colorimetric assay of serum triglycerides. This work was supported by NIH Office of the Director Grant R24OD016724, and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants R01HD065007 and T32HD07186. The authors declare no conflicts of interest.	Acosta O, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.009; Ahlsson FSE, 2007, PEDIATRICS, V120, P958, DOI 10.1542/peds.2007-0165; Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Aye ILMH, 2013, PLACENTA, V34, pS40, DOI 10.1016/j.placenta.2012.11.024; Aye ILMH, 2015, P NATL ACAD SCI USA, V112, P12858, DOI 10.1073/pnas.1515484112; Aye ILMH, 2014, MOL ENDOCRINOL, V28, P512, DOI 10.1210/me.2013-1401; Bellatorre A, 2018, J PEDIATR-US, V192, P165, DOI 10.1016/j.jpeds.2017.09.008; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bomba-Opon DA, 2009, NEUROENDOCRINOL LETT, V30, P729; Branca F., 2007, CHALLENGE OBESITY WH; Brumbaugh DE, 2013, J PEDIATR-US, V162, P930, DOI 10.1016/j.jpeds.2012.11.017; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Dearden L, 2018, MOL METAB, V15, P8, DOI 10.1016/j.molmet.2018.04.007; Diaz P, 2015, AM J PHYSIOL-REG I, V309, pR1569, DOI 10.1152/ajpregu.00385.2015; Evagelidou EN, 2006, DIABETES CARE, V29, P1197, DOI 10.2337/dc05-2401; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Hendler I, 2005, AM J OBSTET GYNECOL, V193, P979, DOI 10.1016/j.ajog.2005.06.041; Jansson N, 2008, AM J CLIN NUTR, V87, P1743, DOI 10.1093/ajcn/87.6.1743; Jansson N, 2013, J CLIN ENDOCR METAB, V98, P105, DOI 10.1210/jc.2012-2667; Jansson T, 2013, CLIN OBSTET GYNECOL, V56, P591, DOI 10.1097/GRF.0b013e3182993a2e; Johansson K, 2015, NEW ENGL J MED, V372, P2267, DOI 10.1056/NEJMc1503863; Jones HN, 2010, DIABETES, V59, P1161, DOI 10.2337/db09-0824; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Lanoix D, 2012, PLACENTA, V33, P151, DOI 10.1016/j.placenta.2011.12.008; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Lekva T, 2017, J CLIN ENDOCR METAB, V102, P2552, DOI 10.1210/jc.2017-00289; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Nien JK, 2007, J PERINAT MED, V35, P522, DOI 10.1515/JPM.2007.123; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Qiao LP, 2017, DIABETES, V66, P1126, DOI 10.2337/db16-1096; Qiao LP, 2016, DIABETOLOGIA, V59, P2417, DOI 10.1007/s00125-016-4061-x; Ramirez VI, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000010; Retnakaran R, 2010, DIABETOLOGIA, V53, P268, DOI 10.1007/s00125-009-1600-8; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Rosario FJ, 2015, OBESITY, V23, P1663, DOI 10.1002/oby.21165; Rosario FJ, 2012, J PHYSIOL-LONDON, V590, P1495, DOI 10.1113/jphysiol.2011.226399; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Soheilykhah S, 2009, GYNECOL ENDOCRINOL, V25, P593, DOI 10.1080/09513590902972109; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stocker C, 2004, INT J OBESITY, V28, P129, DOI 10.1038/sj.ijo.0802476; Stocker CJ, 2007, AM J PHYSIOL-REG I, V292, pR1810, DOI 10.1152/ajpregu.00676.2006; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Thorn SR, 2014, DIABETES, V63, P2702, DOI 10.2337/db14-0276; Thornburg KL, 2016, PLACENTA, V48, pS47, DOI 10.1016/j.placenta.2016.10.012; Tsai PJ, 2005, NUTRITION, V21, P1095, DOI 10.1016/j.nut.2005.03.008; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Wang XM, 2007, INDIAN J PEDIATR, V74, P561, DOI 10.1007/s12098-007-0108-9; Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160; YOGEV Y, 2010, AM J OBSTET GYNECOL, V202, pe1	57	18	18	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2899	2909		10.1096/fj.201801015R	http://dx.doi.org/10.1096/fj.201801015R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30346829	Green Published, Bronze			2022-12-28	WOS:000457296600109
J	Arao, Y; Hamilton, KJ; Wu, SP; Tsai, MJ; DeMayo, FJ; Korach, KS				Arao, Yukitomo; Hamilton, Katherine J.; Wu, San-Pin; Tsai, Ming-Jer; DeMayo, Francesco J.; Korach, Kenneth S.			Dysregulation of hypothalamic-pituitary estrogen receptor alpha-mediated signaling causes episodic LH secretion and cystic ovary	FASEB JOURNAL			English	Article						polycystic ovary; negative feedback regulation; gonadotropin	GONADOTROPIN-RELEASING-HORMONE; LUTEINIZING-HORMONE; NEGATIVE FEEDBACK; ER-ALPHA; CLOMIPHENE CITRATE; NULL MICE; DELETION; CELLS; RECOMBINATION; INFERTILITY	Polycystic ovary syndrome (PCOS) is a hypothalamic-pituitary-gonadal (HPG) axis disorder. PCOS symptoms most likely result from a disturbance in the complex feedback regulation system of the HPG axis, which involves gonadotrophic hormones and ovarian steroid hormones. However, the nature of this complex and interconnecting feedback regulation makes it difficult to dissect the molecular mechanisms responsible for PCOS phenotypes. Global estrogen receptor alpha (ER alpha) knockout (KO) mice exhibit a disruption of the HPG axis, resulting in hormonal dysregulation in which female ER alpha KO mice have elevated levels of serum estradiol (E2), testosterone, and LH. The ER alpha KO females are anovulatory and develop cystic hemorrhagic ovaries that are thought to be due to persistently high circulating levels of LH from the pituitary. However, the role of ER alpha in the pituitary is still controversial because of the varied phenotypes reported in pituitary-specific ER alpha KO mouse models. Therefore, we developed a mouse model where ER alpha is reintroduced to be exclusively expressed in the pituitary on the background of a global ER alpha-null (PitERtgKO) mouse. Serum E2 and LH levels were normalized in PitERtgKO females and were comparable to wild-type serum levels. However, the ovaries of PitERtgKO adult mice displayed a more overt cystic and hemorrhagic phenotype when compared with ER alpha KO littermates. We determined that anomalous sporadic LH secretion caused the severe ovarian phenotype of PitERtgKO females. Our observations suggest that pituitary ER alpha is involved in the estrogen negative feedback regulation, whereas hypothalamic ER alpha is necessary for the precise control of LH secretion. Uncontrolled, irregular LH secretion may be the root cause of the cystic ovarian phenotype with similarities to PCOS.-Arao, Y., Hamilton, K. J., Wu, S.-P., Tsai, M.-J., DeMayo, F. J., Korach, K. S. Dysregulation of hypothalamic-pituitary estrogen receptor alpha-mediated signaling causes episodic LH secretion and cystic ovary.	[Arao, Yukitomo; Hamilton, Katherine J.; Korach, Kenneth S.] NIEHS, Receptor Biol Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Wu, San-Pin; DeMayo, Francesco J.] NIEHS, Pregnancy & Female Reprod Grp, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Tsai, Ming-Jer] Baylor Coll Med, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Baylor College of Medicine	Korach, KS (corresponding author), NIEHS, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021; , San Pin Wu/AAF-8371-2020	, San Pin Wu/0000-0001-9626-784X; Arao, Yukitomo/0000-0003-1560-351X	NIH NIEHS from the Division of Intramural Research of the NIEHS [1ZIAES070065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065] Funding Source: NIH RePORTER	NIH NIEHS from the Division of Intramural Research of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank David Monroy and the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Comparative Medicine Branch staff for animal care, the staff of the NIEHS Histology Core for histology, and Dr. Janet Hall and Dr. Natalie Shaw (NIEHS, Clinical Research Unit) for critical comments on this study. This study was supported by NIH NIEHS Grant 1ZIAES070065 (to K.S.K.) from the Division of Intramural Research of the NIEHS. The authors declare no conflicts of interest.	Abatan OI, 2008, J AM ASSOC LAB ANIM, V47, P8; Amory JK, 2003, J STEROID BIOCHEM, V85, P357, DOI 10.1016/S0960-0760(03)00205-X; Arao Y, 2018, MOL METAB, V18, P68, DOI 10.1016/j.molmet.2018.09.006; Azziz R, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.57; Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196; Cheong RY, 2014, ENDOCRINOLOGY, V155, P1418, DOI 10.1210/en.2013-1943; COQUELIN A, 1982, AM J PHYSIOL, V243, pE257, DOI 10.1152/ajpendo.1982.243.3.E257; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Couse JF, 1999, ENDOCRINOLOGY, V140, P5855, DOI 10.1210/en.140.12.5855; Couse JF, 2005, ENDOCRINOLOGY, V146, P3247, DOI 10.1210/en.2005-0213; Couse JF, 2004, ENDOCRINOLOGY, V145, P4693, DOI 10.1210/en.2004-0548; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Couse JF, 2006, ENDOCRINOLOGY, V147, P3666, DOI 10.1210/en.2006-0276; Cushman LJ, 2000, GENESIS, V28, P167, DOI 10.1002/1526-968X(200011/12)28:3/4<167::AID-GENE120>3.3.CO;2-E; ELLIS GB, 1982, ENDOCRINOLOGY, V110, P1618, DOI 10.1210/endo-110-5-1618; Gieske MC, 2008, ENDOCRINOLOGY, V149, P20, DOI 10.1210/en.2007-1084; Hakkarainen J, 2015, FASEB J, V29, P3806, DOI 10.1096/fj.14-269035; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Lee S, 2009, ENDOCRINOLOGY, V150, P3855, DOI 10.1210/en.2008-1774; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Lin H, 2009, BIOL REPROD, V80, P1232, DOI 10.1095/biolreprod.108.074229; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Ma YP, 2017, ENDOCRINOLOGY, V158, P98, DOI 10.1210/en.2016-1608; Marshall J C, 1993, Trans Am Clin Climatol Assoc, V104, P31; MARSHALL JC, 1986, NEW ENGL J MED, V315, P1459; Moskovic DJ, 2012, BJU INT, V110, P1524, DOI 10.1111/j.1464-410X.2012.10968.x; Perez-Millan MI, 2013, GENESIS, V51, P785, DOI 10.1002/dvg.22425; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REAME N, 1984, J CLIN ENDOCR METAB, V59, P328, DOI 10.1210/jcem-59-2-328; RISMA KA, 1995, P NATL ACAD SCI USA, V92, P1322, DOI 10.1073/pnas.92.5.1322; Shaw ND, 2010, J CLIN ENDOCR METAB, V95, P1955, DOI 10.1210/jc.2009-2108; Singh SP, 2009, BIOL REPROD, V81, P488, DOI 10.1095/biolreprod.108.075259; SIR T, 1989, HORM METAB RES, V21, P583, DOI 10.1055/s-2007-1009293; SODERSTEN P, 1983, J ENDOCRINOL, V97, P145, DOI 10.1677/joe.0.0970145; Taniguchi F, 2007, FASEB J, V21, P586, DOI 10.1096/fj.06-6681com; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Wintermantel TM, 2006, NEURON, V52, P271, DOI 10.1016/j.neuron.2006.07.023; Wu SP, 2010, MOL ENDOCRINOL, V24, P1297, DOI 10.1210/me.2010-0068; Xu PW, 2015, J CLIN INVEST, V125, P2861, DOI 10.1172/JCI80941	40	10	11	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7375	7386		10.1096/fj.201802653RR	http://dx.doi.org/10.1096/fj.201802653RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30866655	Bronze, Green Published			2022-12-28	WOS:000476114200057
J	Borhani, S; Corciulo, C; Larranaga-Vera, A; Cronstein, BN				Borhani, Soheila; Corciulo, Carmen; Larranaga-Vera, Ane; Cronstein, Bruce N.			Adenosine A(2A) receptor (A2AR) activation triggers Akt signaling and enhances nuclear localization of beta-catenin in osteoblasts	FASEB JOURNAL			English	Article						canonical Wnt pathway; bone regeneration; CGS21680	BONE-DEVELOPMENT; CYCLIC-AMP; KINASE-B; WNT; PHOSPHORYLATION; CELLS; STIMULATION; PATHWAY	Osteoblast differentiation and proliferation are regulated by several modulators, among which are adenosine A(2A) receptors (A2ARs) and Wingless/Integrated-beta-catenin pathways. Cytosolic beta-catenin stabilization promotes its nuclear translocation and transcriptional activity. In the present study, we seek to determine whether there is a connection between A2AR stimulation and cellular beta-catenin levels in osteoblasts. Osteoblast precursor cell line (MC3T3-E1) and primary murine osteoblasts were treated with CGS21680, a highly selective A2AR agonist. We analyzed cellular content and nuclear translocation of phosphorylated (p)-serine 552 (S552) beta-catenin in response to A2AR stimulation in MC3T3-E1 cells, in both wild-type and A2AR knockout (A2AKO) mice. Moreover, we measured cellular beta-catenin levels in MC3T3-E1 cells transfected with scrambled or protein kinase B (Akt) small interfering RNA following A2AR activation. CGS21680 (1 mu M) stimulated an increase in both the cellular content and nuclear translocation of p-S552 beta-catenin after 15 min of incubation. A2AR activation had no tangible effect on the cellular beta-catenin level either in A2AKO mice or in osteoblasts with diminished Akt content. Our findings demonstrate an interaction between A2AR, beta-catenin, and Akt signaling in osteoblasts. The existence of such a crosstalk has significant repercussions in the development of novel therapeutic approaches targeting medical conditions associated with reduced bone density.-Borhani, S., Corciulo, C., Larranaga-Vera, A., Cronstein, B. N. Adenosine A(2A) receptor (A2AR) activation triggers Akt signaling and enhances nuclear localization of beta-catenin in osteoblasts.	[Borhani, Soheila] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60607 USA; [Corciulo, Carmen; Larranaga-Vera, Ane; Cronstein, Bruce N.] NYU, Sch Med, Dept Med, New York, NY 10016 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; New York University	Cronstein, BN (corresponding author), NYU, Sch Med, Div Translat Med, Clin Translat Sci Inst, 227 East 30th St, New York, NY 10016 USA.	bruce.cronstein@nyulangone.org	Larranaga-Vera, Ane/AAH-1779-2019	CORCIULO, CARMEN/0000-0002-1865-3494; Borhani, Soheila/0000-0001-8259-2940; Cronstein, Bruce/0000-0002-4295-7383	Arthritis Foundation; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR056672, R01 AR068593]; New York University (NYU) Health and Hospitals Corp. (HHC) Clinical and Translational Science Institute [UL1 TR000038]; Translational Research Laboratory Instruments at NYU-Langone Health; AstraZeneca	Arthritis Foundation; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York University (NYU) Health and Hospitals Corp. (HHC) Clinical and Translational Science Institute; Translational Research Laboratory Instruments at NYU-Langone Health; AstraZeneca(AstraZeneca)	This work was supported by grants from the Arthritis Foundation and the U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR056672 and R01 AR068593), and by the New York University (NYU) Health and Hospitals Corp. (HHC) Clinical and Translational Science Institute (UL1 TR000038), and the Translational Research Laboratory Instruments at NYU-Langone Health. Dr. Aranzazu Mediero (Fundacion Jimenez Diaz, Madrid, Spain) originally generated the calvarial sections used in this work as part of a previously published work. B.N.C. has patents on the use of adenosine A<INF>2A</INF> receptor agonists for the promotion of bone growth and regeneration. B.N.C. has a grant from AstraZeneca. B.N.C. has consulted for Eli Lilly & Co. and AstraZeneca. B.N.C. has significant equity in Regenosine and CanFite Biopharmaceuticals and lesser equity in Amgen, Novartis, Baxter, Abbott, Gilead, and Bristol-Myers, Squibb. The remaining authors declare no conflicts of interest.	Ahmad A, 2013, BIOCHEM BIOPH RES CO, V434, P566, DOI 10.1016/j.bbrc.2013.03.115; Anderson EC, 2010, GASTROENTEROLOGY, V139, P718, DOI 10.1053/j.gastro.2010.07.012; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gervitz LM, 2002, NEUROSCI LETT, V328, P175, DOI 10.1016/S0304-3940(02)00495-0; Goretsky T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18421-8; He WJ, 2013, FASEB J, V27, P3446, DOI 10.1096/fj.13-231233; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mediero A, 2018, FASEB J, V32, P3487, DOI 10.1096/fj.201700217R; Mediero A, 2015, FASEB J, V29, P1577, DOI 10.1096/fj.14-265066; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Perez-Aso M, 2014, FASEB J, V28, P802, DOI 10.1096/fj.13-241646; Regard JB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007997; Shaikh G, 2016, BRIT J PHARMACOL, V173, P3279, DOI 10.1111/bph.13615; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Takasuga S, 1999, J BIOL CHEM, V274, P19545, DOI 10.1074/jbc.274.28.19545; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; Vincenzi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065561; Wang DW, 2015, CELL PHYSIOL BIOCHEM, V36, P1563, DOI 10.1159/000430319; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Zhang BC, 2011, BBA-MOL CELL RES, V1813, P73, DOI 10.1016/j.bbamcr.2010.10.001; Zhang J, 2017, AM J PATHOL, V187, P1935, DOI 10.1016/j.ajpath.2017.05.005	29	9	10	2	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7555	7562		10.1096/fj.201900014R	http://dx.doi.org/10.1096/fj.201900014R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30866652	Green Published			2022-12-28	WOS:000476114200071
J	Bottemanne, P; Paquot, A; Ameraoui, H; Alhouayek, M; Muccioli, GG				Bottemanne, Pauline; Paquot, Adrien; Ameraoui, Hafsa; Alhouayek, Mireille; Muccioli, Giulio G.			The alpha/beta-hydrolase domain 6 inhibitor WWL70 decreases endotoxin-induced lung inflammation in mice, potential contribution of 2-arachidonoylglycerol, and lysoglycerophospholipids	FASEB JOURNAL			English	Article						serine hydrolase; bioactive lipid; MAGL; prostaglandin; PGE(2)	RESPIRATORY-DISTRESS-SYNDROME; HYDROLYZING ACID AMIDASE; MACROPHAGE ACTIVATION; ABHD6; LIPOPOLYSACCHARIDE; RESPONSES; BLOCKADE	Lung inflammation plays a crucial role in the pathogenesis of many respiratory diseases that are in need of new therapeutic strategies. Previously, we showed that inhibition of alpha/beta-hydrolase domain 6 (ABHD6) decreased macrophage activation and exerted anti-inflammatory effects. Therefore, we thought to assess the effects of ABHD6 inhibition in a mouse model of acute lung injury (ALI) induced by intratracheal administration of lipopolysaccharides. ABHD6 inhibition with N-methyl-N-{[3-(4-pyridinyl)phenyl]methyl}-carbamic acid 4 '-(aminocarbonyl)(1,1 '-biphenyl)-4-yl ester (WWL70) decreases most of the hallmarks of ALI, including neutrophil infiltration, cytokine secretion, and protein extravasation. mRNA expression of proinflammatory markers in the cells recovered in the bronchoalveolar lavage was also decreased. Interestingly, ABHD6 inhibition was more efficient than monoacylglycerol lipase inhibition by 4-nitrophenyl-4-[dibenzo(d)(14)dioxol-5-yl(hydroxy)methyl]piperidine-1-carboxylate. We also studied ABHD6 inhibition on primary alveolar macrophages and neutrophils to explore their potential implication in the effects of ABHD6 inhibition in vivo. Moreover, we quantified by high-performance liquid chromatography-mass spectrometry the levels of reported substrates of ABHD6 [i.e., 2-arachidonoylglycerol (2-AG) and lysophospholipids]. The potential implication of these lipid mediators in the effects of WWL70 was further investigated on primary alveolar macrophages. Taken together, these data support ABHD6 inhibition as an interesting anti-inflammatory strategy in acute lung inflammation and assess the possible contribution of 2-AG and lysophospholipids in the observed effects.-Bottemanne, P., Paquot, A., Ameraoui, H., Alhouayek, M., Muccioli, G. G. The alpha/beta-hydrolase domain 6 inhibitor WWL70 decreases endotoxin-induced lung inflammation in mice, potential contribution of 2-arachidonoylglycerol, and lysoglycerophospholipids.	[Bottemanne, Pauline; Paquot, Adrien; Ameraoui, Hafsa; Alhouayek, Mireille; Muccioli, Giulio G.] UCLouvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Av E Mounier 72,B1-72-01, B-1200 Brussels, Belgium	Universite Catholique Louvain	Muccioli, GG (corresponding author), UCLouvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Av E Mounier 72,B1-72-01, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be	; Alhouayek, Mireille/R-5058-2018	Muccioli, Giulio/0000-0002-1600-9259; Alhouayek, Mireille/0000-0002-9193-0718; Bottemanne, Pauline/0000-0003-0414-4127	Fonds de la Recherche Scientifique (FRS-FNRS; Brussels, Belgium); Fonds Speciaux de Recherches (FSR; UCLouvain); FRS-FNRS [PDR T.0148.14, CDR J.0084.18]; FSR	Fonds de la Recherche Scientifique (FRS-FNRS; Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de Recherches (FSR; UCLouvain); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); FSR	The authors thank H.P. Patil and C. Loira-Pastoriza from Dr. R. Vanbever's laboratory [Universite Catholique de Louvain (UCLouvain)] for helpful discussions related to the mouse model, Dr. L. Dumoutier's laboratory (UCLouvain) for access to cytospin, and Dr. V. Mutemberezi (UCLouvain) for help with lipid quantification. The Mass Spectrometry of Metabolites (MASSMET) platform (UCLouvain) is acknowledged for access to the LC-MS. G.G.M. is the recipient of grants from the Fonds de la Recherche Scientifique (FRS-FNRS; Brussels, Belgium) and from the Fonds Speciaux de Recherches (FSR; UCLouvain). P.B. is a research fellow of the Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA; Brussels, Belgium). M.A. is a postdoctoral fellow from the FRS-FNRS. G.G.M. is the recipient of grants from the FRS-FNRS (PDR T.0148.14, CDR J.0084.18) and from the FSR. The authors declare no conflicts of interest.	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Alhouayek M, 2018, FASEB J, V32, P5000, DOI 10.1096/fj.201701205R; Alhouayek M, 2018, TRENDS PHARMACOL SCI, V39, P586, DOI 10.1016/j.tips.2018.02.011; Alhouayek M, 2017, BBA-MOL CELL BIOL L, V1862, P474, DOI 10.1016/j.bbalip.2017.01.001; Alhouayek M, 2015, FASEB J, V29, P650, DOI 10.1096/fj.14-255208; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P295, DOI 10.1016/j.drudis.2013.07.009; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Costola-De-Souza C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077706; De Berdt P, 2018, CELL MOL LIFE SCI, V75, P2843, DOI 10.1007/s00018-018-2764-5; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Hoogerwerf JJ, 2008, AM J RESP CRIT CARE, V178, P34, DOI 10.1164/rccm.200708-1261OC; Hsu KL, 2013, J MED CHEM, V56, P8270, DOI 10.1021/jm400899c; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marrs WR, 2011, J BIOL CHEM, V286, P28723, DOI 10.1074/jbc.M110.202853; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Masquelier J, 2018, BBA-MOL CELL BIOL L, V1863, P1458, DOI 10.1016/j.bbalip.2018.09.003; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mutemberezi V, 2016, ANAL BIOANAL CHEM, V408, P733, DOI 10.1007/s00216-015-9150-z; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; Hung ND, 2011, LIPIDS, V46, P893, DOI 10.1007/s11745-011-3589-2; Pribasnig MA, 2015, J BIOL CHEM, V290, P29869, DOI 10.1074/jbc.M115.669168; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Shim JW, 2009, EXP MOL MED, V41, P584, DOI 10.3858/emm.2009.41.8.064; Swamydas M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7718; Tanaka M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0783-4; Thomas G, 2013, CELL REP, V5, P508, DOI 10.1016/j.celrep.2013.08.047; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Vernooy JHJ, 2001, AM J RESP CELL MOL, V24, P569, DOI 10.1165/ajrcmb.24.5.4156; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	42	13	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7635	7646		10.1096/fj.201802259R	http://dx.doi.org/10.1096/fj.201802259R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30896979	Bronze			2022-12-28	WOS:000476114200078
J	Castano-Martinez, T; Schumacher, F; Schumacher, S; Kochlik, B; Weber, D; Grune, T; Biemann, R; McCann, A; Abraham, K; Weikert, C; Kleuse, B; Schurmann, A; Laeger, T				Castano-Martinez, Teresa; Schumacher, Fabian; Schumacher, Silke; Kochlik, Bastian; Weber, Daniela; Grune, Tilman; Biemann, Ronald; McCann, Adrian; Abraham, Klaus; Weikert, Cornelia; Kleuse, Burkhard; Schuermann, Annette; Laeger, Thomas			Methionine restriction prevents onset of type 2 diabetes in NZO mice	FASEB JOURNAL			English	Article						energy expenditure; hyperglycemia; obesity; vegan; vegetarian	INSULIN SENSITIVITY; AMINO-ACIDS; METABOLIC-RESPONSES; GLUCOSE-HOMEOSTASIS; ENERGY-EXPENDITURE; FATTY RATS; FGF21; PROTEIN; MECHANISMS; SIGNAL	Dietary methionine restriction (MR) is well known to reduce body weight by increasing energy expenditure (EE) and insulin sensitivity. An elevated concentration of circulating fibroblast growth factor 21 (FGF21) has been implicated as a potential underlying mechanism. The aims of our study were to test whether dietary MR in the context of a high-fat regimen protects against type 2 diabetes in mice and to investigate whether vegan and vegetarian diets, which have naturally low methionine levels, modulate circulating FGF21 in humans. New Zealand obese (NZO) mice, a model for polygenic obesity and type 2 diabetes, were placed on isocaloric high-fat diets (protein, 16 kcal%; carbohydrate, 52 kcal%; fat, 32 kcal%) that provided methionine at control (Con; 0.86% methionine) or low levels (0.17%) for 9 wk. Markers of glucose homeostasis and insulin sensitivity were analyzed. Among humans, low methionine intake and circulating FGF21 levels were investigated by comparing a vegan and a vegetarian diet to an omnivore diet and evaluating the effect of a short-term vegetarian diet on FGF21 induction. In comparison with the Con group, MR led to elevated plasma FGF21 levels and prevented the onset of hyperglycemia in NZO mice. MR-fed mice exhibited increased insulin sensitivity, higher plasma adiponectin levels, increased EE, and up-regulated expression of thermogenic genes in subcutaneous white adipose tissue. Food intake and fat mass did not change. Plasma FGF21 levels were markedly higher in vegan humans compared with omnivores, and circulating FGF21 levels increased significantly in omnivores after 4 d on a vegetarian diet. These data suggest that MR induces FGF21 and protects NZO mice from high-fat diet-induced glucose intolerance and type 2 diabetes. The normoglycemic phenotype in vegans and vegetarians may be caused by induced FGF21. MR akin to vegan and vegetarian diets in humans may offer metabolic benefits via increased circulating levels of FGF21 and merits further investigation.-Castano-Martinez, T., Schumacher, F., Schumacher, S., Kochlik, B., Weber, D., Grune, T., Biemann, R., McCann, A., Abraham, K., Weikert, C., Kleuser, B., Schurmann, A., Laeger, T. Methionine restriction prevents onset of type 2 diabetes in NZO mice.	[Castano-Martinez, Teresa; Schumacher, Silke; Schuermann, Annette; Laeger, Thomas] German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Diabetol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany; [Kochlik, Bastian; Weber, Daniela; Grune, Tilman] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Toxicol, Nuthetal, Germany; [Castano-Martinez, Teresa; Schuermann, Annette; Laeger, Thomas] German Ctr Diabet Res, Munich, Germany; [Schumacher, Fabian] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany; [Schumacher, Fabian; Kleuse, Burkhard] Univ Potsdam, Dept Toxicol, Nuthetal, Germany; [Schuermann, Annette] Univ Potsdam, Inst Nutr Sci, Nuthetal, Germany; [Kochlik, Bastian; Weber, Daniela; Grune, Tilman; Kleuse, Burkhard] NutriAct Competence Cluster Nutr Res Berlin Potsd, Nuthetal, Germany; [Biemann, Ronald] Otto von Guericke Univ, Inst Clin Chem & Pathobiochem, Magdeburg, Germany; [McCann, Adrian] Bevital AS, Lab Bygget, Bergen, Norway; [Abraham, Klaus; Weikert, Cornelia] German Fed Inst Risk Assessment, Dept Food Safety, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Duisburg Essen; University of Potsdam; University of Potsdam; Otto von Guericke University; Federal Institute for Risk Assessment	Laeger, T (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Diabetol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	thomas.laeger@dife.de	Laeger, Thomas/B-1256-2011; Schumacher, Fabian/ABC-1750-2020	Laeger, Thomas/0000-0002-2763-0497; Schumacher, Fabian/0000-0001-8703-3275; Schurmann, Annette/0000-0002-4113-4377; Weber, Daniela/0000-0002-2054-6233; Kochlik, Bastian/0000-0003-0214-7092; Kleuser, Burkhard/0000-0002-1888-9595; Grune, Tilman/0000-0003-4775-9973; Abraham, Klaus/0000-0003-1895-9909	German Ministry of Education and Research; Brandenburg State [German Center for Diabetes Research (DZD)] [82DZD00302]; Deutsche Forschungsgemeinschaft (DFG) [LA 3042/3-1, LA 3042/4-1]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Brandenburg State [German Center for Diabetes Research (DZD)]; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank A. Helms, J. Wurfel, C. Gumz, and A. Teichmann (German Institute of Human Nutrition) for their skillful technical assistance. The authors thank the staff of the animal housing facility located at the Max Rubner Laboratory (Potsdam-Rehbruecke, Germany) for their skillful assistance and excellent technical support. Linguistic refinements of the text by N. Kuhn are gratefully acknowledged. This work was supported by the German Ministry of Education and Research and the Brandenburg State [German Center for Diabetes Research (DZD) Grant 82DZD00302; to A.S.]. T.L. was supported by Grants LA 3042/3-1 and LA 3042/4-1 from the Deutsche Forschungsgemeinschaft (DFG). The authors declare no conflicts of interest.	Ahlstrom P, 2017, J MOL ENDOCRINOL, V59, P339, DOI 10.1530/JME-17-0096; Baumeier C, 2015, BBA-MOL CELL BIOL L, V1851, P566, DOI 10.1016/j.bbalip.2015.01.013; Brown-Borg HM, 2017, AGEING RES REV, V39, P87, DOI 10.1016/j.arr.2016.08.007; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Fontana L, 2016, CELL REP, V16, P520, DOI 10.1016/j.celrep.2016.05.092; Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K; Grant L, 2016, MECH AGEING DEV, V157, P35, DOI 10.1016/j.mad.2016.07.003; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Hill CM, 2018, FRONT NEUROENDOCRIN, V51, P125, DOI 10.1016/j.yfrne.2018.06.002; Hill CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07498-w; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Kharitonenkov A, 2017, J INTERN MED, V281, P233, DOI 10.1111/joim.12580; Kitada M, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0255-1; Kochlik B, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201701062; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Laeger T, 2018, DIABETOLOGIA, V61, P1459, DOI 10.1007/s00125-018-4595-1; Laeger T, 2017, DIABETOLOGIA, V60, P2274, DOI 10.1007/s00125-017-4389-x; Laeger T, 2016, CELL REP, V16, P707, DOI 10.1016/j.celrep.2016.06.044; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Laeger T, 2014, AM J PHYSIOL-REG I, V307, pR310, DOI 10.1152/ajpregu.00116.2014; Lees EK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10381-3; Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu Y, 2014, BEST PRACT RES CL EN, V28, P33, DOI 10.1016/j.beem.2013.08.003; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lopez-Torres M, 2008, BBA-GEN SUBJECTS, V1780, P1337, DOI 10.1016/j.bbagen.2008.01.007; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McCarty MF, 2009, MED HYPOTHESES, V72, P125, DOI 10.1016/j.mehy.2008.07.044; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; NURJHAN N, 1992, J CLIN INVEST, V89, P169, DOI 10.1172/JCI115558; ORENTREICH N, 1993, J NUTR, V123, P269; PUHAKAINEN I, 1992, J CLIN ENDOCR METAB, V75, P789, DOI 10.1210/jc.75.3.789; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Rodiger M, 2018, MOL METAB, V8, P167, DOI 10.1016/j.molmet.2017.11.011; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Schmidt JA, 2016, EUR J CLIN NUTR, V70, P306, DOI 10.1038/ejcn.2015.144; Singhal G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148252; Solon-Biet SM, 2016, CELL METAB, V24, P555, DOI 10.1016/j.cmet.2016.09.001; Sonksen P, 2000, BRIT J ANAESTH, V85, P69, DOI 10.1093/bja/85.1.69; Stone KP, 2015, OBESITY, V23, P1836, DOI 10.1002/oby.21177; Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464; VERONI MC, 1991, DIABETES, V40, P1480, DOI 10.2337/diabetes.40.11.1480; Wanders D, 2017, DIABETES, V66, P858, DOI 10.2337/db16-1212; Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; White PJ, 2016, MOL METAB, V5, P538, DOI 10.1016/j.molmet.2016.04.006; YOUNG VR, 1990, AM J CLIN NUTR, V51, P270, DOI 10.1093/ajcn/51.2.270; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	51	41	42	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7092	7102		10.1096/fj.201900150R	http://dx.doi.org/10.1096/fj.201900150R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30841758	Green Published, hybrid			2022-12-28	WOS:000476114200035
J	Kusuyama, J; Amir, MS; Albertson, BG; Bandow, K; Ohnishi, T; Nakamura, T; Noguchi, K; Shima, K; Semba, I; Matsuguchi, T				Kusuyama, Joji; Amir, Muhammad Subhan; Albertson, Brent G.; Bandow, Kenjiro; Ohnishi, Tomokazu; Nakamura, Toshiaki; Noguchi, Kazuyuki; Shima, Kaori; Semba, Ichiro; Matsuguchi, Tetsuya			JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopontin expression in osteoblasts through the induction of inhibitor of DNA binding 4 (Id4)	FASEB JOURNAL			English	Article						osteogenesis; osteocalcin; DUSP16; Gpha1; Esm1	MESENCHYMAL STEM; BONE SIALOPROTEIN; ACTIVATION; PROTEIN; OSTEOCALCIN; PHOSPHORYLATION; MINERALIZATION; PHOSPHATASE; METASTASIS; MECHANISMS	Osteoblasts are versatile cells involved in multiple whole-body processes, including bone formation and immune response. Secretory amounts and patterns of osteoblast-derived proteins such as osteopontin (OPN) and osteocalcin (OCN) modulate osteoblast function. However, the regulatory mechanism of OPN and OCN expression remains unknown. Here, we demonstrate that p54/p46 c-jun N-terminal kinase (JNK) inhibition suppresses matrix mineralization and OCN expression but increases OPN expression in MC3T3-E1 cells and primary osteoblasts treated with differentiation inducers, including ascorbic acid, bone morphogenic protein-2, or fibroblast growth factor 2. Preinhibition of JNK before the onset of differentiation increased the number of osteoblasts that highly express OPN but not OCN (OPN-OBs), indicating that JNK affects OPN secretory phenotype at the early stage of osteogenic differentiation. Additionally, we identified JNK2 isoform as being critically involved in OPN-OB differentiation. Microarray analysis revealed that OPN-OBs express characteristic transcription factors, cell surface markers, and cytokines, including glycoprotein hormone alpha 2 and endothelial cell-specific molecule 1. Moreover, we found that inhibitor of DNA binding 4 is an important regulator of OPN-OB differentiation and that dual-specificity phosphatase 16, a JNK-specific phosphatase, functions as an endogenous regulator of OPN-OB induction. OPN-OB phenotype was also observed following LPS from Porphyromonas gingivalis stimulation during osteogenic differentiation. Collectively, these results suggest that the JNK-Id4 signaling axis is crucial in the control of OPN and OCN expression during osteoblastic differentiation.-Kusuyama, J., Amir, M. S., Albertson, B. G., Bandow, K., Ohnishi, T., Nakamura, T., Noguchi, K., Shima, K., Semba, I., Matsuguchi, T. JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopontin expression in osteoblasts through the induction of inhibitor of DNA binding 4 (Id4).	[Kusuyama, Joji; Amir, Muhammad Subhan; Ohnishi, Tomokazu; Matsuguchi, Tetsuya] Kagoshima Univ, Grad Sch Med & Dent Sci, Field Dev Med, Dept Oral Biochem, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan; [Amir, Muhammad Subhan] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Kagoshima, Japan; [Nakamura, Toshiaki; Noguchi, Kazuyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Field Oral & Maxillofacial Rehabil, Kagoshima, Japan; [Shima, Kaori; Semba, Ichiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Field Oncol, Kagoshima, Japan; [Albertson, Brent G.] Harvard Med Sch, Dept Med, Sect Integrat Physiol & Metab, Joslin Diabet Ctr, Boston, MA 02115 USA; [Amir, Muhammad Subhan] Airlangga Univ, Fac Dent, Dept Oral & Maxillofacial Surg, Surabaya, Indonesia; [Bandow, Kenjiro] Meikai Univ, Dept Oral Biol & Tissue Engn, Sch Dent, Saitama, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Kagoshima University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Airlangga University; Meikai University	Matsuguchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Field Dev Med, Dept Oral Biochem, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	tmatsugu@dent.kagoshima-u.ac.jp	Amir, Muhammad Subhan/AAD-3006-2021; Matsuguchi, Tetsuya/HGU-0412-2022; Kusuyama, Joji/AAQ-7547-2020	Amir, Muhammad Subhan/0000-0002-0522-9758; Kusuyama, Joji/0000-0003-4054-1939; Bandow, Kenjiro/0000-0002-1362-3034; Semba, Ichiro/0000-0002-4588-2380	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Association for Oral Biology; Kanzawa Medical Research Foundation; Nakatomi Foundation; Japan Foundation for Aging and Health	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Association for Oral Biology; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Nakatomi Foundation; Japan Foundation for Aging and Health	The authors thank Yoko Amita and Yuka Kajiya (both from the Kagoshima University Graduate School of Medical and Dental Science) for secretarial assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japanese Association for Oral Biology Grant-in-Aid for Young Scientists, the Kanzawa Medical Research Foundation, the Nakatomi Foundation, and the Japan Foundation for Aging and Health. The authors declare no conflicts of interest.	Ahn HJ, 2009, FEBS LETT, V583, P2922, DOI 10.1016/j.febslet.2009.07.056; Asou Y, 2001, ENDOCRINOLOGY, V142, P1325, DOI 10.1210/en.142.3.1325; Bandow K, 2010, BIOCHEM BIOPH RES CO, V402, P755, DOI 10.1016/j.bbrc.2010.10.103; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0; Carlinfante G, 2003, CLIN EXP METASTAS, V20, P437, DOI 10.1023/A:1025419708343; Chellaiah MA, 2003, MOL BIOL CELL, V14, P173, DOI 10.1091/mbc.E02-06-0354; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Gaur T, 2009, J CELL PHYSIOL, V220, P174, DOI 10.1002/jcp.21747; Huang YF, 2012, J BONE MINER RES, V27, P1093, DOI 10.1002/jbmr.1548; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kanazawa I, 2015, WORLD J DIABETES, V6, P1345, DOI 10.4239/wjd.v6.i18.1345; Kanbur Nuray O, 2002, Int J Adolesc Med Health, V14, P235; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Kido J, 2001, J PERIODONTAL RES, V36, P328, DOI 10.1034/j.1600-0765.2001.360509.x; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kruger TE, 2014, CRIT REV ONCOL HEMAT, V89, P330, DOI 10.1016/j.critrevonc.2013.08.013; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Kusuyama J, 2017, BIOCHEM J, V474, P3421, DOI 10.1042/BCJ20170332; Kusuyama J, 2017, MOL BIOL CELL, V28, P1326, DOI 10.1091/mbc.E16-10-0716; Kusuyama J, 2014, J BIOL CHEM, V289, P10330, DOI 10.1074/jbc.M113.546382; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Matsuguchi T, 2001, MOL CELL BIOL, V21, P6999, DOI 10.1128/MCB.21.20.6999-7009.2001; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Mizokami A, 2017, BIOCHEM PHARMACOL, V132, P1, DOI 10.1016/j.bcp.2017.02.001; Musikacharoen T, 2003, J BIOL CHEM, V278, P9167, DOI 10.1074/jbc.M211829200; Musikacharoen T, 2011, J BIOL CHEM, V286, P24896, DOI 10.1074/jbc.M111.245019; Nakao J, 2014, BONE, V58, P17, DOI 10.1016/j.bone.2013.09.018; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Patel D, 2015, BBA-REV CANCER, V1855, P92, DOI 10.1016/j.bbcan.2014.12.002; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; RIECHMANN V, 1994, NUCLEIC ACIDS RES, V22, P749, DOI 10.1093/nar/22.5.749; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Sathi GA, 2009, ORAL ONCOL, V45, P856, DOI 10.1016/j.oraloncology.2009.02.001; Shah M, 2015, EUR CELLS MATER, V29, P155, DOI 10.22203/eCM.v029a12; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Suzuki D, 2012, CALCIFIED TISSUE INT, V91, P88, DOI 10.1007/s00223-012-9614-5; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tangseefa P, 2018, J CELL PHYSIOL, V233, P3769, DOI 10.1002/jcp.26163; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Terashima A, 2016, IMMUNITY, V44, P1434, DOI 10.1016/j.immuni.2016.05.012; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Xu R, 2017, J BONE MINER RES, V32, P1811, DOI 10.1002/jbmr.3184; Zhang Y, 2008, J CELL BIOCHEM, V105, P487, DOI 10.1002/jcb.21844	48	10	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7331	7347		10.1096/fj.201802465R	http://dx.doi.org/10.1096/fj.201802465R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30884976	Bronze			2022-12-28	WOS:000476114200054
J	Li, T; Shen, YF; Lin, FX; Fu, WY; Liu, SW; Wang, CQ; Liang, JZ; Fan, XY; Ye, XT; Tang, Y; Ding, M; Yang, YJ; Lei, CH; Hu, S				Li, Tian; Shen, Yafeng; Lin, Fangxing; Fu, Wenyan; Liu, Shuowu; Wang, Chuqi; Liang, Jizhou; Fan, Xiaoyan; Ye, Xuting; Tang, Ying; Ding, Min; Yang, Yongji; Lei, Changhai; Hu, Shi			Targeting RyR2 with a phosphorylation site-specific nanobody reverses dysfunction of failing cardiomyocytes in rats	FASEB JOURNAL			English	Article						gene therapy; heart failure; AAV; intracellular antibody	CHANNEL RYANODINE RECEPTOR; RETICULUM CA2+ LEAK; HEART-FAILURE; PKA PHOSPHORYLATION; GENE-THERAPY; SERINE 2808; RELEASE; HYPERPHOSPHORYLATION; CONSTRUCTION; LIBRARY	Chronic PKA phosphorylation of ryanodine receptor 2 (RyR2) has been shown to increase diastolic sarcoplasmic reticulum (SR) Ca2+ leakage and lead to cardiac dysfunction. We hypothesize that intracellular gene delivery of an RyR2-targeting phosphorylation site-specific nanobody could preserve the contractility of the failing myocardium. In the present study, we acquired RyR2-specific nanobodies from a phage display library that were variable domains of Camelidae heavy chain-only antibodies. One of the nanobodies, AR185, inhibited RyR2 phosphorylation in vitro and was chosen for further investigation. We investigated the potential of adeno-associated virus (AAV)9-mediated cardiac expression of AR185 to combat postischemic heart failure (HF). AAV gene delivery elevated the intracellular expression of the AR185 protein in a rat model of ischemic HF, and this treatment normalized the systolic and diastolic dysfunction of the failing myocardium in vivo by reversing myocardial Ca2+ handling. Furthermore, AR185 gene transfer to failing cardiomyocytes reduced the frequency of SR calcium leaks, thereby restoring the attenuated intracellular calcium transients and SR calcium load. Moreover, AR185 gene transfer inhibited the PKA-mediated phosphorylation of RyR2 in failing cardiomyocytes. Our results provide preclinical experimental evidence that the cardiac expression of RyR2 nanobodies with AAV9 vectors is a promising therapeutic strategy for HF.-Li, T., Shen, Y., Lin, F., Fu, W., Liu, S., Wang, C., Liang, J., Fan, X., Ye, X., Tang, Y., Ding, M., Yang, Y., Lei, C., Hu, S. Targeting RyR2 with a phosphorylation site-specific nanobody reverses dysfunction of failing cardiomyocytes in rats.	[Li, Tian; Shen, Yafeng; Lin, Fangxing; Fan, Xiaoyan; Ye, Xuting; Tang, Ying; Yang, Yongji; Lei, Changhai; Hu, Shi] Second Mil Med Univ, Coll Basic Med Sci, Dept Biophys, Shanghai, Peoples R China; [Li, Tian; Liu, Shuowu; Wang, Chuqi; Liang, Jizhou; Lei, Changhai; Hu, Shi] Second Mil Med Univ, Dept Biophys, Team SMMU China Int Genetically Engn Machine iGEM, Shanghai, Peoples R China; [Fu, Wenyan] Tongji Univ, Shanghai Matern & Infant Hosp 1, Dept Obstet & Gynecol, Sch Med, Shanghai, Peoples R China; [Ding, Min] Pharchoice Therapeut Inc, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Tongji University	Lei, CH; Hu, S (corresponding author), Second Mil Med Univ, Dept Biophys, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	lei@smmu.edu.cn; hus@smmu.edu.cn	Hu, Shi/ABF-4231-2020		National Natural Science Foundation of China [81773261, 81602690]; Shanghai Chenguang Program [17CG35]; Military Medicine Special Grant from the Second Military Medical University [2017JS01]; General Financial Grant from the China Postdoctoral Science Foundation [2016M593006]; Shanghai First Maternity and Infant Hospital [2018A01]; Second Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Chenguang Program; Military Medicine Special Grant from the Second Military Medical University; General Financial Grant from the China Postdoctoral Science Foundation; Shanghai First Maternity and Infant Hospital; Second Military Medical University	The authors thank Y. Bao and Z. Zou (Second Military Medical University) for generous help with the research. This study was financially supported by the National Natural Science Foundation of China (Grants 81773261 and 81602690), the Shanghai Chenguang Program (17CG35), a Military Medicine Special Grant from the Second Military Medical University (2017JS01), a General Financial Grant from the China Postdoctoral Science Foundation (2016M593006), Shanghai First Maternity and Infant Hospital (Grant 2018A01), and postdoctoral scientific research funds from Second Military Medical University. M.D. is employed by Pharchoice Therapeutics and is a shareholder in Pharchoice Therapeutics. The remaining authors declare no conflicts of interest.	Chen WW, 2016, EUR HEART J SUPPL, V18, pF2, DOI 10.1093/eurheartj/suw030; Chen WZ, 2008, J MOL BIOL, V382, P779, DOI 10.1016/j.jmb.2008.07.054; Cho GW, 2016, BBA-MOL BASIS DIS, V1862, P763, DOI 10.1016/j.bbadis.2016.01.011; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Goehringer C, 2009, CARDIOVASC RES, V82, P404, DOI 10.1093/cvr/cvp061; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Ho Mitchell, 2009, V525, P293, DOI 10.1007/978-1-59745-554-1_15; Houser SR, 2014, CIRC RES, V114, P1320, DOI 10.1161/CIRCRESAHA.114.300569; Hu ST, 2016, PHYSIOL RES, V65, P43, DOI 10.33549/physiolres.933052; Hu S, 2016, CANCER LETT, V382, P32, DOI 10.1016/j.canlet.2016.08.022; Hulot JS, 2016, EUR HEART J, V37, P1651, DOI 10.1093/eurheartj/ehw019; Khodabakhsh F, 2018, INT REV IMMUNOL, V37, P316, DOI 10.1080/08830185.2018.1526932; Li T, 2018, J DRUG TARGET, V26, P895, DOI 10.1080/1061186X.2018.1450412; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mika D, 2015, P NATL ACAD SCI USA, V112, P2023, DOI 10.1073/pnas.1419992112; Munkvik M, 2010, MED SCI SPORT EXER, V42, P847, DOI 10.1249/MSS.0b013e3181c29ec1; Paulino EC, 2010, HYPERTENSION, V56, P629, DOI 10.1161/HYPERTENSIONAHA.110.156141; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Peyvandi F, 2017, J THROMB HAEMOST, V15, P1448, DOI 10.1111/jth.13716; Pleger ST, 2005, MOL THER, V12, P1120, DOI 10.1016/j.ymthe.2005.08.002; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Roussel J, 2015, BBA-MOL BASIS DIS, V1852, P749, DOI 10.1016/j.bbadis.2015.01.011; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Steeland S, 2016, DRUG DISCOV TODAY, V21, P1076, DOI 10.1016/j.drudis.2016.04.003; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Veldwijk MR, 2002, MOL THER, V6, P272, DOI 10.1006/mthe.2002.0569; Vincke Cecile, 2012, Methods Mol Biol, V907, P145, DOI 10.1007/978-1-61779-974-7_8; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yancy CW, 2016, J AM COLL CARDIOL, V68, P1495, DOI 10.1016/j.jacc.2016.08.013; Zhang HY, 2012, CIRC RES, V110, P831, DOI 10.1161/CIRCRESAHA.111.255158; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	37	4	4	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7467	7478		10.1096/fj.201802354R	http://dx.doi.org/10.1096/fj.201802354R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30885011	Bronze, Green Submitted			2022-12-28	WOS:000476114200064
J	Pickard, A; Chang, J; Alachkar, N; Calverley, B; Garva, R; Arvan, P; Meng, QJ; Kadler, KE				Pickard, Adam; Chang, Joan; Alachkar, Nissrin; Calverley, Ben; Garva, Richa; Arvan, Peter; Meng, Qing-Jun; Kadler, Karl E.			Preservation of circadian rhythms by the protein folding chaperone, BiP	FASEB JOURNAL			English	Article						4PBA; collagen; ER stress; Per2; luc; UDCA	ENDOPLASMIC-RETICULUM STRESS; COLLAGEN-I; ER STRESS; CLOCK; MOUSE; PROLIFERATION; DEXAMETHASONE; EXPRESSION; SECRETION; REVEALS	Dysregulation of collagen synthesis is associated with disease progression in cancer and fibrosis. Collagen synthesis is coordinated with the circadian clock, which in cancer cells is, curiously, deregulated by endoplasmic reticulum (ER) stress. We hypothesized interplay between circadian rhythm, collagen synthesis, and ER stress in normal cells. Here we show that fibroblasts with ER stress lack circadian rhythms in gene expression upon clock-synchronizing time cues. Overexpression of binding immunoglobulin protein (BiP) or treatment with chemical chaperones strengthens the oscillation amplitude of circadian rhythms. The significance of these findings was explored in tendon, where we showed that BiP expression is ramped preemptively prior to a surge in collagen synthesis at night, thereby preventing protein misfolding and ER stress. In turn, this forestalls activation of the unfolded protein response in order for circadian rhythms to be maintained. Thus, targeting ER stress could be used to modulate circadian rhythm and restore collagen homeostasis in disease.-Pickard, A., Chang, J., Alachkar, N., Calverley, B., Garva, R., Arvan, P., Meng, Q.-J., Kadler, K. E. Preservation of circadian rhythms by the protein folding chaperone, BiP.	[Pickard, Adam; Chang, Joan; Alachkar, Nissrin; Calverley, Ben; Garva, Richa; Meng, Qing-Jun; Kadler, Karl E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Alachkar, Nissrin; Calverley, Ben] Univ Manchester, Fac Sci & Engn, Sch Math, Manchester, Lancs, England; [Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA	University of Manchester; University of Manchester; University of Michigan System; University of Michigan	Pickard, A; Kadler, KE (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	adam.pickard@manchester.ac.uk; karl.kadler@manchester.ac.uk	KADLER, KARL/ABI-2403-2020; Chang, Joan/AAO-8732-2020	KADLER, KARL/0000-0003-4977-4683; Chang, Joan/0000-0002-7283-9759; GARVA, RICHA/0000-0001-7752-8936; Meng, Qing Jun/0000-0002-9426-8336	Wellcome Trust Investigator and Wellcome Centre Core Awards [110126/Z/15/Z, 203128/Z/16/Z]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK40344]; Wellcome 4-yr Ph.D. Studentship [210062/Z/17/Z]; University of Manchester Strategic Fund; MRC [G0900414, MR/L011840/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Wellcome Trust Investigator and Wellcome Centre Core Awards; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome 4-yr Ph.D. Studentship; University of Manchester Strategic Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank P.A. and Raymond Boot-Handford (University of Michigan, Ann Arbor, MI, USA and University of Manchester, Manchester, United Kingdom, respectively) for congenital goiter-mutant thyroglobulin expression vectors. This research was funded by Wellcome Trust Investigator and Wellcome Centre Core Awards to K.E.K. (110126/Z/15/Z and 203128/Z/16/Z). P.A. was funded by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK40344. B.C. is funded by a Wellcome 4-yr Ph.D. Studentship (210062/Z/17/Z). Light microscopes in the Bioimaging Facility were additionally supported by the University of Manchester Strategic Fund. The authors declare no conflicts of interest.	Alvarez MB, 2012, J CELL PHYSIOL, V227, P1873, DOI 10.1002/jcp.22915; Barnett CP, 2011, EUR J HUM GENET, V19, P624, DOI 10.1038/ejhg.2010.259; Bek MF, 2006, AM J PATHOL, V168, P20, DOI 10.2353/ajpath.2006.040774; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brenner RE, 2001, PEDIATR PULM, V32, P1, DOI 10.1002/ppul.1081; Bu YW, 2018, NAT CELL BIOL, V20, P104, DOI 10.1038/s41556-017-0006-y; Cancino J, 2014, DEV CELL, V30, P280, DOI 10.1016/j.devcel.2014.06.018; Cortez L, 2014, PRION, V8, P197, DOI 10.4161/pri.28938; DiChiara AS, 2016, ACS CHEM BIOL, V11, P1408, DOI 10.1021/acschembio.5b01083; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Hwang J, 2017, ACS NANO, V11, P9825, DOI 10.1021/acsnano.7b03150; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Janich P, 2015, GENOME RES, V25, P1848, DOI 10.1101/gr.195404.115; Kadler KE, 1996, BIOCHEM J, V316, P1; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Koo JH, 2016, GASTROENTEROLOGY, V150, P181, DOI 10.1053/j.gastro.2015.09.039; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Maillo C, 2017, NAT CELL BIOL, V19, P94, DOI 10.1038/ncb3461; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Markan S, 2009, MOL CELL BIOCHEM, V324, P131, DOI 10.1007/s11010-008-9991-2; Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pickard A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004988; Pickard A, 2012, J INVEST DERMATOL, V132, P2691, DOI 10.1038/jid.2012.201; Pratt ZL, 2012, J VIROL, V86, P4380, DOI 10.1128/JVI.06966-11; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Shim SM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan0630; Svensson RB, 2017, ACTA BIOMATER, V50, P293, DOI 10.1016/j.actbio.2017.01.006; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yeung C.-Y. C., 2018, 304014 BIORXIV, DOI 10.1101/304014v2; Yeung CYC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13555; Yeung CYC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05183; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	42	15	15	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7479	7489		10.1096/fj.201802366RR	http://dx.doi.org/10.1096/fj.201802366RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30888851	hybrid, Green Published			2022-12-28	WOS:000476114200065
J	Hernandez, S; Fried, DE; Grubisic, V; McClain, JL; Gulbransen, BD				Hernandez, Siomara; Fried, David E.; Grubisic, Vladimir; McClain, Jonathon L.; Gulbransen, Brian D.			Gastrointestinal neuroimmune disruption in a mouse model of Gulf War illness	FASEB JOURNAL			English	Article						pyridostigmine bromide; cholinergic signaling; enteric nervous system	NICOTINIC ACETYLCHOLINE-RECEPTOR; ENTERIC NERVOUS-SYSTEM; CELL-PROLIFERATION; HEALTH-STATUS; VAGUS NERVE; VETERANS; GLIA; MOTILITY; NEURONS; ACTIVATION	Gulf War illness (GWI) is a chronic multisymptom disorder that is prominent in Gulf War veterans. Major unexplained symptoms of GWI include functional gastrointestinal disorders and undiagnosed illnesses, including neurologic disorders. Exposure to the antinerve gas drug pyridostigmine bromide (PB) is linked to the development of GWI, but the exact mechanisms remain unclear. Here, we tested the hypothesis that PB alters gut function by disrupting the neural and immune systems of the intestine. We exposed male and female mice to physiologically comparable amounts of PB that match the dose, route, and time frame of exposure experienced by Gulf War veterans and assessed the acute and chronic impacts on gastrointestinal functions, the functional architecture of the enteric nervous system, and immune responses in the gut and brain. Exposure to PB drove acute alterations to colonic motility and structure in both male and female mice that transitioned to chronic changes in gut functions. PB drove acute alterations to enteric neural and glial activity, glial reactivity, and neuron survival with glial reactivity persisting into the chronic phase in male mice. Despite having no effect on colonic permeability, exposure to PB caused major shifts in the expression of proinflammatory cytokines and chemokines in the colon and brain that suggest immunosuppressive effects. Interestingly, immune disruption was still evident in the colon and brain in female animals at 1 mo following exposure to PB. Together, our results show that the paradigm of PB exposure experienced by veterans of the Persian Gulf War contributes to long-lasting pathophysiology by driving enteric neuroinflammation, promoting immunosuppression, and altering functional anatomy of the colon in a sex-dependent manner.Hernandez, S., Fried, D. E., Grubii, V., McClain, J. L., Gulbransen, B. D. Gastrointestinal neuroimmune disruption in a mouse model of Gulf War illness.	[Hernandez, Siomara; Fried, David E.; Grubisic, Vladimir; McClain, Jonathon L.; Gulbransen, Brian D.] Michigan State Univ, Dept Physiol, 567 Wilson Rd, E Lansing, MI 48824 USA; [Gulbransen, Brian D.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Gulbransen, BD (corresponding author), Michigan State Univ, Dept Physiol, 567 Wilson Rd, E Lansing, MI 48824 USA.	gulbrans@msu.edu		Grubisic, Vladimir/0000-0003-1429-2844	Department of Defense-Congressionally Directed Medical Research Programs (DOD - CDMRP) [W81XWH1610631]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK103723]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103723] Funding Source: NIH RePORTER	Department of Defense-Congressionally Directed Medical Research Programs (DOD - CDMRP); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by grants from the Department of Defense-Congressionally Directed Medical Research Programs (DOD - CDMRP; W81XWH1610631, to B.D.G.) and the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (R01DK103723, to B.D.G.). The authors declare no conflicts of interest.	Alhasson F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172914; Baez-Pagan CA, 2015, J NEUROIMMUNE PHARM, V10, P468, DOI 10.1007/s11481-015-9601-5; Belkind-Gerson J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02890-y; Berthoud TK, 2009, J IMMUNOL METHODS, V340, P33, DOI 10.1016/j.jim.2008.09.021; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bradley JS, 1997, CELL TISSUE RES, V289, P455, DOI 10.1007/s004410050891; Brierley SM, 2014, NAT REV GASTRO HEPAT, V11, P611, DOI 10.1038/nrgastro.2014.103; Brown IAM, 2016, CELL MOL GASTROENTER, V2, P77, DOI 10.1016/j.jcmgh.2015.08.007; Browning KN, 2017, GASTROENTEROLOGY, V152, P730, DOI 10.1053/j.gastro.2016.10.046; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Camp AJ, 2009, INT J BIOCHEM CELL B, V41, P2118, DOI 10.1016/j.biocel.2009.05.007; Chiari A, 1999, ANESTHESIOLOGY, V91, P1447, DOI 10.1097/00000542-199911000-00038; Costantini TW, 2012, AM J PATHOL, V181, P478, DOI 10.1016/j.ajpath.2012.04.005; Coughlin S.S., 2017, J ENV HLTH SCI, V3; Coughlin SS, 2013, J MIL VETERANS HEALT, V21, P4; De Giorgio R, 2016, ADV EXP MED BIOL, V891, P123, DOI 10.1007/978-3-319-27592-5_12; Degen LP, 1996, GUT, V39, P299, DOI 10.1136/gut.39.2.299; Delvalle NM, 2018, AM J PHYSIOL-GASTR L, V315, pG473, DOI 10.1152/ajpgi.00155.2018; Dunphy RC, 2003, PAIN, V102, P79, DOI 10.1016/S0304-3959(02)00342-1; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; France M, 2012, NEUROGASTROENT MOTIL, V24, pe450, DOI 10.1111/j.1365-2982.2012.01981.x; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Fried DE, 2017, AM J PHYSIOL-GASTR L, V313, pG570, DOI 10.1152/ajpgi.00154.2017; Fujii T, 2017, J PHARMACOL SCI, V134, P1, DOI 10.1016/j.jphs.2017.05.002; Fulco C. E., 2000, GULF WAR HLTH, V1; Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; GABELLA G, 1984, J NEUROCYTOL, V13, P73, DOI 10.1007/BF01148319; GIOIA A, 1958, BRIT J PHARM CHEMOTH, V13, P467, DOI 10.1111/j.1476-5381.1958.tb00239.x; Golomb BA, 2008, P NATL ACAD SCI USA, V105, P4295, DOI 10.1073/pnas.0711986105; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Goverse G, 2016, J PHYSIOL-LONDON, V594, P5771, DOI 10.1113/JP271537; Graves J. C., 2008, GULF WAR ILLNESS HLT; Grubisic V, 2017, J PHYSIOL-LONDON, V595, P3409, DOI 10.1113/JP273492; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; HEATON KW, 1992, GUT, V33, P818, DOI 10.1136/gut.33.6.818; JOINER PD, 1973, J PHARMACOL EXP THER, V186, P552; Kosmidis C, 2018, J CANCER, V9, P232, DOI 10.7150/jca.22962; Lalo U, 2004, BRIT J PHARMACOL, V142, P1227, DOI 10.1038/sj.bjp.0705878; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; LOEWENSTEINLICHTENSTEIN Y, 1995, NAT MED, V1, P1082, DOI 10.1038/nm1095-1082; Matos JF, 2016, WORLD J GASTROENTERO, V22, P5761, DOI 10.3748/wjg.v22.i25.5761; McClain JL, 2015, CELL MOL GASTROENTER, V1, P631, DOI 10.1016/j.jcmgh.2015.08.004; McClain JL, 2014, GASTROENTEROLOGY, V146, P497, DOI 10.1053/j.gastro.2013.10.061; MCCONALOGUE K, 1994, BAILLIERE CLIN ENDOC, V8, P51, DOI 10.1016/S0950-351X(05)80226-5; Michaelson MD, 1996, DEV BIOL, V179, P251, DOI 10.1006/dbio.1996.0255; Morris KT, 2014, BRIT J CANCER, V110, P1211, DOI 10.1038/bjc.2013.822; Murphy FM, 1999, MIL MED, V164, P327, DOI 10.1093/milmed/164.5.327; Nasser Y, 2006, AM J PHYSIOL-GASTR L, V291, pG912, DOI 10.1152/ajpgi.00067.2006; National Cancer Institute-NIH, 2018, INT 2; Nouri-Shirazi M, 2007, IMMUNOL LETT, V109, P155, DOI 10.1016/j.imlet.2007.02.005; O'Grady NP, 1999, J INFECT DIS, V179, P136, DOI 10.1086/314559; Ogden Cynthia L, 2004, Adv Data, P1; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Razani-Boroujerdi S, 2008, J NEUROIMMUNOL, V194, P83, DOI 10.1016/j.jneuroim.2007.11.019; Rosenblum JM, 2010, J IMMUNOL, V184, P3450, DOI 10.4049/jimmunol.0903831; Schumm WR, 2002, PSYCHOL REP, V90, P707, DOI 10.2466/PR0.90.3.707-721; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Soderholm JD, 2002, AM J PHYSIOL-GASTR L, V283, pG1257, DOI 10.1152/ajpgi.00314.2002; Sostek MB, 1996, AM J GASTROENTEROL, V91, P2494; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Thacker M, 2011, NEUROGASTROENT MOTIL, V23, pE500, DOI 10.1111/j.1365-2982.2011.01696.x; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; von Boyen GBT, 2004, GUT, V53, P222, DOI 10.1136/gut.2003.012625; Wang DW, 2009, CHIN J TRAUMATOL, V12, P355, DOI 10.3760/cma.j.issn.1008-1275.2009.06.007; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang L, 2007, AM J PHYSIOL-GASTR L, V292, pG419, DOI 10.1152/ajpgi.00289.2006; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Wolfe J, 2002, J OCCUP ENVIRON MED, V44, P271, DOI 10.1097/00043764-200203000-00015; Zdanowski R, 2015, CENT EUR J IMMUNOL, V40, P373, DOI 10.5114/ceji.2015.54602; Zhou QQ, 2018, CLIN J PAIN, V34, P944, DOI 10.1097/AJP.0000000000000611	76	17	18	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6168	6184		10.1096/fj.201802572R	http://dx.doi.org/10.1096/fj.201802572R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30789759	Green Published, Bronze			2022-12-28	WOS:000466932600030
J	Peng, W; Tong, C; Li, L; Huang, CY; Ran, YX; Chen, XH; Bai, YX; Liu, YM; Zhao, JL; Tan, B; Luo, XF; Wang, H; Wen, L; Zhang, C; Zhang, H; Ding, YB; Qi, HB; Baker, PN				Peng, Wei; Tong, Chao; Li, Lei; Huang, Chengyu; Ran, Yuxin; Chen, Xuehai; Bai, Yuxiang; Liu, Yamin; Zhao, Jianlin; Tan, Bin; Luo, Xiaofang; Wang, Hao; Wen, Li; Zhang, Chen; Zhang, Hua; Ding, Yubin; Qi, Hongbo; Baker, Philip N.			Trophoblastic proliferation and invasion regulated by ACTN4 is impaired in early onset preeclampsia	FASEB JOURNAL			English	Article						migration; AKT; podosome; placenta	ALPHA-ACTININ; BINDING-PROTEINS; SCREEN REVEALS; BETA-CATENIN; ALPHA-ACTININ-4; ACTIVATION; MOTILITY; COMPLEX; DIFFERENTIATION; CYTOSKELETON	Successful pregnancy requires normal placentation, which largely depends on the tight regulation of proliferation, invasion, and migration of trophoblast cells. Abnormal functioning of trophoblast cells may cause failure of uterine spiral artery remodeling, which may be related to pregnancy-related disorders, such as preeclampsia. Here, we reported that an actin-binding protein, -actinin (ACTN)4, was dysregulated in placentas from early onset preeclampsia. Moreover, knockdown of ACTN4 markedly inhibited trophoblast cell proliferation by reducing AKT membrane translocation. Furthermore, E-cadherin regulated ACTN4 and -catenin colocalization on trophoblast cell podosomes, and ACTN4 down-regulation suppressed the E-cadherin-induced cell invasion increase via depolymerizing actin filaments. Moreover, loss of ACTN4 recapitulated a number of the features of human preeclampsia. Therefore, our data indicate that ACNT4 plays a role in trophoblast function and is required for normal placental development.Peng, W., Tong, C., Li, L., Huang, C., Ran, Y., Chen, X., Bai, Y., Liu, Y., Zhao, J., Tan, B., Luo, X., Wang, H., Wen, L., Zhang, C., Zhang, H., Ding, Y., Qi, H., Baker, P. N. Trophoblastic proliferation and invasion regulated by ACTN4 is impaired in early onset preeclampsia.	[Peng, Wei; Tong, Chao; Li, Lei; Ran, Yuxin; Chen, Xuehai; Bai, Yuxiang; Liu, Yamin; Zhao, Jianlin; Tan, Bin; Luo, Xiaofang; Wang, Hao; Wen, Li; Zhang, Chen; Zhang, Hua; Qi, Hongbo] Chongqing Med Univ, Dept Obstet, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Peng, Wei; Tong, Chao; Li, Lei; Ran, Yuxin; Chen, Xuehai; Bai, Yuxiang; Liu, Yamin; Zhao, Jianlin; Tan, Bin; Luo, Xiaofang; Wang, Hao; Wen, Li; Zhang, Chen; Zhang, Hua; Qi, Hongbo; Baker, Philip N.] Chongqing Med Univ, State Key Lab Maternal & Fetal Med Chongqing Muni, Chongqing, Peoples R China; [Peng, Wei; Tong, Chao; Li, Lei; Ran, Yuxin; Chen, Xuehai; Bai, Yuxiang; Liu, Yamin; Zhao, Jianlin; Tan, Bin; Luo, Xiaofang; Wang, Hao; Wen, Li; Zhang, Chen; Zhang, Hua; Qi, Hongbo; Baker, Philip N.] Chongqing Med Univ, Int Collaborat Lab Reprod & Dev, Chinese Minist Educ, Chongqing, Peoples R China; [Huang, Chengyu; Ding, Yubin] Chongqing Med Univ, Sch Publ Hlth & Management, Lab Reprod Biol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China; [Li, Lei] Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China; [Baker, Philip N.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Leicester	Qi, HB (corresponding author), Chongqing Med Univ, Dept Obstet, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China.; Ding, YB (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Lab Reprod Biol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	dingyb@gmail.com; qihongbock@163.com	Qi, Hongbo/AAJ-5536-2020; Tong, Chao/AAM-2225-2020	Tong, Chao/0000-0003-0828-2674; Ding, Yubin/0000-0002-7870-9445	National Key Research and Development Program of Reproductive Health and Major Birth Defects Control and Prevention [2018YFC1004103, 2016YFC1000407]; National Natural Science Foundation of China [81520108013, 81771613, 81671488, 81871189, 81801482, 81601305, 81601304]; Chongqing Municipal Education Commission [CXTDX201601014]; Science and Technology Commission of Chongqing [cstc2017jcyjBX0045]; Chongqing Entrepreneurship and Innovation Supporting Program [cx2017104]; 111 Plan of the Ministry of Education of the People's Republic of China; State Administration of Foreign Experts Affairs of China	National Key Research and Development Program of Reproductive Health and Major Birth Defects Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Municipal Education Commission; Science and Technology Commission of Chongqing; Chongqing Entrepreneurship and Innovation Supporting Program; 111 Plan of the Ministry of Education of the People's Republic of China; State Administration of Foreign Experts Affairs of China	The authors thank Xue and Junwei Gu (both from the School of Public Health and Management, Chongqing Medical University) for technical assistance of animal study and primary cytotrophoblast isolation. This work was supported by the National Key Research and Development Program of Reproductive Health and Major Birth Defects Control and Prevention (2018YFC1004103, 2016YFC1000407), the National Natural Science Foundation of China (81520108013, 81771613, 81671488, 81871189, 81801482, 81601305, 81601304), Chongqing Municipal Education Commission (CXTDX201601014), Science and Technology Commission of Chongqing (cstc2017jcyjBX0045), and Chongqing Entrepreneurship and Innovation Supporting Program for Returned Overseas Students (cx2017104). The authors also appreciate the support from the 111 Plan of the Ministry of Education of the People's Republic of China and the State Administration of Foreign Experts Affairs of China.	An HT, 2016, ONCOGENE, V35, P5893, DOI 10.1038/onc.2016.117; Araki N, 2000, J CELL SCI, V113, P3329; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Beards F, 2017, THERANOSTICS, V7, P2940, DOI 10.7150/thno.18845; Berania I, 2017, INT J CANCER, V141, P2318, DOI 10.1002/ijc.30915; Berkane N, 2017, ENDOCR REV, V38, P123, DOI 10.1210/er.2016-1065; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Bridger PS, 2008, BIOL REPROD, V79, P274, DOI 10.1095/biolreprod.108.067637; Burke SD, 2016, J CLIN INVEST, V126, P2561, DOI 10.1172/JCI83918; Burton GJ, 2014, PLACENTA, V35, P289, DOI 10.1016/j.placenta.2014.02.007; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Collin GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037925; Corso J, 2016, P NATL ACAD SCI USA, V113, P5688, DOI 10.1073/pnas.1601053113; Cureton N, 2017, THERANOSTICS, V7, P3715, DOI 10.7150/thno.19678; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Fayyad AM, 2005, EARLY HUM DEV, V81, P865, DOI 10.1016/j.earlhumdev.2005.09.005; Fu L, 2017, P NATL ACAD SCI USA, V114, pE4631, DOI 10.1073/pnas.1703178114; Hamill KJ, 2013, FASEB J, V27, P546, DOI 10.1096/fj.12-217406; Hara T, 2007, MOL CELL PROTEOMICS, V6, P479, DOI 10.1074/mcp.M600129-MCP200; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; James JL, 2010, J PATHOL, V221, P363, DOI 10.1002/path.2719; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Karumanchi SA, 2006, METH MOLEC MED, V122, P393; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kong SB, 2018, GENESIS, V56, DOI 10.1002/dvg.23101; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Liao Q, 2017, BRIT J CANCER, V117, P563, DOI 10.1038/bjc.2017.193; Magdolen U, 2004, BIOL CHEM, V385, P801, DOI 10.1515/BC.2004.105; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Murphy DJ, 2000, HYPERTENS PREGNANCY, V19, P221, DOI 10.1081/PRG-100100138; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Patel A, 2012, EUR J CELL BIOL, V91, P171, DOI 10.1016/j.ejcb.2011.11.006; Plaks V, 2013, P NATL ACAD SCI USA, V110, P11109, DOI 10.1073/pnas.1309561110; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; Silva-Ayala D, 2013, P NATL ACAD SCI USA, V110, P10270, DOI 10.1073/pnas.1304932110; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Sun Y, 2016, MOL BIOL CELL, V27, P75, DOI 10.1091/mbc.E15-05-0319; Thomas DG, 2017, SEMIN CELL DEV BIOL, V71, P68, DOI 10.1016/j.semcdb.2017.05.024; Tobita T, 2017, PLACENTA, V59, pS37, DOI 10.1016/j.placenta.2017.09.012; Wang N, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0635-9; Wang Q, 2018, J CERAM SCI TECHNOL, V9, P1, DOI 10.4416/JCST2017-00044; Yung HW, 2014, J PATHOL, V234, P262, DOI 10.1002/path.4394; Zhang BZ, 2018, THERANOSTICS, V8, P2765, DOI 10.7150/thno.22904; Zhang YY, 2018, ONCOGENE, V37, P4033, DOI 10.1038/s41388-018-0260-x; Zhou CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029236	57	9	9	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6327	6338		10.1096/fj.201802058RR	http://dx.doi.org/10.1096/fj.201802058RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30776251	Green Submitted, Bronze			2022-12-28	WOS:000466932600041
J	Zhao, LX; Ge, YH; Li, JB; Xiong, CH; Law, PY; Xu, JR; Qiu, Y; Chen, HZ				Zhao, Lan-Xue; Ge, Yan-Hui; Li, Jia-Bing; Xiong, Cai-Hong; Law, Ping-Yee; Xu, Jian-Rong; Qiu, Yu; Chen, Hong-Zhuan			M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP-PKA and PI3K-Akt	FASEB JOURNAL			English	Article						mTOR; signal transduction; GluA1 Ser845; GluA1 trafficking	LONG-TERM POTENTIATION; ACETYLCHOLINE-RECEPTOR; IN-VIVO; ACTIVATION; KINASE; MTOR; TRAFFICKING; MATURATION; INTERNALIZATION; MODULATION	M1 muscarinic acetylcholine receptors are highly expressed in key areas that control cognition, such as the cortex and hippocampus, representing one potential therapeutic target for cognitive dysfunctions of Alzheimer's disease and schizophrenia. We have reported that M1 receptors facilitate cognition by promoting membrane insertion of -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor AMPA receptor subunit 1 (GluA1) through phosphorylation at Ser845. However, the signaling pathway is still unclear. Here we showed that adenylyl cyclase inhibitor 2',5'-dideoxyadenosine and PKA inhibitor KT5720 inhibited enhancement of phosphorylation of Ser845 and membrane insertion of GluA1 induced by M1 receptor activation. Furthermore, PI3K inhibitor LY294002 and protein kinase B (Akt) inhibitor IV blocked the effects of M1 receptors as well. Remarkably, the increase of the activity of PI3K-Akt signaling induced by M1 receptor activation could be abolished by cAMP-PKA inhibitors. Moreover, inhibiting the mammalian target of rapamycin (mTOR) complex 1, an important downstream effector of PI3K-Akt, by short-term application of rapamycin attenuated the effects of M1 receptors on GluA1. Furthermore, such effect was unrelated to possible protein synthesis promoted by mTOR. Taken together, these data demonstrate that M1 receptor activation induces membrane insertion of GluA1 via a signaling linking cAMP-PKA and PI3K-Akt-mTOR pathways but is irrelevant to protein synthesis.Zhao, L.-X., Ge, Y.-H., Li, J.-B., Xiong, C.-H., Law, P.-Y., Xu, J.-R., Qiu, Y., Chen, H.-Z. M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP-PKA and PI3K-Akt.	[Zhao, Lan-Xue; Ge, Yan-Hui; Li, Jia-Bing; Xiong, Cai-Hong; Xu, Jian-Rong; Qiu, Yu] Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA; [Chen, Hong-Zhuan] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, 1200 Cailun Rd, Shanghai 201210, Peoples R China	Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities; Shanghai University of Traditional Chinese Medicine	Qiu, Y (corresponding author), Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.; Chen, HZ (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, 1200 Cailun Rd, Shanghai 201210, Peoples R China.	qiuy@shsmu.edu.cn; yaoli@shsmu.edu.cn		Qiu, Yu/0000-0002-1236-1941	National Natural Science Foundation of China [81473217, 81573415, 81872841, 81872840]; Shanghai Jiao Tong University Medical-Engineering Cross Fund [YG2017ZD14]; General Financial Grant from the China Postdoctoral Science Foundation [2016M601619]; International Science and Technology Cooperation Program of China [2011DFA33180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University Medical-Engineering Cross Fund; General Financial Grant from the China Postdoctoral Science Foundation; International Science and Technology Cooperation Program of China	The authors thank Ying-Hui Yan (Children's Hospital of Soochow University, Jiangsu, Suzhou, China) for scientific suggestions. This work was supported by the National Natural Science Foundation of China (81473217, 81573415, 81872841, 81872840), Shanghai Jiao Tong University Medical-Engineering Cross Fund (YG2017ZD14), the General Financial Grant from the China Postdoctoral Science Foundation (2016M601619), and the International Science and Technology Cooperation Program of China (2011DFA33180). The authors declare no conflicts of interest.	Arendt KL, 2010, NAT NEUROSCI, V13, P36, DOI 10.1038/nn.2462; Bassani S, 2013, CELL MOL LIFE SCI, V70, P4411, DOI 10.1007/s00018-013-1309-1; Blancquaert S, 2010, MOL ENDOCRINOL, V24, P1453, DOI 10.1210/me.2010-0087; Borroto-Escuela DO, 2018, PHARMACOL REP, V70, P936, DOI 10.1016/j.pharep.2018.04.002; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Bymaster FP, 2003, EUR J NEUROSCI, V17, P1403, DOI 10.1046/j.1460-9568.2003.02588.x; Carruthers SP, 2015, NEUROSCI BIOBEHAV R, V55, P393, DOI 10.1016/j.neubiorev.2015.05.011; Chen Y, 2017, NEURON, V96, P1070, DOI 10.1016/j.neuron.2017.10.023; Ciullo I, 2001, ONCOGENE, V20, P1186, DOI 10.1038/sj.onc.1204219; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; de Joussineau C, 2014, HUM MOL GENET, V23, P5418, DOI 10.1093/hmg/ddu265; Deng H, 2010, AM J RESP CELL MOL, V42, P744, DOI 10.1165/rcmb.2009-0037OC; Dennis SH, 2016, CEREB CORTEX, V26, P414, DOI 10.1093/cercor/bhv227; Dickinson BA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-18; Digby GJ, 2012, J NEUROSCI, V32, P8532, DOI 10.1523/JNEUROSCI.0337-12.2012; Dong JY, 2018, J AFFECT DISORDERS, V227, P633, DOI 10.1016/j.jad.2017.11.041; Felder CC, 2018, NEUROPHARMACOLOGY, V136, P449, DOI 10.1016/j.neuropharm.2018.01.028; de Sevilla DF, 2010, J NEUROSCI, V30, P11032, DOI 10.1523/JNEUROSCI.1848-10.2010; Ghoshal A, 2016, NEUROPSYCHOPHARMACOL, V41, P598, DOI 10.1038/npp.2015.189; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Gururajan A, 2014, J NEUROCHEM, V129, P377, DOI 10.1111/jnc.12622; Halayko AJ, 2004, AM J RESP CELL MOL, V31, P266, DOI 10.1165/rcmb.2003-0272OC; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Hell JW, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7067; Henley Jeremy M, 2013, Dialogues Clin Neurosci, V15, P11; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Jahromi LP, 2018, MED HYPOTHESES, V110, P120, DOI 10.1016/j.mehy.2017.12.007; Jiang ST, 2014, NEUROSCI BULL, V30, P295, DOI 10.1007/s12264-013-1406-z; Kam AYF, 2010, J NEUROSCI, V30, P15304, DOI 10.1523/JNEUROSCI.4255-10.2010; Keshwani MM, 2012, P NATL ACAD SCI USA, V109, pE1221, DOI 10.1073/pnas.1202741109; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kibaly C, 2016, BIOL PSYCHIAT, V79, P906, DOI 10.1016/j.biopsych.2015.04.019; Koles L, 2016, PURINERG SIGNAL, V12, P1, DOI 10.1007/s11302-015-9480-5; Lebois EP, 2018, NEUROPHARMACOLOGY, V136, P362, DOI 10.1016/j.neuropharm.2017.11.018; Lee K, 2016, ADV PROTEIN CHEM STR, V103, P203, DOI 10.1016/bs.apcsb.2015.10.004; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Ma L, 2011, AM J PHYSIOL-LUNG C, V300, pL701, DOI 10.1152/ajplung.00119.2009; Marlo JE, 2009, MOL PHARMACOL, V75, P577, DOI 10.1124/mol.108.052886; Melancon BJ, 2013, DRUG DISCOV TODAY, V18, P1185, DOI 10.1016/j.drudis.2013.09.005; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Moran SP, 2018, NEUROPSYCHOPHARMACOL, V43, P1763, DOI 10.1038/s41386-018-0033-9; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Nathanson NM, 2000, P NATL ACAD SCI USA, V97, P6245, DOI 10.1073/pnas.97.12.6245; Park P, 2016, J NEUROSCI, V36, P622, DOI 10.1523/JNEUROSCI.3625-15.2016; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Serulle Y, 2008, CHANNELS, V2, P230, DOI 10.4161/chan.2.4.6391; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sun CY, 2014, MOL CELL ENDOCRINOL, V382, P835, DOI 10.1016/j.mce.2013.10.017; Tillo SE, 2017, CELL REP, V19, P617, DOI 10.1016/j.celrep.2017.03.070; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Wang C, 2014, MOL NEUROBIOL, V49, P120, DOI 10.1007/s12035-013-8505-8; Xu JT, 2014, J CLIN INVEST, V124, P592, DOI 10.1172/JCI70236; Yan YH, 2014, NEUROSCI LETT, V566, P231, DOI 10.1016/j.neulet.2014.02.059; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03680-2; Zhao LX, 2018, FASEB J, V32, P4247, DOI 10.1096/fj.201800029R	61	13	13	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6622	6631		10.1096/fj.201802351R	http://dx.doi.org/10.1096/fj.201802351R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794430				2022-12-28	WOS:000466932600064
J	Lu, CY; Shi, X; Allen, A; Baez-Nieto, D; Nikish, A; Sanjana, NE; Pan, JQ				Lu, Congyi; Shi, Xi; Allen, Andrew; Baez-Nieto, David; Nikish, Alexandria; Sanjana, Neville E.; Pan, Jen Q.			Overexpression of NEUROG2 and NEUROG1 in human embryonic stem cells produces a network of excitatory and inhibitory neurons	FASEB JOURNAL			English	Article						neurogenin; induced neuronal network; GABAergic; SCN2A	AUTISM SPECTRUM DISORDER; CODING MUTATIONS; EPILEPSY; SPECIFICATION; GENERATION; INDUCTION; MOUSE; LHX5	Overexpression of mouse neurogenin (Neurog)2 alone or in combination with mouse Neurog2/1 in human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) can rapidly produce high-yield excitatory neurons. Here, we report a detailed characterization of human neuronal networks induced by the expression of human NEUROG2 together with human NEUROG2/1 in hESCs using molecular, cellular, and electrophysiological measurements over 60 d after induction. Both excitatory synaptic transmission and network firing activity increased over time. Strikingly, inhibitory synaptic transmission and GABAergic cells were identified from NEUROG2/1 induced neurons (iNs). To illustrate the application of such iNs, we demonstrated that the heterozygous knock out of SCN2A, whose loss-of-function mutation is strongly implicated in autism risk, led to a dramatic reduction in network activity in the NEUROG2/1 iNs. Our findings not only extend our understanding of the NEUROG2/1-induced human neuronal network but also substantiate NEUROG2/1 iNs as an in vitro system for modeling neuronal and functional deficits on a human genetic background.	[Lu, Congyi; Shi, Xi; Allen, Andrew; Baez-Nieto, David; Pan, Jen Q.] Broad Inst, Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 01720 USA; [Lu, Congyi; Sanjana, Neville E.] New York Genome Ctr, New York, NY USA; [Lu, Congyi; Shi, Xi] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nikish, Alexandria] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lu, Congyi; Sanjana, Neville E.] NYU, Dept Biol, New York, NY 10003 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); New York University	Pan, JQ (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 01720 USA.	jpan@broadinstitute.org		Nikish, Alexandria/0000-0001-7320-4897; Allen, Andrew/0000-0002-7232-2143	Stanley Center for Psychiatric Research; U.S. National Institutes of Health, National Institute of Mental Health [R21 MH099448-02, R01 MH115045-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP2HG010099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH115045] Funding Source: NIH RePORTER	Stanley Center for Psychiatric Research; U.S. National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Dr. Wenting Wang (Institute of Neuroscience, Fourth Military Medical University, Xi'an, China) for his advice on electrophysiological experiments, Dr. Qian Chen (McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA), and Rhiannon Macrae (Broad Institute, Cambridge, MA, USA) for help with the manuscript. This work was supported by funding from the Stanley Center for Psychiatric Research, and U.S. National Institutes of Health, National Institute of Mental Health Grants R21 MH099448-02 (to J.Q.) and R01 MH115045-01 (to J.Q.). The authors declare no conflicts of interest.	Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Ben-Shalom R, 2017, BIOL PSYCHIAT, V82, P224, DOI 10.1016/j.biopsych.2017.01.009; Busskamp V, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145508; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P241, DOI 10.1007/s13311-012-0118-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Frega M, 2017, JOVE-J VIS EXP, DOI 10.3791/54900; Gascon S, 2017, CELL STEM CELL, V21, P18, DOI 10.1016/j.stem.2017.06.011; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; Hafezparast M, 2002, LANCET NEUROL, V1, P215, DOI 10.1016/S1474-4422(02)00100-X; Hibaoui Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00267; Ho SM, 2016, METHODS, V101, P113, DOI 10.1016/j.ymeth.2015.11.019; Howell KB, 2015, NEUROLOGY, V85, P958, DOI 10.1212/WNL.0000000000001926; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Lam RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169506; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Lu C, 2016, MOL PSYCHIATR, V21, P159, DOI 10.1038/mp.2015.173; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Miquelajauregui A, 2010, J NEUROSCI, V30, P10551, DOI 10.1523/JNEUROSCI.5563-09.2010; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Neniskyte U, 2017, NAT REV NEUROSCI, V18, P658, DOI 10.1038/nrn.2017.110; OGIWARA I, 2018, BIOL, V1, DOI DOI 10.1038/S42003-018-0099-2; Peters D.T., 2008, STEMBOOK; Pillai A, 2007, DEVELOPMENT, V134, P357, DOI 10.1242/dev.02717; Planells-Cases R, 2000, BIOPHYS J, V78, P2878, DOI 10.1016/S0006-3495(00)76829-9; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schwarz N, 2016, J NEUROL, V263, P334, DOI 10.1007/s00415-015-7984-0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xu R, 2007, MOL CELL NEUROSCI, V35, P292, DOI 10.1016/j.mcn.2007.03.003; Yang N, 2017, NAT METHODS, V14, P621, DOI [10.1038/NMETH.4291, 10.1038/nmeth.4291]; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	40	14	14	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5287	5299		10.1096/fj.201801110RR	http://dx.doi.org/10.1096/fj.201801110RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30698461	Bronze, Green Published			2022-12-28	WOS:000462888500053
J	Schira, J; Heinen, A; Poschmann, G; Ziegler, B; Hartung, HP; Stuhler, K; Kury, P				Schira, Jessica; Heinen, Andre; Poschmann, Gereon; Ziegler, Brigida; Hartung, Hans-Peter; Stuehler, Kai; Kuery, Patrick			Secretome analysis of nerve repair mediating Schwann cells reveals Smad-dependent trophism	FASEB JOURNAL			English	Article						peripheral; dedifferentiation; glia; mass spectrometry; Fingolimod	GROWTH-FACTOR-BETA; N-TERMINAL KINASE; PERIPHERAL-NERVE; C-JUN; FUNCTIONAL RECOVERY; PROTEASE NEXIN-1; NEGATIVE REGULATOR; NEURITE OUTGROWTH; SIGNALING CASCADE; REGENERATION	Schwann cells promote nerve regeneration by adaptation of a regenerative phenotype referred to as repair mediating Schwann cell. Down-regulation of myelin proteins, myelin clearance, formation of Bungner's bands, and secretion of trophic factors characterize this cell type. We have previously shown that the sphingosine-1-phosphate receptor agonist Fingolimod/FTY720P promotes the generation of this particular Schwann cell phenotype by activation of dedifferentiation markers and concomitant release of trophic factors resulting in enhanced neurite growth of dorsal root ganglion neurons. Despite its biomedical relevance, a detailed characterization of the corresponding Schwann cell secretome is lacking, and the impact of FTY720P on enhancing neurite growth is not defined. Here, we applied a label-free quantitative mass spectrometry approach to characterize the secretomes derived from primary neonatal and adult rat Schwann cells in response to FTY720P. We identified a large proportion of secreted proteins with a high overlap between the neonatal and adult Schwann cells, which can be associated with biologic processes such as development, axon growth, and regeneration. Moreover, FTY720P-treated Schwann cells release proteins downstream of Smad signaling known to support neurite growth. Our results therefore uncover a network of trophic factors involved in glial-mediated repair of the peripheral nervous system.	[Schira, Jessica; Heinen, Andre; Ziegler, Brigida; Hartung, Hans-Peter; Kuery, Patrick] Heinrich Heine Univ, Med Fac, Dept Neurol, Dusseldorf, Germany; [Schira, Jessica; Poschmann, Gereon; Stuehler, Kai] Heinrich Heine Univ, Mol Prote Lab, Biomed Res Ctr, Dusseldorf, Germany; [Stuehler, Kai] Univ Hosp Dusseldorf, Inst Mol Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Schira, J (corresponding author), Heinrich Heine Univ, Neuroregenerat Lab, Dept Neurol, Moorenstr 5, D-40225 Dusseldorf, Germany.	J.Schira@uni-duesseldorf.de		Poschmann, Gereon/0000-0003-2448-0611; Kury, Patrick/0000-0002-2654-1126; Schira-Heinen, Jessica/0000-0002-2184-9746	Deutsche Forschungsgemeinschaft (DFG) [KU1934/2_1, KU1934/5_1, HE 6443/1-1]; Stifterverband/Novartisstiftung; Walter and Ilse Rose Foundation; James and Elisabeth Cloppenburg, Peek and Cloppenburg Dusseldorf Stiftung; Christiane and Claudia Hempel Foundation for Stem Cell Research; Forschungskommission of the Heinrich-Heine-University Dusseldorf	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Stifterverband/Novartisstiftung; Walter and Ilse Rose Foundation; James and Elisabeth Cloppenburg, Peek and Cloppenburg Dusseldorf Stiftung; Christiane and Claudia Hempel Foundation for Stem Cell Research; Forschungskommission of the Heinrich-Heine-University Dusseldorf	The authors thank Marion Gehrke (Molecular Proteomics Laboratory and Institute for Molecular Medicine) for sample preparation for LC-MS/MS analysis, and Anja Stefanski (Molecular Proteomics Laboratory and Institute for Molecular Medicine) for technical support of the LC-MS/MS analysis. Research on myelin repair and neuroregeneration in the laboratory of P.K. was supported by the Deutsche Forschungsgemeinschaft (DFG; Grants KU1934/2_1, KU1934/5_1; HE 6443/1-1) and by the Stifterverband/Novartisstiftung. The Multiple Sclerosis Center at the Department of Neurology was supported, in part, by the Walter and Ilse Rose Foundation and the James and Elisabeth Cloppenburg, Peek and Cloppenburg Dusseldorf Stiftung. J.S. was supported by the Christiane and Claudia Hempel Foundation for Stem Cell Research. Research in the laboratory of K. S. was supported by the Forschungskommission of the Heinrich-Heine-University Dusseldorf. P.K. performed consultancy work for Geneuro; H.-P.H. received compensation for consulting, speaking, and serving on steering committees from Bayer Healthcare, Biogen, Geneuro, MedImmune, Merck, Novartis, Opexa, Receptos Celgene, Roche, Sanofi Genzyme, and Teva with approval by the Rector of Heinrich-Heine-University; and all remaining authors declare no conflicts of interest.	ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Au E, 2007, J NEUROSCI, V27, P7208, DOI 10.1523/JNEUROSCI.0509-07.2007; Bampton ETW, 2005, EUR J NEUROSCI, V21, P2611, DOI 10.1111/j.1460-9568.2005.04128.x; Banyai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010758; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Bonner J, 2001, J NEUROSCI, V21, P9782, DOI 10.1523/JNEUROSCI.21-24-09782.2001; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; Chao T, 2013, ANN NEUROL, V73, P210, DOI 10.1002/ana.23781; Chen HL, 2012, INT J MOL SCI, V13, P9380, DOI 10.3390/ijms13079380; Cua RC, 2013, GLIA, V61, P972, DOI 10.1002/glia.22489; EINHEBER S, 1995, J CELL BIOL, V129, P443, DOI 10.1083/jcb.129.2.443; Elegheert J, 2017, NEURON, V96, P242, DOI 10.1016/j.neuron.2017.09.011; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Fukaya K, 2003, J NEUROPATH EXP NEUR, V62, P162, DOI 10.1093/jnen/62.2.162; GUENARD V, 1995, J NEUROSCI, V15, P419; Heinen A, 2008, P NATL ACAD SCI USA, V105, P8748, DOI 10.1073/pnas.0802659105; Heinen A, 2015, EXP NEUROL, V271, P25, DOI 10.1016/j.expneurol.2015.05.002; Hiraiwa M, 1997, P NATL ACAD SCI USA, V94, P4778, DOI 10.1073/pnas.94.9.4778; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Jessen KR, 2015, DEV CELL, V34, P613, DOI 10.1016/j.devcel.2015.09.005; Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200; Kury P, 1997, DEVELOPMENT, V124, P1251; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lee JA, 2008, MECH DEVELOP, V125, P167, DOI 10.1016/j.mod.2007.09.009; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lino MM, 2007, J NEUROSCI, V27, P3677, DOI 10.1523/JNEUROSCI.0277-07.2007; Ma LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095098; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Malik AR, 2013, J BIOL CHEM, V288, P8544, DOI 10.1074/jbc.M112.411629; Marcos S, 2015, J NEUROSCI, V35, P4729, DOI 10.1523/JNEUROSCI.3304-13.2015; Meier C, 1999, J NEUROSCI, V19, P3847; MEIER R, 1989, NATURE, V342, P548, DOI 10.1038/342548a0; Melendez-Vasquez CV, 2001, P NATL ACAD SCI USA, V98, P1235, DOI 10.1073/pnas.98.3.1235; Minor K, 2009, J NEUROCHEM, V109, P706, DOI 10.1111/j.1471-4159.2009.05977.x; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; MULLIGAN LP, 1991, NEUROSCI LETT, V128, P42, DOI 10.1016/0304-3940(91)90756-J; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Panteri R, 2006, MOL CELL NEUROSCI, V32, P133, DOI 10.1016/j.mcn.2006.03.004; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Park JA, 2008, GLIA, V56, P247, DOI 10.1002/glia.20600; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Rayego-Mateos S, 2013, J MOL CELL BIOL, V5, P323, DOI 10.1093/jmcb/mjt030; Roet KCD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109401; ROGISTER B, 1993, J NEUROSCI RES, V34, P32, DOI 10.1002/jnr.490340105; Scarlato M, 2003, EXP NEUROL, V183, P489, DOI 10.1016/S0014-4886(03)00046-3; SCHERER SS, 1993, GLIA, V8, P265, DOI 10.1002/glia.440080407; Schira J, 2015, MOL CELL PROTEOMICS, V14, P2630, DOI 10.1074/mcp.M115.049312; SCHMIDT JT, 1991, J NEUROBIOL, V22, P40, DOI 10.1002/neu.480220105; Sharma S, 2011, J PHARMACOL PHARMACO, V2, P49, DOI 10.4103/0976-500X.77118; SHASHOUA VE, 1991, ANN NY ACAD SCI, V627, P94; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sulaiman OAR, 2002, GLIA, V37, P206, DOI 10.1002/glia.10022; Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Szepanowski F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0612-9; TANAKA J, 1994, J NEUROSCI, V14, P1038, DOI 10.1523/JNEUROSCI.14-03-01038.1994; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Tzekova N, 2014, J CLIN IMMUNOL, V34, pS86, DOI 10.1007/s10875-014-0015-6; van Erp S, 2015, DEV CELL, V35, P537, DOI 10.1016/j.devcel.2015.11.008; Vincent AJ, 2008, DEV DYNAM, V237, P1449, DOI 10.1002/dvdy.21495; Wahab NA, 2005, J AM SOC NEPHROL, V16, P340, DOI 10.1681/ASN.2003100905; Xin CY, 2006, BRIT J PHARMACOL, V147, P164, DOI 10.1038/sj.bjp.0706452; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yanagisawa H, 2010, NEUROSCI RES, V66, P111, DOI 10.1016/j.neures.2009.10.002; Zainul Z, 2018, J NEUROSCI, V38, P4243, DOI 10.1523/JNEUROSCI.3119-17.2018; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302; Zheng M, 2000, J NEUROBIOL, V42, P212, DOI 10.1002/(SICI)1097-4695(20000205)42:2<212::AID-NEU5>3.3.CO;2-3; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	79	19	19	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4703	4715		10.1096/fj.201801799R	http://dx.doi.org/10.1096/fj.201801799R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592632	Bronze			2022-12-28	WOS:000462888500006
J	Schnell, L; Felix, I; Muller, B; Sadi, M; von Bank, F; Papatheodorou, P; Popoff, MR; Aktories, K; Waltenberger, E; Benz, R; Weichbrodt, C; Fauler, M; Frick, M; Barth, H				Schnell, Leonie; Felix, Ina; Mueller, Bastian; Sadi, Mirko; von Bank, Franziska; Papatheodorou, Panagiotis; Popoff, Michel R.; Aktories, Klaus; Waltenberger, Eva; Benz, Roland; Weichbrodt, Conrad; Fauler, Michael; Frick, Manfred; Barth, Holger			Revisiting an old antibiotic: bacitracin neutralizes binary bacterial toxins and protects cells from intoxication	FASEB JOURNAL			English	Article						bacterial binary AB-toxins; anthrax toxin; toxin inhibitor	BOTULINUM C2 TOXIN; LIPID BILAYER-MEMBRANES; PERFRINGENS IOTA-TOXIN; DIPHTHERIA-TOXIN; ANTHRAX LETHAL; ADP-RIBOSYLATION; CHANNEL FUNCTION; TYROSINE GLYCOSYLATION; BINDING-KINETICS; CLOSTRIDIUM	The antibiotic bacitracin (Bac) inhibits cell wall synthesis of gram-positive bacteria. Here, we discovered a totally different activity of Bac: the neutralization of bacterial exotoxins. Bac prevented intoxication of mammalian cells with the binary enterotoxins Clostridiumbotulinum C2, C. perfringens iota, C. difficile transferase (CDT), and Bacillus anthracis lethal toxin. The transport (B) subunits of these toxins deliver their respective enzyme (A) subunits into cells. Following endocytosis, the B subunits form pores in membranes of endosomes, which mediate translocation of the A subunits into the cytosol. Bac inhibited formation of such B pores in lipid bilayers in vitro and in living cells, thereby preventing translocation of the A subunit into the cytosol. Bac preserved the epithelial integrity of toxin-treated CaCo-2 monolayers, a model for the human gut epithelium. In conclusion, Bac should be discussed as a therapeutic option against infections with medically relevant toxin-producing bacteria, including C. difficile and B. anthracis, because it inhibits bacterial growth and neutralizes the secreted toxins.	[Schnell, Leonie; Felix, Ina; Mueller, Bastian; Sadi, Mirko; von Bank, Franziska; Papatheodorou, Panagiotis; Barth, Holger] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Popoff, Michel R.] Inst Pasteur, Dept Anaerob Bacteria, Paris, France; [Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Freiburg, Germany; [Waltenberger, Eva; Benz, Roland] Jacobs Univ Bremen, Dept Life Sci & Chem, Bremen, Germany; [Weichbrodt, Conrad] Nanion Technol, Munich, Germany; [Fauler, Michael; Frick, Manfred] Univ Ulm, Inst Gen Physiol, Ulm, Germany	Ulm University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Freiburg; Jacobs University; Ulm University	Barth, H (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	holger.barth@uni-ulm.de	Aktories, Klaus/CAJ-5682-2022; Frick, Manfred/E-1374-2012	Aktories, Klaus/0000-0002-5397-0436; Frick, Manfred/0000-0002-4763-1104; Papatheodorou, Panagiotis/0000-0003-3571-695X	German Research Foundation (DFG) [316249678-CRC, 1279]; PharmCompNet Baden-Wurttemberg (project Barth); IGradU	German Research Foundation (DFG)(German Research Foundation (DFG)); PharmCompNet Baden-Wurttemberg (project Barth); IGradU	The work was supported by the German Research Foundation (DFG) project number 316249678-CRC (Collaborative Research Center) 1279/project C02 and the PharmCompNet Baden-Wurttemberg (project Barth). L.S. and B.M. are members of the International Graduate School in Molecular Medicine Ulm (IGradU) and thank the IGradU for the support. The authors declare no conflicts of interest.	AKTORIES K, 1992, MOL MICROBIOL, V6, P2905, DOI 10.1111/j.1365-2958.1992.tb01749.x; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Angeles DC, 2005, BIOCHEM BIOPH RES CO, V327, P361, DOI 10.1016/j.bbrc.2004.11.167; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Barth H, 2011, EUR J CELL BIOL, V90, P944, DOI 10.1016/j.ejcb.2010.11.007; Beitzinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066099; Beitzinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046964; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; Benz R, 2017, CURR TOP MICROBIOL, V406, P229, DOI 10.1007/82_2017_17; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; Bronnhuber A, 2014, TOXICOLOGY, V316, P25, DOI 10.1016/j.tox.2013.12.006; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Dickerhof N, 2011, FEBS J, V278, P2034, DOI 10.1111/j.1742-4658.2011.08119.x; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Ernst K, 2017, CURR TOP MICROBIOL, V406, P163, DOI 10.1007/82_2016_14; Ernst K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02882-y; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; FALNES PO, 1992, J BIOL CHEM, V267, P12284; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Gatsogiannis C, 2013, NATURE, V495, P520, DOI 10.1038/nature11987; Gerding DN, 2014, GUT MICROBES, V5, P15, DOI 10.4161/gmic.26854; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Hilger H, 2009, INFECT IMMUN, V77, P5593, DOI 10.1128/IAI.00710-09; IKAI Y, 1995, J ANTIBIOT, V48, P233, DOI 10.7164/antibiotics.48.233; Jank T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8807; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Karala AR, 2010, FEBS J, V277, P2454, DOI 10.1111/j.1742-4658.2010.07660.x; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Knapp O, 2016, BBA-BIOMEMBRANES, V1858, P512, DOI 10.1016/j.bbamem.2015.08.006; Kreidler AM, 2017, ARCH TOXICOL, V91, P1431, DOI 10.1007/s00204-016-1716-9; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; LEPPLA SH, 1991, METHOD ENZYMOL, V195, P153; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Ming LJ, 2002, J INORG BIOCHEM, V91, P46, DOI 10.1016/S0162-0134(02)00464-6; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nagahama M, 2011, INFECT IMMUN, V79, P4353, DOI 10.1128/IAI.05677-11; Nestorovich EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023927; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; OHISHI I, 1980, INFECT IMMUN, V30, P668; OHISHI I, 1986, BIOCHEM BIOPH RES CO, V136, P802, DOI 10.1016/0006-291X(86)90511-5; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Perelle S, 1997, FEMS MICROBIOL LETT, V146, P117, DOI [10.1016/S0378-1097(96)00463-6, 10.1111/j.1574-6968.1997.tb10180.x]; Perelle S, 1996, FEBS LETT, V395, P191, DOI 10.1016/0014-5793(96)01035-6; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; ROTH RA, 1981, BIOCHEM BIOPH RES CO, V98, P431, DOI 10.1016/0006-291X(81)90858-5; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; SCHERING B, 1988, EUR J BIOCHEM, V171, P225, DOI 10.1111/j.1432-1033.1988.tb13780.x; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Schnell L, 2016, TOXICON, V116, P23, DOI 10.1016/j.toxicon.2015.04.012; Stiles BG, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00011; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	65	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5755	5771		10.1096/fj.201802453R	http://dx.doi.org/10.1096/fj.201802453R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30699302	Bronze			2022-12-28	WOS:000462888500089
J	van der Wijk, AE; Wisniewska-Kruk, J; Vogels, IMC; van Veen, HA; Ip, WF; van der Wel, NN; van Noorden, CJF; Schlingemann, RO; Klaassen, I				van der Wijk, Anne-Eva; Wisniewska-Kruk, Joanna; Vogels, Ilse M. C.; van Veen, Henk A.; Ip, Wing Fung; van der Wel, Nicole N.; van Noorden, Cornelis J. F.; Schlingemann, Reinier O.; Klaassen, Ingeborg			Expression patterns of endothelial permeability pathways in the development of the blood-retinal barrier in mice	FASEB JOURNAL			English	Article						tight junctions; transcellular permeability; VEGF signaling	VESICLE-ASSOCIATED PROTEIN; HUMAN DIABETIC-RETINOPATHY; ANTIGEN PAL-E; VASCULAR DEVELOPMENT; GENE-EXPRESSION; UP-REGULATION; BRAIN-TUMOR; VEGF-A; ANGIOGENESIS; MARKER	Insight into the molecular and cellular processes in blood-retinal barrier (BRB) development, including the contribution of paracellular and transcellular pathways, is still incomplete but may help to understand the inverse process of BRB loss in pathologic eye conditions. In this comprehensive observational study, we describe in detail the formation of the BRB at the molecular level in physiologic conditions, using mice from postnatal day (P)3 to P25. Our data indicate that immature blood vessels already have tight junctions at P5, before the formation of a functional BRB. Expression of the endothelial cell-specific protein plasmalemma vesicle-associated protein (PLVAP), which is known to be involved in transcellular transport and associated with BRB permeability, decreased during development and was absent when a functional barrier was formed. Moreover, we show that PLVAP deficiency causes a transient delay in retinal vascular development and changes in mRNA expression levels of endothelial permeability pathway proteins.	[van der Wijk, Anne-Eva; Wisniewska-Kruk, Joanna; Vogels, Ilse M. C.; Ip, Wing Fung; van Noorden, Cornelis J. F.; Schlingemann, Reinier O.; Klaassen, Ingeborg] Univ Amsterdam, Dept Ophthalmol, Amsterdam UMC,Canc Ctr Amsterdam, Ocular Angiogenesis Grp,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands; [van der Wijk, Anne-Eva; Wisniewska-Kruk, Joanna; Vogels, Ilse M. C.; Ip, Wing Fung; van Noorden, Cornelis J. F.; Schlingemann, Reinier O.; Klaassen, Ingeborg] Univ Amsterdam, Dept Med Biol, Amsterdam UMC,Canc Ctr Amsterdam, Ocular Angiogenesis Grp,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands; [van Veen, Henk A.; van der Wel, Nicole N.] Univ Amsterdam, Dept Med Biol, Amsterdam UMC, Electron Microscopy Ctr Amsterdam, Amsterdam, Netherlands; [van Noorden, Cornelis J. F.] Univ Amsterdam, Dept Med Biol, Amsterdam UMC, Cellular Imaging Core Facil, Amsterdam, Netherlands; [van Noorden, Cornelis J. F.] Natl Inst Biol, Dept Genet Toxicol & Tumor Biol, Ljubljana, Slovenia; [Schlingemann, Reinier O.] Univ Lausanne, Jules Gonin Eye Hosp, Dept Ophthalmol, Lausanne, Switzerland	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; National Institute of Biology - Slovenia; University of Lausanne	Klaassen, I (corresponding author), Amsterdam UMC, Ocular Angiogenesis Grp, Dept Med Biol, Meibergdreef 15,Room L3-154, NL-1105 AZ Amsterdam, Netherlands.	i.klaassen@amc.uva.nl	Van Der Wel, Nicole/AAE-7569-2020	van der Wijk, Anne-Eva/0000-0002-7436-5323; Klaassen, Ingeborg/0000-0003-1695-9403; van der Wel, Nicole/0000-0001-6392-3417	U.S. National Institutes of Health [032525-UCD]; Diabetes Fonds (Dutch Diabetes Fund) [2014.00.1784]; Landelijke Stichting voor Blinden en Slechtzienden; Novartis Fonds; St. MD Fonds [UitZicht 2014-33]; Nederlandse Vereniging ter Verbetering van het Lot der Blinden, Rotterdamse Stichting Blindenbelangen [B20140050]; Stichting Blindenhulp	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Fonds (Dutch Diabetes Fund); Landelijke Stichting voor Blinden en Slechtzienden; Novartis Fonds; St. MD Fonds; Nederlandse Vereniging ter Verbetering van het Lot der Blinden, Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp	In memory of the authors' dear friend and colleague, Joanna Wisniewska-Kruk (1986-2016), who will always be remembered with a smile. The authors thank Dr. R. A. Hoebe of the Cellular Imaging Core Facility (University of Amsterdam, Amsterdam, The Netherlands) for his advice with respect to quantification of vascular density and help with making the supplemental video and Dr. A. Jonker (Department of Medical Biology, AMC, Amsterdam, The Netherlands) for designing the ImageJ macro to determine the length of the vascular sprouting front. The mouse strain used for this research project, B6; 129S5-Plvap<SUP>tm1Lex</SUP>/Mmucd, identification number 032525-UCD, was obtained from the Mutant Mouse Regional Resource Center (MMRRC), a U.S. National Institutes of Health-funded strain repository, and was donated to the MMRRC by Genentech. This study was made possible by the financial support of the Diabetes Fonds (Dutch Diabetes Fund, Grant 2014.00.1784) and by the following foundations: Landelijke Stichting voor Blinden en Slechtzienden, Novartis Fonds, and St. MD Fonds, which contributed through UitZicht (Grant UitZicht 2014-33); the Nederlandse Vereniging ter Verbetering van het Lot der Blinden, Rotterdamse Stichting Blindenbelangen (Grant B20140050); and Stichting Blindenhulp. This study was published with the help of Edmond en Marianne Blaauw Fonds voor Oogheelkunde. The funding organizations had no role in the design or conduct of this research. They provided unrestricted grants. The authors declare no conflicts of interest.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Chen J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-279; Chow BW, 2017, NEURON, V93, P1325, DOI 10.1016/j.neuron.2017.02.043; Elkadri A, 2015, CELL MOL GASTROENTER, V1, P381, DOI 10.1016/j.jcmgh.2015.05.001; Felinski EA, 2005, CURR EYE RES, V30, P949, DOI 10.1080/02713680500263598; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gardner TW, 1996, BIOCHEM J, V320, P717, DOI 10.1042/bj3200717; Gariano RF, 2003, PROG RETIN EYE RES, V22, P295, DOI 10.1016/S1350-9462(02)00062-9; Gerhardt H, 2005, EXP SUPPL, V94, P3; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Herrnberger L, 2012, HISTOCHEM CELL BIOL, V138, P709, DOI 10.1007/s00418-012-0987-3; Hofman P, 2001, OPHTHALMIC RES, V33, P156, DOI 10.1159/000055663; Hofman P, 2000, CURR EYE RES, V21, P637, DOI 10.1076/0271-3683(200008)21:2;1-V;FT637; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; Kowluru RA, 1998, DIABETES, V47, P464, DOI 10.2337/diabetes.47.3.464; Kremer C, 1997, CANCER RES, V57, P3852; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; LEENSTRA S, 1993, CANCER, V72, P3061, DOI 10.1002/1097-0142(19931115)72:10<3061::AID-CNCR2820721031>3.0.CO;2-6; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Luo Y, 2011, INVEST OPHTH VIS SCI, V52, P7556, DOI 10.1167/iovs.11-7185; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Niemela H, 2005, BLOOD, V106, P3405, DOI 10.1182/blood-2005-01-0254; RISAU W, 1990, TRENDS NEUROSCI, V13, P174, DOI 10.1016/0166-2236(90)90043-A; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; Schlingemann R., 1988, ANN NY ACAD SCI, V529, P111; SCHLINGEMANN RO, 1985, LAB INVEST, V52, P71; Schlingemann RO, 1997, OPHTHALMIC RES, V29, P130, DOI 10.1159/000268007; Schlingemann RO, 1999, DIABETOLOGIA, V42, P596, DOI 10.1007/s001250051200; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003; Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189; Stan RV, 2004, AM J PHYSIOL-HEART C, V286, pH1347, DOI 10.1152/ajpheart.00909.2003; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Umans RA, 2017, DEV BIOL, V425, P101, DOI 10.1016/j.ydbio.2017.03.017; van der Wijk AE, 2018, TISSUE CELL, V52, P42, DOI 10.1016/j.tice.2018.03.010; Wisniewska-Kruk J, 2016, AM J PATHOL, V186, P1044, DOI 10.1016/j.ajpath.2015.11.019; Witmer AN, 2002, INVEST OPHTH VIS SCI, V43, P849; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	51	8	8	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5320	5333		10.1096/fj.201801499RRR	http://dx.doi.org/10.1096/fj.201801499RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30698992	hybrid, Green Published			2022-12-28	WOS:000462888500056
J	Mellouk, A; Bobe, P				Mellouk, Amine; Bobe, Pierre			CD8(+), but not CD4(+) effector/memory T cells, express the CD44(high)CD45RB(high) phenotype with aging, which displays reduced expression levels of P2X(7) receptor and ATP-induced cellular responses	FASEB JOURNAL			English	Article						T-EM lymphocyte; T-CM lymphocyte; naive T lymphocyte; purinergic signaling	TUMOR-NECROSIS-FACTOR; P2X7 RECEPTOR; L-SELECTIN; ACTIVATION; LYMPHOCYTES; RELEASE; STIMULATION; INHIBITION; CHANNEL; PROTEIN	Previously we reported that the sensitivity of CD4(+) T cells to ATP does not depend on P2X(7) receptor (P2X(7)R) expression levels but on their activation and differentiation stages. Therefore, here we have investigated a potential relationship between the sensitivity of CD8(+) T cells to ATP and their stages of differentiation. Thus, the CD8(+) subpopulation exhibits a drastically reduced sensitivity to ATP with aging, which parallels the strong increase of an effector/memory CD8(+) subset expressing high levels of CD44 cell adhesion molecule and CD45RB transmembrane phosphatase (CD44(hi)CD45RB(hi)). Using l-selectin/CD62L, CC-chemokine receptor 7, and CD127/IL-7 receptor- markers, we showed that effector/memory CD8(+) T cells belong to a central or effector memory subset. In contrast, the CD44(hi)CD45RB(hi) effector/memory subset is absent or poorly expressed in the CD4(+) T subpopulation regardless of age. While ATP treatment can trigger channel and pore formation, CD62L shedding, phosphatidylserine exposure, and cell death in the CD44(lo)CD45RB(hi)-naive CD8(+) subset, it is unable to induce these cellular activities in the CD44(hi)CD45RB(hi) effector/memory CD8(+) subset. Importantly, both CD44(lo)CD45RB(hi)-naive and CD44(hi)CD45RB(hi) effector/memory subsets express similar low levels of P2X(7)R, demonstrating that the sensitivity of CD8(+) T cells to ATP depends on the stage of differentiation instead of P2X(7)R expression levels.Mellouk, A., Bobe, P. CD8(+), but not CD4(+) effector/memory T cells, express the CD44(high)CD45RB(high) phenotype with aging, which displays reduced expression levels of P2X(7) receptor and ATP-induced cellular responses.	[Mellouk, Amine; Bobe, Pierre] Univ Paris Saclay, Univ Paris Sud, INSERM, Unite Mixte UMR 1174, Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bobe, P (corresponding author), Univ Paris Sud, INSERM, UMR1174, Rue Adeles, F-91405 Orsay, France.	pierre.bobe@u-psud.fr		Bobe, Pierre/0000-0002-8835-6786	Agence Nationale de la Recherche [ANR-13-ISV6-0003]	Agence Nationale de la Recherche(French National Research Agency (ANR))	Rabbit polyclonal anti-P2X<INF>7</INF>R antisera were kindly provided by J. M. Kanellopoulos and K. Benihoud (both from Universite Paris-Sud). This work was funded by the Agence Nationale de la Recherche (ANR-13-ISV6-0003). The authors declare no conflicts of interest.	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Bleesing JJH, 2001, CELL IMMUNOL, V213, P72, DOI 10.1006/cimm.2001.1865; Chen LF, 2006, J IMMUNOL, V176, P3115, DOI 10.4049/jimmunol.176.5.3115; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Delarasse C, 2011, J BIOL CHEM, V286, P2596, DOI 10.1074/jbc.M110.200618; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; DIVIRGILIO F, 1989, J IMMUNOL, V143, P1955; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; FILIPPINI A, 1990, J BIOL CHEM, V265, P334; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gu B, 1998, BLOOD, V92, P946; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Ho J, 2008, J IMMUNOL, V180, P2573, DOI 10.4049/jimmunol.180.4.2573; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Koni PA, 2013, J IMMUNOL, V190, P3189, DOI 10.4049/jimmunol.1203364; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Le Gall SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052161; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Ma CS, 2004, IMMUNOL CELL BIOL, V82, P67, DOI 10.1046/j.0818-9641.2003.01206.x; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Martina MN, 2015, IMMUNOL CELL BIOL, V93, P305, DOI 10.1038/icb.2014.99; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Meraldi V, 2005, VACCINE, V23, P2801, DOI 10.1016/j.vaccine.2004.10.044; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Purvis HA, 2014, J IMMUNOL, V193, P1142, DOI 10.4049/jimmunol.1302467; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Safya H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00360; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Sluyter R., 2014, INFLAMM CELL SIGNAL, V1, P44; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Tsukimoto M, 2009, BIOCHEM BIOPH RES CO, V384, P512, DOI 10.1016/j.bbrc.2009.05.011; WILEY JS, 1992, ARCH BIOCHEM BIOPHYS, V292, P411, DOI 10.1016/0003-9861(92)90010-T; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458	53	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3225	3236		10.1096/fj.201800867R	http://dx.doi.org/10.1096/fj.201800867R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383448				2022-12-28	WOS:000459794800013
J	Shigeno, Y; Zhang, HL; Banno, T; Usuda, K; Nochi, T; Inoue, R; Watanabe, G; Jin, WZ; Benno, Y; Nagaoka, K				Shigeno, Yuko; Zhang, Haolin; Banno, Taihei; Usuda, Kento; Nochi, Tomonori; Inoue, Ryo; Watanabe, Gen; Jin, Wanzhu; Benno, Yoshimi; Nagaoka, Kentaro			Gut microbiota development in mice is affected by hydrogen peroxide produced from amino acid metabolism during lactation	FASEB JOURNAL			English	Article						LAO1; infant; milk	INTESTINAL MICROBIOTA; DENDRITIC CELLS; HUMAN-MILK; OXIDASE; INFANTS; IL4I1; COLONIZATION; EXPRESSION; CHILDHOOD; IMPACT	The development of gut microbiota during infancy is an important event that affects the health status of the host; however, the mechanism governing it is not fully understood. l-Amino acid oxidase 1 (LAO1) is a flavoprotein that catalyzes the oxidative deamination of particular l-amino acids and converts them into keto acids, ammonia, and H2O2. Our previous study showed that LAO1 is present in mouse milk and exerts protection against bacteria by its production of H2O2. The data led us to consider whether LAO1, H2O2, or both could impact infant gut microbiota development via mother's milk consumption in mice. Different gut microbiota profiles were observed in the wild-type (WT) and LAO1-knockout mouse pups. The WT pups' microbiota was relatively simple and composed of only a few dominant bacteria, such as Lactobacillus, whereas the lactating knockout pups had high microbiota diversity. Cross-fostering experiments indicated that WT milk (containing LAO1) has the ability to suppress the diversity of microbiota in pups. We observed that the stomach content of pups fed WT milk had LAO1 proteins and the ability to produce H2O2. Moreover, culture experiments showed that Lactobacillus was abundant in the feces of pups fed WT milk and that Lactobacillus was more resistant to H2O2 than Bifidobacterium and Escherichia. Human breast milk produces very little H2O2, which could be the reason for Lactobacillus not being dominant in the feces of breast-fed human infants. In mouse mother's milk, H2O2 is generated from the process of free amino acid metabolism, and H2O2 may be a key player in regulating the initial acquisition and development of gut microbiota, especially growth of Lactobacillus, during infancy.Shigeno, Y., Zhang, H., Banno, T., Usuda, K., Nochi, T., Inoue, R., Watanabe, G., Jin, W., Benno, Y., Nagaoka, K. Gut microbiota development in mice is affected by hydrogen peroxide produced from amino acid metabolism during lactation.	[Shigeno, Yuko; Zhang, Haolin; Usuda, Kento; Watanabe, Gen; Nagaoka, Kentaro] Tokyo Univ Agr & Technol, Dept Vet Med, Lab Vet Physiol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan; [Shigeno, Yuko; Banno, Taihei; Benno, Yoshimi] RIKEN, Innovat Ctr, Benno Lab, Wako, Saitama, Japan; [Nochi, Tomonori] Tohoku Univ, Grad Sch Agr Sci, Lab Mucosal Immunol, Sendai, Miyagi, Japan; [Inoue, Ryo] Kyoto Prefectural Univ, Dept Agr & Life Sci, Lab Anim Sci, Kyoto, Japan; [Jin, Wanzhu] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Tokyo University of Agriculture & Technology; RIKEN; Tohoku University; Kyoto Prefectural University; Chinese Academy of Sciences; Institute of Zoology, CAS	Nagaoka, K (corresponding author), Tokyo Univ Agr & Technol, Dept Vet Med, Lab Vet Physiol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	nagaokak@cc.tuat.ac.jp	Shigeno, Yuko/AAQ-9644-2020; Nagaoka, Kentaro/C-2019-2013; Watanabe/G-1134-2013; 张(Zhang), 浩林 (Haolin)/AGP-9653-2022; Nochi, Tomonori/U-2533-2019; Jin, Wanzhu/B-5699-2012	Shigeno, Yuko/0000-0003-4327-9913; Nagaoka, Kentaro/0000-0003-1038-1380; Watanabe/0000-0001-7611-4678; 张(Zhang), 浩林 (Haolin)/0000-0001-6178-7431; Nochi, Tomonori/0000-0003-1800-6972; Jin, Wanzhu/0000-0002-5860-2958	Japan Society for the Promotion of Science [26660248, 17K19797]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Naoya Nemoto (Hitachi High-Tech Global, Tokyo, Japan) and Yasunori Matsumoto (Yamato Scientific, Tokyo, Japan) for providing technical support and Mizuna Hayashi (Aichi Prefectural Institute of Public Health, Nagoya, Japan) for technical assistance in bacterial culture. This work was supported by Grants-in-Aid for Scientific Research 26660248 and 17K19797, from the Japan Society for the Promotion of Science (to K.N.). The authors declare no conflicts of interest.	Al-Shehri SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135047; Anandasabapathy N, 2014, J EXP MED, V211, P1875, DOI 10.1084/jem.20131397; Backhed F, 2015, CELL HOST MICROBE, V17, P852, DOI 10.1016/j.chom.2015.05.012; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Butch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group, 2000, LANCET, V355, P1104; Cakebread JA, 2015, J AGR FOOD CHEM, V63, P7311, DOI 10.1021/acs.jafc.5b01836; Collado MC, 2015, PEDIATR RES, V77, P726, DOI 10.1038/pr.2015.54; Chu CC, 1997, P NATL ACAD SCI USA, V94, P2507, DOI 10.1073/pnas.94.6.2507; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Gdalevich M, 2001, J AM ACAD DERMATOL, V45, P520, DOI 10.1067/mjd.2001.114741; Guaraldi F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00094; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Houghteling PD, 2015, J PEDIATR GASTR NUTR, V60, P294, DOI 10.1097/MPG.0000000000000597; Hughes AL, 2010, IMMUNOGENETICS, V62, P753, DOI 10.1007/s00251-010-0482-8; Inoue R, 2016, BIOSCI BIOTECH BIOCH, V80, P2450, DOI 10.1080/09168451.2016.1222267; Isolauri E, 2015, BENEF MICROBES, V6, P167, DOI 10.3920/BM2014.0114; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Karav S, 2016, APPL ENVIRON MICROB, V82, P3622, DOI 10.1128/AEM.00547-16; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Marquet J, 2010, EUR J IMMUNOL, V40, P2557, DOI 10.1002/eji.201040428; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; Rodriguez JM, 2015, MICROB ECOL HEALTH D, V26, DOI 10.3402/mehd.v26.26050; Molinier-Frenkel V, 2016, GENES IMMUN, V17, P148, DOI 10.1038/gene.2015.55; Nagaoka K, 2014, ANIM SCI J, V85, P976, DOI 10.1111/asj.12237; Nagaoka K, 2009, FASEB J, V23, P2514, DOI 10.1096/fj.08-126466; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Putignani L, 2014, PEDIATR RES, V76, P2, DOI 10.1038/pr.2014.49; Rutten NBMM, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0519-0; Santarlasci V, 2012, IMMUNITY, V36, P201, DOI 10.1016/j.immuni.2011.12.013; Scholtens S, 2008, OBESITY, V16, P2498, DOI 10.1038/oby.2008.403; Sun YP, 2002, J BIOL CHEM, V277, P19080, DOI 10.1074/jbc.M200936200; Underwood MA, 2013, PEDIATR CLIN N AM, V60, P189, DOI 10.1016/j.pcl.2012.09.008; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; WELLNER D, 1961, J BIOL CHEM, V236, P2357; Weng M, 2013, J DEV ORIG HLTH DIS, V4, P203, DOI 10.1017/S2040174412000712; YOSHIOKA H, 1983, PEDIATRICS, V72, P317; Yu ZL, 2012, APPL BIOCHEM BIOTECH, V167, P1, DOI 10.1007/s12010-012-9611-1	43	10	11	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3343	3352		10.1096/fj.201801462R	http://dx.doi.org/10.1096/fj.201801462R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30433825	Bronze			2022-12-28	WOS:000459794800022
J	Untereiner, A; Abdo, S; Bhattacharjee, A; Gohil, H; Pourasgari, F; Ibeh, N; Lai, M; Batchuluun, B; Wong, A; Khuu, N; Liu, Y; Al Rijjal, D; Winegarden, N; Virtanen, C; Orser, BA; Cabrera, O; Varga, G; Rocheleau, J; Dai, FF; Wheeler, MB				Untereiner, Ashley; Abdo, Shaaban; Bhattacharjee, Alpana; Gohil, Himaben; Pourasgari, Farzaneh; Ibeh, Neke; Lai, Mi; Batchuluun, Battsetseg; Wong, Anthony; Khuu, Nicholas; Liu, Ying; Al Rijjal, Dana; Winegarden, Neil; Virtanen, Carl; Orser, Beverley A.; Cabrera, Over; Varga, Gabor; Rocheleau, Jonathan; Dai, Feihan F.; Wheeler, Michael B.			GABA promotes -cell proliferation, but does not overcome impaired glucose homeostasis associated with diet-induced obesity	FASEB JOURNAL			English	Article						insulin secretion; glucose tolerance; diet-induced obesity; single cell RNA-seq; GABAA receptor	GAMMA-AMINOBUTYRIC-ACID; PANCREATIC BETA-CELLS; INSULIN-SECRETION; EXPRESSION; MOUSE; REVEALS; RELEASE; ISLETS; ADULT; RESISTANCE	-Aminobutyric acid (GABA) administration has been shown to increase -cell mass, leading to a reversal of type 1 diabetes in mice. Whether GABA has any effect on cells of healthy and prediabetic/glucose-intolerant obese mice remains unknown. In the present study, we show that oral GABA administration (ad libitum) to mice indeed increased pancreatic -cell mass, which led to a modest enhancement in insulin secretion and glucose tolerance. However, GABA treatment did not further increase insulin-positive islet area in high fat diet-fed mice and was unable to prevent or reverse glucose intolerance and insulin resistance. Mechanistically, whether in vivo or in vitro, GABA treatment increased -cell proliferation. In vitro, the effect was shown to be mediated via the GABA(A) receptor. Single-cell RNA sequencing analysis revealed that GABA preferentially up-regulated pathways linked to -cell proliferation and simultaneously down-regulated those networks required for other processes, including insulin biosynthesis and metabolism. Interestingly, single-cell differential expression analysis revealed GABA treatment gave rise to a distinct subpopulation of cells with a unique transcriptional signature, including urocortin 3 (ucn3), wnt4, and hepacam2. Taken together, this study provides new mechanistic insight into the proliferative nature of GABA but suggests that -cell compensation associated with prediabetes overlaps with, and negates, its proliferative effects.Untereiner, A., Abdo, S., Bhattacharjee, A., Gohil, H., Pourasgari, F., Ibeh, N., Lai, M., Batchuluun, B., Wong, A., Khuu, N., Liu, Y., Al Rijjal, D., Winegarden, N., Virtanen, C., Orser, B. A., Cabrera, O., Varga, G., Rocheleau, J., Dai, F. F., Wheeler, M. B. GABA promotes -cell proliferation, but does not overcome impaired glucose homeostasis associated with diet-induced obesity.	[Untereiner, Ashley; Abdo, Shaaban; Gohil, Himaben; Pourasgari, Farzaneh; Batchuluun, Battsetseg; Wong, Anthony; Al Rijjal, Dana; Rocheleau, Jonathan; Dai, Feihan F.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Orser, Beverley A.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Bhattacharjee, Alpana; Lai, Mi; Liu, Ying; Rocheleau, Jonathan; Dai, Feihan F.; Wheeler, Michael B.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Ibeh, Neke; Virtanen, Carl] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Khuu, Nicholas; Winegarden, Neil] Univ Hlth Network, Princess Margaret Genom Ctr, Toronto, ON, Canada; [Cabrera, Over; Varga, Gabor] Eli Lilly & Co, Lilly Corp Ctr, Diabet & Complicat Res, Indianapolis, IN 46285 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Eli Lilly	Dai, FF; Wheeler, MB (corresponding author), Dept Physiol, 1 Kings Coll Circle Room 3352, Toronto, ON M5S 1A8, Canada.	f.dai@utoronto.ca; michael.wheeler@utoronto.ca		Untereiner, Ashley/0000-0002-1994-6651; Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Institutes of Health Research [FDN-143219]; New Ideas Grant from Ontario Institutes for Regenerative Medicine [OMNI-2017]; Faculty of Medicine at the University of Toronto; Banting and Best Diabetes Center; Banting and Best Diabetes Center Summer-Student Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); New Ideas Grant from Ontario Institutes for Regenerative Medicine; Faculty of Medicine at the University of Toronto(University of Toronto); Banting and Best Diabetes Center; Banting and Best Diabetes Center Summer-Student Award	The authors thank Islet Core and Clinical Islet Laboratory (Alberta Islet Distribution Program, University of Alberta, Edmonton, AB, Canada) and UHN Islet Isolation Program (UHN, Toronto, ON, Canada) for providing us with human islets from review board-approved donors. This study was supported by the Canadian Institutes of Health Research (Grant FDN-143219) and a New Ideas Grant (OMNI-2017) from the Ontario Institutes for Regenerative Medicine and the Faculty of Medicine at the University of Toronto (to M.B.W.). A.U. and S.A. were supported by Banting and Best Diabetes Center postdoctoral fellowships. A.W. was supported by Banting and Best Diabetes Center Summer-Student Award. The authors declare no conflicts of interest.	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Ackermann AM, 2018, CELL METAB, V28, P787, DOI 10.1016/j.cmet.2018.07.002; Allister EM, 2013, DIABETES, V62, P1623, DOI 10.2337/db12-0981; Asghar Z, 2006, DIABETOLOGIA, V49, P90, DOI 10.1007/s00125-005-0045-y; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Ben-Othman N, 2017, CELL, V168, P73, DOI 10.1016/j.cell.2016.11.002; Ben-Yaakov G, 2003, INT J DEV NEUROSCI, V21, P153, DOI 10.1016/S0736-5748(03)00027-3; Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Biju Mangatt P, 2002, J Biochem Mol Biol Biophys, V6, P209, DOI 10.1080/10258140290018667; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Braun M, 2004, J GEN PHYSIOL, V123, P191, DOI 10.1085/jgp.200308966; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Collombat P, 2009, CELL CYCLE, V8, P3450, DOI 10.4161/cc.8.21.9791; Dai FF, 2015, J BIOL CHEM, V290, P25045, DOI 10.1074/jbc.M115.648592; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dorrell C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11756; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Geigerseder Christof, 2004, Reprod Biol Endocrinol, V2, P13, DOI 10.1186/1477-7827-2-13; GILON P, 1991, ENDOCRINOLOGY, V129, P2521, DOI 10.1210/endo-129-5-2521; GU XH, 1993, LIFE SCI, V52, P687, DOI 10.1016/0024-3205(93)90229-V; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Korol SV, 2018, EBIOMEDICINE, V30, P273, DOI 10.1016/j.ebiom.2018.03.014; Li J, 2017, CELL, V168, P86, DOI 10.1016/j.cell.2016.11.010; Li JF, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00260; LIU QR, 1993, J BIOL CHEM, V268, P2106; Liu WJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00362; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Luu L, 2013, DIABETOLOGIA, V56, P2010, DOI 10.1007/s00125-013-2946-5; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Massumi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164457; Mendu SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042959; MESSERSMITH EK, 1993, NEUROCHEM RES, V18, P463, DOI 10.1007/BF00967250; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; PETTY F, 1984, J AFFECT DISORDERS, V6, P131, DOI 10.1016/0165-0327(84)90018-1; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Prud'homme GJ, 2014, BIOCHEM BIOPH RES CO, V452, P649, DOI 10.1016/j.bbrc.2014.08.135; Prud'homme GJ, 2013, TRANSPLANTATION, V96, P616, DOI 10.1097/TP.0b013e31829c24be; Purwana I, 2014, DIABETES, V63, P4197, DOI 10.2337/db14-0153; ROBBINS MS, 1981, DIABETES, V30, P168, DOI 10.2337/diabetes.30.2.168; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; SENER A, 1984, EXPERIENTIA, V40, P1026, DOI 10.1007/BF01971448; Shang WT, 2018, FOOD FUNCT, V9, P2820, DOI 10.1039/c8fo00331a; Si X, 2018, J AGR FOOD CHEM, V66, P881, DOI 10.1021/acs.jafc.7b04994; Sohrabipour S, 2018, EUR J PHARMACOL, V826, P75, DOI 10.1016/j.ejphar.2018.01.047; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Tamura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126003; Taneera J, 2012, DIABETOLOGIA, V55, P1985, DOI 10.1007/s00125-012-2548-7; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tian JD, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/6403539; Tian J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00515-y; Tian JD, 2013, DIABETES, V62, P3760, DOI 10.2337/db13-0931; Tian J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025338; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Wang P, 2015, NAT MED, V21, P383, DOI 10.1038/nm.3820; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	68	27	30	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3968	3984		10.1096/fj.201801397R	http://dx.doi.org/10.1096/fj.201801397R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509117	Bronze			2022-12-28	WOS:000459794800069
J	Vrakas, CN; Herman, AB; Ray, M; Kelemen, SE; Scalia, R; Autieri, MV				Vrakas, Christine N.; Herman, Allison B.; Ray, Mitali; Kelemen, Sheri E.; Scalia, Rosario; Autieri, Michael V.			RNA stability protein ILF3 mediates cytokine-induced angiogenesis	FASEB JOURNAL			English	Article						endothelial cell; RNA-binding protein; proangiogenic factor; VEGF; IL-19	DOUBLE-STRANDED-RNA; 3' UNTRANSLATED REGION; AU-RICH ELEMENTS; MESSENGER-RNA; BINDING PROTEIN; DEPENDENT PHOSPHORYLATION; 3'-UNTRANSLATED REGION; GENE-EXPRESSION; NUCLEAR EXPORT; NF90	Interleukin enhancer-binding factor 3 (ILF3), an RNA-binding protein, is best known for its role in innate immunity by participation in cellular antiviral responses. A role for ILF3 in angiogenesis is unreported. ILF3 expression in CD31(+) capillaries of hypoxic cardiac tissue was detected by immunohistochemistry. Proangiogenic stimuli induce ILF3 mRNA and protein expression in cultured human coronary artery endothelial cells (hCAECs). Angiogenic indices, including proliferation, migration, and tube formation, are all significantly reduced in hCAECs when ILF3 is knocked down using small interfering RNA (siRNA), but are significantly increased when ILF3 is overexpressed using adenovirus. Protein and mRNA abundance of several angiogenic factors including CXCL1, VEGF, and IL-8 are decreased when ILF3 is knocked down by siRNA. These factors are increased when ILF3 is overexpressed by adenovirus. ILF3 is phosphorylated and translocates from the nucleus to the cytoplasm in response to angiogenic stimuli. Proangiogenic transcripts containing adenine and uridine-rich elements were bound to ILF3 through RNA immunoprecipitation. ILF3 stabilizes proangiogenic transcripts including VEGF, CXCL1, and IL-8 in hCAECs. Together these data suggest that in endothelial cells, the RNA stability protein, ILF3, plays a novel and central role in angiogenesis. Our working hypothesis is that ILF3 promotes angiogenesis through cytokine-inducible mRNA stabilization of proangiogenic transcripts.Vrakas, C. N., Herman, A. B., Ray, M., Kelemen, S. E., Scalia, R., Autieri, M. V. RNA stability protein ILF3 mediates cytokine-induced angiogenesis.	[Vrakas, Christine N.; Herman, Allison B.; Ray, Mitali; Kelemen, Sheri E.; Scalia, Rosario; Autieri, Michael V.] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Independence Blue Cross Cardiovasc Res Ctr, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Autieri, MV (corresponding author), Temple Univ, Sch Med, Dept Physiol, Independence Blue Cross Cardiovasc Res Ctr, Room 1050,MERB 3500 N Broad St, Philadelphia, PA 19140 USA.	mautieri@temple.edu	Herman, Ali/GON-8233-2022	Herman, Ali/0000-0003-3826-3247	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL141108, HL117724]; American Heart Association [18PRE34080191, 17PRE33670798, 16PRE31220005, 13GRNT1685003]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK111042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117724, R01HL141108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111042] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL141108 and HL117724, and American Heart Association Grant 13GRNT1685003 (to M.V.A.); and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK111042 (to R.S.). C.N.V., A.B.H., and M.R. were supported by American Heart Association Predoctoral Fellowships 18PRE34080191, 17PRE33670798, and 16PRE31220005, respectively. The authors declare no conflicts of interest.	Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Bekesova S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00336; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Castella S, 2015, WIRES RNA, V6, P243, DOI 10.1002/wrna.1270; Cha HJ, 2011, HEPATO-GASTROENTEROL, V58, P790; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Choi HJ, 2009, TOXICOL APPL PHARM, V240, P46, DOI 10.1016/j.taap.2009.06.023; Cuneo AA, 2010, J MOL CELL CARDIOL, V49, P647, DOI 10.1016/j.yjmcc.2010.04.016; England RN, 2013, AM J PHYSIOL-CELL PH, V305, pC255, DOI 10.1152/ajpcell.00069.2013; Epstein SE, 2004, CIRCULATION, V109, P2826, DOI 10.1161/01.CIR.0000132468.82942.F5; Fung PA, 1997, P NATL ACAD SCI USA, V94, P1064, DOI 10.1073/pnas.94.4.1064; Gauchotte G, 2017, J PATHOL, V242, P421, DOI 10.1002/path.4916; GILLIS P, 1991, J BIOL CHEM, V266, P3172; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Herman AB, 2018, CELL REP, V24, P1176, DOI 10.1016/j.celrep.2018.07.002; Herman AB, 2017, CLIN SCI, V131, P2687, DOI 10.1042/CS20171373; Jain S, 2011, ARTERIOSCL THROM VAS, V31, P167, DOI 10.1161/ATVBAHA.110.214916; Kako F, 2016, AM J PHYSIOL-CELL PH, V310, pC931, DOI 10.1152/ajpcell.00006.2016; Kim TW, 2010, BIOCHEM BIOPH RES CO, V391, P963, DOI 10.1016/j.bbrc.2009.11.174; Kohno T, 2003, CANCER RES, V63, P5091; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Kuwano M, 2001, INTERNAL MED, V40, P565, DOI 10.2169/internalmedicine.40.565; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; KUZUYA M, 1994, J CELL PHYSIOL, V161, P267, DOI 10.1002/jcp.1041610211; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Li Y, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020047; Li Y, 2014, J VIROL, V88, P7199, DOI 10.1128/JVI.00225-14; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Ray M, 2018, ARTERIOSCL THROM VAS, V38, P1297, DOI 10.1161/ATVBAHA.118.310929; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Richards J, 2015, J MOL CELL CARDIOL, V79, P21, DOI 10.1016/j.yjmcc.2014.11.002; Sakuma T, 2008, J NEURO-ONCOL, V88, P143, DOI 10.1007/s11060-008-9559-8; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; Shamanna RA, 2011, MOL CELL BIOL, V31, P4832, DOI 10.1128/MCB.05849-11; Sharp TE, 2017, CIRC RES, V121, P1263, DOI 10.1161/CIRCRESAHA.117.311174; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shi JX, 2014, INT IMMUNOPHARMACOL, V22, P480, DOI 10.1016/j.intimp.2014.07.031; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Song D, 2017, BIOCHEM BIOPH RES CO, V488, P211, DOI 10.1016/j.bbrc.2017.05.037; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Szekanecz Zoltan, 2008, P83, DOI 10.1007/978-3-7643-7650-5_6; Tahergorabi Z, 2012, IRAN J BASIC MED SCI, V15, P1110; Thapar R, 2015, ACS CHEM BIOL, V10, P652, DOI 10.1021/cb500860x; Vries MHM, 2015, ANGIOGENESIS, V18, P163, DOI 10.1007/s10456-014-9454-1; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Wang H, 2016, TUMOR BIOL, V37, P14451, DOI 10.1007/s13277-016-5397-z	53	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3304	3316		10.1096/fj.201801315R	http://dx.doi.org/10.1096/fj.201801315R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383449	Green Published			2022-12-28	WOS:000459794800019
J	Yan, JK; Zhang, T; Dai, LN; Gu, BL; Zhu, J; Yan, WH; Cai, W; Wang, Y				Yan, Jun-Kai; Zhang, Tian; Dai, Li-Na; Gu, Bei-Lin; Zhu, Jie; Yan, Wei-Hui; Cai, Wei; Wang, Ying			CELF1/p53 axis: a sustained antiproliferative signal leading to villus atrophy under total parenteral nutrition	FASEB JOURNAL			English	Article						IEC proliferation; RNA binding protein	CUG-BINDING PROTEIN-1; EPITHELIAL-CELL PROLIFERATION; MESSENGER-RNA; MOUSE MODEL; DOWN-REGULATION; CACO-2 CELLS; CANCER-CELLS; E-CADHERIN; APOPTOSIS; TRANSLATION	Intestinal villus atrophy is a major complication of total parenteral nutrition (TPN). Our previous study revealed that TPN-induced villus atrophy is accompanied by elevated expression of CUGBP, Elav-like family member 1 (CELF1); however, its mechanism of action has not been fully understood. Herein, we report a pivotal role of CELF1/p53 axis, which induces a sustained antiproliferative signal, leading to suppressed proliferation of intestinal epithelial cells (IECs). By using a rat model of TPN, we found synchronous upregulation of CELF1 and p53 in jejunum mucosa, accompanied by a 51% decrease in crypt cell proliferation rate. By using HCT-116 cells as an IEC model in vitro, we found that the expression of CELF1 altered dynamically in parallel to proliferation rate, suggesting a self-adaptive expression pattern in IECs in vitro. Furthermore, ectopic overexpression of CELF1 elicited a significant antiproliferative effect in HCT-116, Caco-2, and IEC-6 cells, whereas knockdown of CELF1 elicited a significant proproliferative effect. Moreover, cell-cycle assay revealed that ectopic overexpression of CELF1 induced sustained G2 arrest and G1 arrest in HCT-116 and IEC-6 cells, respectively, which could be abolished by p53 silencing. Mechanistically, polysomal profiling and nascent protein analysis revealed that regulation of p53 by CELF1 was mediated through accelerating its protein translation in polysomes. Taken together, our findings revealed a sustained suppression of IEC proliferation evoked by CELF1/p53 axis, which may be a potential therapeutic target for the treatment of TPN-induced villus atrophy.Yan, J.-K., Zhang, T., Dai, L.-N., Gu, B.-L., Zhu, J., Yan, W.-H., Cai, W., Wang, Y. CELF1/p53 axis: a sustained antiproliferative signal leading to villus atrophy under total parenteral nutrition.	[Yan, Jun-Kai; Zhang, Tian; Dai, Li-Na; Gu, Bei-Lin; Zhu, Jie; Yan, Wei-Hui; Cai, Wei; Wang, Ying] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai, Peoples R China; [Yan, Jun-Kai; Gu, Bei-Lin; Cai, Wei; Wang, Ying] Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Cai, W; Wang, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Xin Hua Hosp,Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.	caiw204@sjtu.edu.cn; wangying02@xinhuamed.com.cn			Shanghai Municipal Commission of Health and Family Planning [20184Y0337]; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [17DZ2272000]; National Natural Science Foundation of China [81630039, 81700787]	Shanghai Municipal Commission of Health and Family Planning; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Shanghai Municipal Commission of Health and Family Planning (20184Y0337); Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition (17DZ2272000); and National Natural Science Foundation of China [81630039 (to W.C.) and 81700787 (to Y.K.Y.)]. The authors declare no conflicts of interest.	Belcheva A, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600200; Braga M, 2009, CLIN NUTR, V28, P378, DOI 10.1016/j.clnu.2009.04.002; Breaux M, 2015, MOL CELL BIOL, V35, P3005, DOI 10.1128/MCB.00421-15; BROOK, 1992, CELL, V69, P385; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang ET, 2012, BIOCHEM J, V446, P113, DOI 10.1042/BJ20120112; Cui YH, 2012, MOL BIOL CELL, V23, P151, DOI 10.1091/mbc.E11-05-0456; Dupont A, 2014, GUT MICROBES, V5, P761, DOI 10.4161/19490976.2014.972238; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Feng YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG236, DOI 10.1152/ajpgi.00142.2011; Feng YJ, 2010, AM J PHYSIOL-GASTR L, V298, pG833, DOI 10.1152/ajpgi.00030.2010; Feng YJ, 2009, J PHYSIOL-LONDON, V587, P641, DOI 10.1113/jphysiol.2008.162719; Freeman JJ, 2015, FASEB J, V29, P2943, DOI 10.1096/fj.14-269480; Grossmann J, 1998, AM J PATHOL, V153, P53, DOI 10.1016/S0002-9440(10)65545-9; Hansraj NZ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12858; He C, 2017, GASTROENTEROLOGY, V152, P1434, DOI 10.1053/j.gastro.2017.01.049; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Jain AK, 2012, AM J PHYSIOL-GASTR L, V302, pG218, DOI 10.1152/ajpgi.00280.2011; Jones K, 2012, AGEING RES REV, V11, P442, DOI 10.1016/j.arr.2012.02.007; Kim HH, 2008, MOL CELL, V29, P151, DOI 10.1016/j.molcel.2008.01.005; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18174; Liu JB, 2011, ARCH ANIM NUTR, V65, P376, DOI 10.1080/1745039X.2011.594352; Liu L, 2015, MOL BIOL CELL, V26, P1797, DOI 10.1091/mbc.E14-11-1500; Liu L, 2014, MOL BIOL CELL, V25, P3308, DOI 10.1091/mbc.E14-03-0853; Natarajan G, 2008, AM J PHYSIOL-GASTR L, V294, pG1235, DOI 10.1152/ajpgi.00037.2008; Nightingale J, 2006, GUT S4, V55, piv1, DOI [10.1136/gut.2006.091108, DOI 10.1136/GUT.2006.091108]; Oste M, 2010, BRIT J NUTR, V104, P989, DOI 10.1017/S0007114510001613; Qi LW, 2015, AM J CHINESE MED, V43, P743, DOI 10.1142/S0192415X15500469; Ray RM, 2001, AM J PHYSIOL-GASTR L, V281, pG37, DOI 10.1152/ajpgi.2001.281.1.G37; Ray RM, 1999, AM J PHYSIOL-CELL PH, V276, pC684, DOI 10.1152/ajpcell.1999.276.3.C684; Rowland KJ, 2008, MOL CELL ENDOCRINOL, V288, P63, DOI 10.1016/j.mce.2008.02.014; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Shalimar, 2013, ARCH PATHOL LAB MED, V137, P1262, DOI 10.5858/arpa.2012-0354-OA; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Talwar S, 2013, RNA BIOL, V10, P277, DOI 10.4161/rna.23315; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timmons Jennifer, 2012, J Gastrointest Dig Syst, V2; Tolhurst Gwen, 2012, Handb Exp Pharmacol, P309, DOI 10.1007/978-3-642-24716-3_14; Vincent A, 2015, STEM CELL RES, V14, P105, DOI 10.1016/j.scr.2014.12.002; Vlasova IA, 2008, RNA BIOL, V5, P201, DOI 10.4161/rna.7056; Wang JY, 2007, AMINO ACIDS, V33, P241, DOI 10.1007/s00726-007-0518-z; Wang J. Y., 2017, WILEY INTERDISCIP RE, V8; Wang XF, 2016, THORAC CANCER, V7, P32, DOI 10.1111/1759-7714.12268; Wu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep10501; Xiao L, 2014, CURR OPIN PHARMACOL, V19, P46, DOI 10.1016/j.coph.2014.07.006; Xiao L, 2011, MOL BIOL CELL, V22, P3055, DOI 10.1091/mbc.E11-01-0069; Xiao WD, 2014, FASEB J, V28, P2073, DOI 10.1096/fj.13-238311; Yan JK, 2018, J CELL MOL MED, V22, P1562, DOI 10.1111/jcmm.13430; Yan JK, 2017, CELL PHYSIOL BIOCHEM, V41, P711, DOI 10.1159/000458430; Yan JK, 2016, CELL PHYSIOL BIOCHEM, V39, P1581, DOI 10.1159/000447860; Yu TX, 2016, AM J PHYSIOL-CELL PH, V310, pC54, DOI 10.1152/ajpcell.00112.2015; Zhou Y, 2014, CELL BIOL INT, V38, P1408, DOI 10.1002/cbin.10356; Zhu J., 2016, JPEN J PARENTER ENTE, V42, P436	55	4	4	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3378	3391		10.1096/fj.201801695R	http://dx.doi.org/10.1096/fj.201801695R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30514107	Bronze			2022-12-28	WOS:000459794800025
J	Yao, HP; Ge, TD; Zhang, Y; Li, M; Yang, S; Li, H; Wang, F				Yao, Haipei; Ge, Tandi; Zhang, Yao; Li, Min; Yang, Shuai; Li, Hui; Wang, Fang			BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro	FASEB JOURNAL			English	Article						epithelial-mesenchymal transition; bone morphogenetic proteins; transforming growth factor-	BONE MORPHOGENETIC PROTEIN-7; INDUCED PULMONARY-FIBROSIS; MESENCHYMAL TRANSITION; TGF-BETA; EXPRESSION; INHIBITION; RECEPTORS; MODEL	The major pathogenesis of proliferative vitreoretinopathy (PVR) is that retinal pigment epithelial (RPE) cells undergo epithelial-mesenchymal transition (EMT) because of disordered growth factors, such as TGF-, in the vitreous humor. Bone morphogenetic proteins (BMPs) are pluripotent growth factors. In this study, we identified the antifibrotic activity of BMP7 in a PVR model both in vivo and in vitro. BMP7 expression was confirmed on the PVR proliferative membranes. BMP7 was down-regulated in the PVR vitreous humor and TGF--induced RPE cell EMT. In the in vivo studies, BMP7 injection attenuated PVR progression in the eyes of the rabbit model. Additionally, BMP7 treatment maintained RPE cell phenotypes and relieved TGF-2-induced EMT, migration, and gel contraction in vitro. BMP7 inhibited the TGF-2-induced up-regulation of fibronectin and -smooth muscle actin and the down-regulation of E-cadherin and zona occludens-1 by balancing the TGF-2/Smad2/3 and BMP7/Smad1/5/9 pathways. These findings provide direct evidence of the ability of BMP7 in PVR inhibition and the potential of BMP7 for use in PVR therapeutic intervention.Yao, H., Ge, T., Zhang, Y., Li, M., Yang, S., Li, H., Wang, F. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.	[Yao, Haipei; Ge, Tandi; Zhang, Yao; Li, Min; Yang, Shuai; Li, Hui; Wang, Fang] Shanghai Tenth Peoples Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Yao, Haipei; Zhang, Yao; Yang, Shuai; Wang, Fang] Tongji Univ, Tongji Eye Inst, Sch Med, Shanghai, Peoples R China	Tongji University	Li, H; Wang, F (corresponding author), Tongji Univ, Sch Med, Dept Ophthalmol, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200092, Peoples R China.	13817185959@163.com; 18917683335@163.com			National Nature Science Foundation of China [81770939, 81500727]; Shanghai Municipal Commission of Health and Family Planning [20174Y0052]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	This work was supported, in part, by the National Nature Science Foundation of China (Grants 81770939 and 81500727), and by the Shanghai Municipal Commission of Health and Family Planning (Grant 20174Y0052). The authors declare no conflicts of interest.	Agrawal RN, 2007, NAT PROTOC, V2, P67, DOI 10.1038/nprot.2007.4; Ali IHA, 2014, BRIT J PHARMACOL, V171, P3620, DOI 10.1111/bph.12724; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Pastor JC, 2016, PROG RETIN EYE RES, V51, P125, DOI 10.1016/j.preteyeres.2015.07.005; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chiba C, 2014, EXP EYE RES, V123, P107, DOI 10.1016/j.exer.2013.07.009; Cirillo F, 2017, FASEB J, V31, P2146, DOI 10.1096/fj.201600878R; FASTENBERG DM, 1982, AM J OPHTHALMOL, V93, P565, DOI 10.1016/S0002-9394(14)77370-2; Fuchshofer R, 2007, INVEST OPHTH VIS SCI, V48, P715, DOI 10.1167/iovs.06-0226; Fuchshofer R, 2009, EXP EYE RES, V88, P1020, DOI 10.1016/j.exer.2009.01.002; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; Hao ZM, 2012, MOL THER, V20, P2043, DOI 10.1038/mt.2012.148; He S, 2015, INVEST OPHTH VIS SCI, V56, P5579, DOI 10.1167/iovs.14-16258; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Ishikawa K, 2015, SCI REP-UK, V5, DOI 10.1038/srep16386; Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046; Kimura K, 2014, INVEST OPHTH VIS SCI, V55, P2621, DOI 10.1167/iovs.13-13501; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liang D, 2016, CHEM-BIOL INTERACT, V243, P72, DOI 10.1016/j.cbi.2015.11.012; Liu Y, 2008, INVEST OPHTH VIS SCI, V49, P1429, DOI 10.1167/iovs.07-0451; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Parapuram SK, 2003, INVEST OPHTH VIS SCI, V44, P1767, DOI 10.1167/iovs.02-0528; Peng HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014750; Shu DY, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20611; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wladis EJ, 2013, RETINA-J RET VIT DIS, V33, P807, DOI 10.1097/IAE.0b013e31826d350a; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Yang GX, 2013, TOXICOL LETT, V220, P103, DOI 10.1016/j.toxlet.2013.04.017; Yang S, 2015, DISCOV MED, V20, P207; Yang YL, 2011, J CELL BIOCHEM, V112, P2558, DOI 10.1002/jcb.23180; Yao HP, 2016, SCI REP-UK, V6, DOI 10.1038/srep32182; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang Y, 2013, EXP EYE RES, V109, P98, DOI 10.1016/j.exer.2013.02.010	41	23	25	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3212	3224		10.1096/fj.201800858RR	http://dx.doi.org/10.1096/fj.201800858RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383450	Bronze			2022-12-28	WOS:000459794800012
J	Guo, LL; Huang, JB; Chen, ML; Piotrowski, E; Song, N; Zahner, G; Paust, HJ; Alawi, M; Geffers, R; Thaiss, F				Guo, Linlin; Huang, Jiabin; Chen, Meilan; Piotrowski, Eveline; Song, Ning; Zahner, Gunther; Paust, Hans-Joachim; Alawi, Malik; Geffers, Robert; Thaiss, Friedrich			T-lymphocyte-specific knockout of IKK-2 or NEMO induces T(h)17 cells in an experimental nephrotoxic nephritis mouse model	FASEB JOURNAL			English	Article						NTN; NF-B; transcription factors; canonical; noncanonical pathway; transcriptome	NF-KAPPA-B; TH17 CELLS; IMMUNE-RESPONSE; EXPRESSION; BETA; IMBALANCE; PROMOTES; DISEASE; INFLAMMATION; ACTIVATION	Experimental nephrotoxic serum nephritis (NTN) is a model for T-cell-mediated human rapid progressive glomerulonephritis. T-cell receptor stimulation involves intracellular signaling events that ultimately lead to the activation of transcription factors, such as NF-B. We explored the involvement of the NF-B components IKK-2 and NEMO in NTN, by using cell-specific knockouts of IKK-2 and NEMO in CD4(+) T lymphocytes. Our results demonstrate that although the course of disease was not grossly altered in CD4xIKK2 and CD4xNEMO animals, renal regulatory T cells were significantly reduced and T helper (T-h)1 and T(h)17 cells significantly increased in both knockout mouse groups. The expression of the renal cytokines and chemokines IL-1, CCL-2, and CCL-20 was also significantly altered in both knockout mice. Lymphocyte transcriptome analysis confirmed the increased expression of T(h)17-related cytokines in spleen CD4(+) T cells. Moreover, our array data demonstrate an interrupted canonical NF-B pathway and an increased expression of noncanonical NF-B pathway-related genes in nephritic CD4xNEMO mice, highlighting different downstream effects of deletion of IKK-2 or NEMO in T lymphocytes. We propose that better understanding of the role of IKK-2 and NEMO in nephritis is essential for the clinical application of kinase inhibitors in patients with glomerulonephritis.Guo, L., Huang, J., Chen, M., Piotrowski, E., Song, N., Zahner, G., Paust, H.-J., Alawi, M., Geffers, R., Thaiss, F. T-lymphocyte-specific knockout of IKK-2 or NEMO induces T(h)17 cells in an experimental nephrotoxic nephritis mouse model.	[Guo, Linlin; Chen, Meilan; Piotrowski, Eveline; Song, Ning; Zahner, Gunther; Paust, Hans-Joachim; Thaiss, Friedrich] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Martini St 52, D-20246 Hamburg, Germany; [Huang, Jiabin] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, Hamburg, Germany; [Alawi, Malik] Leibniz Inst Expt Virol, Heinrich Pette Inst, Virus Genom, Hamburg, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Genome Analyt, Braunschweig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; Helmholtz Association; Helmholtz-Center for Infection Research	Thaiss, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Martini St 52, D-20246 Hamburg, Germany.	thaiss@uke.de		Huang, Jiabin/0000-0002-3480-7115; Thaiss, Friedrich/0000-0003-1202-0933; , Malik/0000-0002-5993-7709	FACS Unit at the UKE; German Research Foundation [DFG Th 343/12-2]	FACS Unit at the UKE; German Research Foundation(German Research Foundation (DFG))	The authors thank Dr. Anna Reinicke Vogt [University Medical Center Hamburg-Eppendorf (UKE)] for language editing. The authors acknowledge the technical support of the FACS Unit at the UKE. This study was supported by a grant from the German Research Foundation (Grant: DFG Th 343/12-2 to F.T.). The doctoral thesis of M.C. is part of this publication. The authors declare no conflicts of interest.	Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brahler S, 2012, AM J PHYSIOL-RENAL, V303, pF1473, DOI 10.1152/ajprenal.00031.2012; de Oliveira KAP, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0280-5; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Gasparini C, 2012, CURR PHARM DESIGN, V18, P5735, DOI 10.2174/138161212803530763; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gotot J, 2016, J AM SOC NEPHROL, V27, P1917, DOI 10.1681/ASN.2015060699; Gray CM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004557; Grinberg-Bleyer Y, 2018, J IMMUNOL, V200, P2362, DOI 10.4049/jimmunol.1800042; Guo L, 2016, AM J PHYSIOL-RENAL, V311, pF1005, DOI 10.1152/ajprenal.00242.2016; He ZH, 2017, J IMMUNOL, V199, P955, DOI 10.4049/jimmunol.1700457; Heuser C, 2017, CELL REP, V21, P578, DOI 10.1016/j.celrep.2017.09.082; Kitching AR, 2011, J AM SOC NEPHROL, V22, P235, DOI 10.1681/ASN.2010050536; Krebs CF, 2016, IMMUNITY, V45, P1078, DOI 10.1016/j.immuni.2016.10.020; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Kuttkat N, 2017, GUT, V66, P908, DOI 10.1136/gutjnl-2015-311119; Lee MJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0116-1; Li JH, 2018, J IMMUNOL, V200, P1325, DOI 10.4049/jimmunol.1701310; Li L, 2011, J EXP MED, V208, P787, DOI 10.1084/jem.20091346; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Ma CS, 2016, J EXP MED, V213, P1589, DOI 10.1084/jem.20151467; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Mankan AK, 2011, P NATL ACAD SCI USA, V108, P6567, DOI 10.1073/pnas.1018331108; Oh H, 2017, IMMUNITY, V47, P450, DOI 10.1016/j.immuni.2017.08.010; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Panzer U, 2009, AM J PHYSIOL-RENAL, V297, pF429, DOI 10.1152/ajprenal.90435.2008; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Riedel JH, 2016, J AM SOC NEPHROL, V27, P3666, DOI 10.1681/ASN.2015101077; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Sharma S, 2014, CURR PROTOC IMMUNOL, V105, DOI DOI 10.34.1-10.34.13; Silva GEB, 2011, DIS MARKERS, V31, P9, DOI [10.1155/2011/940827, 10.3233/DMA-2011-0795]; Sun NN, 2016, INFLAMMATION, V39, P2008, DOI 10.1007/s10753-016-0436-x; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Tipping PG, 2006, J AM SOC NEPHROL, V17, P1253, DOI 10.1681/ASN.2005091013; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vlantis K, 2016, IMMUNITY, V44, P553, DOI 10.1016/j.immuni.2016.02.020; Volchenkov R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00698; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Wang K, 2012, CELL SIGNAL, V24, P1556, DOI 10.1016/j.cellsig.2012.03.022; Xiao X, 2016, IMMUNITY, V44, P1271, DOI 10.1016/j.immuni.2016.05.013; Yu JY, 2014, J IMMUNOL, V193, P422, DOI 10.4049/jimmunol.1303237; Zhang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21348	49	2	2	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2359	2371		10.1096/fj.201800485RR	http://dx.doi.org/10.1096/fj.201800485RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30285578				2022-12-28	WOS:000457296600066
J	Jiang, Q; Sun, BF; Liu, Q; Cai, M; Wu, RF; Wang, FQ; Yao, YX; Wang, YZ; Wang, XX				Jiang, Qin; Sun, Baofa; Liu, Qing; Cai, Min; Wu, Ruifan; Wang, Fengqin; Yao, Yongxi; Wang, Yizhen; Wang, Xinxia			MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m(6)A-YTHDF1-dependent mechanism	FASEB JOURNAL			English	Article						mRNA m(6)A; porcine model; intramuscular fat; meRIP-seq; longissimus dorsi muscle	ADIPOSE-TISSUE; NUCLEAR-RNA; FAT; OBESITY; ASSOCIATION; EXPRESSION; MUSCLE; GENES; TRANSLATION; PIG	Intramuscular fat is considered a potential factor that is associated with meat quality in animal production and insulin resistance in humans. N-6-methyladenosine (m(6)A) modification of mRNA plays an important role in regulating adipogenesis. However, the effects of m(6)A on the adipogenesis of intramuscular preadipocytes and associated mechanisms remain unknown. Here, we performed m(6)A sequencing to compare m(6)A methylome of the longissimus dorsi muscles (LDMs) between Landrace pigs (lean-type breed) and Jinhua pigs (obese-type breed with higher levels of intramuscular fat). Transcriptome-wide m(6)A profiling of porcine LDMs was highly conserved with humans and mice. Furthermore, we identified a unique methylated gene in Jinhua pigs named mitochondrial carrier homology 2 (MTCH2). The m(6)A levels of MTCH2 mRNA were reduced by introducing a synonymous mutation, and adipogenesis test results showed that the MTCH2 mutant was inferior with regard to adipogenesis compared with the MTCH2 wild-type. We then found that MTCH2 protein expression was positively associated with m(6)A levels, and an YTH domain family protein 1-RNA immunoprecipitation-quantitative PCR assay indicated that MTCH2 mRNA was a target of the YTH domain family protein 1. This study provides comprehensive m(6)A profiles of LDM transcriptomes in pigs and suggests an essential role for m(6)A modification of MTCH2 in intramuscular fat regulation.Jiang, Q., Sun, B., Liu, Q., Cai, M., Wu, R., Wang, F., Yao, Y., Wang, Y., Wang, X. MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m(6)A-YTHDF1-dependent mechanism.	[Jiang, Qin; Liu, Qing; Cai, Min; Wu, Ruifan; Wang, Fengqin; Yao, Yongxi; Wang, Yizhen; Wang, Xinxia] Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Baofa] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China; [Wang, Fengqin; Wang, Yizhen; Wang, Xinxia] Minist Agr, Key Lab Anim Nutr & Feed Sci Eastern China, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Ministry of Agriculture & Rural Affairs	Wang, XX (corresponding author), Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	xinxiawang@zju.edu.cn	Wu, Ruifan/AHH-6097-2022; dong, wang/T-9093-2019	Wu, Ruifan/0000-0003-4917-5197; wang, yizhen/0000-0002-3908-7102	Special Fund for Cultivation and Breeding of New Transgenic Organism [2014ZX0800949B]; National Natural Science Foundation of China [31572413, 31630075]; Natural Science Foundation of Zhejiang Province [LZ17C1700001]	Special Fund for Cultivation and Breeding of New Transgenic Organism; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the Special Fund for Cultivation and Breeding of New Transgenic Organism (Grant 2014ZX0800949B), the National Natural Science Foundation of China (Grants 31572413 and 31630075), and the Natural Science Foundation of Zhejiang Province (Grant LZ17C1700001). The authors declare no conflicts of interest.	Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Buzaglo-Azriel L, 2016, CELL REP, V14, P1602, DOI 10.1016/j.celrep.2016.01.046; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chen FF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102101; Dodson MV, 2010, J FOOD SCI, V75, pR1, DOI 10.1111/j.1750-3841.2009.01396.x; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Guo J, 2011, J ANIM SCI, V89, P185, DOI 10.2527/jas.2010-2983; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hilton TN, 2008, PHYS THER, V88, P1336, DOI 10.2522/ptj.20080079; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kulyte A, 2011, J CLIN ENDOCR METAB, V96, pE1661, DOI 10.1210/jc.2010-3050; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Peng Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122047; Rottiers V, 2017, OBESITY, V25, P616, DOI 10.1002/oby.21751; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Sodhi SS, 2014, MOL BIOL REP, V41, P6305, DOI 10.1007/s11033-014-3513-y; Sorci M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0843-z; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vettor R, 2009, AM J PHYSIOL-ENDOC M, V297, pE987, DOI 10.1152/ajpendo.00229.2009; Walters EM, 2017, LAB ANIMAL, V46, P167, DOI 10.1038/laban.1215; Wang HY, 2013, MOL BIOSYST, V9, P2154, DOI 10.1039/c3mb70084d; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang XX, 2018, INT J OBESITY, V42, P1912, DOI 10.1038/s41366-018-0027-z; Wang XX, 2015, BIOCHEM BIOPH RES CO, V459, P201, DOI 10.1016/j.bbrc.2015.02.048; Wang YD, 2017, BMC GENOMICS, V18, DOI [10.1186/s12864-017-4201-9, 10.1186/s12863-017-0550-2]; Wang Z., 2015, PLOS ONE, V12; Wang ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141138; Wu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053181; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yamada T, 2010, J VET MED SCI, V72, P991, DOI 10.1292/jvms.10-0031; Zhang GH, 2014, BIOCHEM CELL BIOL, V92, P259, DOI 10.1139/bcb-2014-0019; Zhang SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep35063; Zhang T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172389; Zhao CZ, 2016, EXP CELL RES, V344, P11, DOI 10.1016/j.yexcr.2016.02.019; Zhao SM, 2012, GENET MOL BIOL, V35, P783, DOI 10.1590/S1415-47572012005000079; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	47	41	46	9	51	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2971	2981		10.1096/fj.201801393RRR	http://dx.doi.org/10.1096/fj.201801393RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30339471	Green Published			2022-12-28	WOS:000457296600114
J	Lorand, L; Iismaa, SE				Lorand, Laszlo; Iismaa, Siiri E.			Transglutaminase diseases: from biochemistry to the bedside	FASEB JOURNAL			English	Article						TGase; factor XIII; FXIII; protein 4; 2	FACTOR-XIII-A; TISSUE TRANSGLUTAMINASE; CROSS-LINKING; MESENCHYMAL TRANSITION; TARGETED INACTIVATION; CELIAC-DISEASE; MICE LACKING; GENE; STABILIZATION; IDENTIFICATION	In humans, 9 members of the transglutaminase (TG) family have been identified, of which 8 [factor XIII (FXIII)A and TG1-TG7] catalyze post-translational protein-modifying reactions, and 1 does not (protein 4.2). The TG enzymatic activities considered in our discussion of human disease include deamidation of glutamine (Gln) residues, amine incorporation into Gln residues, and protein crosslinking. Except for TG7, which remains poorly studied, all individual TG members have been correlated with disparate human diseases that arise from either TG function or lack of function. Loss of TG function is associated with numerous orphan diseases that affect a relatively small number of individuals: loss of FXIIIa (transamidase-activated form) crosslinking leads to defects in blood coagulation in FXIII deficiency; loss of TG1 and TG5 cross linking leads to defects in epidermal cornification in lamellar ichthyosis and acral peeling skin syndrome, respectively; loss of TG3 crosslinking in hair-cuticle formation leads to uncombable hair syndrome; the predicted loss of TG6 crosslinking leads to spinocerebellar ataxia-35; and loss of the structural erythrocyte membrane protein, protein 4.2, leads to hereditary spherocytosis type 5. The enzymatic activity of TG2 is involved in the exacerbation of celiac disease and in at least 1 case of hemoglobinopathy, characterized by shortened erythrocyte lifespan. TGs are also autoantigens in a number of immune diseases, resulting in the production of autoantibodies against FXIIIa in acquired FXIII deficiency, TG2 in celiac disease, TG3 in dermatitis herpetiformis, TG4 in autoimmume polyglandular syndrome type 1, and TG6 in gluten axonal neuropathy and gluten ataxia. Much still remains to be learned and confirmed with respect to disease mechanisms, particularly with respect to TG-related immune diseases, in which development of isozyme-specific inhibitors may be useful for treatment.Lorand, L., Iismaa, S. E. Transglutaminase diseases: from biochemistry to the bedside.	[Lorand, Laszlo] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Iismaa, Siiri E.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia; [Iismaa, Siiri E.] Univ New South Wales, St Vincents Clin Sch, Kensington, NSW, Australia	Northwestern University; Feinberg School of Medicine; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Iismaa, SE (corresponding author), Victor Chang Cardiac Res Inst, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	s.iismaa@victorchang.edu.au	Iismaa, Siiri/C-9300-2013	Iismaa, Siiri/0000-0003-2409-7356	National Health and Medical Research Council of Australia [573732, 1074386]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	H The authors thank Dr. Kurt J. Isselbacher and Dr. Alessio Fasano (both from Harvard Medical School and Massachussetts General Hospital, Boston, MA, USA) for the benefit of discussion about celiac disease. S.E.I. is grateful for support from the National Health and Medical Research Council of Australia (Grants 573732 and 1074386). The authors declare no conflicts of interest.	Ablin RJ, 2017, ANTICANCER RES, V37, P481, DOI 10.21873/anticanres.11340; Basmanav FBU, 2016, AM J HUM GENET, V99, P1292, DOI 10.1016/j.ajhg.2016.10.004; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Bernassola F, 2002, FASEB J, V16, P1371, DOI 10.1096/fj.01-0689com; BOARD PG, 1993, BLOOD REV, V7, P229, DOI 10.1016/0268-960X(93)90010-2; Bognar P, 2014, J INVEST DERMATOL, V134, P105, DOI 10.1038/jid.2013.307; BOUHASSIRA EE, 1992, BLOOD, V79, P1846; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Cheng T, 2014, J MOL CELL BIOL, V6, P506, DOI 10.1093/jmcb/mju039; Cosgrove D, 2018, KIDNEY INT, V94, P303, DOI 10.1016/j.kint.2018.02.024; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Dean MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003185; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Dubbink HJ, 1998, GENOMICS, V51, P434, DOI 10.1006/geno.1998.5393; DUCKERT F, 1960, THROMB DIATH HAEMOST, V5, P179, DOI 10.1055/s-0038-1654918; Fisher ML, 2016, CANCER RES, V76, P7265, DOI 10.1158/0008-5472.CAN-16-2032; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; HAYASHI S, 1974, BIOCHEM BIOPH RES CO, V57, P1038, DOI 10.1016/0006-291X(74)90801-8; Hitomi K., 2015, TRANSGLUTAMINASES MU, P63; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Iismaa S. E., 2015, TRANSGLUTAMINASES MU, P83; Iismaa S. E, 2016, ANN TRANSLATIONAL S1, V4, P35; Iismaa SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063346; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Ikenaga N, 2017, GUT, V66, P1697, DOI 10.1136/gutjnl-2016-312473; Iversen R, 2013, J IMMUNOL, V190, P5981, DOI 10.4049/jimmunol.1300183; John S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034252; Johnson GVW, 2004, J NEUROSCI METH, V134, P151, DOI 10.1016/j.jneumeth.2003.11.006; Johnson TS, 1997, J CLIN INVEST, V99, P2950, DOI 10.1172/JCI119490; Keillor JW, 2016, EXPERT OPIN THER PAT, V26, P49, DOI 10.1517/13543776.2016.1115836; Kim DS, 2010, BIOCHEM BIOPH RES CO, V403, P479, DOI 10.1016/j.bbrc.2010.11.063; Koseki-Kuno S, 2003, BLOOD, V102, P4410, DOI 10.1182/blood-2003-05-1467; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; Landegren N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9186; Lauer P, 2002, THROMB HAEMOSTASIS, V88, P967, DOI 10.1055/s-0037-1613342; Lionetti E, 2012, J PEDIATR-US, V161, P908, DOI 10.1016/j.jpeds.2012.05.008; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LOPACIUK S, 1978, J CLIN INVEST, V61, P1196, DOI 10.1172/JCI109035; LORAND L, 1955, P SOC EXP BIOL MED, V89, P45; Lorand L, 2005, J THROMB HAEMOST, V3, P1337, DOI 10.1111/j.1538-7836.2005.01213.x; Lorand L, 1996, P NATL ACAD SCI USA, V93, P14310, DOI 10.1073/pnas.93.25.14310; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 1999, BLOOD, V93, P909, DOI 10.1182/blood.V93.3.909.403k17_909_917; Lorand L, 2000, ARTERIOSCL THROM VAS, V20, P2, DOI 10.1161/01.ATV.20.1.2; LORAND L, 1972, BIOCHEMISTRY-US, V11, P434, DOI 10.1021/bi00753a021; Lorand L, 2002, NEUROCHEM INT, V40, P7, DOI 10.1016/S0197-0186(01)00056-0; Lorand L, 1980, Prog Hemost Thromb, V5, P245; LORAND L, 1950, NATURE, V166, P694, DOI 10.1038/166694a0; LORAND L, 1976, P NATL ACAD SCI USA, V73, P4479, DOI 10.1073/pnas.73.12.4479; LORAND L, 1981, P NATL ACAD SCI-BIOL, V78, P1356, DOI 10.1073/pnas.78.3.1356; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lorand L, 1998, NAT GENET, V20, P231, DOI 10.1038/3033; Lorand L, 2007, FASEB J, V21, P1627, DOI 10.1096/fj.07-0602ufm; Lorand Laszlo, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P385; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Menalled LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099520; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Mousa A, 2017, CELL DEATH DIFFER, V24, P844, DOI 10.1038/cdd.2017.21; Muszbek L, 2018, J THROMB HAEMOST, V16, P822, DOI 10.1111/jth.13982; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nemes Zoltan, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P347; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Perelis M, 2015, SCIENCE, V350, DOI 10.1126/science.aac4250; Peters LL, 1999, J CLIN INVEST, V103, P1527, DOI 10.1172/JCI5766; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Pitolli C, 2017, AMINO ACIDS, V49, P635, DOI 10.1007/s00726-016-2356-3; Porzio O, 2007, Hum Mutat, V28, P1150, DOI 10.1002/humu.9511; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; SARKAR NK, 1957, BIOCHIM BIOPHYS ACTA, V25, P451, DOI 10.1016/0006-3002(57)90512-7; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Sharief LAT, 2013, HAEMOPHILIA, V19, pE349, DOI 10.1111/hae.12259; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; SIMON M, 1984, CELL, V36, P827, DOI 10.1016/0092-8674(84)90032-1; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; Tatsukawa H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25674-4; Tatsukawa H, 2017, SCI REP-UK, V7, DOI 10.1038/srep45049; Thibaut S, 2005, J INVEST DERMATOL, V125, P581, DOI 10.1111/j.0022-202X.2005.23868.x; Van Strien ME, 2011, GLIA, V59, P1622, DOI 10.1002/glia.21204; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wang Z, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0573-2; WILLIAMSASHMAN HG, 1977, BIOCHEM BIOPH RES CO, V79, P1192, DOI 10.1016/0006-291X(77)91132-9; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710	90	17	18	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					3	12		10.1096/fj.201801544R	http://dx.doi.org/10.1096/fj.201801544R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30593123				2022-12-28	WOS:000457401500002
J	Lindgren, IM; Drake, RR; Chattergoon, NN; Thornburg, KL				Lindgren, Isa M.; Drake, Rachel R.; Chattergoon, Natasha N.; Thornburg, Kent L.			Down-regulation of MEIS1 promotes the maturation of oxidative phosphorylation in perinatal cardiomyocytes	FASEB JOURNAL			English	Article						fetal heart; development; metabolic shift; glycolysis; mitochondrial respiration	HEMATOPOIETIC STEM-CELLS; METABOLIC PHENOTYPE; POSTNATAL CHANGES; FETAL SHEEP; GROWTH; HYPOXIA; OXYGEN; CONSUMPTION; NEWBORN; DIFFERENTIATION	Fetal cardiomyocytes shift from glycolysis to oxidative phosphorylation around the time of birth. Myeloid ecotropic viral integration site 1 (MEIS1) is a transcription factor that promotes glycolysis in hematopoietic stem cells. We reasoned that MEIS1 could have a similar role in the developing heart. We hypothesized that suppression of MEIS1 expression in fetal sheep cardiomyocytes leads to a metabolic switch as found at birth. Expression of MEIS1 was assayed in left ventricular cardiac tissue and primary cultures of cardiomyocytes from fetal (100- and 135-d gestation, term = 145 d), neonatal, and adult sheep. Cultured cells were treated with short interfering RNA (siRNA) to suppress MEIS1. Oxygen consumption rate was assessed with the Seahorse metabolic flux analyzer, and mitochondrial activity was assessed by staining cells with MitoTracker Orange. Cardiomyocyte respiratory capacity increased with advancing age concurrently with decreased expression of MEIS1. MEIS1 suppression with siRNA increased maximal oxygen consumption in fetal cells but not in postnatal cells. Mitochondrial activity was increased and expression of glycolytic genes decreased when MEIS1 expression was suppressed. Thus, we conclude that MEIS1 is a key regulator of cardiomyocyte metabolism and that the normal down-regulation of MEIS1 with age underlies a gradual switch to oxidative metabolism.-Lindgren, I. M., Drake, R. R., Chattergoon, N. N., Thornburg, K. L. Down-regulation of MEIS1 promotes the maturation of oxidative phosphorylation in perinatal cardiomyocytes.	[Lindgren, Isa M.; Drake, Rachel R.; Chattergoon, Natasha N.; Thornburg, Kent L.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Ctr Dev Hlth, 3303 SW Bond Ave,CH14T, Portland, OR 97239 USA	Oregon Health & Science University	Lindgren, IM (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Ctr Dev Hlth, 3303 SW Bond Ave,CH14T, Portland, OR 97239 USA.	isamarialindgren@gmail.com		Drake, Rachel/0000-0002-1699-9192	M. Lowell Edwards Endowment; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [408 P01HD034430, R21 HD090529]; Sixten Gemzeus Foundation; Carl Tryggers Foundation; Sweden-America Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD034430, R21HD090529] Funding Source: NIH RePORTER	M. Lowell Edwards Endowment; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sixten Gemzeus Foundation; Carl Tryggers Foundation; Sweden-America Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Sonnet Jonker and Samantha Louey for helpful comments on the manuscript and Haeri Choi for technical support (all from Oregon Health and Science University). This research was supported by the M. Lowell Edwards Endowment, and the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grants 408 P01HD034430 and R21 HD090529 to K.L.T.). I.M.L. was supported by training grants from the Sixten Gemzeus Foundation, the Carl Tryggers Foundation, and the Sweden-America Foundation. The authors declare no conflicts of interest.	American Heart Association, 2016, PROJECTIONS CARDIOVA; Arciuch VGA, 2013, CANCER RES, V73, P5459, DOI 10.1158/0008-5472.CAN-13-1429; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BEATTY CH, 1968, PEDIATRICS, V42, P5; Breckenridge RA, 2014, J CARDIOVASC DEV DIS, V1, P29, DOI 10.3390/jcdd1010029; Breckenridge RA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001666; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Chattergoon NN, 2012, FASEB J, V26, P397, DOI 10.1096/fj.10-179895; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; COMLINE RS, 1972, J PHYSIOL-LONDON, V222, P233, DOI 10.1113/jphysiol.1972.sp009795; DAWES GS, 1980, J PHYSIOL-LONDON, V309, P405, DOI 10.1113/jphysiol.1980.sp013516; Dunbar SB, 2018, CIRCULATION, V137, pE558, DOI 10.1161/CIR.0000000000000570; FISHER DJ, 1981, PEDIATR RES, V15, P843, DOI 10.1203/00006450-198115050-00003; FISHER DJ, 1980, AM J PHYSIOL, V238, pH399, DOI 10.1152/ajpheart.1980.238.3.H399; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; GROSS SJ, 1983, NEW ENGL J MED, V308, P237, DOI 10.1056/NEJM198302033080501; Hay WW, 2008, NEONATOLOGY, V94, P245, DOI 10.1159/000151643; Jonker SS, 2016, J ENDOCRINOL, V228, pR1, DOI 10.1530/JOE-15-0309; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; Jonker SS, 2015, FASEB J, V29, P4346, DOI 10.1096/fj.15-272013; Kirito K, 2004, MOL CELL BIOL, V24, P6751, DOI 10.1128/MCB.24.15.6751-6762.2004; KLOPFENSTEIN HS, 1978, CIRC RES, V42, P839, DOI 10.1161/01.RES.42.6.839; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; March of Dimes, 2016, 2016 PREM BIRTH REP; Mills RJ, 2017, P NATL ACAD SCI USA, V114, pE8372, DOI 10.1073/pnas.1707316114; Neary MT, 2014, J MOL CELL CARDIOL, V74, P340, DOI 10.1016/j.yjmcc.2014.06.013; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patterson AJ, 2010, CURR MOL MED, V10, P653; Perales-Clemente E, 2014, ANTIOXID REDOX SIGN, V21, P1648, DOI 10.1089/ars.2014.6000; RELLER MD, 1987, PEDIATR RES, V22, P621, DOI 10.1203/00006450-198712000-00001; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; RUDOLPH AM, 1970, CIRCULATION, V41, P343, DOI 10.1161/01.CIR.41.2.343; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; SPARKS JW, 1982, J CLIN INVEST, V70, P179, DOI 10.1172/JCI110591; Sundgren NC, 2003, J PHYSIOL-LONDON, V548, P881, DOI 10.1113/jphysiol.2003.038778; Thureen P J, 2001, Semin Neonatol, V6, P403, DOI 10.1053/siny.2001.0061; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; WELLS RJ, 1972, AM J PHYSIOL, V222, P1488, DOI 10.1152/ajplegacy.1972.222.6.1488; Zhang CC, 2014, ANTIOXID REDOX SIGN, V20, P1891, DOI 10.1089/ars.2012.5019	44	16	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7417	7426		10.1096/fj.201801330RR	http://dx.doi.org/10.1096/fj.201801330RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30884246	Green Published			2022-12-28	WOS:000476114200060
J	Shao, S; Fang, H; Zhang, JL; Jiang, M; Xue, K; Ma, JY; Zhang, JY; Lei, J; Zhang, YY; Li, B; Yuan, X; Dang, EL; Wang, G				Shao, Shuai; Fang, Hui; Zhang, Jingliang; Jiang, Man; Xue, Ke; Ma, Jingyi; Zhang, Jieyu; Lei, Jie; Zhang, Yangyang; Li, Bing; Yuan, Xu; Dang, Erle; Wang, Gang			Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes	FASEB JOURNAL			English	Article						GPP; autoimmune; neutrophils; vesicles; OLFM4	MONOCYTE ADSORPTION APHERESIS; IL-36; MATRIX-METALLOPROTEINASE-9; PROLIFERATION; GRANULOCYTE; MECHANISM; MICROVESICLES; INFILTRATION; AUTOIMMUNE; CYTOKINES	Generalized pustular psoriasis (GPP) is a rare and severe inflammatory skin disease that can be life-threatening. Gene mutations are found in some cases, but its immune pathogenesis is largely unknown. Here, we observed that the neutrophil:lymphocyte ratio in patients with GPP was higher than that in healthy controls and decreased after effective treatment. Neutrophils isolated from patients with GPP induced higher expressions of inflammatory genes including IL-1 beta, IL-36G, IL-18, TNF-alpha, and C-X-C motif chemokine ligands in keratinocytes than normal neutrophils did. Moreover, neutrophils from patients with GPP secreted more exosomes than controls, which were then rapidly internalized by keratinocytes, increasing the expression of these inflammatory molecules via activating NF-kappa B and MAPK signaling pathways. The proteomic profiles in neutrophil exosomes further characterized functional proteins and identified olfactomedin 4 as the critical differentially expressed protein that mediates the autoimmune inflammatory responses of GPP. These results demonstrate that neutrophil exosomes have an immune-regulatory effect on keratinocytes, which modulates immune cell migration and autoinflammation in GPP.-Shao, S., Fang, H., Zhang, J., Jiang, M., Xue, K., Ma, J., Zhang, J., Lei, J., Zhang, Y., Li, B., Yuan, X., Dang, E., Wang, G. Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes.	[Shao, Shuai; Fang, Hui; Zhang, Jingliang; Jiang, Man; Xue, Ke; Ma, Jingyi; Zhang, Jieyu; Lei, Jie; Zhang, Yangyang; Li, Bing; Yuan, Xu; Dang, Erle; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Dang, EL; Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China.	dangerle@fmmu.edu.cn; xjwgang@fmrnu.edu.cn	Wang, Gang/H-6710-2019; zhang, yangyang/GZG-7467-2022	Dang, Erle/0000-0003-4761-6673; Wang, Gang/0000-0002-5842-8080; Li, Bing/0000-0002-8080-9883	National Natural Science Foundation of China [81430073, 81673051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank the psoriasis patients and healthy donors for their participation in this study. This study was supported by the National Natural Science Foundation of China (81430073 and 81673051). The authors declare no conflicts of interest.	Alder MN, 2017, CRIT CARE MED, V45, pE426, DOI 10.1097/CCM.0000000000002102; Almutairi D, 2018, J CUTAN MED SURG, V22, P507, DOI 10.1177/1203475418758986; Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Ataseven Arzu, 2014, Mater Sociomed, V26, P231, DOI 10.5455/msm.2014.231-233; Bachelez H, 2018, BRIT J DERMATOL, V178, P614, DOI 10.1111/bjd.16232; Balato A, 2016, J INVEST DERMATOL, V136, P1520, DOI 10.1016/j.jid.2016.03.020; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Bridgewood C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00200; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Cheung KL, 2016, J EXP MED, V213, P2399, DOI 10.1084/jem.20160258; Clancy DM, 2018, CELL REP, V22, P2937, DOI 10.1016/j.celrep.2018.02.062; Clark HL, 2016, J IMMUNOL, V196, P336, DOI 10.4049/jimmunol.1502037; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Cymbaluk-Ploska A, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/6589262; D'Amico F, 2018, INFLAMM RES, V67, P609, DOI 10.1007/s00011-018-1147-6; Duvallet E, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1198865; Eken C, 2008, J IMMUNOL, V180, P817, DOI 10.4049/jimmunol.180.2.817; Fang H, 2018, J PATHOL, V245, P114, DOI 10.1002/path.5061; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Fujii A, 2018, THER APHER DIAL, V22, P92, DOI 10.1111/1744-9987.12596; Fujisawa T, 2015, THER APHER DIAL, V19, P336, DOI 10.1111/1744-9987.12342; Henry CM, 2016, CELL REP, V14, P708, DOI 10.1016/j.celrep.2015.12.072; Jin H, 2015, J DERMATOL, V42, P674, DOI 10.1111/1346-8138.12863; Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Koike Y, 2017, BRIT J DERMATOL, V177, P1732, DOI 10.1111/bjd.15509; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kormelink TG, 2018, SEMIN IMMUNOPATHOL, V40, P439, DOI 10.1007/s00281-018-0681-1; Lee YS, 2018, ACS NANO, V12, P2531, DOI 10.1021/acsnano.7b08297; Liang Y, 2017, CURR OPIN IMMUNOL, V49, P1, DOI 10.1016/j.coi.2017.07.007; Liu WL, 2018, AM J PHYSIOL-CELL PH, V315, pC494, DOI 10.1152/ajpcell.00336.2017; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Macleod T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24880; Mahil SK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2514; Majumdar R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002336; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McBride JD, 2017, J INVEST DERMATOL, V137, P1622, DOI 10.1016/j.jid.2017.04.021; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nicolas E, 2011, LEUKEMIA, V25, P57, DOI 10.1038/leu.2010.251; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Papadaki G, 2016, EUR J IMMUNOL, V46, P2542, DOI 10.1002/eji.201646542; Prieto D, 2017, BLOOD, V130, P777, DOI 10.1182/blood-2017-02-769851; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Riani M, 2017, J ALLERGY CLIN IMMUN, V139, P863, DOI 10.1016/j.jaci.2016.08.012; Rogalski C, 2002, J INVEST DERMATOL, V118, P49, DOI 10.1046/j.0022-202x.2001.01650.x; Rood KM, 2016, AM J REPROD IMMUNOL, V76, P108, DOI 10.1111/aji.12523; Sabbione F, 2017, J INNATE IMMUN, V9, P387, DOI 10.1159/000460293; Saikaly SK, 2016, CUREUS, V8, DOI 10.7759/cureus.652; Setta-Kaffetzi N, 2014, AM J HUM GENET, V94, P790, DOI 10.1016/j.ajhg.2014.04.005; Shao S, 2016, J INVEST DERMATOL, V136, P1418, DOI 10.1016/j.jid.2016.03.002; Shen GF, 2017, EUR J IMMUNOL, V47, P900, DOI 10.1002/eji.201546203; Slater TW, 2017, J IMMUNOL, V198, P2886, DOI 10.4049/jimmunol.1601810; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tonello S, 2017, J DERMATOL SCI, V88, P110, DOI 10.1016/j.jdermsci.2017.05.010; Twelves S, 2019, J ALLERGY CLIN IMMUN, V143, P1021, DOI 10.1016/j.jaci.2018.06.038; Umezawa Y, 2003, ARCH DERMATOL RES, V295, pS43, DOI 10.1007/s00403-002-0371-6; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vargas A, 2016, AM J RESP CELL MOL, V55, P450, DOI 10.1165/rcmb.2016-0033OC; Walz W, 2017, NEUROCHEM RES, V42, P2560, DOI 10.1007/s11064-017-2265-1; Wang L, 2018, J STRATEGY MANAG, V11, P52, DOI 10.1108/JSMA-11-2016-0083; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Welin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069575; Wu Xiaoqi, 2017, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V42, P173, DOI 10.11817/j.issn.1672-7347.2017.02.009; Yamamoto M, 2013, DIS MARKERS, V34, P153, DOI [10.1155/2013/702763, 10.3233/DMA-120958]; Zhang L, 2017, J EUR ACAD DERMATOL, V31, pE491, DOI 10.1111/jdv.14334; Zhang WG, 2017, J PATHOL, V241, P392, DOI 10.1002/path.4848	71	38	39	3	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6813	6828		10.1096/fj.201802090RR	http://dx.doi.org/10.1096/fj.201802090RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811955				2022-12-28	WOS:000476114200012
J	Geng, J; Wei, MZ; Yuan, X; Liu, ZQ; Wang, XX; Zhang, DM; Luo, L; Wu, JC; Guo, WJ; Qin, ZH				Geng, Ji; Wei, Mingzhen; Yuan, Xiao; Liu, Ziqi; Wang, Xinxin; Zhang, Dingmei; Luo, Li; Wu, Junchao; Guo, Wenjie; Qin, Zheng-Hong			TIGAR regulates mitochondrial functions through SIRT1-PGC1 pathway and translocation of TIGAR into mitochondria in skeletal muscle	FASEB JOURNAL			English	Article						exhaustive exercise; type IIA fiber; mitochondrial content	GENE-EXPRESSION; TP53-INDUCED GLYCOLYSIS; EXERCISE PERFORMANCE; APOPTOSIS REGULATOR; ENERGY-PRODUCTION; S-SULFHYDRATION; ATP SYNTHASE; RESISTANCE; LOCALIZATION; FATIGUE	TP53-induced glycolysis and apoptosis regulator (TIGAR), a glycolytic inhibitor, plays vital roles in regulating cellular metabolism and oxidative stress. However, the role of highly expressed TIGAR in skeletal muscle remains unexplored. In the present study, TIGAR levels varied in different skeletal muscles and fibers. An exhaustive swimming test with a load corresponding to 5% of body weight was utilized in mice to assess the effects of TIGAR on exercise-induced fatigue and muscle damage. The running time and metabolic indicators were significantly greater in wild-type (WT) mice compared with TIGAR knockout (KO) mice. Poor exercise capacity was accompanied by decreased type IIA fibers in TIGAR KO mice. Decreased mitochondrial number and mitochondrial oxidative phosphorylation were observed more in TIGAR KO mice than in WT mice, which were involved in sirtuin 1 (SIRT1)-mediated deacetylation of peroxisome proliferator-activated receptor coactivator 1 (PGC1), and resveratrol treatment in TIGAR KO mice can increase mitochondrial content and exercise time. Much more TIGAR was also detected in mitochondria during exhaustive exercise. In addition, TIGAR, rather than mitochondria-targeted TIGAR achieved by in vitro plasmid transfection, promoted SIRT1-PGC1 pathway. Glutathione S-transferase-TIGAR pull-down assay followed by liquid chromatography mass spectrometry found that TIGAR interacted with ATP synthase F1 subunit (ATP5A1), and its binding to ATP5A1 increased during exhaustive exercise. Overexpression of mitochondrial-TIGAR enhanced ATP generation, maintained mitochondrial membrane potential and reduced mitochondrial oxidative stress under hypoxia condition. Taken together, our results uncovered a novel role for TIGAR in mitochondrial regulation in fast-twitch oxidative skeletal muscle through SIRT1-PGC1 and translocation into mitochondria, which contribute to the increase in exercise endurance of mice.Geng, J., Wei, M., Yuan, X., Liu, Z., Wang, X., Zhang, D., Luo, L., Wu, J., Guo, W., Qin, Z.-H. TIGAR regulates mitochondrial functions through SIRT1-PGC1 pathway and translocation of TIGAR into mitochondria in skeletal muscle.	[Geng, Ji; Wei, Mingzhen; Liu, Ziqi; Wang, Xinxin; Zhang, Dingmei; Wu, Junchao; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; [Geng, Ji; Wei, Mingzhen; Liu, Ziqi; Wang, Xinxin; Zhang, Dingmei; Wu, Junchao; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Lab Aging & Nervous Dis, Suzhou, Peoples R China; [Luo, Li] Soochow Univ, Sch Phys Educ & Sports Sci, Suzhou, Peoples R China; [Yuan, Xiao] Soochow Univ, Affiliated Hosp 1, Pathol Dept, Suzhou, Peoples R China; [Guo, Wenjie] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Nanjing University	Qin, ZH (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Med Coll, 199 Renai Rd, Suzhou 215123, Peoples R China.	qinzhenhong@suda.edu.cn	Wang, Xin/AAN-8435-2021; Zhang, Dingmei/ABC-7476-2020; Wang, Xin/GYU-1129-2022	Wang, Xin/0000-0002-4457-7376; Geng, Ji/0000-0002-6055-7156; Zhang, Dingmei/0000-0003-2169-6994	National Natural Science Foundation of China [81730092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 81730092 to Z.-H.Q.). The authors declare no conflicts of interest.	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; BANGSBO J, 1990, J PHYSIOL-LONDON, V422, P539, DOI 10.1113/jphysiol.1990.sp018000; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Campbell WG, 2001, AM J PHYSIOL-CELL PH, V280, pC763, DOI 10.1152/ajpcell.2001.280.4.C763; Cannavino J, 2015, J PHYSIOL-LONDON, V593, P1981, DOI 10.1113/jphysiol.2014.286740; Cao LJ, 2015, NEUROSCI BULL, V31, P527, DOI 10.1007/s12264-015-1538-4; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chamari K, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0012-1; Chen JY, 2018, NEUROPHARMACOLOGY, V131, P377, DOI 10.1016/j.neuropharm.2018.01.012; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002; Feng J, 2018, ONCOL LETT, V15, P155, DOI 10.3892/ol.2017.7303; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; Geng J, 2018, FREE RADICAL RES, V52, P1240, DOI 10.1080/10715762.2018.1489133; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Haizlip KM, 2015, PHYSIOLOGY, V30, P30, DOI 10.1152/physiol.00024.2014; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310; Iizuka K, 2014, ANN CLIN LAB SCI, V44, P272; Jacobs RA, 2013, J GERONTOL A-BIOL, V68, P1010, DOI 10.1093/gerona/gls335; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; JANSSON E, 1983, HISTOCHEMISTRY, V78, P121, DOI 10.1007/BF00491118; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; Ko YH, 2016, J BIOL CHEM, V291, P26291, DOI 10.1074/jbc.M116.740209; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lavery GG, 2008, J BIOL CHEM, V283, P8453, DOI 10.1074/jbc.M710067200; Lee P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.205; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li M, 2014, J NEUROSCI, V34, P7458, DOI 10.1523/JNEUROSCI.4655-13.2014; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu JB, 2018, HUM PATHOL, V77, P54, DOI 10.1016/j.humpath.2017.12.029; Ma T, 2017, BIOCHEM PHARMACOL, V143, P90, DOI 10.1016/j.bcp.2017.07.018; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; Modis K, 2016, PHARMACOL RES, V113, P116, DOI 10.1016/j.phrs.2016.08.023; Mohamed JS, 2014, DIABETES, V63, P1546, DOI 10.2337/db13-1364; Murton AJ, 2014, J APPL PHYSIOL, V116, P113, DOI 10.1152/japplphysiol.00426.2013; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ni R, 2016, DIABETES, V65, P255, DOI 10.2337/db15-0963; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Qi ZT, 2011, FREE RADICAL BIO MED, V50, P794, DOI 10.1016/j.freeradbiomed.2010.12.022; Qian SX, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0360-4; Reyes NL, 2015, P NATL ACAD SCI USA, V112, P424, DOI 10.1073/pnas.1413021112; Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schiller D, 2008, MOL CELL BIOL, V28, P4424, DOI 10.1128/MCB.00007-08; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Tajsharghi H, 2010, BRAIN, V133, P1451, DOI 10.1093/brain/awq083; Takeda K, 2011, J NUTR SCI VITAMINOL, V57, P246, DOI 10.3177/jnsv.57.246; TESCH PA, 1986, EUR J APPL PHYSIOL, V55, P362, DOI 10.1007/BF00422734; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Wang CN, 2018, MOL CELL ENDOCRINOL, V474, P65, DOI 10.1016/j.mce.2018.02.011; Wang CK, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12440; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Wu RE, 2013, MOLECULES, V18, P4689, DOI 10.3390/molecules18044689; Yu HP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09853; Yuan LS, 2018, ONCOL REP, V39, P525, DOI 10.3892/or.2017.6132; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047; Zhou H, 2017, BIOINFORMATICS, V33, P843, DOI 10.1093/bioinformatics/btw723; Zhou JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27096	69	17	17	7	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6082	6098		10.1096/fj.201802209R	http://dx.doi.org/10.1096/fj.201802209R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30726106	Bronze			2022-12-28	WOS:000466932600024
J	Glantschnig, C; Koenen, M; Gil-Lozano, M; Karbiener, M; Pickrahn, I; Williams-Dautovich, J; Patel, R; Cummins, CL; Giroud, M; Hartleben, G; Vogl, E; Bluher, M; Tuckermann, J; Uhlenhaut, H; Herzig, S; Scheideler, M				Glantschnig, Christina; Koenen, Mascha; Gil-Lozano, Manuel; Karbiener, Michael; Pickrahn, Ines; Williams-Dautovich, Jasmine; Patel, Rucha; Cummins, Carolyn L.; Giroud, Maude; Hartleben, Gotz; Vogl, Elena; Blueher, Matthias; Tuckermann, Jan; Uhlenhaut, Henriette; Herzig, Stephan; Scheideler, Marcel			A miR-29a-driven negative feedback loop regulates peripheral glucocorticoid receptor signaling	FASEB JOURNAL			English	Article						adipogenesis; adipose tissue; miRNA; arthritis; metabolism	ADIPOCYTE DIFFERENTIATION; RHEUMATOID-ARTHRITIS; PPAR-GAMMA; CORTICOSTEROID RESISTANCE; MOLECULAR-MECHANISMS; ADIPOGENESIS; EXPRESSION; CHROMATIN; HORMONES; PROMOTES	The glucocorticoid receptor (GR) represents the crucial molecular mediator of key endocrine, glucocorticoid hormone-dependent regulatory circuits, including control of glucose, protein, and lipid homeostasis. Consequently, aberrant glucocorticoid signaling is linked to severe metabolic disorders, including insulin resistance, obesity, and hyperglycemia, all of which also appear upon chronic glucocorticoid therapy for the treatment of inflammatory conditions. Of note, long-term glucocorticoid exposure under these therapeutic conditions typically induces glucocorticoid resistance, requiring higher doses and consequently triggering more severe metabolic phenotypes. However, the molecular basis of acquired glucocorticoid resistance remains unknown. In a screen of differential microRNA expression during glucocorticoid-dependent adipogenic differentiation of human multipotent adipose stem cells, we identified microRNA 29a (miR-29a) as one of the most down-regulated transcripts. Overexpression of miR-29a impaired adipogenesis. We found that miR-29a represses GR in human adipogenesis by directly targeting its mRNA, and downstream analyses revealed that GR mediates most of miR-29a's anti-adipogenic effects. Conversely, miR-29a expression depends on GR activation, creating a novel miR-29-driven feedback loop. miR-29a and GR expression were inversely correlated both in murine adipose tissue and in adipose tissue samples obtained from human patients. In the latter, miR-29a levels were additionally strongly negatively correlated with body mass index and adipocyte size. Importantly, inhibition of miR-29 in mice partially rescued the down-regulation of GR during dexamethasone treatment. We discovered that, in addition to modulating GR function under physiologic conditions, pharmacologic glucocorticoid application in inflammatory disease also induced miR-29a expression, correlating with reduced GR levels. This effect was abolished in mice with impaired GR function. In summary, we uncovered a novel GR-miR-29a negative feedback loop conserved between mice and humans, in health and disease. For the first time, we elucidate a microRNA-related mechanism that might contribute to GR dysregulation and resistance in peripheral tissues.Glantschnig, C., Koenen, M., Gil-Lozano, M., Karbiener, M., Pickrahn, I., Williams-Dautovich, J., Patel, R., Cummins, C. L., Giroud, M., Hartleben, G., Vogl, E., Bluher, M., Tuckermann, J., Uhlenhaut, H., Herzig, S., Scheideler, M. A miR-29a-driven negative feedback loop regulates peripheral glucocorticoid receptor signaling.	[Glantschnig, Christina; Gil-Lozano, Manuel; Giroud, Maude; Hartleben, Gotz; Vogl, Elena; Herzig, Stephan; Scheideler, Marcel] Helmholtz Ctr Munich, IDC, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany; [Uhlenhaut, Henriette] Helmholtz Ctr Munich, Res Grp Mol Endocrinol, Neuherberg, Germany; [Glantschnig, Christina; Gil-Lozano, Manuel; Giroud, Maude; Hartleben, Gotz; Vogl, Elena; Herzig, Stephan; Scheideler, Marcel] Heidelberg Univ Hosp, Joint Heidelberg IDC, Inner Med 1, Heidelberg, Germany; [Glantschnig, Christina; Gil-Lozano, Manuel; Giroud, Maude; Hartleben, Gotz; Vogl, Elena; Herzig, Stephan; Scheideler, Marcel] German Ctr Diabet Res DZD, Neuherberg, Germany; [Koenen, Mascha; Tuckermann, Jan] Ulm Univ, Inst Comparat Mol Endocrinol, Ulm, Germany; [Karbiener, Michael] Univ Hosp, Med Univ Graz, Dept Otorhinolaryngol, Div Phoniatr Speech & Swallowing, Graz, Austria; [Pickrahn, Ines] Univ Salzburg, Dept Legal Med, Salzburg, Austria; [Williams-Dautovich, Jasmine; Patel, Rucha; Cummins, Carolyn L.] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Blueher, Matthias] Med Res Ctr, Clin Endocrinol & Nephrol, Leipzig, Germany; [Herzig, Stephan] Tech Univ Munich, Sch Med, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Ulm University; Medical University of Graz; Salzburg University; University of Toronto; Technical University of Munich	Herzig, S; Scheideler, M (corresponding author), Helmholtz Ctr Munich, IDC, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.	stephan.herzig@helmholtz-muenchen.de; marcel.scheideler@helmholtz-muenchen.de	Koenen, Mascha/GWZ-9700-2022; Uhlenhaut, Henriette/AAP-5400-2020; Uhlenhaut, Henriette/AFR-1141-2022; Scheideler, Marcel/B-3087-2015	Scheideler, Marcel/0000-0003-4650-7387; Koenen, Mascha/0000-0002-1024-4506; Cummins, Carolyn/0000-0001-7603-6577; Uhlenhaut, Henriette/0000-0002-4220-4779	European Seventh Framework Programme (FP7) Project DIABAT [Health-F2-2011-27873]; Austrian Science Fund (FWF) [P25729-B19]; Austrian Academy of Sciences Fellowship [OAW-DOC 24325]; Collaborative Research Centre/Transregio (CRC/TRR) 205 "The Adrenal"; European Union Research and Innovation Funding Program (FP7) Brainage; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft (Grants Priority Program Immunobone) [1468/Tu 220/6-1, 1468/Tu 220//6-2]; Deutsche Forschungsgemeinschaft (Collaborative Research Centre) [1149/C02/INST 40/492-1, DFG-ANR/TU 220/13-1, 314061271]	European Seventh Framework Programme (FP7) Project DIABAT; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Academy of Sciences Fellowship(Austrian Science Fund (FWF)); Collaborative Research Centre/Transregio (CRC/TRR) 205 "The Adrenal"; European Union Research and Innovation Funding Program (FP7) Brainage; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (Grants Priority Program Immunobone)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Collaborative Research Centre)(German Research Foundation (DFG))	The authors thank Christian Dani and Ez-Zoubir Amri (Institut de Biologie Valrose, Universite Nice Sophia Antipolis, France) for providing human multipotent adipose stem cells, Lara Shahidian (Institute of Functional Epigenetics, Helmholtz Center Munich, Germany) for technical help, Frits Mattijssen (previously at Institute for Diabetes and Cancer, Helmholtz Center Munich, Germany) for feedback on the manuscript, and Chloe Szwer for language editing. The authors also thank Quirin Reinold (Institute for Diabetes and Cancer, Helmholtz Center Munich, Germany) for highly competent technical assistance and Peter Weber (Institute for Diabetes and Cancer, and Research Unit of Radiation Cytogenetics, Helmholtz Center Munich, Germany) and David Rugamer (previously at Department of Statistics, Ludwig-Maximiians-Universitat Munich, Germany) for advice on statistical analysis. This work was supported by the European Seventh Framework Programme (FP7) Project DIABAT (Health-F2-2011-27873 to M.S. and S.H.), the Austrian Science Fund (FWF; P25729-B19 to M.S.), an Austrian Academy of Sciences Fellowship (OAW-DOC 24325 to C.G.), the Collaborative Research Centre/Transregio (CRC/TRR) 205 "The Adrenal" (to H.U. and S.H.), the Deutsche Forschungsgemeinschaft (Grants Priority Program Immunobone 468/Tu 220/6-1 and /6-2, Collaborative Research Centre 1149/C02/INST 40/492-1, DFG-ANR/TU 220/13-1, and Project Number 314061271), and the European Union Research and Innovation Funding Program (FP7) Brainage. M.G.L. and M.G. were partially funded by postdoctoral fellowships of the Alexander von Humboldt Foundation. The authors declare no conflicts of interest.	Adcock IM, 2012, CURR OPIN PHARMACOL, V12, P246, DOI 10.1016/j.coph.2012.02.006; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; [Anonymous], MOL CELL BIOL, V16, P202, DOI [DOI 10.1128/MCB.00260-16, 10.1128/MCB.16.1.202, DOI 10.1128/MCB.16.1.202]; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barnes Peter J, 2009, Lancet, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Baschant U, 2013, MOL CELL ENDOCRINOL, V380, P108, DOI 10.1016/j.mce.2013.06.009; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chikanza IC, 2004, RHEUMATOLOGY, V43, P1337, DOI 10.1093/rheumatology/keh333; Christensen AD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00213; Clayton SA, 2018, J BIOL CHEM, V293, P1865, DOI 10.1074/jbc.R117.000366; COHEN A, 1960, JAMA-J AM MED ASSOC, V174, P831, DOI 10.1001/jama.1960.03030070009002; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; de Guia RM, 2015, EMBO J, V34, P344, DOI 10.15252/embj.201490464; de Guia RM, 2014, HORM MOL BIOL CLIN I, V19, P117, DOI 10.1515/hmbci-2014-0021; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engin A, 2017, ADV EXP MED BIOL, V960, P221, DOI 10.1007/978-3-319-48382-5_9; Farrell RJ, 2003, J ENDOCRINOL, V178, P339, DOI 10.1677/joe.0.1780339; Gomes PR, 2014, AM J PHYSIOL-ENDOC M, V306, pE109, DOI 10.1152/ajpendo.00364.2013; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Gu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep38491; Hartmann K, 2016, PHYSIOL REV, V96, P409, DOI 10.1152/physrev.00011.2015; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Karbiener M, 2014, STEM CELLS, V32, P1578, DOI 10.1002/stem.1603; Karbiener M, 2011, RNA BIOL, V8, P850, DOI 10.4161/rna.8.5.16153; Kilroy G, 2016, J BIOL CHEM, V291, P27289, DOI 10.1074/jbc.M116.744672; Kilroy G, 2012, ENDOCRINOLOGY, V153, P1206, DOI 10.1210/en.2011-1725; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Koenen M, 2018, ANN RHEUM DIS, V77, P1610, DOI 10.1136/annrheumdis-2017-212762; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kroot EJA, 2006, ANN NY ACAD SCI, V1069, P300, DOI 10.1196/annals.1351.028; Ledderose C, 2012, CRIT CARE MED, V40, P2745, DOI 10.1097/CCM.0b013e31825b8ebc; Lee MJ, 2014, BBA-MOL BASIS DIS, V1842, P473, DOI 10.1016/j.bbadis.2013.05.029; Lian WS, 2017, J MOL MED, V95, P1327, DOI 10.1007/s00109-017-1583-8; Lowin T, 2009, ARTHRITIS RHEUM-US, V60, P3623, DOI 10.1002/art.24985; Mattijssen F, 2014, J BIOL CHEM, V289, P19279, DOI 10.1074/jbc.M114.570044; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Motulsky HJ., GRAPHPAD STAT GUIDE; Movahedi M, 2016, EUR J EPIDEMIOL, V31, P1045, DOI 10.1007/s10654-016-0167-1; Mudhasani R, 2011, J CELL PHYSIOL, V226, P1399, DOI 10.1002/jcp.22475; Mudhasani R, 2010, J CELL BIOCHEM, V110, P812, DOI 10.1002/jcb.22625; Mueller KM, 2017, DIABETES, V66, P272, DOI 10.2337/db16-0381; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pek SLT, 2016, MOL CELL ENDOCRINOL, V427, P112, DOI 10.1016/j.mce.2016.03.010; Pisani Didier F, 2011, Front Endocrinol (Lausanne), V2, P87, DOI 10.3389/fendo.2011.00087; Raff H, 2015, J PHYSIOL-LONDON, V593, P493, DOI 10.1113/jphysiol.2014.282871; Ramamoorthy S, 2013, MOL CELL BIOL, V33, P1711, DOI 10.1128/MCB.01151-12; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Roh HC, 2018, CELL METAB, V27, P1121, DOI 10.1016/j.cmet.2018.03.005; Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Rose S, 2013, ANN RHEUM DIS, V72, P89, DOI 10.1136/annrheumdis-2012-201431; Ru Peng, 2017, RNA Dis, V4, DOI 10.14800/rd.1525; Ru P, 2016, CELL REP, V16, P1527, DOI 10.1016/j.celrep.2016.07.017; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Smith KM, 2012, J IMMUNOL, V189, P1567, DOI 10.4049/jimmunol.1103171; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; van Nieuwenhuijze A, 2017, CELL MOL LIFE SCI, V74, P2095, DOI 10.1007/s00018-017-2456-6; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wang FS, 2013, ARTHRITIS RHEUM-US, V65, P1530, DOI 10.1002/art.37948; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang SS, 2017, PROG NEURO-PSYCHOPH, V79, P417, DOI 10.1016/j.pnpbp.2017.07.024; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang RH, 2014, J MOL ENDOCRINOL, V52, P235, DOI 10.1530/JME-13-0273; Zhang XM, 2016, OBESITY, V24, P1097, DOI 10.1002/oby.21467; Zhu YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170636	86	23	24	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5924	5941		10.1096/fj.201801385RR	http://dx.doi.org/10.1096/fj.201801385RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30742779	Bronze, Green Submitted			2022-12-28	WOS:000466932600011
J	He, Y; Yu, LJ; Liu, JY; Li, YQ; Wu, YH; Huang, ZF; Wu, D; Wang, H; Wu, ZH; Qiu, GX				He, Yu; Yu, Lingjia; Liu, Jieying; Li, Yaqian; Wu, Yuanhao; Huang, Zhenfei; Wu, Di; Wang, Hai; Wu, Zhihong; Qiu, Guixing			Enhanced osteogenic differentiation of human bone-derived mesenchymal stem cells in 3-dimensional printed porous titanium scaffolds by static magnetic field through up-regulating Smad4	FASEB JOURNAL			English	Article						osteogenesis; bone defect; proteomics	PROLIFERATION RATE; TGF-BETA; REGENERATION; VIABILITY; MT	The reconstruction of large bone defects remains a significant challenge for orthopedists. Three-dimensional-printed (3DP) scaffold is considered a promising repair material. Static magnetic field (SMF) treatment is an effective and noninvasive therapeutic method to improve bone regeneration. However, the osteogenic effect of SMF on human bone-derived mesenchymal stem cells (hBMSCs) in 3DP scaffolds, as well as its potential mechanism, are unclear. In this study, the osteogenic effect of SMF on hBMSCs in a 3DP scaffold was investigated in vitro and in vivo. In addition, the potential mechanism for promoting osteogenesis was investigated by proteomic analysis. The results showed that SMF promoted osteogenic differentiation of hBMSCs in vitro. A total of 185 differential proteins were identified under SMF conditions by proteomic analysis. The osteogenic effect might be associated with bone morphogenetic protein-Smad1/5/8-signaling pathway and increased transport of phosphorylated Smad1/5/8 and phosphorylated Smad2/3 to the nucleus by up-regulating Smad4 under SMF conditions. The in vivo experiment showed that bone regeneration and osseointegration was enhanced by SMF in the rat model of bone defect. In conclusion, moderate SMF was a safe and effective method for enhancing osteogenesis in 3DP scaffolds in vitro and in vivo.He, Y., Yu, L., Liu, J., Li, Y., Wu, Y., Huang, Z., Wu, D., Wang, H., Wu, Z., Qiu, G. Enhanced osteogenic differentiation of human bone-derived mesenchymal stem cells in 3-dimensional printed porous titanium scaffolds by static magnetic field through up-regulating Smad4.	[He, Yu; Yu, Lingjia; Huang, Zhenfei; Wu, Di; Wang, Hai; Qiu, Guixing] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China; [Liu, Jieying; Li, Yaqian; Wu, Yuanhao; Wu, Zhihong] Peking Union Med Coll, Peking Union Med Coll Hosp, Cent Lab, Beijing, Peoples R China; [Liu, Jieying; Li, Yaqian; Wu, Yuanhao; Wu, Zhihong] Chinese Acad Med Sci, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China; [Wu, Zhihong] Beijing Key Lab Genet Res Bone & Joint Dis, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Wang, H (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China.; Wang, H (corresponding author), Chinese Acad Med Sci, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China.; Wu, ZH (corresponding author), Beijing Key Lab Genet Res Bone & Joint Dis, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China.	wanghai907@hotmail.com; wuzh3000@126.com	wu, zhi/GXH-3041-2022; Wu, Yuanhao/ABM-9242-2022; Liu, Jieying/ADZ-7556-2022; LI, YAQIAN/GQH-2240-2022		Fundamental Research Funds for Central Public Welfare Research Institutes, Chinese Academy of Medical Sciences [2016ZX310177-7]; National High-Tech Research and Development Program of China (863 Program) [2015AA020316, 2015AA033601]; Youth Foundation of Peking Union Medical College Hospital [PUMCH-2016-2.4]; Science and Technology Innovation Project of Medicine and Health, Chinese Academy of Medical Sciences [2017-I2M-2-001]	Fundamental Research Funds for Central Public Welfare Research Institutes, Chinese Academy of Medical Sciences; National High-Tech Research and Development Program of China (863 Program); Youth Foundation of Peking Union Medical College Hospital; Science and Technology Innovation Project of Medicine and Health, Chinese Academy of Medical Sciences	The authors thank Drs. Jingjing Tian and Lin Kang (Peking Union Medical College and Chinese Academy of Medical Sciences) for their help on the experiment. The authors also thank Dr. Sarah Dodds (Liwen Bianji, Edanz Editing, Beijing, China) for editing the English text of a draft of this manuscript. This work was supported by the Fundamental Research Funds for Central Public Welfare Research Institutes, Chinese Academy of Medical Sciences (2016ZX310177-7), the National High-Tech Research and Development Program of China (863 Program, 2015AA020316, 2015AA033601), Youth Foundation of Peking Union Medical College Hospital (PUMCH-2016-2.4), and Science and Technology Innovation Project of Medicine and Health, Chinese Academy of Medical Sciences (2017-I2M-2-001). The authors declare no conflicts of interest.	Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x; Aydin N, 2011, INT ORTHOP, V35, P135, DOI 10.1007/s00264-009-0932-9; Ba XL, 2011, BIOMATERIALS, V32, P7831, DOI 10.1016/j.biomaterials.2011.06.053; Beier JP, 2010, J TISSUE ENG REGEN M, V4, P216, DOI 10.1002/term.229; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chiu KH, 2007, ANN BIOMED ENG, V35, P1932, DOI 10.1007/s10439-007-9370-2; Costantino Cosimo, 2007, Acta Biomed, V78, P198; Hsu SH, 2010, CYTOTECHNOLOGY, V62, P143, DOI 10.1007/s10616-010-9271-3; Huang HM, 2006, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000203464.35561.be; Jouni FJ, 2013, IN VITRO CELL DEV-AN, V49, P212, DOI 10.1007/s11626-013-9580-x; Kim EC, 2015, BIOELECTROMAGNETICS, V36, P267, DOI 10.1002/bem.21903; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; Lewallen EA, 2016, GENE, V581, P95, DOI 10.1016/j.gene.2016.01.015; Li Y, 2012, ANN BIOMED ENG, V40, P2611, DOI 10.1007/s10439-012-0602-8; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Liu H, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045012; Mehra A, 2002, BIOCHEM CELL BIOL, V80, P605, DOI 10.1139/O02-161; Moon YJ, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.75; Nune KC, 2016, J BIOMED MATER RES A, V104, P517, DOI 10.1002/jbm.a.35592; Puricelli Edela, 2009, Head Face Med, V5, P1, DOI 10.1186/1746-160X-5-1; Xiu P, 2016, ACS APPL MATER INTER, V8, P17964, DOI 10.1021/acsami.6b05893; Xu NF, 2016, SPINE, V41, pE50, DOI 10.1097/BRS.0000000000001179; Xu SZ, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/620984; Yamaguchi-Sekino S, 2011, MAGN RESON MED SCI, V10, P1, DOI 10.2463/mrms.10.1; Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205; Yan QC, 1998, MED ENG PHYS, V20, P397, DOI 10.1016/S1350-4533(98)00051-4; Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054; Yin B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040575; Zafari J, 2015, ELECTROMAGN BIOL MED, V34, P216, DOI 10.3109/15368378.2015.1076452; Zhang H, 2018, BONE, V107, P36, DOI 10.1016/j.bone.2017.10.024; Zhang JY, 2014, APPL ENERG, V114, P146, DOI 10.1016/j.apenergy.2013.09.057	32	28	30	7	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6069	6081		10.1096/fj.201802195R	http://dx.doi.org/10.1096/fj.201802195R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30763124	Bronze			2022-12-28	WOS:000466932600023
J	Soni, S; O'Dea, KP; Tan, YY; Cho, K; Abe, E; Romano, R; Cui, J; Ma, DQ; Sarathchandra, P; Wilson, MR; Takata, M				Soni, Sanooj; O'Dea, Kieran P.; Tan, Ying Ying; Cho, Kahori; Abe, Eiko; Romano, Rosalba; Cui, Jiang; Ma, Daqing; Sarathchandra, Padmini; Wilson, Michael R.; Takata, Masao			ATP redirects cytokine trafficking and promotes novel membrane TNF signaling via microvesicles	FASEB JOURNAL			English	Article						extracellular vesicles; protein signalling; cellular communication; danger signals	NECROSIS-FACTOR-ALPHA; ACUTE LUNG INJURY; ACID SPHINGOMYELINASE; ALVEOLAR MACROPHAGES; RELEASE; ACTIVATION; CELLS; RECEPTORS; INTERLEUKIN-1-BETA; STIMULATION	Cellular stress or injury induces release of endogenous danger signals such as ATP, which plays a central role in activating immune cells. ATP is essential for the release of nonclassically secreted cytokines such as IL-1 but, paradoxically, has been reported to inhibit the release of classically secreted cytokines such as TNF. Here, we reveal that ATP does switch off soluble TNF (17 kDa) release from LPS-treated macrophages, but rather than inhibiting the entire TNF secretion, ATP packages membrane TNF (26 kDa) within microvesicles (MVs). Secretion of membrane TNF within MVs bypasses the conventional endoplasmic reticulum- and Golgi transport-dependent pathway and is mediated by acid sphingomyelinase. These membrane TNF-carrying MVs are biologically more potent than soluble TNF in vivo, producing significant lung inflammation in mice. Thus, ATP critically alters TNF trafficking and secretion from macrophages, inducing novel unconventional membrane TNF signaling via MVs without direct cell-to-cell contact. These data have crucial implications for this key cytokine, particularly when therapeutically targeting TNF in acute inflammatory diseases.Soni, S., O'Dea, K. P., Tan, Y. Y., Cho, K., Abe, E., Romano, R., Cui, J., Ma, D., Sarathchandra, P., Wilson, M. R., Takata, M. ATP redirects cytokine trafficking and promotes novel membrane TNF signaling via microvesicles.	[Soni, Sanooj; O'Dea, Kieran P.; Tan, Ying Ying; Cho, Kahori; Abe, Eiko; Romano, Rosalba; Cui, Jiang; Ma, Daqing; Wilson, Michael R.; Takata, Masao] Imperial Coll London, Chelsea & Westminster Hosp, Fac Med, Sect Anaesthet Pain Med & Intens Care, 369 Fulham Rd, London SW10 9NH, England; [Sarathchandra, Padmini] Imperial Coll London, Natl Heart & Lung Inst, Harefield Hosp, Heart Sci Ctr, Harefield, Middx, England	Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Takata, M (corresponding author), Imperial Coll London, Chelsea & Westminster Hosp, Fac Med, Sect Anaesthet Pain Med & Intens Care, 369 Fulham Rd, London SW10 9NH, England.	m.takata@imperial.ac.uk	Ma, Daqing/GLT-2735-2022	Ma, Daqing/0000-0003-1235-0537; Tan, Ying Ying/0000-0002-7452-606X; Soni, Sanooj/0000-0001-8126-8313	Medical Research Council; Chelsea and Westminster Health Charity; British Journal of Anaesthesia [P54008]; MRC [MR/M018164/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chelsea and Westminster Health Charity; British Journal of Anaesthesia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council and British Journal of Anaesthesia (P54008) and the Chelsea and Westminster Health Charity. The authors declare no conflicts of interest.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Barbera-Cremades M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00862; Beckmann N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00331; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chiaruttini G, 2016, CELL REP, V14, P2624, DOI 10.1016/j.celrep.2016.02.055; Cohen HB, 2013, BLOOD, V122, P1935, DOI 10.1182/blood-2013-04-496216; CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Dorr AD, 2011, J APPL PHYSIOL, V111, P177, DOI 10.1152/japplphysiol.00007.2011; Drago F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00910; Dubois-Colas N, 2014, J INFECT DIS, V210, P824, DOI 10.1093/infdis/jiu135; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Fehrenbach H, 2003, EUR RESPIR J, V21, P421, DOI 10.1183/09031936.03.00083002; Giuliani AL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00123; Gulinelli S, 2012, EUR J IMMUNOL, V42, P3334, DOI 10.1002/eji.201142268; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Jiang H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-69; Kawamura H, 2012, IMMUNOLOGY, V136, P448, DOI 10.1111/j.1365-2567.2012.03601.x; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Lacy P, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00190; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Levin C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01214; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Miguel RDV, 2012, J IMMUNOL METHODS, V384, P191, DOI 10.1016/j.jim.2012.07.018; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Nalos M, 2008, INTENS CARE MED, V34, P1891, DOI 10.1007/s00134-008-1156-y; O'Dea KP, 2005, AM J RESP CRIT CARE, V172, P1119, DOI 10.1164/rccm.200504-605OC; Patel BV, 2013, J IMMUNOL, V190, P4274, DOI 10.4049/jimmunol.1202437; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perry DM, 2014, J BIOL CHEM, V289, P22401, DOI 10.1074/jbc.M114.589648; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Qiu P, 2013, CRIT CARE MED, V41, P2419, DOI 10.1097/CCM.0b013e3182982add; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Salome RG, 2000, J APPL PHYSIOL, V88, P10, DOI 10.1152/jappl.2000.88.1.10; Scott AJ, 2011, J BIOL CHEM, V286, P35466, DOI 10.1074/jbc.M111.277434; Shah D, 2014, AM J PHYSIOL-LUNG C, V306, pL152, DOI 10.1152/ajplung.00229.2013; Shurety W, 2001, LAB INVEST, V81, P107, DOI 10.1038/labinvest.3780216; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Soni S, 2016, THORAX, V71, P1020, DOI 10.1136/thoraxjnl-2015-208032; Thomas LM, 2010, J IMMUNOL, V185, P3740, DOI 10.4049/jimmunol.1001231; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Wilson MR, 2005, AM J PHYSIOL-LUNG C, V288, pL599, DOI 10.1152/ajplung.00304.2004; Woods SJ, 2015, AM J PHYSIOL-LUNG C, V308, pL912, DOI 10.1152/ajplung.00048.2015; Xuan W, 2016, SCI REP-UK, V6, DOI 10.1038/srep26277; Zhang HG, 2006, J IMMUNOL, V176, P7385, DOI 10.4049/jimmunol.176.12.7385; Zhao H, 2013, AM J TRANSPLANT, V13, P2006, DOI 10.1111/ajt.12293	61	24	24	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6442	6455		10.1096/fj.201802386R	http://dx.doi.org/10.1096/fj.201802386R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30776316	Green Published, hybrid			2022-12-28	WOS:000466932600050
J	Wang, YR; Ren, YH; Pan, JM				Wang, Yingrui; Ren, Yahui; Pan, Junmin			Regulation of flagellar assembly and length in Chlamydomonas by LF4, a MAPK-related kinase	FASEB JOURNAL			English	Article						cilia assembly; length control; intraflagellar transport; phosphorylation; kinesin	INTRAFLAGELLAR TRANSPORT; CILIARY LENGTH; PROTEIN-KINASE; ORGANELLE SIZE; REINHARDTII; PHOSPHORYLATION; KINESIN; IFT; CILIOGENESIS; MODEL	Members of the MAPK superfamily are known as key regulators of ciliogenesis. Long flagellar (LF) 4, a MAPK-related kinase in Chlamydomonas, is the first kinase that was implicated in ciliary assembly and length. However, little is known about its cellular properties, regulation, and molecular functions. LF4 is localized both in the flagella and cell body with enrichment at the 2 basal bodies, shown by super-resolution microscopy. LF4 is constitutively phosphorylated at T159 at the kinase activation loop and remains at the basal bodies during flagellar assembly. Gene mutations that affect the kinase activity or T159 phosphorylation alter the localization of LF4 at the basal bodies, and the mutants fail to rescue lf4-3, a null mutant. LF4 does not affect the velocities of intraflagellar transport (IFT). However, LF4 null mutation induces accumulation of IFT proteins in the flagellum and reduces the phosphorylation of the kinesin-II subunit FLA8/KIF3B, indicating that LF4 negatively regulates IFT entry. Furthermore, LF2, a cell cycle-related kinase, and LF3, a novel protein, are required for LF4 phosphorylation. Our study demonstrates that LF4 is likely a constitutively active kinase that is regulated by LF2 and regulates IFT entry at the basal bodies to control flagellar assembly and length.Wang, Y., Ren, Y., Pan, J. Regulation of flagellar assembly and length in Chlamydomonas by LF4, a MAPK-related kinase.	[Wang, Yingrui; Ren, Yahui; Pan, Junmin] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Key Lab Prot Sci, MOE,Sch Life Sci, 1 Qinghuayuan,Renhuanlou 413, Beijing 100084, Peoples R China; [Pan, Junmin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China	Tsinghua University; Qingdao National Laboratory for Marine Science & Technology	Pan, JM (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Key Lab Prot Sci, MOE,Sch Life Sci, 1 Qinghuayuan,Renhuanlou 413, Beijing 100084, Peoples R China.	panjunmin@tsinghua.edu.cn	Wang, Yingrui/H-2073-2016	Wang, Yingrui/0000-0001-5532-3454	National Natural Science Foundation of China [31330044, 31671387]; National Key Research and Development Program of China [2017YFA0503500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	The authors thank Dr. Pete Lefebvre (University of Minnesota, Minneapolis, MN, USA) for discussion. The authors are also grateful to Drs. Joel Rosenbaum (Yale University, New Haven, CT, USA), Robert Bloodgood (University of Virginia, Charlottesville, VA, USA), Kaiyao Huang (Institute of Hydrobiology, Wuhan, China), and Karl Lechtreck (University of Georgia, Athens, GA, USA) for providing antibodies and plasmids. The authors also thank the Core Facility of the Center for Biomedical Analysis (Tsinghua University) for assistance with cell imaging analysis. This work was supported by the National Natural Science Foundation of China (31330044, 31671387) and the National Key Research and Development Program of China (2017YFA0503500) (to J.P.). The authors declare no conflicts of interest.	Asleson CM, 1998, GENETICS, V148, P693; Bengs F, 2005, MOL MICROBIOL, V55, P1606, DOI 10.1111/j.1365-2958.2005.04498.x; Berman SA, 2003, CURR BIOL, V13, P1145, DOI 10.1016/S0960-9822(03)00415-9; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; BLOODGOOD RA, 1994, J CELL BIOL, V127, P803, DOI 10.1083/jcb.127.3.803; Broekhuis JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108470; Burghoorn J, 2007, P NATL ACAD SCI USA, V104, P7157, DOI 10.1073/pnas.0606974104; Cao MQ, 2013, P NATL ACAD SCI USA, V110, P12337, DOI 10.1073/pnas.1302364110; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Fu Z., 2012, PROTEIN KINASES, P229; Geimer S, 2005, EUKARYOT CELL, V4, P1253, DOI 10.1128/EC.4.7.1253-1263.2005; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hilton LK, 2013, CURR BIOL, V23, P2208, DOI 10.1016/j.cub.2013.09.038; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Ko HW, 2010, DEV CELL, V18, P237, DOI 10.1016/j.devcel.2009.12.014; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; Liang YW, 2018, CURR BIOL, V28, P2429, DOI 10.1016/j.cub.2018.05.069; Liang YW, 2014, DEV CELL, V30, P585, DOI 10.1016/j.devcel.2014.07.019; Liang YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069902; Lin HW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005508; Ludington WB, 2013, P NATL ACAD SCI USA, V110, P3925, DOI 10.1073/pnas.1217354110; Luo MN, 2011, CURR BIOL, V21, P586, DOI 10.1016/j.cub.2011.02.046; Lv B, 2017, J CELL SCI, V130, P1662, DOI 10.1242/jcs.200758; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; McCooke JK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-393; Meng D, 2016, MOL BIOL CELL, V27, P838, DOI 10.1091/mbc.E15-10-0707; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Nguyen RL, 2005, GENETICS, V169, P1415, DOI 10.1534/genetics.104.027615; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Ou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048773; Pan JM, 2014, CURR BIOL, V24, pR75, DOI 10.1016/j.cub.2013.11.043; Phirke P, 2011, DEV BIOL, V357, P235, DOI 10.1016/j.ydbio.2011.06.028; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; SANDERS MA, 1989, J CELL BIOL, V108, P1751, DOI 10.1083/jcb.108.5.1751; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Smith LA, 2006, J AM SOC NEPHROL, V17, P2821, DOI 10.1681/ASN.2006020136; Tam LW, 2007, J CELL BIOL, V176, P819, DOI 10.1083/jcb.200610022; Tam LW, 2013, MOL BIOL CELL, V24, P588, DOI 10.1091/mbc.E12-10-0718; Tam LW, 2003, J CELL BIOL, V163, P597, DOI 10.1083/jcb.200307143; Wilson NF, 2004, EUKARYOT CELL, V3, P1307, DOI 10.1128/EC.3.5.1307-1319.2004; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Wu Q, 2018, FASEB J, V32, P3689, DOI 10.1096/fj.201701396RR; Yang Y, 2013, EMBO REP, V14, P741, DOI 10.1038/embor.2013.80; Yi PS, 2018, TRAFFIC, V19, P522, DOI 10.1111/tra.12572; Zheng XD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11874; Zhu B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006627; Zhu X, 2017, CELL MOL LIFE SCI, V74, P3425, DOI 10.1007/s00018-017-2525-x	57	11	11	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6431	6441		10.1096/fj.201802375RR	http://dx.doi.org/10.1096/fj.201802375RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794426				2022-12-28	WOS:000466932600049
J	Li, YF; Chu, JH; Feng, WT; Yang, MZ; Zhang, YH; Zhang, YQ; Qin, Y; Xu, J; Li, J; Vasilatos, SN; Fu, ZY; Huang, Y; Yin, YM				Li, Yongfei; Chu, Jiahui; Feng, Wanting; Yang, Mengzhu; Zhang, Yanhong; Zhang, Yanqiu; Qin, Ye; Xu, Juan; Li, Jun; Vasilatos, Shauna N.; Fu, Ziyi; Huang, Yi; Yin, Yongmei			EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties	FASEB JOURNAL			English	Article						breast cancer; CSC; trastuzumab resistance; CRISPR/Cas9	INITIATING CELLS; EXPRESSION; CHEMOTHERAPY; ACTIVATION; PROGNOSIS; FAMILY; MEMBER; GRADE; STAGE	Trastuzumab is a successful, rationally designed therapy that provides significant clinical benefit for human epidermal growth factor receptor-2 (HER2)-positive breast cancer patients. However, about half of individuals with HER2-positive breast cancer do not respond to trastuzumab treatment because of various resistance mechanisms, including but not limited to: 1) shedding of the HER2 extracellular domain, 2) steric hindrance (e.g., MUC4 and MUC1), 3) parallel pathway activation (this is the general mechanism cited in the quote above), 4) perturbation of downstream signaling events (e.g., PTEN loss or PIK3CA mutation), and 5) immunologic mechanisms (such as FcR polymorphisms). EPHA5, a receptor tyrosine kinase, has been demonstrated to act as an anticancer agent in several cancer cell types. In this study, deletion of EPHA5 can significantly increase the resistance of HER2-positive breast cancer patients to trastuzumab. To investigate how EPHA5 deficiency induces trastuzumab resistance, clustered regularly interspaced short palindromic repeat technology was used to create EPHA5-deficient variants of breast cancer cells. EPHA5 deficiency effectively increases breast cancer stem cell (BCSC)-like properties, including NANOG, CD133+, E-cadherin expression, and the CD44(+)/CD24(-/low) phenotype, concomitantly enhancing mammosphere-forming ability. EPHA5 deficiency also caused significant aggrandized tumor malignancy in trastuzumab-sensitive xenografts, coinciding with the up-regulation of BCSC-related markers and intracellular Notch1 and PTEN/AKT signaling pathway activation. These findings highlight that EPHA5 is a potential prognostic marker for the activity of Notch1 and better sensitivity to trastuzumab in HER2-positive breast cancer. Moreover, patients with HER2-positive breast cancers expressing high Notch1 activation and low EPHA5 expression could be the best candidates for anti-Notch1 therapy.	[Li, Yongfei; Chu, Jiahui; Feng, Wanting; Yang, Mengzhu; Zhang, Yanhong; Zhang, Yanqiu; Li, Jun; Fu, Ziyi; Yin, Yongmei] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Xu, Juan; Fu, Ziyi] Nanjing Med Univ, Affiliated Obstet & Gynecol Hosp, Nanjing Maternal & Child Hlth Med Inst, Nanjing, Jiangsu, Peoples R China; [Li, Yongfei; Qin, Ye; Vasilatos, Shauna N.; Huang, Yi] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Li, Yongfei] Nanjing Univ TCM, Affiliated Hosp, Jiangsu Prov Hosp Tradit Chinese Med TMC, Dept Breast Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing University of Chinese Medicine	Yin, YM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	ymyin@njmu.edu.cn	Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X	National Natural Science Foundation of China [81172503, 81572603, 81302304, 81402139, 81570804]; Key Projects of Jiangsu Health Department [RC201153]; Second Level of 333 Project of Jiangsu Province [BRA2017534]; Third Level of 333 Project of Jiangsu Province [BRA2015470]; Project of Jiangsu Provincial Medical Talent [ZDRCA2016023]; Project of Jiangsu Provincial Medical Youth Talent [QNRC2016095]; General Project of Nanjing Health Bureau [YKK17179]; Project of Jiangsu Provincial Postgraduate Research and Practice Innovation [KYLX16_1116]; Project of Wu Jieping Medical Foundation [320.6750.17006]; Key Open Topics of Oncology Individualized Collaborative Innovation Center [JX21817902/008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects of Jiangsu Health Department; Second Level of 333 Project of Jiangsu Province; Third Level of 333 Project of Jiangsu Province; Project of Jiangsu Provincial Medical Talent; Project of Jiangsu Provincial Medical Youth Talent; General Project of Nanjing Health Bureau; Project of Jiangsu Provincial Postgraduate Research and Practice Innovation; Project of Wu Jieping Medical Foundation; Key Open Topics of Oncology Individualized Collaborative Innovation Center	This study was financially supported by the National Natural Science Foundation of China (Grants 81172503, 81572603, 81302304, 81402139, and 81570804), Key Projects of Jiangsu Health Department (Grant RC201153), the Second Level of 333 Project of Jiangsu Province (Grant BRA2017534), the Third Level of 333 Project of Jiangsu Province (Grant BRA2015470), the Project of Jiangsu Provincial Medical Talent (Grant ZDRCA2016023), the Project of Jiangsu Provincial Medical Youth Talent (Grant QNRC2016095), General Project of Nanjing Health Bureau (Grant YKK17179), the Project of Jiangsu Provincial Postgraduate Research and Practice Innovation (Grant KYLX16_1116), the Project of Wu Jieping Medical Foundation (Grant 320.6750.17006), and Key Open Topics of Oncology Individualized Collaborative Innovation Center (JX21817902/008). The authors declare no conflicts of interest.	Abarrategi A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3631764; Baker AT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00360; Boulbes DR, 2015, BREAST CANCER RES TR, V151, P501, DOI 10.1007/s10549-015-3414-3; Boyle ST, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0592-0; Burnett JP, 2017, CANCER LETT, V394, P52, DOI 10.1016/j.canlet.2017.02.023; Cameron D, 2017, LANCET, V389, P1195, DOI 10.1016/S0140-6736(16)32616-2; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Chen X, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0292-1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dhillon J, 2010, ONCOGENE, V29, P6294, DOI 10.1038/onc.2010.365; Ding KS, 2014, J BIOL CHEM, V289, P16057, DOI 10.1074/jbc.M113.529552; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Eisenstein M, 2015, NATURE, V527, pS110, DOI 10.1038/527S110a; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; Fukushima K, 2006, AM J PHYSIOL-GASTR L, V291, pG812, DOI 10.1152/ajpgi.00250.2005; Giaginis C, 2010, PATHOL ONCOL RES, V16, P267, DOI 10.1007/s12253-009-9221-6; Goltsov A, 2014, CELLS-BASEL, V3, P563, DOI 10.3390/cells3020563; Gu SD, 2017, HISTOL HISTOPATHOL, V32, P491, DOI 10.14670/HH-11-815; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Kabraji S, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0877-7; Kim H, 2014, J MATER CHEM A, V2, P33, DOI 10.1039/c3ta12522j; Kojima H, 2017, INT J ONCOL, V51, P49, DOI 10.3892/ijo.2017.4001; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Krusche B, 2016, ELIFE, V5, DOI 10.7554/eLife.14845; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Li SB, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1025-3; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mimoto R, 2017, ONCOGENE, V36, P1862, DOI 10.1038/onc.2016.349; O'Brien NA, 2014, CLIN CANCER RES, V20, P3507, DOI 10.1158/1078-0432.CCR-13-2769; Oliveras-Ferraros C, 2012, CELL CYCLE, V11, P4020, DOI 10.4161/cc.22225; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Pandya K, 2016, CLIN CANCER RES, V22, P175, DOI 10.1158/1078-0432.CCR-15-0179; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pradeep CR, 2012, ONCOGENE, V31, P3569, DOI 10.1038/onc.2011.547; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodriguez CE, 2018, J CELL BIOCHEM, V119, P1381, DOI 10.1002/jcb.26298; Song KH, 2017, CANCER RES, V77, P5039, DOI 10.1158/0008-5472.CAN-17-0072; Staquicini FI, 2015, J BIOL CHEM, V290, P7345, DOI 10.1074/jbc.M114.630525; Wang XL, 2017, INT J EXP PATHOL, V98, P34, DOI 10.1111/iep.12219; Wong H, 2011, ONCOLOGIST, V16, P1535, DOI 10.1634/theoncologist.2011-0165; Zhang W, 2017, ONCOGENE, V36, P3890, DOI 10.1038/onc.2017.15; Zhong HH, 2016, CANCER RES, V76, P480, DOI 10.1158/0008-5472.CAN-15-0883; Zhuang GL, 2010, CANCER RES, V70, P299, DOI 10.1158/0008-5472.CAN-09-1845	45	20	20	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4851	4865		10.1096/fj.201701561RRRR	http://dx.doi.org/10.1096/fj.201701561RRRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30620624				2022-12-28	WOS:000462888500018
J	Puissant, MM; Muere, C; Levchenko, V; Manis, AD; Martino, P; Forster, HV; Palygin, O; Staruschenko, A; Hodges, MR				Puissant, Madeleine M.; Muere, Clarissa; Levchenko, Vladislav; Manis, Anna D.; Martino, Paul; Forster, Hubert V.; Palygin, Oleg; Staruschenko, Alexander; Hodges, Matthew R.			Genetic mutation of Kcnj16 identifies Kir5.1-containing channels as key regulators of acute and chronic pH homeostasis	FASEB JOURNAL			English	Article						pH regulation; control of breathing; ion channels	SENSORINEURAL DEAFNESS; SEROTONERGIC NEURONS; POTASSIUM CHANNELS; CAROTID-BODY; K+ CHANNEL; KIR5.1; SENSITIVITY; MODULATION; EXPRESSION; KIR4.1	Acute and chronic homeostatic pH regulation is critical for the maintenance of optimal cellular function. Renal mechanisms dominate global pH regulation over longer time frames, and rapid adjustments in ventilation compensate for acute pH and CO2 changes. Ventilatory CO2 and pH chemoreflexes are primarily determined by brain chemoreceptors with intrinsic pH sensitivity likely driven by K+ channels. Here, we studied acute and chronic pH regulation in Kcnj16 mutant Dahl salt-sensitive (SSKcnj16-/-) rats; Kcnj16 encodes the pH-sensitive inwardly rectifying K+ 5.1 (Kir5.1) channel. SSKcnj16-/- rats hyperventilated at rest, likely compensating for a chronic metabolic acidosis. Despite their resting hyperventilation, SSKcnj16-/- rats showed up to 45% reduction in the ventilatory response to graded hypercapnic acidosis vs. controls. SSKcnj16-/- rats chronically treated with bicarbonate or the carbonic anhydrase inhibitor hydrochlorothiazide had partial restoration of arterial pH, but there was a further reduction in the ventilatory response to hypercapnic acidosis. SSKcnj16-/- rats also had a nearly absent hypoxic ventilatory response, suggesting major contributions of Kir5.1 to O-2- and CO2-dependent chemoreflexes. Although previous studies demonstrated beneficial effects of a high-K+ diet (HKD) on cardiorenal phenotypes in SSKcnj16-/- rats, HKD failed to restore the observed ventilatory phenotypes. We conclude that Kir5.1 is a key regulator of renal H+ handling and essential for acute and chronic regulation of arterial pH as determinants of the ventilatory CO2 chemoreflex.	[Puissant, Madeleine M.; Muere, Clarissa; Levchenko, Vladislav; Manis, Anna D.; Martino, Paul; Forster, Hubert V.; Palygin, Oleg; Staruschenko, Alexander; Hodges, Matthew R.] Med Coll Wisconsin, Dept Physiol, BSB-504,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Palygin, Oleg; Hodges, Matthew R.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Martino, Paul] Carthage Coll, Dept Biol, Kenosha, WI USA	Medical College of Wisconsin; Medical College of Wisconsin	Hodges, MR (corresponding author), Med Coll Wisconsin, Dept Physiol, BSB-504,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mhodges@mcw.edu	Palygin, Oleg/AAT-3047-2020; Hodges, Matthew/GZB-0433-2022	Palygin, Oleg/0000-0002-3680-5527; Staruschenko, Alexander/0000-0002-5190-8356	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [HL007852, HL122358, HL135749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007852, R01HL122358, R35HL135749] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grants HL007852 (to M.M.P. and A.D.M.), HL122358 (to M.R.H.), and HL135749 (to A.S.). The authors declare no conflicts of interest.	Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Brasko C, 2017, BRAIN STRUCT FUNCT, V222, P41, DOI 10.1007/s00429-016-1199-8; Corcoran AE, 2009, RESP PHYSIOL NEUROBI, V168, P49, DOI 10.1016/j.resp.2009.04.014; Cui N, 2001, J CELL PHYSIOL, V189, P229, DOI 10.1002/jcp.10021; D'Adamo MC, 2011, J BIOL CHEM, V286, P192, DOI 10.1074/jbc.M110.189290; FENCL V, 1966, AM J PHYSIOL, V210, P459, DOI 10.1152/ajplegacy.1966.210.3.459; Funk GD, 2018, J PHYSIOL-LONDON, V596, P2935, DOI 10.1113/JP275707; Gourine AV, 2017, J APPL PHYSIOL, V123, P1344, DOI 10.1152/japplphysiol.00194.2017; Haruna Y, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9483; Hodges MR, 2013, RESP PHYSIOL NEUROBI, V186, P221, DOI 10.1016/j.resp.2013.02.020; Hodges MR, 2002, J APPL PHYSIOL, V93, P974, DOI 10.1152/japplphysiol.00019.2002; HORNBEIN TF, 1963, J APPL PHYSIOL, V18, P580, DOI 10.1152/jappl.1963.18.3.580; Juang JMJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06733; Lachheb S, 2008, AM J PHYSIOL-RENAL, V294, pF1398, DOI 10.1152/ajprenal.00288.2007; Mouradian GC, 2012, J PHYSIOL-LONDON, V590, P3335, DOI 10.1113/jphysiol.2012.234658; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Nattie E, 2009, J APPL PHYSIOL, V106, P1464, DOI 10.1152/japplphysiol.00112.2008; Palygin O, 2017, ACTA PHYSIOL, V219, P260, DOI 10.1111/apha.12703; Palygin O, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92331; PAPPENHEIMER JR, 1965, AM J PHYSIOL, V208, P436, DOI 10.1152/ajplegacy.1965.208.3.436; Paulais M, 2011, P NATL ACAD SCI USA, V108, P10361, DOI 10.1073/pnas.1101400108; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Pessia M, 2001, J PHYSIOL-LONDON, V532, P359, DOI 10.1111/j.1469-7793.2001.0359f.x; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Pineda J, 1997, NEUROSCIENCE, V77, P723, DOI 10.1016/S0306-4522(96)00485-X; Puissant MM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00034; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Richerson GB, 2001, RESP PHYSIOL, V129, P175, DOI 10.1016/S0034-5687(01)00289-4; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Tanemoto M, 2002, NEURON, V34, P387, DOI 10.1016/S0896-6273(02)00675-X; Trapp S, 2011, EXP PHYSIOL, V96, P451, DOI 10.1113/expphysiol.2010.055848; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; Wu J, 2004, J MEMBRANE BIOL, V197, P179, DOI 10.1007/s00232-004-0652-4; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x; Yamamoto Y, 2008, HISTOL HISTOPATHOL, V23, P799, DOI 10.14670/HH-23.799	37	14	14	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5067	5075		10.1096/fj.201802257R	http://dx.doi.org/10.1096/fj.201802257R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30605394	Green Published			2022-12-28	WOS:000462888500035
J	Chan, JKY; Gil-Farina, I; Johana, N; Rosales, C; Tan, YW; Ceiler, J; Mcintosh, J; Ogden, B; Waddington, SN; Schmidt, M; Biswas, A; Choolani, M; Nathwani, AC; Mattar, CNZ				Chan, Jerry K. Y.; Gil-Farina, Irene; Johana, Nuryanti; Rosales, Cecilia; Tan, Yi Wan; Ceiler, Jessika; Mcintosh, Jenny; Ogden, Bryan; Waddington, Simon N.; Schmidt, Manfred; Biswas, Arijit; Choolani, Mahesh; Nathwani, Amit C.; Mattar, Citra N. Z.			Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques	FASEB JOURNAL			English	Article						nonhuman primate; immune tolerance; genotoxicity	INNATE IMMUNE-RESPONSES; LONG-TERM SAFETY; IN-UTERO; EFFICIENT TRANSDUCTION; VIRUS VECTORS; HUMAN FIX; PROTHROMBIN COMPLEX; MURINE MODEL; LIVER; AAV	Adeno-associated viral vectors (AAVs) achieve stable therapeutic expression without long-term toxicity in adults with hemophilia. To avert irreversible complications in congenital disorders producing early pathogenesis, safety and efficacy of AAV-intrauterine gene transfer (IUGT) requires assessment. We therefore performed IUGT of AAV5 or -8 with liver-specific promoter-1 encoding either human coagulation factors IX (hFIX) or X (hFX) into Macaca fascicularis fetuses at approximate to 0.4 gestation. The initial cohort received 1 x 10(12) vector genomes (vgs) of AAV5-hFIX (n = 5; 0.45 x 10(13) vg/kg birth weight), resulting in approximate to 3.0% hFIX at birth and 0.6-6.8% over 19-51 mo. The next cohort received 0.2-1 x 10(13) vg boluses. AAV5-hFX animals (n = 3; 3.57 x 10(13) vg/kg) expressed <1% at birth and 9.4-27.9% up to 42 mo. AAV8-hFIX recipients (n = 3; 2.56 x 10(13) vg/kg) established 4.2-41.3% expression perinatally and 9.8-25.3% over 46 mo. Expression with AAV8-hFX (n = 6, 3.12 x 10(13) vg/kg) increased from <1% perinatally to 9.8-13.4% >35 mo. Low expressers (<1%, n = 3) were postnatally challenged with 2 x 10(11) vg/kg AAV5 resulting in 2.4-13.2% expression and demonstrating acquired tolerance. Linear amplification-mediated-PCR analysis demonstrated random integration of 57-88% of AAV sequences retrieved from hepatocytes with no events occurring in or near oncogenesis-associated genes. Thus, early-IUGT in macaques produces sustained curative expression related significantly to integrated AAV in the absence of clinical toxicity, supporting its therapeutic potential for early-onset monogenic disorders.Chan, J. K. Y., Gil-Farina I., Johana, N., Rosales, C., Tan, Y. W., Ceiler, J., Mcintosh, J., Ogden, B., Waddington, S. N., Schmidt, M., Biswas, A., Choolani, M., Nathwani, A. C., Mattar, C. N. Z. Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques.	[Chan, Jerry K. Y.; Johana, Nuryanti; Tan, Yi Wan] KK Womens & Childrens Hosp, Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke Natl Univ Singapore NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Gil-Farina, Irene; Ceiler, Jessika; Biswas, Arijit] German Canc Res Ctr, Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Rosales, Cecilia; Schmidt, Manfred; Nathwani, Amit C.] UCL, United Coll London UCL Canc Inst, London, England; [Waddington, Simon N.] UCL, Inst Womens Hlth, London, England; [Mcintosh, Jenny; Choolani, Mahesh; Mattar, Citra N. Z.] Natl Univ Singapore, Yong Loo Lin Sch Med, Obstet & Gynaecol, Level 12 Tower Block, Singapore 119228, Singapore; [Ogden, Bryan] Singapore Hlth Serv Pte, SingHlth Expt Med Ctr, Singapore, Singapore; [Waddington, Simon N.] Univ Witwatersrand, Fac Hlth Sci, Wits South African Med Res Council SAMRC Antivira, Johannesburg, South Africa; [Schmidt, Manfred] GeneWerk, Heidelberg, Germany	KK Women's & Children's Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of London; University College London; University of London; University College London; National University of Singapore; University of Witwatersrand	Chan, JKY (corresponding author), KK Womens & Childrens Hosp, Reprod Med, Singapore, Singapore.; Mattar, CNZ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Obstet & Gynaecol, Level 12 Tower Block, Singapore 119228, Singapore.	jerrychan@duke-nus.edu.sg; citramattar@nus.edu.sg	Waddington, Simon/G-3778-2011	Waddington, Simon/0000-0003-4970-4730; Mattar, Citra Nurfarah/0000-0003-0068-6957	Singapore Ministry of Health's National Medical Research Council (NMRC) [NMRC/CSA/043/2012, NMRC/CSA(SI)/008/2016, CIRG/1459/2016]; NMRC [NMRC/TA/0003/2012, NMRC/CSA-INV/0012/2016]; Singapore's Ministry of Health's NMRC Grant [NMRC/CSA(SI)/008/2016]; NC3Rs Grant [NC/L001780/1]; Medical Research Council [MR/P026494/1]; MRC [MR/R015325/1, G0902219, G0502121, MR/P026494/1, MR/L013185/1] Funding Source: UKRI	Singapore Ministry of Health's National Medical Research Council (NMRC)(Ministry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NMRC(National Medical Research Council, Singapore); Singapore's Ministry of Health's NMRC Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NC3Rs Grant(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Durga Elangovam, Rowell Fragata, Lay Geok Tan (all from the Yong Loo Lin School of Medicine, National University of Singapore), Darvi Michell B. Sergi, Jose Sebastian David, and Vivienne Liang (all from SingHealth Experimental Medicine Centre) for contributions to the animal experiments and for providing veterinary support for the macaque colony. This work was supported by research funding from the Singapore Ministry of Health's National Medical Research Council (NMRC) Grants NMRC/CSA/043/2012, NMRC/CSA(SI)/008/2016 and CIRG/1459/2016 (to J.K.Y.C.); and NMRC Grants NMRC/TA/0003/2012 and NMRC/CSA-INV/0012/2016 (both to C.N.Z.M.). Salary support came from the Singapore's Ministry of Health's NMRC Grant NMRC/CSA(SI)/008/2016 (to J.C.); from the NC3Rs Grant NC/L001780/1 and Medical Research Council Grant MR/P026494/1 (to S.N.W.); and from NMRC/CSA/007/2009 and NMRC/CSA/0059/2014 (to M.C.). This work was produced in Singapore, London, United Kingdom, and Heidelberg, Germany. A.C.N. reports patents related to factor IX in gene therapy vectors (U.S. Patent No. 8,030,065, U.S. Patent No. 8,168,425, and European Patent No. 1,804,839). M.S. is cofounder and CEO of GeneWerk. The remaining authors declare no conflicts of interest.	Arens A, 2012, HUM GENE THER METHOD, V23, P111, DOI 10.1089/hgtb.2011.219; Attard C, 2013, J THROMB HAEMOST, V11, P1850, DOI 10.1111/jth.12372; Behrman R. E., 2007, MEASUREMENT FETAL IN; Binny C, 2012, BLOOD, V119, P957, DOI 10.1182/blood-2011-09-377630; Boelig MM, 2016, BIOL BLOOD MARROW TR, V22, P991, DOI 10.1016/j.bbmt.2016.01.017; Buckley SMK, 2011, THER DELIV, V2, P461, DOI 10.4155/TDE.11.17; Chandler RJ, 2017, HUM GENE THER, V28, P314, DOI 10.1089/hum.2017.009; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Chong MSK, 2010, METHODS MOL BIOL, V614, P135, DOI 10.1007/978-1-60761-533-0_9; Cooper DN, 1997, THROMB HAEMOSTASIS, V78, P161; Cotugno G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033286; David AL, 2006, ULTRASOUND OBST GYN, V28, P82, DOI 10.1002/uog.2815; David Anna L, 2012, Methods Mol Biol, V891, P9, DOI 10.1007/978-1-61779-873-3_2; David AL, 2011, HUM GENE THER, V22, P419, DOI 10.1089/hum.2010.007; Davidoff AM, 2005, MOL THER, V11, P875, DOI 10.1016/j.ymthe.2004.12.022; Del Monte U, 2009, CELL CYCLE, V8, P505, DOI 10.4161/cc.8.3.7608; Descamps D, 2009, CURR GENE THER, V9, P115, DOI 10.2174/156652309787909544; Epcacan S, 2015, EUR J CLIN INVEST, V45, P1087, DOI 10.1111/eci.12511; Ferreira Carlos R, 2017, Transl Sci Rare Dis, V2, P1, DOI 10.3233/TRD-160005; George LA, 2017, NEW ENGL J MED, V377, P2215, DOI 10.1056/NEJMoa1708538; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; Guedj F, 2013, PRENATAL DIAG, V33, P614, DOI 10.1002/pd.4134; HANSMANN M, 1991, ULTRASOUND OBST GYN, V1, P162, DOI 10.1046/j.1469-0705.1991.01030162.x; Hinderer C, 2018, HUM GENE THER, V29, P285, DOI 10.1089/hum.2018.015; Inagaki K, 2008, J VIROL, V82, P9513, DOI 10.1128/JVI.01001-08; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Kohler M, 1998, THROMB HAEMOSTASIS, V80, P399; Lechler E, 1999, THROMB RES, V95, pS39, DOI 10.1016/S0049-3848(99)00083-3; Leone P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003454; Li H, 2011, MOL THER, V19, P2021, DOI 10.1038/mt.2011.81; Liu YC, 2012, STEM CELLS, V30, P1911, DOI 10.1002/stem.1164; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mattar CN, 2013, GENE THER, V20, P69, DOI 10.1038/gt.2011.216; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P697, DOI 10.1016/j.bpobgyn.2012.06.006; Mattar Citra N, 2012, Methods Mol Biol, V891, P249, DOI 10.1007/978-1-61779-873-3_12; Mattar CNZ, 2017, MOL THER, V25, P1843, DOI 10.1016/j.ymthe.2017.04.003; Mattar CNZ, 2011, MOL THER, V19, P1950, DOI 10.1038/mt.2011.107; Mauldin Jill, 2000, Indian Journal of Pediatrics, V67, P899, DOI 10.1007/BF02723955; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Merianos DJ, 2009, J CLIN INVEST, V119, P2590, DOI 10.1172/JCI38979; Miao CH, 2000, J VIROL, V74, P3793, DOI 10.1128/JVI.74.8.3793-3803.2000; Miesbach W, 2018, BLOOD, V131, P1022, DOI 10.1182/blood-2017-09-804419; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Monahan PE, 2000, MOL MED TODAY, V6, P433, DOI 10.1016/S1357-4310(00)01810-4; Morovvati S., 2015, HEMATOLOGY, DOI [10.1179/1607845415Y.0000000019, DOI 10.1179/1607845415Y.0000000019]; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Nakai H, 2002, J VIROL, V76, P11343, DOI 10.1128/JVI.76.22.11343-11349.2002; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2002, BLOOD, V100, P1662, DOI 10.1182/blood-2002-02-0589; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Nathwani AC, 2007, BLOOD, V109, P1414, DOI 10.1182/blood-2006-03-010181; Nathwani AC, 2017, HEMATOL ONCOL CLIN N, V31, P853, DOI 10.1016/j.hoc.2017.06.011; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Nijagal A, 2011, J CLIN INVEST, V121, P582, DOI 10.1172/JCI44907; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Pipe SW, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26865; Rogers GL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00194; Sabatino DE, 2007, MOL THER, V15, P1677, DOI 10.1038/sj.mt.6300219; Sugano H, 2012, HUM GENE THER, V23, P399, DOI 10.1089/hum.2011.148; Thrasher AJ, 2005, BLOOD, V105, P4255, DOI 10.1182/blood-2004-12-4837; Uprichard J, 2002, BLOOD REV, V16, P97, DOI 10.1054/blre.2002.0191; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; Wang LL, 2011, MOL THER, V19, P2012, DOI 10.1038/mt.2011.151; Wang YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043039; Zaiss AK, 2005, CURR GENE THER, V5, P323, DOI 10.2174/1566523054065039; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456	72	15	15	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3954	3967		10.1096/fj.201801391R	http://dx.doi.org/10.1096/fj.201801391R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30517034	hybrid, Green Published			2022-12-28	WOS:000459794800068
J	Kim, JS; Lee, H; Nirmala, FS; Jung, CH; Kim, MJ; Jang, YJ; Ha, TY; Ahn, J				Kim, Ji-Sun; Lee, Hyunjung; Nirmala, Farida Sukma; Jung, Chang Hwa; Kim, Min Jung; Jang, Young-Jin; Ha, Tae Youl; Ahn, Jiyun			Dihydrodaidzein and 6-hydroxydaidzein mediate the fermentation-induced increase of antiosteoporotic effect of soybeans in ovariectomized mice	FASEB JOURNAL			English	Article						isoflavone; osteogenesis; metabolite; bioavailability; cheonggukjang	PRODUCT CHEONGGUKJANG; ISOFLAVONE DAIDZEIN; HIP FRACTURE; DIFFERENTIATION; METABOLISM; GLUCOSE; EQUOL	The consumption of soybeans is known to have beneficial effects on osteoporosis in postmenopausal women. However, the effects of soybean fermentation on the bioavailability and the antiosteoporotic effect have not yet been elucidated. To address this question, we fed ovariectomized C57BL/6J mice with a 5% nonfermented raw soybean (RS)- or fermented soybean (FS)-supplemented diet. After 18 wk of treatment, microcomputed tomography showed that FSs significantly increased bone mineral density compared with RSs. This was because of the up-regulation of bone morphogenic protein 2 (Bmp2) and its downstream target osteopontin in bone tissues. We analyzed isoflavone metabolite profiles in the sera of RS- or FS-fed mice and observed that the levels of 19 isoflavone metabolites were significantly increased in the sera of FS-fed mice. Among these metabolites, we observed that both dihydrodaidzein (DHD) and 6-hydroxydaidzein (6-HD) increased osteogenesis via Bmp2 signaling pathway in MC3T3-E1 cells and reduced receptor activator of nuclear factor -B ligand-induced osteoclastogenesis in RAW264.7 cells through the inhibition of NF-B activation and MAPK phosphorylation. These data suggest that improved bioavailability of FSs resulted from the production of active metabolites such as DHD and 6-HD after consumption. DHD and 6-HD can be used as potential therapeutics for the amelioration of osteoporotic bone loss.Kim, J.-S., Lee, H., Nirmala, F. S., Jung, C. H., Kim, M. J., Jang, Y.-J., Ha, T. Y., Ahn, J. Dihydrodaidzein and 6-hydroxydaidzein mediate the fermentation-induced increase of anti-osteoporotic effect of soybeans in ovariectomized mice.	[Kim, Ji-Sun; Lee, Hyunjung; Nirmala, Farida Sukma; Jung, Chang Hwa; Kim, Min Jung; Jang, Young-Jin; Ha, Tae Youl; Ahn, Jiyun] Korea Food Res Inst, Res Div Food Funct, 245 Nongsaengmyeong Ro Iseo Myeon, Wanju Gun 55365, Jeollabuk Do, South Korea; [Kim, Ji-Sun] Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea; [Nirmala, Farida Sukma; Jung, Chang Hwa; Ha, Tae Youl; Ahn, Jiyun] Korea Univ Sci & Technol, Dept Food Biotechnol, Wanju Gun, South Korea	Korea Food Research Institute (KFRI); Korea University	Ahn, J (corresponding author), Korea Food Res Inst, Res Div Food Funct, 245 Nongsaengmyeong Ro Iseo Myeon, Wanju Gun 55365, Jeollabuk Do, South Korea.	jyan@kfri.re.kr	Jang, Young Jin/AAT-1192-2020; Jang, Young Jin/GLU-3087-2022	Kim, Ji-Sun/0000-0002-9568-1114	Korea Food Research Institute	Korea Food Research Institute	This work was supported by the Korea Food Research Institute. The authors thank Dr. Sang Hee Lee (Korea Food Research Institute, Wanju-gun, South Korea) for providing the isoflavone profile. The authors declare no conflicts of interest.	Ahn J, 2013, EMBO MOL MED, V5, P1602, DOI 10.1002/emmm.201302647; Ahn J, 2013, FOOD CHEM TOXICOL, V51, P439, DOI 10.1016/j.fct.2012.08.048; Atherton KM, 2006, BIOCHEM PHARMACOL, V72, P624, DOI 10.1016/j.bcp.2006.05.015; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chai C, 2012, J CHROMATOGR B, V880, P42, DOI 10.1016/j.jchromb.2011.11.013; Chen L, 2013, J AGR FOOD CHEM, V61, P10714, DOI 10.1021/jf402694m; Chen YC, 2003, BIOSCI BIOTECH BIOCH, V67, P903, DOI 10.1271/bbb.67.903; Choi JH, 2016, J CLIN BIOCHEM NUTR, V59, P31, DOI 10.3164/jcbn.15-30; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Fujioka M, 2004, J NUTR, V134, P2623, DOI 10.1093/jn/134.10.2623; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Hirata H, 2016, TOHOKU J EXP MED, V239, P95, DOI 10.1620/tjem.239.95; Hirota A, 2004, BIOSCI BIOTECH BIOCH, V68, P1372, DOI 10.1271/bbb.68.1372; Hong H, 2010, J MED FOOD, V13, P640, DOI 10.1089/jmf.2009.1092; Hwang IS, 2014, NUTR RES, V34, P355, DOI 10.1016/j.nutres.2014.02.004; Hwang IS, 2014, MOL MED REP, V9, P166, DOI 10.3892/mmr.2013.1757; Hwang KM, 2008, J MED FOOD, V11, P717, DOI 10.1089/jmf.2007.0151; Jang CH, 2006, FOOD SCI BIOTECHNOL, V15, P643; Jeong Ji-Kang, 2014, J Carcinog, V13, P9, DOI 10.4103/1477-3163.137699; Jung Yun-Jung, 2015, Prev Nutr Food Sci, V20, P260, DOI 10.3746/pnf.2015.20.4.260; Kampkotter A, 2008, NUTR RES, V28, P620, DOI 10.1016/j.nutres.2008.06.002; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kim DJ, 2008, J MED FOOD, V11, P215, DOI 10.1089/jmf.2007.560; Kim MJ, 2013, J OBES, V2013, DOI 10.1155/2013/874981; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lauderdale DS, 1997, AM J EPIDEMIOL, V146, P502; Lee DH, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700322; Lee K. H., 2006, J KOREAN DIET ASS, V12, P289; Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2016, KOR HLTH STAT 2015 K; Nam YR, 2015, NUTR RES PRACT, V9, P235, DOI 10.4162/nrp.2015.9.3.235; Rafii F, 2015, METABOLITES, V5, P56, DOI 10.3390/metabo5010056; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Scotti L, 2012, CURR TOP MED CHEM, V12, P2785; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2009, AM J CLIN NUTR, V90, P1029, DOI 10.3945/ajcn.2009.27981; SILVERMAN SL, 1988, AM J PUBLIC HEALTH, V78, P1482, DOI 10.2105/AJPH.78.11.1482; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tousen Y, 2011, MENOPAUSE, V18, P563, DOI 10.1097/gme.0b013e3181f85aa7; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Wu WJ, 2014, J MED FOOD, V17, P1298, DOI 10.1089/jmf.2013.3095; XU X, 1994, J NUTR, V124, P825, DOI 10.1093/jn/124.6.825; Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029	45	9	10	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3252	3263		10.1096/fj.201800953R	http://dx.doi.org/10.1096/fj.201800953R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30376359	Bronze			2022-12-28	WOS:000459794800015
J	Liang, XT; Ding, Y; Lin, F; Zhang, YL; Zhou, XH; Meng, QS; Lu, XY; Jiang, GJ; Zhu, HM; Chen, Y; Lian, QZ; Fan, HM; Liu, ZM				Liang, Xiaoting; Ding, Yue; Lin, Fang; Zhang, Yuelin; Zhou, Xiaohui; Meng, Qingshu; Lu, Xingyue; Jiang, Guojun; Zhu, Hongming; Chen, Yu; Lian, Qizhou; Fan, Huimin; Liu, Zhongmin			Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways	FASEB JOURNAL			English	Article						MSC; aging; myocardial infarction	HEART; TRANSPLANTATION; PROLIFERATION; EXPRESSION; ISCHEMIA; EFFICACY; ROS	The age-related functional exhaustion limits potential efficacy of mesenchymal stem cells (MSC) in treating cardiovascular disease. Therefore, rejuvenation of aged MSC in the elderly population is of great interest. We have previously reported that Erb-B2 receptor tyrosine kinase 4 (ERBB4) plays a critical role in regulating MSC survival under hypoxia. The aim of this study was to investigate whether ERBB4 rejuvenates aged MSC and how ERBB4 enhances therapeutic efficacy of aged MSC in treating myocardial infarction (MI). Compared with vector aged MSC (aged-MSC), ERBB4-engineered aged MSC (ER4-aged-MSC) conferred resistance to oxidative stress-induced cell death and ameliorated the senescent phenotype in vitro. Four weeks after MI, the ER4-aged-MSC group exhibited enhanced blood vessel density, reduced cardiac remodeling and apoptosis with improved heart function compared with the aged-MSC group. Overexpression of ERBB4 caused an increase in phosphorylated v-akt murine thymoma viral oncogene homolog 1 (AKT), and phosphorylated ERK expression under hypoxia. ER4-aged-MSC secreted higher levels of angiopoietin, epithelial neutrophil activating peptide 78, VEGF, and fibroblast growth factor 2, and enhanced tube formation in HUVEC. The impact of ERBB4 on protein expression, proangiogenesis, cell behavior, and cytokine secretion was abolished by inhibiting PI3K/AKT and MAPK/ERK signaling pathway.Liang, X., Ding, Y., Lin, F., Zhang, Y., Zhou, X., Meng, Q., Lu, X., Jiang, G., Zhu, H., Chen, Y., Lian, Q., Fan, H., Liu, Z. Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways.	[Liang, Xiaoting; Lin, Fang; Zhou, Xiaohui; Meng, Qingshu; Zhu, Hongming] Tongji Univ, Sch Med, Shanghai East Hosp, Clin Translat Med Res Ctr, Shanghai, Peoples R China; [Liang, Xiaoting; Zhu, Hongming; Liu, Zhongmin] Tongji Univ, Sch Med, Shanghai East Hosp, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China; [Fan, Huimin; Liu, Zhongmin] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Cardiovasc & Thorac Surg, Shanghai, Peoples R China; [Ding, Yue; Chen, Yu] Second Mil Med Univ, Changzheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China; [Zhang, Yuelin] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Emergency, Guangzhou, Guangdong, Peoples R China; [Zhang, Yuelin; Lu, Xingyue; Jiang, Guojun] Bengbu Med Coll, Fac Pharm, Bengbu, Peoples R China; [Zhang, Yuelin; Lian, Qizhou] Univ Hong Kong, Dept Med, Hong Kong, Peoples R China	Tongji University; Tongji University; Tongji University; Naval Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Bengbu Medical College; University of Hong Kong	Liang, XT; Fan, HM (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Shanghai, Peoples R China.	liangxt@tongji.edu.cn; frankfan@tongji.edu.cn	Zhang, Yuelin/C-4569-2009; Lian, Qizhou/Y-1613-2019	Zhang, Yuelin/0000-0002-0065-1116	National Natural Science Foundation of China [81500207, 81670458, 81600282]; Program for Young Excellent Talents of Tongji University [2015KJ073]; National Key Research and Development Program of China [2017YFA0105600]; Shanghai Sailing Program [16YF1409500]; Health industry Project of Pudong Health Bureau of Shanghai [PW2013E-1]; Shanghai Municipal Health and Family Planning Commission [(2018-2020)-FWTX-2007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Young Excellent Talents of Tongji University; National Key Research and Development Program of China; Shanghai Sailing Program; Health industry Project of Pudong Health Bureau of Shanghai; Shanghai Municipal Health and Family Planning Commission	The authors thank Ying Lu (Clinical Translational Medical Research Center, Shanghai East Hospital, Shanghai) for excellent technical assistance. This work was supported by the National Natural Science Foundation of China (Grants 81500207 to X.L.; 81670458 to X.Z.; and 81600282 to H.Z.), the Program for Young Excellent Talents of Tongji University (2015KJ073), the National Key Research and Development Program of China (2017YFA0105600), the Shanghai Sailing Program (16YF1409500), the Health industry Project of Pudong Health Bureau of Shanghai (PW2013E-1), and the Shanghai Municipal Health and Family Planning Commission [ZY(2018-2020)-FWTX-2007]. The authors declare no conflicts of interest.	An Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0082-8; Aubert G, 2014, PROG MOL BIOL TRANSL, V125, P89, DOI 10.1016/B978-0-12-397898-1.00004-9; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Charif N, 2017, BIO-MED MATER ENG, V28, pS57, DOI 10.3233/BME-171624; Choudhery MS, 2012, CELL BIOL INT, V36, P747, DOI 10.1042/CBI20110183; Denu RA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5841716; Dickerson JW, 2009, NEUROSCIENCE, V163, P482, DOI 10.1016/j.neuroscience.2009.06.008; Edrey YH, 2012, AGING CELL, V11, P213, DOI 10.1111/j.1474-9726.2011.00772.x; Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Fan M, 2010, REJUV RES, V13, P429, DOI 10.1089/rej.2009.0986; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gao LR, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0399-z; Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388; Heusch G, 2016, CIRC RES, V119, P194, DOI 10.1161/CIRCRESAHA.116.308925; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Liang HL, 2013, EUR HEART J, V34, P1681, DOI 10.1093/eurheartj/ehr131; Liang X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.91; Liu XB, 2014, J HEART LUNG TRANSPL, V33, P1083, DOI 10.1016/j.healun.2014.05.008; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Porrello ER, 2010, CIRC RES, V107, P1292, DOI 10.1161/CIRCRESAHA.110.235168; Rodrigo SF, 2013, J CARDIOVASC TRANSL, V6, P816, DOI 10.1007/s12265-013-9507-7; Shakeri H, 2018, CARDIOVASC RES, V114, P1041, DOI 10.1093/cvr/cvy059; Turinetto V, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071164; Wadugu B, 2012, AM J PHYSIOL-HEART C, V302, pH2139, DOI 10.1152/ajpheart.00063.2012; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x; Zhang YL, 2017, EXP CELL RES, V356, P74, DOI 10.1016/j.yexcr.2017.04.012; Zhang YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11235	33	58	59	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4559	4570		10.1096/fj.201801690R	http://dx.doi.org/10.1096/fj.201801690R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566395	Bronze			2022-12-28	WOS:000459794800116
J	McGlory, C; Gorissen, SHM; Kamal, M; Bahniwal, R; Hector, AJ; Baker, SK; Chabowski, A; Phillips, SM				McGlory, Chris; Gorissen, Stefan H. M.; Kamal, Michael; Bahniwal, Ravninder; Hector, Amy J.; Baker, Steven K.; Chabowski, Adrian; Phillips, Stuart M.			Omega-3 fatty acid supplementation attenuates skeletal muscle disuse atrophy during two weeks of unilateral leg immobilization in healthy young women	FASEB JOURNAL			English	Article						fish oil; protein synthesis; proteolysis	MYOFIBRILLAR PROTEIN-SYNTHESIS; FISH-OIL SUPPLEMENTATION; DOCOSAHEXAENOIC ACID; RESISTANCE EXERCISE; ANABOLIC RESISTANCE; VOLUNTARY STRENGTH; FATTY-ACIDS; MEN; METABOLISM; EXPRESSION	Omega-3 (n-3) fatty acid supplementation enhances muscle protein synthesis and muscle size. Whether n-3 fatty acid supplementation attenuates human muscle disuse atrophy is unknown. We determined the influence of n-3 fatty acid supplementation on muscle size, mass, and integrated rates of myofibrillar protein synthesis (MyoPS) following 2 wk of muscle disuse and recovery in women. Twenty women (BMI = 23.0 +/- 2.3 kg/m(2), age = 22 +/- 3 yr) underwent 2 wk of unilateral limb immobilization followed by 2 wk of return to normal activity. Starting 4 wk prior to immobilization, participants consumed either 5 g/d of n-3 fatty acid or an isoenergetic quantity of sunflower oil (control). Muscle size and mass were measured pre- and postimmobilization, and after recovery. Serial muscle biopsies were obtained to measure integrated (daily) MyoPS. Following immobilization, the decline in muscle volume was greater in the control group compared to the n-3 fatty acid group (14 vs. 8%, P < 0.05) and was not different from preimmobilization at recovery in the n-3 fatty acid group; however, it was still lower in the control group (P < 0.05). Muscle mass was reduced in the control group only (P < 0.05). MyoPS was higher in the n-3 group compared with the control group at all times (P < 0.05). We conclude that n-3 fatty acid supplementation attenuates skeletal muscle disuse atrophy in young women, which may be mediated by higher rates of MyoPS.McGlory, C., Gorissen, S. H. M., Kamal, M., Bahniwal, R., Hector, A. J., Baker, S. K., Chabowski, A., Phillips, S. M. Omega-3 fatty acid supplementation attenuates skeletal muscle disuse atrophy during two weeks of unilateral leg immobilization in healthy young women.	[McGlory, Chris; Gorissen, Stefan H. M.; Kamal, Michael; Bahniwal, Ravninder; Hector, Amy J.; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Baker, Steven K.] McMaster Univ, Dept Med, Div Phys Med & Rehabil, Hamilton, ON, Canada; [Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, Bialystok, Poland	McMaster University; McMaster University; Medical University of Bialystok	McGlory, C (corresponding author), McMaster Univ, Dept Kinesiol, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.	mcglorc@mcmaster.ca	Phillips, Stuart/B-2343-2009; Gorissen, Stefan/ABA-1008-2021; Chabowski, Adrian/T-2225-2018	Phillips, Stuart/0000-0002-1956-4098; Gorissen, Stefan/0000-0003-3737-9053; Kamal, Michael/0000-0002-3055-6793; Chabowski, Adrian/0000-0002-7407-8156	Diabetes Canada; European Society for Clinical Nutrition and Metabolism; Canadian Institutes of Health Research	Diabetes Canada; European Society for Clinical Nutrition and Metabolism; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Evelyn Tsakiridis, Ibrahim Mohammad, Erin Webb, and Yifan Cao (all from McMaster University) for their technical assistance during laboratory analysis. C.M. acknowledges Research Fellowships from Diabetes Canada and the European Society for Clinical Nutrition and Metabolism. This study was supported by a Canadian Institutes of Health Research Award to S.M.P. The authors declare no conflicts of interest.	Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; Bostock EL, 2017, J NUTR HEALTH AGING, V21, P51, DOI 10.1007/s12603-016-0710-5; Calder PC, 2017, BIOCHEM SOC T, V45, P1105, DOI 10.1042/BST20160474; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cunningham ML, 2002, TOXICOL SCI, V70, P157, DOI 10.1093/toxsci/70.2.157; Da Boit M, 2017, AM J CLIN NUTR, V105, P151, DOI 10.3945/ajcn.116.140780; Devries MC, 2018, AM J CLIN NUTR, V107, P217, DOI 10.1093/ajcn/nqx028; Dufner DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE1277, DOI 10.1152/ajpendo.00580.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Gingras AA, 2007, J PHYSIOL-LONDON, V579, P269, DOI 10.1113/jphysiol.2006.121079; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Herbst EAF, 2014, J PHYSIOL-LONDON, V592, P1341, DOI 10.1113/jphysiol.2013.267336; Kamolrat T, 2013, BIOCHEM BIOPH RES CO, V432, P593, DOI 10.1016/j.bbrc.2013.02.041; Lalia AZ, 2017, AGING-US, V9, P1096, DOI 10.18632/aging.101210; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald AJ, 2013, RAPID COMMUN MASS SP, V27, P1769, DOI 10.1002/rcm.6622; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2955, DOI 10.1113/JP272570; McGlory C, 2018, J GERONTOL A-BIOL, V73, P1070, DOI 10.1093/gerona/glx203; McGlory C, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12715; McGlory C, 2014, PROSTAG LEUKOTR ESS, V90, P199, DOI 10.1016/j.plefa.2014.03.001; Miller BF, 2016, J APPL PHYSIOL, V121, P594, DOI 10.1152/japplphysiol.00137.2016; Mollica JP, 2009, ANAL BIOCHEM, V386, P270, DOI 10.1016/j.ab.2008.12.029; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Murphy CH, 2016, AM J CLIN NUTR, V104, P1594, DOI 10.3945/ajcn.116.136424; Phillips SM, 2014, J PHYSIOL-LONDON, V592, P5341, DOI 10.1113/jphysiol.2014.273615; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Reid MB, 2014, J PHYSIOL-LONDON, V592, P5345, DOI 10.1113/jphysiol.2014.279406; Rodacki CLN, 2012, AM J CLIN NUTR, V95, P428, DOI 10.3945/ajcn.111.021915; SALE DG, 1987, J APPL PHYSIOL, V62, P1786, DOI 10.1152/jappl.1987.62.5.1786; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SCHANTZ P, 1983, ACTA PHYSIOL SCAND, V117, P219, DOI 10.1111/j.1748-1716.1983.tb07200.x; Smith GI, 2015, AM J CLIN NUTR, V102, P115, DOI 10.3945/ajcn.114.105833; Smith GI, 2011, CLIN SCI, V121, P267, DOI 10.1042/CS20100597; Smith GI, 2011, AM J CLIN NUTR, V93, P402, DOI 10.3945/ajcn.110.005611; VANDERVUSSE GJ, 1980, BIOCHIM BIOPHYS ACTA, V617, P347, DOI 10.1016/0005-2760(80)90176-9; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wall BT, 2016, AM J PHYSIOL-ENDOC M, V310, pE137, DOI 10.1152/ajpendo.00227.2015; Wilkinson DJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE571, DOI 10.1152/ajpendo.00650.2013; Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005; You JS, 2010, APPL PHYSIOL NUTR ME, V35, P310, DOI 10.1139/H10-022; You JS, 2010, J NUTR BIOCHEM, V21, P929, DOI 10.1016/j.jnutbio.2009.07.007	44	53	54	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4586	4597		10.1096/fj.201801857RRR	http://dx.doi.org/10.1096/fj.201801857RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30629458	Bronze			2022-12-28	WOS:000459794800118
J	Tascher, G; Gerbaix, M; Maes, P; Chazarin, B; Ghislin, S; Antropova, E; Vassilieva, G; Ouzren-Zarhloul, N; Gauquelin-Koch, G; Vico, L; Frippiat, JP; Bertile, F				Tascher, Georg; Gerbaix, Maude; Maes, Pauline; Chazarin, Blandine; Ghislin, Stephanie; Antropova, Evgenia; Vassilieva, Galina; Ouzren-Zarhloul, Nassima; Gauquelin-Koch, Guillemette; Vico, Laurence; Frippiat, Jean-Pol; Bertile, Fabrice			Analysis of femurs from mice embarked on board BION-M1 biosatellite reveals a decrease in immune cell development, including B cells, after 1 wk of recovery on Earth	FASEB JOURNAL			English	Article						lymphopoiesis; bone; immunity; proteomics; gravity	AMPHIBIAN PLEURODELES-WALTL; IMMUNOGLOBULIN HEAVY-CHAINS; BONE-MARROW; SPACEFLIGHT CONDITIONS; TRANSCRIPTION; HYPERGRAVITY; REPERTOIRE; PRECURSORS; EXPRESSION; INFECTION	Bone loss and immune dysregulation are among the main adverse outcomes of spaceflight challenging astronauts' health and safety. However, consequences on B-cell development and responses are still under-investigated. To fill this gap, we used advanced proteomics analysis of femur bone and marrow to compare mice flown for 1 mo on board the BION-M1 biosatellite, followed or not by 1 wk of recovery on Earth, to control mice kept on Earth. Our data revealed an adverse effect on B lymphopoiesis 1 wk after landing. This phenomenon was associated with a 41% reduction of B cells in the spleen. These reductions may contribute to explain increased susceptibility to infection even if our data suggest that flown animals can mount a humoral immune response. Future studies should investigate the quality/efficiency of produced antibodies and whether longer missions worsen these immune alterations.Tascher, G., Gerbaix, M., Maes, P., Chazarin, B., Ghislin, S., Antropova, E., Vassilieva, G., Ouzren-Zarhloul, N., Gauquelin-Koch, G., Vico, L., Frippiat, J.-P., Bertile, F. Analysis of femurs from mice embarked on board BION-M1 biosatellite reveals a decrease in immune cell development, including B cells, after 1 wk of recovery on Earth.	[Tascher, Georg; Maes, Pauline; Chazarin, Blandine; Bertile, Fabrice] Univ Strasbourg, CNRS, IPHC, UMR 7178, 25 Rue Becquerel, F-67087 Strasbourg 2, France; [Tascher, Georg; Gerbaix, Maude; Chazarin, Blandine; Gauquelin-Koch, Guillemette] CNES, Paris, France; [Gerbaix, Maude; Vico, Laurence] Univ Jean Monnet, Univ Lyon, Fac Med, INSERM,Unite 1059 Sainbiose, Campus Sante Innovat, St Etienne, France; [Ghislin, Stephanie; Ouzren-Zarhloul, Nassima; Frippiat, Jean-Pol] Lorraine Univ, Fac Med, Stress Immun Pathogens Lab, Equipe Accueil 7300, Vandoeuvre Les Nancy, France; [Antropova, Evgenia; Vassilieva, Galina] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences	Bertile, F (corresponding author), Univ Strasbourg, CNRS, IPHC, UMR 7178, 25 Rue Becquerel, F-67087 Strasbourg 2, France.	fbertile@unistra.fr	Bertile, Fabrice/F-1287-2019; Vico, Laurence/O-1927-2018; Bertile, Fabrice/ABE-1479-2020; Vassilieva, Galina Yu./AAG-3853-2020	Bertile, Fabrice/0000-0001-5510-4868; Vico, Laurence/0000-0002-2110-287X; Bertile, Fabrice/0000-0001-5510-4868; Vassilieva, Galina Yu./0000-0003-0879-889X; Tascher, Georg/0000-0002-5907-3947	French Space Agency (CNES); French National Center for Scientific Research, Strasbourg University; French Proteomic Infrastructure (ProFI) [ANR-10-INSB-08-03]; French Ministry of Higher Education and Research; Universite de Lorraine; Region Lorraine [65.1]; Program of Fundamental Research of the Institute for Biomedical Problems [65.1]; Impact Biomolecules Project of the Lorraine Universite d'Excellence [ANR 15-004]	French Space Agency (CNES)(Centre National D'etudes Spatiales); French National Center for Scientific Research, Strasbourg University; French Proteomic Infrastructure (ProFI); French Ministry of Higher Education and Research; Universite de Lorraine; Region Lorraine(Region Grand-Est); Program of Fundamental Research of the Institute for Biomedical Problems; Impact Biomolecules Project of the Lorraine Universite d'Excellence	This work was supported by the French Space Agency (CNES), the French National Center for Scientific Research, Strasbourg University (H2E projEx; IdEx), the French Proteomic Infrastructure (ProFI; ANR-10-INSB-08-03), the French Ministry of Higher Education and Research, the Universite de Lorraine, the Region Lorraine, and the Program of Fundamental Research (Theme 65.1) of the Institute for Biomedical Problems. Members of the Stress Immunity Pathogens Laboratory acknowledge support from the Impact Biomolecules Project of the Lorraine Universite d'Excellence (Investissements d'Avenir-ANR 15-004). The authors are also grateful to the neXtProt team, who helped extract target tissue expression information. The authors declare no conflicts of interest.	Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carapito C, 2014, PROTEOMICS, V14, P1014, DOI 10.1002/pmic.201300415; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188; Fonte C, 2015, DEV COMP IMMUNOL, V53, P371, DOI 10.1016/j.dci.2015.08.006; Frippiat JP, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.40; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; Gerbaix M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00746; Gerbaix M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03014-2; Gerbaix M, 2015, BONE, V71, P94, DOI 10.1016/j.bone.2014.10.011; Ghislin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09318; Gueguinou N, 2012, PSYCHONEUROENDOCRINO, V37, P137, DOI 10.1016/j.psyneuen.2011.05.015; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Schaerlinger B, 2008, MOL IMMUNOL, V45, P776, DOI 10.1016/j.molimm.2007.06.356; Sotnezova EV, 2017, B EXP BIOL MED+, V162, P496, DOI 10.1007/s10517-017-3647-8; Team RC., 2022, LANG ENV STAT COMP; Thiel CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05580-x; VACEK A, 1991, FOLIA BIOL-PRAGUE, V37, P35; Vernikos J, 1996, BIOESSAYS, V18, P1029, DOI 10.1002/bies.950181215; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Woods CC, 2003, FASEB J, V17, P1526, DOI 10.1096/fj.02-0749fje; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639	40	22	22	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3772	3783		10.1096/fj.201801463R	http://dx.doi.org/10.1096/fj.201801463R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521760	Green Submitted, Bronze			2022-12-28	WOS:000459794800055
J	Wray, R; Iscla, I; Kovacs, Z; Wang, JM; Blount, P				Wray, Robin; Iscla, Irene; Kovacs, Zoltan; Wang, Junmei; Blount, Paul			Novel compounds that specifically bind and modulate MscL: insights into channel gating mechanisms	FASEB JOURNAL			English	Article						mechanosensitive; osmoregulation; antibiotic	MECHANOSENSITIVE CHANNEL; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; S4-S5 LINKER; HELIX; DOMAINS; ACTIVATION; RESISTANCE; MUTATIONS; RESIDUES	The bacterial mechanosensitive channel of large conductance (MscL) normally functions as an emergency release valve discharging cytoplasmic solutes upon osmotic stress. Opening the large pore of MscL inappropriately is detrimental to the cell, and thus it has been speculated to be a potential antibiotic target. Although MscL is one of the best studied mechanosensitive channels, no chemical that influenced bacterial growth by modulating MscL is known. We therefore used a high-throughput screen to identify compounds that slowed growth in an MscL-dependent manner. We characterized 2 novel sulfonamide compounds identified in the screen. We demonstrated that, although both increase MscL gating, one of these compounds does not work through the folate pathway, as other antimicrobial sulfonamides; indeed, the sulfonamide portion of the compound is not needed for activity. The only mode of action appears to be MscL activation. The binding pocket is where an -helix runs along the cytoplasmic membrane and interacts with a neighboring subunit; analogous motifs have been observed in several prokaryotic and eukaryotic channels. The data not only demonstrate that MscL is a viable antibiotic target, but also give insight into the gating mechanisms of MscL, and they may have implications for developing agonists for other channels.Wray, R., Iscla, I., Kovacs, Z., Wang, J., Blount, P. Novel compounds that specifically bind and modulate MscL: insights into channel gating mechanisms.	[Wray, Robin; Iscla, Irene; Blount, Paul] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 15261 USA; [Kovacs, Zoltan] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Wang, Junmei] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, 3501 Terrace St, Pittsburgh, PA 15213 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Blount, P (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 15261 USA.; Wang, JM (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, 3501 Terrace St, Pittsburgh, PA 15213 USA.	junmei.wang@pitt.edu; paul.blount@utsouthwestern.edu	Wang, Junmei/ACQ-2446-2022	Wang, Junmei/0000-0002-9607-8229; Iscla, Irene/0000-0001-8936-430X	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [R01 GM061028, GM121780]; NIH National Institute of Biomedical Imaging and Bioengineering [P41-EB015908]; Welch Foundation [I-1420]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121780, R01GM061028] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); NIH National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Limin Yang (University of Texas, Southwestern Medical Center) and Andriy Anishkin (University of Maryland, College Park, MD, USA) for helpful suggestions and critical reading of the manuscript. This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Grants R01 GM061028 and GM121780, and NIH National Institute of Biomedical Imaging and Bioengineering Grant P41-EB015908 (to Z.K.); Welch Foundation Grant I-1420 (to P.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding organizations. The authors declare no conflicts of interest.	[Anonymous], 2015, GLIDE 6 8; Bartlett JL, 2006, BIOPHYS J, V91, P3684, DOI 10.1529/biophysj.106.088062; Bartlett JL, 2004, P NATL ACAD SCI USA, V101, P10161, DOI 10.1073/pnas.0402040101; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Batiza AF, 2002, P NATL ACAD SCI USA, V99, P5643, DOI 10.1073/pnas.082092599; Bavi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11984; Blount P, 1999, Methods Enzymol, V294, P458; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; BLOUNT P, 1993, J BIOL CHEM, V268, P16388; Blount Paul, 2008, V11, P25; Blount Paul, 2008, V1, P71; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Case D. A., 2015, AMBER 14 TOOLS MOL S; Cox CD, 2018, ANNU REV PHYSIOL, V80, P71, DOI 10.1146/annurev-physiol-021317-121351; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2007, BIOPHYS J, V92, P1224, DOI 10.1529/biophysj.106.090316; Iscla I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137994; Iscla I, 2015, J ANTIBIOT, V68, P453, DOI 10.1038/ja.2015.4; Iscla I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5891; Iscla I, 2012, CHANNELS, V6, P255, DOI 10.4161/chan.20756; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Iscla I, 2011, FASEB J, V25, P694, DOI 10.1096/fj.10-170878; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Levin G, 2004, BIOPHYS J, V86, P2862, DOI 10.1016/S0006-3495(04)74338-6; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Maurer JA, 2001, BBA-BIOMEMBRANES, V1514, P165, DOI 10.1016/S0005-2736(01)00390-X; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Rao SS, 2016, J ANTIBIOT, V69, P879, DOI 10.1038/ja.2016.45; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; SKOLD O, 1976, ANTIMICROB AGENTS CH, V9, P49, DOI 10.1128/AAC.9.1.49; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Sybyl X, 2013, MOL MOD SOFTW PACK V; Teng JF, 2016, P NATL ACAD SCI USA, V113, P11847, DOI 10.1073/pnas.1613523113; Teng JF, 2015, P NATL ACAD SCI USA, V112, P3386, DOI 10.1073/pnas.1502366112; Vedantam G, 1998, ANTIMICROB AGENTS CH, V42, P88, DOI 10.1128/AAC.42.1.88; Wang JM, 2012, J CHEM INF MODEL, V52, P1199, DOI 10.1021/ci300064d; Wray R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002473; Xiao L, 2017, J CHEM THEORY COMPUT, V13, P3398, DOI 10.1021/acs.jctc.7b00382; Yang F, 2017, PROTEIN CELL, V8, P169, DOI 10.1007/s13238-016-0353-7; Zhou XL, 2007, P NATL ACAD SCI USA, V104, P15555, DOI 10.1073/pnas.0704039104	53	11	11	0	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3180	3189		10.1096/fj.201801628R	http://dx.doi.org/10.1096/fj.201801628R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30359098	Green Published, Bronze			2022-12-28	WOS:000459794800009
J	Liu, AD; Yang, JK; Hu, Q; Dirsch, O; Dahmen, U; Zhang, CT; Gewirtz, DA; Fang, HS; Sun, J				Liu, Anding; Yang, Jiankun; Hu, Qi; Dirsch, Olaf; Dahmen, Uta; Zhang, Cuntai; Gewirtz, David A.; Fang, Haoshu; Sun, Jian			Young plasma attenuates age-dependent liver ischemia reperfusion injury	FASEB JOURNAL			English	Article						autophagy; hepatocyte; AMPK; ULK1; rats	ISCHEMIA/REPERFUSION INJURY; AUTOPHAGY; AMPK; PHOSPHORYLATION; REJUVENATION; ACTIVATION; PROTECTS; DECLINE; GROWTH; CELLS	Aging is often associated with a decreased autophagic activity that contributes to the high sensitivity of aged livers to ischemia reperfusion injury (IRI). Blood from young animals can positively affect aged animals. This study was designed to evaluate the effect of young plasma in a model of liver IRI in aged rats. Aged rats were treated with pooled plasma collected from young rats before ischemia. Administration of young plasma restored aging-induced suppression in hepatic autophagic activity and reduced liver IRI. Inhibition of the young-plasma-restored autophagic activity abrogated the beneficial effect of young plasma against liver IRI. Similarly, young serum restored autophagic activity and reduced cellular injury after hypoxia/reoxygenation (H/R) in primary old rat hepatocytes. Mechanistic studies showed thatadministration of young plasma increased AMPK phosphorylation and led to unc-51-like autophagy activating kinase (ULK)1 activation. Furthermore, AMPK-inhibition abrogated the young serum-induced ULK1 activation and autophagic activity and diminished the protective action of young serum against H/R injury in primary old rat hepatocytes, whereas AMPK-activation potentiated the effects of young serum. Young plasma could restore age-impaired autophagy, at least in part, via AMPK/ULK1 signaling. Restoration of age-impaired autophagic activity may be a critical contributing mechanism to young-plasma-afforded protection against liver IRI in aged rats.Liu, A., Yang, J., Hu, Q., Dirsch, O., Dahmen, U., Zhang, C., Gewirtz, D. A., Fang, H., Sun, J. Young plasma attenuates age-dependent liver ischemia reperfusion injury.	[Liu, Anding; Yang, Jiankun] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Expt Med Ctr, Wuhan, Hubei, Peoples R China; [Hu, Qi; Zhang, Cuntai] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Hubei, Peoples R China; [Dirsch, Olaf] Klinikum Chemnitz, Inst Pathol, Chemnitz, Germany; [Dahmen, Uta] Friedrich Schiller Univ Jena, Dept Gen Visceral & Vasc Surg, Expt Transplantat Surg, Jena, Germany; [Gewirtz, David A.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Massey Canc Ctr, Richmond, VA USA; [Fang, Haoshu] Anhui Med Univ, Dept Pathophysiol, Hefei, Anhui, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yan Jiang West Rd, Guangzhou 510120, Guangdong, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chemnitz Clinic; Friedrich Schiller University of Jena; Virginia Commonwealth University; Anhui Medical University; Sun Yat Sen University; Sun Yat Sen University	Sun, J (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yan Jiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.	sjmed02@outlook.com	Liu, Anding/AAU-2477-2020		National Natural Science Fund of China (NSFC) [81300343]	National Natural Science Fund of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Science Fund of China (NSFC) Grant 81300343 (to A.L.). The authors declare no conflicts of interest.	Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chang JT, 2017, ELIFE, V6, DOI 10.7554/eLife.18459; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cursio R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/417590; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0; Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Iwamoto T, 2008, TRANSPLANTATION, V85, P1240, DOI 10.1097/TP.0b013e31816c7e90; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kireev RA, 2012, J SURG RES, V178, P922, DOI 10.1016/j.jss.2012.04.060; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lai Q, 2011, J GASTROINTEST LIVER, V20, P383; Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708; Liu AD, 2016, ONCOTARGET, V7, P78372, DOI 10.18632/oncotarget.13281; Liu AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25042; Liu AD, 2014, CRIT CARE MED, V42, pE762, DOI 10.1097/CCM.0000000000000659; Liu AD, 2013, LIVER TRANSPLANT, V19, P762, DOI 10.1002/lt.23666; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338; Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3; Middeldorp J, 2016, JAMA NEUROL, V73, P1325, DOI 10.1001/jamaneurol.2016.3185; Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11; Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001; Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003; Salpeter SJ, 2013, DIABETES, V62, P3300, DOI 10.2337/db13-er09; Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006; Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9; Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318; Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Yun N, 2014, FREE RADICAL BIO MED, V68, P168, DOI 10.1016/j.freeradbiomed.2013.12.014; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang DY, 2016, AUTOPHAGY, V12, P1447, DOI 10.1080/15548627.2016.1185576	48	12	12	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3063	3073		10.1096/fj.201801234R	http://dx.doi.org/10.1096/fj.201801234R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30383439	Bronze			2022-12-28	WOS:000457296600121
J	Wang, YT; Li, Y; Zou, JJ; Polster, SP; Lightle, R; Moore, T; Dimaano, M; He, TC; Weber, CR; Awad, IA; Shen, L				Wang, Yitang; Li, Ye; Zou, Jinjing; Polster, Sean P.; Lightle, Rhonda; Moore, Thomas; Dimaano, Matthew; He, Tong-Chuan; Weber, Christopher R.; Awad, Issam A.; Shen, Le			The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation	FASEB JOURNAL			English	Article						actin cytoskeleton; tight junction; tumor necrosis factor	TIGHT JUNCTION BARRIER; RHO-KINASE; VASCULAR-PERMEABILITY; MDCK CELLS; PROTEIN INTERACTIONS; BINDING-PROTEIN; E-CADHERIN; OCCLUDIN; EXPRESSION; MUTATIONS	Epithelial barrier maintenance and regulation requires an intact perijunctional actomyosin ring underneath the cell-cell junctions. By searching for known factors affecting the actin cytoskeleton, we identified Krev interaction trapped protein 1 (KRIT1) as a major regulator for epithelial barrier function through multiple mechanisms. KRIT1 is expressed in both small intestinal and colonic epithelium, and KRIT1 knockdown in differentiated Caco-2 intestinal epithelium decreases epithelial barrier function and increases cation selectivity. KRIT1 knockdown abolished Rho-associated protein kinase-induced and myosin II motor inhibitor-induced barrier loss by limiting both small and large molecule permeability but did not affect myosin light chain kinase-induced increases in epithelial barrier function. These data suggest that KRIT1 participates in Rho-associated protein kinase- and myosin II motor-dependent (but not myosin light chain kinase-dependent) epithelial barrier regulation. KRIT1 knockdown exacerbated low-dose TNF-induced barrier loss, along with increased cleaved caspase-3 production. Both events are blocked by pan-caspase inhibition, indicating that KRIT1 regulates TNF-induced barrier loss through limiting epithelial apoptosis. These data indicate that KRIT1 controls epithelial barrier maintenance and regulation through multiple pathways, suggesting that KRIT1 mutation in cerebral cavernous malformation disease may alter epithelial function and affect human health.Wang, Y., Li, Y., Zou, J., Polster, S. P., Lightle, R., Moore, T., Dimaano, M., He, T.-C., Weber, C. R., Awad, I. A., Shen, L. The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation.	[Wang, Yitang; Li, Ye; Polster, Sean P.; Lightle, Rhonda; Moore, Thomas; Awad, Issam A.; Shen, Le] Univ Chicago, Dept Surg, Sect Neurosurg, 5841 S Maryland Ave,MC1089, Chicago, IL 60637 USA; [Wang, Yitang; Li, Ye; Zou, Jinjing; Weber, Christopher R.; Shen, Le] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Dimaano, Matthew] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [He, Tong-Chuan] Univ Chicago, Dept Orthopaed Surg & Rehabil Med, Chicago, IL 60637 USA; [Zou, Jinjing] Wuhan Univ, Renmin Hosp, Dept Pulm & Crit Care Med, Wuhan, Hubei, Peoples R China	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Wuhan University	Shen, L (corresponding author), Univ Chicago, Dept Surg, Sect Neurosurg, 5841 S Maryland Ave,MC1089, Chicago, IL 60637 USA.	leshen@uchicago.edu	Wang, Yin/HCI-9352-2022; wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yanbo/HFZ-8018-2022; Wang, Yuan/HHC-1520-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022	Weber, Christopher/0000-0002-2117-3184; Polster, Sean/0000-0002-3229-5021	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [K01DK092381, P30DK042086]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (through The University of Chicago Digestive Disease Research Core Center Pilot and Feasibility Award Program); Safadi Program of Excellence in Clinical and Translational Neuroscience at The University of Chicago; National Natural Science Foundation of China [81400008]; American Association of Neurological Surgeons; Judy and Bill Davis Fund in Neurovascular Surgery Research at The University of Chicago Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (through The University of Chicago Digestive Disease Research Core Center Pilot and Feasibility Award Program); Safadi Program of Excellence in Clinical and Translational Neuroscience at The University of Chicago; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Association of Neurological Surgeons; Judy and Bill Davis Fund in Neurovascular Surgery Research at The University of Chicago Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank The University of Chicago Integrated Light Microscopy Core for assistance with imaging; Candace Chan and The University of Chicago Digestive Research Core Center for enteroid culture; Douglas Marchuk (Duke University, Durham, NC, USA) for providing KRIT1 encoding plasmid; Wenli Dai, Pan Li, Yuehua Wei, and Qing Wu (all from The University of Chicago) for technical support and critical reading of the manuscript; and Ying Cao (The University of Chicago) for advice on biostatistical analyses. This research was supported, in part, by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants K01DK092381 (to L.S.) and P30DK042086 (to L.S., through The University of Chicago Digestive Disease Research Core Center Pilot and Feasibility Award Program); the Pilot Award from the Safadi Program of Excellence in Clinical and Translational Neuroscience at The University of Chicago (to L.S.); National Natural Science Foundation of China Grant 81400008 (to J.Z.); and the Dempsey Research Award from the American Association of Neurological Surgeons (to S.P.P.). L.S. also received partial support from the Judy and Bill Davis Fund in Neurovascular Surgery Research at The University of Chicago Medicine. The authors declare no conflicts of interest.	Akers A, 2017, NEUROSURGERY, V80, P665, DOI 10.1093/neuros/nyx091; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Balda MS, 2016, CURR OPIN CELL BIOL, V42, P94, DOI 10.1016/j.ceb.2016.05.006; BENTZEL CJ, 1976, NATURE, V264, P666, DOI 10.1038/264666a0; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Buckley A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029314; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Corr M, 2012, ARTERIOSCL THROM VAS, V32, P2702, DOI 10.1161/ATVBAHA.112.300115; Deng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113064; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; DUFFEY ME, 1981, NATURE, V294, P451, DOI 10.1038/294451a0; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Girard R, 2017, J NEUROSURG, V127, P102, DOI 10.3171/2016.5.JNS16687; Gitter AH, 2001, GASTROENTEROLOGY, V121, P1320, DOI 10.1053/gast.2001.29694; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goitre L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08373-4; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Hecht G, 1996, AM J PHYSIOL-CELL PH, V271, pC1678, DOI 10.1152/ajpcell.1996.271.5.C1678; Imai M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14208; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; McCarthy KM, 2000, J CELL SCI, V113, P3387; McDonald DA, 2012, STROKE, V43, P571, DOI 10.1161/STROKEAHA.111.625467; MEZA I, 1982, J CELL BIOCHEM, V18, P407, DOI 10.1002/jcb.1982.240180403; Mikati AG, 2015, J CEREBR BLOOD F MET, V35, P1632, DOI 10.1038/jcbfm.2015.98; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Schmitz H, 1999, J CELL SCI, V112, P137; Schulzke JD, 2006, ANN NY ACAD SCI, V1072, P288, DOI 10.1196/annals.1326.027; Schumann M, 2017, CELL MOL GASTROENTER, V3, P150, DOI 10.1016/j.jcmgh.2016.12.006; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shenkar R, 2017, STROKE, V48, P187, DOI 10.1161/STROKEAHA.116.015013; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sutton TA, 2001, AM J PHYSIOL-RENAL, V281, pF810, DOI 10.1152/ajprenal.2001.281.5.F810; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Williams JM, 2015, VET PATHOL, V52, P445, DOI 10.1177/0300985814559404; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	65	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2132	2143		10.1096/fj.201800343R	http://dx.doi.org/10.1096/fj.201800343R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252535	Green Published			2022-12-28	WOS:000457296600049
J	Blazquez-Bermejo, C; Carreno-Gago, L; Molina-Granada, D; Aguirre, J; Ramon, J; Torres-Torronteras, J; Cabrera-Perez, R; Martin, MA; Dominguez-Gonzalez, C; de la Cruz, X; Lombes, A; Garcia-Arumi, E; Marti, R; Camara, Y				Blazquez-Bermejo, Cora; Carreno-Gago, Lidia; Molina-Granada, David; Aguirre, Josu; Ramon, Javier; Torres-Torronteras, Javier; Cabrera-Perez, Raquel; Angel Martin, Miguel; Dominguez-Gonzalez, Cristina; de la Cruz, Xavier; Lombes, Anne; Garcia-Arumi, Elena; Marti, Ramon; Camara, Yolanda			Increased dNTP pools rescue mtDNA depletion in human POLG-deficient fibroblasts	FASEB JOURNAL			English	Article						mitochondria; mitochondrial DNA replication; polymerase gamma; therapy; deoxynucleosides	MITOCHONDRIAL-DNA REPLICATION; IN-VITRO SUPPLEMENTATION; POLYMERASE-GAMMA; MUTATIONS; DEFECTS; INSTABILITY; METABOLISM; ASYMMETRY	Polymerase gamma catalytic subunit (POLG) gene encodes the enzyme responsible for mitochondrial DNA (mtDNA) synthesis. Mutations affecting POLG are the most prevalent cause of mitochondrial disease because of defective mtDNA replication and lead to a wide spectrum of clinical phenotypes characterized by mtDNA deletions or depletion. Enhancing mitochondrial deoxyribonucleoside triphosphate (dNTP) synthesis effectively rescues mtDNA depletion in different models of defective mtDNA maintenance due to dNTP insufficiency. In this study, we studied mtDNA copy number recovery rates following ethidium bromide-forced depletion in quiescent fibroblasts from patients harboring mutations in different domains of POLG. Whereas control cells spontaneously recovered initial mtDNA levels, POLG-deficient cells experienced a more severe depletion and could not repopulate mtDNA. However, activation of deoxyribonucleoside (dN) salvage by supplementation with dNs plus erythro-9-(2-hydroxy-3-nonyl) adenine (inhibitor of deoxyadenosine degradation) led to increased mitochondrial dNTP pools and promoted mtDNA repopulation in all tested POLG-mutant cells independently of their specific genetic defect. The treatment did not compromise POLG fidelity because no increase in multiple deletions or point mutations was detected. Our study suggests that physiologic dNTP concentration limits the mtDNA replication rate. We thus propose that increasing mitochondrial dNTP availability could be of therapeutic interest for POLG deficiency and other conditions in which mtDNA maintenance is challenged.-Blazquez-Bermejo, C., Carreno-Gago, L., Molina-Granada, D., Aguirre, J., Ramon, J., Torres-Torronteras, J., Cabrera-Perez, R., Martin, M. a., Dominguez-Gonzalez, C., de la Cruz, X., Lombes, A., Garcia-Arumi, E., Marti, R., Camara, Y. Increased dNTP pools rescue mtDNA depletion in human POLG-deficient fibroblasts.	[Blazquez-Bermejo, Cora; Carreno-Gago, Lidia; Molina-Granada, David; Ramon, Javier; Torres-Torronteras, Javier; Cabrera-Perez, Raquel; Garcia-Arumi, Elena; Marti, Ramon; Camara, Yolanda] Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona, Spain; [Blazquez-Bermejo, Cora; Carreno-Gago, Lidia; Molina-Granada, David; Ramon, Javier; Torres-Torronteras, Javier; Cabrera-Perez, Raquel; Angel Martin, Miguel; Dominguez-Gonzalez, Cristina; de la Cruz, Xavier; Garcia-Arumi, Elena; Marti, Ramon; Camara, Yolanda] Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Translat Bioinformat Grp, Barcelona, Spain; [Aguirre, Josu] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain; [Angel Martin, Miguel] Inst Invest Hosp 12 Octubre I 12, Lab Enfermedades Mitocondriales, Madrid, Spain; [Dominguez-Gonzalez, Cristina] Inst Invest Hosp 12 Octubre I 12, IfUnidad Neuromuscular, Madrid, Spain; [de la Cruz, Xavier] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Lombes, Anne] Univ Paris 05, Grp Hosp Univ GHU Pitie Salpetriere, AP HP,CNRS,Unite Mixte Rech UMR 8104, Serv Biochim Metabol,Inst Cochin,INSERM,Unite 101, Paris, France; [Lombes, Anne] Univ Paris 05, Grp Hosp Univ GHU Pitie Salpetriere, Ctr Genet Mol & Chromosom, Paris, France	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; ICREA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Camara, Y (corresponding author), Vall dHebron Inst Recerca, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.	yolanda.camara@vhir.org	Torres-Torronteras, Javier/K-4974-2014; Garcia-Arumi, Elena/ABH-4229-2020; Martí, Ramon/Q-3442-2016; Cámara, Yolanda/K-4597-2014; Pérez, Raquel Cabrera/AAE-4039-2021; Martin, Miguel A/S-2758-2018	Torres-Torronteras, Javier/0000-0002-6092-9458; Martí, Ramon/0000-0002-8273-9540; Cámara, Yolanda/0000-0003-2458-6942; Martin, Miguel A/0000-0003-4741-772X; Aguirre, Josu/0000-0002-9601-636X; Dominguez, Cristina/0000-0001-5151-988X; De la Cruz Montserrat, Fco. Xavier/0000-0002-9738-8472; Molina Granada, David/0000-0002-8260-7775; Garcia-Arumi, Elena/0000-0003-0096-3336; Ramon, Javier/0000-0002-0673-9338	Spanish Ministry of Industry, Economy and Competitiveness [BFU2014-52618-R, SAF2016-80255-R]; Spanish Instituto de Salud Carlos III [PI15/01428, PI15/00465, PMP 15/00025]; European Regional Development Fund (ERDF); ERDF (Interreg V-A Spain-France-Andorra programme) [PIREPRED-EFA086/15]; French Muscular Dystrophy Association (AFM Telethon) [19965]; Generalitat de Catalunya (PERIS Program) [SLT002/16/00370]	Spanish Ministry of Industry, Economy and Competitiveness; Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); ERDF (Interreg V-A Spain-France-Andorra programme); French Muscular Dystrophy Association (AFM Telethon); Generalitat de Catalunya (PERIS Program)	The authors thank all patients and their families for essential collaboration in this study. The authors also thank Dr. Irene Bruno [Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Burlo Garofolo, Trieste, Italy] and Dr. Caterina Garone [Medical Research Council (MRC), Cambridge, United Kingdom] for valuable clinical characterization of patients and help in gathering the necessary human samples for the study. The authors also thank Dr. Emiliano Gonzalez-Vioque (Hospital Universitario Puerta del Hierro, Madrid, Spain) for helpful discussions. Finally, the authors thank all contributing funding agencies: the Spanish Ministry of Industry, Economy and Competitiveness (Grant BFU2014-52618-R to Y.C. and Grant SAF2016-80255-R to X.D.L.C.), the Spanish Instituto de Salud Carlos III [Grant PI15/01428 to E.G.-A., Grant PI15/00465 to R.M., and Grant PMP 15/00025 to M.a.M. and R.M., cofinanced with the European Regional Development Fund (ERDF)], the ERDF (Interreg V-A Spain-France-Andorra programme, grant PIREPRED-EFA086/15 to X.D.L.C.), and The French Muscular Dystrophy Association (AFM Telethon) (Grant 19965 to A.L. and Y.C.). J.T. was funded by a fellowship granted by the Generalitat de Catalunya (PERIS Program: SLT002/16/00370). R.M., Y.C., C.B.-B., J.T.-T., and R.C.-P., Vall d'Hebron Research Institute (VHIR), and Biomedical Network Research Centre on Rare Diseases (CIBERER) have filed patent applications covering the potential use of deoxynucleoside treatment for POLG gene deficiency and other mitochondrial DNA replication defects in humans. VHIR and CIBERER have licensed pending patent applications related to the technology to Modis Therapeutics, Inc., and VHIR and CIBERER may be eligible to receive payments related to the development and commercialization of the technology. Any potential licensing fees earned will be paid to VHIR and CIBERER and are shared with all inventors mentioned above through VHIR and CIBERER policies on distribution and objectivity in research. R.M. serves as a paid consultant to Modis Therapeutics, Inc. and has equity in the company. The remaining authors declare no conflicts of interest.	Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054; Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219; Bortot B, 2009, DIGEST LIVER DIS, V41, P494, DOI 10.1016/j.dld.2008.11.013; Bromberg Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S8; Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022; Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074; Camara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641; Camara Y, 2013, DRUG DISCOV TODAY, V18, P950, DOI 10.1016/j.drudis.2013.06.009; Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424; Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380; Desler C, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/701518; El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017; Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r; Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x; Gandhi V, 2005, BLOOD, V106, P4253, DOI 10.1182/blood-2005-03-1309; Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; GRAY H, 1992, J BIOL CHEM, V267, P5835; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Hecker SJ, 2008, J MED CHEM, V51, P2328, DOI 10.1021/jm701260b; Hirschhorn R, 1983, Birth Defects Orig Artic Ser, V19, P73; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229; Lopez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401; Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922; Martomo SA, 2002, MUTAT RES-FUND MOL M, V499, P197, DOI 10.1016/S0027-5107(01)00283-4; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mathews CK, 2014, FASEB J, V28, P3832, DOI 10.1096/fj.14-251249; Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019; Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010; Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013; Riera C, 2014, WIRES COMPUT MOL SCI, V4, P249, DOI 10.1002/wcms.1170; Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779; Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007; Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012; Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395; Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520; Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192; Tchikviladze M, 2015, J NEUROL NEUROSUR PS, V86, P646, DOI 10.1136/jnnp-2013-306799; Tedeschi A, 2015, HAEMATOLOGICA, V100, pE501, DOI 10.3324/haematol.2015.132035; Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005; Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438	53	10	10	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7168	7179		10.1096/fj.201801591R	http://dx.doi.org/10.1096/fj.201801591R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30848931	Bronze			2022-12-28	WOS:000476114200041
J	Gu, Y; Becker, V; Zhao, YJ; Menger, MD; Laschke, MW				Gu, Yuan; Becker, Vivien; Zhao, Yingjun; Menger, Michael D.; Laschke, Matthias W.			miR-370 inhibits the angiogenic activity of endothelial cells by targeting smoothened (SMO) and bone morphogenetic protein (BMP)-2	FASEB JOURNAL			English	Article						miRNA; angiogenesis; proliferation; migration; tube formation	MICRORNA-370 SUPPRESSES; GROWTH-FACTOR; OVEREXPRESSION; MECHANISM	MicroRNAs (miRNAs) crucially modulate fundamental biologic processes such as angiogenesis. In the present study, we focused on the molecular function of miRNA-370-3p (miR-370) in regulating the angiogenic activity of endothelial cells (ECs). Transfection with miR-370 mimic (miR-370m) significantly inhibited the sprouting of human dermal microvascular EC (HDMEC) and HUVEC spheroids and mouse aortic rings, whereas miR-370 inhibitor (miR-370i) promoted sprout formation. Additional in vitro assays demonstrated the pleiotropic inhibitory effects of miR-370m on HDMEC proliferation, migration, and tube formation. Moreover, Matrigel plugs containing miR-370m-transfected HDMECs exhibited a reduced microvessel density after implantation into CD1 nude mice when compared with controls. In contrast, miR-370i exerted proangiogenic effects. Mechanistic analyses revealed that miR-370 directly targets smoothened (SMO) and down-regulates bone morphogenetic protein (BMP)-2 expression in HDMECs. Accordingly, inhibition of SMO by cyclopamine reversed miR-370i-induced HDMEC proliferation and migration. In addition, BMP-2 treatment counteracted miR-370m-suppressed tube formation of HDMECs, whereas blockade of BMP-2 with neutralizing antibody significantly inhibited miR-370i-induced tube formation. Taken together, these novel findings indicate that miR-370 is a potent inhibitor of angiogenesis, which directly targets SMO and BMP-2.-Gu, Y., Becker, V., Zhao, Y., Menger, M. D., Laschke, M. W. miR-370 inhibits the angiogenic activity of endothelial cells by targeting smoothened (SMO) and bone morphogenetic protein (BMP)-2.	[Gu, Yuan; Becker, Vivien; Menger, Michael D.; Laschke, Matthias W.] Saarland Univ, Inst Clin & Expt Surg, Kirrbergerstr 1, D-66421 Homburg, Germany; [Zhao, Yingjun] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Oncol,Inst Biomed Sci, Shanghai, Peoples R China	Universitatsklinikum des Saarlandes; Fudan University	Laschke, MW (corresponding author), Saarland Univ, Inst Clin & Expt Surg, Kirrbergerstr 1, D-66421 Homburg, Germany.	matthias.laschke@uks.eu		Gu, Yuan/0000-0003-1401-6233	Medical Faculty of Saarland University (HOMFORexzellenz 2015)	Medical Faculty of Saarland University (HOMFORexzellenz 2015)	The authors thank Janine Becker, Christina Max, and Ruth Nickels (all from the Institute for Clinical and Experimental Surgery, Saarland University) for excellent technical assistance. This work was supported by a research grant to Y.G. from the Medical Faculty of Saarland University (HOMFORexzellenz 2015). The authors declare no conflicts of interest.	Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chang KW, 2013, ORAL DIS, V19, P611, DOI 10.1111/odi.12046; Chen XP, 2014, CANCER LETT, V353, P201, DOI 10.1016/j.canlet.2014.07.026; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gu Y, 2017, FASEB J, V31, P3321, DOI 10.1096/fj.201601263R; Gu Y, 2016, ONCOTARGET, V7, P5258, DOI 10.18632/oncotarget.6676; Gu Y, 2013, ANTI-CANCER DRUG, V24, P781, DOI 10.1097/CAD.0b013e328362fb84; Gupta R, 2018, LAB INVEST, V98, P682, DOI 10.1038/s41374-018-0028-5; Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633; Heusschen R, 2010, BBA-REV CANCER, V1805, P87, DOI 10.1016/j.bbcan.2009.09.005; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Icli B, 2013, CIRC RES, V113, P1231, DOI 10.1161/CIRCRESAHA.113.301780; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lo SS, 2012, ONCOGENE, V31, P226, DOI 10.1038/onc.2011.226; Lu CH, 2015, DIGEST DIS SCI, V60, P2038, DOI 10.1007/s10620-015-3585-0; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Renault MA, 2010, J MOL CELL CARDIOL, V49, P490, DOI 10.1016/j.yjmcc.2010.05.003; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Wang XH, 2017, BRATISL MED J, V118, P202, DOI 10.4149/BLL_2017_040; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Zhang XL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-56; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	35	14	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7213	7224		10.1096/fj.201802085RR	http://dx.doi.org/10.1096/fj.201802085RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30865837	Bronze			2022-12-28	WOS:000476114200045
J	Lei, JJ; Li, HQ; Mo, ZH; Liu, KJ; Zhu, LJ; Li, CY; Chen, WL; Zhang, L				Lei, Jun-Jie; Li, Hui-Qing; Mo, Zhi-Huai; Liu, Ke-Jia; Zhu, Ling-Juan; Li, Chun-Yi; Chen, Wen-Li; Zhang, Lei			Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription	FASEB JOURNAL			English	Article						CD4(+)CD25(+) T cell; proliferation; gene silencing	ISCHEMIC-STROKE; T-CELLS; EXPRESSION; ACTIVATION; BLOOD; ANGIOGENESIS; ASSOCIATION; DYSFUNCTION; THERAPY; CANCER	The effective therapeutic approach of cerebral infarction is limited because of its underlying complexity. Recently, multiple long noncoding RNAs (lncRNAs) have been identified in the pathogenesis of cerebral infarction. Here, the current study aims to explore the interaction among lncRNA cyclin-dependent kinase inhibitor-2B-antisense RNA 1 (CDKN2B-AS1), transcription factor B-cell lymphoma/leukemia 11A (BCL11A), and MAPKK kinase kinase 1 (MAP4K1) and further investigate whether they affect cerebral infarction progression. The expression of CDKN2B-AS1, BCL11A, and MAP4K1 was altered in lymphocytes extracted from patients with cerebral infarction. In order to identify their roles in regulatory T (T-reg) cells, the proliferation and apoptosis of the CD4(+)CD25(+) T-reg cells were examined, and levels of IL-4, IL-10, and TGF-beta were determined. Also, the RNA crosstalk among CDKN2B-AS1, BCL11A, and MAP4K1 was validated. Finally, we established a rat model of middle cerebral arterial occlusion to evaluate the neurologic impairment and cerebral infarction volume. The results revealed that lymphocytes in patients with cerebral infarction presented with the up-regulated expression of CDKN2B-AS1. Moreover, BCL11A could specifically bind to CDKN2B-AS1 and MAP4K1 promoter so as to inhibit MAP4K1. Moreover, it was observed that down-regulated CDKN2B-AS1 inhibited CD4(+)CD25(+) T-reg-cell proliferation, reduced levels of IL-4, IL-10, and TGF-beta and cerebral infarction volume, and elevated MAP4K1 expression. Collectively, our study provides evidence that CDKN2B-AS1 silencing could increase MAP4K1 expression to inhibit the CD4(+)CD25(+) T-reg-cell proliferation by reducing enrichment of transcription factor BCL11A, thereby protecting against cerebral infarction progression, highlighting a promising therapeutic strategy for treating cerebral infarction.-Lei, J.-J., Li, H.-Q., Mo, Z.-H., Liu, K.-J., Zhu, L.-J., Li, C.-Y., Chen, W.-L., Zhang, L. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription.	[Lei, Jun-Jie; Li, Hui-Qing; Mo, Zhi-Huai; Liu, Ke-Jia; Zhu, Ling-Juan; Li, Chun-Yi; Zhang, Lei] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Neurol, 52 Meihua East Rd, Zhuhai 519000, Guangdong, Peoples R China; [Chen, Wen-Li] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Pharmacol, 52 Meihua East Rd, Zhuhai 519000, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, L (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 5, Dept Neurol, 52 Meihua East Rd, Zhuhai 519000, Guangdong, Peoples R China.; Chen, WL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 5, Dept Pharmacol, 52 Meihua East Rd, Zhuhai 519000, Guangdong, Peoples R China.	chenwenl@mail3sysu.edu.cn; zhangl92@sysu.edu.cn	Chen, Wenli/AAG-1880-2020		National Natural Science Funds of China [81601001]; Youth Teachers Cultivation Project of Sun Yat-sen University [17ykpy63]; Five-Five Youth Talent Project of The Fifth Affiliated Hospital of Sun Yat-sen University; Prognosis Registration Research of Treatment for Acute Ischemic Stroke in China [KLK-CBV-2015-001-C]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Youth Teachers Cultivation Project of Sun Yat-sen University; Five-Five Youth Talent Project of The Fifth Affiliated Hospital of Sun Yat-sen University; Prognosis Registration Research of Treatment for Acute Ischemic Stroke in China	This study was supported by National Natural Science Funds of China (81601001), Youth Teachers Cultivation Project of Sun Yat-sen University (17ykpy63), Five-Five Youth Talent Project of The Fifth Affiliated Hospital of Sun Yat-sen University, and Prognosis Registration Research of Treatment for Acute Ischemic Stroke in China (KLK-CBV-2015-001-C). The authors declare no conflicts of interest.	AbdulAzeez S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030395; Ayuk SM, 2016, J PHOTOCH PHOTOBIO B, V161, P368, DOI 10.1016/j.jphotobiol.2016.05.027; Bayoglu B, 2016, CLIN BIOCHEM, V49, P821, DOI 10.1016/j.clinbiochem.2016.02.012; Brea D, 2014, J CELL MOL MED, V18, P1571, DOI 10.1111/jcmm.12304; Cao W, 2017, ORAL ONCOL, V65, P94, DOI 10.1016/j.oraloncology.2016.12.017; Chen FH, 2018, BIOCHEM BIOPH RES CO, V496, P184, DOI 10.1016/j.bbrc.2018.01.022; Chen YC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0986-z; Cruz Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121854; Deng YB, 2001, CHINESE MED J-PEKING, V114, P1295; Du YF, 2018, ONCOL LETT, V15, P4912, DOI 10.3892/ol.2018.7910; Dykstra-Aiello C, 2016, STROKE, V47, P2896, DOI 10.1161/STROKEAHA.116.013869; Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114; Hu YH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/813045; Huang Y., 2018, LIFE SCI, DOI 10.1016/j.lfs.2018.12.047; Jiang BY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-61; Katsura K, 2012, J NIPPON MED SCH, V79, P104, DOI 10.1272/jnms.79.104; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Li LJ, 2017, BIOMED PHARMACOTHER, V96, P165, DOI 10.1016/j.biopha.2017.09.113; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Liao JQ, 2016, GENE, V578, P158, DOI 10.1016/j.gene.2015.12.032; Mehta SL, 2015, J NEUROSCI, V35, P16443, DOI 10.1523/JNEUROSCI.2943-15.2015; Naess H, 2016, ACTA NEUROL SCAND, V133, P415, DOI 10.1111/ane.12477; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Qi X, 2017, NEUROSCIENCE, V348, P98, DOI 10.1016/j.neuroscience.2017.02.002; Schut ES, 2012, NEUROCRIT CARE, V16, P421, DOI 10.1007/s12028-011-9634-4; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wang KH, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007079, 10.1097/md.0000000000007079]; Wang Q, 2012, BBA-MOL CELL RES, V1823, P1807, DOI 10.1016/j.bbamcr.2012.07.004; Wang SH, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6205485; Wang XH, 2012, J BIOL CHEM, V287, P34091, DOI 10.1074/jbc.M112.371062; Wang Y, 2012, MOL MED REP, V5, P260, DOI 10.3892/mmr.2011.621; Xing SH, 2012, AUTOPHAGY, V8, P63, DOI 10.4161/auto.8.1.18217; Xiong L, 2018, J STROKE CEREBROVASC, V27, P2336, DOI 10.1016/j.jstrokecerebrovasdis.2018.04.020; Yan J, 2012, J NEUROIMMUNOL, V243, P89, DOI 10.1016/j.jneuroim.2011.12.019; Yan J, 2009, J NEUROIMMUNOL, V206, P112, DOI 10.1016/j.jneuroim.2008.11.001; Ye H, 2015, J NEUROL SCI, V348, P81, DOI 10.1016/j.jns.2014.11.010; Yoshida M, 2018, CLIN GENET, V93, P368, DOI 10.1111/cge.13067; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhan RY, 2017, BIOCHEM BIOPH RES CO, V490, P700, DOI 10.1016/j.bbrc.2017.06.104; Zhang BK, 2013, INT IMMUNOPHARMACOL, V16, P461, DOI 10.1016/j.intimp.2013.04.028; Zhang EB, 2014, ONCOTARGET, V5, P2276, DOI 10.18632/oncotarget.1902; Zhang W, 2008, IMMUNOL LETT, V120, P96, DOI 10.1016/j.imlet.2008.07.005; Zhang ZH, 2013, GENET TEST MOL BIOMA, V17, P47, DOI 10.1089/gtmb.2012.0253; Zhao JK, 2017, CLIN PSYCHOPHARM NEU, V15, P53, DOI 10.9758/cpn.2017.15.1.53	47	17	18	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7037	7048		10.1096/fj.201802252R	http://dx.doi.org/10.1096/fj.201802252R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30870006	Bronze			2022-12-28	WOS:000476114200030
J	Leng, XY; Ji, X; Hou, YG; Settlage, R; Jiang, HL				Leng, Xinyan; Ji, Xu; Hou, Yuguo; Settlage, Robert; Jiang, Honglin			Roles of the proteasome and inhibitor of DNA binding 1 protein in myoblast differentiation	FASEB JOURNAL			English	Article						cattle; myotube; skeletal muscle; ubiquitin	GROWTH-FACTOR-I; SKELETAL-MUSCLE; MITOCHONDRIAL ACTIVITY; MEDIATED DEGRADATION; GENE-EXPRESSION; SATELLITE CELL; UBIQUITIN; MYOGENIN; MYOD; OVEREXPRESSION	This study was conducted to further understand the mechanism that controls myoblast differentiation, a key step in skeletal muscle formation. RNA sequencing of primary bovine myoblasts revealed many genes encoding the ubiquitin-proteasome system were up-regulated during myoblast differentiation. This up-regulation was accompanied by increased proteasomal activity. Treating myoblasts with the proteasome-specific inhibitor lactacystin impeded myoblast differentiation. Adenovirus-mediated overexpression of inhibitor of DNA binding 1 (ID1) protein inhibited myoblast differentiation too. Further experiments were conducted to determine whether the proteasome promotes myoblast differentiation by degrading ID1 protein. Both ID1 protein and mRNA expression decreased during myoblast differentiation. However, treating myoblasts with lactacystin reversed the decrease in ID1 protein but not in ID1 mRNA expression. Surprisingly, this reversal was not observed when myoblasts were also treated with the mRNA translation inhibitor cycloheximide. Direct incubation of ID1 protein with proteasomes from myoblasts did not show differentiation stage-associated degradation of ID1 protein. Furthermore, ubiquitinated ID1 protein was not detected in lactacystin-treated myoblasts. Overall, the results of this study suggest that, during myoblast differentiation, the proteasomal activity is up-regulated to further myoblast differentiation and that the increased proteasomal activity improves myoblast differentiation partly by inhibiting the synthesis, not the degradation, of ID1 protein.-Leng, X., Ji, X., Hou, Y., Settlage, R., Jiang, H. Roles of the proteasome and inhibitor of DNA binding 1 protein in myoblast differentiation.	[Leng, Xinyan; Ji, Xu; Hou, Yuguo; Jiang, Honglin] Virginia Tech, Dept Anim & Poultry Sci, 3130 Litton Reaves Hall, Blacksburg, VA 24061 USA; [Settlage, Robert] Virginia Tech, Adv Res Comp Unit, Div Informat Technol, Blacksburg, VA 24061 USA; [Ji, Xu] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Nanjing Agricultural University	Jiang, HL (corresponding author), Virginia Tech, Dept Anim & Poultry Sci, 3130 Litton Reaves Hall, Blacksburg, VA 24061 USA.	hojiang@vt.edu		, Honglin/0000-0001-9540-5788	Agriculture and Food Research Initiative Competitive from the U.S. Department of Agrictulture (USDA) National Institute of Food and Agriculture Animal Genome Program [2016-67015-24471]	Agriculture and Food Research Initiative Competitive from the U.S. Department of Agrictulture (USDA) National Institute of Food and Agriculture Animal Genome Program	This study was supported, in part, by Agriculture and Food Research Initiative Competitive Grant 2016-67015-24471 from the U.S. Department of Agrictulture (USDA) National Institute of Food and Agriculture Animal Genome Program. The authors declare no conflicts of interest.	AHN JY, 1991, J BIOL CHEM, V266, P15746; ALLEN RE, 1979, J ANIM SCI, V49, P115, DOI 10.2527/jas1979.491115x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Barbieri Elena, 2011, J Aging Res, V2011, P845379, DOI 10.4061/2011/845379; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Bell RAV, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0086-6; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Bi P, 2012, J ANIM SCI, V90, P924, DOI 10.2527/jas.2011-4594; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; BRAUN T, 1991, NUCLEIC ACIDS RES, V19, P5645, DOI 10.1093/nar/19.20.5645; Brooks SA, 2010, WIRES RNA, V1, P240, DOI 10.1002/wrna.11; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Emmerich CH, 2015, BIOCHEM BIOPH RES CO, V466, P1, DOI 10.1016/j.bbrc.2015.08.109; Fink E, 2003, J MUSCLE RES CELL M, V24, P421, DOI 10.1023/A:1027387501614; Gardrat F, 1999, BIOCHEM MOL BIOL INT, V47, P387; Ge X, 2012, J ANIM SCI, V90, P1126, DOI 10.2527/jas.2011-4358; Ge XM, 2013, MOL CELL ENDOCRINOL, V372, P23, DOI 10.1016/j.mce.2013.03.017; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; GUNDERSEN K, 1995, MOL CELL BIOL, V15, P7127; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kim SS, 1998, FEBS LETT, V433, P47, DOI 10.1016/S0014-5793(98)00883-7; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; KOROHODA W, 1993, FOLIA HISTOCHEM CYTO, V31, P9; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Moyes C. D., 1997, American Journal of Physiology, V272, pC1345; Oksbjerg N, 2004, DOMEST ANIM ENDOCRIN, V27, P219, DOI 10.1016/j.domaniend.2004.06.007; Perez J, 2008, CHEM SOC REV, V37, P2658, DOI 10.1039/b707074h; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Sun LP, 2005, J BIOL CHEM, V280, P26448, DOI 10.1074/jbc.M500373200; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trausch-Azar JS, 2004, J BIOL CHEM, V279, P32614, DOI 10.1074/jbc.M403794200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagatsuma A, 2011, MOL CELL BIOCHEM, V349, P139, DOI 10.1007/s11010-010-0668-2; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	63	5	6	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7403	7416		10.1096/fj.201800574RR	http://dx.doi.org/10.1096/fj.201800574RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30865843	Bronze			2022-12-28	WOS:000476114200059
J	Shimura, T; Koyama, M; Aono, D; Kunugita, N				Shimura, Tsutomu; Koyama, Mao; Aono, Daiki; Kunugita, Naoki			Epicatechin as a promising agent to countermeasure radiation exposure by mitigating mitochondrial damage in human fibroblasts and mouse hematopoietic cells	FASEB JOURNAL			English	Article						radioprotection; parkin; ROS; Nrf2; mouse platelet	IONIZING-RADIATION; DNA-DAMAGE; VITAMIN-E; DYSFUNCTION; NUCLEAR; PARKIN; REPAIR; MICE	Accidental radiation exposure that is due to a nuclear accident or terrorism using radioactive materials has severe detrimental effects on human health, and it can manifest as acute radiation syndrome depending on the dose and distribution of the radiation. Therefore, the development of radiation countermeasure agents is urgently needed to protect humans against radiation injury. Besides nuclear DNA, the mitochondria are important targets of ionizing radiation (IR) because these organelles generate reactive oxygen species (ROS). Recently, we revealed that mitochondrial ROS-activated cell signaling is associated with IR-induced tumor formation. Here, we investigated the effectiveness of ascorbic acid and epicatechin (EC) in scavenging ROS as radiation countermeasure agents by using human cells and mouse. Preradiation and postradiation treatments with EC mitigate ROS-mediated mitochondrial damage, IR-induced oxidative stress responses including reduction of superoxide dismutase activity, and elevated nuclear factor erythroid 2-related factor 2 expression, and they improve human fibroblast survival. As well as in vitro, EC mitigated ROS-mediated mitochondrial damage after exposure to IR in vivo in mouse platelets. Furthermore, oral administration of EC significantly enhanced the recovery of mouse hematopoietic cells from radiation injury in vivo. In summary, EC is a potentially viable countermeasure agent that is immediately effective against accidental IR exposure by targeting mitochondria-mediated oxidative stress.-Shimura, T., Koyama, M., Aono, D., Kunugita, N. Epicatechin as a promising agent to countermeasure radiation exposure by mitigating mitochondrial damage in human fibroblasts and mouse hematopoietic cells.	[Shimura, Tsutomu; Koyama, Mao; Aono, Daiki; Kunugita, Naoki] Natl Inst Publ Hlth, Dept Environm Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan; [Koyama, Mao; Aono, Daiki] Meiji Pharmaceut Univ, Tokyo, Japan	National Institute of Public Health - Japan; Meiji Pharmaceutical University	Shimura, T (corresponding author), Natl Inst Publ Hlth, Dept Environm Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	tsimura@niph.go.jp		Kunugita, Naoki/0000-0002-6516-8379	Japanese Ministry of Education and Science [18H03377, 17K19944]; Japanese Ministry of the Environment, Industrial Disease Clinical Research Grants from the Japanese Ministry of Health, Labour, and Welfare; National Institute for Fusion Science (NIFS) Collaborative Research Program [NIFS13KOBA028]	Japanese Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of the Environment, Industrial Disease Clinical Research Grants from the Japanese Ministry of Health, Labour, and Welfare; National Institute for Fusion Science (NIFS) Collaborative Research Program(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Fusion Science (NIFS) - Japan)	The authors thank Kazuyuki Ishi, Kenji Hattori (both from Meiji Pharmaceutical University), and Ichiro Yamaguchi (National Institute of Public Health) for their support on this study. This research was supported by the Japanese Ministry of Education and Science (Kiban B: 18H03377), (Houga: 17K19944), Research on Health Effects of Radiation organized by the Japanese Ministry of the Environment, Industrial Disease Clinical Research Grants from the Japanese Ministry of Health, Labour, and Welfare, and, in part, by the National Institute for Fusion Science (NIFS) Collaborative Research Program (NIFS13KOBA028). This work was performed at the Joint Usage/Research Center (Radiation Biology Center) of Kyoto University, and the Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University, Nagasaki University, and Fukushima Medical University. The authors declare no conflicts of interest.	[Anonymous], 2006, INT J RAD ONCOLOGY B, DOI [DOI 10.1016/J.IJR0BP.2006.06.027, 10.1016/j.ijrobp.2006.06.027]; Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Braselmann H, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0529-y; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Clayton D A, 1975, Basic Life Sci, V5B, P589; Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gottumukkala Raju V S S, 2014, Int Sch Res Notices, V2014, P628196, DOI 10.1155/2014/628196; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grimm A, 2016, BIOGERONTOLOGY, V17, P281, DOI 10.1007/s10522-015-9618-4; Hall E.J, 2006, RADIOBIOLOGY RADIOLO, V6, P576; Heylmann D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22682; Ito Y, 2013, INT J MOL SCI, V14, P19618, DOI 10.3390/ijms141019618; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Komatsu K, 1996, AM J HUM GENET, V58, P885; MEISTER A, 1994, CANCER RES, V54, pS1969; Nair CKK, 2008, MUTAT RES-GEN TOX EN, V650, P48, DOI 10.1016/j.mrgentox.2007.10.001; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117020; Shimura T, 2006, ONCOGENE, V25, P5921, DOI 10.1038/sj.onc.1209624; Shimura T, 2010, ONCOGENE, V29, P4826, DOI 10.1038/onc.2010.238; Shimura T, 2017, CELL CYCLE, V16, P2345, DOI 10.1080/15384101.2017.1387697; Shimura T, 2016, CELL CYCLE, V15, P1099, DOI 10.1080/15384101.2016.1156276; Shimura T, 2016, ONCOTARGET, V7, P3559, DOI 10.18632/oncotarget.6518; Shimura T, 2014, CELL CYCLE, V13, P1248, DOI 10.4161/cc.28139; Shin HA, 2014, J RADIAT RES, V55, P32, DOI 10.1093/jrr/rrt085; Shin YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069151; Singh PK, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/741301; Singh VK, 2013, J RADIAT RES, V54, P973, DOI 10.1093/jrr/rrt048; Sinha M, 2012, FREE RADICAL RES, V46, P842, DOI 10.3109/10715762.2012.684245; Soroush F, 2018, FASEB J, V32, P6436, DOI 10.1096/fj.201701099; Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XY, 1999, PROG LIPID RES, V38, P309, DOI 10.1016/S0163-7827(99)00008-9; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Yamamoto T, 2010, J RADIAT RES, V51, P145, DOI 10.1269/jrr.09078	44	9	9	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6867	6876		10.1096/fj.201802246RR	http://dx.doi.org/10.1096/fj.201802246RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30840834	Bronze			2022-12-28	WOS:000476114200016
J	Zheng, L; Gao, JW; Jin, KT; Chen, ZZ; Yu, WY; Zhu, KJ; Huang, WJ; Liu, FJ; Mei, LW; Lou, C; He, DW				Zheng, Lin; Gao, Jiawei; Jin, Kangtao; Chen, Zhenzhong; Yu, Weiyang; Zhu, Kejun; Huang, Wenjun; Liu, Feijun; Mei, Liangwei; Lou, Chao; He, Dengwei			Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						osteoporosis; osteoclastogenesis; osteogenesis; therapeutics	THIOREDOXIN-INTERACTING PROTEIN; FACTOR EXPRESSION; IN-VITRO; CELLS; MICE; IDENTIFICATION; PROLIFERATION; OSTEOPOROSIS; PROGRESSION; ACTIVATION	Current pharmacological intervention for the treatment of osteolytic bone diseases such as osteoporosis focuses on the prevention of excessive osteoclastic bone resorption but does not enhance osteoblast-mediated bone formation. In our study, we have shown that 4-iodo-6-phenylpyrimidine (4-IPP), an irreversible inhibitor of macrophage migration inhibitory factor (MIF), can inhibit receptor activator of NF-kappa B ligand (RANKL)-induced osteoclastogenesis and potentiate osteoblast-mediated mineralization and bone nodule formation in vitro. Mechanistically, 4-IPP inhibited RANKL-induced p65 phosphorylation and nuclear translocation by preventing the interaction of MIF with thioredoxin-interacting protein-p65 complexes. This led to the suppression of late osteoclast marker genes such as nuclear factor of activated T cells cytoplasmic 1, resulting in impaired osteoclast formation. In contrast, 4-IPP potentiated osteoblast differentiation and mineralization also through the inhibition of the p65/NF-kappa B signaling cascade. In the murine model of pathologic osteolysis induced by titanium particles, 4-IPP protected against calvarial bone destruction. Similarly, in the murine model of ovariectomy-induced osteoporosis, 4-IPP treatment ameliorated the bone loss associated with estrogen deficiency by reducing osteoclastic activities and enhancing osteoblastic bone formation. Collectively, these findings provide evidence for the pharmacological targeting of MIF for the treatment of osteolytic bone disorders.-Zheng, L., Gao, J., Jin, K., Chen, Z., Yu, W., Zhu, K., Huang, W., Liu, F., Mei, L., Lou, C., He, D. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-kappa B signaling pathway.	[Zheng, Lin; Gao, Jiawei; Jin, Kangtao; Chen, Zhenzhong; Yu, Weiyang; Zhu, Kejun; Huang, Wenjun; Liu, Feijun; Mei, Liangwei; Lou, Chao; He, Dengwei] Zhejiang Univ, Affiliated Lishui Hosp, Dept Orthoped,Wenzhou Med Univ, Affiliated Hosp 5,Lishui Cent Hosp, 289 Kuocang Rd, Lishui 323000, Peoples R China	Wenzhou Medical University; Zhejiang University	Lou, C; He, DW (corresponding author), Zhejiang Univ, Affiliated Lishui Hosp, Dept Orthoped,Wenzhou Med Univ, Affiliated Hosp 5,Lishui Cent Hosp, 289 Kuocang Rd, Lishui 323000, Peoples R China.	dr_louchao@foxmail.com; hedw120@163.com	Zheng, Lin/AAE-8093-2021	Zheng, Lin/0000-0002-7585-6968; He, Dengwei/0000-0003-2394-2124	Natural Science Foundation of Zhejiang Provincial (CN) [LY17C100002]; Public Welfare Project of Zhejiang Provincial Science and Technology Department [2016C33245]; Zhejiang Province Scientific Project of Health and Medicine of China [2018KY936]; Zhejiang Experimental Animal and Technology Program Foundation of China [2018C37099]	Natural Science Foundation of Zhejiang Provincial (CN); Public Welfare Project of Zhejiang Provincial Science and Technology Department; Zhejiang Province Scientific Project of Health and Medicine of China; Zhejiang Experimental Animal and Technology Program Foundation of China	This work was supported by grants from the Natural Science Foundation of Zhejiang Provincial (CN) (Grant LY17C100002), Public Welfare Project of Zhejiang Provincial Science and Technology Department (Grant 2016C33245), the Zhejiang Province Scientific Project of Health and Medicine of China (Grant 2018KY936), and the Zhejiang Experimental Animal and Technology Program Foundation of China (Grant 2018C37099). The authors declare no conflicts of interest.	Aitken CJ, 2004, J BONE MINER RES, V19, P2057, DOI 10.1359/JBMR.040913; Bacher M, 1997, AM J PATHOL, V150, P235; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cao WG, 2005, BIOL REPROD, V73, P565, DOI 10.1095/biolreprod.104.038331; Chen S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12853; Chen ZH, 2015, J BIOL CHEM, V290, P30163, DOI 10.1074/jbc.M115.663518; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Gu R, 2015, CYTOKINE, V72, P135, DOI 10.1016/j.cyto.2014.11.015; Harvey NC, 2017, LANCET, V390, P2243, DOI 10.1016/S0140-6736(17)32850-7; Hermanowski-Vosatka A, 1999, BIOCHEMISTRY-US, V38, P12841, DOI 10.1021/bi991352p; Hu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16008-x; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jacquin C, 2009, BONE, V45, P640, DOI 10.1016/j.bone.2009.06.028; Kim HR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3279; Kim K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020601; Kim KW, 2016, KOREAN J INTERN MED, V31, P634, DOI 10.3904/kjim.2016.098; Kim MJ, 2017, CELL SIGNAL, V34, P110, DOI 10.1016/j.cellsig.2017.03.007; Kindt N, 2013, INT J ONCOL, V43, P185, DOI 10.3892/ijo.2013.1944; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kobayashi T, 2011, OSTEOPOROSIS INT, V22, P1955, DOI 10.1007/s00198-010-1385-0; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Lizotte J, 2012, TOXICOL LETT, V215, P167, DOI 10.1016/j.toxlet.2012.10.006; Ma JJ, 2015, BIOCHEM J, V469, P399, DOI 10.1042/BJ20150151; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Madeira MFM, 2012, MICROBES INFECT, V14, P198, DOI 10.1016/j.micinf.2011.09.005; Movila A, 2016, J BONE MINER RES, V31, P1688, DOI 10.1002/jbmr.2854; Nishihira J, 1998, CYTOKINE, V10, P199, DOI 10.1006/cyto.1997.0276; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Onodera S, 1996, IMMUNOLOGY, V89, P430, DOI 10.1046/j.1365-2567.1996.d01-751.x; Onodera S, 1999, SEMIN THROMB HEMOST, V25, P563, DOI 10.1055/s-2007-994966; Onodera S, 2006, J BONE MINER RES, V21, P876, DOI 10.1359/JBMR.060310; Oshima S, 2006, FEBS LETT, V580, P1251, DOI 10.1016/j.febslet.2006.01.038; Ranganathan V, 2017, ARTHRITIS RHEUMATOL, V69, P1796, DOI 10.1002/art.40175; Rocklin R E, 1975, Rheumatology, V6, P98; Rowe MA, 2017, ARTHRITIS RHEUMATOL, V69, P352, DOI 10.1002/art.39844; Sampey AV, 2001, ARTHRITIS RHEUM-US, V44, P1273, DOI 10.1002/1529-0131(200106)44:6<1273::AID-ART219>3.0.CO;2-8; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2110; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Subbannayya T, 2016, J CELL COMMUN SIGNAL, V10, P165, DOI 10.1007/s12079-016-0326-x; Varinelli L, 2015, ENDOCR-RELAT CANCER, V22, P759, DOI 10.1530/ERC-15-0299; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Xie Z, 2018, J BONE MINER RES, V33, P667, DOI 10.1002/jbmr.3334; Yamada K, 2012, NUTR RES, V32, P116, DOI 10.1016/j.nutres.2011.12.010; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zheng YH, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw131	54	18	18	5	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7667	7683		10.1096/fj.201802364RR	http://dx.doi.org/10.1096/fj.201802364RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30893559	Bronze			2022-12-28	WOS:000476114200080
J	Chhabra, Y; Nelson, CN; Plescher, M; Barclay, JL; Smith, AG; Andrikopoulos, S; Mangiafico, S; Waxman, DJ; Brooks, AJ; Waters, MJ				Chhabra, Yash; Nelson, Caroline N.; Plescher, Monika; Barclay, Johanna L.; Smith, Aaron G.; Andrikopoulos, Sof; Mangiafico, Salvatore; Waxman, David J.; Brooks, Andrew J.; Waters, Michael J.			Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity	FASEB JOURNAL			English	Article						metabolism; gluconeogenesis; hepatic glucose output	SKELETAL-MUSCLE; HEPATIC GLUCONEOGENESIS; GENE-EXPRESSION; NEGATIVE REGULATOR; RECEPTOR SUBSTRATE-1; TARGETED DISRUPTION; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; LARON SYNDROME; FATTY LIVER	Growth hormone (GH) has an important function as an insulin antagonist with elevated insulin sensitivity evident in humans and mice lacking a functional GH receptor (GHR). We sought the molecular basis for this sensitivity by utilizing a panel of mice possessing specific deletions of GHR signaling pathways. Metabolic clamps and glucose homeostasis tests were undertaken in these obese adult C57BL/6 male mice, which indicated impaired hepatic gluconeogenesis. Insulin sensitivity and glucose disappearance rate were enhanced in muscle and adipose of mice lacking the ability to activate the signal transducer and activator of transcription (STAT)5 via the GHR (Ghr-391(-/-)) as for GHR-null (GHR(-/-)) mice. These changes were associated with a striking inhibition of hepatic glucose output associated with altered glycogen metabolism and elevated hepatic glycogen content during unfed state. The enhanced hepatic insulin sensitivity was associated with increased insulin receptor and insulin receptor substrate 1 activation along with activated downstream protein kinase B signaling cascades. Although phosphoenolpyruvate carboxykinase (Pck)-1 expression was unchanged, its inhibitory acetylation was elevated because of decreased sirtuin-2 expression, thereby promoting loss of PCK1. Loss of STAT5 signaling to defined chromatin immunoprecipitation targets would further increase lipogenesis, supporting hepatosteatosis while lowering glucose output. Finally, up-regulation of IL-15 expression in muscle, with increased secretion of adiponectin and fibroblast growth factor 1 from adipose tissue, is expected to promote insulin sensitivity.Chhabra, Y., Nelson, C. N., Plescher, M., Barclay, J. L., Smith, A. G., Andrikopoulos, S., Mangiafico, S., Waxman, D. J., Brooks, A. J., Waters, M. J. Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity.	[Chhabra, Yash; Brooks, Andrew J.] Univ Queensland, Diamantina Inst, Translat Res Inst, 37 Kent St, Brisbane, Qld 4102, Australia; [Barclay, Johanna L.] Univ Queensland, Mater Res Inst, Translat Res Inst, Brisbane, Qld, Australia; [Smith, Aaron G.] Univ Queensland, Sch Biomed Sci, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Chhabra, Yash; Nelson, Caroline N.; Plescher, Monika; Barclay, Johanna L.; Brooks, Andrew J.; Waters, Michael J.] Univ Queensland, Inst Mol Biosci, 306 Carmody Rd, Brisbane, Qld 4072, Australia; [Plescher, Monika] Univ Bonn, Med Fac, Inst Cellular Neurosci, Bonn, Germany; [Andrikopoulos, Sof; Mangiafico, Salvatore] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Waxman, David J.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	University of Queensland; Mater Research; University of Queensland; Queensland University of Technology (QUT); University of Queensland; University of Queensland; University of Bonn; University of Melbourne; Boston University	Chhabra, Y (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, 37 Kent St, Brisbane, Qld 4102, Australia.; Waters, MJ (corresponding author), Univ Queensland, Inst Mol Biosci, 306 Carmody Rd, Brisbane, Qld 4072, Australia.	y.chhabra1@uq.edu.au; m.waters@uq.edu.au	Brooks, Andrew/A-9969-2011; Barclay, Johanna/G-6293-2012	Brooks, Andrew/0000-0002-2691-1668; Barclay, Johanna/0000-0001-5737-1775; Plescher, Monika/0000-0002-3515-9789; Chhabra, Yash/0000-0003-2883-4675	National Health and Medical Research Council [1083612, 1124026, 401668]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK033765]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK033765, R01DK033765] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank The University of Queensland Institute for Molecular Biosciences Animal House Facility for animal husbandry services. The research was supported by National Health and Medical Research Council grants 1083612 (to A.G.S.), 1124026 (to A.J.B.), and 401668 (to M.J.W.). D.J.W. was supported, in part, by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK033765. The authors declare no conflicts of interest.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; BOUGNERES PF, 1985, J CLIN ENDOCR METAB, V61, P1152, DOI 10.1210/jcem-61-6-1152; Boutant M, 2014, MOL METAB, V3, P5, DOI 10.1016/j.molmet.2013.10.006; Busquets S, 2006, BBA-GEN SUBJECTS, V1760, P1613, DOI 10.1016/j.bbagen.2006.09.001; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Chhabra Y, 2018, ONCOGENE, V37, P489, DOI 10.1038/onc.2017.352; Chhabra Y, 2011, EXPERT REV ENDOCRINO, V6, P71, DOI [10.1586/eem.10.73, 10.1586/EEM.10.73]; Corbit KC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91001; COTES PM, 1949, NATURE, V164, P209, DOI 10.1038/164209a0; Cutfield WS, 2000, LANCET, V355, P610, DOI 10.1016/S0140-6736(99)04055-6; da Rocha AF, 2013, MOL CELL BIOCHEM, V375, P89, DOI 10.1007/s11010-012-1531-4; Dominici FP, 2002, EXP BIOL MED, V227, P149, DOI 10.1177/153537020222700301; Dominici FP, 1999, AM J PHYSIOL-ENDOC M, V277, pE447, DOI 10.1152/ajpendo.1999.277.3.E447; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Frara S, 2016, TRENDS ENDOCRIN MET, V27, P470, DOI 10.1016/j.tem.2016.04.014; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068105; Geering B, 2007, BIOCHEM SOC T, V35, P199, DOI 10.1042/BST0350199; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Hoybye C, 2008, HORM METAB RES, V40, P498, DOI 10.1055/s-2008-1065322; Husbands S, 2001, CLIN ENDOCRINOL, V55, P87, DOI 10.1046/j.1365-2265.2001.01298.x; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Kanety H, 2009, EUR J ENDOCRINOL, V161, P837, DOI 10.1530/EJE-09-0419; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; Kim YD, 2012, DIABETES, V61, P2484, DOI 10.2337/db11-1665; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Ling GY, 2010, MOL CELL BIOL, V30, P5531, DOI 10.1128/MCB.00601-10; List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086; List EO, 2013, MOL ENDOCRINOL, V27, P524, DOI 10.1210/me.2012-1330; Longo KA, 2010, GROWTH HORM IGF RES, V20, P73, DOI 10.1016/j.ghir.2009.08.002; Mangiafico SP, 2011, J ENDOCRINOL, V210, P335, DOI 10.1530/JOE-11-0126; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; Mejhert N, 2010, J CLIN ENDOCR METAB, V95, P2451, DOI 10.1210/jc.2009-2049; Meyer RD, 2009, MOL ENDOCRINOL, V23, P1914, DOI 10.1210/me.2009-0242; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; MOLLER N, 1990, J CLIN ENDOCR METAB, V70, P1179, DOI 10.1210/jcem-70-4-1179; MOLLER N, 1990, AM J PHYSIOL, V258, pE86, DOI 10.1152/ajpendo.1990.258.1.E86; Nellemann B, 2014, ACTA PHYSIOL, V210, P392, DOI 10.1111/apha.12183; Nelson CN, 2018, GROWTH HORM IGF RES, V42-43, P40, DOI 10.1016/j.ghir.2018.08.004; NG SF, 1990, METABOLISM, V39, P264, DOI 10.1016/0026-0495(90)90045-E; Nordstrom SM, 2013, MOL ENDOCRINOL, V27, P1333, DOI 10.1210/me.2013-1110; Panasyuk G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1667; Panici JA, 2009, J GERONTOL A-BIOL, V64, P1126, DOI 10.1093/gerona/glp111; Prattali RR, 2005, FEBS LETT, V579, P3152, DOI 10.1016/j.febslet.2005.04.075; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasca D, 2014, BLOOD, V124, P121, DOI 10.1182/blood-2013-11-538819; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sugathan A, 2013, MOL CELL BIOL, V33, P3594, DOI 10.1128/MCB.00280-13; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Turei D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/737591; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Uruno A, 2016, MOL CELL BIOL, V36, P1655, DOI 10.1128/MCB.01095-15; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; White UA, 2007, DIABETES, V56, P1623, DOI 10.2337/db06-1286; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan JG, 1996, P NATL ACAD SCI USA, V93, P4953, DOI 10.1073/pnas.93.10.4953; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang Y, 2002, BBA-MOL CELL BIOL L, V1584, P115, DOI 10.1016/S1388-1981(02)00298-6; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	77	16	17	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6412	6430		10.1096/fj.201802328R	http://dx.doi.org/10.1096/fj.201802328R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30779881	Bronze, Green Published			2022-12-28	WOS:000466932600048
J	Kim, TH; Ly, C; Christodoulides, A; Nowell, CJ; Gunning, PW; Sloan, EK; Rowat, AC				Kim, Tae-Hyung; Ly, Chau; Christodoulides, Alexei; Nowell, Cameron J.; Gunning, Peter W.; Sloan, Erica K.; Rowat, Amy C.			Stress hormone signaling through -adrenergic receptors regulates macrophage mechanotype and function	FASEB JOURNAL			English	Article						deformability; phagocytosis; chemotaxis; actin	FILOPODIA FORMATION; ARP2/3 COMPLEX; T-CELLS; PHAGOCYTOSIS; ACTIVATION; MIGRATION; SYSTEM; DIFFERENTIATION; DEFORMABILITY; LOCALIZATION	Critical functions of immune cells require them to rapidly change their shape and generate forces in response to cues from their surrounding environment. However, little is known about how soluble factors that may be present in the microenvironment modulate key aspects of cellular mechanobiologysuch as immune cell deformability and force generationto impact functions such as phagocytosis and migration. Here we show that signaling by soluble stress hormones through -adrenoceptors (-AR) reduces the deformability of macrophages; this is dependent on changes in the organization of the actin cytoskeleton and is associated with functional changes in phagocytosis and migration. Pharmacologic interventions reveal that the impact of -AR signaling on macrophage deformability is dependent on actin-related proteins 2/3, indicating that stress hormone signaling through -AR shifts actin organization to favor branched structures rather than linear unbranched actin filaments. These findings show that through remodeling of the actin cytoskeleton, -AR-mediated stress hormone signaling modulates macrophage mechanotype to impact functions that play a critical role in immune response.Kim, T.-H., Ly, C., Christodoulides, A., Nowell, C. J., Gunning, P. W., Sloan, E. K., Rowat, A. C. Stress hormone signaling through -adrenergic receptors regulates macrophage mechanotype and function.	[Kim, Tae-Hyung; Ly, Chau; Christodoulides, Alexei; Rowat, Amy C.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Kim, Tae-Hyung; Sloan, Erica K.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA 90024 USA; [Ly, Chau; Rowat, Amy C.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Sloan, Erica K.; Rowat, Amy C.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Sloan, Erica K.] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA USA; [Nowell, Cameron J.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic, Australia; [Gunning, Peter W.] Univ New South Wales Sydney, Sch Med Sci, Kensington, NSW, Australia; [Sloan, Erica K.] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Monash University; University of New South Wales Sydney; Peter Maccallum Cancer Center	Sloan, EK (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.; Rowat, AC (corresponding author), Univ Calif Los Angeles, Terasaki Life Sci Bldg 1125, Los Angeles, CA 90095 USA.	erica.sloan@monash.edu; rowat@ucla.edu	Kim, Tae-Hyung/B-1523-2009; Gunning, Peter W/E-9058-2010	Gunning, Peter/0000-0003-0833-3128; Christodoulides, Alexei/0000-0003-0685-3154; Ly, Chau/0000-0003-4010-8836	U.S. National Institutes of Health (NIH) [CA-16042, AI-28697]; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine at UCLA; NIH/National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute [UL1TR000124]; University of California Cancer Research Coordinating Committe [CRR-18-52690]; National Science Foundation [CAREER DBI-1254185]; Australian National Health and Medical Research Council (NHMRC) [APP1147498]; Center for AIDS Research	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonsson Comprehensive Cancer Center; David Geffen School of Medicine at UCLA(University of California System); NIH/National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute; University of California Cancer Research Coordinating Committe; National Science Foundation(National Science Foundation (NSF)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Center for AIDS Research	The authors thank Dr. Sherie L. Morrison [University of California, Los Angeles (UCLA)] for providing U937 cell line, and the UCLA Statistical Consulting Group for advice on data analysis. Flow cytometry ImageStream, and IncuCyte analyses were performed in the UCLA Flow Cytometry Core Facility, which is supported by U.S. National Institutes of Health (NIH) Awards CA-16042 (National Cancer Institute) and AI-28697 (National Institute of Allergy and Infectious Diseases) and by the Jonsson Comprehensive Cancer Center, the Center for AIDS Research, and the David Geffen School of Medicine at UCLA. This work was supported by NIH/National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute Grant UL1TR000124, the University of California Cancer Research Coordinating Committe (CRR-18-52690), the National Science Foundation (CAREER DBI-1254185 to A.C.R.), and the Australian National Health and Medical Research Council (NHMRC) APP1147498. The authors declare no conflicts of interest.	Bendell AC, 2017, INTEGR BIOL-UK, V9, P695, DOI 10.1039/c7ib00070g; Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104; Bufi N, 2015, BIOPHYS J, V108, P2181, DOI 10.1016/j.bpj.2015.03.047; Cao XO, 2016, CURR BIOL, V26, P2398, DOI 10.1016/j.cub.2016.08.046; Chen Y, 2017, EXP HEMATOL ONCOL, V6, DOI 10.1186/s40164-017-0083-4; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chiarella SE, 2014, J CLIN INVEST, V124, P2935, DOI 10.1172/JCI75157; Chitu V, 2005, MOL BIOL CELL, V16, P2947, DOI 10.1091/mbc.e04-10-0914; Cojoc D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001072; Creed SJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0655-3; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; Di Cerbo A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19563-z; Dimchev G, 2017, MOL BIOL CELL, V28, P1311, DOI 10.1091/mbc.E16-05-0334; Efimova N, 2018, J CELL BIOL, V217, P1827, DOI 10.1083/jcb.201708103; Ekpenyong AE, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602536; Ekpenyong AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045237; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fritzsche M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501337; Gabriele S, 2009, BIOPHYS J, V96, P4308, DOI 10.1016/j.bpj.2009.02.037; Gill N. K., 2017, PROTOC EXCH, DOI [10.1038/protex.2017.101, DOI 10.1038/PR0TEX.2017.101]; Groot-Kormelink PJ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-57; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; Hida A, 2000, IMMUNOLOGY, V99, P553, DOI 10.1046/j.1365-2567.2000.00985.x; Hoelzle DJ, 2014, JOVE-J VIS EXP, DOI 10.3791/51474; Hoffmann AK, 2014, FASEB J, V28, P3075, DOI 10.1096/fj.13-247049; Honold L, 2018, CIRC RES, V122, P113, DOI 10.1161/CIRCRESAHA.117.311071; Isogai T, 2015, J CELL SCI, V128, P3796, DOI 10.1242/jcs.176768; Itagaki K, 2004, J IMMUNOL, V172, P601, DOI 10.4049/jimmunol.172.1.601; Izeboud CA, 1999, J RECEPT SIGNAL TR R, V19, P191, DOI 10.3109/10799899909036645; Jevnikar Z, 2012, EUR J IMMUNOL, V42, P3429, DOI 10.1002/eji.201242610; Kage F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14832; Kapellos TS, 2016, BIOCHEM PHARMACOL, V116, P107, DOI 10.1016/j.bcp.2016.07.011; Kim TH, 2016, J CELL SCI, V129, P4563, DOI 10.1242/jcs.194803; Labernadie A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6343; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; LIU MY, 1992, EXP HEMATOL, V20, P974; MacQueen LA, 2012, J BIOMECH, V45, P2797, DOI 10.1016/j.jbiomech.2012.08.040; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; May RC, 2001, J CELL SCI, V114, P1061; MAZUR MT, 1977, J CELL BIOL, V75, P185, DOI 10.1083/jcb.75.1.185; McWhorter FY, 2015, CELL MOL LIFE SCI, V72, P1303, DOI 10.1007/s00018-014-1796-8; Mennens SFB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17787-z; Miller MR, 2017, J CELL SCI, V130, P1730, DOI 10.1242/jcs.195099; Muthu K, 2010, J LEUKOCYTE BIOL, V88, P715, DOI 10.1189/jlb.0410186; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nicholls AJ, 2018, J LEUKOCYTE BIOL, V103, P295, DOI 10.1002/JLB.3MA0517-194RR; Nyberg KD, 2017, BIOPHYS J, V113, P1574, DOI 10.1016/j.bpj.2017.06.073; Nyberg KD, 2016, LAB CHIP, V16, P3330, DOI 10.1039/c6lc00169f; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024; Pizarro-Cerda J, 2017, TRENDS CELL BIOL, V27, P93, DOI 10.1016/j.tcb.2016.08.001; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pon CK, 2016, FASEB J, V30, P1144, DOI 10.1096/fj.15-277798; PRENTKI M, 1979, J CELL BIOL, V81, P592, DOI 10.1083/jcb.81.3.592; Previtera ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145813; Qi DP, 2015, SCI REP-UK, V5, DOI 10.1038/srep17595; Qin JF, 2015, BMB REP, V48, P295, DOI 10.5483/BMBRep.2015.48.5.008; Revach OY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09466; Rottner K, 2017, J CELL SCI, V130, P3427, DOI 10.1242/jcs.206433; Rougerie P, 2013, IMMUNOL REV, V256, P222, DOI 10.1111/imr.12118; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Serio M, 1996, IMMUNOPHARM IMMUNOT, V18, P247, DOI 10.3109/08923979609052735; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Thauland TJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah3737; Thiam HR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10997; TSAI MA, 1994, BIOPHYS J, V66, P2166, DOI 10.1016/S0006-3495(94)81012-4; van den Dries K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2402; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Verhoeckx KCM, 2004, PROTEOMICS, V4, P1014, DOI 10.1002/pmic.200300669; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wirth T, 2014, BRAIN BEHAV IMMUN, V38, P100, DOI 10.1016/j.bbi.2014.01.007; Yang LF, 2017, J TOXICOL SCI, V42, P763, DOI 10.2131/jts.42.763; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08357-4	81	18	20	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3997	4006		10.1096/fj.201801429RR	http://dx.doi.org/10.1096/fj.201801429RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509116	Green Published, Bronze			2022-12-28	WOS:000459794800071
J	Savoia, M; Cencioni, C; Mori, M; Atlante, S; Zaccagnini, G; Devanna, P; Di Marcotullio, L; Botta, B; Martelli, F; Zeiher, AM; Pontecorvi, A; Farsetti, A; Spallotta, F; Gaetano, C				Savoia, Matteo; Cencioni, Chiara; Mori, Mattia; Atlante, Sandra; Zaccagnini, Germana; Devanna, Paolo; Di Marcotullio, Lucia; Botta, Bruno; Martelli, Fabio; Zeiher, Andreas M.; Pontecorvi, Alfredo; Farsetti, Antonella; Spallotta, Francesco; Gaetano, Carlo			P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation	FASEB JOURNAL			English	Article						PCAF; IDH2; -ketoglutarate; metabolism; mitochondrion	EPSILON-LYSINE ACETYLATION; CARDIAC MESENCHYMAL CELLS; FATTY-ACID OXIDATION; MOLECULAR-DYNAMICS; SIR2 HOMOLOG; PCAF; METABOLISM; SUBSTRATE; DISTINCT; CANCER	The epigenetic enzyme p300/CBP-associated factor (PCAF) belongs to the GCN5-related N-acetyltransferase (GNAT) family together with GCN5. Although its transcriptional and post-translational function is well characterized, little is known about its properties as regulator of cell metabolism. Here, we report the mitochondrial localization of PCAF conferred by an 85 aa mitochondrial targeting sequence (MTS) at the N-terminal region of the protein. In mitochondria, one of the PCAF targets is the isocitrate dehydrogenase 2 (IDH2) acetylated at lysine 180. This PCAF-regulated post-translational modification might reduce IDH2 affinity for isocitrate as a result of a conformational shift involving predictively the tyrosine at position 179. Site-directed mutagenesis and functional studies indicate that PCAF regulates IDH2, acting at dual level during myoblast differentiation: at a transcriptional level together with MyoD, and at a post-translational level by direct modification of lysine acetylation in mitochondria. The latter event determines a decrease in IDH2 function with negative consequences on muscle fiber formation in C2C12 cells. Indeed, a MTS-deprived PCAF does not localize into mitochondria, remains enriched into the nucleus, and contributes to a significant increase of muscle-specific gene expression enhancing muscle differentiation. The role of PCAF in mitochondria is a novel finding shedding light on metabolic processes relevant to early muscle precursor differentiation.Savoia, M., Cencioni, C., Mori, M., Atlante, S., Zaccagnini, G., Devanna, P., Di Marcotullio, L., Botta, B., Martelli, F., Zeiher, A. M., Pontecorvi, A., Farsetti, A., Spallotta, F., Gaetano, C. P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation.	[Savoia, Matteo; Atlante, Sandra; Spallotta, Francesco] Goethe Univ, Dept Cardiol, Div Cardiovasc Epigenet, Frankfurt, Germany; [Zeiher, Andreas M.] Goethe Univ, Dept Cardiol, Internal Med Clin 3, Frankfurt, Germany; [Cencioni, Chiara; Farsetti, Antonella] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Mori, Mattia] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy; [Zaccagnini, Germana; Martelli, Fabio] Policlin San Donato, Ist Ricovero & Cura Carattere Sci, Mol Cardiol Lab, Milan, Italy; [Devanna, Paolo] Max Plank Inst Psycholinguist, Neurogenet Vocal Commun Grp, Nijmegen, Netherlands; [Di Marcotullio, Lucia] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Botta, Bruno] Sapienza Univ Rome, Dipartimento Chim & Tecnol Farmaco, Rome, Italy; [Di Marcotullio, Lucia] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Pontecorvi, Alfredo] Univ Cattolica Sacro Cuore Roma, Inst Med Pathol, Rome, Italy; [Pontecorvi, Alfredo] Fdn Policlin Univ A Gemelli Ist Ricovero & Cura C, Rome, Italy; [Gaetano, Carlo] Ist Clin Sci Maugeri, Lab Epigenet, Via Maugeri 4, I-27100 Pavia, Italy; [Spallotta, Francesco] Ist Ricovero & Cura Carattere Sci, Candiolo Canc Inst, Fdn Piemonte Oncol, Turin, Italy	Goethe University Frankfurt; Goethe University Frankfurt; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Siena; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Policlinico San Donato; Max Planck Society; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituti Clinici Scientifici Maugeri IRCCS; IRCCS Fondazione del Piemonte per l'Oncologia	Gaetano, C (corresponding author), Ist Clin Sci Maugeri, Lab Epigenet, Via Maugeri 4, I-27100 Pavia, Italy.; Spallotta, F (corresponding author), Ist Ricovero & Cura Carattere Sci, Candiolo Canc Inst, Fdn Piemonte Oncol, Turin, Italy.	fspallotta@gmail.com; carlo.gaetano@icsmaugeri.it	Martelli, Fabio/AAL-3788-2020; Farsetti, Antonella/I-8710-2018; Atlante, Sandra/K-3917-2018; Zaccagnini, Germana/J-7722-2016; Spallotta, Francesco/AAB-6261-2019; Cencioni, Chiara/I-8490-2018; Gaetano, Carlo/P-9997-2019	Martelli, Fabio/0000-0002-8624-7738; Farsetti, Antonella/0000-0002-8603-7925; Atlante, Sandra/0000-0001-8090-9895; Zaccagnini, Germana/0000-0002-9441-4735; Spallotta, Francesco/0000-0002-0466-6286; Cencioni, Chiara/0000-0001-6284-539X; Gaetano, Carlo/0000-0002-5238-1832; Mori, Mattia/0000-0003-2398-1254; Botta, Bruno/0000-0001-8707-4333; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178	LOEWE Cell and Gene Therapy Center (LOEWE-CGT), Goethe University; Deutsche Forschungsgemeinschaft [SFB834]; Ph.D. Program in Sciences of Nutrition, Metabolism, Ageing, and Gender Pathologies (Universita Cattolica del Sacro Cuore, Rome, Italy); August Scheidel-Stiftung; Amandus und Barbara Pauli Stiftung; German Research Foundation (DFG) Excellence Cluster Cardio Pulmonary; Italian Ministry of Health (Ricerca Corrente); Italian Ministry of Health [5X1000, RF-2011-02347907, PE-2011-02348537]; Telethon-Italy [GGP14092]; French Muscular Dystrophy Association (AFM-Telethon) Grant [18477]; Italian Ministry of Education, University and Research [PRIN2015ZHKFTA, PRIN2015HPMLFY_004]; Italian Association for Cancer Research (AIRC) Grant [IG20801]	LOEWE Cell and Gene Therapy Center (LOEWE-CGT), Goethe University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ph.D. Program in Sciences of Nutrition, Metabolism, Ageing, and Gender Pathologies (Universita Cattolica del Sacro Cuore, Rome, Italy); August Scheidel-Stiftung; Amandus und Barbara Pauli Stiftung; German Research Foundation (DFG) Excellence Cluster Cardio Pulmonary(German Research Foundation (DFG)); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Italian Ministry of Health(Ministry of Health, Italy); Telethon-Italy(Fondazione Telethon); French Muscular Dystrophy Association (AFM-Telethon) Grant; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research (AIRC) Grant(Fondazione AIRC per la ricerca sul cancro)	The authors thank Dr. Rosaria Benedetti and Prof. Lucia Altucci (Universita degli Studi della Campania L. Vanvitelli, Naples, Italy), for their help with the PCAF radioactivity assay. This work was supported by the following: LOEWE Cell and Gene Therapy Center (LOEWE-CGT), Goethe University, and Deutsche Forschungsgemeinschaft Program SFB834 "Endothelial Signaling and Vascular Repair," Project B11 Grants (to C.G.) M.S. was the recipient of a fellowship from the Ph.D. Program in Sciences of Nutrition, Metabolism, Ageing, and Gender Pathologies (Universita Cattolica del Sacro Cuore, Rome, Italy). C.C. and F.S. were funded by August Scheidel-Stiftung and Amandus und Barbara Pauli Stiftung 2016. F.S. was funded by the German Research Foundation (DFG) Excellence Cluster Cardio Pulmonary. This work was also supported by Italian Ministry of Health (Ricerca Corrente; to C.G., G.Z., and F.M.), The Italian Ministry of Health (5X1000, RF-2011-02347907, and PE-2011-02348537), Telethon-Italy (Grant GGP14092), and French Muscular Dystrophy Association (AFM-Telethon) Grant 18477 supported F.M. This work was also partially funded by the Italian Ministry of Education, University and Research (PRIN2015ZHKFTA to A.F. and PRIN2015HPMLFY_004 to A.P.), and by Italian Association for Cancer Research (AIRC) Grant IG20801 (to L.D.M.). The authors declare no conflicts of interest.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Atlante S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0802-8; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Bastiaansen AJNM, 2013, ARTERIOSCL THROM VAS, V33, P1902, DOI 10.1161/ATVBAHA.113.301579; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Carrico C, 2018, CELL METAB, V27, P497, DOI 10.1016/j.cmet.2018.01.016; Chatterjee A, 2016, CELL, V167, P722, DOI 10.1016/j.cell.2016.09.052; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colussi C, 2012, ARTERIOSCL THROM VAS, V32, P2435, DOI 10.1161/ATVBAHA.112.254011; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Davuluri G, 2016, J PHYSIOL-LONDON, V594, P7341, DOI 10.1113/JP272796; de Jong RCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185820; Etchegaray JP, 2016, MOL CELL, V62, P695, DOI 10.1016/j.molcel.2016.05.029; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Foster DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067513; GABRIEL JL, 1986, METABOLISM, V35, P661, DOI 10.1016/0026-0495(86)90175-7; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hofer A, 2014, EXP GERONTOL, V56, P202, DOI 10.1016/j.exger.2014.03.006; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Maurice T, 2008, NEUROPSYCHOPHARMACOL, V33, P1584, DOI 10.1038/sj.npp.1301551; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Papamokos GV, 2012, BIOPHYS J, V102, P1926, DOI 10.1016/j.bpj.2012.03.030; Ponnaluri VKC, 2017, EPIGENETICS-US, V12, P123, DOI 10.1080/15592294.2016.1265713; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Schiaffino S, 2015, SCAND J MED SCI SPOR, V25, P41, DOI 10.1111/sms.12606; Shintaku J, 2016, CELL REP, V17, P514, DOI 10.1016/j.celrep.2016.09.010; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Spallotta F, 2018, CIRC RES, V122, P31, DOI 10.1161/CIRCRESAHA.117.311300; Spallotta Francesco, 2013, Commun Integr Biol, V6, pe25466, DOI 10.4161/cib.25466; Spallotta F, 2013, J BIOL CHEM, V288, P22915, DOI 10.1074/jbc.M113.484337; Sun C, 2014, CELL REP, V9, P2250, DOI 10.1016/j.celrep.2014.11.029; Suryanarayanan V., 2018, J BIOMOL STRUCT DYN, V120, P823; Swaminathan V, 2007, Subcell Biochem, V41, P397; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Vecellio M, 2014, DIABETES, V63, P2132, DOI 10.2337/db13-0731; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Xie XL, 2017, STRUCTURE, V25, P506, DOI 10.1016/j.str.2016.12.017; Xu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10337-7; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang H, 2008, J BIOL CHEM, V283, P7580, DOI 10.1074/jbc.M707192200; Zhong X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43539; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643; Zou XH, 2017, CANCER RES, V77, P3990, DOI 10.1158/0008-5472.CAN-16-2393	70	9	9	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4107	4123		10.1096/fj.201800788R	http://dx.doi.org/10.1096/fj.201800788R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526058	Bronze			2022-12-28	WOS:000459794800081
J	Xu, JR; Tan, PP; Li, H; Cui, YY; Qiu, Y; Wang, H; Zhang, X; Li, J; Zhu, L; Zhou, W; Chen, HZ				Xu, Jianrong; Tan, Panpan; Li, Hui; Cui, Yongyao; Qiu, Yu; Wang, Hao; Zhang, Xuan; Li, Juan; Zhu, Liang; Zhou, Wei; Chen, Hongzhuan			Direct SUMOylation of M1 muscarinic acetylcholine receptor increases its ligand-binding affinity and signal transduction	FASEB JOURNAL			English	Article						site-directed mutagenesis; GPCR; agonist; radio-ligand binding	POSTTRANSLATIONAL MODIFICATIONS; SUMO; INTERNALIZATION; TRAFFICKING; MODULATION; COMPLEX	SUMOylation is a significant post-translational modification (PTM) by the small ubiquitin-related modifier (SUMO). Increasing evidence shows SUMOylation regulates GPCR signaling; however, very few GPCRs have been shown to be SUMOylation targets to date. In this study, we identified M1 muscarinic acetylcholine receptor (M1 mAChR), a member of the GPCRs, as a new SUMO substrate. When the mAChR was activated by the agonist carbachol, the colocalization of the M1 mAChR and SUMO-1 protein markedly decreased in immunoprecipitation and immunofluorescence assays. SUMOylation of the M1 mAChR played an important role in increasing the ligand-binding affinity to M1 mAChR, signaling efficiencies, and receptor endocytosis. Through the site-directed mutagenesis approach, K327 was identified as the SUMOylation site of the M1 mAChR. Mutation of the consensus SUMOylation site of the M1 mAChR reduces not only the colocalization of SUMO-1, but also the ligand-binding affinity and signal transduction. The function of M1 mAChR was regulated by SUMOylation through the stabilization of active-state conformation revealed by molecular dynamics simulations. Our results provide evidence that M1 SUMOylation is an important PTM involved in regulation of the affinity for agonists and for activation of signaling pathways.Xu, J., Tan, P., Li, H., Cui, Y., Qiu, Y., Wang, H., Zhang, X., Li, J., Zhu, L., Zhou, W., Chen, H. Direct SUMOylation of M1 muscarinic acetylcholine receptor increases its ligand-binding affinity and signal transduction.	[Xu, Jianrong; Tan, Panpan; Li, Hui; Cui, Yongyao; Qiu, Yu; Wang, Hao; Zhang, Xuan; Li, Juan; Zhu, Liang; Zhou, Wei; Chen, Hongzhuan] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Inst Med Sci, Shanghai 200025, Peoples R China; [Zhou, Wei] Shanghai Jiao Tong Univ, Sch Med, Coll Stomatol, Shanghai, Peoples R China; [Zhou, Wei] Shanghai Ninth Peoples Hosp, Lab Oral Microbiota & Syst Dis, Shanghai, Peoples R China; [Zhou, Wei] Natl Clin Res Ctr Oral Dis, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China; [Zhou, Wei] Shanghai Key Lab Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China; [Zhou, Wei] Shanghai Res Inst Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China; [Chen, Hongzhuan] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, 1200 Cailun Rd, Shanghai 201203, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine	Chen, HZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Inst Med Sci, Shanghai 200025, Peoples R China.; Zhou, W (corresponding author), Natl Clin Res Ctr Oral Dis, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Zhou, W (corresponding author), Shanghai Key Lab Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Zhou, W (corresponding author), Shanghai Res Inst Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Chen, HZ (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, 1200 Cailun Rd, Shanghai 201203, Peoples R China.; Zhou, W (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Coll Stomatol, Lab Oral Microbiota & System Dis,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.	sweetzw@hotmail.com; hongzhuan_chen@hotmail.com	ZHU, Liang/O-5270-2019	ZHU, Liang/0000-0002-9383-392X	National Natural Science Foundation of China [81273519, 81503174, 81670992, 81573415]; Shanghai Municipal Science and Technology Commission [11ZR1419300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China grants 81273519 (to W.Z.), 81503174 (to J.X.), 81670992 (to W.Z.), and 81573415 (to H.C.); and Shanghai Municipal Science and Technology Commission Grant 11ZR1419300 (to W.Z.). The authors declare no conflicts of interest.	ALLARD WJ, 1987, NUCLEIC ACIDS RES, V15, P10604, DOI 10.1093/nar/15.24.10604; Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; [Anonymous], 2010, MOL OP ENV MOE; Barry J, 2011, INT J BIOCHEM CELL B, V43, P37, DOI 10.1016/j.biocel.2010.09.022; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Bradley SJ, 2017, J CLIN INVEST, V127, P487, DOI 10.1172/JCI87526; BUCKLEY NJ, 1989, MOL PHARMACOL, V35, P469; Case D. A., 2021, AMBER 2022; Choi JH, 2016, NEUROPHARMACOLOGY, V102, P229, DOI 10.1016/j.neuropharm.2015.11.021; Coelho-Silva Leticia, 2017, Neuronal Signal, V1, pNS20160010, DOI 10.1042/NS20160010; Daaka Y, 2012, BBA-GEN SUBJECTS, V1820, P743, DOI 10.1016/j.bbagen.2011.03.007; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Felberbaum R, 2012, MOL CELL BIOL, V32, P64, DOI 10.1128/MCB.05878-11; Feligioni M, 2009, EUR J NEUROSCI, V29, P1348, DOI 10.1111/j.1460-9568.2009.06692.x; Fisher A, 2012, J NEUROCHEM, V120, P22, DOI 10.1111/j.1471-4159.2011.07507.x; Fox JEM, 2012, CAN J PHYSIOL PHARM, V90, P765, DOI 10.1139/Y11-134; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grimsey N, 2011, IUBMB LIFE, V63, P403, DOI 10.1002/iub.442; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Li Q, 2013, PSYCHONEUROENDOCRINO, V38, P2542, DOI 10.1016/j.psyneuen.2013.05.016; Li Q, 2013, PSYCHONEUROENDOCRINO, V38, P1145, DOI 10.1016/j.psyneuen.2012.11.005; Luo J, 2013, NEUROMOL MED, V15, P692, DOI 10.1007/s12017-013-8253-y; Ma GQ, 2016, DEV CELL, V39, P438, DOI 10.1016/j.devcel.2016.09.014; Marcelli S, 2018, PHARMACOL RES, V130, P420, DOI 10.1016/j.phrs.2017.12.023; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Norskov-Lauritsen L, 2015, EUR J PHARMACOL, V763, P233, DOI 10.1016/j.ejphar.2015.05.015; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Salom D, 2012, BIOCHEMISTRY-US, V51, P214, DOI 10.1021/bi201707v; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schorova Lenka, 2016, Front Synaptic Neurosci, V8, P9, DOI 10.3389/fnsyn.2016.00009; Teng SL, 2012, AMINO ACIDS, V43, P447, DOI 10.1007/s00726-011-1100-2; Thal DM, 2016, NATURE, V531, P335, DOI 10.1038/nature17188; Torrecilla I, 2006, CURR PHARM DESIGN, V12, P1797, DOI 10.2174/138161206776873716; Uwada J, 2014, J CELL SCI, V127, P3131, DOI 10.1242/jcs.148478; van Koppen CJ, 2004, MOL PHARMACOL, V66, P365, DOI 10.1124/mol.104.003822; Xu JR, 2012, J BIOMOL STRUCT DYN, V30, P30, DOI 10.1080/07391102.2012.674188; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42749; Zhou W, 2008, CELL MOL NEUROBIOL, V28, P263, DOI 10.1007/s10571-007-9251-0	46	9	9	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3237	3251		10.1096/fj.201800936R	http://dx.doi.org/10.1096/fj.201800936R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30407877	Bronze			2022-12-28	WOS:000459794800014
J	Salvany, S; Casanovas, A; Tarabal, O; Piedrafita, L; Hernandez, S; Santafe, M; Soto-Bernardini, MC; Caldero, J; Schwab, MH; Esquerda, JE				Salvany, Sara; Casanovas, Anna; Tarabal, Olga; Piedrafita, Lidia; Hernandez, Sara; Santafe, Manuel; Clara Soto-Bernardini, Maria; Caldero, Jordi; Schwab, Markus H.; Esquerda, Josep E.			Localization and dynamic changes of neuregulin-1 at C-type synaptic boutons in association with motor neuron injury and repair	FASEB JOURNAL			English	Article						spinal cord; C-bouton; nerve transection; microglia; motor neuron afferents	SIGMA-1 RECEPTOR; ENDOPLASMIC-RETICULUM; SPINAL MOTONEURONS; CELL-DEATH; SYNAPSES; CHANNELS; MICE; INTERNEURONS; EXPRESSION; TERMINALS	C-type synaptic boutons (C-boutons) provide cholinergic afferent input to spinal cord motor neurons (MNs), which display an endoplasmic reticulum (ER)-related subsurface cistern (SSC) adjacent to their postsynaptic membrane. A constellation of postsynaptic proteins is clustered at C-boutons, including M2 muscarinic receptors, potassium channels, and sigma-1 receptors. In addition, we previously found that neuregulin (NRG)1 is associated with C-boutons at postsynaptic SSCs, whereas its ErbB receptors are located in the presynaptic compartment. C-bouton-mediated regulation of MN excitability has been implicated in MN disease, but NRG1-mediated functions and the impact of various pathologic conditions on C-bouton integrity have not been studied in detail. Here, we investigated changes in C-boutons after electrical stimulation, pharmacological treatment, and peripheral nerve axotomy. SSC-linked NRG1 clusters were severely disrupted in acutely stressed MNs and after tunicamycin-induced ER stress. In axotomized MNs, C-bouton loss occurred in concomitance with microglial recruitment and was prevented by the ER stress inhibitor salubrinal. Activated microglia displayed a positive chemotaxis to C-boutons. Analysis of transgenic mice overexpressing NRG1 type I and type III isoforms in MNs indicated that NRG1 type III acts as an organizer of SSC-like structures, whereas NRG1 type I promotes synaptogenesis of presynaptic cholinergic terminals. Moreover, MN-derived NRG1 signals may regulate the activity of perineuronal microglial cells. Together, these data provide new insights into the molecular and cellular pathology of C-boutons in MN injury and suggest that distinct NRG1 isoform-mediated signaling functions regulate the complex matching between pre- and postsynaptic C-bouton elements.-Salvany, S., Casanovas, A., Tarabal, O., Piedrafita, L., Hernandez, S., Santafe, M., Soto-Bernardini, M. C., Caldero, J., Schwab, M. H., Esquerda, J. E. Localization and dynamic changes of neuregulin-1 at C-type synaptic boutons in association with motor neuron injury and repair.	[Salvany, Sara; Casanovas, Anna; Tarabal, Olga; Piedrafita, Lidia; Hernandez, Sara; Caldero, Jordi; Esquerda, Josep E.] Univ Lleida, Unitat Neurobiol Cellular, Dept Med Expt, IRBLLEIDA,Fac Med, Av Rovira Roure 80,Biomed 1, Lleida 25198, Catalonia, Spain; [Santafe, Manuel] Univ Rovira & Virgili, Fac Med & Ciencies Salut, UHN, Reus, Catalonia, Spain; [Clara Soto-Bernardini, Maria] Escuela Biol, Inst Tecnol Costa Rica TEC, CIB, Cartago, Costa Rica; [Schwab, Markus H.] Hannover Med Sch, Inst Cellular Neurophysiol, Hannover, Germany; [Schwab, Markus H.] Univ Vet Med Hannover, Ctr Syst Neurosci ZSN, Hannover, Germany	Universitat de Lleida; Universitat Rovira i Virgili; Instituto Tecnologico de Costa Rica; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation	Esquerda, JE (corresponding author), Univ Lleida, Unitat Neurobiol Cellular, Dept Med Expt, IRBLLEIDA,Fac Med, Av Rovira Roure 80,Biomed 1, Lleida 25198, Catalonia, Spain.; Schwab, MH (corresponding author), Hannover Med Sch, Carl Neuberg Str 1, D-30625 Hannover, Germany.	schwab.markus@mh-hannover.de; josep.esquerda@mex.udl.cat	Hernández, Sara/HHN-5230-2022; Santafe, Manel M/GSN-5961-2022; Mostazo, Olga Tarabal/C-6620-2011; Hernandez, Sara/N-4017-2014; Calderó, Jordi/A-7373-2010; Santafe, Manel/AHA-4042-2022; Salvany, Sara/AAK-4384-2021; Esquerda, Josep E/A-7377-2010	Santafe, Manel M/0000-0002-5462-5108; Mostazo, Olga Tarabal/0000-0001-7741-3223; Hernandez, Sara/0000-0002-6451-724X; Calderó, Jordi/0000-0003-1972-0115; Santafe, Manel/0000-0002-5462-5108; Esquerda, Josep E/0000-0003-1413-2103; Piedrafita Llorens, Lidia/0000-0001-8151-7447	Spanish Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER) [SAF2015-70801-R]; Spanish Ministerio de Educacion, Cultura, y Deporte (FPU); Deutsche Forschungsgemeinschaft (DFG); DFG [SCHW741/4-1]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Spanish Ministerio de Educacion, Cultura, y Deporte (FPU)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The authors thank Klaus A. Nave (Max-Planck-Institute of Experimental Medicine, Gottingen, Germany) for advice and for supplying neuregulin-1-mutant mice; Jesus Maria Lopez (Universidad Complutense de Madrid, Madrid, Spain), Ester Desfilis, and Jose Antonio Moreno for providing spinal cord samples from nonrodent animals; Anais Panosa and Xavier Calomarde (all from Universitat de Lleida-Institut de Recerca Biomedica de Lleida) for technical support with confocal and electron microscopy; and the Serveis Cientifico-Tecnics Anima Facility of the University of Lleida for mouse care and housing. This work was supported by grants to J.E.E. and J.C. from the Spanish Ministerio de Economia y Competitividad cofinanced by the Fondo Europeo de Desarrollo Regional (FEDER; SAF2015-70801-R). S.S. holds a grant from Spanish Ministerio de Educacion, Cultura, y Deporte (FPU). M.H.S. holds a Heisenberg Fellowship from the Deutsche Forschungsgemeinschaft (DFG) and acknowledges funding by a DFG research grant (SCHW741/4-1). The authors declare no conflicts of interest.	Acharjee S, 2018, J NEUROSCI, V38, P9019, DOI 10.1523/JNEUROSCI.0398-18.2018; Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Aliaga L, 2013, HUM MOL GENET, V22, P4293, DOI 10.1093/hmg/ddt279; Alvarez FJ, 2011, J NEUROPHYSIOL, V106, P2450, DOI 10.1152/jn.01095.2010; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Calvo M, 2011, GLIA, V59, P554, DOI 10.1002/glia.21124; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; Carp JS, 2008, J NEUROPHYSIOL, V100, P474, DOI 10.1152/jn.90422.2008; Casanovas A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40155; Chery N, 2000, J NEUROSCI METH, V96, P133, DOI 10.1016/S0165-0270(99)00195-8; CONRADI S, 1969, ACTA PHYSIOL SCAND, P85; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; Deardorff AS, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00106; Deardorff AS, 2013, J PHYSIOL-LONDON, V591, P875, DOI 10.1113/jphysiol.2012.240879; Dukkipati SS, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0281-16.2016; Fox PD, 2015, J CELL SCI, V128, P2096, DOI 10.1242/jcs.166009; Gajewska-Wozniak O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161614; Gallart-Palau X, 2014, FASEB J, V28, P3618, DOI 10.1096/fj.13-248583; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; Herron LR, 2012, NEUROSCIENCE, V226, P313, DOI 10.1016/j.neuroscience.2012.09.031; Jiang YQ, 2016, J NEUROSCI, V36, P193, DOI 10.1523/JNEUROSCI.3441-15.2016; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kitzman P, 2006, EXP NEUROL, V197, P407, DOI 10.1016/j.expneurol.2005.10.005; Kucharz K, 2011, J NEUROSCI RES, V89, P1150, DOI 10.1002/jnr.22646; Kucharz K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005250; Lasiene J, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0286-7; Lee YI, 2016, P NATL ACAD SCI USA, V113, pE479, DOI 10.1073/pnas.1519156113; Li SH, 2013, ANN NEUROL, V74, P768, DOI 10.1002/ana.24005; Liu M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1147-z; Luty AA, 2010, ANN NEUROL, V68, P639, DOI 10.1002/ana.22274; Madry C, 2018, NEURON, V97, P299, DOI 10.1016/j.neuron.2017.12.002; Mancuso R, 2016, NEUROBIOL DIS, V95, P168, DOI 10.1016/j.nbd.2016.07.023; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; Mavlyutov TA, 2013, NEUROSCIENCE, V240, P129, DOI 10.1016/j.neuroscience.2013.02.035; Mavlyutov TA, 2015, J PHARMACOL SCI, V127, P10, DOI 10.1016/j.jphs.2014.12.013; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Meyer D, 1997, DEVELOPMENT, V124, P3575; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Milan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135525; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Misonou H, 2008, J NEUROSCI, V28, P8529, DOI 10.1523/JNEUROSCI.1417-08.2008; Moghaddasi M, 2007, J NEUROSCI METH, V159, P1, DOI 10.1016/j.jneumeth.2006.06.009; Muennich EAL, 2004, J PHYSIOL-LONDON, V554, P673, DOI 10.1113/jphysiol.2003.056192; Nagao M, 1998, J NEUROPATH EXP NEUR, V57, P329, DOI 10.1097/00005072-199804000-00004; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Ngo ST, 2012, J CELL SCI, V125, P1531, DOI 10.1242/jcs.095109; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Penas C, 2011, J NEUROTRAUM, V28, P831, DOI 10.1089/neu.2010.1674; Pullen AH, 2009, EUR J NEUROSCI, V29, P551, DOI 10.1111/j.1460-9568.2008.06602.x; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Romer SH, 2014, BRAIN RES, V1547, P1, DOI 10.1016/j.brainres.2013.12.012; Saxena S, 2013, NEURON, V80, P80, DOI 10.1016/j.neuron.2013.07.027; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sedel F, 2004, J NEUROSCI, V24, P2236, DOI 10.1523/JNEUROSCI.4464-03.2004; Song F, 2014, AMYOTROPH LAT SCL FR, V15, P77, DOI 10.3109/21678421.2013.853802; Song F, 2012, J NEUROPATH EXP NEUR, V71, P104, DOI 10.1097/NEN.0b013e3182423c43; Stassart RM, 2013, NAT NEUROSCI, V16, P48, DOI 10.1038/nn.3281; Syroid DE, 1996, P NATL ACAD SCI USA, V93, P9229, DOI 10.1073/pnas.93.17.9229; Takahashi Y, 2013, AM J HUM GENET, V93, P900, DOI 10.1016/j.ajhg.2013.09.008; Velanac V, 2012, GLIA, V60, P203, DOI 10.1002/glia.21255; Vullhorst D, 2017, J NEUROSCI, V37, P5232, DOI 10.1523/JNEUROSCI.2630-16.2017; Vullhorst D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8222; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Willem M, 2016, BRAIN RES BULL, V126, P178, DOI 10.1016/j.brainresbull.2016.07.003; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; 2009, SPIN CORD CHRIST, P1	76	19	19	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7833	7851		10.1096/fj.201802329R	http://dx.doi.org/10.1096/fj.201802329R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30912977	Green Submitted			2022-12-28	WOS:000476234700005
J	Gao, Y; Zhou, SH; Luu, S; Glowacki, J				Gao, Yuan; Zhou, Shuanhu; Luu, Simon; Glowacki, Julie			Megalin mediates 25-hydroxyvitamin D-3 actions in human mesenchymal stem cells	FASEB JOURNAL			English	Article						vitamin D; LRP2; gp330; osteoblastogenesis	VITAMIN-D METABOLISM; MARROW STROMAL CELLS; GROWTH-FACTOR; 1,25-DIHYDROXYVITAMIN D-3; RECEPTOR MEGALIN; EXPRESSION; DIFFERENTIATION; HORMONE; CUBILIN; LEPTIN	Osteoblast differentiation of human mesenchymal stem cells (hMSCs) is stimulated by 1 alpha,25-dihydroxycholecalciferol [1 alpha,25(OH)(2)D-3] and 25-hydroxycholecalciferol [25(OH)D-3]; the latter's effects require intracellular hydroxylation to 1 alpha,25(OH)(2)D-3. Thus, hMSCs are both a source of and target for 1 alpha,25(OH)(2)D-3. Megalin is a transmembrane receptor for serum d-binding protein (DBP) in kidney cells and is required for uptake of the 25(OH)D-3-DBP complex. We tested the hypothesis that megalin is required for D actions in hMSCs with cells from surgically discarded marrow for RT-PCR, for effects of 25(OH)D-3 and 1 alpha,25(OH)(2)D-3, for 1 alpha,25(OH)(2)D-3 biosynthesis, for osteoblastogenesis, and for small interfering RNA for megalin (si-Meg) and control (si-Ctr). In hMSCs with high constitutive megalin expression, both 1 alpha,25(OH)(2)D-3 and 25(OH)D-3 stimulated osteoblastogenesis (P < 0.05), but only 1 alpha,25(OH)(2)D-3 did so in hMSCs with lower megalin (lo-Meg, P < 0.001) or in si-Meg cells (P < 0.05). In addition, 1 alpha,25(OH)(2)D-3 biosynthesis was significantly lower in lo-Meg (46%, P = 0.034) and in si-Meg (23%, P < 0.001) than each control. Leptin significantly stimulated megalin expression 2.1-fold in lo-Meg cells (P < 0.01). These studies show that megalin is expressed in hMSCs and is required for the biosynthesis of 1 alpha,25(OH)(2)D-3 and for the 25(OH)D-3/DBP complex to stimulate vitamin D receptor targets and osteoblastogenesis.-Gao, Y., Zhou, S., Luu, S., Glowacki, J. Megalin mediates 25-hydroxyvitamin D-3 actions in human mesenchymal stem cells.	[Gao, Yuan; Zhou, Shuanhu; Luu, Simon; Glowacki, Julie] Harvard Med Sch, Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Gao, Yuan] Shanghai Jiao Tong Univ, Sch Med, Dept Orthoped Surg, Xin Hua Hosp, Shanghai, Peoples R China; [Glowacki, Julie] Harvard Sch Dent Med, Dept Oral & Maxillofacial Surg, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Shanghai Jiao Tong University; Harvard University; Harvard School of Dental Medicine	Glowacki, J (corresponding author), Brigham & Womens Hosp, Dept Orthoped Surg, 60 Fenwood Rd, Boston, MA 02115 USA.	jglowacki@partners.org			Department of Orthopedic Surgery; Brigham and Women's Hospital; Gillian Reny Stepping Strong Center for Trauma Innovation; China Scholarship Council (CSC)	Department of Orthopedic Surgery; Brigham and Women's Hospital; Gillian Reny Stepping Strong Center for Trauma Innovation; China Scholarship Council (CSC)(China Scholarship Council)	The authors thank Anna Gorska, M.S. and Christopher Bertucci, Ph.D. (Brigham and Women's Hospital) for work with human mesenchymal stem cells. The authors thank the surgeons and nurses of the Department of Orthopedic Surgery, Brigham and Women's Hospital for their help with specimens. This work was supported by grants from the Department of Orthopedic Surgery, Brigham and Women's Hospital, and The Gillian Reny Stepping Strong Center for Trauma Innovation. Y.G. was supported by the China Scholarship Council (CSC). The granting entities had no involvement in the planning, execution, or reporting of the study. The authors declare no conflicts of interest.	ADAMS JS, 1990, J BONE MINER RES, V5, P1265; Alsalem JA, 2014, INVEST OPHTH VIS SCI, V55, P2140, DOI 10.1167/iovs.13-13019; ARNAUD J, 1993, HUM GENET, V92, P183; Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; Bikle DD, 2017, ENDOCRIN METAB CLIN, V46, P901, DOI 10.1016/j.ecl.2017.07.013; BIKLE DD, 1986, BIOCHEMISTRY-US, V25, P1545, DOI 10.1021/bi00355a013; Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012; Cioffi JA, 1997, MOL HUM REPROD, V3, P467, DOI 10.1093/molehr/3.6.467; D'Ippolito G, 2002, BONE, V31, P269, DOI 10.1016/S8756-3282(02)00820-7; Fromigue O, 1997, CYTOKINE, V9, P613, DOI 10.1006/cyto.1997.0209; Geng S, 2013, METABOLISM, V62, P768, DOI 10.1016/j.metabol.2013.01.003; Geng S, 2011, J BONE MINER RES, V26, P1145, DOI 10.1002/jbmr.298; Hilpert J, 2002, KIDNEY INT, V62, P1672, DOI 10.1046/j.1523-1755.2002.00634.x; HOWARD GA, 1981, J BIOL CHEM, V256, P7738; Hsu JY, 2001, CANCER RES, V61, P2852; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Li J, 2016, AM SOC BONE MINERAL; Liu P, 1999, CALCIFIED TISSUE INT, V65, P173, DOI 10.1007/s002239900678; Lou YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep42816; Lundgren S, 1997, J HISTOCHEM CYTOCHEM, V45, P383, DOI 10.1177/002215549704500306; Mahadevappa R, 2014, AM J PHYSIOL-RENAL, V306, pF147, DOI 10.1152/ajprenal.00378.2013; Mocharla H, 1997, J BONE MINER RES, V12, P726, DOI 10.1359/jbmr.1997.12.5.726; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Norden AGW, 2002, J AM SOC NEPHROL, V13, P125, DOI 10.1681/ASN.V131125; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Park H, 2017, AM J CLIN NUTR, V106, P1439, DOI 10.3945/ajcn.117.153429; Pasco JA, 2001, J CLIN ENDOCR METAB, V86, P1884, DOI 10.1210/jc.86.5.1884; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rowling MJ, 2006, J NUTR, V136, P2754, DOI 10.1093/jn/136.11.2754; Safadi FF, 1999, J CLIN INVEST, V103, P239, DOI 10.1172/JCI5244; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Scott MG, 2015, CLIN CHEM, V61, P462, DOI 10.1373/clinchem.2014.222521; Segersten U, 2002, J CLIN ENDOCR METAB, V87, P2967, DOI 10.1210/jc.87.6.2967; Seifert M, 2004, J STEROID BIOCHEM, V89-90, P375, DOI 10.1016/j.jsbmb.2004.03.002; Sellmeyer DE, 2007, OSTEOPOROSIS INT, V18, P973, DOI 10.1007/s00198-007-0336-x; Suruda C, 2017, PEDIATR NEPHROL, V32, P621, DOI 10.1007/s00467-016-3535-x; Tsuprykov O, 2018, J STEROID BIOCHEM, V180, P87, DOI 10.1016/j.jsbmb.2017.11.014; Willnow TE, 2017, PFLUG ARCH EUR J PHY, V469, P907, DOI 10.1007/s00424-017-1992-0; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zhou SH, 2017, ANN NY ACAD SCI, V1402, P43, DOI 10.1111/nyas.13464; Zhou SH, 2013, J STEROID BIOCHEM, V136, P342, DOI 10.1016/j.jsbmb.2012.09.009; Zhou SH, 2010, ENDOCRINOLOGY, V151, P14, DOI 10.1210/en.2009-0969	45	12	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7684	7693		10.1096/fj.201802578R	http://dx.doi.org/10.1096/fj.201802578R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30893561	Bronze			2022-12-28	WOS:000476114200081
J	Jia, BL; Yuan, D; Lan, WJ; Xuan, YH; Jeon, CO				Jia, Baolei; Yuan, De Peng; Lan, Wen Jun; Xuan, Yuan Hu; Jeon, Che Ok			New insight into the classification and evolution of glucose transporters in the Metazoa	FASEB JOURNAL			English	Article						GLUT; protein family; network; gene fusion; gene duplication	PROTEIN; REGULATOR; DIVERSITY; FAMILY; MODEL	Because glucose is an essential energy source for living organisms, glucose transporters (GLUTs) are present in all species worldwide. Encoded by the solute carrier family 2 gene family, the GLUT proteins generally have 12 transmembrane helices (TMHs). In total, 14 GLUT proteins have been identified in humans (hGLUTs), and they are divided into 3 classes on the basis of their transport characteristics and sequence similarities. Herein, we report the use of protein sequence similarity networks (SSNs) to visualize the sequence trends of 4101 GLUT proteins across the Metazoa. The SSNs separated the metazoan proteins into 3 new classes that were different from the traditional classification system. In the new system, 9 of the 14 hGLUTs (hGLUT1-5, 7, 9, 11, and 14) were grouped into class I, 3 (hGLUT10, 12, and 13) were grouped into class II, and 2 (hGLUT6 and 8) were grouped into class III, as also supported by the phylogenetic tree. Multiple sequence alignments further showed that the conserved residues in each class were different. Furthermore, the hGLUTs in each class showed unique evolutionary characteristics, with similar nonsynonymous-to-synonymous divergence ratios and similar regions under conservative selection pressure. Of note, GLUTs with 3, 6, 18, 24, and 36 TMHs were identified among the metazoan genomes, and 1 Chinese hamster protein with 6 TMHs showed GLUT activity. In summary, this large-scale sequence analysis provided new insights into the classification and evolution of GLUTs and further showed that gene duplication and fusion could have been important drivers during the evolution of these transporter molecules.-Jia, B., Yuan, D. P., Lan, W. J., Xuan, Y. H., Jeon, C. O. New insight into the classification and evolution of glucose transporters in the Metazoa.	[Jia, Baolei; Lan, Wen Jun] Qilu Univ Technol, Sch Bioengn, Jinan, Shandong, Peoples R China; [Jia, Baolei; Jeon, Che Ok] Chung Ang Univ, Dept Life Sci, 84 HeukSeok Ro, Seoul 06974, South Korea; [Yuan, De Peng; Xuan, Yuan Hu] Shenyang Agr Univ, Coll Plant Protect, Dongling Rd 120, Shenyang 110866, Liaoning, Peoples R China	Qilu University of Technology; Chung Ang University; Shenyang Agricultural University	Jeon, CO (corresponding author), Chung Ang Univ, Dept Life Sci, 84 HeukSeok Ro, Seoul 06974, South Korea.; Xuan, YH (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Dongling Rd 120, Shenyang 110866, Liaoning, Peoples R China.	xuanyuanhu115@syau.edu.cn; cojeon@cau.ac.kr	Jia, Baolei/AIF-1053-2022		National Research Foundation of the Korean Ministry of Science and Information and Communications Technology (ICT) [2017M3C1B5019250, 2018R1A5A1025077]	National Research Foundation of the Korean Ministry of Science and Information and Communications Technology (ICT)	This work was supported by by the National Research Foundation of the Korean Ministry of Science and Information and Communications Technology (ICT) (2017M3C1B5019250 and 2018R1A5A1025077). The authors declare no conflicts of interest.	Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Di Daniel E, 2009, BIOCHEM SOC T, V37, P1139, DOI 10.1042/BST0371139; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Jia BL, 2018, J AGR FOOD CHEM, V66, P8371, DOI 10.1021/acs.jafc.8b02454; Jia BL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00180; Jia BL, 2017, BBA-GEN SUBJECTS, V1861, P2922, DOI 10.1016/j.bbagen.2017.08.019; Jia BL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43489; Jia B, 2017, BBA-GEN SUBJECTS, V1861, P323, DOI 10.1016/j.bbagen.2016.12.001; Jia BL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01380; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Mayer AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38586; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Park MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125361; Peralvarez-Marin A, 2006, MOL MEMBR BIOL, V23, P127, DOI 10.1080/09687860500435019; Preitner F, 2009, P NATL ACAD SCI USA, V106, P15501, DOI 10.1073/pnas.0904411106; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Steinway SN, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-284; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tarazona-Santos E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009827; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Uldry M, 2001, EMBO J, V20, P4467, DOI 10.1093/emboj/20.16.4467; Wang J, 2017, ONCOTARGET, V8, P16875, DOI 10.18632/oncotarget.15171; Wilson-O'Brien AL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-152; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Zottola R. J., 1994, MOL DETERMINANTS GLU	43	11	11	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7519	7528		10.1096/fj.201802617R	http://dx.doi.org/10.1096/fj.201802617R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30888203	Bronze			2022-12-28	WOS:000476114200068
J	Medrano, G; Cailleux, F; Guan, PH; Kuruvilla, K; Barlow-Anacker, AJ; Gosain, A				Medrano, Giuliana; Cailleux, Frederic; Guan, Peihong; Kuruvilla, Korah; Barlow-Anacker, Amanda J.; Gosain, Ankush			B-lymphocyte-intrinsic and -extrinsic defects in secretory immunoglobulin A production in the neural crest-conditional deletion of endothelin receptor B model of Hirschsprung-associated enterocolitis	FASEB JOURNAL			English	Article						IgA; polymeric Ig receptor; aganglionosis; megacolon; mucosal immunity	CROHNS-DISEASE; BASIC SCIENCE; MURINE MODEL; IGA; ANTAGONIST; BOSENTAN	Hirschsprung disease (HSCR) is a common cause of intestinal obstruction in the newborn. Hirschsprung-associated enterocolitis (HAEC) is a significant and life-threatening complication of HSCR, affecting up to 60% of patients. Animal models of endothelin receptor B (EdnrB) mutation reliably model human HSCR and HAEC. We previously demonstrated intestinal dysbiosis and a gut-specific deficiency of B-lymphocyte-produced secretory IgA (sIgA), the primary effector molecule of mucosal immunity, in mice with homozygous neural crest cell-conditional deletion of EdnrB (EdnrB(NCC-/-)). To determine mechanisms for sIgA deficiency, we examined intrinsic and extrinsic aspects of B-lymphocyte development and function. Expression of the endothelin axis components [endothelin-1 (ET-1), endothelin-3 (ET-3), endothelin receptor A (EdnrA), EdnrB] were determined over a developmental time course. B-lymphocyte survival and Ig production were assayed in vitro. Polymeric Ig receptor (pIgR)-mediated IgA transport into the intestinal lumen was interrogated. We found endothelin axis component (EdnrA, EdnrB, ET-1, ET-3) expression in developing extramedullary hematopoietic organs and that some splenic B lymphocytes express EdnrB. Splenic B lymphocytes from EdnrB(NCC-/-) mice showed no intrinsic defect in survival vs. wild-type (WT) B lymphocytes. In vitro stimulation of splenic B lymphocytes demonstrated decreased IgA, IgG, and IgM production in EdnrB(NCC-/-) vs. WT mice. Additionally, small intestinal pIgR was decreased similar to 50% in EdnrB(NCC-/-) mice. These results suggest an intrinsic B-lymphocyte defect in antibody production as well as an extrinsic defect in IgA transport in the EdnrB(NCC-/-) model of HAEC. Our results are consistent with human HAEC observations of decreased luminal sIgA and mouse models of other inflammatory bowel diseases, in which decreased pIgR is seen in concert with a dysregulated microbiota. Finally, our results suggest targeting the dysbiotic microbiome and pIgR-mediated sIgA transport as potential therapeutic approaches in prevention and treatment of HAEC.-Medrano, G., Cailleux, F., Guan, P., Kuruvilla, K., Barlow-Anacker, A. J., Gosain, A. B-lymphocyte-intrinsic and -extrinsic defects in secretory immunoglobulinA production in the neural crest-conditional deletion of endothelin receptor B model of Hirschsprung-associated enterocolitis.	[Medrano, Giuliana; Cailleux, Frederic; Guan, Peihong; Kuruvilla, Korah; Gosain, Ankush] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Div Pediat Surg, Memphis, TN USA; [Barlow-Anacker, Amanda J.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Gosain, Ankush] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Wisconsin System; University of Wisconsin Madison	Gosain, A (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA.	agosain@uthsc.edu	Pushpamangalam Kuruvilla, Korah/AFS-1915-2022	Pushpamangalam Kuruvilla, Korah/0000-0001-5722-7562; Gosain, Ankush/0000-0002-0428-1503	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK098271, DK114543]; American College of Surgeons (George H. A. Clowes Career Development Award); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK098271, R03DK114543] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American College of Surgeons (George H. A. Clowes Career Development Award); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Kara Matteson, M.S. (Department of Clinical Laboratory Services, University of Tennessee Health Science Center), for technical assistance and Joseph Pierre, Ph.D. (Department of Pediatrics, University of Tennessee Health Science Center), for assistance in interpreting results. This work was supported by grants from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (DK098271, DK114543) and the American College of Surgeons (George H. A. Clowes Career Development Award to A.G.). The authors declare no conflicts of interest.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Agace WW, 2017, IMMUNITY, V46, P532, DOI 10.1016/j.immuni.2017.04.004; Aghamohammadi A, 2009, J CLIN IMMUNOL, V29, P130, DOI 10.1007/s10875-008-9229-9; Anthoni C, 2006, INT J COLORECTAL DIS, V21, P409, DOI 10.1007/s00384-005-0015-3; Arsenescu R, 2008, MUCOSAL IMMUNOL, V1, P399, DOI 10.1038/mi.2008.32; Barlow-Anacker AJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45645; Brandtzaeg P, 2008, MUCOSAL IMMUNOL, V1, P31, DOI 10.1038/mi.2007.9; Bruno MEC, 2011, MUCOSAL IMMUNOL, V4, P468, DOI 10.1038/mi.2011.8; Cheng Z, 2011, PEDIATR SURG INT, V27, P145, DOI 10.1007/s00383-010-2787-y; Druckenbrod NR, 2008, GENESIS, V46, P396, DOI 10.1002/dvg.20415; Elisa T, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/147616; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Gosain A, 2017, PEDIATR SURG INT, V33, P517, DOI 10.1007/s00383-017-4065-8; Gosain A, 2016, PEDIATR SURG INT, V32, P313, DOI 10.1007/s00383-016-3862-9; Gosain A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128822; Guruli G, 2004, BLOOD, V104, P2107, DOI 10.1182/blood-2003-10-3559; Hermsen JL, 2009, LANGENBECK ARCH SURG, V394, P17, DOI 10.1007/s00423-008-0339-x; Heuckeroth RO, 2018, NAT REV GASTRO HEPAT, V15, P152, DOI 10.1038/nrgastro.2017.149; Hogaboam CM, 1996, EUR J PHARMACOL, V309, P261, DOI 10.1016/0014-2999(96)00276-2; IMAMURA A, 1992, GUT, V33, P801, DOI 10.1136/gut.33.6.801; Kaetzel CS, 2014, IMMUNOL LETT, V162, P10, DOI 10.1016/j.imlet.2014.05.008; Kandalaft LE, 2009, CLIN CANCER RES, V15, P4521, DOI 10.1158/1078-0432.CCR-08-0543; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kowalczyk A, 2015, ARCH IMMUNOL THER EX, V63, P41, DOI 10.1007/s00005-014-0310-1; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; MacLean GA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26123-y; Malendowicz LK, 1998, LIFE SCI, V62, P1959, DOI 10.1016/S0024-3205(98)00165-9; Medrano G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181881; MURCH SH, 1992, LANCET, V339, P381, DOI 10.1016/0140-6736(92)90077-G; Parker KD, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01598; Pierre JF, 2014, J PEDIATR SURG, V49, P1242, DOI 10.1016/j.jpedsurg.2014.01.060; Reikvam DH, 2012, EUR J IMMUNOL, V42, P2959, DOI 10.1002/eji.201242543; Rolig AS, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000689; Sampaio ALF, 2000, J LEUKOCYTE BIOL, V67, P189, DOI 10.1002/jlb.67.2.189; Sano Y, 2009, AM J SURG, V198, P105, DOI 10.1016/j.amjsurg.2008.08.018; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; TEITELBAUM DH, 1989, J PEDIATR SURG, V24, P1271, DOI 10.1016/S0022-3468(89)80566-4; Turula H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050237; Wang N, 2012, CURR OPIN ALLERGY CL, V12, P602, DOI 10.1097/ACI.0b013e3283594219; Ward NL, 2012, NEUROGASTROENT MOTIL, V24, P874, DOI 10.1111/j.1365-2982.2012.01937.x; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Yamaguchi E, 2007, J GASTROEN HEPATOL, V22, P1134, DOI 10.1111/j.1440-1746.2006.04822.x	43	5	6	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7615	7624		10.1096/fj.201801913R	http://dx.doi.org/10.1096/fj.201801913R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30908942	Green Published, Bronze			2022-12-28	WOS:000476114200076
J	Mohammed, S; Vineetha, NS; James, S; Aparna, JS; Lankadasari, MB; Allegood, JC; Li, QZ; Spiegel, S; Harikumar, KB				Mohammed, Sabira; Vineetha, Nalanda S.; James, Shirley; Aparna, Jayasekharan S.; Lankadasari, Manendra Babu; Allegood, Jeremy C.; Li, Quan-Zhen; Spiegel, Sarah; Harikumar, Kuzhuvelil B.			Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus	FASEB JOURNAL			English	Article						S1P; pDCs; pristane; IFN; autoimmunity	PLASMACYTOID DENDRITIC CELLS; SIGLEC-H; SPHINGOSINE-1-PHOSPHATE; AUTOIMMUNITY; INFLAMMATION; RECEPTOR; DISEASE; MICE; DEFICIENCY; EXPRESSION	Systemic lupus erythematosus is an autoimmune disease characterized by overproduction of type 1 IFN that causes multiple organ dysfunctions. Plasmacytoid dendritic cells (pDCs) that secrete large amounts of IFN have recently been implicated in the initiation of the disease in preclinical mouse models. Sphingosine-1-phosphate, a bioactive sphingolipid metabolite, is produced by 2 highly conserved isoenzymes, sphingosine kinase (SphK) 1 and SphK2, and regulates diverse processes important for immune responses and autoimmunity. However, not much is known about the role of SphK2 in autoimmune disorders. In this work, we examined the role of SphK2 in pDC development and activation and in the pristane-induced lupus model in mice that mimics the hallmarks of the human disease. Increases in pDC-specific markers were observed in peripheral blood of SphK2 knockout mice. In agreement, the absence of SphK2 increased the differentiation of FMS-like tyrosine kinase 3 ligand dendritic cells as well as expression of endosomal TLRs, TLR7 and TLR9, that modulate production of IFN. Surprisingly, however, SphK2 deficiency did not affect the initiation or progression of pristane-induced lupus. Moreover, although absence of SphK2 increased pDC frequency in pristane-induced lupus, there were no major changes in their activation status. Additionally, SphK2 expression was unaltered in lupus patients. Taken together, our results suggest that SphK2 may play a role in dendritic cell development. Yet, because its deletion had no effect on the clinical lupus parameters in this preclinical model, inhibitors of SphK2 might not be useful for treatment of this devastating disease.-Mohammed, S., Vineetha, N. S., James, S., Aparna, J. S., Lankadasari, M. B., Allegood, J. C., Li, Q.-Z., Spiegel, S., Harikumar, K. B. Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus.	[Mohammed, Sabira; James, Shirley; Aparna, Jayasekharan S.; Lankadasari, Manendra Babu; Harikumar, Kuzhuvelil B.] RGCB, Thiruvananthapuram, Kerala, India; [Mohammed, Sabira; Lankadasari, Manendra Babu] MAHE, Manipal, Karnataka, India; [Vineetha, Nalanda S.] Govt Med Coll, Dept Nephrol, Thiruvananthapuram, Kerala, India; [Allegood, Jeremy C.; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Manipal Academy of Higher Education (MAHE); Virginia Commonwealth University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Harikumar, KB (corresponding author), RGCB, Canc Res Program, Thiruvananthapuram 695014, Kerala, India.	harikumar@rgcb.res.in	Harikumar, Kuzhuvelil/AAC-2407-2020; Lankadasari, Manendra/AAI-9639-2021	Harikumar, Kuzhuvelil/0000-0002-1763-4179; Jazir, Sabira Mohammed/0000-0002-0332-3660; Lankadasari, Manendra Babu/0000-0002-5579-435X	Indian Council of Medical Research; University Grant Commission; U.S. National Institutes of Health, National Institute of General Medical Sciences [R01GM043880]; Indian Government's Department of Science and Technology [SR/FT/LS-159/2012]; Council for Scientific and Industrial Research [37 (1720)/18/EMR-II]; Department of Biotechnology (DBT) [BT/RLF/Re-entry/38/2011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); University Grant Commission(University Grants Commission, India); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Indian Government's Department of Science and Technology; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are thankful to the personnel of the Flow Cytometry Core Facility and Bioimaging Facility for excellent technical assistance, and the Animal Research Facility for mouse colony maintenance. S.M. and M.B.L. acknowledge the senior research fellowship from the Indian Council of Medical Research and the University Grant Commission, respectively. S.M. acknowledges the Doctoral Advisory Committee for valuable suggestions. The work was supported by the U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01GM043880 (to S.S.), a fast-track grant from the Indian Government's Department of Science and Technology (SR/FT/LS-159/2012), a grand-in-aid scheme of the Council for Scientific and Industrial Research [37 (1720)/18/EMR-II], and, in part, by a faculty start-up grant and Department of Biotechnology (DBT) Ramalingaswami Re-Entry Fellowship (BT/RLF/Re-entry/38/2011) to K.B.H. The authors declare no conflicts of interest.	Alperovich G, 2007, LUPUS, V16, P18, DOI 10.1177/0961203306073136; Ando S, 2010, BIOCHEM BIOPH RES CO, V394, P804, DOI 10.1016/j.bbrc.2010.03.078; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Chauvistre H, 2014, EUR J IMMUNOL, V44, P2478, DOI 10.1002/eji.201344150; Checa A, 2017, LUPUS, V26, P1023, DOI 10.1177/0961203316686707; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Combes A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00695-1; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Dilioglou S, 2003, EXP MOL PATHOL, V75, P217, DOI 10.1016/S0014-4800(03)00072-8; Fitzgerald-Bocarsly P, 2007, BIOCHIMIE, V89, P843, DOI 10.1016/j.biochi.2007.04.018; Fitzpatrick Leo R., 2011, Inflammopharmacology, V19, P75, DOI 10.1007/s10787-010-0060-6; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lima S, 2017, J BIOL CHEM, V292, P3074, DOI 10.1074/jbc.M116.762377; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Meadows KRT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193236; Mohammed S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00296; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagahashi M, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00219; Newton J, 2017, FASEB J, V31, P1719, DOI 10.1096/fj.201601041R; Okazaki H, 2002, J RHEUMATOL, V29, P707; Pyne NJ, 2017, TRENDS PHARMACOL SCI, V38, P581, DOI 10.1016/j.tips.2017.04.003; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Ronnblom L, 2006, ARTHRITIS RHEUM-US, V54, P408, DOI 10.1002/art.21571; Ronnblom L, 2003, ARTHRITIS RES THER, V5, P68, DOI 10.1186/ar625; Rovere P, 1998, J IMMUNOL, V161, P4467; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Saitoh SI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01687-x; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Snider AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053521; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tsai HC, 2016, DRUGS, V76, P1067, DOI 10.1007/s40265-016-0603-2; Watson L, 2012, J CLIN IMMUNOL, V32, P1019, DOI 10.1007/s10875-012-9710-3; Wenderfer SE, 2008, KIDNEY INT, V74, P1319, DOI 10.1038/ki.2008.396; Xin Q, 2015, J IMMUNOL, V194, P5437, DOI 10.4049/jimmunol.1403028; Xu Y, 2015, ARTHRITIS RHEUMATOL, V67, P225, DOI 10.1002/art.38882; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587	50	9	10	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7061	7071		10.1096/fj.201802535R	http://dx.doi.org/10.1096/fj.201802535R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30840833	Bronze, Green Published			2022-12-28	WOS:000476114200032
J	Martucci, LL; Amar, M; Chaussenot, R; Benet, G; Bauer, O; de Zelicourt, A; Nosjean, A; Launay, JM; Callebert, J; Sebrie, C; Galione, A; Edeline, JM; de la Porte, S; Fossier, P; Granon, S; Vaillend, C; Cancela, JM				Martucci, Lora L.; Amar, Muriel; Chaussenot, Remi; Benet, Gabriel; Bauer, Oscar; de Zelicourt, Antoine; Nosjean, Anne; Launay, Jean-Marie; Callebert, Jacques; Sebrie, Catherine; Galione, Antony; Edeline, Jean-Marc; de la Porte, Sabine; Fossier, Philippe; Granon, Sylvie; Vaillend, Cyrille; Cancela, Jose-Manuel			A multiscale analysis in CD38(-/-) mice unveils major prefrontal cortex dysfunctions	FASEB JOURNAL			English	Article						behavior; oxytocin; autism; monoamines; excitation	EXCITATION-INHIBITION BALANCE; AUTISM SPECTRUM DISORDER; LONG-TERM POTENTIATION; EMBRYONIC STEM-CELLS; ADP-RIBOSYL CYCLASE; SOCIAL-BEHAVIOR; PLASMA OXYTOCIN; SYNAPTIC PLASTICITY; CD38; MODULATION	Autism spectrum disorder (ASD) is characterized by early onset of behavioral and cognitive alterations. Low plasma levels of oxytocin (OT) have also been found in ASD patients; recently, a critical role for the enzyme CD38 in the regulation of OT release was demonstrated. CD38 is important in regulating several Ca2+-dependent pathways, but beyond its role in regulating OT secretion, it is not known whether a deficit in CD38 expression leads to functional modifications of the prefrontal cortex (PFC), a structure involved in social behavior. Here, we report that CD38(-/-) male mice show an abnormal cortex development, an excitation-inhibition balance shifted toward a higher excitation, and impaired synaptic plasticity in the PFC such as those observed in various mouse models of ASD. We also show that a lack of CD38 alters social behavior and emotional responses. Finally, examining neuromodulators known to control behavioral flexibility, we found elevated monoamine levels in the PFC of CD38(-/-) adult mice. Overall, our study unveiled major changes in PFC physiologic mechanisms and provides new evidence that the CD38(-/-) mouse could be a relevant model to study pathophysiological brain mechanisms of mental disorders such as ASD.Martucci, L. L., Amar, M., Chaussenot, R., Benet, G., Bauer, O., de Zelicourt, A., Nosjean, A., Launay, J.-M., Callebert, J., Sebrie, C., Galione, A., Edeline, J.-M., de la Porte, S., Fossier, P., Granon, S., Vaillend, C., Cancela, J.-M., A multiscale analysis in CD38(-/-) mice unveils major prefrontal cortex dysfunctions.	[Martucci, Lora L.; Amar, Muriel; Chaussenot, Remi; Benet, Gabriel; Bauer, Oscar; de Zelicourt, Antoine; Nosjean, Anne; Edeline, Jean-Marc; Fossier, Philippe; Granon, Sylvie; Vaillend, Cyrille; Cancela, Jose-Manuel] Paris Saclay Univ, Paris Sud Univ, CNRS, Neurosci Paris Saclay Inst NeuroPSI,Unite Mixte R, Orsay, France; [Sebrie, Catherine] Paris Saclay Univ, Paris Sud Univ, CNRS, Imagerie Resonance Magnet Medicale & Multimodalit, Orsay, France; [Martucci, Lora L.; de Zelicourt, Antoine; de la Porte, Sabine] Univ Versailles St Quentin En Yvelines UVSQ, Unite Format & Rech UFR Sci Sante Simone Veil, INSERM U1179, Handicap Neuromusculaire Physiol Biotherapie & Ph, Montigny Le Bretonneux, France; [Bauer, Oscar] Inst Pasteur, CNRS, UMR 3571, Genes Synapses & Cognit,Genet Humaine & Fonct Cog, Paris, France; [Launay, Jean-Marie; Callebert, Jacques] Hop Lariboisiere, INSERM, Unite 942, Paris, France; [Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford	Cancela, JM (corresponding author), Paris Saclay Univ, Paris Sud Univ, Neurosci Paris Saclay Inst NeuroPSI CNRS UMR 9197, F-91405 Orsay, France.	jose-manuel.cancela@u-psud.fr	callebert, jacques/L-4569-2017; de la PORTE, Sabine/AAE-4208-2022; Vaillend, Cyrille/K-4626-2012	de la PORTE, Sabine/0000-0002-7725-8646; Vaillend, Cyrille/0000-0002-8783-8185; MARTUCCI, Lora/0000-0002-5335-2822; Granon, sylvie/0000-0001-9384-3119; Cancela, Jose-Manuel/0000-0002-6234-1500; Galione, Antony/0000-0002-4132-7646; launay, jean-marie/0000-0003-4809-1020	Centre National de la Recherche Scientifique (CNRS), INSERM, Paris-Sud University; Fondation Jerome Lejeune; international CNRS Laboratoire international Associe(LIA) grant; Paris-Sud University; France Life Imaging Grant [ANR-11-INBS-0006]	Centre National de la Recherche Scientifique (CNRS), INSERM, Paris-Sud University; Fondation Jerome Lejeune; international CNRS Laboratoire international Associe(LIA) grant; Paris-Sud University; France Life Imaging Grant	The authors thank Dr. Frances Lund (University of Alabama-Birmingham, Birmingham, AL, USA) for providing CD38<SUP>-/-</SUP> mice. This research was supported by grants from Centre National de la Recherche Scientifique (CNRS), INSERM, Paris-Sud University. Funding for this work was provided by la Fondation Jerome Lejeune (to J.-M.C. and P.F.), and by an international CNRS Laboratoire international Associe(LIA) grant (to J.-M.C. and A.G.). L.L.M. and A.Z. are recipients of a Ph.D. fellowship from Paris-Sud University. The authors also thank the zootechnic platform at the Neuroscience Paris-Saclay Institute for mice breeding and care. This work was also partly funded by France Life Imaging Grant ANR-11-INBS-0006. The authors declare no conflicts of interest.	Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Avale ME, 2011, FASEB J, V25, P2145, DOI 10.1096/fj.10-178558; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bourgeron T, 2016, CR BIOL, V339, P300, DOI 10.1016/j.crvi.2016.05.004; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Bruzzone S, 2004, J NEUROCHEM, V89, P264, DOI 10.1111/j.1471-4159.2003.02326.x; Cambon K, 2010, NEUROSCIENCE, V171, P840, DOI 10.1016/j.neuroscience.2010.09.015; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; Ceni C, 2006, BIOCHEM J, V395, P417, DOI 10.1042/BJ20051321; Ceni C, 2003, BIOCHEM J, V370, P175, DOI 10.1042/BJ20020604; Chabout J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00468; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Chanda S, 2016, MOL PSYCHIATR, V21, P169, DOI 10.1038/mp.2015.20; Chini CCS, 2017, MOL CELL ENDOCRINOL, V455, P62, DOI 10.1016/j.mce.2016.11.003; Clement Y, 2009, PLOS ONE, V4, pA74, DOI 10.1371/journal.pone.0007745; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Coura RS, 2013, FASEB J, V27, P4343, DOI 10.1096/fj.13-231084; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Faure A, 2017, BEHAV BRAIN RES, V320, P383, DOI 10.1016/j.bbr.2016.11.003; Feldman R, 2012, BIOL PSYCHIAT, V72, P175, DOI 10.1016/j.biopsych.2011.12.025; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; HARONYNICOLAS H, 2017, WAGNER, V6, DOI DOI 10.7554/ELIFE.18904; Hattori T, 2017, GLIA, V65, P974, DOI 10.1002/glia.23139; Higashida H, 2016, J PHYSIOL SCI, V66, P275, DOI 10.1007/s12576-015-0425-0; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Joseph A, 2017, J NEUROSCI, V37, P6778, DOI 10.1523/JNEUROSCI.0618-17.2017; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Khundrakpam BS, 2017, CEREB CORTEX, V27, P1721, DOI 10.1093/cercor/bhx038; Kim S, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0195-5; Ko J, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00041; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Le Roux N, 2008, EUR J NEUROSCI, V27, P3244, DOI 10.1111/j.1460-9568.2008.06288.x; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lerer E, 2010, AUTISM RES, V3, P293, DOI 10.1002/aur.156; Liu HX, 2008, NEUROSCI LETT, V448, P67, DOI 10.1016/j.neulet.2008.09.084; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; Meunier CNJ, 2017, NEUROPHARMACOLOGY, V113, P124, DOI 10.1016/j.neuropharm.2016.09.025; Meunier CNJ, 2013, NEUROPHARMACOLOGY, V71, P37, DOI 10.1016/j.neuropharm.2013.03.003; Meunier CNJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120286; Miranda R, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0053-9; Mitre M, 2016, J NEUROSCI, V36, P2517, DOI 10.1523/JNEUROSCI.2409-15.2016; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Moreau AW, 2013, NEUROSCIENCE, V238, P148, DOI 10.1016/j.neuroscience.2013.02.013; Moreau AW, 2010, CEREB CORTEX, V20, P456, DOI 10.1093/cercor/bhp114; Munesue T, 2010, NEUROSCI RES, V67, P181, DOI 10.1016/j.neures.2010.03.004; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Nosjean A, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00447; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; Parker KJ, 2017, P NATL ACAD SCI USA, V114, P8119, DOI 10.1073/pnas.1705521114; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pittaras E, 2016, BRAIN STRUCT FUNCT, V221, P4615, DOI 10.1007/s00429-016-1192-2; Pittarast EC, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00171; Powell K, 2004, PLOS BIOL, V2, P1054, DOI 10.1371/journal.pbio.0020267; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudebeck PH, 2007, EUR J NEUROSCI, V26, P2315, DOI 10.1111/j.1460-9568.2007.05844.x; Selimbeyoglu A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6733; Takahashi J, 2003, BIOCHEM BIOPH RES CO, V312, P434, DOI 10.1016/j.bbrc.2003.10.143; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Wang WT, 2012, J ANXIETY DISORD, V26, P215, DOI 10.1016/j.janxdis.2011.11.004; Watanabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039561; Wei WJ, 2012, J BIOL CHEM, V287, P35599, DOI 10.1074/jbc.M112.392530; Wei WJ, 2015, STEM CELLS, V33, P2664, DOI 10.1002/stem.2057; Willott J. F., 2006, CURR PROTOC NEUROSCI; Willott JF, 1998, HEARING RES, V119, P27, DOI 10.1016/S0378-5955(98)00029-X; Winslow JT, 2000, HORM BEHAV, V37, P145, DOI 10.1006/hbeh.1999.1566; Yamada M, 1997, BRAIN RES, V756, P52, DOI 10.1016/S0006-8993(97)00117-0; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang HF, 2016, NEUROSCI BULL, V32, P423, DOI 10.1007/s12264-016-0046-5; Zheng JJ, 2014, NAT NEUROSCI, V17, P391, DOI 10.1038/nn.3634	85	14	14	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5823	5835		10.1096/fj.201800489R	http://dx.doi.org/10.1096/fj.201800489R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30844310	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000466932600003
J	Wang, YF; Zhang, XL; Tian, JL; Shan, JJ; Hu, YF; Zhai, YQ; Guo, J				Wang, Yifan; Zhang, Xiaolong; Tian, Jilai; Shan, Jinjun; Hu, Yunfeng; Zhai, Yiqian; Guo, Jun			Talin promotes integrin activation accompanied by generation of tension in talin and an increase in osmotic pressure in neurite outgrowth	FASEB JOURNAL			English	Article						neuronal polarization; DOK1; intracellular mechanical force	NERVE GROWTH-FACTOR; AXON GROWTH; CALCIUM-CHANNELS; VINCULIN BINDING; STRUCTURAL TENSION; LIVE CELLS; ADHESION; FORCE; COMPLEX; CYTOSKELETON	Neuronal polarization depends on the interaction of intracellular chemical and mechanical activities in which the cytoplasmic protein, talin, plays a pivotal role during neurite growth. To better understand the mechanism underlying talin function in neuronal polarization, we overexpressed several truncated forms of talin and found that the presence of the rod domain within the overexpressed talin is required for its positive effect on neurite elongation because the neurite number only increased when the talin head region was overexpressed. The tension in the talin rod was recognized using a Forster resonance energy transfer-based tension probe. Nerve growth factor treatment resulted in inward tension of talin elicited by microfilament force and outward osmotic pressure. By contrast, the glial scar-inhibitor aggrecan weakened these forces, suggesting that interactions between inward pull forces in the talin rod and outward osmotic pressure participate in neuronal polarization. Integrin activation is also involved in up-regulation of talin tension and osmotic pressure. Aggrecan stimuli resulted in up-regulation of docking protein 1 (DOK1), leading to the down-regulation of integrin activity and attenuation of the intracellular mechanical force. Our study suggests interactions between the intracellular inward tension in talin and the outward osmotic pressure as the effective channel for promoting neurite outgrowth, which can be up-regulated by integrin activation and down-regulated by DOK1.Wang, Y., Zhang, X., Tian, J., Shan, J., Hu, Y., Zhai, Y., Guo, J. Talin promotes integrin activation accompanied by generation of tension in talin and an increase in osmotic pressure in neurite outgrowth.	[Wang, Yifan; Zhang, Xiaolong; Tian, Jilai; Hu, Yunfeng; Zhai, Yiqian; Guo, Jun] Nanjing Univ Chinese Med, State Key Lab Cultivat Base Tradit Chinese Med TC, Sch Med & Life Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Yifan; Zhang, Xiaolong; Tian, Jilai; Hu, Yunfeng; Zhai, Yiqian; Guo, Jun] Nanjing Univ Chinese Med, Key Lab Drug Targets & Drugs Degenerat Dis, Nanjing, Jiangsu, Peoples R China; [Shan, Jinjun; Guo, Jun] Nanjing Univ Chinese Med, Jiangsu Key Lab Pediat Resp Dis, Inst Pediat, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Guo, J (corresponding author), Nanjing Univ Chinese Med, Dept Biochem & Mol Biol, Sch Med & Life Sci, 138 Xianling St, Nanjing 210023, Jiangsu, Peoples R China.	guoj@njucm.edu.cn	Tian, Jilai/X-1727-2019	Tian, Jilai/0000-0002-5695-9881; jun, Guo/0000-0002-8525-8267	National Natural Science Foundation of China [81573409]; Natural Science Foundation of Jiangsu Province [BK20161574]; Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Traditional Chinese and Western Medicine); Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX18_1565]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Traditional Chinese and Western Medicine); Postgraduate Research and Practice Innovation Program of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (81573409) and Natural Science Foundation of Jiangsu Province (BK20161574), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Traditional Chinese and Western Medicine) and Postgraduate Research and Practice Innovation Program of Jiangsu Province (KYCX18_1565). The authors declare no conflicts of interest.	Alvarez B, 2008, J CELL PHYSIOL, V214, P474, DOI 10.1002/jcp.21215; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Arcangeli A, 2006, TRENDS CELL BIOL, V16, P631, DOI 10.1016/j.tcb.2006.10.003; Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Athamneh AIM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07402-6; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Ayali A, 2010, INTEGR BIOL-UK, V2, P178, DOI 10.1039/b927402b; Bharadwaj M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14348; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cerna J, 2006, J MOL BIOL, V362, P954, DOI 10.1016/j.jmb.2006.07.075; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; Cheah M, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030020; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen TT, 2019, ANTIOXID REDOX SIGN, V30, P1503, DOI 10.1089/ars.2017.7366; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Davis MJ, 2002, CELL BIOCHEM BIOPHYS, V36, P41, DOI 10.1385/CBB:36:1:41; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Dehmelt L, 2006, BRAIN CELL BIOL, V35, P39, DOI 10.1007/s11068-006-9001-0; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Ellis SJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004756; Eva R, 2014, CURR OPIN NEUROBIOL, V27, P179, DOI 10.1016/j.conb.2014.03.018; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024808; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Goult BT, 2013, J BIOL CHEM, V288, P8238, DOI 10.1074/jbc.M112.438119; Gov NS, 2009, EUR PHYS J E, V29, P337, DOI 10.1140/epje/i2009-10476-8; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Guo J, 2014, P NATL ACAD SCI USA, V111, pE5252, DOI 10.1073/pnas.1411683111; Guo J, 2014, ANTIOXID REDOX SIGN, V20, P986, DOI 10.1089/ars.2013.5708; Guo YC, 2018, REV NEUROSCIENCE, V29, P125, DOI 10.1515/revneuro-2017-0047; Hirata H, 2014, AM J PHYSIOL-CELL PH, V306, pC607, DOI 10.1152/ajpcell.00122.2013; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Ingber DE, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/4/046603; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jacquemet G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13297; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kassianidou E, 2015, BBA-MOL CELL RES, V1853, P3065, DOI 10.1016/j.bbamcr.2015.04.006; Kerstein PC, 2017, J NEUROSCI, V37, P1568, DOI 10.1523/JNEUROSCI.2769-16.2016; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Kukkurainen S, 2014, MOL BIOSYST, V10, P3217, DOI 10.1039/c4mb00341a; Lantoine J, 2016, BIOMATERIALS, V89, P14, DOI 10.1016/j.biomaterials.2016.02.041; Li H, 2014, REV NEUROSCIENCE, V25, P527, DOI 10.1515/revneuro-2013-0062; Li JF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/470418; Liu JM, 2015, NAT STRUCT MOL BIOL, V22, P383, DOI 10.1038/nsmb.2999; Mercier PL, 2011, MOL ONCOL, V5, P438, DOI 10.1016/j.molonc.2011.07.003; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Morgan JR, 2004, J CELL BIOL, V167, P43, DOI 10.1083/jcb.200406020; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; NEBE B, 1995, EXP CELL RES, V218, P479, DOI 10.1006/excr.1995.1181; Neumann J, 2016, PROTEIN ENG DES SEL, V29, P503, DOI 10.1093/protein/gzw031; NUCKOLLS GH, 1990, J CELL BIOL, V110, P1635, DOI 10.1083/jcb.110.5.1635; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Roossien DH, 2014, J CELL SCI, V127, P3593, DOI 10.1242/jcs.152611; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Saxena M, 2017, NANO LETT, V17, P7242, DOI 10.1021/acs.nanolett.7b02476; SCHWARTZ MA, 1991, P NATL ACAD SCI USA, V88, P7849, DOI 10.1073/pnas.88.17.7849; Seng S, 2006, MOL CELL BIOL, V26, P8371, DOI 10.1128/MCB.02167-05; Shakibael M, 2003, HISTOL HISTOPATHOL, V18, P343, DOI 10.14670/HH-18.343; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tan CL, 2015, MOL CELL NEUROSCI, V68, P1, DOI 10.1016/j.mcn.2015.03.011; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Tavares L, 2015, GLIA, V63, P1155, DOI 10.1002/glia.22806; Toriyama M, 2013, CURR BIOL, V23, P529, DOI 10.1016/j.cub.2013.02.017; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Triplett JW, 2006, AM J PHYSIOL-CELL PH, V291, pC909, DOI 10.1152/ajpcell.00113.2006; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van't Hoff JH., 1887, ZPHYSIK CHEM, V1, P481, DOI DOI 10.1515/ZPCH-1887-0151; Waitkus-Edwards KR, 2002, CIRC RES, V90, P473, DOI 10.1161/hh0402.105899; Wang DY, 2016, MOL NEUROBIOL, V53, P4582, DOI 10.1007/s12035-015-9394-9; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Wu X, 2001, J BIOL CHEM, V276, P30285, DOI 10.1074/jbc.M102436200; Xu XH, 2011, CNS DRUGS, V25, P555, DOI 10.2165/11587830-000000000-00000; Yang C, 2015, BBA-MOL CELL RES, V1853, P1889, DOI 10.1016/j.bbamcr.2015.05.001; Yao MX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11966; Ye F, 2014, CELL, V156, DOI 10.1016/j.cell.2014.02.048; Yoshimura T, 2006, ANN NY ACAD SCI, V1086, P116, DOI 10.1196/annals.1377.013; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	103	11	11	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6311	6326		10.1096/fj.201801949RR	http://dx.doi.org/10.1096/fj.201801949RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768370	Bronze			2022-12-28	WOS:000466932600040
J	Hedges, CP; Bishop, DJ; Hickey, AJR				Hedges, Christopher P.; Bishop, David J.; Hickey, Anthony J. R.			Voluntary wheel running prevents the acidosis-induced decrease in skeletal muscle mitochondrial reactive oxygen species emission	FASEB JOURNAL			English	Article						pH; mitochondria function; oxidative phosphorylation; oxidative stress; ROS	SUPEROXIDE-PRODUCTION; FIBER COMPOSITION; ENZYME-ACTIVITY; H2O2 RELEASE; EXERCISE; ADAPTATIONS; PH; INTERVAL; RESPIRATION; CAPACITY	Decreases in pH (acidosis) in vitro can alter skeletal muscle mitochondrial function [respiration and reactive oxygen species (ROS) emission]. However, because skeletal muscles readily adapt to exercise, the effects of acidosis may be different on sedentary vs. trained muscle. The aim of this work was to compare the effects of pH on skeletal muscle mitochondrial function between sedentary vs. exercise-trained male Sprague-Dawley rats (n = 10 in each cohort). Rates of mitochondrial respiration and ROS emission were determined from the soleus muscle of both cohorts over a physiologic range of pH values (pH 6.2-7.1). Exercise-trained rats had 14% higher mean muscle buffering capacities; 46 and 40% greater enzyme activity of citrate synthase and lactate dehydrogenase, respectively; and greater activity of respiratory complexes I-IV. ADP-stimulated respiration with complex I and II substrates was similar to 25% greater in exercise-trained rats but was unaffected by pH in either cohort. In both cohorts, lowering pH decreased respiration only in complex I- and complex II-supported nonphosphorylating (leak) state. However, as pH decreased, ROS emissions in complex I- and complex II-supported leak state decreased only in sedentary rats; in exercise-trained rats, ROS emissions in this state remained constant. We hypothesize that this effect may result from modulation at complex III, which declined 47% per unit pH in sedentary rats, in comparison to 23% in exercise-trained rats. Taken together, these data suggest that pH regulates mitochondrial respiratory complexes and that exercise training can decrease the effects of pH on skeletal muscle mitochondrial function.	[Hedges, Christopher P.; Hickey, Anthony J. R.] Univ Auckland, Sch Biol Sci, Appl Surg & Metab Lab, Auckland, New Zealand; [Hedges, Christopher P.; Bishop, David J.] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Bishop, David J.] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia	University of Auckland; Victoria University; Edith Cowan University	Hickey, AJR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	a.hickey@auckland.ac.nz	Bishop, David John/X-9826-2019	Bishop, David John/0000-0002-6956-9188; Hedges, Christopher/0000-0003-1104-0385	Faculty Research and Development Fund grant	Faculty Research and Development Fund grant	The authors thank Amorita Volschenk (University of Auckland) for expert technical assistance throughout the study, Dr. Cian McGinley (Sportscotland Institute of Sport, Stirling, United Kingdom) for advice on muscle buffer capacity experiments, and Dr. Kathy Ruggiero (University of Auckland) for guidance with statistical analyses. This project was funded by a Faculty Research and Development Fund grant (to A.J.R.H.). The authors declare no conflicts of interest.	Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505; Banh S, 2013, FEBS LETT, V587, P1799, DOI 10.1016/j.febslet.2013.04.035; Bishop DJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE225, DOI 10.1152/ajpendo.00738.2009; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CRISWELL D, 1993, MED SCI SPORT EXER, V25, P1135; Daussin FN, 2008, J APPL PHYSIOL, V104, P1436, DOI 10.1152/japplphysiol.01135.2007; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Foster C, 2015, J SPORT SCI MED, V14, P747; Gnaiger E, 1998, J EXP BIOL, V201, P1129; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Granata C, 2016, FASEB J, V30, P3413, DOI 10.1096/fj.201500100R; Grivennikova VG, 2013, BBA-BIOENERGETICS, V1827, P446, DOI 10.1016/j.bbabio.2013.01.002; Harkema SJ, 1997, AM J PHYSIOL-CELL PH, V272, pC491, DOI 10.1152/ajpcell.1997.272.2.C491; HERMANSEN L, 1972, J APPL PHYSIOL, V32, P304, DOI 10.1152/jappl.1972.32.3.304; Jubrias SA, 2003, J PHYSIOL-LONDON, V553, P589, DOI 10.1113/jphysiol.2003.045872; Kemp G, 2005, AM J PHYSIOL-REG I, V289, pR895, DOI 10.1152/ajpregu.00641.2004; KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; MANNION AF, 1993, J APPL PHYSIOL, V75, P1412, DOI 10.1152/jappl.1993.75.3.1412; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; SAHLIN K, 1978, ACTA PHYSIOL SCAND, V104, P370, DOI 10.1111/j.1748-1716.1978.tb06289.x; Selivanov VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001115; Servais S, 2003, FREE RADICAL BIO MED, V35, P24, DOI 10.1016/S0891-5849(03)00177-1; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Thomas C, 2007, AM J PHYSIOL-ENDOC M, V293, pE916, DOI 10.1152/ajpendo.00164.2007; Tonkonogi M, 1999, AM J PHYSIOL-CELL PH, V277, pC288, DOI 10.1152/ajpcell.1999.277.2.C288; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Venditti P, 1999, ARCH BIOCHEM BIOPHYS, V372, P315, DOI 10.1006/abbi.1999.1494; Walsh B, 2002, J APPL PHYSIOL, V92, P2273, DOI 10.1152/japplphysiol.01132.2001; Wang L, 2009, MED SCI SPORT EXER, V41, P2136, DOI 10.1249/MSS.0b013e3181abc1ec; Weston AR, 1996, ACTA PHYSIOL SCAND, V157, P211, DOI 10.1046/j.1365-201X.1996.488225000.x; Zoll J, 2003, J CELL PHYSIOL, V194, P186, DOI 10.1002/jcp.10224	37	2	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4996	5004		10.1096/fj.201801870R	http://dx.doi.org/10.1096/fj.201801870R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596520	Bronze			2022-12-28	WOS:000462888500029
J	Wan, P; Zhang, Q; Liu, WY; Jia, YL; Ai, S; Wang, TC; Wang, WB; Pan, P; Yang, G; Xiang, Q; Huang, SY; Yang, QY; Zhang, W; Liu, F; Tan, QP; Zhang, W; Wu, KL; Liu, YL; Wu, JG				Wan, Pin; Zhang, Qi; Liu, Weiyong; Jia, Yaling; Ai, Sha; Wang, Tianci; Wang, Wenbiao; Pan, Pan; Yang, Ge; Xiang, Qi; Huang, Siyu; Yang, Qingyu; Zhang, Wei; Liu, Fang; Tan, Qiuping; Zhang, Wen; Wu, Kailang; Liu, Yingle; Wu, Jianguo			Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation	FASEB JOURNAL			English	Article						innate immune response; interleukin 1 beta, IL-1 beta; proinflammatory cytokines; Skp1-Cullin1-F-box complex; ubiquitin-proteasome system	PATTERN-RECOGNITION RECEPTORS; PROTEIN; LIGASE; DEUBIQUITINATION; DESTRUCTION; DEGRADATION; CASPASE-1; INNATE; DOMAIN	Activation of the NACHT, leucine-rich repeat, and pyrin domains-containing protein 3 (collectively known as NLRP3) inflammasome plays a key role in host immune response, which is the first line of defense against cellular stresses and pathogen infections. However, excessive inflammasome activation damages host cells, and therefore it must be precisely controlled. Here, we discover that Cullin1 (CUL1), a key component of the Skp1-Cullin1-F-box E3 ligase, plays a critical role in controlling the NLRP3 inflammasome. CUL1 represses inflammasome assembly in cultured cells, suppresses NLRP3 function in human monocytic cell line macrophages, and attenuates inflammatory responses in mouse model. Detailed studies demonstrate that CUL1 interacts with NLRP3 and promotes NLRP3 ubiquitination, but not protein degradation, to repress the NLRP3 inflammasome activation. Moreover, upon inflammatory stimuli, including ATP and nigericin treatments, CUL1 disassociates from NLRP3 to release the repression of the NLRP3 inflammasome. Thus, this study reveals a distinct and unique mechanism underlying the control of systematic activation of the NLRP3 inflammasome.	[Wan, Pin; Zhang, Qi; Liu, Weiyong; Jia, Yaling; Ai, Sha; Wang, Tianci; Pan, Pan; Yang, Ge; Xiang, Qi; Huang, Siyu; Yang, Qingyu; Zhang, Wei; Liu, Fang; Wu, Kailang; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Wang, Wenbiao; Liu, Yingle; Wu, Jianguo] Jinan Univ, Inst Med Microbiol, Key Lab Virol Guangzhou, Guangzhou, Guangdong, Peoples R China; [Tan, Qiuping; Zhang, Wen] Guangdong LongFan Biol Sci & Technol Co, Foshan, Peoples R China	Wuhan University; Jinan University	Liu, YL; Wu, JG (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.; Wu, JG (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.; Wu, JG (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	mvlwu@whu.edu.cn; jwu@whu.edu.cn	Yang, Heroine/GRY-2630-2022; wang, wenbiao/AAQ-9104-2021; Liu, Fang/HCH-6710-2022	Liu, Fang/0000-0003-0972-9968; Wu, Jianguo/0000-0002-8326-2895	National Natural Science Foundation of China [81730061, 31230005, 81471942, 31200134, 31270206]; National Health and Family Planning Commission of China (National Mega Project on Major Infectious Disease Prevention) [2017ZX10103005, 2017ZX10202201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission of China (National Mega Project on Major Infectious Disease Prevention)	The authors thank Dr. Jiahuai Han (State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Fujian, China) for kindly providing the cDNA of genes Cullin1 and NLRP3. This work was supported by National Natural Science Foundation of China (81730061, 31230005, 81471942, 31200134, and 31270206) and the National Health and Family Planning Commission of China (National Mega Project on Major Infectious Disease Prevention) (2017ZX10103005 and 2017ZX10202201). The authors declare no conflicts of interest.	Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Han S, 2015, J BIOL CHEM, V290, P18124, DOI 10.1074/jbc.M115.645549; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kawashima A, 2017, J IMMUNOL, V199, P3614, DOI 10.4049/jimmunol.1700184; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moriyama M, 2016, J VIROL, V90, P4105, DOI 10.1128/JVI.00120-16; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Winkler S, 2015, SEMIN IMMUNOPATHOL, V37, P419, DOI 10.1007/s00281-015-0494-4; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7115	43	28	29	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5793	5807		10.1096/fj.201801681R	http://dx.doi.org/10.1096/fj.201801681R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30653357	Bronze			2022-12-28	WOS:000462888500092
J	Wang, Y; La, M; Pham, T; Lovrecz, GO; Nie, GY				Wang, Yao; La, Mylinh; Tam Pham; Lovrecz, George O.; Nie, Guiying			High levels of HtrA4 detected in preeclamptic circulation may disrupt endothelial cell function by cleaving the main VEGFA receptor KDR	FASEB JOURNAL			English	Article						early onset preeclampsia; angiogenesis; endothelial dysfunction; HUVEC	GROWTH-FACTOR RECEPTOR-2; EARLY-ONSET PREECLAMPSIA; TYROSINE KINASE-1; GENE-EXPRESSION; PREGNANCY; RISK; DYSFUNCTION; MORTALITY; PROTEIN; FAMILY	Systemic endothelial dysfunction is a key characteristic of preeclampsia (PE), which is a serious disorder of human pregnancy. We have previously reported that high-temperature requirement factor (Htr)A4 is a placenta-specific protease that is secreted into the maternal circulation and significantly up-regulated in PE, especially early-onset PE. We have also demonstrated that high levels of HtrA4 detected in the early onset PE circulation induce endothelial dysfunction in HUVECs. In the current study, we investigated whether HtrA4 could cleave the main receptor of VEGFA, the kinase domain receptor (KDR), thereby inhibiting VEGFA signaling. We first demonstrated that HtrA4 cleaved recombinant KDR in vitro. We then confirmed that HtrA4 reduced the level of KDR in HUVECs and inhibited the VEGFA-induced phosphorylation of Akt kinase, which is essential for downstream signaling. Further functional studies demonstrated that HtrA4 prevented the VEGFA-induced tube formation in HUVECs and dose-dependently inhibited the VEGFA-induced angiogenesis in explants of mouse aortic rings. These data strongly suggest that high levels of HtrA4 in the maternal circulation could cleave the main receptor of VEGFA in endothelial cells to induce a wide-spread impairment of angiogenesis. Our studies therefore suggest that HtrA4 is a potential causal factor of early onset PE.	[Wang, Yao; Nie, Guiying] Hudson Inst Med Res, Ctr Reprod Hlth, Implantat & Placental Dev Lab, Clayton, Vic, Australia; [Wang, Yao; Nie, Guiying] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [Nie, Guiying] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [La, Mylinh; Tam Pham; Lovrecz, George O.] Commonwealth Sci & Ind Res Org CSIRO Mfg, Clayton, Vic, Australia	Hudson Institute of Medical Research; Monash University; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nie, GY (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	guiying.nie@hudson.org.au			National Health and Medical Research Council of Australia [1041835, 1108365]; Dora Lush (Biomedical) Research Scholarship; Victorian State Government Operational Infrastructure Scheme; National Collaborative Research Infrastructure Strategy	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dora Lush (Biomedical) Research Scholarship; Victorian State Government Operational Infrastructure Scheme; National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science)	The authors thank Dr. Sonia Teoh for assistance with studies involving mice and Dr. Sophea Heng (both from Hudson Institute of Medical Research) for assistance with confocal imaging. This work was supported by National Health and Medical Research Council of Australia Fellowship 1041835 and Project Grant 1108365 (to G.N.), a Dora Lush (Biomedical) Research Scholarship (to Y.W.), the Victorian State Government Operational Infrastructure Scheme, and the National Collaborative Research Infrastructure Strategy. The authors declare no conflicts of interest.	Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Brew O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161504; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Cross Sarah N, 2012, Rev Obstet Gynecol, V5, P2; Dellinger MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028947; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Inagaki A, 2012, PLACENTA, V33, P919, DOI 10.1016/j.placenta.2012.08.003; Kaartokallio T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14107; Lapaire O, 2012, FETAL DIAGN THER, V31, P147, DOI 10.1159/000337325; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Liu CH, 2018, MOL MED REP, V18, P2937, DOI 10.3892/mmr.2018.9289; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mellembakken JR, 2002, HYPERTENSION, V39, P155, DOI 10.1161/hy0102.100778; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Palmer KR, 2015, HYPERTENSION, V66, P1251, DOI 10.1161/HYPERTENSIONAHA.115.05883; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Poston Lucilla, 2006, Pharmacol Rep, V58 Suppl, P69; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; RODGERS GM, 1988, AM J OBSTET GYNECOL, V159, P908, DOI 10.1016/S0002-9378(88)80169-8; Schipper EJI, 2005, J MATERN-FETAL NEO M, V18, P283, DOI 10.1080/14767050500246466; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Singh H, 2015, J CLIN ENDOCR METAB, V100, pE936, DOI 10.1210/jc.2014-3969; Singh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108235; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Vitoratos N, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/908649; Wang Y, 2018, SLAS DISCOV, V23, P1092, DOI 10.1177/1087057116682425; Wang Y, 2016, PLACENTA, V47, P46, DOI 10.1016/j.placenta.2016.09.003; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1	46	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5058	5066		10.1096/fj.201802151RR	http://dx.doi.org/10.1096/fj.201802151RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601675				2022-12-28	WOS:000462888500034
J	Kumar, S; Rani, R; Karns, R; Gandhi, CR				Kumar, Sudhir; Rani, Richa; Karns, Rebekah; Gandhi, Chandrashekhar R.			Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression	FASEB JOURNAL			English	Article						PPAR; PMP70; ACOX1; CPT1a	STELLATE CELLS; NONALCOHOLIC STEATOHEPATITIS; FIBROSIS; PEROXISOME; COENZYME	Levels of augmenter of liver regeneration (ALR), a multifunctional protein, are reduced in steatohepatitis. ALR depletion from ALR(flox/flox)/Alb-Cre [ALR-L-knockout (KO)] mouse causes robust steatosis and apoptosis of hepatocytes, and pericellular fibrosis between 1 and 2 wk postbirth. Steatosis regresses by 4 wk upon reappearance of ALR-expressing hepatocytes. We investigated mechanisms of ALR depletion-induced steatosis. ALR-L-KO mice (1-, 2-, and 4 wk old) and Adeno-Cre-transfected ALR(flox/flox) hepatocytes were used for in vivo and in vitro studies. ALR depletion from hepatocytes in vivo downregulated peroxisome proliferator-activated receptor (PPAR)-, carnitine palmitoyl transferase I (CPT1)a, peroxisomal membrane protein 70 (PMP70) (modest down-regulation), and acyl-CoA oxidase 1 (ACOX1). The markedly up-regulated (20X) novel microRNA-540 (miR-540) was identified to target PPAR, PMP70, ACOX1, and CPT1a. ALR depletion from primary hepatocytes increased oxidative stress, miR-540 expression, and steatosis and down-regulated PPAR, ACOX1, PMP70, and CPT1a expression. Anti-miR-540 mitigated ALR depletion-induced steatosis and prevented loss of PPAR, ACOX1, PMP70, and CPT1a expression. Antioxidant N-acetylcysteine and recombinant ALR (rALR) both inhibited ALR depletion-induced miR-540 expression and lipid accumulation in hepatocytes. Finally, treatment of ALR-L-KO mice with rALR between 1 and 2 wk prevented miR-540 expression, and arrested steatosis and fibrosis. We conclude that ALR deficiency-mediated oxidative stress induces generation of miR-540, which promotes steatosis by dysregulating peroxisomal and mitochondrial lipid homeostasis.Kumar, S., Rani, R., Karns, R., Gandhi, C. R. Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.	[Kumar, Sudhir; Rani, Richa; Karns, Rebekah; Gandhi, Chandrashekhar R.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Kumar, Sudhir; Rani, Richa; Gandhi, Chandrashekhar R.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA; [Gandhi, Chandrashekhar R.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati	Gandhi, CR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, 3333 Burnett Ave, Cincinnati, OH 45229 USA.	chandrashekhar.gandhi@cchmc.org	Kumar, Sudhir/J-3844-2019		U.S. Department of Defense Congressionally Direct Medical Research Program [W81XWH-14-PRMRP-IIRA]; U.S. National Institutes of Health Exploratory/Developmental Research, National Institute on Alcohol Abuse and Alcoholism [R21 AA020846]; Veterans Affairs Merit Review Award [1IO1BX001174]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	U.S. Department of Defense Congressionally Direct Medical Research Program; U.S. National Institutes of Health Exploratory/Developmental Research, National Institute on Alcohol Abuse and Alcoholism; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. Department of Defense Congressionally Direct Medical Research Program Grant W81XWH-14-PRMRP-IIRA, U.S. National Institutes of Health Exploratory/Developmental Research, National Institute on Alcohol Abuse and Alcoholism Grant R21 AA020846, and Veterans Affairs Merit Review Award 1IO1BX001174 (to C.R.G.). The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Davoodian Parivash, 2017, Gastroenterol Hepatol Bed Bench, V10, P112; Ding JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13729; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; FRANCAVILLA A, 1994, HEPATOLOGY, V20, P747, DOI 10.1002/hep.1840200328; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Fu RQ, 2017, MOL MED REP, V16, P4327, DOI 10.3892/mmr.2017.7054; Gandhi CR, 2017, J HEPATOL, V67, P1104, DOI 10.1016/j.jhep.2017.06.001; Gandhi CR, 2015, GASTROENTEROLOGY, V148, P379, DOI 10.1053/j.gastro.2014.10.008; Gandhi CR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-10; Gandhi CR, 2010, J CELL PHYSIOL, V222, P365, DOI 10.1002/jcp.21957; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gori M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741465; Iwase T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03081; Kennedy LL, 2016, LAB INVEST, V96, P1256, DOI 10.1038/labinvest.2016.112; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Khanizadeh S, 2017, MICROB PATHOGENESIS, V110, P688, DOI 10.1016/j.micpath.2017.03.004; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumar S, 2017, J LEUKOCYTE BIOL, V101, P429, DOI 10.1189/jlb.2A0516-239R; Kumar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147864; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loyer X, 2016, GUT, V65, P1882, DOI 10.1136/gutjnl-2014-308883; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; Mello T, 2016, PPAR RES, V2016, DOI 10.1155/2016/7403230; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Murakami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116434; Murakami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106314; Nalesnik MA, 2017, HEPATOLOGY, V66, P266, DOI 10.1002/hep.29047; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Osmundsen H., 1987, PEROXISOMES BIOL MED, P152; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Polimeno L, 2000, DIGEST LIVER DIS, V32, P510, DOI 10.1016/S1590-8658(00)80009-2; Rani R, 2017, AM J PATHOL, V187, P2008, DOI 10.1016/j.ajpath.2017.05.015; SANTOS MJ, 1994, J BIOL CHEM, V269, P24890; Sanyal A. J., 1675, NEW ENGL J MED, V362, P1675; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tryndyak VP, 2012, TOXICOL APPL PHARM, V262, P52, DOI 10.1016/j.taap.2012.04.018; Uemura T, 2001, BRIT J PHARMACOL, V133, P1125, DOI 10.1038/sj.bjp.0704151; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Varanasi U, 1996, J BIOL CHEM, V271, P2147, DOI 10.1074/jbc.271.4.2147; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Yang F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00929; Zhou Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15089	52	17	18	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3825	3840		10.1096/fj.201802015R	http://dx.doi.org/10.1096/fj.201802015R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30540918	Green Published, Bronze			2022-12-28	WOS:000459794800059
J	Lee, M; Moon, Y; Lee, S; Lee, C; Jun, Y				Lee, Miriam; Moon, Yeojin; Lee, Sanghwa; Lee, Changwook; Jun, Youngsoo			Ergosterol interacts with Sey1p to promote atlastin-mediated endoplasmic reticulum membrane fusion in Saccharomyces cerevisiae	FASEB JOURNAL			English	Article						yeast; proteoliposome; microsome; SNARE; sterol biosynthesis	HOMOTYPIC ER FUSION; CONTACT SITES; GTPASE SEY1P; SUBCELLULAR MEMBRANES; LIPID-COMPOSITION; PROVIDE INSIGHT; CHOLESTEROL; YEAST; PROTEIN; GP41	Sterols play critical roles in various membrane fusion events, including soluble NSF attachment protein receptor-mediated membrane fusion, mainly by modulating the physical properties of biologic membranes; however, it remains unclear whether they also function in atlastin-mediated endoplasmic reticulum (ER) membrane fusion. Although ergosterol, the major sterol in yeast, is essential for fusion of Sey1p (yeast atlastin)-containing liposomes with an ER-mimicking lipid composition, fusion of phosphatidylcholine/phosphatidylserine liposomes does not require sterols. Here, we examined whether sterols are important for Sey1p-mediated ER fusion in Saccharomyces cerevisiae using an in vitro ER fusion assay with isolated yeast ER microsomes. Ergosterol-specific ligands inhibited microsome fusion, indicating that ergosterol is critical for ER fusion. However, microsomes isolated from yeast strains lacking genes that encode enzymes involved in synthesis of ergosterol from lanosterol still fused, suggesting that other sterols can replace ergosterol and support Sey1p-mediated ER fusion. Importantly, disruption of sterol-binding motifs in the transmembrane regions of Sey1p markedly reduced ER fusion. Sey1p physically interacted with Erg11p and Erg4p, which function in ergosterol biosynthesis, suggesting that Sey1p recruits ergosterol-synthesizing enzymes to fusion sites and thereby enriches ergosterol, which, in turn, may recruit more Sey1p. This positive feedback loop may facilitate ER membrane fusion by concentrating fusion factors at fusion sites.Lee, M., Moon, Y., Lee, S., Lee, C., Jun, Y. Ergosterol interacts with Sey1p to promote atlastin-mediated endoplasmic reticulum membrane fusion in Saccharomyces cerevisiae.	[Lee, Miriam; Moon, Yeojin; Jun, Youngsoo] Gwangju Inst Sci & Technol, Sch Life Sci, 1 Oryong Dong, Gwangju 61005, South Korea; [Lee, Miriam; Moon, Yeojin; Jun, Youngsoo] Gwangju Inst Sci & Technol, Silver Hlth Bio Res Ctr, Gwangju, South Korea; [Lee, Miriam; Moon, Yeojin; Lee, Sanghwa; Lee, Changwook; Jun, Youngsoo] Gwangju Inst Sci & Technol, Cell Logist Res Ctr, Gwangju, South Korea; [Lee, Sanghwa] Gwangju Inst Sci & Technol, Adv Photon Res Inst, Gwangju, South Korea; [Lee, Changwook] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Dept Biol Sci, Ulsan, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Ulsan National Institute of Science & Technology (UNIST)	Jun, Y (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, 1 Oryong Dong, Gwangju 61005, South Korea.	junys@gist.ac.kr	Jun, Youngsoo/Q-3624-2018	Jun, Youngsoo/0000-0002-2387-032X; Lee, Sanghwa/0000-0001-6986-7583	National Research Foundation of Korea [2016R1A5A1007318]; GIST Research Institute at the Gwangju Institute of Science and Technology	National Research Foundation of Korea(National Research Foundation of Korea); GIST Research Institute at the Gwangju Institute of Science and Technology	This work was supported by National Research Foundation of Korea Grant 2016R1A5A1007318 awarded to the Cell Logistics Research Center and by a grant from the GIST Research Institute at the Gwangju Institute of Science and Technology. The authors declare no conflicts of interest.	Anwar K, 2012, J CELL BIOL, V197, P209, DOI 10.1083/jcb.201111115; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Brachmann CB, 1998, YEAST, V14, P115; Byrnes LJ, 2013, EMBO J, V32, P369, DOI 10.1038/emboj.2012.353; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Chen SSL, 2009, J VIROL, V83, P870, DOI 10.1128/JVI.01088-08; Drin G, 2016, BIOCHEM SOC T, V44, P486, DOI 10.1042/BST20150265; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Enrich C, 2015, J CELL SCI, V128, P1071, DOI 10.1242/jcs.164459; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Kim KT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09162-9; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; LANGE Y, 1991, J LIPID RES, V32, P329; Lee M, 2015, J CELL BIOL, V210, P451, DOI 10.1083/jcb.201501043; LEES ND, 1995, LIPIDS, V30, P221, DOI 10.1007/BF02537824; Mo CQ, 2005, BBA-MOL CELL BIOL L, V1737, P152, DOI 10.1016/j.bbalip.2005.11.002; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Murray DH, 2011, BIOCHEMISTRY-US, V50, P9014, DOI 10.1021/bi201307u; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Raiborg C, 2015, EMBO J, V34, P1848, DOI 10.15252/embj.201591481; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Saheki Y, 2017, ANNU REV BIOCHEM, V86, P659, DOI 10.1146/annurev-biochem-061516-044932; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Selitrennik M, 2016, BIOCHEM SOC T, V44, P419, DOI 10.1042/BST20150182; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Sugiura S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20407; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; te Welscher YM, 2010, ANTIMICROB AGENTS CH, V54, P2618, DOI 10.1128/AAC.01794-09; ten Brinke MM, 2017, ELIFE, V6, DOI 10.7554/eLife.28132; Tong JS, 2009, P NATL ACAD SCI USA, V106, P5141, DOI 10.1073/pnas.0813138106; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P11869, DOI 10.1021/bi8014828; Vishwanathan SA, 2008, J VIROL, V82, P5118, DOI 10.1128/JVI.00305-08; Welscher YMT, 2008, J BIOL CHEM, V283, P6393, DOI 10.1074/jbc.M707821200; Wong LH, 2016, BIOCHEM SOC T, V44, P517, DOI 10.1042/BST20150275; Yan LM, 2015, J CELL BIOL, V210, P961, DOI 10.1083/jcb.201502078; Yang ST, 2016, CHEM PHYS LIPIDS, V199, P136, DOI 10.1016/j.chemphyslip.2016.05.003; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	46	4	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3590	3600		10.1096/fj.201800779RR	http://dx.doi.org/10.1096/fj.201800779RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30462528				2022-12-28	WOS:000459794800040
J	Ulsund, AH; Dahl, M; Frimurer, TM; Manfra, O; Schwartz, TW; Levy, FO; Andressen, KW				Ulsund, Andrea Hembre; Dahl, Marie; Frimurer, Thomas M.; Manfra, Ornella; Schwartz, Thue W.; Levy, Finn Olav; Andressen, Kjetil Wessel			Preassociation between the 5-HT7 serotonin receptor and G protein G(s): molecular determinants and association with low potency activation of adenylyl cyclase	FASEB JOURNAL			English	Article						FRAP; preassembly; precoupling; collision coupling; FRET	CRYO-EM STRUCTURE; ATYPICAL ANTIPSYCHOTICS CLOZAPINE; CRYSTAL-STRUCTURE; SPLICE VARIANTS; DOWN-REGULATION; GLP-1 RECEPTOR; AGONIST; PHARMACOLOGY; STIMULATION; COMPLEX	According to early models of GPCR signaling, G proteins only interact with activated receptors. However, some GPCRs were shown to assemble with G proteins before receptor activation, in accordance with more recent models. Previously, we found that the 5-HT7 receptor, as opposed to the 5-HT4 receptor, was preassociated with G(s), but the molecular determinants for this interaction are still elusive. In a series of chimeric 5-HT7 receptors with intracellular segments from 5-HT4, we determined the receptor-G protein interaction by performing antibody-immobilized fluorescence recovery after photobleaching and fluorescence resonance energy transfer. We identified the intracellular loop 3 and C-tail of the 5-HT7 receptor to be responsible for the preassociation with G(s), and we further delineated the TM5 extension in the intracellular loop 3 and helix 8 in the C-tail as the molecular determinants. These chimeric exchanges converted the 5-HT7 receptor into a collision-coupled receptor that recruited G proteins only upon agonist activation, whereas reciprocal exchanges converted 5-HT4 to a preassociated receptor. The 5-HT7 receptor displayed 2-component agonist-induced G(s) signaling with high and low potency. In addition, the same segments were involved in low-potency signaling and preassociation. The correspondence between G(s) preassociation and low-potency G(s) signaling is a novel aspect of GPCR pharmacology.Ulsund, A. H., Dahl, M., Frimurer, T. M., Manfra, O., Schwartz, T. W., Levy, F. O., Andressen, K. W. Preassociation between the 5-HT7 serotonin receptor and G protein G(s): molecular determinants and association with low potency activation of adenylyl cyclase.	[Ulsund, Andrea Hembre; Dahl, Marie; Manfra, Ornella; Levy, Finn Olav; Andressen, Kjetil Wessel] Univ Oslo, Fac Med, Inst Clin Med, Dept Pharmacol, Oslo, Norway; [Ulsund, Andrea Hembre; Dahl, Marie; Manfra, Ornella; Levy, Finn Olav; Andressen, Kjetil Wessel] Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway; Oslo Univ Hosp, Oslo, Norway; [Frimurer, Thomas M.; Schwartz, Thue W.] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Schwartz, Thue W.] Univ Copenhagen, Fac Hlth Sci, Mol Pharmacol Lab, Dept Biomed Res, Copenhagen, Denmark	University of Oslo; University of Oslo; University of Oslo; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Levy, FO (corresponding author), Univ Oslo, Fac Med, Dept Pharmacol, Sognsvannsveien 20,POB 1057 Blindern, N-0316 Oslo, Norway.	f.o.levy@medisin.uio.no		Andressen, Kjetil Wessel/0000-0003-1094-1501; Frimruer, Thomas/0000-0002-9682-8245	Norwegian Council on Cardiovascular Diseases; Research Council of Norway; Stiftelsen Kristian Gerhard Jebsen; Novo Nordisk Foundation; Anders Jahre Foundation for the Promotion of Science; Family Blix Foundation; Helgesen Foundation; University of Oslo	Norwegian Council on Cardiovascular Diseases; Research Council of Norway(Research Council of Norway); Stiftelsen Kristian Gerhard Jebsen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Anders Jahre Foundation for the Promotion of Science; Family Blix Foundation; Helgesen Foundation; University of Oslo	The authors thank Kristin Nordskogen Smeby (University of Oslo) for technical assistance, N. A. Lambert (Augusta University, Augusta, GA, USA) for the G beta gamma Venus plasmid, and G. Schulte (Karolinska Institutet, Stockholm, Sweden) for the G gamma Venus plasmid. This research was supported by the Norwegian Council on Cardiovascular Diseases, the Research Council of Norway, Stiftelsen Kristian Gerhard Jebsen, the Novo Nordisk Foundation, the Anders Jahre Foundation for the Promotion of Science, the Family Blix Foundation, the Helgesen Foundation, and grants from the University of Oslo. The authors declare no conflicts of interest.	Andressen KW, 2015, BRIT J PHARMACOL, V172, P3846, DOI 10.1111/bph.13169; Andressen KW, 2018, FASEB J, V32, P1059, DOI 10.1096/fj.201700486R; Andressen KW, 2006, MOL PHARMACOL, V69, P207, DOI 10.1124/mol.105.015396; Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Ayoub Mohammed Akli, 2013, Front Endocrinol (Lausanne), V4, P196, DOI 10.3389/fendo.2013.00196; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Bach T, 2001, N-S ARCH PHARMACOL, V363, P146, DOI 10.1007/s002100000299; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bruheim S, 2003, RECEPTOR CHANNEL, V9, P107, DOI 10.1080/10606820308245; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Garcia-Nafria J, 2018, NATURE, V558, P620, DOI 10.1038/s41586-018-0241-9; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; HOYER D, 1994, PHARMACOL REV, V46, P157; Kaiser A, 2018, MOL PHARMACOL, V93, P387, DOI 10.1124/mol.117.110544; Keuerleber S, 2012, J BIOL CHEM, V287, P42104, DOI 10.1074/jbc.M112.393579; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Krobert KA, 2006, EUR J PHARMACOL, V532, P1, DOI 10.1016/j.ejphar.2005.11.039; Krobert KA, 2001, N-S ARCH PHARMACOL, V363, P620, DOI 10.1007/s002100000369; Krobert KA, 2002, BRIT J PHARMACOL, V135, P1563, DOI 10.1038/sj.bjp.0704588; Kvachnina E, 2009, BBA-MOL CELL RES, V1793, P1646, DOI 10.1016/j.bbamcr.2009.08.008; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Manfra O, 2015, ACS CHEM NEUROSCI, V6, P1206, DOI 10.1021/cn500339p; Matthys A, 2011, MOL NEUROBIOL, V43, P228, DOI 10.1007/s12035-011-8175-3; Newman-Tancredi A, 2002, MOL PHARMACOL, V62, P590, DOI 10.1124/mol.62.3.590; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2011, NATURE, V477, P540, DOI 10.1038/477540a; Thomas DR, 1999, BRIT J PHARMACOL, V128, P158, DOI 10.1038/sj.bjp.0702759; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	41	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3870	3886		10.1096/fj.201800805RR	http://dx.doi.org/10.1096/fj.201800805RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30508496	Bronze, Green Submitted			2022-12-28	WOS:000459794800062
J	Arora, K; Sequeira, JM; Alarcon, JM; Wasek, B; Arning, E; Bottiglieri, T; Quadros, EV				Arora, Kaveri; Sequeira, Jeffrey M.; Alarcon, Juan M.; Wasek, Brandi; Arning, Erland; Bottiglieri, Teodoro; Quadros, Edward V.			Neuropathology of vitamin B-12 deficiency in the Cd320(-/-) mouse	FASEB JOURNAL			English	Article						CNS; neuropathy; demyelination; spinal cord	LUMBAR SPINAL-CORD; CELLULAR UPTAKE; PERIPHERAL NEUROPATHY; COMBINED DEGENERATION; S-ADENOSYLMETHIONINE; COBALAMIN; RAT; METABOLISM; RECEPTOR; PROTEIN	In humans, vitamin B-12 deficiency causes peripheral and CNS manifestations. Loss of myelin in the peripheral nerves and the spinal cord (SC) contributes to peripheral neuropathy and motor deficits. The metabolic basis for the demyelination and brain disorder is unknown. The transcobalamin receptor-knockout mouse (Cd320(-/-)) develops cobalamin (Cbl) deficiency in the nervous system, with mild anemia. A decreased S-adenosylmethionine:S-adenosylhomocysteine ratio and increased methionine were seen in the brain with no significant changes in neurotransmitter metabolites. The structural pathology in the SC presented as loss of myelin in the axonal tracts with inflammation. The sciatic nerve (SN) showed increased nonuniform, internodal segments suggesting demyelination, and remyelination in progress. Consistent with these changes, the Cd320(-/-) mouse showed an increased latency to thermal nociception. Further, lower amplitude of compound action potential in the SN suggested that the functional capacity of the heavily myelinated axons were preferentially compromised, leading to loss of peripheral sensation. Although the metabolic basis for the demyelination and the structural and functional alterations of the nervous system in Cbl deficiency remain unresolved, the Cd320(-/-) mouse provides a unique model to investigate the pathologic consequences of vitamin B-12 deficiency. Arora, K., Sequeira, J. M., Alarcon, J. M., Wasek, B., Arning, E., Bottiglieri, T., Quadros, E. V. Neuropathology of vitamin B-12 deficiency in the Cd320(-/-) mouse.	[Arora, Kaveri] Suny Downstate Med Ctr, Sch Grad Studies, Brooklyn, NY 11203 USA; [Sequeira, Jeffrey M.; Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Alarcon, Juan M.] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Wasek, Brandi; Arning, Erland; Bottiglieri, Teodoro] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Baylor Scott & White Health; Baylor University Medical Center	Quadros, EV (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	edward.quadros@downstate.edu		Bottiglieri, Teodoro/0000-0002-4199-7551	U.S. National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases [DK064732]; NIH National Institute of Neurological Disorders and Stroke Grant [NS091830]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS091830] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Neurological Disorders and Stroke Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grant DK064732 (to E.V.Q.), and NIH National Institute of Neurological Disorders and Stroke Grant NS091830 (to J.M.A.) The authors declare no conflicts of interest.	AGAMANOLIS DP, 1978, J NEUROPATH EXP NEUR, V37, P273, DOI 10.1097/00005072-197805000-00006; Ahmed Z, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12157; [Anonymous], 1998, REP STAND COMM SCI E; Arora K, 2017, FASEB J, V31, P3098, DOI 10.1096/fj.201700025R; Arora K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177156; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Birn H, 2002, AM J PHYSIOL-RENAL, V282, pF408, DOI 10.1152/ajprenal.00206.2000; Cain DM, 2001, J NEUROPHYSIOL, V85, P1561, DOI 10.1152/jn.2001.85.4.1561; CANNATA JJB, 1965, J BIOL CHEM, V240, P3249; CHANARIN I, 1985, BLOOD, V66, P479; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Chung T, 2014, NEUROIMAG CLIN N AM, V24, P49, DOI 10.1016/j.nic.2013.03.023; Fenton Jon, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.03.2011.4030; Fernandez-Roig S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-41; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; GARRISON CJ, 1994, EXP NEUROL, V129, P237, DOI 10.1006/exnr.1994.1165; GARRISON CJ, 1991, BRAIN RES, V565, P1, DOI 10.1016/0006-8993(91)91729-K; Gartner L. P., 2001, COLOUR TXB HISTOLOGY; Hannibal L, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00027; HARTE RA, 1953, J NUTR, V49, P669, DOI 10.1093/jn/49.4.669; HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001; Hemmer B, 1998, J NEUROL NEUROSUR PS, V65, P822, DOI 10.1136/jnnp.65.6.822; Inoue-Choi M, 2012, INT J MOL EPIDEMIOL, V3, P160; JACOB JJC, 1978, BRIT J PHARMACOL, V64, P91, DOI 10.1111/j.1476-5381.1978.tb08645.x; Kalita J, 2014, NUTR NEUROSCI, V17, P156, DOI 10.1179/1476830513Y.0000000073; KRISTENSSON K, 1986, NATURE, V322, P544, DOI 10.1038/322544a0; KUNZE K, 1976, HDB CLIN NEUROLOGY, V28, P141; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; Loughlin AJ, 1997, J NEUROSCI RES, V47, P384; MCCOMBE PA, 1984, J NEUROL SCI, V66, P117, DOI 10.1016/0022-510X(84)90147-3; Ogburn KD, 2006, NEUROBIOL DIS, V22, P294, DOI 10.1016/j.nbd.2005.11.006; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; PANT SS, 1968, ACTA NEUROL SCAND, VS 44, P7; Paul L, 2017, MOL ASPECTS MED, V53, P43, DOI 10.1016/j.mam.2016.11.004; Quadros E. V., 2000, Modern analytical methodologies in fat- and water-soluble vitamins., P313; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Quadros EV, 2005, BIOCHEM BIOPH RES CO, V327, P1006, DOI 10.1016/j.bbrc.2004.12.103; QUADROS EV, 1989, AM J PHYSIOL, V256, pC296, DOI 10.1152/ajpcell.1989.256.2.C296; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; ROOS D, 1978, ACTA NEUROL SCAND, V59, P3; Saporta MA, 2009, BRAIN, V132, P3263, DOI 10.1093/brain/awp274; SAVAGE DG, 1995, BAILLIERE CLIN HAEM, V8, P657, DOI 10.1016/S0950-3536(05)80225-2; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; SCOTT JSD, 1984, CLIN SCI, V67, P299, DOI 10.1042/cs0670299; Shipton MJ, 2015, CLIN MED, V15, P145, DOI 10.7861/clinmedicine.15-2-145; STAHLBERG KG, 1967, SCAND J HAEMATOL, V4, P312; SUMNER AJ, 1982, ANN NEUROL, V11, P469, DOI 10.1002/ana.410110506; SWETT JE, 1991, EXP NEUROL, V114, P82, DOI 10.1016/0014-4886(91)90087-S; TAYLOR RT, 1967, J BIOL CHEM, V242, P1509; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Wasek B, 2018, J NEUROSCI METH, V307, P188, DOI 10.1016/j.jneumeth.2018.05.016; Watkins D, 2011, AM J MED GENET C, V157C, P33, DOI 10.1002/ajmg.c.30288	57	14	15	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2563	2573		10.1096/fj.201800754RR	http://dx.doi.org/10.1096/fj.201800754RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30303736	Green Published			2022-12-28	WOS:000457296600082
J	Hu, B; Sun, XW; Yang, YT; Ying, ZM; Meng, JH; Zhou, CH; Jiang, GY; Li, SH; Wu, FF; Zhao, X; Zhu, HX; Wu, HB; Cai, XZ; Shi, ZL; Yan, SG				Hu, Bin; Sun, Xuewu; Yang, Yute; Ying, Zhimin; Meng, Jiahong; Zhou, Chenhe; Jiang, Guangyao; Li, Sihao; Wu, Fengfeng; Zhao, Xiang; Zhu, Hanxiao; Wu, Haobo; Cai, Xunzi; Shi, Zhongli; Yan, Shigui			Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling	FASEB JOURNAL			English	Article						osteoclast; osteoporosis; NFATc1	NF-KAPPA-B; RECEPTOR ACTIVATOR; INHIBITS OSTEOCLASTOGENESIS; RANK EXPRESSION; CRUCIAL ROLE; DIFFERENTIATION; BISPHOSPHONATES; MECHANISMS; PREVENTION; RESORPTION	Postmenopausal osteoporosis is initiated by estrogen withdrawal and is characterized mainly by overactivated osteoclastic bone resorption. Targeting TNF receptor-associated factor 6 (TRAF6) or its downstream signaling pathways to modulate osteoclast formation and function is an appealing strategy for osteoclast-related disorders. In the present study, we determined the effect of tomatidine, a steroidal alkaloid derived from Solanaceae, on the formation and function of receptor activator of NF-B (RANK) ligand-induced osteoclasts and the underlying mechanism. Tomatidine inhibited osteoclast formation in a dose-dependent manner and decreased the expression of osteoclast marker genes. Actin ring formation and osteoclastic bone resorption were attenuated in the presence of tomatidine in vitro. Eight weeks after ovariectomy, tomatidine prevented estrogen deficiency-induced bone loss and restored the mechanical properties of the femur. At the molecular level, tomatidine abrogated phosphorylation of c-Jun N-terminal kinase (JNK)/p38, NF-B, and protein kinase B (Akt) pathway proteins by suppressing RANK expression, inhibiting the binding of TRAF6 to RANK, and downregulating the osteoclastogenesis marker-related protein expression. In summary, these data demonstrated that tomatidine attenuated osteoclast formation and function by modulating multiple TRAF6-mediated pathways. Therefore, tomatidine could be a novel candidate for the treatment of osteoclast-related disorders, including osteoporosis.Hu, B., Sun, X., Yang, Y., Ying, Z., Meng, J., Zhou, C., Jiang, G., Li, S., Wu, F., Zhao, X., Zhu, H., Wu, H., Cai, X., Shi, Z., Yan, S. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.	[Hu, Bin; Ying, Zhimin; Meng, Jiahong; Zhou, Chenhe; Jiang, Guangyao; Li, Sihao; Zhao, Xiang; Zhu, Hanxiao; Wu, Haobo; Cai, Xunzi; Shi, Zhongli; Yan, Shigui] Zhejiang Univ, Affiliated Hosp 2, Dept Orthoped Surg, Hangzhou, Zhejiang, Peoples R China; [Sun, Xuewu; Yang, Yute] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Orthopaed, Hangzhou, Zhejiang, Peoples R China; [Hu, Bin; Ying, Zhimin; Meng, Jiahong; Zhou, Chenhe; Jiang, Guangyao; Li, Sihao; Zhao, Xiang; Zhu, Hanxiao; Wu, Haobo; Cai, Xunzi; Shi, Zhongli; Yan, Shigui] Zhejiang Univ, Orthoped Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wu, Fengfeng] Zhejiang Univ, Huzhou Hosp, Huzhou Cent Hosp, Dept Orthoped Surg, Huzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Huzhou University; Zhejiang University	Yan, SG (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	zrjwsj@zju.edu.cn	Zhou, Chenhe/AAI-9226-2020	YING, ZHIMIN/0000-0001-5910-5016; Yan, Shigui/0000-0001-9096-2868	National Natural Science Foundation of China [81772360, 81401785]; Natural Science Foundation of Zhejiang Province [LY17H060004, Y17H060027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National Natural Science Foundation of China (81772360 and 81401785) and Natural Science Foundation of Zhejiang Province (LY17H060004 and Y17H060027). The authors declare no conflicts of interest.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bai S, 2008, J BIOL CHEM, V283, P30861, DOI 10.1074/jbc.M802525200; Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Borromeo GL, 2015, J BONE MINER RES, V30, P749, DOI 10.1002/jbmr.2428; Boudot C, 2010, BONE, V46, P1416, DOI 10.1016/j.bone.2010.01.383; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappuzzo KA, 2004, ANN PHARMACOTHER, V38, P294, DOI 10.1345/aph.1D353; Cardelli P, 2015, ORAL IMPLANTOL ROME, V8, P52; Chen L, 2008, EUR J IMMUNOL, V38, P2845, DOI 10.1002/eji.200838192; Chiu FL, 2008, FEBS LETT, V582, P2407, DOI 10.1016/j.febslet.2008.05.049; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; Dyle MC, 2014, J BIOL CHEM, V289, P14913, DOI 10.1074/jbc.M114.556241; Edwards BJ, 2013, J BONE JOINT SURG AM, V95A, P297, DOI 10.2106/JBJS.K.01181; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Friedman M, 2013, J AGR FOOD CHEM, V61, P9534, DOI 10.1021/jf402654e; Ghirardi A, 2014, EUR J CLIN PHARMACOL, V70, P1129, DOI 10.1007/s00228-014-1708-8; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Ke K, 2017, J ENDOCRINOL, V235, P85, DOI 10.1530/JOE-16-0591; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Loi F, 2016, BONE, V86, P119, DOI 10.1016/j.bone.2016.02.020; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Nakanishi A, 2013, INT J MOL MED, V31, P874, DOI 10.3892/ijmm.2013.1258; Oursler MJ, 2010, J CELL BIOCHEM, V110, P1058, DOI 10.1002/jcb.22640; Silva-Beltran NP, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/284071; Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559; Qiu SX, 2007, CHEM BIOL, V14, P860, DOI 10.1016/j.chembiol.2007.06.010; Takahashi N, 2003, METH MOLEC MED, V80, P129; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tan EM, 2017, J BONE MINER RES, V32, P846, DOI 10.1002/jbmr.3031; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weaver MJ, 2010, J AM ACAD ORTHOP SUR, V18, P367, DOI 10.5435/00124635-201006000-00009; Wu XM, 2012, TRANSNATIONAL CORPORATIONS IN CHINA: RESEARCH AND DEVELOPMENT, P1; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yuan FL, 2015, BONE, V75, P128, DOI 10.1016/j.bone.2015.02.017; Zalli D, 2016, J BONE MINER RES, V31, P1701, DOI 10.1002/jbmr.2851; Zhu X, 2016, J BONE MINER RES, V31, P560, DOI 10.1002/jbmr.2710	44	19	19	4	40	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2574	2586		10.1096/fj.201800920R	http://dx.doi.org/10.1096/fj.201800920R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30285579				2022-12-28	WOS:000457296600083
J	Kim, DY; Woo, YM; Lee, S; Oh, S; Shin, Y; Shin, JO; Park, EY; Ko, JY; Lee, EJ; Bok, J; Yoo, KH; Park, JH				Kim, Do Yeon; Woo, Yu Mi; Lee, Sunyoung; Oh, Sumin; Shin, Yubin; Shin, Jeong-Oh; Park, Eun Young; Ko, Je Yeong; Lee, Eun Ji; Bok, Jinwoong; Yoo, Kyung Hyun; Park, Jong Hoon			Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease	FASEB JOURNAL			English	Article						ADPKD; DNA methylation; microRNA; ZEB2; N-cadherin	EPITHELIAL-CELLS; MICRORNAS; GENES; EXPRESSION; METHYLATION; PROGRESSION; MECHANISM; MODEL; DNA; INACTIVATION	Altered miRNA (miR) expression occurs in various diseases. However, the therapeutic effect of miRNAs in autosomal dominant polycystic kidney disease (ADPKD) is unclear. Genome-wide analyses of miRNA expression and DNA methylation status were conducted to identify crucial miRNAs in end-stage ADPKD. miR-192 and -194 levels were down-regulated with hypermethylation at these loci, mainly in the intermediate and late stages, not in the early stage, of cystogenesis, suggesting their potential impact on cyst expansion. Cyst expansion has been strongly associated with endothelial-mesenchymal transition (EMT). Zinc finger E-box-binding homeobox-2 and cadherin-2, which are involved in EMT, were directly regulated by miR-192 and -194. The therapeutic effect of miR-192 and -194 in vivo and in vitro were assessed. Restoring these miRs by injection of precursors influenced the reduced size of cysts in Pkd1 conditional knockout mice. miR-192 and -194 may act as potential therapeutic targets to control the expansion and progression of cysts in patients with ADPKD.Kim, D. Y., Woo, Y. M., Lee, S., Oh, S., Shin, Y., Shin, J.-O., Park, E. Y., Ko, J. Y., Lee, E. J., Bok, J., Yoo, K. H., Park, J. H. Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.	[Kim, Do Yeon; Woo, Yu Mi; Lee, Sunyoung; Oh, Sumin; Shin, Yubin; Park, Eun Young; Ko, Je Yeong; Lee, Eun Ji; Yoo, Kyung Hyun; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea; [Kim, Do Yeon; Woo, Yu Mi; Lee, Sunyoung; Oh, Sumin; Shin, Yubin; Park, Eun Young; Ko, Je Yeong; Lee, Eun Ji; Yoo, Kyung Hyun; Park, Jong Hoon] Sookmyung Womens Univ, Res Inst Womens Hlth, Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea; [Shin, Jeong-Oh; Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea	Sookmyung Women's University; Sookmyung Women's University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoo, KH; Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea.; Yoo, KH; Park, JH (corresponding author), Sookmyung Womens Univ, Res Inst Womens Hlth, Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea.	khryu@sookmyung.ac.kr; parkjh@sookmyung.ac.kr	Bok, Jinwoong/B-8982-2016	Bok, Jinwoong/0000-0003-1958-1872	Bio and Medical Technology Development Program [2015M3A9B6027557]; Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation [2014M3C9A2067613]; National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2016R1A5A1011974]; Sookmyung Women's University [1-1703-2021]	Bio and Medical Technology Development Program; Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation; National Research Foundation of Korea (NRF) - Korean Government (MSIP); Sookmyung Women's University	This work was supported by Bio and Medical Technology Development Program Grant 2015M3A9B6027557 (to J.H.P.); Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation Grant 2014M3C9A2067613 (to J.H.P.); National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) 2016R1A5A1011974 (to J.H.P.); and Sookmyung Women's University Grant 1-1703-2021 (to K.H.Y.). The authors declare no conflicts of interest.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chiang YP, 2012, EXP THER MED, V3, P560, DOI 10.3892/etm.2011.436; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1026, DOI 10.1002/art.23283; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GABOW PA, 1993, AM J KIDNEY DIS, V22, P511, DOI 10.1016/S0272-6386(12)80921-8; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; Grantham JJ, 1996, AM J KIDNEY DIS, V28, P788, DOI 10.1016/S0272-6386(96)90378-9; Hajarnis S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14395; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Happe H, 2014, NAT REV NEPHROL, V10, P587, DOI 10.1038/nrneph.2014.137; Happe H, 2013, KIDNEY INT, V83, P1099, DOI 10.1038/ki.2013.13; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ibraghimov-Beskrovnaya O, 2008, CELL MOL LIFE SCI, V65, P605, DOI 10.1007/s00018-007-7362-x; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Kocyigit I, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0600-z; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Lakhia R, 2016, J AM SOC NEPHROL, V27, P2319, DOI 10.1681/ASN.2015060634; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Lee SO, 2008, J CLIN INVEST, V118, P3714, DOI 10.1172/JCI34922; Lennox KA, 2011, GENE THER, V18, P1111, DOI 10.1038/gt.2011.100; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20856-6; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, pF397, DOI 10.1152/ajprenal.00310.2002; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Norman J, 2011, BBA-MOL BASIS DIS, V1812, P1327, DOI 10.1016/j.bbadis.2011.06.012; Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56; Pandey P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-624; Park JH, 2014, BMB REP, V47, P417, DOI 10.5483/BMBRep.2014.47.8.109; Patel V, 2013, P NATL ACAD SCI USA, V110, P10765, DOI 10.1073/pnas.1301693110; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Raphael KL, 2009, KIDNEY INT, V75, P626, DOI 10.1038/ki.2008.659; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Schieren G, 2006, NEPHROL DIAL TRANSPL, V21, P1816, DOI 10.1093/ndt/gfl071; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Shin Y, 2018, FASEB J, V32, P3574, DOI 10.1096/fj.201700923R; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wessely O, 2012, J AM SOC NEPHROL, V23, P1909, DOI 10.1681/ASN.2012101026; Woo YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14083-8; Woo Y, 2014, HUM GENET, V133, P281, DOI 10.1007/s00439-013-1378-0; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yang Y, 2018, J AM SOC NEPHROL, V29, P2310, DOI 10.1681/ASN.2018010074; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	56	21	21	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2870	2884		10.1096/fj.201800563RR	http://dx.doi.org/10.1096/fj.201800563RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332302				2022-12-28	WOS:000457296600107
J	Lu, Y; Zhang, XS; Zhou, XM; Gao, YY; Chen, CL; Liu, JP; Ye, ZN; Zhang, ZH; Wu, LY; Li, W; Hang, CH				Lu, Yue; Zhang, Xiang-Sheng; Zhou, Xiao-Ming; Gao, Yong-Yue; Chen, Chun-Lei; Liu, Jing-Peng; Ye, Zhen-Nan; Zhang, Zi-Huan; Wu, Ling-Yun; Li, Wei; Hang, Chun-Hua			Peroxiredoxin 1/2 protects brain against H2O2-induced apoptosis after subarachnoid hemorrhage	FASEB JOURNAL			English	Article						hydroperoxide; oxidative stress; inflammation; ASK1	OXIDATIVE STRESS; INJURY; ACTIVATION; ADENANTHIN; PROTEINS; INFLAMMATION; MODULATORS; PATHWAY; STROKE	Recent studies suggest that peroxiredoxin1/2 (Prx1/2) may be involved in the pathophysiology of postischemic inflammatory responses in the brain. In this study, we assessed the distribution and function of Prx1/2 in mice after experimental subarachnoid hemorrhage (SAH). We investigated the distribution of Prx1/2 in the brains of mice both in vivo and in vitro using immunofluorescence staining. The expression of Prx1/2 after SAH was determined by Western blot. Adenanthin was used to inhibit Prx1/2 function, and Prx1/2 overexpression was achieved by injecting adeno-associated virus. Oxidative stress and neuronal apoptosis were assessed both in vivo and in vitro. The neurologic function, inflammatory response, and related cellular signals were analyzed. The results showed that Prx1 was mainly expressed in astrocytes, and Prx2 was abundant in neurons. The expression of Prx1/2 was elevated after SAH, and their expression levels peaked before proinflammatory cytokines. Inhibiting Prx1/2 promoted neuronal apoptosis by increasing the hydrogen peroxide (H2O2) levels via the apoptosis signal-regulating kinase 1/p38 pathway. By contrast, overexpression of Prx1/2 attenuated oxidative stress and neuronal apoptosis after SAH. Thus, early expression of Prx1/2 may protect the brain from oxidative damage after SAH and may provide a novel target for treating SAH.Lu, Y., Zhang, X.-S., Zhou, X.-M., Gao, Y.-Y., Chen, C.-L., Liu, J.-P., Ye, Z.-N., Zhang, Z.-H., Wu, L.-Y., Li, W., Hang, C.-H. Peroxiredoxin 1/2 protects brain against H2O2-induced apoptosis after subarachnoid hemorrhage.	[Lu, Yue; Zhang, Xiang-Sheng; Gao, Yong-Yue; Wu, Ling-Yun; Li, Wei; Hang, Chun-Hua] Nanjing Univ, Drum Tower Hosp, Dept Neurosurg, Med Sch, 321 Zhongshan Rd, Nanjing 210006, Jiangsu, Peoples R China; [Zhang, Xiang-Sheng; Zhou, Xiao-Ming] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Chen, Chun-Lei] Nanjing Med Univ, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Liu, Jing-Peng; Ye, Zhen-Nan] South Med Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Zhang, Zi-Huan] Zhongdu Hosp, Dept Neurosurg, Bengbu, Peoples R China	Nanjing University; Naval Medical University; Nanjing Medical University; Southern Medical University - China	Li, W; Hang, CH (corresponding author), Nanjing Univ, Drum Tower Hosp, Dept Neurosurg, Med Sch, 321 Zhongshan Rd, Nanjing 210006, Jiangsu, Peoples R China.	lwxzlw@126.com; hang_neurosurgery@163.com	Wu, Ling/GZN-2235-2022; Li, Wei/ABE-4301-2021	LU, Yue/0000-0001-9111-5943	National Natural Science Foundation of China (NSFC) [81771291, 81371294, 81501022, 81401029]; National Science Foundation of Jiangsu Province [BK20141375]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science Foundation of Jiangsu Province	This work was supported by National Natural Science Foundation of China (NSFC) Grants 81771291 (to C.-H.H.), 81371294 (to C.-H.H.), 81501022 (to X.-S.Z.), and 81401029 (to W.L.), and National Science Foundation of Jiangsu Province Grant BK20141375. The authors declare no conflicts of interest.	Attia Mohammed Sabri, 2015, Acta Neurochir Suppl, V120, P311, DOI 10.1007/978-3-319-04981-6_53; Cao SL, 2016, STROKE, V47, P1626, DOI 10.1161/STROKEAHA.116.013146; Connor David E Jr, 2017, Pathophysiology, V24, P169, DOI 10.1016/j.pathophys.2017.04.003; Gan Y, 2012, ANTIOXID REDOX SIGN, V17, P719, DOI 10.1089/ars.2011.4298; Garcia-Bonilla L, 2012, NAT MED, V18, P858, DOI 10.1038/nm.2797; Gules I, 2003, ACT NEUR S, V86, P483; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Kamalvand G, 2003, AMYLOID, V10, P151, DOI 10.3109/13506120308998997; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Leak RK, 2013, STROKE, V44, P1124, DOI 10.1161/STROKEAHA.111.680157; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Li W, 2014, MOL NEUROBIOL, V49, P187, DOI 10.1007/s12035-013-8509-4; Liu CX, 2012, NAT CHEM BIOL, V8, P486, DOI [10.1038/NCHEMBIO.935, 10.1038/nchembio.935]; Liu DL, 2016, INT IMMUNOPHARMACOL, V41, P82, DOI 10.1016/j.intimp.2016.10.025; Lu Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1118-4; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Muchowicz A, 2014, BIOCHEM PHARMACOL, V89, P210, DOI 10.1016/j.bcp.2014.02.022; Park MH, 2016, PHARMACOL THERAPEUT, V163, P1, DOI 10.1016/j.pharmthera.2016.03.018; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Shichita T, 2017, NAT MED, V23, P723, DOI 10.1038/nm.4312; Shichita T, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00319; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Soethoudt M, 2014, FREE RADICAL BIO MED, V77, P331, DOI 10.1016/j.freeradbiomed.2014.09.025; Stolzing A, 2004, FASEB J, V18, P743, DOI 10.1096/fj.03-0374fje; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang Feng, 2009, P187, DOI 10.1007/978-1-60327-185-1_15; Zhang M, 2015, ONCOL LETT, V10, P1841, DOI 10.3892/ol.2015.3424; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	37	32	35	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3051	3062		10.1096/fj.201801150R	http://dx.doi.org/10.1096/fj.201801150R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30351993	Bronze			2022-12-28	WOS:000457296600120
J	Wu, LW; Chen, WL; Huang, SM; Chan, JYH				Wu, Li-Wei; Chen, Wei-Liang; Huang, Shih-Ming; Chan, James Yi-Hsin			Platelet-derived growth factor-AA is a substantial factor in the ability of adipose-derived stem cells and endothelial progenitor cells to enhance wound healing	FASEB JOURNAL			English	Article						mesenchymal stem cells; PDGF; growth factor; nitric oxide; angiogenesis	NITRIC-OXIDE; SYNTHASE GENE; PIVOTAL ROLE; TISSUE; ANGIOGENESIS; EXPRESSION; ISCHEMIA; PDGF	Nonhealing wounds with various forms of complications have been a major challenge for patients with different diseases, and few data are available regarding the clinical significance of platelet-derived growth factor-AA (PDGF-AA) in the enhanced wound healing with stem cells, and the precise molecular mechanism remains unclear. The study aims to investigate the role of PDGF-AA in adipose-derived stem cells (ASCs) and endothelial progenitor cells (EPCs) enhancing wound healing. In this study, ASCs and EPCs were applied to treat wounds in an animal wound model with a wound-healing assay. We knocked down PDGF-AA expression in ASCs using the PDGF-AA short hairpin RNA technique and investigated the related molecular mechanism. The wound model and wound-healing assay of the study showed that transplantation of ASCs could enhance wound healing. The results showed that the PDGF-AA knockdown ASC group had much less improvement of wound healing than other groups treated with wild-type ASCs in wound tissues. The regulation of PDGF-AA in ASCs may contribute to improve wound healing through the PI3K/Akt/eNOS signaling pathway. The data indicated that PDGF-AA might play a vital role in ASCs and EPCs enhancing wound healing, possibly by its effects on angiogenesis. It would be a potential approach using PDGF-AA for clinical treatment of chronic wounds.Wu, L.-W., Chen, W.-L., Huang, S.-M., Chan, J. Y.-H. Platelet-derived growth factor AA is a substantial factor in the ability of adipose-derived stem cells and endothelial progenitor cells to enhance wound healing.	[Wu, Li-Wei; Chen, Wei-Liang; Huang, Shih-Ming; Chan, James Yi-Hsin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei 114, Taiwan; [Wu, Li-Wei; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Huang, Shih-Ming] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chan, James Yi-Hsin] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Wu, Li-Wei] Triserv Gen Hosp, Penghu Branch, Div Family Med, Taipei, Taiwan; [Wu, Li-Wei; Chen, Wei-Liang] Triserv Gen Hosp, Natl Def Med Ctr, Div Family Med, Taipei, Taiwan; [Wu, Li-Wei; Chen, Wei-Liang] Triserv Gen Hosp, Natl Def Med Ctr, Div Geriatr Med, Dept Family & Community Med, Taipei, Taiwan; [Wu, Li-Wei; Chan, James Yi-Hsin] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Chan, JYH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei 114, Taiwan.	bigmouth0825@gmail.com			Tri-Service General Hospital, National Defense Medical Center [TSGH-C106-153, TSGH-PH-106-3, TSGH-PH-107-4, TSGH-PH-108-13, MAB-106-039, MAB-107-043, MAB-108-069]	Tri-Service General Hospital, National Defense Medical Center	This study was supported, in part, by the following grants from the Tri-Service General Hospital, National Defense Medical Center: TSGH-C106-153, TSGH-PH-106-3, TSGH-PH-107-4, TSGH-PH-108-13, MAB-106-039, MAB-107-043, and MAB-108-069. The authors declare no conflicts of interest.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423; Bauer V, 2010, GEN PHYSIOL BIOPHYS, V29, P319, DOI 10.4149/gpb_2010_04_319; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Bouletreau PJ, 2002, PLAST RECONSTR SURG, V110, P139, DOI 10.1097/00006534-200207000-00025; Bueno-Beti C, 2013, J CELL MOL MED, V17, P1475, DOI 10.1111/jcmm.12133; Chen WL, 2017, ONCOTARGET, V8, P54115, DOI 10.18632/oncotarget.11132; Cherubino M, 2011, ANN PLAS SURG, V66, P210, DOI 10.1097/SAP.0b013e3181e6d06c; Dai NT, 2015, ANN PLAS SURG, V74, pS139, DOI 10.1097/SAP.0000000000000453; Guo XB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04153-2; Ha JM, 2016, KOREAN J PHYSIOL PHA, V20, P533, DOI 10.4196/kjpp.2016.20.5.533; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231; Hong SJ, 2011, ACTA OTO-LARYNGOL, V131, P1198, DOI 10.3109/00016489.2011.599816; Horikawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17948; Huang AF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-115; Huang SP, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-51; Huang SP, 2012, ANN PLAS SURG, V69, P656, DOI 10.1097/SAP.0b013e318273f909; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; Iwami Y, 2004, J CELL MOL MED, V8, P488, DOI 10.1111/j.1582-4934.2004.tb00473.x; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Katusic ZS, 2002, ARTERIOSCL THROM VAS, V22, P1254, DOI 10.1161/01.ATV.0000026860.08501.0F; Kawamoto A, 2001, CIRCULATION, V103, P634; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kim WS, 2015, HISTOL HISTOPATHOL, V30, P793, DOI 10.14670/HH-11-598; Lee SH, 2012, ANN DERMATOL, V24, P136, DOI 10.5021/ad.2012.24.2.136; Lee SH, 2011, ANN DERMATOL, V23, P150, DOI 10.5021/ad.2011.23.2.150; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; MacLauchlan S, 2011, P NATL ACAD SCI USA, V108, pE1137, DOI 10.1073/pnas.1104357108; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Namba T, 2003, CIRCULATION, V108, P2250, DOI 10.1161/01.CIR.0000093190.53478.78; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Song SH, 2012, J DERMATOL SCI, V66, P98, DOI 10.1016/j.jdermsci.2012.02.010; Wilson A, 2011, CELL PROLIFERAT, V44, P86, DOI 10.1111/j.1365-2184.2010.00736.x; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zhou KH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002202; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	42	26	28	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2388	2395		10.1096/fj.201800658R	http://dx.doi.org/10.1096/fj.201800658R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30265575				2022-12-28	WOS:000457296600068
J	Lu, H; Cherepanova, NA; Gilmore, R; Contessa, JN; Lehrman, MA				Lu, Hua; Cherepanova, Natalia A.; Gilmore, Reid; Contessa, Joseph N.; Lehrman, Mark A.			Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunction	FASEB JOURNAL			English	Article						glycobiology; glycosylation; glycoprotein; herpesvirus; lipid-linked oligosaccharide	ASPARAGINE-LINKED OLIGOSACCHARIDES; MEMBRANE-PROTEINS; N-GLYCOSYLATION; GLYCOPROTEIN-D; OLIGOSACCHARYLTRANSFERASE; 2-DEOXY-D-GLUCOSE; POLYPEPTIDES; FIBROBLASTS; INFECTIVITY; INHIBITION	Herpes simplex virus 1 (HSV-1) is a contagious neurotropic herpesvirus responsible for oral lesions and herpesviral encephalitis. The HSV-1 envelope contains N-glycosylated proteins involved in infection and that are candidate drug targets. NGI-1 is a small-molecule inhibitor of oligosaccharyltransferase (OST) complexes STT3A-OST and STT3B-OST, which catalyze cotranslational and post-translational N-glycosylation, respectively. Because host OSTs attach HSV-1 glycans, NGI-1 might have anti-HSV-1 activity. We evaluated HSV-1 function using NGI-1 and human embryonic kidney 293 knockout lines for OST isoform-specific catalytic and accessory subunits. N-glycosylation of 2 representative envelope proteins (gC and gD) was primarily dependent upon STT3A-OST, but to a large extent replaceable by STT3B-OST. Knockouts impairing STT3A- or STT3B-OST activity, by themselves, did not appreciably affect HSV-1 function (plaque-forming units, normalized to viral particles measured by unglycosylated capsid protein VP5 content). However, with cells lacking STT3B-OST activity (missing the catalytic subunit STT3B or the oxidoreductase subunits magnesium transporter 1/tumor suppressor candidate 3) and thus solely dependent upon STT3A-OST for N-glycosylation, NGI-1 treatment resulted in HSV-1 having cell type-dependent dysfunction (affecting infectivity with Vero cells much more than with the 293 lines). Ablation of post-translational N-glycosylation can therefore make HSV-1 infectivity, and possibly masking of immunogenic peptide epitopes by glycans, highly sensitive to pharmacological inhibition of cotranslational N-glycosylation.-Lu, H., Cherepanova, N. A., Gilmore, R., Contessa, J. N., Lehrman, M. A. Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunction.	[Lu, Hua; Lehrman, Mark A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd,Room ND9-300D, Dallas, TX 75390 USA; [Cherepanova, Natalia A.; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Biochem, Worcester, MA 01655 USA; [Contessa, Joseph N.] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA; [Contessa, Joseph N.] Yale Sch Med, Dept Pharmacol, New Haven, CT USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Worcester; Yale University; Yale University	Lehrman, MA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd,Room ND9-300D, Dallas, TX 75390 USA.	mark.lehrman@utsouthwestern.edu			U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01-GM038545, R01-GM043768, R01-GM127383]; NIH National Cancer Institute [R01-CA172391]; NATIONAL CANCER INSTITUTE [R01CA172391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043768, R01GM127383, R01GM038545] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants R01-GM038545 (to M.A.L.), R01-GM043768 (to R.G.), R01-GM127383 (to J.N.C.), and NIH National Cancer Institute Grant R01-CA172391 (to J.N.C.). Experiments with HSV-1 were performed with the oversight of the University of Texas Southwestern Medical Center Office of Safety and Business Continuity. J.N.C. has ownership interest (including stock, patents, etc.) in NGI-1. The remaining authors declare no other conflicts of interest.	Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Bagdonaite I, 2018, GLYCOBIOLOGY, V28, P443, DOI 10.1093/glycob/cwy021; Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784; Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; CAMPADELLIFIUME G, 1982, J VIROL, V43, P1061, DOI 10.1128/JVI.43.3.1061-1071.1982; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; COHEN GH, 1980, J VIROL, V36, P429, DOI 10.1128/JVI.36.2.429-439.1980; COMPTON T, 1984, J VIROL, V52, P630, DOI 10.1128/JVI.52.2.630-637.1984; COURTNEY RJ, 1973, VIROLOGY, V52, P447, DOI 10.1016/0042-6822(73)90340-1; Doores KJ, 2015, FEBS J, V282, P4679, DOI 10.1111/febs.13530; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Gao NG, 2013, GLYCOBIOLOGY, V23, P1111, DOI 10.1093/glycob/cwt067; Gao NG, 2011, MOL BIOL CELL, V22, P2994, DOI 10.1091/mbc.E11-04-0286; Gay A, 2015, BIOPHYS J, V108, P1459, DOI 10.1016/j.bpj.2015.02.008; JOHNSON DC, 1983, CELL, V32, P987, DOI 10.1016/0092-8674(83)90083-1; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; KNOWLES RW, 1976, J VIROL, V18, P644, DOI 10.1128/JVI.18.2.644-651.1976; KUHN JE, 1988, J GEN VIROL, V69, P2847, DOI 10.1099/0022-1317-69-11-2847; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lavie M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00910; LEHRMAN M A, 1991, Glycobiology, V1, P553, DOI 10.1093/glycob/1.6.553; Lin DL, 2017, MBIO, V8, DOI [10.1128/mbio.00939-17, 10.1128/mBio.00939-17]; Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194; Lu H, 2018, P NATL ACAD SCI USA, V115, P9557, DOI 10.1073/pnas.1806034115; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Merchan JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013699; Ng BG, 2018, TRENDS GENET, V34, P466, DOI 10.1016/j.tig.2018.03.002; PATTERSON SI, 1994, J CELL BIOL, V124, P521, DOI 10.1083/jcb.124.4.521; POUYSSEGUR J, 1977, CELL, V11, P941, DOI 10.1016/0092-8674(77)90305-1; Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054; Rider PJF, 2017, J VIROL, V91, DOI 10.1128/JVI.00873-17; Rinis N, 2018, CELL CHEM BIOL, V25, P1231, DOI 10.1016/j.chembiol.2018.07.005; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; Shrimal S, 2017, J CELL BIOL, V216, P3625, DOI 10.1083/jcb.201702159; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; SODORA DL, 1991, J VIROL, V65, P4424, DOI 10.1128/JVI.65.8.4424-4431.1991; SODORA DL, 1989, J VIROL, V63, P5184, DOI 10.1128/JVI.63.12.5184-5193.1989; SODORA DL, 1991, J VIROL, V65, P4432, DOI 10.1128/JVI.65.8.4432-4441.1991; SPEAR PG, 1976, J VIROL, V17, P991, DOI 10.1128/JVI.17.3.991-1008.1976; TALSINGER R, 1994, VIROLOGY, V202, P1050, DOI 10.1006/viro.1994.1437; TALSINGER R, 1995, J VIROL, V69, P4471, DOI 10.1128/JVI.69.7.4471-4483.1995; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; ZHU XY, 1992, J BIOL CHEM, V267, P8895	46	7	7	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6801	6812		10.1096/fj.201802044RR	http://dx.doi.org/10.1096/fj.201802044RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811219	Bronze, Green Published			2022-12-28	WOS:000476114200011
J	Oh, SH; Choi, SY; Choi, HJ; Ryu, HM; Kim, YJ; Jung, HY; Cho, JH; Kim, CD; Park, SH; Kwon, TH; Kim, YL				Oh, Se-Hyun; Choi, Soon-Youn; Choi, Hyo-Jung; Ryu, Hye-Myung; Kim, You-Jin; Jung, Hee-Yeon; Cho, Jang-Hee; Kim, Chan-Duck; Park, Sun-Hee; Kwon, Tae-Hwan; Kim, Yong-Lim			The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia	FASEB JOURNAL			English	Article						febuxostat; MEK; ERK; reactive oxygen species	OXIDATIVE STRESS; URIC-ACID; MAPK; HYDROETHIDINE; SUPEROXIDE; ACTIVATION; FLUORESCENCE; INFLAMMATION; CHOLESTEROL; AQUAPORIN-5	Hypercholesterolemia is reported to increase reactive oxygen species (ROS) and to promote breast cancer progression. ROS play an important role in tumor biology, and xanthine oxidase (XO) is an enzyme that generates ROS. The effects of febuxostat (FBX), an XO inhibitor, on breast cancer cell migration under LDL stimulation in vitro and metastasis of breast cancer associated with hypercholesterolemia in vivo were studied. In vitro, FBX significantly inhibited LDL-induced ROS production and cell migration. Treatment of small interfering RNA against XO was consistent with the findings of FBX treatment. In vivo, a significant increase of tumor growth and pulmonary metastasis was observed in a xenograft mouse model with 4T1 cells on a high cholesterol diet (HCD), both of which were markedly inhibited by FBX or allopurinol treatment. Moreover, ERK represented the main target-signaling pathway that was affected by FBX treatment in a xenograft mouse model on an HCD evaluated by NanoString nCounter analysis. Consistently, MEK/ERK inhibitors directly decreased the LDL-induced cell migration in vitro. In conclusion, FBX mitigates breast cancer cell migration and pulmonary metastasis in the hyperlipidemic condition, associated with decreased ROS generation and MAPK phosphorylation. The inhibition of ERK pathways is likely to underlie the XO inhibitor-mediated suppression of breast cancer cell migration.-Oh, S.-H., Choi, S.-Y., Choi, H.-J., Ryu, H.-M., Kim, Y.-J., Jung, H.-Y., Cho, J.-H., Kim, C.-D., Park, S.-H., Kwon, T.-H., Kim, Y.-L. The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia.	[Oh, Se-Hyun; Choi, Soon-Youn; Ryu, Hye-Myung; Kim, You-Jin; Jung, Hee-Yeon; Cho, Jang-Hee; Kim, Chan-Duck; Park, Sun-Hee; Kwon, Tae-Hwan; Kim, Yong-Lim] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Oh, Se-Hyun; Choi, Hyo-Jung; Kim, You-Jin] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Sch Med, Daegu, South Korea; [Choi, Soon-Youn; Kwon, Tae-Hwan; Kim, Yong-Lim] Kyungpook Natl Univ, Dept Biomed Sci, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Kwon, TH (corresponding author), Kyungpook Natl Univ, Sch Med, Dongin Long 101, Daegu 41944, South Korea.; Kim, YL (corresponding author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, 50 Samduk Dong 2Ga, Daegu 41940, South Korea.	thkwon@knu.ac.kr; ylkim@knu.ac.kr	Choi, Soon Youn/AHC-8865-2022; Kwon, Tae-Hwan/ABA-1981-2020; Cho, Jang-hee/ABD-3534-2020; Park, Sun/GSD-9620-2022	Cho, Jang-hee/0000-0002-7031-5214; 	Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute (KHIDI) [HI15C0001, HC15C1129]; National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology (ICT) and Future Planning [2014R1A5A2009242, 2017R1A2B2005849]	Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute (KHIDI); National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology (ICT) and Future Planning	This study was supported by a grant from the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute (KHIDI) (HI15C0001, HC15C1129) and by the National Research Foundation of Korea (NRF), which is funded by the Ministry of Science, Information and Communications Technology (ICT) and Future Planning (2014R1A5A2009242, 2017R1A2B2005849). The authors declare no conflicts of interest.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Balamurugan K, 2016, INT J CANCER, V138, P1058, DOI 10.1002/ijc.29519; Benov L, 1998, FREE RADICAL BIO MED, V25, P826, DOI 10.1016/S0891-5849(98)00163-4; Bocca C, 2007, J NUTR BIOCHEM, V18, P332, DOI 10.1016/j.jnutbio.2006.07.001; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Choi HJ, 2015, AM J PHYSIOL-RENAL, V308, pF737, DOI 10.1152/ajprenal.00376.2014; Dandona P, 2007, J HYPERTENS, V25, P731, DOI 10.1097/HJH.0b013e3280127948; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Direito I, 2016, CELL MOL LIFE SCI, V73, P1623, DOI 10.1007/s00018-016-2142-0; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; El-Bassossy HM, 2015, TRANSL RES, V165, P621, DOI 10.1016/j.trsl.2014.11.008; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Gwinner W, 2006, KIDNEY INT, V69, P481, DOI 10.1038/sj.ki.5000121; Hartney T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027531; Honorat JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071329; Jensen HH, 2016, INT J BIOCHEM CELL B, V79, P271, DOI 10.1016/j.biocel.2016.09.005; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kachroo A, 2014, BRAIN RES, V1563, P103, DOI 10.1016/j.brainres.2014.03.031; Kataoka H, 2015, EUR J PHARMACOL, V746, P174, DOI 10.1016/j.ejphar.2014.11.013; Kaushik N, 2015, SCI REP-UK, V5, DOI 10.1038/srep08587; Kim EJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2927; Kong XJ, 2017, NATURE, V550, P270, DOI 10.1038/nature24037; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Kotepui M, 2016, WSPOLCZESNA ONKOL, V20, P13, DOI 10.5114/wo.2014.40560; Krishnamurthy B, 2015, CHEM-BIOL INTERACT, V237, P96, DOI 10.1016/j.cbi.2015.05.013; Kruk J, 2014, ASIAN PAC J CANCER P, V15, P9579, DOI 10.7314/APJCP.2014.15.22.9579; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Lee SH, 2016, J FOOD DRUG ANAL, V24, P855, DOI 10.1016/j.jfda.2016.03.010; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031; Nomura J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04554; Nomura J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075527; Park SH, 2007, J AM SOC NEPHROL, V18, P1497, DOI 10.1681/ASN.2005080866; Reczek CR, 2017, ANNU REV CANC BIOL, V1, P79, DOI 10.1146/annurev-cancerbio-041916-065808; Romagnali M, 2010, FREE RADICAL BIO MED, V49, P171, DOI 10.1016/j.freeradbiomed.2010.03.024; Schwartz MA, 2001, J CELL SCI, V114, P2553; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang CH, 2017, CELL PHYSIOL BIOCHEM, V42, P729, DOI 10.1159/000477890; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Wu AH, 2009, AM J CLIN NUTR, V89, P1145, DOI 10.3945/ajcn.2008.26915; Zhang Y, 2014, CELL TISSUE RES, V358, P633, DOI 10.1007/s00441-014-2010-x; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	49	20	20	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7301	7314		10.1096/fj.201802415RR	http://dx.doi.org/10.1096/fj.201802415RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30860872	Bronze			2022-12-28	WOS:000476114200052
J	Sun, QK; He, QF; Xu, JB; Liu, QY; Lu, YJ; Zhang, ZC; Xu, XL; Sun, BC				Sun, Qikai; He, Qifeng; Xu, Jianbo; Liu, Qiaoyu; Lu, Yijun; Zhang, Zechuan; Xu, Xiaoliang; Sun, Beicheng			Guanine nucleotide-binding protein G(i)alpha 2 aggravates hepatic ischemia-reperfusion injury in mice by regulating MLK3 signaling	FASEB JOURNAL			English	Article						GNAI2; liver I; R; cell death; inflammation	LIVER ISCHEMIA; KAPPA-B; ACTIVATION; KINASE; LYMPHOCYTES; INVOLVEMENT; G-ALPHA(I2); INHIBITOR; GENE	Hepatic ischemia-reperfusion (I/R) injury is a major challenge in liver resection and transplantation surgeries. Previous studies have revealed that guanine nucleotide-binding protein G(i)alpha 2 (GNAI2) was involved in the progression of myocardial and cerebral I/R injury, but the role and function of GNAI2 in hepatic I/R have not been elucidated. The hepatocyte-specific GNAI2 knockout (GNAI2(hep-/-)) mice were generated and subjected to hepatic I/R injury. Primary hepatocytes isolated from GNAI2(hep-/-) and GNAI2(flox/flox) mice were cultured and challenged to hypoxia-reoxygenation insult. The specific function of GNAI2 in I/R-triggered hepatic injury and the underlying molecular mechanism were explored by various phenotypic analyses and molecular biology methods. In this study, we demonstrated that hepatic GNAI2 expression was significantly increased in liver transplantation patients and wild-type mice after hepatic I/R. Interestingly, hepatocyte-specific GNAI2 deficiency attenuated I/R-induced liver damage, inflammation cytokine expression, macrophage/neutrophil infiltration, and hepatocyte apoptosis in vivo and in vitro. Mechanistically, up-regulation of GNAI2 phosphorylates mixed-lineage protein kinase 3 (MLK3) through direct binding, which exacerbated hepatic I/R damage via MAPK and NF-kappa B pathway activation. Furthermore, blocking MLK3 signaling reversed GNAI2-mediated hepatic I/R injury. Our study firstly identifies GNAI2 as a promising target for prevention of hepatic I/R-induced injury and related liver diseases.-Sun, Q., He, Q., Xu, J., Liu, Q., Lu, Y., Zhang, Z., Xu, X., Sun, B. Guanine nucleotide-binding protein G(i)alpha 2 aggravates hepatic ischemia-reperfusion injury in mice by regulating MLK3 signaling.	[Sun, Qikai; He, Qifeng; Xu, Jianbo; Lu, Yijun; Zhang, Zechuan; Sun, Beicheng] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Sun, Qikai; He, Qifeng; Xu, Jianbo; Liu, Qiaoyu; Lu, Yijun; Zhang, Zechuan; Xu, Xiaoliang; Sun, Beicheng] Nanjing Med Univ, Clin Coll, Dept Hepatobiliary Surg, Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Qikai; He, Qifeng; Xu, Jianbo; Liu, Qiaoyu; Lu, Yijun; Zhang, Zechuan; Xu, Xiaoliang; Sun, Beicheng] Nanjing Univ, Med Sch, Dept Hepatobiliary Surg, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University; Nanjing University	Sun, BC (corresponding author), Nanjing Med Univ, Clin Coll, Dept Hepatobiliary Surg, Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	sunbc@nju.edu.cn			National Key Research and Development Program of China [2016YFC0905900]; National Natural Science Foundation of China [81430062]; Innovative Research Groups of the National Natural Science Foundation [81521004]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Groups of the National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Key Research and Development Program of China (2016YFC0905900), The State Key Program of National Natural Science Foundation of China (81430062), and the Innovative Research Groups of the National Natural Science Foundation (81521004 to B.S.). The authors declare no conflicts of interest.	Arinze IJ, 2005, J BIOL CHEM, V280, P9786, DOI 10.1074/jbc.M414006200; Boularan C, 2015, J IMMUNOL, V195, P2090, DOI 10.4049/jimmunol.1500523; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Devanathan V, 2015, P NATL ACAD SCI USA, V112, P6491, DOI 10.1073/pnas.1505887112; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Hamada N, 2017, J NEUROCHEM, V140, P82, DOI 10.1111/jnc.13878; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hou JJ, 2014, J HEPATOL, V60, P306, DOI 10.1016/j.jhep.2013.09.028; Hwang IY, 2007, J IMMUNOL, V179, P439, DOI 10.4049/jimmunol.179.1.439; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Marker DF, 2013, J NEUROSCI, V33, P9998, DOI 10.1523/JNEUROSCI.0598-13.2013; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Nastos C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/906965; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Ng PWP, 2001, ONCOGENE, V20, P4484, DOI 10.1038/sj.onc.1204513; Nieuwenhuijs VB, 2006, DIGEST DIS SCI, V51, P1087, DOI 10.1007/s10620-006-8014-y; Ogden SK, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad0353; Ojetti V, 2003, DIGEST LIVER DIS, V35, P309, DOI 10.1016/S1590-8658(03)00073-2; Plummer NW, 2012, P NATL ACAD SCI USA, V109, P21366, DOI 10.1073/pnas.1219810110; Rattanasinchai C, 2016, CANCERS, V8, DOI 10.3390/cancers8050051; Sakai N, 2012, HEPATOLOGY, V55, P888, DOI 10.1002/hep.24756; Satsangi J, 2000, GASTROENTEROLOGY, V118, pA336, DOI 10.1016/S0016-5085(00)83442-3; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Song T, 2015, AM J TRANSL RES, V7, P2786; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; Uehara T, 2005, J HEPATOL, V42, P850, DOI 10.1016/j.jhep.2005.01.030; Wang D, 2003, TRANSPLANT P, V35, P3134, DOI 10.1016/j.transproceed.2003.10.021; Waterson RE, 2011, CARDIOVASC RES, V91, P45, DOI 10.1093/cvr/cvr054; Wiege K, 2012, J IMMUNOL, V189, P980, DOI 10.4049/jimmunol.1200891; Yamauchi J, 2000, J BIOL CHEM, V275, P7633, DOI 10.1074/jbc.275.11.7633; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yue S, 2016, HEPATOLOGY, V64, P1683, DOI 10.1002/hep.28739; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhao J, 2007, CELL SIGNAL, V19, P831, DOI 10.1016/j.cellsig.2006.10.006; Zhong M, 2012, MOL CANCER RES, V10, P1380, DOI 10.1158/1541-7786.MCR-12-0219	38	6	6	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7049	7060		10.1096/fj.201802462R	http://dx.doi.org/10.1096/fj.201802462R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30840837				2022-12-28	WOS:000476114200031
J	Andrews, D; Oliviero, G; De Chiara, L; Watson, A; Rochford, E; Wynne, K; Kennedy, C; Clerkin, S; Doyle, B; Godson, C; Connell, P; O'Brien, C; Cagney, G; Crean, J				Andrews, Darrell; Oliviero, Giorgio; De Chiara, Letizia; Watson, Ariane; Rochford, Emily; Wynne, Kieran; Kennedy, Ciaran; Clerkin, Shane; Doyle, Benjamin; Godson, Catherine; Connell, Paul; O'Brien, Colm; Cagney, Gerard; Crean, John			Unravelling the transcriptional responses of TGF-: Smad3 and EZH2 constitute a regulatory switch that controls neuroretinal epithelial cell fate specification	FASEB JOURNAL			English	Article						PRC2; differentiation; chromatin; interactome	REPRESSIVE COMPLEX 2; E-CADHERIN; DEVELOPMENTAL GENES; GENOME-WIDE; BETA; EXPRESSION; METHYLATION; CHROMATIN; REVEALS; SNAIL	Cell differentiation is directed by extracellular cues and intrinsic epigenetic modifications, which control chromatin organization and transcriptional activation. Central to this process is PRC2, which modulates the di- and trimethylation of lysine 27 on histone 3; however, little is known concerning the direction of PRC2 to specific loci. Here, we have investigated the physical interactome of EZH2, the enzymatic core of PRC2, during retinoic acid-mediated differentiation of neuroepithelial, pluripotent NT2 cells and the dedifferentiation of neuroretinal epithelial ARPE19 cells in response to TGF-. We identified Smad3 as an EZH2 interactor in both contexts. Co-occupation of the CDH1 promoter by Smad3 and EZH2 and the cooperative, functional nature of the interaction were established. We propose that the interaction between Smad3 and EZH2 targets the core polycomb assembly to defined regions of the genome to regulate transcriptional repression and forms a molecular switch that controls promoter access through epigenetic mechanisms leading to gene silencing.Andrews, D., Oliviero, G., De Chiara, L., Watson, A., Rochford, E., Wynne, K., Kennedy, C., Clerkin, S., Doyle, B., Godson, C., Connell, P., O'Brien, C., Cagney, G., Crean, J. Unravelling the transcriptional responses of TGF-: Smad3 and EZH2 constitute a regulatory switch that controls neuroretinal epithelial cell fate specification.	[Andrews, Darrell; Kennedy, Ciaran; Clerkin, Shane; Godson, Catherine; Crean, John] Univ Coll Dublin, Diabet Complicat Res Ctr, Dublin, Ireland; [Rochford, Emily; Wynne, Kieran; Kennedy, Ciaran; Clerkin, Shane; Doyle, Benjamin; Cagney, Gerard; Crean, John] Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst Biomol & Biomed Sci, Dublin, Ireland; [Andrews, Darrell; Godson, Catherine; Connell, Paul; O'Brien, Colm] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin, Ireland; [Oliviero, Giorgio] Univ Coll Dublin, Natl Inst Bioproc Res & Training, Dublin, Ireland; [Watson, Ariane] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland; [De Chiara, Letizia] Univ Florence, Ctr Eccellenza DeNothe, Dept Biomed Expt & Clin Sci, Florence, Italy; [Connell, Paul; O'Brien, Colm] Mater Misericordiae Univ Hosp, Dept Ophthalmol, Dublin, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin; University College Dublin; University of Florence; Mater Misericordiae University Hospital; University College Dublin	Crean, J (corresponding author), Univ Coll Dublin, Diabet Complicat Res Ctr, UCD Sch Biomol & Biomed Sci, Conway Inst Biomol & Biomed Sci, Dublin 4, Ireland.	john.crean@ucd.ie	De Chiara, Letizia/AAK-1209-2021	De Chiara, Letizia/0000-0002-8548-2031; Watson, Ariane/0000-0002-1969-0190; /0000-0002-4337-6177; Godson, Catherine/0000-0003-0655-1041; WYNNE, KIERAN/0000-0001-5759-5285; Kennedy, Ciaran/0000-0003-1967-8754	Science Foundation Ireland (SFI); Irish Research Council (IRC); Fighting Blindness Foundation	Science Foundation Ireland (SFI)(Science Foundation Ireland); Irish Research Council (IRC)(Irish Research Council for Science, Engineering and Technology); Fighting Blindness Foundation	The authors acknowledge the help of the University College Dublin (UCD) Conway Genomics and Proteomics Core Facilities. The authors also acknowledge Dr. Adrian Bracken (Trinity College Dublin), for the kind gift of EZH2 antibody for coimmunoprecipitation experiments. This study was supported by Science Foundation Ireland (SFI), the Irish Research Council (IRC), and the Fighting Blindness Foundation. The authors declare no conflicts of interest.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bertero A, 2018, NATURE, V555, P256, DOI 10.1038/nature25784; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Casari A, 2014, DEV BIOL, V396, P81, DOI 10.1016/j.ydbio.2014.09.025; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; De Chiara L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42407; De Chiara Letizia, 2017, Sci Rep, V7, P46802, DOI 10.1038/srep46802; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Du D, 2018, EMBO REP, V19, P135, DOI 10.15252/embr.201744250; Estaras C, 2012, DEVELOPMENT, V139, P2681, DOI 10.1242/dev.078345; Faherty N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-525; Faherty N, 2012, J CELL SCI, V125, P5621, DOI 10.1242/jcs.105528; Feller C, 2015, MOL CELL, V57, P559, DOI 10.1016/j.molcel.2014.12.008; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Heninger Anne-Kristin, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4824; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Jesus ABD, 2009, CELL CYCLE, V8, P394; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kloet SL, 2016, NAT STRUCT MOL BIOL, V23, P682, DOI 10.1038/nsmb.3248; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lin Y., 2014, CURR PHARM DEDS, V20, P1968; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21602; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Monteiro R, 2016, DEV CELL, V38, P358, DOI 10.1016/j.devcel.2016.06.024; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Oliviero G, 2016, MOL CELL PROTEOMICS, V15, P3450, DOI 10.1074/mcp.M116.062240; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tien CL, 2015, DEVELOPMENT, V142, P722, DOI 10.1242/dev.111997; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Yoon SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7546; Yoshitake Y, 1999, DEV BIOL, V215, P375, DOI 10.1006/dbio.1999.9473; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	48	6	6	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6667	6681		10.1096/fj.201800566RR	http://dx.doi.org/10.1096/fj.201800566RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30779601				2022-12-28	WOS:000466932600068
J	Cazzaniga, A; Locatelli, L; Castiglioni, S; Maier, JAM				Cazzaniga, Alessandra; Locatelli, Laura; Castiglioni, Sara; Maier, Jeanette A. M.			The dynamic adaptation of primary human endothelial cells to simulated microgravity	FASEB JOURNAL			English	Article						HUVEC; RWV; stress response	THIOREDOXIN-INTERACTING PROTEIN; OXIDATIVE STRESS; NITRIC-OXIDE; GENE-EXPRESSION; CYTOSKELETON; IMPACT; GROWTH; EXPOSURE	Culture of human endothelial cells for 10 d in real microgravity onboard the International Space Station modulated more than 1000 genes, some of which are involved in stress response. On Earth, 24 h after exposure to simulated microgravity, endothelial cells up-regulate heat shock protein (HSP) 70. To capture a broad view of endothelial stress response to gravitational unloading, we cultured primary human endothelial cells for 4 and 10 d in the rotating wall vessel, a U.S. National Aeronautics and Space Administration-developed surrogate system for benchtop microgravity research on Earth. We highlight the crucial role of the early increase of HSP70 because its silencing markedly impairs cell survival. Once HSP70 up-regulation fades away after 4 d of simulated microgravity, a complex and articulated increase of various stress proteins (sirtuin 2, paraoxonase 2, superoxide dismutase 2, p21, HSP27, and phosphorylated HSP27, all endowed with cytoprotective properties) occurs and counterbalances the up-regulation of the pro-oxidant thioredoxin interacting protein (TXNIP). Interestingly, TXNIP was the most overexpressed transcript in endothelial cells after spaceflight. We conclude that HSP70 up-regulation sustains the initial adaptive response of endothelial cells to mechanical unloading and drives them toward the acquisition of a novel phenotype that maintains cell viability and function through the sequential involvement of different stress proteins.Cazzaniga, A., Locatelli, L., Castiglioni, S., Maier, J. A. M. The dynamic adaptation of primary human endothelial cells to simulated microgravity.	[Cazzaniga, Alessandra; Locatelli, Laura; Castiglioni, Sara; Maier, Jeanette A. M.] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Via GB Grassi 74, I-20157 Milan, Italy	University of Milan	Maier, JAM (corresponding author), Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Via GB Grassi 74, I-20157 Milan, Italy.	jeanette.maier@unimi.it	LOCATELLI, LAURA/AAP-4110-2021; castiglioni, sara/H-9289-2012	LOCATELLI, LAURA/0000-0002-4568-7825; Cazzaniga, Alessandra/0000-0001-7153-2256; castiglioni, sara/0000-0002-8785-9891	Italian Space Agency	Italian Space Agency(Agenzia Spaziale Italiana (ASI))	This work was supported, in part, by the Italian Space Agency [Coculture of Endothelial Cells and Osteoblast in Space: Effects on Osteoblast Activity (ENDOSTEO) Project]. The authors declare no conflict of interest.	Afolayan AJ, 2014, AM J PHYSIOL-LUNG C, V306, pL351, DOI 10.1152/ajplung.00264.2013; Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Aubert AE, 2005, ACTA CARDIOL, V60, P129, DOI 10.2143/AC.60.2.2005024; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Baratchi S, 2017, TRENDS MOL MED, V23, P850, DOI 10.1016/j.molmed.2017.07.007; Beck M, 2014, INT J MOL MED, V34, P606, DOI 10.3892/ijmm.2014.1785; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Castiglioni S, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7060124; Castiglioni S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16538; Cazzaniga A, 2016, BIOCHEM BIOPH RES CO, V473, P181, DOI 10.1016/j.bbrc.2016.03.075; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; Cotrupi S, 2005, BBA-MOL CELL RES, V1746, P163, DOI 10.1016/j.bbamcr.2005.10.002; DeBalsi KL, 2014, J BIOL CHEM, V289, P8106, DOI 10.1074/jbc.M113.511535; Dejeans N, 2010, GENES NUTR, V5, P263, DOI 10.1007/s12263-010-0166-x; Demontis GC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00547; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Griffoni C, 2011, J CELL BIOCHEM, V112, P265, DOI 10.1002/jcb.22921; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hatton JP, 1999, FASEB J, V13, pS23, DOI 10.1096/fasebj.13.9001.s23; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Janmaleki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32418; Kapitonova M Y, 2012, Malays J Pathol, V34, P103; Kapitonova MY, 2013, B EXP BIOL MED+, V154, P796, DOI 10.1007/s10517-013-2059-7; Lane T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00050; Leidi M, 2010, EUR J CELL BIOL, V89, P654, DOI 10.1016/j.ejcb.2010.05.001; Liu JN, 2013, INT J MOL SCI, V14, P5633, DOI 10.3390/ijms14035633; Liu Yongqing, 2008, Genomics Proteomics & Bioinformatics, V6, P29, DOI 10.1016/S1672-0229(08)60018-2; Maier JAM, 2006, INT J IMMUNOPATH PH, V19, P279, DOI 10.1177/039463200601900205; Maier JAM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/434803; Mariotti M, 2009, MICROGRAVITY SCI TEC, V21, P141, DOI 10.1007/s12217-008-9066-8; Mariotti M, 2008, J CELL BIOCHEM, V104, P129, DOI 10.1002/jcb.21605; Najrana T, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00140; Quinta HR, 2011, CELL SIGNAL, V23, P1907, DOI 10.1016/j.cellsig.2011.07.023; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Risso A, 2005, PROTEOMICS, V5, P1827, DOI 10.1002/pmic.200401082; Spindel ON, 2014, CIRC RES, V114, P1125, DOI 10.1161/CIRCRESAHA.114.301315; Spindel ON, 2012, ARTERIOSCL THROM VAS, V32, P1264, DOI 10.1161/ATVBAHA.111.244681; Sun HB, 2015, BIOCHEM BIOPH RES CO, V463, P377, DOI 10.1016/j.bbrc.2015.04.152; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Vidyasagar A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-7; Wang JH, 2009, NEUROCHEM INT, V55, P710, DOI 10.1016/j.neuint.2009.07.002; Yee A, 2008, ANN BIOMED ENG, V36, P571, DOI 10.1007/s10439-008-9452-9	44	19	20	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5957	5966		10.1096/fj.201801586RR	http://dx.doi.org/10.1096/fj.201801586RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817172	Green Submitted, Bronze			2022-12-28	WOS:000466932600013
J	Kim, AR; Park, JI; Oh, HT; Kim, KM; Hwang, JH; Jeong, MG; Kim, EH; Hwang, ES; Hong, JH				Kim, A. Rum; Park, Jung Il; Oh, Ho Taek; Kim, Kyung Mm; Hwang, Jun-Ha; Jeong, Mi Gyeong; Kim, Ee-Hyun; Hwang, Eun Sook; Hong, Jeong-Ho			TAZ stimulates liver regeneration through interleukin-6-induced hepatocyte proliferation and inhibition of cell death after liver injury	FASEB JOURNAL			English	Article						CCl4; fibrogenesis; cytokine; partial hepatectomy	ORGAN SIZE CONTROL; NF-KAPPA-B; TISSUE HOMEOSTASIS; SIGNALING PATHWAY; HIPPO/YAP PATHWAY; RAPID ACTIVATION; DNA-SYNTHESIS; STAT3; GROWTH; PROGRESSION	In response to liver injury, the liver undergoes a regeneration process to retain its mass and function. However, the regeneration mechanism has not been fully clarified. This study investigated the role of transcriptional coactivator with PDZ-binding motif (TAZ), a Hippo-signaling effector, in liver regeneration. We observed that TAZ stimulates liver regeneration after liver injury. After partial hepatectomy (PHx) or carbon tetrachloride damage, TAZ was required for liver regeneration to increase hepatic cell proliferation and resist hepatic apoptosis, which were decreased in liver-specific TAZ knockout (LKO) mice. TAZ stimulated macrophage infiltration, resulting in IL-6 production, which induced liver regeneration. In LKO mice, IL-6-induced activation of signal transducer and activator of transcription 3, ERK, and PKB was decreased. We also observed that periductal fibrogenesis was significantly increased in LKO mice during liver regeneration after PHx, which was caused by increased hepatic apoptosis. Our results suggest that TAZ stimulates liver regeneration through IL-6-induced hepatocyte proliferation and inhibition of cell death after liver injury.Kim, A. R., Park, J. I., Oh, H. T., Kim, K. M., Hwang, J.-H., Jeong, M. G., Kim, E.-H., Hwang, E. S., Hong, J.-H. TAZ stimulates liver regeneration through interleukin-6-induced hepatocyte proliferation and inhibition of cell death after liver injury.	[Kim, A. Rum; Park, Jung Il; Oh, Ho Taek; Kim, Kyung Mm; Hwang, Jun-Ha; Hong, Jeong-Ho] Korea Univ, Sch Life Sci & Biotechnol, Dept Life Sci, 145 Anam Ro, Seoul 02841, South Korea; [Jeong, Mi Gyeong; Kim, Ee-Hyun; Hwang, Eun Sook] Ewha Womans Univ, Coll Pharm, Seoul, South Korea	Korea University; Ewha Womans University	Hwang, ES; Hong, JH (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Dept Life Sci, 145 Anam Ro, Seoul 02841, South Korea.	eshwang@ewha.ac.kr; jh_hong@korea.ac.kr			National Research Foundation of Korea (NRF) grants - Korean government [2015R1A5A1009024, 2017R1D1A1B03034651, 2018R1A5A2025286]; Korea Basic Science Institute [C39531]; Korea University	National Research Foundation of Korea (NRF) grants - Korean government; Korea Basic Science Institute; Korea University	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean government (2015R1A5A1009024, 2017R1D1A1B03034651, and 2018R1A5A2025286). This work was also supported by the Korea Basic Science Institute (C39531), and a grant from Korea University. The authors declare no conflict of interests.	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769; Bansal MB, 2005, J HEPATOL, V42, P548, DOI 10.1016/j.jhep.2004.11.043; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Byun MR, 2017, CANCER LETT, V410, P32, DOI 10.1016/j.canlet.2017.09.003; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97; Grijalva JL, 2014, AM J PHYSIOL-GASTR L, V307, pG196, DOI 10.1152/ajpgi.00077.2014; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Higgins GM, 1931, ARCH PATHOL, V12, P186; Ichikawa T, 2001, HEPATOLOGY, V34, P918, DOI 10.1053/jhep.2001.29132; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Lee CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03956-7; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Moh A, 2007, LAB INVEST, V87, P1018, DOI 10.1038/labinvest.3700630; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Preisegger KH, 1999, LAB INVEST, V79, P103; Rechnagel R O, 1973, CRC Crit Rev Toxicol, V2, P263, DOI 10.3109/10408447309082019; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Su T, 2015, ELIFE, V4, DOI 10.7554/eLife.02948; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Yi J, 2016, HEPATOLOGY, V64, P1757, DOI 10.1002/hep.28768; Yimlamai D, 2015, J HEPATOL, V63, P1491, DOI 10.1016/j.jhep.2015.07.008; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang WJ, 2015, CANCER RES, V75, P4450, DOI 10.1158/0008-5472.CAN-14-3396; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	50	18	19	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5914	5923		10.1096/fj.201801256RR	http://dx.doi.org/10.1096/fj.201801256RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30742777	Bronze			2022-12-28	WOS:000466932600010
J	Li, JM; Kang, F; Gong, XS; Bai, Y; Dai, JJ; Zhao, CR; Dou, C; Cao, Z; Liang, MM; Dong, R; Jiang, H; Yang, XC; Dong, SW				Li, Jianmei; Kang, Fei; Gong, Xiaoshan; Bai, Yun; Dai, Jingjin; Zhao, Chunrong; Dou, Ce; Cao, Zhen; Liang, Mengmeng; Dong, Rui; Jiang, Hong; Yang, Xiaochao; Dong, Shiwu			Ceria nanoparticles enhance endochondral ossification-based critical-sized bone defect regeneration by promoting the hypertrophic differentiation of BMSCs via DHX15 activation	FASEB JOURNAL			English	Article						endochondral bone formation; bone regeneration; cerium oxide	MESENCHYMAL STEM-CELLS; CHONDROGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; GROWTH; P38; VASCULARIZATION; DEGRADATION; CANCER; MMP13	Central ischemic necrosis is one of the biggest obstacles in the clinical application of traditional tissue-engineered bone (TEB) in critical-sized bone defect regeneration. Because of its ability to promote vascular invasion, endochondral ossification-based TEB has been applied for bone defect regeneration. However, inadequate chondrocyte hypertrophy can hinder vascular invasion and matrix mineralization during endochondral ossification. In light of recent studies suggesting that ceria nanoparticles (CNPs) improve the blood vessel distribution within TEB, we modified TEB scaffold surfaces with CNPs and investigated the effect and mechanism of CNPs on endochondral ossification-based bone regeneration. The CNPs used in this study were synthesized by the microemulsion method and modified with alendronate-anchored polyethylene glycol 600. We showed that CNPs accelerated new bone formation and enhanced endochondral ossification-based bone regeneration in both a subcutaneous ectopic osteogenesis model and a mouse model of critical-sized bone defects. Mechanistically, CNPs significantly promoted endochondral ossification-based bone regeneration by ensuring sufficient hypertrophic differentiation via the activation of the RNA helicase, DEAH (Asp-Glu-Ala-His) box helicase 15, and its downstream target, p38 MAPK. These results suggested that CNPs could be applied as a biomaterial to improve the efficacy of endochondral ossification-based bone regeneration in critical-sized bone defects.Li, J., Kang, F., Gong, X., Bai, Y., Dai, J., Zhao, C., Dou, C., Cao, Z., Liang, M., Dong, R., Jiang, H., Yang, X., Dong, S. Ceria nanoparticles enhance endochondral ossification-based critical-sized bone defect regeneration by promoting the hypertrophic differentiation of BMSCs via DHX15 activation.	[Li, Jianmei; Kang, Fei; Gong, Xiaoshan; Bai, Yun; Dai, Jingjin; Zhao, Chunrong; Dou, Ce; Cao, Zhen; Liang, Mengmeng; Dong, Rui; Jiang, Hong; Yang, Xiaochao; Dong, Shiwu] Third Mil Med Univ, Sch Biomed Engn, Dept Biomed Mat Sci, Gaotanyan St 30, Chongqing 400038, Peoples R China; [Dong, Shiwu] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University; Army Medical University	Yang, XC; Dong, SW (corresponding author), Third Mil Med Univ, Sch Biomed Engn, Dept Biomed Mat Sci, Gaotanyan St 30, Chongqing 400038, Peoples R China.	xcyang@tmmu.edu.cn; dongshiwu@tmmu.edu.cn			National Key Technology Research and Development Program of China [2017YFC1103300]; Nature Science Foundation of China [31870962, 81471782]; Key Project of Logistics Research Plan of the People's Liberation Army [AWS17J004]; Innovation Funding of the Third Military Medical University [2018XYY05]	National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Logistics Research Plan of the People's Liberation Army; Innovation Funding of the Third Military Medical University	This work was funded by the National Key Technology Research and Development Program of China (2017YFC1103300), the Nature Science Foundation of China (31870962 and 81471782), the Key Project of Logistics Research Plan of the People's Liberation Army (AWS17J004), and the Innovation Funding of the Third Military Medical University (2018XYY05). The authors declare no conflicts of interest.	Akiyama M, 2009, CELL TRANSPLANT, V18, P443, DOI 10.3727/096368909788809820; Ba PF, 2017, MOL MED REP, V16, P63, DOI 10.3892/mmr.2017.6563; Bai Y, 2018, FASEB J, V32, P4573, DOI 10.1096/fj.201701411R; Das S, 2013, NANOMEDICINE-UK, V8, P1483, DOI [10.2217/NNM.13.133, 10.2217/nnm.13.133]; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Feng Q, 2017, ACTA BIOMATER, V53, P329, DOI 10.1016/j.actbio.2017.02.015; Huang L, 2001, J POLYM SCI POL PHYS, V39, P496, DOI 10.1002/1099-0488(20010301)39:5<496::AID-POLB1023>3.0.CO;2-H; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kaivalya M, 2011, J BIOCHEM MOL TOXIC, V25, P108, DOI 10.1002/jbt.20366; Kang HM, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201802642; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li J, 2016, BIOMED RES INT, V2016, P1; Li JJ, 2015, BIOMATERIALS, V54, P226, DOI 10.1016/j.biomaterials.2015.03.001; Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Mandoli C, 2010, ADV FUNCT MATER, V20, P1617, DOI 10.1002/adfm.200902363; Mariani E, 2014, INT J MOL SCI, V15, P8667, DOI 10.3390/ijms15058667; Mosallanejad K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004841; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Rivera-Gil P, 2011, NANO TODAY, V6, P20, DOI 10.1016/j.nantod.2010.12.006; Rocca A, 2015, INT J NANOMED, V10, P433, DOI 10.2147/IJN.S76329; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sivaraj KK, 2016, DEVELOPMENT, V143, P2706, DOI 10.1242/dev.136861; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Tai MF, 2016, J NANOMATER, V2016, DOI 10.1155/2016/8612505; Thakor AS, 2013, CA-CANCER J CLIN, V63, P395, DOI 10.3322/caac.21199; Thompson EM, 2016, TISSUE ENG PT A, V22, P556, DOI [10.1089/ten.tea.2015.0457, 10.1089/ten.TEA.2015.0457]; Thompson EM, 2015, J TISSUE ENG REGEN M, V9, P889, DOI 10.1002/term.1918; Thouverey C, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.80; Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038; Tortelli F, 2009, EUR CELLS MATER, V17, P1; Veiseh O, 2015, NAT REV DRUG DISCOV, V14, P45, DOI 10.1038/nrd4477; Verseijden F, 2010, CELL TRANSPLANT, V19, P1007, DOI 10.3727/096368910X492571; Wang JR, 2016, GENETICS, V202, P1055, DOI 10.1534/genetics.115.180109; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wei M, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0310-5; Xiang JY, 2016, ACS APPL MATER INTER, V8, P4489, DOI 10.1021/acsami.6b00158; Xiao YF, 2016, INT J NANOMED, V11, P3023, DOI 10.2147/IJN.S103648; Xu JB, 2016, ADV FUNCT MATER, V26, P2463, DOI 10.1002/adfm.201504070; Xue WQ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7571363; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yang ZY, 2014, RSC ADV, V4, P59965, DOI 10.1039/c4ra12007h; Yokel RA, 2012, TOXICOL SCI, V127, P256, DOI 10.1093/toxsci/kfs067; Zhang KY, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201701642	44	15	15	2	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6378	6389		10.1096/fj.201802187R	http://dx.doi.org/10.1096/fj.201802187R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30776318	Bronze			2022-12-28	WOS:000466932600045
J	Apasu, JE; Schuette, D; LaRanger, R; Steinle, JA; Nguyen, LD; Grosshans, HK; Zhang, ML; Cai, WL; Yan, Q; Robert, ME; Mak, M; Ehrlich, BE				Apasu, Jonathan E.; Schuette, Daniel; LaRanger, Ryan; Steinle, Julia A.; Nguyen, Lien D.; Grosshans, Henrike K.; Zhang, Meiling; Cai, Wesley L.; Yan, Qin; Robert, Marie E.; Mak, Michael; Ehrlich, Barbara E.			Neuronal calcium sensor 1 (NCS1) promotes motility and metastatic spread of breast cancer cells in vitro and in vivo	FASEB JOURNAL			English	Article						cell migration; xenograft model; calcium binding protein; metastasis; Ca2+ signaling	LIM KINASES; GENE; OSCILLATIONS; MECHANISMS; MIGRATION; ENHANCEMENT; EXOCYTOSIS; PROTEIN-1; RECEPTOR; TUMOR	Increased levels of the calcium-binding protein neuronal calcium sensor 1 (NCS1) predict an unfavorable patient outcome in several aggressive cancers, including breast and liver tumors. Previous studies suggest that NCS1 overexpression facilitates metastatic spread of these cancers. To investigate this hypothesis, we explored the effects of NCS1 overexpression on cell proliferation, survival, and migration patterns in vitro in 2- and 3-dimensional (2/3-D). Furthermore, we translated our results into an in vivo mouse xenograft model. Cell-based proliferation assays were used to demonstrate the effects of overexpression of NCS1 on growth rates. In vitro colony formation and wound healing experiments were performed and 3-D migration dynamics were studied using collagen gels. Nude mice were injected with breast cancer cells to monitor NCS1-dependent metastasis formation over time. We observed that increased NCS1 levels do not change cellular growth rates, but do significantly increase 2- and 3-D migration dynamics in vitro. Likewise, NCS1-overexpressing cells have an increased capacity to form distant metastases and demonstrate better survival and less necrosis in vivo. We found that NCS1 preferentially localizes to the leading edge of cells and overexpression increases the motility of cancer cells. Furthermore, this phenotype is correlated with an increased number of metastases in a xenograft model. These results lay the foundation for exploring the relevance of an NCS1-mediated pathway as a metastatic biomarker and as a target for pharmacologic interventions.	[Apasu, Jonathan E.; Schuette, Daniel; Steinle, Julia A.; Nguyen, Lien D.; Grosshans, Henrike K.; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, 333 Cedar St,Room B-147,POB 208026, New Haven, CT 06520 USA; [LaRanger, Ryan; Mak, Michael] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Zhang, Meiling; Cai, Wesley L.; Yan, Qin; Robert, Marie E.] Yale Univ, Dept Pathol, New Haven, CT USA; [Apasu, Jonathan E.] Univ Bonn, Bonn, Germany; [Steinle, Julia A.] Univ Munster, Munster, Germany	Yale University; Yale University; Yale University; University of Bonn; University of Munster	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St,Room B-147,POB 208026, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021; Yan, Qin/E-8893-2012	/0000-0001-9657-9704; Yan, Qin/0000-0003-4077-453X; Nguyen, Lien/0000-0001-8096-1570; Schuette, Daniel/0000-0002-4746-537X	German Academic Scholarship Foundation; Yale University; NSF Graduate Research Fellowship [DGE-1122492]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [5P01DK057751]; NIH National Institute of Biomedical Imaging and Bioengineering [1R21EB026630]; U.S. Department of Defense [W81XWH-15-1-0117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751] Funding Source: NIH RePORTER	German Academic Scholarship Foundation; Yale University; NSF Graduate Research Fellowship(National Science Foundation (NSF)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); U.S. Department of Defense(United States Department of Defense); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Sabine Lang (Yale University) for technical and administrative support. The authors acknowledge helpful discussions with Allison Brill, Dr. David Calderwood, and Dr. Tamar Taddei (Yale University). J.E.A., D.S., J.A.S., and H.K.G. received a scholarship from the German Academic Scholarship Foundation. M.Z. received a Brown Coxe Postdoctoral Fellowship from Yale University. W.L.C. received NSF Graduate Research Fellowship DGE-1122492. This work was supported, in part, by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant 5P01DK057751 (to B.E.E. and M.E.R.), NIH National Institute of Biomedical Imaging and Bioengineering (Grant 1R21EB026630 to M.M.), and U.S. Department of Defense Grant W81XWH-15-1-0117 (to Q.Y.). B.E.E. is a founder of Osmol Therapeutics, a company that is targeting NCS1 for therapeutic purposes. Primary data are maintained in the Ehrlich Laboratory at Yale University. Reagents not commercially available are available from the Ehrlich Laboratory. The authors declare no conflicts of interest.	Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Ando Hideaki, 2018, Advances in Biological Regulation, V68, P64, DOI 10.1016/j.jbior.2017.12.001; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Blasiole B, 2005, J NEUROBIOL, V64, P285, DOI 10.1002/neu.20138; Boeckel GR, 2018, BBA-MOL CELL RES, V1865, P1660, DOI 10.1016/j.bbamcr.2018.05.005; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Choe Chi-Un, 2006, Sci STKE, V2006, pre15; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; D'Onofrio S, 2015, J NEUROPHYSIOL, V113, P709, DOI 10.1152/jn.00828.2014; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Florea AM, 2009, NEUROTOXICOLOGY, V30, P803, DOI 10.1016/j.neuro.2009.04.014; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Guerrico AMG, 2005, ONCOGENE, V24, P2307, DOI 10.1038/sj.onc.1208476; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Li R, 2013, CLIN EXP METASTAS, V30, P483, DOI 10.1007/s10585-012-9553-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Moore LM, 2017, MOL CANCER RES, V15, P942, DOI 10.1158/1541-7786.MCR-16-0408; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Prunier C, 2017, ONCOTARGET, V8, P41749, DOI 10.18632/oncotarget.16978; Rajebhosale M, 2003, J BIOL CHEM, V278, P6075, DOI 10.1074/jbc.M204702200; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; Schuette D, 2018, CANCER EPIDEM BIOMAR, V27, P1091, DOI 10.1158/1055-9965.EPI-18-0167; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Smedler E, 2014, BBA-GEN SUBJECTS, V1840, P964, DOI 10.1016/j.bbagen.2013.11.015; Stewart TA, 2015, BBA-BIOMEMBRANES, V1848, P2502, DOI 10.1016/j.bbamem.2014.08.016; Stuelten CH, 2018, NAT REV CANCER, V18, P296, DOI 10.1038/nrc.2018.15; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Taketo MM, 2011, CANCER PREV RES, V4, P324, DOI 10.1158/1940-6207.CAPR-11-0046; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Xiao MB, 2018, ONCOL LETT, V15, P175, DOI 10.3892/ol.2017.7295; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	55	6	6	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4802	4813		10.1096/fj.201802004R	http://dx.doi.org/10.1096/fj.201802004R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592625	Green Published, Bronze			2022-12-28	WOS:000462888500014
J	Chauhan, AS; Kumar, M; Chaudhary, S; Dhiman, A; Patidar, A; Jakhar, P; Jaswal, P; Sharma, K; Sheokand, N; Malhotra, H; Raje, CI; Raje, M				Chauhan, Anoop Singh; Kumar, Manoj; Chaudhary, Surbhi; Dhiman, Asmita; Patidar, Anil; Jakhar, Priyanka; Jaswal, Pallavi; Sharma, Kapil; Sheokand, Navdeep; Malhotra, Himanshu; Raje, Chaaya Iyengar; Raje, Manoj			Trafficking of a multifunctional protein by endosomal microautophagy: linking two independent unconventional secretory pathways	FASEB JOURNAL			English	Article						GAPDH; lysosomal exocytosis; exosomal exocytosis; nonclassical protein secretion; misfolded protein aggregate	CHAPERONE-MEDIATED AUTOPHAGY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; LYSOSOMAL EXOCYTOSIS; FUNCTIONAL DIVERSITY; ALZHEIMERS-DISEASE; MEMBRANE-PROTEINS; EXOSOME RELEASE; BIOGENESIS; PHOSPHATIDYLSERINE; TRANSFERRIN	During physiologic stresses, like micronutrient starvation, infection, and cancer, the cytosolic moonlighting protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is trafficked to the plasma membrane (PM) and extracellular milieu (ECM). Our work demonstrates that GAPDH mobilized to the PM, and the ECM does not utilize the classic endoplasmic reticulum-Golgi route of secretion; instead, it is first selectively translocated into early and late endosomes from the cytosol via microautophagy. GAPDH recruited to this common entry point is subsequently delivered into multivesicular bodies, leading to its membrane trafficking through secretion via exosomes and secretory lysosomes. We present evidence that both pathways of GAPDH membrane trafficking are up-regulated upon iron starvation, potentially by mobilization of intracellular calcium. These pathways also play a role in clearance of misfolded intracellular polypeptide aggregates. Our findings suggest that cells build in redundancy for vital cellular pathways to maintain micronutrient homeostasis and prevent buildup of toxic intracellular misfolded protein refuse.	[Chauhan, Anoop Singh; Kumar, Manoj; Chaudhary, Surbhi; Dhiman, Asmita; Patidar, Anil; Jakhar, Priyanka; Jaswal, Pallavi; Sharma, Kapil; Sheokand, Navdeep; Malhotra, Himanshu; Raje, Manoj] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India; [Raje, Chaaya Iyengar] Natl Inst Pharmaceut Educ & Res, Mohali, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Raje, M (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	manoj@imtech.res.in	Malik, Navdeep/V-9125-2019; Malik, Navdeep/AAU-3303-2020; Chauhan, Anoop/GYD-7325-2022; Raje, Chaaya Iyengar/AAU-2651-2021	Malik, Navdeep/0000-0003-1113-2562; Chauhan, Anoop/0000-0001-8722-2404; KUMAR, MANOJ/0000-0001-6934-2103; , Asmita/0000-0002-6415-6819; Chaudhary, Surbhi/0000-0002-7457-7166; Iyengar, Chaaya/0000-0003-4434-0536	India's Department of Biotechnology; Council of Scientific and Industrial Research; University Grants Commission; Department of Biotechnology; Department of Science and Technology of the Government of India	India's Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Department of Biotechnology; Department of Science and Technology of the Government of India(Department of Science & Technology (India))	Anil Theophilus, Randeep Sharma, and Dr. Subash Pawar (all from the Institute of Microbial Technology) are acknowledged for technical assistance. A.S.C., A.P., and A.D. received fellowships from India's Department of Biotechnology. N.S., P. Jakhar, P. Jaswal, and K.S. received fellowships from the Council of Scientific and Industrial Research, and H.M. and S.C. received fellowships from the University Grants Commission. Financial assistance from the Department of Biotechnology and the Department of Science and Technology of the Government of India is acknowledged. This article is Institute of Microbial Technology (IMTECH) Communication 029/2014. The authors declare no conflicts of interest.	ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Appelqvist H, 2013, J CELL SCI, V126, P5578, DOI 10.1242/jcs.130633; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Boradia VM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5730; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Chauhan AS, 2017, FASEB J, V31, P2638, DOI 10.1096/fj.201600982R; CHAUHAN AS, 2015, SCI REP UK, V5; Chen JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077023; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Cortez LM, 2010, FEBS LETT, V584, P625, DOI 10.1016/j.febslet.2009.12.012; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Gonzalez AE, 2017, FASEB J, V31, P2446, DOI 10.1096/fj.201600713R; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hwang S, 2015, FASEB J, V29; Hwang S, 2015, EMBO MOL MED, V7, P1307, DOI 10.15252/emmm.201505256; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jansen FH, 2009, MOL CELL PROTEOMICS, V8, P1192, DOI 10.1074/mcp.M800443-MCP200; Kaneda M, 1997, J BIOCHEM-TOKYO, V122, P1233; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Klaips CL, 2018, J CELL BIOL, V217, P51, DOI 10.1083/jcb.201709072; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kumar S, 2012, INT J BIOCHEM CELL B, V44, P189, DOI 10.1016/j.biocel.2011.10.016; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Malhotra H, 2016, J BIOMED NANOTECHNOL, V12, P1101, DOI 10.1166/jbn.2016.2229; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mazzola JL, 2001, J NEUROCHEM, V76, P442, DOI 10.1046/j.1471-4159.2001.00033.x; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Miura N, 2012, EUKARYOT CELL, V11, P1075, DOI 10.1128/EC.00075-12; Morozova K, 2016, J BIOL CHEM, V291, P18096, DOI 10.1074/jbc.M116.736744; Mukherjee A, 2016, AUTOPHAGY, V12, P1984, DOI 10.1080/15548627.2016.1208887; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; Rawat P, 2012, BIOCHEM CELL BIOL, V90, P329, DOI [10.1139/O11-058, 10.1139/o11-058]; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Seidler N. W., 2012, GAPDH BIOLOGICAL PRO, V985; Sheokand N, 2016, J CELL SCI, V129, P843, DOI 10.1242/jcs.180356; Sheokand N, 2013, BBA-GEN SUBJECTS, V1830, P3816, DOI 10.1016/j.bbagen.2013.03.019; Shibuya A, 2002, HEPATOL RES, V22, P174, DOI 10.1016/S1386-6346(01)00134-6; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sirover MA, 2014, INT J BIOCHEM CELL B, V57, P20, DOI 10.1016/j.biocel.2014.09.026; Sirover MA, 2013, OXID STRESS APPL BAS, P25, DOI 10.1007/978-1-62703-598-9_4; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; Stolp ZD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068835; Takenouchi T, 2015, IMMUNOL LETT, V167, P116, DOI 10.1016/j.imlet.2015.08.002; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tekirdag K, 2018, J BIOL CHEM, V293, P5414, DOI 10.1074/jbc.R117.818237; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Tisdale EJ, 2016, EXP CELL RES, V349, P310, DOI 10.1016/j.yexcr.2016.10.025; Uytterhoeven V, 2015, NEURON, V88, P735, DOI 10.1016/j.neuron.2015.10.012; van Leeuwen W, 2018, J CELL BIOL, V217, P2261, DOI 10.1083/jcb.201802003; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Xu P, 2013, J CELL BIOL, V202, P875, DOI 10.1083/jcb.201305094; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	77	13	13	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5626	5640		10.1096/fj.201802102R	http://dx.doi.org/10.1096/fj.201802102R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30640524	Bronze			2022-12-28	WOS:000462888500079
J	Hu, RK; Huang, WL; Liu, JF; Jin, MM; Wu, Y; Li, JY; Wang, JY; Yu, ZH; Wang, H; Cao, Y				Hu, Ruikun; Huang, Weilai; Liu, Jiangfang; Jin, Miaomiao; Wu, Yue; Li, Jingyu; Wang, Jingyi; Yu, Zehao; Wang, Hong; Cao, Ying			Mutagenesis of putative ciliary genes with the CRISPR/Cas9 system in zebrafish identifies genes required for retinal development	FASEB JOURNAL			English	Article						cilium; retina; genetic screen	CILIOPATHY PROTEIN; TRANSPORT; COMPLEX; GENOME; PHOTORECEPTORS; DISSECTION; MEMBRANES; INTERACTS; SURVIVAL; DISEASE	Cilia are conserved microtubule-based organelles that function as mechanical and chemical sensors in various cell types. By bioinformatic, genomic, and proteomic studies, more than 2000 proteins have been identified as cilium-associated proteins or putative ciliary proteins; these proteins are referred to as the ciliary proteome or the ciliome. However, little is known about the function of these numerous putative ciliary proteins in cilia. To identify the possible new functional proteins or pathways in cilia, we carried out a small-scale genetic screen targeting 54 putative ciliary genes by using the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system. We successfully constructed 54 zebrafish mutants, and 8 of them displayed microphthalmias. Three of these 8 genes encode proteins for protein transport, suggesting the important roles of protein transport in retinal development. In situ hybridization revealed that all these genes are expressed in zebrafish eyes. Furthermore, polo-like kinase 1 was required for ciliogenesis in neural tube. We uncovered the potential function of the ciliary genes for the retinal development of zebrafish.	[Hu, Ruikun; Huang, Weilai; Liu, Jiangfang; Jin, Miaomiao; Wu, Yue; Li, Jingyu; Wang, Jingyi; Yu, Zehao; Wang, Hong; Cao, Ying] Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Life Sci & Technol, Clin & Translat Res Ctr, 1239 Siping Rd,Med Bldg 1315, Shanghai 200092, Peoples R China	Tongji University	Cao, Y (corresponding author), Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Life Sci & Technol, Clin & Translat Res Ctr, 1239 Siping Rd,Med Bldg 1315, Shanghai 200092, Peoples R China.	yingcao@tongji.edu.cn	Li, Jing/GYU-5036-2022; WANG, JINGYI/GSJ-1241-2022; Li, Jingyu/GSD-1924-2022; wang, jing/GVT-8700-2022	Wu, Yue/0000-0002-2337-0923; yu, zehao/0000-0002-7290-8005	National Key Research and Development Program of China [2017YFA0104600]; National Natural Science Foundation of China [31771597, 31571515]; National Basic Research Program of China (973 Program) [2012CB966601, 2013CB945300]; Ministry of Science and Technology of China [2011DFB30010]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The authors thank the members of the Y.C. Laboratory for helpful discussions. This project was supported by National Key Research and Development Program of China Grant 2017YFA0104600, National Natural Science Foundation of China Grants 31771597 and 31571515, National Basic Research Program of China (973 Program) Grants 2012CB966601 and 2013CB945300, and Ministry of Science and Technology of China Grant 2011DFB30010. The authors declare no conflicts of interest.	Attanasio M, 2015, CURR OPIN NEPHROL HY, V24, P366, DOI 10.1097/MNH.0000000000000134; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Choi SY, 2015, INVEST OPHTH VIS SCI, V56, P3361, DOI 10.1167/iovs.14-15692; DERETIC D, 1995, J CELL SCI, V108, P215; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Dona M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005574; Dutta N, 2016, BIOL OPEN, V5, P1283, DOI 10.1242/bio.020461; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; Gerth-Kahlert C, 2018, KLIN MONATSBL AUGENH, V235, P264, DOI 10.1055/a-0573-9199; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22281; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Hsu Y, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007057; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Juan T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04284-8; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lim YS, 2011, BIOL CELL, V103, P209, DOI 10.1042/BC20100150; Lin CY, 2015, INT J DEV BIOL, V59, P435, DOI 10.1387/ijdb.150310ht; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nielsen BS, 2015, J CELL SCI, V128, P3543, DOI 10.1242/jcs.173559; Niu XB, 2014, J BIOL CHEM, V289, P11971, DOI 10.1074/jbc.M114.547190; Pujic Z, 2004, SEMIN CELL DEV BIOL, V15, P105, DOI 10.1016/j.semcdb.2003.09.008; Rao KN, 2016, HUM MOL GENET, V25, P4533, DOI 10.1093/hmg/ddw281; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Song P, 2016, INVEST OPHTH VIS SCI, V57, P4517, DOI 10.1167/iovs.16-19898; Sorrells S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002922; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; West MA, 2000, ADV INT ST, V5, P1; Wheway G, 2014, ORGANOGENESIS, V10, P69, DOI 10.4161/org.26710; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wu Q, 2015, FASEB J, V29, P4989, DOI 10.1096/fj.15-273409; Xu WY, 2017, J AM SOC NEPHROL, V28, P118, DOI 10.1681/ASN.2015080906; Yin J, 2012, INVEST OPHTH VIS SCI, V53, P4943, DOI 10.1167/iovs.12-9511	50	5	5	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5248	5256		10.1096/fj.201802140R	http://dx.doi.org/10.1096/fj.201802140R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30624971				2022-12-28	WOS:000462888500050
J	Angom, RS; Wang, Y; Wang, EF; Pal, K; Bhattacharya, S; Watzlawik, JO; Rosenberry, TL; Das, P; Mukhopadhyay, D				Angom, Ramcharan Singh; Wang, Ying; Wang, Enfeng; Pal, Krishnendu; Bhattacharya, Santanu; Watzlawik, Jens O.; Rosenberry, Terrone L.; Das, Pritam; Mukhopadhyay, Debabrata			VEGF receptor-1 modulates amyloid 1-42 oligomer-induced senescence in brain endothelial cells	FASEB JOURNAL			English	Article						oligomers; Alzheimer's disease; cerebrovascular; aging; dysfunction	TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; BETA PEPTIDES; ANGIOGENESIS; BARRIER; NEURODEGENERATION; HYPOTHESIS; IMPAIRMENT; MECHANISM	Aggregated amyloid (A) peptides in the Alzheimer's disease (AD) brain are hypothesized to trigger several downstream pathologies, including cerebrovascular dysfunction. Previous studies have shown that A peptides can have antiangiogenic properties, which may contribute to vascular dysfunction in the early stages of the disease process. We have generated data showing that brain endothelial cells (ECs) exposed to toxic A1-42 oligomers can readily enter a senescence phenotype. To determine the effect of A oligomers on brain ECs, we treated early passaged human brain microvascular ECs and HUVECs with high MW A1-42 oligomers (5 mu M, for 72 h). For controls, we used no peptide treatment, 5 mu M A1-42 monomers, and 5 mu M A1-42 fibrils, respectively. Brain ECs treated with A1-42 oligomers showed increased senescence-associated -galactosidase staining and increased senescence-associated p21/p53 expression. Treatment with either A1-42 monomer or A1-42 fibrils did not induce senescence in this assay. We then measured vascular endothelial growth factor receptor (VEGFR) expression in the A1-42 oligomer-treated ECs, and these cells showed significantly increased VEGFR-1 expression and decreased VEGFR-2 levels. Overexpression of VEGFR-1 in brain ECs readily induced senescence, suggesting a direct role of VEGFR-1 signaling events in this paradigm. More importantly, small interfering RNA-mediated knockdown of VEGFR-1 expression in brain ECs was able to prevent up-regulation of p21 protein expression and significantly reduced induction of senescence following A1-42 oligomer treatment. Our studies show that exposure to A1-42 oligomers may impair vascular functions by altering VEGFR-1 expression and causing ECs to enter a senescent phenotype. Altered VEGFR expression has been documented in brains of AD patients and suggests that this pathway may play a role in AD disease pathogenesis. These studies suggest that modulating VEGFR-1 expression and signaling events could potentially prevent senescence and rejuvenate EC functions, and provides us with a novel target to pursue for prevention and treatment of cerebrovascular dysfunction in AD.Angom, R. S., Wang, Y., Wang, E., Pal, K., Bhattacharya, S., Watzlawik, J. O., Rosenberry, T. L., Das, P., Mukhopadhyay, D. VEGF receptor-1 modulates amyloid 1-42 oligomer-induced senescence in brain endothelial cells.	[Angom, Ramcharan Singh; Wang, Ying; Wang, Enfeng; Pal, Krishnendu; Bhattacharya, Santanu; Das, Pritam; Mukhopadhyay, Debabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 4500 San Pablo Rd.,Griffin 451, Jacksonville, FL 32224 USA; [Watzlawik, Jens O.; Rosenberry, Terrone L.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic	Das, P; Mukhopadhyay, D (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 4500 San Pablo Rd.,Griffin 451, Jacksonville, FL 32224 USA.	das.pritam@mayo.edu; mukhopadhyay.debabrata@mayo.edu		Wang, Ying/0000-0002-7852-386X; Pal, Krishnendu/0000-0002-4006-213X	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL140411]; NIH National Cancer Institute [CA78383-20]; Florida Department of Health Cancer Research Chair's Fund [3J-02]	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health Cancer Research Chair's Fund	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL140411 and NIH National Cancer Institute Grant CA78383-20 (to D.M.), and Florida Department of Health Cancer Research Chair's Fund Grant 3J-02 (to D.M.). The authors declare no conflicts of interest.	Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bennett RE, 2018, P NATL ACAD SCI USA, V115, pE1289, DOI 10.1073/pnas.1710329115; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cho SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18042-1; Donnini S, 2010, FASEB J, V24, P2385, DOI 10.1096/fj.09-146456; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jack CR, 2013, NEUROLOGY, V81, P1732, DOI 10.1212/01.wnl.0000435556.21319.e4; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Koster KP, 2016, J CEREBR BLOOD F MET, V36, P1865, DOI 10.1177/0271678X16669956; Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Meyer EP, 2008, P NATL ACAD SCI USA, V105, P3587, DOI 10.1073/pnas.0709788105; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Moore BD, 2009, BIOCHEMISTRY-US, V48, P11796, DOI 10.1021/bi901571t; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Paris D, 2005, MOL BRAIN RES, V136, P212, DOI 10.1016/j.molbrainres.2005.02.011; Paris D, 2004, NEUROSCI LETT, V366, P80, DOI 10.1016/j.neulet.2004.05.017; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Patel NS, 2010, J NEUROCHEM, V112, P66, DOI 10.1111/j.1471-4159.2009.06426.x; Rajani RM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam9507; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Religa P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02053; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; STEWART PA, 1992, LAB INVEST, V67, P734; Tai LM, 2016, ACTA NEUROPATHOL, V131, P709, DOI 10.1007/s00401-016-1547-z; Tay WM, 2013, J MOL BIOL, V425, P2494, DOI 10.1016/j.jmb.2013.04.003; Thomas R, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0387-3; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Wang P, 2011, BIOCHEM BIOPH RES CO, V411, P620, DOI 10.1016/j.bbrc.2011.07.003; Wang ZZ, 2000, STROKE, V31, P534, DOI 10.1161/01.STR.31.2.534; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Yamazaki Y, 2016, STROKE, V47, P1068, DOI 10.1161/STROKEAHA.115.010835; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	53	14	14	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4626	4637		10.1096/fj.201802003R	http://dx.doi.org/10.1096/fj.201802003R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30576228	Bronze, Green Published			2022-12-28	WOS:000459794800121
J	Chen, KH; Feng, L; Hu, W; Chen, J; Wang, XY; Wang, LM; He, YN				Chen, Kehong; Feng, Lei; Hu, Wei; Chen, Jia; Wang, Xiaoyue; Wang, Liming; He, Yani			Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy	FASEB JOURNAL			English	Article						OPTN; tubulointerstitial inflammation; mitochondria; IL-1; IL-18	NF-KAPPA-B; INJURY; EXPRESSION; PATHWAY; DISEASE; KIDNEY; RECRUITMENT; SENESCENCE; AUTOPHAGY; DYNAMICS	Tubulointerstitial inflammation plays a critical role in the progression of diabetic nephropathy (DN), and nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasomes contribute to renal interstitial inflammation in DN. Decreased expression of optineurin (OPTN) is also associated with the progression of DN. We investigated the role of OPTN in activation of the NLRP3 inflammasome in DN. We initially examined the renal biopsy tissues of 172 patients with type 2 DN and 32 nondiabetic patients with renal hamartoma. Expression of renal OPTN was significantly lower in patients with DN and negatively correlated with urinary levels of IL-1 and IL-18. Confocal microscopy analysis of the biopsies indicated no NLRP3 or IL-1 staining in OPTN-positive renal tubular epithelial cells (RTECs), indicating a negative correlation of OPTN expression with the activation of NLRP3 inflammasome. In vitro studies of murine RTECs indicated the levels of OPTN mRNA and protein decreased significantly after stimulation by a high glucose (HG) treatment. Relative to RTECs given HG, RTECs overexpressing OPTN showed significantly lower levels of NLRP3 expression, cleavage of caspase-1 and IL-1, and release of IL-1 and IL-18. Overexpression of OPTN in the presence of HG significantly increased the costaining of microtubule-associated protein 1A/1B-light chain 3-II and translocase of outer mitochondrial membrane 20 in RTECs, suggesting that OPTN enhances mitophagy. In addition, mitochondrial division inhibitor 1 blocked the inhibitory effect of OPTN overexpression on the activation of NLRP3 inflammasome in the presence of HG, indicating that OPTN overexpression inhibited NLRP3 inflammasome activation by enhancement of mitophagy. OPTN gene silencing significantly enhanced production of mitochondrial reactive oxygen species (mtROS) in the presence of HG. Compared with HG+OPTN small interfering RNA (siRNA)-treated RTECs, HG+OPTN siRNA+MitoTempo-treated RTECs attenuated NLRP3 inflammasome activation, suggesting that OPTN gene silencing activates the NLRP3 inflammasome by increasing mtROS in HG-treated RTECs. Taken together, our results demonstrate that OPTN inhibits the activation of NLRP3 inflammasome by enhancing mitophagy.Chen, K., Feng, L., Hu, W., Chen, J., Wang, X., Wang, L., He, Y. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.	[Chen, Kehong; Feng, Lei; Hu, Wei; Chen, Jia; Wang, Xiaoyue; Wang, Liming; He, Yani] Army Mil Med Univ, Res Inst Surg, Daping Hosp, Dept Nephrol, Chongqing, Peoples R China; [Hu, Wei] Peoples Liberat Army PLA 324 Hosp, Dept Nephrol, Chongqing, Peoples R China	Army Medical University	He, YN (corresponding author), Army Med Univ, Daping Hosp, Res Inst Surg, Dept Nephrol, Daping St, Chongqing 400042, Peoples R China.	19346028@qq.com			National Natural Science Foundation of China [81770731, 81670661]; 12th Five-year Science Foundation [AWS14C003]; National Science and Technology Support Plan [2015BAI12B06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-year Science Foundation; National Science and Technology Support Plan	The authors thank Dr. Jianhui Sun and Lihua Bo (both from Daping Hospital) for their clinical and technical support. This work was supported by grants from the National Natural Science Foundation of China (81770731, 81670661), the 12th Five-year Science Foundation (AWS14C003), and the National Science and Technology Support Plan (2015BAI12B06). Prof. Shan Youan (Army Military Medical University) kindly provided the green fluorescent protein-tagged pAdTrack-Vector adenovirus and the green fluorescent protein-tagged pAdTrack-optineurin adenovirus. K.C. and L.F. were joint first authors of this work. The authors declare no conflicts of interest.	Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772; An Y, 2015, NEPHROL DIAL TRANSPL, V30, P257, DOI 10.1093/ndt/gfu250; Bai YL, 2006, CELL PHYSIOL BIOCHEM, V17, P57, DOI 10.1159/000091464; Bidani AK, 2004, HYPERTENSION, V44, P595, DOI 10.1161/01.HYP.0000145180.38707.84; Chen J, 2017, AM J PHYSIOL-RENAL, V313, pF273, DOI 10.1152/ajprenal.00689.2016; Chen KH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0127-z; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; COHEN MP, 1979, J EXP MED, V149, P623, DOI 10.1084/jem.149.3.623; Dang WT, 2018, CLIN RHEUMATOL, V37, P2547, DOI 10.1007/s10067-018-4149-4; Dey S, 2018, CIRC RES, V123, P356, DOI 10.1161/CIRCRESAHA.118.312708; Elliott EI, 2018, J IMMUNOL, V200, P3047, DOI 10.4049/jimmunol.1701723; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/NCHEMBIO.2287, 10.1038/nchembio.2287]; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Han YC, 2018, REDOX BIOL, V16, P32, DOI 10.1016/j.redox.2018.02.013; Hill GS, 2008, CURR OPIN NEPHROL HY, V17, P266, DOI 10.1097/MNH.0b013e3282f88a1f; Huang QC, 2016, AUTOPHAGY, V12, P999, DOI 10.1080/15548627.2016.1166318; Hwang S, 2017, J DIABETES COMPLICAT, V31, P1704, DOI 10.1016/j.jdiacomp.2017.08.009; Iannantuoni F, 2019, ANTIOXID REDOX SIGN, V30, P232, DOI 10.1089/ars.2018.7582; Iglesias-de la Cruz MC, 2002, KIDNEY INT, V62, P901, DOI 10.1046/j.1523-1755.2002.00528.x; Ito S, 2015, AUTOPHAGY, V11, P547, DOI 10.1080/15548627.2015.1017190; Kastl L, 2014, FEBS LETT, V588, P175, DOI 10.1016/j.febslet.2013.11.033; Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002; Kim H, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0270-y; Lang Y, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1549549; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Legrand-Poels S, 2014, BIOCHEM PHARMACOL, V92, P131, DOI 10.1016/j.bcp.2014.08.013; Lei CY, 2017, NEUROSCIENCE, V360, P48, DOI 10.1016/j.neuroscience.2017.07.053; Li S, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3537609; Liang X, 2017, TOXICOL IND HEALTH, V33, P737, DOI 10.1177/0748233717712409; Liu J, 2014, CELL SIGNAL, V26, P110, DOI 10.1016/j.cellsig.2013.10.002; Marshall CB, 2016, AM J PHYSIOL-RENAL, V311, pF831, DOI 10.1152/ajprenal.00313.2016; MAUER SM, 1981, AM J MED, V70, P603, DOI 10.1016/0002-9343(81)90582-9; Meena NP, 2016, FEBS LETT, V590, P1498, DOI 10.1002/1873-3468.12176; Moore AS, 2016, P NATL ACAD SCI USA, V113, pE3349, DOI 10.1073/pnas.1523810113; Munitic I, 2013, J IMMUNOL, V191, P6231, DOI 10.4049/jimmunol.1301696; Park J, 2015, NEUROSCI LETT, V584, P191, DOI 10.1016/j.neulet.2014.10.016; Park S, 2014, AUTOPHAGY, V10, P1906, DOI 10.4161/auto.32177; Pirkle JL, 2013, MINERVA UROL NEFROL, V65, P37; Prieto J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11124; Rossing P, 2018, NEPHROL THER, V14, pS31, DOI 10.1016/j.nephro.2018.02.007; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Slowicka K, 2016, TRENDS IMMUNOL, V37, P621, DOI 10.1016/j.it.2016.07.002; Slowicka K, 2016, EUR J IMMUNOL, V46, P971, DOI 10.1002/eji.201545863; Tumurkhuu G, 2018, CELL METAB, V28, P432, DOI 10.1016/j.cmet.2018.05.027; Von Stockum S, 2016, NEUROBIOL DIS, V90, P58, DOI 10.1016/j.nbd.2015.11.002; Wang XC, 2013, EXP THER MED, V6, P1243, DOI 10.3892/etm.2013.1306; Wong YC, 2015, AUTOPHAGY, V11, P422, DOI 10.1080/15548627.2015.1009792; Wood LG, 2019, J ALLERGY CLIN IMMUN, V143, P305, DOI 10.1016/j.jaci.2018.04.037; Yu X, 2017, J HEPATOL, V66, P693, DOI 10.1016/j.jhep.2016.12.018; Zhai  Y., 2018, MOLECULES, V23; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650; Zhao WY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33201; Zhou M, 2015, EUR REV MED PHARMACO, V19, P4866; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	58	40	40	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4571	4585		10.1096/fj.201801749RRR	http://dx.doi.org/10.1096/fj.201801749RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30571313	Bronze			2022-12-28	WOS:000459794800117
J	Giussani, S; Pietrocola, G; Donnarumma, D; Norais, N; Speziale, P; Fabbrini, M; Margarit, I				Giussani, Stefania; Pietrocola, Giampiero; Donnarumma, Danilo; Norais, Nathalie; Speziale, Pietro; Fabbrini, Monica; Margarit, Immaculada			The Streptococcus agalactiae complement interfering protein combines multiple complement-inhibitory mechanisms by interacting with both C4 and C3 ligands	FASEB JOURNAL			English	Article						GBS; neonatal infection; B cells; virulence factor	BINDING-PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FACTOR-H; ANTIGEN; POLYSACCHARIDE; PREVENTION; FIBRINOGEN; PATHWAYS; EVASION	Group B Streptococcus (GBS) colonizes the human lower intestinal and genital tracts and constitutes a major threat to neonates from pregnant carrier mothers and to adults with underlying morbidity. The pathogen expresses cell-surface virulence factors that enable cell adhesion and penetration and that counteract innate and adaptive immune responses. Among these, the complement interfering protein (CIP) was recently described for its capacity to interact with the human C4b ligand and to interfere with the classical- and lectin-complement pathways. In the present study, we provide evidence that CIP can also interact with C3, C3b, and C3d. Immunoassay-based competition experiments showed that binding of CIP to C3d interferes with the interaction between C3d and the complement receptor 2/cluster of differentiation 21 (CR2/CD21) receptor on B cells. By B-cell intracellular signaling assays, CIP was confirmed to down-regulate CR2/CD21-dependent B-cell activation. The CIP domain involved in C3d binding was mapped via hydrogen deuterium exchange-mass spectrometry. The data obtained reveal a new role for this GBS polypeptide at the interface between the innate and adaptive immune responses, adding a new member to the growing list of virulence factors secreted by gram-positive pathogens that incorporate multiple immunomodulatory functions.Giussani, S., Pietrocola, G., Donnarumma, D., Norais, N., Speziale, P., Fabbrini, M., Margarit, I. The Streptococcus agalactiae complement interfering protein combines multiple complement-inhibitory mechanisms by interacting with both C4 and C3 ligands.	[Giussani, Stefania; Donnarumma, Danilo; Norais, Nathalie; Fabbrini, Monica; Margarit, Immaculada] GlaxoSmithKline GSK, Via Fiorentina 1, I-53100 Siena, Italy; [Giussani, Stefania; Pietrocola, Giampiero; Speziale, Pietro] Univ Pavia, Mol Med Dept, Unit Biochem, Pavia, Italy	University of Pavia	Margarit, I (corresponding author), GlaxoSmithKline GSK, Via Fiorentina 1, I-53100 Siena, Italy.; Speziale, P (corresponding author), Univ Pavia, Mol Med Dept, Unit Biochem, Pavia, Italy.	pspeziale@unipv.it; immaculada.x.margarit-y-ros@gsk.com	Donnarumma, Danilo/AAH-1744-2021	Donnarumma, Danilo/0000-0001-9471-0254; Giussani, Stefania/0000-0002-6088-4958	GlaxoSmithKline Biologicals SA (Rixensart, Belgium)	GlaxoSmithKline Biologicals SA (Rixensart, Belgium)	The authors thank Marzia Monica Giuliani for scientific discussion, Chiara Sammicheli and Simona Tavarini for their support in flow cytometry, Barbara Brogioni for her support on SPR, and Francesca Angiolini for her support on B cell experiments (all from GlaxoSmithKline, Siena, Italy). This study was sponsored by GlaxoSmithKline Biologicals SA (Rixensart, Belgium). D.D., N.N., M.F., and I.M. are employees of GlaxoSmithKline Vaccines. I.M. reports ownership of GSK shares and/or restricted GSK shares and is listed as an inventor on patents owned by the GSK group of companies.	Bajic G, 2013, P NATL ACAD SCI USA, V110, P16426, DOI 10.1073/pnas.1311261110; Berends ETM, 2014, FEMS MICROBIOL REV, V38, P1146, DOI 10.1111/1574-6976.12080; Brown CK, 2005, P NATL ACAD SCI USA, V102, P18391, DOI 10.1073/pnas.0504954102; Buhlmann D, 2016, J IMMUNOL, V197, P620, DOI 10.4049/jimmunol.1600053; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Cheng Q, 2002, INFECT IMMUN, V70, P6409, DOI 10.1128/IAI.70.11.6409-6415.2002; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Chuzeville S, 2015, MICROB PATHOGENESIS, V88, P1, DOI 10.1016/j.micpath.2015.07.018; Cyster JG, 2000, IMMUNOL REV, V176, P181; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Domina M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160702; Fairlie T, 2013, OBSTET GYNECOL, V121, P570, DOI 10.1097/AOG.0b013e318280d4f6; Gibbs RS, 2004, OBSTET GYNECOL, V104, P1062, DOI 10.1097/01.AOG.0000144128.03913.c2; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Haspel N, 2008, PROTEIN SCI, V17, P1894, DOI 10.1110/ps.036624.108; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Heath PT, 2007, BEST PRACT RES CL OB, V21, P411, DOI 10.1016/j.bpobgyn.2007.01.003; Herbert MA, 2004, CURR OPIN INFECT DIS, V17, P225, DOI 10.1097/00001432-200406000-00009; Jarva H, 2004, J IMMUNOL, V172, P3111, DOI 10.4049/jimmunol.172.5.3111; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Margarit I, 2009, FASEB J, V23, P3100, DOI 10.1096/fj.09-131458; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Maruvada R, 2009, FASEB J, V23, P3967, DOI 10.1096/fj.09-138149; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Pietrocola G, 2016, J IMMUNOL, V196, P385, DOI 10.4049/jimmunol.1501954; Rego S, 2016, J BIOL CHEM, V291, P15985, DOI 10.1074/jbc.M116.726562; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Upadhyay A, 2008, J BIOL CHEM, V283, P22113, DOI 10.1074/jbc.M802636200; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Woehl JL, 2017, PROTEIN SCI, V26, P1595, DOI 10.1002/pro.3195; Woehl JL, 2014, J IMMUNOL, V193, P6161, DOI 10.4049/jimmunol.1401600	42	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4448	4457		10.1096/fj.201801991R	http://dx.doi.org/10.1096/fj.201801991R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30566365	Green Published, hybrid			2022-12-28	WOS:000459794800107
J	Wang, XT; Xin, LB; Duan, ZC; Zuo, ZY; Wang, Y; Ren, YY; Zhang, W; Sun, XM; Liu, X; Ge, L; Yang, X; Yao, Z; Yang, J				Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yang, Xi; Yao, Zhi; Yang, Jie			Global Tudor-SN transgenic mice are protected from obesity-induced hepatic steatosis and insulin resistance	FASEB JOURNAL			English	Article						Tudor-SN; Srebp2; cholesterol; HFD	FATTY-ACID SYNTHESIS; P100 COACTIVATOR; LIPID DROPLETS; LIVER-DISEASE; PROTEIN; CHOLESTEROL; HOMEOSTASIS; OVEREXPRESSION; METABOLISM; TGF-BETA-1	In the current study, we explored the impact of Tudor-staphylococcal nuclease (SN) on obesity induced by a high-fat diet (HFD) in mice, because the functional involvement of Tudor-SN in lipid metabolism in vivo is unknown. HFD-transgenic (Tg) mice exhibited reductions in hepatic steatosis and systemic insulin resistance. There was no difference in hepatic lipid accumulation between chow-fed wild-type (WT) and chow-fed Tg mice; consistently, no difference in activation of the lipogenic pathway was detected. Overactivation of hepatic nuclear sterol regulatory element-binding protein (nSrebp2)-2, the central regulator of cholesterol metabolic proteins, was observed in HFD-Tg livers along with improved cholesterol homeostasis, but no such changes were observed in HFD-WT livers. Consistent results were observed in vitro in -mouse liver 12 cells treated with palmitate mimicking the HFD state. In addition, global gene analysis indicated that various downstream targets of nSrebp2, were up-regulated in HFD-Tg livers. Moreover, HFD-WT mice displayed islet hypertrophy and suppression of glucose-induced insulin secretion from islets, whereas HFD-Tg mice had normal pancreatic islets. This finding suggests that the improved pancreatic metabolism of HFD-Tg mice is related to the systemic effect of insulin resistance, not to the autonomous influence of pancreatic cells. Tudor-SN is likely to be a key regulator for ameliorating HFD-induced hepatic steatosis and systemic insulin resistance in vivo.Wang, X., Xin, L., Duan, Z., Zuo, Z., Wang, Y., Ren, Y., Zhang, W., Sun, X., Liu, X., Ge, L., Yang, X., Yao, Z., Yang, J. Global Tudor-SN transgenic mice are protected from obesity-induced hepatic steatosis and insulin resistance.	[Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Minist Educ, Key Lab Immune Microenvironm & Dis, Tianjin, Peoples R China; [Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Key Lab Cellular & Mol Immunol, Tianjin, Peoples R China; [Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin, Peoples R China; [Yang, Xi] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; University of Manitoba	Yao, Z; Yang, J (corresponding author), Tianjin Med Univ, 22 Qixiangtailu Rd, Tianjin 300070, Peoples R China.	yaozhi@tmu.edu.cn; yangj@tmu.edu.cn		Ge, Lin/0000-0001-7653-2554; Yang, Xi/0000-0002-8831-7488; Wang, Xinting/0000-0001-9292-3619	National Science Foundation for Distinguished Young Scholars of China [31125012]; Innovation Team Development Plan of the Ministry of Education [IRT13085]; National Natural Science Foundation of China [31300709, 31870747, 31370749]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Innovation Team Development Plan of the Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge histology assistancefrom Hongshuai Li (Tianjin Medical University). This work was supported by Grant 31125012 from the National Science Foundation for Distinguished Young Scholars of China (to J.Y.), Grant IRT13085 from the Innovation Team Development Plan of the Ministry of Education (to J.Y.), Grant 31300709 (to X.W.), and Grants 31870747 and 31370749 (to J.Y.) from National Natural Science Foundation of China. The authors declare no conflicts of interest.	Arretxe E, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv858; Beaven SW, 2013, CELL METAB, V18, P106, DOI 10.1016/j.cmet.2013.04.021; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Broadhurst MK, 2001, J ENDOCRINOL, V171, P329, DOI 10.1677/joe.0.1710329; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Ding YY, 2016, EBIOMEDICINE, V7, P135, DOI 10.1016/j.ebiom.2016.04.002; Duan ZC, 2014, J BIOL CHEM, V289, P8364, DOI 10.1074/jbc.M113.523456; Fashe T, 2013, TISSUE CELL, V45, P21, DOI 10.1016/j.tice.2012.09.001; Fu X, 2018, CELL DEATH DIFFER, V25, P1625, DOI 10.1038/s41418-018-0068-9; Gao XJ, 2015, FEBS J, V282, P874, DOI 10.1111/febs.13186; Garcia-Arcos I, 2010, J PHYSIOL BIOCHEM, V66, P73, DOI 10.1007/s13105-010-0011-0; Gutierrez-Beltran E, 2016, CELL DEATH DIFFER, V23, P1739, DOI 10.1038/cdd.2016.93; Haas ME, 2013, TRENDS ENDOCRIN MET, V24, P391, DOI [10.101, 10.1016/j.tem.2013.04.001]; Han S, 2009, J CLIN INVEST, V119, P1029, DOI 10.1172/JCI36523; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Keenan TW, 2000, BBA-GEN SUBJECTS, V1523, P84, DOI 10.1016/S0304-4165(00)00106-9; Krishan S, 2016, DIABETES METAB SYND, V10, pS77, DOI 10.1016/j.dsx.2016.01.034; Laatsch A, 2009, ATHEROSCLEROSIS, V204, P105, DOI 10.1016/j.atherosclerosis.2008.07.046; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Liu CC, 2015, J NEUROSCI, V35, P5851, DOI 10.1523/JNEUROSCI.5180-14.2015; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Miao J, 2014, J LIPID RES, V55, P659, DOI 10.1194/jlr.M043711; Mobin MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12848; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Navarro-Imaz H, 2016, BBA-MOL CELL BIOL L, V1861, P988, DOI 10.1016/j.bbalip.2016.05.011; Palacios L, 2006, BBA-MOL CELL BIOL L, V1761, P698, DOI 10.1016/j.bbalip.2006.05.005; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Ponziani FR, 2015, EXPERT REV GASTROENT, V9, P1055, DOI 10.1586/17474124.2015.1056156; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Scherer T, 2016, DIABETES, V65, P1511, DOI 10.2337/db15-1552; Su C, 2017, BBA-MOL CELL RES, V1864, P562, DOI 10.1016/j.bbamcr.2016.12.018; Su C, 2015, J BIOL CHEM, V290, P7208, DOI 10.1074/jbc.M114.625046; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Yu L, 2017, ONCOGENE, V36, P3903, DOI 10.1038/onc.2017.30; Yu L, 2015, CANCER RES, V75, P1275, DOI 10.1158/0008-5472.CAN-14-2387	43	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3731	3745		10.1096/fj.201801253RR	http://dx.doi.org/10.1096/fj.201801253RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521378	Bronze			2022-12-28	WOS:000459794800052
J	Xie, SS; Jin, J; Xu, ZQ; Huang, YL; Zhang, W; Zhao, L; Lo, LJ; Peng, JR; Liu, W; Wang, FD; Shu, Q; Zhou, TH				Xie, Shanshan; Jin, Juan; Xu, Zhangqi; Huang, Yuliang; Zhang, Wen; Zhao, Lu; Lo, Li Jan; Peng, Jinrong; Liu, Wei; Wang, Fudi; Shu, Qiang; Zhou, Tianhua			Centrosomal protein FOR20 is essential for cilia-dependent development in zebrafish embryos	FASEB JOURNAL			English	Article						ciliogenesis; morphants; ciliopathies; Kupffer's vesicle	KUPFFERS VESICLE; SIZE CONTROL; CILIOGENESIS; TRANSITION; MECHANISMS; PRONEPHROS; DEFECTS; FLOW	Centrosomal proteins play critical roles in ciliogenesis. Mutations in many centrosomal proteins have been documented to contribute to developmental defects and cilium-related diseases. Centrosomal protein fibroblast growth factor receptor 1 oncogene partner-related protein of 20 kDa (FOR20) is crucial for ciliogenesis in mammalian cells and the unicellular eukaryote Paramecium; however, the biologic significance of FOR20 in vertebrate development remains unclear. We cloned the zebrafish homolog of the for20 gene and found that for20 mRNA is enriched in ciliated tissues during early zebrafish development. Knockdown of for20 by morpholino oligonucleotides in zebrafish results in multiple ciliary phenotypes, including curved body, hydrocephaly, pericardial edema, kidney cysts, and left-right asymmetry defects. for20 morphants show reduced number and length of cilia in Kupffer's vesicle and pronephric ducts. High-speed video microscopy reveals that cilia in most for20 morphants are consistently paralyzed or beat arrhythmically. To confirm the ciliary phenotypes of for20 morphants, we used the CRISPR/Cas9 system to disrupt for20 gene in zebrafish. for20 mutants exhibit multiple ciliary phenotypes resembling the defects in for20 morphants. All of these phenotypes in for20 morphants and mutants are significantly reversed by exogenous expression of for20 mRNA. Taken together, these data suggest that FOR20 is required for cilium-mediated processes during zebrafish embryogenesis.Xie, S., Jin, J., Xu, Z., Huang, Y., Zhang, W., Zhao, L., Lo, L. J., Peng, J., Liu, W., Wang, F., Shu, Q., Zhou, T. Centrosomal protein FOR20 is essential for cilia-dependent development in zebrafish embryos.	[Xie, Shanshan; Shu, Qiang] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310052, Zhejiang, Peoples R China; [Xie, Shanshan; Jin, Juan; Xu, Zhangqi; Huang, Yuliang; Zhang, Wen; Zhao, Lu; Liu, Wei; Wang, Fudi; Zhou, Tianhua] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Lo, Li Jan; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Minist Educ MOE, Key Lab Mol Anim Nutr, Hangzhou, Zhejiang, Peoples R China; [Zhou, Tianhua] Joint Inst Genet & Genom Med Zhejiang Univ & Univ, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Shu, Q (corresponding author), Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310052, Zhejiang, Peoples R China.; Zhou, TH (corresponding author), Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China.	shuqiang@zju.edu.cn; tzhou@zju.edu.cn	Wang, Fudi/L-7888-2018; xie, shanshan/GSM-8999-2022; zhou, tianhua/K-4908-2013; Zhao, Lu/CAG-9052-2022	Wang, Fudi/0000-0001-8730-0003; zhou, tianhua/0000-0002-1791-2124; XIE, SHANSHAN/0000-0003-4294-8169	Chinese National Natural Scientific Foundation [31801132, 31620103911, 91740205, 31571446]	Chinese National Natural Scientific Foundation	The authors thank Dr. Xubo Niu (Boston Children's Hospital, Harvard University, Boston, MA, USA) for providing pCS2+ and pCS2+-foxa3 vector and Jun Chen (School of Life Science, Zhejiang University) for valuable suggestions and technology assistance; this work was supported by Chinese National Natural Scientific Foundation Grants 31801132, 31620103911, 91740205, and 31571446. The authors declare no conflicts of interest.	Aubusson-Fleury A, 2012, J CELL SCI, V125, P4395, DOI 10.1242/jcs.108639; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Chandrasekar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063123; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chavali PL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0468; Feng SJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.32; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gokey JJ, 2016, DEV DYNAM, V245, P22, DOI [10.1002/DVDY.24355, 10.1002/dvdy.24355]; Hamada H, 2012, DEV CELL, V22, P911, DOI 10.1016/j.devcel.2012.05.003; Hilgendorf KI, 2016, CURR OPIN CELL BIOL, V39, P84, DOI 10.1016/j.ceb.2016.02.008; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Juan H, 2001, GENES CELLS, V6, P923, DOI 10.1046/j.1365-2443.2001.00481.x; Kim S, 2013, CURR OPIN CELL BIOL, V25, P506, DOI 10.1016/j.ceb.2013.04.011; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058589; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pickett J, 2007, NAT REV MOL CELL BIO, V8, P676, DOI 10.1038/nrm2243; Sedjai F, 2010, J CELL SCI, V123, P2391, DOI 10.1242/jcs.065045; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; Shen MH, 2013, CELL RES, V23, P1284, DOI 10.1038/cr.2013.127; Sorrells S, 2013, JOVE-J VIS EXP, DOI 10.3791/51060; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tumaneng K, 2012, CURR BIOL, V22, pR368, DOI 10.1016/j.cub.2012.03.003; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yang XL, 2011, CELL RES, V21, P715, DOI 10.1038/cr.2011.63; Zhang C, 2016, CELL RES, V26, P239, DOI 10.1038/cr.2015.152; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004	40	6	6	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3613	3622		10.1096/fj.201801235RR	http://dx.doi.org/10.1096/fj.201801235RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30475641	Bronze			2022-12-28	WOS:000459794800042
J	Yu, YT; Situ, QJ; Jia, WY; Li, JX; Wu, Q; Lei, JZ				Yu, Yingting; Situ, Qiaojun; Jia, Wangyue; Li, Junxiang; Wu, Qiong; Lei, Jinzhi			Data driven mathematical modeling reveals the dynamic mechanism of MSC-induced neovascularization	FASEB JOURNAL			English	Article						extracellular matrix; COL1A1; endothelial cells	MESENCHYMAL STEM-CELLS; BLOOD-VESSELS; ANGIOGENESIS; MIGRATION; MATRIX; MMP-2	Coculture of mesenchymal stem cells (MSCs) and vascular endothelial cells (ECs) in vitro leads to the formation of a capillary-like reticular structure by ECs, which has great potential as a better substitute for artificial blood vessels in terms of stability and functionality. To investigate the mechanisms of the early neovascularization induced by MSCs, we analyzed the kinematic features of the motion of ECs and concluded that the dynamic interaction between cells and the extracellular matrix would reveal the capillary-like structure formation. Based on this hypothesis, we proposed a mathematical model to simulate the vascular-like migration pattern of ECs in silico, which was confirmed by in vitro studies. These in vitro studies validated that the dynamic secretion and degradation of collagen I is the critical factor for capillary structure formation. The model proposed based on cell tracking, single cell sequencing, and mathematical simulation provides a better understanding of the neovascularization process induced by MSCs and a possible simple explanation guiding this important cellular behavior.Yu, Y., Situ, Q., Jia, W., Li, J., Wu, Q., Lei, J. Data driven mathematical modeling reveals the dynamic mechanism of MSC-induced neovascularization.	[Yu, Yingting; Jia, Wangyue; Li, Junxiang; Wu, Qiong; Lei, Jinzhi] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Yu, Yingting; Jia, Wangyue; Li, Junxiang; Wu, Qiong] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing, Peoples R China; [Yu, Yingting; Jia, Wangyue; Li, Junxiang; Wu, Qiong] Tsinghua Univ, Sch Life Sci, Life Sci New Bldg,Tsinghua Yuan 1, Beijing 100084, Peoples R China; [Situ, Qiaojun; Lei, Jinzhi] Tsinghua Univ, Zhou Pei Yuan Ctr Appl Math, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Wu, Q (corresponding author), Tsinghua Univ, Sch Life Sci, Life Sci New Bldg,Tsinghua Yuan 1, Beijing 100084, Peoples R China.; Lei, JZ (corresponding author), Tsinghua Univ, Zhou Pei Yuan Ctr Appl Math, Beijing 100084, Peoples R China.	wuqiong@mail.tsinghua.edu.cn; jzlei@mail.tsinghua.edu.cn	wu, qiong/GRY-4672-2022; Lei, Jinzhi/M-6311-2018	Lei, Jinzhi/0000-0002-2670-6760	Natural Sciences Foundation of China [31470933, 31170940, 91730301]; Tsinghua University Initiative Scientific Research Program [20131089199]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	This research was supported by the Natural Sciences Foundation of China (grant Nos. 31470933, 31170940, and 91730301), and the Tsinghua University Initiative Scientific Research Program (no. 20131089199). The authors declare no conflicts of interest.	Anderson JD, 2016, STEM CELLS, V34, P601, DOI 10.1002/stem.2298; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Burns JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021888; Czirok A, 2013, WIRES SYST BIOL MED, V5, P587, DOI 10.1002/wsbm.1233; D'Alessio A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/126582; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Freiman A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0251-6; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Holmes D, 2017, NATURE, V548, pS42, DOI 10.1038/548S42a; Hu GW, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt546; Kim SW, 2006, STEM CELLS, V24, P1620, DOI 10.1634/stemcells.2005-0365; Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Lee HC, 2012, CIRC J, V76, P1750, DOI 10.1253/circj.CJ-11-1135; Lee H, 2013, BIOCHEM BIOPH RES CO, V437, P232, DOI 10.1016/j.bbrc.2013.06.046; Li HY, 2013, J CELL BIOCHEM, V114, P650, DOI 10.1002/jcb.24407; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016767; Li JX, 2015, STEM CELLS DEV, V24, P610, DOI 10.1089/scd.2014.0330; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Melchiorri AJ, 2014, TISSUE ENG PART B-RE, V20, P218, DOI [10.1089/ten.teb.2013.0541, 10.1089/ten.TEB.2013.0541]; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Merks RMH, 2006, NONLINEARITY, V19, pC1, DOI 10.1088/0951-7715/19/1/000; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; Samuel R, 2013, P NATL ACAD SCI USA, V110, P12774, DOI 10.1073/pnas.1310675110; Scianna M, 2013, J THEOR BIOL, V333, P174, DOI 10.1016/j.jtbi.2013.04.037; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; Sipp D, 2018, NATURE, V561, P455, DOI 10.1038/d41586-018-06756-9; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; van Oers RFM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003774; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287	37	4	4	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3496	3509		10.1096/fj.201801652R	http://dx.doi.org/10.1096/fj.201801652R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30517036	Bronze			2022-12-28	WOS:000459794800033
J	Cauvi, DM; Hawisher, D; Dores-Silva, PR; Lizardo, RE; De Maio, A				Cauvi, David M.; Hawisher, Dennis; Dores-Silva, Paulo R.; Lizardo, Radhames E.; De Maio, Antonio			Macrophage reprogramming by negatively charged membrane phospholipids controls infection	FASEB JOURNAL			English	Article						phosphatidylserine; extracellular vesicles; sepsis; inflammation	MYRISTOYL-ELECTROSTATIC SWITCH; NEUTROPHIL RECRUITMENT; PHOSPHATIDYLSERINE; VESICLES; BINDING; ALPHA; ACTIVATION; CHEMOKINES; RESOLUTION; CLEARANCE	Extracellular vesicles (ECVs) are heterogeneous membrane-enclosed structures containing proteins, nucleic acids, and lipids that participate in intercellular communication by transferring their contents to recipient cells. Although most of the attention has been directed at the biologic effect of proteins and microRNA, the contribution of phospholipids present in ECVs on cellular activation has not been extensively addressed. We investigated the biologic effect of phosphatidylserine (PS) and phosphatidylcholine (PC), 2 phospholipids highly abundant in ECVs. A transcriptomic analysis revealed that approximate to 4700 genes were specifically modified by exposing peritoneal macrophages to PS or PC liposomes in vivo. Among them, the expression of several chemokines and cytokines was highly upregulated by PS liposome treatment, translating into a massive neutrophil infiltration of the peritoneum capable of neutralizing a septic polymicrobial insult. Both the l and d stereoisomers of PS induced the same response, suggesting that the effect was related to the negative charge of the phospholipid head. We concluded that an increase in the internal negative charge of the cell triggers a signaling cascade activating an innate immune response capable of controlling infection.Cauvi, D. M., Hawisher, D., Dores-Silva, P. R., Lizardo, R. E., De Maio, A. Macrophage reprogramming by negatively charged membrane phospholipids controls infection.	[Cauvi, David M.; Hawisher, Dennis; Dores-Silva, Paulo R.; De Maio, Antonio] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [Lizardo, Radhames E.] Naval Med Ctr, Dept Surg, San Diego, CA USA	University of California System; University of California San Diego; United States Department of Defense; United States Navy; Naval Medical Center San Diego	De Maio, A (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ademaio@ucsd.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [R01 GM098455-04, R01 GM114473-01]; University of California San Diego (UCSD) Clinical and Translational Research Institute (CTRI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114473] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of California San Diego (UCSD) Clinical and Translational Research Institute (CTRI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants R01 GM098455-04 and R01 GM114473-01, as well as a grant from the University of California San Diego (UCSD) Clinical and Translational Research Institute (CTRI). The authors thank the UCSD Institute for Genomic Medicine and the Center for Computational Biology and Bioinformatics (CCBB) for their work, and Barbara Rho for her excellent editing of the manuscript. The authors declare no conflicts of interest.	BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cauvi DM, 2012, J BIOL CHEM, V287, P19804, DOI 10.1074/jbc.M112.359562; Colao IL, 2018, TRENDS MOL MED, V24, P242, DOI 10.1016/j.molmed.2018.01.006; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Epand RM, 1998, BIOCHEMISTRY-US, V37, P12068, DOI 10.1021/bi980527c; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Greenlee-Wacker MC, 2016, IMMUNOL REV, V273, P357, DOI 10.1111/imr.12453; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Kalra H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020170; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Lucas N, 2011, J BIOL CHEM, V286, P41265, DOI 10.1074/jbc.M111.300806; McKelvey KJ, 2015, J CIRC BIOMARK, V4, P7, DOI [10.5772/61186, DOI 10.5772/61186]; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; McPherson RA, 1999, ONCOGENE, V18, P3862, DOI 10.1038/sj.onc.1202730; Olivotto M, 1996, BIOESSAYS, V18, P495, DOI 10.1002/bies.950180612; Pugin J, 1999, AM J RESP CELL MOL, V20, P458, DOI 10.1165/ajrcmb.20.3.3311; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Skotland T, 2017, PROG LIPID RES, V66, P30, DOI 10.1016/j.plipres.2017.03.001; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Yang F, 2017, INFLAMMATION, V40, P311, DOI 10.1007/s10753-016-0458-4; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	38	6	6	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2995	3009		10.1096/fj.201801579R	http://dx.doi.org/10.1096/fj.201801579R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30325674	Green Published			2022-12-28	WOS:000457296600116
J	Weingarten, G; Ben Yaakov, A; Dror, E; Russ, J; Magin, TM; Kahn, CR; Wertheimer, E				Weingarten, Galina; Ben Yaakov, Aya; Dror, Erez; Russ, Jenny; Magin, Thomas M.; Kahn, C. Ronald; Wertheimer, Efrat			Insulin receptor plays a central role in skin carcinogenesis by regulating cytoskeleton assembly	FASEB JOURNAL			English	Article						epidermis; keratin; keratinocyte; transformation	METABOLIC SYNDROME; CANCER; KERATINS; MOUSE; PHOSPHORYLATION; DIFFERENTIATION; COMPLICATIONS; PATHOGENESIS; PROTEINS; KNOCKOUT	Diabetes mellitus prevalence is increasing rapidly and is a major cause of mortality and morbidity worldwide. In addition to the known severe complications associated with the disease, in recent years diabetes has been recognized as a major risk factor for cancer. Patients with diabetes experience significantly higher incidence of and higher mortality rates from many types of cancer. However, to date there are no conclusive data on the pathophysiology underlying the association between these two diseases. We previously reported that insulin regulates skin proliferation and differentiation, while IGF1 had different sometimes contrasting effects to those of insulin, suggesting direct involvement of insulin in transformation. To this end, we developed an epidermal skin-specific insulin receptor knockout (SIRKO) mouse, in which the insulin receptor (IR) is inactivated only in skin, with no other metabolic consequences. We found that IR inactivation by itself resulted in a marked decrease in skin tumorigenesis. In the control group 100% of the mice developed tumors, but in the SIRKO group tumor incidence was over 60% lower, and 25% of the SIRKO mice did not develop tumors at all, and the tumors that did develop were smaller and benign in their appearance. Furthermore, IR inactivation in vitro not only prevented cell transformation but also reversed the keratinocyte-transformed phenotype. We found that IR inactivation led to a striking abnormality in the major keratin cytoskeleton filaments structure in both in vivo and in vitro, a change that we were able to link to the decreased transformation potential in IR-null cells. In summary, we identified a unique pathway in which IR regulates cytoskeletal assembly, thus affecting skin transformation, opening a new potential target for cancer treatment and prevention.Weingarten, G., Ben Yaakov, A., Dror, E., Russ, J., Magin, T. M., Kahn, C. R., Wertheimer, E. Insulin receptor plays a central role in skin carcinogenesis by regulating cytoskeleton assembly.	[Weingarten, Galina; Ben Yaakov, Aya; Dror, Erez; Russ, Jenny; Wertheimer, Efrat] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel; [Magin, Thomas M.] Univ Leipzig, Inst Biol, Leipzig, Germany; [Magin, Thomas M.] Univ Leipzig, SIKT, Leipzig, Germany; [Kahn, C. Ronald] Joslin Diabet Ctr, Boston, MA 02215 USA; [Kahn, C. Ronald] Harvard Med Sch, Boston, MA USA	Tel Aviv University; Sackler Faculty of Medicine; Leipzig University; Leipzig University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Wertheimer, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel.	effyw@post.tau.ac.il	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	Israel Cancer Research Fund (ICRF); Tel Aviv University (TAU) Citernik Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, P30DK036836, R37DK031036] Funding Source: NIH RePORTER	Israel Cancer Research Fund (ICRF); Tel Aviv University (TAU) Citernik Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We dedicate this article to the memory of I. Hammel (1950-2016), an EM-acknowledged scientist and the chair of the Pathology Department at Sackler Faculty of Medicine, Tel Aviv University. This work was supported by the Israel Cancer Research Fund (ICRF; to E.W.) and by the Tel Aviv University (TAU) Citernik Fund (to E.W.). The authors declare no conflicts of interest.	Ben-Shmuel S, 2016, HANDB EXP PHARMACOL, V233, P355, DOI 10.1007/164_2015_12; Boucher J, 2014, COLD SPRING HARB PER, V6; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chen HX, 2013, CHIN J CANCER, V32, P242, DOI 10.5732/cjc.012.10263; Coulombe PA, 2017, J INVEST DERMATOL, V137, pE67, DOI 10.1016/j.jid.2016.04.039; De Meyts P., 2000, INSULIN RECEPTOR ITS; Garcia-Jimenez C, 2016, BRIT J CANCER, V114, P716, DOI 10.1038/bjc.2016.37; Gonzalez-Saldivar G, 2017, DERMATOLOGY THER, V7, P37, DOI 10.1007/s13555-016-0160-3; GRAHAM RC, 1965, J HISTOCHEM CYTOCHEM, V13, P604, DOI 10.1177/13.7.604; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P537, DOI 10.1016/S2213-8587(16)30010-9; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; HAMMEL I, 1989, J ELECTRON MICR TECH, V11, P27, DOI 10.1002/jemt.1060110105; Holden SE, 2016, ENDOCR DEV, V31, P135, DOI 10.1159/000439410; Homberg M, 2014, INT REV CEL MOL BIO, V311, P265, DOI 10.1016/B978-0-12-800179-0.00007-6; Hua F, 2016, CANCER LETT, V374, P54, DOI 10.1016/j.canlet.2016.02.006; Janssen JAMJL, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00224; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kim HJ, 2015, BIOMOL THER, V23, P301, DOI 10.4062/biomolther.2015.032; Klil-Drori AJ, 2017, NAT REV CLIN ONCOL, V14, P85, DOI 10.1038/nrclinonc.2016.120; Knobel M, 2015, CELL TISSUE RES, V360, P583, DOI 10.1007/s00441-014-2105-4; Kurdi AT, 2013, LANCET, V382, pE31, DOI 10.1016/S0140-6736(13)60145-2; Li CY, 2013, DIABETES CARE, V36, P1569, DOI 10.2337/dc12-1432; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Napolitano M, 2015, SCI WORLD J, V2015; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Quondamatteo F, 2014, CELL TISSUE RES, V355, P1, DOI 10.1007/s00441-013-1751-2; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Roth J, 2012, DIABETES-METAB RES, V28, P293, DOI 10.1002/dmrr.2300; Sadagurski M, 2006, MOL CELL BIOL, V26, P2675, DOI 10.1128/MCB.26.7.2675-2687.2006; Sadagurski M, 2005, J BIOL CHEM, V280, P14536, DOI 10.1074/jbc.M410227200; Sadagurski M, 2007, J CELL PHYSIOL, V213, P519, DOI 10.1002/jcp.21131; Sawant MS, 2017, INT REV CEL MOL BIO, V330, P171, DOI 10.1016/bs.ircmb.2016.09.005; Shlomai G, 2016, J CLIN ONCOL, V34, P4261, DOI 10.1200/JCO.2016.67.4044; Shoichetman T, 2001, J HISTOCHEM CYTOCHEM, V49, P1199, DOI 10.1177/002215540104901001; Singh P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0805-3; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tennenbaum T, 1998, CANCER RES, V58, P1435; Terron-Kwiatkowski A, 2006, J INVEST DERMATOL, V126, P607, DOI 10.1038/sj.jid.5700152; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Tseng HW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004070; Vigneri R, 2016, J ENDOCRINOL INVEST, V39, P1365, DOI 10.1007/s40618-016-0508-7; Wang FR, 2016, METHOD ENZYMOL, V568, P303, DOI 10.1016/bs.mie.2015.09.032; Wertheimer E, 2000, J INVEST DERMATOL, V115, P24, DOI 10.1046/j.1523-1747.2000.00008.x; Wertheimer E, 2004, ISR MED ASSOC J, V6, P287; Wertheimer E, 2001, ENDOCRINOLOGY, V142, P1234, DOI 10.1210/en.142.3.1234; Wertheimer E., 2004, DIABETES MELLITUS, P1411; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Wojciechowska J, 2016, EXP CLIN ENDOCR DIAB, V124, P263, DOI 10.1055/s-0042-100910; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6	51	2	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2241	2251		10.1096/fj.201800847R	http://dx.doi.org/10.1096/fj.201800847R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30332298	Green Published			2022-12-28	WOS:000457296600057
J	Jiang, X; Zhang, ZT; Cheng, K; Wu, Q; Jiang, L; Pielak, GJ; Liu, ML; Li, CG				Jiang, Xin; Zhang, Zeting; Cheng, Kai; Wu, Qiong; Jiang, Ling; Pielak, Gary J.; Liu, Maili; Li, Conggang			Membrane-mediated disorder-to-order transition of SNAP25 flexible linker facilitates its interaction with syntaxin-1 and SNARE-complex assembly	FASEB JOURNAL			English	Article						prefusion state; protein NMR; intrinsically disordered region; circular dichroism	CYSTEINE-RICH DOMAIN; SNAP-25; SYNAPTOBREVIN; PALMITOYLATION; PHOSPHORYLATION; ASSOCIATION; EXOCYTOSIS; MECHANISM; SUGGESTS	The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex comprises synaptosome-associated protein of 25 kDa (SNAP25), syntaxin-1a (syx-1), and synaptobrevin 2, which is essential for many physiologic processes requiring membrane fusion. Several studies imply that the loop region of SNAP25 plays important roles in SNARE-complex assembly. However, why and how the flexible loop facilitates the complex assembly remains poorly understood because it is purposely deleted in almost all structural studies. By using NMR spectroscopy and circular dichroism spectropolarimetry, we characterized SNAP25 structure and interactions with other SNAREs in aqueous buffer and in the membrane. We found that the N-terminal of the SNAP25 loop region binds with membrane, and this interaction induced a disorder-to-order conformational change of the loop, resulting in enhanced interaction between the C-terminal of the SNAP25 loop and syx-1. We further proved that SNARE-complex assembly efficiency decreased when we disrupted the electrostatic interaction between C-terminal of the SNAP25 loop and syx-1, suggesting that the SNAP25 loop region facilitates SNARE-complex assembly through promoting prefusion SNARE binary complex formation. Our work elucidates the role of the flexible loop and the membrane environment in SNARE-complex assembly at the residue level, which helps to understand membrane fusion, a fundamental transport and communication process in cells.-Jiang, X., Zhang, Z., Cheng, K., Wu, Q., Jiang, L., Pielak, G. J., Liu, M., Li, C. Membrane-mediated disorder-to-order transition of SNAP25 flexible linker facilitates its interaction with syntaxin-1 and SNARE-complex assembly.	[Jiang, Xin; Zhang, Zeting; Cheng, Kai; Wu, Qiong; Jiang, Ling; Liu, Maili; Li, Conggang] Chinese Acad Sci, Natl Ctr Magnet Resonance Wuhan, Wuhan Inst Phys & Math,Wuhan Natl Lab Optoelect, Key Lab Magnet Resonance Biol Syst,State Key Lab, Wuhan 430072, Hubei, Peoples R China; [Jiang, Xin; Jiang, Ling; Liu, Maili; Li, Conggang] Grad Univ Chinese Acad Sci, Beijing, Peoples R China; [Pielak, Gary J.] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC USA; [Pielak, Gary J.] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC USA; [Pielak, Gary J.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Pielak, Gary J.] Univ North Carolina Chapel Hill, Integrat Program Biol & Genome Sci, Chapel Hill, NC USA	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Huazhong University of Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Liu, ML (corresponding author), Chinese Acad Sci, Natl Ctr Magnet Resonance Wuhan, Wuhan Inst Phys & Math,Wuhan Natl Lab Optoelect, Key Lab Magnet Resonance Biol Syst,State Key Lab, Wuhan 430072, Hubei, Peoples R China.; Li, CG (corresponding author), Chinese Acad Sci, West Xiaohongshan 30, Wuhan 430072, Hubei, Peoples R China.	ml.liu@wipm.ac.cn; conggangli@wipm.ac.cn	Liu, Maili/A-8543-2011; Li, Conggang/B-6363-2011	Liu, Maili/0000-0002-9359-915X; Li, Conggang/0000-0002-5798-1722	Ministry of Science and Technology of China [2017YFA0505400]; Innovation Team of Hubei Province [2016CFA002]; National Natural Sciences Foundation of China [21735005, 21575156, 21203243, 21673284]; K. C. Wong Education Foundation; Chinese Academy of Sciences [QYZDJ-SSW-SLH027]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Innovation Team of Hubei Province; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); K. C. Wong Education Foundation; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grant 2017YFA0505400; Innovation Team of Hubei Province Grant 2016CFA002; National Natural Sciences Foundation of China Grants 21735005, 21575156, 21203243, and 21673284; the K. C. Wong Education Foundation; and the Chinese Academy of Sciences (QYZDJ-SSW-SLH027). The authors declare no conflicts of interest.	Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Brewer KD, 2011, P NATL ACAD SCI USA, V108, P12723, DOI 10.1073/pnas.1105128108; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chamberlain LH, 2013, BIOCHEM SOC T, V41, P62, DOI 10.1042/BST20120243; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Dawidowski D, 2016, STRUCTURE, V24, P392, DOI 10.1016/j.str.2016.01.005; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Foley TD, 2012, CELL MOL NEUROBIOL, V32, P201, DOI 10.1007/s10571-011-9748-4; Galves JM, 2014, ADHD-ATTEND DEFICIT, V6, P19, DOI 10.1007/s12402-013-0123-9; Gao J, 2016, CELL SIGNAL, V28, P425, DOI 10.1016/j.cellsig.2015.12.014; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Greaves J, 2011, J CELL SCI, V124, P1351, DOI 10.1242/jcs.079095; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Karlsen AS, 2013, NEUROCHEM RES, V38, P1219, DOI 10.1007/s11064-012-0918-7; Kiessling V, 2010, BIOPHYS J, V99, P4047, DOI 10.1016/j.bpj.2010.10.022; Kreutzberger AJB, 2016, BIOPHYS J, V110, P2147, DOI 10.1016/j.bpj.2016.04.011; Kunieda K, 2015, ACS CHEM NEUROSCI, V6, P1715, DOI 10.1021/acschemneuro.5b00196; Laidlaw KME, 2017, BIOCHEM SOC T, V45, P1271, DOI 10.1042/BST20170202; Liang BY, 2013, P NATL ACAD SCI USA, V110, P19384, DOI 10.1073/pnas.1314699110; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Nagy G, 2008, MOL BIOL CELL, V19, P3769, DOI 10.1091/mbc.E07-12-1218; Pallavi B, 2003, J BIOL CHEM, V278, P12737, DOI 10.1074/jbc.M208598200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Vogel K, 2000, J BIOL CHEM, V275, P2959, DOI 10.1074/jbc.275.4.2959; Weber P, 2017, ELIFE, V6, DOI [10.7554/elife.19394, 10.7554/eLife.19394]; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xu JH, 2013, CELL REP, V3, P1414, DOI 10.1016/j.celrep.2013.03.010; Yu HJ, 2015, J AM CHEM SOC, V137, P12873, DOI 10.1021/jacs.5b08306	38	4	4	1	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7985	7994		10.1096/fj.201802796R	http://dx.doi.org/10.1096/fj.201802796R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30916996	Bronze			2022-12-28	WOS:000476234700015
J	Niu, YJ; Nie, ZW; Shin, KT; Zhou, WJ; Cui, XS				Niu, Ying-Jie; Nie, Zheng-Wen; Shin, Kyung-Tae; Zhou, Wenjun; Cui, Xiang-Shun			PINK1 regulates mitochondrial morphology via promoting mitochondrial fission in porcine preimplantation embryos	FASEB JOURNAL			English	Article						mitochondrial dynamics; oxidative stress; autophagy	IN-VITRO; PARKINSONS-DISEASE; DYNAMICS; FUSION; DYSFUNCTION; METABOLISM; ORGANELLES; MACHINERY; MUTATIONS; MITOPHAGY	Phosphatase and tensin homolog-induced kinase 1 (PINK1) on the outer membranes of impaired mitochondria promotes mitophagy and regulates mitochondrial morphology. Mammalian oocytes and early embryos are mitochondria rich, but mitochondrial dynamics during preimplantation embryo development is not well-studied. To investigate whether PINK1 is required for mitochondrial dynamics in porcine preimplantation embryos, gene knockdown and inhibitors were used, and mitochondrial dynamics were observed by transmission electron microscopy. PINK1 knockdown significantly impaired blastocyst formation and quality, induced mitochondrial elongation and swelling, and reduced mitochondrial DNA copy number. PINK1 knockdown-induced mitochondrial elongation caused mitochondrial dysfunction, oxidative stress, and ATP deficiency, significantly increasing autophagy and apoptosis. Profission dynamin-related protein 1 overexpression prevented PINK1 knockdown-induced impairment of embryo development, mitochondrial elongation, and dysfunction. Thus, PINK1 promotes mitochondrial fission in porcine preimplantation embryos.-Niu, Y.-J., Nie, Z.-W., Shin, K.-T., Zhou, W., Cui, X.-S. PINK1 regulates mitochondrial morphology via promoting mitochondrial fission in porcine preimplantation embryos.	[Niu, Ying-Jie; Nie, Zheng-Wen; Shin, Kyung-Tae; Zhou, Wenjun; Cui, Xiang-Shun] Chungbuk Natl Univ, Dept Anim Sci, Chungdae Ro 1, Cheongju 28644, Chungbuk, South Korea	Chungbuk National University	Cui, XS (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Chungdae Ro 1, Cheongju 28644, Chungbuk, South Korea.	xscui@cbnu.ac.kr		Niu, Ying-Jie/0000-0003-1829-1718	National Research Foundation of Korea - Korea government (Ministry of Science and Information and Communication Technology) [2018R1A2B6001173]; China Scholarship Council [(2017)3109]	National Research Foundation of Korea - Korea government (Ministry of Science and Information and Communication Technology); China Scholarship Council(China Scholarship Council)	This work was supported by the National Research Foundation of Korea funded by the Korea government (Ministry of Science and Information and Communication Technology; 2018R1A2B6001173). Y.-J.N. thanks the China Scholarship Council for its financial support [(2017)3109]. The authors declare no conflicts of interest.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Bertolin G, 2013, AUTOPHAGY, V9, P1801, DOI 10.4161/auto.25884; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Eleftheriadis T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00279; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Ferris J, 2016, REPROD TOXICOL, V59, P128, DOI 10.1016/j.reprotox.2015.12.002; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-22; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002; Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Khurana NK, 2000, BIOL REPROD, V62, P847, DOI 10.1095/biolreprod62.4.847; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; NASRESFAHANI MH, 1990, DEVELOPMENT, V109, P501; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rojansky R, 2016, ELIFE, V5, DOI 10.7554/eLife.17896; Sarmann J, 2009, J BIOL CHEM, V284, P16482, DOI 10.1074/jbc.M808255200; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Sutton-McDowall ML, 2012, THERIOGENOLOGY, V77, P1632, DOI 10.1016/j.theriogenology.2011.12.008; Thompson JG, 1996, J REPROD FERTIL, V106, P299, DOI 10.1530/jrf.0.1060299; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu WD, 2011, HUM MOL GENET, V20, P3227, DOI 10.1093/hmg/ddr235	40	18	19	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7882	7895		10.1096/fj.201802473R	http://dx.doi.org/10.1096/fj.201802473R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30897005				2022-12-28	WOS:000476234700008
J	Hwang, JS; Lee, WJ; Hur, J; Lee, HG; Kim, E; Lee, GH; Choi, MJ; Lim, DS; Paek, KS; Seo, HG				Hwang, Jung Seok; Lee, Won Jin; Hur, Jinwoo; Lee, Hyuk Gyoon; Kim, Eunsu; Lee, Gyeong Hee; Choi, Mi-Jung; Lim, Dae-Seog; Paek, Kyung Shin; Seo, Han Geuk			Rosiglitazone-dependent dissociation of HuR from PPAR-gamma regulates adiponectin expression at the posttranscriptional level	FASEB JOURNAL			English	Article						human antigen R; posttranscriptional regulation; rosiglitazone	ACTIVATED-RECEPTOR-GAMMA; CYTOPLASMIC MESSENGER-RNA; INCREASES PLASMA-LEVELS; LIGAND-BINDING DOMAIN; GENE-EXPRESSION; DOWN-REGULATION; PROTEIN; ALPHA; PHOSPHORYLATION; SECRETION	Peroxisome proliferator-activated receptor (PPAR)-gamma has been implicated as a key player in the regulation of adiponectin levels via both transcriptional and posttranscriptional mechanisms. Herein, we show that PPAR-gamma interacts with human antigen R (HuR) and that the PPAR-gamma-HuR complex dissociates following activation of PPAR-gamma by rosiglitazone, a specific ligand of PPAR-gamma. This rosiglitazone-dependent dissociation of HuR from PPAR-gamma leads to nucleocytoplasmic shuttling of HuR and its binding to the 3 '-UTR of adiponectin mRNA. PPAR-gamma with H321A and H447A double mutation (PPAR-gamma(H321/447A)), a mutant lacking ligand-binding activity, impaired HuR dissociation from the PPAR-gamma-HuR complex, resulting in reduced nucleocytoplasmic shuttling, even in the presence of rosiglitazone. Consequently, rosiglitazone up-regulated adiponectin levels by modulating the stability of adiponectin mRNA, whereas these effects were abolished by HuR ablation or blocked in cells expressing the PPAR-gamma(H321/447A) mutant, indicating that the interaction of PPAR-gamma and HuR is a critical event during adiponectin expression. Taken together, the findings demonstrate a novel mechanism for regulating adiponectin expression at the posttranscriptional level and suggest that ligand-mediated activation of PPAR-gamma to interfere with interaction of HuR could offer a therapeutic strategy for inflammation-associated diseases that involve decreased adiponectin mRNA stability.-Hwang, J. S., Lee, W. J., Hur, J., Lee, H. G., Kim, E., Lee, G. H., Choi, M.-J., Lim, D.-S., Paek, K. S., Seo, H. G. Rosiglitazone-dependent dissociation of HuR from PPAR-gamma regulates adiponectin expression at the posttranscriptional level.	[Hwang, Jung Seok; Lee, Won Jin; Hur, Jinwoo; Lee, Hyuk Gyoon; Kim, Eunsu; Lee, Gyeong Hee; Choi, Mi-Jung; Seo, Han Geuk] Konkuk Univ, Sanghuh Coll Life Sci, 120 Neungdong Ro, Seoul 05029, South Korea; [Lim, Dae-Seog] CHA Univ, Dept Biotechnol, Seongnam, South Korea; [Paek, Kyung Shin] Semyung Univ, Dept Nursing, Jechon, South Korea	Konkuk University; Pochon Cha University; Semyung University	Seo, HG (corresponding author), Konkuk Univ, Sanghuh Coll Life Sci, 120 Neungdong Ro, Seoul 05029, South Korea.	hgseo@konkuk.ac.kr		Lee, Won Jin/0000-0003-1164-8198	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2017R1A2A2A05001249, 2015R1A5A1009701, 2016R1C1B1009853]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported in part by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2017R1A2A2A05001249, 2015R1A5A1009701, and 2016R1C1B1009853). The authors declare no conflicts of interest.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Benegiamo G, 2018, CELL METAB, V27, P404, DOI 10.1016/j.cmet.2017.12.010; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Chandrasekar B, 2008, J BIOL CHEM, V283, P4200, DOI 10.1074/jbc.M708142200; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Choi YH, 2004, FEBS LETT, V557, P73, DOI 10.1016/S0014-5793(03)01449-2; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Doran AC, 2008, CIRC RES, V103, P624, DOI 10.1161/CIRCRESAHA.108.175893; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Fisman EZ, 2014, CARDIOL J, V21, P1, DOI 10.5603/CJ.a2013.0054; Ghanim H, 2006, J CLIN ENDOCR METAB, V91, P3553, DOI 10.1210/jc.2005-2609; Hou XY, 2013, EUR J PHARMACOL, V715, P196, DOI 10.1016/j.ejphar.2013.05.021; Hwang J. S., 2015, TUMOR BIOL, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128014; Hwang JS, 2016, PHARMACOL RES, V114, P47, DOI 10.1016/j.phrs.2016.10.014; Ikeda Y, 2000, J BIOL CHEM, V275, P33142, DOI 10.1074/jbc.M002319200; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Ke YS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14632; Kim HB, 2006, DIABETES, V55, P1342, DOI 10.2337/db05-1507; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li L, 2009, CYTOKINE, V45, P12, DOI 10.1016/j.cyto.2008.10.006; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Liu ML, 2012, BIOCHIMIE, V94, P2126, DOI 10.1016/j.biochi.2012.01.008; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Liu Y, 2014, AM J PHYSIOL-ENDOC M, V306, pE975, DOI 10.1152/ajpendo.00699.2013; Long QQ, 2010, ENDOCRINOLOGY, V151, P3195, DOI 10.1210/en.2009-1501; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Luo NL, 2011, AM J PHYSIOL-ENDOC M, V301, pE180, DOI 10.1152/ajpendo.00614.2010; Luo NL, 2010, DIABETES, V59, P791, DOI 10.2337/db09-1338; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Majuri A, 2007, EUR J ENDOCRINOL, V156, P263, DOI 10.1530/eje.1.02331; Mansour M, 2014, PROG MOL BIOL TRANSL, V121, P217, DOI 10.1016/B978-0-12-800101-1.00007-7; Nie M, 2005, J BIOL CHEM, V280, P2550, DOI 10.1074/jbc.M410616200; Pang LJ, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-15; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shibata T, 2015, BIOSCI BIOTECH BIOCH, V79, P1044, DOI 10.1080/09168451.2015.1012149; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Yanagisawa M, 2012, MOL NUTR FOOD RES, V56, P1783, DOI 10.1002/mnfr.201200284; Yang WS, 2002, DIABETES CARE, V25, P376, DOI 10.2337/diacare.25.2.376; Yoon JH, 2014, NUCLEIC ACIDS RES, V42, P1196, DOI 10.1093/nar/gkt903; Zhang YY, 2015, INFLAMMATION, V38, P756, DOI 10.1007/s10753-014-9986-y	56	5	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7707	7720		10.1096/fj.201802643R	http://dx.doi.org/10.1096/fj.201802643R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30897345	Bronze			2022-12-28	WOS:000476114200083
J	Wang, ZQ; Cai, M; Wei, L; Tay, R; Zhang, F; Wu, P; Huynh, A; Cao, XM; Di Paolo, G; Peng, JM; Milewicz, DM; Du, GW				Wang, Ziqing; Cai, Ming; Wei, Li; Tay, Rachel; Zhang, Feng; Wu, Ping; Huynh, Anh; Cao, Xiumei; Di Paolo, Gilbert; Peng, Junmin; Milewicz, Dianna M.; Du, Guangwei			Phosphatidic acid generated by PLD2 promotes the plasma membrane recruitment of IQGAP1 and neointima formation	FASEB JOURNAL			English	Article						phospholipase D; PA; VSMC; migration	MUSCLE-CELL-MIGRATION; PHOSPHOLIPASE-D; GROWTH-FACTOR; BINDING; ACTIVATION; ATHEROSCLEROSIS; MECHANISMS; SIGNAL; RHO; PHOSPHORYLATION	Very little is known about how lipid signaling regulates intima hyperplasia after vascular injury. Herein, we report that deletion and pharmacological inhibition of phospholipase D (PLD)2, which generates the signaling lipid phosphatidic acid (PA), reduced neointimal formation in the mouse carotid artery ligation model. PLD2 deficiency inhibits migration of vascular smooth muscle cells (VSMCs) into the intima in mice as well as migration and formation of membrane ruffles in primary VSMCs. PA specifically binds to the IQ motif-containing guanosine triphosphatase-activating protein 1 (IQGAP1) scaffold protein. The binding between PA and IQGAP is required for the plasma membrane recruitment of IQGAP1. Similar to PLD2 inhibition, knockdown of IQGAP1 blocks ruffle formation and migration in VSMCs, which are rescued by expression of the exogenous IQGAP1 but not the PA binding-deficient mutant. These data reveal that the PLD2-PA-IQGAP1 pathway plays an important role in VSMC migration and injury-induced vascular remodeling, and implicate PLD2 as a candidate target for therapeutic interventions.-Wang, Z., Cai, M., Tay, L. W. R., Zhang, F., Wu, P., Huynh, A., Cao, X., Di Paolo, G., Peng, J., Milewicz, D. M., Du, G. Phosphatidic acid generated by PLD2 promotes the plasma membrane recruitment of IQGAP1 and neointima formation.	[Wang, Ziqing; Cai, Ming; Wei, Li; Tay, Rachel; Zhang, Feng; Wu, Ping; Huynh, Anh; Cao, Xiumei; Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA; [Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Cai, Ming] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Gastrointestinal Surg, Union Hosp, Wuhan, Hubei, Peoples R China; [Di Paolo, Gilbert] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Ctr Prote & Metabol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zhang, Feng] Quzhou Peoples Hosp, Quzhou, Peoples R China; [Di Paolo, Gilbert] Denali Therapeut, San Francisco, CA USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology; Columbia University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Du, GW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	guangwei.du@uth.tmc.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Du, Guangwei/0000-0003-4193-6975	U.S. National Institutes of Health (NIH) National Heath, Lung, and Blood Institute [R01HL119478]; NIH, National Institute of General Medical Sciences [R01GM114260]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114260] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heath, Lung, and Blood Institute; NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for IQ motif-containing guanosine triphosphatase (GTPase)-activating protein 1 (IQGAP1) constructs from Drs. Kozo Kabuchi (Nagoya University, Nagoya, Japan [glutathione S-transferase (GST)-N, M, Ras GTPase-activating protein related domain, C, and green fluorescent protein-tagged IQGAP1), Richard A. Anderson (University of Wisconsin-Madison, Madison, WI, USA) (His-C2), and Ruth Kroschewski (ETH Zurich, Zurich, Switzerland) (GST-C1). The authors also thank Dr. Suyoung Choi (University of Wisconsin-Madison) for advice on purifying GST-C1. Confocal microscopy was performed at the Center for Advanced Microscopy, Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth). This work was supported by grants from the U.S. National Institutes of Health (NIH) National Heath, Lung, and Blood Institute (R01HL119478, to G.D.) and the NIH, National Institute of General Medical Sciences (R01GM114260, to J.P.). The authors declare no conflicts of interest.	ABEDI H, 1995, CARDIOVASC RES, V30, P544, DOI 10.1016/0008-6363(95)00092-5; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; BURSTEN SL, 1992, AM J PHYSIOL, V262, pC328, DOI 10.1152/ajpcell.1992.262.2.C328; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Choi Suyong, 2015, Advances in Biological Regulation, V60, P29, DOI 10.1016/j.jbior.2015.10.004; Choi S, 2013, EMBO J, V32, P2617, DOI 10.1038/emboj.2013.191; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Du GW, 2000, MOL BIOL CELL, V11, P4359, DOI 10.1091/mbc.11.12.4359; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Golovina VA, 2006, NAT PROTOC, V1, P2681, DOI 10.1038/nprot.2006.425; Gomez-Cambronero J, 2014, J BIOL CHEM, V289, P22557, DOI 10.1074/jbc.R114.574152; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; He JQ, 2017, FASEB J, V31, P2893, DOI 10.1096/fj.201601353R; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; INUI H, 1994, J BIOL CHEM, V269, P30546; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jiang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13875; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kohno T, 2013, AM J PHYSIOL-CELL PH, V305, pC591, DOI 10.1152/ajpcell.00011.2013; Ktistakis NT, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3151pe46; Kuhel DG, 2002, ARTERIOSCL THROM VAS, V22, P955, DOI 10.1161/01.ATV.0000017994.77066.75; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Nelson RK, 2015, J LIPID RES, V56, P2229, DOI 10.1194/jlr.R059220; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Raghu P, 2009, BBA-MOL CELL BIOL L, V1791, P889, DOI 10.1016/j.bbalip.2009.03.013; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Roach AN, 2012, J LIPID RES, V53, P2598, DOI 10.1194/jlr.M028597; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shome K, 2000, ENDOCRINOLOGY, V141, P2200, DOI 10.1210/en.141.6.2200; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Tang ZH, 2008, CIRCULATION, V118, P764, DOI 10.1161/CIRCULATIONAHA.107.761932; Tay LWR, 2017, METHOD ENZYMOL, V583, P359, DOI 10.1016/bs.mie.2016.09.043; Touyz RM, 1999, HYPERTENSION, V34, P976, DOI 10.1161/01.HYP.34.4.976; Wang ZQ, 2017, DEV CELL, V43, P186, DOI 10.1016/j.devcel.2017.09.012; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zhang LN, 2008, CURR VASC PHARMACOL, V6, P37, DOI 10.2174/157016108783331321; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013	58	6	6	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6713	6725		10.1096/fj.201800390RR	http://dx.doi.org/10.1096/fj.201800390RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811216	Bronze, Green Published			2022-12-28	WOS:000476114200004
J	Mohr, J; Voggel, J; Vohlen, C; Dinger, K; Dafinger, C; Fink, G; Gobel, H; Liebau, MC; Dotsch, J; Alcazar, MAA				Mohr, Jasmine; Voggel, Jenny; Vohlen, Christina; Dinger, Katharina; Dafinger, Claudia; Fink, Gregor; Goebel, Heike; Liebau, Max C.; Doetsch, Joerg; Alcazar, Miguel A. Alejandre			IL-6/Smad2 signaling mediates acute kidney injury and regeneration in a murine model of neonatal hyperoxia	FASEB JOURNAL			English	Article						CKD; inflammation; nephrogenesis; neonatal chronic lung disease	INTRAUTERINE GROWTH RESTRICTION; YOUNG-ADULT AGE; OXIDATIVE STRESS; PRETERM INFANTS; RENAL-FUNCTION; RISK-FACTORS; FACTOR-BETA; INTERLEUKIN-6; BIRTH; EXPRESSION	Prematurity is linked to incomplete nephrogenesis and risk of chronic kidney diseases (CKDs). Oxygen is life-saving in that context but induces injury in numerous organs. Here, we studied the structural and functional impact of hyperoxia on renal injury and its IL-6 dependency. Newborn wild-type (WT) and IL-6 knockout (IL-6(-/-)) mice were exposed to 85% O-2 for 28 d, followed by room air until postnatal d (P) 70. Controls were in room air throughout life. At P28, hyperoxia reduced estimated kidney cortex area (KCA) in WT; at P70, KCA was greater, number of glomeruli was fewer, fractional potassium excretion was higher, and glomerular filtration rate was slightly lower than in controls. IL-6(-/-) mice were protected from these changes after hyperoxia. Mechanistically, the acute renal injury phase (P28) showed in WT but not in IL-6(-/-) mice an activation of IL-6 (signal transducer and activator of transcription 3) and TGF- [mothers against decapentaplegic homolog (Smad)2] signaling, increased inflammatory markers, disrupted mitochondrial biogenesis, and reduced tubular proliferation. Regenerative phase at P70 was characterized by tubular proliferation in WT but not in IL-6(-/-) mice. These data demonstrate that hyperoxia increases the risk of CKD through a novel IL-6-Smad2 axis. The amenability of these pathways to pharmacological approaches may offer new avenues to protect premature infants from CKD.Mohr, J., Voggel, J., Vohlen, C., Dinger, K., Dafinger, C., Fink, G., Gobel, H., Liebau, M. C., Dotsch, J., Alejandre Alcazar, M. A. IL-6/Smad2 signaling mediates acute kidney injury and regeneration in a murine model of neonatal hyperoxia.	[Mohr, Jasmine; Vohlen, Christina; Dinger, Katharina; Alcazar, Miguel A. Alejandre] Univ Cologne, Fac Med, Translat Expt Pediat, Cologne, Germany; [Mohr, Jasmine; Voggel, Jenny; Vohlen, Christina; Dinger, Katharina; Dafinger, Claudia; Fink, Gregor; Liebau, Max C.; Doetsch, Joerg; Alcazar, Miguel A. Alejandre] Univ Cologne, Fac Med, Dept Pediat & Adolescent Med, Cologne, Germany; [Mohr, Jasmine; Vohlen, Christina; Dafinger, Claudia; Liebau, Max C.; Alcazar, Miguel A. Alejandre] Univ Cologne, Fac Med, CMMC, Cologne, Germany; [Dafinger, Claudia; Liebau, Max C.] Univ Cologne, Fac Med, Nephrol Res Lab, Dept Med 2, Cologne, Germany; [Goebel, Heike] Univ Cologne, Fac Med, Inst Pathol, Cologne, Germany; [Goebel, Heike] Univ Hosp Cologne, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Alcazar, MAA (corresponding author), Univ Cologne, Translat Expt Pediat Expt Pulmonol, Dept Pediat & Adolescent Med, Kerpener Str 62, D-50937 Cologne, Germany.	miguel.alejandre-alcazar@uk-koeln.de	Liebau, Max Christoph/K-3470-2019	Liebau, Max Christoph/0000-0003-0494-9080; Voggel, Jenny/0000-0001-9120-2203; Goebel, Heike/0000-0002-0171-7025; Fink, Gregor/0000-0001-7042-1706; Alejandre Alcazar, Miguel Angel/0000-0002-3176-0411	Marga und Walter Boll Stiftung; Center of Molecular Medicine Cologne (CMMC), University Hospital Cologne; Deutsche Forschungsgemeinschaft [1632/2-1]	Marga und Walter Boll Stiftung; Center of Molecular Medicine Cologne (CMMC), University Hospital Cologne; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank the Larsson Laboratory (Max Planck Institute for Biology of Ageing, Cologne, Germany) for kindly providing polyclonal rabbit anti-mitochondrial transcription factor A antibody. This work was supported by Marga und Walter Boll Stiftung (M.A.A.A.); the Center of Molecular Medicine Cologne (CMMC), University Hospital Cologne (M.A.A.A.); and Deutsche Forschungsgemeinschaft (1632/2-1; M.A.A.A.). The authors declare no conflicts of interest.	Alcazar MAA, 2012, ENDOCRINOLOGY, V153, P1397, DOI 10.1210/en.2011-1670; Alcazar MAA, 2011, NEPHROL DIAL TRANSPL, V26, P2453, DOI 10.1093/ndt/gfq825; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Askenazi D, 2015, PEDIATR NEPHROL, V30, P1511, DOI 10.1007/s00467-015-3087-5; Bacchetta J, 2009, KIDNEY INT, V76, P445, DOI 10.1038/ki.2009.201; Bartram MP, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0053-1; Bienaime F, 2016, J AM SOC NEPHROL, V27, P3690, DOI 10.1681/ASN.2015091014; Black MJ, 2015, AM J PHYSIOL-REG I, V309, pR1153, DOI 10.1152/ajpregu.00403.2014; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Bruun JM, 2003, EUR J ENDOCRINOL, V148, P535, DOI 10.1530/eje.0.1480535; Caglar K, 2002, KIDNEY INT, V62, P1408, DOI 10.1111/j.1523-1755.2002.kid556.x; Carmody JB, 2013, PEDIATRICS, V131, P1168, DOI 10.1542/peds.2013-0009; Choi CW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035250500404085; Cooper R, 2009, INT J EPIDEMIOL, V38, P235, DOI 10.1093/ije/dyn154; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Faa G, 2010, J MATERN-FETAL NEO M, V23, P129, DOI 10.3109/14767058.2010.510646; Georgeson GD, 2002, EUR J OBSTET GYN R B, V103, P136, DOI 10.1016/S0301-2115(02)00050-7; GOLDSTEIN RS, 1988, FASEB J, V2, P2241, DOI 10.1096/fasebj.2.7.3280378; Gubhaju L, 2009, AM J PHYSIOL-RENAL, V297, pF1668, DOI 10.1152/ajprenal.00163.2009; Hallan S, 2008, AM J KIDNEY DIS, V51, P10, DOI 10.1053/j.ajkd.2007.09.013; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Jiang JS, 2015, PEDIATR NEONATOL, V56, P235, DOI 10.1016/j.pedneo.2014.11.003; Kandasamy Y, 2013, PEDIATR NEPHROL, V28, P1791, DOI 10.1007/s00467-013-2462-3; Kasper P, 2017, ENDOCRINOLOGY, V158, P3399, DOI 10.1210/en.2017-00489; Keijzer-Veen MG, 2010, PEDIATR NEPHROL, V25, P499, DOI 10.1007/s00467-009-1371-y; Keijzer-Veen MG, 2005, J AM SOC NEPHROL, V16, P2762, DOI 10.1681/ASN.2004090783; Lawlor KE, 2014, BBA-GEN SUBJECTS, V1840, P1433, DOI 10.1016/j.bbagen.2013.08.014; Lecart C, 2000, BIOL NEONATE, V77, P217, DOI 10.1159/000014219; Lee Yuan-Shun, 2005, Chang Gung Med J, V28, P846; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Murakami K, 1997, PEDIATR NEPHROL, V11, P334, DOI 10.1007/s004670050289; Navarro G, 2014, SEMIN ARTHRITIS RHEU, V43, P458, DOI 10.1016/j.semarthrit.2013.08.001; Nicholas SB, 2015, ADV CHRONIC KIDNEY D, V22, P6, DOI 10.1053/j.ackd.2014.07.002; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684; Perrone S, 2007, CLIN BIOCHEM, V40, P656, DOI 10.1016/j.clinbiochem.2007.01.012; Popescu CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082421; Ratner V, 2009, AM J RESP CELL MOL, V40, P511, DOI 10.1165/rcmb.2008-0341RC; Reckelhoff JF, 1997, AM J PHYSIOL-REG I, V272, pR1985, DOI 10.1152/ajpregu.1997.272.6.R1985; Rivera L, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00033; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Ryan D, 2018, EBIOMEDICINE, V27, P275, DOI 10.1016/j.ebiom.2017.12.016; Sen N, 2011, MOL CELL, V44, P621, DOI 10.1016/j.molcel.2011.08.044; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Starr MC, 2018, CURR OPIN PEDIATR, V30, P228, DOI 10.1097/MOP.0000000000000607; Stritzke Amelie, 2017, Mol Cell Pediatr, V4, P2, DOI 10.1186/s40348-016-0068-0; Sureshbabu A, 2015, REDOX BIOL, V4, P208, DOI 10.1016/j.redox.2015.01.001; Sutherland MR, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12887; Sutherland MR, 2013, AM J PHYSIOL-RENAL, V304, pF1308, DOI 10.1152/ajprenal.00172.2012; Takahashi T, 2000, RENAL FAILURE, V22, P345, DOI 10.1081/JDI-100100878; THOMPSON NL, 1989, J CELL BIOL, V108, P661, DOI 10.1083/jcb.108.2.661; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251	59	11	12	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5887	5902		10.1096/fj.201801875RR	http://dx.doi.org/10.1096/fj.201801875RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30721632				2022-12-28	WOS:000466932600008
J	Fritzen, AM; Lundsgaard, AM; Jeppesen, JF; Sjoberg, KA; Hoeg, LD; Deleuran, HH; Wojtaszewski, JFP; Richter, EA; Kiens, B				Fritzen, Andreas Maechel; Lundsgaard, Anne-Marie; Jeppesen, Jacob Fuglsbjerg; Sjoberg, Kim Anker; Hoeg, Louise Dalgas; Deleuran, Henrik Hall; Wojtaszewski, Jorgen F. P.; Richter, Erik A.; Kiens, Bente			Fatty acid type-specific regulation of SIRT1 does not affect insulin sensitivity in human skeletal muscle	FASEB JOURNAL			English	Article						sirtuins; nutrition; lipid metabolism; NAD	MITOCHONDRIAL-FUNCTION; ENERGY-EXPENDITURE; GENE-EXPRESSION; OLEIC-ACID; SHORT-TERM; METABOLISM; MICE; DIET; RESISTANCE; OXIDATION	The nicotinamide adenine dinucleotide-dependent deacetylase, sirtuin (SIRT)1, in skeletal muscle is reduced in insulin-resistant states. However, whether this is an initial mechanism responsible for mediating insulin resistance in human skeletal muscle remains to be investigated. Also, SIRT1 acts as a mitochondrial gene transcriptional regulator and is induced by a short-term, high-fat diet (HFD) in human skeletal muscle. Whether saturated or unsaturated fatty acids (FAs) in the diet are important for this is unknown. We subjected 17 healthy, young men to a eucaloric control (Con) diet and 1 of 2 hypercaloric [+75% energy (E%)] HFDs for 3 d enriched in either saturated (Sat) FA (79 E% fat; Sat) or unsaturated FA (78 E% fat; Unsat). After Sat, SIRT1 protein content and activity in skeletal muscle increased (P < 0.05; similar to 40%) while remaining unchanged after Unsat. Whole-body insulin sensitivity and insulin-stimulated leg glucose uptake were reduced (P < 0.01; similar to 20%) to a similar extent compared to Con after both HFDs. We demonstrate a novel FA type-dependent regulation of SIRT1 protein in human skeletal muscle. Moreover, regulation of SIRT1 does not seem to be an initiating factor responsible for mediating insulin resistance in human skeletal muscle.	[Fritzen, Andreas Maechel; Lundsgaard, Anne-Marie; Jeppesen, Jacob Fuglsbjerg; Sjoberg, Kim Anker; Hoeg, Louise Dalgas; Deleuran, Henrik Hall; Wojtaszewski, Jorgen F. P.; Richter, Erik A.; Kiens, Bente] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Sect Mol Physiol, Copenhagen, Denmark	University of Copenhagen	Kiens, B (corresponding author), Univ Copenhagen, Univ Pk 13, DK-2100 Copenhagen, Denmark.	bkiens@nexs.ku.dk	Richter, Erik A./Y-8131-2019; Fritzen, Andreas/D-4103-2015; Sjoberg, Kim/D-7612-2015; Kiens, Bente/B-1375-2015	Richter, Erik A./0000-0002-6850-3056; Fritzen, Andreas/0000-0001-8793-9739; Sjoberg, Kim/0000-0001-6880-4804; Kiens, Bente/0000-0001-5705-5625; wojtaszewski, jorgen/0000-0001-8185-3408; Lundsgaard, Anne-Marie/0000-0002-5584-2366	Danish Ministry of Food, Agriculture, and Fisheries; Danish Medical Research Council; Lundbeck Research Foundation; Novo-Nordisk Research Foundation; European Union [LSHM-CT-2004-005272]; Danish Ministry of Science, Technology, and Innovation; Danish Diabetes Academy [NNF17SA0031406]; Alfred Benzon Foundation; Council for Independent Research/Medicine [4092-00309]	Danish Ministry of Food, Agriculture, and Fisheries; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Research Foundation(Lundbeckfonden); Novo-Nordisk Research Foundation(Novo Nordisk Foundation); European Union(European Commission); Danish Ministry of Science, Technology, and Innovation; Danish Diabetes Academy; Alfred Benzon Foundation; Council for Independent Research/Medicine	The authors acknowledge the skilled technical assistance of Irene Bech Nielsen, Betina Bolmgren, and Nicoline Resen Andersen (University of Copenhagen). This study was supported by grants from the Danish Ministry of Food, Agriculture, and Fisheries; the Danish Medical Research Council; the Lundbeck Research Foundation; the Novo-Nordisk Research Foundation; and an integrated project funded by the European Union (LSHM-CT-2004-005272). This work was carried out as a part of the Investment Capital for University Research (UNIK) Program: Food, Fitness, and Pharma for Health and Disease. The UNIK Project was supported by the Danish Ministry of Science, Technology, and Innovation. Postdoctoral fellowships of A.M.F. and A.M.L. were funded by The Danish Diabetes Academy, which is funded the Novo Nordisk Foundation (Grant NNF17SA0031406). Furthermore, A.M.F. was supported by the Alfred Benzon Foundation. K.A.S. was supported by a postdoctoral research grant from the Council for Independent Research/Medicine (4092-00309). The authors declare no conflicts of interest.	Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bakke SS, 2012, BBA-MOL CELL BIOL L, V1821, P1323, DOI 10.1016/j.bbalip.2012.07.001; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bergouignan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030164; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brandon AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121959; Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caron AZ, 2014, FASEB J, V28, P1306, DOI 10.1096/fj.13-243568; Cui XN, 2017, AM J PHYSIOL-ENDOC M, V313, pE493, DOI 10.1152/ajpendo.00122.2017; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Draznin B, 2012, HORM METAB RES, V44, P650, DOI 10.1055/s-0032-1312656; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fritzen AM, 2016, J PHYSIOL-LONDON, V594, P745, DOI 10.1113/JP271405; Fritzen AM, 2015, J PHYSIOL-LONDON, V593, P4765, DOI 10.1113/JP270821; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gliemann L, 2013, J PHYSIOL-LONDON, V591, P5047, DOI 10.1113/jphysiol.2013.258061; Helge JW, 1998, J APPL PHYSIOL, V85, P1342, DOI 10.1152/jappl.1998.85.4.1342; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hoeg LD, 2011, DIABETES, V60, P64, DOI 10.2337/db10-0698; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; JONES PJH, 1985, AM J CLIN NUTR, V42, P769, DOI 10.1093/ajcn/42.5.769; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Lim JH, 2013, J BIOL CHEM, V288, P7117, DOI 10.1074/jbc.M112.415729; Lowry H., 1972, FLEXIBLE SYSTEM ENZY; Lundsgaard AM, 2017, DIABETES, V66, P2583, DOI 10.2337/db17-0046; Lundsgaard AM, 2017, MOL METAB, V6, P22, DOI 10.1016/j.molmet.2016.11.001; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Pehmoller C, 2012, DIABETES, V61, P2743, DOI 10.2337/db11-1572; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Seyssel K, 2014, J CLIN ENDOCR METAB, V99, pE1254, DOI 10.1210/jc.2013-4379; Storgaard H, 2004, J CLIN ENDOCR METAB, V89, P1301, DOI 10.1210/jc.2003-031243; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Svensson K, 2017, ACTA PHYSIOL, V221, P193, DOI 10.1111/apha.12897; Tsintzas K, 2007, J CLIN ENDOCR METAB, V92, P3967, DOI 10.1210/jc.2007-1104; White AT, 2013, DIABETOLOGIA, V56, P1629, DOI 10.1007/s00125-013-2912-2; White AT, 2014, AM J PHYSIOL-ENDOC M, V307, pE764, DOI 10.1152/ajpendo.00001.2014; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	50	3	3	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5510	5519		10.1096/fj.201801950R	http://dx.doi.org/10.1096/fj.201801950R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30707625				2022-12-28	WOS:000462888500070
J	Wu, YZ; Chan, KYY; Leung, KT; Lam, HS; Tam, YH; Lee, KH; Li, K; Ng, PC				Wu, Yu Zheng; Chan, Kathy Yuen Yee; Leung, Kam Tong; Lam, Hugh Simon; Tam, Yuk Him; Lee, Kim Hung; Li, Karen; Ng, Pak Cheung			Dysregulation of miR-431 and target gene FOXA1 in intestinal tissues of infants with necrotizing enterocolitis	FASEB JOURNAL			English	Article						Forkhead protein; microRNA; proinflammation; enterocyte	HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; MIRNA EXPRESSION; MICRORNAS; CANCER; REGULATORS; INVASION; DISEASE; MODELS	The level of microRNA (miR)-431 was found to be markedly up-regulated in intestinal tissue of necrotizing enterocolitis (NEC). The objective of this study was to identify the target gene of miR-431 and to investigate the role of the miR-431-FOXA1 axis in the pathophysiology of NEC. The target gene of miR-431 was identified by in silico target prediction bioinformatics, luciferase assay, and Western blotting. Effects of miR-431 on downstream expression signals, cell proliferation, and apoptosis were investigated by overexpression in Caco-2 cells upon stimulation by LPS or lipoteichoic acid (LTA). FOXA1 was identified as the target gene of miR-431. Overexpression of miR-431 in Caco-2 cells significantly inhibited FOXA1, ESRRG, and HNF4A and activated IL-6, LGR5, NFKB2, PLA2G2A, PRKCZ, and TNF. IL-8 and -10 were enhanced when costimulated with LPS or LTA. These potential downstream genes were also significantly dysregulated in primary NEC tissues compared with surgical-control tissues. Overexpression of miR-431 significantly decreased proliferation and increased apoptosis of Caco-2 cells. A proposed network of miR-431-FOXA1 interaction with LPS and LTA receptors demonstrates dysregulation of transcription factors, inflammatory mediators, epithelium tight junction regulators, and cell proliferation and apoptosis signals. The miR-431-FOXA1 axis could in part be responsible for the intensification of the inflammatory response in NEC tissues and contribute to the proinflammatory pathophysiology.	[Wu, Yu Zheng; Chan, Kathy Yuen Yee; Leung, Kam Tong; Lam, Hugh Simon; Li, Karen; Ng, Pak Cheung] Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Dept Paediat, Level 6-F,Lui Che Woo Clin Sci Bldg, Hong Kong, Peoples R China; [Tam, Yuk Him; Lee, Kim Hung] Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Dept Surg, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Ng, PC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Dept Paediat, Level 6-F,Lui Che Woo Clin Sci Bldg, Hong Kong, Peoples R China.	pakcheungng@cuhk.edu.hk	Wu, Yuzheng/HHN-8865-2022; Lam, Hugh Simon/G-8373-2015; Leung, Kam Tong/I-8569-2017; Chan, Kathy/AAE-8538-2021	Lam, Hugh Simon/0000-0001-9912-0544; Leung, Kam Tong/0000-0002-7695-2513; Chan, Kathy/0000-0002-6501-9592	Hong Kong Special Administrative Region Health and Medical Research Fund Project [02130566]	Hong Kong Special Administrative Region Health and Medical Research Fund Project	This study was supported by the Hong Kong Special Administrative Region Health and Medical Research Fund Project 02130566. The authors declare no conflicts of interest.	Ares GJ, 2018, SEMIN PEDIATR SURG, V27, P29, DOI 10.1053/j.sempedsurg.2017.11.006; Chan KYY, 2014, ANN SURG, V260, P1128, DOI 10.1097/SLA.0000000000000374; Coggins SA, 2015, CLIN PERINATOL, V42, P133, DOI 10.1016/j.clp.2014.10.012; Dou CW, 2015, ONCOTARGET, V6, P13216, DOI 10.18632/oncotarget.3916; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Gupta A, 2016, EARLY HUM DEV, V97, P17, DOI 10.1016/j.earlhumdev.2016.03.008; Han XR, 2018, J CELL PHYSIOL, V233, P5895, DOI 10.1002/jcp.26394; Heida FH, 2017, J PERINATOL, V37, P67, DOI 10.1038/jp.2016.165; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kalla R, 2015, GUT, V64, P504, DOI 10.1136/gutjnl-2014-307891; Lee KP, 2015, GENE DEV, V29, P1605, DOI 10.1101/gad.263574.115; Lim JC, 2015, PEDIATR SURG INT, V31, P509, DOI 10.1007/s00383-015-3697-9; Lorenzen JM, 2015, J PHYSIOL-LONDON, V593, P1777, DOI 10.1113/JP270318; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ng PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135737; O'Sullivan F, 2017, WORLD J GASTROENTERO, V23, P7369, DOI 10.3748/wjg.v23.i41.7369; Papillon Stephanie, 2013, Adv Pediatr, V60, P263, DOI 10.1016/j.yapd.2013.04.011; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Patel RM, 2015, PEDIATR RES, V78, P232, DOI 10.1038/pr.2015.97; Ross SP, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00087; Roy I, 2014, GUT, V63, P1202, DOI 10.1136/gutjnl-2013-305886; Roy SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201172; Schmidt MF, 2014, TRENDS BIOTECHNOL, V32, P578, DOI 10.1016/j.tibtech.2014.09.002; Schultz NA, 2012, WORLD J SURG, V36, P2699, DOI 10.1007/s00268-012-1705-y; Sharma R, 2006, J PERINATOL, V26, P342, DOI 10.1038/sj.jp.7211510; Tu HH, 2015, ONCOTARGETS THER, V8, P2227, DOI 10.2147/OTT.S87976; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Ree MH, 2016, ALIMENT PHARM THER, V43, P102, DOI 10.1111/apt.13432; van der Sluis M, 2008, BIOCHEM BIOPH RES CO, V369, P1108, DOI 10.1016/j.bbrc.2008.02.158; Veenstra M, 2014, SURGERY, V156, P578, DOI 10.1016/j.surg.2014.04.031; Wang D, 2018, ACTA PHARMACOL SIN, V39, P124, DOI 10.1038/aps.2017.89; Wu RM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8713; Xu XM, 2016, WORLD J GASTROENTERO, V22, P2206, DOI 10.3748/wjg.v22.i7.2206; Ye DZ, 2009, GASTROENTEROLOGY, V137, P2052, DOI 10.1053/j.gastro.2009.08.059; Yu Q, 2018, ONCOL LETT, V15, P8088, DOI 10.3892/ol.2018.8347; Zhu X, 2016, ONCOTARGET, V7, P13139, DOI 10.18632/oncotarget.7545	41	20	24	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5143	5152		10.1096/fj.201801470R	http://dx.doi.org/10.1096/fj.201801470R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30624964	Bronze			2022-12-28	WOS:000462888500042
J	Lei, JT; Qi, RX; Tang, YG; Wang, WN; Wei, GH; Nussinov, R; Ma, BY				Lei, Jiangtao; Qi, Ruxi; Tang, Yegen; Wang, Wenning; Wei, Guanghong; Nussinov, Ruth; Ma, Buyong			Conformational stability and dynamics of the cancer-associated isoform 133p53 are modulated by p53 peptides and p53-specific DNA	FASEB JOURNAL			English	Article						160p53 cancer; p53 aggregation; p53 response element	PRION-LIKE AGGREGATION; MUTANT P53; TRANSFER-RNA; CORE DOMAIN; MUTATIONS; DELTA-133P53; CELL; EXPRESSION; P53-BETA; PHOSPHORYLATION	p53 is a tumor suppressor protein that maintains genome stability, but its 133p53 and 160p53 isoforms promote breast cancer cell invasion. The sequence truncations in the p53 core domain raise key questions related to their physicochemical properties, including structural stabilities, interaction mechanisms, and DNA-binding abilities. Herein, we investigated the conformational dynamics of 133p53 and 160p53 with and without binding to p53-specific DNA by using molecular dynamics simulations. We observed that the core domains of the 2 truncated isoforms are much less stable than wild-type (wt) p53, and the increased solvent exposure of their aggregation-triggering segment indicates their higher aggregation propensities than wt p53. We also found that 133p53 stability is modulable by peptide or DNA interactions. Adding a p53 peptide (derived from truncated p53 sequence 107-129) may help stabilize 133p53. Most importantly, our simulations of p53 isomer-DNA complexes indicate that 133p53 dimer, but not 160p53 dimer, could form a stable complex with p53-specific DNA, which is consistent with recent experiments. This study provides physicochemical insight into 133p53, 133p53-DNA complexes, 133p53's pathologic mechanism, and peptide-based inhibitor design against p53-related cancers.Lei, J., Qi, R., Tang, Y., Wang, W., Wei, G., Nussinov, R., Ma, B. Conformational stability and dynamics of the cancer-associated isoform 133p53 are modulated by p53 peptides and p53-specific DNA.	[Lei, Jiangtao; Qi, Ruxi; Wei, Guanghong] Fudan Univ, Key Lab Computat Phys Sci, State Key Lab Surface Phys, Minist Educ,Dept Phys, Shanghai, Peoples R China; [Tang, Yegen; Wang, Wenning] Fudan Univ, Inst Biomed Sci, Dept Chem, Shanghai, Peoples R China; [Nussinov, Ruth; Ma, Buyong] NCI, Basic Sci Program, Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick, MD 21701 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Inst Mol Med, Sackler Sch Med, Dept Human Genet & Mol Med, Tel Aviv, Israel	Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Ma, BY (corresponding author), NCI, Basic Sci Program, Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick, MD 21701 USA.; Wei, GH (corresponding author), Fudan Univ, Collaborat Innovat Ctr Adv Microstruct Nanjing, Key Lab Computat Phys Sci, State Key Lab Surface Phys,Minist Educ,Dept Phys, Shanghai, Peoples R China.	ghwei@fudan.edu.cn; mabuyong@mail.nih.gov	Lei, Jiangtao/GQR-1824-2022; Ma, Buyong/F-9491-2011	Lei, Jiangtao/0000-0002-1340-6259; Ma, Buyong/0000-0002-7383-719X; Nussinov, Ruth/0000-0002-8115-6415	Ministry of Science and Technology of China [2016YFA0501702]; National Natural Science Foundation of China [11674065]; U.S. National Institutes of Health (NIH) Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010440] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health (NIH) Frederick National Laboratory for Cancer Research; Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by the Ministry of Science and Technology of China (Grant 2016YFA0501702) and the National Natural Science Foundation of China (Grant 11674065). This work has also been funded in whole, or in part, by the U.S. National Institutes of Health (NIH) Frederick National Laboratory for Cancer Research under contract HHSN261200800001E. This research was supported, in part, by the Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. All simulations reported in this work were performed using the high-performance computational facilities at the NIH Biowulf Cluster and the National High Performance Computing Center of Fudan University. The authors declare no conflicts of interest.	Alexander RW, 2010, FEBS LETT, V584, P376, DOI 10.1016/j.febslet.2009.11.061; Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Aoubala M, 2011, CELL DEATH DIFFER, V18, P248, DOI 10.1038/cdd.2010.91; Arsic N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172125; Arsic N, 2015, STEM CELL REP, V4, P531, DOI 10.1016/j.stemcr.2015.02.001; Bernard H, 2013, ONCOGENE, V32, P2150, DOI 10.1038/onc.2012.242; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Blandino G, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0705-7; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Candeias MM, 2016, EMBO REP, V17, P1542, DOI 10.15252/embr.201541956; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davidson WR, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-102; Dichtel-Danjoy ML, 2013, CELL DEATH DIFFER, V20, P108, DOI 10.1038/cdd.2012.100; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gadea G, 2016, ELIFE, V5, DOI [10.7554/elife.14734, 10.7554/eLife.14734]; Gong HJ, 2018, CELL DEATH DIFFER, V25, P1063, DOI 10.1038/s41418-018-0085-8; Gong L, 2018, ONCOGENE, V37, P2150, DOI 10.1038/s41388-017-0117-8; Gong L, 2015, CELL RES, V25, P351, DOI 10.1038/cr.2015.22; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hinault C, 2011, DIABETES, V60, P1210, DOI 10.2337/db09-1379; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Huang Q, 2014, BBA-PROTEINS PROTEOM, V1844, P198, DOI 10.1016/j.bbapap.2013.04.002; Ji XN, 2014, INT J MOL SCI, V15, P13275, DOI 10.3390/ijms150813275; Joerger AC, 2016, ANNU REV BIOCHEM, V85, P375, DOI 10.1146/annurev-biochem-060815-014710; Joruiz S. M., 2016, COLD SPRING HARB PER, V6; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoch A, 2017, NUCLEIC ACIDS RES, V45, P10206, DOI 10.1093/nar/gkx630; Khoo KH, 2009, J MOL BIOL, V393, P161, DOI 10.1016/j.jmb.2009.08.013; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kim S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003993; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Li M, 2015, NEUROBIOL AGING, V36, P2725, DOI 10.1016/j.neurobiolaging.2015.06.021; Lukman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080221; Ma BY, 2007, NUCLEIC ACIDS RES, V35, P2986, DOI 10.1093/nar/gkm192; Ma BY, 2005, P NATL ACAD SCI USA, V102, P3988, DOI 10.1073/pnas.0500215102; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Marcel V, 2014, CELL DEATH DIFFER, V21, P1377, DOI 10.1038/cdd.2014.73; Marcel V, 2009, CELL MOL LIFE SCI, V66, P391, DOI 10.1007/s00018-008-8336-3; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Maynard AT, 2001, J AM CHEM SOC, V123, P1047, DOI 10.1021/ja0011616; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Pan YP, 2005, BIOCHEMISTRY-US, V44, P1423, DOI 10.1021/bi047845y; Pehar M, 2014, AGING CELL, V13, P449, DOI 10.1111/acel.12192; Pehar M, 2010, AGING CELL, V9, P174, DOI 10.1111/j.1474-9726.2010.00547.x; Pyrkosz AB, 2010, J MOL BIOL, V397, P1350, DOI 10.1016/j.jmb.2010.02.003; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roth I, 2016, ONCOGENE, V35, P4981, DOI 10.1038/onc.2016.45; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Silva JL, 2018, ACCOUNTS CHEM RES, V51, P181, DOI 10.1021/acs.accounts.7b00473; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Slatter TL, 2011, BLOOD, V117, P5166, DOI 10.1182/blood-2010-11-321851; Solomon H, 2017, CELL DEATH DIFFER, V24, P2187, DOI 10.1038/cdd.2017.139; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Stracquadanio G, 2016, NAT REV CANCER, V16, P251, DOI 10.1038/nrc.2016.15; Terrier O, 2012, J VIROL, V86, P8452, DOI 10.1128/JVI.07143-11; Ungewitter E, 2010, GENE DEV, V24, P2408, DOI 10.1101/gad.1987810; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2443, DOI 10.1073/pnas.1500262112; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546	75	20	20	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4225	4235		10.1096/fj.201801973R	http://dx.doi.org/10.1096/fj.201801973R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30540922	Bronze, Green Published			2022-12-28	WOS:000459794800090
J	Martin, DDO; Schmidt, ME; Nguyen, YT; Lazic, N; Hayden, MR				Martin, Dale D. O.; Schmidt, Mandi E.; Nguyen, Yen T.; Lazic, Nikola; Hayden, Michael R.			Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance	FASEB JOURNAL			English	Article						Huntington disease; polyglutamine; proteolysis; aggregation	MOUSE MODEL; POSTTRANSLATIONAL MYRISTOYLATION; AUTOPHAGY; DISEASE; PROTEIN; PROTEOLYSIS; ACTIVATION; EXPRESSION; FRAGMENTS; TOXICITY	Huntington disease (HD) is a progressive neurodegenerative disease that initially affects the striatum and leads to changes in behavior and loss of motor coordination. It is caused by an expansion in the polyglutamine repeat at the N terminus of huntingtin (HTT) that leads to aggregation of mutant HTT. The loss of wild-type function, in combination with the toxic gain of function mutation, initiates various cell death pathways. Wild-type and mutant HTT are regulated by different posttranslational modifications that can positively or negatively regulate their function or toxicity. In particular, we have previously shown that caspase cleavage of mutant HTT at amino acid position aspartate 586 (D586) by caspase-6 is critical for the pathogenesis of the disease in an HD mouse model. Herein, we describe the identification of a new caspase cleavage site at position D572 that is mediated by caspase-1. Inhibition of caspase-1 also appeared to decrease proteolysis at D586, likely by blocking the downstream activation of caspase-6 through caspase-1. Inhibition of caspase cleavage at D572 significantly decreased mutant HTT aggregation and significantly increased the turnover of soluble mutant HTT. This suggests that caspase-1 may be a viable target to inhibit caspase cleavage of mutant HTT at both D572 and D586 to promote mutant HTT clearance.Martin, D. D. O., Schmidt, M. E., Nguyen, Y. T., Lazic, N., Hayden, M. R. Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance.	[Martin, Dale D. O.; Schmidt, Mandi E.; Nguyen, Yen T.; Lazic, Nikola; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, 950 28th Ave W, Vancouver, BC V5Z 4H4, Canada; [Martin, Dale D. O.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada	University of British Columbia; University of Waterloo	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, 950 28th Ave W, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419	Canadian Institutes of Health Research (CIHR) [20R90174]; CIHR; Michael Smith Foundation for Health Research; Bluma Tischler Fellowship from The University of British Columbia	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Bluma Tischler Fellowship from The University of British Columbia	The authors thank Dr. Shaun Sanders (Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA) for critical review of the manuscript and members of the Hayden laboratory for useful discussions. In particular, Dr. Niels Skotte (Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark) was helpful in determining the half-lives of proteins. This work was supported by the Canadian Institutes of Health Research (CIHR 20R90174). D.D.O.M. was supported by postdoctoral fellowships from CIHR and the Michael Smith Foundation for Health Research as well as the Bluma Tischler Fellowship from The University of British Columbia. M.E.S. was awarded a Vanier Canada Graduate Scholarship from CIHR. The authors declare no conflicts of interest.	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Ehrnhoefer DE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0518-0; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; El-Daher MT, 2015, EMBO J, V34, P2255, DOI 10.15252/embj.201490808; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Guo H, 2006, CELL DEATH DIFFER, V13, P285, DOI 10.1038/sj.cdd.4401753; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martin DDO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25903-w; Martin DDO, 2015, BIOCHEM SOC T, V43, P229, DOI 10.1042/BST20140281; Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003; Martin DDO, 2014, HUM MOL GENET, V23, P3166, DOI 10.1093/hmg/ddu027; Martin DDO, 2012, FASEB J, V26, P13, DOI 10.1096/fj.11-182360; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Ochaba J, 2014, P NATL ACAD SCI USA, V111, P16889, DOI 10.1073/pnas.1420103111; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Pryor WM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005633; Rui YN, 2015, NAT CELL BIOL, V17, P262, DOI 10.1038/ncb3101; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wong BKY, 2015, NEUROBIOL DIS, V76, P24, DOI 10.1016/j.nbd.2014.12.030; Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014; Zala D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060162; Zhang Y, 2003, J NEUROCHEM, V87, P1184, DOI 10.1046/j.1471-4159.2003.02105.x	30	14	14	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3190	3197		10.1096/fj.201701510RRR	http://dx.doi.org/10.1096/fj.201701510RRR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30423259	Green Submitted, Bronze			2022-12-28	WOS:000459794800010
J	Xin, LB; Zhao, R; Lei, J; Song, JC; Yu, L; Gao, R; Ha, CB; Ren, YY; Liu, X; Liu, YX; Yao, Z; Yang, J				Xin, Lingbiao; Zhao, Ran; Lei, Jing; Song, Jianchan; Yu, Lin; Gao, Ru; Ha, Chuanbo; Ren, Yuanyuan; Liu, Xin; Liu, Yixin; Yao, Zhi; Yang, Jie			SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells	FASEB JOURNAL			English	Article						metastasis; transcription coactivator; histone acetylation	STAPHYLOCOCCAL NUCLEASE; TUDOR-SN; COACTIVATOR; MECHANISMS; PROTEIN; TRANSCRIPTION; METASTASIS; TGF-BETA-1; PATHWAY; COMPLEX	Staphylococcal nuclease domain-containing protein 1 (SND1) has been reported as an oncoprotein in a variety of cancers involving multiple processes, including proliferation, angiogenesis, and metastasis. However, the mechanisms underlying metastasis remain largely unknown. Herein, by using the ovarian cancer cell line SKOV3, which has high metastasis ability, we showed that loss-of-function of SND1 dramatically suppressed the invasion and migration of SKOV3 cells. We then performed gene expression profiles and further verified (by use of quantitative PCR and Western blot analysis) that loss-of-function of SND1 resulted in up-regulation of epithelial markers, such as epithelial cadherin and claudin 1, and down-regulation of mesenchymal markers, including neural cadherin and vimentin. Moreover, we illustrated that SLUG, a key transcription factor implicated in epithelial-mesenchymal transition and metastasis, acts as an essential effector of the SND1-promoted epithelial-mesenchymal transition process via regulating N-CAD and VIM expression (or E-CAD and CLDN1). The underlying molecular mechanisms illustrated that SND1 regulates the gene transcriptional activation of SLUG by increasing chromatin accessibility through the recruitment of the acetyltransferases GCN5 and CBP/p300 to the SLUG promoter proximal region. Overall, SND1 was identified as a novel upstream regulator of SLUG, which plays important roles in regulating the E-CAD/N-CAD expression switch.Xin, L., Zhao, R., Lei, J., Song, J., Yu, L., Gao, R., Ha, C., Ren, Y., Liu, X., Liu, Y., Yao, Z., Yang, J. SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells.	[Xin, Lingbiao; Zhao, Ran; Lei, Jing; Yu, Lin; Gao, Ru; Ha, Chuanbo; Ren, Yuanyuan; Liu, Xin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Minist Educ, Key Lab Immune Microenvironm & Dis, Tianjin, Peoples R China; [Xin, Lingbiao; Zhao, Ran; Lei, Jing; Yu, Lin; Gao, Ru; Ha, Chuanbo; Ren, Yuanyuan; Liu, Xin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Key Lab Cellular & Mol Immunol Tianjin, Tianjin, Peoples R China; [Xin, Lingbiao; Lei, Jing; Yu, Lin; Gao, Ru; Ren, Yuanyuan; Liu, Xin; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Qixiangtai Rd 22, Tianjin 300070, Peoples R China; [Zhao, Ran; Ha, Chuanbo; Yao, Zhi] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin 300070, Peoples R China; [Song, Jianchan; Liu, Yixin] Tianjin Cent Hosp Gynecol Obstet, Dept Pathol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yang, J (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Qixiangtai Rd 22, Tianjin 300070, Peoples R China.; Yao, Z (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin 300070, Peoples R China.	yaozhi@tmu.edu.cn; yangj@tmu.edu.cn	Yu, Lin/AAH-1131-2019	Yu, Lin/0000-0002-9972-3799	National Science Foundation for Distinguished Young Scholars of China [31125012]; Innovation Team Development Plan of the Ministry of Education [IRT13085]; National Science Foundation of China [31870747, 31370749, 31670759, 81572882, 81572867, 81802588]; Natural Science Foundation of Tianjin [17JCQNJC12600]; Science and Technology Development Fund of Tianjin Education Commission for Higher Education [2016YD18]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Innovation Team Development Plan of the Ministry of Education; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Science and Technology Development Fund of Tianjin Education Commission for Higher Education	The authors thank Prof. Lei Shi for kindly providing the lentivirus plasmids and the cell lines, Prof. Li Zhao for providing the GLuc reporter plasmid, and Xin Song for help with optical imaging (all from Tianjin Medical University). This work was supported by Grants from the National Science Foundation for Distinguished Young Scholars of China (31125012), the Innovation Team Development Plan of the Ministry of Education (IRT13085), the National Science Foundation of China (31870747, 31370749, and 31670759 to J.Y.; 81572882 to Z.Y.; 81572867 to X.L.; and 81802588 to L.X.), the Natural Science Foundation of Tianjin (17JCQNJC12600 to L.X.), and the Science and Technology Development Fund of Tianjin Education Commission for Higher Education (2016YD18 to L.X.). The authors declare no conflicts of interest.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Arretxe E, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv858; Cappellari M, 2014, ONCOGENE, V33, P3794, DOI 10.1038/onc.2013.360; Cardenas H, 2014, EPIGENETICS-US, V9, P1461, DOI 10.4161/15592294.2014.971608; Chen K, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.138; Chen Y, 2017, BRIT J CANCER, V117, P1192, DOI 10.1038/bjc.2017.265; Elbarbary RA, 2017, SCIENCE, V356, P859, DOI 10.1126/science.aai9372; Grassi ML, 2017, J PROTEOMICS, V151, P2, DOI 10.1016/j.jprot.2016.06.009; Idoux-Gillet Y, 2018, ONCOGENE, V37, P578, DOI 10.1038/onc.2017.355; Jaaback K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005340.pub4; Josefowicz SZ, 2016, MOL CELL, V64, P347, DOI 10.1016/j.molcel.2016.09.026; Ju JY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00988-5; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Liu X, 2011, CELL MOL IMMUNOL, V8, P88, DOI 10.1038/cmi.2010.47; Mitra T, 2017, CELL PHYSIOL BIOCHEM, V41, P1336, DOI 10.1159/000464436; Rajasekaran D, 2016, J BIOL CHEM, V291, P10736, DOI 10.1074/jbc.M116.715359; Saarikettu J, 2010, HYBRIDOMA, V29, P231, DOI 10.1089/hyb.2009.0114; Santhekadur PK, 2014, FEBS OPEN BIO, V4, P353, DOI 10.1016/j.fob.2014.03.012; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Singh M, 2018, PHARMACOL THERAPEUT, V182, P80, DOI 10.1016/j.pharmthera.2017.08.009; Su C, 2015, J BIOL CHEM, V290, P7208, DOI 10.1074/jbc.M114.625046; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wan LL, 2014, CANCER CELL, V26, P92, DOI 10.1016/j.ccr.2014.04.027; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yu L, 2017, ONCOGENE, V36, P3903, DOI 10.1038/onc.2017.30; Yu L, 2015, CANCER RES, V75, P1275, DOI 10.1158/0008-5472.CAN-14-2387; Zhang XH, 2012, PROG BIOCHEM BIOPHYS, V39, P307, DOI 10.3724/SP.J.1206.2011.00284	33	18	19	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3795	3806		10.1096/fj.201801728R	http://dx.doi.org/10.1096/fj.201801728R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509125	Bronze			2022-12-28	WOS:000459794800057
J	Chauhan, AS; Liu, XG; Jing, J; Lee, H; Yadav, RK; Liu, JD; Zhou, YB; Gan, BY				Chauhan, Anoop Singh; Liu, Xiaoguang; Jing, Ji; Lee, Hyemin; Yadav, Raj Kumar; Liu, Jindou; Zhou, Yubin; Gan, Boyi			STIM2 interacts with AMPK and regulates calcium-induced AMPK activation	FASEB JOURNAL			English	Article						CaMKK2; energy stress; LKB1; STIM1	DEPENDENT PROTEIN-KINASE; UPSTREAM KINASE; CELL-GROWTH; CA2+; COMPLEX; BETA; PHOSPHORYLATION; ARCHITECTURE; PATHWAY; GLUCOSE	AMPK is a crucial regulator of energy homeostasis that acts downstream of its upstream kinase liver kinase B1 (LKB1) and calcium/calmodulin-dependent protein kinase 2 (CaMKK2). LKB1 primarily phosphorylates AMPK after energy stress, whereas calcium-mediated activation of AMPK requires CaMKK2, although the regulatory mechanisms of calcium-mediated AMPK activation remain unclear. Using biochemical, microscopic, and genetic approaches, we demonstrate that the stromal interaction molecule (STIM)2, a calcium sensor, acts as a novel regulator of CaMKK2-AMPK signaling. We reveal that STIM2 interacts with AMPK and CaMKK2 and that the increase in intracellular calcium levels promotes AMPK colocalization and interaction with STIM2. We further show that STIM2 deficiency attenuates calcium-induced but not energy stress-induced AMPK activation, possibly by regulating the CaMKK2-AMPK interaction. Together, our results identify a previously unappreciated mechanism that modulates calcium-mediated AMPK activation.Chauhan, A. S., Liu, X., Jing, J., Lee, H., Yadav, R. K., Liu, J., Zhou, Y., Gan B. STIM2 interacts with AMPK and regulates calcium-induced AMPK activation.	[Chauhan, Anoop Singh; Liu, Xiaoguang; Lee, Hyemin; Yadav, Raj Kumar; Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Gan, Boyi] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Jing, Ji; Liu, Jindou; Zhou, Yubin] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Zhou, Yubin] Texas A&M Univ, Coll Med, Dept Med Physiol, Temple, TX 76508 USA; [Chauhan, Anoop Singh] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Liu, Jindou] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; University of Birmingham; Beijing Normal University	Gan, BY (corresponding author), Univ Texas MD Anderson Canc Ctr, Zayed Bldg,Z7-3034,6565 MD Anderson Blvd, Houston, TX 77030 USA.	bgan@mdanderson.org	Chauhan, Anoop/GYD-7325-2022; Gan, Boyi/HDM-4206-2022; Zhou, Yubin/D-4748-2011	Chauhan, Anoop/0000-0001-8722-2404; Zhou, Yubin/0000-0001-7962-0517; LIU, XIAOGUANG/0000-0001-6977-5128	Andrew Sabin Family Fellow Award; Sister Institution Network Fund; U.S. National Institutes of Health (NIH) National Cancer Institute [CA181196]; NIH National Institute of General Medical Sciences [R01GM112003]; Welch Foundation [BE-1913]; American Cancer Society [RSG-16-215-01 TBE]; NIH Cancer Center Support Grant [P30CA016672]; Anna Fuller Fund; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA181196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112003] Funding Source: NIH RePORTER	Andrew Sabin Family Fellow Award; Sister Institution Network Fund; U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); American Cancer Society(American Cancer Society); NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna Fuller Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank all members of the B.G. laboratory for their advice and technical assistance. This research was supported by the Andrew Sabin Family Fellow Award, the Sister Institution Network Fund, the Anna Fuller Fund, U.S. National Institutes of Health (NIH) National Cancer Institute Grant CA181196 (to B.G.), NIH National Institute of General Medical Sciences Grant R01GM112003, Welch Foundation Grant BE-1913, American Cancer Society Grant RSG-16-215-01 TBE (to Y.Z.), and NIH Cancer Center Support Grant P30CA016672 to The University of Texas M.D. Anderson Cancer Center. The authors declare no conflicts of interest.	Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dai FY, 2017, P NATL ACAD SCI USA, V114, P3192, DOI 10.1073/pnas.1619588114; Fogarty S, 2016, MOL CANCER RES, V14, P683, DOI 10.1158/1541-7786.MCR-15-0479; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Gudlur A, 2013, CURR TOP MEMBR, V71, P33, DOI 10.1016/B978-0-12-407870-3.00002-0; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hogan PG, 2015, BIOCHEM BIOPH RES CO, V460, P40, DOI 10.1016/j.bbrc.2015.02.110; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jing J, 2015, NAT CELL BIOL, V17, P1339, DOI 10.1038/ncb3234; Koppula P, 2017, J BIOL CHEM, V292, P14240, DOI 10.1074/jbc.M117.798405; Lin A, 2014, ONCOGENE, V33, P3183, DOI 10.1038/onc.2013.273; Lin AF, 2014, CANCER RES, V74, P1682, DOI 10.1158/0008-5472.CAN-13-1729; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XW, 2016, CELL CYCLE, V15, P1948, DOI 10.1080/15384101.2016.1184515; Liu XW, 2016, NAT CELL BIOL, V18, P431, DOI 10.1038/ncb3328; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00325; Ross FA, 2016, FEBS J, V283, P2987, DOI 10.1111/febs.13698; Ross FA, 2016, BIOCHEM J, V473, P189, DOI 10.1042/BJ20150910; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Wang WQ, 2015, CELL REP, V13, P524, DOI 10.1016/j.celrep.2015.09.014; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xiao ZD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00902-z; Xiao ZD, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1187322; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	47	28	28	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2957	2970		10.1096/fj.201801225R	http://dx.doi.org/10.1096/fj.201801225R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30335546	Green Published, hybrid			2022-12-28	WOS:000457296600113
J	Essandoh, K; Deng, S; Wang, XH; Jiang, M; Mu, XJ; Peng, JT; Li, YT; Peng, TQ; Wagner, KU; Rubinstein, J; Fan, GC				Essandoh, Kobina; Deng, Shan; Wang, Xiaohong; Jiang, Min; Mu, Xingjiang; Peng, Jiangtong; Li, Yutian; Peng, Tianqing; Wagner, Kay-Uwe; Rubinstein, Jack; Fan, Guo-Chang			Tsg101 positively regulates physiologic-like cardiac hypertrophy through FIP3-mediated endosomal recycling of IGF-1R	FASEB JOURNAL			English	Article						Rab11-FIP3; exercise training; cardiac remodeling; membrane receptor; endosomes	CELL-CYCLE ARREST; GROWTH; RECEPTOR; PROTEIN; INTERNALIZATION; OVEREXPRESSION; PROLIFERATION; UBIQUITIN; MEDIATE; AKT	Development of physiologic cardiac hypertrophy has primarily been ascribed to the IGF-1 and its receptor, IGF-1 receptor (IGF-1R), and subsequent activation of the protein kinase B (Akt) pathway. However, regulation of endosome-mediated recycling and degradation of IGF-1R during physiologic hypertrophy has not been investigated. In a physiologic hypertrophy model of treadmill-exercised mice, we observed that levels of tumor susceptibility gene 101 (Tsg101), a key member of the endosomal sorting complex required for transport, were dramatically elevated in the heart compared with sedentary controls. To determine the role of Tsg101 on physiologic hypertrophy, we generated a transgenic (TG) mouse model with cardiac-specific overexpression of Tsg101. These TG mice exhibited a physiologic-like cardiac hypertrophy phenotype at 8 wk evidenced by: 1) the absence of cardiac fibrosis, 2) significant improvement of cardiac function, and 3) increased total and plasma membrane levels of IGF-1R and increased phosphorylation of Akt. Mechanistically, we identified that Tsg101 interacted with family-interacting protein 3 (FIP3) and IGF-1R, thereby stabilizing FIP3 and enhancing recycling of IGF-1R. In vitro, adenovirus-mediated overexpression of Tsg101 in neonatal rat cardiomyocytes resulted in cell hypertrophy, which was blocked by addition of monensin, an inhibitor of endosome-mediated recycling, and by small interfering RNA-mediated knockdown (KD) of FIP3. Furthermore, cardiac-specific KD of Tsg101 showed a significant reduction in levels of endosomal recycling compartment members (Rab11a and FIP3), IGF-1R, and Akt phosphorylation. Most interestingly, Tsg101-KD mice failed to develop cardiac hypertrophy after intense treadmill training. Taken together, our data identify Tsg101 as a novel positive regulator of physiologic cardiac hypertrophy through facilitating the FIP3-mediated endosomal recycling of IGF-1R.-Essandoh, K., Deng, S., Wang, X., Jiang, M., Mu, X., Peng, J., Li, Y., Peng, T., Wagner, K.-U., Rubinstein, J., Fan, G.-C. Tsg101 positively regulates physiologic-like cardiac hypertrophy through FIP3-mediated endosomal recycling of IGF-1R.	[Essandoh, Kobina; Deng, Shan; Wang, Xiaohong; Mu, Xingjiang; Li, Yutian; Fan, Guo-Chang] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Deng, Shan; Peng, Jiangtong] Huazhong Univ Sci & Technol, Union Hosp, Dept Cardiol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Jiang, Min; Rubinstein, Jack] Univ Cincinnati, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45267 USA; [Peng, Tianqing] Lawson Hlth Res Inst, Crit Illness Res, London, ON, Canada; [Wagner, Kay-Uwe] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI USA	University System of Ohio; University of Cincinnati; Huazhong University of Science & Technology; University System of Ohio; University of Cincinnati; Western University (University of Western Ontario); Barbara Ann Karmanos Cancer Institute; Wayne State University	Fan, GC (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	fangg@ucmail.uc.edu	Fan, Guo-Chang/E-1153-2012; Peng, Tianqing/G-3340-2011	Fan, Guo-Chang/0000-0002-0439-8277; Wagner, Kay-Uwe/0000-0002-5081-0226; Li, Yutian/0000-0002-5118-0916; Rubinstein, Jack/0000-0002-8811-1551	U.S. National Institutes of Health; National Institute of General Medical Sciences [R01 GM-112930, GM-126061]; American Heart Association (AHA) Established Investigator Award [17EIA33400063]; AHA Predoctoral Fellowship [18PRE34030123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126061, R01GM132149, R01GM112930] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association (AHA) Established Investigator Award(American Heart Association); AHA Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported partially by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants R01 GM-112930 and GM-126061, American Heart Association (AHA) Established Investigator Award 17EIA33400063 (to G.-C.F.), and AHA Predoctoral Fellowship 18PRE34030123 (to K.E.). The authors declare no conflicts of interest.	Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Carstens MJ, 2004, J BIOL CHEM, V279, P35984, DOI 10.1074/jbc.M400408200; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Delaughter MC, 1999, FASEB J, V13, P1923, DOI 10.1096/fasebj.13.14.1923; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Haugland Rosaria P., 2008, V418, P1; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Horgan CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032030; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Ismaili N, 2005, J BIOL CHEM, V280, P11120, DOI 10.1074/jbc.M500059200; Junutula JR, 2004, J BIOL CHEM, V279, P33430, DOI 10.1074/jbc.M404633200; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; O'Reilly MK, 2011, J IMMUNOL, V186, P1554, DOI 10.4049/jimmunol.1003005; Prasad H, 2015, J BIOL CHEM, V290, P5311, DOI 10.1074/jbc.M114.602219; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Rubinstein J, 2014, AM J PHYSIOL-HEART C, V306, pH574, DOI 10.1152/ajpheart.00854.2013; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Rush JS, 2013, MOL CELL ENDOCRINOL, V381, P188, DOI 10.1016/j.mce.2013.07.029; Shimizu I, 2016, J MOL CELL CARDIOL, V97, P245, DOI 10.1016/j.yjmcc.2016.06.001; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404; Yang LW, 2016, J BIOL CHEM, V291, P15700, DOI 10.1074/jbc.M116.715805; Zhang AL, 2014, J BIOL CHEM, V289, P29180, DOI 10.1074/jbc.M114.576561; Zhu G, 2004, INT J CANCER, V109, P541, DOI 10.1002/ijc.20014	39	10	11	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7451	7466		10.1096/fj.201802338RR	http://dx.doi.org/10.1096/fj.201802338RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30884248	Green Published			2022-12-28	WOS:000476114200063
J	Lopez-Vicario, C; Titos, E; Walker, ME; Alcaraz-Quiles, J; Casulleras, M; Duran-Guell, M; Flores-Costa, R; Perez-Romero, N; Forne, M; Dalli, J; Claria, J				Lopez-Vicario, Cristina; Titos, Esther; Walker, Mary E.; Alcaraz-Quiles, Jose; Casulleras, Mireia; Duran-Guell, Marta; Flores-Costa, Roger; Perez-Romero, Noelia; Forne, Montserrat; Dalli, Jesmond; Claria, Joan			Leukocytes from obese individuals exhibit an impaired SPM signature	FASEB JOURNAL			English	Article						specialized proresolving mediator; lipoxygenases; obesity	PRORESOLVING LIPID MEDIATORS; RESOLVIN D1; MEMBRANE ASSOCIATION; NUCLEAR-LOCALIZATION; INSULIN-RESISTANCE; 5-LIPOXYGENASE; INFLAMMATION; RESOLUTION; OMEGA-3-FATTY-ACIDS; PHOSPHORYLATION	Specialized proresolving mediators (SPMs) biosynthesized from docosahexaenoic acids (DHAs) including resolvins (Rvs), protectins, and maresins are potent endogenous autacoids that actively resolve inflammation, protect organs, and stimulate tissue regeneration. Our hypothesis was that failure of resolution programs may lead to unremitting inflammation in obesity, contributing to the development of metabolic comorbidities in this condition. Obese individuals with persistent low-grade systemic inflammation showed reduced leukocyte production of the DHA-derived monohydroxy fatty acid 17-hydroxy-DHA (HDHA) and unbalanced formation of SPMs (in particular D-series Rvs) accompanied by enhanced production of proinflammatory lipid mediators such as leukotriene B-4. Mechanistic studies attributed this impairment to reduced 15-lipoxygenase (LOX) activity rather than altered DHA cellular uptake. Moreover, leukocytes from obese individuals exhibited decreased 5-LOX levels and reduced 5-LOX Ser271 phosphorylation and distinct intracellular 5-LOX redistribution. However, 15-LOX appears to be the most critical factor for the deficient production of SPMs by obese leukocytes because the formation of D-series Rvs was completely rescued by incubation with the intermediate precursor 17-HDHA. These data provide proof of concept that administration of intermediate precursors of SPM biosynthesis (e.g., 17-HDHA) could be more efficient in overriding impaired formation of these proresolving lipid mediators in conditions characterized by dysfunctional LOX activity, such as obesity.-Lopez-Vicario, C., Titos, E., Walker, M. E., Alcaraz-Quiles, J., Casulleras, M., Duran-Guell, M., Flores-Costa, R., Perez-Romero, N., Forne, M., Dalli, J., Claria, J. Leukocytes from obese individuals exhibit an impaired SPM signature.	[Lopez-Vicario, Cristina; Titos, Esther; Alcaraz-Quiles, Jose; Casulleras, Mireia; Duran-Guell, Marta; Flores-Costa, Roger; Claria, Joan] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Hosp Clin, Biochem & Mol Genet Serv,Ctr Invest Biomed Red En, Madrid, Spain; [Titos, Esther; Claria, Joan] Univ Barcelona, Dept Biomed Sci, Barcelona, Spain; [Walker, Mary E.; Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Lipid Mediator Unit,Biochem Pharmacol, London, England; [Walker, Mary E.; Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England; [Perez-Romero, Noelia] Hosp Univ Mutua Terrassa, Surg Dept, Terrassa, Spain; [Forne, Montserrat] Hosp Univ Mutua Terrassa, Gastroenterol Dept, Terrassa, Spain; [Claria, Joan] European Fdn Study Chron Liver Failure EF Clif, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of London; Queen Mary University London; University of London; Queen Mary University London; Hospital Universitario Mutua Terrassa; Hospital Universitario Mutua Terrassa	Lopez-Vicario, C; Claria, J (corresponding author), Hosp Clin Barcelona, Dept Biochem & Mol Genet, Villarroel 170, Barcelona 08036, Spain.	clopezv@clinic.cat; jclaria@clinic.cat	Titos, Esther/AAA-5394-2019	Titos, Esther/0000-0002-2543-2243; Dalli, Jesmond/0000-0001-6328-3640; Duran, Marta/0000-0002-3265-395X; Casulleras, Mireia/0000-0002-2899-5826; Lopez-Vicario, Cristina/0000-0002-6609-8501; Noelia, Perez-Romero/0000-0001-6715-9591	Spanish Ministerio de Economia y Competitividad (MEC) under the European Regional Development Fund (ERDF) [SAF15/63674-R, PIE14/00045]; Instituto de Salud Carlos III; Generalitat de Catalunya [2017SGR1449]; European Research Council (ERC) under the European Union [677542]; Barts Charity [MGU0343]; Sir Henry Dale Fellowship - Wellcome Trust [107613/Z/15/Z]; Sir Henry Dale Fellowship - Royal Society [107613/Z/15/Z]	Spanish Ministerio de Economia y Competitividad (MEC) under the European Regional Development Fund (ERDF); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); European Research Council (ERC) under the European Union(European Research Council (ERC)); Barts Charity; Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society	The authors thank Anabel Martinez-Puchol (Fundacio Clinic per la Recerca Biomedica, Barcelona, Spain) for technical assistance. This study was supported by the Spanish Ministerio de Economia y Competitividad (MEC; SAF15/63674-R and PIE14/00045) under the European Regional Development Fund (ERDF). CIBEREHD is funded by the Instituto de Salud Carlos III. The authors' laboratory is a Consolidated Research Group recognized by the Generalitat de Catalunya (2017SGR1449). This study was carried out at the Center Esther Koplowitz, Institut d'investigacions Biomediques August Pi i Sunyer (IDIBAPS), which is part of the Centres de Recerca de Catalunya (CERCA) Programme and Generalitat de Catalunya. J.D. received funding from the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (Grant 677542), and Barts Charity (Grant MGU0343). J.D. was also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 107613/Z/15/Z). The authors declare no conflicts of interest.	Abdelaal M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.107; Capodici C, 1998, J CLIN INVEST, V102, P165, DOI 10.1172/JCI592; Chatterjee A, 2017, FASEB J, V31, P3393, DOI 10.1096/fj.201700082R; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; COFFEY M, 1992, J BIOL CHEM, V267, P570; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Flamand N, 2009, J BIOL CHEM, V284, P306, DOI 10.1074/jbc.M805593200; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Hong S, 2007, J AM SOC MASS SPECTR, V18, P128, DOI 10.1016/j.jasms.2006.09.002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo M, 2003, P NATL ACAD SCI USA, V100, P12165, DOI 10.1073/pnas.2133253100; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Rathod KS, 2017, J CLIN INVEST, V127, P169, DOI 10.1172/JCI89429; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; ROUZER CA, 1987, P NATL ACAD SCI USA, V84, P7393, DOI 10.1073/pnas.84.21.7393; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Titos E, 2016, J IMMUNOL, V197, P3360, DOI 10.4049/jimmunol.1502522; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Unamuno X, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12997; Ungaro F, 2017, GASTROENTEROLOGY, V153, P1363, DOI 10.1053/j.gastro.2017.07.048; Werz O, 2002, J BIOL CHEM, V277, P14793, DOI 10.1074/jbc.M111945200; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054	33	32	33	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7072	7083		10.1096/fj.201802587R	http://dx.doi.org/10.1096/fj.201802587R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30840838	Green Submitted, Bronze			2022-12-28	WOS:000476114200033
J	Yu, SH; Zhang, YL; Wu, YY; Yang, HY; Chen, Y; Yang, YB; Zhang, Z				Yu, Shuhui; Zhang, Yali; Wu, Yuyun; Yang, Hongying; Chen, Yang; Yang, Yingbin; Zhang, Ze			Subcellular localization of mutated -catenins with different incidences of cis-peptide bonds at the Xaa246-P247 site in HepG2 cells	FASEB JOURNAL			English	Article						missense mutations; ICPB; interaction; APC; E-cadherin	BETA-CATENIN; PROLINE ISOMERIZATION; TRANS ISOMERIZATION; E-CADHERIN; CONFORMATION; PROTEIN; STABILIZATION; SPECIFICITY; ADHESION	Mutations may ultimately change the local conformation of proteins; however, little attention has been paid to alterations in protein function caused by the incidence of cis-peptide bonds (ICPB) in mammalian cells. In this study, a statistical approach, coimmunoprecipitation, and immunofluorescence staining have been used to confirm that S246Y and S246W missense mutations, which help increase the ICPB in Xaa246-P247 (Xaa is any amino acid) in human -catenin, can reduce the interactions between -catenin and adenomatous polyposis coli (APC) and between -catenin and Ca2(+)-dependent cell adhesion molecule family in epithelial tissue (E-cadherin), eventually leading to increased nuclear migration of -catenin in the HepG2 cell line (an immortalized cell line consisting of human liver carcinoma cells). Conversely, S246L and S246M missense mutations, which reduce the ICPB in Xaa246-P247 in human -catenin, can enhance interactions between -catenin and APC and between -catenin and E-cadherin, leading to decreased nuclear migration of -catenin. These results not only indicate that a change in the ICPB may be an important cause of functional protein changes but also provide a new basis for the study of genetic disease prediction, gene diagnosis, individualized treatment, and protein modification at the gene level for clinicians and other professionals.Yu, S., Zhang, Y., Wu, Y., Yang, H., Chen, Y., Yang, Y., Zhang, Z. Subcellular localization of mutated -catenins with different incidences of cis-peptide bonds at the Xaa246-P247 site in HepG2 cells.	[Yu, Shuhui; Zhang, Ze] Chongqing Univ, Sch Life Sci, Chongqing, Peoples R China; [Yu, Shuhui] Southwest Univ, Informat Inst, Chongqing, Peoples R China; [Zhang, Yali; Wu, Yuyun; Yang, Hongying; Chen, Yang; Yang, Yingbin] Southwest Univ, Sch Life Sci, 2 Tiansheng Rd, Chongqing 400716, Peoples R China; [Zhang, Yali] Army Mil Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China	Chongqing University; Southwest University - China; Southwest University - China	Yang, YB (corresponding author), Southwest Univ, Sch Life Sci, 2 Tiansheng Rd, Chongqing 400716, Peoples R China.; Zhang, Z (corresponding author), Univ Chongqing, Sch Life Sci, Daxuecheng South Rd 55, Chongqing 401331, Peoples R China.	yybin@swu.edu.cn; zezhang@cqu.edu.cn			National Natural Science Foundation of China (NSFC) [31501100]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC; Grant 31501100). The authors declare no conflicts of interest.	[Anonymous], 1970, Biochemistry, V9, P3471; Dar MS, 2016, BBA-MOL CELL RES, V1863, P2345, DOI 10.1016/j.bbamcr.2016.06.010; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Evans TC, 1996, BIOCHEMISTRY-US, V35, P8210, DOI 10.1021/bi9606354; Exarchos KP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-113; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Follis AV, 2015, MOL CELL, V59, P677, DOI 10.1016/j.molcel.2015.06.029; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Hamelberg D, 2009, J AM CHEM SOC, V131, P147, DOI 10.1021/ja806146g; Huang TS, 2015, STEM CELLS, V33, P1419, DOI 10.1002/stem.1944; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Joseph AP, 2012, AMINO ACIDS, V43, P1369, DOI 10.1007/s00726-011-1211-9; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Maguire PB, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700419; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Pahlke D, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-8; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Perera L, 1998, BIOCHEMISTRY-US, V37, P10920, DOI 10.1021/bi980263u; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; Truckses DM, 1996, PROTEIN SCI, V5, P1907, DOI 10.1002/pro.5560050917; Tsuge H, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv094; Verstak B, 2013, J IMMUNOL, V191, P6101, DOI 10.4049/jimmunol.1300849; Wu WJ, 1998, BIOPOLYMERS, V45, P381, DOI 10.1002/(SICI)1097-0282(19980415)45:5<381::AID-BIP6>3.0.CO;2-H; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yang YB, 2010, EXP CELL RES, V316, P3329, DOI 10.1016/j.yexcr.2010.02.014; Yu ST, 2010, CANCER RES, V70, P2585, DOI 10.1158/0008-5472.CAN-09-3841	33	2	2	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6574	6583		10.1096/fj.201801937RR	http://dx.doi.org/10.1096/fj.201801937RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807699	Green Published, hybrid			2022-12-28	WOS:000466932600060
J	Bernardini, A; Lorenzo, M; Nardini, M; Mantovani, R; Gnesutta, N				Bernardini, Andrea; Lorenzo, Mariangela; Nardini, Marco; Mantovani, Roberto; Gnesutta, Nerina			The phosphorylatable Ser320 of NF-YA is involved in DNA binding of the NF-Y trimer	FASEB JOURNAL			English	Article						transcription factor; DNA-protein interactions; post-translational modification; cyclin-dependent kinase; histone-fold domain	TRANSCRIPTION FACTOR; UP-REGULATION; CDK2-DEPENDENT PHOSPHORYLATION; FACTOR CBF; CCAAT BOX; B-SUBUNIT; ACTIVATION; GENE; EXPRESSION; SPECIFICITY	Nuclear factor Y (NF-Y) is a transcription factor trimer binding to the functionally important CCAAT box, present in promoters of growth-promoting and cell cycle-regulated genes. The regulatory nuclear factor YA (NF-YA) subunit confers sequence-specificity to the histone-like nuclear factor YB/YC dimer. NF-YA harbors 2 serines-Ser320 and Ser326-shown to be phosphorylated by cyclin-dependent kinase 2. High-throughput proteomics data indicate that they are phosphorylated in vivo. Specifically, Ser320 makes structural contacts with the DNA phosphate backbone; Ser320-P is the major NF-YA phosphorylation isoform following overexpression in HeLa cells, increasing upon mitotic arrest. EMSA with recombinant Ala and Glu mutants confirm a role of Ser320, but not Ser326, in stabilization of DNA binding. Transactivation assays of the CCAAT-dependent MDR1 and RHOB promoters show loss in transcription function for Ser320Glu and Ser320Ala NF-YA mutants. Phylogenetic analysis of NF-YA proteins indicates that Ser320 is indeed evolutionarily conserved. We conclude that phosphorylation of this residue belongs to the core mechanisms of DNA-binding control, possibly driven by the necessity to unfasten binding of or to evict NF-Y from CCAAT sites under specific conditions of growth regulation.	[Bernardini, Andrea; Lorenzo, Mariangela; Nardini, Marco; Mantovani, Roberto; Gnesutta, Nerina] Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy	University of Milan	Mantovani, R; Gnesutta, N (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.	mantor@unimi.it; nerina.gnesutta@unimi.it	Gnesutta, Nerina/I-5432-2015; Bernardini, Andrea/ABC-5669-2021	Gnesutta, Nerina/0000-0002-2465-8881; Bernardini, Andrea/0000-0001-5082-5295	Italian Association for Cancer Research [IG 2014/IG-15267, IG 2016/IG-19050, IG 2013/IG-14130]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	The authors thank D. Kardassis [University of Crete/Institute of Molecular Biology and Biotechnology (Forth), Heraklion, Greece] and Dr. K. Scotto (Cancer Institute of New Jersey-Rutgers, New Brunswick, NJ, USA) for gifts of the RHOB and MDR1 promoters constructs. This work was supported by Italian Association for Cancer Research Investgator Grants IG 2014/IG-15267 (to M.N.), IG 2016/IG-19050, and IG 2013/IG-14130 (to R.M.). The authors declare no conflicts of interest.	Ahn J, 2011, BIOCHEM BIOPH RES CO, V409, P211, DOI 10.1016/j.bbrc.2011.04.121; Arampatzi P, 2013, NUCLEIC ACIDS RES, V41, P2202, DOI 10.1093/nar/gks1365; Bellorini M, 1997, GENE, V193, P119, DOI 10.1016/S0378-1119(97)00109-1; Bi WM, 1997, J BIOL CHEM, V272, P26562, DOI 10.1074/jbc.272.42.26562; Bisikirska B, 2016, CANCER RES, V76, P664, DOI 10.1158/0008-5472.CAN-15-0828; Ceribelli M, 2009, J BIOL CHEM, V284, P34189, DOI 10.1074/jbc.M109.008417; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Cicchillitti L, 2017, ONCOTARGET, V8, P7935, DOI 10.18632/oncotarget.13854; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485; Cui H, 2016, NEUROSCI LETT, V631, P40, DOI 10.1016/j.neulet.2016.08.003; Dardaei L, 2015, ONCOTARGET, V6, P25175, DOI 10.18632/oncotarget.4488; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Garipov A, 2013, MOL CANCER RES, V11, P360, DOI 10.1158/1541-7786.MCR-12-0661; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Guo J, 2016, MOL MED REP, V14, P5007, DOI 10.3892/mmr.2016.5897; Gurtner A, 2017, BBA-GENE REGUL MECH, V1860, P604, DOI 10.1016/j.bbagrm.2016.12.005; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu Z, 2000, J BIOL CHEM, V275, P2979, DOI 10.1074/jbc.275.4.2979; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; LI XY, 1992, J BIOL CHEM, V267, P8984; Lu FL, 2016, CELL, V165, P1375, DOI 10.1016/j.cell.2016.05.050; MAITY SN, 1992, J BIOL CHEM, V267, P8286; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Nardone V, 2017, BBA-GENE REGUL MECH, V1860, P571, DOI 10.1016/j.bbagrm.2016.09.006; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Raccaud M, 2018, FEBS LETT, V592, P878, DOI 10.1002/1873-3468.12828; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Sekiya T, 2017, FEBS OPEN BIO, V7, P397, DOI 10.1002/2211-5463.12189; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Sinha S, 1996, MOL CELL BIOL, V16, P328; Suske G, 2017, BBA-GENE REGUL MECH, V1860, P590, DOI 10.1016/j.bbagrm.2016.08.011; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Tong YA, 2015, CANCER CELL, V27, P712, DOI 10.1016/j.ccell.2015.04.005; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x; Xu ZH, 2016, ONCOL REP, V35, P3630, DOI 10.3892/or.2016.4761; Yoshioka Y, 2008, GENES CELLS, V13, P117, DOI 10.1111/j.1365-2443.2007.01155.x; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Yun Un-Jung, 2006, Cancer Res Treat, V38, P224, DOI 10.4143/crt.2006.38.4.224; Zambelli F, 2017, BBA-GENE REGUL MECH, V1860, P581, DOI 10.1016/j.bbagrm.2016.10.007	57	3	3	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4790	4801		10.1096/fj.201801989R	http://dx.doi.org/10.1096/fj.201801989R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30589568				2022-12-28	WOS:000462888500013
J	Fang, LY; Sun, XH; Wang, Y; Du, LQ; Ji, KH; Wang, JH; He, NN; Liu, Y; Wang, Q; Zhai, HZ; Hao, JX; Xu, C; Liu, Q				Fang, Lianying; Sun, Xiaohui; Wang, Yan; Du, Liqing; Ji, Kaihua; Wang, Jinhan; He, Ningning; Liu, Yang; Wang, Qin; Zhai, Hezheng; Hao, Jianxiu; Xu, Chang; Liu, Qiang			RMI1 contributes to DNA repair and to the tolerance to camptothecin	FASEB JOURNAL			English	Article						double-strand breaks; RAD51; genome instability	HUMAN RECQ HELICASES; REPLICATION STRESS; MRN COMPLEX; DAMAGE RESPONSE; ACTIVATION; DISTINCT	Maintenance of genome integrity is critical for faithful propagation of genetic information and the prevention of the mutagenesis induced by various DNA damage events. RecQ-mediated genome instability protein 1 (RMI1), together with Bloom syndrome protein and topoisomerase III alpha, form an evolutionarily conserved complex that is critical for the maintenance of genomic stability. Herein, we report that RMI1 depletion increases cell sensitivity to camptothecin treatment, as shown by an elevation of genotoxic stress-induced DNA double-strand breaks, a stronger activation of the DNA damage response, and a greater G2/M cell cycle delay. Our findings support that, upon DNA damage, RMI1 forms nuclear foci at the damaged regions, interacts with RAD51, and facilitates the recruitment of RAD51 to initiate homologous recombination. Our data reveal the importance of RMI1 in response to DNA double-strand breaks and shed light on the molecular mechanisms by which RMI1 contributes to maintain genome stability.	[Fang, Lianying; Sun, Xiaohui; Wang, Yan; Du, Liqing; Ji, Kaihua; Wang, Jinhan; He, Ningning; Liu, Yang; Wang, Qin; Zhai, Hezheng; Hao, Jianxiu; Xu, Chang; Liu, Qiang] Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, 238 Baidi Rd, Tianjin, Peoples R China; [Fang, Lianying; Sun, Xiaohui; Wang, Yan; Du, Liqing; Ji, Kaihua; Wang, Jinhan; He, Ningning; Liu, Yang; Wang, Qin; Zhai, Hezheng; Hao, Jianxiu; Xu, Chang; Liu, Qiang] Peking Union Med Coll, 238 Baidi Rd, Tianjin, Peoples R China; [Fang, Lianying] Shandong Acad Med Sci, Radiat Med Inst, Jinan, Peoples R China; [Xu, Chang] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Nankai University	Xu, C; Liu, Q (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, 238 Baidi Rd, Tianjin, Peoples R China.; Xu, C; Liu, Q (corresponding author), Peking Union Med Coll, 238 Baidi Rd, Tianjin, Peoples R China.	xuchang@irm-cams.ac.cn; liuqiang@irm-cams.ac.cn	Liu, Qiang/AFK-6590-2022; Liu, Qiang/HHZ-3181-2022; liu, liu yang/Y-8494-2019	Liu, Qiang/0000-0002-7668-6868; Sun, Xiaohui/0000-0001-8218-1885	National Natural Science Foundation of China [31670859, 31200634]; CAMS Innovation Fund for Medical Science [2017-I2M-1-016, 2017-I2M-1-021]; Natural Science Foundation of Tianjin [15KPXM01SF056]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2016ZX310068, 2016ZX310198, 2016RC310019, 2016RC310017]; Fundamental Research Funds for the Central Universities [10023201601602]; Research Funds for the Innovation Team of IRM-CAMS Grant [1650]; PUMC Youth Fund [3332016100, 3332015101]; Fundamental Research Funds for CAMS PUMC Grant [2016ZX310074]; State Key Laboratory of Medicinal Chemical Biology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Science; Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Funds for the Innovation Team of IRM-CAMS Grant; PUMC Youth Fund; Fundamental Research Funds for CAMS PUMC Grant; State Key Laboratory of Medicinal Chemical Biology	This study was supported by National Natural Science Foundation of China Grants 31670859 and 31200634; CAMS Innovation Fund for Medical Science Grants 2017-I2M-1-016 and 2017-I2M-1-021); Natural Science Foundation of Tianjin Grant 15KPXM01SF056; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences Grants 2016ZX310068, 2016ZX310198, 2016RC310019, and 2016RC310017; Fundamental Research Funds for the Central Universities Grant 10023201601602; Research Funds for the Innovation Team of IRM-CAMS Grant 1650; PUMC Youth Fund Grants 3332016100 and 3332015101; Fundamental Research Funds for CAMS & PUMC Grant 2016ZX310074; and the State Key Laboratory of Medicinal Chemical Biology. The authors declare no conflicts of interest.	Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Berniak K, 2013, CYTOM PART A, V83, P913, DOI 10.1002/cyto.a.22327; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Cruz C, 2018, ANN ONCOL, V29, P1203, DOI 10.1093/annonc/mdy099; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; Haber JE, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700229; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Khan FA, 2017, J NUCLEIC ACIDS, V2017, DOI 10.1155/2017/6439169; Khurana S, 2015, GENES-BASEL, V6, P858, DOI 10.3390/genes6030858; Lavin MF, 2015, BIOMOLECULES, V5, P2877, DOI 10.3390/biom5042877; Lawrence KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005150; Lee J, 2013, MOL BIOL CELL, V24, P1343, DOI 10.1091/mbc.E13-01-0025; Lu LC, 2014, ADV EXP MED BIOL, V804, P129, DOI 10.1007/978-3-319-04843-7_7; Magdalou I, 2014, SEMIN CELL DEV BIOL, V30, P154, DOI 10.1016/j.semcdb.2014.04.035; Mavragani IV, 2017, CANCERS, V9, DOI 10.3390/cancers9070091; Mazouzi A, 2014, EXP CELL RES, V329, P85, DOI 10.1016/j.yexcr.2014.09.030; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Ozer O, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180018; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Sung P, 2018, J BIOL CHEM, V293, P10500, DOI 10.1074/jbc.TM118.003212; Tripathi V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03393-8; Tubbs A, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.002; Urban V, 2017, BIOPHYS CHEM, V225, P20, DOI 10.1016/j.bpc.2016.11.005; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; von Morgen P, 2018, BIOL CELL, V110, P137, DOI 10.1111/boc.201700067; Wang W., 2017, BIOMED RES INT, V2017; West SC, 2015, COLD SH Q B, V80, P103, DOI 10.1101/sqb.2015.80.027649; Xu C, 2017, BIOCHEM BIOPH RES CO, V494, P158, DOI 10.1016/j.bbrc.2017.10.062; Xue XY, 2013, J BIOL CHEM, V288, P14221, DOI 10.1074/jbc.M113.465609; Zhang TY, 2012, CELL REP, V2, P1498, DOI 10.1016/j.celrep.2012.11.002	38	6	6	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5561	5570		10.1096/fj.201802014R	http://dx.doi.org/10.1096/fj.201802014R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30676768	Bronze			2022-12-28	WOS:000462888500074
J	Huang, XR; Wu, CX; Park, YS; Long, XW; Hoang, QYQ; Liao, JL				Huang, Xiaorong; Wu, Chunxiang; Park, Yangshin; Long, Xuwei; Hoang, Quyen Q.; Liao, Jingling			The Parkinson's disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2	FASEB JOURNAL			English	Article						disease-associated mutation; monomer-dimer; GTPase activity	GTPASE ACTIVITY; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; KINASE-ACTIVITY; PROTEIN; BINDING; LOCALIZATION; NUCLEOTIDES; INSIGHTS; REVEALS; MUTANT	Parkinson disease-associated mutations within the GTPase domain Ras of complex proteins (ROC) of leucine rich repeat kinase 2 (LRRK2) result in an abnormal over-activation of its kinase domain. However, the mechanisms involved remain unclear. Recent study has shown that LRRK2 G-domain cycles between monomeric and dimeric conformations upon binding to GTP or guanosine diphosphate, and that the Parkinson's disease (PD)-associated R1441C/G/H mutations impair the G-domain monomer-dimer dynamics and trap the G-domain in a constitutive monomeric conformation. That led us to question whether other disease-associated mutations in G-domain would also affect its conformation. Here, we report that another PD-associated N1437H mutation also impairs its monomer-dimer conformational dynamics and GTPase activity. In contrast with mutations at R1441, ROCN1437H was found to be locked in a stable dimeric conformation in solution and its GTPase activity was similar to 4-fold lower than that of the wild-type. Furthermore, the N1437H mutation reduced the GTP binding affinity by similar to 2.5-fold when compared with other pathogenic G-domain mutations. Moreover, ROCN1437H was found to have a slower GTP dissociation rate, indicating that N1437H might interrupt the nucleotide exchange cycle. Taken together, our data support that conformational dynamics is important for LRRK2 GTPase activity and that the N1437H mutation impairs GTPase activity by locking the ROC domain in a persistently dimeric state.	[Huang, Xiaorong; Long, Xuwei; Liao, Jingling] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China; [Wu, Chunxiang; Park, Yangshin; Hoang, Quyen Q.; Liao, Jingling] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Park, Yangshin; Hoang, Quyen Q.] Indiana Univ, Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Park, Yangshin; Hoang, Quyen Q.] Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA; [Liao, Jingling] Wuhan Univ Sci & Technol, Sch Med, Dept Publ Hlth, Wuhan, Hubei, Peoples R China	Nanjing University of Science & Technology; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Wuhan University of Science & Technology	Liao, JL (corresponding author), Nanjing Univ Sci & Technol, Xiaolingwei 200, Nanjing 210094, Jiangsu, Peoples R China.	jingliao@iu.edu	Long, Xuwei/GLU-2908-2022; Huang, Xiaorong/GVU-4903-2022		National Nature Science Foundation of China [31500596]; Fundamental Research Funds for the Central Universities [30916011309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111639, R01GM115844] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the experimental equipment support provided by the State Key Laboratory of Natural Medicines, China Pharmaceutic University (Nanjing, China). This work was supported by grants from the National Nature Science Foundation of China (31500596), and by the Fundamental Research Funds for the Central Universities (30916011309). The authors declare no conflicts of interest.	Aasly JO, 2010, MOVEMENT DISORD, V25, P2156, DOI 10.1002/mds.23265; Nguyen APT, 2017, ADV NEUROBIOL, V14, P71, DOI 10.1007/978-3-319-49969-7_4; Atashrazm F, 2016, CLIN PHARMACOL-ADV A, V8, P177, DOI 10.2147/CPAA.S102191; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Biosa A, 2013, HUM MOL GENET, V22, P1140, DOI 10.1093/hmg/dds522; Ramirez MB, 2017, HUM MOL GENET, V26, P2747, DOI 10.1093/hmg/ddx161; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Civiero L, 2017, ADV NEUROBIOL, V14, P107, DOI 10.1007/978-3-319-49969-7_6; Cookson MR, 2017, ADV NEUROBIOL, V14, P227, DOI 10.1007/978-3-319-49969-7_12; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deyaert E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01103-4; Esteves AR, 2014, EXP NEUROL, V261, P206, DOI 10.1016/j.expneurol.2014.05.025; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Guaitoli G, 2016, P NATL ACAD SCI USA, V113, pE4357, DOI 10.1073/pnas.1523708113; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li YC, 2009, BBA-MOL BASIS DIS, V1792, P1194, DOI 10.1016/j.bbadis.2009.09.010; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Liu ZY, 2015, FASEB J, V29, DOI 10.1096/fj.15-277095; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Nixon-Abell J, 2016, BIOCHEM SOC T, V44, P1625, DOI 10.1042/BST20160240; Petsko GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-108; Puschmann A, 2012, PARKINSONISM RELAT D, V18, P332, DOI 10.1016/j.parkreldis.2011.11.019; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Wider C, 2010, NEURODEGENER DIS, V7, P175, DOI 10.1159/000289232; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zhao J, 2015, BIOCHEM J, V469, P107, DOI 10.1042/BJ20141305	35	12	13	3	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4814	4823		10.1096/fj.201802031R	http://dx.doi.org/10.1096/fj.201802031R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592623	Bronze, Green Published			2022-12-28	WOS:000462888500015
J	Papatheodorou, P; Song, S; Lopez-Urena, D; Witte, A; Marques, F; Ost, GS; Schorch, B; Chaves-Olarte, E; Aktories, K				Papatheodorou, Panagiotis; Song, Shuo; Lopez-Urena, Diana; Witte, Alexander; Marques, Felicia; Ost, Gerhard Stefan; Schorch, Bjoern; Chaves-Olarte, Esteban; Aktories, Klaus			Cytotoxicity of Clostridium difficile toxins A and B requires an active and functional SREBP-2 pathway	FASEB JOURNAL			English	Article						bacterial toxins; toxin uptake; toxin pore; toxin inhibitor; cholesterol	RECEPTOR; CELLS; IDENTIFICATION; PROTEINS; MODE; RISK	Clostridium difficile is associated with antibiotic-associated diarrhea and pseudomembranous colitis in humans. Its 2 major toxins, toxins A and B, enter host cells and inactivate GTPases of the Ras homologue/rat sarcoma family by glucosylation. Pore formation of the toxins in the endosomal membrane enables the translocation of their glucosyltransferase domain into the cytosol, and membrane cholesterol is crucial for this process. Here, we asked whether the activity of the sterol regulatory element-binding protein 2 (SREBP-2) pathway, which regulates the cholesterol content in membranes, affects the susceptibility of target cells toward toxins A and B. We show that the SREBP-2 pathway is crucial for the intoxication process of toxins A and B by using pharmacological inhibitors (PF-429242, 25-hydroxycholesterol) and cells that are specifically deficient in SREBP-2 pathway signaling. SREBP-2 pathway inhibition disturbed the cholesterol-dependent pore formation of toxin B in cellular membranes. Preincubation with the cholesterol-lowering drug simvastatin protected cells from toxin B intoxication. Inhibition of the SREBP-2 pathway was without effect when the enzyme portion of toxin B was introduced into target cells via the cell delivery property of anthrax protective antigen. Taken together, these findings allowed us to identify the SREBP-2 pathway as a suitable target for the development of antitoxin therapeutics against C. difficile toxins A and B.	[Papatheodorou, Panagiotis; Song, Shuo; Witte, Alexander; Marques, Felicia; Ost, Gerhard Stefan; Schorch, Bjoern; Aktories, Klaus] Albert Ludwigs Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Fak Med, Freiburg, Germany; [Lopez-Urena, Diana; Chaves-Olarte, Esteban] Univ Costa Rica, Fac Microbiol, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Papatheodorou, Panagiotis] Univ Klinikum Ulm, Ulm, Germany; [Song, Shuo] Southern Univ Sci & Technol, Shenzhen, Peoples R China; [Witte, Alexander] Univ Klinikum Tubingen, Tubingen, Germany	University of Freiburg; Universidad Costa Rica; Ulm University; Southern University of Science & Technology; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Papatheodorou, P (corresponding author), Univ Klinikum Ulm, Inst Pharmakol & Toxikol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	panagiotis.papatheodorou@uni-ulm.de	Aktories, Klaus/CAJ-5682-2022; song, shuo/AAO-4335-2020; Schorch, Björn/T-2522-2019	Aktories, Klaus/0000-0002-5397-0436; song, shuo/0000-0001-6224-2302; Lopez-Urena, Diana/0000-0002-2117-921X; Schorch, Bjorn/0000-0001-8311-0210; Papatheodorou, Panagiotis/0000-0003-3571-695X	Deutsche Forschungsgemeinschaft [AK6/16-4]; Centre for Biological Signaling Studies; University of Costa Rica [B7158, B8117]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre for Biological Signaling Studies; University of Costa Rica	The authors thank Ferdy van Diemen and Thijn Brummelkamp (Netherlands Cancer Institute, Amsterdam, The Netherlands) for the haploid genetic screen, Otilia Wunderlich (Universitat Freiburg) and Marlen Cordero (University of Costa Rica) for excellent technical assistance and the Joseph L. Goldstein (The University of Texas at Austin, Austin, TX, USA) and John Collier (Harvard Medical School, Boston, MA, USA) laboratories for sharing material. This work was supported by Grant AK6/16-4 from the Deutsche Forschungsgemeinschaft (to K.A. and P.P.), the Centre for Biological Signaling Studies (to K.A.), and the Vice-Presidency for Research, University of Costa Rica (Projects B7158 and B8117). The authors declare no conflicts of interest.	Aktories K, 2017, ANNU REV MICROBIOL, V71, P281, DOI 10.1146/annurev-micro-090816-093458; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; Gerhard R, 2017, CURR TOP MICROBIOL, V406, P79, DOI 10.1007/82_2016_17; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Motzkus-Feagans CA, 2012, GUT, V61, P1538, DOI 10.1136/gutjnl-2011-301378; Mullen PJ, 2016, NAT REV CANCER, V16, P718, DOI 10.1038/nrc.2016.76; Nseir W, 2013, J ANTIMICROB CHEMOTH, V68, P1889, DOI 10.1093/jac/dkt101; Papatheodorou P, 2018, ADV EXP MED BIOL, V1050, P77, DOI 10.1007/978-3-319-72799-8_6; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Saliba W, 2014, CLIN MICROBIOL INFEC, V20, P1061, DOI 10.1111/1469-0691.12672; Schorch B, 2014, P NATL ACAD SCI USA, V111, P6431, DOI 10.1073/pnas.1323790111; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169	28	7	7	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4883	4892		10.1096/fj.201801440R	http://dx.doi.org/10.1096/fj.201801440R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592645	Bronze			2022-12-28	WOS:000462888500020
J	Zhang, T; Han, WQ; Zhao, KX; Yang, WL; Lu, XY; Jia, YW; Qin, A; Qian, Y				Zhang, Tan; Han, Weiqi; Zhao, Kangxian; Yang, Wanlei; Lu, Xuanyuan; Jia, Yewei; Qin, An; Qian, Yu			Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts	FASEB JOURNAL			English	Article						natural products; bone repair; osteoclastogenesis; osteoblastogenesis; ERK signaling pathway	EXTRACELLULAR-MATRIX; HEPATIC-FIBROSIS; CATHEPSIN K; DIFFERENTIATION; INHIBITION; PATHWAYS; ERK; POPULATION; REPAIR; CELLS	Bone fracture healing is a complex, dynamic process that involves various cell types, with osteoclasts and osteoblasts playing indispensable roles. In this study, we found that psoralen, the main active ingredient in Psoralea corylifolia L. fruit extract, enhanced bone fracture healing through activation of osteoclast and osteoblast activity via the ERK signaling pathway. In detail, psoralen promoted receptor activator of nuclear factor-kappa B ligand-induced osteoclastogenesis, mRNA expression of osteoclast-specific genes, and osteoclastic bone resorption in primary bone marrow-derived macrophages. Meanwhile, psoralen induced osteogenic differentiation by promoting the mRNA expression of the osteoblast differentiation markers alkaline phosphatase, runt-related transcription factor 2, osterix, and osteocalcin. At the molecular level, psoralen preferentially activated ERK1/2 but not JNK or p38 MAPKs. Further experiments revealed that psoralen-induced osteoclast and osteoblast differentiation was abrogated by a specific inhibitor of phosphorylated ERK. In addition, psoralen accelerated bone fracture healing in a rat tibial fracture model, and the numbers of osteoclasts and osteoblasts were increased in psoralen-treated fracture callus. Taken together, our findings indicate that psoralen accelerates bone fracture healing through activation of osteoclasts and osteoblasts via ERK signaling and has potential as a novel drug in the orthopedic clinic for the treatment of bone fractures.	[Zhang, Tan; Han, Weiqi; Zhao, Kangxian; Yang, Wanlei; Lu, Xuanyuan; Jia, Yewei; Qian, Yu] Zhejiang Univ, Sch Med, Shaoxing Peoples Hosp, Dept Orthopaed, 568 Zhongxing North Rd, Shaoxing 312000, Zhejiang, Peoples R China; [Qin, An] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Orthoped Implants, Dept Orthoped,Shanghai Peoples Hosp 9, Shanghai, Peoples R China	Zhejiang University; Shanghai Jiao Tong University	Qian, Y (corresponding author), Zhejiang Univ, Sch Med, Shaoxing Peoples Hosp, Dept Orthopaed, 568 Zhongxing North Rd, Shaoxing 312000, Zhejiang, Peoples R China.	doctor120@hotmail.com		Jia, Yewei/0000-0001-5447-973X	National Natural Science Foundation of China [81871801, 81572126]; Natural Science Foundation of Zhejiang Province [LY15H060005]; Zhejiang Basic Public Welfare Research Project [LGF18H060010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Basic Public Welfare Research Project	The authors thank Wang Linxia (Shaoxing University, Zhejiang, China) for skillful molecular technical assistance. This study was funded by the National Natural Science Foundation of China (Grant 81871801), the National Natural Science Foundation of China (Grant 81572126), the Natural Science Foundation of Zhejiang Province (Grant LY15H060005), and the Zhejiang Basic Public Welfare Research Project (LGF18H060010). The authors declare no conflicts of interest.	Amin S, 2014, J BONE MINER RES, V29, P581, DOI 10.1002/jbmr.2072; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Che CT, 2016, MOLECULES, V21, DOI 10.3390/molecules21030239; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fang QL, 2018, BBA-MOL BASIS DIS, V1864, P252, DOI 10.1016/j.bbadis.2017.09.026; Gentile MA, 2014, BONE, V66, P72, DOI 10.1016/j.bone.2014.04.032; Gomez-Barrena E, 2015, BONE, V70, P93, DOI 10.1016/j.bone.2014.07.033; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Hak DJ, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2014.04.002; Han WQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36330; Hankenson KD, 2015, ADV DRUG DELIVER REV, V94, P3, DOI 10.1016/j.addr.2015.09.008; Hankenson KD, 2014, INJURY, V45, pS8, DOI 10.1016/j.injury.2014.04.003; He LH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42385; He YX, 2012, OSTEOPOROSIS INT, V23, P377, DOI 10.1007/s00198-011-1812-x; Kameda Y, 2013, J BONE MINER RES, V28, P2463, DOI 10.1002/jbmr.1989; Karvande A, 2017, J PHARM PHARMACOL, V69, P1381, DOI 10.1111/jphp.12764; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.95; Kostenuik P, 2017, J ORTHOP RES, V35, P213, DOI 10.1002/jor.23460; Li FM, 2017, EXP THER MED, V14, P2385, DOI 10.3892/etm.2017.4771; Lin X, 2016, CELL PHYSIOL BIOCHEM, V40, P1422, DOI 10.1159/000453194; Linder M, 2018, CELL DEATH DIFFER, V25, P1094, DOI 10.1038/s41418-017-0054-7; Luchetti F, 2014, J PINEAL RES, V56, P382, DOI 10.1111/jpi.12133; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Mehta S, 2015, J MED ECON, V18, P1102, DOI 10.3111/13696998.2015.1083361; Mills LA, 2017, ACTA ORTHOP, V88, P434, DOI 10.1080/17453674.2017.1321351; Oh JH, 2015, MOL CELLS, V38, P279, DOI 10.14348/molcells.2015.2340; Okada T, 2006, DIABETES, V55, P1666, DOI 10.2337/db05-1285; Pajarinen J, 2019, BIOMATERIALS, V196, P80, DOI 10.1016/j.biomaterials.2017.12.025; PARFITT AM, 1988, BONE, V9, P67, DOI 10.1016/8756-3282(88)90029-4; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Soung DY, 2013, BONE, V55, P248, DOI 10.1016/j.bone.2013.02.010; Srivastava S, 2014, BIOCHIMIE, V101, P132, DOI 10.1016/j.biochi.2014.01.005; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Tang DZ, 2011, BIOCHEM BIOPH RES CO, V405, P256, DOI 10.1016/j.bbrc.2011.01.021; Wang P, 2017, INT J BIOL SCI, V13, P996, DOI 10.7150/ijbs.19986; Wang T, 2017, J CELL PHYSIOL, V232, P913, DOI 10.1002/jcp.25641; Wong RWK, 2011, J ORTHOP RES, V29, P158, DOI 10.1002/jor.21124; Wu CY, 2013, FITOTERAPIA, V91, P205, DOI 10.1016/j.fitote.2013.09.005; Wu HB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0540-y; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xu LL, 2015, FASEB J, V29, P1143, DOI 10.1096/fj.14-254169; Yang BY, 2016, J ETHNOPHARMACOL, V191, P107, DOI 10.1016/j.jep.2016.05.017; Yang HL, 2016, BIOMATERIALS, V80, P1, DOI 10.1016/j.biomaterials.2015.11.046; Yang WL, 2018, J CELL PHYSIOL, V233, P4606, DOI 10.1002/jcp.26372; Zalli D, 2016, J BONE MINER RES, V31, P1701, DOI 10.1002/jbmr.2851; Zhai ZJ, 2014, BRIT J PHARMACOL, V171, P663, DOI 10.1111/bph.12463; Zhang XP, 2012, ACUPUNCT MED, V30, P324, DOI 10.1136/acupmed-2012-010167; Zhang ZR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060588; Zou WG, 2011, J CLIN INVEST, V121, P4383, DOI 10.1172/JCI59041	53	32	38	5	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5399	5410		10.1096/fj.201801797R	http://dx.doi.org/10.1096/fj.201801797R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702934	Bronze			2022-12-28	WOS:000462888500062
J	Zhang, X; Wang, LQ; Qiu, K; Xu, DD; Yin, JD				Zhang, Xin; Wang, Liqi; Qiu, Kai; Xu, Doudou; Yin, Jingdong			Dynamic membrane proteome of adipogenic and myogenic precursors in skeletal muscle highlights EPHA2 may promote myogenic differentiation through ERK signaling	FASEB JOURNAL			English	Article						cell membrane proteins; adipogenesis; myogenesis	STEM-CELLS; PROLIFERATION; ACTIVATION; KINASE; APOPTOSIS; FUSION; MODEL; RAP1	The balance of myogenic and adipogenic differentiation is crucial for skeletal muscle homeostasis. Given the vital role of membrane proteins (MBPs) in cell signal perception, membrane proteomics was conducted to delineate mechanisms regulating differentiation of adipogenic and myogenic precursors in skeletal muscle. Adipogenic and myogenic precursors with divergent differentiation potential were isolated from the longissimus dorsi muscle of neonatal pigs by the preplate method. A total of 85 differentially expressed MBPs (P < 0.05 and fold change 1.2 or 0.83) between 2 precursors were detected via isobaric tags for relative and absolute quantitation (iTRAQ) assay, including 67 up-regulated and 18 down-regulated in myogenic precursors. Functional enrichment analysis uncovered that myogenic and adipogenic precursors showed significant differences in cytoskeleton organization, syncytium formation, environmental information processing, and organismal systems. Furthermore, key MBPs in regulating cell differentiation were also characterized, including ITGB3, ITGAV, ITPR3, and EPHA2. Noteworthily, EPHA2 was required for myogenic differentiation, and it may promote myogenic differentiation through ERK signaling. Collectively, our study provided an insight into the distinct MBP profile between myogenic and adipogenic precursors in skeletal muscle and served as a solid basis for supporting the role of MBPs in regulating differentiation.	[Zhang, Xin; Wang, Liqi; Qiu, Kai; Xu, Doudou; Yin, Jingdong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	China Agricultural University	Yin, JD (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	yinjd@cau.edu.cn		Qiu, Kai/0000-0002-6575-5346; Zhang, Xin/0000-0003-2632-4567; Yin, Jingdong/0000-0003-4623-0568	Major Project of National Natural Science Foundation of China [31790412]; National Key R&D Program of China [2018YFD0500402]; National Natural Science Foundation of China [31672431]	Major Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the Major Project of National Natural Science Foundation of China (Grant No. 31790412), National Key R&D Program of China (Grant No. 2018YFD0500402), and National Natural Science Foundation of China (Grant No. 31672431). The authors declare no conflicts of interest.	Agley CC, 2013, J CELL SCI, V126, P5610, DOI 10.1242/jcs.132563; Alonso-Martin S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00058; Antigny F, 2014, CELL CALCIUM, V56, P513, DOI 10.1016/j.ceca.2014.10.014; Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Benoit B, 2017, NAT MED, V23, P990, DOI 10.1038/nm.4363; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brunelli S, 2007, DEV BIOL, V304, P604, DOI 10.1016/j.ydbio.2007.01.006; Castiglioni A, 2014, STEM CELL REP, V2, P92, DOI 10.1016/j.stemcr.2013.12.006; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen XF, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0770-z; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Du M, 2013, J ANIM SCI, V91, P1419, DOI 10.2527/jas.2012-5670; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Elsafadi M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.196; Feng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.462; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Hindi SM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003832; Hong HN, 2018, J CANCER RES CLIN, V144, P1649, DOI 10.1007/s00432-018-2683-8; Flamini MI, 2017, HORM CANCER-US, V8, P16, DOI 10.1007/s12672-016-0280-3; Kabbani N, 2008, PROTEOMICS, V8, P4146, DOI 10.1002/pmic.200800139; Keefe AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8087; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; Lee SJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.296; Liu HJ, 2011, FASEB J, V25, P1914, DOI 10.1096/fj.10-170449; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Michailovici I, 2014, DEVELOPMENT, V141, P2611, DOI 10.1242/dev.107078; Milanesi A, 2016, ENDOCRINOLOGY, V157, P4, DOI 10.1210/en.2015-1443; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Minami M, 2011, MOL BIOL CELL, V22, P3508, DOI 10.1091/mbc.E11-03-0183; Morandi EM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28889; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pisani DF, 2010, STEM CELLS, V28, P753, DOI 10.1002/stem.317; Pizon V, 1996, EUR J CELL BIOL, V69, P224; Pizon V, 2000, ONCOGENE, V19, P6074, DOI 10.1038/sj.onc.1203984; Qiu K, 2018, J PROTEOME RES, V17, P3853, DOI 10.1021/acs.jproteome.8b00530; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sohn J, 2015, HUM MOL GENET, V24, P3814, DOI 10.1093/hmg/ddv125; Song MY, 2004, AM J CLIN NUTR, V79, P874; Sun WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44133; Swartz ME, 2001, DEVELOPMENT, V128, P4669; Takasugi M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15728; Takegahara Y, 2014, EXP CELL RES, V324, P105, DOI 10.1016/j.yexcr.2014.03.021; Uezumi A, 2016, STEM CELL REP, V7, P263, DOI 10.1016/j.stemcr.2016.07.004; Uezumi A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00068; Xu BY, 2014, J BIOSCI BIOENG, V117, P624, DOI 10.1016/j.jbiosc.2013.10.018; Yeung F, 2013, CELL REP, V3, P1847, DOI 10.1016/j.celrep.2013.05.032; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664	54	10	12	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5495	5509		10.1096/fj.201801907R	http://dx.doi.org/10.1096/fj.201801907R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668921	Green Published, hybrid			2022-12-28	WOS:000462888500069
J	Zhou, L; Gao, W; Wang, K; Huang, Z; Zhang, L; Zhang, Z; Zhou, J; Nice, EC; Huang, CH				Zhou, Li; Gao, Wei; Wang, Kui; Huang, Zhao; Zhang, Lu; Zhang, Zhe; Zhou, Jing; Nice, Edouard C.; Huang, Canhua			Brefeldin A inhibits colorectal cancer growth by triggering Bip/Akt-regulated autophagy	FASEB JOURNAL			English	Article						cancer therapy; ER stress; autophagic flux	ER STRESS; CELL-DEATH; APOPTOSIS; MITOCHONDRIAL; STATISTICS; RESISTANCE	Colorectal cancer (CRC) is one of the most prevalent neoplastic diseases worldwide, and effective treatment remains a challenge. Here, we found that the macrolide antibiotic brefeldin A (BFA) exhibits considerable antitumor activity both in vitro and in vivo. Induction of complete autophagic flux is characterized as a key event in BFA-induced CRC suppression. Mechanistically, BFA provokes endoplasmic reticulum stress-mediated binding immunoglobulin protein (Bip) expression, leading to increased Bip/Akt interaction and resultant decreased Akt phosphorylation, thereby activating autophagy. Autophagy inhibition or Bip suppression relieves BFA-induced cell death, suggesting a key role for Bip-regulated autophagy in the antitumor properties of BFA. Moreover, BFA acts synergistically with paclitaxel or 5-fluorouracil in CRC suppression. Collectively, our study provides an important molecular basis for BFA-induced autophagy and suggests that the antibiotic BFA could be repositioned as a potential anticancer drug for CRC treatment.	[Zhou, Li; Gao, Wei; Wang, Kui; Huang, Zhao; Zhang, Lu; Zhang, Zhe; Zhou, Jing; Huang, Canhua] Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Deans Off 17,Sect 3,South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China; [Zhou, Li; Gao, Wei; Wang, Kui; Huang, Canhua] Sichuan Univ, West China Sch Basic Sci & Forens Med, Chengdu, Sichuan, Peoples R China; [Zhou, Li; Gao, Wei; Huang, Canhua] Hainan Med Univ, Affiliated Hosp 2, Dept Oncol, Haikou, Hainan, Peoples R China; [Nice, Edouard C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Sichuan University; Sichuan University; Hainan Medical University; Monash University	Huang, CH (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Deans Off 17,Sect 3,South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China.	hcanhua@scu.edu.cn	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Huang, Zhao/0000-0001-9994-2070	Chinese National Natural Science Foundation of China (NSFC) [81430071, 81790251, 81672381, 81602194]; National Key Research and Development Program of China [2016YFC1200203]	Chinese National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by grants from the Chinese National Natural Science Foundation of China (NSFC; 81430071, 81790251, 81672381, 81602194) and the National Key Research and Development Program of China (2016YFC1200203). The authors declare no conflicts of interest.	B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; de la Cruz-Morcillo MA, 2012, ONCOGENE, V31, P1073, DOI 10.1038/onc.2011.321; Dou QH, 2016, CANCER RES, V76, P4457, DOI 10.1158/0008-5472.CAN-15-2887; El-Shami K, 2015, CA-CANCER J CLIN, V65, P427, DOI 10.3322/caac.21286; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Gao M, 2014, ONCOGENE, V33, P745, DOI 10.1038/onc.2013.2; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Huang HR, 2017, BIOORG MED CHEM LETT, V27, P2286, DOI 10.1016/j.bmcl.2017.04.047; Huang YH, 2018, GUT, V67, P307, DOI 10.1136/gutjnl-2016-311909; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lee H, 2012, HUM MOL GENET, V21, P101, DOI 10.1093/hmg/ddr445; Lee SA, 2013, BASIC CLIN PHARMACOL, V113, P329, DOI 10.1111/bcpt.12107; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Moon JL, 2012, BIOCHEM BIOPH RES CO, V417, P760, DOI 10.1016/j.bbrc.2011.12.030; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Sausville E A, 1996, Cancer J Sci Am, V2, P52; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; TAMURA G, 1968, J ANTIBIOT, V21, P160, DOI 10.7164/antibiotics.21.160; Tang B, 2015, AUTOPHAGY, V11, P344, DOI 10.1080/15548627.2015.1023682; Tseng CN, 2014, MOLECULES, V19, P17464, DOI 10.3390/molecules191117464; Tseng CN, 2013, MOLECULES, V18, P10242, DOI 10.3390/molecules180910242; Wang K, 2011, AUTOPHAGY, V7, P966, DOI 10.4161/auto.7.9.15863; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang HH, 2015, CANCER LETT, V356, P781, DOI 10.1016/j.canlet.2014.10.029; Zhang ZD, 2016, GENE, V584, P75, DOI 10.1016/j.gene.2016.03.012	37	21	22	4	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5520	5534		10.1096/fj.201801983R	http://dx.doi.org/10.1096/fj.201801983R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668917				2022-12-28	WOS:000462888500071
J	Zhou, YL; Lv, MX; Li, T; Zhang, TG; Duncan, R; Wang, LY; Lu, XL				Zhou, Yilu; Lv, Mengxi; Li, Tong; Zhang, Tiange; Duncan, Randall; Wang, Liyun; Lu, X. Lucas			Spontaneous calcium signaling of cartilage cells: from spatiotemporal features to biophysical modeling	FASEB JOURNAL			English	Article						autocatalytic; threshold regulating; articular; chondrocytes; fingerprint	INTRACELLULAR CALCIUM; ARTICULAR CHONDROCYTES; INDUCED MECHANOTRANSDUCTION; EXTRACELLULAR ATP; GENE-EXPRESSION; OSCILLATIONS; RELEASE; WAVES; FLOW; CHANNELS	Intracellular calcium ([Ca2+](i)) oscillation is a fundamental signaling response of cartilage cells under mechanical loading or osmotic stress. Chondrocytes are usually considered as nonexcitable cells with no spontaneous [Ca2+](i) signaling. This study proved that chondrocytes can exhibit robust spontaneous [Ca2+](i) signaling without explicit external stimuli. The intensity of [Ca2+](i) peaks from individual chondrocytes maintain a consistent spatiotemporal pattern, acting as a unique fingerprint for each cell. Statistical analysis revealed lognormal distributions of the temporal parameters of [Ca2+](i) peaks, as well as strong linear correlations between their means and sds. Based on these statistical findings, we hypothesized that the spontaneous [Ca2+](i) peaks may result from an autocatalytic process and that [Ca2+](i) oscillation is controlled by a threshold-regulating mechanism. To test these 2 mechanisms, we established a multistage biophysical model by assuming the spontaneous [Ca2+](i) signaling of chondrocytes as a combination of deterministic and stochastic processes. The theoretical model successfully explained the lognormal distribution of the temporal parameters and the fingerprint feature of [Ca2+](i) peaks. In addition, by using antagonists for 10 pathways, we revealed that the initiation of spontaneous [Ca2+](i) peaks in chondrocytes requires the presence of extracellular Ca2+, and that the PLC-inositol 1,4,5-trisphosphate pathway, which controls the release of calcium from the endoplasmic reticulum, can affect the initiation of spontaneous [Ca2+](i) peaks in chondrocytes. The purinoceptors and transient receptor potential vanilloid 4 channels on the plasma membrane also play key roles in the spontaneous [Ca2+](i) signaling of chondrocytes. In contrast, blocking the T-type or L-type voltage-gated calcium channel promoted the spontaneous calcium signaling. This study represents a systematic effort to understand the features and initiation mechanisms of spontaneous [Ca2+](i) signaling in chondrocytes, which are critical for chondrocyte mechanobiology.	[Zhou, Yilu; Li, Tong; Zhang, Tiange; Wang, Liyun; Lu, X. Lucas] Univ Delaware, Dept Mech Engn, 130 Acad St,SPL126, Newark, DE 19716 USA; [Li, Tong] Univ Delaware, Dept Biol Sci, Newark, DC USA; [Lv, Mengxi] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DC USA; [Duncan, Randall] Dalian Univ Technol, Dept Engn Mech, Dalian, Peoples R China	University of Delaware; University of Delaware; University of Delaware; Dalian University of Technology	Lu, XL (corresponding author), Univ Delaware, Dept Mech Engn, 130 Acad St,SPL126, Newark, DE 19716 USA.	xlu@udel.edu	Lv, Mengxi/HGA-8647-2022; Duncan, Randall/AAK-3888-2020; lu, xl/HDO-8340-2022; Li, Tong/AAS-7522-2020	Li, Tong/0000-0003-3567-5908; Duncan, Randall/0000-0001-5733-6603	U.S. Department of Defense [W81XWH-13-1-0148]; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR054385]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054385] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Jie Ma (Department of Biomedical Engineering, University of Delaware) for help in analyzing calcium peak traces. This work was supported by the U.S. Department of Defense (Grant W81XWH-13-1-0148 to X.L.L.) and the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant AR054385 to L.W.). The authors declare no conflicts of interest.	Adachi T, 2009, J BIOMECH, V42, P1989, DOI 10.1016/j.jbiomech.2009.04.034; Armbruster D., 2005, NETWORKS INTERACTING, V3; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bhosale G, 2015, ANN NY ACAD SCI, V1350, P107, DOI 10.1111/nyas.12885; Bian L, 2008, J BIOMECH, V41, P1153, DOI 10.1016/j.jbiomech.2008.01.026; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Browning JA, 2004, BIORHEOLOGY, V41, P299; Bugrim AE, 1999, CELL CALCIUM, V25, P219, DOI 10.1054/ceca.1999.0027; Chao PHG, 2006, AM J PHYSIOL-CELL PH, V291, pC718, DOI 10.1152/ajpcell.00127.2005; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P167; D'Andrea P, 1998, BIOCHEM J, V329, P681, DOI 10.1042/bj3290681; Daluz H.M, 2019, FUNDAMENTALS FINGERP, Vsecond, P1; Deepak V, 2017, FASEB J, V31, P3027, DOI 10.1096/fj.201601280R; Degala S, 2011, ARCH BIOCHEM BIOPHYS, V505, P112, DOI 10.1016/j.abb.2010.08.003; Del Negro CA, 2011, J NEUROSCI, V31, P1017, DOI 10.1523/JNEUROSCI.4731-10.2011; Donahue SW, 2003, J BIOMECH, V36, P35, DOI 10.1016/S0021-9290(02)00318-4; Duncan RL, 1998, SEMIN NEPHROL, V18, P178; Dupont G, 2014, WIRES SYST BIOL MED, V6, P227, DOI 10.1002/wsbm.1261; Duszynski J, 2006, BBA-BIOENERGETICS, V1757, P380, DOI 10.1016/j.bbabio.2006.04.017; Evans J, 1996, STRAIGHT FORWARD STA, V1st; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; Fodor J, 2013, CELL CALCIUM, V54, P1, DOI 10.1016/j.ceca.2013.03.003; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; FURUYA K, 1993, PFLUG ARCH EUR J PHY, V422, P295, DOI 10.1007/BF00374284; Garcia M, 2010, J ORTHOP RES, V28, P510, DOI 10.1002/jor.21025; Godin LM, 2007, BIOMECH MODEL MECHAN, V6, P391, DOI 10.1007/s10237-006-0059-5; Gong XY, 2019, J CELL PHYSIOL, V234, P9711, DOI 10.1002/jcp.27657; Grandolfo M, 1998, J BONE MINER RES, V13, P443, DOI 10.1359/jbmr.1998.13.3.443; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Guilak F, 1999, J ORTHOPAED RES, V17, P421, DOI 10.1002/jor.1100170319; Guilak F, 2010, ANN NY ACAD SCI, V1192, P404, DOI 10.1111/j.1749-6632.2010.05389.x; Guzman-Aranguez A, 2008, EUR J PHARMACOL, V584, P72, DOI 10.1016/j.ejphar.2008.02.002; Hattori S, 2007, BIOCHEM BIOPH RES CO, V358, P99, DOI 10.1016/j.bbrc.2007.04.142; Hayes JA, 2012, P NATL ACAD SCI USA, V109, P8286, DOI 10.1073/pnas.1200912109; He Z, 2016, OSTEOARTHR CARTILAGE, V24, P892, DOI 10.1016/j.joca.2015.11.015; HENTSCHEL HGE, 1983, PHYS REV A, V28, P417, DOI 10.1103/PhysRevA.28.417; Hernjak N, 2005, BIOPHYS J, V89, P3790, DOI 10.1529/biophysj.105.065771; HOEFFDING W, 1948, DUKE MATH J, V15, P773, DOI 10.1215/S0012-7094-48-01568-3; Hung CT, 1997, AM J PHYSIOL-CELL PH, V272, pC1611, DOI 10.1152/ajpcell.1997.272.5.C1611; Huo B, 2010, CELL CALCIUM, V47, P234, DOI 10.1016/j.ceca.2009.12.005; Huo B, 2010, PHILOS T R SOC A, V368, P617, DOI 10.1098/rsta.2009.0221; Huo B, 2008, CELL MOL BIOENG, V1, P58, DOI 10.1007/s12195-008-0011-0; Jing D, 2014, FASEB J, V28, P1582, DOI 10.1096/fj.13-237578; Jung HJ, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.5; Jung HJ, 2015, BONE, V76, P88, DOI 10.1016/j.bone.2015.03.014; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Knight MM, 2009, J ANAT, V214, P275, DOI 10.1111/j.1469-7580.2008.01021.x; Kono T, 2006, CELL BIOCHEM FUNCT, V24, P103, DOI 10.1002/cbf.1304; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Kwon J, 2017, EXP NEUROBIOL, V26, P42, DOI 10.5607/en.2017.26.1.42; Lee JI, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-19; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Lewis KJ, 2017, P NATL ACAD SCI USA, V114, P11775, DOI 10.1073/pnas.1707863114; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Lopez L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00350; Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474; Lv MX, 2018, J ORTHOP RES, V36, P730, DOI 10.1002/jor.23768; Machaca K, 2011, CELL CALCIUM, V49, P323, DOI 10.1016/j.ceca.2011.05.004; Mancilla EE, 2007, J CELL BIOCHEM, V101, P389, DOI 10.1002/jcb.21183; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Matta C, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0521-4; Matta C, 2015, PFLUG ARCH EUR J PHY, V467, P429, DOI 10.1007/s00424-014-1529-8; Matta Csaba, 2013, Front Biosci (Schol Ed), V5, P305; Meister S, 2010, NEOPLASIA, V12, P550, DOI 10.1593/neo.10228; Millward-Sadler SJ, 2004, BIORHEOLOGY, V41, P567; Nguyen V, 2005, B MATH BIOL, V67, P393, DOI 10.1016/j.bulm.2004.08.010; O'Conor CJ, 2014, P NATL ACAD SCI USA, V111, P1316, DOI 10.1073/pnas.1319569111; Onimaru H, 2012, J PHYSIOL SCI, V62, P71, DOI 10.1007/s12576-011-0179-2; Parker I, 1996, CELL CALCIUM, V20, P105, DOI 10.1016/S0143-4160(96)90100-1; Parvizi J, 2002, J ORTHOPAED RES, V20, P51, DOI 10.1016/S0736-0266(01)00069-9; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Pingguan-Murphy B, 2006, J CELL PHYSIOL, V209, P389, DOI 10.1002/jcp.20747; Qusous A, 2012, GEN PHYSIOL BIOPHYS, V31, P299, DOI 10.4149/gpb_2012_035; Ralevic V, 1998, PHARMACOL REV, V50, P413; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roberts SR, 2001, J APPL PHYSIOL, V90, P1385, DOI 10.1152/jappl.2001.90.4.1385; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Rudiger S, 2014, PHYS REP, V534, P39, DOI 10.1016/j.physrep.2013.09.002; Sauer H, 2000, AM J PHYSIOL-CELL PH, V279, pC295, DOI 10.1152/ajpcell.2000.279.2.C295; SERVINVENCES M, 2017, G R, V6, DOI DOI 10.7554/ELIFE.21074; Shuai J W, 2002, Phys Rev Lett, V88, P068102; Srinivasan PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127290; Steward AJ, 2016, TISSUE ENG PT A, V22, P831, DOI [10.1089/ten.tea.2015.0047, 10.1089/ten.TEA.2015.0047]; Sun XH, 2012, BONE, V51, P860, DOI 10.1016/j.bone.2012.08.116; Sun XH, 2012, BONE, V50, P581, DOI 10.1016/j.bone.2011.12.015; TANG YH, 1994, BIOPHYS J, V67, P2223, DOI 10.1016/S0006-3495(94)80707-6; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Voets T, 2009, EMBO J, V28, P4, DOI 10.1038/emboj.2008.261; Wagenmakers EJ, 2005, J MATH PSYCHOL, V49, P195, DOI 10.1016/j.jmp.2005.02.003; Wang YL, 2007, P NATL ACAD SCI USA, V104, P15941, DOI 10.1073/pnas.0707246104; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Xu J, 2009, OSTEOARTHR CARTILAGE, V17, P397, DOI 10.1016/j.joca.2008.07.001; Yellowley CE, 1999, J CELL PHYSIOL, V180, P402, DOI 10.1002/(SICI)1097-4652(199909)180:3<402::AID-JCP11>3.0.CO;2-4; Zhou YL, 2016, ANN BIOMED ENG, V44, P1138, DOI 10.1007/s10439-015-1406-4; Zhou YL, 2015, J BIOMECH, V48, P990, DOI 10.1016/j.jbiomech.2015.02.005	102	13	13	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4675	4687		10.1096/fj.201801460R	http://dx.doi.org/10.1096/fj.201801460R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601690	Bronze, Green Published			2022-12-28	WOS:000462888500004
J	McNeill, B; Ostojic, A; Rayner, KJ; Ruel, M; Suuronen, EJ				McNeill, Brian; Ostojic, Aleksandra; Rayner, Katey J.; Ruel, Marc; Suuronen, Erik J.			Collagen biomaterial stimulates the production of extracellular vesicles containing microRNA-21 and enhances the proangiogenic function of CD34(+) cells	FASEB JOURNAL			English	Article						cell therapy; ischemia; Spry1; angiogenesis; culture preconditioning	ENDOTHELIAL PROGENITOR CELLS; CIRCULATING ANGIOGENIC CELLS; MARROW MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; STEM-CELLS; MYOCARDIAL-INFARCTION; CD34-POSITIVE CELLS; GROWTH-FACTOR; UP-REGULATION; THERAPEUTIC NEOVASCULARIZATION	CD34(+) cells are promising for revascularization therapy, but their clinical use is limited by low cell counts, poor engraftment, and reduced function after transplantation. In this study, a collagen type I biomaterial was used to expand and enhance the function of human peripheral blood CD34(+) cells, and potential underlying mechanisms were examined. Compared to the fibronectin control substrate, biomaterial-cultured CD34(+) cells from healthy donors had enhanced proliferation, migration toward VEGF, angiogenic potential, and increased secretion of CD63(+)CD81(+) extracellular vesicles (EVs). In the biomaterial-derived EVs, greater levels of the angiogenic microRNAs (miRs), miR-21 and -210, were detected. Notably, biomaterial-cultured CD34(+) cells had reduced mRNA and protein levels of Sprouty (Spry)1, which is an miR-21 target and negative regulator of endothelial cell proliferation and angiogenesis. Similar to the results of healthy donor cells, biomaterial culture increased miR-21 and -210 expression in CD34(+) cells from patients who underwent coronary artery bypass surgery, which also exhibited improved VEGF-mediated migration and angiogenic capacity. Therefore, collagen biomaterial culture may be useful for expanding the number and enhancing the function of CD34(+) cells in patients, possibly mediated through suppression of Spry1 activity by EV-derived miR-21. These results may provide a strategy to enhance the therapeutic potency of CD34(+) cells for vascular regeneration.McNeill, B., Ostojic, A., Rayner, K. J., Ruel, M., Suuronen, E. J. Collagen biomaterial stimulates the production of extracellular vesicles containing microRNA-21 and enhances the proangiogenic function of CD34(+) cells.	[McNeill, Brian; Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Heart Inst, Div Cardiac Surg, 40 Ruskin St,H5227, Ottawa, ON K1Y 4W7, Canada; [Rayner, Katey J.] Univ Ottawa, Heart Inst, Atherosclerosis Genom & Cell Biol Grp, Ottawa, ON, Canada; [Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Rayner, Katey J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa	Suuronen, EJ (corresponding author), Univ Ottawa, Heart Inst, Div Cardiac Surg, 40 Ruskin St,H5227, Ottawa, ON K1Y 4W7, Canada.	esuuronen@ottawaheart.ca			Canadian Institutes of Health Research [MOP-77536]; Ontario Research Fund for Research Excellence from the Ontario Ministry of Research and Innovation [RE07-086]; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund for Research Excellence from the Ontario Ministry of Research and Innovation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors thank C. Eren Cimenci and D. Giroux (University of Ottawa Heart Institute) for technical assistance. This work was supported by the Canadian Institutes of Health Research Grant MOP-77536 (to M.R. and E.J.S.), and by the Ontario Research Fund for Research Excellence from the Ontario Ministry of Research and Innovation (Grant RE07-086 to E.J.S.). B.M. was supported by a Research Fellowship from the Heart and Stroke Foundation of Canada. The authors declare no conflicts of interest.	Ahmadi A, 2014, BIOMATERIALS, V35, P4749, DOI 10.1016/j.biomaterials.2014.02.028; Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BENDER JG, 1991, BLOOD, V77, P2591; Benesch M, 2004, BRIT J HAEMATOL, V125, P58, DOI 10.1111/j.1365-2141.2004.04857.x; Besnier M, 2014, FASEB J, V28, P3351, DOI 10.1096/fj.13-245753; Bhatwadekar AD, 2015, DIABETES, V64, P4226, DOI 10.2337/db15-0521; Bhatwadekar AD, 2010, DIABETES, V59, P2010, DOI 10.2337/db10-0287; Chen DC, 2014, CELL TRANSPLANT, V23, P1599, DOI 10.3727/096368914X678562; Criqui MH, 2008, J AM COLL CARDIOL, V52, P1736, DOI 10.1016/j.jacc.2008.07.060; Dedobbeleer C, 2009, J CARDIOVASC PHARM, V53, P480, DOI 10.1097/FJC.0b013e3181a7b572; Eidenschink L, 2012, CYTOM PART B-CLIN CY, V82B, P18, DOI 10.1002/cyto.b.20611; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fadini GP, 2010, DIABETES CARE, V33, P1097, DOI 10.2337/dc09-1999; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Frljak S, 2018, STEM CELL TRANSL MED, V7, P168, DOI 10.1002/sctm.17-0197; Grass TM, 2006, ACTA HISTOCHEM, V108, P293, DOI 10.1016/j.acthis.2006.09.005; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gupta PK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-143; Hagikura K, 2010, INT J CARDIOL, V142, P56, DOI 10.1016/j.ijcard.2008.12.108; Hazra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079067; Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Ii M, 2006, CIRC RES, V98, P697, DOI 10.1161/01.RES.0000209948.50943.ea; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Krug S, 2012, BBA-MOL CELL RES, V1823, P789, DOI 10.1016/j.bbamcr.2012.01.006; Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09; Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011; Lee SJ, 2010, MOL CELL BIOCHEM, V338, P255, DOI 10.1007/s11010-009-0359-z; Li M, 2013, EXP CLIN TRANSPLANT, V11, P435, DOI 10.6002/ect.2012.0129; Liu B, 2014, INT J CARDIOL, V177, P764, DOI 10.1016/j.ijcard.2014.11.005; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Losordo DW, 2012, CIRC-CARDIOVASC INTE, V5, P821, DOI 10.1161/CIRCINTERVENTIONS.112.968321; Lou YL, 2012, MOL CELL BIOCHEM, V370, P45, DOI 10.1007/s11010-012-1396-6; Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]; Ludwig A, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-20; Mackie AR, 2012, CIRC RES, V111, P312, DOI 10.1161/CIRCRESAHA.112.266015; Mackie AR, 2011, TEX HEART I J, V38, P474; McNeill B, 2015, FASEB J, V29, P1198, DOI 10.1096/fj.14-261586; Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosis.2005.10.009; Mielcarek M, 2012, BLOOD, V119, P2675, DOI 10.1182/blood-2011-12-396275; Mocharla P., 2018, CIRCULATION S21, V124; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Pelus LM, 2008, CURR OPIN HEMATOL, V15, P285, DOI 10.1097/MOH.0b013e328302f43a; Pirro Matteo, 2008, Ther Adv Cardiovasc Dis, V2, P329, DOI 10.1177/1753944708094769; Quyyumi AA, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.025; Rossi F, 2010, MICROVASC RES, V80, P274, DOI 10.1016/j.mvr.2010.05.003; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; Sahoo S, 2011, CIRCULATION, V124; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Sakashita K, 2015, LEUKEMIA, V29, P606, DOI 10.1038/leu.2014.239; Salama H, 2010, WORLD J GASTROENTERO, V16, P5297, DOI 10.3748/wjg.v16.i42.5297; Scheubel RJ, 2010, INT J CARDIOL, V139, P134, DOI 10.1016/j.ijcard.2008.10.009; Taguchi A, 2008, J CEREBR BLOOD F MET, V28, P445, DOI 10.1038/sj.jcbfm.9600541; Teraa M, 2015, CIRCULATION, V131, P851, DOI 10.1161/CIRCULATIONAHA.114.012913; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Whiteley J, 2014, STEM CELL REV REP, V10, P338, DOI 10.1007/s12015-014-9496-1; Wood HB, 1997, BLOOD, V90, P2300; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zekri ARN, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0106-1; Zeng L, 2014, GENE THER, V21, P37, DOI 10.1038/gt.2013.55; Zhou Y, 2016, STEM CELLS, V34, P924, DOI 10.1002/stem.2321; Zubair AC, 2010, CYTOTHERAPY, V12, P178, DOI 10.3109/14653240903493409	77	8	8	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4166	4177		10.1096/fj.201801332R	http://dx.doi.org/10.1096/fj.201801332R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526047				2022-12-28	WOS:000459794800085
J	Park, DR; Nam, TS; Kim, YW; Bae, YS; Kim, UH				Park, Dae-Ryoung; Nam, Tae-Sik; Kim, Ye-Won; Bae, Yun Soo; Kim, Uh-Hyun			Oxidative activation of type III CD38 by NADPH oxidase-derived hydrogen peroxide in Ca2+ signaling	FASEB JOURNAL			English	Article						cADPR; ROS; LAK cells; Nox4; ADP-ribosyl cyclase	CYCLIC ADP-RIBOSE; ANGIOTENSIN-II; PROTEIN; ACID; CYCLASE; SURFACE; INTERNALIZATION; CYSTEINE; TOPOLOGY; P22PHOX	Reactive oxygen species (ROS) derived from NADPH oxidase (Nox) has been shown to activate ADP-ribosyl cyclase (ARC), which produces the Ca2+ mobilizing second messenger, cyclic ADP-ribose (cADPR). In the present study, we examined how ROS activates cluster of differentiation (CD)38, a mammalian prototype of ARC. CD38 exists in type II and III forms with opposing membrane orientation. This study showed the coexpression of type II and III CD38 in lymphokine-activated killer (LAK) cells. The catalytic site of the constitutively active type II CD38 faces the outside of the cell or the inside of early endosomes (EEs), whereas the basally inactive type III CD38 faces the cytosol. Type III CD38 interacted with Nox4/phosphorylated-p22phox (p-p22phox) in EEs of LAK cells upon IL-8 treatment. H2O2 derived from Nox4 activated type III CD38 by forming a disulfide bond between Cys164 and Cys177, resulting in increased cADPR formation. Our study identified the mechanism by which type III CD38 is activated in an immune cell (LAK), in which H2O2 generated by Nox4 oxidizes and activates type III CD38 to generate cADPR. These findings provide a novel model of cross-talk between ROS and Ca2+ signaling.Park, D.-R., Nam, T.-S., Kim, Y.-W., Bae, Y. S., Kim, U.-H. Oxidative activation of type III CD38 by NADPH oxidase-derived hydrogen peroxide in Ca2+ signaling.	[Park, Dae-Ryoung; Nam, Tae-Sik; Kim, Ye-Won; Kim, Uh-Hyun] Chonbuk Natl Univ, Med Sch, Dept Biochem, Jeonju 561182, South Korea; [Park, Dae-Ryoung; Nam, Tae-Sik; Kim, Ye-Won; Kim, Uh-Hyun] Chonbuk Natl Univ, Med Sch, Natl Creat Res Lab Ca2 Signaling Network, Jeonju, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Med Sch, Inst Cardiovasc Res, Jeonju, South Korea; [Bae, Yun Soo] Ewha Womans Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Ewha Womans University	Kim, UH (corresponding author), Chonbuk Natl Univ, Med Sch, Dept Biochem, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr			Korean National Research Foundation [2012R1A3A2026453]	Korean National Research Foundation(National Research Foundation of Korea)	The authors thank Dr. Donghee Kim (Rosalind Franklin University, North Chicago, IL, USA), and Dr. Chansu Park (Chonbuk National University) for critical reading of the manuscript. This work was supported by Korean National Research Foundation Grant 2012R1A3A2026453 (to U.-H.K.). The authors declare no conflicts of interest.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cho YS, 2000, J BIOL CHEM, V275, P1685, DOI 10.1074/jbc.275.3.1685; De Flora A, 1997, INT J BIOCHEM CELL B, V29, P1149, DOI 10.1016/S1357-2725(97)00062-9; Fellner SK, 2005, AM J PHYSIOL-RENAL, V289, pF1012, DOI 10.1152/ajprenal.00144.2005; GLICK DL, 1991, CELL REGUL, V2, P211, DOI 10.1091/mbc.2.3.211; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Gul R, 2012, AM J PHYSIOL-HEART C, V302, pH901, DOI 10.1152/ajpheart.00250.2011; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Han MK, 2002, J BIOL CHEM, V277, P5315, DOI 10.1074/jbc.M106439200; HENDERSON LM, 1993, EUR J BIOCHEM, V217, P973, DOI 10.1111/j.1432-1033.1993.tb18328.x; Heppner DE, 2016, J BIOL CHEM, V291, P23282, DOI 10.1074/jbc.M116.749028; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Kim UH, 2014, MESSENGER, V3, P6, DOI [DOI 10.1166/MSR.2014.1030, 10.1166/msr.2014.1030]; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Ohta Y, 2011, MOL CELL BIOCHEM, V352, P293, DOI 10.1007/s11010-011-0765-x; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Rah SY, 2007, J BIOL CHEM, V282, P5653, DOI 10.1074/jbc.M609478200; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Reddie KG, 2008, MOL BIOSYST, V4, P521, DOI 10.1039/b719986d; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; TOHGO A, 1994, J BIOL CHEM, V269, P28555; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001; Zhao Y. J., 2013, P 2013 FASEB SCI RES; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379; Zocchi E, 1999, FASEB J, V13, P273, DOI 10.1096/fasebj.13.2.273; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	50	12	12	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3404	3419		10.1096/fj.201800235R	http://dx.doi.org/10.1096/fj.201800235R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30452880	Bronze			2022-12-28	WOS:000459794800027
J	Sakami, S; Imanishi, Y; Palczewski, K				Sakami, Sanae; Imanishi, Yoshikazu; Palczewski, Krzysztof			Muller glia phagocytose dead photoreceptor cells in a mouse model of retinal degenerative disease	FASEB JOURNAL			English	Article						phagocytosis; rod photoreceptors; retinitis pigmentosa; rhodopsin	RETINITIS-PIGMENTOSA; MICROGLIAL RESPONSE; LIGHT; REGENERATION; IDENTIFICATION; PROLIFERATION; LOCALIZATION; PRECURSORS; MIGRATION	Retinitis pigmentosa is a devastating, blinding disorder that affects 1 in 4000 people worldwide. During the progression of the disorder, phagocytic clearance of dead photoreceptor cell bodies has a protective role by preventing additional retinal damage from accumulation of cellular debris. However, the cells responsible for the clearance remain unidentified. Taking advantage of a mouse model of retinitis pigmentosa (Rho(P23H/P23H)), we clarified the roles of Muller glia in the phagocytosis of rod photoreceptor cells. During the early stage of retinal degeneration, Muller glial cells participated in the phagocytosis of dying or dead rod photoreceptors throughout the outer nuclear layer. Nearly 50% of Muller glia engaged in phagocytosis. Among the Muller phagosomes, >90% matured into phagolysosomes. Those observations indicated that Muller glial cells are the primary contributor to phagocytosis. In contrast, macrophages migrate to the inner part of the outer nuclear layer during photoreceptor degeneration, participating in the phagocytosis of a limited population of dying or dead photoreceptor cells. In healthy retinas of wild-type mice, Muller glial cells phagocytosed cell bodies of dead rod photoreceptors albeit at a lower frequency. Taken together, the phagocytic function of Muller glia is responsible for retinal homeostasis and reorganization under normal and pathologic conditions.Sakami, S., Imanishi, Y., Palczewski, K. Muller glia phagocytose dead photoreceptor cells in a mouse model of retinal degenerative disease.	[Sakami, Sanae; Imanishi, Yoshikazu; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Palczewski, Krzysztof] Gavin Herbert Eye Inst, Irvine, CA 92697 USA	Case Western Reserve University	Imanishi, Y; Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Palczewski, K (corresponding author), Gavin Herbert Eye Inst, Irvine, CA 92697 USA.	yxi19@case.edu; kpalczew@uci.edu	Imanishi, Yoshikazu/E-8178-2010	Imanishi, Yoshikazu/0000-0003-4696-4836; Imanishi, Sanae/0000-0001-9884-2123	U.S. National Institutes of Health (NIH), National Eye Institute [EY027283, U01 EY025451, EY R24024864, R01EY028884]; NIH Office of the Director [S10OD024996]; NATIONAL EYE INSTITUTE [R24EY027283, R01EY009339, R01EY028884, U01EY025451] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	MAb 1D4B (anti-LAMP1) developed by Dr. August J. Thomas was obtained from the Developmental Studies Hybridoma Bank, created by the National Institute of Child Health and Development and maintained at the University of Iowa. The authors would like to thank Dr. Hisashi Fujioka, Director of the Electron Microscopy Core Facility at Case Western Reserve University (CWRU), for his support of our EM studies. The authors would also like to thank Dr. Eric A. Pierce and Dr. Qin Liu (Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA) for the anti-RP1 antibody, and Dr. Robert Molday (University of British Columbia, Vancouver BC, Canada) for the mAb 1D4 (anti-rhodopsin C-terminal domain). This research was supported in part by grants from the U.S. National Institutes of Health (NIH), National Eye Institute Grants EY027283 (to K.P.), U01 EY025451 (to K.P.), EY R24024864 (to K.P.), and R01EY028884 (to Y.I.). Confocal microscopy employing a Leica TCS SP2 MP and Leica TCS SP8 (supported by the NIH Office of the Director Grant S10OD024996) was conducted at the light microscopy imaging core facility at CWRU. The authors declare no conflicts of interest.	ALGVERE P, 1983, AM J OPHTHALMOL, V96, P345, DOI 10.1016/S0002-9394(14)77826-2; Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Bejarano-Escobar R, 2017, J ANAT, V231, P471, DOI 10.1111/joa.12653; Bejarano-Escobar R, 2012, J EXP BIOL, V215, P3799, DOI 10.1242/jeb.072124; Bejarano-Escobar R, 2011, DEV DYNAM, V240, P1841, DOI 10.1002/dvdy.22673; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; BURKE JM, 1982, OPHTHALMIC RES, V14, P317, DOI 10.1159/000265209; CALEY DW, 1972, AM J ANAT, V133, P179, DOI 10.1002/aja.1001330205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen YY, 2015, INVEST OPHTH VIS SCI, V56, P2553, DOI 10.1167/iovs.14-16298; Chen YY, 2014, J BIOL CHEM, V289, P9288, DOI 10.1074/jbc.M114.551713; Chiang WC, 2015, MOL NEUROBIOL, V52, P679, DOI 10.1007/s12035-014-8881-8; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; Dowling J. E., 1987, RETINA APPROACHABLE; Egensperger R, 1996, DEV BRAIN RES, V97, P1, DOI 10.1016/S0165-3806(96)00119-8; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; Francke M, 2001, J NEUROCYTOL, V30, P131, DOI 10.1023/A:1011987107034; Friedenwald JS, 1932, ARCH OPHTHALMOL-CHIC, V8, P173, DOI 10.1001/archopht.1932.00820150025003; HUGHES WF, 1979, EXP NEUROL, V66, P587, DOI 10.1016/0014-4886(79)90204-8; Jorstad NL, 2017, NATURE, V548, P103, DOI 10.1038/nature23283; KOHNO T, 1982, JPN J OPHTHALMOL, V26, P53; Koshibu A, 1978, Nippon Ganka Gakkai Zasshi, V82, P471; KUWABARA T, 1974, INVEST OPHTH VISUAL, V13, P725; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; LONG KO, 1986, EXP EYE RES, V43, P193, DOI 10.1016/S0014-4835(86)80087-2; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; MILLER B, 1986, AM J OPHTHALMOL, V102, P188, DOI 10.1016/0002-9394(86)90143-1; MORI S, 1969, J COMP NEUROL, V135, P57, DOI 10.1002/cne.901350104; Morris AC, 2005, INVEST OPHTH VIS SCI, V46, P4762, DOI 10.1167/iovs.05-0797; NISHIZONO H, 1993, TISSUE CELL, V25, P305, DOI 10.1016/0040-8166(93)90028-J; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Paquet-Durand F, 2014, ADV EXP MED BIOL, V801, P575, DOI 10.1007/978-1-4614-3209-8_73; PENFOLD PL, 1986, GRAEF ARCH CLIN EXP, V224, P549, DOI 10.1007/BF02154744; Ramon y Cajal S, 1972, STRUCTURE RETINA; Reichenbach A, 1995, PROG RETIN EYE RES, V15, P139, DOI 10.1016/1350-9462(95)00008-9; REICHENBACH A, 1995, GLIA, V13, P195, DOI 10.1002/glia.440130306; ROSENTHAL AR, 1975, AM J OPHTHALMOL, V79, P613, DOI 10.1016/0002-9394(75)90801-6; RunggerBrandle E, 1996, INVEST OPHTH VIS SCI, V37, P702; Sakami S, 2014, HUM MOL GENET, V23, P1723, DOI 10.1093/hmg/ddt561; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Santos AM, 2010, J COMP NEUROL, V518, P477, DOI 10.1002/cne.22227; SARTHY PV, 1979, BRAIN RES, V176, P208; Singh MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13537; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Vecino E, 2004, INT J DEV BIOL, V48, P965, DOI 10.1387/ijdb.041891ev; Verhoeff F H, 1930, Trans Am Ophthalmol Soc, V28, P176; WAGNER EC, 1991, EXP EYE RES, V53, P583, DOI 10.1016/0014-4835(91)90216-2; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	55	27	27	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3680	3692		10.1096/fj.201801662R	http://dx.doi.org/10.1096/fj.201801662R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30462532	Green Published, Bronze			2022-12-28	WOS:000459794800048
J	Sociali, G; Grozio, A; Caffa, I; Schuster, S; Becherini, P; Damonte, P; Sturla, L; Fresia, C; Passalacqua, M; Mazzola, F; Raffaelli, N; Garten, A; Kiess, W; Cea, M; Nencioni, A; Bruzzone, S				Sociali, Giovanna; Grozio, Alessia; Caffa, Irene; Schuster, Susanne; Becherini, Pamela; Damonte, Patrizia; Sturla, Laura; Fresia, Chiara; Passalacqua, Mario; Mazzola, Francesca; Raffaelli, Nadia; Garten, Antje; Kiess, Wieland; Cea, Michele; Nencioni, Alessio; Bruzzone, Santina			SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells	FASEB JOURNAL			English	Article						nicotinamide phosphoribosyltransferase; Sirtuin 6; nicotinamide adenine dinucleotide	NAD(+) SALVAGE PATHWAY; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDATIVE STRESS; PROMOTES; BIOSYNTHESIS; ACTIVATION; APOPTOSIS; PROTEIN; RESTRICTION; INHIBITORS	Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme in the NAD(+) salvage pathway from nicotinamide. By controlling the biosynthesis of NAD(+), NAMPT regulates the activity of NAD(+)-converting enzymes, such as CD38, poly-ADP-ribose polymerases, and sirtuins (SIRTs). SIRT6 is involved in the regulation of a wide number of metabolic processes. In this study, we investigated the ability of SIRT6 to regulate intracellular NAMPT activity and NAD(P)(H) levels. BxPC-3 cells and MCF-7 cells were engineered to overexpress a catalytically active or a catalytically inactive SIRT6 form or were engineered to silence endogenous SIRT6 expression. In SIRT6-overexpressing cells, NAD(H) levels were up-regulated, as a consequence of NAMPT activation. By immunopurification and incubation with recombinant SIRT6, NAMPT was found to be a direct substrate of SIRT6 deacetylation, with a mechanism that up-regulates NAMPT enzymatic activity. Extracellular NAMPT release was enhanced in SIRT6-silenced cells. Also glucose-6-phosphate dehydrogenase activity and NADPH levels were increased in SIRT6-overexpressing cells. Accordingly, increased SIRT6 levels reduced cancer cell susceptibility to H2O2-induced oxidative stress and to doxorubicin. Our data demonstrate that SIRT6 affects intracellular NAMPT activity, boosts NAD(P)(H) levels, and protects against oxidative stress. The use of SIRT6 inhibitors, together with agents inducing oxidative stress, may represent a promising treatment strategy in cancer.Sociali, G., Grozio, A., Caffa, I., Schuster, S., Becherini, P., Damonte, P., Sturla, L., Fresia, C., Passalacqua, M., Mazzola, F., Raffaelli, N., Garten, A., Kiess, W., Cea, M., Nencioni, A., Bruzzone, S. SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.	[Sociali, Giovanna; Grozio, Alessia; Sturla, Laura; Fresia, Chiara; Passalacqua, Mario; Bruzzone, Santina] Univ Genoa, CEBR, Dept Expt Med, Sect Biochem, Genoa, Italy; [Caffa, Irene; Becherini, Pamela; Damonte, Patrizia; Cea, Michele; Nencioni, Alessio] Univ Genoa, Dept Internal Med, Genoa, Italy; [Schuster, Susanne; Garten, Antje; Kiess, Wieland] Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig CPL, Leipzig, Germany; [Mazzola, Francesca] Polytech Univ Marche, Dept Clin Sci, Ancona, Italy; [Raffaelli, Nadia] Polytech Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Garten, Antje] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Cea, Michele; Nencioni, Alessio] San Martino Univ Hosp, Natl Inst Canc Res IST, Sci Inst Res & Healthcare IRCCS, Genoa, Italy; [Bruzzone, Santina] CNR, Inst Prot Biochem, Naples, Italy; [Grozio, Alessia] Washington Univ, Sch Med, St Louis, MO USA	University of Genoa; University of Genoa; Leipzig University; Marche Polytechnic University; Marche Polytechnic University; University of Birmingham; University of Genoa; IRCCS AOU San Martino IST; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Washington University (WUSTL)	Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Sect Biochem, Viale Benedetto XV 1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	Bruzzone, Santina/A-4264-2015; cea, Michele/K-3863-2018; Caffa, Irene/J-9835-2016; Passalacqua, Mario/W-1973-2019; Mazzola, Francesca/ADC-1197-2022; Nencioni, Alessio/K-3692-2018	Bruzzone, Santina/0000-0003-2034-3716; cea, Michele/0000-0002-1530-6729; Caffa, Irene/0000-0003-1111-9915; Passalacqua, Mario/0000-0003-2779-6259; Mazzola, Francesca/0000-0001-9140-012X; FRESIA, CHIARA MARTA/0000-0002-9177-4655; NENCIONI, ALESSIO/0000-0001-5068-8884; Gaul, Susanne/0000-0003-4780-1844; Grozio, Alessia/0000-0003-4699-3303	Italian Association for Cancer Research (AIRC) [IG AIRC 17736, GR-2011-02347192]; Athero-B-Cell Grant [FP7 GA 602114]; Pancreas Grant [GA 56986]; Fondazione Umberto Veronesi; U.S. Army, Department of Defense, Breast Cancer Research Program [BC161452P1]; 5x1000 Funds from the Hospital Policlinico San Martino, Scientific Institute for Research and Healthcare (IRCCS) for Oncology; University of Genova; Ghislieri College (Pavia, Italy)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Athero-B-Cell Grant; Pancreas Grant; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); U.S. Army, Department of Defense, Breast Cancer Research Program(United States Department of Defense); 5x1000 Funds from the Hospital Policlinico San Martino, Scientific Institute for Research and Healthcare (IRCCS) for Oncology; University of Genova; Ghislieri College (Pavia, Italy)	The authors thank Prof. Antonio De Flora (University of Genoa) for helpful discussions; Prof. Giuseppe Orsomando (Polytechnic University of Marche) for providing the plasmid pTrcHisA-NMNAT1; Prof. Shin-Ichiro Imai (Washington University, St. Louis, MO, USA) for providing the plasmids of FLAG-tagged NAMPT (WT and mutant forms K53R and K79); Prof. Greg Zipfel (Washington University) for providing the SIRT1 KO mice; and Prof. Raul Mostoslavsky (Harvard Medical School, Boston, MA, USA) for providing Sirt6<SUP>+/-</SUP> mice. This work was supported by the Italian Association for Cancer Research (AIRC) Grants IG AIRC 17736 (to A.N.) and GR-2011-02347192 (to A.N. and A. Grozio); Athero-B-Cell Grant FP7 GA 602114 (to A.N.); and Pancreas Grant GA 56986 (to A.N. and S.B.); the Fondazione Umberto Veronesi (to A.N.); U.S. Army, Department of Defense, Breast Cancer Research Program Grant BC161452P1 (to A.N.); 5x1000 Funds from the Hospital Policlinico San Martino, Scientific Institute for Research and Healthcare (IRCCS) for Oncology (to M.C. and A.N.); and the University of Genova (to S.B.). I.C. and P.D. are supported by Fondazione Umberto Veronesi. G.S. is recipient of a fellowship for young investigators granted by Ghislieri College (Pavia, Italy). The authors declare no conflicts of interest.	Audrito V, 2015, BLOOD, V125, P111, DOI 10.1182/blood-2014-07-589069; Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2010, J BIOL CHEM, V285, P21165, DOI 10.1074/jbc.M109.097964; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Buonvicino D, 2018, CELL CHEM BIOL, V25, P471, DOI 10.1016/j.chembiol.2018.01.012; Cagnetta A, 2018, HAEMATOLOGICA, V103, P80, DOI 10.3324/haematol.2017.176248; Carbone F, 2017, COMPR PHYSIOL, V7, P603, DOI 10.1002/cphy.c160029; Cea M, 2016, BLOOD, V127, P1138, DOI 10.1182/blood-2015-06-649970; Dolle C, 2013, CURR TOP MED CHEM, V13, P2907; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Fresia C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26658; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Grimley R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039847; Grolla AA, 2015, PIGM CELL MELANOMA R, V28, P718, DOI 10.1111/pcmr.12420; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Hong SM, 2016, ONCOGENE, V35, P3544, DOI 10.1038/onc.2015.415; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Lerrer B, 2016, CARCINOGENESIS, V37, P108, DOI 10.1093/carcin/bgv167; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luanpitpong S, 2012, BIOCHEM PHARMACOL, V83, P1643, DOI 10.1016/j.bcp.2012.03.010; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Ming M, 2014, CANCER RES, V74, P5925, DOI 10.1158/0008-5472.CAN-14-1308; Montecucco F, 2013, CURR DRUG TARGETS, V14, P637; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Schuster S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091045; Sociali G, 2015, EUR J MED CHEM, V102, P530, DOI 10.1016/j.ejmech.2015.08.024; Soncini D, 2014, J BIOL CHEM, V289, P34189, DOI 10.1074/jbc.M114.594721; Song TY, 2015, BIOGERONTOLOGY, V16, P789, DOI 10.1007/s10522-015-9605-9; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Tao NN, 2017, BIOCHEM BIOPH RES CO, V485, P713, DOI 10.1016/j.bbrc.2017.02.111; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Tsang WP, 2003, LIFE SCI, V73, P2047, DOI 10.1016/S0024-3205(03)00566-6; Xu SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26619; Yoon MJ, 2015, CELL METAB, V21, P706, DOI 10.1016/j.cmet.2015.04.002; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zamporlini F, 2014, FEBS J, V281, P5104, DOI 10.1111/febs.13050; Zhang NN, 2016, CELL CYCLE, V15, P1009, DOI 10.1080/15384101.2016.1152427; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zoppoli G, 2010, EXP HEMATOL, V38, P979, DOI 10.1016/j.exphem.2010.07.013	56	34	35	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3704	3717		10.1096/fj.201800321R	http://dx.doi.org/10.1096/fj.201800321R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30514106	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000459794800050
J	Boyle, AK; Rinaldi, SF; Rossi, AG; Saunders, PTK; Norman, JE				Boyle, Ashley K.; Rinaldi, Sara F.; Rossi, Adriano G.; Saunders, Philippa T. K.; Norman, Jane E.			Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models	FASEB JOURNAL			English	Article						pregnancy; preterm birth; statins; inflammation; contraction	VASCULAR SMOOTH-MUSCLE; INFLAMMATORY CYTOKINE PRODUCTION; COA REDUCTASE INHIBITOR; RHO-ASSOCIATED KINASE; NF-KAPPA-B; MURINE MODEL; ANTIINFLAMMATORY ROLE; HUMAN PARTURITION; UTERINE MYOCYTES; MOUSE MODEL	Preterm birth (PTB), the leading cause of neonatal morbidity and mortality, urgently requires novel therapeutic agents. Spontaneous PTB, resulting from preterm labor, is commonly caused by intrauterine infection/inflammation. Statins are well-established, cholesterol-lowering drugs that can reduce inflammation and inhibit vascular smooth muscle contraction. We show that simvastatin reduced the incidence of PTB in a validated intrauterine LPS-induced PTB mouse model, decreased uterine proinflammatory mRNA concentrations (IL-6, Cxcl1, and Ccl2), and reduced serum IL-6 concentration. In human myometrial cells, simvastatin reduced proinflammatory mediator mRNA and protein expression (IL-6 and IL-8) and increased anti-inflammatory cytokine mRNA expression (IL-10 and IL-13). Critically, simvastatin inhibited myometrial cell contraction, basally and during inflammation, and reduced phosphorylated myosin light chain concentration. Supplementation with mevalonate and geranylgeranyl pyrophosphate, but not farnesyl pyrophosphate, abolished these anticontractile effects, indicating that the Rho/Rho-associated protein kinase pathway is critically involved. Thus, simvastatin reduces PTB incidence in mice, inhibits myometrial contractions, and exhibits key anti-inflammatory effects, providing a rationale for investigation into the repurposing of statins to treat preterm labor in women.Boyle, A. K., Rinaldi, S. F., Rossi, A. G., Saunders, P. T. K., Norman, J. E. Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models.	[Boyle, Ashley K.; Rinaldi, Sara F.; Norman, Jane E.] Univ Edinburgh, Ctr Reprod Hlth, MRC, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland; [Rossi, Adriano G.; Saunders, Philippa T. K.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Boyle, AK (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	ashley.boyle@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; Norman, Jane/0000-0001-6031-6953	Tommy's Centre for Maternal and Fetal Health in the Medical Research Council (MRC) Centre for Reproductive Health [MR/N022556/1]; National Health Service (NHS) Research Scotland (NRS), through the Edinburgh Clinical Research Facility (CRF); MRC [MR/N022556/1, G0601481, MR/K013386/1] Funding Source: UKRI	Tommy's Centre for Maternal and Fetal Health in the Medical Research Council (MRC) Centre for Reproductive Health; National Health Service (NHS) Research Scotland (NRS), through the Edinburgh Clinical Research Facility (CRF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by and undertaken in the Tommy's Centre for Maternal and Fetal Health in the Medical Research Council (MRC) Centre for Reproductive Health (Grant MR/N022556/1). The authors also acknowledge the financial support of the National Health Service (NHS) Research Scotland (NRS), through the Edinburgh Clinical Research Facility (CRF). The authors declare no conflicts of interest.	Aguilar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009965; Ali N, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0086-5; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; [Anonymous], 1977, Acta Obstet Gynecol Scand, V56, P247; Basraon SK, 2015, AM J REPROD IMMUNOL, V74, P54, DOI 10.1111/aji.12372; Basraon SK, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.020; Bateman BT, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1035; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; BRADFUTE DL, 1994, J BIOL CHEM, V269, P6645; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Chen YL, 2016, BIOMED REP, V5, P491, DOI 10.3892/br.2016.756; Costantine M, 2016, AM J OBSTET GYNECOL, V214, pS201, DOI 10.1016/j.ajog.2015.10.399; CRANKSHAW DJ, 1994, CAN J PHYSIOL PHARM, V72, P870, DOI 10.1139/y94-123; de Sotomayor MA, 2001, EUR J PHARMACOL, V415, P217, DOI 10.1016/S0014-2999(01)00819-6; Dichtl W, 2003, ARTERIOSCL THROM VAS, V23, P58, DOI 10.1161/01.ATV.0000043456.48735.20; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Edison RJ, 2004, AM J MED GENET A, V131A, P287, DOI 10.1002/ajmg.a.30386; Gibb H, 2005, AM J MED GENET A, V135A, P230, DOI 10.1002/ajmg.a.30685; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez JM, 2014, MOL HUM REPROD, V20, P579, DOI 10.1093/molehr/gau019; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Haas DM, 2014, INT J WOMENS HEALTH, V6, P343, DOI 10.2147/IJWH.S44048; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Harrison MS, 2016, SEMIN FETAL NEONAT M, V21, P74, DOI 10.1016/j.siny.2015.12.007; Hilgendorff A, 2003, INT J CLIN PHARM TH, V41, P397; Hudson CA, 2012, MOL HUM REPROD, V18, P265, DOI 10.1093/molehr/gar078; Hutchinson JL, 2014, FASEB J, V28, P94, DOI 10.1096/fj.13-237040; Iwata A, 2012, CLIN EXP IMMUNOL, V168, P234, DOI 10.1111/j.1365-2249.2012.04564.x; Kang S, 2014, TOXICOL SCI, V138, P446, DOI 10.1093/toxsci/kfu011; Karalis DG, 2016, J CLIN LIPIDOL, V10, P1081, DOI 10.1016/j.jacl.2016.07.002; Kawahara S, 2008, DIABETES, V57, P2784, DOI 10.2337/db08-0302; Kidera Yasuhiro, 2010, J Exp Clin Cancer Res, V29, P127, DOI 10.1186/1756-9966-29-127; Kusters DM, 2012, EXPERT REV CARDIOVAS, V10, P363, DOI [10.1586/erc.11.196, 10.1586/ERC.11.196]; Kuzuya M, 2004, J CARDIOVASC PHARM, V43, P808, DOI 10.1097/00005344-200406000-00010; Lampi MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147033; Lefkou E, 2016, J CLIN INVEST, V126, P2933, DOI 10.1172/JCI86957; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Mackler AM, 2003, BIOL REPROD, V69, P1165, DOI 10.1095/biolreprod.103.015586; Makieva S, 2016, J CLIN ENDOCR METAB, V101, P1055, DOI 10.1210/jc.2015-2851; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Monga M, 1996, BIOL REPROD, V55, P427, DOI 10.1095/biolreprod55.2.427; Moran CJ, 2002, MOL HUM REPROD, V8, P196, DOI 10.1093/molehr/8.2.196; Mraiche F, 2005, BRIT J PHARMACOL, V144, P715, DOI 10.1038/sj.bjp.0706114; Nagaoka T, 2007, INVEST OPHTH VIS SCI, V48, P825, DOI 10.1167/iovs.06-0856; Najib NM, 2003, BIOPHARM DRUG DISPOS, V24, P183, DOI 10.1002/bdd.347; Nasu K, 2009, FERTIL STERIL, V92, P2097, DOI 10.1016/j.fertnstert.2009.06.055; Nurenberg G, 2012, ANAL BIOANAL CHEM, V402, P671, DOI 10.1007/s00216-011-5262-2; Pedroni SMA, 2014, BBA-MOL BASIS DIS, V1842, P107, DOI 10.1016/j.bbadis.2013.10.011; Pehlivanoglu B, 2013, J TURK-GER GYNECOL A, V14, P230, DOI 10.5152/jtgga.2013.67763; Perez-Guerrero C, 2005, PHARMACOLOGY, V74, P209, DOI 10.1159/000085957; Petersen EE, 2008, AM J MED GENET A, V146A, P2701, DOI 10.1002/ajmg.a.32493; Rajagopal SP, 2015, MOL HUM REPROD, V21, P672, DOI 10.1093/molehr/gav027; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC; Rinaldi SF, 2015, AM J PATHOL, V185, P1201, DOI 10.1016/j.ajpath.2015.01.009; Rinaldi SF, 2011, EXPERT REV CLIN IMMU, V7, P675, DOI [10.1586/ECI.11.58, 10.1586/eci.11.58]; ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/j.1749-6632.1994.tb21771.x; Samizo K, 1999, BIOCHEM BIOPH RES CO, V261, P95, DOI 10.1006/bbrc.1999.0956; Schaafsma D, 2008, AM J PHYSIOL-LUNG C, V295, pL214, DOI 10.1152/ajplung.00498.2007; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; SOMLYO AP, 1994, NATURE, V372, P812; Tanaka S, 2010, J PHARMACOL SCI, V114, P454, DOI 10.1254/jphs.10229FP; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Veillard NR, 2006, ATHEROSCLEROSIS, V188, P51, DOI 10.1016/j.atherosclerosis.2005.10.015; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Xiao HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059233; Xu HS, 2006, ARTHRITIS RHEUM-US, V54, P3441, DOI 10.1002/art.22169; Yildirim FIA, 2016, FUND CLIN PHARMACOL, V30, P96, DOI 10.1111/fcp.12173; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445; Zarek J, 2014, J OBSTET GYNAECOL CA, V36, P506, DOI 10.1016/S1701-2163(15)30565-X; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	79	18	18	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2743	2758		10.1096/fj.201801104R	http://dx.doi.org/10.1096/fj.201801104R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30312114	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000457296600097
J	Kenne, E; Rasmuson, J; Renne, T; Vieira, ML; Muller-Esterl, W; Herwald, H; Lindbom, L				Kenne, Ellinor; Rasmuson, Joel; Renne, Thomas; Vieira, Monica L.; Mueller-Esterl, Werner; Herwald, Heiko; Lindbom, Lennart			Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation	FASEB JOURNAL			English	Article						vascular permeability; bradykinin; leukocyte; degranulation	HEPARIN-BINDING PROTEIN; VASCULAR-PERMEABILITY; HANTAVIRUS INFECTION; ACTIVATION; MECHANISMS; FIBRINOGEN; RELEASE; ACCUMULATION; COMPARTMENTS; INVOLVEMENT	Neutrophil recruitment and plasma exudation are key elements in the immune response to injury or infection. Activated neutrophils stimulate opening of the endothelial barrier; however, the underlying mechanisms have remained largely unknown. In this study, we identified a pivotal role of the proinflammatory kallikrein-kinin system and consequent formation of bradykinin in neutrophil-evoked vascular leak. In mouse and hamster models of acute inflammation, inhibitors of bradykinin generation, and signaling markedly reduced plasma exudation in response to chemoattractant activation of neutrophils. The neutrophil-driven leak was likewise suppressed in mice deficient in either the bradykinin B-2 receptor or factor XII (initiator of the kallikrein-kinin system). In human endothelial cell monolayers, material secreted from activated neutrophils induced cytoskeletal rearrangement, leading to paracellular gap formation in a bradykinin-dependent manner. As a mechanistic basis, we found that a neutrophil-derived heparin-binding protein (HBP/azurocidin) displaced the bradykinin precursor high-molecular-weight kininogen from endothelial cells, thereby enabling proteolytic processing of kininogen into bradykinin by neutrophil and plasma proteases. These data provide novel insight into the signaling pathway by which neutrophils open up the endothelial barrier and identify the kallikrein-kinin system as a target for therapeutic interventions in acute inflammatory reactions.Kenne, E., Rasmuson, J., Renne, T., Vieira, M. L., Muller-Esterl, W., Herwald, H., Lindbom, L. Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation.	[Kenne, Ellinor; Rasmuson, Joel; Lindbom, Lennart] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Renne, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, Hamburg, Germany; [Vieira, Monica L.; Herwald, Heiko] Lund Univ, Dept Clin Sci, Lund, Sweden; [Vieira, Monica L.] Butantan Inst, Biotechnol Ctr, Sao Paulo, Brazil; [Mueller-Esterl, Werner] Goethe Univ, Inst Biochem 2, Frankfurt, Germany	Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; Lund University; Instituto Butantan; Goethe University Frankfurt	Lindbom, L (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	lennart.lindbom@ki.se	Vieira, Mônica/AAE-9391-2021; Kenne, Ellinor/HCH-1218-2022; Herwald, Heiko/AAN-3708-2021	Vieira, Mônica/0000-0002-4162-8086; Herwald, Heiko/0000-0002-8111-2842; Renne, Thomas/0000-0003-4594-5975	Swedish Research Council; Swedish Heart-Lung Foundation; Torsten Soderberg Foundation; Swedish Foundation for Strategic Research; Lars Hierta Memorial Fund; Alfred Osterlund Foundation; German Research Society [SFB877]; European Research Council [ERC-StG-2012-311575]; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Lars Hierta Memorial Fund; Alfred Osterlund Foundation; German Research Society(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Karolinska Institutet(Karolinska Institutet)	The authors thank Dr. Hans Flodgaard (Novo Nordisk, Bagvaerd, Denmark) for valuable advice and gift of reagents. PK inhibitor VA999026 was a kind gift of Vantia Ltd. (Southampton, United Kingdom). This work was supported by grants from the Swedish Research Council, Swedish Heart-Lung Foundation, Torsten Soderberg Foundation, Swedish Foundation for Strategic Research, Lars Hierta Memorial Fund, Alfred Osterlund Foundation, German Research Society Grant SFB877 (to T.R.), European Research Council Grant ERC-StG-2012-311575 (to T.R.), and Karolinska Institutet. The authors declare no conflicts of interest.	Antonen J, 2013, SCAND J INFECT DIS, V45, P494, DOI 10.3109/00365548.2012.755268; ARFORS KE, 1987, BLOOD, V69, P338; Bjorkqvist J, 2013, BIOL CHEM, V394, P1195, DOI 10.1515/hsz-2013-0144; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Breslin JW, 2004, AM J PHYSIOL-HEART C, V286, pH1057, DOI 10.1152/ajpheart.00841.2003; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; CAMPANELLI D, 1990, J CLIN INVEST, V85, P904, DOI 10.1172/JCI114518; DelMaschio A, 1996, J CELL BIOL, V135, P497, DOI 10.1083/jcb.135.2.497; Di Gennaro A, 2009, FASEB J, V23, P1750, DOI 10.1096/fj.08-121277; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Griesbacher T, 2002, BRIT J PHARMACOL, V137, P692, DOI 10.1038/sj.bjp.0704910; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Imamura T, 2002, BIOCHEM BIOPH RES CO, V294, P423, DOI 10.1016/S0006-291X(02)00490-4; Iversen LF, 1997, NAT STRUCT BIOL, V4, P265, DOI 10.1038/nsb0497-265; Kahn R, 2009, J IMMUNOL, V182, P7906, DOI 10.4049/jimmunol.0803624; Kaplan AP, 2014, ADV IMMUNOL, V121, P41, DOI 10.1016/B978-0-12-800100-4.00002-7; Koma T, 2014, J VIROL, V88, P7178, DOI 10.1128/JVI.00254-14; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; LOIKE JD, 1992, ANN NY ACAD SCI, V667, P163, DOI 10.1111/j.1749-6632.1992.tb51608.x; Ma T, 2012, J NEURO-ONCOL, V106, P291, DOI 10.1007/s11060-011-0685-3; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Meini S, 1996, BRIT J PHARMACOL, V117, P1619, DOI 10.1111/j.1476-5381.1996.tb15331.x; MULLERESTERL W, 1988, METHOD ENZYMOL, V163, P240; Olofsson AM, 1999, J CLIN INVEST, V104, P885, DOI 10.1172/JCI6671; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; RAUD J, 1994, HDB IMMUNOPHARMACOLO, P127; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; ROSENGREN S, 1989, MICROVASC RES, V38, P243, DOI 10.1016/0026-2862(89)90003-4; Schmaier AH, 2016, J THROMB HAEMOST, V14, P28, DOI 10.1111/jth.13194; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Stuardo M, 2004, J LEUKOCYTE BIOL, V75, P631, DOI 10.1189/jlb.1103546; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785; Taylor SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003470; Walzog B, 1999, AM J PHYSIOL-GASTR L, V276, pG1125, DOI 10.1152/ajpgi.1999.276.5.G1125; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Williams A, 2003, TRANSFUS APHER SCI, V29, P255, DOI 10.1016/S1473-0502(03)00170-8; WIRTH K, 1991, BRIT J PHARMACOL, V102, P774, DOI 10.1111/j.1476-5381.1991.tb12249.x	45	20	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2599	2609		10.1096/fj.201801329R	http://dx.doi.org/10.1096/fj.201801329R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30281335				2022-12-28	WOS:000457296600085
J	Liu, B; Li, JR; Yan, HF; Tian, DP; Li, H; Zhang, YZ; Guo, TT; Wu, XZ; Luo, WH; Zhou, YB				Liu, Bin; Li, Jiarong; Yan, Hongfei; Tian, Dongping; Li, Hui; Zhang, Yingzhan; Guo, Tingting; Wu, Xiangzhong; Luo, Wenhong; Zhou, Yingbi			TP and/or EP3 receptors mediate the vasoconstrictor and pressor responses of prostaglandin F-2 in mice and/or humans	FASEB JOURNAL			English	Article						prostanoid; cyclooxygenase; blood pressure	ENDOTHELIUM-DEPENDENT CONTRACTIONS; PROSTACYCLIN SYNTHESIS; PROSTANOID RECEPTORS; FP-RECEPTORS; AORTA; RELAXATION; EXPRESSION; INCREASES	The vasoconstrictor and/or pressor effects of prostaglandin (PG)F-2 participate in the development of vascular pathologies and limit the clinical use of the agent. This study aimed to determine the receptor types responsible for the vasoconstrictor activity of PGF(2) and whether they mediate the pressor response evoked by the prostanoid under in vivo conditions. Experiments were performed on genetically altered mice and/or on vessels from these mice or humans. Here we show that deletion of the thromboxane-prostanoid receptor (TP-/-) abolished or drastically diminished the contraction to PGF(2) in isolated mouse vessels (some of which were resistance arteries) and reduced the elevation in blood pressure evoked by the prostanoid under in vivo conditions. In accordance, TP antagonism abolished the contraction in small arteries of human omentum. Further deletion of E prostanoid receptor type 3 (EP3(-/-)) removed the PGF(2)-evoked contraction that remained in some TP-/- arteries and added to the effect of TP-/- on the elevation in blood pressure evoked by the prostanoid under in vivo conditions. In contrast, the uterine contraction to PGF(2) mediated via the F prostanoid receptor (FP) was unaltered in TP-/-/EP3(-/-) mice. These results demonstrate that the non-FP receptors TP and/or EP3 mediate the vasoconstrictor and pressor effects of PGF(2), which are still of concern under clinical conditions.Liu, B., Li, J., Yan, H., Tian, D., Li, H., Zhang, Y., Guo, T., Wu, X., Luo, W., Zhou, Y. TP and/or EP3 receptors mediate the vasoconstrictor and pressor responses of prostaglandin F-2 in mice and/or humans.	[Liu, Bin; Li, Jiarong; Zhang, Yingzhan; Guo, Tingting; Wu, Xiangzhong; Zhou, Yingbi] Shantou Univ, Coll Med, Cardiovasc Res Ctr, 22 Xin Ling Rd, Shantou 515041, Peoples R China; [Tian, Dongping] Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China; [Li, Hui; Luo, Wenhong] Shantou Univ, Coll Med, Cent Lab, Shantou, Peoples R China; [Yan, Hongfei] Shantou Univ, Coll Med, Dept Pathol, Affiliated Canc Hosp, Shantou, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University	Liu, B; Zhou, YB (corresponding author), Shantou Univ, Coll Med, Cardiovasc Res Ctr, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	bliu0210@yahoo.com; yz_sumc@163.com	li, jia/GVT-7587-2022		National Natural Science Foundation of China [81470572, 31771272, 81770678]; Department of Education under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases [2016032]; Major Research Program for Universities of Guangdong Province [2017KZDXM037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases; Major Research Program for Universities of Guangdong Province	This work was supported by National Natural Science Foundation of China Grants 81470572 and 31771272 (to Y.Z.) and 81770678 (to B.L.); Department of Education under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases Grant 2016032 (to B.L.); and Major Research Program for Universities of Guangdong Province Grant 2017KZDXM037 (to B.L.). The authors declare no conflicts of interest.	Alvarez Y, 2005, J HYPERTENS, V23, P767, DOI 10.1097/01.hjh.0000163145.12707.63; BJORO K, 1986, GYNECOL OBSTET INVES, V22, P1, DOI 10.1159/000298881; Chandraharan E, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3875; CHEN J, 1995, BRIT J PHARMACOL, V116, P3035, DOI 10.1111/j.1476-5381.1995.tb15960.x; Cirillo R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.010; Dong YL, 2000, BIOL REPROD, V62, P533, DOI 10.1095/biolreprod62.3.533; FUCHS AR, 1987, J STEROID BIOCHEM, V27, P1073, DOI 10.1016/0022-4731(87)90192-0; GILES H, 1991, BRIT J PHARMACOL, V104, P541, DOI 10.1111/j.1476-5381.1991.tb12465.x; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gross GA, 1998, P NATL ACAD SCI USA, V95, P11875, DOI 10.1073/pnas.95.20.11875; HAUGEN G, 1992, SCAND J CLIN LAB INV, V52, P141, DOI 10.3109/00365519209088778; HAYASHI S, 1985, J PHARMACOL EXP THER, V233, P628; Islam MZ, 2017, MICROVASC RES, V114, P52, DOI 10.1016/j.mvr.2017.06.001; JONES RL, 1982, BRIT J PHARMACOL, V76, P423, DOI 10.1111/j.1476-5381.1982.tb09236.x; Kawada N, 2004, AM J PHYSIOL-RENAL, V287, pF753, DOI 10.1152/ajprenal.00423.2003; KAWAI Y, 1991, AM J PHYSIOL, V260, pH1538, DOI 10.1152/ajpheart.1991.260.5.H1538; LAWRENCE RA, 1992, BRIT J PHARMACOL, V105, P817, DOI 10.1111/j.1476-5381.1992.tb09063.x; Li ZH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42167; Liu B, 2017, EUR J PHARMACOL, V813, P140, DOI 10.1016/j.ejphar.2017.08.015; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09288-w; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Liu DL, 2015, AM J PHYSIOL-HEART C, V309, pH804, DOI 10.1152/ajpheart.00150.2015; Luo WH, 2016, EUR J PHARMACOL, V780, P148, DOI 10.1016/j.ejphar.2016.03.043; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Saito O, 2003, AM J PHYSIOL-RENAL, V284, pF1164, DOI 10.1152/ajprenal.00441.2002; Sanchez T, 2006, EUR J PHARMACOL, V529, P16, DOI 10.1016/j.ejphar.2005.10.040; SENIOR J, 1992, BRIT J PHARMACOL, V107, P215, DOI 10.1111/j.1476-5381.1992.tb14489.x; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Tian XY, 2012, ANTIOXID REDOX SIGN, V16, P363, DOI 10.1089/ars.2010.3874; TODA N, 1988, J CARDIOVASC PHARM, V11, P354, DOI 10.1097/00005344-198803000-00014; Vanhoutte PM, 2011, HYPERTENSION, V57, P526, DOI 10.1161/HYPERTENSIONAHA.110.165100; Vivancos M, 2002, NITRIC OXIDE-BIOL CH, V6, P255, DOI 10.1006/niox.2001.0410; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Yu Y, 2009, P NATL ACAD SCI USA, V106, P7985, DOI 10.1073/pnas.0811834106; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005	38	11	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2451	2459		10.1096/fj.201801064RR	http://dx.doi.org/10.1096/fj.201801064RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277822				2022-12-28	WOS:000457296600073
